Psyllid ID: psy16951

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280--
Protein Sequence
MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ
Secondary Structure (PSIPRED)
cccccccHHccccccccccEEEEccEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccEEEEEEEcccccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEEEEcccccccccccccHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccccccEEEEEEEEcccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHccccccccccccccccHHHHHEEEEcccccEEEEEEEcccccccEEEEEEEcccccccHHHHHHHHHHHHHcccccEEEEEEEEccccccEEEEcccEEEEEEEEcccccHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccEEEEEccccHHHEEEcccccEEEEccccccccccccccHHccccccccccEEcccccccHHHHcccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccccccccccc
Coil and Loop (DISEMBL)
MNTMGLNLIFQMGCLcskeavyvksdKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEhhktfvhpnilplldhaltgcadpvlnsTSQVlmvlpyypkgtlandLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLlandnnpllmdlgsvaPAVVKVCGSAEAQNLQDVAAErcsmpyrapelfhvdsycvvdqrtdvwsLGCLLYAMcyfkspfdtvyergDSVALAVISgnitfpentpfpqyq
Flexible Loop (DISEMBL)
MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISgnitfpentpfpqyq
Low Complexity Region (SEG)
MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ
Disordered region (IsUnstruct)
****GLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITF**********
Disordered Region (DISOPRED)
****G*NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPEN*P*****
Disordered Region (DISEMBL)
MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ
Disordered Region (DISPRO)
**********************VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	282	2.2.26 [Sep-21-2011]
P57760	305	Serine/threonine-protein	yes	N/A	0.897	0.829	0.450	1e-64
O88697	305	Serine/threonine-protein	yes	N/A	0.897	0.829	0.454	5e-64
O75716	305	Serine/threonine-protein	yes	N/A	0.897	0.829	0.442	4e-63
Q10078	344	Serine/threonine-protein	yes	N/A	0.921	0.755	0.308	6e-37
Q12003	364	Serine/threonine-protein	yes	N/A	0.950	0.736	0.273	2e-34
Q54VV7	1126	Probable serine/threonine	yes	N/A	0.822	0.206	0.318	4e-31
Q54ET3	369	Probable serine/threonine	no	N/A	0.567	0.433	0.350	3e-23
Q9NSY1	1161	BMP-2-inducible protein k	no	N/A	0.812	0.197	0.316	3e-22
Q91Z96	1138	BMP-2-inducible protein k	no	N/A	0.812	0.201	0.312	1e-21
F1MH24	957	AP2-associated protein ki	no	N/A	0.829	0.244	0.3	2e-21

>sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus GN=Stk16 PE=2 SV=2

 Score =  246 bits (628), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 118/262 (45%), Positives = 178/262 (67%), Gaps = 9/262 (3%)

Query: 14  CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
           C+CS+  V + + +Y  V+K+GEGGFS V L+E       YALK+I+CH ++DQ +A RE
Sbjct: 6   CVCSRGTVIIDNKRYLFVQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDQEEAQRE 65

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
            + H+ F HPNIL L+ ++L         +  +  ++LP++ +GTL N++E      +++
Sbjct: 66  ADMHRLFQHPNILRLMAYSLK-----ERGAKHEAWLLLPFFKRGTLWNEIERLKDQGNFL 120

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
           +   IL + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A ++V
Sbjct: 121 TEDQILPLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIQV 177

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D 
Sbjct: 178 EGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 237

Query: 254 VYERGDSVALAVISGNITFPEN 275
           V+++GDSVALAV   +++ P++
Sbjct: 238 VFQKGDSVALAV-QNDLSIPQS 258

Membrane-associated protein kinase that phosphorylates on serine and threonine residues. In vitro substrates include DRG1, ENO1 and EIF4EBP1. Also autophosphorylates (By similarity). May be involved in secretory vesicle trafficking or intracellular signaling. May have a role in regulating stromal-epithelial interactions that occur during ductal morphogenesis in the mammary gland. May be involved in TGF-beta signaling. Able to autophosphorylate on Tyr residue; it is however unclear whether it has tyrosine-protein kinase toward other proteins.
Rattus norvegicus (taxid: 10116)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|O88697|STK16_MOUSE Serine/threonine-protein kinase 16 OS=Mus musculus GN=Stk16 PE=1 SV=3

 Score =  244 bits (623), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 119/262 (45%), Positives = 175/262 (66%), Gaps = 9/262 (3%)

Query: 14  CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
           C+CS+  V + + +Y  V+K+GEGGFS V L+E       YALK+I+CH ++DQ +A RE
Sbjct: 6   CVCSRGTVIIDNKRYLFVQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDQEEAQRE 65

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
            E H+ F HPNIL L+ ++L         +  +  ++LP++ KGTL N++E       ++
Sbjct: 66  AEMHRLFQHPNILRLMAYSLK-----ERGAKHEAWLLLPFFKKGTLWNEIERLKDQGSFL 120

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
           +   IL + L I   ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A ++V
Sbjct: 121 TEDQILPLLLGISRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIQV 177

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D 
Sbjct: 178 EGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 237

Query: 254 VYERGDSVALAVISGNITFPEN 275
           V+++GDSVALAV    ++ P++
Sbjct: 238 VFQKGDSVALAV-QNELSIPQS 258

Membrane-associated protein kinase that phosphorylates on serine and threonine residues. In vitro substrates include DRG1, ENO1 and EIF4EBP1. Also autophosphorylates (By similarity). May be involved in secretory vesicle trafficking or intracellular signaling. May have a role in regulating stromal-epithelial interactions that occur during ductal morphogenesis in the mammary gland. May be involved in TGF-beta signaling. Able to autophosphorylate on Tyr residue; it is however unclear whether it has tyrosine-protein kinase toward other proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|O75716|STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4

 Score =  241 bits (615), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 116/262 (44%), Positives = 175/262 (66%), Gaps = 9/262 (3%)

Query: 14  CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
           C+CS+  V + + +Y  ++K+GEGGFS V L+E       YALK+I+CH ++D+ +A RE
Sbjct: 6   CVCSRGTVIIDNKRYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 65

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
            + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E      +++
Sbjct: 66  ADMHRLFNHPNILRLVAYCLR-----ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 120

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
           +   IL + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A + V
Sbjct: 121 TEDQILWLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 177

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D 
Sbjct: 178 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 237

Query: 254 VYERGDSVALAVISGNITFPEN 275
           V+++GDSVALAV    ++ P++
Sbjct: 238 VFQKGDSVALAV-QNQLSIPQS 258

Membrane-associated protein kinase that phosphorylates on serine and threonine residues. In vitro substrates include DRG1, ENO1 and EIF4EBP1. Also autophosphorylates. May be involved in secretory vesicle trafficking or intracellular signaling. May have a role in regulating stromal-epithelial interactions that occur during ductal morphogenesis in the mammary gland. May be involved in TGF-beta signaling. Able to autophosphorylate on Tyr residue; it is however unclear whether it has tyrosine-protein kinase toward other proteins.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q10078|PPK13_SCHPO Serine/threonine-protein kinase ppk13 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk13 PE=3 SV=2

 Score =  154 bits (390), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 152/295 (51%), Gaps = 35/295 (11%)

Query: 15  LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIRE 73
           L   + V + +++Y I + +GEGGF+ V L+++   +K YALKKI C  G +   +A++E
Sbjct: 19  LFDNDVVCINNERYRIQKLLGEGGFAFVYLVQNVSNEKLYALKKIKCSFGNKGIKKAMKE 78

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
            ++H+ F    +L    H L   AD     +  V ++ PY+ KG++A  +    +   Y+
Sbjct: 79  ADYHRKFKSNYLLKSYTHQLVKEAD----GSEFVYILFPYFAKGSVAQVIRNCDIEGSYI 134

Query: 134 SSVDILKMFLKICEAVKVFHD-------AKP----------------------IAYAHRD 164
           S   IL     +C+A++  H+        +P                      ++Y H D
Sbjct: 135 SEKRILVWCSCLCKALQYLHENVAGDSPKQPEVNDLIMFDEPQVPQNTSNNNLVSYIHGD 194

Query: 165 LKTANVLL-ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD 223
           +K  N+LL  N    +L D GS+    +    ++EA  +QD A+E C+MP+RAPELFHV 
Sbjct: 195 IKPDNLLLHENSREIVLTDFGSICLVPIFASNNSEAIAIQDKASENCTMPFRAPELFHVK 254

Query: 224 SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPF 278
           +   + ++ D+WS GC LY + +  SPF+    +G S+ALAV +   +FP   P+
Sbjct: 255 AGSTITEKADIWSFGCTLYTIMFHASPFEREVSQGGSLALAVCNAQYSFPRKHPY 309

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q12003|ENV7_YEAST Serine/threonine-protein kinase ENV7 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=ENV7 PE=1 SV=1

 Score =  145 bits (367), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 152/329 (46%), Gaps = 61/329 (18%)

Query: 9   IFQMGCLC---SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ----------TKKRYA 55
           +FQ  C C   S   + V   +Y I   +GEGG S V L++ S+          T + YA
Sbjct: 8   LFQNLCCCRGFSDATIRVNDKRYRIQRLLGEGGMSFVYLVQLSKNSLIIDNGIATPELYA 67

Query: 56  LKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP 115
           LKKIIC   E  +  +RE+E++K F  P ++  +D  +    D     +  + +VLPYY 
Sbjct: 68  LKKIICPSVESISNGMREIENYKRFQSPYVIKSIDSQVMQEKD----GSKTIYIVLPYYS 123

Query: 116 KGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD--------------------- 154
            G+L + +  R +   ++S  + +++ L +   +   HD                     
Sbjct: 124 LGSLQDSINRRLLEGTFVSEAECVRIMLGVTRGLLCLHDPASRQDNATSRVNVDAVSMTY 183

Query: 155 ----------------------AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
                                 A  IAYAHRD+  +N+L ++D  P++ DLGS + A + 
Sbjct: 184 SDETAMLLEDTPLEMDMLSSNSAGSIAYAHRDITPSNILFSSDGLPVIGDLGSCSQADIT 243

Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +    +   LQ+   + C++PY  PEL ++    V+  + D+WSLGC  Y + +  SPF+
Sbjct: 244 IENRHQLSELQEWVNDNCTLPYTPPELLNLKLNQVLSSKVDIWSLGCTFYTLMFGISPFE 303

Query: 253 TVYE-RGDSVALAVISGNITFPENTPFPQ 280
              +  G S+  A+ +G  +FP N+ F +
Sbjct: 304 REEQIHGASLTYAINTGKYSFPRNSRFSE 332

Serine/threonine-protein kinase involved in vacuolar processing and morphology.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54VV7|Y0111_DICDI Probable serine/threonine-protein kinase DDB_G0280111 OS=Dictyostelium discoideum GN=DDB_G0280111 PE=3 SV=1

 Score =  135 bits (339), Expect = 4e-31,   Method: Composition-based stats.
 Identities = 79/248 (31%), Positives = 132/248 (53%), Gaps = 16/248 (6%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLL 89
           V++I EGGFS V L++ S T K YALK+I+    ++      E+   K    H NI+ +L
Sbjct: 19  VKQIAEGGFSYVFLVKDSNTSKHYALKRILIRDEDELKGVKHEISIMKRLTKHKNIVKIL 78

Query: 90  D-HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           D H ++        + +++ +++ Y   G L   ++ R       +  +ILK+F  ICE+
Sbjct: 79  DYHKVSD------KNNTEMFILMEYCSGGHLVEIMQKRLSSGSKFTDQEILKIFQDICES 132

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
           V   H  +P+   HRDLK  NVLL  ++    L D GS    + ++    E QN +D  +
Sbjct: 133 VAYMHSQQPLII-HRDLKVENVLLDEESGIYKLCDFGSATEEITRMKNKTEMQNAEDDIS 191

Query: 208 ERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS 267
              ++ YRAPE+       V++++ D+W+LGCLLY + ++ +PF+      DS +L +++
Sbjct: 192 RHTTLQYRAPEIVDFYRSPVINEKIDIWALGCLLYKLLFYVTPFE------DSGSLGILN 245

Query: 268 GNITFPEN 275
            N T P N
Sbjct: 246 SNYTIPPN 253

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54ET3|Y6373_DICDI Probable serine/threonine-protein kinase DDB_G0291350 OS=Dictyostelium discoideum GN=DDB_G0291350 PE=3 SV=1

 Score =  108 bits (271), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 11/171 (6%)

Query: 14  CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
           C  S +   +   KY +   +GEGGFS V L++ +   K+YALK +IC  +E    A RE
Sbjct: 8   CYPSDKTFNINGVKYTVNRILGEGGFSFVYLVKDNSNSKKYALKVMICQTQESINTAKRE 67

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL------RS 127
           +   +TF H NI+ L+DH+++  +      T +  ++LPYY  GTL + ++       + 
Sbjct: 68  INAFQTFNHENIMKLIDHSISNHS----QDTKEYRLLLPYYKDGTLQDLIDNQRTIYGKD 123

Query: 128 VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP 178
             K        L+ FLK+CEA++VFH+  P   AHRD+K  N++L N   P
Sbjct: 124 TKKPLFKEKKCLQFFLKVCEAIQVFHNHSP-PLAHRDIKPGNIVLQNLRRP 173

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9NSY1|BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2

 Score =  105 bits (262), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 21/250 (8%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPL 88
           + E + EGGFSTV L+  +    R ALK++  +   D     RE+   K    H NI+  
Sbjct: 53  LEESLAEGGFSTVFLV-RTHGGIRCALKRMYVNNMPDLNVCKREITIMKELSGHKNIVGY 111

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR-SVGKHYMSSVDILKMFLKICE 147
           LD A+   +D V     +VL+++ Y   G + N +  +   G    +  ++L++F   CE
Sbjct: 112 LDCAVNSISDNVW----EVLILMEYCRAGQVVNQMNKKLQTG---FTEPEVLQIFCDTCE 164

Query: 148 AVKVFHDAK-PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           AV   H  K PI   HRDLK  N+LL +  N +L D GS     +          +++  
Sbjct: 165 AVARLHQCKTPII--HRDLKVENILLNDGGNYVLCDFGSATNKFLNPQKDG-VNVVEEEI 221

Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI 266
            +  ++ YRAPE+ ++     +  + D+W+LGCLLY +C+F  PF      G+S  +A+ 
Sbjct: 222 KKYTTLSYRAPEMINLYGGKPITTKADIWALGCLLYKLCFFTLPF------GES-QVAIC 274

Query: 267 SGNITFPENT 276
            GN T P+N+
Sbjct: 275 DGNFTIPDNS 284

May be involved in osteoblast differentiation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91Z96|BMP2K_MOUSE BMP-2-inducible protein kinase OS=Mus musculus GN=Bmp2k PE=1 SV=1

 Score =  103 bits (258), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 127/250 (50%), Gaps = 21/250 (8%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPL 88
           + E + EGGFSTV L+  + +  R ALK++  +   D     RE+   K    H NI+  
Sbjct: 50  LEESLAEGGFSTVFLV-RTHSGIRCALKRMYVNNTPDLNICKREITIMKELSGHKNIVGY 108

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR-SVGKHYMSSVDILKMFLKICE 147
           LD A+   +D V     +VL+++ Y   G + N +  +   G    +  ++L++F   CE
Sbjct: 109 LDCAVNSISDNVW----EVLILMEYCRAGQVVNQMNKKLQTG---FTESEVLQIFCDTCE 161

Query: 148 AVKVFHDAK-PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           AV   H  K PI   HRDLK  N+LL +  N +L D GS     +          +++  
Sbjct: 162 AVARLHQCKTPII--HRDLKVENILLNDAGNYVLCDFGSATNKFLNPQKDG-VNVVEEEI 218

Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI 266
            +  ++ YRAPE+ ++     +  + D+W+LGCLLY +C+F  PF      G+S  +A+ 
Sbjct: 219 KKYTTLSYRAPEMINLYGGKPITTKADIWALGCLLYKLCFFTLPF------GES-QVAIC 271

Query: 267 SGNITFPENT 276
            G+ T P+N+
Sbjct: 272 DGSFTIPDNS 281

May be involved in osteoblast differentiation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F1MH24|AAK1_BOVIN AP2-associated protein kinase 1 OS=Bos taurus GN=AAK1 PE=1 SV=2

 Score =  102 bits (255), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 127/250 (50%), Gaps = 16/250 (6%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLD 90
           E + EGGF+ V L+  S   K  ALK++  +   D     RE++  +    H NI+  +D
Sbjct: 50  EVLAEGGFAIVFLVRTSNGMK-CALKRMFVNNEHDLQVCKREIQIMRDLSGHKNIVGYID 108

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
            ++   +        +VL+++ +   G + N +  R   +   +  ++L++F   CEAV 
Sbjct: 109 SSINSVSS---GDVWEVLILMDFCRGGQVVNLMNQRL--QTGFTENEVLQIFCDTCEAVA 163

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H  K     HRDLK  N+LL +  + +L D GS A    +   +     ++D   +  
Sbjct: 164 RLHQCK-TPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTEGVNAVEDEIKKYT 221

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNI 270
           ++ YRAPE+ ++ S  V+  + D+W+LGCLLY +CYF  PF      G+S  +A+  GN 
Sbjct: 222 TLSYRAPEMVNLYSGKVITTKADIWALGCLLYKLCYFTLPF------GES-QVAICDGNF 274

Query: 271 TFPENTPFPQ 280
           T P+N+ + Q
Sbjct: 275 TIPDNSRYSQ 284

Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	282
156547996	318	PREDICTED: serine/threonine-protein kina	0.992	0.880	0.660	1e-112
383865679	318	PREDICTED: serine/threonine-protein kina	0.992	0.880	0.65	1e-112
340724702	307	PREDICTED: serine/threonine-protein kina	0.992	0.912	0.639	1e-108
350398408	318	PREDICTED: serine/threonine-protein kina	0.992	0.880	0.635	1e-108
380021181	318	PREDICTED: serine/threonine-protein kina	0.992	0.880	0.621	1e-106
307181418	318	Serine/threonine-protein kinase 16 [Camp	0.992	0.880	0.617	1e-105
307205079	307	Serine/threonine-protein kinase 16 [Harp	0.946	0.869	0.651	1e-103
332028434	318	Serine/threonine-protein kinase 16 [Acro	0.992	0.880	0.614	1e-101
91084617	318	PREDICTED: similar to GA11523-PA [Tribol	0.992	0.880	0.589	2e-98
345485394	287	PREDICTED: serine/threonine-protein kina	0.875	0.860	0.597	6e-95

>gi|156547996|ref|XP_001605375.1| PREDICTED: serine/threonine-protein kinase 16-like isoform 1 [Nasonia vitripennis]

 Score =  411 bits (1056), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 185/280 (66%), Positives = 236/280 (84%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LIF+MGC+C+KE++ V   K+ ++E +G+GGFSTVSL+E S T K+YA+KKII
Sbjct: 1   MNSLGLSLIFKMGCICAKESITVNGKKFTVLEHLGDGGFSTVSLVEDSITHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A++E+E+H    HPN++ L+D    G ADPV+N+TS+VL+VLPYY KGTLA
Sbjct: 61  CHGPEDQRLAVKEIEYHSVVNHPNVIELVDSTHQGTADPVVNATSEVLLVLPYYHKGTLA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           ++LE R+  K YM S+DIL +FL+ICE VK FH+AKP   AHRDLKTAN++L +   P++
Sbjct: 121 HELERRAKMKEYMGSIDILNIFLQICEGVKAFHEAKPDPLAHRDLKTANIVLGDGMTPVI 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA VKVCG+  AQ+LQ++AAERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVAPARVKVCGNQAAQSLQELAAERCSMPYRAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYAMCYFKSPFDTVYERGDSVALAVIS NITFPEN P+ +
Sbjct: 241 LYAMCYFKSPFDTVYERGDSVALAVISANITFPENAPYNE 280

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383865679|ref|XP_003708300.1| PREDICTED: serine/threonine-protein kinase 16-like [Megachile rotundata]

 Score =  409 bits (1052), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 182/280 (65%), Positives = 231/280 (82%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LI +MGC+CSKE + V S  Y + E +GEGGFST+ L+E + T+K+YA+KKII
Sbjct: 1   MNSLGLSLILKMGCICSKETITVNSRNYTVREHLGEGGFSTILLVEDASTRKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A +E+E+H    HPN++  +D    G ADP++NSTS+ LMVLPYY +GT+A
Sbjct: 61  CHGLEDQRLAAKEIEYHNLVKHPNVIECIDFTYKGTADPIVNSTSEALMVLPYYHRGTIA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           N+LE R+  K YMS++DIL +FL+ICE VK FH+AKP   AHRDLKTAN++L + N P++
Sbjct: 121 NELERRARNKDYMSTIDILNIFLQICEGVKAFHEAKPEPLAHRDLKTANIVLGDGNTPVI 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA VKVCGS  AQ LQD+AAERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVAPARVKVCGSQAAQTLQDLAAERCSMPYRAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFDTVYERGDSVALAVIS NITFP++ P+ +
Sbjct: 241 LYALCYFKSPFDTVYERGDSVALAVISANITFPDDAPYNE 280

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340724702|ref|XP_003400720.1| PREDICTED: serine/threonine-protein kinase 16-like isoform 1 [Bombus terrestris]

 Score =  399 bits (1024), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 179/280 (63%), Positives = 228/280 (81%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LI +MGC+CSKE + + S KY + E +GEGGFSTV L+E + T K+YA+KKII
Sbjct: 1   MNSLGLSLILKMGCICSKETITINSRKYTVREHLGEGGFSTVLLVEDTITHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A +E+E++    HPNI+  +D    G ADP+ N+TS+VL+VLPYY +GTLA
Sbjct: 61  CHGLEDQRLAAKEIEYYNLVKHPNIIECIDSTYKGTADPIANATSEVLIVLPYYHRGTLA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           N+LE R+  K YMS++DIL +FL+ICE VK FH+  P   AHRDLKTAN++L + N P+L
Sbjct: 121 NELERRAKNKDYMSALDILNIFLQICEGVKAFHETTPEPLAHRDLKTANIVLDDGNTPIL 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA VK+CGS  AQ LQD+AAERCSMPY+APELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVAPARVKICGSQAAQTLQDLAAERCSMPYKAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFD VYERGDSVALAV+S NITFPE+ P+ +
Sbjct: 241 LYALCYFKSPFDAVYERGDSVALAVMSANITFPEDAPYTE 280

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350398408|ref|XP_003485183.1| PREDICTED: serine/threonine-protein kinase 16-like isoform 1 [Bombus impatiens]

 Score =  398 bits (1022), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 178/280 (63%), Positives = 228/280 (81%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LI +MGC+CSK+ + + S KY + E +GEGGFSTV L+E   T K+YA+KKII
Sbjct: 1   MNSLGLSLILKMGCICSKDTITINSRKYTVREHLGEGGFSTVLLVEDIMTHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A +E+E++    HPNI+  +D    G ADP+ N+TS+VL+VLPYY +GTLA
Sbjct: 61  CHGLEDQRLAAKEIEYYNLVKHPNIIECIDSTYKGTADPIANATSEVLIVLPYYHRGTLA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           N+LE R+  K YMS++DIL +FL+ICE VK FH+  P   AHRDLKTAN++L + N P+L
Sbjct: 121 NELERRARNKDYMSAIDILNIFLQICEGVKAFHETTPEPLAHRDLKTANIVLDDGNTPIL 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA VK+CGS  AQ+LQD+AAERCSMPY+APELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVAPARVKICGSQAAQSLQDLAAERCSMPYKAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFD VYERGDSVALAV+S NITFPE+ P+ +
Sbjct: 241 LYALCYFKSPFDAVYERGDSVALAVMSANITFPEDAPYTE 280

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380021181|ref|XP_003694450.1| PREDICTED: serine/threonine-protein kinase 16-like [Apis florea]

 Score =  392 bits (1006), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 174/280 (62%), Positives = 228/280 (81%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LI +MGC+CSKE + V S  Y + E +GEGGFS V L+E + T K+YA+KKII
Sbjct: 1   MNSLGLSLILKMGCICSKETITVNSRNYTVREHLGEGGFSIVLLVEDTITHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A +E+E++    HPN++  +D    G  DP++N+TS+VL++LPYY +GTLA
Sbjct: 61  CHGLEDQRLAAKEIEYYNLVKHPNVIECIDSTYKGTIDPIINATSEVLIILPYYHRGTLA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           N+LE R+  K++M ++DIL +FL+ICE VK FH+AKP   AHRDLKTAN+LL + + P++
Sbjct: 121 NELERRAKNKNHMGALDILNIFLQICEGVKAFHEAKPEPLAHRDLKTANILLDDGSIPII 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA +K+CGS  AQ LQD+AAERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVAPARIKICGSQAAQTLQDLAAERCSMPYRAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFDTVYERGDSVALAV+S NI FPE+ P+ +
Sbjct: 241 LYALCYFKSPFDTVYERGDSVALAVMSANIIFPEDAPYTE 280

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307181418|gb|EFN69013.1| Serine/threonine-protein kinase 16 [Camponotus floridanus]

 Score =  387 bits (994), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 173/280 (61%), Positives = 228/280 (81%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GLNLI ++GC+C+KE + V S KY + E +GEGGFSTV L+E   T K+YA+KKI+
Sbjct: 1   MNSLGLNLILRLGCICAKETITVNSRKYRVREHLGEGGFSTVLLVEDVVTHKKYAIKKIV 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           C+G EDQ  A+RE+E++K   HPN++  +D    G ADP+LN+TS+V +VLPYY KGT+A
Sbjct: 61  CYGSEDQQLAMREIEYYKLIKHPNVIECIDSTRIGTADPILNTTSEVFIVLPYYHKGTVA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           N+LE R+    YM+ +DIL +FL+ICE VK FH+ KP   AHRDLKTAN++L +D  P++
Sbjct: 121 NELERRARNCDYMNPIDILSIFLQICEGVKAFHEIKPEPLAHRDLKTANIVLNDDGTPII 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGS+A A V+VCG+  A+ LQD+AAERCSMPYRAPELF+V+SY +VD+RTD+WSLGC+
Sbjct: 181 MDLGSMATARVQVCGTQAARVLQDLAAERCSMPYRAPELFNVESYSMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFDTVYERGDSVALAV+S ++TFPENTP+ +
Sbjct: 241 LYALCYFKSPFDTVYERGDSVALAVMSAHVTFPENTPYNE 280

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307205079|gb|EFN83550.1| Serine/threonine-protein kinase 16 [Harpegnathos saltator]

 Score =  382 bits (980), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 174/267 (65%), Positives = 218/267 (81%)

Query: 12  MGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI 71
           MGC+C+KE V V S KY I E +GEGGFSTV L E + T K+YA+KKIICHG EDQ  A+
Sbjct: 1   MGCICAKETVTVNSRKYTIREHLGEGGFSTVFLAEDTATHKKYAIKKIICHGPEDQQLAM 60

Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
           +EVE++K   HPN++  +D A  G ADP++N+TS+VL+VLPYY +GTLA++LE R+    
Sbjct: 61  KEVEYYKQIKHPNVIKCIDSAREGAADPIVNTTSEVLIVLPYYHRGTLADELEQRAKNND 120

Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV 191
           YMS VDIL +FL+ICE VK FH+AKP   AHRDLKTAN++L++D  P++MDLGSV  A V
Sbjct: 121 YMSPVDILNIFLQICEGVKAFHEAKPEPLAHRDLKTANIVLSDDGTPVIMDLGSVTTARV 180

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +VCG+  A+ LQD+AAERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC LYA+CYFKSPF
Sbjct: 181 QVCGTQAARTLQDLAAERCSMPYRAPELFNVESYCMVDERTDIWSLGCTLYALCYFKSPF 240

Query: 252 DTVYERGDSVALAVISGNITFPENTPF 278
           DTVYERGDSVALAVIS ++TFPE  P+
Sbjct: 241 DTVYERGDSVALAVISAHVTFPEGAPY 267

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332028434|gb|EGI68477.1| Serine/threonine-protein kinase 16 [Acromyrmex echinatior]

 Score =  374 bits (961), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 172/280 (61%), Positives = 221/280 (78%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GLNLI +MGC+C+KE + + S KY +       GFSTV L+E   T K+YA+KKII
Sbjct: 1   MNSLGLNLILRMGCICTKEIITINSRKYKVCLHYVSSGFSTVLLVEDIVTHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A +EVE++K   HPN++  LD    G ADP++N+TS++L+VLPYY KGTLA
Sbjct: 61  CHGPEDQQLATKEVEYYKLIKHPNVIECLDSTCKGTADPIVNTTSEILIVLPYYHKGTLA 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           NDLE R+    YM+ +DIL +FL+ICE VK FH+AKP   AHRDLKTAN++L +   P++
Sbjct: 121 NDLERRAKNCDYMNPIDILSIFLQICEGVKAFHEAKPEPLAHRDLKTANIVLNDVGIPVI 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVA A VKVC +  A+ LQD+A ERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 181 MDLGSVATARVKVCSTQAARTLQDLATERCSMPYRAPELFNVESYCMVDERTDIWSLGCI 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           LYA+CYFKSPFDTVYERGDSVALAV+S ++ FPE+TP+ +
Sbjct: 241 LYALCYFKSPFDTVYERGDSVALAVMSAHVKFPEDTPYNE 280

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91084617|ref|XP_974511.1| PREDICTED: similar to GA11523-PA [Tribolium castaneum] gi|270008645|gb|EFA05093.1| hypothetical protein TcasGA2_TC015191 [Tribolium castaneum]

 Score =  365 bits (936), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 165/280 (58%), Positives = 217/280 (77%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN +GL++I +MGC+C++E+V V   KY + E++GEGGFSTV LIE+  TK++YALK+I+
Sbjct: 1   MNALGLSMIVKMGCICTRESVDVNGVKYVVKERLGEGGFSTVDLIENKGTKRKYALKRIL 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CH  EDQ  A+ E+ ++K   HPNI+ L+D    G AD V+N+TS+  +VLPYY +GTL 
Sbjct: 61  CHSLEDQKVAMDEISYYKKLRHPNIIELVDSTFKGTADIVVNATSEAYIVLPYYRRGTLQ 120

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           + L LRS  ++Y+   ++L++F +I +AVK  HD  P   AHRDLK  NV L  D  P+L
Sbjct: 121 DYLTLRSFNRNYLDVKEVLRLFSEISQAVKYLHDFAPEPVAHRDLKAGNVCLTEDMTPVL 180

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGS APA V+VCG+ +AQ LQD+AAERCSM YRAPELFHV+SYCV+DQRTD+WSLGCL
Sbjct: 181 MDLGSCAPAKVQVCGAQDAQKLQDLAAERCSMTYRAPELFHVESYCVIDQRTDIWSLGCL 240

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
           L+A+CYFKSP+D VYERGDSV LAVISG++ FPE+TPF +
Sbjct: 241 LFALCYFKSPYDLVYERGDSVNLAVISGSVHFPEDTPFDE 280

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345485394|ref|XP_003425260.1| PREDICTED: serine/threonine-protein kinase 16-like isoform 2 [Nasonia vitripennis]

 Score =  353 bits (905), Expect = 6e-95,   Method: Compositional matrix adjust.
 Identities = 166/278 (59%), Positives = 211/278 (75%), Gaps = 31/278 (11%)

Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           MN++GL+LIF+MGC+C+KE++ V   K+ ++E +G+GGFSTVSL+E S T K+YA+KKII
Sbjct: 1   MNSLGLSLIFKMGCICAKESITVNGKKFTVLEHLGDGGFSTVSLVEDSITHKKYAIKKII 60

Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
           CHG EDQ  A++E+E+H    HPN++ L+D    G ADPV+N+TS+VL+VLPYY      
Sbjct: 61  CHGPEDQRLAVKEIEYHSVVNHPNVIELVDSTHQGTADPVVNATSEVLLVLPYY------ 114

Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
               +R                      VK FH+AKP   AHRDLKTAN++L +   P++
Sbjct: 115 ---HVR----------------------VKAFHEAKPDPLAHRDLKTANIVLGDGMTPVI 149

Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           MDLGSVAPA VKVCG+  AQ+LQ++AAERCSMPYRAPELF+V+SYC+VD+RTD+WSLGC+
Sbjct: 150 MDLGSVAPARVKVCGNQAAQSLQELAAERCSMPYRAPELFNVESYCMVDERTDIWSLGCI 209

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPF 278
           LYAMCYFKSPFDTVYERGDSVALAVIS NITFPEN P+
Sbjct: 210 LYAMCYFKSPFDTVYERGDSVALAVISANITFPENAPY 247

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	282
FB|FBgn0037491	320	CG1227 [Drosophila melanogaste	0.992	0.875	0.485	1.5e-74
RGD|629474	305	Stk16 "serine/threonine kinase	0.893	0.826	0.456	1.7e-59
UNIPROTKB|Q2KI50	305	STK16 "Uncharacterized protein	0.904	0.836	0.446	3.5e-59
UNIPROTKB|F1SR81	305	STK16 "Uncharacterized protein	0.893	0.826	0.448	5.7e-59
MGI|MGI:1313271	305	Stk16 "serine/threonine kinase	0.893	0.826	0.460	7.3e-59
UNIPROTKB|O75716	305	STK16 "Serine/threonine-protei	0.893	0.826	0.448	2.5e-58
UNIPROTKB|E2RC53	305	STK16 "Uncharacterized protein	0.893	0.826	0.444	3.2e-58
ZFIN|ZDB-GENE-050417-102	306	stk16 "serine/threonine kinase	0.918	0.846	0.442	3.2e-58
UNIPROTKB|B8ZZN3	350	STK16 "Serine/threonine-protei	0.865	0.697	0.435	4.2e-57
UNIPROTKB|E1BYG3	305	STK16 "Uncharacterized protein	0.904	0.836	0.439	2.9e-55

FB|FBgn0037491 CG1227 [Drosophila melanogaster (taxid:7227)]

 Score = 752 (269.8 bits), Expect = 1.5e-74, P = 1.5e-74
 Identities = 137/282 (48%), Positives = 201/282 (71%)

Query:     1 MNTMGLNLIFQMGCL--CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKK 58
             M ++G  LI + GCL  C KE + +   +Y I E++  GGFS + L E++ T++ YA+K+
Sbjct:     1 MQSIGWTLIMKRGCLFSCRKETLNINGSRYTIRERLATGGFSLIDLGENASTRRSYAIKR 60

Query:    59 IICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGT 118
             I CH  +DQ  A+RE+E+ +     N++ ++D+ L G AD V+N+TS + +VLPYY  G+
Sbjct:    61 ITCHSIDDQNIALREIENCRKIDSENVIRVVDYELKGQADIVINTTSTLFIVLPYYKHGS 120

Query:   119 LANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP 178
             LA+ L+LRS  + +M    IL++FL +CE +K  H+A P+  AHRDLKTAN+ L++   P
Sbjct:   121 LADHLQLRSRKQDHMPEAQILQIFLGVCEGLKAIHEAMPVPLAHRDLKTANICLSDSFEP 180

Query:   179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG 238
             +++DLGS+  A +++ G  +AQ LQD A ER S+ YRAPELF V +YC +D+RTD+WSLG
Sbjct:   181 IIVDLGSMTEARLQIVGQTDAQRLQDEAEERSSIVYRAPELFTVKTYCTIDERTDIWSLG 240

Query:   239 CLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
             C+LYAMCYF SP+D +YERGDSVALAV+SGNI  PE++ + +
Sbjct:   241 CVLYAMCYFNSPYDPIYERGDSVALAVLSGNINIPEDSIYTE 282

GO:0004672 "protein kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0045793 "positive regulation of cell size" evidence=IGI

RGD|629474 Stk16 "serine/threonine kinase 16" [Rattus norvegicus (taxid:10116)]

 Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
 Identities = 120/263 (45%), Positives = 181/263 (68%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V + + +Y  V+K+GEGGFS V L+E       YALK+I+CH ++DQ +A RE
Sbjct:     6 CVCSRGTVIIDNKRYLFVQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDQEEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              + H+ F HPNIL L+ ++L         +  +  ++LP++ +GTL N++E L+  G ++
Sbjct:    66 ADMHRLFQHPNILRLMAYSLKE-----RGAKHEAWLLLPFFKRGTLWNEIERLKDQG-NF 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   IL + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A ++
Sbjct:   120 LTEDQILPLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIQ 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPEN 275
              V+++GDSVALAV   +++ P++
Sbjct:   237 MVFQKGDSVALAV-QNDLSIPQS 258

GO:0001077 "RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0016020 "membrane" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0071560 "cellular response to transforming growth factor beta stimulus" evidence=IDA

UNIPROTKB|Q2KI50 STK16 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 607 (218.7 bits), Expect = 3.5e-59, P = 3.5e-59
 Identities = 120/269 (44%), Positives = 181/269 (67%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  + +   +Y  + K+GEGGFS V L+E     + YALK+I+CH ++DQ +A RE
Sbjct:     6 CICSRGTLTIDHKRYLFIHKLGEGGFSFVDLVEGLHDGQFYALKRILCHEQQDQEEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E L+  G ++
Sbjct:    66 ADMHRLFHHPNILRLVAYCLRE-----RGTKHEAWLLLPFFKRGTLWNEIEKLKDKG-NF 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   I+++ L IC  ++  H AK   YAHRDLK  N+LL N+  P+LMDLGS+  A + 
Sbjct:   120 LTEEQIIRLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGNEGQPVLMDLGSMNQACIH 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPENTPFPQY 281
              V+++GDSVALAV    ++ P++   P+Y
Sbjct:   237 MVFQKGDSVALAV-QNQLSIPQS---PRY 261

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1SR81 STK16 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 605 (218.0 bits), Expect = 5.7e-59, P = 5.7e-59
 Identities = 118/263 (44%), Positives = 181/263 (68%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V + + +Y  ++K+GEGGFS V L+E  +  + YALK+I+CH ++D+ +A RE
Sbjct:     6 CVCSRGTVIIDNKRYLFIQKLGEGGFSYVDLVEGLRDGQFYALKRILCHEQQDREEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E L+  G ++
Sbjct:    66 ADMHRLFHHPNILRLVAYCLRE-----RGTKHEAWLLLPFFKRGTLWNEIEKLKDKG-NF 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   IL++ L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A + 
Sbjct:   120 LTEEQILRLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPEN 275
              V+++GDSVALAV    ++ P++
Sbjct:   237 MVFQKGDSVALAV-QNQLSVPQS 258

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1313271 Stk16 "serine/threonine kinase 16" [Mus musculus (taxid:10090)]

 Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
 Identities = 121/263 (46%), Positives = 178/263 (67%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V + + +Y  V+K+GEGGFS V L+E       YALK+I+CH ++DQ +A RE
Sbjct:     6 CVCSRGTVIIDNKRYLFVQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDQEEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              E H+ F HPNIL L+ ++L         +  +  ++LP++ KGTL N++E L+  G  +
Sbjct:    66 AEMHRLFQHPNILRLMAYSLKE-----RGAKHEAWLLLPFFKKGTLWNEIERLKDQGS-F 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   IL + L I   ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A ++
Sbjct:   120 LTEDQILPLLLGISRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIQ 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPEN 275
              V+++GDSVALAV    ++ P++
Sbjct:   237 MVFQKGDSVALAV-QNELSIPQS 258

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001077 "RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0071560 "cellular response to transforming growth factor beta stimulus" evidence=ISO

UNIPROTKB|O75716 STK16 "Serine/threonine-protein kinase 16" [Homo sapiens (taxid:9606)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 118/263 (44%), Positives = 178/263 (67%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V + + +Y  ++K+GEGGFS V L+E       YALK+I+CH ++D+ +A RE
Sbjct:     6 CVCSRGTVIIDNKRYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E L+  G ++
Sbjct:    66 ADMHRLFNHPNILRLVAYCLRE-----RGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NF 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   IL + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A + 
Sbjct:   120 LTEDQILWLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPEN 275
              V+++GDSVALAV    ++ P++
Sbjct:   237 MVFQKGDSVALAV-QNQLSIPQS 258

GO:0005524 "ATP binding" evidence=IEA

GO:0004715 "non-membrane spanning protein tyrosine kinase activity" evidence=IEA

GO:0001077 "RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA

GO:0071560 "cellular response to transforming growth factor beta stimulus" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|E2RC53 STK16 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 117/263 (44%), Positives = 179/263 (68%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V + + +Y  ++K+GEGGFS V L+E       YALK+I+CH ++D+ +A RE
Sbjct:     6 CVCSRGTVLIDNKRYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
              + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E L+  G ++
Sbjct:    66 ADMHRLFHHPNILRLVAYCLRE-----RGTKHEAWLLLPFFKRGTLWNEIERLKDKG-NF 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++   IL++ L IC  ++  H A+   YAHRDLK  N+LL ++  P+LMDLGS+  A + 
Sbjct:   120 LTEDQILQLLLGICRGLEAIH-AR--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D
Sbjct:   177 VEGSRQALALQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPEN 275
              V+++GDSVALAV    ++ P++
Sbjct:   237 MVFQKGDSVALAV-QNQLSIPQS 258

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-050417-102 stk16 "serine/threonine kinase 16" [Danio rerio (taxid:7955)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 120/271 (44%), Positives = 177/271 (65%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+ A+ + + +YY ++K+ EGGFS V L+E +   + YALK+I+CH RE + +A  E
Sbjct:     6 CICSRSAITIDNKRYYFLQKLEEGGFSYVDLVEGAHDGRFYALKRILCHDREARKEAQTE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
             VE H+ F HPN+L     +LT       +   +  ++LPY  KG++ + LE LR  G  +
Sbjct:    66 VEMHRLFNHPNVL-----SLTAYTFMERSGKCEAWLLLPYISKGSVWSVLEKLRDKGS-F 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             M    IL +   ICE +K  HD     YAHRDLK  NVLL  ++ P LMDLGS+  A ++
Sbjct:   120 MPESRILHILHGICEGLKAIHDK---GYAHRDLKPTNVLLDENDRPFLMDLGSMNKARIE 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V GS EA  +QD AA+RC++ YRAPELF+V+S+C++D+RTD+WSLGC+LY M   + P+D
Sbjct:   177 VRGSREAMTVQDWAAQRCTISYRAPELFNVESHCIIDERTDIWSLGCVLYCMMMLEGPYD 236

Query:   253 TVYERGDSVALAVISGNITFPENTPF-PQYQ 282
              ++++GDSVALAV    ++ P+   + P+ Q
Sbjct:   237 LIFQKGDSVALAV-QNPVSIPQPCSYSPELQ 266

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

UNIPROTKB|B8ZZN3 STK16 "Serine/threonine-protein kinase 16" [Homo sapiens (taxid:9606)]

 Score = 540 (195.1 bits), Expect = 4.2e-57, Sum P(2) = 4.2e-57
 Identities = 111/255 (43%), Positives = 167/255 (65%)

Query:    22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV 81
             +V  D   ++  +   GFS V L+E       YALK+I+CH ++D+ +A RE + H+ F 
Sbjct:    59 HVGDDHGPLLTPLAHSGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 118

Query:    82 HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILK 140
             HPNIL L+ + L         +  +  ++LP++ +GTL N++E L+  G ++++   IL 
Sbjct:   119 HPNILRLVAYCLRE-----RGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NFLTEDQILW 172

Query:   141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
             + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+  A + V GS +A 
Sbjct:   173 LLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 229

Query:   201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D V+++GDS
Sbjct:   230 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 289

Query:   261 VALAVISGNITFPEN 275
             VALAV    ++ P++
Sbjct:   290 VALAV-QNQLSIPQS 303

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1BYG3 STK16 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 570 (205.7 bits), Expect = 2.9e-55, P = 2.9e-55
 Identities = 117/266 (43%), Positives = 168/266 (63%)

Query:    14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIRE 73
             C+CS+  V +   +Y +++++ EGGFS V L+E  +  + YALK+I+CH +ED+  A+RE
Sbjct:     6 CVCSRGTVSLGGARYLLLQRLAEGGFSYVDLVEGLRDGRFYALKRILCHDKEDRQAALRE 65

Query:    74 VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHY 132
             VE H  F HPNIL L  H +         +  +  ++LPY   GTL +++E LR  G  +
Sbjct:    66 VEMHNLFQHPNILRLEAHCMVE-----KGAKHEAWLLLPYVKGGTLWSEVEALREKGT-F 119

Query:   133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             M    IL +   IC  ++  H      YAHRDLK  NVLL  D+ P+LMDLGS+  A ++
Sbjct:   120 MPEQRILLILRGICSGLQAIHGK---GYAHRDLKPTNVLLDEDDQPILMDLGSMNRARME 176

Query:   193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             V  S EA  +QD AA+RC++ YRAPELF V S C++D+RTD+WSLGC+LY M + + PFD
Sbjct:   177 VTNSREAMAVQDWAAQRCTISYRAPELFTVPSQCIIDERTDIWSLGCVLYCMMFGEGPFD 236

Query:   253 TVYERGDSVALAVISGNITFPENTPF 278
              ++++GDSVALAV    I  P  + +
Sbjct:   237 AIFQKGDSVALAV-QNPIAIPTTSRY 261

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005798 "Golgi-associated vesicle" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O88697	STK16_MOUSE	2, ., 7, ., 1, 0, ., 2	0.4541	0.8971	0.8295	yes	N/A
O75716	STK16_HUMAN	2, ., 7, ., 1, 0, ., 2	0.4427	0.8971	0.8295	yes	N/A
Q10078	PPK13_SCHPO	2, ., 7, ., 1, 1, ., 1	0.3084	0.9219	0.7558	yes	N/A
P57760	STK16_RAT	2, ., 7, ., 1, 0, ., 2	0.4503	0.8971	0.8295	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	282
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-38
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-19
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-14
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-13
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-08
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-07
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-05
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-04
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.001
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	0.002
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.002
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	0.003
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.003
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.003
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	0.004
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.004
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.004
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.004
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (351), Expect = 8e-40
 Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC-HGREDQAQAIREVEHHKTFVHPNIL 86
           Y I+EK+GEG F  V L    +T K  A+K I     ++D+ + +RE++  K   HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
            L D         V     ++ +V+ Y   G L + L+     +  +S  +      +I 
Sbjct: 61  RLYD---------VFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQIL 107

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD 204
            A++  H        HRDLK  N+LL  D +             VK+   G A   +  +
Sbjct: 108 SALEYLHSKG---IVHRDLKPENILLDEDGH-------------VKLADFGLARQLDPGE 151

Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                  +  Y APE+     Y    +  D+WSLG +LY +   K PF 
Sbjct: 152 KLTTFVGTPEYMAPEVLLGKGY---GKAVDIWSLGVILYELLTGKPPFP 197

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (341), Expect = 3e-38
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 28/229 (12%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPN 84
           KY I+++IG+G F  V L+      K Y LK+I       +++  A+ EV+  K   HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +                + +V+ Y   G L+  ++ +           IL  F++
Sbjct: 61  IIKYYESFEEKGK---------LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +C A+K  H  K +   HRD+K  N+ L ++    L D G     + KV       +  D
Sbjct: 112 LCLALKYLHSRKIL---HRDIKPQNIFLTSNGLVKLGDFG-----ISKV-----LSSTVD 158

Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +A      P Y +PEL     Y   + ++D+WSLGC+LY +C  K PF+
Sbjct: 159 LAKTVVGTPYYLSPELCQNKPY---NYKSDIWSLGCVLYELCTLKHPFE 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  132 bits (334), Expect = 8e-38
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 30/219 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-REVEHHKTFVHPNILPLLDHA 92
           +GEGGF TV L    +T K+ A+K I         + + RE+E  K   HPNI+ L    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG-- 58

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
                  V    + + +V+ Y   G+L    +L    +  +S  +IL++ L+I E ++  
Sbjct: 59  -------VFEDENHLYLVMEYCEGGSL---KDLLKENEGKLSEDEILRILLQILEGLEYL 108

Query: 153 HDAKPIAYAHRDLKTANVLLANDN-NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC- 210
           H        HRDLK  N+LL +DN    L D G           S    + + +      
Sbjct: 109 HSNG---IIHRDLKPENILLDSDNGKVKLADFGL----------SKLLTSDKSLLKTIVG 155

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  Y APE+     Y    +++D+WSLG +LY +   K 
Sbjct: 156 TPAYMAPEVLLGKGYY--SEKSDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  124 bits (314), Expect = 2e-34
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 29/227 (12%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNI 85
           Y ++ K+G G F TV   +H  T K  A+K +     +      A RE+   +   HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L+D                + +V+ Y   G L  D   R      +S  +  K+ L+I
Sbjct: 61  VRLID---------AFEDKDHLYLVMEYCEGGDLF-DYLSRGGP---LSEDEAKKIALQI 107

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              ++  H    I   HRDLK  N+LL  +    + D G    A   +  S+        
Sbjct: 108 LRGLEYLHSNGII---HRDLKPENILLDENGVVKIADFGL---AKKLLKSSSSLTTF--- 158

Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                +  Y APE+    +      + DVWSLG +LY +   K PF 
Sbjct: 159 ---VGTPWYMAPEVLLGGNG--YGPKVDVWSLGVILYELLTGKPPFS 200

Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (266), Expect = 1e-26
 Identities = 60/253 (23%), Positives = 99/253 (39%), Gaps = 24/253 (9%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC---HGREDQAQAIREVEHHKTFVHP-NI 85
           I+ K+GEG F  V L      +K  ALK +        ++  + +RE++   +  HP NI
Sbjct: 4   ILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L D                + +V+ Y   G+L  DL  +   K  +S  + L +  +I
Sbjct: 61  VKLYD---------FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQI 110

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLL-ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             A++  H    I   HRD+K  N+LL  +     L+D G    A +     + +     
Sbjct: 111 LSALEYLHSKGII---HRDIKPENILLDRDGRVVKLIDFGL---AKLLPDPGSTSSIPAL 164

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA 264
            +    +  Y APE+    S       +D+WSLG  LY +     PF+       +    
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224

Query: 265 VISGNITFPENTP 277
            I   +  P    
Sbjct: 225 KIILELPTPSLAS 237

Length = 384

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 98.7 bits (246), Expect = 1e-24
 Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 30/226 (13%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--AQAIREVEHHKTFVHPNILP 87
           +++K+G+G + +V  ++     + YALK++       +    A+ E+    +  HPNI+ 
Sbjct: 4   VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS 63

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
             +  L G          ++ +V+ Y P G L+  +  R   +  +   +I ++F+++  
Sbjct: 64  YKEAFLDGN---------KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            ++  H+ K +   HRDLK+AN+LL  ++   + DLG     + KV      +N+   A 
Sbjct: 115 GLQALHEQKIL---HRDLKSANILLVANDLVKIGDLG-----ISKVL----KKNM---AK 159

Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            +   P Y APE++    Y     ++D+WSLGCLLY M  F  PF+
Sbjct: 160 TQIGTPHYMAPEVWKGRPY---SYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.7 bits (231), Expect = 3e-22
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 29/232 (12%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHP 83
            Y ++E IG+G F TV  +      K    K+ I +G   +    Q + EV   +   HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKE-IDYGNMTEKEKQQLVSEVNILRELKHP 59

Query: 84  NILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           NI+   D         +++ ++Q L +V+ Y   G LA  ++     + Y+    I ++ 
Sbjct: 60  NIVRYYDR--------IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111

Query: 143 LKICEAVKVFHDAKPIAYA--HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
            ++  A+   H+         HRDLK AN+ L  +NN  L D G     + K+ G     
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG-----LAKILGHD--- 163

Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                A      P Y +PE  +  SY   D+++D+WSLGCL+Y +C    PF
Sbjct: 164 --SSFAKTYVGTPYYMSPEQLNHMSY---DEKSDIWSLGCLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 68/229 (29%), Positives = 98/229 (42%), Gaps = 22/229 (9%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--QAIREVEHHKTFV 81
           K   Y I+ K+GEG F  V      +T +  ALKKI+ H  +D     A+RE++  K   
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN++PL+D A+    D        V MV PY     L+  LE  SV    ++   I   
Sbjct: 66  HPNVVPLIDMAVER-PDKSKRKRGSVYMVTPYM-DHDLSGLLENPSV---KLTESQIKCY 120

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV-----APAVVKVCGS 196
            L++ E +   H+       HRD+K AN+L+ N     + D G        P   K  G 
Sbjct: 121 MLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 197 AEAQNLQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAM 244
              +   ++   R    YR PEL      Y       D+W +GC+   M
Sbjct: 178 GGTRKYTNLVVTRW---YRPPELLLGERRYTTA---VDIWGIGCVFAEM 220

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 30/228 (13%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNI 85
           + I+ KIG+G F  V  +     K+ YA+K+I      R ++ +AI E           I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +   +  L            ++ +V+ Y   G L + L L+      +    + + F++I
Sbjct: 62  IRYYESFLDK---------GKLNIVMEYAENGDL-HKL-LKMQRGRPLPEDQVWRFFIQI 110

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +   H  K +   HRD+K+ N+ L   +N  + DLG     V K+            
Sbjct: 111 LLGLAHLHSKKIL---HRDIKSLNLFLDAYDNVKIGDLG-----VAKLLS---DNTN--F 157

Query: 206 AAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           A      PY  +PEL     Y   ++++DVW+LG +LY  C  K PFD
Sbjct: 158 ANTIVGTPYYLSPELCEDKPY---NEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.7 bits (215), Expect = 5e-20
 Identities = 69/258 (26%), Positives = 110/258 (42%), Gaps = 34/258 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ---AIREVEHHKTFVH 82
             + I +KIG+G FS V         +  ALKK+      D       ++E++  K   H
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PN++  L   +           +++ +VL     G L+  ++     K  +    I K F
Sbjct: 62  PNVIKYLASFI---------ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +++C A++  H  + +   HRD+K ANV +       L DLG       K   +  A +L
Sbjct: 113 VQLCSALEHMHSKRIM---HRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSL 166

Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
                     P Y +PE  H + Y   + ++D+WSLGCLLY M   +SPF      GD +
Sbjct: 167 -------VGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPF-----YGDKM 211

Query: 262 ALAVISGNITFPENTPFP 279
            L  +   I   +  P P
Sbjct: 212 NLYSLCKKIEKCDYPPLP 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.9 bits (211), Expect = 2e-19
 Identities = 67/270 (24%), Positives = 105/270 (38%), Gaps = 42/270 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           D +   + IGEG FSTV L +  +T K YA+K     ++I   +    +  +EV   +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS-SVDIL 139
            HP I+ L                  +  VL Y P G L   +      + Y S      
Sbjct: 60  GHPGIIKLYYTF---------QDEENLYFVLEYAPNGELLQYI------RKYGSLDEKCT 104

Query: 140 KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA-------PAVV 191
           + +  +I  A++  H    I   HRDLK  N+LL  D +  + D G+         P   
Sbjct: 105 RFYAAEILLALEYLHSKGII---HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 192 KVCGSAEAQNLQDVAAERCSM----PYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           K   +     ++       S      Y +PEL    +     + +D+W+LGC++Y M   
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELL---NEKPAGKSSDLWALGCIIYQMLTG 218

Query: 248 KSPFDTVYERGDSVALAVISGNITFPENTP 277
           K PF    E        ++    +FP N P
Sbjct: 219 KPPFRGSNE--YLTFQKILKLEYSFPPNFP 246

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 83.4 bits (207), Expect = 8e-19
 Identities = 59/253 (23%), Positives = 94/253 (37%), Gaps = 65/253 (25%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAI-REVEHHKTFVHPNILPL 88
            E +G G F +V L     T +  A+K + +    E++ +A+ RE+    +  HPNI+  
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK---- 144
                           + + + L Y   G+L+                 +LK F K    
Sbjct: 65  YGSERD-------EEKNTLNIFLEYVSGGSLS----------------SLLKKFGKLPEP 101

Query: 145 --------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
                   I E +   H        HRD+K AN+L+ +D    L D G            
Sbjct: 102 VIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC----------- 147

Query: 197 AEAQNLQDVAAERCSMPYR------APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
             A+ L D+     +   R      APE+   + Y    +  D+WSLGC +  M   K P
Sbjct: 148 --AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG---RAADIWSLGCTVIEMATGKPP 202

Query: 251 FDTVYERGDSVAL 263
           +    E G+ +A 
Sbjct: 203 W---SELGNPMAA 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 8e-19
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 45/235 (19%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNI 85
           Y  + +IGEG +  V    + +T +  ALKKI     ++     AIRE++  +   HPNI
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDILKMFL 143
           + L +  +T            + MV  Y       +DL   L S    +  +   +K ++
Sbjct: 61  VRLKE-IVTSKG------KGSIYMVFEYMD-----HDLTGLLDSPEVKF--TESQIKCYM 106

Query: 144 K-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           K + E ++  H    +   HRD+K +N+L+ ND    L D G              A+  
Sbjct: 107 KQLLEGLQYLHSNGIL---HRDIKGSNILINNDGVLKLADFGL-------------ARPY 150

Query: 203 QDVAAERCS-----MPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               +   +     + YR PE L     Y       D+WS+GC+L A  +   P 
Sbjct: 151 TKRNSADYTNRVITLWYRPPELLLGATRY---GPEVDMWSVGCIL-AELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 82.9 bits (206), Expect = 1e-18
 Identities = 65/243 (26%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNI 85
           Y  +EK+GEG +  V      +T +  ALKKI     E+   + A+RE+   K   HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI------L 139
           + LLD         V+++  ++ +V  Y        DL      K Y+           +
Sbjct: 61  VKLLD---------VIHTERKLYLVFEY-----CDMDL------KKYLDKRPGPLSPNLI 100

Query: 140 KMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           K  +  +   +   H  + +   HRDLK  N+L+  D    L D G     + +  G   
Sbjct: 101 KSIMYQLLRGLAYCHSHRIL---HRDLKPQNILINRDGVLKLADFG-----LARAFGIPL 152

Query: 199 AQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                +V     ++ YRAPE L     Y       D+WS+GC+   M   K  F      
Sbjct: 153 RTYTHEVV----TLWYRAPEILLGSKHY---STAVDIWSVGCIFAEMITGKPLF-----P 200

Query: 258 GDS 260
           GDS
Sbjct: 201 GDS 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 38/230 (16%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
            + I+EKIG+GGF  V    H +T K  A+K I    +E + + I E++  K   HPNI+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
                 L    D       ++ +V+ +   G+L + L+        ++   I  +  ++ 
Sbjct: 61  KYYGSYL--KKD-------ELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELL 108

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA-----PAVVKVCGSAEAQN 201
           + ++  H    I   HRD+K AN+LL +D    L+D G  A      A   + G      
Sbjct: 109 KGLEYLHSNGII---HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG------ 159

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                    +  + APE+ +   Y   D + D+WSLG     +   K P+
Sbjct: 160 ---------TPYWMAPEVINGKPY---DYKADIWSLGITAIELAEGKPPY 197

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.9 bits (202), Expect = 2e-18
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 35/230 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
           +Y ++  +GEG F    L++H  + ++YA+K+I +         + +E        HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +   +            +   + +V+ Y   G L   ++L+  GK +     IL+ F+++
Sbjct: 61  VAFKES---------FEADGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDT-ILQWFVQM 109

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C  V+  H+ + +   HRD+K+ N+ L  +    L D GS             A+ L   
Sbjct: 110 CLGVQHIHEKRVL---HRDIKSKNIFLTQNGKVKLGDFGS-------------ARLLTSP 153

Query: 206 AAERCS---MPYRAP-ELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            A  C+    PY  P E++    Y   + ++D+WSLGC+LY +C  K PF
Sbjct: 154 GAYACTYVGTPYYVPPEIWENMPY---NNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.4 bits (201), Expect = 3e-18
 Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 40/253 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICH-GREDQAQAIREVEHHKTFVHPN 84
           KY  V+KIGEG F    L++  +  K+Y +K+I I     +++ ++ +EV       HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD-ILKMFL 143
           I+   +                + +V+ Y   G L   +  +   +  +   D IL  F+
Sbjct: 61  IVQYQES---------FEENGNLYIVMDYCEGGDLYKKINAQ---RGVLFPEDQILDWFV 108

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +IC A+K  HD K +   HRD+K+ N+ L  D    L D G     + +V  S       
Sbjct: 109 QICLALKHVHDRKIL---HRDIKSQNIFLTKDGTIKLGDFG-----IARVLNST-----V 155

Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD--S 260
           ++A      PY  +PE+     Y   + ++D+W+LGC+LY MC  K  F    E G+  +
Sbjct: 156 ELARTCIGTPYYLSPEICENRPY---NNKSDIWALGCVLYEMCTLKHAF----EAGNMKN 208

Query: 261 VALAVISGNITFP 273
           + L +I G  ++P
Sbjct: 209 LVLKIIRG--SYP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.3 bits (198), Expect = 8e-18
 Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 28/228 (12%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPN 84
           KY  +  +G G F  V L      +K   +K+I      ++++  A  E +  K   HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   ++ L             +++V+ Y P GTLA  ++ R      +    IL  F++
Sbjct: 61  IIEYYENFL---------EDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQ 109

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A+   H  K I   HRDLKT N+LL  D + +++ +G     + K+  S        
Sbjct: 110 ILLALHHVH-TKLIL--HRDLKTQNILL--DKHKMVVKIGDFG--ISKILSSKSKA--YT 160

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           V    C   Y +PEL     Y   +Q++D+W+LGC+LY +   K  F+
Sbjct: 161 VVGTPC---YISPELCEGKPY---NQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 59/248 (23%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ------AQAIREVEHHKTFV 81
           Y  VEKIGEG +  V       T +  ALKKI    R +       + AIRE+   K   
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELN 56

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV----- 136
           HPNI+ LLD         V++S +++ +V  +        DL+L    K YM S      
Sbjct: 57  HPNIVRLLD---------VVHSENKLYLVFEFL-------DLDL----KKYMDSSPLTGL 96

Query: 137 --DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
              ++K +L ++ + +   H  + +   HRDLK  N+L+  +    L D G +A A    
Sbjct: 97  DPPLIKSYLYQLLQGIAYCHSHRVL---HRDLKPQNLLIDREGALKLADFG-LARAF--- 149

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                   ++    E  ++ YRAPE L     Y       D+WS+GC+   M   +  F 
Sbjct: 150 -----GVPVRTYTHEVVTLWYRAPEILLGSRQYSTP---VDIWSIGCIFAEMVNRRPLFP 201

Query: 253 TVYERGDS 260
                GDS
Sbjct: 202 -----GDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 9e-17
 Identities = 73/261 (27%), Positives = 111/261 (42%), Gaps = 44/261 (16%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPN 84
           + I +KIG G FS V        +K  ALKK+      D   +   ++E++  K   HPN
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++  LD  +    D  LN      +VL     G L+  ++     K  +    + K F++
Sbjct: 64  VIKYLDSFI---EDNELN------IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVAPAVVKVCGSAE 198
           +C AV+  H  + +   HRD+K ANV +       L DLG      S   A   + G+  
Sbjct: 115 LCSAVEHMHSRRVM---HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                          Y +PE  H + Y   + ++D+WSLGCLLY M   +SPF      G
Sbjct: 172 ---------------YMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPF-----YG 208

Query: 259 DSVALAVISGNITFPENTPFP 279
           D + L  +   I   +  P P
Sbjct: 209 DKMNLFSLCQKIEQCDYPPLP 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 62/263 (23%), Positives = 102/263 (38%), Gaps = 50/263 (19%)

Query: 30  IVEKIGEGGFSTVSL----IEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPN 84
           + +K+GEG F  V       +   T+ + A+K +     E++ +  + E    K   HPN
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL     G           + +V  Y P G L     LR  G+  ++  D+L+M L+
Sbjct: 63  IVRLL-----GV---CTQG-EPLYIVTEYMPGGDL--LDFLRKHGEK-LTLKDLLQMALQ 110

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           I + ++         + HRDL   N L+  +              VVK+   G +     
Sbjct: 111 IAKGMEYLESKN---FVHRDLAARNCLVTENL-------------VVKISDFGLSRDIYE 154

Query: 203 QD--VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFD--TVY 255
            D         +P +  APE            ++DVWS G LL+ +    + P+   +  
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESL---KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211

Query: 256 ERGDSVALAVISGN-ITFPENTP 277
           E    V   +  G  +  PEN P
Sbjct: 212 E----VLELLEDGYRLPRPENCP 230

Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 43/226 (19%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQA------QAIREVEHHKTF 80
           Y I+ KIGEG FS V   +  +T K YA+K +  H +  +Q       QA+R +      
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---- 56

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQV--LMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
            HPNIL L++       D      + V  LM +  Y         EL    K  +    +
Sbjct: 57  -HPNILRLIEVLF----DRKTGRLALVFELMDMNLY---------ELIKGRKRPLPEKRV 102

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
                ++ +++   H    I   HRD+K  N+L+  D+   L D GS         G   
Sbjct: 103 KSYMYQLLKSLDHMH-RNGI--FHRDIKPENILI-KDDILKLADFGS-------CRGIYS 151

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                +  + R    YRAPE    D Y     + D+W++GC+ + +
Sbjct: 152 KPPYTEYISTRW---YRAPECLLTDGY--YGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 74.6 bits (183), Expect = 1e-15
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 29/228 (12%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNI 85
           Y  V  +G+G +  VSL+ H    K+Y +KK+      R ++  A +E +      HPNI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +   +                + +V+ +   G L + L+ +  GK    +  +++ F++I
Sbjct: 62  VAYRESWEGE--------DGLLYIVMGFCEGGDLYHKLKEQK-GKLLPEN-QVVEWFVQI 111

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
             A++  H+   +   HRDLKT NV L   N   + DLG     + +V      +N  D+
Sbjct: 112 AMALQYLHEKHIL---HRDLKTQNVFLTRTNIIKVGDLG-----IARVL-----ENQCDM 158

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           A+     P Y +PELF    Y   + ++DVW+LGC +Y M   K  F+
Sbjct: 159 ASTLIGTPYYMSPELFSNKPY---NYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 1e-15
 Identities = 55/227 (24%), Positives = 83/227 (36%), Gaps = 45/227 (19%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNI 85
           Y  + KIGEG +  V       T +  A+KKI      +     A+RE++  K   HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------KHYMSSVDIL 139
           + LLD         V      + +V  +     L   ++ R  G      K Y+      
Sbjct: 61  IKLLD---------VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL------ 104

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               ++ + +   H    +   HRDLK  N+L+  +    L D G           S  +
Sbjct: 105 ---YQLLQGLAFCHSHGIL---HRDLKPENLLINTEGVLKLADFGL--------ARSFGS 150

Query: 200 QN--LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                      R    YRAPEL   D         D+WS+GC+   +
Sbjct: 151 PVRPYTHYVVTRW---YRAPELLLGDKG--YSTPVDIWSVGCIFAEL 192

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 40/233 (17%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           Y  +  +G+G F   +L   ++       K   L ++    R D   A+ E+       H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD---ALNEIVILSLLQH 58

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMV-LPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           PNI+   +H +              L++ + Y   GTL  D  +R  G+ +   + +L  
Sbjct: 59  PNIIAYYNHFMD----------DNTLLIEMEYANGGTLY-DKIVRQKGQLFEEEM-VLWY 106

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  AV   H A  +   HRD+KT N+ L       L D G     + K+ GS     
Sbjct: 107 LFQIVSAVSYIHKAGIL---HRDIKTLNIFLTKAGLIKLGDFG-----ISKILGS----- 153

Query: 202 LQDVAAERC--SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            +   AE    +  Y +PEL     Y   + ++D+W+LGC+LY +   K  FD
Sbjct: 154 -EYSMAETVVGTPYYMSPELCQGVKY---NFKSDIWALGCVLYELLTLKRTFD 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 4e-15
 Identities = 68/254 (26%), Positives = 102/254 (40%), Gaps = 51/254 (20%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T K YA+K +    ++ +    +EVEH  T    NIL  ++H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL----KKKKIIKRKEVEH--TLTERNILSRINHPF 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-KICEAVKVF 152
                    +  ++ +VL Y P G L + L      K    S +  + +  +I  A++  
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLS-----KEGRFSEERARFYAAEIVLALEYL 109

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK------VCGSAEAQNLQDVA 206
           H    I   +RDLK  N+LL  D +  L D G       +       CG+ E        
Sbjct: 110 HSLGII---YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE-------- 158

Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD-----TVYERGDSV 261
                  Y APE+     Y    +  D WSLG LLY M   K PF       +YE+    
Sbjct: 159 -------YLAPEVLLGKGY---GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK---- 204

Query: 262 ALAVISGNITFPEN 275
              ++   + FPE 
Sbjct: 205 ---ILKDPLRFPEF 215

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 5e-15
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 43/236 (18%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV----- 81
           +Y I++KIGEG F  + L +     +   +K+I     +     ++E E  K  V     
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI-----DLTKMPVKEKEASKKEVILLAK 55

Query: 82  --HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD-I 138
             HPNI+                   ++ +V+ Y   G L   +  +   +  + S D I
Sbjct: 56  MKHPNIVTFFAS---------FQENGRLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQI 103

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           L  F++I   +K  HD K +   HRD+K+ N+ L+   N ++  LG          G A 
Sbjct: 104 LSWFVQISLGLKHIHDRKIL---HRDIKSQNIFLSK--NGMVAKLGDF--------GIAR 150

Query: 199 AQNLQDVAAERC-SMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             N     A  C   PY  +PE+     Y   + +TD+WSLGC+LY +C  K PF+
Sbjct: 151 QLNDSMELAYTCVGTPYYLSPEICQNRPY---NNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 36/225 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            + Y  +EKIGEG    V       T K  A+KK+    +  +   I E+   K   HPN
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-IINEILIMKDCKHPN 76

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   D  L G          ++ +V+ Y   G+L + +    V    M+   I  +  +
Sbjct: 77  IVDYYDSYLVG---------DELWVVMEYMDGGSLTDIITQNFV---RMNEPQIAYVCRE 124

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + + ++  H    I   HRD+K+ N+LL+ D +  L D G  A        + E      
Sbjct: 125 VLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQ------LTKEKSK--- 172

Query: 205 VAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
               R S+   PY  APE+     Y     + D+WSLG +   M 
Sbjct: 173 ----RNSVVGTPYWMAPEVIKRKDY---GPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 71.0 bits (175), Expect = 2e-14
 Identities = 56/228 (24%), Positives = 85/228 (37%), Gaps = 44/228 (19%)

Query: 30  IVEKIGEGGFSTVS---LIEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVHPN 84
           + +K+GEG F  V    L      K+     K +     +Q     +RE    +   HPN
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDILKMF 142
           I+ LL     G           +++V+ Y P G    DL   LR      +S  D+L   
Sbjct: 63  IVKLL-----GVC----TEEEPLMIVMEYMPGG----DLLDYLRKNRPKELSLSDLLSFA 109

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--G-SAEA 199
           L+I   ++       I   HRDL   N L+  +              VVK+   G S + 
Sbjct: 110 LQIARGMEYLESKNFI---HRDLAARNCLVGENL-------------VVKISDFGLSRDL 153

Query: 200 QNLQDVAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
            +      +   +P R  APE            ++DVWS G LL+ + 
Sbjct: 154 YDDDYYKVKGGKLPIRWMAPESL---KEGKFTSKSDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.6 bits (173), Expect = 4e-14
 Identities = 74/246 (30%), Positives = 106/246 (43%), Gaps = 50/246 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVH 82
           D+Y  VEKIGEG +  V       T +  ALKKI    +ED+   + AIRE+   K   H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQH 60

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD----- 137
            NI+ L D         V++S  ++ +V  Y        DL+L+   KH  SS D     
Sbjct: 61  GNIVRLQD---------VVHSEKRLYLVFEYL-------DLDLK---KHMDSSPDFAKNP 101

Query: 138 -ILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVC 194
            ++K +L +I   +   H  + +   HRDLK  N+L+    N L L D G      + V 
Sbjct: 102 RLIKTYLYQILRGIAYCHSHRVL---HRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
                   +    E  ++ YRAPE+             D+WS+GC+   M   K  F   
Sbjct: 158 --------RTFTHEVVTLWYRAPEILL--GSRHYSTPVDIWSVGCIFAEMVNQKPLFP-- 205

Query: 255 YERGDS 260
              GDS
Sbjct: 206 ---GDS 208

Length = 294

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 71.3 bits (174), Expect = 7e-14
 Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 41/249 (16%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHP 83
           ++Y +++KIG G F  V L++H +T++ +  K I   G    +++Q + EV   +   H 
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVL-PYYPKGTLANDLE--LRSVGK-HYMSSVDIL 139
           NI+  +D          LN  +Q L +L  +   G L+ +++   +  GK    + VDI 
Sbjct: 73  NIVRYIDR--------FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124

Query: 140 KMFLKI---CEAVKVFHDAKPIAYAHRDLKTANVLL-----------ANDNNPLLMDLGS 185
           +  L     C  +K   + + +   HRDLK  N+ L           A  NN     L  
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVL--HRDLKPQNIFLSTGIRHIGKITAQANN-----LNG 177

Query: 186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYR-APELF--HVDSYCVVDQRTDVWSLGCLLY 242
              A +   G ++   ++ +A      PY  +PEL      SY   D ++D+W+LGC++Y
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSY---DDKSDMWALGCIIY 234

Query: 243 AMCYFKSPF 251
            +C  K+PF
Sbjct: 235 ELCSGKTPF 243

Length = 1021

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 30/221 (13%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPN 84
           +Y I+ +IGEG    V   +  +T +  ALKK+     E     QA+RE++  +   HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++ LLD         V    S  ++V+ Y P   L+  L         +    +      
Sbjct: 61  VVKLLD---------VFPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRM 107

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + + V   H    +   HRDLK AN+L++ D    + D G                    
Sbjct: 108 LLKGVAYMHANGIM---HRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQ 160

Query: 205 VAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           VA       YRAPE L+    Y   D   D+W++GC+   +
Sbjct: 161 VATRW----YRAPELLYGARKY---DPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 42/241 (17%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPN 84
            Y  +EKIGEG +  V    + +T +  A+KKI     E+   + AIRE+   K   HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDILKMF 142
           I+ L D         VL   S++ ++  +     L+ DL+  L S+ K      +++K +
Sbjct: 61  IVCLQD---------VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSY 106

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           L +I + +   H  + +   HRDLK  N+L+ N     L D G            A    
Sbjct: 107 LYQILQGILFCHSRRVL---HRDLKPQNLLIDNKGVIKLADFG---------LARAFGIP 154

Query: 202 LQDVAAERCSMPYRAPE-LFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
           ++    E  ++ YRAPE L     Y   V    D+WS+G +   M   K  F      GD
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPV----DIWSIGTIFAEMATKKPLF-----HGD 205

Query: 260 S 260
           S
Sbjct: 206 S 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 67/242 (27%), Positives = 104/242 (42%), Gaps = 53/242 (21%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ------AQAIREVEHHKTFVHPN 84
           VEKIGEG +  V    +  T +  ALKKI    R D       + AIRE+   K   HPN
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L 
Sbjct: 61  IVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASPLSGIPLP 100

Query: 145 ICEAVKVFHDAKPIAYA------HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A 
Sbjct: 101 LIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARAF 150

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
              ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F      G
Sbjct: 151 GVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFP-----G 203

Query: 259 DS 260
           DS
Sbjct: 204 DS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 68.3 bits (168), Expect = 1e-13
 Identities = 54/227 (23%), Positives = 84/227 (37%), Gaps = 43/227 (18%)

Query: 30  IVEKIGEGGFSTVS---LIEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVHPN 84
           + +K+GEG F  V    L      KK     K +     +Q     +RE    +   HPN
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 85  ILPLLDHALTGCADPVLNSTSQVLM-VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           ++ LL     G       +  + L  V+ Y   G L + L      +  +S  D+L   L
Sbjct: 63  VVKLL-----GVC-----TEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFAL 109

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I   ++       I   HRDL   N L+  +              VVK+     +++L 
Sbjct: 110 QIARGMEYLESKNFI---HRDLAARNCLVGENL-------------VVKISDFGLSRDLY 153

Query: 204 D---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           D          +P R  APE            ++DVWS G LL+ + 
Sbjct: 154 DDDYYRKRGGKLPIRWMAPESL---KEGKFTSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 38/223 (17%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQA----QAIREVEHHKTFV 81
           +Y   +K+GEG ++ V      +T +  A+KKI +   +E +      A+RE++  +   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDIL 139
           HPNI+ LLD         V    S + +V  +     +  DLE  ++        + DI 
Sbjct: 61  HPNIIGLLD---------VFGHKSNINLVFEF-----METDLEKVIKDKSIVLTPA-DIK 105

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
              L     ++  H        HRDLK  N+L+A+D    L D G     + +  GS   
Sbjct: 106 SYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG-----LARSFGSPNR 157

Query: 200 QNLQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           +    V        YRAPEL F    Y V     D+WS+GC+ 
Sbjct: 158 KMTHQVVTRW----YRAPELLFGARHYGVG---VDMWSVGCIF 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.7 bits (169), Expect = 2e-13
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 30/221 (13%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVHPN 84
           +Y +++ IG G +  V      +T ++ A+KKI  +     D  + +RE++  +   H N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDILKMF 142
           I+ LLD  L     P     + V +V           DL   ++S     ++  D ++ F
Sbjct: 61  IIGLLD-ILR---PPSPEDFNDVYIVTELME-----TDLHKVIKS--PQPLTD-DHIQYF 108

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQ 200
           L +I   +K  H A  I   HRDLK +N+L+ N N  L + D G    A        E  
Sbjct: 109 LYQILRGLKYLHSANVI---HRDLKPSNILV-NSNCDLKICDFGL---ARGVDPDEDEKG 161

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
            L +    R    YRAPEL    S     +  D+WS+GC+ 
Sbjct: 162 FLTEYVVTRW---YRAPELLLSSSRY--TKAIDIWSVGCIF 197

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 71/261 (27%), Positives = 109/261 (41%), Gaps = 44/261 (16%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPN 84
           + I +KIG G FS V            ALKK+      D   +A  I+E++  K   HPN
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    +  +   D  LN      +VL     G L+  ++     K  +    + K F++
Sbjct: 64  VI---KYYASFIEDNELN------IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVAPAVVKVCGSAE 198
           +C A++  H  + +   HRD+K ANV +       L DLG      S   A   + G+  
Sbjct: 115 LCSALEHMHSRRVM---HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                          Y +PE  H + Y   + ++D+WSLGCLLY M   +SPF      G
Sbjct: 172 ---------------YMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPF-----YG 208

Query: 259 DSVALAVISGNITFPENTPFP 279
           D + L  +   I   +  P P
Sbjct: 209 DKMNLYSLCKKIEQCDYPPLP 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 67.9 bits (167), Expect = 3e-13
 Identities = 60/267 (22%), Positives = 98/267 (36%), Gaps = 55/267 (20%)

Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +K+GEG F  V    L          A+K +      E++   ++E    K   HPN++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-----ANDLELRSVGKHYMSSVDILKMF 142
           LL     G           + +VL Y   G L      +     S  K  +S  D+L   
Sbjct: 61  LL-----GVC----TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           ++I + ++     K +   HRDL   N L+  D              VVK+     ++++
Sbjct: 112 IQIAKGMEYLASKKFV---HRDLAARNCLVGEDL-------------VVKISDFGLSRDV 155

Query: 203 QD----VAAERCSMPYR--APELFHVDSYCVVDQR----TDVWSLGCLLYAMCYF-KSPF 251
            D           +P R  APE        + D      +DVWS G LL+ +     +P+
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPE-------SLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208

Query: 252 DTVYERGDSVALAVISGN-ITFPENTP 277
             +    + V   +  G  +  PE  P
Sbjct: 209 PGL--SNEEVLEYLRKGYRLPKPEYCP 233

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.6 bits (166), Expect = 4e-13
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVH 82
           D+Y  + +I EG +  V      +T +  ALKK+    +E +     ++RE+       H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME-KEKEGFPITSLREINILLKLQH 63

Query: 83  PNILPLLDHALTGCADPVLNSTS-QVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILK 140
           PNI+ +         + V+ S   ++ MV+ Y     + +DL+ L    K      ++  
Sbjct: 64  PNIVTV--------KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKC 110

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           + L++   V   HD       HRDLKT+N+LL N               ++K+C    A+
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNR-------------GILKICDFGLAR 154

Query: 201 NLQDVAAERCSMP----YRAPE-LFHVDSYCVVDQRTDVWSLGC 239
                      +     YRAPE L     Y       D+WS+GC
Sbjct: 155 EYGSPLKPYTQLVVTLWYRAPELLLGAKEY---STAIDMWSVGC 195

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 50/233 (21%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQA-IREV---EHHKTFVH 82
           Y  + +IGEG + TV       T +  ALKK+ +    E    + +RE+   +  ++F H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDILK 140
           PNI+ LLD     C  P  +   ++ +V  +     +  DL   L    K  +    I  
Sbjct: 61  PNIVRLLDV----CHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKD 111

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---------SVAPAVV 191
           +  ++   V   H  + +   HRDLK  N+L+ +D    + D G         ++   VV
Sbjct: 112 LMRQLLRGVDFLHSHRIV---HRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                              ++ YRAPE+    SY       D+WS+GC+   +
Sbjct: 169 -------------------TLWYRAPEVLLQSSYATP---VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 46/227 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRED-QAQAIREVEHHKTFVHP 83
           +KY ++  +GEG +  V    +  T +  A+KK       ED +  A+REV+  +   H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L +               ++ +V  Y  + TL   LE    G   +    +     
Sbjct: 61  NIVNLKE---------AFRRKGRLYLVFEYVER-TLLELLEASPGG---LPPDAVRSYIW 107

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEA-- 199
           ++ +A+   H    I   HRD+K  N+L++                V+K+C  G A A  
Sbjct: 108 QLLQAIAYCHSHNII---HRDIKPENILVSESG-------------VLKLCDFGFARALR 151

Query: 200 ----QNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLL 241
                 L D  A R    YRAPEL   D +Y    +  DVW++GC++
Sbjct: 152 ARPASPLTDYVATRW---YRAPELLVGDTNY---GKPVDVWAIGCIM 192

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 8e-13
 Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 47/261 (18%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPN 84
            Y + + IG G F  V    + +T    A+K+I       E     ++E++  K   HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+  +    T            + ++L Y   G+L   ++     K       ++ +++ 
Sbjct: 61  IVKYIGSIETS---------DSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVY 106

Query: 145 -ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            + + +   H+   I   HRD+K AN+L   D    L D G              A  L 
Sbjct: 107 QVLQGLAYLHEQGVI---HRDIKAANILTTKDGVVKLADFGV-------------ATKLN 150

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
           DV+ +  S+   PY  APE+  +         +D+WSLGC +  +     P+   Y+   
Sbjct: 151 DVSKDDASVVGTPYWMAPEVIEMSG---ASTASDIWSLGCTVIELLTGNPPY---YDLNP 204

Query: 260 SVALAVISGNITFPENTPFPQ 280
             AL  I  +    ++ P P+
Sbjct: 205 MAALFRIVQD----DHPPLPE 221

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 65.2 bits (159), Expect = 2e-12
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 36/236 (15%)

Query: 28  YYIVEKIGEGGFSTVSLIE-HSQTKKRYALKKIICH------GREDQAQAIREVEHHKTF 80
           Y ++E +G G F  V  +   +  +   ALK+I  H       + ++ ++I ++    T 
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 81  V-----HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
           +     HPNI+      L        +    V+ ++   P G   N L+ +   K   + 
Sbjct: 62  IKEQLRHPNIVRYYKTFLEN------DRLYIVMDLIEGAPLGEHFNSLKEK---KQRFTE 112

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             I  +F+++  A++  H  K I   HRDL   N++L  D+   + D G           
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLAKQ------- 163

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 L  V     ++ Y  PE+   + Y    ++ DVW+ GC+LY MC  + PF
Sbjct: 164 KQPESKLTSVVG---TILYSCPEIVKNEPY---GEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 64.5 bits (158), Expect = 4e-12
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-REVEHHKTFVHPNILPL 88
            V+ +G+G    V  + H  T K YALKKI   G E+  + + RE++  ++   P ++  
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
             +              ++ +VL Y   G+LA DL L+ VGK  +    +  +  +I + 
Sbjct: 65  --YG-------AFYKEGEISIVLEYMDGGSLA-DL-LKKVGK--IPEPVLAYIARQILKG 111

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +   H  + I   HRD+K +N+L+ +     + D G        +    E  N  D    
Sbjct: 112 LDYLHTKRHII--HRDIKPSNLLINSKGEVKIADFG--------ISKVLE--NTLDQCNT 159

Query: 209 RC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
              ++ Y +PE    +SY       D+WSLG  L 
Sbjct: 160 FVGTVTYMSPERIQGESYSY---AADIWSLGLTLL 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 32/226 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVH 82
            +Y  +E IG G +  V     +++ K+ A+KKI  H  +    A   +RE++  + F H
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKH 63

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+ + D      AD        V +V+       + +DL         ++   I    
Sbjct: 64  DNIIAIRDILRPPGAD-----FKDVYVVMDL-----MESDLHHIIHSDQPLTEEHIRYFL 113

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQN 201
            ++   +K  H A  I   HRDLK +N LL N++  L + D G +A  +       E + 
Sbjct: 114 YQLLRGLKYIHSANVI---HRDLKPSN-LLVNEDCELRIGDFG-MARGLSS--SPTEHKY 166

Query: 202 L--QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAM 244
              + VA    +  YRAPEL   +  Y       D+WS+GC+   M
Sbjct: 167 FMTEYVA----TRWYRAPELLLSLPEY---TTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 5e-12
 Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 60/244 (24%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D + I+ ++G+G F  V   +H +T    A K I     E+    + E++      HPNI
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAN---DLE-------LRSVGKHYMSS 135
           + L +              +++ +++ +   G L +   +LE       +R V +     
Sbjct: 65  VGLYE---------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ---- 111

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
                    + EA+   H  K I   HRDLK  N+LL  D +  L D G      V    
Sbjct: 112 ---------MLEALNFLHSHKVI---HRDLKAGNILLTLDGDVKLADFG------VSAKN 153

Query: 196 SAEAQNLQDVAAERCSM---PY-RAPEL-----FHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +  Q       +R +    PY  APE+     F  + Y   D + D+WSLG  L  +  
Sbjct: 154 KSTLQ-------KRDTFIGTPYWMAPEVVACETFKDNPY---DYKADIWSLGITLIELAQ 203

Query: 247 FKSP 250
            + P
Sbjct: 204 MEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 63.9 bits (156), Expect = 7e-12
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 48/236 (20%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           + ++  IG+G F  V +++   TKK +A+K   K  C  +      + E           
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERR--------- 52

Query: 85  ILPLLDHALTGCADPVLN--STSQ----VLMVLPYYPKGTLANDLELR-SVGKHYMSSVD 137
           IL  L+H        ++N   + Q    + +V+     G      +LR  + +    S +
Sbjct: 53  ILQELNHPF------LVNLWYSFQDEENMYLVVDLLLGG------DLRYHLSQKVKFSEE 100

Query: 138 ILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            +K ++ +I  A++  H    I   HRD+K  N+LL    +  + D   +A    KV   
Sbjct: 101 QVKFWICEIVLALEYLHSKGII---HRDIKPDNILLDEQGHVHITDFN-IA---TKVTPD 153

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                    +    +  Y APE+     Y       D WSLG   Y     K P+ 
Sbjct: 154 ---TLTTSTSG---TPGYMAPEVLCRQGY---SVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 67/258 (25%), Positives = 104/258 (40%), Gaps = 50/258 (19%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH--- 82
           D    ++ +G G F  V L+    ++  YALK +          AI EV   K   H   
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM----------AIPEVIRLKQEQHVHN 50

Query: 83  -PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
              +L  + H          +    + M++ Y P G L +   LR+ G+   S+   L  
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS--YLRNSGR--FSNSTGLFY 106

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  A++  H +K I Y  RDLK  N+LL  + +  L D G              A+ 
Sbjct: 107 ASEIVCALEYLH-SKEIVY--RDLKPENILLDKEGHIKLTDFGF-------------AKK 150

Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----DTVY 255
           L+D     C  P Y APE+     +   ++  D W+LG L+Y M     PF       +Y
Sbjct: 151 LRDRTWTLCGTPEYLAPEVIQSKGH---NKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207

Query: 256 ERGDSVALAVISGNITFP 273
           E        +++G + FP
Sbjct: 208 E-------KILAGKLEFP 218

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 49/231 (21%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ----AIREVEHHKTFV 81
           +KY  +  +GEG +  V   +H +T +  A+KK +    ED       A+RE+   K   
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFL--ESEDDKMVKKIAMREIRMLKQLR 58

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H N++ L++         V     ++ +V  +    T+ +DLE    G        + K 
Sbjct: 59  HENLVNLIE---------VFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESR---VRKY 105

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I   ++  H    I   HRD+K  N+L++                VVK+C    A+ 
Sbjct: 106 LFQILRGIEFCHSHNII---HRDIKPENILVSQS-------------GVVKLCDFGFART 149

Query: 202 LQ-------DVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAM 244
           L        D  A R    YRAPEL   D  Y    +  D+W++GCL+  M
Sbjct: 150 LAAPGEVYTDYVATRW---YRAPELLVGDTKY---GRAVDIWAVGCLVTEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 37/226 (16%)

Query: 29  YIVEKIGEGGFSTVSL----IEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVH 82
             ++++GEG F  V L         T ++ A+K +  H  E+Q ++   RE+E  +T  H
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDH 65

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+        G  +     + +++M   Y P G+L + L+     +  ++   +L   
Sbjct: 66  ENIV-----KYKGVCEKPGGRSLRLIM--EYLPSGSLRDYLQRH---RDQINLKRLLLFS 115

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +IC+ +      +   Y HRDL   N+L+ +++   + D G +A  + +       +  
Sbjct: 116 SQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG-LAKVLPEDKDYYYVKEP 171

Query: 203 QDVA----AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +      A  C    +    F   S        DVWS G  LY +
Sbjct: 172 GESPIFWYAPECLRTSK----FSSAS--------DVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 34/262 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVH 82
            KY  + KIG+G F  V    H +TK+  ALKK++    E +     A+RE++  +   H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLLKH 70

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKM 141
            N++ L++   T  A P         +V  +       +DL  L S      +  +I K+
Sbjct: 71  ENVVNLIEICRTK-ATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVKFTLSEIKKV 124

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
              +   +   H  K +   HRD+K AN+L+  D    L D G      +          
Sbjct: 125 MKMLLNGLYYIHRNKIL---HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 202 LQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
            + V     ++ YR PEL   +  Y       D+W  GC++  M + +SP      +G++
Sbjct: 182 NRVV-----TLWYRPPELLLGERDY---GPPIDMWGAGCIMAEM-WTRSPI----MQGNT 228

Query: 261 VA--LAVIS---GNITFPENTP 277
               L +IS   G+IT PE  P
Sbjct: 229 EQHQLTLISQLCGSIT-PEVWP 249

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPL 88
           +++ IG+G F  V L ++   K   A+K   C   +  AQA + E        H N++ L
Sbjct: 10  LLQTIGKGEFGDVMLGDYRGNK--VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           L          ++     + +V  Y  KG+L +   LRS G+  +    +LK  L +CEA
Sbjct: 65  LG--------VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEA 114

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           ++         + HRDL   NVL++ DN   + D G           + EA + QD    
Sbjct: 115 MEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTG-- 159

Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           +  + + APE      +     ++DVWS G LL+ +  F
Sbjct: 160 KLPVKWTAPEALREKKFST---KSDVWSFGILLWEIYSF 195

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 56/257 (21%), Positives = 86/257 (33%), Gaps = 58/257 (22%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKK-----IICHGREDQAQAIREVEHHKTF 80
           D + +++ IG G F  V L+    T + YA+K      +I   + +Q   +R        
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI---KRNQIAHVRAERDILAD 57

Query: 81  VH-PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P I+ L        +         + +V+ Y P G L N           +   D+ 
Sbjct: 58  ADSPWIVKLY------YS---FQDEEHLYLVMEYMPGGDLMN----------LLIRKDVF 98

Query: 140 -----KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS------VAP 188
                + +  I E V        + + HRD+K  N+L+  D +  L D G          
Sbjct: 99  PEETARFY--IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156

Query: 189 AVVKVCGSAEAQNLQDVAAERCSMP--------------YRAPELFHVDSYCVVDQRTDV 234
               +  S       +V   R                  Y APE+     Y       D 
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY---GLECDW 213

Query: 235 WSLGCLLYAMCYFKSPF 251
           WSLG +LY M Y   PF
Sbjct: 214 WSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 61/233 (26%), Positives = 92/233 (39%), Gaps = 37/233 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHPN 84
           +K   + ++GEG   +V+      T   +ALK I      D Q Q +RE+E +K+   P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL--KMF 142
           I+      L         S+S + + + Y   G+      L S+ K        +  K+ 
Sbjct: 61  IVKYYGAFL-------DESSSSIGIAMEYCEGGS------LDSIYKKVKKRGGRIGEKVL 107

Query: 143 LKICEAV----KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
            KI E+V       H  K I   HRD+K +N+LL       L D G     V  + G+  
Sbjct: 108 GKIAESVLKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +            Y APE      Y +    +DVWSLG  L  +   + PF
Sbjct: 165 GTSF-----------YMAPERIQGKPYSI---TSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 58/256 (22%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-------IREVEHHKT 79
           +Y I+  IG+GG   V L       +R ALKKI    RED ++        +RE +    
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI----REDLSENPLLKKRFLREAKIAAD 58

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP----KGTLANDLELRSVGK--HYM 133
            +HP I+P+     + C+D        V   +PY      K  L +  +  S+ K     
Sbjct: 59  LIHPGIVPV----YSICSD-----GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109

Query: 134 SSVD-ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +SV   L +F KIC  ++  H +K +   HRDLK  N+LL      +++D G+   A+ K
Sbjct: 110 TSVGAFLSIFHKICATIEYVH-SKGV--LHRDLKPDNILLGLFGEVVILDWGA---AIFK 163

Query: 193 VCGSAEAQNLQDVAA-------ERCSMP--------YRAPE--LFHVDSYCVVDQRTDVW 235
                E ++L D+            ++P        Y APE  L    S     + TD++
Sbjct: 164 ---KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-----ESTDIY 215

Query: 236 SLGCLLYAMCYFKSPF 251
           +LG +LY M     P+
Sbjct: 216 ALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 7e-11
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 32/211 (15%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH 91
             IG+G F  V L ++    ++ A+K +       Q   + E     T  HPN++ LL  
Sbjct: 12  ATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGV 68

Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKV 151
            L G         + + +V  Y  KG+L +   LRS G+  ++    L   L +CE ++ 
Sbjct: 69  VLQG---------NPLYIVTEYMAKGSLVD--YLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 152 FHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCS 211
             +     + HRDL   NVL++ D    + D G           + EA   QD    +  
Sbjct: 118 LEEKN---FVHRDLAARNVLVSEDLVAKVSDFGL----------AKEASQGQDSG--KLP 162

Query: 212 MPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
           + + APE      +     ++DVWS G LL+
Sbjct: 163 VKWTAPEALREKKF---STKSDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.1 bits (148), Expect = 8e-11
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 37/229 (16%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A+K++    +  +   I E+   +   HPNI+
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 80  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 125

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G  A              +    
Sbjct: 126 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCA-------------QITPEQ 169

Query: 207 AERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++R +M   PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 67/267 (25%), Positives = 104/267 (38%), Gaps = 68/267 (25%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           D +  ++ +G G F  V L+ H  + K YALK     KI+          +++VEH    
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV---------KLKQVEH--VL 49

Query: 81  VHPNILPLLDH-----ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
               IL  + H           D      S + +V+ Y P G L +   LR  G+     
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFS--HLRKSGRF---P 99

Query: 136 VDILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVV 191
             + + +  ++  A++  H    I Y  RDLK  N+LL +D    + D G    V     
Sbjct: 100 EPVARFYAAQVVLALEYLHSLD-IVY--RDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +CG+ E               Y APE+     Y    +  D W+LG L+Y M     PF
Sbjct: 157 TLCGTPE---------------YLAPEIILSKGY---GKAVDWWALGILIYEMLAGYPPF 198

Query: 252 DT-----VYERGDSVALAVISGNITFP 273
                  +YE+       ++ G + FP
Sbjct: 199 FDDNPIQIYEK-------ILEGKVRFP 218

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 42/230 (18%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHK-TFVHPNILPLL 89
           IG G ++ V L+E  +T++ YA+K   K + +  ED    I  V+  K  F   +  P L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDED----IDWVQTEKHVFETASNHPFL 58

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE----LRSVGKHYMSSVDILKMFLKI 145
              L  C      + S++  V+ +   G L   ++    L      + S+        +I
Sbjct: 59  -VGLHSC----FQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA--------EI 105

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
             A+   H+ + I Y  RDLK  NVLL  + +  L D G        +C   E     D 
Sbjct: 106 SLALNFLHE-RGIIY--RDLKLDNVLLDAEGHIKLTDYG--------MC--KEGIRPGDT 152

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
            +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 153 TSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 54/232 (23%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-AQAIREVEHHKTFVHPNIL 86
           +  +EK+GEG ++TV    +  T +  ALK+I     E   + AIRE+   K   H NI+
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS--------VDI 138
            L D         V+++ +++++V  Y     +  DL      K YM +         + 
Sbjct: 62  RLHD---------VIHTENKLMLVFEY-----MDKDL------KKYMDTHGVRGALDPNT 101

Query: 139 LKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           +K F  ++ + +   H+ + +   HRDLK  N+L+       L D G            A
Sbjct: 102 VKSFTYQLLKGIAFCHENRVL---HRDLKPQNLLINKRGELKLADFG---------LARA 149

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRT-----DVWSLGCLLYAM 244
               +   + E  ++ YRAP++       ++  RT     D+WS+GC++  M
Sbjct: 150 FGIPVNTFSNEVVTLWYRAPDV-------LLGSRTYSTSIDIWSVGCIMAEM 194

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 31/228 (13%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHG----REDQAQAIR-EVEHHKTFVHPNI 85
           +++G G FS+       +T    A+K++         +E+  +A+R E+       HP+I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + +L      C D   N      + + +   G++++   L   G  +  +V I     ++
Sbjct: 66  IRMLG---ATCEDSHFN------LFVEWMAGGSVSH--LLSKYGA-FKEAVII-NYTEQL 112

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQD 204
              +   H+ + I   HRD+K AN+L+ +    L + D G+ A    K  G+ E Q  Q 
Sbjct: 113 LRGLSYLHENQII---HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG-QL 168

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +     ++ + APE+   + Y    +  DVWS+GC++  M   K P++
Sbjct: 169 LG----TIAFMAPEVLRGEQY---GRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 66/275 (24%), Positives = 109/275 (39%), Gaps = 52/275 (18%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           ++ +G+G    V L+    T K +ALK +      D+ + I+  +  +      IL  LD
Sbjct: 6   IKLLGKGDVGRVFLVRLKGTGKLFALKVL------DKKEMIKRNKVKRVLTEQEILATLD 59

Query: 91  HALTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-KI 145
           H       P L ++ Q    + +V+ Y P G L   L+ +        S ++ + +  ++
Sbjct: 60  HPFL----PTLYASFQTETYLCLVMDYCPGGELFRLLQRQP---GKCLSEEVARFYAAEV 112

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD-----LGSVAPAVV------KVC 194
             A++  H    I Y  RDLK  N+LL    + +L D        V P  V         
Sbjct: 113 LLALEYLH-LLGIVY--RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 195 GSAEAQNLQDVAAERCSMP---------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
            S+      +  +E  S           Y APE+   D +       D W+LG LLY M 
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEML 226

Query: 246 YFKSPFDTVYERGDS---VALAVISGNITFPENTP 277
           Y  +PF     +G +       ++   +TFP + P
Sbjct: 227 YGTTPF-----KGSNRDETFSNILKKEVTFPGSPP 256

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 73/231 (31%), Positives = 105/231 (45%), Gaps = 45/231 (19%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-AQ-AIREVEHHKTFV-HP 83
           KY I++K+G+G +  V      +TK+  ALKKI    R    AQ   RE+   +    HP
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67

Query: 84  NILPLLDHALTGCADPVLNSTSQ--VLMVLPYYPKGTLANDLE-------LRSVGKHYMS 134
           NI+ LL+         V+ + +   + +V  Y     +  DL        L  V K Y  
Sbjct: 68  NIVKLLN---------VIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-- 111

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
              I+   LK   A+K  H    I   HRDLK +N+LL +D    L D G +A ++ ++ 
Sbjct: 112 ---IMYQLLK---ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFG-LARSLSELE 161

Query: 195 GSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            + E   L D  A R    YRAPE L     Y    +  D+WS+GC+L  M
Sbjct: 162 ENPENPVLTDYVATRW---YRAPEILLGSTRY---TKGVDMWSVGCILGEM 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.0 bits (142), Expect = 4e-10
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 31/226 (13%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A+K+I    +  +   I E+   K   +PNI+
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 80  NFLDSFLVG---------DELFVVMEYLAGGSLTD-----VVTETCMDEAQIAAVCRECL 125

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ NVLL  D +  L D G         C  A+    Q   
Sbjct: 126 QALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFG--------FC--AQITPEQSKR 172

Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 173 STMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 58.4 bits (141), Expect = 4e-10
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPLLD 90
           E IGEG F  V   E+  T ++ A+K I C   +  AQA + E        H N++ LL 
Sbjct: 12  EIIGEGEFGAVLQGEY--TGQKVAVKNIKC---DVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
             L           + + +V+    KG L N   LR+ G+  +S + +L+  L + E ++
Sbjct: 67  VILH----------NGLYIVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
                K +   HRDL   N+L++ D    + D G     + +V           V   + 
Sbjct: 115 YLESKKLV---HRDLAARNILVSEDGVAKVSDFG-----LARV-------GSMGVDNSKL 159

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF 251
            + + APE      +     ++DVWS G LL+ +  Y ++P+
Sbjct: 160 PVKWTAPEALKHKKF---SSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 72/240 (30%), Positives = 96/240 (40%), Gaps = 69/240 (28%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ------AIREVEHHKTF 80
           KY  +EKIGEG + TV   ++ +T +  ALK++    R D         A+RE+   K  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKEL 56

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD--- 137
            H NI+ L D         VL+S  ++ +V  Y  +     DL      K Y  S +   
Sbjct: 57  KHKNIVRLYD---------VLHSDKKLTLVFEYCDQ-----DL------KKYFDSCNGDI 96

Query: 138 ---ILKMF-------LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSV 186
              I+K F       L  C +  V          HRDLK  N LL N N  L L D G  
Sbjct: 97  DPEIVKSFMFQLLKGLAFCHSHNVL---------HRDLKPQN-LLINKNGELKLADFGLA 146

Query: 187 APAVVKV-CGSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
               + V C SAE   L           YR P+ LF    Y       D+WS GC+   +
Sbjct: 147 RAFGIPVRCYSAEVVTLW----------YRPPDVLFGAKLY---STSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 66/238 (27%), Positives = 95/238 (39%), Gaps = 54/238 (22%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL- 86
           + I+ ++G+GG+  V L +   T +  ALK++    ++     + EV H  T    +IL 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRM----KKSLLFKLNEVRHVLT--ERDILT 56

Query: 87  ----PLLDHALTGCADPVLNSTSQVLMVLPYYPKG---TLANDLELRSVG--KHYMSSVD 137
                 L   L    D        + + + Y P G   TL N+L + S    + YM+   
Sbjct: 57  TTKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA--- 108

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK---VC 194
             +MF    EAV   H+   + Y HRDLK  N L+    +  L D G     V     V 
Sbjct: 109 --EMF----EAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV 159

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           GS +               Y APE+     Y   D   D WSLGC+LY       PF 
Sbjct: 160 GSPD---------------YMAPEVLRGKGY---DFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 5e-10
 Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 41/228 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFV-H 82
           +  + +VE IGEG +  V    H +T +  A+K  I    ED+ + I+ E    + +  H
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 83  PNILPL----LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL--ELRSVGKHYMSSV 136
           PNI       +     G  D       Q+ +V+     G+   DL   LR  GK  +   
Sbjct: 63  PNIATFYGAFIKKNPPGNDD-------QLWLVMELCGGGS-VTDLVKGLRKKGKR-LKEE 113

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            I  +  +    +   H+ K I   HRD+K  N+LL  +    L+D G           S
Sbjct: 114 WIAYILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGV----------S 160

Query: 197 AEAQNLQDVAAERCSM---PY-RAPELFHVDSY--CVVDQRTDVWSLG 238
           A+   L      R +    PY  APE+   D       D R+DVWSLG
Sbjct: 161 AQ---LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.6 bits (141), Expect = 6e-10
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 31/226 (13%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 81  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 126

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G         C  A+    Q   
Sbjct: 127 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FC--AQITPEQSKR 173

Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 174 STMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 31/259 (11%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +K++ Y +V+ IG G F  V L+ H  T+K YA+K +       + + I+  +    +  
Sbjct: 40  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL------SKFEMIKRSDSAFFWEE 93

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            +I+   +                + MV+ Y P G L N           MS+ D+ + +
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----------LMSNYDVPEKW 143

Query: 143 LKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
            +    E V        + + HRD+K  N+LL    +  L D G+        C     +
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--------CMKMNKE 195

Query: 201 NLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
            +        +  Y +PE+      D Y    +  D WS+G  LY M    +PF      
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Query: 258 GDSVALAVISGNITFPENT 276
           G    +     ++TFP++ 
Sbjct: 254 GTYSKIMNHKNSLTFPDDN 272

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 65/230 (28%), Positives = 96/230 (41%), Gaps = 32/230 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           IG G ++ V L+   +  + YA+K   K + H  ED      + E H  F   +  P L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWV--QTEKH-VFEQASSNPFL- 58

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
             L  C      +TS++ +V+ Y   G    DL      +  +          +IC A+ 
Sbjct: 59  VGLHSC----FQTTSRLFLVIEYVNGG----DLMFHMQRQRKLPEEHARFYAAEICIALN 110

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H+ + I Y  RDLK  NVLL  D +  L D G        +C   E     D  +  C
Sbjct: 111 FLHE-RGIIY--RDLKLDNVLLDADGHIKLTDYG--------MC--KEGLGPGDTTSTFC 157

Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
             P Y APE+   + Y       D W+LG L++ M   +SPFD + +  D
Sbjct: 158 GTPNYIAPEILRGEEYGF---SVDWWALGVLMFEMMAGRSPFDIITDNPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.2 bits (141), Expect = 7e-10
 Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 47/226 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ----AIREVEHHKTFV 81
           +KY  + KIGEG +  V    + +T +  A+KK +    ED       A+RE+   K   
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLK 58

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN++ L++         V     ++ +V  Y    T+ N+LE    G   +    I K+
Sbjct: 59  HPNLVNLIE---------VFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIKKI 105

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ- 200
             +  +AV   H    I   HRD+K  N+L+                  +K+C    A+ 
Sbjct: 106 IWQTLQAVNFCHKHNCI---HRDVKPENILITKQG-------------QIKLCDFGFARI 149

Query: 201 ------NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
                 +  D  A R    YRAPEL   D+        DVW++GC+
Sbjct: 150 LTGPGDDYTDYVATRW---YRAPELLVGDT--QYGPPVDVWAIGCV 190

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +  Y +   IG G F  V       T ++ A+KK++    +D     RE+   K   H N
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHIN 120

Query: 85  ILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           I+ L D+  T C     N  +  L +V+ + P+        +    KHY  +   L +FL
Sbjct: 121 IIFLKDYYYTECFKK--NEKNIFLNVVMEFIPQ-------TVHKYMKHYARNNHALPLFL 171

Query: 144 ------KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
                 ++C A+   H +K I   HRDLK  N+L+  + + L            K+C   
Sbjct: 172 VKLYSYQLCRALAYIH-SKFIC--HRDLKPQNLLIDPNTHTL------------KLCDFG 216

Query: 198 EAQNL---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAM 244
            A+NL   Q   +  CS  YRAPEL     +Y       D+WSLGC++  M
Sbjct: 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT---HIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 50/271 (18%)

Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR 72
                 +    K   + + E +G G F  V + +H  T + YA+K +    ++ +   ++
Sbjct: 5   YMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL----KKREILKMK 60

Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           +V+H       +IL  L H             ++V  +L +   G L     LR  G+  
Sbjct: 61  QVQH--VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT--HLRKAGRF- 115

Query: 133 MSSVDILKMF-LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAP 188
               D+ K +  ++  A +  H  K I Y  RDLK  N+LL N  +  + D G    V  
Sbjct: 116 --PNDVAKFYHAELVLAFEYLHS-KDIIY--RDLKPENLLLDNKGHVKVTDFGFAKKVPD 170

Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC--- 245
               +CG+ E               Y APE+     +    +  D W++G LLY      
Sbjct: 171 RTFTLCGTPE---------------YLAPEVIQSKGH---GKAVDWWTMGVLLYEFIAGY 212

Query: 246 ---YFKSPFDTVYERGDSVALAVISGNITFP 273
              +  +PF   YE+       +++G + FP
Sbjct: 213 PPFFDDTPFRI-YEK-------ILAGRLKFP 235

Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVH 82
           K + Y  +EK+GEG ++TV       T+   ALK+I + H       AIREV   K   H
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS------SV 136
            NI+ L D         ++++   + +V  Y  K     DL      K YM       S+
Sbjct: 64  ANIVTLHD---------IVHTDKSLTLVFEYLDK-----DL------KQYMDDCGNIMSM 103

Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             +K+FL +I   +   H  K +   HRDLK  N+L+       L D G           
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVL---HRDLKPQNLLINERGELKLADFG---------LA 151

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A++   +  + E  ++ YR P++    S      + D+W +GC+ + M
Sbjct: 152 RAKSVPTKTYSNEVVTLWYRPPDVLLGSSE--YSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 42/233 (18%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-REVEHHKTFVH---P 83
           Y  +E IG G +  V   +H  T +  ALK I     +D    I REV           P
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI         G     L     + +++ Y   G++   ++   + + Y+S   I++  L
Sbjct: 63  NITKYY-----GS---YLKGPR-LWIIMEYAEGGSVRTLMKAGPIAEKYISV--IIREVL 111

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
               A+K  H    I   HRD+K AN+L+ N  N  L D G  A              L 
Sbjct: 112 ---VALKYIHKVGVI---HRDIKAANILVTNTGNVKLCDFGVAA-------------LLN 152

Query: 204 DVAAERCSM---PY-RAPELF-HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +++R +    PY  APE+      Y   D + D+WSLG  +Y M     P+
Sbjct: 153 QNSSKRSTFVGTPYWMAPEVITEGKYY---DTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 59/240 (24%), Positives = 86/240 (35%), Gaps = 33/240 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVH 82
             + +   +G G F  V ++    T   YA+K +   +   +E  +    E +       
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P I P L +A              + +V+ Y P G      +L S+   Y    D     
Sbjct: 61  PWI-PQLQYAF--------QDKDNLYLVMEYQPGG------DLLSLLNRYEDQFDEDMAQ 105

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV-KVCGSAEAQN 201
             + E V   H    + Y HRD+K  NVL+    +  L D GS A     K+  S     
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165

Query: 202 LQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPF--DTVYE 256
             D         Y APE+      D         D WSLG + Y M Y +SPF   T  +
Sbjct: 166 TPD---------YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 49/205 (23%), Positives = 76/205 (37%), Gaps = 40/205 (19%)

Query: 60  IC--HGREDQAQAI-----------REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ 106
           +C  HG E + + I           RE++  KT  H  I+ L+               S 
Sbjct: 110 VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIH---------AYRWKST 160

Query: 107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK 166
           V MV+P Y       DL         +     + +  ++ EA+   H    I   HRD+K
Sbjct: 161 VCMVMPKY-----KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGII---HRDVK 212

Query: 167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC 226
           T N+ L    N +L D G+        C      +         ++   +PEL  +D YC
Sbjct: 213 TENIFLDEPENAVLGDFGA-------ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 227 VVDQRTDVWSLGCLLYAMCYFKSPF 251
               +TD+WS G +L+ M       
Sbjct: 266 A---KTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 57.2 bits (138), Expect = 1e-09
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 41/232 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHG----REDQAQAI-----REVEHHKTFVHPN 84
           IG G F +V L  ++ + +  A+K++         +D+ +++     RE+   K   H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL-KMFL 143
           I+  L  +L             + + L Y P G++A  L       +Y +  + L + F+
Sbjct: 68  IVQYLGSSL---------DADHLNIFLEYVPGGSVAALLN------NYGAFEETLVRNFV 112

Query: 144 K-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEA 199
           + I + +   H+   I   HRD+K AN+L+ N     + D G    +    +    +   
Sbjct: 113 RQILKGLNYLHNRGII---HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +LQ       S+ + APE+    SY    ++ D+WSLGCL+  M   K PF
Sbjct: 170 PSLQG------SVFWMAPEVVKQTSY---TRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 26/233 (11%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPN 84
           KY+I   +G G   TV   +     + +A+K +   G    D+ +A  EV      ++ +
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC---CLLNCD 89

Query: 85  ILPLL----DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
              ++    D A     +P   +   + +VL Y   G L  +++ R+         +   
Sbjct: 90  FFSIVKCHEDFAKKDPRNPE--NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           +F+++  AV   H    I   HRD+K+AN+LL ++    L D G        V       
Sbjct: 148 LFIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD----- 199

Query: 201 NLQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
              DV    C  PY  APE++    Y    ++ D++SLG LLY +   K PFD
Sbjct: 200 ---DVGRTFCGTPYYVAPEIWRRKPY---SKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 64/261 (24%), Positives = 100/261 (38%), Gaps = 37/261 (14%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           +K++ Y +V+ IG G F  V L+ H  ++K YA+K   K     R D A    E +    
Sbjct: 40  MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P ++ L       CA         + MV+ Y P G L N           MS+ D+ 
Sbjct: 100 ANSPWVVQLF------CA---FQDDKYLYMVMEYMPGGDLVN----------LMSNYDVP 140

Query: 140 KMFLKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           + + K    E V        +   HRD+K  N+LL    +  L D G+        C   
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT--------CMKM 192

Query: 198 EAQNLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
           +   +        +  Y +PE+      D Y    +  D WS+G  L+ M    +PF   
Sbjct: 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLFEMLVGDTPFYAD 250

Query: 255 YERGDSVALAVISGNITFPEN 275
              G    +     ++ FPE+
Sbjct: 251 SLVGTYSKIMDHKNSLNFPED 271

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 65/234 (27%), Positives = 98/234 (41%), Gaps = 48/234 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHP 83
             +Y  +  IGEG +  V    H  T  + A+KKI     +   Q  +RE++  + F H 
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 84  NILPLLDHALTGCADPVLNSTS----------QVLMVLPYYPKGTLANDLELRSVGKHYM 133
           NI+ +LD         ++   S          Q LM            + +L  + K   
Sbjct: 64  NIIGILD---------IIRPPSFESFNDVYIVQELM------------ETDLYKLIKTQH 102

Query: 134 SSVDILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
            S D ++ FL +I   +K  H A  +   HRDLK +N+LL N N  L + D G    A +
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSANVL---HRDLKPSNLLL-NTNCDLKICDFGL---ARI 155

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
                     L +  A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 156 ADPEHDHTGFLTEYVATRW---YRAPEIMLNSKGY---TKAIDIWSVGCILAEM 203

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 39/260 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALK--KIICHGR---EDQAQAIREVEHHKTFV 81
           +Y + +++G+G F TV L++  +      LK  K I  G     +  QA +E +      
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND--LELRSVGKHYMSSVDIL 139
           HP I+      L                ++  Y +G   +    EL+  GK  +S   + 
Sbjct: 61  HPAIVKFHASFLE----------RDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVC 109

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
           + F+++   V   H  + +   HRDLK  N+ L N+    L+ +G    + + + GS   
Sbjct: 110 EWFIQLLLGVHYMHQRRIL---HRDLKAKNIFLKNN----LLKIGDFGVSRL-LMGSC-- 159

Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
               D+A      P Y +PE      Y   D ++D+WSLGC+LY MC     F+   +  
Sbjct: 160 ----DLATTFTGTPYYMSPEALKHQGY---DSKSDIWSLGCILYEMCCLAHAFEG--QNF 210

Query: 259 DSVALAVISGNI-TFPENTP 277
            SV L ++ G   + PE   
Sbjct: 211 LSVVLRIVEGPTPSLPETYS 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 38/226 (16%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKT 79
           D+Y  +  +G G +  V     ++T ++ A+KK+        H +    +  RE+   K 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKH 70

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H N++ LLD          L     V +V        +  DL    V    +S   I 
Sbjct: 71  MDHENVIGLLD---VFTPASSLEDFQDVYLVTHL-----MGADLN-NIVKCQKLSDDHIQ 121

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G        +    + 
Sbjct: 122 FLVYQILRGLKYIHSAGII---HRDLKPSNIAVNEDCELKILDFG--------LARHTDD 170

Query: 200 QNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           +    VA    +  YRAPE + +   Y   +Q  D+WS+GC++  +
Sbjct: 171 EMTGYVA----TRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 65/248 (26%), Positives = 99/248 (39%), Gaps = 33/248 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           I +G +  V L +   T   YA+K I        A  IR+ +  +     +IL       
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKK------ADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                        + +V+ Y P G LA+ LE  +VG   +          +I  A++  H
Sbjct: 55  VVKLYYSFQGKKNLYLVMEYLPGGDLASLLE--NVG--SLDEDVARIYIAEIVLALEYLH 110

Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKVC--GSAEAQNLQDVAAERC 210
               I   HRDLK  N+L+ ++ +  L D G S    V +       E ++ + V     
Sbjct: 111 SNGII---HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV----G 163

Query: 211 SMPYRAPE--LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF--DTVYERGDSVALAVI 266
           +  Y APE  L    S  V     D WSLGC+LY       PF  +T  E    +   ++
Sbjct: 164 TPDYIAPEVILGQGHSKTV-----DWWSLGCILYEFLVGIPPFHGETPEE----IFQNIL 214

Query: 267 SGNITFPE 274
           +G I +PE
Sbjct: 215 NGKIEWPE 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     T ++ A+KK+    ++ +     EV   + + HPNI+ +    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+   
Sbjct: 86  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 132 HAQGVI---HRDIKSDSILLTSDGRVKLSDFG--------FC----AQVSKEVPRRKSLV 176

Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APE+     Y       D+WSLG ++  M   + P+
Sbjct: 177 GTPYWMAPEVISRLPY---GTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.9 bits (134), Expect = 4e-09
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 31/226 (13%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A+K++    +  +   I E+   +   +PNI+
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 80  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 125

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A+   H  + I   HRD+K+ N+LL  D +  L D G         C  A+    Q   
Sbjct: 126 QALDFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FC--AQITPEQSKR 172

Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 173 STMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 35/230 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHKTFV 81
           +Y  ++++G G + +V      +T ++ A+KK+    R  Q++     A RE+   K   
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKRAYRELTLLKHMQ 72

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H N++ LLD   +       +      +V+PY          +L+ +  H +S   +  +
Sbjct: 73  HENVIGLLDVFTSA---VSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSEDKVQYL 122

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             ++   +K  H A  I   HRDLK  N+ +  D    ++D G        +   A+A+ 
Sbjct: 123 VYQMLCGLKYIHSAGII---HRDLKPGNLAVNEDCELKILDFG--------LARHADAEM 171

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              V        YRAPE+  + ++   +Q  D+WS+GC++  M   K+ F
Sbjct: 172 TGYVVTRW----YRAPEV--ILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.0 bits (135), Expect = 4e-09
 Identities = 62/235 (26%), Positives = 88/235 (37%), Gaps = 58/235 (24%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR---EVEH--------HKTFVH 82
           IG+G F  V L +H    K YA+K +       Q +AI    E +H         K   H
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVL-------QKKAILKKKEQKHIMAERNVLLKNVKH 55

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-----LRSVGKHYMSSVD 137
           P ++ L  H           +  ++  VL Y   G L   L+          + Y +   
Sbjct: 56  PFLVGL--HY-------SFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA--- 103

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
                 +I  A+   H    I   +RDLK  N+LL +  + +L D G        +C   
Sbjct: 104 ------EIASALGYLHSLNII---YRDLKPENILLDSQGHVVLTDFG--------LC--K 144

Query: 198 EAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           E        +  C  P Y APE+     Y   D+  D W LG +LY M Y   PF
Sbjct: 145 EGIEHSKTTSTFCGTPEYLAPEVLRKQPY---DRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 40/264 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQA--QAIREV---EHHKTF 80
           +Y  V +IGEG +  V      +   R+ ALK++     E+      IREV    H +TF
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVDI 138
            HPN++ L D     C     +  +++ +V  +     +  DL   L  V +  + +  I
Sbjct: 62  EHPNVVRLFDV----CTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETI 112

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
             M  ++   +   H  + +   HRDLK  N+L+ +     L D G       ++  ++ 
Sbjct: 113 KDMMFQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 169

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
              L           YRAPE+    SY       D+WS+GC+   M   K  F     RG
Sbjct: 170 VVTLW----------YRAPEVLLQSSYAT---PVDLWSVGCIFAEMFRRKPLF-----RG 211

Query: 259 DSVA--LAVISGNITFPENTPFPQ 280
            S    L  I   I  P    +P+
Sbjct: 212 SSDVDQLGKILDVIGLPGEEDWPR 235

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 44/230 (19%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVH 82
           K + Y  ++K+GEG ++TV       T+   ALK+I + H       AIREV   K   H
Sbjct: 3   KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS------SV 136
            NI+ L D         ++++   + +V  Y     L +DL      K Y+       S+
Sbjct: 63  ANIVTLHD---------IIHTERCLTLVFEY-----LDSDL------KQYLDNCGNLMSM 102

Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             +K+F+ ++   +   H  K +   HRDLK  N+L+       L D G           
Sbjct: 103 HNVKIFMFQLLRGLSYCHKRKIL---HRDLKPQNLLINEKGELKLADFG---------LA 150

Query: 196 SAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A++   +  + E  ++ YR P+ L     Y       D+W +GC+LY M
Sbjct: 151 RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST---PIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 60/226 (26%), Positives = 88/226 (38%), Gaps = 40/226 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI--REVEHHKTFVHPNILPLLDH 91
           IG+G F  V L  H   +K YA+K +       Q +AI  ++ E H       +L  + H
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-----LRSVGKHYMSSVDILKMFLKIC 146
                      +  ++  VL Y   G L   L+     L    + Y +         +I 
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIA 106

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
            A+   H    +   +RDLK  N+LL +  + +L D G        +C      N     
Sbjct: 107 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG--------LCKENIEHN--GTT 153

Query: 207 AERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  C  P Y APE+ H   Y   D+  D W LG +LY M Y   PF
Sbjct: 154 STFCGTPEYLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 30/229 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           D+Y  ++++G G + TV      +T  + A+KK+    + +    +A RE+   K   H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           N++ LLD       D  L+      +V+P+   GT     +L  + KH   S D ++  +
Sbjct: 75  NVIGLLD---VFTPDLSLDRFHDFYLVMPFM--GT-----DLGKLMKHEKLSEDRIQFLV 124

Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++ + +K  H A  I   HRDLK  N+ +  D    ++D G       ++ G       
Sbjct: 125 YQMLKGLKYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV----- 176

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                   +  YRAPE+  + ++    Q  D+WS+GC++  M   K  F
Sbjct: 177 -------VTRWYRAPEV--ILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 34/210 (16%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ---AIREVEHHKTFVHPNILPLL 89
           +IG G F  V      +T +  A+KK+   G++   +    I+EV   +   HPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI--- 78

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     + +
Sbjct: 79  --EYKGCY--LREHTAWLVM---EYCLGSASDILE---VHKKPLQEVEIAAICHGALQGL 128

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H  + I   HRD+K  N+LL       L D GS +              L   A   
Sbjct: 129 AYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSAS--------------LVSPANSF 171

Query: 210 CSMPY-RAPELFHVDSYCVVDQRTDVWSLG 238
              PY  APE+         D + DVWSLG
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 22/228 (9%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D + I++ IG G F  V++++   T++ YA+K +      ++ + ++  E        N+
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL------NKWEMLKRAETACFREERNV 54

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L   D              + + +V+ YY  G L   L L S  +  +   D+ + +  I
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL---LTLLSKFEDRLPE-DMARFY--I 108

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            E V   H    + Y HRD+K  NVLL  + +  L D GS     +K+      Q+   V
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGS----CLKMNQDGTVQSSVAV 164

Query: 206 AAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                +  Y +PE+     D         D WSLG  +Y M Y ++PF
Sbjct: 165 G----TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 23/221 (10%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAI-REVEHHKTFVHPNILPLLD 90
           KIG G F  V    +  T +  A+K+I I        + I  E++  +   HPN++    
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                    V     +V + + Y   GTL   LE   +   ++  V  L++     E + 
Sbjct: 67  ---------VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL----EGLA 113

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H    +   HRD+K AN+ L ++    L D G      +K   +   + +Q +A    
Sbjct: 114 YLHSHGIV---HRDIKPANIFLDHNGVIKLGDFGCAV--KLKNNTTTMGEEVQSLAG--- 165

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  Y APE+          +  D+WSLGC++  M   K P+
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 32/222 (14%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+GGF  V   +   T K YA KK+      D+ +  +            IL  +    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL------DKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELR----SVGKHYMSSVDILKMFLKICEAV 149
                    +   + +V+      TL N  +L+    +VG+        +    +I   +
Sbjct: 55  IVSLAYAFETKDDLCLVM------TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL 108

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +  H  + I Y  RDLK  NVLL +  N  + DLG           + E +  + +    
Sbjct: 109 EHLHQRR-IVY--RDLKPENVLLDDHGNVRISDLGL----------AVELKGGKKIKGRA 155

Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +  Y APE+   + Y   D   D ++LGC LY M   +SPF
Sbjct: 156 GTPGYMAPEVLQGEVY---DFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 60/264 (22%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR----EVEHHKTFVHPNILPL 88
           +G+G F  V L     T +  A+K++       +  + +     E++  K   H  I+  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL-----RSVGKHYMSSVDILKMFL 143
                 GC    L     + + + Y P G++ + L+       +V + Y           
Sbjct: 70  Y-----GC----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--------- 111

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I E V+  H    +   HRD+K AN+L  +  N  L D G+             ++ LQ
Sbjct: 112 QILEGVEYLHSNMIV---HRDIKGANILRDSAGNVKLGDFGA-------------SKRLQ 155

Query: 204 DVAAERCSM------PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
            + +    M      PY  +PE+   + Y    ++ DVWS+GC +  M   K P+   +E
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVISGEGY---GRKADVWSVGCTVVEMLTEKPPWAE-FE 211

Query: 257 RGDSVALAVISGNITFPENTPFPQ 280
                A+A I    T P N   P 
Sbjct: 212 -----AMAAIFKIATQPTNPQLPS 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 30/258 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + +  ++ I  G +  V L+ H +T++R+A+KKI       Q   +R  +  + FV  +I
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI-----NKQNLILRN-QIQQVFVERDI 54

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM-FLK 144
           L   ++           +   + MV+ Y   G  A    L+++G      VD+ +M F +
Sbjct: 55  LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT--LLKNIGA---LPVDMARMYFAE 109

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC-----GSAEA 199
              A++  H+       HRDLK  N+L+ +  +  L D G     ++ +      G  E 
Sbjct: 110 TVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF--DTVYE 256
              + +  + C  P Y APE+     Y    +  D W++G +LY       PF  DT  E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGY---GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Query: 257 RGDSVALAVISGNITFPE 274
               +   VIS +I +PE
Sbjct: 224 ----LFGQVISDDIEWPE 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 37/226 (16%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           I+EK+GEG + +V    H +T +  A+K +     ED  + I+E+   K    P I+   
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                          + + +V+ Y   G++ +D+ ++   K  ++  +I  +  +  + +
Sbjct: 65  GSYFKN---------TDLWIVMEYCGAGSV-SDI-MKITNKT-LTEEEIAAILYQTLKGL 112

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +  H  K I   HRD+K  N+LL  +    L D G              +  L D  A+R
Sbjct: 113 EYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGV-------------SGQLTDTMAKR 156

Query: 210 CSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            ++   P+  APE+     Y   + + D+WSLG     M   K P+
Sbjct: 157 NTVIGTPFWMAPEVIQEIGY---NNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.3 bits (125), Expect = 6e-08
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVH 82
           K + Y  ++K+GEG ++TV       T    ALK+I + H       AIREV   K   H
Sbjct: 4   KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM----SSVDI 138
            NI+ L D         ++++   + +V  Y  K     DL      K Y+    +S+++
Sbjct: 64  ANIVTLHD---------IIHTEKSLTLVFEYLDK-----DL------KQYLDDCGNSINM 103

Query: 139 --LKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             +K+FL ++   +   H  K +   HRDLK  N+L+       L D G           
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVL---HRDLKPQNLLINERGELKLADFG---------LA 151

Query: 196 SAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A++   +  + E  ++ YR P+ L     Y     + D+W +GC+ Y M
Sbjct: 152 RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST---QIDMWGVGCIFYEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 51.9 bits (124), Expect = 9e-08
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 50/234 (21%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREV---EHHKTFV 81
           +Y  V +IG G + TV       +    ALK +     ED      +REV   +  + F 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV----- 136
           HPNI+ L+D     CA    +  ++V +V  +        D +LR+    Y+  V     
Sbjct: 61  HPNIVRLMDV----CATSRTDRETKVTLVFEHV-------DQDLRT----YLDKVPPPGL 105

Query: 137 ------DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
                 D+++ FL+    +   H    +   HRDLK  N+L+ +     L D G    A 
Sbjct: 106 PAETIKDLMRQFLR---GLDFLHANCIV---HRDLKPENILVTSGGQVKLADFGL---AR 156

Query: 191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           +  C  A    L  V     ++ YRAPE+    +Y       D+WS+GC+   M
Sbjct: 157 IYSCQMA----LTPVVV---TLWYRAPEVLLQSTYAT---PVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 36/233 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           ++ + I+ ++G+G F  V   ++ +T    A K I     E+    + E+E   T  HP 
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFL 143
           I+ LL                ++ +++ + P G + A  LEL       ++   I  +  
Sbjct: 71  IVKLLG---------AFYWDGKLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVICR 117

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++ EA++  H  K I   HRDLK  NVLL  D +  L D G              A+N++
Sbjct: 118 QMLEALQYLHSMKII---HRDLKAGNVLLTLDGDIKLADFG------------VSAKNVK 162

Query: 204 DVAAERCSM---PY-RAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSP 250
            +   R S    PY  APE+   ++      D + D+WSLG  L  M   + P
Sbjct: 163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 40/235 (17%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI----ICHGREDQAQ-----AIR-EVEHHKTFV 81
           E IG+G +  V L  +  T +  A+K++       GR D  Q     A+R E+E  K   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H NI+  L     G       +   + + L Y P G++ +   LR+ G+       +++ 
Sbjct: 67  HLNIVQYL-----GFE----TTEEYLSIFLEYVPGGSIGS--CLRTYGRF---EEQLVRF 112

Query: 142 FL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           F  ++ E +   H    +   HRDLK  N+L+  D    + D G ++     +  + +  
Sbjct: 113 FTEQVLEGLAYLHSKGIL---HRDLKADNLLVDADGICKISDFG-ISKKSDDIYDNDQNM 168

Query: 201 NLQDVAAERCSMPYRAPELFHVD--SYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
           ++Q       S+ + APE+ H     Y     + D+WSLGC++  M   + P+  
Sbjct: 169 SMQG------SVFWMAPEVIHSYSQGY---SAKVDIWSLGCVVLEMFAGRRPWSD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 36/224 (16%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 87  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLKALSVL 132

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSM 212
           H    I   HRD+K+ ++LL +D    L D G  A        S E    + +       
Sbjct: 133 HAQGVI---HRDIKSDSILLTHDGRVKLSDFGFCAQV------SKEVPRRKSLVG----T 179

Query: 213 PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-----YFKSP 250
           PY  APEL     Y       D+WSLG ++  M      YF  P
Sbjct: 180 PYWMAPELISRLPY---GPEVDIWSLGIMVIEMVDGEPPYFNEP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 63/239 (26%), Positives = 92/239 (38%), Gaps = 45/239 (18%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G +  V       T+ R A+K+I             E+  H    H NI+  L    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL---- 71

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-ICEAVKVF 152
            G      N   ++ M     P G+L+  L LRS       +   +  + K I E +K  
Sbjct: 72  -GSD--SENGFFKIFM--EQVPGGSLS-AL-LRSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG-SVAPAVVKVCGSAEAQNLQDVAAERC 210
           HD + +   HRD+K  NVL+   +  + + D G S   A +  C       LQ       
Sbjct: 125 HDNQIV---HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ------- 174

Query: 211 SMPYRAPELFHVDSYCVVDQ-------RTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
              Y APE        V+D+         D+WSLGC +  M   K PF    E G+  A
Sbjct: 175 ---YMAPE--------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQA 219

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 34/253 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L     T +  A K++      +  +  +EV   +  +   +L  L H  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQV--QFDPESPETSKEVSALECEIQ--LLKNLQHER 65

Query: 94  T----GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                GC       T  + M   Y P G++ +  +L++ G   ++     K   +I E +
Sbjct: 66  IVQYYGCLRDRAEKTLTIFM--EYMPGGSVKD--QLKAYGA--LTESVTRKYTRQILEGM 119

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H    +   HRD+K AN+L  +  N  L D G+ +  +  +C S     ++ V    
Sbjct: 120 SYLHSNMIV---HRDIKGANILRDSAGNVKLGDFGA-SKRLQTICMSGTG--IRSVTG-- 171

Query: 210 CSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG 268
              PY  +PE+   + Y    ++ DVWSLGC +  M   K P+   YE     A+A I  
Sbjct: 172 --TPYWMSPEVISGEGY---GRKADVWSLGCTVVEMLTEKPPW-AEYE-----AMAAIFK 220

Query: 269 NITFPENTPFPQY 281
             T P N   P +
Sbjct: 221 IATQPTNPQLPSH 233

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 35/222 (15%)

Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPN 84
           +  +GEG F  VSL      +  T +  A+K  K  C G+++ +   +E+   KT  H N
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHEN 67

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+        GC          + +++ Y P G+L + L      KH ++   +L    +
Sbjct: 68  IV-----KYKGCCSE--QGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQ 115

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           ICE +   H      Y HRDL   NVLL ND    + D G +A AV       E      
Sbjct: 116 ICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEYYR 165

Query: 205 VAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           V  E    P  + A E    + +      +DVWS G  LY +
Sbjct: 166 V-REDGDSPVFWYAVECLKENKFSYA---SDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 54/221 (24%), Positives = 80/221 (36%), Gaps = 50/221 (22%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G GGF  V L++     + +ALK +    ++       + EH   F    IL   +H  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQQEH--IFSEKEILEECNHPF 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG-------KHYMSSVDILKMFLKIC 146
                        + M++ Y   G L     LR  G       + Y++          + 
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWT--ILRDRGLFDEYTARFYIAC---------VV 103

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK-----VCGSAEAQN 201
            A +  H+ + I Y  RDLK  N+LL ++    L+D G              CG+ E   
Sbjct: 104 LAFEYLHN-RGIIY--RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE--- 157

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
                       Y APE+     Y   D   D WSLG LLY
Sbjct: 158 ------------YVAPEIILNKGY---DFSVDYWSLGILLY 183

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 34/231 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + I+ ++G+G F  V   ++ +T    A K I     E+    + E++   +  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFLK 144
           + LLD              + + +++ +   G + A  LEL    +  ++   I  +  +
Sbjct: 65  VKLLD---------AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQ 111

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             EA+   H+ K I   HRDLK  N+L   D +  L D G              A+N + 
Sbjct: 112 TLEALNYLHENKII---HRDLKAGNILFTLDGDIKLADFG------------VSAKNTRT 156

Query: 205 VAAERC--SMPY-RAPELFHVDSYC--VVDQRTDVWSLGCLLYAMCYFKSP 250
           +         PY  APE+   ++      D + DVWSLG  L  M   + P
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 44/219 (20%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVHPNILPLLDH 91
           IG G F  V  +   +  KR ALKK+  +        +  RE++    F H N+L  LD 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD- 66

Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-KICEAVK 150
                  P      + + V+       + +DL    V    +SS D +K+FL +I   +K
Sbjct: 67  ----ILQPPHIDPFEEIYVV----TELMQSDLHKIIVSPQPLSS-DHVKVFLYQILRGLK 117

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD---V 205
             H A  +   HRD+K  N LL N N             V+K+C  G A  +   +   +
Sbjct: 118 YLHSAGIL---HRDIKPGN-LLVNSN------------CVLKICDFGLARVEEPDESKHM 161

Query: 206 AAERCSMPYRAPELF----HVDSYCVVDQRTDVWSLGCL 240
             E  +  YRAPE+     H  S        D+WS+GC+
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTS------AVDIWSVGCI 194

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 45/220 (20%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ------AIREVEHHKTFVHPNIL 86
           +IGEG +  V     + + +  ALKK+    R D  +      ++RE+       HPNI+
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKV----RMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
            L    + G           + +V+ Y  +  LA+ L+         S   +  + L++ 
Sbjct: 70  ELK-EVVVG------KHLDSIFLVMEYCEQ-DLASLLDNMPTP---FSESQVKCLMLQLL 118

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
             ++  H+   I   HRDLK +N+LL  D               +K+     A+     A
Sbjct: 119 RGLQYLHENFII---HRDLKVSNLLL-TDK------------GCLKIADFGLARTYGLPA 162

Query: 207 AER----CSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
                   ++ YRAPE L    +Y       D+W++GC+L
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTY---TTAIDMWAVGCIL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 36/224 (16%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     T K+ A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L +  A+   
Sbjct: 89  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYL 134

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSM 212
           H+   I   HRD+K+ ++LL +D    L D G  A        S E    + +       
Sbjct: 135 HNQGVI---HRDIKSDSILLTSDGRIKLSDFGFCAQV------SKEVPKRKSLVG----T 181

Query: 213 PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-----YFKSP 250
           PY  APE+     Y       D+WSLG ++  M      YF  P
Sbjct: 182 PYWMAPEVISRLPY---GTEVDIWSLGIMVIEMIDGEPPYFNEP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 22/180 (12%)

Query: 101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAY 160
             S  ++L+++ Y   G L   ++ R          ++  +F +I  A+   H  K +  
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMM-- 191

Query: 161 AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYR-APEL 219
            HRDLK+AN+ L       L D G        V          DVA+  C  PY  APEL
Sbjct: 192 -HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS--------LDVASSFCGTPYYLAPEL 242

Query: 220 FHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFP 279
           +    Y    ++ D+WSLG +LY +     PF    +R   +   V+ G        PFP
Sbjct: 243 WERKRY---SKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQVLYGKY-----DPFP 292

Length = 478

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 59/228 (25%), Positives = 87/228 (38%), Gaps = 44/228 (19%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK----KIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           IG+G F  V L +     K YA+K    KI+ + +E +          K   HP ++ L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDILKMFLK 144
                        +T ++  VL +   G L   L+          + Y +         +
Sbjct: 62  --------HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA---------E 104

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A+   H    +   +RDLK  N+LL +  + +L D G        +C    AQ+  D
Sbjct: 105 IASALGYLHSINIV---YRDLKPENILLDSQGHVVLTDFG--------LCKEGIAQS--D 151

Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                C  P Y APE+     Y   D   D W LG +LY M Y   PF
Sbjct: 152 TTTTFCGTPEYLAPEVIRKQPY---DNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 3e-07
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 32/224 (14%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QAIREVEHHKTFVH 82
           K+D Y  +EK+GEG ++TV   +     K  ALK I     E     AIRE    K   H
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+ L D          +  T + L ++  Y    L   ++    G H     + +K+F
Sbjct: 63  ANIVLLHD----------IIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLF 108

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           L ++   +   H    +   HRDLK  N+L+++     L D G            A++  
Sbjct: 109 LFQLLRGLSYIHQRYIL---HRDLKPQNLLISDTGELKLADFG---------LARAKSVP 156

Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
               + E  ++ YR P+ L     Y       D+W +GC+   M
Sbjct: 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTC---LDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 51/234 (21%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIIC-----HGREDQAQAIREVEHHKTFVHPNIL 86
           E +G G F +V    +      +A+K++        G+E   Q  +E+       HPNI+
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD-ILKMFLK- 144
             L                 + + L   P G+LA  L      K Y S  + +++++ + 
Sbjct: 66  QYLGTEREE---------DNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQ 110

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I   ++  HD   +   HRD+K AN+L+  +    L D G +A  VV+            
Sbjct: 111 ILLGLEYLHDRNTV---HRDIKGANILVDTNGVVKLADFG-MAKQVVE----------FS 156

Query: 205 VAAERCSMPY-RAPELFHVDSYCVVDQR------TDVWSLGCLLYAMCYFKSPF 251
            A      PY  APE        V+ Q+       D+WSLGC +  M   K P+
Sbjct: 157 FAKSFKGSPYWMAPE--------VIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII-CHGRED-QAQAIREVEHHKTFVHP 83
           +K+ ++  +GEG +  V    H +TK+  A+KK       E+ +   +RE++  +T    
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L +               ++ +V  Y  K    N LEL    +   + V   K+  
Sbjct: 61  NIVELKE---------AFRRRGKLYLVFEYVEK----NMLELL---EEMPNGVPPEKVRS 104

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I + +K  H        HRD+K  N+L+++++   L D G       +        N  
Sbjct: 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFG-----FARNLSEGSNANYT 159

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           +  A R    YR+PEL     Y    +  D+WS+GC+L
Sbjct: 160 EYVATRW---YRSPELLLGAPY---GKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 64/255 (25%), Positives = 96/255 (37%), Gaps = 47/255 (18%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           IG+G F  V  +    T++ YA+K +     + +  A +EV H  T    NIL  +   L
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL----SKKEIVAKKEVAH--TIGERNIL--VRTLL 52

Query: 94  TGCADPV-----LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                 V       + S + +V  Y   G L   L+         +   I ++ L    A
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL----A 108

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK------VCGSAEAQNL 202
           ++  H    +   +RDLK  N+LL    +  L D G     +         CG+ E    
Sbjct: 109 LEHLHKYDIV---YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTE---- 161

Query: 203 QDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
                      Y APE L     Y    +  D WSLG L++ MC   SPF    E    +
Sbjct: 162 -----------YLAPEVLLDEKGY---TKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQM 205

Query: 262 ALAVISGNITFPENT 276
              +  G + FP+N 
Sbjct: 206 YRNIAFGKVRFPKNV 220

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 42/184 (22%)

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP+++ + D  ++G             MVLP+Y    L   L  RS       ++ I K 
Sbjct: 116 HPSVIRMKDTLVSGAI---------TCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK- 164

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS-----VAPAVVKVCGS 196
             +I E ++  H  + I   HRD+KT N+ + + +   + DLG+     VAPA + + G+
Sbjct: 165 --QILEGLRYLHAQRII---HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
            E                 APE+   D Y   + + D+WS G +L+ M  + S   T++E
Sbjct: 220 VETN---------------APEVLARDKY---NSKADIWSAGIVLFEMLAYPS---TIFE 258

Query: 257 RGDS 260
              S
Sbjct: 259 DPPS 262

Length = 357

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 6e-07
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 42/230 (18%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           IG G ++ V L+   +T++ YA+K   K + +  ED      + E H  F   +  P L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWV--QTEKH-VFEQASNHPFL- 58

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDILKMFLKI 145
             L  C      + S++  V+ Y   G L   ++ +        + Y + + +       
Sbjct: 59  VGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------- 107

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
             A+   H+   I   +RDLK  NVLL ++ +  L D G        +C   E     D 
Sbjct: 108 --ALNYLHERGII---YRDLKLDNVLLDSEGHIKLTDYG--------MC--KEGLRPGDT 152

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
            +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.4 bits (118), Expect = 6e-07
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRED-QAQAIREVEHHKTFVHP 83
           DK+ I+ +IGEG +  V       T +  ALKK+ + + +E     AIRE++  +   H 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 84  NILPLLDHALTGCADPV--LNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDILK 140
           NI+ L +  +T   D +          +V  Y     + +DL  L   G  + S   I  
Sbjct: 67  NIVNLKE-IVTDKQDALDFKKDKGAFYLVFEY-----MDHDLMGLLESGLVHFSEDHIKS 120

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              ++ E +   H      + HRD+K +N+LL N     L D G        +     ++
Sbjct: 121 FMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG--------LARLYNSE 169

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR----TDVWSLGCLL 241
             +    +  ++ YR PEL       + ++R     DVWS GC+L
Sbjct: 170 ESRPYTNKVITLWYRPPELL------LGEERYGPAIDVWSCGCIL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + Y ++++IG G +  V       T +  A+K I     +D     +E+   K   HPNI
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +      L            ++ +V+ Y   G+L    ++  V +  +S + I      +
Sbjct: 63  VAYFGSYL---------RRDKLWIVMEYCGGGSLQ---DIYQVTRGPLSELQIAY----V 106

Query: 146 C-EAVK---VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           C E +K     H+   I   HRD+K AN+LL  D +  L D G V+           AQ 
Sbjct: 107 CRETLKGLAYLHETGKI---HRDIKGANILLTEDGDVKLADFG-VS-----------AQ- 150

Query: 202 LQDVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
           L    A+R S    PY  APE+  V+     D + D+W+LG
Sbjct: 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 7e-07
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 50/219 (22%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +E+IG+G F  V     ++TK+  A+K I     ED+   I +++   T           
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE---IEDIQQEIT----------- 54

Query: 91  HALTGCADPVLN-------STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
             L+ C  P +          +++ +++ Y   G+  + L+   + + Y+++  IL+  L
Sbjct: 55  -VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREIL 111

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           K    +   H  + I   HRD+K ANVLL+   +  L D G              A  L 
Sbjct: 112 K---GLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGV-------------AGQLT 152

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
           D   +R +    P+  APE+    +Y   D + D+WSLG
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAY---DFKADIWSLG 188

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 48.9 bits (116), Expect = 8e-07
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 50/219 (22%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +EKIG+G F  V     ++T+K  A+K I     ED+   I +++   T           
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE---IEDIQQEIT----------- 54

Query: 91  HALTGCADPVLNS-------TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
             L+ C  P +          +++ +++ Y   G+  + LE   + +  +++  IL+  L
Sbjct: 55  -VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREIL 111

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           K    +   H  K I   HRD+K ANVLL+      L D G              A  L 
Sbjct: 112 K---GLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGV-------------AGQLT 152

Query: 204 DVAAER---CSMPY-RAPELFHVDSYCVVDQRTDVWSLG 238
           D   +R      P+  APE+    +Y   D + D+WSLG
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLG 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.9 bits (116), Expect = 8e-07
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 50/219 (22%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +E+IG+G F  V     ++T++  A+K I     ED+   I +++   T           
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE---IEDIQQEIT----------- 54

Query: 91  HALTGCADPVLNS-------TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
             L+ C  P +          +++ +++ Y   G+    L+L   G        I  M  
Sbjct: 55  -VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGP--FDEFQIATMLK 108

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I + +   H  K I   HRD+K ANVLL+   +  L D G              A  L 
Sbjct: 109 EILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGV-------------AGQLT 152

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
           D   +R +    P+  APE+    +Y   D + D+WSLG
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIQQSAY---DSKADIWSLG 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 9e-07
 Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 38/225 (16%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL------P 87
           +G+G F  V L E   T + +A+K +    ++D      +VE   T V   +L      P
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKAL----KKDVVLEDDDVE--CTMVERRVLALAWEHP 56

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
            L H    C      +   +  V+ Y   G L     ++S G+   +         +I  
Sbjct: 57  FLTHLF--CT---FQTKEHLFFVMEYLNGGDLM--FHIQSSGRFDEARARFYAA--EIIC 107

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            ++  H  K I Y  RDLK  NVLL  D +  + D G        +C   E  N +  A+
Sbjct: 108 GLQFLH-KKGIIY--RDLKLDNVLLDKDGHIKIADFG--------MC--KENMNGEGKAS 154

Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             C  P Y APE+     Y   ++  D WS G LLY M   +SPF
Sbjct: 155 TFCGTPDYIAPEILKGQKY---NESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.9 bits (116), Expect = 9e-07
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 39/225 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+G F  V L+    + K YA   LKK +   +++ A  + E    K   HP  L  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSLK 61

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF-LKICEAV 149
           ++          +  ++  V+ Y   G L   L      +  + S D  + +  +I  A+
Sbjct: 62  YS--------FQTKDRLCFVMEYVNGGELFFHLS-----RERVFSEDRTRFYGAEIVSAL 108

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H  K +   +RDLK  N++L  D +  + D G        +C     + + D A  +
Sbjct: 109 DYLHSGKIV---YRDLKLENLMLDKDGHIKITDFG--------LC----KEGITDAATMK 153

Query: 210 --CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             C  P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 154 TFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 35/232 (15%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICH-----GREDQAQAIRE-VEHHKTFVHPNI 85
           E +G+G + TV     +Q  +  A+K++          E + + ++E V+  K+  H NI
Sbjct: 6   EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL--KMFL 143
           +  L   L             + + + + P G+++      S+   +    + +  K   
Sbjct: 65  VQYLGTCLDDNT---------ISIFMEFVPGGSIS------SILNRFGPLPEPVFCKYTK 109

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I + V   H+   +   HRD+K  NV+L  +    L+D G       ++          
Sbjct: 110 QILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCAR----RLAWVGLHGTHS 162

Query: 204 DVAAERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
           ++       PY  APE+ +   Y    +++D+WS+GC ++ M   K P  ++
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGY---GRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 62/247 (25%), Positives = 96/247 (38%), Gaps = 69/247 (27%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEH-HKTFVHPNI---- 85
            +IG G F TV+ + H  +    A+K+I      ++Q + + +++   ++   P I    
Sbjct: 10  GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 86  ------------LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
                       + L+D +L      V      V+      P+  L         GK  +
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVYEVLKSVI------PEEIL---------GKIAV 114

Query: 134 SSV---DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
           ++V   + LK  LKI                HRD+K +N+LL  + N  L D G      
Sbjct: 115 ATVKALNYLKEELKII---------------HRDVKPSNILLDRNGNIKLCDFG------ 153

Query: 191 VKVCGSAEAQNLQD-VAAER---CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
             + G      L D +A  R   C  PY APE     +    D R+DVWSLG  LY +  
Sbjct: 154 --ISG-----QLVDSIAKTRDAGCR-PYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Query: 247 FKSPFDT 253
            K P+  
Sbjct: 206 GKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 51/233 (21%), Positives = 95/233 (40%), Gaps = 56/233 (24%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
           + + ++E IG+G F  V      +T +  A+K I +    ++     +E+     F    
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEI----QF---- 52

Query: 85  ILPLLDHALTGCADP---------VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
                   L+ C  P         +  S   ++M   Y   G+  + L+   + + Y++ 
Sbjct: 53  --------LSQCRSPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGKLDETYIAF 102

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             IL+   ++   ++  H+   I   HRD+K AN+LL+ + +  L D G        V G
Sbjct: 103 --ILR---EVLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFG--------VSG 146

Query: 196 SAEAQNLQDVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                 L    ++R +    P+  APE+     Y   D++ D+WSLG     +
Sbjct: 147 Q-----LTSTMSKRNTFVGTPFWMAPEVIKQSGY---DEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 23/215 (10%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
           D Y ++E IG G  + V         ++ A+K+I +   +    +  +EV+      HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++       T           ++ +V+PY   G+L  D+   S  +  +    I  +  +
Sbjct: 61  VV----KYYTS-----FVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKE 110

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + + ++  H    I   HRD+K  N+LL  D +  + D G  A        + + +    
Sbjct: 111 VLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK--T 165

Query: 205 VAAERCSMPYRAPELFH-VDSYCVVDQRTDVWSLG 238
                C M   APE+   V  Y   D + D+WS G
Sbjct: 166 FVGTPCWM---APEVMEQVHGY---DFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 34/225 (15%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILP 87
           + +IG G F  V    +S T +  A+KK+   G+   E     I+EV+  +   HPN + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI- 84

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                  GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     +
Sbjct: 85  ----EYKGCY--LKEHTAWLVM---EYCLGSASDLLE---VHKKPLQEVEIAAITHGALQ 132

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H    I   HRD+K  N+LL       L D GS + +                A 
Sbjct: 133 GLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKS--------------SPAN 175

Query: 208 ERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                PY  APE+         D + DVWSLG     +   K P 
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 65/258 (25%), Positives = 108/258 (41%), Gaps = 58/258 (22%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL------P 87
           +G+G F  V L E   T + YA+K +    ++D      +VE   T V   +L      P
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKIL----KKDVVIQDDDVEC--TMVEKRVLALSGKPP 61

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-------YMSSVDILK 140
            L   L  C      +  ++  V+ Y   G L    +++ VG+        Y + + I  
Sbjct: 62  FLTQ-LHSC----FQTMDRLYFVMEYVNGGDLM--YQIQQVGRFKEPHAVFYAAEIAIGL 114

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
            FL           +K I Y  RDLK  NV+L ++ +  + D G        +C     +
Sbjct: 115 FFLH----------SKGIIY--RDLKLDNVMLDSEGHIKIADFG--------MC----KE 150

Query: 201 NLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
           N+ D    +  C  P Y APE+     Y    +  D W+ G LLY M   ++PF+   E 
Sbjct: 151 NMWDGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEG--ED 205

Query: 258 GDSVALAVISGNITFPEN 275
            D +  +++  N+ +P++
Sbjct: 206 EDELFQSIMEHNVAYPKS 223

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 64/240 (26%), Positives = 92/240 (38%), Gaps = 56/240 (23%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYA---LKK--IICHGREDQAQAI----REVEHHKTFVHPN 84
           +G G F  V L E+ +T + YA   LKK  II     D+ +++    R  E   +  HP 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDII---ARDEVESLMCEKRIFETANSERHPF 63

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA----NDLELRSVGKHYMSSVDILK 140
           ++ L       C      +   V  V+ Y   G L      D+        Y + V    
Sbjct: 64  LVNLF-----AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV---- 110

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
                   ++  H+ K I Y  RDLK  N+LL  +    + D G        +C   E  
Sbjct: 111 -----VLGLQYLHENK-IVY--RDLKLDNLLLDTEGFVKIADFG--------LC--KEGM 152

Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
              D  +  C  P + APE+    SY    +  D W LG L+Y M   +SPF      GD
Sbjct: 153 GFGDRTSTFCGTPEFLAPEVLTETSY---TRAVDWWGLGVLIYEMLVGESPF-----PGD 204

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 56/257 (21%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH-- 91
           +G+G F  V L E   T + YA+K +    ++D      +VE   T V   +L L D   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKIL----KKDVVIQDDDVEC--TMVEKRVLALQDKPP 61

Query: 92  ---ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-------YMSSVDILKM 141
               L  C      +  ++  V+ Y   G L     ++ VGK        Y + + +   
Sbjct: 62  FLTQLHSC----FQTVDRLYFVMEYVNGGDLM--YHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           FL            + I Y  RDLK  NV+L ++ +  + D G        +C     ++
Sbjct: 116 FLH----------RRGIIY--RDLKLDNVMLDSEGHIKIADFG--------MC----KEH 151

Query: 202 LQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
           + D    R  C  P Y APE+     Y    +  D W+ G LLY M   + PFD   E  
Sbjct: 152 MVDGVTTRTFCGTPDYIAPEIIAYQPY---GKSVDWWAYGVLLYEMLAGQPPFDG--EDE 206

Query: 259 DSVALAVISGNITFPEN 275
           D +  +++  N+++P++
Sbjct: 207 DELFQSIMEHNVSYPKS 223

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 47.8 bits (113), Expect = 2e-06
 Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 34/225 (15%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ---AIREVEHHKTFVHPNILP 87
           + +IG G F  V      +T +  A+KK+   G++   +    I+EV+  +   HPN + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI- 88

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                  GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     +
Sbjct: 89  ----EYKGCY--LREHTAWLVM---EYCLGSASDLLE---VHKKPLQEVEIAAITHGALQ 136

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H    I   HRD+K  N+LL       L D GS +              +   A 
Sbjct: 137 GLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSAS--------------IASPAN 179

Query: 208 ERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                PY  APE+         D + DVWSLG     +   K P 
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 61/249 (24%), Positives = 96/249 (38%), Gaps = 44/249 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+G F  V L E   T + YA   LKK +    +D    + E    +        P L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE---KRVLALAGKHPFLT 59

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL-----RSVGKHYMSSVDILKMFLKI 145
             L  C      +  ++  V+ Y   G L   ++          + Y + + +   FL  
Sbjct: 60  Q-LHSC----FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL-- 112

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
                  H+ + I Y  RDLK  NVLL ++ +  + D G        +C   E       
Sbjct: 113 -------HE-RGIIY--RDLKLDNVLLDSEGHIKIADFG--------MC--KEGILGGVT 152

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA 264
            +  C  P Y APE+     Y       D W+LG LLY M   +SPF+   E  D +  +
Sbjct: 153 TSTFCGTPDYIAPEILSYQPY---GPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQS 207

Query: 265 VISGNITFP 273
           ++   + +P
Sbjct: 208 ILEDEVRYP 216

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 36/239 (15%)

Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + V+   ++Y  +  +G G + +V     ++ +++ A+KK+      + H R    +  R
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHAR----RTYR 63

Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD   T      + + ++V +V        +  DL    V    
Sbjct: 64  ELRLLKHMKHENVIGLLD-VFTPATS--IENFNEVYLV-----TNLMGADLN-NIVKCQK 114

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +S   +  +  ++   +K  H A  I   HRDLK +NV +  D    ++D G    A  +
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGII---HRDLKPSNVAVNEDCELRILDFGLARQADDE 171

Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   K+ F
Sbjct: 172 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 69/261 (26%), Positives = 103/261 (39%), Gaps = 66/261 (25%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD--H 91
           +G+G F  V L E   T + YA+K +    ++D      +VE   T V   +L L     
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKIL----KKDVIIQDDDVE--CTMVEKRVLALPGKPP 61

Query: 92  ALTGCADPVLNSTSQVL----MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
            LT      L+S  Q +     V+ Y   G L     ++ VGK                E
Sbjct: 62  FLTQ-----LHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGKFK--------------E 100

Query: 148 AVKVFHDA-----------KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
              VF+ A           K I Y  RDLK  NV+L  + +  + D G        +C  
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKGIIY--RDLKLDNVMLDAEGHIKIADFG--------MC-- 148

Query: 197 AEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
              +N+      R  C  P Y APE+     Y    +  D W+ G LLY M   + PFD 
Sbjct: 149 --KENIFGGKTTRTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQPPFDG 203

Query: 254 VYERGDSVALAVISGNITFPE 274
             E  D +  +++  N+++P+
Sbjct: 204 --EDEDELFQSIMEHNVSYPK 222

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 38/131 (29%), Positives = 56/131 (42%), Gaps = 19/131 (14%)

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I  A+   HD K I Y  RDLK  NVLL ++ +  L D G     +             
Sbjct: 104 EITSALMFLHD-KGIIY--RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--------- 151

Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
              +  C  P Y APE+     Y       D W++G LLY M    +PF+   E  D + 
Sbjct: 152 -TTSTFCGTPDYIAPEILQEMLYGPS---VDWWAMGVLLYEMLCGHAPFEA--ENEDDLF 205

Query: 263 LAVISGNITFP 273
            A+++  + +P
Sbjct: 206 EAILNDEVVYP 216

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 56/219 (25%), Positives = 82/219 (37%), Gaps = 27/219 (12%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           IG+G F  V  +    T++ YALK I    R+    +  EV H  T     +L  ++   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTI----RKAHIVSRSEVTH--TLAERTVLAQVNCPF 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    S  ++ +VL +   G L + L+         +     ++      A++  H
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC----ALENLH 110

Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   +RDLK  N+LL    +  L D G        +C      +  D     C  P
Sbjct: 111 KFNVI---YRDLKPENILLDYQGHIALCDFG--------LCKLNMKDD--DKTNTFCGTP 157

Query: 214 -YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            Y APEL     Y       D W+LG LLY M     PF
Sbjct: 158 EYLAPELLLGHGYTKA---VDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 24/224 (10%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+GGF  V  ++   T K YA KK+      D+ +  ++       +   IL  ++   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL------DKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    S + + +V+     G L     + +VG+  +    ++    +I   +   H
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               +   +RD+K  NVLL +  N  L DLG           + E ++ + +     +  
Sbjct: 113 SMDIV---YRDMKPENVLLDDQGNCRLSDLGL----------AVELKDGKTITQRAGTNG 159

Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
           Y APE+   + Y       D +++GC +Y M   ++PF    E+
Sbjct: 160 YMAPEILKEEPY---SYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 22/228 (9%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + I++ IG G F  V++++     K +A+K +      ++ + ++  E        ++
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL------NKWEMLKRAETACFREERDV 54

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L   D+             + + +V+ YY  G L   L L S  +  +   D+ + +L  
Sbjct: 55  LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDL---LTLLSKFEDRLPE-DMARFYL-- 108

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            E V        + Y HRD+K  N+L+  + +  L D GS     +K+      Q+   V
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS----CLKLMEDGTVQSSVAV 164

Query: 206 AAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                +  Y +PE+     D         D WSLG  +Y M Y ++PF
Sbjct: 165 G----TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 63/245 (25%), Positives = 94/245 (38%), Gaps = 53/245 (21%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           +K++ + +++ IG G F  V L+ H  +K+ YA+K   K     R D A    E      
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE---RDI 96

Query: 80  FVHPN---ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
             H N   I+ L        A         + MV+ Y P G L N           MS+ 
Sbjct: 97  MAHANSEWIVQLH------YA---FQDDKYLYMVMEYMPGGDLVN----------LMSNY 137

Query: 137 DILKMFLK--ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
           DI + + +    E V        + + HRD+K  N+LL    +  L D G+        C
Sbjct: 138 DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--------C 189

Query: 195 GSAEAQNLQDVAAERCSMP-----YRAPELFH---VDSYCVVDQRTDVWSLGCLLYAMCY 246
              +A  +      RC        Y +PE+      D Y    +  D WS+G  LY M  
Sbjct: 190 MKMDANGMV-----RCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 242

Query: 247 FKSPF 251
             +PF
Sbjct: 243 GDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 47.1 bits (113), Expect = 3e-06
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 69/236 (29%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII---------CHGREDQAQAIREVEHHK 78
           Y +++++G+G F +V L  + +T +  A+KK+           + RE   +++R++  H 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE--VKSLRKLNEH- 57

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
               PNI+ L +         V     ++  V  Y  +G L   ++ R       S   I
Sbjct: 58  ----PNIVKLKE---------VFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVI 101

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
             +  +I + +   H      + HRDLK  N+L++                VVK+     
Sbjct: 102 RSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPE-------------VVKIA---- 141

Query: 199 AQNLQD--VAAERCSMP----------YRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
                D  +A E  S P          YRAPE L    SY       D+W+LGC++
Sbjct: 142 -----DFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSY---SSPVDIWALGCIM 189

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 40/227 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI----ICHGREDQAQAIREVEHHKTFV-------- 81
           +GEG +  V     + T K  A+KK+    I +      Q +     H T +        
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 82  --HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H NI+ L+D         V      + +V+       +A+DL+     K  ++   + 
Sbjct: 77  IKHENIMGLVD---------VYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVK 122

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVKVCG 195
            + L+I   + V H      + HRDL  AN+ + +     + D G       P       
Sbjct: 123 CILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 196 SAE-AQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCL 240
             E  Q  +++ ++  ++ YRAPE L   + Y       D+WS+GC+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKY---HFAVDMWSVGCI 223

Length = 335

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.0 bits (111), Expect = 4e-06
 Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 36/254 (14%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE----DQAQAIR-EVEHHKTFVHPNILPL 88
           +G+G F  V L   + T +  A+K++           +  A+  E++  K  +H  I+  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                 GC    +  T  + M   + P G++ +  +L+S G   ++     K   +I E 
Sbjct: 70  Y-----GCLRDPMERTLSIFM--EHMPGGSIKD--QLKSYGA--LTENVTRKYTRQILEG 118

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           V   H    +   HRD+K AN+L  +  N  L D G+ +  +  +C S     ++ V   
Sbjct: 119 VSYLHSNMIV---HRDIKGANILRDSVGNVKLGDFGA-SKRLQTICLSGTG--MKSVTG- 171

Query: 209 RCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS 267
               PY  +PE+   + Y    ++ D+WS+GC +  M   K P+       +  A+A I 
Sbjct: 172 ---TPYWMSPEVISGEGY---GRKADIWSVGCTVVEMLTEKPPW------AEFEAMAAIF 219

Query: 268 GNITFPENTPFPQY 281
              T P N   P +
Sbjct: 220 KIATQPTNPVLPPH 233

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L++   T + YA+K +    +++   A  EV H  T     +L    H  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAH--TLTENRVLQNSRHPF 56

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF-LKICEAVKVF 152
                    +  ++  V+ Y   G L   L      +  + S D  + +  +I  A+   
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYL 111

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H  K + Y  RDLK  N++L  D +  + D G        +C     + ++D A  +  C
Sbjct: 112 HSEKNVVY--RDLKLENLMLDKDGHIKITDFG--------LC----KEGIKDGATMKTFC 157

Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 158 GTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 32  EKIGEGGFSTVSLIE-HSQTKK-RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPL 88
           ++IG G F  V L E H    K R  +K++      ++Q   ++EV+ ++   HPN+L  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL-KMFLKICE 147
           L      C + +       L+VL + P G L N L         M+  D+L +M  ++  
Sbjct: 61  LGQ----CIESI-----PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD--V 205
            +   H A    + H DL   N  L  D +  + D            G A  Q  +D  +
Sbjct: 112 GLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDY-----------GLALEQYPEDYYI 157

Query: 206 AAERCSMPYR--APELFHV--DSYCVVDQ--RTDVWSLGCLLYAM 244
             +  ++P R  APEL  +        DQ  ++++WSLG  ++ +
Sbjct: 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 63/251 (25%), Positives = 98/251 (39%), Gaps = 63/251 (25%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPNILP 87
           V +IG G   TV  + H  T + YALK I  +G  +     Q  RE+E  +   HPN++ 
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 88  ---LLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-----ANDLELRSVGKHYMSSVDIL 139
              + DH          N   QVL  L +   G+L     A++  L  V +  +S +  L
Sbjct: 137 CHDMFDH----------NGEIQVL--LEFMDGGSLEGTHIADEQFLADVARQILSGIAYL 184

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
                        H    +   HRD+K +N+L+ +  N  + D G              A
Sbjct: 185 -------------HRRHIV---HRDIKPSNLLINSAKNVKIADFG---------VSRILA 219

Query: 200 QNLQDVAAERCSMPYRAPELFHV-------DSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           Q +    +   ++ Y +PE  +        D Y       D+WSLG  +      + PF 
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA-----GDIWSLGVSILEFYLGRFPF- 273

Query: 253 TVYERGDSVAL 263
            V  +GD  +L
Sbjct: 274 GVGRQGDWASL 284

Length = 353

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 30/221 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF  V   +   T K YA KK+       R+ ++ A+ E +         IL  ++
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ---------ILEKVN 58

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                       +   + +VL     G L     +  +G+        +    +IC  ++
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H  + +   +RDLK  N+LL +  +  + DLG      V V    E Q ++       
Sbjct: 117 DLHQERIV---YRDLKPENILLDDHGHIRISDLG----LAVHV---PEGQTIKGRVG--- 163

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++ Y APE+   + Y       D W+LGCLLY M   +SPF
Sbjct: 164 TVGYMAPEVVKNERYTF---SPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 30/227 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF  V   +   T K YA K++       R+ ++ A+ E +         IL  ++
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ---------ILEKVN 58

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                       +   + +VL     G L     + ++G         L    +I   ++
Sbjct: 59  SQFVVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H    +   +RDLK  N+LL +  +  + DLG      VK+    E ++++       
Sbjct: 117 DLHRENTV---YRDLKPENILLDDYGHIRISDLG----LAVKI---PEGESIRGRVG--- 163

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
           ++ Y APE+ +   Y +     D W LGCL+Y M   +SPF    E+
Sbjct: 164 TVGYMAPEVLNNQRYTL---SPDYWGLGCLIYEMIEGQSPFRGRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 8e-06
 Identities = 34/104 (32%), Positives = 46/104 (44%), Gaps = 20/104 (19%)

Query: 155 AKPIAYAH------RDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           A  I Y H      RDLK  N+LL +  + +L D G        +C   E    ++  + 
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG--------LC--KEGVEPEETTST 155

Query: 209 RCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            C  P Y APE+   + Y   D+  D W LG +LY M Y   PF
Sbjct: 156 FCGTPEYLAPEVLRKEPY---DRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 45.6 bits (108), Expect = 9e-06
 Identities = 54/248 (21%), Positives = 95/248 (38%), Gaps = 47/248 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALK-KIICHGREDQAQAIREVEHHKTFVHPNILPL 88
            ++++G G F  V   ++ + + +Y +  K+I  G   + + I E +      H  ++ L
Sbjct: 8   FLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                      V      + +V  Y   G L N   LR  GK +     +L+M   +CE 
Sbjct: 65  YG---------VCTKQRPIYIVTEYMSNGCLLN--YLREHGKRF-QPSQLLEMCKDVCEG 112

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---V 205
           +      +   + HRDL   N L+ +D               VKV     ++ + D    
Sbjct: 113 MAYLESKQ---FIHRDLAARNCLV-DDQ------------GCVKVSDFGLSRYVLDDEYT 156

Query: 206 AAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFDTVYERGDS-- 260
           ++     P R   PE+     Y     ++DVW+ G L++ +    K P    YER ++  
Sbjct: 157 SSVGSKFPVRWSPPEVLL---YSKFSSKSDVWAFGVLMWEVYSLGKMP----YERFNNSE 209

Query: 261 VALAVISG 268
               V  G
Sbjct: 210 TVEKVSQG 217

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.8 bits (108), Expect = 9e-06
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 33/222 (14%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 56

Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF-LKICEAVKVF 152
                    +  ++  V+ Y   G L   L    V      + +  + +  +I  A++  
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYL 111

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C
Sbjct: 112 H-SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKTFC 156

Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 157 GTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 52/228 (22%), Positives = 98/228 (42%), Gaps = 27/228 (11%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
             +Y  +  +G G    V     S   KR A+KKI+    +    A+RE++  +   H N
Sbjct: 4   GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63

Query: 85  ILPLLDHALTGCAD-----PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           I+ + +      +D       L   + V +V  Y        + +L +V +    S +  
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-------ETDLANVLEQGPLSEEHA 116

Query: 140 KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA-VVKVCGSA 197
           ++F+ ++   +K  H A  +   HRDLK ANV +  ++  L++ +G    A +V    S 
Sbjct: 117 RLFMYQLLRGLKYIHSANVL---HRDLKPANVFINTED--LVLKIGDFGLARIVDPHYSH 171

Query: 198 EAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           +    + +     +  YR+P  L   ++Y    +  D+W+ GC+   M
Sbjct: 172 KGYLSEGLV----TKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEM 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGR----EDQAQAIREVEHHKTFVHPN 84
             IG+G F  V   +LI+    K   A+K +    R    E+  Q ++E    K F HPN
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +L LL   L     P        L+VLPY   G L N   +RS   H  +  D++   L+
Sbjct: 58  VLSLLGICLPSEGSP--------LVVLPYMKHGDLRN--FIRS-ETHNPTVKDLIGFGLQ 106

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + + ++     K   + HRDL   N +L       + D G       K     E  ++ +
Sbjct: 107 VAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK-----EYYSVHN 158

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
               +  + + A E      +     ++DVWS G LL+
Sbjct: 159 HTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLW 193

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 16/116 (13%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP-YRAPELF 220
           +RDLK  NVLL ND N  + DLG           + E ++ Q         P + APEL 
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGL----------AVELKDGQSKTKGYAGTPGFMAPELL 169

Query: 221 HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA--VISGNITFPE 274
             + Y   D   D ++LG  LY M   + PF    E+ ++  L   +++ ++T+P+
Sbjct: 170 QGEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 32/105 (30%), Positives = 43/105 (40%), Gaps = 30/105 (28%)

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
           AV+  HD K I   HRD+K  N+ L  D   +L D G+  P                   
Sbjct: 279 AVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMP----------------FEK 319

Query: 208 ERCSMPY--------RAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           ER +  Y         +PE+   D YC +   TD+WS G +L  M
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDM 361

Length = 501

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 62/231 (26%), Positives = 92/231 (39%), Gaps = 38/231 (16%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVH- 82
           D Y  +EKIGEG +  V       T K  ALKK      E+     A+RE+   +     
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 83  PNILPLLD--HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGK---HYMSS 135
             I+ LLD  H          N    + +V  Y     L +DL+  + S G+     + +
Sbjct: 61  IYIVRLLDVEHVEEK------NGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPA 109

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVC 194
             I     ++ + V   H    +   HRDLK  N+L+      L + DLG          
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHGVM---HRDLKPQNLLVDKQKGLLKIADLG---------L 157

Query: 195 GSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           G A +  ++    E  ++ YRAPE L     Y       D+WS+GC+   M
Sbjct: 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHY---STPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 37/227 (16%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHPNILPLL 89
           + ++G G    VS + H  T K  A+K I     E  Q Q +RE++       P I+   
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV--- 62

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL-KMFLKICEA 148
                G      N+   + + + Y   G+L  D  L+ V         IL K+ + + + 
Sbjct: 63  -----GFYGAFYNNG-DISICMEYMDGGSL--DKILKEVQGRI--PERILGKIAVAVLKG 112

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +   H+   I   HRD+K +N+L+ +                +K+C    +  L +  A+
Sbjct: 113 LTYLHEKHKII--HRDVKPSNILVNSRGQ-------------IKLCDFGVSGQLVNSLAK 157

Query: 209 R---CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                S  Y APE    + Y V   ++D+WSLG  L  +   + P+ 
Sbjct: 158 TFVGTS-SYMAPERIQGNDYSV---KSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 28/220 (12%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL-DHA 92
           +G+G F  V L E   T + +A+K +    ++D      +VE   T V   +L L  +H 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKAL----KKDVVLMDDDVEC--TMVEKRVLSLAWEHP 56

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
                     +   +  V+ Y   G L     ++S  K  +          +I   ++  
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHKFDLPRATFYAA--EIICGLQFL 112

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSM 212
           H +K I Y  RDLK  N+LL  D +  + D G     ++   G A+           C  
Sbjct: 113 H-SKGIVY--RDLKLDNILLDTDGHIKIADFGMCKENML---GDAKTCTF-------CGT 159

Query: 213 P-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           P Y APE+     Y   +   D WS G LLY M   +SPF
Sbjct: 160 PDYIAPEILLGQKY---NTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 35/222 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPN 84
           KY  ++ IG G +  V   ++S+T ++ A+KKI      R D  + +RE++  +   H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 85  ILPLLDHALTGCADPVL-NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS-SVDILKMF 142
           ++ + D        P    + + V +V           D +L  + +   + S D  + F
Sbjct: 66  VIAIKD-----IMPPPHREAFNDVYIVYELM-------DTDLHQIIRSSQTLSDDHCQYF 113

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQ 200
           L ++   +K  H A  +   HRDLK +N+LL N N  L + D G           S +  
Sbjct: 114 LYQLLRGLKYIHSANVL---HRDLKPSNLLL-NANCDLKICDFGLARTT------SEKGD 163

Query: 201 NLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
            + +    R    YRAPE L +   Y       DVWS+GC+ 
Sbjct: 164 FMTEYVVTRW---YRAPELLLNCSEYTTA---IDVWSVGCIF 199

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 38/254 (14%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKII----CHGREDQAQAIR-EVEHHKTFVHPNILPL 88
           +G G F  V L   + T +  A+K++           +  A+  E++  K   H  I+  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 89  LDHALTGC-ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                 GC  DP      ++ + + Y P G++ +  +L++ G   ++     +   +I +
Sbjct: 70  Y-----GCLRDP---EEKKLSIFVEYMPGGSIKD--QLKAYGA--LTENVTRRYTRQILQ 117

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            V   H    +   HRD+K AN+L  +  N  L D G+ +  +  +C S     ++ V  
Sbjct: 118 GVSYLHSNMIV---HRDIKGANILRDSAGNVKLGDFGA-SKRIQTICMSGTG--IKSVTG 171

Query: 208 ERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI 266
                PY  +PE+   + Y    ++ DVWS+ C +  M   K P+   YE     A+A I
Sbjct: 172 ----TPYWMSPEVISGEGY---GRKADVWSVACTVVEMLTEKPPW-AEYE-----AMAAI 218

Query: 267 SGNITFPENTPFPQ 280
               T P     P 
Sbjct: 219 FKIATQPTKPMLPD 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 57/245 (23%), Positives = 89/245 (36%), Gaps = 56/245 (22%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D + I++ IG G F  V++++   T + YA+K +                        N 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKIL------------------------NK 36

Query: 86  LPLLDHALTGC----ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
             +L  A T C     D ++N   + +  L Y       ++  L  V  +Y+   D+L +
Sbjct: 37  WEMLKRAETACFREERDVLVNGDRRWITNLHY----AFQDENNLYLVMDYYVGG-DLLTL 91

Query: 142 FLK-------------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
             K             + E V        + Y HRD+K  NVLL  + +  L D GS   
Sbjct: 92  LSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGS--- 148

Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCY 246
                C    A           +  Y +PE+     D         D WSLG  +Y M Y
Sbjct: 149 -----CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203

Query: 247 FKSPF 251
            ++PF
Sbjct: 204 GETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 35/222 (15%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + ++ A+K +    ++ +     EV   + + H N++ +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          + L VL  + +G    D+    V +  ++   I  +   + +A+   
Sbjct: 88  LVG----------EELWVLMEFLQGGALTDI----VSQTRLNEEQIATVCESVLQALCYL 133

Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL  D    L D G         C    AQ  +DV   +   
Sbjct: 134 HSQGVI---HRDIKSDSILLTLDGRVKLSDFG--------FC----AQISKDVPKRKSLV 178

Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APE+     Y       D+WSLG ++  M   + P+
Sbjct: 179 GTPYWMAPEVISRTPYGT---EVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 58/237 (24%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVH 82
           K + Y  ++K+GEG ++TV       T +  ALK+I + H       AIRE    K   H
Sbjct: 3   KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV-DILKM 141
            NI+ L D         ++++   + +V  Y     L  DL      K YM      L M
Sbjct: 63  ANIVTLHD---------IIHTKKTLTLVFEY-----LDTDL------KQYMDDCGGGLSM 102

Query: 142 FLKICEAVKVF-----------HDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPA 189
                  V++F           H  + +   HRDLK  N LL ++   L L D       
Sbjct: 103 -----HNVRLFLFQLLRGLAYCHQRRVL---HRDLKPQN-LLISERGELKLADF------ 147

Query: 190 VVKVCGSAEAQNL--QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                G A A+++  +  + E  ++ YR P++  + S        D+W +GC+ Y M
Sbjct: 148 -----GLARAKSVPSKTYSNEVVTLWYRPPDVL-LGSTEYSTS-LDMWGVGCIFYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 38/235 (16%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +  +   +V+K+G G F  V +  ++ + K  A+K +       QA  + E    KT  H
Sbjct: 3   IPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQA-FLEEANLMKTLQH 60

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             ++ L           V+     + ++  Y  KG+L + L+    GK  +    ++   
Sbjct: 61  DKLVRLY---------AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LIDFS 109

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I E +          Y HRDL+ ANVL++      LM          K+     A+ +
Sbjct: 110 AQIAEGMAYIERKN---YIHRDLRAANVLVSE----SLM---------CKIADFGLARVI 153

Query: 203 QD---VAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF 251
           +D    A E    P  + APE  +  S+ +   ++DVWS G LLY +  Y K P+
Sbjct: 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 30/227 (13%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF  V   +   T K YA KK+       R+ +A A+ E           IL  ++
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE---------KRILEKVN 58

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                       +   + +VL     G L     + ++G         +    ++C  ++
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFDEQRAIFYAAELCCGLE 116

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
                + I Y  RDLK  N+LL +  +  + DLG           + +    + V     
Sbjct: 117 DLQRER-IVY--RDLKPENILLDDRGHIRISDLGL----------AVQIPEGETVRGRVG 163

Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
           ++ Y APE+ + + Y       D W LGCL+Y M   +SPF    ER
Sbjct: 164 TVGYMAPEVINNEKYTF---SPDWWGLGCLIYEMIQGQSPFRKRKER 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 44.3 bits (104), Expect = 3e-05
 Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 40/228 (17%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ---AIREVEHHKTFVHPNILP 87
           + +IG G F  V      +  +  A+KK+   G++   +    I+EV   +   HPN + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI- 78

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                  GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     +
Sbjct: 79  ----QYRGCY--LREHTAWLVM---EYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQ 126

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS---VAPAVVKVCGSAEAQNLQD 204
            +   H    I   HRD+K  N+LL+      L D GS   +APA   V           
Sbjct: 127 GLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----------- 172

Query: 205 VAAERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                   PY  APE+         D + DVWSLG     +   K P 
Sbjct: 173 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 50/241 (20%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVE--HHKT 79
           ++++    +  +G G   +VS ++H  T    A K +    +   + Q +RE++  H   
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             +          +       LN  + + M + +   G+L  D   +  G      V+IL
Sbjct: 62  SPY----------IVSFYGAFLNE-NNICMCMEFMDCGSL--DRIYKKGGP---IPVEIL 105

Query: 140 -KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-------SVAPAVV 191
            K+ + + E +   ++   I   HRD+K +N+L+ +     L D G       S+A   V
Sbjct: 106 GKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              G++                Y +PE      Y V   ++DVWSLG  +  +   K PF
Sbjct: 164 ---GTST---------------YMSPERIQGGKYTV---KSDVWSLGISIIELALGKFPF 202

Query: 252 D 252
            
Sbjct: 203 A 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 36/222 (16%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKT 79
           ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  RE+   K 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKH 72

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H N++ LLD      +    N    V  ++     G   N++    V    ++   + 
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQKLTDDHVQ 123

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G               
Sbjct: 124 FLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFG---------LARHTD 171

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
             +    A R    YRAPE+    ++   +Q  D+WS+GC++
Sbjct: 172 DEMTGYVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIM 208

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 39/225 (17%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVHPN 84
           +Y I E IG+G +  V     + T ++ A+KKI  +     D  + +RE++  +   HP+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKG----TLANDLELRSVGKHYMSSVDILK 140
           I+ +    L     P       + +V             AND +L    +H+       +
Sbjct: 61  IVEIKHIMLP----PSRREFKDIYVVFELMESDLHQVIKAND-DLTP--EHH-------Q 106

Query: 141 MFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAE 198
            FL ++  A+K  H A      HRDLK  N+ LAN +  L + D G    A      +  
Sbjct: 107 FFLYQLLRALKYIHTANVF---HRDLKPKNI-LANADCKLKICDFGLARVAFND---TPT 159

Query: 199 AQNLQDVAAERCSMPYRAPEL---FHVDSYCVVDQRTDVWSLGCL 240
           A    D  A R    YRAPEL   F    +       D+WS+GC+
Sbjct: 160 AIFWTDYVATRW---YRAPELCGSF----FSKYTPAIDIWSIGCI 197

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 39/219 (17%)

Query: 32  EKIGEGGFSTV--SLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            K+G G F  V   L    + + R A+K +       Q    +EV+  K   H +++ L 
Sbjct: 12  RKLGSGYFGEVWEGLW---KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL- 67

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
             A+    +PV   T   LM      KG+L     LRS     +    ++ M  ++ E +
Sbjct: 68  -FAVCSVGEPVYIITE--LM-----EKGSLLA--FLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD--VAA 207
               +   I   HRDL   N+L+  D              V KV     A+ +++    +
Sbjct: 118 AYLEEQNSI---HRDLAARNILVGED-------------LVCKVADFGLARLIKEDVYLS 161

Query: 208 ERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAM 244
               +PY+  APE     S+     ++DVWS G LLY M
Sbjct: 162 SDKKIPYKWTAPEAA---SHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 38/217 (17%)

Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           ++++G G F  V L +     K     K+I  G   +   I E +      HPN++ L  
Sbjct: 9   LKELGSGQFGVVHLGK--WRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                    V      + +V  Y   G L N L  R   K  + +  +L M   +CEA++
Sbjct: 67  ---------VCTKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAME 114

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VAA 207
                    + HRDL   N L+  DN             VVKV     A+ + D    ++
Sbjct: 115 YLESN---GFIHRDLAARNCLVGEDN-------------VVKVSDFGLARYVLDDQYTSS 158

Query: 208 ERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +    P +   PE+F    Y     ++DVWS G L++
Sbjct: 159 QGTKFPVKWAPPEVF---DYSRFSSKSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 28/90 (31%), Positives = 41/90 (45%), Gaps = 13/90 (14%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           +RDLK  N+LL +  +  + DLG           + E    + +     ++ Y APE+  
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGL----------AVEIPEGETIRGRVGTVGYMAPEVVK 174

Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            + Y       D W LGCL+Y M   KSPF
Sbjct: 175 NERYTF---SPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 34/219 (15%)

Query: 32  EKIGEGGFSTVS---LIEHSQTKKRYALKKIIC-HGREDQAQAIREVEHHKTFVHPNILP 87
           +++G G F +V     +  S  +   A+K +   H    + + +RE        HP I+ 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 88  LLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
           L+     G C          +++V+   P G L   L      +  +   D+ ++  ++ 
Sbjct: 61  LI-----GVCKGE------PLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVA 105

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKVCGSAEAQNLQDV 205
             +          + HRDL   NVLL N +   + D G S A       GS   +     
Sbjct: 106 MGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA----GSDYYRATT-- 156

Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R  + + APE  +   Y     ++DVWS G  L+  
Sbjct: 157 -AGRWPLKWYAPECIN---YGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 35/101 (34%), Positives = 41/101 (40%), Gaps = 16/101 (15%)

Query: 152 FHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCS 211
           F  +K I Y  RDLK  NV+L  D +  + D G     V    G   A          C 
Sbjct: 111 FLHSKGIIY--RDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNRASTF-------CG 158

Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+     Y       D WS G LLY M   +SPF
Sbjct: 159 TPDYIAPEILQGLKYTF---SVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 38/225 (16%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +   +  +V++IG G F  V L  +   K++ A+K I   G   +   I E +      H
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWL-GYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSH 58

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P ++ L           V    S + +V  +   G L++ L  +   +   S   +L M 
Sbjct: 59  PKLVQLYG---------VCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMC 106

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           L +CE +     +  I   HRDL   N L+  +              VVKV      + +
Sbjct: 107 LDVCEGMAYLESSNVI---HRDLAARNCLVGENQ-------------VVKVSDFGMTRFV 150

Query: 203 QD---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            D    ++     P +  +PE+F    Y     ++DVWS G L++
Sbjct: 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKY---SSKSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 35/223 (15%)

Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICHGREDQ-AQAIREVEHHKTFVHPNI 85
           +  +GEG F  V L     E   T ++ A+K +      +  A   +E+E  +   H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +        G C +   +  + + +++ + P G+L    E     K+ ++    LK  ++
Sbjct: 69  V-----KYKGICTE---DGGNGIKLIMEFLPSGSLK---EYLPRNKNKINLKQQLKYAVQ 117

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+ +      +   Y HRDL   NVL+ +++   + D G        +  + E      
Sbjct: 118 ICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG--------LTKAIETDKEYY 166

Query: 205 VAAERCSMP--YRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
              +    P  + APE L     Y      +DVWS G  LY +
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIA----SDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 15/159 (9%)

Query: 34  IGEGGFSTV---SLIEHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPNILPL 88
           +GEG F +V    L +   ++ + A+K  K+  H   +  + + E    K F HPN++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS---VGKHYMSSVDILKMFLKI 145
           +       +   L    + +++LP+   G L + L L S        +    +LK  + I
Sbjct: 67  IGVCFEASS---LQKIPKPMVILPFMKHGDLHSFL-LYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
              ++   +   I   HRDL   N +L  D    + D G
Sbjct: 123 ALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFG 158

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 50/232 (21%), Positives = 92/232 (39%), Gaps = 34/232 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + ++++IG G +  V    +  T +  A+K I     ED A   +E+   K   H NI
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +      L            ++ + + +   G+L +   +       +S   I  +  + 
Sbjct: 69  VAYFGSYL---------RRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRET 115

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +   H    +   HRD+K AN+LL ++ +  L D G  A              +   
Sbjct: 116 LQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSA-------------QITAT 159

Query: 206 AAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP-FD 252
            A+R S    PY  APE+  V+     +Q  D+W++G     +   + P FD
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 49/253 (19%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+G F  V L+    T K YA   LKK +   +++ A  + E    +   HP  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-FLTALK 61

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF-LKICEAV 149
           ++          +  ++  V+ Y   G L        + +  + S D  + +  +I  A+
Sbjct: 62  YSF--------QTHDRLCFVMEYANGGEL-----FFHLSRERVFSEDRARFYGAEIVSAL 108

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVAPAVVKVCGSAEAQNLQ 203
              H    +   +RDLK  N++L  D +  + D G      S    +   CG+ E     
Sbjct: 109 GYLHSCDVV---YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----- 160

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
                     Y APE+   + Y    +  D W LG ++Y M   + PF   Y +      
Sbjct: 161 ----------YLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPF---YNQDHEKLF 204

Query: 264 AVI-SGNITFPEN 275
            +I    I FP  
Sbjct: 205 ELILMEEIRFPRT 217

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 47/231 (20%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVHPN 84
           I + IG G F  V    L    + +   A+K +   G  D+ +   + E      F HPN
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPN 66

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH--YMSSVDILKMF 142
           I+ L           V+  +  V+++  Y   G+L  D  LR   ++    +   ++ M 
Sbjct: 67  IIRLEG---------VVTKSRPVMIITEYMENGSL--DKFLR---ENDGKFTVGQLVGML 112

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
             I   +K   +   + Y HRDL   N+L+ ++              V KV     ++ L
Sbjct: 113 RGIASGMKYLSE---MNYVHRDLAARNILVNSN-------------LVCKVSDFGLSRRL 156

Query: 203 QDVAAERCSM----PYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           +D  A   +     P R  APE     +Y      +DVWS G +++ +  +
Sbjct: 157 EDSEATYTTKGGKIPIRWTAPEAI---AYRKFTSASDVWSFGIVMWEVMSY 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 41/230 (17%)

Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHK 78
           V+  +++Y  ++ +G G F  V       T +  A+KKI+          +  RE++  K
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGT-LANDLELRSVGKHYMSSVD 137
              H NI+ L D  ++   D      +++L        GT L   L  R + K +     
Sbjct: 65  HLRHENIISLSDIFISPLEDIYF--VTELL--------GTDLHRLLTSRPLEKQF----- 109

Query: 138 ILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC-- 194
            ++ FL +I   +K  H A  +   HRDLK +N+L+ N+N  L            K+C  
Sbjct: 110 -IQYFLYQILRGLKYVHSAGVV---HRDLKPSNILI-NENCDL------------KICDF 152

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           G A  Q+ Q +     +  YRAPE+    ++   D   D+WS GC+   M
Sbjct: 153 GLARIQDPQ-MTGYVSTRYYRAPEIML--TWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 24/116 (20%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVV--KVCGSAEAQNLQDVAAERCSMPYRAPE- 218
           HRD+K  N+L+    +  L D G     +   K  G+ +               Y APE 
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD---------------YLAPET 164

Query: 219 LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPE 274
           +  V      D+ +D WSLGC+++   +   PF    E  D+V   ++S  I +PE
Sbjct: 165 ILGVGD----DKMSDWWSLGCVIFEFLFGYPPFHA--ETPDAVFDNILSRRINWPE 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 60/236 (25%), Positives = 90/236 (38%), Gaps = 57/236 (24%)

Query: 34  IGEGGFSTVSLIEH---SQTKKRYALKKI----ICHGREDQAQAIREVEHHKTFVHPNIL 86
           +G+GG+  V  +     + T K +A+K +    I   ++D A    E    +   HP I+
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-----LRSVGKHYMSSVDILKM 141
            L+    TG          ++ ++L Y   G L   LE     +      Y+S       
Sbjct: 64  DLIYAFQTG---------GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS------- 107

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK--VCG 195
             +I  A++  H  + I Y  RDLK  N+LL    +  L D G    S+    V    CG
Sbjct: 108 --EISLALEHLH-QQGIIY--RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG 162

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + E               Y APE+          +  D WSLG L+Y M     PF
Sbjct: 163 TIE---------------YMAPEIL---MRSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 40/231 (17%)

Query: 34  IGEGGFSTVS----LIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHPNILPL 88
           +G G F TV     + E  + K   A+K +      +   + + E     +  HP+++ L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY--MSSVDILKMFLKIC 146
           L   L+          SQV ++    P G L     L  V  H   + S  +L   ++I 
Sbjct: 75  LGICLS----------SQVQLITQLMPLGCL-----LDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           + +    + + +   HRDL   NVL+    +  + D G     + K+    E +      
Sbjct: 120 KGMSYLEEKRLV---HRDLAARNVLVKTPQHVKITDFG-----LAKLLDVDEKE----YH 167

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFDTV 254
           AE   +P +  A E      + +   ++DVWS G  ++ +  F   P++ +
Sbjct: 168 AEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 40/172 (23%), Positives = 59/172 (34%), Gaps = 34/172 (19%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIE-----HSQTKKRYALKKIICHGREDQAQA--IREVE 75
           V+ D   +  ++GEG F  V L E         K+  A+K  +     + A+    RE E
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREAE 60

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
               F H NI+        G            +MV  Y   G L     LRS G      
Sbjct: 61  LLTNFQHENIVKFYGVCTEG---------DPPIMVFEYMEHGDLNK--FLRSHGPDAAFL 109

Query: 136 V------------DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND 175
                         +L++ ++I   +          + HRDL T N L+  D
Sbjct: 110 KSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 16/159 (10%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK------KIICHGREDQAQAIREVEHHKTFVHPNILP 87
           +GEG F +V  +E    +    LK      KI    R +    + E    K F HPN++ 
Sbjct: 7   LGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH--YMSSVDILKMFLKI 145
           L+   L              +++LP+   G L + L    +G    Y+ +  ++K    I
Sbjct: 65  LIGVCLQTVES---EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
              ++         + HRDL   N +L  + N  + D G
Sbjct: 122 ASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 5e-04
 Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 35/216 (16%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPL 88
           EKIG+G F  V      +     A+K   C      + + + ++E E  K + HPNI+ L
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKT--CRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           +          V      + +V+   P G+L   L  +      ++   +L+M L     
Sbjct: 58  IG---------VCVQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAG 105

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           ++       I   HRDL   N L+  +N   + D G             E   +  V+  
Sbjct: 106 MEYLESKNCI---HRDLAARNCLVGENNVLKISDFG---------MSREEEGGIYTVSDG 153

Query: 209 RCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
              +P  + APE  +   Y      +DVWS G LL+
Sbjct: 154 LKQIPIKWTAPEALNYGRYTS---ESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 27/178 (15%)

Query: 49  QTKKRYALKKI-ICHGREDQ--AQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS 105
            T    A+K +      E+   A+  RE        HPNI+ LLD   +G A P L    
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGL---- 53

Query: 106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL 165
            +  V  Y P  TL   L         + + +  ++ L++ +A+   H+   +   HRDL
Sbjct: 54  -LFAVFEYVPGRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQGIV---HRDL 105

Query: 166 KTANVLLANDN---NPLLMD--LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPE 218
           K  N++++      +  ++D  +G++ P V      A+   L        +  Y APE
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGV----RDADVATLTRTTEVLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 40.3 bits (94), Expect = 6e-04
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 39/227 (17%)

Query: 32  EKIGEGGFSTVSL--IEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNILPL 88
           ++IG G F  V L  +    T  +  +K++ +    ++Q + + E + +++  H N+L  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL-- 58

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE- 147
               L  C +      +  L+V+ + P G L     LRS  K  + + D   +    CE 
Sbjct: 59  --QCLGQCTE-----VTPYLLVMEFCPLGDLKG--YLRSCRKAELMTPDPTTLQRMACEI 109

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD--V 205
           A+ + H  K   + H DL   N LL  D   L + +G          G +  +  +D  V
Sbjct: 110 ALGLLHLHKN-NFIHSDLALRNCLLTAD---LTVKIGDY--------GLSHNKYKEDYYV 157

Query: 206 AAERCSMPYR--APELFHVD----SYCVVDQ--RTDVWSLGCLLYAM 244
             ++  +P R  APEL  VD    +  VVDQ   ++VWSLG  ++ +
Sbjct: 158 TPDQLWVPLRWIAPEL--VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.3 bits (94), Expect = 6e-04
 Identities = 54/219 (24%), Positives = 82/219 (37%), Gaps = 30/219 (13%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QAIREVEHHKTFVHPNIL 86
           Y  +EK+GEG ++TV         +  ALK I     E     AIRE    K   H NI+
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
            L D          +  T + L  +  Y    LA  +     G H     ++     ++ 
Sbjct: 67  LLHD----------IIHTKETLTFVFEYMHTDLAQYMIQHPGGLH---PYNVRLFMFQLL 113

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
             +   H    +   HRDLK  N+L++      L D G            A++   Q  +
Sbjct: 114 RGLAYIHGQHIL---HRDLKPQNLLISYLGELKLADFG---------LARAKSIPSQTYS 161

Query: 207 AERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           +E  ++ YR P+ L     Y       D+W  GC+   M
Sbjct: 162 SEVVTLWYRPPDVLLGATDY---SSALDIWGAGCIFIEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 43/243 (17%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREV 74
           V  D+  + + +GEG F  V + E     K       + A+K +     E D +  I E+
Sbjct: 15  VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 75  EHHKTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR------- 126
           E  K    H NI+ LL      C          + +++ Y  KG L   L  R       
Sbjct: 75  EMMKMIGKHKNIINLLG----ACT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEY 125

Query: 127 -----SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM 181
                 V +  +S  D++    ++   ++     K I   HRDL   NVL+  DN   + 
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIA 182

Query: 182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           D G +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL
Sbjct: 183 DFG-LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLL 232

Query: 242 YAM 244
           + +
Sbjct: 233 WEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 25/125 (20%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELF- 220
           +RD+K  N+LL ++ + +L D G     + K     E +          ++ Y AP++  
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFG-----LSKEFHEDEVERAYSFCG---TIEYMAPDIVR 179

Query: 221 -----HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPEN 275
                H       D+  D WS+G L+Y +    SPF TV   G+  + A IS  I     
Sbjct: 180 GGDGGH-------DKAVDWWSMGVLMYELLTGASPF-TV--DGEKNSQAEISRRI-LKSE 228

Query: 276 TPFPQ 280
            P+PQ
Sbjct: 229 PPYPQ 233

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 39.7 bits (92), Expect = 9e-04
 Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 27/230 (11%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           + +VE +G G +  V    H +T +  A+K +   G E++ +  +E+   K + H   + 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 66

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
               A      P ++   Q+ +V+ +   G++  DL +++   + +    I  +  +I  
Sbjct: 67  TYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVT-DL-IKNTKGNTLKEEWIAYICREILR 122

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H  K I   HRD+K  NVLL  +    L+D G  A              L     
Sbjct: 123 GLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSA-------------QLDRTVG 166

Query: 208 ERCSM---PY-RAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPF 251
            R +    PY  APE+   D       D ++D+WSLG     M     P 
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 39.7 bits (93), Expect = 9e-04
 Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 20/122 (16%)

Query: 137 DIL-KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
           DIL K+ + I +A++  H    ++  HRD+K +NVL+  +               VK+C 
Sbjct: 103 DILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQ-------------VKLCD 147

Query: 196 SAEAQNLQDVAAERC---SMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              +  L D  A+       PY APE  + + +    D ++DVWSLG  +  +   + P+
Sbjct: 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207

Query: 252 DT 253
           D+
Sbjct: 208 DS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 28/235 (11%)

Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEH 76
           ++ +    +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+  
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K   H NI+ LL+          L     V +V+          D  L  V +  +   
Sbjct: 70  MKCVNHKNIISLLN---VFTPQKSLEEFQDVYLVMELM-------DANLCQVIQMELDHE 119

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            +  +  ++   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G+
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFG-----LARTAGT 171

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +       V     +  YRAPE+     Y    +  D+WS+GC++  M   K  F
Sbjct: 172 SFMMTPYVV-----TRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 61/249 (24%), Positives = 96/249 (38%), Gaps = 44/249 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL-LDHA 92
           +G+G F  V L E   T + YA+K +    ++D      +V+   T     IL L   H 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVL----KKDVILQDDDVDC--TMTEKRILALAAKHP 56

Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDILKMFLKI 145
                     +  ++  V+ Y   G L   +       E RS  + Y + V +  MFL  
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS--RFYAAEVTLALMFL-- 112

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
                  H    I   +RDLK  N+LL  + +  L D G        +C       +   
Sbjct: 113 -------HRHGVI---YRDLKLDNILLDAEGHCKLADFG--------MCKEGILNGV--T 152

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA 264
               C  P Y APE+     Y       D W+LG L+Y M   + PF+   E  D +  +
Sbjct: 153 TTTFCGTPDYIAPEILQELEY---GPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFES 207

Query: 265 VISGNITFP 273
           ++  ++ +P
Sbjct: 208 ILHDDVLYP 216

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 17/121 (14%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE-AQNLQDVAAERC-SMPYRAPEL 219
           +RD+K  N+LL ++ + +L D G           S E     ++ A   C ++ Y APE+
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGL----------SKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 220 FHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFP 279
               S    D+  D WSLG L + +    SPF      G+  + + IS  I      PFP
Sbjct: 178 IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTV---DGEQNSQSEISRRI-LKSKPPFP 232

Query: 280 Q 280
           +
Sbjct: 233 K 233

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 34/230 (14%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y +++++G G +  V    +  T +  A+K I     +D +   +E+   K   H NI+ 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                L         S  ++ + + Y   G+L +   +       +S + I  +  +  +
Sbjct: 71  YFGSYL---------SREKLWICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQ 117

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H        HRD+K AN+LL ++ +  L D G  A     +             A
Sbjct: 118 GLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-------------A 161

Query: 208 ERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP-FD 252
           +R S    PY  APE+  V+     +Q  D+W++G     +   + P FD
Sbjct: 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 22/98 (22%)

Query: 160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VAAERCSMP--Y 214
           Y HRDL+ AN+L++             A  V K+     A+ ++D    A E    P  +
Sbjct: 123 YIHRDLRAANILVS-------------ASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 215 RAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF 251
            APE  +  S+ +   ++DVWS G LL  +  Y + P+
Sbjct: 170 TAPEAINFGSFTI---KSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHKTFV 81
           +Y  ++ IG G    V     +  ++  A+KK+    R  Q Q     A RE+   K   
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKCVN 81

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H NI+ LL+          L     V +V+          D  L  V +  +    +  +
Sbjct: 82  HKNIIGLLN---VFTPQKSLEEFQDVYIVMELM-------DANLCQVIQMELDHERMSYL 131

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             ++   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G++    
Sbjct: 132 LYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFG-----LARTAGTSFM-- 181

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
              +     +  YRAPE+     Y    +  D+WS+GC++  M
Sbjct: 182 ---MTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 56/261 (21%), Positives = 87/261 (33%), Gaps = 105/261 (40%)

Query: 27  KYYIVEKIGEGGFSTVSLI--EHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHKT 79
           KY I   IG G +  V     ++ +  K YA+KK    G ++Q       A RE+   + 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRE 58

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPY-------------YPKGTLANDLELR 126
             H N++ L++  L        ++   V ++  Y               K        ++
Sbjct: 59  LKHENVVSLVEVFLE-------HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 127 SV------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND----- 175
           S+      G HY+ S  +L                      HRDLK AN+L+  +     
Sbjct: 112 SLLWQILNGVHYLHSNWVL----------------------HRDLKPANILVMGEGPERG 149

Query: 176 -------------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELF-- 220
                        N PL   L  + P VV                   ++ YRAPEL   
Sbjct: 150 VVKIGDLGLARLFNAPLKP-LADLDPVVV-------------------TIWYRAPELLLG 189

Query: 221 --HVDSYCVVDQRTDVWSLGC 239
             H           D+W++GC
Sbjct: 190 ARHYTK------AIDIWAIGC 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 45/229 (19%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKK--RYALKKI--ICHGREDQAQAIREVEHHKTFV-H 82
           Y +++++G+G +  V    +++T +    A+KKI  +   +    +A+RE++  + F  H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRS----VGKHYMSSV 136
            NI  L D       D V       L    Y  +  +  DL   +RS       H+ S  
Sbjct: 62  KNITCLYD------MDIVFPGNFNEL----YLYEELMEADLHQIIRSGQPLTDAHFQS-- 109

Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVK 192
                F+ +I   +K  H A  +   HRDLK  N+L+  D    + D G     +    +
Sbjct: 110 -----FIYQILCGLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161

Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
                 A  + +  A R    YRAPE+    S+    +  DVWS+GC+L
Sbjct: 162 -----NAGFMTEYVATRW---YRAPEIML--SFQSYTKAIDVWSVGCIL 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 54/250 (21%), Positives = 99/250 (39%), Gaps = 51/250 (20%)

Query: 15  LCSKEAVYVKSDKYYIVEKIGEG--GFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR 72
           LC++    ++   + I+E    G  GF   + I+ ++T +   +K     G   +A  +R
Sbjct: 81  LCAEARAGIEKAGFSILETFTPGAEGF-AFACID-NKTCEHVVIKAGQRGGTATEAHILR 138

Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
            + H      P+I+ L                    ++LP Y       DL      K  
Sbjct: 139 AINH------PSIIQLKG---------TFTYNKFTCLILPRY-----KTDLYCYLAAKRN 178

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++  DIL +   +  A++  H+ + I   HRD+K  N+ + +  +  L D G+    V  
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRII---HRDIKAENIFINHPGDVCLGDFGAACFPV-- 233

Query: 193 VCGSAEAQNLQDVAAERC-----SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
                      D+ A +      ++   APEL   D Y       D+WS G +L+ M   
Sbjct: 234 -----------DINANKYYGWAGTIATNAPELLARDPY---GPAVDIWSAGIVLFEMA-- 277

Query: 248 KSPFDTVYER 257
            +  D+++E+
Sbjct: 278 -TCHDSLFEK 286

Length = 391

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 38.0 bits (88), Expect = 0.003
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 39/180 (21%)

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 62  FDHPNIIHL---------EGVVTKSKPVMIVTEYMENGSL--DAFLRKHDGQF-TVIQLV 109

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 110 GMLRGIASGMKYLSD---MGYVHRDLAARNILV-NSN------------LVCKVSDFGLS 153

Query: 200 QNLQD--VAAERCS---MPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D   AA       +P R  APE     +Y      +DVWS G +++  M Y + P+
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAI---AYRKFTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 38.1 bits (89), Expect = 0.003
 Identities = 30/99 (30%), Positives = 40/99 (40%), Gaps = 25/99 (25%)

Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER----CSMPYRAP 217
           HRD+K +N+LL    N             VK+C    +  L D  A+     C+  Y AP
Sbjct: 138 HRDVKPSNILLDASGN-------------VKLCDFGISGRLVDSKAKTRSAGCA-AYMAP 183

Query: 218 ELF----HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           E          Y   D R DVWSLG  L  +   + P+ 
Sbjct: 184 ERIDPPDPNPKY---DIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 28/218 (12%)

Query: 33  KIGEGGFSTVSLIEHSQTK--KRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           K+G G +  V   +    K  K YALK+I   G      A RE+   +   HPN++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIAL-- 63

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-----I 145
                     L+ + + + +L  Y +  L + ++     K     + + +  +K     I
Sbjct: 64  ------QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG--SAEAQNLQ 203
            + +   H    +   HRDLK AN+L+  +      + G V  A +      ++  + L 
Sbjct: 118 LDGIHYLHANWVL---HRDLKPANILVMGEGP----ERGRVKIADMGFARLFNSPLKPLA 170

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           D+     +  YRAPEL     +    +  D+W++GC+ 
Sbjct: 171 DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 37.7 bits (88), Expect = 0.003
 Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 22/98 (22%)

Query: 160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VAAERCSMP--Y 214
           Y HRDL   N+L+  +              V K+     A+ ++D    A E    P  +
Sbjct: 124 YIHRDLAARNILVGENL-------------VCKIADFGLARLIEDDEYTAREGAKFPIKW 170

Query: 215 RAPELFHVDSYCVVDQRTDVWSLGCLLYA-MCYFKSPF 251
            APE     +Y     ++DVWS G LL   + Y + P+
Sbjct: 171 TAPE---AANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 37.9 bits (88), Expect = 0.004
 Identities = 53/258 (20%), Positives = 94/258 (36%), Gaps = 60/258 (23%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHP 83
           + ++ V+ IG+G F  V L++   T K YA+K ++     ++DQ   ++           
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK--------AER 52

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           ++L   D                + +++ + P G L   L      K+   S D+ + + 
Sbjct: 53  DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFY- 106

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------------------- 184
            + E V        + + HRD+K  N+L+    +  L D G                   
Sbjct: 107 -MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165

Query: 185 ------------SVAPAVVKVCGSAEAQNLQDVAAERCSMPYR--------APELFHVDS 224
                       SVA   + +  S++ Q +      R  M Y         APE+F    
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQ-IATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224

Query: 225 YCVVDQRTDVWSLGCLLY 242
           Y    Q  D WSLG +++
Sbjct: 225 Y---GQECDWWSLGAIMF 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 50/228 (21%)

Query: 31  VEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           ++++G+G F +V L  +      T +  A+KK+     E      RE+E  K+  H NI+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 87  PLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-- 143
                   G C      +   V+  LPY   G+L + L+     KH    +D  K+ L  
Sbjct: 69  -----KYKGVCYSAGRRNLRLVMEYLPY---GSLRDYLQ-----KH-RERLDHRKLLLYA 114

Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG--SVAPAVVKVCGSAEAQ 200
            +IC+ ++     +   Y HRDL T N+L+ ++N   + D G   V P            
Sbjct: 115 SQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP------------ 159

Query: 201 NLQDVAAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             QD    +   P      + APE      + V    +DVWS G +LY
Sbjct: 160 --QDKEYYKVREPGESPIFWYAPESLTESKFSV---ASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 37.7 bits (87), Expect = 0.004
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 28/218 (12%)

Query: 33  KIGEGGFSTVSLIEHSQTK--KRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           K+G G +  V   +    K  + YALK+I   G      A RE+   +   HPN++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISL-- 63

Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-----I 145
                     L+   + + +L  Y +  L + ++     K     V + +  +K     I
Sbjct: 64  ------QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG--SAEAQNLQ 203
            + +   H    +   HRDLK AN+L+  +      + G V  A +      ++  + L 
Sbjct: 118 LDGIHYLHANWVL---HRDLKPANILVMGEGP----ERGRVKIADMGFARLFNSPLKPLA 170

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           D+     +  YRAPEL     +    +  D+W++GC+ 
Sbjct: 171 DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 41/162 (25%), Positives = 62/162 (38%), Gaps = 28/162 (17%)

Query: 82  HPNILPLLD-HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           HP +L LLD   + G             +VLP Y +  L   L  R      +    +  
Sbjct: 219 HPAVLALLDVRVVGGLT----------CLVLPKY-RSDLYTYLGARL---RPLGLAQVTA 264

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           +  ++  A+   H    I   HRD+KT NVL+    +  L D G    A     GS    
Sbjct: 265 VARQLLSAIDYIHGEGII---HRDIKTENVLVNGPEDICLGDFG----AACFARGSWSTP 317

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
               +A    ++   APE+   D Y       D+WS G +++
Sbjct: 318 FHYGIAG---TVDTNAPEVLAGDPYT---PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 37.7 bits (87), Expect = 0.004
 Identities = 66/241 (27%), Positives = 93/241 (38%), Gaps = 68/241 (28%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD + I+E IG+G +  V  + + +   + A+K  I     D  + I E E+       N
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK--ILDPIHDIDEEI-EAEY-------N 66

Query: 85  ILPLL-DHALTGCADPVLNSTSQVLMVLPYYPKGTLAND-----LELRSVGKHYMSSVDI 138
           IL  L DH             + V     YY K     D     LEL + G    S  D+
Sbjct: 67  ILKALSDHP------------NVVKFYGMYYKKDVKNGDQLWLVLELCNGG----SVTDL 110

Query: 139 LKMFLKICE----------------AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
           +K FLK  E                 ++  H  K I   HRD+K  N+LL  +    L+D
Sbjct: 111 VKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVD 167

Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPY-RAPELF----HVDSYCVVDQRTDVWSL 237
            G           SA+  + +         P+  APE+      +DS    D R DVWSL
Sbjct: 168 FGV----------SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS--TYDARCDVWSL 215

Query: 238 G 238
           G
Sbjct: 216 G 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 37.6 bits (87), Expect = 0.004
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 17/160 (10%)

Query: 34  IGEGGFSTVS---LIEHSQTKKRYALK----KIICHGREDQAQAIREVEHHKTFVHPNIL 86
           +G+G F +V    L     + ++ A+K     I      D  + +RE    K F HPN++
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVI 64

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH--YMSSVDILKMFLK 144
            L+  +L   A   L      +++LP+   G L   L +  +G+    +    +++  + 
Sbjct: 65  KLIGVSLRSRAKGRLPIP---MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
           I   ++       I   HRDL   N +L  +    + D G
Sbjct: 122 IASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFG 158

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	282
KOG2345|consensus	302		100.0
KOG0595|consensus	429		100.0
KOG0598|consensus	357		100.0
KOG0591|consensus	375		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0581|consensus	364		100.0
KOG0192|consensus	362		100.0
KOG0592|consensus	604		100.0
KOG0605|consensus	550		100.0
KOG0600|consensus	560		100.0
KOG0616|consensus	355		100.0
KOG0197|consensus	468		100.0
KOG1989|consensus	738		100.0
KOG0583|consensus	370		100.0
KOG0593|consensus	396		100.0
KOG0610|consensus	459		100.0
KOG0597|consensus	808		100.0
KOG0582|consensus	516		100.0
KOG0588|consensus	786		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0198|consensus	313		100.0
KOG0585|consensus	576		100.0
KOG0694|consensus	694		100.0
KOG0578|consensus	550		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0659|consensus	318		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0589|consensus	426		100.0
KOG0661|consensus	538		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0193|consensus	678		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0611|consensus	668		100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721|consensus	904		100.0
KOG0580|consensus	281		100.0
KOG0663|consensus	419		100.0
KOG0033|consensus	355		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
KOG1026|consensus	774		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0594|consensus	323		100.0
KOG1187|consensus	361		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0658|consensus	364		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0660|consensus	359		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0194|consensus	474		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0032|consensus	382		100.0
KOG1095|consensus	1025		100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0667|consensus	586		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4717|consensus	864		100.0
KOG4279|consensus	1226		100.0
KOG0574|consensus	502		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG2052|consensus	513		100.0
KOG4250|consensus	732		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0612|consensus	1317		100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0577|consensus	948		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0586|consensus	596		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0579|consensus	1187		100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4257|consensus	974		100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0986|consensus	591		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0984|consensus	282		100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0607|consensus	463		100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0599|consensus	411		100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0584|consensus	632		100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0199|consensus	1039		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4236|consensus	888		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0596|consensus	677		100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0196|consensus	996		100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1006|consensus	361		100.0
KOG0662|consensus	292		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0604|consensus	400		100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4278|consensus	1157		100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0696|consensus	683		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG4645|consensus	1509		100.0
KOG1025|consensus	1177		100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG1035|consensus	1351		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0983|consensus	391		100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1094|consensus	807		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.98
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
KOG3653|consensus	534		99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
KOG0666|consensus	438		99.98
KOG0587|consensus	953		99.98
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
KOG0669|consensus	376		99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
KOG0608|consensus	1034		99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG0695|consensus	593		99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG1152|consensus	772		99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0671|consensus	415		99.97
KOG0614|consensus	732		99.97
KOG0200|consensus	609		99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG1290|consensus	590		99.97
KOG0603|consensus	612		99.97
KOG1151|consensus	775		99.97
KOG0664|consensus	449		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0576|consensus	829		99.95
KOG1345|consensus	378		99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0670|consensus	752		99.95
KOG0665|consensus	369		99.94
KOG1163|consensus	341		99.94
KOG1027|consensus	903		99.94
KOG0668|consensus	338		99.94
KOG1024|consensus	563		99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG1167|consensus	418		99.92
KOG0195|consensus	448		99.91
KOG1165|consensus	449		99.9
KOG1164|consensus	322		99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0590|consensus	601		99.79
KOG4158|consensus	598		99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
smart00090	237	RIO RIO-like kinase.	99.76
KOG1166|consensus	974		99.76
KOG0603|consensus	612		99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
KOG0606|consensus	1205		99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG1240|consensus	1431		99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
KOG1023|consensus	484		99.57
KOG1033|consensus	516		99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
KOG0590|consensus	601		99.52
KOG0601|consensus	524		99.37
KOG1266|consensus	458		99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.29
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.28
KOG1243|consensus	690		99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG0601|consensus	524		99.21
KOG0606|consensus	1205		99.18
KOG3741|consensus	655		98.92
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.92
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.9
KOG3087|consensus	229		98.73
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.65
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.6
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.59
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.47
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.35
PRK09902	216	hypothetical protein; Provisional	98.29
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
COG4248	637	Uncharacterized protein with protein kinase and he	98.13
KOG0576|consensus	829		98.07
KOG2137|consensus	700		98.01
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.93
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.81
KOG1235|consensus	538		97.81
PF01636	239	APH: Phosphotransferase enzyme family This family	97.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.46
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.31
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.22
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.08
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.08
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.78
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.75
PRK05231	319	homoserine kinase; Provisional	96.74
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.67
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.62
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.58
KOG1035|consensus	1351		96.49
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.25
KOG1826|consensus	2724		96.14
PLN02876	822	acyl-CoA dehydrogenase	95.99
PLN02236	344	choline kinase	95.48
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.23
KOG2268|consensus	465		95.22
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	94.79
PRK10593	297	hypothetical protein; Provisional	94.62
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.52
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.34
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.19
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.01
KOG1033|consensus	516		92.98
COG2334	331	Putative homoserine kinase type II (protein kinase	91.79
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	91.32
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.29
KOG1236|consensus	565		91.15
KOG2270|consensus	520		90.68
PRK11768	325	serine/threonine protein kinase; Provisional	90.48
PTZ00384	383	choline kinase; Provisional	90.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	89.89
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	89.28
PTZ00296	442	choline kinase; Provisional	88.76
PHA03111	444	Ser/Thr kinase; Provisional	88.2
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	86.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	85.78

>KOG2345|consensus

Probab=100.00  E-value=5.5e-47  Score=299.75  Aligned_cols=259  Identities=44%  Similarity=0.862  Sum_probs=239.3

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      +.+....|+.++|++.+.||+|+|+.|+.+++..++..||+|++.+.+.++.+...+|++..++++|||++++.++.+.+
T Consensus        11 c~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   11 CRRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             eCCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            44889999999999999999999999999999999999999999999988999999999999999999999999887764


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                      ..    -.....|++++|...|||.+.+......+..+++.+++.++.+++.||++||...+ ..+||||||.||++..+
T Consensus        91 ~~----D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~  165 (302)
T KOG2345|consen   91 EK----DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDS  165 (302)
T ss_pred             hc----cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCC
Confidence            22    13567999999999999999999888888899999999999999999999999966 49999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +.+++.|||++...........++...+......+|..|.|||.+.....+.++.++|||||||++|+|++|..||+...
T Consensus       166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence            99999999998888777777888888888899999999999999998888888999999999999999999999999988


Q ss_pred             cCccceeeeeeeccccCCCCCCCC
Q psy16951        256 ERGDSVALAVISGNITFPENTPFP  279 (282)
Q Consensus       256 ~~~~~~~~~~~~~~~~~p~~~~~~  279 (282)
                      .+...+...+..+++.+|.+.|.+
T Consensus       246 ~~GgSlaLAv~n~q~s~P~~~~ys  269 (302)
T KOG2345|consen  246 QQGGSLALAVQNAQISIPNSSRYS  269 (302)
T ss_pred             hcCCeEEEeeeccccccCCCCCcc
Confidence            899999999999999999988865

>KOG0595|consensus

Probab=100.00  E-value=1.4e-47  Score=322.29  Aligned_cols=203  Identities=26%  Similarity=0.413  Sum_probs=177.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|.+.++||+|+||+||+|+++.++.+||||.+.+.  ..+..+-...|+.+++.++|||||.+++         +.
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d---------~~   78 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLD---------CI   78 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEE---------EE
Confidence            357899999999999999999999999999999999766  4555666788999999999999999998         56


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC------
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND------  175 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~------  175 (282)
                      +....+|+|||||.+|+|.+++..+    ..+++..++.++.|++.||++||++   +|+||||||+|||+...      
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCC
Confidence            6678999999999999999999754    3699999999999999999999999   89999999999999875      


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      -.+||+|||+++...          +..-.....|++-|||||++....|   +.|+|+||+|+++|++++|+.||....
T Consensus       152 ~~LKIADFGfAR~L~----------~~~~a~tlcGSplYMAPEV~~~~~Y---dAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQ----------PGSMAETLCGSPLYMAPEVIMSQQY---DAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             ceEEecccchhhhCC----------chhHHHHhhCCccccCHHHHHhccc---cchhhHHHHHHHHHHHHhCCCCccccC
Confidence            346899999876321          2233445679999999999987777   889999999999999999999998533

>KOG0598|consensus

Probab=100.00  E-value=8.5e-46  Score=308.57  Aligned_cols=224  Identities=26%  Similarity=0.381  Sum_probs=188.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .+..++|++++.||+|+||+|+.++.+.|++.+|+|.++...   ..+.+....|..++.+++||.|+.+.-        
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~y--------   92 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIY--------   92 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEE--------
Confidence            577899999999999999999999999999999999886432   334556778999999999999999986        


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                       .+.+...+|+|+||+.||.|..+++    ....+++..+..++.+|+.||.|||++   ||+||||||+|||++..|++
T Consensus        93 -sFQt~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   93 -SFQTEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             -ecccCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence             4566789999999999999999887    345689999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      +++|||+++..         ...........||+.|||||++.+..|   +..+|.||+|+++|||++|.+||.+.  ..
T Consensus       165 ~LtDFgL~k~~---------~~~~~~t~tfcGT~eYmAPEil~~~gy---~~~vDWWsLGillYeML~G~pPF~~~--~~  230 (357)
T KOG0598|consen  165 KLTDFGLCKED---------LKDGDATRTFCGTPEYMAPEILLGKGY---DKAVDWWSLGILLYEMLTGKPPFYAE--DV  230 (357)
T ss_pred             EEeccccchhc---------ccCCCccccccCCccccChHHHhcCCC---CcccchHhHHHHHHHHhhCCCCCcCc--cH
Confidence            99999987532         111122334679999999999999987   89999999999999999999999863  33


Q ss_pred             cceeeeeeeccccCCCC
Q psy16951        259 DSVALAVISGNITFPEN  275 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~  275 (282)
                      ..+...+..++...|+.
T Consensus       231 ~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  231 KKMYDKILKGKLPLPPG  247 (357)
T ss_pred             HHHHHHHhcCcCCCCCc
Confidence            34555566666444433

>KOG0591|consensus

Probab=100.00  E-value=7.6e-47  Score=304.06  Aligned_cols=230  Identities=27%  Similarity=0.442  Sum_probs=193.3

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .....+|+++++||+|.||+||++....+|+.||.|.+...  +.+.++.+..|+.++++|+||||+++++..+.     
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~-----   89 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI-----   89 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh-----
Confidence            44566799999999999999999999999999999999744  34456678899999999999999999875433     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc--CCCCCccccCCCCCcEEeecCCC
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD--AKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                        ++...+++|||+|..|+|...+.........+++..++.++.|++.||..+|+  .+. -|+||||||.||+++.+|.
T Consensus        90 --~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~-~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   90 --EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRG-TVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             --ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccc-ceeeccCcchheEEcCCCc
Confidence              23344999999999999999999888888999999999999999999999999  432 2889999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +|+.|||+++..         .....-..+.+||+.||+||.+...+|   +.+|||||+||++|||+.-++||++.  .
T Consensus       167 vKLGDfGL~r~l---------~s~~tfA~S~VGTPyYMSPE~i~~~~Y---~~kSDiWslGCllyEMcaL~~PF~g~--n  232 (375)
T KOG0591|consen  167 VKLGDFGLGRFL---------SSKTTFAHSLVGTPYYMSPERIHESGY---NFKSDIWSLGCLLYEMCALQSPFYGD--N  232 (375)
T ss_pred             eeeccchhHhHh---------cchhHHHHhhcCCCcccCHHHHhcCCC---CcchhHHHHHHHHHHHHhcCCCcccc--c
Confidence            999999987643         222333557789999999999999988   89999999999999999999999873  3


Q ss_pred             ccceeeeeeeccc-cCC
Q psy16951        258 GDSVALAVISGNI-TFP  273 (282)
Q Consensus       258 ~~~~~~~~~~~~~-~~p  273 (282)
                      -..+...|..++. ++|
T Consensus       233 ~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  233 LLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             HHHHHHHHHcCCCCCCc
Confidence            3444555666654 355

>KOG0575|consensus

Probab=100.00  E-value=4.5e-45  Score=320.72  Aligned_cols=221  Identities=23%  Similarity=0.397  Sum_probs=190.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .+|+..+.||+|+|+.||++++..+|..||+|.+...   .....+...+|+++.+.|+|||||+++.         .++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~---------~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYH---------FFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeee---------Eee
Confidence            5699999999999999999999999999999998642   3455667789999999999999999998         567


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+|+|.|.|.+++|..++..    .+.+.+..++.+++||+.||.|||++   +|+|||||..|++++.+.++||+|
T Consensus        89 Ds~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecc
Confidence            78999999999999999988873    35699999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++..         ......+.....||++|.|||++....+   +..+||||+||++|.|++|++||+.  .......
T Consensus       162 FGLAt~---------le~~~Erk~TlCGTPNYIAPEVl~k~gH---sfEvDiWSlGcvmYtLL~G~PPFet--k~vkety  227 (592)
T KOG0575|consen  162 FGLATQ---------LEYDGERKKTLCGTPNYIAPEVLNKSGH---SFEVDIWSLGCVMYTLLVGRPPFET--KTVKETY  227 (592)
T ss_pred             cceeee---------ecCcccccceecCCCcccChhHhccCCC---CCchhhhhhhhHHHhhhhCCCCccc--chHHHHH
Confidence            998742         1223345567789999999999998887   8899999999999999999999986  3334455


Q ss_pred             eeeeeccccCCCCC
Q psy16951        263 LAVISGNITFPENT  276 (282)
Q Consensus       263 ~~~~~~~~~~p~~~  276 (282)
                      ..+....+++|...
T Consensus       228 ~~Ik~~~Y~~P~~l  241 (592)
T KOG0575|consen  228 NKIKLNEYSMPSHL  241 (592)
T ss_pred             HHHHhcCccccccc
Confidence            56666677777643

>KOG0615|consensus

Probab=100.00  E-value=2.7e-45  Score=308.50  Aligned_cols=223  Identities=27%  Similarity=0.413  Sum_probs=183.5

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-------HHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-------QAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-------~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ..+.|.+.+.||+|+||.|-+|..+.|++.||||++..+....       .....+|+++|++++|||||++++      
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d------  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD------  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee------
Confidence            4678889999999999999999999999999999986432211       112468999999999999999998      


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-  175 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-  175 (282)
                         ++......|+|+||+.+|.|.+++.    ....+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+ 
T Consensus       244 ---~f~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  244 ---FFEVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDA  313 (475)
T ss_pred             ---eeecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCC
Confidence               4555678899999999999999876    456788888899999999999999999   99999999999999876 


Q ss_pred             --CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        176 --NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       176 --~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                        -.+|++|||+++..          .+.......+||+.|.|||++.+..+.....+.|+||+||+||-+++|.+||++
T Consensus       314 e~~llKItDFGlAK~~----------g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~  383 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVS----------GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE  383 (475)
T ss_pred             cceEEEecccchhhcc----------ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence              67899999987631          122234456799999999999988776556789999999999999999999986


Q ss_pred             cccCccceeeeeeeccccCC
Q psy16951        254 VYERGDSVALAVISGNITFP  273 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~p  273 (282)
                      ... +..+...+..|++.+.
T Consensus       384 ~~~-~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  384 EYT-DPSLKEQILKGRYAFG  402 (475)
T ss_pred             ccC-CccHHHHHhcCccccc
Confidence            322 2235556777776654

>KOG0581|consensus

Probab=100.00  E-value=1.6e-44  Score=301.06  Aligned_cols=226  Identities=22%  Similarity=0.316  Sum_probs=187.4

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ..+..++.+.+..||+|..|+||+++|+.|++.+|+|.+..+ ....+.++.+|+++++..+||+||++++.|..     
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----  148 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----  148 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----
Confidence            456667899999999999999999999999999999999544 34456788999999999999999999997765     


Q ss_pred             CCCCCc-eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951        100 VLNSTS-QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus       100 ~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .. .+.++||||.+|||++.+...    +.+++..+-.++.+|+.||.|||..+  +|+||||||+|+|++..|.+
T Consensus       149 ----~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  149 ----NGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             ----CCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCE
Confidence                34 599999999999999988643    55899999999999999999999743  78999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc--
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE--  256 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~--  256 (282)
                      |++|||.+....          . ....+.+||..|||||.+.+..|   +.++||||||+.++|+++|+.||-...+  
T Consensus       219 KicDFGVS~~lv----------n-S~a~tfvGT~~YMsPERi~g~~Y---s~~sDIWSLGLsllE~a~GrfP~~~~~~~~  284 (364)
T KOG0581|consen  219 KICDFGVSGILV----------N-SIANTFVGTSAYMSPERISGESY---SVKSDIWSLGLSLLELAIGRFPYPPPNPPY  284 (364)
T ss_pred             EeccccccHHhh----------h-hhcccccccccccChhhhcCCcC---CcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence            999999865321          1 13346689999999999999988   8899999999999999999999975311  


Q ss_pred             -Cccceeeeeee-ccccCCCC
Q psy16951        257 -RGDSVALAVIS-GNITFPEN  275 (282)
Q Consensus       257 -~~~~~~~~~~~-~~~~~p~~  275 (282)
                       ....+...|+. ..|.+|++
T Consensus       285 ~~~~~Ll~~Iv~~ppP~lP~~  305 (364)
T KOG0581|consen  285 LDIFELLCAIVDEPPPRLPEG  305 (364)
T ss_pred             CCHHHHHHHHhcCCCCCCCcc
Confidence             11233334444 45677776

>KOG0192|consensus

Probab=100.00  E-value=5.7e-44  Score=309.62  Aligned_cols=237  Identities=22%  Similarity=0.306  Sum_probs=189.8

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      ...+.+..+...+.+.||+|+||+||+|.|+++. .||||.+......  ....|.+|+.++.+++||||+.+.|++...
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678888999999999999999999999995443 2999988644332  256899999999999999999999965542


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-ccccCCCCCcEEeec
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA-YAHRDLKTANVLLAN  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~-i~H~dlk~~nil~~~  174 (282)
                              ....++||||+++|+|.+.+...  ....++...++.++.||+.|+.|||++   + |+||||||+|+|++.
T Consensus       112 --------~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~  178 (362)
T KOG0192|consen  112 --------PGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDL  178 (362)
T ss_pred             --------CCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcC
Confidence                    12699999999999999999753  356799999999999999999999999   6 899999999999999


Q ss_pred             CC-CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DN-NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~-~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++ ++||+|||+++.....         ........||+.|||||++.+. -.+++.|+||||||+++|||+||+.||.+
T Consensus       179 ~~~~~KI~DFGlsr~~~~~---------~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~  248 (362)
T KOG0192|consen  179 KGKTLKIADFGLSREKVIS---------KTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFED  248 (362)
T ss_pred             CCCEEEECCCccceeeccc---------cccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence            97 9999999987643111         0223336789999999999953 11249999999999999999999999987


Q ss_pred             cccCccceeeeeeeccccCCCCCCC
Q psy16951        254 VYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      .....-...+.....++.+|..+|+
T Consensus       249 ~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  249 LAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCH
Confidence            6552212223345557888877664

>KOG0592|consensus

Probab=100.00  E-value=6.3e-44  Score=309.33  Aligned_cols=235  Identities=25%  Similarity=0.362  Sum_probs=193.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      ....+|.+.+.||.|+|++|++|+...++++||||++...--   .......+|-+.|.+| .||.|++++-        
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~--------  141 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYF--------  141 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEE--------
Confidence            346799999999999999999999999999999998743211   1122345688889999 7999999987        


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                       .+.++..+|+|+||+++|.|.+.+...    +.+++..+..++.||+.||+|||++   ||+||||||+|||++.++++
T Consensus       142 -TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhi  213 (604)
T KOG0592|consen  142 -TFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHI  213 (604)
T ss_pred             -EeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcE
Confidence             455678899999999999999999754    4589999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCch--hhhhhHh--hhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSA--EAQNLQD--VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~--~~~~~~~--~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|+|||.++..........  .......  ..+.+||..|.+||++.....   +..+|+|+|||++|+|+.|++||.+ 
T Consensus       214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~---~~~sDiWAlGCilyQmlaG~PPFra-  289 (604)
T KOG0592|consen  214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA---GPSSDLWALGCILYQMLAGQPPFRA-  289 (604)
T ss_pred             EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC---CcccchHHHHHHHHHHhcCCCCCcc-
Confidence            9999998875433222211  0111111  256789999999999988765   8899999999999999999999987 


Q ss_pred             ccCccceeeeeeeccccCCCCCCC
Q psy16951        255 YERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                       ..+..+..+|..-.+.+|++.|+
T Consensus       290 -~NeyliFqkI~~l~y~fp~~fp~  312 (604)
T KOG0592|consen  290 -ANEYLIFQKIQALDYEFPEGFPE  312 (604)
T ss_pred             -ccHHHHHHHHHHhcccCCCCCCH
Confidence             44566777788889999999885

>KOG0605|consensus

Probab=100.00  E-value=4.7e-43  Score=303.79  Aligned_cols=237  Identities=22%  Similarity=0.342  Sum_probs=193.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhH---HHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      -+..++|+++.+||+|+||+||+|+-+.||..+|+|+++.+.-...   +....|-.+|....+|.||+++-        
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY--------  208 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY--------  208 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE--------
Confidence            5688999999999999999999999999999999999975544333   34456888888899999999987        


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                       .+.+...+||||||++||++..+|.    ....+++..+..++.+.+.|+..||+.   |++||||||+|+|++..|++
T Consensus       209 -sFQD~~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  209 -SFQDKEYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             -EecCCCeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence             4556789999999999999998886    346799999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhh---------------cc-----Cch-----h----h---------hhhHhhhhccCCCCccCCccc
Q psy16951        179 LLMDLGSVAPAVVK---------------VC-----GSA-----E----A---------QNLQDVAAERCSMPYRAPELF  220 (282)
Q Consensus       179 ~~~df~~~~~~~~~---------------~~-----~~~-----~----~---------~~~~~~~~~~~t~~y~~PE~~  220 (282)
                      |++|||++....-+               ..     ...     .    .         .......+.+||+.|+|||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            99999987543210               00     000     0    0         001113356899999999999


Q ss_pred             ccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeecc--ccCCCCCCCC
Q psy16951        221 HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPENTPFP  279 (282)
Q Consensus       221 ~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~~p~~~~~~  279 (282)
                      .+..|   +..+|.||+|||+|||+.|.+||.+  +.+......+...+  +.+|++.+.+
T Consensus       361 l~kgY---~~~cDwWSLG~ImyEmLvGyPPF~s--~tp~~T~rkI~nwr~~l~fP~~~~~s  416 (550)
T KOG0605|consen  361 LGKGY---GKECDWWSLGCIMYEMLVGYPPFCS--ETPQETYRKIVNWRETLKFPEEVDLS  416 (550)
T ss_pred             hcCCC---CccccHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHHHhhhccCCCcCccc
Confidence            99998   8999999999999999999999987  44555666666665  6778776653

>KOG0600|consensus

Probab=100.00  E-value=8.1e-44  Score=306.32  Aligned_cols=217  Identities=24%  Similarity=0.324  Sum_probs=181.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .|.....+.|+-+++||+|.||.||+|++..||+.||+|++.....  ......++|+.+|++|+||||+++.+..... 
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-  188 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-  188 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec-
Confidence            5666678899999999999999999999999999999999987663  3456678999999999999999999854431 


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            ....+|||+||+ ..+|..++..   ..-.+.+.++..++.|++.||+|+|++   |++|||||.+|||++.+|
T Consensus       189 ------~~~siYlVFeYM-dhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G  255 (560)
T KOG0600|consen  189 ------LSGSIYLVFEYM-DHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNG  255 (560)
T ss_pred             ------CCceEEEEEecc-cchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCC
Confidence                  246899999999 4567666542   334689999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+||+|||++.+...        ....+-...+-|..|.|||.++|...  ++...|+||+||||.||++|++.|++..+
T Consensus       256 ~LKiaDFGLAr~y~~--------~~~~~~T~rVvTLWYRpPELLLG~t~--Yg~aVDlWS~GCIl~El~~gkPI~~G~tE  325 (560)
T KOG0600|consen  256 VLKIADFGLARFYTP--------SGSAPYTSRVVTLWYRPPELLLGATS--YGTAVDLWSVGCILAELFLGKPILQGRTE  325 (560)
T ss_pred             CEEeccccceeeccC--------CCCcccccceEEeeccChHHhcCCcc--cccceeehhhhHHHHHHHcCCCCcCCccH
Confidence            999999999864321        11122345566889999999999753  69999999999999999999999998666


Q ss_pred             Ccc
Q psy16951        257 RGD  259 (282)
Q Consensus       257 ~~~  259 (282)
                      .++
T Consensus       326 veQ  328 (560)
T KOG0600|consen  326 VEQ  328 (560)
T ss_pred             HHH
Confidence            444

>KOG0616|consensus

Probab=100.00  E-value=4.5e-43  Score=283.97  Aligned_cols=222  Identities=23%  Similarity=0.355  Sum_probs=192.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhH---HHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...++|+.++.||.|+||+|.+++++.+|.-+|+|.+......+.   +...+|..+++.+.||.++++.+.        
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t--------  112 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT--------  112 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe--------
Confidence            667899999999999999999999999999999998865443332   345679999999999999999884        


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                       +.+...+++||||.++|.|..++..    .+++++..++.++.||+.|++|||++   +|++|||||+|||++.+|++|
T Consensus       113 -~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  113 -FKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             -eccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEE
Confidence             4456899999999999999998864    34699999999999999999999999   788999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      ++|||+++-.            ..+....+||+.|+|||++...+|   +..+|.||||+++|||+.|.+||.+  .++.
T Consensus       185 itDFGFAK~v------------~~rT~TlCGTPeYLAPEii~sk~y---nkavDWWalGVLIYEMlaG~pPF~~--~~~~  247 (355)
T KOG0616|consen  185 ITDFGFAKRV------------SGRTWTLCGTPEYLAPEIIQSKGY---NKAVDWWALGVLIYEMLAGYPPFYD--DNPI  247 (355)
T ss_pred             EEeccceEEe------------cCcEEEecCCccccChHHhhcCCC---CcchhHHHHHHHHHHHHcCCCCCcC--CChH
Confidence            9999976522            122345678999999999999988   8999999999999999999999987  4446


Q ss_pred             ceeeeeeeccccCCCCCC
Q psy16951        260 SVALAVISGNITFPENTP  277 (282)
Q Consensus       260 ~~~~~~~~~~~~~p~~~~  277 (282)
                      .+...|+.++..+|.-..
T Consensus       248 ~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  248 QIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             HHHHHHHhCcccCCcccC
Confidence            777889999999996554

>KOG0197|consensus

Probab=100.00  E-value=1.2e-43  Score=308.20  Aligned_cols=237  Identities=21%  Similarity=0.364  Sum_probs=192.5

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.++.+.+.++++||+|.||+||+|.+.++ ..||+|.+... .-....|.+|+++|++|+|+|||++++.+.    
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~----  271 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT----  271 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe----
Confidence            788999999999999999999999999999543 46899987644 345567889999999999999999999544    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .+..++|||||++.|+|.++|..  .....+...+.+.++.||++|++||.++   ++|||||-.+|||++.+..
T Consensus       272 -----~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~  341 (468)
T KOG0197|consen  272 -----KQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLV  341 (468)
T ss_pred             -----cCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCce
Confidence                 34579999999999999999975  2456789999999999999999999999   7889999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      +||+|||+++..  ...      .........-+..|.|||++....+   +.+|||||||++|||++| |+.||.+- +
T Consensus       342 vKIsDFGLAr~~--~d~------~Y~~~~~~kfPIkWtAPEa~~~~~F---S~kSDVWSFGVlL~E~fT~G~~py~~m-s  409 (468)
T KOG0197|consen  342 VKISDFGLARLI--GDD------EYTASEGGKFPIKWTAPEALNYGKF---SSKSDVWSFGVLLWELFTYGRVPYPGM-S  409 (468)
T ss_pred             EEEccccccccc--CCC------ceeecCCCCCCceecCHHHHhhCCc---ccccceeehhhhHHHHhccCCCCCCCC-C
Confidence            999999998721  111      1111111222567999999987665   999999999999999999 88998753 2


Q ss_pred             CccceeeeeeeccccCCCCCCCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENTPFPQYQ  282 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~~~~~~~  282 (282)
                      ..+-+...-.+.+++.|+++|+.+|+
T Consensus       410 n~ev~~~le~GyRlp~P~~CP~~vY~  435 (468)
T KOG0197|consen  410 NEEVLELLERGYRLPRPEGCPDEVYE  435 (468)
T ss_pred             HHHHHHHHhccCcCCCCCCCCHHHHH
Confidence            23333333456689999999998774

>KOG1989|consensus

Probab=100.00  E-value=8.1e-41  Score=304.99  Aligned_cols=251  Identities=31%  Similarity=0.582  Sum_probs=203.5

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALT   94 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~   94 (282)
                      .-...+.+...++++.+.|.+|||+.||+|.....+.+||+|++...+....+...+|+++|+.|+ |+|||.|++.+..
T Consensus        27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            334678888999999999999999999999999888999999998888888889999999999997 9999999984322


Q ss_pred             cCCCCCCCC-CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         95 GCADPVLNS-TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        95 ~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .+   .-.. ...++|.||||.+|+|-+++..+...  .+.+.+++.|++|+++|+.+||.+.+ .|+|||||.+|+|+.
T Consensus       107 ~~---~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls  180 (738)
T KOG1989|consen  107 NR---SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLS  180 (738)
T ss_pred             cc---cCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEc
Confidence            11   1222 46789999999999999999877543  39999999999999999999999988 699999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+++.|+||||.+........................|+.|+|||++.--.-.+++.|+|||||||+||.||+.++||++
T Consensus       181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~  260 (738)
T KOG1989|consen  181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE  260 (738)
T ss_pred             CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence            99999999999765332222111112222334445668999999999532223569999999999999999999999974


Q ss_pred             cccCccceeeeeeeccccCCCCCCC
Q psy16951        254 VYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                            .=..+|+.+++.+|+..++
T Consensus       261 ------sg~laIlng~Y~~P~~p~y  279 (738)
T KOG1989|consen  261 ------SGKLAILNGNYSFPPFPNY  279 (738)
T ss_pred             ------CcceeEEeccccCCCCccH
Confidence                  2247899999999987554

>KOG0583|consensus

Probab=100.00  E-value=1.2e-41  Score=297.34  Aligned_cols=227  Identities=28%  Similarity=0.423  Sum_probs=190.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC----Cc-hhHHHHHHHHHHhhhCC-CCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH----GR-EDQAQAIREVEHHKTFV-HPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~----~~-~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~   94 (282)
                      .....+.|++.+.||+|+||+|+.|.+..++..||+|.+...    .. ...+...+|+.+++.++ ||||+++++    
T Consensus        12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e----   87 (370)
T KOG0583|consen   12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE----   87 (370)
T ss_pred             cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE----
Confidence            356678999999999999999999999999999999966543    11 22345568999999998 999999998    


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                           ++.....+++||||+.+|.|.+.+..    ..++.+..+..++.|++.|+.|+|++   ||+||||||+|++++.
T Consensus        88 -----v~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   88 -----VFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG  155 (370)
T ss_pred             -----EEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence                 45556779999999999999998874    45688999999999999999999999   8999999999999999


Q ss_pred             C-CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc-ccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        175 D-NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS-YCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       175 ~-~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~-~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      + +.+|++|||++....         ..........||+.|+|||++.+.. |.  +.++||||+|++||.|++|..||.
T Consensus       156 ~~~~~Kl~DFG~s~~~~---------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~--g~~aDvWS~GViLy~ml~G~~PF~  224 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISP---------GEDGLLKTFCGSPAYAAPEVLSGKGTYS--GKAADVWSLGVILYVLLCGRLPFD  224 (370)
T ss_pred             CCCCEEEeccccccccC---------CCCCcccCCCCCcccCCHHHhCCCCCcC--CchhhhhhhHHHHHHHHhCCCCCC
Confidence            9 999999999865321         1222344567899999999999987 84  789999999999999999999998


Q ss_pred             ccccCccceeeeeeeccccCCCCC
Q psy16951        253 TVYERGDSVALAVISGNITFPENT  276 (282)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~p~~~  276 (282)
                      +  +....+...+..+.+.+|...
T Consensus       225 d--~~~~~l~~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  225 D--SNVPNLYRKIRKGEFKIPSYL  246 (370)
T ss_pred             C--ccHHHHHHHHhcCCccCCCCc
Confidence            6  333445555788888888765

>KOG0593|consensus

Probab=100.00  E-value=1.7e-41  Score=275.63  Aligned_cols=204  Identities=23%  Similarity=0.376  Sum_probs=169.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.|+.+.++|+|+||.|++++++.||..||||++..+...  ..+...+|+..+++++|+|+|.+++.         +..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV---------Frr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV---------FRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH---------HHh
Confidence            5788899999999999999999999999999998665543  35567899999999999999999994         445


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++|+|||. .++.+.+..   .+..+++..+..+++|++.|+.|+|++   +++||||||+|||+..++.+|++||
T Consensus        73 krklhLVFE~~d-hTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDF  145 (396)
T KOG0593|consen   73 KRKLHLVFEYCD-HTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDF  145 (396)
T ss_pred             cceeEEEeeecc-hHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccc
Confidence            688999999994 466565653   345589999999999999999999999   8899999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |+++...         .+...=...+-|..|.|||.+.|+..  ++++.||||+||++.||++|++.|.+..+
T Consensus       146 GFAR~L~---------~pgd~YTDYVATRWYRaPELLvGDtq--YG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  146 GFARTLS---------APGDNYTDYVATRWYRAPELLVGDTQ--YGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hhhHhhc---------CCcchhhhhhhhhhccChhhhcccCc--CCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            9765321         11122223445778999999999643  59999999999999999999999976444

>KOG0610|consensus

Probab=100.00  E-value=2.9e-41  Score=284.53  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=206.6

Q ss_pred             ccchhhhhhhhcccc-cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhh
Q psy16951          3 TMGLNLIFQMGCLCS-KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHK   78 (282)
Q Consensus         3 ~~~~~~~~~~~~~~~-~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~   78 (282)
                      +++.+..|....... .....+..+.|++++.||.|.-|+||+++.++++..+|+|++....-.   ...+..-|-++|+
T Consensus        53 h~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~  132 (459)
T KOG0610|consen   53 HKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILS  132 (459)
T ss_pred             CCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHH
Confidence            345556666655554 567888999999999999999999999999999999999998644332   3334566899999


Q ss_pred             hCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q psy16951         79 TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        79 ~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~  158 (282)
                      .++||.+++++.         .+++....|++||||+||.|..+++..  ..+.+++..++.++.+++.||+|||-.   
T Consensus       133 ~lDHPFlPTLYa---------~fet~~~~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---  198 (459)
T KOG0610|consen  133 LLDHPFLPTLYA---------SFETDKYSCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---  198 (459)
T ss_pred             hcCCCccchhhh---------eeeccceeEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---
Confidence            999999999998         566778999999999999999877654  567799999999999999999999999   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCc----------------------------hhh-----------
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS----------------------------AEA-----------  199 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~----------------------------~~~-----------  199 (282)
                      |||.|||||+|||+-.+|+++++||.++..........                            ...           
T Consensus       199 GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~  278 (459)
T KOG0610|consen  199 GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR  278 (459)
T ss_pred             ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence            99999999999999999999999999764322211000                            000           


Q ss_pred             --------hhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeecccc
Q psy16951        200 --------QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNIT  271 (282)
Q Consensus       200 --------~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  271 (282)
                              ....+..+.+||..|.|||++.|+..   +.++|.|+||+++|||++|..||.+.+  .+....+++...+.
T Consensus       279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH---gsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~  353 (459)
T KOG0610|consen  279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH---GSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLK  353 (459)
T ss_pred             cchhhhcCCCCccccccccccccccceeeecCCC---CchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCc
Confidence                    01122345678999999999999998   889999999999999999999998743  34456678888889


Q ss_pred             CCCCC
Q psy16951        272 FPENT  276 (282)
Q Consensus       272 ~p~~~  276 (282)
                      +|+.+
T Consensus       354 Fp~~~  358 (459)
T KOG0610|consen  354 FPEEP  358 (459)
T ss_pred             CCCCC
Confidence            99765

>KOG0597|consensus

Probab=100.00  E-value=5.6e-42  Score=298.39  Aligned_cols=199  Identities=28%  Similarity=0.455  Sum_probs=174.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|.+.+.||+|.||.||+|+.+.|...||+|.+...++.  +.....+|+++++.++||||+++++         +++.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~e---------sfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLE---------SFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHH---------hhcc
Confidence            5788899999999999999999999999999998765543  4556789999999999999999998         7778


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+|+|.|||.+ +|...+..    ...+++.++..+++++..||.|||+.   +|+|||+||+||++..++++|++||
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechh
Confidence            8999999999966 88887763    35599999999999999999999999   7889999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |+++-+..         +..-..+..||+.|||||...+.+|   +..+|.||+||++||+++|++||..
T Consensus       145 g~Ar~m~~---------~t~vltsikGtPlYmAPElv~e~py---d~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  145 GLARAMST---------NTSVLTSIKGTPLYMAPELVEEQPY---DHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             hhhhhccc---------CceeeeeccCcccccCHHHHcCCCc---cchhhHHHHHHHHHHHhcCCCCchH
Confidence            98763321         1222345678999999999998887   8899999999999999999999974

>KOG0582|consensus

Probab=100.00  E-value=1.5e-40  Score=282.41  Aligned_cols=241  Identities=21%  Similarity=0.279  Sum_probs=194.4

Q ss_pred             hhcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccc
Q psy16951         12 MGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLD   90 (282)
Q Consensus        12 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~   90 (282)
                      .+...+...|.++.++|++.++||.|..++||+|+...++..||||++...... +...+.+|+..|+.++||||++++.
T Consensus        12 ~~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~   91 (516)
T KOG0582|consen   12 PSASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHC   91 (516)
T ss_pred             cccccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEE
Confidence            355677888999999999999999999999999999999999999999754433 3477889999999999999999998


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcE
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~ni  170 (282)
                      .|..+         ..+|+||.|+.+||+.+.+...-.++  +++..+..++++++.||.|||++   |-+|||+|+.||
T Consensus        92 sFvv~---------~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnI  157 (516)
T KOG0582|consen   92 SFVVD---------SELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNI  157 (516)
T ss_pred             EEEec---------ceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccE
Confidence            76653         78999999999999999887654433  89999999999999999999999   788999999999


Q ss_pred             EeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        171 LLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      |++.+|.++++|||.+....-  .  . .+...+.....||+.|||||++.-.-. -|+.|+||||||++..||++|..|
T Consensus       158 Li~~dG~VkLadFgvsa~l~~--~--G-~R~~~rf~tfvgtp~wmAPEvl~q~~~-GYdfKaDIwSfGITA~ELA~G~aP  231 (516)
T KOG0582|consen  158 LIDSDGTVKLADFGVSASLFD--S--G-DRQVTRFNTFVGTPCWMAPEVLMQQLH-GYDFKADIWSFGITACELAHGHAP  231 (516)
T ss_pred             EEcCCCcEEEcCceeeeeecc--c--C-ceeeEeeccccCcccccChHHhhhccc-CccchhhhhhhhHHHHHHhcCCCC
Confidence            999999999999997654321  1  1 111111245578999999999643321 248999999999999999999999


Q ss_pred             CCccccCccceeeeeeeccccCCC
Q psy16951        251 FDTVYERGDSVALAVISGNITFPE  274 (282)
Q Consensus       251 f~~~~~~~~~~~~~~~~~~~~~p~  274 (282)
                      |....+ - ++.+.-+.+.|+.|.
T Consensus       232 f~k~pP-m-kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  232 FSKYPP-M-KVLLLTLQNDPPTLL  253 (516)
T ss_pred             cccCCh-H-HHHHHHhcCCCCCcc
Confidence            986433 2 233344555555554

>KOG0588|consensus

Probab=100.00  E-value=2.5e-41  Score=299.07  Aligned_cols=225  Identities=29%  Similarity=0.407  Sum_probs=195.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+-|++.+.||.|+.|.|..|+|..||..+|||.+.....   .....+.+|+.+|+-+.||||+.+++         ++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd---------Vw   81 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYD---------VW   81 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeee---------ee
Confidence            5778999999999999999999999999999999965532   23456778999999999999999998         66


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      +...++|+|.||+++|.|.+.+..    .+.+++..+..++.||+.|+.|+|..   +|+||||||+|+|++..+++||+
T Consensus        82 e~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   82 ENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             ccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeee
Confidence            677899999999999999998863    45689999999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||.+..          ..+..-....+|++-|.|||++.|..|+  +.++||||+|||||.|+||+.||.+  +.-..+
T Consensus       155 DFGMAsL----------e~~gklLeTSCGSPHYA~PEIV~G~pYd--G~~sDVWSCGVILfALLtG~LPFdD--dNir~L  220 (786)
T KOG0588|consen  155 DFGMASL----------EVPGKLLETSCGSPHYAAPEIVSGRPYD--GRPSDVWSCGVILFALLTGKLPFDD--DNIRVL  220 (786)
T ss_pred             ccceeec----------ccCCccccccCCCcccCCchhhcCCCCC--CCccccchhHHHHHHHHhCCCCCCC--ccHHHH
Confidence            9998642          2223334456789999999999999996  8999999999999999999999985  445567


Q ss_pred             eeeeeeccccCCCCCCCC
Q psy16951        262 ALAVISGNITFPENTPFP  279 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~~~~  279 (282)
                      ...+.+|.+..|.+.|..
T Consensus       221 LlKV~~G~f~MPs~Is~e  238 (786)
T KOG0588|consen  221 LLKVQRGVFEMPSNISSE  238 (786)
T ss_pred             HHHHHcCcccCCCcCCHH
Confidence            778899999999887753

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-40  Score=290.39  Aligned_cols=210  Identities=21%  Similarity=0.323  Sum_probs=169.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++++.||+|+||+||+|++..++..||+|.+....   ......+.+|+.+++.++|+||+++++.+         .
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~---------~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF---------Q   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE---------e
Confidence            57999999999999999999999999999999885432   22234567799999999999999998843         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+++|+|.+.+..    ...+++.++..++.|++.||.|||++   ||+||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~D  144 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSD  144 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEee
Confidence            45789999999999999998863    34589999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCch-----------------h----h-----hhhHhhhhccCCCCccCCcccccCcccCCCCccchhh
Q psy16951        183 LGSVAPAVVKVCGSA-----------------E----A-----QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS  236 (282)
Q Consensus       183 f~~~~~~~~~~~~~~-----------------~----~-----~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws  236 (282)
                      ||++...........                 .    .     ..........||+.|+|||++.+..+   +.++||||
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---~~~~DvwS  221 (363)
T cd05628         145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY---NKLCDWWS  221 (363)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC---CCchhhhh
Confidence            998653211000000                 0    0     00000123468999999999988766   78999999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q psy16951        237 LGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~  254 (282)
                      |||++|||++|..||.+.
T Consensus       222 lGvil~ell~G~~Pf~~~  239 (363)
T cd05628         222 LGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             hHHHHHHHHhCCCCCCCC
Confidence            999999999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0198|consensus

Probab=100.00  E-value=1.3e-40  Score=281.00  Aligned_cols=233  Identities=20%  Similarity=0.307  Sum_probs=179.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ..++...+.||+|+||.||++....+|...|||.+...+....+.+.+|+.+|++++|||||++++....      .++ 
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~------~~~-   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS------REN-   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc------ccC-
Confidence            5667888999999999999999998899999999876644445667899999999999999999984221      111 


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~df  183 (282)
                      ..++++|||+++|+|.+++....  . .+++..+..+.+|+++||.|||++   |++||||||+|||++. ++.+|++||
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDF  162 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADF  162 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccC
Confidence            36999999999999999887532  2 589999999999999999999998   8999999999999999 799999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc-ccCcccee
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV-YERGDSVA  262 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~-~~~~~~~~  262 (282)
                      |.+.....      ............||+.|||||++.....  .+.++||||+||++.||+||++||... ........
T Consensus       163 G~a~~~~~------~~~~~~~~~~~~Gtp~~maPEvi~~g~~--~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~  234 (313)
T KOG0198|consen  163 GLAKKLES------KGTKSDSELSVQGTPNYMAPEVIRNGEV--ARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL  234 (313)
T ss_pred             cccccccc------ccccccccccccCCccccCchhhcCCCc--CCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH
Confidence            97653211      0111122335678999999999985322  145999999999999999999999863 22222222


Q ss_pred             eeeeeccccCCCCCCC
Q psy16951        263 LAVISGNITFPENTPF  278 (282)
Q Consensus       263 ~~~~~~~~~~p~~~~~  278 (282)
                      +......|.+|+..++
T Consensus       235 ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  235 IGREDSLPEIPDSLSD  250 (313)
T ss_pred             HhccCCCCCCCcccCH
Confidence            2222234566665543

>KOG0585|consensus

Probab=100.00  E-value=4.6e-40  Score=281.29  Aligned_cols=232  Identities=24%  Similarity=0.375  Sum_probs=182.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--------------HHHHHHHHHHhhhCCCCCcccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--------------QAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--------------~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      ....+|++...||+|.||.|-+|+...+++.||||++.......              .+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45679999999999999999999999999999999885432211              2366789999999999999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      .+. +++      .....+|||+|||..|.+..--    .....+.+.+++.+++++..||+|||.+   ||+||||||+
T Consensus       174 iEv-LDD------P~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPs  239 (576)
T KOG0585|consen  174 IEV-LDD------PESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPS  239 (576)
T ss_pred             EEe-ecC------cccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchh
Confidence            982 221      1246799999999998875411    1122288999999999999999999999   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC---cccCCCCccchhhHHHHHHHHH
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD---SYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~---~~~~~~~~~Diws~G~il~el~  245 (282)
                      |+|++.+|++||+|||.+..+.......    .........||+.|+|||.+.++   .+  .+.+.||||+||+||-|+
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~----~d~~L~~tvGTPAF~APE~c~~~~~~~~--~g~a~DiWalGVTLYCll  313 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEG----SDDQLSRTVGTPAFFAPELCSGGNSFSY--SGFALDIWALGVTLYCLL  313 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccc----cHHHHhhcCCCccccchHhhcCCCCccc--cchhhhhhhhhhhHHHhh
Confidence            9999999999999999875432221111    11122337899999999999873   33  378999999999999999


Q ss_pred             hCCCCCCccccCccceeeeeeeccccCCCCC
Q psy16951        246 YFKSPFDTVYERGDSVALAVISGNITFPENT  276 (282)
Q Consensus       246 tg~~pf~~~~~~~~~~~~~~~~~~~~~p~~~  276 (282)
                      .|+.||.+  +....+...|......+|++.
T Consensus       314 fG~~PF~~--~~~~~l~~KIvn~pL~fP~~p  342 (576)
T KOG0585|consen  314 FGQLPFFD--DFELELFDKIVNDPLEFPENP  342 (576)
T ss_pred             hccCCccc--chHHHHHHHHhcCcccCCCcc
Confidence            99999976  334455666777777777653

>KOG0694|consensus

Probab=100.00  E-value=4.6e-40  Score=292.50  Aligned_cols=225  Identities=22%  Similarity=0.374  Sum_probs=188.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGC   96 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~   96 (282)
                      ..+..++|.++.+||+|.||+|++++.+++++.+|||.++...   +.+.+....|..++.-. +||.++.++.      
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~------  436 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS------  436 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc------
Confidence            5678899999999999999999999999999999999886542   34455566677776665 5999999998      


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                         ++....++++||||+.||++.+...     ...+++..+..|++.|+.||+|||++   ||++||||.+|||+|.+|
T Consensus       437 ---~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eG  505 (694)
T KOG0694|consen  437 ---CFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEG  505 (694)
T ss_pred             ---ccccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccC
Confidence               5556789999999999999655332     24589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      ++||+|||+++..         .-.........||+.|+|||++.+..|   +...|.|||||++|||+.|+.||.+  +
T Consensus       506 h~kiADFGlcKe~---------m~~g~~TsTfCGTpey~aPEil~e~~Y---t~aVDWW~lGVLlyeML~Gq~PF~g--d  571 (694)
T KOG0694|consen  506 HVKIADFGLCKEG---------MGQGDRTSTFCGTPEFLAPEVLTEQSY---TRAVDWWGLGVLLYEMLVGESPFPG--D  571 (694)
T ss_pred             cEEeccccccccc---------CCCCCccccccCChhhcChhhhccCcc---cchhhHHHHHHHHHHHHcCCCCCCC--C
Confidence            9999999987532         112223455679999999999999988   9999999999999999999999987  4


Q ss_pred             CccceeeeeeeccccCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENT  276 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~  276 (282)
                      .++.+...|....+.+|-..
T Consensus       572 dEee~FdsI~~d~~~yP~~l  591 (694)
T KOG0694|consen  572 DEEEVFDSIVNDEVRYPRFL  591 (694)
T ss_pred             CHHHHHHHHhcCCCCCCCcc
Confidence            55677777888777777543

>KOG0578|consensus

Probab=100.00  E-value=2.8e-40  Score=288.34  Aligned_cols=201  Identities=26%  Similarity=0.421  Sum_probs=179.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +...|....+||+|..|.||.|+...++..||||++.......++-+.+|+.+|+..+|+|||.+++.++.+        
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--------  342 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--------  342 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--------
Confidence            356788889999999999999999999999999999988888888899999999999999999999977653        


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                       ..+|+||||+++|+|.+.+..     ..+.+.++..+|++++.||+|||.+   ||+|||||.+||++..+|.+|++||
T Consensus       343 -deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  343 -DELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             -ceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence             779999999999999987753     3489999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |++...         .....+...-+||+.|||||++....|   +.+.||||||++++||+-|++||-.
T Consensus       414 GFcaqi---------~~~~~KR~TmVGTPYWMAPEVvtrk~Y---G~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  414 GFCAQI---------SEEQSKRSTMVGTPYWMAPEVVTRKPY---GPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             eeeecc---------ccccCccccccCCCCccchhhhhhccc---CccccchhhhhHHHHHhcCCCCccC
Confidence            976532         111224456689999999999998888   8999999999999999999999953

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=287.19  Aligned_cols=210  Identities=24%  Similarity=0.337  Sum_probs=169.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++++.||+|+||+||+|++..++..||||++....   ......+.+|+++++.++||||+++++.+         .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~---------~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF---------Q   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE---------E
Confidence            57999999999999999999999999999999986432   22334567899999999999999998844         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  144 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSD  144 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEee
Confidence            45789999999999999988763    34589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhh-----------------------------hHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        183 LGSVAPAVVKVCGSAEAQN-----------------------------LQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ||++...............                             ........||+.|+|||++.+..+   +.++|
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~D  221 (364)
T cd05599         145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY---NKECD  221 (364)
T ss_pred             cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC---CCeee
Confidence            9976532111000000000                             000112358999999999987766   88999


Q ss_pred             hhhHHHHHHHHHhCCCCCCcc
Q psy16951        234 VWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       234 iws~G~il~el~tg~~pf~~~  254 (282)
                      |||+||++|||++|..||.+.
T Consensus       222 iwSlG~il~el~~G~~Pf~~~  242 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFCSD  242 (364)
T ss_pred             eecchhHHHHhhcCCCCCCCC
Confidence            999999999999999999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0659|consensus

Probab=100.00  E-value=1.2e-39  Score=260.49  Aligned_cols=204  Identities=26%  Similarity=0.393  Sum_probs=170.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|...++||+|.||.||+|++..||+.||||++...+.++  ..+.++|+..++.++|+||+.+.+.         +..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~---------F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV---------FPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh---------ccC
Confidence            57888999999999999999999999999999998765543  4577899999999999999999994         445


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+-+|+||+ ..+|+..+..   ....+.+.++..|+.+++.|+.|+|++   .|+||||||.|+|++.+|.+|++||
T Consensus        73 ~~~l~lVfEfm-~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   73 KSNLSLVFEFM-PTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             CCceEEEEEec-cccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecc
Confidence            67899999999 5677776653   234588999999999999999999999   7899999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |+++.....     ..    .....+-|..|.|||.+.|...  ++...|+||.|||+.||+.|.+-|.+..+
T Consensus       146 GLAr~f~~p-----~~----~~~~~V~TRWYRAPELLfGsr~--Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  146 GLARFFGSP-----NR----IQTHQVVTRWYRAPELLFGSRQ--YGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             cchhccCCC-----Cc----ccccceeeeeccChHHhccchh--cCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            988743211     11    1111145778999999988653  58999999999999999999988876444

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=276.95  Aligned_cols=218  Identities=24%  Similarity=0.343  Sum_probs=176.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+++++.++||||+++++.         ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~---------~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT---------EH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh---------hc
Confidence            579999999999999999999999999999999864322   234467789999999999999999873         44


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...++++|||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~D  144 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTD  144 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEe
Confidence            55789999999999999988763    24578899999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++....            .......||+.|+|||++.+..+   +.++||||+|+++|+|++|+.||.+...  ....
T Consensus       145 fg~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~  207 (291)
T cd05612         145 FGFAKKLR------------DRTWTLCGTPEYLAPEVIQSKGH---NKAVDWWALGILIYEMLVGYPPFFDDNP--FGIY  207 (291)
T ss_pred             cCcchhcc------------CCcccccCChhhcCHHHHcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            99754210            01112357889999999987766   7899999999999999999999975322  2223


Q ss_pred             eeeeeccccCCCCC
Q psy16951        263 LAVISGNITFPENT  276 (282)
Q Consensus       263 ~~~~~~~~~~p~~~  276 (282)
                      ..+..+.+.+|...
T Consensus       208 ~~i~~~~~~~~~~~  221 (291)
T cd05612         208 EKILAGKLEFPRHL  221 (291)
T ss_pred             HHHHhCCcCCCccC
Confidence            33444555555443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-39  Score=286.56  Aligned_cols=211  Identities=22%  Similarity=0.277  Sum_probs=169.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..|++++.||+|+||+||+|++..++..||+|++....   ......+.+|+++++.++||||+++++.+.         
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~---------   71 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ---------   71 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe---------
Confidence            36899999999999999999999999999999986432   233456788999999999999999998443         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||++   ||+||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~D  144 (381)
T cd05626          72 DKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTD  144 (381)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEee
Confidence            45789999999999999988753    34578889999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchh-----------------------------------hh---hhHhhhhccCCCCccCCcccccCc
Q psy16951        183 LGSVAPAVVKVCGSAE-----------------------------------AQ---NLQDVAAERCSMPYRAPELFHVDS  224 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~-----------------------------------~~---~~~~~~~~~~t~~y~~PE~~~~~~  224 (282)
                      ||++............                                   ..   .........||+.|+|||++.+..
T Consensus       145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  224 (381)
T cd05626         145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG  224 (381)
T ss_pred             CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC
Confidence            9976422100000000                                   00   000012346899999999998776


Q ss_pred             ccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        225 YCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       225 ~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +   +.++||||+||++|||++|..||....
T Consensus       225 ~---~~~~DiwSlG~il~elltG~~Pf~~~~  252 (381)
T cd05626         225 Y---TQLCDWWSVGVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             C---CCccceeehhhHHHHHHhCCCCCcCCC
Confidence            6   889999999999999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0589|consensus

Probab=100.00  E-value=4.4e-40  Score=284.85  Aligned_cols=224  Identities=29%  Similarity=0.487  Sum_probs=186.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|+.++++|+|+||.++..+++..+..+++|++....  ...+...++|+.++++++||||+.+.+.|..        
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~--------   74 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE--------   74 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc--------
Confidence            578999999999999999999999999999999996543  3344467899999999999999999986443        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...++|+|+||+||++.+.+....  +..+++..+..|+.|++.|+.|||++   +|+|||||+.||++.+++.+++.|
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecc
Confidence            4455999999999999999888653  46789999999999999999999988   788999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||+++..         ........+..||+.|+|||.+.+.+|   +.|+||||+||++|||++-+++|.+.+..  .+.
T Consensus       150 fGlaK~l---------~~~~~~a~tvvGTp~YmcPEil~d~pY---n~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~Li  215 (426)
T KOG0589|consen  150 FGLAKIL---------NPEDSLASTVVGTPYYMCPEILSDIPY---NEKSDIWSLGCCLYEMCTLKPAFKASNMS--ELI  215 (426)
T ss_pred             hhhhhhc---------CCchhhhheecCCCcccCHHHhCCCCC---CccCcchhhcchHHHHHhcccccCccchH--HHH
Confidence            9987632         111124456789999999999999988   99999999999999999999999874432  233


Q ss_pred             eeeeecc-ccCCCC
Q psy16951        263 LAVISGN-ITFPEN  275 (282)
Q Consensus       263 ~~~~~~~-~~~p~~  275 (282)
                      ..+..+. .++|..
T Consensus       216 ~ki~~~~~~Plp~~  229 (426)
T KOG0589|consen  216 LKINRGLYSPLPSM  229 (426)
T ss_pred             HHHhhccCCCCCcc
Confidence            3444444 344443

>KOG0661|consensus

Probab=100.00  E-value=1.4e-40  Score=284.49  Aligned_cols=210  Identities=24%  Similarity=0.428  Sum_probs=176.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCC-CCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~  100 (282)
                      +..++|.++++||.|.||.||+|....++..||||+++..-.. +...-+||+..+++++ ||||+++++.++.      
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d------   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD------   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc------
Confidence            4568999999999999999999999999999999998644322 3334578999999998 9999999995443      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....+++||||+ .-.|++++..+   ...+++.++..|+.||++||.|+|.+   |+.|||+||+|||+.....+||
T Consensus        81 --~~~~L~fVfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKi  151 (538)
T KOG0661|consen   81 --NDRILYFVFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKI  151 (538)
T ss_pred             --cCceEeeeHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEe
Confidence              223899999999 66899988765   56799999999999999999999999   8889999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      +|||+++....+.          .-...+.|..|+|||++....+  ++.+.|+||+|||++|+.+-++.|-+.++.++
T Consensus       152 aDFGLARev~Skp----------PYTeYVSTRWYRAPEvLLrs~~--Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq  218 (538)
T KOG0661|consen  152 ADFGLAREVRSKP----------PYTEYVSTRWYRAPEVLLRSGY--YSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ  218 (538)
T ss_pred             cccccccccccCC----------CcchhhhcccccchHHhhhccc--cCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence            9999987542221          1123455778999999988765  69999999999999999999999988665443

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=286.25  Aligned_cols=210  Identities=22%  Similarity=0.330  Sum_probs=168.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++++.||+|+||+||++.+..++..||||.+....   ......+.+|+++++.++||||+++++.+.         
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~---------   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ---------   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE---------
Confidence            47999999999999999999999999999999885432   223345678999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +....++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~D  144 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSD  144 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEee
Confidence            45789999999999999988753    34578899999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhcc--------Cchhhhh------------------------------hHhhhhccCCCCccCCcccccCc
Q psy16951        183 LGSVAPAVVKVC--------GSAEAQN------------------------------LQDVAAERCSMPYRAPELFHVDS  224 (282)
Q Consensus       183 f~~~~~~~~~~~--------~~~~~~~------------------------------~~~~~~~~~t~~y~~PE~~~~~~  224 (282)
                      ||++........        .......                              ........||+.|+|||++.+..
T Consensus       145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence            997642110000        0000000                              00001235889999999998776


Q ss_pred             ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        225 YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       225 ~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +   +.++||||+||++|||++|..||.+.
T Consensus       225 ~---~~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         225 Y---GQECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             C---CCceeeEecchhhhhhhcCCCCCCCC
Confidence            6   88999999999999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-39  Score=282.25  Aligned_cols=231  Identities=19%  Similarity=0.214  Sum_probs=183.7

Q ss_pred             cccccccEEEecccEEEEEEeccCCceEEEEEEecCCC-ceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCccccc
Q psy16951         14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-KRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLL   89 (282)
Q Consensus        14 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~   89 (282)
                      .........+..++|++.+.||+|+||.||+|.+..++ ..||+|.+....   ......+.+|+.+++.++||||++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   97 (340)
T PTZ00426         18 TKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY   97 (340)
T ss_pred             ccccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence            34445667788899999999999999999999876655 689999885332   23344677899999999999999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      +.+.         ....++++|||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+|
T Consensus        98 ~~~~---------~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~N  161 (340)
T PTZ00426         98 GSFK---------DESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPEN  161 (340)
T ss_pred             EEEE---------eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHH
Confidence            8543         45789999999999999988763    34588999999999999999999999   89999999999


Q ss_pred             EEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        170 VLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       170 il~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      |+++.++.++++|||++....            .......||+.|+|||++.+..+   +.++|+||+||++|||++|..
T Consensus       162 ILl~~~~~ikL~DFG~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~ell~G~~  226 (340)
T PTZ00426        162 LLLDKDGFIKMTDFGFAKVVD------------TRTYTLCGTPEYIAPEILLNVGH---GKAADWWTLGIFIYEILVGCP  226 (340)
T ss_pred             EEECCCCCEEEecCCCCeecC------------CCcceecCChhhcCHHHHhCCCC---CccccccchhhHHHHHhcCCC
Confidence            999999999999999765321            01123457889999999987765   789999999999999999999


Q ss_pred             CCCccccCccceeeeeeeccccCCCCCC
Q psy16951        250 PFDTVYERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       250 pf~~~~~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ||.+...  ......+..+...+|+..+
T Consensus       227 Pf~~~~~--~~~~~~i~~~~~~~p~~~~  252 (340)
T PTZ00426        227 PFYANEP--LLIYQKILEGIIYFPKFLD  252 (340)
T ss_pred             CCCCCCH--HHHHHHHhcCCCCCCCCCC
Confidence            9975322  2223334555555555443

>KOG0193|consensus

Probab=100.00  E-value=1.1e-39  Score=286.22  Aligned_cols=235  Identities=20%  Similarity=0.266  Sum_probs=191.1

Q ss_pred             hhhhhhhhcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCC
Q psy16951          6 LNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHP   83 (282)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~   83 (282)
                      .|.......+.+...|.|..+...+.+.||+|.||+||+|+|-++   ||||.+......  ..+.|.+|+..+++-+|.
T Consensus       372 ~~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~  448 (678)
T KOG0193|consen  372 KISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE  448 (678)
T ss_pred             ccccccccCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchh
Confidence            344455667777899999999999999999999999999999765   899998766543  456899999999999999


Q ss_pred             CcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccc
Q psy16951         84 NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR  163 (282)
Q Consensus        84 ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~  163 (282)
                      ||+-|.|++..          ..+.+|+..|.+.+|+.+++...   ..+.....+.+++|+++|+.|||.+   +|+||
T Consensus       449 NIlLFMG~~~~----------p~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHr  512 (678)
T KOG0193|consen  449 NILLFMGACMN----------PPLAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHR  512 (678)
T ss_pred             hheeeehhhcC----------CceeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhh
Confidence            99999997654          23499999999999999987543   3478889999999999999999999   89999


Q ss_pred             CCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHH
Q psy16951        164 DLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~e  243 (282)
                      |||..||++..++++||+|||++..   +......    +......|...|||||++......+++.+|||||||+++||
T Consensus       513 DLKSnNIFl~~~~kVkIgDFGLatv---k~~w~g~----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YE  585 (678)
T KOG0193|consen  513 DLKSNNIFLHEDLKVKIGDFGLATV---KTRWSGE----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYE  585 (678)
T ss_pred             hccccceEEccCCcEEEecccceee---eeeeccc----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHH
Confidence            9999999999999999999997542   1111111    11223345667999999987766788999999999999999


Q ss_pred             HHhCCCCCCccccCccceeeeeeec
Q psy16951        244 MCYFKSPFDTVYERGDSVALAVISG  268 (282)
Q Consensus       244 l~tg~~pf~~~~~~~~~~~~~~~~~  268 (282)
                      |++|..||. +.. .+.+.+.+.+|
T Consensus       586 Lltg~lPys-i~~-~dqIifmVGrG  608 (678)
T KOG0193|consen  586 LLTGELPYS-IQN-RDQIIFMVGRG  608 (678)
T ss_pred             HHhCcCCcC-CCC-hhheEEEeccc
Confidence            999999998 333 44444555554

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.6e-39  Score=285.46  Aligned_cols=209  Identities=22%  Similarity=0.281  Sum_probs=168.0

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +|+++++||+|+||+||+|++..++..||+|.+.....   .....+.+|+.+++.++||||+++++.+.         +
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~---------~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ---------D   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE---------e
Confidence            68999999999999999999999999999998864321   23346778999999999999999998543         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||++   ||+||||||+||+++.++.++++||
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence            5789999999999999987753    24578899999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCch------------------------------------hh--hhhHhhhhccCCCCccCCcccccCcc
Q psy16951        184 GSVAPAVVKVCGSA------------------------------------EA--QNLQDVAAERCSMPYRAPELFHVDSY  225 (282)
Q Consensus       184 ~~~~~~~~~~~~~~------------------------------------~~--~~~~~~~~~~~t~~y~~PE~~~~~~~  225 (282)
                      |++...........                                    ..  ..........||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (382)
T cd05625         146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY  225 (382)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence            97542110000000                                    00  00000112358899999999988776


Q ss_pred             cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        226 CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       226 ~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                         +.++||||+||++|||++|+.||.+.
T Consensus       226 ---~~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         226 ---TQLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             ---CCeeeEEechHHHHHHHhCCCCCCCC
Confidence               78999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0611|consensus

Probab=100.00  E-value=1.1e-39  Score=274.48  Aligned_cols=222  Identities=28%  Similarity=0.454  Sum_probs=186.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..+|++.+.||+|.||+|-+|.....|..||||.|....   ..+...+.+|+++|+.|+||||+.+++         ++
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE---------VF  122 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE---------VF  122 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh---------hh
Confidence            457999999999999999999998999999999886543   444556789999999999999999998         77


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      +....+.+||||..+|.|++++..+    ..+++..+..+++||..|+.|+|.+   +++|||||.+|||++.++++||+
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeee
Confidence            7889999999999999999999854    4599999999999999999999999   79999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||++-.         .+. ..-....+|++.|.+||++.|.+|  -++..|-||+|++||.|++|.-||.+.+.  ..+
T Consensus       196 DFGLSNl---------y~~-~kfLqTFCGSPLYASPEIvNG~PY--~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k~l  261 (668)
T KOG0611|consen  196 DFGLSNL---------YAD-KKFLQTFCGSPLYASPEIVNGTPY--KGPEVDSWSLGVLLYTLVYGTMPFDGRDH--KRL  261 (668)
T ss_pred             ccchhhh---------hcc-ccHHHHhcCCcccCCccccCCCCC--CCCccchhhHHHHHHHHhhcccccCCchH--HHH
Confidence            9997532         111 112335678999999999999999  38999999999999999999999986432  223


Q ss_pred             eeeeeeccccCCCCC
Q psy16951        262 ALAVISGNITFPENT  276 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~  276 (282)
                      ...+.+|.+.-|+.+
T Consensus       262 vrQIs~GaYrEP~~P  276 (668)
T KOG0611|consen  262 VRQISRGAYREPETP  276 (668)
T ss_pred             HHHhhcccccCCCCC
Confidence            334666665555443

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.1e-39  Score=285.06  Aligned_cols=211  Identities=24%  Similarity=0.346  Sum_probs=172.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      +...+..++|++.+.||+|+||.||++++..++..||+|.+...   .......+.+|+.+++.++||||+++++.+   
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~---  112 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF---  112 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            34566778999999999999999999999999999999988532   222344567899999999999999999843   


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                            ......++||||+++++|.+.+..     ..+++.++..++.|++.||.|||++   +|+||||||+||+++.+
T Consensus       113 ------~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~  178 (370)
T cd05621         113 ------QDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKH  178 (370)
T ss_pred             ------EcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC
Confidence                  445789999999999999987752     2478889999999999999999998   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc-cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~-~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.+|++|||++....        ...........||+.|+|||++.+... ..++.++|+||+||++|||++|..||.+.
T Consensus       179 ~~~kL~DFG~a~~~~--------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         179 GHLKLADFGTCMKMD--------ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             CCEEEEecccceecc--------cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            999999999765321        000111123468999999999976431 11378999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-39  Score=279.96  Aligned_cols=222  Identities=21%  Similarity=0.292  Sum_probs=178.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .....++|++.+.||+|+||.||+|++..++..||+|.+....   ......+.+|+.+++.++||||+++++.+.    
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   88 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ----   88 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            3345689999999999999999999999999999999885432   123346778999999999999999998443    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....+++|||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.
T Consensus        89 -----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  156 (329)
T PTZ00263         89 -----DENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGH  156 (329)
T ss_pred             -----cCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCC
Confidence                 45789999999999999988763    34578889999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      ++++|||++....            .......||+.|+|||++.+..+   +.++|||||||++|||++|..||.+..  
T Consensus       157 ~kl~Dfg~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~~--  219 (329)
T PTZ00263        157 VKVTDFGFAKKVP------------DRTFTLCGTPEYLAPEVIQSKGH---GKAVDWWTMGVLLYEFIAGYPPFFDDT--  219 (329)
T ss_pred             EEEeeccCceEcC------------CCcceecCChhhcCHHHHcCCCC---CCcceeechHHHHHHHHcCCCCCCCCC--
Confidence            9999999764221            01113457889999999988766   789999999999999999999997532  


Q ss_pred             ccceeeeeeeccccCCCC
Q psy16951        258 GDSVALAVISGNITFPEN  275 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~  275 (282)
                      .......+..+.+.+|..
T Consensus       220 ~~~~~~~i~~~~~~~p~~  237 (329)
T PTZ00263        220 PFRIYEKILAGRLKFPNW  237 (329)
T ss_pred             HHHHHHHHhcCCcCCCCC
Confidence            222233344555555543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-39  Score=279.17  Aligned_cols=213  Identities=20%  Similarity=0.329  Sum_probs=168.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDHAL   93 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~   93 (282)
                      |.+..++|++.++||+|+||.||+|.+.     .++..||+|++..... .....+.+|+.+++.+ +||||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            6788999999999999999999999853     3456799998864432 3345688999999999 8999999998544


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh---------------------------------------------
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---------------------------------------------  128 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------  128 (282)
                      .        ....++++|||+++|+|.+++.....                                             
T Consensus        82 ~--------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (338)
T cd05102          82 K--------PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST  153 (338)
T ss_pred             C--------CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence            3        23468999999999999988864211                                             


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccC
Q psy16951        129 -------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG  195 (282)
Q Consensus       129 -------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~  195 (282)
                                   +...+....++.++.|++.||.|||++   |++||||||+||+++.++.++++|||++.....    
T Consensus       154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~----  226 (338)
T cd05102         154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK----  226 (338)
T ss_pred             CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccccc----
Confidence                         123466778889999999999999998   899999999999999999999999997653210    


Q ss_pred             chhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       196 ~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                         ...........++..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       227 ---~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         227 ---DPDYVRKGSARLPLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             ---CcchhcccCCCCCccccCcHHhhcCCC---CcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence               000011122345678999999987766   889999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721|consensus

Probab=100.00  E-value=1.2e-39  Score=283.99  Aligned_cols=220  Identities=20%  Similarity=0.333  Sum_probs=178.7

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      -.+.|.|+-+....++=||.|+.|.||.|+.  .+..||||+++       +....++..|++|+||||++|.+.|-   
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCt---  182 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCT---  182 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeec---
Confidence            4567888888888888999999999999998  56789999873       11224688899999999999999554   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            ....+|||||||+.|-|+..|..    ...+.+.....|..+||.|+.|||.+   .|+|||||.-||||..+.
T Consensus       183 ------qsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d  249 (904)
T KOG4721|consen  183 ------QSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDD  249 (904)
T ss_pred             ------CCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccc
Confidence                  34789999999999999998863    45688888999999999999999999   477999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+||+|||.++..          ......-+..||+.|||||++.+++.   +.|.|||||||+||||+||..||.+.+.
T Consensus       250 ~VKIsDFGTS~e~----------~~~STkMSFaGTVaWMAPEvIrnePc---sEKVDIwSfGVVLWEmLT~EiPYkdVds  316 (904)
T KOG4721|consen  250 VVKISDFGTSKEL----------SDKSTKMSFAGTVAWMAPEVIRNEPC---SEKVDIWSFGVVLWEMLTGEIPYKDVDS  316 (904)
T ss_pred             eEEeccccchHhh----------hhhhhhhhhhhhHhhhCHHHhhcCCc---ccccceehhHHHHHHHHhcCCCccccch
Confidence            9999999965421          11123345678999999999998875   8999999999999999999999976433


Q ss_pred             Cccceeeeeeec----cccCCCCCCC
Q psy16951        257 RGDSVALAVISG----NITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~~~~----~~~~p~~~~~  278 (282)
                          ..+...-|    ..++|+++|.
T Consensus       317 ----sAIIwGVGsNsL~LpvPstcP~  338 (904)
T KOG4721|consen  317 ----SAIIWGVGSNSLHLPVPSTCPD  338 (904)
T ss_pred             ----heeEEeccCCcccccCcccCch
Confidence                33333222    3566777764

>KOG0580|consensus

Probab=100.00  E-value=7.8e-40  Score=257.95  Aligned_cols=234  Identities=24%  Similarity=0.332  Sum_probs=196.2

Q ss_pred             cccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccc
Q psy16951         14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLD   90 (282)
Q Consensus        14 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~   90 (282)
                      ...+...-.-..++|++.+.||+|-||.||.|+.+.++-.||+|++..+.-   ....++.+|+++.+.|+||||+++++
T Consensus        10 ~~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   10 PFGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             CcccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence            334444455668899999999999999999999999999999998854432   22456788999999999999999999


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcE
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~ni  170 (282)
                      +|.+         ....|+++||.++|+++..|...  ....+++..+..++.|++.|+.|+|.+   +++||||||+|+
T Consensus        90 ~fhd---------~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenl  155 (281)
T KOG0580|consen   90 YFHD---------SKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENL  155 (281)
T ss_pred             heec---------cceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHh
Confidence            6654         57899999999999999988643  345688999999999999999999999   788999999999


Q ss_pred             EeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        171 LLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      |++..+..|++|||.+...           +..+....+||.-|.+||+..+..+   +...|+|++|++.||++.|.+|
T Consensus       156 Llg~~~~lkiAdfGwsV~~-----------p~~kR~tlcgt~dyl~pEmv~~~~h---d~~Vd~w~lgvl~yeflvg~pp  221 (281)
T KOG0580|consen  156 LLGSAGELKIADFGWSVHA-----------PSNKRKTLCGTLDYLPPEMVEGRGH---DKFVDLWSLGVLCYEFLVGLPP  221 (281)
T ss_pred             ccCCCCCeeccCCCceeec-----------CCCCceeeecccccCCHhhcCCCCc---cchhhHHHHHHHHHHHHhcCCc
Confidence            9999999999999975421           1233445678999999999999887   8899999999999999999999


Q ss_pred             CCccccCccceeeeeeeccccCCCCCC
Q psy16951        251 FDTVYERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       251 f~~~~~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      |+...  .+....++...++.+|+..+
T Consensus       222 Fes~~--~~etYkrI~k~~~~~p~~is  246 (281)
T KOG0580|consen  222 FESQS--HSETYKRIRKVDLKFPSTIS  246 (281)
T ss_pred             hhhhh--hHHHHHHHHHccccCCcccC
Confidence            98643  55666777888888886554

>KOG0663|consensus

Probab=100.00  E-value=9.3e-40  Score=268.68  Aligned_cols=209  Identities=23%  Similarity=0.372  Sum_probs=172.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .+.|+.+.+|++|+||.||+|++..|+..||+|+++....++  .-..++|+.++.+.+||||+.+.+.....       
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~-------  147 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS-------  147 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc-------
Confidence            577999999999999999999999999999999997654332  44668999999999999999998865432       


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +-..+|+|||||+ .+|...+..   ....+...++..++.|++.|++|||.+   .|+||||||+|+|+...|.+|++|
T Consensus       148 ~~d~iy~VMe~~E-hDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  148 NMDKIYIVMEYVE-HDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             ccceeeeeHHHHH-hhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecc
Confidence            3356999999994 456665543   235688999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      ||+++..         ..+...-...+-|..|.|||.+.+...  ++++.|+||+|||+.|++++++.|.+..+.+
T Consensus       221 FGLAR~y---------gsp~k~~T~lVVTLWYRaPELLLG~~t--yst~iDMWSvGCI~aE~l~~kPlf~G~sE~d  285 (419)
T KOG0663|consen  221 FGLAREY---------GSPLKPYTPLVVTLWYRAPELLLGAKT--YSTAVDMWSVGCIFAELLTQKPLFPGKSEID  285 (419)
T ss_pred             cchhhhh---------cCCcccCcceEEEeeecCHHHhcCCcc--cCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence            9987643         112222334455888999999998764  6999999999999999999999998755543

>KOG0033|consensus

Probab=100.00  E-value=5e-41  Score=265.83  Aligned_cols=224  Identities=28%  Similarity=0.409  Sum_probs=189.6

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ...+-.++|++.+.||+|.|+.|+++.+..||..+|+|.+..+  ...+-+.+.+|+.+.+.++||||+++++       
T Consensus         5 ~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~-------   77 (355)
T KOG0033|consen    5 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD-------   77 (355)
T ss_pred             cccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhh-------
Confidence            4556688999999999999999999999999999999987533  2335667889999999999999999998       


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---  174 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---  174 (282)
                        .+.+....++|+|++.++.|+..+..+    ..+++..+..+++||+++|.|+|.+   +|+|||+||+|+++-.   
T Consensus        78 --ti~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~  148 (355)
T KOG0033|consen   78 --SIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAK  148 (355)
T ss_pred             --hhcccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccC
Confidence              677789999999999999999887765    4479999999999999999999999   8999999999999843   


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ...+|++|||++...          ..+.-.....||+.||+||++..++|   +.++|||++|++||-|+.|.+||.+ 
T Consensus       149 ~A~vKL~~FGvAi~l----------~~g~~~~G~~GtP~fmaPEvvrkdpy---~kpvDiW~cGViLfiLL~G~~PF~~-  214 (355)
T KOG0033|consen  149 GAAVKLADFGLAIEV----------NDGEAWHGFAGTPGYLSPEVLKKDPY---SKPVDIWACGVILYILLVGYPPFWD-  214 (355)
T ss_pred             CCceeecccceEEEe----------CCccccccccCCCcccCHHHhhcCCC---CCcchhhhhhHHHHHHHhCCCCCCC-
Confidence            356789999986532          12334567789999999999999887   9999999999999999999999986 


Q ss_pred             ccCccceeeeeeeccccCCC
Q psy16951        255 YERGDSVALAVISGNITFPE  274 (282)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~p~  274 (282)
                       +....+...+..+.+.+|.
T Consensus       215 -~~~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  215 -EDQHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             -ccHHHHHHHHhccccCCCC
Confidence             3445566667777766654

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.7e-39  Score=284.31  Aligned_cols=211  Identities=22%  Similarity=0.295  Sum_probs=168.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .+|++++.||+|+||+||+|++..++..||+|.+....   ......+.+|+++++.++|+||+++++.+         .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~---------~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF---------Q   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE---------E
Confidence            47999999999999999999999999999999885332   12334567899999999999999998744         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++||||+++++|.+.+..    ...+++..+..++.||+.||.|||++   ||+||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~D  144 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  144 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEe
Confidence            45789999999999999998763    34578889999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCc---------------------------h--hh-----hhhHhhhhccCCCCccCCcccccCcccCC
Q psy16951        183 LGSVAPAVVKVCGS---------------------------A--EA-----QNLQDVAAERCSMPYRAPELFHVDSYCVV  228 (282)
Q Consensus       183 f~~~~~~~~~~~~~---------------------------~--~~-----~~~~~~~~~~~t~~y~~PE~~~~~~~~~~  228 (282)
                      ||++..........                           .  ..     ..........||+.|+|||++.+..+   
T Consensus       145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---  221 (376)
T cd05598         145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY---  221 (376)
T ss_pred             CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC---
Confidence            99764211000000                           0  00     00000113468999999999988766   


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        229 DQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       229 ~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +.++||||+||++|||++|+.||.+..
T Consensus       222 ~~~~DiwSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         222 TQLCDWWSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             CcceeeeeccceeeehhhCCCCCCCCC
Confidence            889999999999999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-38  Score=281.74  Aligned_cols=213  Identities=24%  Similarity=0.359  Sum_probs=173.2

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      .-+...+..++|++.+.||+|+||.||++++..++..||+|.+....   ......+.+|..+++.++||||+++++.+ 
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-  112 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-  112 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence            34456777899999999999999999999999999999999885322   22344567899999999999999998844 


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                              ......++||||+++++|.+++..     ..+++..+..++.|++.||.|||++   ||+||||||+||+++
T Consensus       113 --------~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~  176 (371)
T cd05622         113 --------QDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD  176 (371)
T ss_pred             --------EcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEC
Confidence                    345789999999999999987752     2478888999999999999999999   899999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc-cCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~-~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .++.++++|||++....        ...........||+.|+|||++.+... ..++.++||||+||++|||++|..||.
T Consensus       177 ~~~~ikL~DfG~a~~~~--------~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         177 KSGHLKLADFGTCMKMN--------KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             CCCCEEEEeCCceeEcC--------cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence            99999999999764321        000111123458999999999976431 113789999999999999999999997


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       249 ~~  250 (371)
T cd05622         249 AD  250 (371)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-38  Score=281.99  Aligned_cols=212  Identities=24%  Similarity=0.340  Sum_probs=172.3

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      .....+..++|++.+.||+|+||.||++++..++..||+|.+...   .....+.+.+|+.+++.++||||+++++.+  
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~--  112 (370)
T cd05596          35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF--  112 (370)
T ss_pred             hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--
Confidence            345567889999999999999999999999999999999988532   122334567899999999999999998743  


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                             ......++|+||+++|+|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.
T Consensus       113 -------~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~  177 (370)
T cd05596         113 -------QDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDK  177 (370)
T ss_pred             -------ecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcC
Confidence                   345789999999999999987752     2478888999999999999999998   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc-cCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~-~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++.++++|||.+....        ...........||+.|+|||++.+... ..++.++||||+||++|||++|..||.+
T Consensus       178 ~~~~kL~DfG~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         178 SGHLKLADFGTCMKMD--------ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCCEEEEeccceeecc--------CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            9999999999764221        000011123457899999999875431 1237899999999999999999999976


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       250 ~  250 (370)
T cd05596         250 D  250 (370)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.1e-39  Score=282.50  Aligned_cols=210  Identities=22%  Similarity=0.325  Sum_probs=169.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++++.||+|+||+||++++..++..||+|.+....   ......+.+|+.++..++|++|+++++.+         .
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~---------~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF---------Q   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE---------E
Confidence            57999999999999999999999999999999885332   22344567799999999999999998843         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~D  144 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSD  144 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEee
Confidence            45789999999999999998763    34588999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCch---------------hh-----------hhhHhhhhccCCCCccCCcccccCcccCCCCccchhh
Q psy16951        183 LGSVAPAVVKVCGSA---------------EA-----------QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS  236 (282)
Q Consensus       183 f~~~~~~~~~~~~~~---------------~~-----------~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws  236 (282)
                      ||++...........               ..           ..........||+.|+|||++.+..+   +.++|+||
T Consensus       145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---~~~~DiwS  221 (360)
T cd05627         145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY---NKLCDWWS  221 (360)
T ss_pred             ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC---CCcceecc
Confidence            997653211000000               00           00000113468899999999988776   88999999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q psy16951        237 LGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~  254 (282)
                      +||++|||++|..||.+.
T Consensus       222 lGvilyel~tG~~Pf~~~  239 (360)
T cd05627         222 LGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccceeeecccCCCCCCCC
Confidence            999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0201|consensus

Probab=100.00  E-value=1.3e-39  Score=276.21  Aligned_cols=206  Identities=23%  Similarity=0.359  Sum_probs=175.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-HHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .....|.-.+.||+|.||.||+|.+..|++.||||.+.....++ -+.+.+|+.++.+++++||.++++.++.+      
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g------   83 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG------   83 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec------
Confidence            34456777799999999999999999999999999997665544 45677899999999999999999976664      


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                         ..+|++||||.+|++.+.+..    ...+.+..+.-++++++.|+.|+|.+   +.+|||||+.||++...|.+|++
T Consensus        84 ---~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~  153 (467)
T KOG0201|consen   84 ---TKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA  153 (467)
T ss_pred             ---ccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence               789999999999999998863    33347888888899999999999999   67799999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |||.+...         .....+....+||+.|||||++.+..|   +.++||||||++.+||++|.+|+.+..+
T Consensus       154 DfgVa~ql---------~~~~~rr~tfvGTPfwMAPEVI~~~~Y---~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  154 DFGVAGQL---------TNTVKRRKTFVGTPFWMAPEVIKQSGY---DTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             ecceeeee---------echhhccccccccccccchhhhccccc---cchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            99976432         111222356789999999999998887   8999999999999999999999986544

>KOG1026|consensus

Probab=100.00  E-value=9.8e-40  Score=296.97  Aligned_cols=241  Identities=24%  Similarity=0.360  Sum_probs=191.7

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLD   90 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~   90 (282)
                      ......+++.+.++.++||+|+||+||+|+-.     .....||||.++..... .+.+|.+|++++..|+|||||+++|
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG  556 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG  556 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            34567788999999999999999999999842     34466999999766555 7889999999999999999999999


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------c----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------G----KHYMSSVDILKMFLKICEAVKVFHDAKPIAY  160 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~----~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i  160 (282)
                      .+..         ..-.++|+||+..|+|-.+|.....      .    +..++..+.+.++.|||.|+.||-++   ..
T Consensus       557 VC~~---------~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~F  624 (774)
T KOG1026|consen  557 VCRE---------GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HF  624 (774)
T ss_pred             EEcc---------CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cc
Confidence            6554         4679999999999999999875421      1    23378889999999999999999999   57


Q ss_pred             cccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHH
Q psy16951        161 AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL  240 (282)
Q Consensus       161 ~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~i  240 (282)
                      |||||-.+|+|+..+-.+||+|||+++.....       ...+-.....-+.+|||||.+.-..+   +++|||||+||+
T Consensus       625 VHRDLATRNCLVge~l~VKIsDfGLsRdiYss-------DYYk~~~~t~lPIRWMppEsIly~kF---TteSDVWs~GVv  694 (774)
T KOG1026|consen  625 VHRDLATRNCLVGENLVVKISDFGLSRDIYSS-------DYYKVRGNTLLPIRWMPPESILYGKF---TTESDVWSFGVV  694 (774)
T ss_pred             cccchhhhhceeccceEEEecccccchhhhhh-------hhhcccCCceeeeecCCHHHhhcCcc---cchhhhhhhhhh
Confidence            79999999999999999999999987632111       11111111223677999999986665   999999999999


Q ss_pred             HHHHHh-CCCCCCccccCccceeeeeeec-cccCCCCCCCCCC
Q psy16951        241 LYAMCY-FKSPFDTVYERGDSVALAVISG-NITFPENTPFPQY  281 (282)
Q Consensus       241 l~el~t-g~~pf~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~  281 (282)
                      |||+++ |+.||++....+  +-..+..+ ..+.|++||...|
T Consensus       695 LWEIFsyG~QPy~glSn~E--VIe~i~~g~lL~~Pe~CP~~vY  735 (774)
T KOG1026|consen  695 LWEIFSYGKQPYYGLSNQE--VIECIRAGQLLSCPENCPTEVY  735 (774)
T ss_pred             hhhhhccccCcccccchHH--HHHHHHcCCcccCCCCCCHHHH
Confidence            999998 899999764422  22223334 4699999998876

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.5e-39  Score=277.29  Aligned_cols=215  Identities=23%  Similarity=0.344  Sum_probs=170.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +.||+|+||.||++++..++..||+|.+....   ......+.+|+.+++.++||||+++.+.+         .....++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~---------~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF---------QTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE---------EcCCEEE
Confidence            36999999999999999999999999886432   22344667899999999999999998743         3457899


Q ss_pred             EEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        109 MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +||||+++++|.+.+..    ...+++.++..++.|++.||.|||++   ||+||||||+||+++.++.++++|||++..
T Consensus        72 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          72 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            99999999999887753    34588999999999999999999999   899999999999999999999999997642


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeec
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG  268 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~  268 (282)
                      ..         ..........||+.|+|||++.+..+   +.++||||+||++|||++|..||.+..  .......+..+
T Consensus       145 ~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~~  210 (323)
T cd05571         145 GI---------SDGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILME  210 (323)
T ss_pred             cc---------cCCCcccceecCccccChhhhcCCCC---CccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHcC
Confidence            11         00111223457899999999987766   889999999999999999999997532  22222233444


Q ss_pred             cccCCCCC
Q psy16951        269 NITFPENT  276 (282)
Q Consensus       269 ~~~~p~~~  276 (282)
                      .+.+|...
T Consensus       211 ~~~~p~~~  218 (323)
T cd05571         211 EIRFPRTL  218 (323)
T ss_pred             CCCCCCCC
Confidence            55555443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.7e-38  Score=268.23  Aligned_cols=201  Identities=24%  Similarity=0.341  Sum_probs=167.0

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .|+..+.||+|+||+||++.+..++..||+|.+.....   .....+.+|+.+++.++|++|+++.+.+.         .
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~---------~   71 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE---------T   71 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc---------c
Confidence            47889999999999999999999999999998864332   22345678999999999999999987443         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+...  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeC
Confidence            56899999999999998776532  233578899999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++....          .........||..|+|||++.+..+   +.++||||+||++|||++|+.||...
T Consensus       147 g~~~~~~----------~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         147 GLAVQIP----------EGETVRGRVGTVGYMAPEVINNEKY---TFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             CCcEEcC----------CCCeecCCCCCCCccCHhhhcCCCC---CcccCchhHHHHHHHHHhCCCCCCCC
Confidence            9764310          0011123457889999999988766   88999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=275.35  Aligned_cols=198  Identities=26%  Similarity=0.394  Sum_probs=168.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|++..++..||+|.+....   ......+.+|+++++.++||||+++++.+         .
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~---------~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF---------Q   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE---------E
Confidence            47999999999999999999999999999999885432   22344677899999999999999998744         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++||||+++++|.+++..    ...+++.++..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~D  144 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTD  144 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEe
Confidence            45789999999999999998853    34588999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++.....            ......||+.|+|||++.+..+   +.++||||+||++|||++|..||...
T Consensus       145 fg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         145 FGLSKGIVT------------YANSVVGSPDYMAPEVLRGKGY---DFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             CcCCccccc------------ccCCcccCccccChhHhcCCCC---CCccceecchHHHhhhhhCCCCCCCC
Confidence            997642210            1223457889999999988765   88999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-38  Score=274.03  Aligned_cols=215  Identities=21%  Similarity=0.349  Sum_probs=168.8

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +.||+|+||.||++++..++..||+|.+...   .......+.+|+.+++.++||||+++++.+         ......+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~---------~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF---------QTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE---------ecCCEEE
Confidence            3699999999999999999999999988643   223344567899999999999999998744         3457899


Q ss_pred             EEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        109 MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +||||+++++|...+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++..
T Consensus        72 lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          72 FVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            99999999999877753    34588999999999999999999999   899999999999999999999999997542


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeec
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG  268 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~  268 (282)
                      ...         .........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+...  ......+...
T Consensus       145 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~~~~~  210 (323)
T cd05595         145 GIS---------DGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILME  210 (323)
T ss_pred             ccC---------CCCccccccCCcCcCCcccccCCCC---CchhchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC
Confidence            100         0011123457889999999987765   8899999999999999999999975322  2222223344


Q ss_pred             cccCCCCC
Q psy16951        269 NITFPENT  276 (282)
Q Consensus       269 ~~~~p~~~  276 (282)
                      .+.+|...
T Consensus       211 ~~~~p~~~  218 (323)
T cd05595         211 EIRFPRTL  218 (323)
T ss_pred             CCCCCCCC
Confidence            44555444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=273.24  Aligned_cols=214  Identities=25%  Similarity=0.347  Sum_probs=170.0

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||.||+|++..++..||+|.+...   .......+.+|+++++.++||||+++++.+         ......++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---------~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF---------QSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE---------ecCCeEEEE
Confidence            79999999999999999999999988532   223345667899999999999999998743         345789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++....
T Consensus        72 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          72 LAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             EcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            999999999988763    34588999999999999999999998   89999999999999999999999999764210


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeeccc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNI  270 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  270 (282)
                               ..........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+...  ......+....+
T Consensus       145 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~~~~~~~~  210 (312)
T cd05585         145 ---------KDDDKTNTFCGTPEYLAPELLLGHGY---TKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQEPL  210 (312)
T ss_pred             ---------cCCCccccccCCcccCCHHHHcCCCC---CCccceechhHHHHHHHhCCCCcCCCCH--HHHHHHHHcCCC
Confidence                     00111223457889999999988766   8899999999999999999999975322  222233444555


Q ss_pred             cCCCCCC
Q psy16951        271 TFPENTP  277 (282)
Q Consensus       271 ~~p~~~~  277 (282)
                      .+|+..+
T Consensus       211 ~~~~~~~  217 (312)
T cd05585         211 RFPDGFD  217 (312)
T ss_pred             CCCCcCC
Confidence            5555443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-38  Score=273.40  Aligned_cols=215  Identities=23%  Similarity=0.366  Sum_probs=170.3

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      .||+|+||.||++++..++..||+|.+....   ......+.+|+.+++.++||||+++.+.         +......++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~---------~~~~~~~~l   72 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS---------FQTKDRLCF   72 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE---------EEcCCEEEE
Confidence            6899999999999999999999999886432   2334567889999999999999999874         334578999


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                      ||||+++++|...+..    ...+++.++..++.||+.||.|||++   |++||||||+||+++.++.++++|||++...
T Consensus        73 v~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          73 VMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            9999999999887753    34588999999999999999999999   8999999999999999999999999976421


Q ss_pred             hhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeecc
Q psy16951        190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN  269 (282)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  269 (282)
                      ..         .........||+.|+|||++.+..+   +.++||||+||++|+|++|+.||.+...  ......+....
T Consensus       146 ~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~~~~~~  211 (328)
T cd05593         146 IT---------DAATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMED  211 (328)
T ss_pred             CC---------cccccccccCCcCccChhhhcCCCC---CccCCccccchHHHHHhhCCCCCCCCCH--HHHHHHhccCC
Confidence            10         0011123457889999999987766   8899999999999999999999975322  22222334455


Q ss_pred             ccCCCCCC
Q psy16951        270 ITFPENTP  277 (282)
Q Consensus       270 ~~~p~~~~  277 (282)
                      +.+|...+
T Consensus       212 ~~~p~~~~  219 (328)
T cd05593         212 IKFPRTLS  219 (328)
T ss_pred             ccCCCCCC
Confidence            55555443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0594|consensus

Probab=100.00  E-value=9.4e-39  Score=265.97  Aligned_cols=214  Identities=26%  Similarity=0.348  Sum_probs=174.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCC-cccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPN-ILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~n-i~~~~~~~~~~~~~~~~  101 (282)
                      ...|+.+++||+|+||+||+|+.+.+|+.||+|++......  .....++|+-+++.++|+| |+.+++.+.....   .
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~---~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN---H   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc---c
Confidence            56688888999999999999999999999999999766543  4557789999999999999 9999986655311   2


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      +....+++|+||+ ...|...+.........++...+..++.||+.||.|+|++   +|+||||||+||+++..|.+|++
T Consensus        87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence            2335799999999 6678777765432213577789999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |||+++...         .+...-....+|..|.|||++.+..+  +++..||||+|||+.||+++++.|.+..+
T Consensus       163 DFGlAra~~---------ip~~~yt~evvTlWYRaPEvLlGs~~--Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  163 DFGLARAFS---------IPMRTYTPEVVTLWYRAPEVLLGSTS--YSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             ccchHHHhc---------CCcccccccEEEeeccCHHHhcCCCc--CCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            999875221         11122334566888999999998843  58999999999999999999999987544

>KOG1187|consensus

Probab=100.00  E-value=4.3e-38  Score=274.43  Aligned_cols=205  Identities=27%  Similarity=0.408  Sum_probs=168.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|.-...||+|+||.||+|....+ ..||||++...+.....+|.+|++++.+++|||+++++|+|..+         
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~---------  143 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEG---------  143 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecC---------
Confidence            46777778999999999999999544 88999988765543144599999999999999999999987653         


Q ss_pred             c-eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        105 S-QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       105 ~-~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      . ..+||+||+++|+|.+++......  .++|...+.|+.++|.||.|||......|+|||||++|||+|.++.+|++||
T Consensus       144 ~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  144 GEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             CceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            3 699999999999999998753221  6899999999999999999999965435999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhc-cCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAE-RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |+++....      .   ....... .||..|++||+......   +.++||||||+++.|++||+.|...
T Consensus       222 GLa~~~~~------~---~~~~~~~~~gt~gY~~PEy~~~g~l---t~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  222 GLAKLGPE------G---DTSVSTTVMGTFGYLAPEYASTGKL---TEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             cCcccCCc------c---ccceeeecCCCCccCChhhhccCCc---CcccccccchHHHHHHHhCCcccCC
Confidence            98743210      0   1111111 68999999999976443   8899999999999999999987764

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.8e-38  Score=272.38  Aligned_cols=220  Identities=21%  Similarity=0.332  Sum_probs=172.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +|++.+.||+|+||+||+|++..++..||+|.+....   .........|..++..+ +|++|+.+++.         +.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---------~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC---------FQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEE---------Ee
Confidence            5889999999999999999999999999999886432   22233456677777777 58888888874         33


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~D  144 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEcc
Confidence            45789999999999999887753    24588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++.....         .........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+..  ...+.
T Consensus       145 fG~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~  210 (323)
T cd05616         145 FGMCKENMW---------DGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEGED--EDELF  210 (323)
T ss_pred             CCCceecCC---------CCCccccCCCChhhcCHHHhcCCCC---CCccchhchhHHHHHHHhCCCCCCCCC--HHHHH
Confidence            997642110         0011223457889999999988766   889999999999999999999997532  22333


Q ss_pred             eeeeeccccCCCCC
Q psy16951        263 LAVISGNITFPENT  276 (282)
Q Consensus       263 ~~~~~~~~~~p~~~  276 (282)
                      ..+....+.+|...
T Consensus       211 ~~i~~~~~~~p~~~  224 (323)
T cd05616         211 QSIMEHNVAYPKSM  224 (323)
T ss_pred             HHHHhCCCCCCCcC
Confidence            34445555555443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0658|consensus

Probab=100.00  E-value=2e-39  Score=270.02  Aligned_cols=206  Identities=26%  Similarity=0.369  Sum_probs=168.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      .|+-.+.+|.|+||.||+|....++.+||||++-..    .+-.-+|+++|+.++||||+++.-+|...+    ..++..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~----~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSST----ESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecC----CCchhH
Confidence            578889999999999999999999999999987322    223346899999999999999987766531    113456


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCceeecccC
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNPLLMDLGS  185 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~~~~df~~  185 (282)
                      +.+|+||++ .+|+..+......+..++.-.+..++.||..|+.|||+.   ||+||||||+|+|+|.+ |.+|++|||+
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            779999995 578877765544566788889999999999999999997   99999999999999998 7889999998


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      ++...          ...+..+..+|..|.|||.+.|...  ++.+.||||.||++.||+-|++.|.+...
T Consensus       173 AK~L~----------~~epniSYicSRyYRaPELifga~~--Yt~~IDiWSaGCV~aELl~g~plFpG~s~  231 (364)
T KOG0658|consen  173 AKVLV----------KGEPNISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVMAELLKGQPLFPGDSS  231 (364)
T ss_pred             ceeec----------cCCCceeEEEeccccCHHHHcCccc--cCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence            76321          1223356677889999999988643  58999999999999999999999987433

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8e-38  Score=271.62  Aligned_cols=219  Identities=22%  Similarity=0.345  Sum_probs=171.4

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCC-CcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHP-NILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~-ni~~~~~~~~~~~~~~~~~  102 (282)
                      +|++++.||+|+||.||+|.+..++..||+|.+...   .......+..|.+++..++|+ +|+.+++.+         .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~---------~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF---------Q   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE---------E
Confidence            589999999999999999999999999999988643   223345667888999988765 577777633         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++||||+++++|.+.+..    ...+++.++..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~D  144 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIAD  144 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEee
Confidence            45689999999999999887753    34578899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++.....         .........||..|+|||++.+..+   +.++||||+||++|||+||+.||.+...  ....
T Consensus       145 fg~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~elltG~~pf~~~~~--~~~~  210 (324)
T cd05587         145 FGMCKENIF---------GGKTTRTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELF  210 (324)
T ss_pred             cCcceecCC---------CCCceeeecCCccccChhhhcCCCC---CcccchhhhHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            997642110         0011223457899999999988766   8899999999999999999999975322  2223


Q ss_pred             eeeeeccccCCCC
Q psy16951        263 LAVISGNITFPEN  275 (282)
Q Consensus       263 ~~~~~~~~~~p~~  275 (282)
                      ..+....+.+|..
T Consensus       211 ~~i~~~~~~~~~~  223 (324)
T cd05587         211 QSIMEHNVSYPKS  223 (324)
T ss_pred             HHHHcCCCCCCCC
Confidence            3344444555543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0660|consensus

Probab=100.00  E-value=2e-38  Score=263.68  Aligned_cols=215  Identities=25%  Similarity=0.352  Sum_probs=175.6

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEec--cCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .+-....|..++.||+|+||.|+.|.+..||..||||++.  ..+....+...+|+.+++.++|+||+.+.+.+...   
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~---   93 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP---   93 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc---
Confidence            3444556666899999999999999999999999999996  56666777889999999999999999999887763   


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                       .......+|+|+|++ +..|...+.    .+..+....+..+++|++.||+|+|+.   +++||||||+|++++.+...
T Consensus        94 -~~~~f~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   94 -SRDKFNDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             -cccccceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCE
Confidence             444567899999999 445555443    444588999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |++|||+++..+..       .........+-|..|.|||.+....  .++...||||+|||+.||++|++.|.+.+.
T Consensus       165 KI~DFGLAR~~~~~-------~~~~~mTeYVaTRWYRAPElll~~~--~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~  233 (359)
T KOG0660|consen  165 KICDFGLARYLDKF-------FEDGFMTEYVATRWYRAPELLLNSS--EYTKAIDIWSVGCILAEMLTGKPLFPGKDY  233 (359)
T ss_pred             Eeccccceeecccc-------CcccchhcceeeeeecCHHHHhccc--cccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence            99999998754221       1112234455688899999996532  358999999999999999999999976443

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-38  Score=272.43  Aligned_cols=206  Identities=25%  Similarity=0.345  Sum_probs=166.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++++.||+|+||+||++++..++..||+|.+....   ......+.+|..+++.++|+||+.+++.         +.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~---------~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYA---------FQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEE---------Ee
Confidence            57999999999999999999999999999999885321   2233456788999999999999999874         34


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++|+||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEE
Confidence            457899999999999999888532   34588999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++....        ...........||+.|+|||++....  ...++.++||||+||++|||++|+.||.+.
T Consensus       146 fg~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         146 FGSCLRLL--------ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCceeecC--------CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            99754211        00001112235788999999997421  112377999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6e-38  Score=273.16  Aligned_cols=206  Identities=24%  Similarity=0.328  Sum_probs=166.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||+||++++..++..||+|.+....   ......+.+|..+++.++|++|+.+++.+         .
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~---------~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF---------Q   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE---------E
Confidence            58999999999999999999999999999999885422   22234467788999999999999998743         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +....++||||+++|+|.+++...   ...+++..+..++.|++.||.|+|++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEe
Confidence            457899999999999999988642   34588899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++....        ...........||+.|+|||++.+..  ...++.++|+||+|+++|||++|+.||.+.
T Consensus       146 fG~a~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         146 FGSCLKMN--------QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ccceeecc--------CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            99764221        00001112235789999999987521  112378999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-37  Score=270.92  Aligned_cols=219  Identities=22%  Similarity=0.338  Sum_probs=169.7

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHH---hhhCCCCCcccccccccccCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEH---HKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~---l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      |++++.||+|+||.||+|++..++..||||.+....   ......+.+|..+   ++.++||||+++++.+.        
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--------   72 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--------   72 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--------
Confidence            678999999999999999999999999999886332   2223345555554   45678999999998443        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       .....++||||+++++|...+.     ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++
T Consensus        73 -~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          73 -TEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             -cCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeC
Confidence             4578999999999999987664     24589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||++....         ..........|++.|+|||++.+..+   +.++||||||+++|||++|+.||.+...  ...
T Consensus       144 Dfg~~~~~~---------~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~G~~pf~~~~~--~~~  209 (324)
T cd05589         144 DFGLCKEGM---------GFGDRTSTFCGTPEFLAPEVLTETSY---TRAVDWWGLGVLIYEMLVGESPFPGDDE--EEV  209 (324)
T ss_pred             cccCCccCC---------CCCCcccccccCccccCHhHhcCCCC---CcccchhhHHHHHHHHHhCCCCCCCCCH--HHH
Confidence            999754210         00111223457889999999987765   8899999999999999999999975322  222


Q ss_pred             eeeeeeccccCCCCCC
Q psy16951        262 ALAVISGNITFPENTP  277 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~~  277 (282)
                      ...+..+.+.+|...+
T Consensus       210 ~~~i~~~~~~~p~~~~  225 (324)
T cd05589         210 FDSIVNDEVRYPRFLS  225 (324)
T ss_pred             HHHHHhCCCCCCCCCC
Confidence            2334444555555443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=274.45  Aligned_cols=211  Identities=25%  Similarity=0.369  Sum_probs=171.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||+||+|++..++..||||.+....   ......+.+|++++..++||||+++++.         +.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~---------~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS---------FQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh---------ee
Confidence            47999999999999999999999999999999886432   2334567889999999999999999874         44


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~D  144 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLAD  144 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeec
Confidence            457899999999999999988643    4588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCc--------------------hhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHH
Q psy16951        183 LGSVAPAVVKVCGS--------------------AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       183 f~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~  242 (282)
                      ||.+..........                    .............||+.|+|||++.+..+   +.++|||||||++|
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~  221 (350)
T cd05573         145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY---GLECDWWSLGVILY  221 (350)
T ss_pred             CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC---CCceeeEecchhhh
Confidence            99765322111000                    00000011223457899999999988765   88999999999999


Q ss_pred             HHHhCCCCCCccc
Q psy16951        243 AMCYFKSPFDTVY  255 (282)
Q Consensus       243 el~tg~~pf~~~~  255 (282)
                      ||++|+.||.+..
T Consensus       222 ell~g~~Pf~~~~  234 (350)
T cd05573         222 EMLYGFPPFYSDT  234 (350)
T ss_pred             hhccCCCCCCCCC
Confidence            9999999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0194|consensus

Probab=100.00  E-value=1.6e-38  Score=279.84  Aligned_cols=241  Identities=18%  Similarity=0.301  Sum_probs=190.6

Q ss_pred             hhhcccccccEEEecccEEEEEEeccCCceEEEEEEecCCC---ce-EEEEEecc---CCchhHHHHHHHHHHhhhCCCC
Q psy16951         11 QMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK---KR-YALKKIIC---HGREDQAQAIREVEHHKTFVHP   83 (282)
Q Consensus        11 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~-vaiK~i~~---~~~~~~~~~~~e~~~l~~l~H~   83 (282)
                      +...-..+..|.+..++..+.++||+|+||+||+|+....+   .. ||||....   .......++.+|+++|++++||
T Consensus       142 ~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~  221 (474)
T KOG0194|consen  142 FLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP  221 (474)
T ss_pred             eecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence            34566778899999999999999999999999999976542   23 89998864   2345567889999999999999


Q ss_pred             CcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccc
Q psy16951         84 NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR  163 (282)
Q Consensus        84 ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~  163 (282)
                      ||++++|++..         +.-+++|||+|++|+|.++|...   +..++..+.+.++.+.+.||+|||++   +++||
T Consensus       222 NVVr~yGVa~~---------~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHR  286 (474)
T KOG0194|consen  222 NVVRFYGVAVL---------EEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHR  286 (474)
T ss_pred             CEEEEEEEEcC---------CCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcch
Confidence            99999996554         46699999999999999999753   23589999999999999999999999   78899


Q ss_pred             CCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHH
Q psy16951        164 DLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~e  243 (282)
                      ||-.+|+|+..++.+|++|||++....         ..........-+..|+|||++....+   +.++|||||||++||
T Consensus       287 DIAARNcL~~~~~~vKISDFGLs~~~~---------~~~~~~~~~klPirWLAPEtl~~~~~---s~kTDV~sfGV~~~E  354 (474)
T KOG0194|consen  287 DIAARNCLYSKKGVVKISDFGLSRAGS---------QYVMKKFLKKLPIRWLAPETLNTGIF---SFKTDVWSFGVLLWE  354 (474)
T ss_pred             hHhHHHheecCCCeEEeCccccccCCc---------ceeeccccccCcceecChhhhccCcc---ccccchhheeeeEEe
Confidence            999999999999999999999876431         01111111133677999999988765   999999999999999


Q ss_pred             HHh-CCCCCCccccCccceeeeeeeccccCCCCCCC
Q psy16951        244 MCY-FKSPFDTVYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       244 l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      +++ |..||.+.....-...+...+.+.+.|+..|.
T Consensus       355 if~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  355 IFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             eeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            988 88899875443222222233445666665553

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-37  Score=268.11  Aligned_cols=202  Identities=19%  Similarity=0.291  Sum_probs=171.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +..++|++++.||+|+||.||++++..++..||+|.+..... .....+.+|+++++.++||||+++++.+..       
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------   74 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------   74 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-------
Confidence            567899999999999999999999999999999998865432 345578899999999999999999985443       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ....+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+++  +++|+||||+||+++.++.++++
T Consensus        75 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          75 --DGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             --CCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence              4679999999999999988763    235789999999999999999999864  69999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||++....           ........+|..|+|||++.+..+   +.++||||+||++|||++|+.||..
T Consensus       147 Dfg~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         147 DFGVSGQLI-----------DSMANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cCccccccc-----------ccccccCCCCcCcCCHhHhcCCCC---CchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999754210           001123457889999999987765   8899999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-37  Score=262.17  Aligned_cols=202  Identities=23%  Similarity=0.369  Sum_probs=165.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++.+.||+|+||+||+|++..++..||+|++....  ......+.+|+++++.++||||+++++.         +..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~---------~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA---------FRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhh---------Eec
Confidence            47999999999999999999999999999999886442  2334567889999999999999999884         344


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||++++.+.....    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Df  144 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF  144 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            578999999998876654332    234588899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....        ..........++..|+|||++.+..+   +.++|+||+||++|||++|+.||.+.
T Consensus       145 g~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         145 GFARNLSE--------GSNANYTEYVATRWYRSPELLLGAPY---GKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cCcccccc--------cccccccccccccccCCcHHHcCCCC---CCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            97653210        00011123357888999999987765   78999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-37  Score=269.01  Aligned_cols=220  Identities=22%  Similarity=0.344  Sum_probs=170.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +|++.+.||+|+||+||+|++..++..||+|.+....   ......+..|..+++.+. |++|+++++.         +.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~---------~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC---------FQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE---------Ee
Confidence            4788999999999999999999999999999886431   223345667888888885 5677777763         33


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++||||+++++|.+.+..    ...+++.++..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~D  144 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEec
Confidence            45689999999999999887753    34588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++.....         .........||..|+|||++.+..+   +.++|+||+|+++|||++|..||.+...  ..+.
T Consensus       145 fg~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~elltG~~pf~~~~~--~~~~  210 (323)
T cd05615         145 FGMCKEHMV---------DGVTTRTFCGTPDYIAPEIIAYQPY---GKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELF  210 (323)
T ss_pred             cccccccCC---------CCccccCccCCccccCHHHHcCCCC---CCccchhhhHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            997642110         0011223457889999999987765   8899999999999999999999976322  2233


Q ss_pred             eeeeeccccCCCCC
Q psy16951        263 LAVISGNITFPENT  276 (282)
Q Consensus       263 ~~~~~~~~~~p~~~  276 (282)
                      ..+....+.+|...
T Consensus       211 ~~i~~~~~~~p~~~  224 (323)
T cd05615         211 QSIMEHNVSYPKSL  224 (323)
T ss_pred             HHHHhCCCCCCccC
Confidence            33444455555443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-37  Score=265.26  Aligned_cols=203  Identities=25%  Similarity=0.371  Sum_probs=165.2

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.++||||+++++.+         ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~---------~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII---------HT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE---------ec
Confidence            57899999999999999999999999999999988654322 234567899999999999999998844         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+. ++|.+.+..   ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence            578999999994 677766643   234578889999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........+|..|+|||++.+...  ++.++||||+||++|+|++|..||.+.
T Consensus       148 g~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         148 GLARAKSV---------PSHTYSNEVVTLWYRPPDVLLGSTE--YSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CcceeccC---------CCccCCCCcccCCCCChHHHcCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            97642110         0111123456888999999876432  378899999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.8e-38  Score=272.60  Aligned_cols=216  Identities=23%  Similarity=0.359  Sum_probs=168.4

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +.||+|+||.||++.+..++..||+|.+...   .......+.+|+++++.++||||+++.+.         +......+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~---------~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS---------FQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE---------EEcCCEEE
Confidence            3699999999999999999999999988543   22234566789999999999999999874         33457899


Q ss_pred             EEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        109 MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +||||+++++|...+..    ...+++..+..++.|++.||.|||+..  |++||||||+||+++.++.++++|||++..
T Consensus        72 lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          72 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            99999999999887653    345889999999999999999999732  899999999999999999999999997642


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeec
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG  268 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~  268 (282)
                      ...         .........||+.|+|||++.+..+   +.++||||+||++|||++|..||.+...  +.....+...
T Consensus       146 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~~  211 (325)
T cd05594         146 GIK---------DGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME  211 (325)
T ss_pred             cCC---------CCcccccccCCcccCCHHHHccCCC---CCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhcC
Confidence            110         0011123457899999999987766   8899999999999999999999975322  2222233344


Q ss_pred             cccCCCCC
Q psy16951        269 NITFPENT  276 (282)
Q Consensus       269 ~~~~p~~~  276 (282)
                      .+.+|...
T Consensus       212 ~~~~p~~~  219 (325)
T cd05594         212 EIRFPRTL  219 (325)
T ss_pred             CCCCCCCC
Confidence            45555443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-37  Score=267.37  Aligned_cols=208  Identities=24%  Similarity=0.319  Sum_probs=164.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||+|.+..++..||||++...  .......+.+|+++++.++||||+++++++...    .....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~~~   76 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP----SRREF   76 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc----CCCCC
Confidence            589999999999999999999999999999988632  223345678899999999999999998866542    11223


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+ +++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||
T Consensus        77 ~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          77 KDIYVVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             ceEEEEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCc
Confidence            4689999999 4688776652    34588999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+......      ...........+|..|+|||++.+.. ..++.++||||+||++|||++|+.||.+
T Consensus       149 ~~~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         149 LARVAFND------TPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cccccccc------cCccccccCCCCCCCcCCHHHHhccc-cccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            76532110      00001112345788999999986521 1237899999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.8e-37  Score=262.41  Aligned_cols=204  Identities=26%  Similarity=0.399  Sum_probs=166.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.++||+|+||.||+|++..++..||+|.+..... .....+.+|+.+++.++||||+++++.+.         
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---------   73 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH---------   73 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc---------
Confidence            45789999999999999999999999999999998865432 23446678999999999999999998443         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++|+|++. ++|.+.+..   ....++...+..++.|++.||.|||++   |++||||||+||+++.++.+|++|
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          74 TERCLTLVFEYLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             CCCeEEEEEeCCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECc
Confidence            4467999999996 588877653   234578889999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+.....         .........+++.|+|||++.+...  ++.++||||+|+++|+|++|+.||.+.
T Consensus       147 fG~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         147 FGLARAKSV---------PTKTYSNEVVTLWYRPPDVLLGSTE--YSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             CcceeeccC---------CCccccCceecccccChHHhcCCcc--cCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            997643211         0111122356788999999875321  378999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0032|consensus

Probab=100.00  E-value=1.7e-37  Score=271.36  Aligned_cols=223  Identities=29%  Similarity=0.400  Sum_probs=187.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCC-CCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~   99 (282)
                      ..+.|++.+.||+|.||.||++....||..+|+|.+.....   .......+|+.+|+++. ||||+.+.+         
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~---------  103 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD---------  103 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE---------
Confidence            35679999999999999999999999999999999865443   34468889999999998 999999998         


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC----
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND----  175 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~----  175 (282)
                      .+++...+++|||+|.+|.|.+.+...     .+++..+..++.|++.++.|+|+.   |++||||||+|+++...    
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~  175 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGS  175 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCC
Confidence            566678999999999999999988754     389999999999999999999998   89999999999998654    


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +.++++|||++...          ..........||+.|+|||++....|   +..+||||+|+++|.|++|.+||.+..
T Consensus       176 ~~ik~~DFGla~~~----------~~~~~~~~~~Gtp~y~APEvl~~~~y---~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  176 GRIKLIDFGLAKFI----------KPGERLHTIVGTPEYVAPEVLGGRPY---GDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             CcEEEeeCCCceEc----------cCCceEeeecCCccccCchhhcCCCC---CcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            46899999986532          11233456679999999999988777   899999999999999999999998743


Q ss_pred             cCccceeeeeeeccccCCCCCCC
Q psy16951        256 ERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       256 ~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                        .......+..+++.++..+=+
T Consensus       243 --~~~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  243 --EFEIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             --hhHHHHHHHcCCCCCCCCCcc
Confidence              334444677777777655433

>KOG1095|consensus

Probab=100.00  E-value=9.3e-38  Score=293.23  Aligned_cols=238  Identities=21%  Similarity=0.331  Sum_probs=190.7

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCC-----ceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      -.+++++..+.+.||+|.||+||.|......     ..||||.+... +..+..+|.+|..+|++++||||++++|.++.
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3477899999999999999999999875443     34899988644 45567789999999999999999999997665


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRS---VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                               ....++++||+.+|+|..++....   .....+...+++.++.|||.|+.||+++   +.+||||..+|+|
T Consensus       767 ---------~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCL  834 (1025)
T KOG1095|consen  767 ---------SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCL  834 (1025)
T ss_pred             ---------CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhhee
Confidence                     467999999999999999987531   1145678899999999999999999999   5779999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhh-ccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA-ERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKS  249 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~-~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~  249 (282)
                      ++....+||+|||+++..        .....-+... ..-+..|||||++....+   +.|+|||||||++||++| |..
T Consensus       835 L~~~r~VKIaDFGlArDi--------y~~~yyr~~~~a~lPvkWm~PEsl~d~iF---tskSDvWsFGVllWEifslG~~  903 (1025)
T KOG1095|consen  835 LDERRVVKIADFGLARDI--------YDKDYYRKHGEAMLPVKWMPPESLKDGIF---TSKSDVWSFGVLLWEIFSLGAT  903 (1025)
T ss_pred             ecccCcEEEcccchhHhh--------hhchheeccCccccceecCCHHHHhhccc---ccccchhhhHHHHHHHHhCCCC
Confidence            999999999999988622        1111111111 234678999999997665   999999999999999999 889


Q ss_pred             CCCccccCccceeeeeeeccccCCCCCCCCCCC
Q psy16951        250 PFDTVYERGDSVALAVISGNITFPENTPFPQYQ  282 (282)
Q Consensus       250 pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  282 (282)
                      ||.+... .+-+.....+++..-|+.+|.++||
T Consensus       904 PY~~~~n-~~v~~~~~~ggRL~~P~~CP~~ly~  935 (1025)
T KOG1095|consen  904 PYPSRSN-FEVLLDVLEGGRLDPPSYCPEKLYQ  935 (1025)
T ss_pred             CCCCcch-HHHHHHHHhCCccCCCCCCChHHHH
Confidence            9976433 2222224566799999999998875

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-37  Score=268.00  Aligned_cols=195  Identities=24%  Similarity=0.352  Sum_probs=158.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhh-CCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKT-FVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~-l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+....   .........|..++.. .+||||+++++.+         ......
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~---------~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF---------QTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE---------EcCCEE
Confidence            36999999999999999999999999886431   2223344556666654 4899999998743         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            999999999999887753    34588999999999999999999998   89999999999999999999999999765


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....         .........||..|+|||++.+..+   +.++||||+||++|||++|+.||.+.
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         145 ENMN---------GEGKASTFCGTPDYIAPEILKGQKY---NESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             ECCC---------CCCccccccCCccccCHHHHcCCCC---CCcccchhHHHHHHHHHhCCCCCCCC
Confidence            2210         0011223457899999999987765   88999999999999999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-37  Score=269.53  Aligned_cols=206  Identities=22%  Similarity=0.325  Sum_probs=165.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.++||+|+||+||++++..++..||+|.+....   ......+.+|+.++..++|++|+++++.+         .
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~---------~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF---------Q   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE---------e
Confidence            57999999999999999999999999999999885321   12233467788899999999999998743         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+++|+|.+.+...   ...+++..+..++.|++.||.|+|++   +++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEee
Confidence            457899999999999999988642   23578889999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++....        ...........||+.|+|||++....  ...++.++|||||||++|||++|+.||...
T Consensus       146 fG~a~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         146 FGSCLKLM--------EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             cchheecc--------cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            99754210        00011112245789999999986321  112378999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-37  Score=261.77  Aligned_cols=197  Identities=25%  Similarity=0.298  Sum_probs=161.6

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||+||++.+..++..||+|.+......   ....+..|+++++.++|+||+++.+.         +......+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~---------~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA---------FQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEE---------EcCCCeEEEE
Confidence            79999999999999999999999988643222   22456789999999999999999874         3345779999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      |||+++++|...+.........+++..++.++.|++.||.|||++   +++||||||+||+++.++.++++|||.+....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            999999999887654333445688999999999999999999999   89999999999999999999999999764211


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .         .........+|+.|+|||++.+..+   +.++|+||+|+++|||++|+.||...
T Consensus       149 ~---------~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         149 D---------GQSKTKGYAGTPGFMAPELLQGEEY---DFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             C---------CCccccccCCCcCccCHHHhcCCCC---CccccHHHHHHHHHHHHhCCCCCCCC
Confidence            0         0011123457889999999988766   78999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-37  Score=268.44  Aligned_cols=216  Identities=23%  Similarity=0.355  Sum_probs=168.1

Q ss_pred             EEeccCCceEEEEEEec---CCCceEEEEEeccC----CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         32 EKIGEGGFSTVSLIEHS---QTKKRYALKKIICH----GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~----~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +.||+|+||.||+++..   .++..||+|.+...    .......+.+|+++++.++||||+++++.+.         ..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~---------~~   72 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ---------TG   72 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe---------cC
Confidence            67999999999999863   47889999988532    2233445678999999999999999988443         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...+++|||+++++|.+.+..    ...+.+..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          73 GKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             CeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            689999999999999987753    34577888899999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeee
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA  264 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~  264 (282)
                      ++....         ..........||+.|+|||++.+..+   +.++||||+|+++|||++|+.||.+...  ......
T Consensus       146 ~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~G~~pf~~~~~--~~~~~~  211 (323)
T cd05584         146 LCKESI---------HEGTVTHTFCGTIEYMAPEILMRSGH---GKAVDWWSLGALMYDMLTGAPPFTAENR--KKTIDK  211 (323)
T ss_pred             CCeecc---------cCCCcccccCCCccccChhhccCCCC---CCcceecccHHHHHHHhcCCCCCCCCCH--HHHHHH
Confidence            764211         00111123457889999999987765   7899999999999999999999975322  222233


Q ss_pred             eeeccccCCCCCC
Q psy16951        265 VISGNITFPENTP  277 (282)
Q Consensus       265 ~~~~~~~~p~~~~  277 (282)
                      +..+...+|+..+
T Consensus       212 ~~~~~~~~~~~~~  224 (323)
T cd05584         212 ILKGKLNLPPYLT  224 (323)
T ss_pred             HHcCCCCCCCCCC
Confidence            4445555555443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.5e-37  Score=274.85  Aligned_cols=211  Identities=26%  Similarity=0.355  Sum_probs=166.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ...++|++.+.||+|+||.||+|.+..++..||||++....    ....+|+.+++.++||||+++.+++...+.. ...
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~-~~~  137 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK-KNE  137 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc-cCC
Confidence            34678999999999999999999999999999999885332    2334699999999999999998876654321 112


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~  181 (282)
                      ....+++||||++ +++.+.+.........++...+..++.|++.||.|||++   +|+||||||+||+++.++ .+|++
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence            2346789999996 577776654444456688999999999999999999999   899999999999998765 68999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....          .........+|+.|+|||++.+...  ++.++||||+||++|||++|.+||.+.
T Consensus       214 DFGla~~~~----------~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        214 DFGSAKNLL----------AGQRSVSYICSRFYRAPELMLGATN--YTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             ccccchhcc----------CCCCcccCCCCcCccCHHHhcCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999865221          0111223457888999999876431  388999999999999999999999764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-37  Score=267.85  Aligned_cols=202  Identities=21%  Similarity=0.326  Sum_probs=162.9

Q ss_pred             cEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC----chhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG----REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~----~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      +|++.+.||+|+||.||+++..   .++..||+|.+....    ......+.+|+.+++.+ +|+||+++++.       
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-------   73 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-------   73 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-------
Confidence            5899999999999999998864   478999999885322    12234567799999999 59999999874       


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                        +.....++++|||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.+
T Consensus        74 --~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~  144 (332)
T cd05614          74 --FQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHV  144 (332)
T ss_pred             --EecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCE
Confidence              3345789999999999999988753    34588999999999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||++.....        ..........||..|+|||++.+...  .+.++||||||+++|||++|+.||...
T Consensus       145 kl~DfG~~~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         145 VLTDFGLSKEFLS--------EEKERTYSFCGTIEYMAPEIIRGKGG--HGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             EEeeCcCCccccc--------cCCCccccccCCccccCHHHhcCCCC--CCCccccccchhhhhhhhcCCCCCCCC
Confidence            9999997642210        00111123457899999999976532  378999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-36  Score=278.08  Aligned_cols=219  Identities=24%  Similarity=0.321  Sum_probs=176.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .....++|++.+.||+|+||+||+|++..++..||||.+....  ......+.+|+..+..++|+|+++++..+..... 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~-  105 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP-  105 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc-
Confidence            3456789999999999999999999999999999999986543  3345567889999999999999998775543210 


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                      ........+++|+||+++|+|.+.+.........+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence            011122357899999999999998876544556789999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +++|||++......       ..........||+.|+|||++.+..+   +.++||||||+++|||++|+.||.+
T Consensus       183 kL~DFGls~~~~~~-------~~~~~~~~~~Gt~~Y~aPE~~~~~~~---s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        183 KLGDFGFSKMYAAT-------VSDDVGRTFCGTPYYVAPEIWRRKPY---SKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             EEEecccCeecccc-------ccccccccccCCcceeCHHHhCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999986532110       00111123457899999999988766   8899999999999999999999975

>KOG0667|consensus

Probab=100.00  E-value=2e-37  Score=274.95  Aligned_cols=201  Identities=27%  Similarity=0.321  Sum_probs=167.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CC-----CcccccccccccCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HP-----NILPLLDHALTGCADPV  100 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~-----ni~~~~~~~~~~~~~~~  100 (282)
                      +|++++.||+|+||+|-+|.+..|++.||||+++.. .....+...|+.+|..++ |.     |+|+++++|..      
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f------  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF------  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc------
Confidence            889999999999999999999999999999977533 444555667899998886 53     79999996654      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC--CCc
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND--NNP  178 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~~~  178 (282)
                         ..++|||+|.+ ..+|++++...  ....++...+..++.||+.||.+||+.   +|+|+||||+|||+...  ..+
T Consensus       260 ---r~HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  260 ---RNHLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             ---ccceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCce
Confidence               58999999988 77999988754  334588999999999999999999998   89999999999999754  467


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      ||+|||+++...-..+..            .=+..|.|||++.|.+|   +.+.||||||||+.||++|.+.|.+.++-+
T Consensus       331 KVIDFGSSc~~~q~vytY------------iQSRfYRAPEVILGlpY---~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRVYTY------------IQSRFYRAPEVILGLPY---DTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             eEEecccccccCCcceee------------eeccccccchhhccCCC---CCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            899999887543333322            22556999999999988   899999999999999999999998755543

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-37  Score=270.52  Aligned_cols=206  Identities=24%  Similarity=0.322  Sum_probs=166.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||+||++++..++..||+|.+.....   .....+.+|+.+++.++|+||+++++.+         .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~---------~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF---------Q   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE---------e
Confidence            579999999999999999999999999999998864322   2344567889999999999999998743         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++||||+++++|.+.+...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEecc
Confidence            457899999999999999987642   24588999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc---cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY---CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~---~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++.....        ..........+|+.|+|||++.....   ..++.++||||+|+++|||++|+.||...
T Consensus       146 fg~a~~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         146 FGSAARLTA--------NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             CCCCeECCC--------CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            997653210        00011122357889999999863211   12378999999999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.3e-37  Score=266.59  Aligned_cols=214  Identities=23%  Similarity=0.366  Sum_probs=167.3

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+...   .......+..|..+++.+ +||||+++++.+         .....+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~---------~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF---------QTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE---------EcCCEE
Confidence            3699999999999999999999999988532   222344566788888766 699999998843         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|||++.
T Consensus        72 ~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             EEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            999999999999887753    24588999999999999999999998   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeee
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~  267 (282)
                      ....         .........||+.|+|||++.+..+   +.++||||+|+++|||++|+.||.+...  ..+...+..
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~  210 (320)
T cd05590         145 EGIF---------NGKTTSTFCGTPDYIAPEILQEMLY---GPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILN  210 (320)
T ss_pred             ecCc---------CCCcccccccCccccCHHHHcCCCC---CCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhc
Confidence            2110         0111223457889999999987765   7899999999999999999999976332  222333444


Q ss_pred             ccccCCCC
Q psy16951        268 GNITFPEN  275 (282)
Q Consensus       268 ~~~~~p~~  275 (282)
                      +.+.+|..
T Consensus       211 ~~~~~~~~  218 (320)
T cd05590         211 DEVVYPTW  218 (320)
T ss_pred             CCCCCCCC
Confidence            44555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.9e-37  Score=266.73  Aligned_cols=194  Identities=26%  Similarity=0.382  Sum_probs=160.6

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|++..++..||+|.+....   ......+.+|..++..+ +||||+++++.+         .....+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~---------~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF---------QTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE---------EcCCEE
Confidence            36899999999999999999999999986432   22334567888888888 699999998843         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  144 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccc
Confidence            999999999999877653    34589999999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ...         ..........||+.|+|||++.+..+   +.++|+||+|+++|+|++|+.||..
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         145 EGI---------RPGDTTSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccc---------cCCCccccccCCccccCHHHHcCCCC---CCccceechHHHHHHHHHCCCCccc
Confidence            210         00111223457889999999988766   7899999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.3e-37  Score=267.44  Aligned_cols=212  Identities=23%  Similarity=0.349  Sum_probs=165.9

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|++..++..||+|.+....   ......+..|.++++.+ +||||+++++.+         ......
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~---------~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF---------QTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE---------EcCCeE
Confidence            36999999999999999999999999885431   22334566788888766 799999998844         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccce
Confidence            999999999999887753    24578889999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeee
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~  267 (282)
                      ....         .........||..|+|||++.+..+   +.++||||+|+++|||++|+.||.....  ......+..
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~~i~~  210 (321)
T cd05591         145 EGIL---------NGVTTTTFCGTPDYIAPEILQELEY---GPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFESILH  210 (321)
T ss_pred             eccc---------CCccccccccCccccCHHHHcCCCC---CCccceechhHHHHHHhcCCCCCCCCCH--HHHHHHHHc
Confidence            2110         0111123457889999999987766   8899999999999999999999975332  223333444


Q ss_pred             ccccCC
Q psy16951        268 GNITFP  273 (282)
Q Consensus       268 ~~~~~p  273 (282)
                      +.+.+|
T Consensus       211 ~~~~~p  216 (321)
T cd05591         211 DDVLYP  216 (321)
T ss_pred             CCCCCC
Confidence            444444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=259.87  Aligned_cols=201  Identities=24%  Similarity=0.335  Sum_probs=166.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .|++.+.||+|+||+||++.+..++..||+|.+......   ....+.+|+.+++.++||||+++++.         +..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~---------~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA---------YET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeee---------ecC
Confidence            488999999999999999999999999999988643322   23456789999999999999999874         334


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....+++|||+++++|.+.+...  ....+++..+..++.|++.||.|+|+.   +++|+||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeC
Confidence            57899999999999998876532  234588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....          .........++..|+|||++.+..+   +.++||||+|+++||+++|+.||.+.
T Consensus       147 g~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         147 GLAVEIP----------EGETIRGRVGTVGYMAPEVVKNERY---TFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             CCceecC----------CCCccccccCCCCccCcHHhcCCCC---CccccchhHHHHHHHHHHCCCCCCCC
Confidence            9764211          0011123357889999999987665   78999999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=276.28  Aligned_cols=207  Identities=23%  Similarity=0.348  Sum_probs=172.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCC-CceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQT-KKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++.+.         .
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~---------~  136 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK---------S  136 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---------E
Confidence            34499999999999999999998777 7889999876666566667788999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++||||+++++|.+.+.........+++..+..++.|++.||.|+|++   +|+||||||+||+++.++.++++||
T Consensus       137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence            5789999999999999988765444445688899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |++.....       ...........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+
T Consensus       214 gla~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        214 GFSKQYSD-------SVSLDVASSFCGTPYYLAPELWERKRY---SKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             cCceecCC-------ccccccccccCCCccccCHhHhCCCCC---CcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            98653210       000011223457899999999987765   8899999999999999999999975

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=269.82  Aligned_cols=196  Identities=22%  Similarity=0.334  Sum_probs=162.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +...+|++++.||+|+||.||++.+..++..||+|...      ...+.+|+++++.++||||+++++.+.         
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~---------  153 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT---------  153 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE---------
Confidence            45678999999999999999999999999999999642      234678999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++|++ .++|...+..    ...++...++.++.|++.||.|+|++   ||+||||||+||+++.++.++++|
T Consensus       154 ~~~~~~lv~e~~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        154 YNKFTCLILPRY-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             ECCeeEEEEecC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEe
Confidence            346789999998 4677776643    34578999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ||++....        ...........||+.|+|||++.+..+   +.++||||+||++|||++|..||.
T Consensus       226 FG~a~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        226 FGAACFPV--------DINANKYYGWAGTIATNAPELLARDPY---GPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             CCcccccc--------cccccccccccCccCCCChhhhcCCCC---CcHHHHHHHHHHHHHHHHCCCCcC
Confidence            99764210        001111223468999999999988766   889999999999999999997764

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.1e-37  Score=267.03  Aligned_cols=194  Identities=27%  Similarity=0.409  Sum_probs=157.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHH-HhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVE-HHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~-~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|.+..++..||+|.+.....   .....+.+|.. +++.++||||+++++.+         ......
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~---------~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF---------QTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE---------EeCCEE
Confidence            369999999999999999999999999854321   22233444544 56788999999998744         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.||+.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~  144 (323)
T cd05575          72 YFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (323)
T ss_pred             EEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence            999999999999887753    34588899999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ...         ..........||+.|+|||++.+..+   +.++||||||+++|||++|..||.+
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         145 EGI---------EHSKTTSTFCGTPEYLAPEVLRKQPY---DRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             ccc---------cCCCccccccCChhhcChhhhcCCCC---CccccccccchhhhhhhcCCCCCCC
Confidence            210         00111123357889999999987765   8899999999999999999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.3e-37  Score=270.09  Aligned_cols=218  Identities=22%  Similarity=0.319  Sum_probs=171.5

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCC-----CceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-----KKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPL   88 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~   88 (282)
                      -..+.|.++.++|++.+.||+|+||.||+|.+..+     +..||+|.+.... ......+.+|+++++.+ +|+||+++
T Consensus        28 ~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          28 PYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             cccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence            34567778899999999999999999999986443     3579999886543 33445678899999999 89999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh----------------------------------------
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV----------------------------------------  128 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------------------------  128 (282)
                      ++.+.         .....+++|||+++|+|.+++.....                                        
T Consensus       108 ~~~~~---------~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (374)
T cd05106         108 LGACT---------HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGS  178 (374)
T ss_pred             eeEec---------CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccc
Confidence            98544         34679999999999999998854311                                        


Q ss_pred             --------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        129 --------------------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       129 --------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                                                ....++...++.++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~D  255 (374)
T cd05106         179 DTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICD  255 (374)
T ss_pred             ccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEee
Confidence                                      012367788899999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVY  255 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~  255 (282)
                      ||++......     .  .........++..|+|||++.+..+   +.++||||||+++|||++ |+.||....
T Consensus       256 fGla~~~~~~-----~--~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         256 FGLARDIMND-----S--NYVVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             ceeeeeccCC-----c--ceeeccCCCCccceeCHHHhcCCCC---CccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            9976532100     0  0000111234567999999987665   889999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-36  Score=263.55  Aligned_cols=202  Identities=19%  Similarity=0.280  Sum_probs=170.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ++.++|++.++||+|+||.||++.+..++..+|+|.+.... ......+.+|+++++.++||||+++++.+..       
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------   74 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------   74 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-------
Confidence            56789999999999999999999999999999999886543 2344568899999999999999999985543       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ....+++|||+++++|.+++..    ...+++..+..++.|++.|+.|||++.  +++|+||||+||+++.++.++++
T Consensus        75 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          75 --DGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             --CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEe
Confidence              4689999999999999998763    234788899999999999999999854  69999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||++....           ........++..|+|||++.+..+   +.++|+||+||++|++++|+.||..
T Consensus       147 Dfg~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         147 DFGVSGQLI-----------DSMANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             eCCcchhhh-----------hhccccCCCCccccCHHHhcCCCC---CcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999754210           011122357888999999987665   7899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.1e-37  Score=265.33  Aligned_cols=214  Identities=24%  Similarity=0.365  Sum_probs=164.4

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHH-HhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVE-HHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~-~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+.....   .....+.+|.. +++.++||||+++++.+         ......
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~---------~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF---------QTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE---------EcCCEE
Confidence            369999999999999999999999998854321   22333444544 57889999999998743         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++.++..++.||+.||.|||++   +++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603          72 YFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            999999999999877653    34578889999999999999999998   89999999999999999999999999754


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeee
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~  267 (282)
                      ...         ..........||+.|+|||++.+..+   +.++||||+||++|||++|..||.+.+.  ..+...+..
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~  210 (321)
T cd05603         145 EGV---------EPEETTSTFCGTPEYLAPEVLRKEPY---DRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILH  210 (321)
T ss_pred             cCC---------CCCCccccccCCcccCCHHHhcCCCC---CCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhc
Confidence            210         00011123357889999999987665   7899999999999999999999976322  222333444


Q ss_pred             ccccCCCC
Q psy16951        268 GNITFPEN  275 (282)
Q Consensus       268 ~~~~~p~~  275 (282)
                      ....+|+.
T Consensus       211 ~~~~~~~~  218 (321)
T cd05603         211 KPLQLPGG  218 (321)
T ss_pred             CCCCCCCC
Confidence            44555543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-36  Score=264.82  Aligned_cols=194  Identities=25%  Similarity=0.372  Sum_probs=159.6

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+...   .......+.+|+.++..+ +||||+++++.+.         .....
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~---------~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ---------TESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE---------eCCEE
Confidence            3699999999999999999999999988643   223334566788888776 7999999998443         45789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~  144 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence            999999999999876652    34589999999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ...         ..........||..|+|||++.+..+   +.++|+||+|+++|||++|+.||..
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         145 EGL---------RPGDTTSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccc---------CCCCccccccCCccccCHHHHcCCCC---CCccceecccHHHHHHhhCCCCCcc
Confidence            210         00111223457889999999988766   7899999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-36  Score=256.09  Aligned_cols=206  Identities=16%  Similarity=0.288  Sum_probs=165.9

Q ss_pred             EecccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      +...+|++.+.||+|+||.||+|.+.   .++..||+|.+..... .....+.+|+..++.++||||+++++.+.     
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   76 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----   76 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----
Confidence            45678999999999999999999864   4567899998865432 33457889999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++||||+++++|.+++...   ...+++.+++.++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus        77 ----~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~  146 (266)
T cd05064          77 ----RGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             ----cCCCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcE
Confidence                346799999999999999887632   24588999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +++|||.+....        ...........++..|+|||++.+..+   +.++||||+|+++||+++ |..||.+.
T Consensus       147 ~l~dfg~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         147 KISGFRRLQEDK--------SEAIYTTMSGKSPVLWAAPEAIQYHHF---SSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             EECCCccccccc--------ccchhcccCCCCceeecCHHHHhhCCc---cchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            999999643210        000001112234567999999987765   889999999999999875 99999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.5e-37  Score=263.97  Aligned_cols=195  Identities=24%  Similarity=0.344  Sum_probs=158.9

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhh-CCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKT-FVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~-l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+....   .........|..+++. ++||||+++++.+.         ....+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~---------~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ---------TKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE---------eCCEE
Confidence            36999999999999999999999999886431   2233445667777765 48999999988443         45689


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++.++..++.|++.||.|||++   +++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence            999999999999987753    24578889999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....         .........||..|+|||++.+..+   +.++||||+||++|||++|..||.+.
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         145 ENML---------GDAKTCTFCGTPDYIAPEILLGQKY---NTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             ECCC---------CCCceeeecCCccccCHHHHcCCCC---CchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            2110         0011123457889999999987766   88999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.7e-37  Score=266.37  Aligned_cols=195  Identities=27%  Similarity=0.385  Sum_probs=157.7

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHH-HhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVE-HHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~-~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+....   ......+..|.. +++.++||||+++++.+         ......
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~---------~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF---------QTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE---------ecCCEE
Confidence            36999999999999999999999999885431   222334445554 46778999999998743         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|||+++++|...+..    ...+++..+..++.||+.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604          72 YFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            999999999999877652    34588999999999999999999998   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ...         ..........||..|+|||++.+..+   +.++||||+||++|||++|..||.+.
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         145 EGI---------AQSDTTTTFCGTPEYLAPEVIRKQPY---DNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             cCC---------CCCCCcccccCChhhCCHHHHcCCCC---CCcCccccccceehhhhcCCCCCCCC
Confidence            210         00111223457889999999988766   78999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-36  Score=263.53  Aligned_cols=215  Identities=23%  Similarity=0.354  Sum_probs=167.9

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+...   .......+.+|.++++.+ +||||+++++.+         .....+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~---------~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF---------QTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE---------EcCCEE
Confidence            3699999999999999999999999988643   122344566788888877 699999999843         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++.++..++.|++.||.|||++   +++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  144 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK  144 (318)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCe
Confidence            999999999999887653    34589999999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeee
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~  267 (282)
                      ....         .........+++.|+|||++.+..+   +.++|+||+||++|+|++|+.||.+...  ......+..
T Consensus       145 ~~~~---------~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~  210 (318)
T cd05570         145 EGIL---------GGVTTSTFCGTPDYIAPEILSYQPY---GPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILE  210 (318)
T ss_pred             ecCc---------CCCcccceecCccccCHHHhcCCCC---CcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHc
Confidence            2100         0111123357889999999988766   8899999999999999999999975322  222223344


Q ss_pred             ccccCCCCC
Q psy16951        268 GNITFPENT  276 (282)
Q Consensus       268 ~~~~~p~~~  276 (282)
                      ..+.+|...
T Consensus       211 ~~~~~~~~~  219 (318)
T cd05570         211 DEVRYPRWL  219 (318)
T ss_pred             CCCCCCCcC
Confidence            455555433

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-36  Score=263.44  Aligned_cols=195  Identities=23%  Similarity=0.312  Sum_probs=158.9

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhh-CCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKT-FVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~-l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|++..++..||+|.+....   .........|..++.. ++||||+++++.+         ......
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~---------~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF---------QTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE---------EeCCEE
Confidence            36999999999999999999999999886432   2233445667777765 4899999998844         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+.+++|...+..    ...+++.++..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             EEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            999999999999887753    34588899999999999999999999   89999999999999999999999999754


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....         .........||..|+|||++.+..+   +.++||||+|+++|||++|..||.+.
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         145 ENVF---------GDNRASTFCGTPDYIAPEILQGLKY---TFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             eccc---------CCCceeccCCCcCccCHHHHcCCCC---CcccchhhhHHHHHHHHhCCCCCCCC
Confidence            2110         0011123457889999999988766   88999999999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.7e-37  Score=265.54  Aligned_cols=195  Identities=27%  Similarity=0.406  Sum_probs=156.6

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHH-HhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVE-HHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~-~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+.....   .....+..|.. .++.++||||+++++.+         ......
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~---------~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF---------QTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE---------EcCCeE
Confidence            369999999999999999999999998854321   12223334443 56788999999998743         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|||+++++|.+.+..    ...+.+..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602          72 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            999999999999987753    34577888899999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ...         ..........||+.|+|||++.+..+   +.++||||+||++|+|++|..||.+.
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         145 ENI---------EHNGTTSTFCGTPEYLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             ccc---------cCCCCcccccCCccccCHHHHcCCCC---CCccccccccHHHHHHhcCCCCCCCC
Confidence            210         00111223457899999999988766   78999999999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-36  Score=257.17  Aligned_cols=209  Identities=15%  Similarity=0.230  Sum_probs=167.5

Q ss_pred             cccEEEecccEEEE--EEeccCCceEEEEEEecCCCceEEEEEeccCCchh---HHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         18 KEAVYVKSDKYYIV--EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        18 ~~~~~~~~~~y~~~--~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      .....++.++++..  ..||+|++|.||+|.+  +|..||||.+.......   .+.+.+|+.++++++||||+++++.+
T Consensus        10 ~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         10 NDIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             CcceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            34445566666666  6799999999999998  78899999886543322   35677999999999999999999876


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ..     ........++++||+++|+|.+.+..    ...++......++.|++.|+.|+|+..  +++||||||+||++
T Consensus        88 ~~-----~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill  156 (283)
T PHA02988         88 ID-----IVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLV  156 (283)
T ss_pred             Ee-----cccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEE
Confidence            54     12234578999999999999998863    245788889999999999999999843  67799999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc--CcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~--~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      +.++.+|++|||++....            .......++..|+|||++.+  ..+   +.++||||||+++|||++|+.|
T Consensus       157 ~~~~~~kl~dfg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~---~~k~Di~SlGvil~el~~g~~P  221 (283)
T PHA02988        157 TENYKLKIICHGLEKILS------------SPPFKNVNFMVYFSYKMLNDIFSEY---TIKDDIYSLGVVLWEIFTGKIP  221 (283)
T ss_pred             CCCCcEEEcccchHhhhc------------cccccccCcccccCHHHhhhccccc---cchhhhhHHHHHHHHHHHCCCC
Confidence            999999999999754210            01112356788999999976  334   8899999999999999999999


Q ss_pred             CCcc
Q psy16951        251 FDTV  254 (282)
Q Consensus       251 f~~~  254 (282)
                      |.+.
T Consensus       222 f~~~  225 (283)
T PHA02988        222 FENL  225 (283)
T ss_pred             CCCC
Confidence            9864

>KOG4717|consensus

Probab=100.00  E-value=6.5e-37  Score=264.48  Aligned_cols=220  Identities=26%  Similarity=0.402  Sum_probs=185.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +-|++.+.||+|.|+.|-+|+|.-||..||||++....-.  ....+.+|+..|+-++||||+++++         ++..
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYE---------ViDT   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYE---------VIDT   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeee---------hhcc
Confidence            4588899999999999999999999999999999654333  3456788999999999999999998         6777


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceeec
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLMD  182 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~d  182 (282)
                      +..+|||.|.-.+|.|.+++-.-   ...+++..+..++.||+.|+.|+|+.   .+|||||||+|+++.. -|-+|++|
T Consensus        89 QTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD  162 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD  162 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence            89999999999999999998753   33489999999999999999999999   5889999999998754 58889999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++-          ...+........|+..|-|||++.|..|+  .++.||||+|+|||-|++|++||+..++.+  ..
T Consensus       163 FGFSN----------kf~PG~kL~TsCGSLAYSAPEILLGDsYD--APAVDiWSLGVILyMLVCGq~PFqeANDSE--TL  228 (864)
T KOG4717|consen  163 FGFSN----------KFQPGKKLTTSCGSLAYSAPEILLGDSYD--APAVDIWSLGVILYMLVCGQPPFQEANDSE--TL  228 (864)
T ss_pred             ccccc----------cCCCcchhhcccchhhccCchhhhcCccC--CcchhhhHHHHHHHHHHhCCCccccccchh--hh
Confidence            99742          23344556677889999999999999996  789999999999999999999999755533  33


Q ss_pred             eeeeeccccCCC
Q psy16951        263 LAVISGNITFPE  274 (282)
Q Consensus       263 ~~~~~~~~~~p~  274 (282)
                      -.|..+++++|.
T Consensus       229 TmImDCKYtvPs  240 (864)
T KOG4717|consen  229 TMIMDCKYTVPS  240 (864)
T ss_pred             hhhhcccccCch
Confidence            345677777774

>KOG4279|consensus

Probab=100.00  E-value=2.2e-37  Score=275.24  Aligned_cols=219  Identities=22%  Similarity=0.304  Sum_probs=175.9

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEec
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLP  112 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e  112 (282)
                      +||+|.||+||-|+++.|..+.|||.+.....+..+-..+|+.+.++++|+||++++|         .+...+++-+.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLG---------s~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLG---------SVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhh---------ccCCCCeEEEEee
Confidence            6999999999999999999999999999888888888899999999999999999999         3445678899999


Q ss_pred             cCCCCChHHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceeecccCccchh
Q psy16951        113 YYPKGTLANDLELRSVGKH-YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLMDLGSVAPAV  190 (282)
Q Consensus       113 ~~~~~sL~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~df~~~~~~~  190 (282)
                      -.+||||.+++..  .|+. .-.+...-.+..||++||.|||++   .|||||||-+|+|++. .|-+||+|||.++-. 
T Consensus       653 qVPGGSLSsLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL-  726 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL-  726 (1226)
T ss_pred             cCCCCcHHHHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh-
Confidence            9999999997753  3432 226788889999999999999999   6889999999999987 567789999965421 


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC-ccceeeeeeecc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER-GDSVALAVISGN  269 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~  269 (282)
                              +....-.....||..|||||++....- -++.++|||||||++.||+||++||....+. ..+.++-+...-
T Consensus       727 --------AginP~TETFTGTLQYMAPEvIDqG~R-GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvH  797 (1226)
T KOG4279|consen  727 --------AGINPCTETFTGTLQYMAPEVIDQGPR-GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVH  797 (1226)
T ss_pred             --------ccCCccccccccchhhhChHhhccCCc-CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecC
Confidence                    100011123467899999999976532 2489999999999999999999999866443 334444455555


Q ss_pred             ccCCCC
Q psy16951        270 ITFPEN  275 (282)
Q Consensus       270 ~~~p~~  275 (282)
                      |++|++
T Consensus       798 P~iPee  803 (1226)
T KOG4279|consen  798 PPIPEE  803 (1226)
T ss_pred             CCCcHH
Confidence            666654

>KOG0574|consensus

Probab=100.00  E-value=2.7e-38  Score=257.27  Aligned_cols=213  Identities=23%  Similarity=0.383  Sum_probs=180.0

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ++++...-.+-+.|+++++||+|+||.||+|.|+.+|..+|||++...  .+.++++.|+.++++.+.|+++++++.++ 
T Consensus        22 Ld~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-   98 (502)
T KOG0574|consen   22 LDSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-   98 (502)
T ss_pred             cChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-
Confidence            333333344566788999999999999999999999999999988644  46778899999999999999999998544 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              ....+|+|||||-.|++.+.+..+   ...+.+..+..+++.-+.||+|||..+   -+|||||..|||++.
T Consensus        99 --------K~sDLWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT  164 (502)
T KOG0574|consen   99 --------KHSDLWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNT  164 (502)
T ss_pred             --------cCCceEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcc
Confidence                    346799999999999999988654   456999999999999999999999985   559999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|..|++|||.+...         ...-.......||+.|||||++..-.|   ++++||||+|++..||+.|++||.++
T Consensus       165 ~G~AKLADFGVAGQL---------TDTMAKRNTVIGTPFWMAPEVI~EIGY---~~~ADIWSLGITaIEMAEG~PPYsDI  232 (502)
T KOG0574|consen  165 DGIAKLADFGVAGQL---------TDTMAKRNTVIGTPFWMAPEVIEEIGY---DTKADIWSLGITAIEMAEGRPPYSDI  232 (502)
T ss_pred             cchhhhhhccccchh---------hhhHHhhCccccCcccccHHHHHHhcc---chhhhHhhhcchhhhhhcCCCCcccc
Confidence            999999999976422         112223445678999999999998887   88999999999999999999999875


Q ss_pred             cc
Q psy16951        255 YE  256 (282)
Q Consensus       255 ~~  256 (282)
                      -+
T Consensus       233 HP  234 (502)
T KOG0574|consen  233 HP  234 (502)
T ss_pred             cc
Confidence            44

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9e-36  Score=262.27  Aligned_cols=205  Identities=22%  Similarity=0.322  Sum_probs=165.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||.||++.+..++..||+|.+...  .......+.+|+.+++.++||||+++++.+....   ..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK---SL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC---Cc
Confidence            458999999999999999999999999999999988533  2334556778999999999999999998665321   12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....++++|||+.+ ++...+.      ..++...+..++.|++.||.|||++   |++||||||+||+++.++.++++
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            223468999999954 5655443      2378888999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+.....          ........+|..|+|||++.+..+   +.++||||+|+++|+|++|+.||.+.
T Consensus       166 Dfg~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         166 DFGLARTACT----------NFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             cCCCcccccc----------CccCCCCcccCCCCCchhccCCCC---CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9997642110          011123456888999999988766   78999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-36  Score=263.46  Aligned_cols=194  Identities=26%  Similarity=0.381  Sum_probs=160.2

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||+||+|++..++..||+|.+....   ......+.+|+.++.++ +||||+.+++.+         .....+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~---------~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF---------QTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE---------EeCCEE
Confidence            36999999999999999999999999986432   22334567888888888 699999998843         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~  144 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK  144 (327)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccce
Confidence            999999999999877653    34589999999999999999999998   89999999999999999999999999754


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ...         ..........||+.|+|||++.+..+   +.++||||+|+++|||++|..||..
T Consensus       145 ~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         145 EGL---------GPGDTTSTFCGTPNYIAPEILRGEEY---GFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ecc---------CCCCceecccCCcccCCHHHHCCCCC---CchheeehhHHHHHHHHhCCCCCCc
Confidence            210         00011123457889999999988766   8899999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-36  Score=266.57  Aligned_cols=216  Identities=21%  Similarity=0.291  Sum_probs=170.2

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLL   89 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~   89 (282)
                      .+-.+.++.++|++.+.||+|+||.||+|.+     ..++..||+|.+.... ......+.+|+.+++.+ +||||++++
T Consensus        26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            3446677888999999999999999999974     3467789999886433 33455678899999999 899999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-----------------------------------------
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----------------------------------------  128 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------------------------------  128 (282)
                      +.+.         .....++||||+++|+|.+++.....                                         
T Consensus       106 ~~~~---------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (375)
T cd05104         106 GACT---------VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS  176 (375)
T ss_pred             eeec---------cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence            8543         34678999999999999988864210                                         


Q ss_pred             ------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951        129 ------------------------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus       129 ------------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                                                    ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~  253 (375)
T cd05104         177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRIT  253 (375)
T ss_pred             cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcE
Confidence                                          112467788899999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +++|||++......       ..........++..|+|||++.+..+   +.++||||||+++|||++ |..||...
T Consensus       254 kl~DfG~a~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         254 KICDFGLARDIRND-------SNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             EEecCccceeccCc-------ccccccCCCCCCcceeChhHhcCCCC---CCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999976532100       00001112234567999999987765   889999999999999998 88999754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.9e-36  Score=254.87  Aligned_cols=206  Identities=25%  Similarity=0.394  Sum_probs=162.0

Q ss_pred             ccEEEEEEeccCCceEEEEEEecC-CCceEEEEEeccCCch--hHHHHHHHHHHhhhC---CCCCcccccccccccCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICHGRE--DQAQAIREVEHHKTF---VHPNILPLLDHALTGCADP   99 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~~~~   99 (282)
                      ++|++.+.||+|+||+||+|++.. ++..||+|.+......  ....+.+|+..++.+   +||||+++++.+...    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~----   76 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS----   76 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc----
Confidence            479999999999999999999854 4688999988644322  233455677666555   699999999866432    


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      .......+++++|++. ++|.+++...  ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~k  150 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  150 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEE
Confidence            1223467999999995 6888877532  234478899999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+......          .......+|..|+|||++.+..+   +.++||||+|+++|||++|.+||.+.
T Consensus       151 l~Dfg~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         151 LADFGLARIYSFQ----------MALTSVVVTLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             EccccceEeccCC----------cccccccccccccChHHHhCCCC---CCccchHHHHHHHHHHHcCCCCcCCC
Confidence            9999976532110          11223457888999999987665   88999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.7e-37  Score=264.75  Aligned_cols=215  Identities=21%  Similarity=0.335  Sum_probs=167.5

Q ss_pred             EEeccCCceEEEEEEe---cCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         32 EKIGEGGFSTVSLIEH---SQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      +.||+|+||.||+++.   ..++..||+|.+.....  .....+.+|++++++++||||+++++.+         .....
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~---------~~~~~   72 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF---------QTEGK   72 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE---------EcCCE
Confidence            5799999999999886   35789999998864322  2334567799999999999999998844         34578


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++|+||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||.+
T Consensus        73 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  145 (318)
T cd05582          73 LYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS  145 (318)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCC
Confidence            9999999999999987753    34588999999999999999999999   8999999999999999999999999975


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeee
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI  266 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~  266 (282)
                      .....         .........||..|+|||++.+..+   +.++||||||+++|||++|+.||.....  ......+.
T Consensus       146 ~~~~~---------~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~i~  211 (318)
T cd05582         146 KESID---------HEKKAYSFCGTVEYMAPEVVNRRGH---TQSADWWSFGVLMFEMLTGSLPFQGKDR--KETMTMIL  211 (318)
T ss_pred             cccCC---------CCCceecccCChhhcCHHHHcCCCC---CCccceeccceEeeeeccCCCCCCCCCH--HHHHHHHH
Confidence            42110         0011123457889999999987665   7899999999999999999999975322  22222333


Q ss_pred             eccccCCCCC
Q psy16951        267 SGNITFPENT  276 (282)
Q Consensus       267 ~~~~~~p~~~  276 (282)
                      .....+|+..
T Consensus       212 ~~~~~~p~~~  221 (318)
T cd05582         212 KAKLGMPQFL  221 (318)
T ss_pred             cCCCCCCCCC
Confidence            4445555443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.6e-36  Score=263.47  Aligned_cols=214  Identities=21%  Similarity=0.329  Sum_probs=169.9

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCcccccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDHA   92 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~~   92 (282)
                      .|.++.++|++.+.||+|+||.||+|....     ++..||+|++..... .....+.+|+++++.+ +|+||+++++.+
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            378889999999999999999999997543     457899998864432 2344677899999999 899999999865


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--------------------------------------------
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--------------------------------------------  128 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------  128 (282)
                      ..        ....+++++||+++++|.+.+.....                                            
T Consensus        81 ~~--------~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (337)
T cd05054          81 TK--------PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKS  152 (337)
T ss_pred             ec--------CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcc
Confidence            43        23578899999999999988754211                                            


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccC
Q psy16951        129 -------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG  195 (282)
Q Consensus       129 -------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~  195 (282)
                                   ....++...+..++.|++.||.|||++   |++||||||+||+++.++.++++|||++.....    
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~----  225 (337)
T cd05054         153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK----  225 (337)
T ss_pred             hhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhccc----
Confidence                         012578888999999999999999998   899999999999999999999999997653211    


Q ss_pred             chhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       196 ~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                         ...........++..|+|||++.+..+   +.++||||+||++||+++ |..||.+.
T Consensus       226 ---~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         226 ---DPDYVRKGDARLPLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             ---CcchhhccCCCCCccccCcHHhcCCCC---CccccHHHHHHHHHHHHHcCCCCCCCC
Confidence               000111123345677999999988766   889999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-35  Score=249.74  Aligned_cols=206  Identities=21%  Similarity=0.319  Sum_probs=169.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+..........+.+|+..+++++||||+++++.+.         .
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~---------~   77 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL---------S   77 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE---------e
Confidence            4678999999999999999999999999999999887655555566778999999999999999988543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++++||+++++|.+.+..    ...+++.++..++.|++.|+.|+|++   |++|+|++|+||+++.++.++++||
T Consensus        78 ~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          78 REKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcC
Confidence            4679999999999999987753    23578999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........++..|+|||.+.......++.++|+||+|+++|||++|..||...
T Consensus       151 g~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         151 GVAAKITA---------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             ccceeecc---------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            97642210         001112234678899999985432222477999999999999999999999654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG2052|consensus

Probab=100.00  E-value=6.3e-36  Score=254.19  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=183.0

Q ss_pred             hhhhhhhcccccccEEEe-----cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-
Q psy16951          7 NLIFQMGCLCSKEAVYVK-----SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-   80 (282)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~-----~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-   80 (282)
                      +++-++..++|..--.+.     ..+..+++.||+|.||+||+|+|+  |..||||++.   ..++.++.+|.++.+++ 
T Consensus       187 Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~---srdE~SWfrEtEIYqTvm  261 (513)
T KOG2052|consen  187 DLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS---SRDERSWFRETEIYQTVM  261 (513)
T ss_pred             HHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEec---ccchhhhhhHHHHHHHHH
Confidence            344444444444333332     568899999999999999999995  5669999884   45566777888887654 


Q ss_pred             -CCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh------
Q psy16951         81 -VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH------  153 (282)
Q Consensus        81 -~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH------  153 (282)
                       +|+||+.|.+....+     ..+-.++|||++|.+.|||+|+|..     ..+.....+.++..++.||.+||      
T Consensus       262 LRHENILgFIaaD~~~-----~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GT  331 (513)
T KOG2052|consen  262 LRHENILGFIAADNKD-----NGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGT  331 (513)
T ss_pred             hccchhhhhhhccccC-----CCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence             899999999876653     2345889999999999999999963     45888999999999999999999      


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc----ccCCC
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS----YCVVD  229 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~----~~~~~  229 (282)
                      +.++ .|+|||||.+|||+++++.|-|+|+|++.-.....     .....+....+||-+|||||++....    +++ =
T Consensus       332 qgKP-aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t-----~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes-y  404 (513)
T KOG2052|consen  332 QGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT-----DTIDIPPNPRVGTKRYMAPEVLDETINMKHFES-Y  404 (513)
T ss_pred             CCCc-hhhccccccccEEEccCCcEEEeeceeeEEecccC-----CcccCCCCCccceeeccChHHhhhhcChhhhhh-h
Confidence            3444 79999999999999999999999999865322111     11122345668899999999995421    111 1


Q ss_pred             CccchhhHHHHHHHHHhC----------CCCCCccccCcc---ceeeeee--eccccCCCCC
Q psy16951        230 QRTDVWSLGCLLYAMCYF----------KSPFDTVYERGD---SVALAVI--SGNITFPENT  276 (282)
Q Consensus       230 ~~~Diws~G~il~el~tg----------~~pf~~~~~~~~---~~~~~~~--~~~~~~p~~~  276 (282)
                      ..+||||||+++||++.+          +.||++..+.+.   .+...+.  +.+|++|.-+
T Consensus       405 k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW  466 (513)
T KOG2052|consen  405 KRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW  466 (513)
T ss_pred             hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc
Confidence            469999999999999764          579987654433   3333332  3356666543

>KOG4250|consensus

Probab=100.00  E-value=1.1e-36  Score=271.71  Aligned_cols=210  Identities=24%  Similarity=0.346  Sum_probs=167.7

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      .+...+.||+|+||.||+++++.||..||||.++.. ..+..+..-+|++++++++|+|||++++.--..  . ......
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~--~-~~~~~~   90 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK--F-LGLVTR   90 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc--c-cCcccc
Confidence            345567899999999999999999999999988643 345566778899999999999999998731111  0 011134


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec--CCCc--eee
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNP--LLM  181 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~--~~~  181 (282)
                      ...++||||++|+|...+..... ...+++.+++.++..+..|+.|||++   ||+||||||.||++..  +|+.  |++
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence            57899999999999998875543 34589999999999999999999999   8999999999999743  3443  799


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |||.++..+          ......+.+||..|.+||.... ..|   +..+|.|||||++|+.+||..||.....
T Consensus       167 DfG~Arel~----------d~s~~~S~vGT~~YLhPel~E~q~~y---~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  167 DFGAARELD----------DNSLFTSLVGTEEYLHPELYERQKKY---TATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cccccccCC----------CCCeeeeecCchhhcChHHHhhccCc---CceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999876321          1123456789999999999985 444   8899999999999999999999976533

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.9e-36  Score=264.02  Aligned_cols=203  Identities=23%  Similarity=0.352  Sum_probs=163.6

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .....++|+.+++||+|+||.||+|.+..+++.||||.+..... .....+.+|+++++.++|+||+++++.+       
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-------  141 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-------  141 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-------
Confidence            44456789999999999999999999999999999998864433 3345678999999999999999998843       


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        .....+++++||+.+++|.+.        ....+..+..++.||+.||.|||++   |++||||||+||+++.++.++
T Consensus       142 --~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  208 (353)
T PLN00034        142 --DHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK  208 (353)
T ss_pred             --ccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence              345789999999999998642        2256777888999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ++|||++.....         .........||..|+|||++.....  ...+.++|||||||++|||++|+.||.
T Consensus       209 L~DfG~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        209 IADFGVSRILAQ---------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             Ecccccceeccc---------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            999997653210         0011123467889999999853211  012568999999999999999999997

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-35  Score=263.72  Aligned_cols=214  Identities=21%  Similarity=0.319  Sum_probs=170.1

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCC-----CceEEEEEeccCCc-hhHHHHHHHHHHhhhCC-CCCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-----KKRYALKKIICHGR-EDQAQAIREVEHHKTFV-HPNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~-H~ni~~~~~~   91 (282)
                      ..|.+++++|.+.+.||+|+||.||+|.+...     +..||||++..... ...+.+.+|+++++.+. ||||++++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            47888899999999999999999999987433     35699998865433 33457889999999996 9999999985


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-------------------------------------------
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------------------------------------------  128 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------------------------------  128 (282)
                      +.         .....++||||+++|+|.+++.....                                           
T Consensus       110 ~~---------~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (400)
T cd05105         110 CT---------KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM  180 (400)
T ss_pred             Ec---------cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence            53         34679999999999999988764311                                           


Q ss_pred             -------------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951        129 -------------------------------------------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus       129 -------------------------------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                                                                       ....++...++.++.|++.||.|||++   +
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  257 (400)
T cd05105         181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---N  257 (400)
T ss_pred             ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                                                             012366778889999999999999998   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      ++|+||||+||+++.++.++++|||++......       ..........++..|+|||++.+..+   +.++||||||+
T Consensus       258 ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwSlGv  327 (400)
T cd05105         258 CVHRDLAARNVLLAQGKIVKICDFGLARDIMHD-------SNYVSKGSTFLPVKWMAPESIFDNLY---TTLSDVWSYGI  327 (400)
T ss_pred             eeCCCCChHhEEEeCCCEEEEEeCCcceecccc-------ccccccCCcCCCcceEChhhhcCCCC---CchhhHHHHHH
Confidence            999999999999999999999999976532100       00011122345678999999987665   88999999999


Q ss_pred             HHHHHHh-CCCCCCcc
Q psy16951        240 LLYAMCY-FKSPFDTV  254 (282)
Q Consensus       240 il~el~t-g~~pf~~~  254 (282)
                      ++|||++ |..||...
T Consensus       328 il~ellt~g~~P~~~~  343 (400)
T cd05105         328 LLWEIFSLGGTPYPGM  343 (400)
T ss_pred             HHHHHHHCCCCCCccc
Confidence            9999997 88999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=280.71  Aligned_cols=216  Identities=24%  Similarity=0.437  Sum_probs=172.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .....++|++++.||+|+||+||+|.+..++..||+|.+....  ......+..|+.+++.++||||+++++.|...   
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---   84 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---   84 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---
Confidence            3455679999999999999999999999999999999886543  33456788999999999999999999866542   


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CCccccCCCCCcEEeec
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKP----IAYAHRDLKTANVLLAN  174 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~----~~i~H~dlk~~nil~~~  174 (282)
                          ....+++||||+++++|.+.+.........+++..++.++.||+.||.|||+...    .+|+||||||+|||+..
T Consensus        85 ----~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         85 ----ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             ----CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence                2357999999999999999887543334568999999999999999999998520    15999999999999964


Q ss_pred             C-----------------CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhH
Q psy16951        175 D-----------------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSL  237 (282)
Q Consensus       175 ~-----------------~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~  237 (282)
                      +                 ..++|+|||++......          .......+|+.|+|||++.+... .++.++|||||
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----------s~~~s~vGTp~YmAPEvL~ge~~-~~s~KSDVWSL  229 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----------SMAHSCVGTPYYWSPELLLHETK-SYDDKSDMWAL  229 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCcccccccc----------ccccccCCCccccCHHHHhccCC-CCCchhHHHHH
Confidence            2                 34799999976432100          01123457899999999965431 23789999999


Q ss_pred             HHHHHHHHhCCCCCCcc
Q psy16951        238 GCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       238 G~il~el~tg~~pf~~~  254 (282)
                      ||++|||++|..||...
T Consensus       230 G~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        230 GCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             HHHHHHHHHCCCCCCcC
Confidence            99999999999999753

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-35  Score=278.02  Aligned_cols=213  Identities=26%  Similarity=0.358  Sum_probs=169.0

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.++||+|+||.||+|.+..++..||+|++....   ......+.+|+++++.++||||+++++.+.         
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~---------   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS---------   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe---------
Confidence            68999999999999999999999999999999986432   223457889999999999999999988443         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVG-------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                      .....+++|||+++++|.+.+......       ....+...++.++.|++.||.|+|++   |++||||||+||+++.+
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d  149 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF  149 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC
Confidence            346799999999999999988642111       12345567788999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCch----h-----hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSA----E-----AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~----~-----~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      +.++++|||.+...........    .     ...........||+.|+|||++.+..+   +.++||||+||++|||+|
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~---S~kSDIWSLGVILyELLT  226 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA---SESTDIYALGVILYQMLT  226 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC---CcHhHHHHHHHHHHHHHH
Confidence            9999999998764311100000    0     000011123458999999999988765   889999999999999999


Q ss_pred             CCCCCCc
Q psy16951        247 FKSPFDT  253 (282)
Q Consensus       247 g~~pf~~  253 (282)
                      |..||..
T Consensus       227 G~~PF~~  233 (932)
T PRK13184        227 LSFPYRR  233 (932)
T ss_pred             CCCCCCC
Confidence            9999975

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-35  Score=259.52  Aligned_cols=206  Identities=23%  Similarity=0.341  Sum_probs=166.5

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...++|++.+.||+|+||.||++.+..++..||||++...  .......+.+|+.+++.++||||+++++.+....   .
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK---S   90 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc---c
Confidence            3458999999999999999999999999999999988643  2334456778999999999999999998665421   1


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .......+++|||+.+ ++.+.+.      ..++...+..++.|++.||.|||++   |++||||||+||+++.++.+++
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence            2234568999999954 5665543      2378888999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++.....          ........+|..|+|||++.+..+   +.++||||+||++|+|++|+.||.+.
T Consensus       161 ~Dfg~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         161 LDFGLARTAGT----------SFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             eeCcccccCCC----------ccccCCccccCCccCHHHHcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99997642210          011123456888999999988766   78999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-35  Score=255.10  Aligned_cols=210  Identities=21%  Similarity=0.336  Sum_probs=164.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC----------------CCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ----------------TKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNI   85 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni   85 (282)
                      ++.++|++.++||+|+||.||+|.+..                ++..||+|.+...... ....+.+|++++++++||||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            457899999999999999999998532                3457999988654333 35578899999999999999


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHH
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---------------GKHYMSSVDILKMFLKICEAVK  150 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------~~~~l~~~~~~~~~~qi~~~l~  150 (282)
                      +++++.+..         ....++++||+.+++|.+++.....               ....++...++.++.|++.||.
T Consensus        82 v~~~~~~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  152 (304)
T cd05096          82 IRLLGVCVD---------EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK  152 (304)
T ss_pred             eEEEEEEec---------CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999985543         3568999999999999998764311               1123567788999999999999


Q ss_pred             HhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCC
Q psy16951        151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQ  230 (282)
Q Consensus       151 ~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~  230 (282)
                      |||++   |++||||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.
T Consensus       153 ~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~  219 (304)
T cd05096         153 YLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG-------DYYRIQGRAVLPIRWMAWECILMGKF---TT  219 (304)
T ss_pred             HHHHC---CccccCcchhheEEcCCccEEECCCccceecccC-------ceeEecCcCCCCccccCHHHHhcCCC---Cc
Confidence            99999   8999999999999999999999999976432110       00001112234678999999987665   88


Q ss_pred             ccchhhHHHHHHHHHh--CCCCCCcc
Q psy16951        231 RTDVWSLGCLLYAMCY--FKSPFDTV  254 (282)
Q Consensus       231 ~~Diws~G~il~el~t--g~~pf~~~  254 (282)
                      ++||||||+++|||++  +..||...
T Consensus       220 ~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         220 ASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             hhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            9999999999999987  56788753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=251.32  Aligned_cols=212  Identities=20%  Similarity=0.322  Sum_probs=169.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCC-----CceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-----KKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      |.+..++|++.+.||+|+||.||+|.+...     +..||+|.+..... .....+.+|+.+++.++||||+++++.+. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-
Confidence            567889999999999999999999997644     38899998764433 34557788999999999999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                              .....++++||+++++|.+++......      ...+++..+..++.|++.||.|+|++   +++|+||||+
T Consensus        80 --------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~  148 (277)
T cd05032          80 --------TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAAR  148 (277)
T ss_pred             --------CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChh
Confidence                    346799999999999999988643211      12367788999999999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||.+.....       ...........++..|+|||.+.+..+   +.++||||||+++||+++ |
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~t~g  218 (277)
T cd05032         149 NCMVAEDLTVKIGDFGMTRDIYE-------TDYYRKGGKGLLPVRWMAPESLKDGVF---TTKSDVWSFGVVLWEMATLA  218 (277)
T ss_pred             eEEEcCCCCEEECCcccchhhcc-------CcccccCCCCCccccccCHHHHhcCCC---CcccchHHHHHHHHHhhccC
Confidence            99999999999999997542110       000011122334678999999976655   789999999999999998 8


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||.+.
T Consensus       219 ~~p~~~~  225 (277)
T cd05032         219 EQPYQGL  225 (277)
T ss_pred             CCCCccC
Confidence            9999753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-35  Score=261.82  Aligned_cols=206  Identities=23%  Similarity=0.317  Sum_probs=163.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||++.+..++..||||++...  .......+.+|+++++.++|+||+++++.+....    ....
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~   76 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPH----IDPF   76 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCC----cccc
Confidence            478899999999999999999999999999988543  2234456788999999999999999998654321    0112


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+. ++|...+.    ....++...+..++.|++.||.|||++   |++||||||+||+++.++.++++|||
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          77 EEIYVVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             ceEEEEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccc
Confidence            36899999985 56666553    345688999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++......        .........++..|+|||++.+...  ++.++||||+||++|||++|+.||.+.
T Consensus       149 ~a~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         149 LARVEEPD--------ESKHMTQEVVTQYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             ceeecccC--------ccccCCCCCcCCCcCCHHHHcCCCC--CCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            76532110        0011122346788999999987542  378999999999999999999999754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-35  Score=251.48  Aligned_cols=201  Identities=23%  Similarity=0.321  Sum_probs=165.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .|+..+.||+|+||+||+|.+..++..||+|.+.....   .....+.+|+++++.++|+||+.+.+.+.         .
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~---------~   71 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE---------T   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe---------c
Confidence            47888999999999999999999999999998864432   22345678999999999999999987443         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+...  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Df  146 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecC
Confidence            57899999999999998777532  234589999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....        .  ........++..|+|||++.+..+   +.++|+||+|+++|++++|..||.+.
T Consensus       147 g~~~~~~--------~--~~~~~~~~g~~~~~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         147 GLAVKIP--------E--GESIRGRVGTVGYMAPEVLNNQRY---TLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             CcceecC--------C--CCcccCCCCCcCccChHHhcCCCC---CcccchHHHHHHHHHHHhCCCCCCCC
Confidence            9754210        0  001123357889999999987665   78999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-35  Score=255.73  Aligned_cols=206  Identities=20%  Similarity=0.321  Sum_probs=165.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +...+|++.+.||+|+||.||+|.+..++.    .||+|.+.... ......+.+|+.+++.++||||+++++.+..   
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence            456789999999999999999999866554    48999886443 3445678899999999999999999986543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++|+|.+.+...   ...++...++.++.|++.||.|||++   |++||||||+||+++.++.
T Consensus        81 -------~~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~  147 (316)
T cd05108          81 -------STVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQH  147 (316)
T ss_pred             -------CCceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCc
Confidence                   2467999999999999887632   34578888999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+......       ...........+..|++||++.+..+   +.++||||||+++||+++ |..||.+.
T Consensus       148 ~kl~DfG~a~~~~~~-------~~~~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         148 VKITDFGLAKLLGAD-------EKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             EEEccccccccccCC-------CcceeccCCccceeecChHHhccCCC---CchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999986532110       00000111223567999999987765   889999999999999997 99999753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0612|consensus

Probab=100.00  E-value=2.3e-37  Score=287.27  Aligned_cols=231  Identities=26%  Similarity=0.356  Sum_probs=183.4

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ..-+..++|+++..||+|+||.|..++++.|++.||.|+++..   ...+.+-|..|-.+|..-+.+=|+.++-      
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy------  142 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY------  142 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH------
Confidence            3456789999999999999999999999999999999988642   2334556777888888777777887765      


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                         .+.+..++|+||||++||+|-.++...    ..+++..+..|+.+|..|+.-||+.   |.|||||||+|||++.+|
T Consensus       143 ---AFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  143 ---AFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             ---HhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence               466779999999999999999988743    2589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|++|||.+.    +    ..+.........+|||-|.+||++....  .+.++..+|.||+||++|||++|..||+..
T Consensus       213 HikLADFGsCl----k----m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  213 HIKLADFGSCL----K----MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             cEeeccchhHH----h----cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            99999999632    1    1222233445678999999999996432  235689999999999999999999999852


Q ss_pred             ccCccceeeee--eeccccCCCCC
Q psy16951        255 YERGDSVALAV--ISGNITFPENT  276 (282)
Q Consensus       255 ~~~~~~~~~~~--~~~~~~~p~~~  276 (282)
                      .-  -..+-.|  ....+.||+.+
T Consensus       285 sl--veTY~KIm~hk~~l~FP~~~  306 (1317)
T KOG0612|consen  285 SL--VETYGKIMNHKESLSFPDET  306 (1317)
T ss_pred             HH--HHHHHHHhchhhhcCCCccc
Confidence            11  1122222  23357777544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-35  Score=250.63  Aligned_cols=200  Identities=25%  Similarity=0.362  Sum_probs=165.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .|+..+.||+|+||.||++.+..++..||+|.+......   ....+.+|+.+++.++|++++.+.+.+.         .
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~---------~   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE---------T   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe---------c
Confidence            478889999999999999999999999999988643322   2345678999999999999999987443         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+...  ....+++.++..++.|++.||.|+|++   +++|+||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Df  146 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDL  146 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeec
Confidence            46899999999999999877543  233588899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |.+....          .........|+..|+|||++.+..+   +.++|+||+|+++|+|++|+.||..
T Consensus       147 g~~~~~~----------~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         147 GLAVHVP----------EGQTIKGRVGTVGYMAPEVVKNERY---TFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             cceeecC----------CCccccCCCCCccccChHHHcCCCC---CCccccHHHHHHHHHHHhCCCCCCC
Confidence            9754210          0011123357889999999987665   8899999999999999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4e-35  Score=250.18  Aligned_cols=205  Identities=25%  Similarity=0.370  Sum_probs=161.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhC---CCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTF---VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|++.+.||+|+||+||+|++..++..||+|.+......  ......+|++.++.+   +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~----~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS----RT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc----cC
Confidence            589999999999999999999999999999988643222  223445666666554   799999999866542    12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......++++|++. ++|.+++...  ....+++..+..++.|++.||.|+|++   |++||||||+||+++.++.++++
T Consensus        77 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~  150 (288)
T cd07863          77 DRETKVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLA  150 (288)
T ss_pred             CCCceEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            23467899999996 5787776532  223478999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+.....          ........+|..|+|||++.+..+   +.++||||+||++|+|++|.+||.+.
T Consensus       151 dfg~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         151 DFGLARIYSC----------QMALTPVVVTLWYRAPEVLLQSTY---ATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ccCccccccC----------cccCCCccccccccCchHhhCCCC---CCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            9997642210          011122356788999999987765   88999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.8e-35  Score=258.80  Aligned_cols=205  Identities=23%  Similarity=0.328  Sum_probs=166.2

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||.||++.+..++..||||++...  .......+.+|+.+++.++||||+++++.+....   ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~---~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK---SL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc---cc
Confidence            468999999999999999999999999999999988643  2334556788999999999999999988654321   12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......++||||+. +++...+.      ..++...+..++.|++.||.|||++   |++||||||+||+++.++.++++
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          99 EEFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             cccCeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence            23456899999995 46666553      2377888999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++.....          ........+|..|+|||++.+..+   +.++||||+||++|+|++|+.||.+.
T Consensus       169 DfG~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         169 DFGLARTAGT----------SFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             eCCCccccCC----------CCcccCCcccCCcCCHHHHhCCCC---CchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            9997652210          011123356888999999988765   88999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-35  Score=248.88  Aligned_cols=207  Identities=20%  Similarity=0.330  Sum_probs=169.4

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+...+|++.+.||+|+||.||+|.+..++..||+|.+... ......+.+|++.++.++|+||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------   72 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-------   72 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-------
Confidence            456778899999999999999999999999999999987643 344567889999999999999999998443       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....+++++||+++++|.+.+...  ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+++
T Consensus        73 --~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl  145 (263)
T cd05052          73 --REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV  145 (263)
T ss_pred             --CCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEe
Confidence              346789999999999999987542  234578889999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      +|||.+.....        ...........+..|+|||.+.+..+   +.++||||||+++|||++ |..||.+
T Consensus       146 ~df~~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         146 ADFGLSRLMTG--------DTYTAHAGAKFPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             CCCcccccccc--------ceeeccCCCCCccccCCHHHhccCCC---CchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99997643211        00001111223557999999987765   789999999999999998 8999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.1e-35  Score=245.93  Aligned_cols=204  Identities=29%  Similarity=0.480  Sum_probs=169.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|++..++..||||.+....   ......+.+|+++++.++||||+++++.+..        
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   73 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--------   73 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--------
Confidence            68999999999999999999999999999999875432   3344567889999999999999999985443        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++++||+++++|.+.+.........+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|
T Consensus        74 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          74 -DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence             4678999999999999988865444445578899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+....         ..........++..|+|||++.+..+   +.++|+||+|+++|||++|..||..
T Consensus       150 ~g~~~~~~---------~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         150 LGLGRFFS---------SKTTAAHSLVGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             cccceecc---------chhHHHhcCCCCccccChhhhccCCC---CchhhHHHHHHHHHHHhcCCCCCcc
Confidence            99754321         00111223356788999999987655   7899999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0577|consensus

Probab=100.00  E-value=5.1e-37  Score=268.72  Aligned_cols=198  Identities=24%  Similarity=0.355  Sum_probs=170.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh---HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +.|.-++.||.|+||.||-|++..+...||||+++.++...   +..++.|+.++++++|||++.|.++++.        
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--------   97 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--------   97 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--------
Confidence            45667789999999999999999999999999999887654   5577899999999999999999996554        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       +...||||||| -||-.+.+..   ...++.+..+..++.+.+.||.|||+.   +.+|||||..|||+..+|.+|++|
T Consensus        98 -e~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen   98 -EHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             -cchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence             57899999999 6787777753   456688999999999999999999999   788999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ||.+...             .+..+.+||+.|||||++....-+-++-++||||+|++..||+..++|+-
T Consensus       170 FGSAsi~-------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  170 FGSASIM-------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             ccchhhc-------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence            9975321             23456789999999999986544445889999999999999999998763

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=247.01  Aligned_cols=204  Identities=22%  Similarity=0.349  Sum_probs=166.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-----hHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-----DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ++|++.+.||+|++|.||++.+..++.+||+|.+......     ....+.+|++++++++||||+++++.+        
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--------   73 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL--------   73 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--------
Confidence            5789999999999999999999999999999988643221     234577899999999999999999844        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       ......++++|++++++|.+.+...    ..+++..+..++.|++.|+.|||++   |++|+||+|+||+++.++.+++
T Consensus        74 -~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l  145 (263)
T cd06625          74 -RDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKL  145 (263)
T ss_pred             -ccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence             3446899999999999999877632    3478889999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+.....     . ...........++..|+|||++.+..+   +.++||||+|+++||+++|+.||.+.
T Consensus       146 ~dfg~~~~~~~-----~-~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         146 GDFGASKRLQT-----I-CSSGTGMKSVTGTPYWMSPEVISGEGY---GRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             eecccceeccc-----c-ccccccccCCCcCccccCcceeccCCC---CchhhhHHHHHHHHHHHhCCCCcccc
Confidence            99997542110     0 000000122345778999999988765   78999999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-35  Score=253.87  Aligned_cols=204  Identities=27%  Similarity=0.401  Sum_probs=164.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.++||+|+||.||+|++..++..||+|.+..... .....+.+|+++++.++||||+++++.+.         
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------   74 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH---------   74 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe---------
Confidence            35789999999999999999999999999999999864432 23345678999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+.+ +|.+.+..   ....++...+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          75 TDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             eCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            34679999999964 77766543   234578889999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+.....         .........++..|+|||++.+...  ++.++||||+|+++|+|+||+.||.+.
T Consensus       148 fg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         148 FGLARAKSV---------PTKTYSNEVVTLWYRPPDVLLGSSE--YSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             cccceecCC---------CccccccccccccccCCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            997642111         0011112345788999999875432  378999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.8e-35  Score=250.10  Aligned_cols=194  Identities=25%  Similarity=0.369  Sum_probs=158.8

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||+||+++...++..||+|.+.....   ........|++++++++||||+++.+.         +......+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~---------~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA---------FESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE---------EecCCeEEEE
Confidence            7999999999999999999999998853221   123345669999999999999999874         3445789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      |||+++++|..++...  ....++...+..++.|++.||.|+|++   |++||||||+||+++.++.++++|||.+....
T Consensus        72 ~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          72 MSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             EecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            9999999998877532  223478888899999999999999998   89999999999999999999999999754221


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .          ........++..|+|||++.+..+   +.++|+||+|+++|||++|+.||...
T Consensus       147 ~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         147 D----------GKTITQRAGTNGYMAPEILKEEPY---SYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             C----------CceeeccCCCCCccCHHHHccCCC---CCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            0          001122357889999999987765   88999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-35  Score=246.85  Aligned_cols=206  Identities=20%  Similarity=0.323  Sum_probs=165.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-----chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-----REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+|++.+.||+|+||.||.|.+..++..||||.+....     ......+.+|+..++.++||||+++++.+...     
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP-----   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC-----
Confidence            57999999999999999999999999999999885332     12234677899999999999999998854321     


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....+++++||+++++|.+.+...    ..+++..++.++.|++.||.|+|++   +++|+||+|+||+++.++.+++
T Consensus        77 --~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          77 --MERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             --CCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEE
Confidence              135688999999999999877532    3478888999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+.......      ..........++..|+|||++.+..+   +.++|+||||+++||+++|+.||...
T Consensus       148 ~Dfg~~~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         148 GDFGASKRLQTIC------LSGTGMKSVTGTPYWMSPEVISGEGY---GRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             CcCcccccccccc------ccccccccCCCCccccChhhhcCCCC---CcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            9999765321100      00011122346788999999987655   78999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-35  Score=246.54  Aligned_cols=207  Identities=22%  Similarity=0.345  Sum_probs=167.6

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|+++++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+        
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--------   70 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVV--------   70 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEE--------
Confidence            5788999999999999999999999974 5667999987543 33456788999999999999999998743        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       ......++++|++++++|.+.+...  ....++...++.++.|++.||.|||+.   +++|+||+|+||+++.++.+++
T Consensus        71 -~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  144 (261)
T cd05072          71 -TKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI  144 (261)
T ss_pred             -cCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEE
Confidence             3456789999999999999987643  234578888899999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||++.+..+   +.++|+||||+++|+|++ |..||.+.
T Consensus       145 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         145 ADFGLARVIED--------NEYTAREGAKFPIKWTAPEAINFGSF---TIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             CCCccceecCC--------CceeccCCCccceecCCHHHhccCCC---ChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            99997643210        00001112234567999999977655   789999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0586|consensus

Probab=100.00  E-value=2.1e-35  Score=260.10  Aligned_cols=224  Identities=30%  Similarity=0.420  Sum_probs=187.6

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ........|.+...||+|.|++|.+|++..|+..||||.+....  ....+...+|+++|+.++||||++++.       
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~-------  122 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFS-------  122 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeee-------
Confidence            33445678999999999999999999999999999999886443  233456789999999999999999998       


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                        +.+.+..+|+||||+.+|.+.+.+..    ...+.+..+..++.|+..+++|+|++   +|+|||||.+|++++.+..
T Consensus       123 --v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mn  193 (596)
T KOG0586|consen  123 --VIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMN  193 (596)
T ss_pred             --eeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccc
Confidence              67778999999999999999998874    34467788999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +||+|||++....          .........|++.|.|||++.+..|+  ++++|+||+|+++|.|+.|..||.+.+- 
T Consensus       194 ikIaDfgfS~~~~----------~~~~lqt~cgsppyAaPEl~~g~~y~--gpe~D~Wslgvvly~LV~GsLPFDG~~l-  260 (596)
T KOG0586|consen  194 IKIADFGFSTFFD----------YGLMLQTFCGSPPYAAPELFNGKKYD--GPEVDIWSLGVVLYALVEGSLPFDGQNL-  260 (596)
T ss_pred             eeeeccccceeec----------ccccccccCCCCCccChHhhcCcccC--CcceehhhhhhhheeeeecccccCCccc-
Confidence            9999999865331          22234466789999999999999984  8999999999999999999999986332 


Q ss_pred             ccceeeeeeeccccCC
Q psy16951        258 GDSVALAVISGNITFP  273 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p  273 (282)
                       ....-+.+.+++.+|
T Consensus       261 -k~Lr~rvl~gk~rIp  275 (596)
T KOG0586|consen  261 -KELRPRVLRGKYRIP  275 (596)
T ss_pred             -ccccchheeeeeccc
Confidence             334445566665555

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-34  Score=248.20  Aligned_cols=219  Identities=24%  Similarity=0.352  Sum_probs=176.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||++.+..++..||+|.+....   ......+.+|+++++.++||||+++++.+.         
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ---------   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE---------
Confidence            47999999999999999999999999999999885432   223456788999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+++++|.+.+...    ..++...+..++.|++.||.|||++   |++|+||+|+||+++.++.++++|
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  144 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITD  144 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEee
Confidence            457899999999999999887642    4588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++.....            ......+++.|++||.+.+...   +.++|+||+|+++|+|++|+.||....  .....
T Consensus       145 fg~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~  207 (290)
T cd05580         145 FGFAKRVKG------------RTYTLCGTPEYLAPEIILSKGY---GKAVDWWALGILIYEMLAGYPPFFDDN--PIQIY  207 (290)
T ss_pred             CCCccccCC------------CCCCCCCCccccChhhhcCCCC---CccccHHHHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence            997643210            0122346788999999977654   789999999999999999999997533  22222


Q ss_pred             eeeeeccccCCCCCC
Q psy16951        263 LAVISGNITFPENTP  277 (282)
Q Consensus       263 ~~~~~~~~~~p~~~~  277 (282)
                      ..+..+.+.+|...+
T Consensus       208 ~~~~~~~~~~~~~~~  222 (290)
T cd05580         208 EKILEGKVRFPSFFS  222 (290)
T ss_pred             HHHhcCCccCCccCC
Confidence            233455566665543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=244.28  Aligned_cols=206  Identities=20%  Similarity=0.322  Sum_probs=166.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-----chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-----REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....     ......+.+|++.++.++|+||+++.+.+...     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP-----   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC-----
Confidence            57999999999999999999999999999999875321     23345678899999999999999999854331     


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....+++++|++++++|.+.+..    ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+++
T Consensus        77 --~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          77 --EEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             --CCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence              23568899999999999987753    23478889999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+......    ..  .........++..|+|||.+.+...   +.++|+||||+++|++++|+.||...
T Consensus       148 ~dfg~~~~~~~~----~~--~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         148 GDFGASKRIQTI----CM--SGTGIKSVTGTPYWMSPEVISGEGY---GRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             Cccccccccccc----cc--cCccccccCCcccccCHhhhcCCCC---CccccHHHHHHHHHHHHhCCCCCCcc
Confidence            999976532110    00  0001122346788999999987654   78999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-35  Score=248.48  Aligned_cols=212  Identities=18%  Similarity=0.298  Sum_probs=165.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      |.+..++|++.+.||+|+||.||+|.+.+     ++..||+|.+.... ......+.+|+.+++.++||||+++++.+  
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--   78 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--   78 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--
Confidence            45678899999999999999999998753     35679999875433 23445678899999999999999998843  


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                             ......++++||+++++|.+.+......      ...++...+..++.|++.|+.|||++   +++|+||||+
T Consensus        79 -------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~  148 (277)
T cd05062          79 -------SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAAR  148 (277)
T ss_pred             -------cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchh
Confidence                   3446799999999999999887542111      12346678889999999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||++......       ..........++..|+|||++.+..+   +.++||||||+++|||++ |
T Consensus       149 Nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~~  218 (277)
T cd05062         149 NCMVAEDFTVKIGDFGMTRDIYET-------DYYRKGGKGLLPVRWMSPESLKDGVF---TTYSDVWSFGVVLWEIATLA  218 (277)
T ss_pred             eEEEcCCCCEEECCCCCccccCCc-------ceeecCCCCccCHhhcChhHhhcCCc---CchhHHHHHHHHHHHHHcCC
Confidence            999999999999999975421100       00001111234667999999987665   889999999999999999 7


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||.+.
T Consensus       219 ~~p~~~~  225 (277)
T cd05062         219 EQPYQGM  225 (277)
T ss_pred             CCCCCCC
Confidence            8999753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.3e-35  Score=248.94  Aligned_cols=211  Identities=25%  Similarity=0.356  Sum_probs=172.4

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +..+.+.|+++++||+|+||.||+|++..++..||+|.+..........+.+|+..++.++||||+++.+.+.       
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------   79 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-------   79 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-------
Confidence            3456688999999999999999999999999999999987776666777889999999999999999998544       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....+++|||+++++|...+...   ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+++
T Consensus        80 --~~~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl  151 (292)
T cd06644          80 --WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKL  151 (292)
T ss_pred             --eCCeEEEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEE
Confidence              346799999999999998766432   23478999999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +|||.+...         ...........++..|+|||++.+...  .+++.++|+||||+++|||++|..||.+..
T Consensus       152 ~dfg~~~~~---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  219 (292)
T cd06644         152 ADFGVSAKN---------VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  219 (292)
T ss_pred             ccCccceec---------cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence            999965321         001111123346778999999864321  124678999999999999999999997643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=260.13  Aligned_cols=193  Identities=25%  Similarity=0.348  Sum_probs=154.1

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhC---CCCCcccccccccccCCCCCCCCCceE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTF---VHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      ||+|+||+||+|++..++..||+|.+.....   ........|..++...   .||||++++..         +.....+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~---------~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS---------FQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE---------EecCCeE
Confidence            7999999999999999999999998853321   1222344566666554   69999999874         3445789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++||||+++++|...+..    ...+++..+..++.||+.||.|||++   |++||||||+||+++.++.++++|||++.
T Consensus        72 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          72 YLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             EEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            999999999999887753    34588999999999999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ....         .........||..|+|||++.+...  ++.++||||+||++|+|++|+.||.+
T Consensus       145 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         145 ANLT---------DNKTTNTFCGTTEYLAPEVLLDEKG--YTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             CCCC---------CCCCccCccCCccccCHHHHcCCCC--CCCccceeccccEEEEeccCCCCCCC
Confidence            2100         0011123457889999999975432  37899999999999999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-35  Score=249.08  Aligned_cols=206  Identities=21%  Similarity=0.314  Sum_probs=169.9

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+..........+.+|+..++.++||||+++++.+.         .
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~---------~   77 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL---------R   77 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE---------e
Confidence            4568888999999999999999999999999999987665555667788999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+..    ...+++.+++.++.|++.|+.|+|+.   |++|+||||+||+++.++.++++||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          78 RDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            4689999999999999997753    34588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....         ..........++..|+|||++.......++.++|+||+|+++|+|++|..||...
T Consensus       151 g~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         151 GVSAQIT---------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             eeeeEcc---------CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence            9754221         0111122345788899999985222122378999999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=241.34  Aligned_cols=207  Identities=23%  Similarity=0.364  Sum_probs=171.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.++|++.+.||+|+||.||+|.+..++..+|+|.+..........+.+|+++++.++||||+++++.+.         +
T Consensus         1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~---------~   71 (262)
T cd06613           1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL---------R   71 (262)
T ss_pred             CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE---------e
Confidence            3578999999999999999999999899999999987666556677889999999999999999998543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++++|++.+++|.+.+...   ...+++.++..++.|++.|+.|||++   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          72 RDKLWIVMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence            57899999999999999877532   24588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....         ..........++..|++||.+.+.....++.++|+||+|+++|+|++|+.||.+.
T Consensus       146 g~~~~~~---------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~  207 (262)
T cd06613         146 GVSAQLT---------ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL  207 (262)
T ss_pred             ccchhhh---------hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9754211         0111112335677899999987651112378999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.3e-35  Score=245.33  Aligned_cols=206  Identities=21%  Similarity=0.332  Sum_probs=165.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-----hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-----EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+.....     .....+.+|+.+++.++||||+++++.+..      
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD------   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc------
Confidence            368899999999999999999999999999998854321     223457789999999999999999875432      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       .....+++++|++++++|.+.+..    ...++...++.++.|++.||.|||++   +++|+||+|+||+++.++.+++
T Consensus        76 -~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          76 -RAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             -CCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence             123578999999999999988753    23478889999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++......      ...........++..|+|||++.+..+   +.++|+||+|+++||+++|+.||...
T Consensus       148 ~dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         148 GDFGASKRLQTI------CMSGTGIRSVTGTPYWMSPEVISGEGY---GRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             ccCCCccccccc------cccCCccccCCccccccCHHHhCCCCC---CchhhhHHHHHHHHHHHHCCCCcccc
Confidence            999976432110      000011112346778999999987655   78999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.4e-35  Score=247.40  Aligned_cols=194  Identities=21%  Similarity=0.261  Sum_probs=163.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++++.||+|+||.||+|.+..++..||+|.+.... ......+.+|++++++++||||+++++.+..         .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV---------E   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE---------C
Confidence            47889999999999999999999999999999886543 3345578899999999999999999985543         4


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|....        .+++..+..++.|++.||.|+|+.   |++|+||||+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg  140 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFG  140 (279)
T ss_pred             CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCC
Confidence            6788999999999986432        367888899999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++....           ........++..|+|||++.+..+   +.++|+||+|+++|+|++|+.||..
T Consensus       141 ~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         141 VSTQLV-----------NSIAKTYVGTNAYMAPERISGEQY---GIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             cceecc-----------cccccCCCCChhhcCceeecCCCC---CCcchHHHHHHHHHHHHhCCCCchh
Confidence            764221           001123356888999999987765   8899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.1e-35  Score=248.57  Aligned_cols=210  Identities=21%  Similarity=0.333  Sum_probs=169.5

Q ss_pred             EecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      |++++|.+.+.||+|+||.||++..     ..++..+|+|.+..........+.+|++++++++||||+++++.+.    
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   77 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----   77 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            5788999999999999999999985     3456779999887666566677899999999999999999998544    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRS---------VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                           .....++++||+++++|.+++....         .....+++.+++.++.|++.||.|+|++   |++||||||+
T Consensus        78 -----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~  149 (288)
T cd05093          78 -----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATR  149 (288)
T ss_pred             -----cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcc
Confidence                 3467999999999999998876432         1123478999999999999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++|+||||+++|+|++ |
T Consensus       150 Nili~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~il~~l~t~g  219 (288)
T cd05093         150 NCLVGENLLVKIGDFGMSRDVYST-------DYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEIFTYG  219 (288)
T ss_pred             eEEEccCCcEEeccCCccccccCC-------ceeecCCCCCccccccCHHHhccCCC---CchhhHHHHHHHHHHHHhCC
Confidence            999999999999999976532100       00001112234667999999987655   789999999999999998 8


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||...
T Consensus       220 ~~p~~~~  226 (288)
T cd05093         220 KQPWYQL  226 (288)
T ss_pred             CCCCCCC
Confidence            9999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-34  Score=248.02  Aligned_cols=202  Identities=25%  Similarity=0.365  Sum_probs=170.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...+|++.+.||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.+.|+|++++.+.+..         
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~---------   88 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV---------   88 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe---------
Confidence            35799999999999999999999999999999999877666666778899999999999999999985543         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+++++|.+++..     ..++..++..++.|++.||.|||++   |++|+||+|+||+++.++.++++||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          89 GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             CCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence            4689999999999999987742     3478889999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........++..|+|||.+.+..+   +.++|+||||+++|++++|+.||...
T Consensus       161 g~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         161 GFCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             ccchhccc---------cccccCcccCCccccCHHHHcCCCC---CccchHHHHHHHHHHHHhCCCCCCCC
Confidence            97542110         0001112346788999999987654   78999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.1e-35  Score=248.63  Aligned_cols=210  Identities=20%  Similarity=0.308  Sum_probs=166.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEe----cCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEH----SQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++.+.||+|+||+||+|.+    ..++..||+|.+..... .....+.+|+++++.++||||+++++.+..   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---   78 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ---   78 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec---
Confidence            4567899999999999999999985    34567899998864333 334577889999999999999999985443   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                            ....+++|||+++++|.+++.....             ....+++.+++.++.|++.||.|||++   +++|+|
T Consensus        79 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~d  149 (283)
T cd05090          79 ------EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKD  149 (283)
T ss_pred             ------CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhc
Confidence                  4678999999999999998753211             123467888999999999999999999   899999


Q ss_pred             CCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        165 LKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       165 lk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |||+||+++.++.++++|||++......       ..........++..|+|||++.+..+   +.++|+||||+++|||
T Consensus       150 lkp~nili~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el  219 (283)
T cd05090         150 LAARNILIGEQLHVKISDLGLSREIYSA-------DYYRVQPKSLLPIRWMPPEAIMYGKF---SSDSDIWSFGVVLWEI  219 (283)
T ss_pred             cccceEEEcCCCcEEeccccccccccCC-------cceecccCCCccceecChHHhccCCC---CchhhhHHHHHHHHHH
Confidence            9999999999999999999976432110       00011122234567999999987665   8899999999999999


Q ss_pred             Hh-CCCCCCcc
Q psy16951        245 CY-FKSPFDTV  254 (282)
Q Consensus       245 ~t-g~~pf~~~  254 (282)
                      ++ |..||.+.
T Consensus       220 ~~~g~~p~~~~  230 (283)
T cd05090         220 FSFGLQPYYGF  230 (283)
T ss_pred             HcCCCCCCCCC
Confidence            98 99999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.3e-34  Score=238.90  Aligned_cols=202  Identities=27%  Similarity=0.446  Sum_probs=168.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|.+.+.||+|++|.||+|.+..++..|++|.+...  .......+.+|++.++.++|||++++++.+.         ..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL---------DK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec---------cC
Confidence            588899999999999999999999999999988643  3445667888999999999999999998544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|.+++...  ....++...+..++.|++.||.|+|++   |++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence            6899999999999999988643  234688899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.....         .........++..|+|||++.+..+   +.++|+||||+++|+|++|+.||...
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  204 (256)
T cd08529         147 VAKLLSD---------NTNFANTIVGTPYYLSPELCEDKPY---NEKSDVWALGVVLYECCTGKHPFDAN  204 (256)
T ss_pred             cceeccC---------ccchhhccccCccccCHHHhcCCCC---CCccchHHHHHHHHHHHhCCCCCCCC
Confidence            7542210         0011122346778999999987665   78999999999999999999999754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=249.25  Aligned_cols=212  Identities=24%  Similarity=0.295  Sum_probs=170.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+......   ....+.+|++.++.++|+||+++++.+         .
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~---------~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF---------Q   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee---------e
Confidence            4799999999999999999999999999999988654332   345678899999999999999998843         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+.+++|.+++...  ....+++..+..++.|++.||.|||+.   |++|+||||+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEee
Confidence            457899999999999999987632  234588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchh--------------------hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHH
Q psy16951        183 LGSVAPAVVKVCGSAE--------------------AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~  242 (282)
                      ||.+............                    ...........|+..|+|||++.+..+   +.++||||||+++|
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Di~slG~ll~  223 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLY  223 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC---CchHHHHHHHHHHH
Confidence            9976533211110000                    000011122356788999999987765   78999999999999


Q ss_pred             HHHhCCCCCCcc
Q psy16951        243 AMCYFKSPFDTV  254 (282)
Q Consensus       243 el~tg~~pf~~~  254 (282)
                      ++++|+.||.+.
T Consensus       224 ~l~~g~~pf~~~  235 (316)
T cd05574         224 EMLYGTTPFKGS  235 (316)
T ss_pred             HHhhCCCCCCCC
Confidence            999999999753

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-34  Score=248.02  Aligned_cols=199  Identities=20%  Similarity=0.278  Sum_probs=166.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+++++.++||||+++++.+.         ..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY---------SD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---------eC
Confidence            479999999999999999999999999999998765432 33456788999999999999999998554         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++++||+++++|.+++...    ..+++..+..++.|++.||.|||++.  +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCC
Confidence            7899999999999999887632    45788999999999999999999743  79999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+....           ........++..|+|||++.+..+   +.++|+||||+++|++++|..||..
T Consensus       146 ~~~~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         146 VSGQLI-----------DSMANSFVGTRSYMSPERLQGTHY---TVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             Cccccc-----------ccccccCCCCcCccChhHhcCCCC---CccchHHHHHHHHHHHHhCCCCCCC
Confidence            754210           001123356788999999877655   7899999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4e-35  Score=249.60  Aligned_cols=211  Identities=21%  Similarity=0.321  Sum_probs=167.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCC-----ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +..++|++.+.||+|+||.||+|.+...+     ..||+|.+..... .....+.+|++.++.++||||+++++.+.   
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~---   78 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT---   78 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc---
Confidence            34568999999999999999999976555     6799998864433 33456789999999999999999998544   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                            .....++++||+++++|.+++.....            ....++...++.++.|++.||.|||++   +++|+|
T Consensus        79 ------~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~d  149 (283)
T cd05048          79 ------KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRD  149 (283)
T ss_pred             ------CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence                  34668999999999999988864311            113577888999999999999999999   899999


Q ss_pred             CCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        165 LKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       165 lk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |||+||+++.++.++++|||++......       ..........++..|+|||.+.+..+   +.++||||||+++|||
T Consensus       150 lkp~Nil~~~~~~~~L~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDv~slG~il~el  219 (283)
T cd05048         150 LAARNCLVGEGLTVKISDFGLSRDIYSA-------DYYRVQSKSLLPVRWMPPEAILYGKF---TTESDIWSFGVVLWEI  219 (283)
T ss_pred             cccceEEEcCCCcEEECCCcceeecccc-------ccccccCCCcccccccCHHHhccCcC---chhhhHHHHHHHHHHH
Confidence            9999999999999999999976532100       00011112234677999999877665   8899999999999999


Q ss_pred             Hh-CCCCCCccc
Q psy16951        245 CY-FKSPFDTVY  255 (282)
Q Consensus       245 ~t-g~~pf~~~~  255 (282)
                      ++ |..||.+..
T Consensus       220 ~~~g~~p~~~~~  231 (283)
T cd05048         220 FSYGLQPYYGFS  231 (283)
T ss_pred             HcCCCCCCCCCC
Confidence            98 999997643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-34  Score=247.82  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=165.5

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.++||+|+||.||+|.+..++..||+|.+..... .....+.+|+..++.++||||+++++.+.         
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~---------   74 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH---------   74 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe---------
Confidence            46789999999999999999999999999999998864432 23446678999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+. ++|...+...   ...++...+..++.|++.||.|||++   +++|+||||+||+++.++.++++|
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          75 TEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             cCCeEEEEEeccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECc
Confidence            4567999999996 5887766532   34578889999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+......         ........++..|+|||++.+...  .+.++||||+|+++|||++|+.||...
T Consensus       148 fg~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         148 FGLARAKSIP---------TKTYSNEVVTLWYRPPDILLGSTD--YSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             CcchhccCCC---------CCcccccceeecccCcHHHhCCCC--CccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9976421100         001112345778999999876432  377999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=262.75  Aligned_cols=202  Identities=22%  Similarity=0.337  Sum_probs=157.6

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCC------Cccccccccccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP------NILPLLDHALTG   95 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~------ni~~~~~~~~~~   95 (282)
                      .+..++|++.+.||+|+||+||+|.+..++..||||++.... ........|+++++.++|.      +++.+.+++.. 
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-  202 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-  202 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-
Confidence            344688999999999999999999999999999999885332 2233445567776666554      46666654322 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                             ....+++|+|++ +++|.+++..    ...+++..+..++.||+.||.|||++.  ||+||||||+||+++.+
T Consensus       203 -------~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        203 -------ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETS  268 (467)
T ss_pred             -------CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecC
Confidence                   235789999988 7788887753    245889999999999999999999732  79999999999999876


Q ss_pred             C----------------CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        176 N----------------NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       176 ~----------------~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      +                .+|++|||.+...            ........||..|+|||++.+..+   +.++|||||||
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~------------~~~~~~~~gt~~Y~APE~~~~~~~---~~~~DiwSlGv  333 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDE------------RHSRTAIVSTRHYRSPEVVLGLGW---MYSTDMWSMGC  333 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccC------------ccccccccCCccccCcHHhhcCCC---CcHHHHHHHHH
Confidence            5                4899999964311            011223467899999999988776   88999999999


Q ss_pred             HHHHHHhCCCCCCcc
Q psy16951        240 LLYAMCYFKSPFDTV  254 (282)
Q Consensus       240 il~el~tg~~pf~~~  254 (282)
                      ++|||++|+.||.+.
T Consensus       334 il~elltG~~pf~~~  348 (467)
T PTZ00284        334 IIYELYTGKLLYDTH  348 (467)
T ss_pred             HHHHHHhCCCCCCCC
Confidence            999999999999753

>KOG0579|consensus

Probab=100.00  E-value=2.7e-36  Score=266.04  Aligned_cols=208  Identities=24%  Similarity=0.353  Sum_probs=181.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.++++..||.|+||.||+|..+.++...|.|.|...+....+.++-|++++..++||+|+++++.++.         .
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~---------e  101 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF---------E  101 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc---------c
Confidence            5667788899999999999999999999999999988888899999999999999999999999987664         3


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+|++.|||.||.++..+...   ...+.+.++..+|+|++.||.|||++   +|+|||||..|||+.-+|.++++|||
T Consensus       102 nkLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG  175 (1187)
T KOG0579|consen  102 NKLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG  175 (1187)
T ss_pred             CceEEEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence            6799999999999998876543   34589999999999999999999999   78899999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+.         ..........+..||+.|||||+..+...  -||..++||||||++|.||+.+.+|....++
T Consensus       176 VSA---------Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp  240 (1187)
T KOG0579|consen  176 VSA---------KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP  240 (1187)
T ss_pred             ccc---------cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence            753         33344455567789999999999976532  2458899999999999999999999987655

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.5e-35  Score=255.28  Aligned_cols=213  Identities=21%  Similarity=0.331  Sum_probs=167.0

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDHAL   93 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~   93 (282)
                      |..+.++|++.+.||+|+||+||+|.+.     .++..||||.+..... .....+.+|+.++..+ +||||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            6778899999999999999999999853     4568899999865433 3345678899999999 6899999998543


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh---------------------------------------------
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---------------------------------------------  128 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------  128 (282)
                      .        .....++++||+++|+|.+++.....                                             
T Consensus        82 ~--------~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (343)
T cd05103          82 K--------PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV  153 (343)
T ss_pred             c--------CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence            2        23568899999999999988764210                                             


Q ss_pred             ------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        129 ------------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       129 ------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                                        ....++..++..++.|++.||.|+|++   +++||||||+||+++.++.++++|||++....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                              012356778889999999999999998   89999999999999999999999999764221


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      .       ...........++..|+|||++.+..+   +.++||||||+++|++++ |..||...
T Consensus       231 ~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         231 K-------DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             c-------CcchhhcCCCCCCcceECcHHhcCCCC---CchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            0       000111112334667999999987665   889999999999999997 89999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4257|consensus

Probab=100.00  E-value=4e-35  Score=258.17  Aligned_cols=234  Identities=21%  Similarity=0.347  Sum_probs=185.6

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEec----CCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      +.+.+.+....+.+.||.|.||.||+|...    +...-||||..+.+ ...+.+.|..|+.+|++++||||++++|.+.
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            355666666667788999999999999853    23345899977653 3455778999999999999999999999654


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .          .-.|+|||.++.|.|.+++..   ....++......+++||..+|.|||+.   +.|||||-.+|||+.
T Consensus       462 e----------~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVs  525 (974)
T KOG4257|consen  462 E----------QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVS  525 (974)
T ss_pred             c----------cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeec
Confidence            3          469999999999999999974   456688999999999999999999999   688999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFD  252 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~  252 (282)
                      .+.-+|++|||+++...-.      . ..+ .....-+..|||||.+....+   +++||||-||+.+||+++ |..||.
T Consensus       526 Sp~CVKLaDFGLSR~~ed~------~-yYk-aS~~kLPIKWmaPESINfRrF---TtASDVWMFgVCmWEIl~lGvkPfq  594 (974)
T KOG4257|consen  526 SPQCVKLADFGLSRYLEDD------A-YYK-ASRGKLPIKWMAPESINFRRF---TTASDVWMFGVCMWEILSLGVKPFQ  594 (974)
T ss_pred             Ccceeeecccchhhhcccc------c-hhh-ccccccceeecCccccchhcc---cchhhHHHHHHHHHHHHHhcCCccc
Confidence            9999999999987643111      0 011 112223567999999988765   999999999999999976 999999


Q ss_pred             ccccCccceeeee-eeccccCCCCCCCCCC
Q psy16951        253 TVYERGDSVALAV-ISGNITFPENTPFPQY  281 (282)
Q Consensus       253 ~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~  281 (282)
                      +... .+ +-..+ .+.+++.|++||+..|
T Consensus       595 gvkN-sD-VI~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  595 GVKN-SD-VIGHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             cccc-cc-eEEEecCCCCCCCCCCCChHHH
Confidence            8543 22 33344 4457999999999766

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.1e-34  Score=241.06  Aligned_cols=204  Identities=29%  Similarity=0.460  Sum_probs=169.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|....++.+||+|.+...   .......+.+|++++++++|+|++++++.+..        
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--------   73 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--------   73 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--------
Confidence            6899999999999999999999999999999988532   23335678899999999999999999985543        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++++||+++++|...+.........++..+++.++.|++.|+.|||+.   |++|+||+|+||+++.++.++++|
T Consensus        74 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          74 -NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             -CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence             4678999999999999988765433345578999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+......         ........++..|+|||.+.+..+   +.++|+||+|+++|++++|+.||..
T Consensus       150 ~~~~~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         150 LGLGRFFSSK---------TTAAHSLVGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             cceeeeccCC---------CcccceecCCccccCHHHhccCCC---CchhcHHHHHHHHHHHHHCCCCccc
Confidence            9975422110         001122346778999999987665   7899999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-34  Score=244.72  Aligned_cols=221  Identities=20%  Similarity=0.246  Sum_probs=175.2

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCccccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTG   95 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~   95 (282)
                      ..+.+....++|++.+.||+|+||.||++.+..++..+|+|.+.... .....+.+|+.+++.+ +||||+++++.+...
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34556668899999999999999999999999999999999875432 2235567889999999 699999999866432


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                          ..+.....++++||+++++|.+.+.........+++..+..++.|++.||.|||++   +++|+||||+||+++.+
T Consensus        88 ----~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          88 ----DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             ----ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence                12345679999999999999987764433445678899999999999999999998   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +.++++|||.+.....         .........++..|+|||++.+..  ...++.++||||+|+++|||++|+.||..
T Consensus       161 ~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         161 GGVKLVDFGVSAQLTS---------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             CCEEEccCCceeeccc---------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999997543210         011112335788899999986432  11237799999999999999999999975


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       232 ~  232 (286)
T cd06638         232 L  232 (286)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.7e-35  Score=248.70  Aligned_cols=210  Identities=22%  Similarity=0.333  Sum_probs=168.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +..++|.+.+.||+|+||.||+|.+.     .++..||+|.+...... ....+.+|+++++.++|+||+++++.+..  
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   79 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--   79 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--
Confidence            35678999999999999999999874     34678999988655444 45678899999999999999999985543  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHH----------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRS----------VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK  166 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk  166 (282)
                             ....++++||+++++|.+++....          .....+++.++..++.|++.|+.|+|++   |++|+|||
T Consensus        80 -------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlk  149 (280)
T cd05049          80 -------GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLA  149 (280)
T ss_pred             -------CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceeccccc
Confidence                   467999999999999999886431          1123467888999999999999999999   89999999


Q ss_pred             CCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       167 ~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      |+||+++.++.++++|||.+.....    .   ..........++..|+|||++.+..+   +.++||||+|+++|||++
T Consensus       150 p~nili~~~~~~kl~d~g~~~~~~~----~---~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~e~~~  219 (280)
T cd05049         150 TRNCLVGYDLVVKIGDFGMSRDVYT----T---DYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVVLWEIFT  219 (280)
T ss_pred             cceEEEcCCCeEEECCcccceeccc----C---cceecCCCCcccceecChhhhccCCc---chhhhHHHHHHHHHHHHh
Confidence            9999999999999999997642110    0   00001112234677999999987765   889999999999999998


Q ss_pred             -CCCCCCcc
Q psy16951        247 -FKSPFDTV  254 (282)
Q Consensus       247 -g~~pf~~~  254 (282)
                       |+.||.+.
T Consensus       220 ~g~~p~~~~  228 (280)
T cd05049         220 YGKQPWYGL  228 (280)
T ss_pred             cCCCCCCCC
Confidence             99999753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0690|consensus

Probab=100.00  E-value=3.5e-36  Score=247.15  Aligned_cols=233  Identities=21%  Similarity=0.320  Sum_probs=188.7

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      .++...-+..++|++++.||+|.||+|-+++.+.+++.+|||+++..   ...+.+.-+.|..+++..+||.+..+.-  
T Consensus       158 ~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY--  235 (516)
T KOG0690|consen  158 EAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY--  235 (516)
T ss_pred             cccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh--
Confidence            34455556788999999999999999999999999999999987533   2233344567889999999999887754  


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                             .+.....+|+||||..+|.|.-+++.    ..-+++..+..+..+|..||.|||++   +|+.||||.+|.++
T Consensus       236 -------sFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlL  301 (516)
T KOG0690|consen  236 -------SFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLL  301 (516)
T ss_pred             -------hhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---Ceeeeechhhhhee
Confidence                   34456899999999999999987764    34589999999999999999999998   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +++|++||+|||+.+..         -..........||+.|+|||++....|   +...|.|.+|+++|||++|..||+
T Consensus       302 DkDGHIKitDFGLCKE~---------I~~g~t~kTFCGTPEYLAPEVleDnDY---graVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  302 DKDGHIKITDFGLCKEE---------IKYGDTTKTFCGTPEYLAPEVLEDNDY---GRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             ccCCceEeeecccchhc---------ccccceeccccCChhhcCchhhccccc---cceeehhhhhHHHHHHHhccCccc
Confidence            99999999999986532         111222345678999999999999888   899999999999999999999998


Q ss_pred             ccccCccceeeeeeeccccCCCCCCC
Q psy16951        253 TVYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ..  ..+.+..-+.-+.+.+|.+.++
T Consensus       370 n~--dh~kLFeLIl~ed~kFPr~ls~  393 (516)
T KOG0690|consen  370 NK--DHEKLFELILMEDLKFPRTLSP  393 (516)
T ss_pred             cc--chhHHHHHHHhhhccCCccCCH
Confidence            42  2234444566677777765543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-34  Score=241.86  Aligned_cols=203  Identities=22%  Similarity=0.427  Sum_probs=163.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|++.++.++||||+++++.+         ..
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---------~~   70 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC---------TQ   70 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE---------cc
Confidence            4578999999999999999999885 4567999987533 33456788899999999999999998844         33


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....+++|||+++++|.+.+...   ...+++..+..++.|++.||.|+|++   |++|+||+|+||+++.++.++++||
T Consensus        71 ~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          71 QKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence            46799999999999999877532   23478899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      |.+.....        ..........++..|+|||++.+..+   +.++|+||||+++||+++ |+.||...
T Consensus       145 g~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         145 GMTRYVLD--------DEYTSSSGAKFPVKWSPPEVFNFSKY---SSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             CCccccCC--------CceeccCCCCCchhhCChhhcccCcc---chhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            97542110        00011112234567999999987665   789999999999999999 89999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=252.79  Aligned_cols=205  Identities=23%  Similarity=0.352  Sum_probs=165.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...++|++++.||+|+||+||+|.+..++..||||++....  ......+.+|+++++.++||||+++++.+....   .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   88 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT---S   88 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc---c
Confidence            34588999999999999999999999999999999886432  223345678999999999999999998665321   1


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .......+++++++ +++|.+.+.     ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.+++
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence            12234578999987 788877653     23588999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||++....            .......+|..|+|||++.+...  ++.++||||+||++|+|++|+.||.+
T Consensus       160 ~Dfg~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         160 LDFGLARQAD------------DEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cCCccceecC------------CCcCCccccccccCchHhcCCcc--CCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999765321            01123457888999999976322  37899999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.8e-34  Score=245.47  Aligned_cols=202  Identities=27%  Similarity=0.385  Sum_probs=170.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||.|++|.||+|.+..++..||+|.+..........+.+|++.++.++|||++++++.+.         .
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------~   87 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL---------V   87 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe---------c
Confidence            3467999999999999999999999999999999987665556677889999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|...+..     ..+++.++..++.|++.|+.|||+.   |++|+||+|+||+++.++.++++||
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          88 GDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             CceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            4689999999999999987742     3478999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........++..|+|||.+.+..+   +.++|+||||+++|++++|+.||.+.
T Consensus       160 g~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         160 GFCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             ccchhccc---------ccccCCCcCCCccccCcchhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            97542110         0001112346778999999987654   78999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=247.26  Aligned_cols=207  Identities=24%  Similarity=0.380  Sum_probs=171.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.++|++.++||.|+||.||++.+..++..||+|.+..........+.+|+++++.++||||+++++.+.         .
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~   73 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF---------Y   73 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe---------c
Confidence            4578999999999999999999998899999999987666666678889999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|...+...   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~  147 (280)
T cd06611          74 ENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADF  147 (280)
T ss_pred             CCeEEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccC
Confidence            46799999999999999877642   24588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....         ..........++..|++||.+.....  .+++.++|+||+|+++|++++|+.||.+.
T Consensus       148 g~~~~~~---------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         148 GVSAKNK---------STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             ccchhhc---------ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            9653210         00111123346788999999864321  22467899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-34  Score=247.52  Aligned_cols=207  Identities=23%  Similarity=0.362  Sum_probs=165.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCce--EEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR--YALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||.||+|.+..++..  +|+|.+.... ......+.+|++++.++ +|+||+++++.+.    
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~----   78 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----   78 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC----
Confidence            35678999999999999999999998877754  5777665332 23445678899999999 8999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                           ....+++++||+++++|.+++.....            ....++..+++.++.|++.|+.|||++   |++||||
T Consensus        79 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl  150 (303)
T cd05088          79 -----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  150 (303)
T ss_pred             -----CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Ccccccc
Confidence                 44679999999999999998864321            123578889999999999999999998   8999999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+||+++.++.++++|||++....        .  .........+..|+|||++.+..+   +.++||||||+++||++
T Consensus       151 kp~Nili~~~~~~kl~dfg~~~~~~--------~--~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~ell  217 (303)
T cd05088         151 AARNILVGENYVAKIADFGLSRGQE--------V--YVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV  217 (303)
T ss_pred             chheEEecCCCcEEeCccccCcccc--------h--hhhcccCCCcccccCHHHHhccCC---cccccchhhhhHHHHHH
Confidence            9999999999999999999753110        0  001111223567999999876655   78999999999999999


Q ss_pred             h-CCCCCCc
Q psy16951        246 Y-FKSPFDT  253 (282)
Q Consensus       246 t-g~~pf~~  253 (282)
                      | |..||..
T Consensus       218 t~g~~p~~~  226 (303)
T cd05088         218 SLGGTPYCG  226 (303)
T ss_pred             hcCCCCccc
Confidence            8 9999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-34  Score=257.14  Aligned_cols=218  Identities=21%  Similarity=0.333  Sum_probs=171.6

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCch-hHHHHHHHHHHhhhCC-CCCccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGRE-DQAQAIREVEHHKTFV-HPNILP   87 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~-H~ni~~   87 (282)
                      +.....|.+..++|.+.+.||+|+||.||+|++.     .++.+||+|++...... ....+.+|+.++..+. ||||++
T Consensus        26 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~  105 (401)
T cd05107          26 LPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVN  105 (401)
T ss_pred             CCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence            4455679999999999999999999999999964     34578999998654332 2346788999999997 999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh---------------------------------------
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---------------------------------------  128 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------------------------  128 (282)
                      +++.+..         ....++|+||+++|+|.+++.....                                       
T Consensus       106 ~~~~~~~---------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (401)
T cd05107         106 LLGACTK---------GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDG  176 (401)
T ss_pred             EEEEEcc---------CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCc
Confidence            9985543         4679999999999999998864210                                       


Q ss_pred             -------------------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16951        129 -------------------------------------------------------GKHYMSSVDILKMFLKICEAVKVFH  153 (282)
Q Consensus       129 -------------------------------------------------------~~~~l~~~~~~~~~~qi~~~l~~lH  153 (282)
                                                                             ....++..++..++.|++.||.|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  256 (401)
T cd05107         177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA  256 (401)
T ss_pred             cccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence                                                                   1123566778889999999999999


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ++   +++||||||+||+++.++.++++|||++......       ..........++..|+|||.+.+..+   +.++|
T Consensus       257 ~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~D  323 (401)
T cd05107         257 SK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRD-------SNYISKGSTFLPLKWMAPESIFNNLY---TTLSD  323 (401)
T ss_pred             cC---CcCcccCCcceEEEeCCCEEEEEecCcceecccc-------cccccCCCcCCCCceeChHHhcCCCC---CcHhH
Confidence            98   8999999999999999999999999976532100       00011112345678999999987665   78999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCcc
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~~  254 (282)
                      |||||+++||+++ |..||...
T Consensus       324 vwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         324 VWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999999998 88999653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0986|consensus

Probab=100.00  E-value=2.9e-36  Score=256.78  Aligned_cols=231  Identities=24%  Similarity=0.337  Sum_probs=188.3

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ...+..+.|+.-++||+|+||+|+-++-+.||+.+|.|++...   .........+|-+++++++.+.||.+--      
T Consensus       179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY------  252 (591)
T KOG0986|consen  179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY------  252 (591)
T ss_pred             hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee------
Confidence            3567788999999999999999999999999999999987422   2223345678999999999999987743      


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                         .+++...+++|+..+.||+|.-++..-  +..-+++..+..++.+|+.||++||+.   +||.|||||+|||+|..|
T Consensus       253 ---AfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~G  324 (591)
T KOG0986|consen  253 ---AFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHG  324 (591)
T ss_pred             ---eecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCC
Confidence               567788999999999999998766532  345689999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      +++|+|+|++..          ........+.+||..|||||++.++.|   +...|.||+||++|||+.|+.||.+..+
T Consensus       325 hvRISDLGLAve----------i~~g~~~~~rvGT~GYMAPEvl~ne~Y---~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  325 HVRISDLGLAVE----------IPEGKPIRGRVGTVGYMAPEVLQNEVY---DFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             CeEeeccceEEe----------cCCCCccccccCcccccCHHHHcCCcc---cCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            999999998653          223445566789999999999999887   8899999999999999999999987544


Q ss_pred             Ccc--ceeeeeeeccccCCCCCC
Q psy16951        257 RGD--SVALAVISGNITFPENTP  277 (282)
Q Consensus       257 ~~~--~~~~~~~~~~~~~p~~~~  277 (282)
                      ...  .+..++......+|+..+
T Consensus       392 Kvk~eEvdrr~~~~~~ey~~kFS  414 (591)
T KOG0986|consen  392 KVKREEVDRRTLEDPEEYSDKFS  414 (591)
T ss_pred             hhhHHHHHHHHhcchhhcccccC
Confidence            333  233344454555554443

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-34  Score=248.78  Aligned_cols=202  Identities=23%  Similarity=0.373  Sum_probs=155.1

Q ss_pred             EEEeccCCceEEEEEEec--CCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         31 VEKIGEGGFSTVSLIEHS--QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      .++||+|+||+||+|++.  .++..||+|.+....  ......+|+.+++.++||||+++++.+...       .....+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH-------ADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC-------CCcEEE
Confidence            468999999999999965  467889999885433  234567899999999999999998865432       245689


Q ss_pred             EEeccCCCCChHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----ecCCCce
Q psy16951        109 MVLPYYPKGTLANDLELRSV-----GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----ANDNNPL  179 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~~~~  179 (282)
                      +++|++. ++|.+.+.....     ....+++..+..++.|++.||.|||++   |++||||||+||++    +..+.+|
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEE
Confidence            9999984 577776643211     122478889999999999999999999   89999999999999    4557899


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||++......      ...........+|+.|+|||++.+...  ++.++||||+||++|||++|++||..
T Consensus       153 l~DfG~a~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         153 IADMGFARLFNSP------LKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             EeecCceeccCCC------CccccccCCccccccccCCHHHcCCCC--cCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9999986532100      001111223457889999999987432  37899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.1e-34  Score=242.81  Aligned_cols=206  Identities=21%  Similarity=0.328  Sum_probs=165.2

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.++.++|++.++||+|+||.||+|.+..+ ..||+|.+.... .....+.+|+++++.++||||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-------   71 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------   71 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-------
Confidence            457788999999999999999999998655 469999876432 23456788999999999999999987421       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++++||+++++|.+++...  ....++...+..++.|++.||.|+|++   +++|+||+|+||+++.++.+++
T Consensus        72 ---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L  143 (262)
T cd05071          72 ---EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  143 (262)
T ss_pred             ---CCCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEe
Confidence               24578999999999999888632  234578889999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||+..+..+   +.++|+||+|+++||++| |..||.+.
T Consensus       144 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         144 ADFGLARLIED--------NEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             ccCCceeeccc--------cccccccCCcccceecCHhHhccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99997642210        00011112335667999999877665   889999999999999999 88899753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-34  Score=241.49  Aligned_cols=206  Identities=20%  Similarity=0.347  Sum_probs=167.2

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.|..++|++.++||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++.++|+||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------   71 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-------   71 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-------
Confidence            5788999999999999999999999864 57789999876433 33457888999999999999999987432       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++++|++.+++|.+.+...  ....++..++..++.|++.||.|||+.   |++|+||+|+||+++.++.+++
T Consensus        72 ---~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05067          72 ---QEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI  143 (260)
T ss_pred             ---cCCcEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEE
Confidence               24589999999999999877532  234578899999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||++.+..+   +.++|+||||+++||+++ |+.||.+.
T Consensus       144 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~~pe~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         144 ADFGLARLIED--------NEYTAREGAKFPIKWTAPEAINYGTF---TIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             ccCcceeecCC--------CCcccccCCcccccccCHHHhccCCc---CcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99997643210        00011112234567999999977665   789999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.4e-34  Score=243.79  Aligned_cols=206  Identities=21%  Similarity=0.326  Sum_probs=162.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHH-hhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEH-HKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~-l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++.+.||+|+||.||++.+..++..||||++..... .....+..|+.. ++.++||||+++++.+..         
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~---------   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR---------   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec---------
Confidence            579999999999999999999999999999998865432 333455556664 566789999999985543         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||++ ++|.+.+.........+++..+..++.|++.|+.|+|++.  +++|+||||+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeec
Confidence            467999999995 7888877654334456899999999999999999999853  6889999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc-cCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~-~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |.+....          .........++..|+|||++.+... ..++.++|+||+|+++|+|++|+.||..
T Consensus       149 g~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         149 GISGYLV----------DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ccccccc----------cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            9754210          0001112346778999999865221 2347899999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.4e-35  Score=247.85  Aligned_cols=210  Identities=21%  Similarity=0.305  Sum_probs=168.9

Q ss_pred             EecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +++.+|.+.++||+|+||.||++..     ..++..+|+|.+..........+.+|++.++.++|+||+++++.+..   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE---   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec---
Confidence            4678899999999999999999974     34567899998877766777788999999999999999999885443   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK  166 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk  166 (282)
                            ....++++||+++++|.+++.....           ....+++..++.++.|++.|+.|||++   |++|+|||
T Consensus        79 ------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlk  149 (280)
T cd05092          79 ------GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLA  149 (280)
T ss_pred             ------CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccccc
Confidence                  4668999999999999988764211           113478889999999999999999998   89999999


Q ss_pred             CCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       167 ~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      |+||+++.++.++++|||++......     .  .........+++.|+|||++.+..+   +.++||||||+++|||++
T Consensus       150 p~nil~~~~~~~kL~dfg~~~~~~~~-----~--~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~  219 (280)
T cd05092         150 TRNCLVGQGLVVKIGDFGMSRDIYST-----D--YYRVGGRTMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEIFT  219 (280)
T ss_pred             HhhEEEcCCCCEEECCCCceeEcCCC-----c--eeecCCCccccccccCHHHhccCCc---CchhhHHHHHHHHHHHHc
Confidence            99999999999999999976422100     0  0000112234677999999987765   889999999999999998


Q ss_pred             -CCCCCCcc
Q psy16951        247 -FKSPFDTV  254 (282)
Q Consensus       247 -g~~pf~~~  254 (282)
                       |.+||...
T Consensus       220 ~g~~p~~~~  228 (280)
T cd05092         220 YGKQPWYQL  228 (280)
T ss_pred             CCCCCCccC
Confidence             89999653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.1e-34  Score=243.79  Aligned_cols=206  Identities=22%  Similarity=0.322  Sum_probs=165.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++.+.||+|+||+||+|.+..++.    +||+|.+..... .....+.+|+.+++.++|+||+++++.+..   
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence            567899999999999999999999877765    489998865433 345577889999999999999999886543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++|+|.+.+..   ....+++..++.++.|++.||.|+|++   +++||||||+||++..++.
T Consensus        81 -------~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~  147 (279)
T cd05109          81 -------STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNH  147 (279)
T ss_pred             -------CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCc
Confidence                   346789999999999987753   234588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||++......       ..........++..|+|||.+.+..+   +.++||||||+++||+++ |..||...
T Consensus       148 ~kL~dfG~~~~~~~~-------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         148 VKITDFGLARLLDID-------ETEYHADGGKVPIKWMALESILHRRF---THQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             EEECCCCceeecccc-------cceeecCCCccchhhCCHHHhccCCC---CchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999976532110       00000111223567999999987665   789999999999999998 89999753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=241.53  Aligned_cols=207  Identities=19%  Similarity=0.299  Sum_probs=167.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|++.+.||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+..+++++||||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------   71 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-------   71 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-------
Confidence            4577889999999999999999999975 45679999886443 33566888999999999999999988443       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++++|++++++|.+++....  ...++...+..++.|++.|+.+||++   |++|+||||+||+++.++.+++
T Consensus        72 --~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l  144 (261)
T cd05068          72 --LEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKV  144 (261)
T ss_pred             --cCCCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEE
Confidence              3467899999999999999876432  34578999999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ...........+..|+|||++.+..+   +.++|+||||+++||+++ |+.||.+.
T Consensus       145 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         145 ADFGLARVIKE--------DIYEAREGAKFPIKWTAPEAALYNRF---SIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             CCcceEEEccC--------CcccccCCCcCceeccCccccccCCC---CchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99997653210        00000111122457999999987665   889999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-34  Score=245.39  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=170.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||++.+..++..||+|.+........+.+.+|+.+++.++|+||+++++.+..         .
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---------~   88 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV---------G   88 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec---------C
Confidence            4789999999999999999999999999999999977666666778899999999999999999985543         4


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+||+++++|.+++..     ..+++.++..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            679999999999999987742     3478889999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.....         .........+++.|++||.+.+..+   +.++|+||+|+++|++++|..||.+.
T Consensus       161 ~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         161 FCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             cceEccC---------CccCcCcccCCccccCHHHHcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7542110         0001122346778999999987655   78999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.2e-34  Score=240.43  Aligned_cols=201  Identities=26%  Similarity=0.546  Sum_probs=166.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +|++.+.||+|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++.+.         ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE---------ADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE---------ECC
Confidence            589999999999999999999999999999988543 2334556778999999999999999988543         457


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      .+++++||+++++|.+.+...  ....+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCc
Confidence            899999999999998877532  234478899999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +....         ..........++..|+|||++.+..+   +.++|+||+|+++|+|++|..||..
T Consensus       147 ~~~~~---------~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         147 ARLLT---------SPGAYACTYVGTPYYVPPEIWENMPY---NNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             ceeec---------ccccccccccCCccccCHHHHccCCc---CchhhhhhhchhheehhhccCCCCC
Confidence            54221         00111123356778999999987665   7899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0984|consensus

Probab=100.00  E-value=5.1e-35  Score=226.30  Aligned_cols=235  Identities=19%  Similarity=0.276  Sum_probs=182.2

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhh-hCCCCCcccccccccccC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHK-TFVHPNILPLLDHALTGC   96 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~-~l~H~ni~~~~~~~~~~~   96 (282)
                      +.+.++.++..-++.||+|++|.|-+.+|..+|...|+|++... +.+..++.++|+.+.. ....|.++++++..+   
T Consensus        39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~---  115 (282)
T KOG0984|consen   39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF---  115 (282)
T ss_pred             CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh---
Confidence            33666677777778999999999999999999999999999654 3445566778888654 557999999999544   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            +....|+.||.+ ..||+.+.......+..+++..+-.++..+..||.|||++-  .++|||+||+|||++.+|
T Consensus       116 ------regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G  186 (282)
T KOG0984|consen  116 ------REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG  186 (282)
T ss_pred             ------ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence                  457899999998 77888877766667778999999999999999999999985  799999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc-cCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~-~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      ++|++|||.+...          ...-....-.|...|||||.+..+-- ..++-+|||||+|+++.||++++.||..- 
T Consensus       187 qVKiCDFGIsG~L----------~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w-  255 (282)
T KOG0984|consen  187 QVKICDFGISGYL----------VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW-  255 (282)
T ss_pred             cEEEcccccceee----------hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc-
Confidence            9999999975321          11111222356778999999964321 12478999999999999999999999753 


Q ss_pred             cCccce-eeeeeeccccCCCCC
Q psy16951        256 ERGDSV-ALAVISGNITFPENT  276 (282)
Q Consensus       256 ~~~~~~-~~~~~~~~~~~p~~~  276 (282)
                      ..+.++ ...+....|.+|.++
T Consensus       256 ~tpF~qLkqvVeep~P~Lp~~~  277 (282)
T KOG0984|consen  256 GTPFQQLKQVVEEPSPQLPADT  277 (282)
T ss_pred             CCHHHHHHHHhcCCCCCCcccc
Confidence            333333 333455556677554

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.9e-34  Score=245.16  Aligned_cols=212  Identities=18%  Similarity=0.321  Sum_probs=165.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      |.+..++|++.+.||+|+||.||+|..+     ..+..||+|.+..... .....+.+|+.+++.++||||+++++.+. 
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence            5678899999999999999999999754     2356899998764432 33446778999999999999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                              .....+++|||+++++|.+++......      ........+..++.|++.||.|+|++   +++|+||||+
T Consensus        80 --------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~  148 (288)
T cd05061          80 --------KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAAR  148 (288)
T ss_pred             --------CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChh
Confidence                    345789999999999999988643211      12345567888999999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||++.....       ...........++..|+|||.+.+..+   +.++|+||||+++||+++ |
T Consensus       149 nili~~~~~~~L~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~~pE~~~~~~~---~~~~DvwslG~~l~el~~~~  218 (288)
T cd05061         149 NCMVAHDFTVKIGDFGMTRDIYE-------TDYYRKGGKGLLPVRWMAPESLKDGVF---TTSSDMWSFGVVLWEITSLA  218 (288)
T ss_pred             eEEEcCCCcEEECcCCccccccc-------cccccccCCCcccccccCHHHhccCCC---ChHhHHHHHHHHHHHHHhCC
Confidence            99999999999999997542110       000011112234567999999987665   889999999999999998 7


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||.+.
T Consensus       219 ~~p~~~~  225 (288)
T cd05061         219 EQPYQGL  225 (288)
T ss_pred             CCCCCCC
Confidence            8899753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-34  Score=255.44  Aligned_cols=202  Identities=23%  Similarity=0.343  Sum_probs=162.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec--CCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS--QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ..+...+|++++.||+|+||.||++...  .++..||+|.+...     ....+|+++++.++||||+++++.+.     
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----  156 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----  156 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----
Confidence            3344668999999999999999999754  45678999987532     23457999999999999999987443     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....+++||++. ++|.+++.    ....+++..++.++.|++.||.|||++   ||+||||||+||+++.++.+
T Consensus       157 ----~~~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~  224 (392)
T PHA03207        157 ----WKSTVCMVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENA  224 (392)
T ss_pred             ----eCCEEEEEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCE
Confidence                3467999999984 67777663    234689999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||++......       ..........||..|+|||++.+..+   +.++||||+||++|||++|..||.+.
T Consensus       225 ~l~DfG~a~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        225 VLGDFGAACKLDAH-------PDTPQCYGWSGTLETNSPELLALDPY---CAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             EEccCccccccCcc-------cccccccccccccCccCHhHhcCCCC---CchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            99999976432110       01111223467899999999987766   78999999999999999999999753

>KOG0607|consensus

Probab=100.00  E-value=5.5e-35  Score=239.48  Aligned_cols=204  Identities=26%  Similarity=0.397  Sum_probs=169.4

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      +.||+|+|+.|-.+....|+++||||++.......+....+|++.+.+.+ |+||+.+++         +++++..+|||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLie---------fFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIE---------FFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHH---------HhcccceEEEE
Confidence            56999999999999999999999999998888888899999999998885 999999998         67778999999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---ceeecccCcc
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---PLLMDLGSVA  187 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~~~~df~~~~  187 (282)
                      ||.+.+|+|..++..+    .++++..+..++.+|+.||.|||.+   ||+||||||+|||-...+.   +||+||.+..
T Consensus       155 fEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccc
Confidence            9999999999988754    5689999999999999999999999   9999999999999876654   5899998765


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccc---cCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH---VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~---~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....+..  ...-.........|+..|||||+..   +... -+..++|.||+|+|+|=|++|++||.+.
T Consensus       228 g~k~~~~--~spastP~L~tPvGSAEfMAPEVVd~fv~qA~-~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  228 GIKLNND--CSPASTPELLTPVGSAEFMAPEVVDVFVDQAT-FYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             ccccCCC--CCCCCCccccCcccchhhcchhHHhhhccccc-cccccccHHHHHHHHHHHHhCCCCccCc
Confidence            3222221  1111122344567888999999984   2211 2478999999999999999999999763

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.3e-34  Score=240.74  Aligned_cols=200  Identities=22%  Similarity=0.342  Sum_probs=167.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +|++.+.||.|+||.||+|.+..++..||+|.+....   ......+.+|++.+++++||||+++++.         +..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~---------~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS---------FQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh---------hcC
Confidence            5899999999999999999999899999999886432   2345577889999999999999999874         445


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+.+++|...+...    ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence            57899999999999999887632    3588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |.+.....          ........++..|+|||.+....+   +.++|+||+|+++|++++|..||....
T Consensus       145 ~~~~~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         145 NIATKVTP----------DTLTTSTSGTPGYMAPEVLCRQGY---SVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ccccccCC----------CccccccCCChhhcCHHHHcccCC---CCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            97542210          001123346778999999987664   889999999999999999999998543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.2e-34  Score=245.33  Aligned_cols=215  Identities=23%  Similarity=0.373  Sum_probs=171.0

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCC-----ceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLLD   90 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~~   90 (282)
                      +..+.+..++|++.+.||+|+||.||++.+....     ..+|+|.+.... ......+.+|+++++.+ +|+||+++++
T Consensus         4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            5678889999999999999999999999986443     779999886432 23445678899999999 7999999998


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS------------VGKHYMSSVDILKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~  158 (282)
                      .+.         ....+++++||+++++|.+++....            .....+++..++.++.|++.||.|||+.   
T Consensus        84 ~~~---------~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---  151 (293)
T cd05053          84 VCT---------QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---  151 (293)
T ss_pred             EEc---------CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---
Confidence            543         3467999999999999999886431            1234578889999999999999999998   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHH
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG  238 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G  238 (282)
                      +++|+||||+||+++.++.++++|||.+.....       ...........++..|+|||++.+..+   +.++||||||
T Consensus       152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG  221 (293)
T cd05053         152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH-------IDYYRKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFG  221 (293)
T ss_pred             CccccccceeeEEEcCCCeEEeCcccccccccc-------ccceeccCCCCCCccccCHHHhccCCc---Ccccceeehh
Confidence            899999999999999999999999997653210       000001111234567999999877665   7899999999


Q ss_pred             HHHHHHHh-CCCCCCcc
Q psy16951        239 CLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       239 ~il~el~t-g~~pf~~~  254 (282)
                      +++||+++ |..||.+.
T Consensus       222 ~il~el~~~g~~p~~~~  238 (293)
T cd05053         222 VLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             hHHHHHhcCCCCCCCCC
Confidence            99999997 88999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.4e-34  Score=243.71  Aligned_cols=206  Identities=18%  Similarity=0.281  Sum_probs=163.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++.+.||+|+||+||+|.+..++.    .|++|.+..... .....+..|+..++.+.||||+++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence            456789999999999999999999877765    478887754332 233466778888899999999999985422   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++++|.+++...   ...+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.
T Consensus        81 -------~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~  147 (279)
T cd05111          81 -------ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSI  147 (279)
T ss_pred             -------CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCc
Confidence                   3477899999999999988632   34588999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+......       ..........++..|++||++.+..+   +.++||||||+++||+++ |..||.+.
T Consensus       148 ~kl~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~~pE~~~~~~~---~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         148 VQIADFGVADLLYPD-------DKKYFYSEHKTPIKWMALESILFGRY---THQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             EEEcCCccceeccCC-------CcccccCCCCCcccccCHHHhccCCc---CchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999976532100       00001112335667999999987765   889999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0599|consensus

Probab=100.00  E-value=1.9e-35  Score=237.54  Aligned_cols=219  Identities=26%  Similarity=0.395  Sum_probs=179.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCC-CCCcccccccccccC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFV-HPNILPLLDHALTGC   96 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~   96 (282)
                      ..|+--+.||.|..+.|.++.++.|+.++|+|++...+..        -.+.-++|+.+++++. ||+|+++.+      
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D------   90 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD------   90 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee------
Confidence            4566677899999999999999999999999988543221        1234467999999995 999999998      


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                         .+++....++|+|.++.|.|.+.+..    .-.+++.....+++|+..|++|+|.+   +|+||||||+|||++.+-
T Consensus        91 ---~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~  160 (411)
T KOG0599|consen   91 ---VYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNM  160 (411)
T ss_pred             ---eccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecccc
Confidence               67778899999999999999999974    34589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc---CCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC---VVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~---~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +++++|||+++          .-.+..+.....||+.|.|||.+.+.-++   -++...|+||+|+|+|.|+.|-+||- 
T Consensus       161 ~i~isDFGFa~----------~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-  229 (411)
T KOG0599|consen  161 NIKISDFGFAC----------QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-  229 (411)
T ss_pred             ceEEeccceee----------ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-
Confidence            99999999864          23344455667899999999999765321   24788999999999999999999996 


Q ss_pred             cccCccceeee-eeeccccCC
Q psy16951        254 VYERGDSVALA-VISGNITFP  273 (282)
Q Consensus       254 ~~~~~~~~~~~-~~~~~~~~p  273 (282)
                        .+.+.++++ +..|++.+.
T Consensus       230 --HRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  230 --HRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             --HHHHHHHHHHHHhcccccC
Confidence              445555544 456666553

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-34  Score=245.10  Aligned_cols=210  Identities=21%  Similarity=0.305  Sum_probs=168.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ++..+|.+.+.||+|+||.||+|.+..     ++..+++|.+..........+.+|++.++.++|+||+++++.+.    
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   77 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG----   77 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc----
Confidence            356789999999999999999998643     45678999887666666677889999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                           .....+++|||+++++|.+++.....            ....+++..++.++.|++.|+.|||++   |++|+||
T Consensus        78 -----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  149 (291)
T cd05094          78 -----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDL  149 (291)
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccc
Confidence                 34679999999999999998864211            123478889999999999999999999   8999999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++||||||+++|||+
T Consensus       150 kp~Nil~~~~~~~~l~dfg~a~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~  219 (291)
T cd05094         150 ATRNCLVGANLLVKIGDFGMSRDVYST-------DYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIF  219 (291)
T ss_pred             CcceEEEccCCcEEECCCCcccccCCC-------ceeecCCCCCcceeecChHHhccCCC---CchhhHHHHHHHHHHHH
Confidence            999999999999999999976422110       00011122345678999999987765   78999999999999999


Q ss_pred             h-CCCCCCcc
Q psy16951        246 Y-FKSPFDTV  254 (282)
Q Consensus       246 t-g~~pf~~~  254 (282)
                      | |+.||...
T Consensus       220 t~g~~p~~~~  229 (291)
T cd05094         220 TYGKQPWFQL  229 (291)
T ss_pred             hCCCCCCCCC
Confidence            8 99999653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-34  Score=243.39  Aligned_cols=205  Identities=29%  Similarity=0.448  Sum_probs=168.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||++.+..++..||+|.+....   ......+.+|+.+++.++|+||+++++.+..        
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------   73 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--------   73 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--------
Confidence            57889999999999999999999999999999875432   2344577889999999999999999985443        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++++|++++++|.+++.........+++.++..++.|++.||.|||++   |++|+||+|+||+++.++.++++|
T Consensus        74 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          74 -DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             -CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence             4679999999999999998865433445688999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+......         ........++..|+|||++.+..+   +.++|+||||+++|+|++|..||.+.
T Consensus       150 fg~~~~~~~~---------~~~~~~~~~~~~~~ape~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         150 LGLGRFFSSK---------TTAAHSLVGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             chhhhccccC---------CcccccccCCcCccCHHHhcCCCc---cchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9965422100         001112346778999999977655   78999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-34  Score=244.47  Aligned_cols=206  Identities=24%  Similarity=0.355  Sum_probs=168.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +.|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|++.++.++|||++++++.+..         ..
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~---------~~   75 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY---------EN   75 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee---------CC
Confidence            446888999999999999999999999999999876666666778899999999999999999986543         46


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+++++|...+..   ....+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||+
T Consensus        76 ~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          76 NLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             EEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence            78999999999999876643   224588999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +....         ..........++..|+|||++.....  ..++.++|+||+||++|||++|+.||....
T Consensus       150 ~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         150 SAKNT---------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             ccccc---------ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            54211         00111123356788999999853211  123679999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-34  Score=240.98  Aligned_cols=204  Identities=19%  Similarity=0.369  Sum_probs=164.5

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.++|++.+.||+|+||+||.|.+.+ +..||+|.+.... .....+.+|+..+++++||||+++++.+.         .
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~   70 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT---------K   70 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc---------c
Confidence            46789999999999999999998854 4569999876433 33467889999999999999999998543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+.+++|.+++...   ...+++.+++.++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        71 ~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          71 QRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             CCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence            45689999999999999887632   23588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~  255 (282)
                      |.+.....        ..........++..|++||.+.+..+   +.++||||||+++|+|++ |+.||....
T Consensus       145 g~~~~~~~--------~~~~~~~~~~~~~~y~~pe~~~~~~~---~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         145 GLSRYVLD--------DEYTSSVGSKFPVRWSPPEVLLYSKF---SSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             ccceecCC--------CceeecCCCccChhhCCHHHHhcCcc---cchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            97542210        00011112234567999999987655   789999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-34  Score=242.38  Aligned_cols=206  Identities=19%  Similarity=0.323  Sum_probs=165.2

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|++.++||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++++++|+|++++++.+.       
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-------   71 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-------   71 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-------
Confidence            4678899999999999999999999875 556799998764332 3456889999999999999999987432       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++++||+++++|.+.+...  ....++..+++.++.|++.||.|||++   +++|+||+|+||+++.++.+++
T Consensus        72 ---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l  143 (260)
T cd05070          72 ---EEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKI  143 (260)
T ss_pred             ---CCCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEe
Confidence               24578999999999999987632  234578899999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||.+.+..+   +.++|+||||+++|++++ |..||.+.
T Consensus       144 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         144 ADFGLARLIED--------NEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CCceeeeeccC--------cccccccCCCCCccccChHHHhcCCC---cchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99997642110        00011112234567999999876654   789999999999999999 88999753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.1e-34  Score=245.37  Aligned_cols=217  Identities=25%  Similarity=0.379  Sum_probs=170.5

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCC-------CceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-------KKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNI   85 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni   85 (282)
                      ......|.+..++|.+.+.||+|+||.||++++.+.       ...+|+|.+.... ......+.+|+++++.+ +||||
T Consensus         7 ~~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   86 (307)
T cd05098           7 LPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI   86 (307)
T ss_pred             CCCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCE
Confidence            334667899999999999999999999999987432       3469999886442 33455678899999999 79999


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFH  153 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH  153 (282)
                      +++++.+.         .....++++||+++++|.+++.....            ....++..+++.++.|++.||.|||
T Consensus        87 ~~~~~~~~---------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH  157 (307)
T cd05098          87 INLLGACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA  157 (307)
T ss_pred             eeEEEEEe---------cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence            99998543         34678999999999999998865321            1134788899999999999999999


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ++   |++|+||||+||+++.++.++++|||.+.....       ...........++..|+|||++.+..+   +.++|
T Consensus       158 ~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~D  224 (307)
T cd05098         158 SK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-------IDYYKKTTNGRLPVKWMAPEALFDRIY---THQSD  224 (307)
T ss_pred             HC---CcccccccHHheEEcCCCcEEECCCcccccccc-------cchhhccccCCCccceeChHHhccCCC---CcHHH
Confidence            98   899999999999999999999999997542210       000000111223467999999987665   78999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCc
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~  253 (282)
                      +||+|+++|||++ |..||.+
T Consensus       225 vwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         225 VWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             HHHHHHHHHHHHcCCCCCCCc
Confidence            9999999999998 8899975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.2e-34  Score=240.74  Aligned_cols=207  Identities=20%  Similarity=0.310  Sum_probs=165.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|.+.+.||+|+||.||+|.+..+   ...||||...... ....+.+.+|+..++.++||||+++++.+..   
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---   78 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---   78 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---
Confidence            46778899999999999999999987543   4578999876554 3455678899999999999999999875432   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++++|.+++...   ...++...++.++.|++.||.|+|++   +++|+||||+||+++.++.
T Consensus        79 -------~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~  145 (270)
T cd05056          79 -------NPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDC  145 (270)
T ss_pred             -------CCcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCC
Confidence                   3468999999999999988532   33578999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVY  255 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~  255 (282)
                      ++++|||++......        .........++..|+|||.+.+..+   +.++||||||+++||+++ |..||.+..
T Consensus       146 ~~l~d~g~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         146 VKLGDFGLSRYLEDE--------SYYKASKGKLPIKWMAPESINFRRF---TSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             eEEccCceeeecccc--------cceecCCCCccccccChhhhccCCC---CchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999976432110        0000112223467999999877665   789999999999999986 999997643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.2e-34  Score=242.86  Aligned_cols=202  Identities=27%  Similarity=0.395  Sum_probs=163.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|++|.||+|.+..++..||+|.+.....  .....+.+|+.+++.++|||++++++.+.         .+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM---------QE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe---------eC
Confidence            58899999999999999999999999999998864432  22456778999999999999999998544         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+||+. ++|.+.+.... ....+++.++..++.|++.||.|||++   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  146 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFG  146 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccc
Confidence            78999999996 67877665322 224588999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+.....         .........++..|+|||++.+...  ++.++|+||+|+++|+|+||..||.+
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         147 LARAFGI---------PVRVYTHEVVTLWYRAPEVLLGSPR--YSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             ceeecCC---------CcccccCCcccccccChHHhcCCCC--cCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            7642211         0011112345778999999876432  37789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.1e-34  Score=246.73  Aligned_cols=214  Identities=21%  Similarity=0.316  Sum_probs=170.2

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLLD   90 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~~   90 (282)
                      +..+.+..++|++.+.||+|+||.||++.+     ..++..||+|.+.... ....+.+.+|+++++++ +||||+++++
T Consensus        27 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          27 DLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             cccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            345778889999999999999999999975     3455689999876543 23345678899999999 7999999998


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcE
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~ni  170 (282)
                      .+..         ....++++||+++++|.+.+...  ....++..++..++.|++.||.|+|++   +++|+||||+||
T Consensus       107 ~~~~---------~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Ni  172 (302)
T cd05055         107 ACTI---------GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNV  172 (302)
T ss_pred             EEec---------CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceE
Confidence            5433         35689999999999999987632  223478999999999999999999998   899999999999


Q ss_pred             EeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCC
Q psy16951        171 LLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKS  249 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~  249 (282)
                      +++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++||||+|+++||+++ |..
T Consensus       173 l~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslGvil~el~t~g~~  242 (302)
T cd05055         173 LLTHGKIVKICDFGLARDIMND-------SNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGILLWEIFSLGSN  242 (302)
T ss_pred             EEcCCCeEEECCCcccccccCC-------CceeecCCCCcccccCCHhhhccCCC---CcHhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999976532110       00000112234677999999987665   789999999999999998 999


Q ss_pred             CCCccc
Q psy16951        250 PFDTVY  255 (282)
Q Consensus       250 pf~~~~  255 (282)
                      ||.+..
T Consensus       243 p~~~~~  248 (302)
T cd05055         243 PYPGMP  248 (302)
T ss_pred             CcCCCC
Confidence            997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.7e-34  Score=244.20  Aligned_cols=209  Identities=22%  Similarity=0.304  Sum_probs=167.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||++.+..++..||+|.+.....   .....+.+|+++++.++||||+++++.+         .
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~---------~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF---------E   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE---------e
Confidence            479999999999999999999999999999998865432   2344667899999999999999998743         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+++++|.+.+..    ...+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~d  144 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTD  144 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEee
Confidence            45789999999999999988853    24578899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchh------hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAE------AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~------~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+............      ...........++..|+|||.+....+   +.++|+||||+++||+++|..||.+
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~vl~el~~g~~pf~~  218 (305)
T cd05609         145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY---GKPVDWWAMGIILYEFLVGCVPFFG  218 (305)
T ss_pred             CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9976532111111000      000001112345778999999877655   8899999999999999999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-33  Score=236.95  Aligned_cols=206  Identities=29%  Similarity=0.482  Sum_probs=169.7

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||.|+||.||++.+..++..||+|.+....  ......+.+|++.++.++||||+++++.+..       ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID-------RSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec-------CCC
Confidence            5889999999999999999999999999999886433  3345567889999999999999999875543       234


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCccccCCCCCcEEeecCCCce
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH-----DAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-----~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      ...++++||+++++|.+.+.........+++..++.++.|++.||.|+|     +.   +++|+||+|+||+++.++.++
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEE
Confidence            5789999999999999988765444566889999999999999999999     66   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+......         ........++..|+|||++.+..+   +.++|+||||+++|++++|+.||...
T Consensus       151 l~d~g~~~~~~~~---------~~~~~~~~~~~~~~~pE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         151 LGDFGLAKILGHD---------SSFAKTYVGTPYYMSPEQLNHMSY---DEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             EecccccccccCC---------cccccccccCCCccChhhhcCCCC---CchhHHHHHHHHHHHHHHCCCcccCc
Confidence            9999976432100         000122356888999999987654   78999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=237.02  Aligned_cols=207  Identities=19%  Similarity=0.326  Sum_probs=168.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|++.++||+|+||.||+|... ++..||+|.+.... .....+.+|+..++.++|+||+++++.+        
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~--------   70 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC--------   70 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee--------
Confidence            4578899999999999999999999975 45779999876433 3456788999999999999999998743        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       ......++++|++++++|.+.+...  ....++...+..++.|++.|+.|||++   +++|+||+|+||+++.++.+++
T Consensus        71 -~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l  144 (261)
T cd05034          71 -SEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKI  144 (261)
T ss_pred             -ecCCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEE
Confidence             3346789999999999999887642  234578899999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+....        ............+..|+|||.+.+..+   +.++|+||+|+++|++++ |+.||.+.
T Consensus       145 ~d~g~~~~~~--------~~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         145 ADFGLARLIE--------DDEYTAREGAKFPIKWTAPEAANYGRF---TIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             Cccccceecc--------chhhhhhhccCCCccccCHHHhccCCc---CchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999754221        011111112234567999999987655   789999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.2e-34  Score=239.96  Aligned_cols=206  Identities=20%  Similarity=0.337  Sum_probs=164.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.++.++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++.+.       
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------   71 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-------   71 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-------
Confidence            457788999999999999999999998655 458999775332 33456788999999999999999987432       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....+++|||+++++|.+.+...  ....++...+..++.|++.||.|+|+.   |++|+||+|+||+++.++.+++
T Consensus        72 ---~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l  143 (260)
T cd05069          72 ---EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKI  143 (260)
T ss_pred             ---CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEE
Confidence               24578999999999999888642  234478889999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||+..+...   +.++|+||+|+++||+++ |..||.+.
T Consensus       144 ~dfg~~~~~~~--------~~~~~~~~~~~~~~y~~Pe~~~~~~~---~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         144 ADFGLARLIED--------NEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CCCccceEccC--------CcccccCCCccchhhCCHHHhccCCc---ChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99997643210        00011112234667999999876655   789999999999999999 89999764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-34  Score=241.75  Aligned_cols=207  Identities=23%  Similarity=0.392  Sum_probs=164.9

Q ss_pred             ecccEEEEEEeccCCceEEEEEEe----cCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEH----SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ..++|++++.||+|+||.||++..    ..++..||+|.+..........+.+|+++++.++||||+++.+.+..     
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   76 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS-----   76 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc-----
Confidence            356899999999999999999984    45788999999876666666778899999999999999999885543     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        .+...+++++||+++++|.+++...   ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus        77 --~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          77 --AGRRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK  148 (284)
T ss_pred             --CCCCceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEE
Confidence              1335689999999999999987532   23478899999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ++|||.+.......      ..........++..|+|||++.+..+   +.++|+||+|+++|||++|..|+.
T Consensus       149 l~dfg~~~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         149 IGDFGLTKVLPQDK------EYYKVREPGESPIFWYAPESLTESKF---SVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             ECCCcccccccCCC------cceeecCCCCCceEeeCHHHhccCCc---ChHHHHHHHHHHHHHHhhcCCcCC
Confidence            99999765321100      00000001122345999999987665   789999999999999999876654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-34  Score=248.25  Aligned_cols=207  Identities=21%  Similarity=0.307  Sum_probs=160.2

Q ss_pred             EEEEeccC--CceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         30 IVEKIGEG--GFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        30 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ++++||+|  +|++||++.++.++..||+|++....  ......+.+|+++++.++||||+++++.+..         ..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~---------~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---------DN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE---------CC
Confidence            56789999  78899999999999999999986543  2334456779999999999999999986554         46


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++|+||+++++|.+++...  ....+++..++.++.|++.||.|||++   +++||||||+||+++.++.++++||+.
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccch
Confidence            799999999999999987543  123478899999999999999999998   899999999999999999999999874


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ..... . ................++..|+|||++.+... .++.++||||+||++|||++|+.||..
T Consensus       148 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         148 NLSMI-N-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ-GYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             hhccc-c-ccccccccccccccccceecccChHHhhcccC-CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            32110 0 00000000000112245677999999976321 137899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-33  Score=235.06  Aligned_cols=202  Identities=28%  Similarity=0.488  Sum_probs=166.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .|++.+.||+|++|.||++.+..++.+||+|++....  ......+.+|++++++++|+|++++++.+..        ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~~   72 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG--------ED   72 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC--------CC
Confidence            4899999999999999999999999999999986433  2344567889999999999999999874321        23


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++++|++++++|.+++...  ....+++.++..++.|++.|+.++|++   |++|+||+|+||+++.++.++++|||
T Consensus        73 ~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          73 GLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence            5689999999999999888642  234578999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+.....         .........++..|+|||++.+..+   +.++|+||+|++++++++|+.||..
T Consensus       148 ~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         148 IARVLEN---------QCDMASTLIGTPYYMSPELFSNKPY---NYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             ceEEecc---------cCCccccccCCcCccChhHhcCCCC---CchhhhHHHHHHHHHHHcCCCCCCC
Confidence            7643210         0011122346788999999987765   7899999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.8e-34  Score=241.44  Aligned_cols=209  Identities=20%  Similarity=0.307  Sum_probs=166.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ++.++|+++..||+|+||.||+|++..     +...|++|.+...... ....+.+|++++++++|+||+++++.+.   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   78 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR---   78 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC---
Confidence            456889999999999999999999753     3467899987654443 4567889999999999999999988443   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG-----KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                            .....++++||+++++|.+++......     ...+++..+..++.|++.||.|||++   +++|+||||+||+
T Consensus        79 ------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nil  149 (275)
T cd05046          79 ------EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCL  149 (275)
T ss_pred             ------CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEE
Confidence                  346789999999999999988643211     11588999999999999999999999   8999999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSP  250 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~p  250 (282)
                      ++.++.++++||+.+.....        ..........++..|++||.+.+...   +.++||||||+++|++++ |..|
T Consensus       150 i~~~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         150 VSSQREVKVSLLSLSKDVYN--------SEYYKLRNALIPLRWLAPEAVQEDDF---STKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             EeCCCcEEEcccccccccCc--------ccccccCCceeEEeecChhhhccCCC---CchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999997542110        00111122344667999999876654   788999999999999999 7889


Q ss_pred             CCcc
Q psy16951        251 FDTV  254 (282)
Q Consensus       251 f~~~  254 (282)
                      |.+.
T Consensus       219 ~~~~  222 (275)
T cd05046         219 FYGL  222 (275)
T ss_pred             cccc
Confidence            9753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-34  Score=240.82  Aligned_cols=199  Identities=32%  Similarity=0.550  Sum_probs=167.2

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHH--HHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--QAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~--~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.+.||+|+||+||++.+..++..||+|.+.........  ...+|+..++.++||||+++++.+..         ..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~---------~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD---------DN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE---------SS
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc---------cc
Confidence            78999999999999999999999999999999776655443  34569999999999999999985544         57


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++|++.+++|.+.+..    ...++...++.++.|++.||.+||++   +++|+||||+||+++.++.++++|||.
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             cccccccccccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            88999999999999998872    34578999999999999999999999   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccc-cCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH-VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~-~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +...         ...........++..|+|||++. +...   +.++|+||+|+++|+|++|..||...
T Consensus       145 ~~~~---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  145 SVKL---------SENNENFNPFVGTPEYMAPEVLQQGKKY---TRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             TEES---------TSTTSEBSSSSSSGGGSCHHHHTTTSSB---STHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccc---------cccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            5421         01111222345677899999987 5544   88999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=239.31  Aligned_cols=211  Identities=20%  Similarity=0.354  Sum_probs=164.4

Q ss_pred             EEEEEEeccCCceEEEEEEecC---CCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQ---TKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      |++.+.||+|+||.||+|.+..   ++..||+|.+.....  .....+.+|++.++.++||||+++++.+....   ...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS---SLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC---ccc
Confidence            5678999999999999998754   447899998865432  33457889999999999999999998655421   122


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSV--GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .....++++||+++++|...+.....  ....++...+..++.|++.||.|+|++   +++|+||||+||+++.++.+++
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEE
Confidence            33568999999999999988765322  224578899999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+........       .........+..|++||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       155 ~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         155 ADFGLSKKIYSGDY-------YRQGRIAKMPVKWIAIESLADRVY---TSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             CCccceeecccccc-------ccccccccCCccccCHhhcccCCC---CcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99997653211100       000111223567999999876655   889999999999999999 88999753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-34  Score=243.47  Aligned_cols=204  Identities=21%  Similarity=0.335  Sum_probs=168.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...+|++.++||.|+||.||+|.+.. +..+|+|.+..........+.+|+..++.++|+||+++++.+         ..
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~---------~~   73 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC---------SV   73 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE---------ec
Confidence            45679999999999999999999977 888999998776665667788999999999999999998843         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+...  ....++..++..++.|++.|+.|||++   |++|+||+|+||+++.++.++++||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          74 GEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             CCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccc
Confidence            46789999999999999988643  234578899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      |.+.....         .........++..|++||++....+   +.++|+||||+++|++++ |+.||...
T Consensus       149 g~~~~~~~---------~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         149 GLARLIKE---------DVYLSSDKKIPYKWTAPEAASHGTF---STKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cchhhcCC---------ccccccCCCCceEecCHHHHccCCC---CchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            97542210         0000112234667999999977655   789999999999999998 89999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-33  Score=235.42  Aligned_cols=201  Identities=29%  Similarity=0.554  Sum_probs=166.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||.+....++..||+|.+...  ......++.+|+..+++++||||+++.+.         +...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~---------~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES---------FEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee---------ecCC
Confidence            589999999999999999999999999999988643  23345578889999999999999999884         3445


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|.+.+...  ....+++.+++.++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~  146 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG  146 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecc
Confidence            7899999999999999877532  223478899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+.....         .........++..|+|||++.+...   +.++|+||||++++++++|+.||..
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         147 IARVLNS---------TVELARTCIGTPYYLSPEICENRPY---NNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             ceeecCc---------chhhhhhccCCccccCHHHhCCCCC---CCccchhHHHHHHHHHHcCCCCccC
Confidence            7542110         0111122346778999999987654   7899999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.9e-34  Score=244.96  Aligned_cols=200  Identities=23%  Similarity=0.366  Sum_probs=167.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.|.....||+|+||.||++.+..++..||||.+..........+.+|+..++.++|+||+++++.+.         ..
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~---------~~   91 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL---------VG   91 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee---------cC
Confidence            456666788999999999999999999999999987665566667889999999999999999988543         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|.+++..     ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658          92 DELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             CeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence            689999999999999887642     3478899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++....         ..........++..|+|||++.+..+   +.++|+||+|+++||+++|+.||..
T Consensus       164 ~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         164 FCAQVS---------KEVPKRKSLVGTPYWMAPEVISRLPY---GTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             chhhcc---------cccccCceeecCccccCHHHHccCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            754211         00111123456788999999977655   7899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-34  Score=245.64  Aligned_cols=210  Identities=21%  Similarity=0.311  Sum_probs=164.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCC-----CceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQT-----KKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ++..+|++.++||+|+||.||+|.+..+     +..||+|.+...... ....+.+|+.+++.++||||+++++.+    
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~----   77 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV----   77 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE----
Confidence            4556788899999999999999987543     578999988654433 245678899999999999999999843    


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                           ......++++||+.+++|..++.....            ....++...+..++.|++.||.|+|++   |++|||
T Consensus        78 -----~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~d  149 (283)
T cd05091          78 -----TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKD  149 (283)
T ss_pred             -----cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence                 344678999999999999988753211            123477888899999999999999998   899999


Q ss_pred             CCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        165 LKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       165 lk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |||+||+++.++.++++|||++.....       ...........+++.|+|||++.+..+   +.++||||+|+++|||
T Consensus       150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el  219 (283)
T cd05091         150 LATRNVLVFDKLNVKISDLGLFREVYA-------ADYYKLMGNSLLPIRWMSPEAIMYGKF---SIDSDIWSYGVVLWEV  219 (283)
T ss_pred             cchhheEecCCCceEeccccccccccc-------chheeeccCccCCccccCHHHHhcCCC---CcchhHHHHHHHHHHH
Confidence            999999999999999999997553210       000011112234678999999976655   7899999999999999


Q ss_pred             Hh-CCCCCCcc
Q psy16951        245 CY-FKSPFDTV  254 (282)
Q Consensus       245 ~t-g~~pf~~~  254 (282)
                      ++ |..||.+.
T Consensus       220 ~~~g~~p~~~~  230 (283)
T cd05091         220 FSYGLQPYCGY  230 (283)
T ss_pred             HcCCCCCCCCC
Confidence            98 88899764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.1e-34  Score=239.32  Aligned_cols=197  Identities=20%  Similarity=0.361  Sum_probs=155.3

Q ss_pred             EeccCCceEEEEEEec--CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         33 KIGEGGFSTVSLIEHS--QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      .||+|+||.||+|.+.  .++..||+|.+..... ...+.+.+|+.++++++||||+++++.+.          ....++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~----------~~~~~l   71 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE----------AEALML   71 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc----------CCCeEE
Confidence            4899999999999875  4456799998865433 33456889999999999999999988432          246899


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                      |+||+++++|.+.+..   ....+++..++.++.|++.||.|+|++   |++|+||||+||+++.++.++++|||.+...
T Consensus        72 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          72 VMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccc
Confidence            9999999999987753   234588999999999999999999998   8999999999999999999999999976421


Q ss_pred             hhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ...      ...........++..|+|||++.+..+   +.++||||||+++||+++ |..||.+.
T Consensus       146 ~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         146 GAD------DSYYKARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             cCC------ccceeccCCCCCCcccCCHHHHccCCC---CchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            100      000000111223567999999887665   789999999999999996 99999754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.1e-34  Score=240.87  Aligned_cols=212  Identities=21%  Similarity=0.302  Sum_probs=168.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .+.|++.+.||+|+||+||+|.+..++..||+|.+.... .....+.+|+..++.+ +|+||+++.+.+.....   ...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~---~~~   80 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP---PGM   80 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC---CCC
Confidence            467888999999999999999999999999999886543 3345677899999988 69999999987764210   112


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+.+++|.+.+...  ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            35789999999999999987642  234578899999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++.....         .........++..|+|||++.+..  ...++.++|+||+|+++|||++|+.||.+.
T Consensus       156 g~~~~~~~---------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         156 GVSAQLDR---------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             CCceeccc---------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            97642210         011122345678899999986431  112477999999999999999999999653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-33  Score=244.38  Aligned_cols=202  Identities=24%  Similarity=0.386  Sum_probs=154.4

Q ss_pred             EEEeccCCceEEEEEEecC--CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQ--TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      ..+||+|+||+||+|.+..  ++..||+|.+....  ....+.+|+++++.++||||+++++.+..       ......+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~~~~~~   76 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS-------HSDRKVW   76 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec-------cCCCeEE
Confidence            4689999999999999654  56889999885433  23456789999999999999999886543       2345789


Q ss_pred             EEeccCCCCChHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----ecCCCce
Q psy16951        109 MVLPYYPKGTLANDLELRSV-----GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----ANDNNPL  179 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~~~~  179 (282)
                      +++||+. ++|.+.+.....     ....+++..+..++.|++.||.|||++   +++||||||+||++    +.++.++
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07867          77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEE
Confidence            9999985 577766543211     122478888999999999999999998   89999999999999    4567899


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||++......      ...........+|..|+|||++.+...  ++.++||||+|+++|||+||++||..
T Consensus       153 l~DfG~a~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         153 IADMGFARLFNSP------LKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             EeeccceeccCCC------cccccccCcceecccccCcHHhcCCCc--cCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9999986532110      001111223456888999999976432  37899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-34  Score=243.19  Aligned_cols=204  Identities=20%  Similarity=0.303  Sum_probs=169.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ++.++|++++.||+|+||+||++.+..++..||+|.+.... ......+.+|+++++.++||||+++++.+..       
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------   74 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-------   74 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-------
Confidence            45678999999999999999999999999999999876543 3345678899999999999999999985443       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ...+++++||+++++|.+.+..    ...++...+..++.|++.|+.|||+.+  +++|+||+|+||+++.++.++++
T Consensus        75 --~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          75 --ENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             --CCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEc
Confidence              4789999999999999887653    235788999999999999999999754  79999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |||++....        .   .......++..|+|||++.+..+   +.++|+||+||++|++++|..||....
T Consensus       147 d~gl~~~~~--------~---~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         147 DFGVSGELI--------N---SIADTFVGTSTYMSPERIQGGKY---TVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             cCCcccchh--------h---hccCccccCcccCCHHHHccCCC---CccchHHHHHHHHHHHHhCCCCCcccc
Confidence            999753210        0   01112357888999999977654   789999999999999999999998543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-33  Score=242.25  Aligned_cols=205  Identities=23%  Similarity=0.364  Sum_probs=162.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCc--eEEEEEeccC-CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKK--RYALKKIICH-GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~i~~~-~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +++|++.+.||+|+||.||+|....++.  .+++|.+... .....+.+.+|++++.++ +||||+++++.+        
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--------   72 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--------   72 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--------
Confidence            4789999999999999999999877664  4688877632 333456788899999999 799999999843        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                       .....+++++||+++++|.+++.....            ....++...+..++.|++.||.|||++   |++|+||||+
T Consensus        73 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~  148 (297)
T cd05089          73 -ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAAR  148 (297)
T ss_pred             -ccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcc
Confidence             334679999999999999998864211            113478889999999999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||++.....          .........+..|+|||++.+..+   +.++||||||+++|||++ |
T Consensus       149 Nill~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlG~il~el~t~g  215 (297)
T cd05089         149 NVLVGENLASKIADFGLSRGEEV----------YVKKTMGRLPVRWMAIESLNYSVY---TTKSDVWSFGVLLWEIVSLG  215 (297)
T ss_pred             eEEECCCCeEEECCcCCCccccc----------eeccCCCCcCccccCchhhccCCC---CchhhHHHHHHHHHHHHcCC
Confidence            99999999999999997532100          000111122456999999987665   789999999999999997 9


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||...
T Consensus       216 ~~pf~~~  222 (297)
T cd05089         216 GTPYCGM  222 (297)
T ss_pred             CCCCCCC
Confidence            9999753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-34  Score=238.68  Aligned_cols=203  Identities=24%  Similarity=0.442  Sum_probs=162.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...+|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|+++++.++||||+++++.+         ..
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~---------~~   70 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC---------TK   70 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEE---------cC
Confidence            3467899999999999999999986 46679999875332 3345677899999999999999998743         33


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++++++|.+++...   ...+++..++.++.|++.|+.|||++   +++|+||||+||+++.++.++++||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          71 QRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             CCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence            46789999999999999887632   23578899999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      |.+....        ...........++..|+|||.+.+..+   +.++|+||||+++||+++ |..||...
T Consensus       145 g~~~~~~--------~~~~~~~~~~~~~~~y~~Pe~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         145 GLARYVL--------DDQYTSSQGTKFPVKWAPPEVFDYSRF---SSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             ccceecc--------cccccccCCCCCCccccCHHHhccCCC---CchhhHHHHHHHHHHHhccCCCCCCCC
Confidence            9754221        000000111123456999999987765   789999999999999999 88999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-34  Score=240.64  Aligned_cols=200  Identities=21%  Similarity=0.352  Sum_probs=168.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|++.++.++|+|++++.+.+..         .
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK---------G   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE---------C
Confidence            57889999999999999999999999999999886543 3344567889999999999999999985543         3


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++++++|.+.+..     ..+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            679999999999999987753     2588999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+......         ........++..|+|||++.+..+   +.++|+||||+++|+++||+.||.+.
T Consensus       144 ~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~---~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         144 VSGQLTST---------MSKRNTFVGTPFWMAPEVIKQSGY---DEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             cceeeccc---------ccccccccCCccccChhhhccCCC---CchhhHHHHHHHHHHHHhCCCCcccC
Confidence            76432111         011223346778999999987765   88999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4e-33  Score=238.35  Aligned_cols=214  Identities=20%  Similarity=0.260  Sum_probs=169.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.+++++ +|||++++++.+...    ...
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~----~~~   94 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA----DKL   94 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec----ccc
Confidence            3688999999999999999999999999999999875432 2344566788889988 799999999876542    111


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+++++|.+.+.........+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.++++|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence            23568999999999999998765444455688999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+.....         .........++..|+|||++.....  ...+.++|+||+|+++|||++|+.||...
T Consensus       172 fg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         172 FGVSAQLTS---------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             cccchhccc---------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            997542110         0001112346778999999864321  11368999999999999999999999753

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-33  Score=238.91  Aligned_cols=209  Identities=20%  Similarity=0.315  Sum_probs=164.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...+|++.+.||+|+||.||+|.+..++.   .||||.+... .......+..|+..++.++||||+++++.+.      
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~------   75 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT------   75 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC------
Confidence            35679999999999999999999877664   5999987644 3344567889999999999999999988543      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++++||+++++|.+++...   ...++..+++.++.|++.|+.|+|++   |++|+||+|+||+++.++.++
T Consensus        76 ---~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          76 ---KSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ---CCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence               346789999999999999877532   34578899999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++|||.+.......    .............+..|++||++.+..+   +.++||||+|+++||+++ |..||...
T Consensus       147 l~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         147 VSDFGLSRFLEDDT----SDPTYTSSLGGKIPIRWTAPEAIAYRKF---TSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ECCCccccccccCc----cccccccccCCCcceeecCHhHhccCcc---cchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            99999754221100    0000000011112456999999987665   789999999999999886 99999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-33  Score=236.37  Aligned_cols=206  Identities=19%  Similarity=0.328  Sum_probs=165.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|++.++||+|+||.||++.+. .+..+|+|.+... ......+.+|+++++.++|+||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------   71 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-------   71 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-------
Confidence            5788999999999999999999999864 4566899977533 334567888999999999999999987432       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        . ...++++||+++++|.+++...  ....++...+..++.|++.||.|+|++   |++|+||+|+||+++.++.+++
T Consensus        72 --~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05073          72 --K-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI  143 (260)
T ss_pred             --C-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence              2 4689999999999999988642  234467788899999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+.....        ..........++..|+|||++....+   +.++|+||||+++|++++ |..||.+.
T Consensus       144 ~d~~~~~~~~~--------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         144 ADFGLARVIED--------NEYTAREGAKFPIKWTAPEAINFGSF---TIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             CCCcceeeccC--------CCcccccCCcccccccCHhHhccCCc---CccccchHHHHHHHHHHhcCCCCCCCC
Confidence            99997542100        00011112234567999999977654   789999999999999999 89999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=237.02  Aligned_cols=205  Identities=20%  Similarity=0.322  Sum_probs=164.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ..++|++.+.||+|+||.||+|.+..+   ...||+|.+.... ......+.+|+..++.++||||+++++.+       
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-------   74 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-------   74 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-------
Confidence            457899999999999999999998644   4579999876443 33455788899999999999999998843       


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        ......++++|++++++|.+++...   ...++...+..++.|++.|+.|||++   +++|+||+|+||+++.++.++
T Consensus        75 --~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          75 --TKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             --ecCCceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEE
Confidence              3346789999999999999987642   23688999999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++|||.+.....       ...........++..|+|||.+.+..+   +.++||||||+++|++++ |..||..
T Consensus       147 l~dfg~~~~~~~-------~~~~~~~~~~~~~~~y~~Pe~~~~~~~---~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         147 VSDFGLSRRLED-------SEATYTTKGGKIPIRWTAPEAIAYRKF---TSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ECccchhhcccc-------cccceeccCCCCCccccChhhhccCCC---ccccchHHHHHHHHHHHccCCCCCCC
Confidence            999997653210       000000112234567999999987655   789999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0584|consensus

Probab=100.00  E-value=1.5e-34  Score=255.17  Aligned_cols=216  Identities=21%  Similarity=0.343  Sum_probs=176.0

Q ss_pred             cccE-EEEEEeccCCceEEEEEEecCCCceEEEEEecc----CCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         25 SDKY-YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC----HGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        25 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~----~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .++| ++..+||+|+|-+||+|.+..+|.+||.-.++.    ......+.+..|+.+|+.|+||||++++..|.+.    
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~----  113 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT----  113 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC----
Confidence            3444 356789999999999999999999999776643    2344557889999999999999999999988763    


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCc
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNP  178 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~  178 (282)
                         ....+-+|+|.+..|+|..++..    .+.++...+..|++||+.||.|||++.+ +|+|||||++||+++.+ |.+
T Consensus       114 ---~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~V  185 (632)
T KOG0584|consen  114 ---DNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEV  185 (632)
T ss_pred             ---CCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCce
Confidence               22568899999999999998874    3558889999999999999999999999 69999999999999765 889


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      ||.|+|++...           ......+..||+.|||||+.. +.|   +...||||||..++||+|+..||+.= ...
T Consensus       186 KIGDLGLAtl~-----------r~s~aksvIGTPEFMAPEmYE-E~Y---nE~VDVYaFGMCmLEMvT~eYPYsEC-~n~  249 (632)
T KOG0584|consen  186 KIGDLGLATLL-----------RKSHAKSVIGTPEFMAPEMYE-ENY---NELVDVYAFGMCMLEMVTSEYPYSEC-TNP  249 (632)
T ss_pred             eecchhHHHHh-----------hccccceeccCccccChHHHh-hhc---chhhhhhhhhHHHHHHHhccCChhhh-CCH
Confidence            99999976421           112234468999999999987 445   88999999999999999999999731 223


Q ss_pred             cceeeeeeec
Q psy16951        259 DSVALAVISG  268 (282)
Q Consensus       259 ~~~~~~~~~~  268 (282)
                      .+++..+.+|
T Consensus       250 AQIYKKV~SG  259 (632)
T KOG0584|consen  250 AQIYKKVTSG  259 (632)
T ss_pred             HHHHHHHHcC
Confidence            4555555555

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-33  Score=239.87  Aligned_cols=202  Identities=25%  Similarity=0.349  Sum_probs=163.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++...||+|+||.||+|.+..++..||+|++.....  .....+.+|+.+++.++|+|++++++.+.         .
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~---------~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR---------R   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe---------e
Confidence            579999999999999999999999999999998864432  23345778999999999999999998543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||++++++.....    ....+++.+++.++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df  144 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDF  144 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcc
Confidence            467999999998887776543    234588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........++..|++||++.+...  ++.++|+||+|+++|+|++|+.||.+.
T Consensus       145 g~~~~~~~---------~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~i~~~l~~g~~p~~~~  204 (286)
T cd07847         145 GFARILTG---------PGDDYTDYVATRWYRAPELLVGDTQ--YGPPVDVWAIGCVFAELLTGQPLWPGK  204 (286)
T ss_pred             ccceecCC---------CcccccCcccccccCCHHHHhCCCC--cCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            97542210         0001112235677999999876432  378999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-33  Score=240.56  Aligned_cols=199  Identities=25%  Similarity=0.398  Sum_probs=160.7

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+......  ....+.+|+++++.++||||+++++.+         .+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~---------~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL---------HSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh---------ccC
Confidence            589999999999999999999999999999988654322  234567899999999999999999844         345


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+. ++|.+.+..   ....+++..++.++.||+.||.|||++   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence            78999999996 577766543   234589999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .+......         ........++..|+|||++.+...  ++.++||||+|+++|+|+||..||.
T Consensus       145 ~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         145 LARAFGIP---------VRCYSAEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             hhhccCCC---------CCCcCCCccccCCcChHHHhCCcc--cCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            75422110         011112345778999999876432  3789999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-33  Score=239.85  Aligned_cols=204  Identities=25%  Similarity=0.375  Sum_probs=161.7

Q ss_pred             ccE-EEEEEeccCCceEEEEEE----ecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         26 DKY-YIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        26 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+..... .....+.+|++.++.++||||+++.+.+..     
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   77 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE-----   77 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            455 899999999999998764    445788999998865432 345677889999999999999999885432     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        ......+++|||+++++|.+++..     ..+++.++..++.|++.||.|||++   +++|+||||+||+++.++.++
T Consensus        78 --~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~  147 (283)
T cd05080          78 --QGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVK  147 (283)
T ss_pred             --CCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEE
Confidence              123568999999999999988753     3489999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+......      ...........++..|+|||.+.+..+   +.++||||||+++|||++|..||..
T Consensus       148 l~dfg~~~~~~~~------~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         148 IGDFGLAKAVPEG------HEYYRVREDGDSPVFWYAVECLKENKF---SYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             EeecccccccCCc------chhhccCCCCCCCceeeCHhHhcccCC---CcccccHHHHHHHHHHHhCCCCCCC
Confidence            9999976432100      000000111234566999999877655   7899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-33  Score=235.85  Aligned_cols=207  Identities=24%  Similarity=0.342  Sum_probs=167.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||+|....++..||+|.+......  ....+.+|++.++.++|+||+++++.+         ...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~---------~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE---------VHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE---------ecC
Confidence            588999999999999999999889999999998765543  566788999999999999999999843         345


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|.+.+..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            789999999999999998763    23478888899999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+........     ..........++..|+|||++.+..-...+.++||||||+++|++++|+.||...
T Consensus       145 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         145 CAVKLKNNTT-----TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccCCCCC-----cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            7543211000     0000011234677899999997654111378999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2e-33  Score=240.68  Aligned_cols=202  Identities=26%  Similarity=0.374  Sum_probs=169.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||.||++....++..||+|.+..........+.+|+.+++.++|||++++++.+..         
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~---------   87 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV---------   87 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee---------
Confidence            35899999999999999999999988999999999876655566778899999999999999999985443         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+++++|.+++..     ..++..++..++.|++.|+.|||++   |++|+||+|+||+++.++.++++||
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          88 GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             CCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence            4678999999999999987752     3477888999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....         .........++..|++||.+.+..+   +.++|+||||+++|++++|+.||...
T Consensus       160 g~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         160 GFCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             cceecccc---------cccccccccCChhhcCchhhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            96542110         0011122346778999999877654   78999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.7e-33  Score=234.02  Aligned_cols=201  Identities=24%  Similarity=0.431  Sum_probs=168.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||.|+||.||.++...++..+++|.+....  ......+.+|++++++++|+||+++++.+.         ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~---------~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM---------DD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe---------cC
Confidence            5899999999999999999999999999999886543  344556789999999999999999998544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|.+.+...  ....++..++..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence            7899999999999999988643  134578899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+......         ........+++.|+|||.+.+..+   +.++|+||+|+++|||++|..||..
T Consensus       147 ~~~~~~~~---------~~~~~~~~~~~~y~ape~~~~~~~---~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         147 ISKILGSE---------YSMAETVVGTPYYMSPELCQGVKY---NFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             ceEEcccc---------cccccccCCCccccCHhhcCCCCC---CCcchhHHHHHHHHHHHHCCCCCCC
Confidence            76432110         001123456888999999987654   7889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=235.50  Aligned_cols=215  Identities=22%  Similarity=0.301  Sum_probs=172.9

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.+.||+|+||.||+|.+..++..+++|.+..... ....+.+|+.+++++ .|+||+++++.+.....   ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~---~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP---PG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC---CC
Confidence            46899999999999999999999998999999998765543 345688899999999 69999999997765311   12


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++++||+++++|.+.+.........+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence            35679999999999999988765433345688999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+....         ..........++..|+|||++.....  ..++.++||||+|+++|++++|+.||.+.
T Consensus       157 ~~~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         157 FGVSAQLD---------STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             Cccceecc---------cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            99754210         11111223456888999999864321  12367899999999999999999999753

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-33  Score=247.47  Aligned_cols=195  Identities=23%  Similarity=0.342  Sum_probs=158.9

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ....|++++.||+|+||.||+|.+..++..||+|.....      ....|+.+++.++||||+++++.+..         
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~---------  128 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS---------  128 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe---------
Confidence            345799999999999999999999999999999964322      23468999999999999999985543         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+|++ .++|.+++..   ....+++..++.++.||+.||.|||++   ||+||||||+||+++.++.++++||
T Consensus       129 ~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  201 (357)
T PHA03209        129 GAITCMVLPHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDL  201 (357)
T ss_pred             CCeeEEEEEcc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecC
Confidence            46789999998 5678776653   234588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC-CCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK-SPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~-~pf~~  253 (282)
                      |.+.....          ........||..|+|||++.+..+   +.++||||+||++|||+++. .+|.+
T Consensus       202 G~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        202 GAAQFPVV----------APAFLGLAGTVETNAPEVLARDKY---NSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             cccccccc----------CcccccccccccccCCeecCCCCC---CchhhHHHHHHHHHHHHHcCCccccC
Confidence            97642110          011123457889999999988766   88999999999999999855 45543

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-34  Score=240.58  Aligned_cols=210  Identities=20%  Similarity=0.292  Sum_probs=165.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +..++|++.+.||+|+||.||+|.+..     ++..||+|.+..... .....+.+|+.+++.++|+||+++++.+..  
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--
Confidence            456789999999999999999999977     778899998864443 334568889999999999999999985443  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                             ....++++||+++++|.+.+.....   ....+++.+++.++.||+.|+.|||++   +++|+||||+||+++
T Consensus        81 -------~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~  150 (277)
T cd05036          81 -------RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLT  150 (277)
T ss_pred             -------CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEe
Confidence                   3567899999999999998865321   112578899999999999999999999   899999999999998


Q ss_pred             cCC---CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCC
Q psy16951        174 NDN---NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKS  249 (282)
Q Consensus       174 ~~~---~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~  249 (282)
                      .++   .++++|||.+......    ..   .........+..|+|||++.+..+   +.++|||||||++|||++ |..
T Consensus       151 ~~~~~~~~kl~dfg~~~~~~~~----~~---~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~~g~~  220 (277)
T cd05036         151 CKGPGRVAKIADFGMARDIYRA----SY---YRKGGRAMLPIKWMPPEAFLDGIF---TSKTDVWSFGVLLWEIFSLGYM  220 (277)
T ss_pred             ccCCCcceEeccCccccccCCc----cc---eecCCCCCccHhhCCHHHHhcCCc---CchhHHHHHHHHHHHHHcCCCC
Confidence            754   5789999976532000    00   000111122456999999987665   889999999999999997 999


Q ss_pred             CCCcc
Q psy16951        250 PFDTV  254 (282)
Q Consensus       250 pf~~~  254 (282)
                      ||...
T Consensus       221 pf~~~  225 (277)
T cd05036         221 PYPGR  225 (277)
T ss_pred             CCCCC
Confidence            99753

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-34  Score=242.55  Aligned_cols=202  Identities=27%  Similarity=0.490  Sum_probs=160.3

Q ss_pred             EEEEEeccCCceEEEEEEec----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         29 YIVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+..... .....+.+|++.+++++||||+++++.+..         
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~---------   72 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE---------   72 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES---------
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc---------
Confidence            56789999999999999997    4467899999865433 346788999999999999999999997663         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+++|+|.+.+...  ....+++..+..++.|++.||.|||++   +++|++|+++||+++.++.+|++||
T Consensus        73 ~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   73 NEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             SSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEEST
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            34599999999999999988754  235688999999999999999999998   7999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      |........       ...........+..|+|||.+....+   +.++||||||+++||+++ |+.||.+.
T Consensus       148 ~~~~~~~~~-------~~~~~~~~~~~~~~~~aPE~~~~~~~---~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  148 GLSRPISEK-------SKYKNDSSQQLPLRYLAPEVLKDGEY---TKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             TTGEETTTS-------SSEEESTTSESGGGGS-HHHHHHSEE---SHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             ccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            976532000       00011122334567999999988765   889999999999999999 67999765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0199|consensus

Probab=100.00  E-value=2.3e-35  Score=262.49  Aligned_cols=241  Identities=20%  Similarity=0.289  Sum_probs=190.8

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      ...+...|..++..+.+.||+|.||.|++|.|...   -..||||.+...... ....|++|+.+|.+|+|+|+++++|.
T Consensus       100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGv  179 (1039)
T KOG0199|consen  100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGV  179 (1039)
T ss_pred             CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeee
Confidence            45567788999999999999999999999998643   366899988654433 56689999999999999999999996


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                      .+.          .-..+|+|.++.|||.+.|..  .....+.-..+..|+.||+.|+.||-.+   ++|||||-.+|++
T Consensus       180 Vl~----------qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNll  244 (1039)
T KOG0199|consen  180 VLD----------QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLL  244 (1039)
T ss_pred             ecc----------chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhhe
Confidence            553          458899999999999999876  2345577788999999999999999999   7889999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSP  250 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~p  250 (282)
                      +-....+||+|||+.+.......-..      -.....-++.|+|||.+....+   +.+||||++||++|||+| |+-|
T Consensus       245 lasprtVKI~DFGLmRaLg~ned~Yv------m~p~rkvPfAWCaPEsLrh~kF---ShaSDvWmyGVTiWEMFtyGEeP  315 (1039)
T KOG0199|consen  245 LASPRTVKICDFGLMRALGENEDMYV------MAPQRKVPFAWCAPESLRHRKF---SHASDVWMYGVTIWEMFTYGEEP  315 (1039)
T ss_pred             ecccceeeeecccceeccCCCCcceE------ecCCCcCcccccCHhHhccccc---cccchhhhhhhhHHhhhccCCCC
Confidence            99999999999998764321111110      0111223677999999987765   899999999999999999 7799


Q ss_pred             CCccccCccceeeee-eeccccCCCCCCCCCCC
Q psy16951        251 FDTVYERGDSVALAV-ISGNITFPENTPFPQYQ  282 (282)
Q Consensus       251 f~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~  282 (282)
                      |-+...  ..+...+ .+.+.+-|+.||..+|+
T Consensus       316 W~G~~g--~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  316 WVGCRG--IQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             CCCCCH--HHHHHhccccccCCCCCCChHHHHH
Confidence            976433  3333333 45578899999887764

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=240.03  Aligned_cols=203  Identities=25%  Similarity=0.374  Sum_probs=163.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|++|.||+|....++..||||.+...... ....+.+|+++++.++|+||+++++.+.         .
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------~   74 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH---------T   74 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe---------c
Confidence            57899999999999999999999889999999998644322 2345678999999999999999998543         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+. ++|.+.+...   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        75 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          75 KKTLTLVFEYLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcc
Confidence            578999999997 4888776532   23578899999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......         ........++..|+|||++.+...  .+.++||||+|+++|+|++|+.||.+.
T Consensus       148 g~~~~~~~~---------~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         148 GLARAKSVP---------SKTYSNEVVTLWYRPPDVLLGSTE--YSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccccccCCC---------CccccccccccccCCcHHhhcCcc--cCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            975421110         001111234677999999875431  378999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.7e-34  Score=239.21  Aligned_cols=207  Identities=22%  Similarity=0.326  Sum_probs=163.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCC---ceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTK---KRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ..++|++.+.||+|+||.||+|.+..++   ..+|+|.+.... ......+.+|+..++.++||||+++++.+.      
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------   75 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT------   75 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe------
Confidence            4578999999999999999999986544   379999876433 233457788999999999999999988543      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++++||+++++|.+++...   ...++..++..++.|++.|+.|+|++   +++|+||||+||+++.++.++
T Consensus        76 ---~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          76 ---KSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             ---cCCccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEE
Confidence               346789999999999999887532   23578889999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++|||.+.......    ..  ........++..|++||++.+..+   +.++|+||||+++||+++ |..||...
T Consensus       147 l~dfg~~~~~~~~~----~~--~~~~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         147 VSDFGLSRVLEDDP----EA--AYTTRGGKIPIRWTAPEAIAYRKF---TSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             eCCCCccccccccc----ce--eeecCCCccceeecCHhHhccCcc---CchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            99999765321100    00  000011122456999999987665   889999999999999886 99999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=244.18  Aligned_cols=208  Identities=26%  Similarity=0.366  Sum_probs=164.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++.+...    ....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPP----SFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecc----cccc
Confidence            468999999999999999999999999999999886432 23345677899999999999999998865443    2233


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++. +++...+.     ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcc
Confidence            456899999995 46665543     24588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |++.....      ............++..|+|||++.+...  ++.++||||+|+++|+|++|+.||.+
T Consensus       151 g~~~~~~~------~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         151 GLARIADP------EHDHTGFLTEYVATRWYRAPEIMLNSKG--YTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             cceeeccc------cccccCCcCCcCcCCCccChHHhhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            97653211      0000111122456888999998765322  37899999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-33  Score=240.28  Aligned_cols=205  Identities=22%  Similarity=0.333  Sum_probs=165.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++++.||+|+||.||++.+..++..||+|.+... .......+.+|+++++.++|+||+++++.+.         ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---------~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF---------IE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee---------cC
Confidence            5789999999999999999999999999999988654 3334567889999999999999999998443         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|...+.... ....+++..+..++.|++.|+.|||+..  +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecC
Confidence            78999999999999988765321 1235889999999999999999999643  79999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc---cCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY---CVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~---~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+....        .   .......++..|+|||.+.+...   ..++.++|+||+|+++|++++|+.||..
T Consensus       149 ~~~~~~--------~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         149 VSGNLV--------A---SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             Cccccc--------C---CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            754210        0   00112245678999999865321   1236789999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-33  Score=239.48  Aligned_cols=201  Identities=23%  Similarity=0.364  Sum_probs=163.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++.+.||+|+||.||+|.+..++.+||+|.+......  ....+.+|+++++.++||||+++++.+         ..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---------~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF---------RR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc---------cc
Confidence            4799999999999999999999989999999987543322  345677899999999999999999844         44


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+.++++.....    ....+++.+++.++.|++.||.|||++   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEee
Confidence            578999999999888876543    223478999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |++......         ........++..|+|||++.+...  .+.++||||||+++|||++|++||..
T Consensus       145 g~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         145 GFARTLAAP---------GEVYTDYVATRWYRAPELLVGDTK--YGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             eeeeeccCC---------ccccCcccceeeccCcHHhccccc--cCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            975422110         011112345678999999875432  36789999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-33  Score=242.64  Aligned_cols=216  Identities=24%  Similarity=0.352  Sum_probs=170.0

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecC-------CCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-------TKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILP   87 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~   87 (282)
                      .+..|.+..++|.+.+.||+|+||.||+|.+..       ....||+|.+.... ......+.+|+.+++.+ +||||++
T Consensus         3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099           3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeee
Confidence            467788999999999999999999999998643       34568999876433 33455678899999999 6999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      +++.+.         .....++++||+++++|.+++.....            ....++..++..++.|++.||.|+|++
T Consensus        83 ~~~~~~---------~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~  153 (314)
T cd05099          83 LLGVCT---------QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR  153 (314)
T ss_pred             EEEEEc---------cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence            998543         34678999999999999998865311            123478888999999999999999998


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchh
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVW  235 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diw  235 (282)
                         |++|+||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++|||
T Consensus       154 ---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Diw  220 (314)
T cd05099         154 ---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI-------DYYKKTSNGRLPVKWMAPEALFDRVY---THQSDVW  220 (314)
T ss_pred             ---CeeeccccceeEEEcCCCcEEEcccccccccccc-------ccccccccCCCCccccCHHHHccCCc---Cccchhh
Confidence               8999999999999999999999999976532100       00000111223457999999987665   7899999


Q ss_pred             hHHHHHHHHHh-CCCCCCcc
Q psy16951        236 SLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       236 s~G~il~el~t-g~~pf~~~  254 (282)
                      |||+++|++++ |..||.+.
T Consensus       221 slG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         221 SFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             HHHHHHHHHHhCCCCCCCCC
Confidence            99999999999 88999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=254.28  Aligned_cols=197  Identities=22%  Similarity=0.295  Sum_probs=160.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ....|.+.+.||+|+||.||+|.+..++..||||...      ...+.+|++++++++|+||+++++.+..         
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~---------  231 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV---------  231 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE---------
Confidence            4568999999999999999999999999999999542      2235689999999999999999985543         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++ .++|...+..   ....+++.+++.++.|++.||.|||++   ||+||||||+||+++.++.++++||
T Consensus       232 ~~~~~lv~e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DF  304 (461)
T PHA03211        232 GGLTCLVLPKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDF  304 (461)
T ss_pred             CCEEEEEEEcc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEccc
Confidence            46789999998 4688776653   234589999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      |++......       ..........||..|+|||++.+..+   +.++|||||||++|||++|..|+.
T Consensus       305 Gla~~~~~~-------~~~~~~~~~~GT~~Y~APE~~~~~~~---~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        305 GAACFARGS-------WSTPFHYGIAGTVDTNAPEVLAGDPY---TPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             CCceecccc-------cccccccccCCCcCCcCHHHHcCCCC---CchHHHHHHHHHHHHHHHcCCCcc
Confidence            986532100       00001123457899999999988766   889999999999999999886543

>KOG4236|consensus

Probab=100.00  E-value=1.1e-34  Score=251.30  Aligned_cols=212  Identities=24%  Similarity=0.326  Sum_probs=171.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +.||+|.||+||-|.++.+|+.||||.|..-  ..+...+..+|+.+++++.||.|+.+.-         .++....+++
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~---------M~ET~ervFV  640 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLEC---------MFETPERVFV  640 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEE---------eecCCceEEE
Confidence            6799999999999999999999999988532  2344567788999999999999998865         5677889999


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---CCceeecccCc
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---NNPLLMDLGSV  186 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~~~~df~~~  186 (282)
                      |||.+.+ +...++...  ...+++++....++.||+.||.|||.+   +|+|+||||+|+|+...   -++|++|||++
T Consensus       641 VMEKl~G-DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  641 VMEKLHG-DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             Eehhhcc-hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence            9999954 444444433  456799999999999999999999999   99999999999999654   46799999987


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeee
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI  266 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~  266 (282)
                      +..     .     +..-..+.+||+.|+|||++....|   +..-|+||.|+|+|--++|.+||+.    ++++...+.
T Consensus       715 RiI-----g-----EksFRrsVVGTPAYLaPEVLrnkGy---NrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQ  777 (888)
T KOG4236|consen  715 RII-----G-----EKSFRRSVVGTPAYLAPEVLRNKGY---NRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQ  777 (888)
T ss_pred             eec-----c-----hhhhhhhhcCCccccCHHHHhhccc---cccccceeeeEEEEEEecccccCCC----ccchhHHhh
Confidence            532     1     1112335679999999999999988   7889999999999999999999974    333444455


Q ss_pred             eccccCCCC
Q psy16951        267 SGNITFPEN  275 (282)
Q Consensus       267 ~~~~~~p~~  275 (282)
                      ...+-+|++
T Consensus       778 NAaFMyPp~  786 (888)
T KOG4236|consen  778 NAAFMYPPN  786 (888)
T ss_pred             ccccccCCC
Confidence            666666644

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-33  Score=235.68  Aligned_cols=201  Identities=21%  Similarity=0.404  Sum_probs=168.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.....  ...+.+|++.++.++|+||+++.+.+.         ..
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~---------~~   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF---------KN   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee---------cC
Confidence            5789999999999999999999998899999998854422  667889999999999999999998544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++++++|.+.+...   ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        71 ~~~~l~~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          71 TDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             CcEEEEEecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence            7799999999999999987532   34578999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.....         .........++..|++||++.+..+   +.++||||+|+++|+|++|+.||...
T Consensus       145 ~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         145 VSGQLTD---------TMAKRNTVIGTPFWMAPEVIQEIGY---NNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             cchhccc---------CccccccccCCccccCHHHHhcCCC---CchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            7542210         0001122335778999999987655   78999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.4e-34  Score=238.29  Aligned_cols=196  Identities=19%  Similarity=0.357  Sum_probs=155.3

Q ss_pred             EeccCCceEEEEEEe--cCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         33 KIGEGGFSTVSLIEH--SQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +||+|+||.||+|.+  ..++..||+|.+.....  .....+.+|+.+++.++||||+++++.+.          ....+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------~~~~~   71 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE----------AESWM   71 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc----------CCCcE
Confidence            589999999999965  45678899998754432  23557788999999999999999987432          24578


Q ss_pred             EEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        109 MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +++|++++++|.+++..    ...+++..+..++.|++.||.|+|++   |++|+||||+||+++.++.++++|||.+..
T Consensus        72 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~  144 (257)
T cd05116          72 LVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  144 (257)
T ss_pred             EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccc
Confidence            99999999999988753    24588999999999999999999998   899999999999999999999999997653


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ....      ...........++..|+|||.+.+..+   +.++|+||||+++||+++ |+.||.+.
T Consensus       145 ~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         145 LGAD------ENYYKAKTHGKWPVKWYAPECMNYYKF---SSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             cCCC------CCeeeecCCCCCCccccCHhHhccCCc---CchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2110      000001112233568999999876554   789999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-33  Score=236.63  Aligned_cols=205  Identities=25%  Similarity=0.328  Sum_probs=170.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|+..+.||.|++|.||++.+..++..+|+|.+..... .....+.+|++.++.++||||+++++.+...       ..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------~~   73 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE-------SS   73 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc-------CC
Confidence            579999999999999999999999999999998865433 3456688999999999999999998865432       23


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++++||+++++|.+.+.........++...+..++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence            568999999999999988765444455688899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+......           ......++..|++||.+.+..+   +.++|+||+|+++|+|++|..||...
T Consensus       151 ~~~~~~~~-----------~~~~~~~~~~y~~pE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         151 VSGELVNS-----------LAGTFTGTSFYMAPERIQGKPY---SITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cccccccc-----------ccccccCCccccCHHHhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            75432110           0012235677999999987665   78999999999999999999999754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-33  Score=237.79  Aligned_cols=206  Identities=25%  Similarity=0.382  Sum_probs=164.1

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh---------HHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---------QAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---------~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +|.+...||+|++|.||+|.+..++..||+|.+.......         .+.+.+|++++++++||||+++++.+.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            3667789999999999999998899999999885433221         245678999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++++||+++++|.+.+..    ...++...+..++.|++.||.|+|++   |++|+||+|+||+++.++.
T Consensus        77 -----~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~  144 (267)
T cd06628          77 -----DADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGG  144 (267)
T ss_pred             -----eCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCC
Confidence                 34678999999999999988853    24478888999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++++|||.+..........   ..........++..|+|||.+.+..+   +.++|+||+|+++|+|++|+.||.+.
T Consensus       145 ~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         145 IKISDFGISKKLEANSLST---KTNGARPSLQGSVFWMAPEVVKQTSY---TRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             EEecccCCCcccccccccC---CccccccccCCCcCccChhHhccCCC---CchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            9999999765321110000   00001112346778999999987655   78999999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-33  Score=235.77  Aligned_cols=209  Identities=23%  Similarity=0.295  Sum_probs=166.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +..+.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|++.++.++|+||+++++.+.         
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------   75 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS---------   75 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec---------
Confidence            44555666678999999999999999999999999987776666778889999999999999999998544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~  181 (282)
                      .....++++|++++++|.+.+.... .....+...+..++.|++.|+.|||++   |++|+||||+||+++. ++.++++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          76 ENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence            3478999999999999999886421 111127788889999999999999998   8999999999999976 6789999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....         ..........++..|+|||++..... .++.++|+||+|+++|++++|..||...
T Consensus       152 dfg~~~~~~---------~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         152 DFGTSKRLA---------GINPCTETFTGTLQYMAPEVIDKGPR-GYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             cchhheecc---------cCCCccccCCCCccccChhhhccccc-cCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            999654210         00011112346788999999865432 1378999999999999999999999754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=238.72  Aligned_cols=206  Identities=21%  Similarity=0.332  Sum_probs=165.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++.+.||+|+||.||+|.+..++.    .||+|.+..... .....+.+|++.++.++||||+++++.+..   
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence            456889999999999999999999866554    689998765543 345678899999999999999999985432   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++||+++++|.+.+...   ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.
T Consensus        81 -------~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~  147 (279)
T cd05057          81 -------SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH  147 (279)
T ss_pred             -------CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCe
Confidence                   5689999999999999987632   23488999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+......       ..........++..|++||.+....+   +.++|+||||+++||+++ |..||.+.
T Consensus       148 ~kL~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~~~~  215 (279)
T cd05057         148 VKITDFGLAKLLDVD-------EKEYHAEGGKVPIKWMALESILHRIY---THKSDVWSYGVTVWELMTFGAKPYEGI  215 (279)
T ss_pred             EEECCCcccccccCc-------ccceecCCCcccccccCHHHhhcCCc---CchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999976532100       00000111223567999999876655   789999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0596|consensus

Probab=100.00  E-value=1.5e-34  Score=251.57  Aligned_cols=236  Identities=27%  Similarity=0.386  Sum_probs=176.1

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCC-CCCccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFV-HPNILPLLDHAL   93 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~   93 (282)
                      ..+-+.++...|+++++||+||.+.||++... ....||+|++....  ......+.+|+++|.+|+ |.+|+.++++=+
T Consensus       352 ~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  352 ANEIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             cCeeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            35677889999999999999999999999985 34456777765433  334557899999999995 999999998543


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                               .++.+|+|||+= +-+|.+.|.....   .++...+..+..|++.++.++|+.   ||||.||||.|+|+ 
T Consensus       431 ---------~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-  493 (677)
T KOG0596|consen  431 ---------TDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-  493 (677)
T ss_pred             ---------cCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-
Confidence                     358899999965 6678888865422   233347888999999999999999   89999999999998 


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc--------CCCCccchhhHHHHHHHHH
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC--------VVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~--------~~~~~~Diws~G~il~el~  245 (282)
                      ..|.+|++|||.+.....       +....-..+..||++||+||++....+.        -++.+|||||+|||||+|+
T Consensus       494 VkG~LKLIDFGIA~aI~~-------DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv  566 (677)
T KOG0596|consen  494 VKGRLKLIDFGIANAIQP-------DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV  566 (677)
T ss_pred             EeeeEEeeeechhcccCc-------cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence            579999999997653211       1111112345789999999999765542        1467999999999999999


Q ss_pred             hCCCCCCccccCccceeeeeeec--cccCCCCCCC
Q psy16951        246 YFKSPFDTVYERGDSVALAVISG--NITFPENTPF  278 (282)
Q Consensus       246 tg~~pf~~~~~~~~~~~~~~~~~--~~~~p~~~~~  278 (282)
                      +|++||..+...-..+ .++...  .+++|+-++.
T Consensus       567 YgktPf~~~~n~~aKl-~aI~~P~~~Iefp~~~~~  600 (677)
T KOG0596|consen  567 YGKTPFGQIINQIAKL-HAITDPNHEIEFPDIPEN  600 (677)
T ss_pred             hcCCchHHHHHHHHHH-HhhcCCCccccccCCCCc
Confidence            9999998653322222 233333  3466654443

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-33  Score=238.64  Aligned_cols=212  Identities=18%  Similarity=0.278  Sum_probs=168.9

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecC----CCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQ----TKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .+..++|++.+.||+|+||.||+|.+..    ++..|++|.+.... ......+.+|+..++.++|+||+++++.+..  
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE--   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            4678999999999999999999999865    35789999876442 3345567889999999999999999886543  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG----KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                            .....++++|++++++|.+.+......    ...++..+++.++.|++.||.|||++   +++|+||||+||++
T Consensus        80 ------~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~  150 (280)
T cd05043          80 ------DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVI  150 (280)
T ss_pred             ------CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEE
Confidence                  235688999999999999987643211    14578999999999999999999998   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.++.++++|||+++........       .......++..|+|||++.+..+   +.++||||||+++||+++ |+.||
T Consensus       151 ~~~~~~kl~d~g~~~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~  220 (280)
T cd05043         151 DEELQVKITDNALSRDLFPMDYH-------CLGDNENRPVKWMALESLVNKEY---SSASDVWSFGVLLWELMTLGQTPY  220 (280)
T ss_pred             cCCCcEEECCCCCcccccCCceE-------EeCCCCCcchhccCHHHHhcCCC---CchhhHHHhHHHHHHHhcCCCCCc
Confidence            99999999999986532111000       00011234567999999987665   889999999999999999 99999


Q ss_pred             Ccc
Q psy16951        252 DTV  254 (282)
Q Consensus       252 ~~~  254 (282)
                      ...
T Consensus       221 ~~~  223 (280)
T cd05043         221 VEI  223 (280)
T ss_pred             CcC
Confidence            754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0196|consensus

Probab=100.00  E-value=1.7e-35  Score=265.94  Aligned_cols=235  Identities=21%  Similarity=0.320  Sum_probs=184.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCC---ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTK---KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .|......+.++||.|.||+|++|+.+..+   ..||||.++.... +.+.+|+.|+-+|.+++||||+++.|       
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEG-------  697 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEG-------  697 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEE-------
Confidence            355566778899999999999999987666   5599999876543 44668999999999999999999998       


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                        +.-+..-.+++.||+++|+|+.+|....   ..+...|+..+++.|+.|++||.+.   |.|||||..+|||++.+--
T Consensus       698 --VVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLv  769 (996)
T KOG0196|consen  698 --VVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLV  769 (996)
T ss_pred             --EEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceE
Confidence              4445577999999999999999887543   3488889999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      ||++|||+++...-.  . ......   ..-.-+.+|.|||++....+   +.+|||||+|++|||.++ |..||=+-  
T Consensus       770 CKVsDFGLSRvledd--~-~~~ytt---~GGKIPiRWTAPEAIa~RKF---TsASDVWSyGIVmWEVmSyGERPYWdm--  838 (996)
T KOG0196|consen  770 CKVSDFGLSRVLEDD--P-EAAYTT---LGGKIPIRWTAPEAIAYRKF---TSASDVWSYGIVMWEVMSYGERPYWDM--  838 (996)
T ss_pred             EEeccccceeecccC--C-Cccccc---cCCccceeecChhHhhhccc---CchhhccccceEEEEecccCCCccccc--
Confidence            999999998632100  0 000000   00111567999999987765   899999999999999877 99998542  


Q ss_pred             Cccceeee-eeeccccCCCCCCCCCCC
Q psy16951        257 RGDSVALA-VISGNITFPENTPFPQYQ  282 (282)
Q Consensus       257 ~~~~~~~~-~~~~~~~~p~~~~~~~~~  282 (282)
                      ..+++... ..+.+.+-|-++|..+||
T Consensus       839 SNQdVIkaIe~gyRLPpPmDCP~aL~q  865 (996)
T KOG0196|consen  839 SNQDVIKAIEQGYRLPPPMDCPAALYQ  865 (996)
T ss_pred             chHHHHHHHHhccCCCCCCCCcHHHHH
Confidence            12223333 345578888899988775

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.8e-33  Score=239.29  Aligned_cols=204  Identities=25%  Similarity=0.336  Sum_probs=162.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|.+.+.||+|+||.||+|....++..||+|.+...... ....+.+|+..++.++|+||+++.+.+.         .
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~---------~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH---------T   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe---------c
Confidence            36899999999999999999999999999999988654332 2345678999999999999999988543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+. +++.+.+..   ....+.+..+..++.|++.||.|||++   +++|+||||+||+++.++.++++||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence            467999999995 677665542   223467888889999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |.+.....         .........++..|+|||++.+...  .+.++|+||+|+++|++++|..||.+..
T Consensus       148 g~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         148 GLARAKSI---------PSQTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccccccCC---------CCCCCCCccccccccCCceeecCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            97642110         0011112235778999999875431  2678999999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.9e-34  Score=243.04  Aligned_cols=199  Identities=20%  Similarity=0.335  Sum_probs=165.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +.|+....||+|+||.||++.+..++..||+|.+..........+.+|+..++.++|||++++++.+.         ...
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~---------~~~   91 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL---------VGE   91 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee---------eCC
Confidence            44556678999999999999998899999999987665556667889999999999999999998544         347


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+++++|...+..     ..+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|||+
T Consensus        92 ~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~  163 (297)
T cd06659          92 ELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGF  163 (297)
T ss_pred             eEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechh
Confidence            89999999999999886642     3478999999999999999999999   899999999999999999999999996


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +....         ..........++..|+|||++.+..+   +.++|+||+|+++|||++|+.||..
T Consensus       164 ~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         164 CAQIS---------KDVPKRKSLVGTPYWMAPEVISRTPY---GTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             Hhhcc---------cccccccceecCccccCHHHHccCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            53210         00111123456888999999987655   7899999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-33  Score=237.78  Aligned_cols=201  Identities=25%  Similarity=0.372  Sum_probs=165.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||+|.+..++..||+|++....  ......+.+|+.+++.++|||++++++.+.         ..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---------~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP---------HG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe---------cC
Confidence            5899999999999999999999999999999986554  333457888999999999999999998543         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+|++ +++|.+.+...   ...+++.++..++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence            7899999999 99999877642   24588999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+......        .........++..|+|||.+.+...  .+.++||||+|+++||+++|.+||.+
T Consensus       145 ~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         145 LARLFSEE--------EPRLYSHQVATRWYRAPELLYGARK--YDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             ecccccCC--------CCCccccccCcccccCceeeecccc--CCchhHHHHHHHHHHHHHcCCcCcCC
Confidence            75422110        0011122356788999999865432  37899999999999999999888864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-33  Score=236.39  Aligned_cols=208  Identities=20%  Similarity=0.301  Sum_probs=164.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      |..++|+..+.||+|+||.||+|....++.   .+|+|.+.... ....+.+.+|++.++.++|+|++++.+.+.     
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   76 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----   76 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----
Confidence            456789999999999999999999876554   78999886543 344567888999999999999999988443     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++++||+++++|.+.+..   ....+++.++..++.|++.|+.|+|++   |++|+||||+||+++.++.+
T Consensus        77 ----~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~  146 (268)
T cd05063          77 ----KFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC  146 (268)
T ss_pred             ----cCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence                34678999999999999987753   224578899999999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +++|||.+......    ..  ..........+..|+|||++.+..+   +.++|+||||+++||+++ |..||...
T Consensus       147 kl~dfg~~~~~~~~----~~--~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         147 KVSDFGLSRVLEDD----PE--GTYTTSGGKIPIRWTAPEAIAYRKF---TSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             EECCCccceecccc----cc--cceeccCCCcCceecCHHHhhcCCc---ChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999975432100    00  0000011122456999999987655   789999999999999997 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-33  Score=237.36  Aligned_cols=194  Identities=25%  Similarity=0.353  Sum_probs=159.3

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||+||++.+..++..||+|.+....   ......+.+|+++++.++||||+++.+.         +......+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~---------~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA---------FETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeE---------EecCCeEEEE
Confidence            699999999999999999999999885432   2234456789999999999999999874         3345789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+.+....  ...+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++|||.+....
T Consensus        72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          72 MTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             EecCCCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            99999999998876432  23588999999999999999999999   89999999999999999999999999654210


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                                .........++..|++||++.+..+   +.++|+||+|+++|+|++|+.||...
T Consensus       147 ----------~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         147 ----------GGKKIKGRAGTPGYMAPEVLQGEVY---DFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             ----------cCCccccccCCCCcCCHHHhcCCCC---CchhhhHHHHHHHHHHhhCCCCCCCC
Confidence                      0111123346778999999987665   78999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-33  Score=240.90  Aligned_cols=215  Identities=23%  Similarity=0.361  Sum_probs=168.7

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecC-------CCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-------TKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILP   87 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~   87 (282)
                      ....|.+..++|.+.+.||+|+||.||+|++..       ++..||+|.+.... ......+.+|+..++.+ +||||++
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101           6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             cCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchh
Confidence            445678999999999999999999999997532       34579999875332 34456788999999999 8999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      +++.+.         .....++++||+++++|.+++.....            ....++...+..++.|++.||.|||++
T Consensus        86 ~~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~  156 (304)
T cd05101          86 LLGACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ  156 (304)
T ss_pred             eeEEEe---------cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC
Confidence            998543         34678999999999999998865311            113467788899999999999999999


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchh
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVW  235 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diw  235 (282)
                         |++||||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++|||
T Consensus       157 ---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~  223 (304)
T cd05101         157 ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNI-------DYYKKTTNGRLPVKWMAPEALFDRVY---THQSDVW  223 (304)
T ss_pred             ---CeeecccccceEEEcCCCcEEECCCccceecccc-------cccccccCCCCCceeeCchhhccCCC---CchhhHH
Confidence               8999999999999999999999999976432100       00011112234567999999987665   7899999


Q ss_pred             hHHHHHHHHHh-CCCCCCc
Q psy16951        236 SLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       236 s~G~il~el~t-g~~pf~~  253 (282)
                      |||+++|++++ |..||.+
T Consensus       224 slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         224 SFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             HHHHHHHHHHcCCCCCccc
Confidence            99999999998 7888865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.4e-33  Score=234.97  Aligned_cols=202  Identities=25%  Similarity=0.355  Sum_probs=169.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++.+.||+|++|.||+|.+..++..||+|++..... .....+.+|+..++.++|+|++++++.+..         .
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------~   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK---------E   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc---------C
Confidence            478999999999999999999999999999999876654 445678899999999999999999985543         4


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...++++||+++++|.+.+...    ..+++..++.++.|++.|+.|+|+ +   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            7899999999999999988642    558999999999999999999999 8   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |.+......         ........++..|+|||.+....+   +.++|+||||+++|++++|+.||....
T Consensus       145 ~~~~~~~~~---------~~~~~~~~~~~~y~~pE~~~~~~~---~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         145 GISKVLENT---------LDQCNTFVGTVTYMSPERIQGESY---SYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             ccceecccC---------CCcccceeecccccCHhhhCCCCC---CchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            975432110         001112345778999999877654   789999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-33  Score=234.67  Aligned_cols=200  Identities=25%  Similarity=0.331  Sum_probs=164.4

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-----hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-----EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|+..+.||+|+||+||+|....++.+|++|.+.....     .....+.+|++.++.++|+||+++.+.+         
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~---------   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE---------   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE---------
Confidence            46778899999999999999988999999998865432     2345678899999999999999999843         


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .+....++++||+++++|.+.+..    ...++...+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++++
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            344679999999999999987753    23478889999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+......          .......++..|++||.+....  ..+.++|+||+|+++|++++|+.||...
T Consensus       145 d~~~~~~~~~~----------~~~~~~~~~~~y~~pe~~~~~~--~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         145 DFGMAKQVVEF----------SFAKSFKGSPYWMAPEVIAQQG--GYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             cCccceecccc----------ccccccCCCcceeCHHHhcCCC--CCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            99965421100          0112345678899999987654  1378999999999999999999999754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-33  Score=236.31  Aligned_cols=199  Identities=21%  Similarity=0.352  Sum_probs=159.6

Q ss_pred             EEeccCCceEEEEEEecC-C--CceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQ-T--KKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~-~--~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|++|.||+|.+.. .  ...||||.+..... .....+.+|+..+++++||||+++++.+.         . ...
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------~-~~~   70 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL---------T-HPL   70 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc---------C-CeE
Confidence            368999999999999855 2  34699998876655 55667889999999999999999987432         2 678


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++|++++++|.+.+.....  ..+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|||.+.
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040          71 MMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             EEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccc
Confidence            999999999999998864321  4578999999999999999999999   89999999999999999999999999765


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ......    ..  ........++..|+|||++.+..+   +.++||||||+++|||++ |..||...
T Consensus       146 ~~~~~~----~~--~~~~~~~~~~~~y~~pE~~~~~~~---~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         146 ALPQNE----DH--YVMEEHLKVPFAWCAPESLRTRTF---SHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             cccccc----cc--eecccCCCCCceecCHHHhcccCc---CchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            321100    00  000112345678999999887665   789999999999999998 99999643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1006|consensus

Probab=100.00  E-value=1.6e-35  Score=237.11  Aligned_cols=229  Identities=22%  Similarity=0.298  Sum_probs=178.6

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCcccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDHALT   94 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~   94 (282)
                      ...-+....++.+-+..||.|+||+|++..|+.+|+..|||+|+..+. ++..+++.|.+...+- +.|||++++|..+.
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            344567778888889999999999999999999999999999987665 6677888888865544 68999999996554


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELR-SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                               ++.-|+.||.+ .-|++.+.... ......+++..+-.+..-...||.||-...  .|+|||+||+|||++
T Consensus       135 ---------EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILld  202 (361)
T KOG1006|consen  135 ---------EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLD  202 (361)
T ss_pred             ---------CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEe
Confidence                     57789999988 67777655432 334456888887777777889999998765  789999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ..|.+|++|||.+.          +-........-.|..+|||||.+....- -+.-+|||||+|++|+|++||..||..
T Consensus       203 r~G~vKLCDFGIcG----------qLv~SiAkT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  203 RHGDVKLCDFGICG----------QLVDSIAKTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             cCCCEeeecccchH----------hHHHHHHhhhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCCCcch
Confidence            99999999999742          2222222334467889999999965432 237799999999999999999999987


Q ss_pred             cccCccceeeeeeec
Q psy16951        254 VYERGDSVALAVISG  268 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~  268 (282)
                      -++.-+++...+.+.
T Consensus       272 w~svfeql~~Vv~gd  286 (361)
T KOG1006|consen  272 WDSVFEQLCQVVIGD  286 (361)
T ss_pred             HHHHHHHHHHHHcCC
Confidence            655444444334433

>KOG0662|consensus

Probab=100.00  E-value=2e-34  Score=218.83  Aligned_cols=203  Identities=26%  Similarity=0.394  Sum_probs=166.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.|+-.++||+|.||+||+|+.+.|.+.||+|.++..+..  ...+..+|+.+++.++|+||+++++         +..+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~d---------vlhs   72 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD---------VLHS   72 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhh---------hhcc
Confidence            3566678999999999999999999999999998765443  3567899999999999999999998         5566


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+.+|+||| +..|..+..   ..+..+....+..++.|++.||.++|++   +++|||+||.|.+++.+|..|++||
T Consensus        73 dkkltlvfe~c-dqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   73 DKKLTLVFEFC-DQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             CceeEEeHHHh-hHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEeccc
Confidence            78899999999 445655544   3556789999999999999999999999   7889999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~  255 (282)
                      |+++.+.+..  .+.       ....-|..|.+|.++.|...  +++.-|+||.|||+.|++. |.+.|.+.+
T Consensus       146 glarafgipv--rcy-------saevvtlwyrppdvlfgakl--y~tsidmwsagcifaelanagrplfpg~d  207 (292)
T KOG0662|consen  146 GLARAFGIPV--RCY-------SAEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_pred             chhhhcCCce--Eee-------eceeeeeeccCcceeeeeeh--hccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence            9876322111  111       12344778999999987653  5889999999999999987 778887643

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=241.01  Aligned_cols=210  Identities=22%  Similarity=0.360  Sum_probs=164.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCC--------------CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQT--------------KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILP   87 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~   87 (282)
                      ++.++|++.+.||+|+||.||++++.++              ...||+|.+.... ......+.+|++++++++|+|+++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            4567999999999999999999987543              2358999886543 233456889999999999999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--------GKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +++.+..         ....+++|||+++++|.+++.....        ....++..+++.++.|++.||.|||++   +
T Consensus        82 ~~~~~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  149 (295)
T cd05097          82 LLGVCVS---------DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---N  149 (295)
T ss_pred             EEEEEcC---------CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---C
Confidence            9985543         4678999999999999998854311        012357788899999999999999998   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      ++|+||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++|+||||+
T Consensus       150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlG~  219 (295)
T cd05097         150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG-------DYYRIQGRAVLPIRWMAWESILLGKF---TTASDVWAFGV  219 (295)
T ss_pred             eeccccChhhEEEcCCCcEEecccccccccccC-------cceeccCcCcCceeecChhhhccCCc---CchhhHHHHHH
Confidence            999999999999999999999999976432100       00011112234667999999877655   88999999999


Q ss_pred             HHHHHHh--CCCCCCcc
Q psy16951        240 LLYAMCY--FKSPFDTV  254 (282)
Q Consensus       240 il~el~t--g~~pf~~~  254 (282)
                      ++|+|++  +..||...
T Consensus       220 ~l~el~~~~~~~p~~~~  236 (295)
T cd05097         220 TLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             HHHHHHHcCCCCCCccc
Confidence            9999988  56788753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.6e-33  Score=233.62  Aligned_cols=198  Identities=21%  Similarity=0.321  Sum_probs=158.5

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      +.||+|+||.||+|.+..++..||+|.+.... ......+.+|+++++.++||||+++++.+.         .....++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT---------QKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---------CCCCeEEE
Confidence            36999999999999999999999999875433 334567889999999999999999998543         34678999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+++..   ....+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|||.+....
T Consensus        72 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          72 MELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             EeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence            999999999988753   233578899999999999999999999   89999999999999999999999999754211


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ..    ..   .........+..|+|||.+.+..+   +.++|+||+|+++||+++ |..||...
T Consensus       146 ~~----~~---~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         146 DG----VY---ASTGGMKQIPVKWTAPEALNYGRY---SSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             cc----cc---cccCCCCCCceeecCchhhcCCCC---ChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            00    00   000011122456999999987665   789999999999999998 88999653

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-33  Score=234.12  Aligned_cols=201  Identities=25%  Similarity=0.449  Sum_probs=164.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.++.++|++.+.||+|+||.||++..  .+..||+|.+...  .....+.+|+..++.++|+|++++++.+..      
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------   70 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE------   70 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc------
Confidence            457788999999999999999999987  4677999987533  234567889999999999999999875432      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++++||+++++|.+.+...  ....+++..++.++.|++.||.|+|++   |++|+||||+||+++.++.+++
T Consensus        71 --~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl  143 (256)
T cd05082          71 --EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKV  143 (256)
T ss_pred             --CCCceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEe
Confidence              235689999999999999987643  223478889999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      +|||.+.....            ......++..|+|||++.+..+   +.++||||||+++|+|++ |+.||..
T Consensus       144 ~dfg~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         144 SDFGLTKEASS------------TQDTGKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             cCCccceeccc------------cCCCCccceeecCHHHHccCCC---CchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99997542110            0011223456999999977655   789999999999999997 9999964

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0604|consensus

Probab=100.00  E-value=1.4e-34  Score=235.10  Aligned_cols=223  Identities=28%  Similarity=0.436  Sum_probs=179.7

Q ss_pred             cccEEEE-EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|.+- ++||-|-.|.|-.+.++.|+..+|+|.+     .+.....+|+++.-.. .|||||.+++.+-.     .+.
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL-----~Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-----s~~  129 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVL-----LDSPKARREVELHWMASGHPHIVSIIDVYEN-----SYQ  129 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHH-----hcCHHHHhHhhhhhhhcCCCceEEeehhhhh-----hcc
Confidence            3455544 5799999999999999999999999976     3455667889976555 69999999987655     455


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~  179 (282)
                      ....+.+|||.+.||.|.+.++.+  +...+.+.++..++.||..|+.|||+.   +|+||||||+|+|...   +...|
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence            677899999999999999998865  345589999999999999999999999   8999999999999854   45678


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc--cC
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY--ER  257 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~--~~  257 (282)
                      ++|||+++..          ...........|+.|.|||++--+.|   +..+|+||+||++|-|++|.+||+..-  ..
T Consensus       205 LtDfGFAK~t----------~~~~~L~TPc~TPyYvaPevlg~eKy---dkscdmwSlgVimYIlLCGyPPFYS~hg~ai  271 (400)
T KOG0604|consen  205 LTDFGFAKET----------QEPGDLMTPCFTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  271 (400)
T ss_pred             eccccccccc----------CCCccccCCcccccccCHHHhCchhc---CCCCCccchhHHHHHhhcCCCcccccCCccC
Confidence            9999986532          11222334556899999999977776   889999999999999999999998632  23


Q ss_pred             ccceeeeeeeccccCCCC
Q psy16951        258 GDSVALAVISGNITFPEN  275 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~  275 (282)
                      ...+..+|..+.+.||+.
T Consensus       272 spgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  272 SPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             ChhHHhHhhccCccCCCh
Confidence            345667788888888854

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.4e-33  Score=234.81  Aligned_cols=205  Identities=21%  Similarity=0.359  Sum_probs=163.4

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +|.+.+.||+|+||+||+|.. .++..+|+|.+.....      .....+.+|++.++.++|+||+++.+.+.       
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-------   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-------
Confidence            477889999999999999987 5788999998864321      12245778999999999999999998543       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++++||+++++|.+++..    ...+++..+..++.|++.||.|+|+.   +++|+||+|+||+++.++.+++
T Consensus        73 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  143 (265)
T cd06631          73 --DDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKL  143 (265)
T ss_pred             --cCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEe
Confidence              34789999999999999988753    23478899999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+........   ............++..|+|||++.+..+   +.++|+||+|+++|++++|+.||...
T Consensus       144 ~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         144 IDFGCARRLAWVGL---HGTHSNMLKSMHGTPYWMAPEVINESGY---GRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             ccchhhHhhhhccc---cccccccccccCCCccccChhhhcCCCC---cchhhHHHHHHHHHHHHhCCCccccC
Confidence            99997543211000   0000111123356888999999987665   78999999999999999999999753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-33  Score=234.03  Aligned_cols=202  Identities=26%  Similarity=0.459  Sum_probs=166.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.+..++|++.+.||+|+||.||+|..  .+..||+|.+..... ....+.+|+.+++.++|+||+++++.+.       
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------   70 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-------   70 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-------
Confidence            346788999999999999999999988  477899998865544 4567889999999999999999998543       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++++|++++++|.+.+...  ....+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.+++
T Consensus        71 --~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l  143 (256)
T cd05039          71 --QGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV  143 (256)
T ss_pred             --CCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEE
Confidence              346799999999999999988643  223588999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+....            ........+..|+|||++....+   +.++|+||||+++||+++ |..||...
T Consensus       144 ~d~g~~~~~~------------~~~~~~~~~~~~~ape~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         144 SDFGLAKEAS------------QGQDSGKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             cccccccccc------------cccccCCCcccccCchhhcCCcC---CcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999764321            00012233567999999876655   789999999999999997 99999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-33  Score=235.86  Aligned_cols=210  Identities=21%  Similarity=0.369  Sum_probs=162.8

Q ss_pred             EEEEEeccCCceEEEEEEecCCCc--eEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTKK--RYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.+.||+|+||.||+|.+..++.  .||+|.+...  .....+.+.+|++.++.++|+||+++++.+.....   ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE---SEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc---ccCC
Confidence            467889999999999999877664  6899987543  23445678889999999999999999987654211   1122


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSV--GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ...++++||+.+++|.+.+.....  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.++++|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence            457899999999999887753321  224578899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ||.+.......       ..........+..|++||+..+..+   +.++||||||+++||+++ |+.||.+.
T Consensus       156 fg~~~~~~~~~-------~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         156 FGLSKKIYNGD-------YYRQGRIAKMPVKWIAIESLADRVY---TTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             CCcccccCccc-------ceecCCcccCCcccCCHHHccCCCc---ChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99765321100       0000112234667999999987665   889999999999999999 88999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-33  Score=236.96  Aligned_cols=203  Identities=23%  Similarity=0.369  Sum_probs=153.0

Q ss_pred             EeccCCceEEEEEEec--CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         33 KIGEGGFSTVSLIEHS--QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +||+|+||+||+|...  .....+|+|.+..... .....+.+|++.++.++|+||+++++.+.         .....++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~---------~~~~~~l   72 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI---------ESIPYLL   72 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC---------CCCceEE
Confidence            5899999999999643  2445788997764433 33456788999999999999999998544         3467999


Q ss_pred             EeccCCCCChHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        110 VLPYYPKGTLANDLELRSV-GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +|||+++++|.+++..... .....++..+..++.|++.|+.|+|++   +++||||||+||+++.++.++++|||.+..
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccc
Confidence            9999999999998864321 112345677889999999999999999   899999999999999999999999997542


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc----cCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY----CVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~----~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ....       ..........++..|+|||++.....    ...+.++||||+|+++|||++ |..||...
T Consensus       150 ~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         150 QYPE-------DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             cccc-------hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            1100       00001122234667999999754211    123779999999999999999 77898753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.7e-33  Score=237.84  Aligned_cols=200  Identities=22%  Similarity=0.328  Sum_probs=166.1

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ..|+.+++||.|+||.||+|.+..++..||+|.+.... ......+.+|++.++.++||||+++.+.+.         +.
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~   74 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL---------KG   74 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE---------EC
Confidence            46788899999999999999999999999999886543 334556788999999999999999998544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+|++++++|.+.+..     ..+++.++..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        75 ~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          75 TKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence            689999999999999987742     3478889999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+......         ........++..|+|||++.+...   +.++|+||||+++|||++|+.||...
T Consensus       147 ~~~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         147 VAGQLTDT---------QIKRNTFVGTPFWMAPEVIQQSAY---DSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             cceeccCC---------ccccccccCcccccCHhHhccCCC---ccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            76432110         011122345778999999977654   78999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4278|consensus

Probab=100.00  E-value=2.5e-34  Score=253.31  Aligned_cols=243  Identities=19%  Similarity=0.291  Sum_probs=193.7

Q ss_pred             hcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         13 GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        13 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      +-+-.-+.|.+.+.+..+-.+||-|.||.||.|.|+.....||||.++.. .-..++|+.|+.+|+.++|||++.+++.|
T Consensus       254 gvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  254 GVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             eecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            33445588999999999999999999999999999999999999987533 33567899999999999999999999965


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ..         +.-+|||.||++.|.|.++|...  ....++.-.++.++.||..|+.||..+   +.+||||-.+|+|+
T Consensus       333 T~---------EpPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLV  398 (1157)
T KOG4278|consen  333 TH---------EPPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLV  398 (1157)
T ss_pred             cc---------CCCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccc
Confidence            54         46799999999999999988654  233466777888899999999999999   78899999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      ..+..+|++|||+++++.-.....        .....-+..|.|||.+..+.   ++.|+|||+||++|||++| |-.||
T Consensus       399 gEnhiVKvADFGLsRlMtgDTYTA--------HAGAKFPIKWTAPEsLAyNt---FSiKSDVWAFGVLLWEIATYGMsPY  467 (1157)
T KOG4278|consen  399 GENHIVKVADFGLSRLMTGDTYTA--------HAGAKFPIKWTAPESLAYNT---FSIKSDVWAFGVLLWEIATYGMSPY  467 (1157)
T ss_pred             cccceEEeeccchhhhhcCCceec--------ccCccCcccccCcccccccc---cccchhhHHHHHHHHHHHhcCCCCC
Confidence            999999999999987542211111        11112245699999997655   4899999999999999998 77899


Q ss_pred             CccccCccceeeeeeeccccCCCCCCCCCCC
Q psy16951        252 DTVYERGDSVALAVISGNITFPENTPFPQYQ  282 (282)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  282 (282)
                      .+++- .+-..+-..+.++.-|++||+++|+
T Consensus       468 PGidl-SqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  468 PGIDL-SQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             CCccH-HHHHHHHhccccccCCCCCCHHHHH
Confidence            76422 1111222355688999999998873

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7e-33  Score=233.75  Aligned_cols=203  Identities=21%  Similarity=0.372  Sum_probs=163.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +|+..+.||+|+||.||++....++..||+|.+.....      .....+.+|+..++.++|+||+++++.+        
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--------   72 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--------   72 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--------
Confidence            47788999999999999999999999999998864321      1245678899999999999999999843        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cce
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPL  179 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~  179 (282)
                       ......++++||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++|+||+|+||+++.++ .++
T Consensus        73 -~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          73 -CEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             -ccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence             345789999999999999988763    23578899999999999999999999   899999999999998776 589


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+......    ... .........++..|+|||.+.+..+   +.++|+||+|+++|++++|..||..
T Consensus       145 l~dfg~~~~~~~~----~~~-~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         145 IADFGAAARLAAK----GTG-AGEFQGQLLGTIAFMAPEVLRGEQY---GRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             Ecccccccccccc----ccc-CCccccccccccceeCHhHhccCCC---CcccchHHHHHHHHHHHhCCCCCCC
Confidence            9999975432110    000 0000112346778999999977665   7899999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-33  Score=239.92  Aligned_cols=206  Identities=21%  Similarity=0.331  Sum_probs=163.5

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|+..+.||+|+||.||+|.+..++.    .||+|.+..... .....+.+|+.+++.++||||+++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---
Confidence            456789999999999999999999877765    578887764433 234467889999999999999999986543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++|+|.+.+..   ....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.
T Consensus        81 -------~~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~  147 (303)
T cd05110          81 -------PTIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH  147 (303)
T ss_pred             -------CCceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence                   236789999999999987753   233578889999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|++|||.+......       ..........++..|++||++.+..+   +.++||||||+++||+++ |..||.+.
T Consensus       148 ~kL~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         148 VKITDFGLARLLEGD-------EKEYNADGGKMPIKWMALECIHYRKF---THQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             eEEccccccccccCc-------ccccccCCCccccccCCHHHhccCCC---ChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999976532100       00001112234667999999987665   889999999999999997 88999753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.8e-33  Score=235.80  Aligned_cols=214  Identities=21%  Similarity=0.279  Sum_probs=169.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ...+.|++.+.||+|+||.||+|.+..++..||+|.+.... .....+..|+..++++ +|+||+++++.+....   ..
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~---~~   88 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS---PP   88 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc---cc
Confidence            35679999999999999999999999999999999875443 3345677888888888 6999999998776421   11


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......+++|||+++++|.+.+...  ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence            2346799999999999999887643  234477888899999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+.....         .........++..|+|||.+....  ...++.++|+||||+++|||++|..||...
T Consensus       164 dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         164 DFGVSAQLDR---------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             eCcchhhhhc---------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            9997542110         011122345678899999986321  112377899999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.2e-33  Score=238.30  Aligned_cols=200  Identities=22%  Similarity=0.323  Sum_probs=164.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|++.++.++||||+++++.+.         ..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~   74 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL---------KG   74 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc---------cC
Confidence            34666778999999999999998899999999886443 334456788999999999999999998543         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+||+++++|.+.+.     ...+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          75 TKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence            67999999999999988764     23578899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.....         .........++..|+|||++.+..+   +.++|+||||+++||+++|..||...
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         147 VAGQLTD---------TQIKRNTFVGTPFWMAPEVIKQSAY---DFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             ccccccC---------cchhhhcccCcccccCHHHhCcCCC---chhhhHHHHHHHHHHHHhCCCCCccc
Confidence            7542210         0111122346778999999987665   78999999999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.8e-33  Score=242.60  Aligned_cols=215  Identities=23%  Similarity=0.364  Sum_probs=168.6

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCC-------CceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-------KKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPL   88 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~   88 (282)
                      ...|.+...+|.+.+.||+|+||.||+|++...       ...||+|.+.... ......+.+|+++++++ +||||+++
T Consensus         4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            467888999999999999999999999986432       2368999776432 33456788999999999 79999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAK  156 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~  156 (282)
                      ++.+.         .....++++||+++++|.+++.....            ....++..+++.++.|++.||.|||++ 
T Consensus        84 ~~~~~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-  153 (334)
T cd05100          84 LGACT---------QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-  153 (334)
T ss_pred             eEEEc---------cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            98543         34678999999999999998864311            123467788899999999999999998 


Q ss_pred             CCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhh
Q psy16951        157 PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS  236 (282)
Q Consensus       157 ~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws  236 (282)
                        |++||||||+||+++.++.++++|||.+.....       ...........++..|+|||++.+..+   +.++||||
T Consensus       154 --givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~s  221 (334)
T cd05100         154 --KCIHRDLAARNVLVTEDNVMKIADFGLARDVHN-------IDYYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWS  221 (334)
T ss_pred             --CeeccccccceEEEcCCCcEEECCcccceeccc-------ccccccccCCCcCceEcCHHHhccCCc---CchhhhHH
Confidence              899999999999999999999999997643210       000001111223467999999987765   78999999


Q ss_pred             HHHHHHHHHh-CCCCCCcc
Q psy16951        237 LGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~t-g~~pf~~~  254 (282)
                      ||+++|||++ |..||.+.
T Consensus       222 lG~il~el~~~g~~p~~~~  240 (334)
T cd05100         222 FGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             HHHHHHHHHhcCCCCCCCC
Confidence            9999999998 88999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.6e-33  Score=237.58  Aligned_cols=215  Identities=14%  Similarity=0.150  Sum_probs=154.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCCchhH-----------HHHHHHHHHhhhCCCCCccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHGREDQ-----------AQAIREVEHHKTFVHPNILP   87 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~-----------~~~~~e~~~l~~l~H~ni~~   87 (282)
                      .+..++|++.+.||+|+||+||+|.+..+   +..+|+|.....+....           .....+...+..++|+++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            35568999999999999999999998877   66777775433322111           11123334556778999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      +++.+...     .......+++++++. .++.+.+..    ....++..+..++.|++.||.|+|++   +++||||||
T Consensus        88 ~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp  154 (294)
T PHA02882         88 YYGCGSFK-----RCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKP  154 (294)
T ss_pred             EEEeeeEe-----cCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            98754331     111234567788763 355544432    12356778899999999999999999   899999999


Q ss_pred             CcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC
Q psy16951        168 ANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       168 ~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg  247 (282)
                      +||+++.++.++++|||++...........  ..........||+.|+|||+..+..+   +.++||||+|+++|||++|
T Consensus       155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~--~~~~~~~~~~gt~~y~ape~~~~~~~---~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIE--YSKEQKDLHRGTLYYAGLDAHNGACV---TRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             HHEEEcCCCcEEEEEcCCceeeccCCcccc--cccccccccCCCccccCHHHhCCCCC---CcHHHHHHHHHHHHHHHhC
Confidence            999999999999999998754321100000  00011223458999999999988776   8899999999999999999


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      +.||.+.
T Consensus       230 ~~P~~~~  236 (294)
T PHA02882        230 KLPWKGF  236 (294)
T ss_pred             CCCCCcc
Confidence            9999865

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-32  Score=229.96  Aligned_cols=201  Identities=28%  Similarity=0.485  Sum_probs=165.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....  ......+.+|++.++.++|||++++++.+         ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~---------~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF---------LED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE---------ecC
Confidence            5899999999999999999999999999999886543  33456778899999999999999998743         345


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~df  183 (282)
                      ...++++|++++++|.+.+...  ....+++..+..++.|++.|+.|+|++   |++|+||+|+||+++.++ .++++||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~  146 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDF  146 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccC
Confidence            7899999999999999988643  234578899999999999999999998   899999999999998655 4689999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+.....          ........++..|+|||.+.+..+   +.++|+||+|+++|++++|..||...
T Consensus       147 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         147 GISKILSS----------KSKAYTVVGTPCYISPELCEGKPY---NQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             CCceecCC----------CccccccccCCcccCchhccCCCC---CcccchHHHHHHHHHHHhCCCCcccC
Confidence            97643210          011112346778999999987654   78999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4e-33  Score=238.75  Aligned_cols=210  Identities=21%  Similarity=0.350  Sum_probs=166.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCC----------------ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTK----------------KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNI   85 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni   85 (282)
                      +..++|++.++||+|+||.||+|.+..++                ..||+|.+..... ...+.+.+|+++++.++||||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence            35689999999999999999998876543                5689998865543 345677889999999999999


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------GKHYMSSVDILKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~  158 (282)
                      +++++.+..         ....++++|++++++|.+++.....       ....+++..++.++.|++.||.|||++   
T Consensus        82 ~~~~~~~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---  149 (296)
T cd05051          82 ARLLGVCTV---------DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---  149 (296)
T ss_pred             eEEEEEEec---------CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---
Confidence            999985543         3678999999999999998864321       123578999999999999999999998   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHH
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG  238 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G  238 (282)
                      +++|+||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++||||||
T Consensus       150 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG  219 (296)
T cd05051         150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS-------DYYRVQGRAPLPIRWMAWESVLLGKF---TTKSDVWAFG  219 (296)
T ss_pred             CccccccchhceeecCCCceEEccccceeecccC-------cceeecCcCCCCceecCHHHhhcCCC---CccchhhhhH
Confidence            8999999999999999999999999975422100       00011122334678999999887655   8899999999


Q ss_pred             HHHHHHHh--CCCCCCcc
Q psy16951        239 CLLYAMCY--FKSPFDTV  254 (282)
Q Consensus       239 ~il~el~t--g~~pf~~~  254 (282)
                      +++||+++  +..||...
T Consensus       220 ~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         220 VTLWEILTLCREQPYEHL  237 (296)
T ss_pred             HHHHHHHhcCCCCCCCCc
Confidence            99999998  67888653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-32  Score=232.45  Aligned_cols=209  Identities=20%  Similarity=0.308  Sum_probs=168.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++.+.||.|+||+||+|....++.++|+|.+.... ......+.+|++.++.++|+|++++++.+.         ..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV---------VG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe---------eC
Confidence            57999999999999999999999899999999886433 234567889999999999999999987443         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++++++|.+.+.... ....+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~  147 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFG  147 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            78999999999999999886432 124578999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.........     .........++..|++||++.....  .+.++|+||||+++|+|++|+.||...
T Consensus       148 ~~~~~~~~~~~-----~~~~~~~~~~~~~y~~Pe~~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         148 VSASLADGGDR-----TRKVRKTFVGTPCWMAPEVMEQVHG--YDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             hHHHhccCccc-----cccccccccCChhhcChHHHccccC--cCcccchHhHhHHHHHHHhCCCCcccc
Confidence            75432111000     0011122346788999999876621  378999999999999999999999754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6e-33  Score=234.86  Aligned_cols=203  Identities=24%  Similarity=0.328  Sum_probs=162.7

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch----------hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE----------DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +|.+.+.||+|+||.||+|....++..||+|.+......          ..+.+.+|+..++.++|||++++++.+    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            578889999999999999999889999999987532111          123567799999999999999998843    


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                           ......++|+||+++++|.+.+...    ..++...+..++.|++.||.|+|++   +++|+||+|+||+++.++
T Consensus        78 -----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~  145 (272)
T cd06629          78 -----TTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADG  145 (272)
T ss_pred             -----ccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCC
Confidence                 3457899999999999999887632    4578889999999999999999998   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .++++|||.+....       ............++..|+|||++..... ..+.++|+||+|+++|++++|..||..
T Consensus       146 ~~~l~d~~~~~~~~-------~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         146 ICKISDFGISKKSD-------DIYDNDQNMSMQGSVFWMAPEVIHSYSQ-GYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             eEEEeecccccccc-------ccccccccccccCCccccCHHHhccccC-CCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            99999999754211       0000011122346788999999876541 137899999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0696|consensus

Probab=100.00  E-value=2.4e-34  Score=242.92  Aligned_cols=225  Identities=22%  Similarity=0.351  Sum_probs=178.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      -|...+|.++.+||+|+||+|-+|+.++|.+.+|||+++..-   ..+.+--..|-.++.-- +-|.++.++..      
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc------  418 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC------  418 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH------
Confidence            677889999999999999999999999999999999875321   11112112344444333 35677777763      


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                         +..-..+|+||||+.+|.|--.++..    ..+.+..+..++.+|+.||-+||++   ||+.||||.+|++++.+|+
T Consensus       419 ---FQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGH  488 (683)
T KOG0696|consen  419 ---FQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGH  488 (683)
T ss_pred             ---hhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCc
Confidence               44457899999999999998777643    4588889999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +||+|||+.+...+         .........||+.|+|||++.-.+|   +..+|.||+|++||||+.|++||.+  +.
T Consensus       489 iKi~DFGmcKEni~---------~~~TTkTFCGTPdYiAPEIi~YqPY---gksvDWWa~GVLLyEmlaGQpPFdG--eD  554 (683)
T KOG0696|consen  489 IKIADFGMCKENIF---------DGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQPPFDG--ED  554 (683)
T ss_pred             eEeeeccccccccc---------CCcceeeecCCCcccccceEEeccc---ccchhHHHHHHHHHHHHcCCCCCCC--CC
Confidence            99999998653211         1122334578999999999987766   9999999999999999999999987  44


Q ss_pred             ccceeeeeeeccccCCCCC
Q psy16951        258 GDSVALAVISGNITFPENT  276 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~~  276 (282)
                      ++.+...+...+.++|...
T Consensus       555 E~elF~aI~ehnvsyPKsl  573 (683)
T KOG0696|consen  555 EDELFQAIMEHNVSYPKSL  573 (683)
T ss_pred             HHHHHHHHHHccCcCcccc
Confidence            5667777888888888654

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.2e-33  Score=238.62  Aligned_cols=210  Identities=21%  Similarity=0.329  Sum_probs=165.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ++.++|++.+.||+|+||.||+|.+..     ++..||+|.+..... .....+.+|+..+++++||||+++++.+.   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~---   78 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA---   78 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc---
Confidence            467899999999999999999998743     678899998865433 33456888999999999999999988543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHH------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRS------------------VGKHYMSSVDILKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~  158 (282)
                            .....++++||+++++|.+.+....                  .....++..+++.++.|++.||.|+|++   
T Consensus        79 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---  149 (288)
T cd05050          79 ------VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---  149 (288)
T ss_pred             ------CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---
Confidence                  3457899999999999999886421                  1122467788899999999999999998   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHH
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG  238 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G  238 (282)
                      +++|+||+|+||+++.++.++++|||.+......       ...........+..|+|||++.+..+   +.++||||||
T Consensus       150 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG  219 (288)
T cd05050         150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-------DYYKASENDAIPIRWMPPESIFYNRY---TTESDVWAYG  219 (288)
T ss_pred             CeecccccHhheEecCCCceEECccccceecccC-------ccccccCCCccChhhcCHHHHhcCCC---CchhHHHHHH
Confidence            8999999999999999999999999975422100       00011112233567999999887665   8899999999


Q ss_pred             HHHHHHHh-CCCCCCcc
Q psy16951        239 CLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       239 ~il~el~t-g~~pf~~~  254 (282)
                      +++|||++ |..||.+.
T Consensus       220 ~il~el~~~~~~p~~~~  236 (288)
T cd05050         220 VVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999997 88898653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.5e-33  Score=235.27  Aligned_cols=203  Identities=25%  Similarity=0.404  Sum_probs=163.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +|++.++||.|++|.||+|.+..++..||||.+...... ....+.+|+++++.++|+||+++++.+.         ...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH---------TEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe---------eCC
Confidence            589999999999999999999999999999998755432 3456678999999999999999998544         346


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+++ +|.+++.... ....+++.++..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~  146 (284)
T cd07836          72 KLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL  146 (284)
T ss_pred             cEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecch
Confidence            78999999974 7877765432 124588999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +......         ........++..|++||++.+...  ++.++|+||+|+++|++++|+.||.+.
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         147 ARAFGIP---------VNTFSNEVVTLWYRAPDVLLGSRT--YSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             hhhhcCC---------ccccccccccccccChHHhcCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            5421110         011112345778999999876432  378999999999999999999999753

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-32  Score=234.77  Aligned_cols=201  Identities=28%  Similarity=0.415  Sum_probs=162.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|+.++.||.|++|.||+|.+..++..||||.+.....  .....+.+|++.+++++||||+++++.+         .+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---------~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---------HTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc---------ccC
Confidence            58999999999999999999999999999998864432  2335678899999999999999999843         345


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+. ++|...+...  ....+++.++..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            77999999995 6787766532  234578999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+......         ........++..|+|||++.+...  .+.++|+||||+++||++||+.||.+
T Consensus       146 ~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         146 LARAFGVP---------VRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             chhhcccC---------ccccccccccccccCCeEEecCCC--CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            75422110         000112234677999998876432  36789999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.8e-33  Score=238.56  Aligned_cols=209  Identities=21%  Similarity=0.328  Sum_probs=162.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecC----------------CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcc
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQ----------------TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNIL   86 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~   86 (282)
                      +.++|++.++||+|+||.||++++..                +...||+|.+..... .....+.+|++.++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            56789999999999999999986532                345689998865432 3456788999999999999999


Q ss_pred             cccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         87 PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------GKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      ++++.+..         ....++++||+++++|.+++.....       ....++..++..++.|++.|+.|+|++   |
T Consensus        83 ~~~~~~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~  150 (296)
T cd05095          83 RLLAVCIT---------SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---N  150 (296)
T ss_pred             eEEEEEec---------CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            99986543         3568999999999999988864321       112366778999999999999999999   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      ++|+||||+||+++.++.++++|||.+......    .   .........++..|++||+..+..+   +.++|+||||+
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~----~---~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~DiwSlG~  220 (296)
T cd05095         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG----D---YYRIQGRAVLPIRWMSWESILLGKF---TTASDVWAFGV  220 (296)
T ss_pred             eecccCChheEEEcCCCCEEeccCcccccccCC----c---ceeccCcCcCccccCCHHHHhcCCc---cchhhhhHHHH
Confidence            999999999999999999999999976422100    0   0000111223567999998877665   88999999999


Q ss_pred             HHHHHHh--CCCCCCcc
Q psy16951        240 LLYAMCY--FKSPFDTV  254 (282)
Q Consensus       240 il~el~t--g~~pf~~~  254 (282)
                      ++|||++  |..||...
T Consensus       221 ~l~el~~~~~~~p~~~~  237 (296)
T cd05095         221 TLWEILTLCKEQPYSQL  237 (296)
T ss_pred             HHHHHHHhCCCCCcccc
Confidence            9999998  67899753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-33  Score=239.67  Aligned_cols=209  Identities=23%  Similarity=0.362  Sum_probs=163.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecC--CCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQ--TKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+....   ........+|+++++.++||||+++++.+...      
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH------   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC------
Confidence            48899999999999999999988  89999999886532   33345667899999999999999999865431      


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec----CC
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVG-KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN----DN  176 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~----~~  176 (282)
                       ....+++|+|++. +++.+.+...... ...+++..++.++.|++.|+.|||++   +++||||||+||+++.    ++
T Consensus        75 -~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          75 -ADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             -CCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccc
Confidence             2367999999996 4666655433222 23678899999999999999999998   8999999999999999    89


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++++|||.+.......      ..........++..|+|||++.+...  ++.++|+||||+++|+|++|+.||.+.
T Consensus       150 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         150 VVKIGDLGLARLFNAPL------KPLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             eEEECCCccccccCCCc------ccccccCCccccccccCHHHHhCCCC--CCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            99999999765321110      00111123345778999999876432  378999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.7e-33  Score=233.13  Aligned_cols=200  Identities=23%  Similarity=0.325  Sum_probs=167.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|++.++.++||||+++++.+.         ..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---------~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY---------NN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee---------cC
Confidence            468889999999999999999999999999998876543 34556789999999999999999988544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...++++|++++++|.+.+...   ...+++..+..++.|++.|+.|+|+ .   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            7899999999999999877642   1568889999999999999999999 7   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....        ..   ......++..|+|||.+.+..+   +.++|+||+|+++|++++|..||...
T Consensus       146 g~~~~~~--------~~---~~~~~~~~~~y~~PE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         146 GVSGQLV--------NS---LAKTFVGTSSYMAPERIQGNDY---SVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             ccchhhH--------HH---HhhcccCChhccCHHHHcCCCC---CchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            9754211        00   0111456778999999987755   88999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-33  Score=235.54  Aligned_cols=201  Identities=23%  Similarity=0.358  Sum_probs=163.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+++++.++|+||+++++.+..         
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   71 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR---------   71 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE---------
Confidence            47999999999999999999999999999999875432  2334577889999999999999999985543         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||++++.+.....    ....++..++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence            467999999998766654332    234478999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-cccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |.+......        .........++..|+|||++.+. .+   +.++|+||+|+++|++++|+.||.+
T Consensus       145 g~~~~~~~~--------~~~~~~~~~~~~~~~~PE~~~~~~~~---~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         145 GFARALRAR--------PASPLTDYVATRWYRAPELLVGDTNY---GKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             ecccccCCC--------ccccccCcccccCCcCCchhcCCCCc---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            975432110        00111223456779999999876 43   7899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7e-33  Score=232.36  Aligned_cols=201  Identities=23%  Similarity=0.390  Sum_probs=163.4

Q ss_pred             EEeccCCceEEEEEEecCC---CceEEEEEeccCCchh-HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQT---KKRYALKKIICHGRED-QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~-~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|.+...   +..||+|.+....... ...+.+|++.++.++|+|++++++.+.         .....
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---------~~~~~   71 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT---------EEEPL   71 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec---------CCCce
Confidence            3689999999999999765   8999999886554443 567788999999999999999988443         35789


Q ss_pred             EEEeccCCCCChHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        108 LMVLPYYPKGTLANDLELRSVG-----KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ++++||+++++|.+.+......     ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~d  148 (262)
T cd00192          72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISD  148 (262)
T ss_pred             EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcc
Confidence            9999999999999988753111     35689999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ||.+........       ........++..|+|||.+....+   +.++||||+|+++|++++ |..||.+.
T Consensus       149 fg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         149 FGLSRDVYDDDY-------YRKKTGGKLPIRWMAPESLKDGIF---TSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             cccccccccccc-------cccccCCCcCccccCHHHhccCCc---chhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            997653211100       011223345778999999987654   889999999999999999 69999764

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-32  Score=235.07  Aligned_cols=209  Identities=26%  Similarity=0.360  Sum_probs=163.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+......  ....+.+|+.+++.+. ||||+++++.+....    .+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~----~~   76 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE----KN   76 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC----CC
Confidence            5799999999999999999999999999999987544322  2346778999999995 699999998665421    11


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCcee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVG-KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLL  180 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~  180 (282)
                      .....++++||+++ +|.+.+...... ...+++..++.++.||+.||.|||++   +++|+||+|+||+++. ++.+++
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEE
Confidence            23458999999975 788877643222 34578999999999999999999998   8999999999999998 889999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||.+......         ........+++.|+|||++.+...  ++.++|+||+|+++|+|++|..||.+
T Consensus       153 ~dfg~~~~~~~~---------~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         153 ADLGLGRAFSIP---------VKSYTHEIVTLWYRAPEVLLGSTH--YSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             eecccceecCCC---------ccccCCcccccCCCChHHhhCCCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            999976422110         001112234677999999865432  37899999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-32  Score=241.48  Aligned_cols=204  Identities=24%  Similarity=0.338  Sum_probs=164.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++.+....   ..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK---SL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC---Cc
Confidence            357899999999999999999999999999999988532  2333456778999999999999999998655321   12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .+....++|+|++. ++|.+.+..      .++...+..++.|++.||.|||++   |++|+||||+||+++.++.++++
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            23356899999995 577776542      278888999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+......          .......++..|+|||.+.+..+   +.++||||+|+++|+|++|+.||..
T Consensus       161 Dfg~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         161 DFGLARTAGTS----------FMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             cCccceeCCCC----------CCCCCCcccccccCHHHHhCCCC---CCchhhHhHHHHHHHHHHCCCCCCC
Confidence            99976532110          00112345778999999987765   8899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-32  Score=231.28  Aligned_cols=197  Identities=21%  Similarity=0.358  Sum_probs=157.1

Q ss_pred             EEeccCCceEEEEEEecCCC---ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTK---KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      ++||+|+||.||+|.+..++   ..||+|.+..... .....+.+|+.+++.+.|+||+++++.+.          ....
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------~~~~   70 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK----------GEPL   70 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc----------CCce
Confidence            36999999999999876554   7899998865544 34557888999999999999999987432          2457


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++||+++++|.+.+...    ..+++..+..++.|++.|+.|||.+   +++|+||||+||+++.++.++++|||.+.
T Consensus        71 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          71 MLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             EEEEEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccc
Confidence            9999999999999988632    3578999999999999999999998   89999999999999999999999999765


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ......      ..........++..|+|||.+.+..+   +.++||||||+++|++++ |..||...
T Consensus       144 ~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         144 ALGAGS------DYYRATTAGRWPLKWYAPECINYGKF---SSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             eeecCC------cccccccCccccccccCHHHhcCCCC---CccchHHHHHHHHHHHHcCCCCCcccC
Confidence            321110      00000111223457999999977665   889999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.5e-33  Score=233.01  Aligned_cols=193  Identities=26%  Similarity=0.343  Sum_probs=160.1

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||.|+||.||++.+..++..||+|.+.....   .....+.+|+++++.++||||+++.+.+.         +....+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK---------DKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE---------cCCccEEE
Confidence            6999999999999998999999998864332   33456788999999999999999988443         45679999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+.+..    ...++...+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|||.+....
T Consensus        72 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~  144 (262)
T cd05572          72 MEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK  144 (262)
T ss_pred             EecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence            999999999998863    23478899999999999999999998   89999999999999999999999999754321


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      ..          .......++..|++||.+.+..+   +.++|+||+|+++|++++|..||....
T Consensus       145 ~~----------~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         145 SG----------QKTWTFCGTPEYVAPEIILNKGY---DFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             cc----------cccccccCCcCccChhHhcCCCC---CChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            10          01122346778999999877655   789999999999999999999997543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-33  Score=236.10  Aligned_cols=206  Identities=22%  Similarity=0.349  Sum_probs=162.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEe----cCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEH----SQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...|++++.||+|+||.||++..    ..++..||+|.+.... ......+.+|+++++.++|||++++.+.+...    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   78 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED----   78 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC----
Confidence            34578999999999999999974    4578899999886443 33445788999999999999999998855431    


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         +....++++||+++++|.+++...   ...+++..+..++.|++.||.|+|++   |++|+||||+||+++.++.++
T Consensus        79 ---~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          79 ---GGNGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             ---CCCceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence               235689999999999999887532   23578899999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ++|||.+.......    .  .........++..|+|||++.+..+   +.++||||||+++||++++..|+.
T Consensus       150 l~dfg~~~~~~~~~----~--~~~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         150 IGDFGLTKAIETDK----E--YYTVKDDLDSPVFWYAPECLIQSKF---YIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             ECCCccccccccCc----c--ceeecCCCCCCccccCHHHhccCCC---CccccchhhhhhhhhhhcCCCCCc
Confidence            99999765321100    0  0000112345667999999887655   789999999999999999876653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.6e-33  Score=237.59  Aligned_cols=209  Identities=22%  Similarity=0.309  Sum_probs=162.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|+..+.||+|+||.||++.+..++..||+|.+..... .....+.+|+..+.++. |+||+++++.+..       
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-------   74 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-------   74 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-------
Confidence            34677788899999999999999999999999999865433 34556788999999996 9999999985443       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELR-SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....++++|++. +++.++.... ......+++..+..++.|++.||.|+|+..  +++||||||+||+++.++.+++
T Consensus        75 --~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl  149 (288)
T cd06616          75 --EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKL  149 (288)
T ss_pred             --CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEE
Confidence              467889999984 4655543321 112356889999999999999999999753  7999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++....          .........++..|+|||++.+.....++.++||||+|+++|++++|+.||...
T Consensus       150 ~dfg~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         150 CDFGISGQLV----------DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             eecchhHHhc----------cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            9999754210          001112234678899999997652112378999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-32  Score=235.56  Aligned_cols=200  Identities=26%  Similarity=0.370  Sum_probs=161.9

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-----hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-----DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|++.+.||+|+||.||+|.+..++.+||||++......     ....+.+|+++++.++|+||+++++.+.        
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--------   72 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG--------   72 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee--------
Confidence            488899999999999999999989999999998655433     2345667999999999999999998543        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       .....++|+||+ +++|.+.+...   ...+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++
T Consensus        73 -~~~~~~lv~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          73 -HKSNINLVFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             -cCCEEEEEEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEc
Confidence             357899999999 89999877532   12588999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.....         .........++..|+|||.+.+...  ++.++|+||+|+++||+++|.+||.+
T Consensus       145 dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         145 DFGLARSFGS---------PNRKMTHQVVTRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             cceeeeeccC---------CCccccccccceeeeCHHHHhCCCC--CCcHHHHHHHHHHHHHHHcCCccccC
Confidence            9997643210         0011112234667999999865332  37899999999999999999888865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-32  Score=232.62  Aligned_cols=203  Identities=21%  Similarity=0.307  Sum_probs=155.2

Q ss_pred             EeccCCceEEEEEEec--CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         33 KIGEGGFSTVSLIEHS--QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      .||+|+||.||+|...  .++..+|+|.+..... .....+.+|+..++.++||||+++++.+.         +....++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------~~~~~~l   72 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT---------EVTPYLL   72 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc---------CCCCcEE
Confidence            5899999999999854  4567899998865443 34457888999999999999999988443         3466899


Q ss_pred             EeccCCCCChHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        110 VLPYYPKGTLANDLELRSV-GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      |+||+++++|.+++..... .....+...+..++.|++.|+.|+|++   +++|+||||+||+++.++.++++|||.+..
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccc
Confidence            9999999999998864322 122356677788999999999999998   899999999999999999999999997542


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc----cCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY----CVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~----~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ..       ............++..|+|||++.+...    ...+.++|+||||+++|||++ |+.||...
T Consensus       150 ~~-------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         150 KY-------KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cc-------CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence            10       0000001112345677999999864321    123679999999999999996 99999754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-32  Score=237.11  Aligned_cols=205  Identities=23%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--HHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+.......  .....+|+.++++++|+||+++++.+...      
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK------   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC------
Confidence            5688999999999999999999999999999999886543222  23456799999999999999998865431      


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       .....++|+|++. ++|.+.+...   ...+++.++..++.|++.||.|||++   |++|+||+|+||+++.++.++++
T Consensus        79 -~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          79 -HLDSIFLVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             -CCCeEEEEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence             2256899999995 5777766532   24588999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+......         ........++..|+|||++.+...  ++.++|+||+|+++|||++|.+||.+
T Consensus       151 dfg~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         151 DFGLARTYGLP---------AKPMTPKVVTLWYRAPELLLGCTT--YTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             ccceeeecCCc---------cCCCCcccccccccChhhhcCCCC--cCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            99976532110         001112234667999999876432  37899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=233.23  Aligned_cols=196  Identities=23%  Similarity=0.369  Sum_probs=155.7

Q ss_pred             EeccCCceEEEEEEecCCCc--eEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceEE
Q psy16951         33 KIGEGGFSTVSLIEHSQTKK--RYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~--~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      .||+|+||.||+|....++.  .+|+|.+.... ......+.+|+++++++ +||||+++++.+.         .....+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---------~~~~~~   72 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE---------HRGYLY   72 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe---------cCCCce
Confidence            58999999999999987775  46888775332 33455788899999999 7999999998543         346789


Q ss_pred             EEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951        109 MVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                      ++|||+++++|.+++.....            ....++..+++.++.|++.|+.|+|++   |++|+||||+||+++.++
T Consensus        73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~  149 (270)
T cd05047          73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  149 (270)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCC
Confidence            99999999999998864311            112478889999999999999999998   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      .++++|||++....          ..........+..|+|||++.+..+   +.++|+||||+++|||++ |..||.+
T Consensus       150 ~~kl~dfgl~~~~~----------~~~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         150 VAKIADFGLSRGQE----------VYVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             eEEECCCCCccccc----------hhhhccCCCCccccCChHHHccCCC---CchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999753110          0011111223567999999876655   789999999999999997 9999965

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-32  Score=234.35  Aligned_cols=192  Identities=26%  Similarity=0.325  Sum_probs=151.3

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhh---hCCCCCcccccccccccCCCCCCCCCce
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHK---TFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~---~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      .||+|+||.||++.+..++..||+|.+.....   .....+.+|...++   ..+||||+.+.+.+.         ....
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~---------~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH---------TPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe---------cCCe
Confidence            38999999999999999999999998854322   12223344444333   346999999877443         3467


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++||||+++++|.+.+..    ...+++.++..++.|++.||.|+|++   +++|+||||+||+++.++.++++|||++
T Consensus        72 ~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~  144 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (279)
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence            9999999999999887753    34589999999999999999999999   8999999999999999999999999976


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .....           .......++..|+|||.+.. ..+   +.++|+||+|+++|++++|..||...
T Consensus       145 ~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         145 CDFSK-----------KKPHASVGTHGYMAPEVLQKGTAY---DSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             eeccc-----------cCccCcCCCcCccCHHHhcCCCCC---CchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            42110           01112357889999999864 333   78999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-33  Score=236.11  Aligned_cols=206  Identities=20%  Similarity=0.334  Sum_probs=161.0

Q ss_pred             cEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +|++.+.||+|+||.||+|....     ....+|+|.+..... .....+.+|+..++.++||||+++++.+.       
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-------   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-------   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-------
Confidence            57889999999999999998743     235688887754432 34457888999999999999999988443       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSV--------------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAY  160 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i  160 (282)
                        .....++++||+.+++|.+++.....                    ....++...++.++.|++.||.|||+.   ++
T Consensus        74 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i  148 (290)
T cd05045          74 --QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KL  148 (290)
T ss_pred             --cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence              34668999999999999988764210                    113467888999999999999999998   89


Q ss_pred             cccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHH
Q psy16951        161 AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL  240 (282)
Q Consensus       161 ~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~i  240 (282)
                      +|+||||+||+++.++.++++|||.+......       ..........++..|+|||++.+..+   +.++||||||++
T Consensus       149 vH~dikp~nill~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~apE~~~~~~~---~~~~Di~slG~~  218 (290)
T cd05045         149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-------DSYVKRSKGRIPVKWMAIESLFDHIY---TTQSDVWSFGVL  218 (290)
T ss_pred             ehhhhhhheEEEcCCCcEEeccccccccccCc-------cchhcccCCCCCccccCHHHHccCCc---chHhHHHHHHHH
Confidence            99999999999999999999999976422110       00011122234667999999877665   789999999999


Q ss_pred             HHHHHh-CCCCCCcc
Q psy16951        241 LYAMCY-FKSPFDTV  254 (282)
Q Consensus       241 l~el~t-g~~pf~~~  254 (282)
                      +|||++ |..||.+.
T Consensus       219 l~el~t~g~~p~~~~  233 (290)
T cd05045         219 LWEIVTLGGNPYPGI  233 (290)
T ss_pred             HHHHHhcCCCCCCCC
Confidence            999998 99999753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4645|consensus

Probab=100.00  E-value=9.8e-35  Score=272.92  Aligned_cols=226  Identities=22%  Similarity=0.269  Sum_probs=177.5

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      -...||.|.||.||.|....||...|+|.+......  ......+|..++..++|||++.+++         +.-.....
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyG---------VEvHRekv 1309 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYG---------VEVHREKV 1309 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCc---------eeecHHHH
Confidence            355799999999999999999999999988655443  2234568999999999999999998         44456789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +|.||||.+|+|.+.+...    .-.++.....+..|++.|+.|||+.   ||||||+||.||+++.+|-+|..|||.+.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence            9999999999999988743    3356777788899999999999999   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeee
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS  267 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~  267 (282)
                      -..    .... ..........||+.|||||++.+....--..+.||||+||++.||+||+.||...+..=.-++-.-.+
T Consensus      1383 ki~----~~~~-~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1383 KIK----NNAQ-TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG 1457 (1509)
T ss_pred             Eec----Cchh-cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc
Confidence            221    1111 11234456789999999999986543222568999999999999999999998654422233333455


Q ss_pred             ccccCCCCC
Q psy16951        268 GNITFPENT  276 (282)
Q Consensus       268 ~~~~~p~~~  276 (282)
                      .+|.+|+..
T Consensus      1458 h~Pq~P~~l 1466 (1509)
T KOG4645|consen 1458 HKPQIPERL 1466 (1509)
T ss_pred             CCCCCchhh
Confidence            578888763

>KOG1025|consensus

Probab=100.00  E-value=4.5e-34  Score=258.03  Aligned_cols=226  Identities=21%  Similarity=0.334  Sum_probs=179.6

Q ss_pred             EEEEEeccCCceEEEEEEecCCC----ceEEEEEec-cCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTK----KRYALKKII-CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~i~-~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +...+||+|+||+||+|.|...|    .+||||++. ..+.+...++.+|+..|.+++|||++++++.++.         
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---------  769 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML---------  769 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---------
Confidence            34568999999999999986554    668999875 4455667789999999999999999999997776         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                       ..+.||+++++.|+|.+++..   ....+.....+.|+.||++|+.|||.+   +++||||-.+|+|+....++|+.||
T Consensus       770 -s~~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  770 -STLQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             -chHHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence             348899999999999998875   345688899999999999999999999   7999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccccCcccee
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYERGDSVA  262 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~~~~~~~  262 (282)
                      |+++....      ...+... ....-+..|||-|.+....|   +.++|||||||++||++| |..|+.+....+- -.
T Consensus       843 gla~ll~~------d~~ey~~-~~gK~pikwmale~i~~~~~---thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~d  911 (1177)
T KOG1025|consen  843 GLAKLLAP------DEKEYSA-PGGKVPIKWMALESIRIRKY---THQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PD  911 (1177)
T ss_pred             chhhccCc------ccccccc-cccccCcHHHHHHHhhccCC---CchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hH
Confidence            98764321      1111111 11122566999999998877   999999999999999999 8899987533221 11


Q ss_pred             eeeeeccccCCCCCCCCCC
Q psy16951        263 LAVISGNITFPENTPFPQY  281 (282)
Q Consensus       263 ~~~~~~~~~~p~~~~~~~~  281 (282)
                      .-..+.+.+-|+.++.++|
T Consensus       912 lle~geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  912 LLEKGERLSQPPICTIDVY  930 (1177)
T ss_pred             HHhccccCCCCCCccHHHH
Confidence            2224456888999887766

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-33  Score=257.57  Aligned_cols=204  Identities=21%  Similarity=0.270  Sum_probs=150.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCce-EEEEEe-----------------ccCCchhHHHHHHHHHHhhhCCCCCcc
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKR-YALKKI-----------------ICHGREDQAQAIREVEHHKTFVHPNIL   86 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~i-----------------~~~~~~~~~~~~~e~~~l~~l~H~ni~   86 (282)
                      .++|+++++||+|+||+||++..+..... +++|.+                 ..........+.+|+++++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            46899999999999999999876433211 122111                 011122344577899999999999999


Q ss_pred             cccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         87 PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                      ++++++.         .....+++++++ .+++...+..... ........++..++.|++.||.|||++   ||+||||
T Consensus       227 ~l~~~~~---------~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDL  293 (501)
T PHA03210        227 KIEEILR---------SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDI  293 (501)
T ss_pred             cEeEEEE---------ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            9998543         456789999988 4566665542211 112234566788999999999999998   8999999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+||+++.++.+||+|||++....        ...........||..|+|||++.+..+   +.++|||||||++|||+
T Consensus       294 KP~NILl~~~~~vkL~DFGla~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvil~ell  362 (501)
T PHA03210        294 KLENIFLNCDGKIVLGDFGTAMPFE--------KEREAFDYGWVGTVATNSPEILAGDGY---CEITDIWSCGLILLDML  362 (501)
T ss_pred             CHHHEEECCCCCEEEEeCCCceecC--------cccccccccccCCcCCCCchhhcCCCC---CcHHHHHHHHHHHHHHH
Confidence            9999999999999999999865321        001111223468899999999988766   88999999999999999


Q ss_pred             hCCC-CCC
Q psy16951        246 YFKS-PFD  252 (282)
Q Consensus       246 tg~~-pf~  252 (282)
                      +|.. ||.
T Consensus       363 ~~~~~p~~  370 (501)
T PHA03210        363 SHDFCPIG  370 (501)
T ss_pred             HCCCCCcc
Confidence            9885 554

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-32  Score=233.10  Aligned_cols=199  Identities=24%  Similarity=0.377  Sum_probs=165.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ..|.....||+|++|.||++.+..++..+|+|++..........+.+|+.+++.++|||++++++.+..         ..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~---------~~   89 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV---------GD   89 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc---------CC
Confidence            356667899999999999999988999999998876555556678899999999999999999985543         46


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+++++|.+.+..     ..++...+..++.|++.|+.|+|++   |++|+||+|+||+++.++.++++|||.
T Consensus        90 ~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648          90 ELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             eEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccccc
Confidence            78999999999999987753     3478899999999999999999999   899999999999999999999999996


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +....         ..........++..|+|||++.+..+   +.++|+||+|+++|++++|+.||..
T Consensus       162 ~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         162 CAQVS---------KEVPRRKSLVGTPYWMAPEVISRLPY---GTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             chhhc---------cCCcccccccCCccccCHHHhcCCCC---CCcccHHHHHHHHHHHHhCCCCCcC
Confidence            43210         00011122346788999999977655   7899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-32  Score=229.03  Aligned_cols=202  Identities=23%  Similarity=0.446  Sum_probs=162.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...+|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|++.++.++|||++++++.+.         .
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~   70 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCT---------E   70 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEc---------c
Confidence            3568999999999999999999885 4678999987533 233456888999999999999999988443         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+...   ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          71 RSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCC
Confidence            46789999999999999877532   23478888999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      |.+....        ...........++..|+|||.+.+..+   +.++|+||+|+++||+++ |..||..
T Consensus       145 g~~~~~~--------~~~~~~~~~~~~~~~~~aPe~~~~~~~---~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         145 GMTRFVL--------DDQYTSSTGTKFPVKWSSPEVFSFSKY---SSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             cceeecc--------cCcccccCCCccchhhcCHhHhccCCc---ChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            9754221        000011112223567999999987665   789999999999999998 9999974

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=233.13  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=164.1

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCC---CCCcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFV---HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~---H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++   |||++++++.+.         
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~---------   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL---------   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee---------
Confidence            5788899999999999999999999999999886543 334556778999998886   999999988544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+++++|.+.+..     ..+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++++|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEcc
Confidence            34679999999999999887642     2588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+.....         .........++..|+|||.+.+...  ++.++|+||||+++|+|++|..||.+.
T Consensus       145 fg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         145 FGVAALLNQ---------NSSKRSTFVGTPYWMAPEVITEGKY--YDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             CCceeecCC---------CccccccccCCcceeCHHHhccCCc--cccchhHHHHHHHHHHHHhCCCCCCCC
Confidence            997543211         0111223356778999999865332  378999999999999999999999754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-32  Score=231.59  Aligned_cols=200  Identities=23%  Similarity=0.339  Sum_probs=164.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +-|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+..++.++||||+++++.+..         .
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~   74 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK---------D   74 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe---------C
Confidence            457888999999999999999988999999998754432 334567789999999999999999985543         4


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++|+||+++++|...+.     ...+++..+..++.|++.|+.++|++   +++|+||+|+||+++.++.++++|||
T Consensus        75 ~~~~lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          75 TKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             CeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecc
Confidence            67999999999999988774     23578999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+.....         .........++..|+|||.+.+...   +.++|+||+|+++|++++|..||...
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         147 VAGQLTD---------TQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             cceeccc---------chhhhccccCCccccChhhhccCCC---CchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            7542210         0111122346778999999876544   78999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.5e-32  Score=230.28  Aligned_cols=199  Identities=27%  Similarity=0.467  Sum_probs=162.6

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      -+..++|++.+.||+|+||.||++..  ++..||+|.+...  .....+.+|+..++.++|||++++++.+..       
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------   70 (254)
T cd05083           2 LLNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-------   70 (254)
T ss_pred             cccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-------
Confidence            45678899999999999999999875  7788999987543  234577889999999999999999885433       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                         ...++++||+++++|.+.+...  ....++...++.++.|++.|+.|+|++   |++|+||||+||+++.++.++++
T Consensus        71 ---~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~  142 (254)
T cd05083          71 ---NGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVS  142 (254)
T ss_pred             ---CCcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEEC
Confidence               2468999999999999988643  234578889999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      |||.+.....            .......+..|+|||++.+..+   +.++|+||+|+++|||++ |..||...
T Consensus       143 Dfg~~~~~~~------------~~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         143 DFGLARVGSM------------GVDNSKLPVKWTAPEALKHKKF---SSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             CCccceeccc------------cCCCCCCCceecCHHHhccCCc---CchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            9997542110            0011223567999999977665   789999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-32  Score=233.09  Aligned_cols=202  Identities=20%  Similarity=0.336  Sum_probs=160.7

Q ss_pred             cEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCCc----hhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHGR----EDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~----~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      +|++.+.||+|+||.||.++..   .+|..||+|.+.....    .....+.+|+.+++.+ +|+||+++++.       
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-------   73 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-------   73 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-------
Confidence            4889999999999999999875   4789999998854321    2335567899999999 59999999873       


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                        +......++++||+++++|.+.+..    ...+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.+
T Consensus        74 --~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  144 (290)
T cd05613          74 --FQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  144 (290)
T ss_pred             --eecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCE
Confidence              3345678999999999999988763    24578889999999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +++|||.+.....        ..........++..|++||.+.+... ..+.++||||+|+++|++++|..||..
T Consensus       145 kl~dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         145 VLTDFGLSKEFHE--------DEVERAYSFCGTIEYMAPDIVRGGDG-GHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             EEeeCccceeccc--------ccccccccccCCcccCChhhccCCCC-CCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            9999997642210        00011112346788999999875321 136789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.9e-32  Score=231.73  Aligned_cols=193  Identities=25%  Similarity=0.318  Sum_probs=152.1

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHH---HHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREV---EHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~---~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      .||+|+||.||+|++..++..||+|.+......   ....+..|.   ..++...||+|+++.+.         +.+...
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~---------~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA---------FHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee---------eecCCE
Confidence            389999999999999999999999988643221   122233333   34445679999998873         444578


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++|+||+++++|...+..    ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        72 ~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence            9999999999999877652    34589999999999999999999998   8999999999999999999999999975


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .....           .......++..|+|||++.+...  ++.++|+||+|+++|+|++|+.||.+.
T Consensus       145 ~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         145 CDFSK-----------KKPHASVGTHGYMAPEVLQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cccCc-----------cCCcCcCCCcCCcCcHHhcCCCC--CCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            42110           01112357888999999875421  378899999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.1e-32  Score=234.73  Aligned_cols=201  Identities=25%  Similarity=0.366  Sum_probs=162.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..+.|+..+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+++++.++||||+++.+.+..      
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~------   86 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR------   86 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe------
Confidence            34669999999999999999999998999999998864432   233567889999999999999999986543      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++|+||+. +++.+.+..   ....+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+++
T Consensus        87 ---~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          87 ---EHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             ---CCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEE
Confidence               467899999996 677665542   234588999999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||.+....             ......++..|+|||++.+.....++.++||||||+++||+++|+.||.+
T Consensus       157 ~dfg~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         157 ADFGSASLVS-------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             eecCcceecC-------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            9999754210             01123457789999998532222247899999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.4e-32  Score=238.06  Aligned_cols=213  Identities=24%  Similarity=0.321  Sum_probs=164.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCC-----C
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD-----P   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~-----~   99 (282)
                      .++|++.+.||.|+||.||+|....++..||+|.+..........+.+|+++++.++||||+++++.+......     .
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57999999999999999999999999999999998776666667788899999999999999998755432100     0


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCc
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNP  178 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~  178 (282)
                      ........++++||+. ++|.+.+.     ...+++..+..++.|++.||.|||++   |++||||||+||+++.+ +.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence            1122346899999996 57776553     23588999999999999999999998   89999999999999754 567


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+......    ..  .........++..|+|||.+.....  ++.++||||+||++|+|++|+.||.+.
T Consensus       155 kl~dfg~~~~~~~~----~~--~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         155 KIGDFGLARIVDPH----YS--HKGYLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             EECCcccceecCCc----cc--cccccccccccccccCHHHHhCccc--cCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999976432100    00  0000112245778999998765322  378999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-32  Score=237.70  Aligned_cols=209  Identities=23%  Similarity=0.322  Sum_probs=165.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|....++.+||+|++....  ......+.+|+.+++.++||||+++++.+...     ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~   78 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP-----GA   78 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc-----CC
Confidence            478999999999999999999999999999999886432  23345667899999999999999998865432     12


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++++||+. ++|.+.+.    ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++++|
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecc
Confidence            3467899999995 67877664    234589999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+........     ..........++..|+|||.+.+...  .+.++|+||+|+++|||++|+.||.+
T Consensus       151 fg~~~~~~~~~~-----~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         151 FGMARGLSSSPT-----EHKYFMTEYVATRWYRAPELLLSLPE--YTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             cccceeecccCc-----CCCcccccccccccccChHHhcCCcc--cccccchHHHHHHHHHHHcCCCccCC
Confidence            997653211100     00011123356788999999865332  37899999999999999999999965

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1035|consensus

Probab=100.00  E-value=1.4e-33  Score=264.01  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=178.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC----
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP----   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~----   99 (282)
                      ..+|+.++.||+|+||.||+++++-+|..||||+|..+. ........+|+..+.+++|||||+|+..|+..+...    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            357888899999999999999999999999999997665 233446778999999999999999999886531000    


Q ss_pred             ----------------------------------------------C---------------------------------
Q psy16951        100 ----------------------------------------------V---------------------------------  100 (282)
Q Consensus       100 ----------------------------------------------~---------------------------------  100 (282)
                                                                    .                                 
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                          0                                 


Q ss_pred             -------------------CC--------CCceEEEEeccCCCCChHHHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHh
Q psy16951        101 -------------------LN--------STSQVLMVLPYYPKGTLANDLELRSVGKHYM-SSVDILKMFLKICEAVKVF  152 (282)
Q Consensus       101 -------------------~~--------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l-~~~~~~~~~~qi~~~l~~l  152 (282)
                                         ..        ....+||-||||+.-++.+.+..    +... .....+.+++||++||.|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHH
Confidence                               00        11457889999988777776652    1212 4678899999999999999


Q ss_pred             hcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccC------chhh---hhhHhhhhccCCCCccCCcccccC
Q psy16951        153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG------SAEA---QNLQDVAAERCSMPYRAPELFHVD  223 (282)
Q Consensus       153 H~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~------~~~~---~~~~~~~~~~~t~~y~~PE~~~~~  223 (282)
                      |++   ||+||||||.||+++.++.+||.|||++.........      ....   .......+..||.-|+|||.+.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   8999999999999999999999999988652211110      0011   112234466789999999999876


Q ss_pred             cccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeeccccCCCCCCCC
Q psy16951        224 SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFP  279 (282)
Q Consensus       224 ~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~  279 (282)
                      ....++.|+|+||+|++++||+.   ||....++...+ ..+..+.++.|++...+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL-~~LR~g~iP~~~~f~~~  842 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL-TNLRKGSIPEPADFFDP  842 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH-HhcccCCCCCCcccccc
Confidence            63345899999999999999986   576533332222 22335556666444444

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.8e-32  Score=236.62  Aligned_cols=206  Identities=25%  Similarity=0.357  Sum_probs=163.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..+|++.+.||+|+||+||+|.+..++..||||.+...  .......+.+|+.+++.++|+||+++++.+...    ...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~----~~~   79 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP----HRE   79 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc----ccc
Confidence            45799999999999999999999999999999988643  223344667899999999999999999865432    111


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+. ++|.+.+.    ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++++|
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            2245899999995 67877664    234589999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+.....         .........++..|+|||++.....  .+.++|+||+|+++|+|++|..||.+
T Consensus       152 fg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         152 FGLARTTSE---------KGDFMTEYVVTRWYRAPELLLNCSE--YTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CccccccCC---------CcccccccccccCccChHHHhcCCC--CCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            997642210         0011122346778999999865322  37899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.1e-32  Score=229.51  Aligned_cols=203  Identities=22%  Similarity=0.333  Sum_probs=154.0

Q ss_pred             EeccCCceEEEEEEecCC--CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         33 KIGEGGFSTVSLIEHSQT--KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~--~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +||+|+||.||+|+....  ...+++|.+.... ......+.+|+..++.++||||+++++.+.         .....++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~---------~~~~~~l   72 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV---------EAIPYLL   72 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec---------CCCccEE
Confidence            599999999999975433  3456788775443 345567889999999999999999998544         3467899


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                      +|||+++++|.+++..........+...+..++.|++.||.|+|++   +++|+||||+||+++.++.++++|||++...
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence            9999999999998875433334466777889999999999999998   8999999999999999999999999975321


Q ss_pred             hhhccCchhhhhhHhhhhccCCCCccCCcccccCcc----cCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY----CVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~----~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ..       ...........++..|+|||++.....    ...+.++||||||+++|||++ +..||...
T Consensus       150 ~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         150 YK-------EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             Cc-------chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            00       000111123456788999999853211    123678999999999999997 56788653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-32  Score=232.87  Aligned_cols=202  Identities=29%  Similarity=0.399  Sum_probs=159.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++.++||+|++|.||+|.+..++.+||+|.+.....  .....+.+|++.++.++||||+++++.+.         .
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH---------S   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe---------c
Confidence            679999999999999999999999999999998864432  23356778999999999999999998544         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceeec
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLMD  182 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~d  182 (282)
                      ....++|+||++ +++.+.+...  ....+++..+..++.|++.||.|||++   +++|+||+|+||+++. ++.++++|
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~d  146 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLAD  146 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcc
Confidence            478999999995 5777766432  223357788889999999999999998   8999999999999985 45689999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+......         ........++..|+|||++.+...  ++.++|+||+|+++|+|+||..||..
T Consensus       147 fg~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        147 FGLARAFGIP---------VRTFTHEVVTLWYRAPEILLGSRH--YSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             cccccccCCC---------ccccccCceeecccCHHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9975421100         000112245678999999865432  37899999999999999999999964

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.4e-32  Score=231.88  Aligned_cols=218  Identities=23%  Similarity=0.330  Sum_probs=167.3

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .-..++|++.++||+|+||.||+|.+..++..||||.+......  ......+|++++++++||||+++++.+...... 
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-   86 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP-   86 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc-
Confidence            34567899999999999999999999999999999988543322  233456799999999999999999866542110 


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      ........++++||+. +++.+.+...   ...+++..++.++.|++.||.|||++   |++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence            1223456899999995 5777666432   23578999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+..........     ........++..|+|||.+.+...  .+.++|+||+|+++|||++|..||.+.
T Consensus       160 l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         160 LADFGLARAFSLSKNSK-----PNRYTNRVVTLWYRPPELLLGERD--YGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             ECcCCCcccccCCcccC-----CCCccCcccCccccCcHHhcCCcc--cCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99999765321111000     001122345778999999876532  378999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-32  Score=232.09  Aligned_cols=203  Identities=26%  Similarity=0.382  Sum_probs=169.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..+.|++...||+|++|.||+|.+..++.+||+|.+..... ....+.+|++.++.++|+|++++++.+..         
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV---------   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE---------
Confidence            56778999999999999999999988899999999875544 56677889999999999999999985544         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++||+++++|.+.+....   ..++...+..++.|++.||.|+|+.   |++|+||+|+||+++.++.++++||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence            378999999999999999887432   3588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.+....         ..........++..|++||++.+..+   +.++|+||||+++|++++|+.||...
T Consensus       161 ~~~~~~~---------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         161 GFAAQLT---------KEKSKRNSVVGTPYWMAPEVIKRKDY---GPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             chhhhhc---------cchhhhccccCCcccCCHhHhcCCCC---CCccccHHHHHHHHHHHhCCCCCCCC
Confidence            9643210         01111122345778999999877655   78999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0983|consensus

Probab=100.00  E-value=8.2e-34  Score=228.19  Aligned_cols=231  Identities=20%  Similarity=0.235  Sum_probs=172.2

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-HHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      ...-..++.+.+..||.|..|.||+++.+.+|...|||.+..++.++ ...++..+.++.+- +.|.|++-+|+|+..  
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--  163 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--  163 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--
Confidence            34444556667788999999999999999999999999997666554 45666777765544 589999999988763  


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ..+++.||.+ ...++.++. +  ....+++..+-.+...+..||.||-.++  +|+|||+||+|||++..|.
T Consensus       164 -------~dV~IcMelM-s~C~ekLlk-r--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gn  230 (391)
T KOG0983|consen  164 -------TDVFICMELM-STCAEKLLK-R--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGN  230 (391)
T ss_pred             -------chHHHHHHHH-HHHHHHHHH-H--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCC
Confidence                   5577888876 334444443 3  2345889888899999999999999998  8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +|++|||.+...          ..........|.+.|||||.+.-.....+.-.+||||||++++||+||+.||.+-+. 
T Consensus       231 iKlCDFGIsGrl----------vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-  299 (391)
T KOG0983|consen  231 IKLCDFGISGRL----------VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-  299 (391)
T ss_pred             EEeeccccccee----------ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-
Confidence            999999975321          111222344678899999999654322347789999999999999999999986433 


Q ss_pred             ccceeeee-eeccccCCCCC
Q psy16951        258 GDSVALAV-ISGNITFPENT  276 (282)
Q Consensus       258 ~~~~~~~~-~~~~~~~p~~~  276 (282)
                      +..+.-.+ -...|.+|+..
T Consensus       300 dFe~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  300 DFEVLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             cHHHHHHHHhcCCCCCCccc
Confidence            33332233 33445666554

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-32  Score=236.00  Aligned_cols=204  Identities=26%  Similarity=0.375  Sum_probs=164.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+......  ....+.+|+++++.++||||+++.+.+...       
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-------   76 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS-------   76 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec-------
Confidence            46899999999999999999999999999999998654332  233567899999999999999998865432       


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++||+. ++|.+.+...   ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|
T Consensus        77 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          77 NLDKIYMVMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             CCCcEEEEehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEee
Confidence            2367999999996 5888777532   23588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+......         ........++..|+|||.+.+...  .+.++|+||+|+++|+|++|.+||..
T Consensus       150 ~g~~~~~~~~---------~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         150 FGLAREYGSP---------LKPYTQLVVTLWYRAPELLLGAKE--YSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             cCceeeccCC---------ccccccccccccccCchhhcCCcc--ccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9976532110         011112345678999999876432  37899999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-32  Score=232.11  Aligned_cols=192  Identities=19%  Similarity=0.200  Sum_probs=151.1

Q ss_pred             EeccCCceEEEEEEecC------------------------CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccc
Q psy16951         33 KIGEGGFSTVSLIEHSQ------------------------TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      .||+|+||.||+|....                        ....||+|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999987532                        224688998865544445677889999999999999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      ++++..         ....++||||+++++|...+..   ....+++..+..++.|++.||.|||++   +++||||||+
T Consensus        82 ~~~~~~---------~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~  146 (274)
T cd05076          82 HGVCVR---------GSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAK  146 (274)
T ss_pred             EEEEEe---------CCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcc
Confidence            996554         3678999999999999887753   234578899999999999999999998   8999999999


Q ss_pred             cEEeecCC-------CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHH
Q psy16951        169 NVLLANDN-------NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL  241 (282)
Q Consensus       169 nil~~~~~-------~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il  241 (282)
                      ||+++..+       .++++|||.+...        .     ......++..|+|||.+.+...  ++.++|+||||+++
T Consensus       147 Nill~~~~~~~~~~~~~kl~d~g~~~~~--------~-----~~~~~~~~~~~~aPe~~~~~~~--~~~~~Dv~slG~~l  211 (274)
T cd05076         147 NILLARLGLAEGTSPFIKLSDPGVSFTA--------L-----SREERVERIPWIAPECVPGGNS--LSTAADKWSFGTTL  211 (274)
T ss_pred             cEEEeccCcccCccceeeecCCcccccc--------c-----cccccccCCcccCchhhcCCCC--CCcHHHHHHHHHHH
Confidence            99997644       3689999964311        0     0112245778999999875421  37899999999999


Q ss_pred             HHHH-hCCCCCCcc
Q psy16951        242 YAMC-YFKSPFDTV  254 (282)
Q Consensus       242 ~el~-tg~~pf~~~  254 (282)
                      ||++ +|+.||...
T Consensus       212 ~el~~~g~~p~~~~  225 (274)
T cd05076         212 LEICFDGEVPLKER  225 (274)
T ss_pred             HHHHhCCCCCcccc
Confidence            9995 689999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.1e-32  Score=227.63  Aligned_cols=196  Identities=22%  Similarity=0.343  Sum_probs=156.2

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      +.||+|+||.||+|... ++..||+|.+..... .....+.+|++.++.++||||+++.+.+.         .....+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT---------QRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe---------cCCccEEE
Confidence            36899999999999864 678899998765433 33456889999999999999999998543         34678999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+.+...   ...+.+..+..++.|++.+|.|+|++   |++|+||+|+||+++.++.++++|||.+....
T Consensus        71 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          71 MELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             EECCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecc
Confidence            9999999999877532   23478899999999999999999998   89999999999999999999999999754211


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      .        ..........++..|+|||++.+..+   +.++|+||||+++|++++ |..||.+.
T Consensus       145 ~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         145 D--------GIYSSSGLKQIPIKWTAPEALNYGRY---SSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             c--------cccccCCCCCCcccccCHHHhccCCC---CchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            0        00000111223567999999977654   789999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-32  Score=229.68  Aligned_cols=192  Identities=19%  Similarity=0.241  Sum_probs=151.5

Q ss_pred             EEeccCCceEEEEEEecC------------CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         32 EKIGEGGFSTVSLIEHSQ------------TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +.||+|+||.||+|....            ....||+|.+..........+.+|+..++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            368999999999998542            234688998766555556678889999999999999999985543     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC--
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN--  177 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--  177 (282)
                          ....++++||+++++|...+..   ....+++..++.++.|++.|+.|||++   +++||||||+||+++.++.  
T Consensus        76 ----~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~  145 (262)
T cd05077          76 ----DVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDG  145 (262)
T ss_pred             ----CCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccC
Confidence                3567899999999999876643   234588899999999999999999998   8999999999999987664  


Q ss_pred             -----ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH-hCCCCC
Q psy16951        178 -----PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF  251 (282)
Q Consensus       178 -----~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~-tg~~pf  251 (282)
                           ++++|||.+....             ......++..|+|||.+.....  ++.++||||||+++|||+ +|..||
T Consensus       146 ~~~~~~~l~d~g~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~el~~~~~~p~  210 (262)
T cd05077         146 ECGPFIKLSDPGIPITVL-------------SRQECVERIPWIAPECVEDSKN--LSIAADKWSFGTTLWEICYNGEIPL  210 (262)
T ss_pred             CCCceeEeCCCCCCcccc-------------CcccccccccccChhhhcCCCC--CCchhHHHHHHHHHHHHHhCCCCCC
Confidence                 7899999653210             0112345778999998864321  378999999999999997 588888


Q ss_pred             Cc
Q psy16951        252 DT  253 (282)
Q Consensus       252 ~~  253 (282)
                      ..
T Consensus       211 ~~  212 (262)
T cd05077         211 KD  212 (262)
T ss_pred             CC
Confidence            64

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.6e-32  Score=226.33  Aligned_cols=202  Identities=27%  Similarity=0.515  Sum_probs=164.5

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||++.+..++..||+|.+....  ......+.+|++.++.++|+||+++++.+         ...
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~---------~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF---------QEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee---------ccC
Confidence            5889999999999999999999999999999885432  23445677899999999999999998843         345


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC-ceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN-PLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~-~~~~df  183 (282)
                      ...++++||+++++|.+.+...  ....+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++. ++++||
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~  146 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF  146 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccc
Confidence            7899999999999999987643  223478899999999999999999998   8999999999999988765 589999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....         ..........++..|+|||++.+..+   +.++|+||||+++||+++|..||...
T Consensus       147 ~~~~~~~---------~~~~~~~~~~~~~~~~ape~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         147 GIARQLN---------DSMELAYTCVGTPYYLSPEICQNRPY---NNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             ccchhcc---------CCcccccccCCCccccCHHHHcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            9654211         00011112346788999999876654   78999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-31  Score=224.57  Aligned_cols=202  Identities=27%  Similarity=0.547  Sum_probs=169.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....  ......+.+|++.++.++|+||+++.+.+.         ..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL---------DG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc---------cC
Confidence            5899999999999999999999999999999886432  334556778999999999999999988544         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++||+++++|...+.........+++..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence            789999999999999998876554456688899999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+......           ......++..|++||.+.+..+   +.++|+||+|+++|++++|+.||...
T Consensus       149 ~~~~~~~~-----------~~~~~~~~~~~~~Pe~~~~~~~---~~~~D~~slG~~~~~l~~g~~p~~~~  204 (256)
T cd08530         149 ISKVLKKN-----------MAKTQIGTPHYMAPEVWKGRPY---SYKSDIWSLGCLLYEMATFAPPFEAR  204 (256)
T ss_pred             chhhhccC-----------CcccccCCccccCHHHHCCCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            75432111           1112345778999999987655   78999999999999999999999753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-32  Score=229.48  Aligned_cols=200  Identities=26%  Similarity=0.402  Sum_probs=153.3

Q ss_pred             EEeccCCceEEEEEEecC---CCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQ---TKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|.+..   ++..||||.+... .......+.+|+.+++.++||||+++++.+..        .....
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~   72 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP--------SEGSP   72 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec--------CCCCc
Confidence            358999999999998643   3467999987533 23445677889999999999999999885442        23457


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++||+++++|.+++...   ........++.++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        73 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058          73 LVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccc
Confidence            8999999999999987632   23356777888999999999999998   89999999999999999999999999764


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC-CCCCCc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFDT  253 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg-~~pf~~  253 (282)
                      .......     ..........++..|+|||.+.+..+   +.++||||||+++|||++| .+||..
T Consensus       147 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         147 DIYDKEY-----YSVHNHTGAKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             cccCCcc-----eeecccccCcCCccccChhHhccCcc---chHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            2211000     00011112234667999999877655   7899999999999999995 567754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-32  Score=229.47  Aligned_cols=203  Identities=25%  Similarity=0.523  Sum_probs=164.0

Q ss_pred             cEEEEEEeccCCceEEEEEEecC-CCceEEEEEeccCCc----------hhHHHHHHHHHHhhh-CCCCCcccccccccc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICHGR----------EDQAQAIREVEHHKT-FVHPNILPLLDHALT   94 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~----------~~~~~~~~e~~~l~~-l~H~ni~~~~~~~~~   94 (282)
                      .|++.+.||+|+||.||+|.+.. ++..+|+|.+.....          .....+.+|+..+.+ ++||||+++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            47888999999999999999987 678899998753321          223456778887765 79999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              .....++++||+++++|.+.+.........++...++.++.|++.||.|||+..  +++|+||+|+||+++.
T Consensus        80 --------~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~  149 (269)
T cd08528          80 --------ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGE  149 (269)
T ss_pred             --------cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECC
Confidence                    457899999999999999887654334456889999999999999999999743  7999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++.++++|||.+.....        .  .......++..|++||++.+..+   +.++|+||||+++|++++|+.||..
T Consensus       150 ~~~~~l~dfg~~~~~~~--------~--~~~~~~~~~~~~~~Pe~~~~~~~---~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         150 DDKVTITDFGLAKQKQP--------E--SKLTSVVGTILYSCPEIVKNEPY---GEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             CCcEEEecccceeeccc--------c--cccccccCcccCcChhhhcCCCC---chHHHHHHHHHHHHHHHhCCCcccc
Confidence            99999999997643210        0  01223456788999999987654   8899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.4e-33  Score=233.59  Aligned_cols=192  Identities=18%  Similarity=0.244  Sum_probs=152.6

Q ss_pred             EEeccCCceEEEEEEecCCC-------ceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         32 EKIGEGGFSTVSLIEHSQTK-------KRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +.||+|+||.||+|.+..++       .+||+|.+..........+.+|+.+++.++||||+++++.+..         .
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~---------~   71 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC---------G   71 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe---------C
Confidence            36999999999999986544       3488887765555555678889999999999999999986544         3


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC-------
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN-------  177 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~-------  177 (282)
                      ...++||||+++++|..++...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.++.       
T Consensus        72 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~  145 (258)
T cd05078          72 DESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPP  145 (258)
T ss_pred             CCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCc
Confidence            5688999999999999887632   23578899999999999999999998   8999999999999988776       


Q ss_pred             -ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC-CCCCc
Q psy16951        178 -PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK-SPFDT  253 (282)
Q Consensus       178 -~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~-~pf~~  253 (282)
                       ++++|||.+...             .......++..|+|||++.+...  .+.++||||+|+++||+++|. .||..
T Consensus       146 ~~~l~d~g~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         146 FIKLSDPGISITV-------------LPKEILLERIPWVPPECIENPQN--LSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             eEEeccccccccc-------------CCchhccccCCccCchhccCCCC--CCchhhHHHHHHHHHHHHcCCCCChhh
Confidence             478888864311             01112345778999999976432  378999999999999999985 67754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-32  Score=227.21  Aligned_cols=201  Identities=23%  Similarity=0.379  Sum_probs=162.7

Q ss_pred             EEEEEEeccCCceEEEEEEecCCC----ceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTK----KRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +++.+.||.|+||.||++.+..++    ..||+|.+...... ....+.+|++.++.++|+||+++++.+..        
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   72 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--------   72 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--------
Confidence            356788999999999999998766    88999988655443 45678889999999999999999985443        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++++|++++++|.+.+....  ...+++.++..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|
T Consensus        73 -~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~d  146 (258)
T smart00219       73 -EEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISD  146 (258)
T ss_pred             -CCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcc
Confidence             467999999999999999876432  11278999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ||.+......       .. .......++..|++||.+.+..+   +.++|+||+|+++++|++ |.+||..
T Consensus       147 fg~~~~~~~~-------~~-~~~~~~~~~~~y~~Pe~~~~~~~---~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      147 FGLSRDLYDD-------DY-YKKKGGKLPIRWMAPESLKDGKF---TSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             cCCceecccc-------cc-cccccCCCcccccChHHhccCCC---CcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9976532111       00 00001225678999999866554   789999999999999998 7899975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-32  Score=230.00  Aligned_cols=210  Identities=27%  Similarity=0.398  Sum_probs=167.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ++|++.+.||+|+||.||++....++.+||+|.+....   ......+.+|.+++++++ ||||+++++.         +
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~---------~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT---------F   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH---------h
Confidence            47999999999999999999999999999999875422   233456778999999998 9999999884         3


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......+++||++.+++|.+.+...    ..+++..++.++.|++.||.+||+.   |++|+||+|+||+++.++.++++
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEec
Confidence            4457899999999999999888632    3589999999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCch-----------hhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        182 DLGSVAPAVVKVCGSA-----------EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       182 df~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      |||.+...........           ............++..|+|||+......   +.++|+||+|++++++++|..|
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~---~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA---GKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC---ChhhhHHHHHHHHHHHHhCCCC
Confidence            9997653211110000           0000011222345778999999876654   7899999999999999999999


Q ss_pred             CCcc
Q psy16951        251 FDTV  254 (282)
Q Consensus       251 f~~~  254 (282)
                      |...
T Consensus       222 ~~~~  225 (280)
T cd05581         222 FRGS  225 (280)
T ss_pred             CCCc
Confidence            9753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-31  Score=224.65  Aligned_cols=203  Identities=29%  Similarity=0.539  Sum_probs=169.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||.|+||.||++.+..++.+||+|++.....  .....+.+|++.++.++|+|++++.+.+..         .
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~---------~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE---------K   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec---------C
Confidence            58899999999999999999998999999999865543  455678889999999999999999885543         3


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++++++|.+.+.........++...+..++.+++.|+.|||++   |++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence            789999999999999998875433346689999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .+......         ........++..|+|||.+.+..+   +.++|+||+|++++++++|..||..
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~p~~~  205 (258)
T cd08215         149 ISKVLSST---------VDLAKTVVGTPYYLSPELCQNKPY---NYKSDIWSLGCVLYELCTLKHPFEG  205 (258)
T ss_pred             ceeecccC---------cceecceeeeecccChhHhccCCC---CccccHHHHHHHHHHHHcCCCCCCC
Confidence            75432110         001112346778999999877665   7899999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1094|consensus

Probab=100.00  E-value=2.9e-33  Score=244.82  Aligned_cols=214  Identities=20%  Similarity=0.316  Sum_probs=172.6

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-HHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      .....-.++++...+.++||+|-||+|.+++-.. +..||+|.+.....+. +.+|.+|+++|.+++||||+++++.|+.
T Consensus       528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cCcchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3444556788999999999999999999999843 6889999997665554 4789999999999999999999997776


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                      +         .-+++++||+++|.|.+++.....  ..+.-.....++.||+.|+.||.+.   ++||||+.++|+|++.
T Consensus       607 D---------ePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~  672 (807)
T KOG1094|consen  607 D---------DPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDG  672 (807)
T ss_pred             C---------CchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecC
Confidence            3         679999999999999999875422  1234455677999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh--CCCCCC
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY--FKSPFD  252 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t--g~~pf~  252 (282)
                      ++++||+|||.++.......    .   +-....+-+..|||||.+....+   +++||+|+||+++||+++  ...||+
T Consensus       673 e~~iKiadfgmsR~lysg~y----y---~vqgr~vlpiRwmawEsillgkF---ttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  673 EFTIKIADFGMSRNLYSGDY----Y---RVQGRAVLPIRWMAWESILLGKF---TTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             cccEEecCcccccccccCCc----e---eeecceeeeeeehhHHHHHhccc---cchhhhhhhHHHHHHHHHHHhhCchh
Confidence            99999999998763211110    0   00112234677999999987765   999999999999999865  779998


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       743 ~l  744 (807)
T KOG1094|consen  743 QL  744 (807)
T ss_pred             hh
Confidence            64

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-32  Score=228.29  Aligned_cols=192  Identities=20%  Similarity=0.262  Sum_probs=154.3

Q ss_pred             EEeccCCceEEEEEEecCCC----------ceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         32 EKIGEGGFSTVSLIEHSQTK----------KRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...+.+|+.+++.++||||+++++.+..       
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-------   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-------
Confidence            36899999999999997766          45788876544333 6778899999999999999999985432       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-----
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-----  176 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-----  176 (282)
                         ...++++||+++++|.+++...   ...++...+..++.|++.||.|||++   |++|+||||+||+++.++     
T Consensus        73 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~  143 (259)
T cd05037          73 ---DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGY  143 (259)
T ss_pred             ---CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCC
Confidence               3568999999999999887643   22578889999999999999999998   899999999999999887     


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                        .++++|||.+.....             .....++..|+|||++.+... ..+.++|+||+|+++||+++ |..||..
T Consensus       144 ~~~~kl~Dfg~a~~~~~-------------~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         144 VPFIKLSDPGIPITVLS-------------REERVERIPWIAPECIRNGQA-SLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             ceeEEeCCCCccccccc-------------ccccccCCCccChhhhcCCCC-CcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence              789999997542110             112345667999999977611 23789999999999999999 5788876


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       210 ~  210 (259)
T cd05037         210 L  210 (259)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-32  Score=230.45  Aligned_cols=204  Identities=27%  Similarity=0.415  Sum_probs=162.9

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.++||.|+||.||+|.+..++..+|+|.+....  ......+.+|+++++.++|+|++++++.+...       ...
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------~~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK-------GKG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC-------CCC
Confidence            678999999999999999999999999999987653  33345678899999999999999999854431       136


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||++ ++|.+.+...   ...+++.+++.++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||.
T Consensus        74 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          74 SIYMVFEYMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             cEEEEecccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence            7999999996 4777766532   24588999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +......        .........++..|+|||.+.+...  ++.++||||||+++||+++|+.||.+..
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         147 ARPYTKR--------NSADYTNRVITLWYRPPELLLGATR--YGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             eeeccCC--------CcccccccccccccCCceeeEcccc--CChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            6432111        0001112235677999998865432  3789999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.4e-32  Score=231.95  Aligned_cols=214  Identities=26%  Similarity=0.352  Sum_probs=165.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCC-CC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA-DP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~-~~   99 (282)
                      ...++|++.+.||+|+||.||+|.+..++..||+|.+.....  .....+.+|++.++.++||||+++++.+..... ..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            456889999999999999999999999999999998864432  233456789999999999999999886654321 11


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      .......+++++||+++ ++.+.+..   ....++..++..++.|++.||.|||+.   |++|+||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence            12233479999999965 66665542   234588999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+......        .........++..|++||.+.+...  .+.++||||+|+++|+|++|++||..
T Consensus       157 l~dfg~~~~~~~~--------~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         157 LADFGLARLYNSE--------ESRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             eCcccccccccCC--------cccccccceeccCccChHHhcCCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999975422110        0001111234667999998865432  37899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.9e-32  Score=231.97  Aligned_cols=194  Identities=24%  Similarity=0.381  Sum_probs=162.2

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ..+||+|+||.||++....++..||||++..........+.+|+..++.++|+|++++++.+.         .....+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL---------VGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE---------eCCEEEEE
Confidence            357999999999999999999999999987665556667889999999999999999998544         34789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +||+++++|.+.+.     ...+++..+..++.|++.||.|+|+.   |++|+||+|+||+++.++.++++|||.+....
T Consensus        96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657          96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            99999999988654     23478899999999999999999998   89999999999999999999999999754221


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .        . ........++..|++||.+.+..+   +.++|+||+|+++|++++|+.||.+
T Consensus       168 ~--------~-~~~~~~~~~~~~y~~pE~~~~~~~---~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         168 K--------E-VPRRKSLVGTPYWMAPELISRLPY---GPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             c--------c-cccccccccCccccCHHHhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            0        0 011123456788999999876554   7899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.1e-32  Score=227.67  Aligned_cols=200  Identities=25%  Similarity=0.350  Sum_probs=159.8

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||.||++++..++..||+|.+.....   .....+.+|++.++.++||||+++++.         .......+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~---------~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS---------FQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh---------eecCcEEEEE
Confidence            6899999999999998999999998864433   344567889999999999999999874         3345789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +|++++++|.+.+...    ..+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|||++....
T Consensus        72 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          72 MEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            9999999999887642    3588999999999999999999998   89999999999999999999999999754221


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ....... ...........++..|++||.......   +.++|+||||+++|++++|..||..
T Consensus       145 ~~~~~~~-~~~~~~~~~~~~~~~~~~Pe~~~~~~~---~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         145 VRRQINL-NDDEKEDKRIVGTPDYIAPEVILGQGH---SKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             cCccccc-ccccccccCcccCccccCHHHhcCCCC---CcchhhHHHHHHHHHHHhCCCCCCC
Confidence            1100000 000011123345778999999877654   7899999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-32  Score=229.50  Aligned_cols=200  Identities=28%  Similarity=0.411  Sum_probs=161.3

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.+.||.|++|.||+|.+..+|..||+|++......  ....+.+|++.++.++|||++++++.+.         ...
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~---------~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH---------SEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec---------cCC
Confidence            67789999999999999999999999999988654322  2356778999999999999999998543         347


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+ .++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~iv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~  145 (283)
T cd07835          72 KLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGL  145 (283)
T ss_pred             eEEEEEecc-CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccc
Confidence            899999999 468888775321  13578999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +......         ........++..|+|||++.+...  ++.++|+||+|+++|+|++|+.||..
T Consensus       146 ~~~~~~~---------~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         146 ARAFGVP---------VRTYTHEVVTLWYRAPEILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             ccccCCC---------ccccCccccccCCCCCceeecCcc--cCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            6422110         011112234778999998876432  37789999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-31  Score=234.91  Aligned_cols=206  Identities=23%  Similarity=0.342  Sum_probs=164.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +...++|++.+.||+|+||.||+|.+..++..||+|++....  ......+.+|++.+++++||||+++.+.+....   
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~---   89 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR---   89 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc---
Confidence            344588999999999999999999998999999999886432  223456778999999999999999988654321   


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      ........+++++++ +++|.+.+.     ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence            122234577888876 788877664     23488899999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+....            .......++..|+|||.+.+...  .+.++||||+|+++|++++|+.||..
T Consensus       161 l~dfg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         161 ILDFGLARHTD------------DEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             Eeccccccccc------------ccccccccCCCccCHHHHhCccC--CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999754210            11123356778999999865321  37899999999999999999999964

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=4.7e-32  Score=230.49  Aligned_cols=207  Identities=22%  Similarity=0.406  Sum_probs=164.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEec----CCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .++|++.+.||+|+||.||+|.+.    .++..||+|.+...... ....+.+|++.++.++|+||+++.+++..     
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~-----   77 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK-----   77 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec-----
Confidence            467888999999999999999864    34789999988755543 46678899999999999999999875432     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        .+....++++||+++++|.+++...   ...++...+..++.|++.||.|||++   |++|+||+|+||+++.++.++
T Consensus        78 --~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          78 --PGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             --CCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEE
Confidence              1246799999999999999888642   22488899999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+.......      ..........++..|++||.+.+..+   +.++|+||||+++|||++|..||..
T Consensus       150 l~dfg~~~~~~~~~------~~~~~~~~~~~~~~~~~Pe~~~~~~~---~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         150 ISDFGLAKVLPEDK------DYYYVKEPGESPIFWYAPECLRTSKF---SSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             EcccccccccccCC------cceeccCCCCCcccccCcHHHccCCC---CcccchHHHhhhhheeeccCCCccc
Confidence            99999764321000      00000111233456999999876654   7899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=8.9e-32  Score=230.68  Aligned_cols=213  Identities=22%  Similarity=0.276  Sum_probs=166.1

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCC-CCCccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFV-HPNILPLLDHAL   93 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~   93 (282)
                      .....+.+..++|++.+.||+|+||+||+|.+..++..||||.+..... .....+.+|+..+.... ||||+++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618           5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             ecceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3456678889999999999999999999999998899999999865433 23445666777666664 999999998554


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .         ....++++|++ .+++.+.+...   ...+++..+..++.|++.|+.|||+..  |++|+||+|+||+++
T Consensus        85 ~---------~~~~~~v~e~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~  149 (296)
T cd06618          85 T---------DSDVFICMELM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLD  149 (296)
T ss_pred             c---------CCeEEEEeecc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEc
Confidence            3         46799999998 45666655432   236888999999999999999999743  799999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc-ccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS-YCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~-~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .++.++++|||.+....       .   ........++..|+|||++.+.. ...++.++|+||||+++|+|++|+.||.
T Consensus       150 ~~~~~kL~dfg~~~~~~-------~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  219 (296)
T cd06618         150 ASGNVKLCDFGISGRLV-------D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK  219 (296)
T ss_pred             CCCCEEECccccchhcc-------C---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999754210       0   00111223567899999997653 1123789999999999999999999996


Q ss_pred             c
Q psy16951        253 T  253 (282)
Q Consensus       253 ~  253 (282)
                      .
T Consensus       220 ~  220 (296)
T cd06618         220 N  220 (296)
T ss_pred             c
Confidence            4

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-31  Score=223.90  Aligned_cols=201  Identities=22%  Similarity=0.357  Sum_probs=167.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|++|.||++.+..++.+||+|.+.....  .....+.+|++.+++++|+|++++++.+.         +.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE---------TS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE---------eC
Confidence            58899999999999999999999999999998876554  45567889999999999999999988543         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++.+++|.+.+...    ..+++..+..++.|++.|+.++|+.   |++|+||+|+||+++.++.++++|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence            6799999999999999887643    4588999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .+......        . .......++..|++||...+...   +.++|+||+|+++|++++|..||....
T Consensus       145 ~~~~~~~~--------~-~~~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         145 VATKLNDV--------S-KDDASVVGTPYWMAPEVIEMSGA---STASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             cceecCCC--------c-ccccccccchhhcCHhhhcCCCC---CcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            76432110        0 00122345778999999876654   789999999999999999999997543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.98  E-value=5.7e-32  Score=226.15  Aligned_cols=197  Identities=24%  Similarity=0.367  Sum_probs=158.5

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ++||+|+||.||++.+.. +..||+|.+...... ....+.+|+++++.++|+||+++++.+.         .....+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV---------QKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe---------cCCCeEEE
Confidence            369999999999999977 899999988655443 4567889999999999999999988543         34678999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +|++.+++|.+.+...   ...++...+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||.+....
T Consensus        71 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          71 MELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999887532   23578889999999999999999999   89999999999999999999999999754221


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ..       ...........+..|+|||.+.+..+   +.++|+||+|+++||+++ |..||...
T Consensus       145 ~~-------~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         145 GG-------IYTVSDGLKQIPIKWTAPEALNYGRY---TSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             CC-------cceeccccCcceeccCChHhhccCCC---CcchhHHHHHHHHHHHHhccCCCCccC
Confidence            00       00000011223556999999877665   889999999999999999 88999754

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.98  E-value=5.1e-32  Score=228.72  Aligned_cols=200  Identities=21%  Similarity=0.358  Sum_probs=157.0

Q ss_pred             EeccCCceEEEEEEecCCC------ceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         33 KIGEGGFSTVSLIEHSQTK------KRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~------~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      .||+|+||.||+|.+....      ..+|||.+.... ......+.+|+..++.++||||+++++.+.         ...
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~~   72 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL---------LNE   72 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec---------CCC
Confidence            5899999999999976443      679999875433 234567889999999999999999998543         345


Q ss_pred             eEEEEeccCCCCChHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-----C
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSV---GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-----N  177 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-----~  177 (282)
                      ..++++||+++++|.+.+.....   ....++..+++.++.|++.|+.|+|++   +++|+||+|+||+++.++     .
T Consensus        73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence            68999999999999998864322   123467889999999999999999998   899999999999999877     7


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||++......       ..........++..|+|||++.+..+   +.++||||||+++|||++ |..||...
T Consensus       150 ~~l~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         150 VKIGDFGLARDIYKS-------DYYRKEGEGLLPVRWMAPESLLDGKF---TTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             eEECCcccccccccc-------cccccCcccCCCccccCHHHHccCCc---ccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            899999976432100       00011112234677999999987665   889999999999999998 99999653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=1.2e-31  Score=231.11  Aligned_cols=220  Identities=27%  Similarity=0.404  Sum_probs=166.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.++||+|+||.||+|.+..++..||+|++......  ....+.+|++.++.++||||+++++.+...... ...
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK-SKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc-ccc
Confidence            58999999999999999999999999999999988644332  234567899999999999999998866542111 113


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++++||+.. ++...+..   ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++|
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            34568999999854 56555542   234589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhh--hhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEA--QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~--~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+.............  ..........++..|+|||.+.+...  .+.++||||+|+++|||++|++||.+.
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCc--cCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            99765321111000000  00011122345778999999865432  378999999999999999999999753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=6.7e-32  Score=234.83  Aligned_cols=206  Identities=22%  Similarity=0.313  Sum_probs=157.2

Q ss_pred             EEeccC--CceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEG--GFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      ..||+|  +||+||++.+..++..||+|.+.....  ...+.+.+|+.+++.++||||+++++.+..         ....
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---------~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT---------GSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec---------CCce
Confidence            457776  999999999999999999998864432  234567789999999999999999985543         4679


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++||+.++++.+.+....  ...+++..+..++.|++.||.|+|++   |++||||||+||+++.++.++++||+...
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             EEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            99999999999998776432  23478899999999999999999998   89999999999999999999999987432


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ...  .................++..|++||++.+... .++.++||||+||++||+++|+.||.+.
T Consensus       150 ~~~--~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         150 SLV--RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY-GYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             hhh--ccCccccccccccccccCccCccChhhhcCCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            110  000000000000111224567999999976432 2378999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=9.1e-32  Score=227.40  Aligned_cols=191  Identities=25%  Similarity=0.382  Sum_probs=153.6

Q ss_pred             ccEEEEEEe--ccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKI--GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +.|++.+.+  |+|+||.||++....++..+|+|.+........     |+.....+ +|||++++++.+.         
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~---------   79 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT---------   79 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe---------
Confidence            456666665  999999999999999999999998754322211     22222222 6999999998544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~  181 (282)
                      .....++|+||+++++|.+++...    ..+++.++..++.|++.|+.|+|+.   |++|+||+|+||+++.++ .++++
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence            346899999999999999988632    3689999999999999999999999   899999999999999988 99999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+....             ......++..|+|||++.+..+   +.++|+||+|+++|++++|+.||..
T Consensus       153 dfg~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~p~~~  208 (267)
T PHA03390        153 DYGLCKIIG-------------TPSCYDGTLDYFSPEKIKGHNY---DVSFDWWAVGVLTYELLTGKHPFKE  208 (267)
T ss_pred             cCccceecC-------------CCccCCCCCcccChhhhcCCCC---CchhhHHHHHHHHHHHHHCCCCCCC
Confidence            999754221             0112346788999999987665   7899999999999999999999974

>KOG3653|consensus

Probab=99.98  E-value=1.2e-32  Score=235.72  Aligned_cols=204  Identities=23%  Similarity=0.320  Sum_probs=161.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhh--hCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHK--TFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~--~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ++.+..++.+.||+|.||.||+|..  +++.||||+++   ..+.+.+.+|-.+.+  .++|+||+.|++.--.+.    
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t----  277 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT----  277 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCC----
Confidence            3467788899999999999999998  55899999985   455667777777665  568999999988544431    


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC------CCccccCCCCCcEEeec
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKP------IAYAHRDLKTANVLLAN  174 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~------~~i~H~dlk~~nil~~~  174 (282)
                       ...-.++||++|.+.|+|.++|..     +.+++....+++..++.||.|||.-.+      .+|+|||||.+|||+..
T Consensus       278 -~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~  351 (534)
T KOG3653|consen  278 -ADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN  351 (534)
T ss_pred             -ccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence             124579999999999999999973     458899999999999999999996432      26999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc--C-CCCccchhhHHHHHHHHHhCC
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC--V-VDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~--~-~~~~~Diws~G~il~el~tg~  248 (282)
                      +.++.|+|||++....+       ..+.......+||.+|||||++.+..--  . --.+.||||+|+++||++++-
T Consensus       352 DlTccIaDFGLAl~~~p-------~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  352 DLTCCIADFGLALRLEP-------GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             CCcEEeeccceeEEecC-------CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99999999998764321       1222334457899999999999764310  0 014699999999999999863

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=1.2e-31  Score=227.80  Aligned_cols=199  Identities=27%  Similarity=0.436  Sum_probs=157.1

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |+++++||+|+||.||+|.+..++..||+|++.... ........+|+..+.++. |+|++++++.+...       ...
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-------~~~   73 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR-------KTG   73 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC-------CCC
Confidence            678999999999999999999999999999886432 222334457888888885 99999999865431       225


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      .+++++||+. +++.+.+...   ...+++.++..++.|++.||.|||++   +++|+||+|+||+++. +.++++|||.
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          74 RLALVFELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             cEEEEEecCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccc
Confidence            7899999996 5777766532   24588999999999999999999999   8999999999999999 9999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +.....          ........++..|+|||++.....  .+.++|+||+||++|||++|..||.+
T Consensus       146 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         146 CRGIYS----------KPPYTEYISTRWYRAPECLLTDGY--YGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             cccccc----------CCCcCCCCCCcccCChhHhhcCCC--CCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            542110          001112345778999998754432  37899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0666|consensus

Probab=99.98  E-value=4.2e-33  Score=227.69  Aligned_cols=207  Identities=25%  Similarity=0.392  Sum_probs=164.2

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCC----ceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTK----KRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ...|+.+..||+|.||.||+|....++    +++|||++.-...  .-..+..+|+.+++.++|||++.+...++.    
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence            467899999999999999999655443    3689998854322  234567899999999999999999887664    


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLEL-RSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND--  175 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--  175 (282)
                          .+..+++++||++ .+|.+.+.. +......++..-+..++.||+.|+.|||++   =|+||||||.||++-.+  
T Consensus        99 ----~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgp  170 (438)
T KOG0666|consen   99 ----HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGP  170 (438)
T ss_pred             ----cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCC
Confidence                2578999999995 466666543 222335688899999999999999999999   68899999999999777  


Q ss_pred             --CCceeecccCccchhhhccCchhhhhhHh---hhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        176 --NNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       176 --~~~~~~df~~~~~~~~~~~~~~~~~~~~~---~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                        |.+||+|+|+++..         ..+...   ....+-|..|.|||.+.|...  ++++.||||.|||+.||+|-++.
T Consensus       171 erG~VKIaDlGlaR~~---------~~plkpl~s~d~VVVTiWYRAPELLLGa~h--YT~AiDvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  171 ERGRVKIADLGLARLF---------NNPLKPLASLDPVVVTIWYRAPELLLGARH--YTKAIDVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             ccCeeEeecccHHHHh---------hccccccccCCceEEEEEecChHHhccccc--ccchhhhHHHHHHHHHHHccCcc
Confidence              89999999987532         212111   122345788999999998765  58999999999999999999999


Q ss_pred             CCcc
Q psy16951        251 FDTV  254 (282)
Q Consensus       251 f~~~  254 (282)
                      |.+.
T Consensus       240 F~g~  243 (438)
T KOG0666|consen  240 FKGR  243 (438)
T ss_pred             ccch
Confidence            9763

>KOG0587|consensus

Probab=99.98  E-value=7.2e-32  Score=245.52  Aligned_cols=235  Identities=22%  Similarity=0.294  Sum_probs=188.0

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGC   96 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~   96 (282)
                      -+....+.+.|++.+.||.|.+|.||+++++.++..+|+|++......+. +...|.++++.. .|||++.+++++.-..
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de-EiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE-EIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH-HHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34456678999999999999999999999999999999998765544433 334466677766 6999999999887532


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                          ....+++|||||||.+||+.+++....  ...+.+..+..+++.++.|+.+||..   .++|||+|-.|||+..++
T Consensus        90 ----~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   90 ----PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             ----CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence                134689999999999999999998765  56799999999999999999999999   477999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+|+.|||.+...         .....+.....||+.|||||++.++..  ..+...+|+||+|++..||+-|.+|+-+-
T Consensus       161 ~VKLvDFGvSaQl---------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  161 EVKLVDFGVSAQL---------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             cEEEeeeeeeeee---------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence            9999999986533         223344556688999999999987642  12467899999999999999999999642


Q ss_pred             ccCccceeeeeeeccccCCCCCCCCC
Q psy16951        255 YERGDSVALAVISGNITFPENTPFPQ  280 (282)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~p~~~~~~~  280 (282)
                      -+         .+.-+.+|.++|+.+
T Consensus       232 HP---------mraLF~IpRNPPPkL  248 (953)
T KOG0587|consen  232 HP---------MRALFLIPRNPPPKL  248 (953)
T ss_pred             ch---------hhhhccCCCCCCccc
Confidence            11         233455666666543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.98  E-value=1.1e-31  Score=227.13  Aligned_cols=211  Identities=19%  Similarity=0.376  Sum_probs=161.0

Q ss_pred             EEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      |++.+.||+|+||.||+|.+.   .++..||||.+....  ....+.+.+|+..++.++||||+++++.+......   .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK---G   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC---C
Confidence            567889999999999999864   467899999886542  33455678899999999999999999866542110   0


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSV--GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .....+++++|+.+++|...+.....  ....++...++.++.|++.|+.|+|++   +++|+||||+||+++.++.+++
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEE
Confidence            11245788999999999887653221  123468888999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||.+......       ..........+++.|++||.+.+..+   +.++||||||+++||+++ |++||.+.
T Consensus       155 ~dfg~~~~~~~~-------~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         155 ADFGLSKKIYSG-------DYYRQGCASKLPVKWLALESLADNVY---TTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             CcccccccccCC-------cceecCCCccCchhhcCHhHHhcCcc---chhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            999976532110       00001112234567999999877665   789999999999999999 88999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.1e-31  Score=232.30  Aligned_cols=201  Identities=25%  Similarity=0.370  Sum_probs=161.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ...|+..+.||+|+||.||++.+..++..||+|.+.....   .....+.+|++.++.++|||++++++.+..       
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------   96 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-------   96 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-------
Confidence            3457888999999999999999999999999998864432   234567889999999999999999985543       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ....++++||+. +++.+.+..   ....+++.++..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++
T Consensus        97 --~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~  167 (317)
T cd06635          97 --EHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA  167 (317)
T ss_pred             --CCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence              467899999996 577665543   234588899999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....             ......++..|+|||++........+.++|+||||+++|||++|+.||.+.
T Consensus       168 dfg~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         168 DFGSASIAS-------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             cCCCccccC-------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999653210             011234677899999985322122478999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=225.80  Aligned_cols=191  Identities=21%  Similarity=0.276  Sum_probs=154.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHH-hhhCCCCCcccccccccccCCCCCCCCCceE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEH-HKTFVHPNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~-l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +.||+|+||.||+|.+..++..||+|.+......   .......|... ....+|+|++++++.+         ......
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~---------~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF---------QSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE---------EcCCeE
Confidence            5699999999999999999999999988543321   12233344444 3455899999999844         345789


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++||+++++|.+++..    ...+++.++..++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||.+.
T Consensus        73 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  145 (260)
T cd05611          73 YLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR  145 (260)
T ss_pred             EEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccce
Confidence            999999999999988753    24578999999999999999999998   89999999999999999999999999754


Q ss_pred             chhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....             .....++..|++||.+.+..+   +.++|+||+|+++|++++|..||...
T Consensus       146 ~~~~-------------~~~~~~~~~y~~pe~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         146 NGLE-------------NKKFVGTPDYLAPETILGVGD---DKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             eccc-------------cccCCCCcCccChhhhcCCCC---cchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            2100             112346778999999987764   78999999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.9e-31  Score=233.44  Aligned_cols=207  Identities=25%  Similarity=0.372  Sum_probs=165.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +-..++|++++.||+|+||.||++.+..++..||+|++...  .......+.+|+++++.++||||+++++.+....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   87 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL---   87 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc---
Confidence            33467899999999999999999999999999999988532  2233456778999999999999999988665421   


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      .......+++++|++ +++|...+.     ...+++..+..++.|++.||.|+|+.   |++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            111224578999998 778876654     23588999999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+....            .......++..|++||++.+...  .+.++|+||+|+++|++++|..||.+.
T Consensus       159 l~dfg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         159 ILDFGLARQTD------------SEMTGYVVTRWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             Eeecccccccc------------cCccccccCCcccCHHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999754210            01122345778999999875322  378999999999999999999999753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0669|consensus

Probab=99.98  E-value=1.2e-34  Score=230.55  Aligned_cols=234  Identities=24%  Similarity=0.330  Sum_probs=180.8

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+-+..+.|+-+.+||+|.||+||+|+.+.+++.||+|++...+.+  .....++|+.+++.++|+|++.+.+.+... .
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk-~   89 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK-A   89 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc-c
Confidence            3455677888889999999999999999999999999877543332  456778999999999999999998877642 2


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                      .+.......+++|+.+|+ .+|...+..   ....++...+..++.+++.||.|+|..   .|+|||+|+.|+|++.++.
T Consensus        90 Tp~~r~r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGI  162 (376)
T ss_pred             CCcccccceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCce
Confidence            234555677999999994 466666643   234588899999999999999999999   5779999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      ++++|||+++.+.......     ..+-..++-|..|.+||.+.|...  ++++.|||+.|||+.||+|+.+.|++..+.
T Consensus       163 lklADFGlar~fs~~~n~~-----kprytnrvvTLwYrppEllLG~r~--yg~~iDiWgAgCimaeMwtrspimqgnteq  235 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVV-----KPRYTNRVVTLWYRPPELLLGDRE--YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             EEeeccccccceecccccC-----CCCcccceeeeecCCHHHhhcccc--cCCcchhHhHHHHHHHHHccCccccCChHH
Confidence            9999999875432111100     011122344788999999998754  589999999999999999999999986554


Q ss_pred             ccceeeeeeec
Q psy16951        258 GDSVALAVISG  268 (282)
Q Consensus       258 ~~~~~~~~~~~  268 (282)
                      .....++.+.|
T Consensus       236 qql~~Is~LcG  246 (376)
T KOG0669|consen  236 QQLHLISQLCG  246 (376)
T ss_pred             HHHHHHHHHhc
Confidence            44444443333

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.7e-31  Score=232.26  Aligned_cols=208  Identities=24%  Similarity=0.342  Sum_probs=166.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|++.+.||+|+||.||+|.+..++..||||++....  ......+.+|++.++.++|+||+++.+.+....    ....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPS----PEDF   76 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccC----cccc
Confidence            5899999999999999999999899999999886543  334567888999999999999999998665431    1223


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|+++ ++|.+.+.    ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++|||
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          77 NDVYIVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             cceEEEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccC
Confidence            46899999996 57776664    233688999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+........      .........++..|+|||++.+...  .+.++|+||+|+++|+|++|..||.+.
T Consensus       149 ~~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         149 LARGVDPDED------EKGFLTEYVVTRWYRAPELLLSSSR--YTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             ceEeeccccc------ccccccccccccCcCCceeeecccC--CCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            7653211100      0011223346778999999987631  388999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.98  E-value=3.1e-31  Score=220.90  Aligned_cols=200  Identities=28%  Similarity=0.457  Sum_probs=168.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      +|++.+.||+|++|.||++.+..++..+++|++..........+.+|++.++.++|+|++++.+.+..         ...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK---------KDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec---------CCe
Confidence            58889999999999999999988999999999876555566778899999999999999999985443         367


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++++|++++++|.+.+...   ...+++..+..++.|++.|+.++|++   |++|+||+|+||+++.++.++++|||.+
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~  145 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS  145 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccc
Confidence            99999999999999877642   24689999999999999999999998   8999999999999999999999999965


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ......        .  ......++..|++||.+.+...   +.++|+||+|++++++++|..||...
T Consensus       146 ~~~~~~--------~--~~~~~~~~~~~~~PE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         146 AQLSDT--------K--ARNTMVGTPYWMAPEVINGKPY---DYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             cccccc--------c--cccceecCCcccCHHHHcCCCC---CccccHHHHHHHHHHHHhCCCCCCCC
Confidence            422100        0  0123346778999999987654   78999999999999999999999754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=3.2e-31  Score=230.95  Aligned_cols=207  Identities=23%  Similarity=0.336  Sum_probs=161.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCC--CceEEEEEeccC--CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQT--KKRYALKKIICH--GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|++.+.||+|+||.||++++..+  +..||+|.+...  .......+.+|+++++++ +||||+++++.+...     .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-----P   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-----c
Confidence            588999999999999999999888  899999988642  222345677899999999 599999998754431     1


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......++++|++. ++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++
T Consensus        76 ~~~~~~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          76 GNFNELYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             ccCCcEEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeC
Confidence            22345788888884 67877664    234588999999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+........     ..........++..|+|||++.+..  ..+.++|+||+|+++|++++|++||.+
T Consensus       148 Dfg~a~~~~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         148 DFGLARGFSENPG-----ENAGFMTEYVATRWYRAPEIMLSFQ--SYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             cCCCceecccccc-----cccccccCcccCccccCcHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            9997653211100     0011112345788899999886532  137899999999999999999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=1.8e-31  Score=230.54  Aligned_cols=205  Identities=21%  Similarity=0.330  Sum_probs=156.6

Q ss_pred             EeccC--CceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEE
Q psy16951         33 KIGEG--GFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        33 ~lg~G--~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +||+|  ++|.||.++...++..||+|++...  .......+.+|++.++.++|+||+++++.+.         .....+
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~---------~~~~~~   75 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI---------VDSELY   75 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee---------cCCeEE
Confidence            34443  5566777777779999999998654  3345567889999999999999999998544         346789


Q ss_pred             EEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        109 MVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       109 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +++||+++++|.+.+...  ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++++||+.+..
T Consensus        76 ~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          76 VVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             EEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcccee
Confidence            999999999999888643  223478889999999999999999999   899999999999999999999999997643


Q ss_pred             hhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .......  ............++..|+|||++.+... .++.++|+||+|+++||+++|+.||...
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         151 MIKHGKR--QRVVHDFPKSSVKNLPWLSPEVLQQNLQ-GYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ecccccc--ccccccccccccccccccCHHHhcCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            2111000  0000111122345677999999876421 1378999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=1.2e-31  Score=234.07  Aligned_cols=207  Identities=27%  Similarity=0.394  Sum_probs=162.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+.+++++ +||||+++++.+..       
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~-------   78 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA-------   78 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc-------
Confidence            57899999999999999999999889999999988532  233445667899999999 99999999985432       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .+....++|+||+. ++|...+..     ..+.+..+..++.|++.||.|||+.   |++|+||+|+||+++.++.++++
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEe
Confidence            13356899999996 588776642     2578888889999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.........    ..........++..|+|||++.+...  .+.++|+||||+++|+|++|+.||.+
T Consensus       150 d~g~~~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         150 DFGLARSLSELEEN----PENPVLTDYVATRWYRAPEILLGSTR--YTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             eccchhcccccccc----ccCcchhcccccccccCceeeecccc--ccccchHHHHHHHHHHHHhCCCCCCC
Confidence            99976532111000    00011122346788999999865432  37899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=3.5e-31  Score=221.50  Aligned_cols=205  Identities=26%  Similarity=0.384  Sum_probs=168.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.....  .....+.+|++.+++++|+||+++++.+...       ..
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE-------EK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC-------CC
Confidence            47889999999999999999998999999998865543  4456778899999999999999998854431       12


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++++|++++++|.+.+...    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence            6799999999999999887643    2688999999999999999999998   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .+.........       .......++..|++||.+.+...   +.++|+||+|++++++++|..||....
T Consensus       147 ~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         147 CAKRLGDIETG-------EGTGSVRGTPYWMAPEVIRGEEY---GRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cEEeccccccc-------ccccCCCCCccccCHhhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            75432111000       01123346778999999987654   789999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0608|consensus

Probab=99.97  E-value=8.9e-32  Score=237.55  Aligned_cols=222  Identities=21%  Similarity=0.273  Sum_probs=173.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHH---HHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .-|-.++.||-|+||+|.+++-..|...||.|.+...+...+.   ....|-.+|..-+++=||+++-         .+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy---------SFQ  699 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY---------SFQ  699 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE---------Eec
Confidence            3466788999999999999999999999999988655443332   3355777888888899999986         455


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+|+||+|.++|++-.+|-.    .+-+++..+..++.++..|+++.|..   |.+||||||+|||||.+|++|++|
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence            67899999999999999887763    34488999999999999999999999   888999999999999999999999


Q ss_pred             ccCccchhhhcc---------------------------C----chhhhhhHh--hhhccCCCCccCCcccccCcccCCC
Q psy16951        183 LGSVAPAVVKVC---------------------------G----SAEAQNLQD--VAAERCSMPYRAPELFHVDSYCVVD  229 (282)
Q Consensus       183 f~~~~~~~~~~~---------------------------~----~~~~~~~~~--~~~~~~t~~y~~PE~~~~~~~~~~~  229 (282)
                      ||++..+.-.-.                           .    .......++  ..+.+||.+|+|||++....|   +
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~---~  849 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY---T  849 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc---c
Confidence            997632211000                           0    000011111  235679999999999998887   8


Q ss_pred             CccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeec
Q psy16951        230 QRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG  268 (282)
Q Consensus       230 ~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~  268 (282)
                      .-+|.||.|||||||+.|++||-+..+.  ....++..+
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~--~tq~kv~nw  886 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPG--ETQYKVINW  886 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCC--cceeeeeeh
Confidence            8999999999999999999999864443  334444444

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-31  Score=224.70  Aligned_cols=200  Identities=24%  Similarity=0.412  Sum_probs=161.6

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.+.||+|++|+||+|....++..||||++..... .......+|+..++.++ |+|++++++.+.         ...
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~---------~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR---------END   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh---------cCC
Confidence            6788999999999999999998999999998854322 23334567899999998 999999998543         457


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++|++ +++|.+.+....  ...+++.++..++.|++.+|.|||++   +++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccc
Confidence            899999999 889988776432  24578999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +......          .......++..|+|||++.....  .+.++|+||||+++||+++|+.||...
T Consensus       146 ~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         146 AREIRSR----------PPYTDYVSTRWYRAPEILLRSTS--YSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             ceeccCC----------CCcCCCCCcccccCceeeecCcC--cCCccchhhHHHHHHHHHhCCCccCCC
Confidence            5422110          01112345778999998865432  378999999999999999999999643

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.5e-31  Score=233.20  Aligned_cols=211  Identities=22%  Similarity=0.340  Sum_probs=162.1

Q ss_pred             cccEEE-EEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--------------HHHHHHHHHHhhhCCCCCccccc
Q psy16951         25 SDKYYI-VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--------------QAQAIREVEHHKTFVHPNILPLL   89 (282)
Q Consensus        25 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--------------~~~~~~e~~~l~~l~H~ni~~~~   89 (282)
                      .++|.. .+.||+|+||+||+|.+..++..||||.+.......              ...+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456764 466999999999999999999999999886443222              11467899999999999999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      +.+.         .....++++|++. ++|.+.+..    ...++...+..++.|++.||.|||++   |++|+||+|+|
T Consensus        87 ~~~~---------~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~n  149 (335)
T PTZ00024         87 DVYV---------EGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPAN  149 (335)
T ss_pred             EEEe---------cCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHH
Confidence            8544         3467999999995 688877753    34588999999999999999999998   89999999999


Q ss_pred             EEeecCCCceeecccCccchhhhccCchhh-----hhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        170 VLLANDNNPLLMDLGSVAPAVVKVCGSAEA-----QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       170 il~~~~~~~~~~df~~~~~~~~~~~~~~~~-----~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |+++.++.++++|||.+.............     ..........++..|+|||.+.+...  .+.++|+||+|+++||+
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        150 IFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK--YHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             eEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCC--CCcHHHHHHHHHHHHHH
Confidence            999999999999999765332110000000     00011112335678999999876432  37899999999999999


Q ss_pred             HhCCCCCCcc
Q psy16951        245 CYFKSPFDTV  254 (282)
Q Consensus       245 ~tg~~pf~~~  254 (282)
                      ++|+.||.+.
T Consensus       228 ~tg~~p~~~~  237 (335)
T PTZ00024        228 LTGKPLFPGE  237 (335)
T ss_pred             HhCCCCCCCC
Confidence            9999999754

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.1e-31  Score=227.43  Aligned_cols=202  Identities=21%  Similarity=0.336  Sum_probs=159.9

Q ss_pred             cEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCCc----hhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHGR----EDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~----~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      +|++.+.||+|+||.||++.+.   .++..||+|.+.....    .....+.+|+++++++ +||||+++++.       
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-------   73 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-------   73 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-------
Confidence            4889999999999999999864   4678899998853321    2234567899999999 59999999874       


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                        +......++|+||+++++|.+.+..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        74 --~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~  144 (288)
T cd05583          74 --FQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHV  144 (288)
T ss_pred             --eecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence              3345779999999999999887753    24578889999999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +++|||.+......        .........++..|++||.+.+... ..+.++|+||+|+++|||++|..||..
T Consensus       145 ~l~dfg~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         145 VLTDFGLSKEFLAE--------EEERAYSFCGTIEYMAPEVIRGGSG-GHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             EEEECccccccccc--------cccccccccCCccccCHHHhcCCCC-CCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            99999975422110        0111122346788999999876541 126789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0695|consensus

Probab=99.97  E-value=2.4e-32  Score=225.66  Aligned_cols=231  Identities=23%  Similarity=0.353  Sum_probs=182.7

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhh-CCCCCcccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKT-FVHPNILPLLDHA   92 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~-l~H~ni~~~~~~~   92 (282)
                      .+..+-+..++|+++++||+|+|++|-.++++.|...+|+|+++..   ..++......|-.+..+ -+||.++.++.  
T Consensus       241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs--  318 (593)
T KOG0695|consen  241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS--  318 (593)
T ss_pred             cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh--
Confidence            3456778899999999999999999999999999999999987532   22222223334444433 36999999987  


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                             ++..+..+++|.||.++|.|--+++    .+..+++..+..+..+|..||.|||++   ||+.||||.+|+|+
T Consensus       319 -------cfqtesrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvll  384 (593)
T KOG0695|consen  319 -------CFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLL  384 (593)
T ss_pred             -------hhcccceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEE
Confidence                   5556788999999999999987665    345699999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +..|++|++|+|..+..         -.+........||++|.|||++.++.|   +...|.|++|++++||+.|..||.
T Consensus       385 daeghikltdygmcke~---------l~~gd~tstfcgtpnyiapeilrgeey---gfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  385 DAEGHIKLTDYGMCKEG---------LGPGDTTSTFCGTPNYIAPEILRGEEY---GFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             ccCCceeecccchhhcC---------CCCCcccccccCCCcccchhhhccccc---CceehHHHHHHHHHHHHcCCCCcc
Confidence            99999999999975421         112223345678999999999999998   899999999999999999999995


Q ss_pred             ccc------cCccceeeeeeeccccCCCC
Q psy16951        253 TVY------ERGDSVALAVISGNITFPEN  275 (282)
Q Consensus       253 ~~~------~~~~~~~~~~~~~~~~~p~~  275 (282)
                      -..      ..++.+...++..++.+|-.
T Consensus       453 ivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  453 IVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             eecCCCcccchhHHHHHHHhhhcccccce
Confidence            221      12333444566666666644

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-31  Score=223.65  Aligned_cols=204  Identities=26%  Similarity=0.382  Sum_probs=160.1

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhC---CCCCcccccccccccCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTF---VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      |++.+.||+|+||.||+|.+..++.+||+|.+......  ....+.+|+.+++++   +|+|++++.+.+...    ...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~----~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP----RTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec----cCC
Confidence            67899999999999999999888999999988643222  233455677766555   699999999876653    111


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++|++. ++|.+++...  ....+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|
T Consensus        77 ~~~~~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~d  150 (287)
T cd07838          77 RELKLTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIAD  150 (287)
T ss_pred             CCceeEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEec
Confidence            2345999999996 5788777542  223588999999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+......          .......++..|+|||++.+..+   +.++|+||+|+++|+|++|.+||.+.
T Consensus       151 fg~~~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~---~~~~Di~s~G~~l~~l~~~~~~~~~~  209 (287)
T cd07838         151 FGLARIYSFE----------MALTSVVVTLWYRAPEVLLQSSY---ATPVDMWSVGCIFAELFRRRPLFRGT  209 (287)
T ss_pred             cCcceeccCC----------cccccccccccccChHHhccCCC---CCcchhhhHHHHHHHHHhCCCcccCC
Confidence            9975432110          11112235778999999987665   78999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=7.2e-31  Score=228.38  Aligned_cols=201  Identities=24%  Similarity=0.346  Sum_probs=162.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +...++|++.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+++++.++||||+++.+.+..     
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----   80 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-----   80 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-----
Confidence            45677899999999999999999999999999999987532  22334567789999999999999999885532     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++++|++ +++|...+.     ...++...+..++.|++.||.|||++   +++|+||+|+||+++.++.++
T Consensus        81 ---~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          81 ---PLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             ---CCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence               234688999998 568877654     23477888888999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+....            .......++..|+|||++.+...  .+.++|+||+|+++|++++|+.||..
T Consensus       149 l~dfg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         149 ICDFGLARIQD------------PQMTGYVSTRYYRAPEIMLTWQK--YDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             eCccccccccC------------CCcCCCcccccccCceeeeccCC--cCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999754210            01122345778999998865321  37899999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-31  Score=224.60  Aligned_cols=199  Identities=26%  Similarity=0.361  Sum_probs=161.5

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.+.||+|++|.||+|.+..++..+|+|++......  ....+.+|++.++.++|+||+++++.+.         ...
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR---------HKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc---------cCC
Confidence            56788999999999999999989999999988654332  4556778999999999999999998543         447


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++||+++ ++.+.+...   ...+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~~v~e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~  144 (283)
T cd05118          72 DLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGL  144 (283)
T ss_pred             CEEEEEeccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeee
Confidence            89999999964 887766542   24588999999999999999999998   899999999999999999999999996


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +......         ........++..|+|||.+.+...  .+.++|+||+|+++|++++|+.||.+
T Consensus       145 ~~~~~~~---------~~~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         145 ARSFGSP---------VRPYTHYVVTRWYRAPELLLGDKG--YSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             eEecCCC---------cccccCccCcccccCcHHHhcCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            5422110         011112345677999999876522  37899999999999999999999965

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=7.6e-31  Score=226.79  Aligned_cols=200  Identities=26%  Similarity=0.387  Sum_probs=160.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +.|...++||+|+||+||+|.+..++..||+|.+.....   .....+.+|++.++.++|||++++++.+..        
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------   92 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--------   92 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--------
Confidence            347777889999999999999999999999998864432   233467789999999999999999985443        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++++||+. +++.+.+..   ....+++.++..++.|++.|+.|||++   |++|+||+|+||+++.++.++++|
T Consensus        93 -~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~d  164 (313)
T cd06633          93 -EHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD  164 (313)
T ss_pred             -CCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEee
Confidence             467999999995 577766643   234578899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+...             .......++..|+|||++.......++.++|+||||+++|+|++|..||...
T Consensus       165 fg~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         165 FGSASKS-------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             cCCCccc-------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9965311             0111234677899999985322122478999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.4e-31  Score=221.01  Aligned_cols=202  Identities=25%  Similarity=0.433  Sum_probs=159.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEecc---C--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC---H--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~---~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|.+.+.||+|+||.||++.+..++..+++|.+..   .  .......+.+|+..++.++||||+++++.+.        
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------   72 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--------   72 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--------
Confidence            58899999999999999999987776666665432   1  1223345667889999999999999998543        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       .....++++||+++++|.+.+.........+++..++.++.|++.|+.|+|+.   |++|+||+|+||+++. +.++++
T Consensus        73 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          73 -ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             -cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeec
Confidence             34678999999999999988865433445689999999999999999999998   8999999999999964 679999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.....         .........++..|++||.+.+..+   +.++|+||+|+++|++++|..||.+
T Consensus       148 d~g~~~~~~~---------~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         148 DFGVSRLLMG---------SCDLATTFTGTPYYMSPEALKHQGY---DSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             ccCceeecCC---------CcccccCCCCCcCccCHHHHccCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997543210         0011112345778999999876655   7789999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.8e-31  Score=228.99  Aligned_cols=202  Identities=24%  Similarity=0.333  Sum_probs=162.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ....|+..+.||+|+||.||+|.+..++..||+|.+...   .......+.+|+++++.++|+|++++.+.+..      
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   86 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR------   86 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc------
Confidence            445688889999999999999999999999999988643   22334467789999999999999999985543      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++|+||+. +++.+.+..   ....++..++..++.|++.|+.|+|++   +++|+||+|+||+++.++.+++
T Consensus        87 ---~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl  156 (308)
T cd06634          87 ---EHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL  156 (308)
T ss_pred             ---CCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEE
Confidence               467899999996 677766542   234578899999999999999999998   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+....             ......++..|+|||++.+......+.++||||||+++|++++|..||...
T Consensus       157 ~dfg~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         157 GDFGSASIMA-------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             CCcccceeec-------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence            9999754221             011234677899999985422112377999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.1e-31  Score=229.02  Aligned_cols=203  Identities=25%  Similarity=0.372  Sum_probs=160.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++...||+|+||.||+|.+..++.+||+|++....  ......+.+|+.+++.++||||+++++.+....   ...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~   90 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV---SGD   90 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc---cCC
Confidence            468999999999999999999999999999999885432  223345778999999999999999998665421   112


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++++|++. .++....      ...++...+..++.|++.||.|||+.   +++||||+|+||+++.++.++++|
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             CCceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence            2345799999985 3554432      23478899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+....            .......++..|+|||++.+...  .+.++|+||+|+++|||++|+.||.+.
T Consensus       161 fg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         161 FGLARHAD------------AEMTGYVVTRWYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCCCcCCC------------CCCCCceeeecccChhhhcCccc--cCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99754210            01112345778999999865321  378999999999999999999999753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.5e-31  Score=218.41  Aligned_cols=213  Identities=27%  Similarity=0.367  Sum_probs=167.1

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      ||+|+||.||++.+..++..+|+|.+......   ....+.+|+++++.++|+|++++++.         +......+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~---------~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA---------FQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH---------eecCCeeEEE
Confidence            69999999999999888999999988654332   34467889999999999999999873         4456789999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +|++++++|.+.+...    ..+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||.+....
T Consensus        72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          72 LEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            9999999999887632    3578999999999999999999998   89999999999999999999999999754321


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeeccc
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNI  270 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  270 (282)
                      ...         .......++..|++||.+.+...   +.++|+||||+++|++++|+.||.....  ......+....+
T Consensus       145 ~~~---------~~~~~~~~~~~~~~Pe~~~~~~~---~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~  210 (250)
T cd05123         145 SEG---------SRTNTFCGTPEYLAPEVLLGKGY---GKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILKDPL  210 (250)
T ss_pred             cCC---------CcccCCcCCccccChHHhCCCCC---CchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcCCC
Confidence            110         11123345778999999877654   7899999999999999999999965322  222222333455


Q ss_pred             cCCCCC
Q psy16951        271 TFPENT  276 (282)
Q Consensus       271 ~~p~~~  276 (282)
                      ++|...
T Consensus       211 ~~~~~~  216 (250)
T cd05123         211 RFPEFL  216 (250)
T ss_pred             CCCCCC
Confidence            555544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-30  Score=228.36  Aligned_cols=206  Identities=24%  Similarity=0.366  Sum_probs=164.7

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +...++|++.+.||+|++|.||+|++..++..||+|++...  .......+.+|+.+++.++|||++++.+.+.....  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   88 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS--   88 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc--
Confidence            33466899999999999999999999999999999987543  22334556789999999999999999886544211  


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                       .......++++|++ +++|.+.+..     ..+++..+..++.|++.||.|+|+.   |++|+||+|+||+++.++.++
T Consensus        89 -~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          89 -LEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             -ccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEE
Confidence             12234589999998 6788876642     4589999999999999999999998   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+.....            ......++..|+|||.+.+...  .+.++||||+|+++|++++|+.||.+
T Consensus       159 L~dfg~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         159 ILDFGLARHTDD------------EMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             Eccccccccccc------------cccCCcccccccCHHHHhCCCC--CCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999997542210            1122345778999999865322  37899999999999999999999964

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=221.26  Aligned_cols=199  Identities=29%  Similarity=0.419  Sum_probs=161.8

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      |++.+.||+|++|.||+|....++.+||+|.+....  ......+.+|++.++.++|+|++++++.+.         +..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---------~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH---------TER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh---------cCC
Confidence            577889999999999999999999999999887553  333456778999999999999999998543         347


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++++|++. ++|.+.+....   ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|||.
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~  144 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL  144 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCc
Confidence            8999999997 58988876431   3588999999999999999999999   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +.....         .........++..|+|||.+.....  .+.++|+||+|+++||+++|..||..
T Consensus       145 ~~~~~~---------~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         145 ARAFGI---------PLRTYTHEVVTLWYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             ccccCC---------CccccCccccCcCcCChHHhcCCcC--CCccccHHHHHHHHHHHHhCCCCCCC
Confidence            543211         0001112234567999999876522  37899999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1152|consensus

Probab=99.97  E-value=1.9e-31  Score=233.27  Aligned_cols=205  Identities=26%  Similarity=0.412  Sum_probs=170.3

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhCC---CCCcccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTFV---HPNILPL   88 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l~---H~ni~~~   88 (282)
                      ...-+..+|..+.++|.|+||.|+.|.++.+..+|+||.|...--        ++.-..-.|+++|..++   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            344556779999999999999999999999999999998743211        11112345999999997   9999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccC-CCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYY-PKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      +.         .+++...+||++|-. ++-.|.+++.    -+..+.+..+..++.|++.|+++||++   ||+|||||=
T Consensus       635 Ld---------fFEddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikd  698 (772)
T KOG1152|consen  635 LD---------FFEDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKD  698 (772)
T ss_pred             hh---------eeecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---Cceeccccc
Confidence            98         677789999999986 4556777665    346699999999999999999999999   899999999


Q ss_pred             CcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC
Q psy16951        168 ANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       168 ~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg  247 (282)
                      +|++++.+|-+|++|||.+..          . ...+.-..+||..|.|||++-|+.|  .+.+-|||++|++||.+.+.
T Consensus       699 envivd~~g~~klidfgsaa~----------~-ksgpfd~f~gtv~~aapevl~g~~y--~gk~qdiwalgillytivyk  765 (772)
T KOG1152|consen  699 ENVIVDSNGFVKLIDFGSAAY----------T-KSGPFDVFVGTVDYAAPEVLGGEKY--LGKPQDIWALGILLYTIVYK  765 (772)
T ss_pred             ccEEEecCCeEEEeeccchhh----------h-cCCCcceeeeeccccchhhhCCCcc--CCCcchhhhhhheeeEEEec
Confidence            999999999999999996531          1 1122335678999999999999999  48999999999999999999


Q ss_pred             CCCCCc
Q psy16951        248 KSPFDT  253 (282)
Q Consensus       248 ~~pf~~  253 (282)
                      ..||+.
T Consensus       766 enpyyn  771 (772)
T KOG1152|consen  766 ENPYYN  771 (772)
T ss_pred             cCCCcC
Confidence            999973

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.6e-30  Score=245.00  Aligned_cols=147  Identities=25%  Similarity=0.349  Sum_probs=128.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|+++++||+|+||+||+|++..++..||||++....   ......+.+|+..++.++||||++++..+         
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~---------   73 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL---------   73 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE---------
Confidence            578999999999999999999999999999999885432   22345677899999999999999998743         


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....+++||||+.+++|.+++..    ...+++..++.++.||+.||.|||.+   +|+||||||+||+++.++.++|+
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEE
Confidence            345789999999999999988753    24578889999999999999999998   89999999999999999999999


Q ss_pred             cccCcc
Q psy16951        182 DLGSVA  187 (282)
Q Consensus       182 df~~~~  187 (282)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4e-30  Score=213.58  Aligned_cols=181  Identities=21%  Similarity=0.270  Sum_probs=146.3

Q ss_pred             CCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCC
Q psy16951         37 GGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPK  116 (282)
Q Consensus        37 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  116 (282)
                      |.+|.||++++..++..||+|.+....     ...+|...+....||||+++++.+.         .....++++||+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~---------~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV---------SEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee---------cCCeEEEEEecCCC
Confidence            889999999999999999999986443     2223444455567999999998443         45789999999999


Q ss_pred             CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCc
Q psy16951        117 GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS  196 (282)
Q Consensus       117 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~  196 (282)
                      ++|.+.+...    ..+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.++++|||.+....      
T Consensus        70 ~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------  136 (237)
T cd05576          70 GKLWSHISKF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------  136 (237)
T ss_pred             CCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccc------
Confidence            9999887642    3488999999999999999999998   89999999999999999999999999643210      


Q ss_pred             hhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       197 ~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                            .......++..|+|||.+.+..+   +.++|+||+|+++||+++|..||..
T Consensus       137 ------~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         137 ------DSCDGEAVENMYCAPEVGGISEE---TEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ------cccccCCcCccccCCcccCCCCC---CchhhHHHHHHHHHHHHHCcchhhc
Confidence                  01112234567999999876655   7899999999999999999988864

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671|consensus

Probab=99.97  E-value=3.9e-32  Score=227.31  Aligned_cols=205  Identities=25%  Similarity=0.348  Sum_probs=160.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC--CC----cccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH--PN----ILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H--~n----i~~~~~~~~~~~~~   98 (282)
                      ..+|.++..+|+|.||.|-++.++.++..||||+++.-.. ..+...-|++.++++.+  |+    ++.+.+        
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~--------  158 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRD--------  158 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeeh--------
Confidence            5689999999999999999999999999999998754433 33444568999998842  22    333433        


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---  175 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---  175 (282)
                       ++.-.++.|+|+|.+ |.|+.+++...  .-..++..++..+.+|++.++.+||+.   +++|-||||+||++...   
T Consensus       159 -wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  159 -WFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             -hhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence             444567899999988 88999988632  233577889999999999999999999   78999999999998532   


Q ss_pred             -----------------CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHH
Q psy16951        176 -----------------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG  238 (282)
Q Consensus       176 -----------------~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G  238 (282)
                                       ..++++|||.+...         .   ......+.|..|.|||++.+.++   +.++||||+|
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~---------~---e~hs~iVsTRHYRAPEViLgLGw---S~pCDvWSiG  296 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFD---------H---EHHSTIVSTRHYRAPEVILGLGW---SQPCDVWSIG  296 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCccee---------c---cCcceeeeccccCCchheeccCc---CCccCceeee
Confidence                             24578888865311         1   11234456888999999999988   9999999999


Q ss_pred             HHHHHHHhCCCCCCccccCccc
Q psy16951        239 CLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       239 ~il~el~tg~~pf~~~~~~~~~  260 (282)
                      |||+|+.||...|++..+.+..
T Consensus       297 CIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  297 CILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eEEEEeeccceecccCCcHHHH
Confidence            9999999999999987655543

>KOG0614|consensus

Probab=99.97  E-value=5.3e-32  Score=233.64  Aligned_cols=209  Identities=24%  Similarity=0.292  Sum_probs=174.9

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .-..+...+++.+..||-|+||.|-++.-......+|+|.++..   ..+..+....|-.+|...+.|.|++++.     
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr-----  487 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR-----  487 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH-----
Confidence            34456788899999999999999998887666556788877544   3344556778999999999999999998     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                          .+.+..++|++||-|-+|.|...+..+    ..+....+..++.-+++|+.|||++   ||+.|||||+|.+++.+
T Consensus       488 ----Tfrd~kyvYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~  556 (732)
T KOG0614|consen  488 ----TFRDSKYVYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNR  556 (732)
T ss_pred             ----HhccchhhhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccC
Confidence                455668899999999999999888643    5588888999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |.+|+.|||+++..          ....+.....||+.|.|||++.+...   ...+|.||+|+++|||++|.+||++.+
T Consensus       557 Gy~KLVDFGFAKki----------~~g~KTwTFcGTpEYVAPEIILnKGH---D~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  557 GYLKLVDFGFAKKI----------GSGRKTWTFCGTPEYVAPEIILNKGH---DRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             CceEEeehhhHHHh----------ccCCceeeecCCcccccchhhhccCc---chhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence            99999999976421          12233345579999999999999887   789999999999999999999998744


Q ss_pred             c
Q psy16951        256 E  256 (282)
Q Consensus       256 ~  256 (282)
                      +
T Consensus       624 p  624 (732)
T KOG0614|consen  624 P  624 (732)
T ss_pred             h
Confidence            3

>KOG0200|consensus

Probab=99.97  E-value=2.3e-30  Score=240.85  Aligned_cols=242  Identities=19%  Similarity=0.321  Sum_probs=184.4

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEec---C----CCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS---Q----TKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILP   87 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~   87 (282)
                      -.+.|.+.+++..+.+.||+|.||.|++|...   .    ....||||.++... ..+...+..|+++|+.+ +|+||+.
T Consensus       287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence            33489999999999999999999999998732   1    24679999886443 34567788999999998 6999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH----hcC--------CCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS----VGK--------HYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      +++.+-         ....++++.||+..|.|.+++....    ...        ..++..+.+.++.||+.|++||++.
T Consensus       367 llG~~t---------~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~  437 (609)
T KOG0200|consen  367 LLGACT---------QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV  437 (609)
T ss_pred             heeeec---------cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence            998443         3577999999999999999887543    000        1388899999999999999999999


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhcc--CCCCccCCcccccCcccCCCCccc
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~--~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                         +++||||-.+||++..+..+|++|||+++..        .....-......  -+..|||||.+....|   +.+||
T Consensus       438 ---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~--------~~~~~y~~~~~~~~LP~kWmApEsl~~~~f---t~kSD  503 (609)
T KOG0200|consen  438 ---PCVHRDLAARNVLITKNKVIKIADFGLARDH--------YNKDYYRTKSSAGTLPVKWMAPESLFDRVF---TSKSD  503 (609)
T ss_pred             ---CccchhhhhhhEEecCCCEEEEccccceecc--------CCCCceEecCCCCccceeecCHHHhccCcc---cccch
Confidence               6889999999999999999999999987521        110000001111  3556999999987655   99999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCccccCccceeeeeeeccccCCCCCCCCCC
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDTVYERGDSVALAVISGNITFPENTPFPQY  281 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  281 (282)
                      |||||++|||++| |..||.+.....+-......+.++..|+.++...|
T Consensus       504 VWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY  552 (609)
T KOG0200|consen  504 VWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIY  552 (609)
T ss_pred             hhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            9999999999999 88999874322333222234446788888766544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=4.7e-30  Score=252.27  Aligned_cols=190  Identities=18%  Similarity=0.214  Sum_probs=152.4

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      .+.....||+|+||.||+|.+..++..||+|++.......    ..|++.+++++||||+++++++..         ...
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~---------~~~  757 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRS---------EKG  757 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEc---------CCC
Confidence            4556678999999999999998899999999885433222    245888999999999999996544         356


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++||||+++|+|.+.+.       .+++..+..++.|++.|+.|+|.....+++|||+||+||+++.++..++. ++..
T Consensus       758 ~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            899999999999999874       27788899999999999999995422289999999999999988877764 4432


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ...             .......+|..|+|||++.+..+   +.++||||||+++|||+||+.||..
T Consensus       830 ~~~-------------~~~~~~~~t~~y~aPE~~~~~~~---~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        830 GLL-------------CTDTKCFISSAYVAPETRETKDI---TEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ccc-------------ccCCCccccccccCcccccCCCC---CcccchhhHHHHHHHHHhCCCCCCc
Confidence            110             00112256788999999987766   8899999999999999999999953

>KOG1290|consensus

Probab=99.97  E-value=1.5e-29  Score=217.51  Aligned_cols=140  Identities=24%  Similarity=0.291  Sum_probs=119.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-----C---CCccccccccccc
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-----H---PNILPLLDHALTG   95 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-----H---~ni~~~~~~~~~~   95 (282)
                      +..+|-++++||+|.|++||++++..++.-||+|+. .......+..+.|++++++++     |   .+||++++.|-. 
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh-  153 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH-  153 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee-
Confidence            358999999999999999999999999999999965 344556677889999999885     2   369999998876 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                          ....+.++|+|+|++ +..|..++....  -+-++...+..+++||+.||.|||...  ||+|-||||+|||+..
T Consensus       154 ----sGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  154 ----SGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCS  223 (590)
T ss_pred             ----cCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeec
Confidence                455678999999999 888888887542  344889999999999999999999887  9999999999999863

>KOG0603|consensus

Probab=99.97  E-value=1.4e-30  Score=230.84  Aligned_cols=197  Identities=27%  Similarity=0.399  Sum_probs=159.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..+.|++...+|.|+|+.|..+.+..++...++|++...    ...-.+|+.++... +||||+++++         .+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~---------v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHD---------VYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecc---------eec
Confidence            467889999999999999999999999999999988544    22223466555444 7999999998         555


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe-ecCCCceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL-ANDNNPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~-~~~~~~~~~  181 (282)
                      +....|+|||.+.++.+.+.+.    .....+ ..+..|+++|+.++.|||.+   |++||||||+|||+ +..++++++
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrlt  458 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLT  458 (612)
T ss_pred             CCceeeeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEE
Confidence            6689999999999988877654    233333 77788999999999999998   89999999999999 588999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      |||.+......            -....-|..|.|||++....|   +..+|+||+|++||+|++|..||.....
T Consensus       459 yFG~a~~~~~~------------~~tp~~t~~y~APEvl~~~~y---t~acD~WSLGvlLy~ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  459 YFGFWSELERS------------CDTPALTLQYVAPEVLAIQEY---TEACDWWSLGVLLYEMLTGRTLFAAHPA  518 (612)
T ss_pred             EechhhhCchh------------hcccchhhcccChhhhccCCC---CcchhhHHHHHHHHHHHhCCCccccCCc
Confidence            99976432111            112244778999999997776   8999999999999999999999986433

>KOG1151|consensus

Probab=99.97  E-value=2.7e-31  Score=226.35  Aligned_cols=242  Identities=25%  Similarity=0.369  Sum_probs=182.6

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhH-------HHHHHHHHHhhhCCCCCcccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-------AQAIREVEHHKTFVHPNILPLLD   90 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-------~~~~~e~~~l~~l~H~ni~~~~~   90 (282)
                      ..++....++|-++..||+|+|++||+|.+.....-||+|+-..+.....       ...-+|-.+.+.|+||-||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            34556667899999999999999999999988888899996544433221       23457999999999999999999


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcE
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~ni  170 (282)
                      ++-.        +...+|-|.|||++..|+-+|.    ....+++..+..++.||+.||.||...++ +|+|-||||.||
T Consensus       535 yfsl--------DtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNI  601 (775)
T KOG1151|consen  535 YFSL--------DTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNI  601 (775)
T ss_pred             eeee--------ccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccE
Confidence            7654        3567999999999999987775    34568999999999999999999999988 699999999999


Q ss_pred             Eeec---CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC--cccCCCCccchhhHHHHHHHHH
Q psy16951        171 LLAN---DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD--SYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       171 l~~~---~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~--~~~~~~~~~Diws~G~il~el~  245 (282)
                      |+..   +|.+||+|||+++.++-.....  ...........||+.|++||.+.-.  +. -++.+.||||.|||+|..+
T Consensus       602 LLv~GtacGeIKITDFGLSKIMdddSy~~--vdGmeLTSQgAGTYWYLPPEcFvVgkePP-KIsnKVDVWSvGVIFyQCl  678 (775)
T KOG1151|consen  602 LLVNGTACGEIKITDFGLSKIMDDDSYNS--VDGMELTSQGAGTYWYLPPECFVVGKEPP-KISNKVDVWSVGVIFYQCL  678 (775)
T ss_pred             EEecCcccceeEeeecchhhhccCCccCc--ccceeeecccCceeeecCcceeecCCCCC-ccccceeeEeeehhhhhhh
Confidence            9964   5778999999987643221110  0111112234689999999998643  22 2578999999999999999


Q ss_pred             hCCCCCCccccCccce-eeeeeec-cccCCCC
Q psy16951        246 YFKSPFDTVYERGDSV-ALAVISG-NITFPEN  275 (282)
Q Consensus       246 tg~~pf~~~~~~~~~~-~~~~~~~-~~~~p~~  275 (282)
                      +|+.||......-+.+ ...++.. ...||+.
T Consensus       679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K  710 (775)
T KOG1151|consen  679 YGRKPFGHNQSQQDILQENTILKATEVQFPPK  710 (775)
T ss_pred             ccCCCCCCchhHHHHHhhhchhcceeccCCCC
Confidence            9999997543433322 2333333 4566654

>KOG0664|consensus

Probab=99.96  E-value=3e-32  Score=219.40  Aligned_cols=210  Identities=23%  Similarity=0.329  Sum_probs=162.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .+.+-.+.||-|+||.||.+.+.++|++||+|++...  +-...+.+.+|+..+..++|.|++..+++....+.++    
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df----  128 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF----  128 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH----
Confidence            3455567899999999999999999999999988532  2234557789999999999999998887543321111    


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      -..+|++.|.+.     ..+....+.+..++.+.+..+++||+.||+|||+.   +|+||||||.|.+++.+-..||+||
T Consensus       129 FqEiYV~TELmQ-----SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  129 FQELYVLTELMQ-----SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             HHHHHHHHHHHH-----hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence            123556666552     23344445677899999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      |+++..        ......+....+-|..|.+||.+.|...  ++...||||.|||+.|++-++..|+..++.
T Consensus       201 GLARve--------e~d~~~hMTqEVVTQYYRAPEiLMGaRh--Ys~AvDiWSVGCIFaELLgRrILFQAq~Pi  264 (449)
T KOG0664|consen  201 GLARTW--------DQRDRLNMTHEVVTQYYRAPELLMGARR--YTGAVDIWSVGCIFAELLQRKILFQAAGPI  264 (449)
T ss_pred             cccccc--------chhhhhhhHHHHHHHHhccHHHhhcchh--hcCccceehhhHHHHHHHhhhhhhhccChH
Confidence            987632        2222233344455888999999998764  588999999999999999999999865443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.5e-29  Score=203.24  Aligned_cols=200  Identities=28%  Similarity=0.403  Sum_probs=163.1

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCce
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      |++.+.||+|++|.||++....++.++|+|.+...... ....+.+|++.++.++|+|++++++.+..         ...
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~---------~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED---------PEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec---------CCc
Confidence            56789999999999999999988999999998766555 56778889999999999999999885433         367


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .++++|++++++|.+.+....   ..++..++..++.+++.++.++|++   +++|+|++|+|++++.++.++++|||.+
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            899999999999998876421   1178889999999999999999999   8999999999999999999999999975


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccc-cCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH-VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~-~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .......        ........++..|++||.+. ...   .+.++|+|+||++++++++|+.||..
T Consensus       146 ~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~~~---~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDL--------AALLKTVKGTPFYLAPEVLLGGKG---YGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCcc--------cccccceeccCCcCCHhHhcCCCC---CCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4321110        00112234566799999984 333   36799999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.8e-28  Score=221.49  Aligned_cols=219  Identities=19%  Similarity=0.243  Sum_probs=150.9

Q ss_pred             EecccEEEEEEeccCCceEEEEEEec----------------CCCceEEEEEeccCCchhHHHHH--------------H
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHS----------------QTKKRYALKKIICHGREDQAQAI--------------R   72 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~i~~~~~~~~~~~~--------------~   72 (282)
                      ...++|++.++||+|+||+||+|...                ..+..||||++..........+.              .
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            36889999999999999999999752                23467999998655433333333              3


Q ss_pred             HHHHhhhCCCCCc-----ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-------------------
Q psy16951         73 EVEHHKTFVHPNI-----LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------------------  128 (282)
Q Consensus        73 e~~~l~~l~H~ni-----~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------  128 (282)
                      |+..+.+++|.++     +++++++........ ......++|+||+++++|.+++.....                   
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGA-FTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhccccccccc-ccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            5566666765544     555555443211111 123568999999999999998863210                   


Q ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhh
Q psy16951        129 -GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA  207 (282)
Q Consensus       129 -~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~  207 (282)
                       ....+++..+..++.|++.||.|+|++   +++||||||+||+++.++.++++|||++......        .......
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~--------~~~~~~~  369 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG--------INFNPLY  369 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC--------CccCccc
Confidence             011234567888999999999999998   8999999999999999999999999976422100        0001111


Q ss_pred             ccCCCCccCCcccccCcccC-----------------CC--CccchhhHHHHHHHHHhCCC-CCCc
Q psy16951        208 ERCSMPYRAPELFHVDSYCV-----------------VD--QRTDVWSLGCLLYAMCYFKS-PFDT  253 (282)
Q Consensus       208 ~~~t~~y~~PE~~~~~~~~~-----------------~~--~~~Diws~G~il~el~tg~~-pf~~  253 (282)
                      ..+++.|++||.+......+                 ++  .+.|+||+||++++|+++.. ||.+
T Consensus       370 g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             cCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            23367899999986432110                 11  24799999999999999884 7753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=7.4e-29  Score=228.73  Aligned_cols=213  Identities=21%  Similarity=0.258  Sum_probs=143.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCC----CceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQT----KKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ....++|++.+.||+|+||.||+|.+..+    +..||+|++......  +...++  .++...+.++..+...+.... 
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~-  202 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPV-  202 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccc-
Confidence            34678999999999999999999999888    899999987533221  111111  122222333433333222110 


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcc
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVG----------------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYA  161 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~  161 (282)
                        ........++++||+.+++|.+.+......                ........+..++.|++.||.|+|++   +|+
T Consensus       203 --~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIi  277 (566)
T PLN03225        203 --SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIV  277 (566)
T ss_pred             --ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence              013456799999999999999887632100                00011334667899999999999998   899


Q ss_pred             ccCCCCCcEEeec-CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccC-------------
Q psy16951        162 HRDLKTANVLLAN-DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCV-------------  227 (282)
Q Consensus       162 H~dlk~~nil~~~-~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~-------------  227 (282)
                      ||||||+|||++. ++.+|++|||++.......        ........+++.|+|||.+......+             
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp  349 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP  349 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--------ccCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence            9999999999986 5789999999875321110        01112345678899999765332210             


Q ss_pred             ------CCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        228 ------VDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       228 ------~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                            +..++||||+||++|||+++..|+.
T Consensus       350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             hhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence                  1345699999999999999877654

>KOG0576|consensus

Probab=99.95  E-value=1.1e-29  Score=225.45  Aligned_cols=206  Identities=21%  Similarity=0.340  Sum_probs=175.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      =+.++|+++.++|.|.||.||++++..+++..|+|.++.....+-+...+|+-.++..+||||+.|++.++         
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl---------   82 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL---------   82 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh---------
Confidence            35789999999999999999999999999999999998887788888888999999999999999999544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+|+.||||.+|+|.+..+..    ..+++.++...+++.+.|+.|+|+.   |-+|||||-.||++...|.+|+.|
T Consensus        83 r~dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   83 RRDKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             hhcCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence            457899999999999999866532    4588999999999999999999999   666999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+...         .....+..+..||+.|||||+-.-+.-.-++..+|||++|++.-|+.--++|-.+
T Consensus       156 fgvsaqi---------tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd  217 (829)
T KOG0576|consen  156 FGVSAQI---------TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD  217 (829)
T ss_pred             cCchhhh---------hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence            9975422         2223445667899999999998543222238899999999999999888877543

>KOG1345|consensus

Probab=99.95  E-value=8.3e-29  Score=199.15  Aligned_cols=221  Identities=26%  Similarity=0.402  Sum_probs=165.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .|.|.+.+.||+|.||.+-+++|++++.++++|-+. ......++|.+|...--.| .|.||+.-++.        .++.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v--------aFqt   93 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEV--------AFQT   93 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHH--------Hhhc
Confidence            578889999999999999999999999999999763 3344567888888876666 48999987764        3445


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec--CCCceee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPLLM  181 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~~~~  181 (282)
                      .+.+.+++||++.|+|..-+..     ..+.+.....++.|++.|+.|+|++   ++||||||.+|||+-.  ..++|++
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence            6789999999999999875542     3477888899999999999999999   8999999999999854  3578999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC---cccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD---SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~---~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      |||.+.....            .......+..|.+||.+.-.   .+ ...+.+|+|.||++++.++||.+||+.... .
T Consensus       166 DFG~t~k~g~------------tV~~~~~~~~y~~pe~~~~~~ne~~-~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~  231 (378)
T KOG1345|consen  166 DFGLTRKVGT------------TVKYLEYVNNYHAPELCDTVVNEKL-VVNPSTDIWQFGIIFFYCLTGKFPWQKASI-M  231 (378)
T ss_pred             ecccccccCc------------eehhhhhhcccCCcHHHhhccccce-EecccccchheeeeeeeeecCCCcchhhhc-c
Confidence            9997532110            00111124568899887532   22 235679999999999999999999984322 3


Q ss_pred             cceeee----eeeccccCCCCC
Q psy16951        259 DSVALA----VISGNITFPENT  276 (282)
Q Consensus       259 ~~~~~~----~~~~~~~~p~~~  276 (282)
                      +.-+++    ..+..+.+|..+
T Consensus       232 d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  232 DKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             CchHHHHHHHhcccCccCchhh
Confidence            322333    234456666554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=6.5e-27  Score=193.47  Aligned_cols=187  Identities=29%  Similarity=0.400  Sum_probs=155.5

Q ss_pred             CceEEEEEEecCCCceEEEEEeccCCchh-HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCC
Q psy16951         38 GFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPK  116 (282)
Q Consensus        38 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  116 (282)
                      +||.||+|.+..++.++|+|.+....... ...+.+|++.++.++|+|++++.+.+..         ....++++|++.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~---------~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED---------EDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee---------CCEEEEEEeCCCC
Confidence            58999999999899999999987655444 6788899999999999999999985443         3679999999999


Q ss_pred             CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCc
Q psy16951        117 GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS  196 (282)
Q Consensus       117 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~  196 (282)
                      ++|.+.+...    ..++...+..++.+++.++.++|+.   +++|+||+|+||+++.++.++++|||.+......    
T Consensus        72 ~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----  140 (244)
T smart00220       72 GDLFDLLKKR----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG----  140 (244)
T ss_pred             CCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc----
Confidence            9999887632    2278899999999999999999998   8999999999999999999999999975422110    


Q ss_pred             hhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       197 ~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                            .......++..|++||.+.+..+   +.++|+||+|++++++++|..||..
T Consensus       141 ------~~~~~~~~~~~~~~pE~~~~~~~---~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      141 ------GLLTTFVGTPEYMAPEVLLGKGY---GKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             ------cccccccCCcCCCCHHHHccCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence                  01223345778999999976554   7799999999999999999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670|consensus

Probab=99.95  E-value=3.4e-28  Score=210.71  Aligned_cols=203  Identities=24%  Similarity=0.293  Sum_probs=162.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC------CCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH------PNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H------~ni~~~~~~~~~~~   96 (282)
                      +.+++|.+..-.|+|-|++|-.|.+...|..||||+|..+. .-...-+.|+++|++|+.      -++++++.+|..  
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--  505 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--  505 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence            34789999999999999999999999999999999886543 333445679999999973      367888876554  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                             ..++|||+|-+ ...|.+.|...+.. -.+....+..|+.|+..||.+|-.+   |++|.||||+|||++...
T Consensus       506 -------knHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  506 -------KNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             -------cceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence                   48899999987 66788878765433 2367788999999999999999999   899999999999998764


Q ss_pred             -CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 -NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 -~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                       .+|+||||.+....        .   +....+.-+..|.|||++.|.+|   ...-|+||.||+||||-||+..|.+.
T Consensus       574 ~iLKLCDfGSA~~~~--------e---neitPYLVSRFYRaPEIiLG~~y---d~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  574 NILKLCDFGSASFAS--------E---NEITPYLVSRFYRAPEIILGLPY---DYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             ceeeeccCccccccc--------c---ccccHHHHHHhccCcceeecCcc---cCCccceeeceeeEEeeccceecCCC
Confidence             55899999764221        1   11112222345999999999988   88999999999999999999999763

>KOG0665|consensus

Probab=99.94  E-value=4.4e-28  Score=198.88  Aligned_cols=208  Identities=22%  Similarity=0.348  Sum_probs=166.1

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEecc--CCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC--HGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~--~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ..+.-..+|.-+..+|.|.- .|-.|.+.-++.+||||++..  .+....++..+|..++..++|+||++++.++.... 
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~-   88 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK-   88 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc-
Confidence            34445567878888999988 677888888999999998742  22334456778999999999999999999776531 


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                        ..+.....|+|||++ ..+|...+..      .+.-..+..++.|++.|++|+|+.   ||+||||||+||++..+..
T Consensus        89 --~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~  156 (369)
T KOG0665|consen   89 --TLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCT  156 (369)
T ss_pred             --cHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhh
Confidence              233345689999999 6777776652      256677899999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .|+.|||++......          ........|..|.|||++.+..+   ...+||||.||++.||.+|+..|.+.
T Consensus       157 lKi~dfg~ar~e~~~----------~~mtpyVvtRyyrapevil~~~~---ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  157 LKILDFGLARTEDTD----------FMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             eeeccchhhcccCcc----------cccCchhheeeccCchheeccCC---cccchhhhhhhHHHHHhhceEEecCc
Confidence            999999986532211          22334455777999999999886   88999999999999999999988753

>KOG1163|consensus

Probab=99.94  E-value=1.1e-27  Score=189.77  Aligned_cols=237  Identities=15%  Similarity=0.176  Sum_probs=182.5

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC-CCcccccccccccCC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH-PNILPLLDHALTGCA   97 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H-~ni~~~~~~~~~~~~   97 (282)
                      ..=.|....|+++++||.|+||.+|.|....+|.+||||.=  ++.....+...|..+.+.+++ ..|.++..+      
T Consensus         8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~E--s~~a~hpqL~yEskvY~iL~~g~GiP~i~~y------   79 (341)
T KOG1163|consen    8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLE--SSKAKHPQLLYESKVYRILQGGVGIPHIRHY------   79 (341)
T ss_pred             hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEee--cccCCCcchhHHHHHHHHhccCCCCchhhhh------
Confidence            34456788999999999999999999999999999999943  333344567788999999986 344444432      


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-  176 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-  176 (282)
                         ......-.+||+.+ +.||++++..   +...++...++-++-|++.-++|+|.+   +.+||||||+|+|+.-+- 
T Consensus        80 ---~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh  149 (341)
T KOG1163|consen   80 ---GTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRH  149 (341)
T ss_pred             ---ccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccc
Confidence               12346788999988 9999998875   455688889999999999999999999   788999999999997654 


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        .+.++|||+++-  +.......+.+........||..|.+-.+..+...   +..-|+-|+|.++.++-.|..||+++
T Consensus       150 ~~kl~LIDFGLaKk--y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq---SRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  150 CNKLYLIDFGLAKK--YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ---SRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             cceEEEEeccchhh--hccccccccCccccCCccceeeeehhhhhhhhhhh---hhhhhhhhhcceeeeeecCCCccccc
Confidence              456999998763  22223333444555667789999999988887766   77899999999999999999999998


Q ss_pred             ccCccceee-eeeeccccCCCCCCC
Q psy16951        255 YERGDSVAL-AVISGNITFPENTPF  278 (282)
Q Consensus       255 ~~~~~~~~~-~~~~~~~~~p~~~~~  278 (282)
                      ......++. .+.+.+.+.|.+--|
T Consensus       225 ka~tk~QKyEkI~EkK~s~~ie~LC  249 (341)
T KOG1163|consen  225 KAATKKQKYEKISEKKMSTPIEVLC  249 (341)
T ss_pred             chhhHHHHHHHHHHhhcCCCHHHHh
Confidence            766655543 356666666644433

>KOG1027|consensus

Probab=99.94  E-value=2.7e-28  Score=221.35  Aligned_cols=199  Identities=23%  Similarity=0.323  Sum_probs=151.4

Q ss_pred             EEeccCCceEE-EEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGFSTV-SLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~g~V-~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +.+|.|+.|+| |+|..  .|++||||++..   ....-..+|+..++.- .||||+++++         ...++.+.|+
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc---------~E~d~qF~YI  580 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYC---------SEQDRQFLYI  580 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEe---------eccCCceEEE
Confidence            45889999865 99988  567999998732   1222446899999888 5999999997         5667789999


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---C--Cceeeccc
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---N--NPLLMDLG  184 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~--~~~~~df~  184 (282)
                      ..|.| .-+|.+.+..................+.|++.||.+||+.   +|+||||||+||||...   +  +++|+|||
T Consensus       581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence            99999 6689988875211111112244577789999999999998   79999999999999873   4  56799999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC-CCCCCccccC
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFDTVYER  257 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg-~~pf~~~~~~  257 (282)
                      +++-....      .....+.....||-.|+|||++.....   ..++||+|+||++|+.++| .+||.+...+
T Consensus       657 lsKkl~~~------~sS~~r~s~~sGt~GW~APE~L~~~~~---~~avDiFslGCvfyYvltgG~HpFGd~~~R  721 (903)
T KOG1027|consen  657 LSKKLAGG------KSSFSRLSGGSGTSGWQAPEQLREDRK---TQAVDIFSLGCVFYYVLTGGSHPFGDSLER  721 (903)
T ss_pred             cccccCCC------cchhhcccCCCCcccccCHHHHhcccc---CcccchhhcCceEEEEecCCccCCCchHHh
Confidence            87643222      112223455678999999999988765   7799999999999999995 8999875554

>KOG0668|consensus

Probab=99.94  E-value=7.7e-28  Score=189.39  Aligned_cols=197  Identities=24%  Similarity=0.382  Sum_probs=154.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++++++|+|-|++||.|....++..++||.++   +...+.+.+|+.+++.+. ||||+++++...+.       
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp-------  105 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDP-------  105 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCc-------
Confidence            5789999999999999999999999999999999885   445667789999999997 99999999854431       


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~~~~  181 (282)
                      .....-+++|+..+.....+.       ..++-.++..++.|++.||.|+|+.   ||.|||+||.|++++.. ...+++
T Consensus       106 ~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlI  175 (338)
T KOG0668|consen  106 ESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLI  175 (338)
T ss_pred             cccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeee
Confidence            235577999999766554433       2367778899999999999999999   89999999999999875 456799


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      |.|++-+.         +. ...-.-++-+..|.-||.+-.-..  +...-|+|||||++..|...+-||-
T Consensus       176 DWGLAEFY---------Hp-~~eYnVRVASRyfKGPELLVdy~~--YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  176 DWGLAEFY---------HP-GKEYNVRVASRYFKGPELLVDYQM--YDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             ecchHhhc---------CC-CceeeeeeehhhcCCchheeechh--ccccHHHHHHHHHHHHHHhccCccc
Confidence            99976432         11 111111223445789999865432  5778999999999999999887764

>KOG1024|consensus

Probab=99.94  E-value=3.1e-28  Score=204.69  Aligned_cols=240  Identities=16%  Similarity=0.218  Sum_probs=180.7

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCC-----ceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      ...+..+++++...+-+|.||+||.|.|+...     +.|-+|.++.. +.-....+..|...+....|||+..+.+.++
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            34566788888899999999999999886543     23445544322 1222335677888888999999999988654


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS----VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      .        +....+.++.+..-|.|..++..-.    .....+...+...++.|++.|+.|||..   +++|.||-.+|
T Consensus       358 e--------~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRN  426 (563)
T KOG1024|consen  358 E--------DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARN  426 (563)
T ss_pred             e--------ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhc
Confidence            3        4567888889888999999887321    1223456678899999999999999999   89999999999


Q ss_pred             EEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CC
Q psy16951        170 VLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FK  248 (282)
Q Consensus       170 il~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~  248 (282)
                      .+++.--++|++|=++++..+....-+.-.       ....+..||+||.+..+.|   +..+|+||||+++|||+| |+
T Consensus       427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGD-------nEnRPvkWMslEal~n~~y---ssasDvWsfGVllWELmtlg~  496 (563)
T KOG1024|consen  427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGD-------NENRPVKWMSLEALQNSHY---SSASDVWSFGVLLWELMTLGK  496 (563)
T ss_pred             ceehhheeEEeccchhccccCcccccccCC-------CCCCcccccCHHHHhhhhh---cchhhhHHHHHHHHHHHhcCC
Confidence            999999999999988776543332222211       2234677999999999887   899999999999999999 88


Q ss_pred             CCCCccccCccceeeeeeeccccCCCCCCCCCC
Q psy16951        249 SPFDTVYERGDSVALAVISGNITFPENTPFPQY  281 (282)
Q Consensus       249 ~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  281 (282)
                      .||-.+++ .++......+++..-|.++|+..|
T Consensus       497 ~PyaeIDP-fEm~~ylkdGyRlaQP~NCPDeLf  528 (563)
T KOG1024|consen  497 LPYAEIDP-FEMEHYLKDGYRLAQPFNCPDELF  528 (563)
T ss_pred             CCccccCH-HHHHHHHhccceecCCCCCcHHHH
Confidence            99976544 222233346668899999998765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=5.3e-25  Score=191.30  Aligned_cols=175  Identities=18%  Similarity=0.136  Sum_probs=129.2

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecC-CCceEEEEEeccC-----CchhHHHHHHHHHHhhhCCCCCccc-cccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICH-----GREDQAQAIREVEHHKTFVHPNILP-LLDHAL   93 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~-----~~~~~~~~~~e~~~l~~l~H~ni~~-~~~~~~   93 (282)
                      .....++|++.+.||+|+||+||+|.+.. ++..||||++...     .......+.+|+++++.++|+|++. +..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            44557889999999999999999999876 6777899986532     1223456889999999999999985 432   


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC-CCCcEEe
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL-KTANVLL  172 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl-k~~nil~  172 (282)
                                ....++||||+++++|.. ..     .  ..   ...++.|++.+|.|+|++   ||+|||| ||+||++
T Consensus        90 ----------~~~~~LVmE~~~G~~L~~-~~-----~--~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv  145 (365)
T PRK09188         90 ----------TGKDGLVRGWTEGVPLHL-AR-----P--HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLM  145 (365)
T ss_pred             ----------cCCcEEEEEccCCCCHHH-hC-----c--cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEE
Confidence                      134799999999999862 11     0  11   145788999999999998   8999999 9999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD  223 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~  223 (282)
                      +.++.++++|||++....-....... ..........+++.|++||++.-.
T Consensus       146 ~~~~~ikLiDFGlA~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        146 GPDGEAAVIDFQLASVFRRRGALYRI-AAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCCCCEEEEECccceecccCcchhhh-hhhhhhhhhhccCccCCcccCChh
Confidence            98999999999987654221111110 011122345577889999998644

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=1.2e-23  Score=169.76  Aligned_cols=184  Identities=31%  Similarity=0.498  Sum_probs=149.1

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEec
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLP  112 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e  112 (282)
                      ||+|.+|.||++....++.++++|.+...... ....+.+|++.++.++|++++++++.+..         ....++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~---------~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED---------ENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec---------CCeEEEEEe
Confidence            68999999999999888999999988654433 34678899999999999999999885433         368999999


Q ss_pred             cCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCceeecccCccchhh
Q psy16951        113 YYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLMDLGSVAPAVV  191 (282)
Q Consensus       113 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~~~~df~~~~~~~~  191 (282)
                      ++.+++|.+++....   ..++...+..++.+++.++.++|++   +++|+||+|.||+++. ++.++++||+.+.....
T Consensus        72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            999899999876421   3478899999999999999999999   8999999999999999 89999999997542211


Q ss_pred             hccCchhhhhhHhhhhccCCCCccCCcccccC-cccCCCCccchhhHHHHHHHH
Q psy16951        192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-~~~~~~~~~Diws~G~il~el  244 (282)
                      ...         ......+...|++||.+... ..   +.++|+|++|++++++
T Consensus       146 ~~~---------~~~~~~~~~~~~~pe~~~~~~~~---~~~~D~~~lg~~~~~l  187 (215)
T cd00180         146 DKS---------LLKTIVGTPAYMAPEVLLGKGYY---SEKSDIWSLGVILYEL  187 (215)
T ss_pred             Ccc---------hhhcccCCCCccChhHhcccCCC---CchhhhHHHHHHHHHH
Confidence            000         12223456779999998765 33   7899999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167|consensus

Probab=99.92  E-value=3.1e-25  Score=188.20  Aligned_cols=208  Identities=25%  Similarity=0.366  Sum_probs=161.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC---CCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ---TKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~   98 (282)
                      -....|..+++||.|.|++||++....   ....||+|.+...+.  .....+|++.+..+. +.||+++.+        
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~--------  102 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNG--------  102 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchh--------
Confidence            346678899999999999999998877   778899998865443  334678999998885 889999988        


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CC
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NN  177 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~  177 (282)
                       ++...++..+|+||.++-...++..       .++..++..+++.++.||.++|.+   ||+|||+||+|++.+.. ++
T Consensus       103 -~~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  103 -CFRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             -hhccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence             5666789999999999988877664       267889999999999999999999   99999999999999876 45


Q ss_pred             ceeecccCccchhhhc-----------cCch---------------------h---hhhhHhhhhccCCCCccCCccccc
Q psy16951        178 PLLMDLGSVAPAVVKV-----------CGSA---------------------E---AQNLQDVAAERCSMPYRAPELFHV  222 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~-----------~~~~---------------------~---~~~~~~~~~~~~t~~y~~PE~~~~  222 (282)
                      -.+.|||++....-.-           ....                     .   ...........||++|.|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            5699999876211000           0000                     0   000011224568999999999986


Q ss_pred             CcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        223 DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       223 ~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      -+-  -+++.||||.|+|+.-++++..||-.
T Consensus       252 ~~~--QttaiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  252 CPR--QTTAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             ccC--cCCccceeeccceeehhhcccccccc
Confidence            543  27789999999999999999999853

>KOG0195|consensus

Probab=99.91  E-value=7.5e-26  Score=182.49  Aligned_cols=226  Identities=17%  Similarity=0.254  Sum_probs=178.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      -++..++.+|.+...|+.|+|+|+++.  ++.|++...  ..+-...|..|.-.++.+.||||..+++         ..+
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlg---------acn  257 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLG---------ACN  257 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhh---------hcc
Confidence            345567788999999999999997665  444555433  3334557888999999999999999998         555


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+.++..|++.|||+..+...  ...-+...++..++.+++.|+.|||+..++ |..-.|..++++++.+-+.+++=
T Consensus       258 sppnlv~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism  334 (448)
T KOG0195|consen  258 SPPNLVIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM  334 (448)
T ss_pred             CCCCceEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec
Confidence            668899999999999999988743  223456778999999999999999999875 77778999999999987777531


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      -              ..+..........++.||+||.+...+.+..-..+|+|||.+++||+.|...||.+..+.+-.++
T Consensus       335 a--------------d~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk  400 (448)
T KOG0195|consen  335 A--------------DTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK  400 (448)
T ss_pred             c--------------cceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence            1              11111112234457889999999887765555789999999999999999999999988888899


Q ss_pred             eeeeeccccCCCCCCC
Q psy16951        263 LAVISGNITFPENTPF  278 (282)
Q Consensus       263 ~~~~~~~~~~p~~~~~  278 (282)
                      +.+.+-++.+|++++.
T Consensus       401 ialeglrv~ippgis~  416 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISR  416 (448)
T ss_pred             hhhccccccCCCCccH
Confidence            9999999999998764

>KOG1165|consensus

Probab=99.90  E-value=1.2e-23  Score=173.87  Aligned_cols=220  Identities=15%  Similarity=0.175  Sum_probs=176.6

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCccccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTG   95 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~   95 (282)
                      ++....+-.-.|++.++||+|.||+.+.|...-++.+||||-=+.  ..+..++..|....+.|. .++|...+-+..  
T Consensus        19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGq--   94 (449)
T KOG1165|consen   19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ--   94 (449)
T ss_pred             CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeecc--
Confidence            455677888999999999999999999999999999999993222  233446667888888875 577776653221  


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                             .+-+-.||+|.+ +.||++++.   .|.+.++...++-++.|++.-++|+|.+   .++.|||||+|+||...
T Consensus        95 -------eG~~NiLVidLL-GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp  160 (449)
T KOG1165|consen   95 -------EGKYNILVIDLL-GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRP  160 (449)
T ss_pred             -------ccchhhhhhhhh-CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCC
Confidence                   234567899988 999999775   5788899999999999999999999999   68899999999999876


Q ss_pred             CC-----ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        176 NN-----PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       176 ~~-----~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      +.     +.++|||+++..  .......+.+.....+..||..||+-....|...   +..-|.-|+|=++.+.+-|..|
T Consensus       161 ~~k~~n~IhiiDFGmAK~Y--rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ---SRRDDLEaLGHvFmYFLRGsLP  235 (449)
T KOG1165|consen  161 GTKDANVIHIIDFGMAKEY--RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLP  235 (449)
T ss_pred             CCCCCceEEEEeccchhhh--cCccccccCccccccccccceeeeEeeccccchh---hhhhhHHHhhhhhhhhccCCCc
Confidence            53     459999998743  3333444555556677789999999999999887   7889999999999999999999


Q ss_pred             CCccccCcc
Q psy16951        251 FDTVYERGD  259 (282)
Q Consensus       251 f~~~~~~~~  259 (282)
                      |+++.....
T Consensus       236 WQGLKA~tn  244 (449)
T KOG1165|consen  236 WQGLKADTN  244 (449)
T ss_pred             cccccCcch
Confidence            998755443

>KOG1164|consensus

Probab=99.90  E-value=5.3e-23  Score=178.34  Aligned_cols=213  Identities=20%  Similarity=0.256  Sum_probs=161.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCC-ceEEEEEeccCCchhHHHHHHHHHHhhhCCC----CCcccccccccccCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTK-KRYALKKIICHGREDQAQAIREVEHHKTFVH----PNILPLLDHALTGCADPVL  101 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H----~ni~~~~~~~~~~~~~~~~  101 (282)
                      +|.+.++||+|+||.||.+....++ ..+|+|............+..|..++..+..    +++..+...+.        
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~--------   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR--------   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc--------
Confidence            8999999999999999999987775 6788886654433332256678888888763    46666665332        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-----
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-----  176 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-----  176 (282)
                      ......++||+.+ +.+|.+......  ...++...++.++.|++.+|+++|+.   |.+||||||+|+.+....     
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~  164 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVR  164 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccc
Confidence            2456789999987 999998664332  46789999999999999999999999   899999999999998653     


Q ss_pred             CceeecccCccchhhhccCchhhhhhHh-hhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQD-VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .+.+.|||+++...+............. ....+||..|+++.+..+...   +.+.|+||++.++.|+..|..||+...
T Consensus       165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~---~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ---GRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc---CCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            5779999988632211111111111111 234568999999999988776   889999999999999999999997654


Q ss_pred             c
Q psy16951        256 E  256 (282)
Q Consensus       256 ~  256 (282)
                      .
T Consensus       242 ~  242 (322)
T KOG1164|consen  242 M  242 (322)
T ss_pred             c
Confidence            4

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.86  E-value=3.2e-22  Score=192.77  Aligned_cols=164  Identities=18%  Similarity=0.188  Sum_probs=109.2

Q ss_pred             hhCCC-CCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q psy16951         78 KTFVH-PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK  156 (282)
Q Consensus        78 ~~l~H-~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  156 (282)
                      +.++| +||..+++.+-.+..+.  .....++.++|++ +++|.+++..   ....++...++.++.||+.||.|+|++ 
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-   99 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDG--LDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ-   99 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccc--cccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC-
Confidence            34445 56777766542221110  1123466777876 7799998853   234588999999999999999999998 


Q ss_pred             CCCccccCCCCCcEEeecCCCce-------------------eecccCccchhhhccCchhh--h-----hhHhhhhccC
Q psy16951        157 PIAYAHRDLKTANVLLANDNNPL-------------------LMDLGSVAPAVVKVCGSAEA--Q-----NLQDVAAERC  210 (282)
Q Consensus       157 ~~~i~H~dlk~~nil~~~~~~~~-------------------~~df~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~  210 (282)
                        ||+||||||+|||+...+.++                   ++|||+++............  .     .........+
T Consensus       100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181        100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence              899999999999996655544                   45555433110000000000  0     0000112346


Q ss_pred             CCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       211 t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |+.|+|||++.+..+   +.++|||||||++|||+++.+|+..
T Consensus       178 t~~Y~APE~~~~~~~---~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        178 MSWYTSPEEDNGSSS---NCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             CcceEChhhhccCCC---CchhhhhhHHHHHHHHhhCCCchhh
Confidence            888999999988776   8899999999999999999988863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.6e-20  Score=161.26  Aligned_cols=205  Identities=27%  Similarity=0.373  Sum_probs=159.4

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCC-CcccccccccccCCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHP-NILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~-ni~~~~~~~~~~~~~~~~~~  103 (282)
                      |.+...||.|+||.||++.+.   ..+++|.+......   ....+.+|+..+..+.|+ +++++...+.         .
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~---------~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ---------D   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe---------c
Confidence            788999999999999999997   67899988654433   366788999999999988 7999988552         2


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceeec
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLMD  182 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~d  182 (282)
                      ....+++++++.++++.+.+...... ..+.......++.|++.++.|+|..   +++|||+||+||+++..+ .+++.|
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~d  145 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLID  145 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEec
Confidence            34489999999999998544422111 2588899999999999999999999   799999999999999988 699999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC---cccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD---SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~---~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+............   ........++..|++||.+.+.   .+   +...|+||+|++++++++|..||...
T Consensus       146 fg~~~~~~~~~~~~~~---~~~~~~~~~t~~~~~pe~~~~~~~~~~---~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         146 FGLAKLLPDPGSTSSI---PALPSTSVGTPGYMAPEVLLGLSLAYA---SSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             cCcceecCCCCccccc---cccccccccccccCCHHHhcCCCCCCC---CchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9976521110000000   0123455678899999999873   33   78999999999999999999998653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=3.6e-21  Score=156.44  Aligned_cols=177  Identities=16%  Similarity=0.191  Sum_probs=125.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHH---H------HHHHHHHhhhCCCCCccccccccccc
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---Q------AIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~------~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .++|++++.+|.|+||.||++..  ++..+|||.+.........   .      +.+|+..+.++.|++|......+...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            68999999999999999999776  4667999988644333322   2      56888899999999999887654431


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                      -. ..+.-....+++|||+++.+|.+...        +++    ....+++.++..+|+.   |++|+|++|+|++++.+
T Consensus       108 ~~-~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        108 ER-KTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cc-ccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            00 00111346899999999999977531        222    2345899999999999   89999999999999988


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      + ++++|||......     ...+.                ...+....+   +.++|+||||+++..+
T Consensus       172 g-i~liDfg~~~~~~-----e~~a~----------------d~~vler~y---~~~~di~~lg~~~~~~  215 (232)
T PRK10359        172 G-LRIIDLSGKRCTA-----QRKAK----------------DRIDLERHY---GIKNEIKDLGYYLLIY  215 (232)
T ss_pred             C-EEEEECCCccccc-----chhhH----------------HHHHHHhHh---cccccccceeEeehHH
Confidence            8 9999999643210     00000                002222334   5689999999876654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=4.8e-21  Score=153.39  Aligned_cols=137  Identities=17%  Similarity=0.185  Sum_probs=103.0

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCch--h------------------------HHHHHHHHHHhhhCCCCC
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--D------------------------QAQAIREVEHHKTFVHPN   84 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~------------------------~~~~~~e~~~l~~l~H~n   84 (282)
                      ...||+|+||.||+|.+. +|.+||||.+......  .                        .....+|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999996 8999999988643211  0                        012234888999998777


Q ss_pred             cccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCcccc
Q psy16951         85 ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF-HDAKPIAYAHR  163 (282)
Q Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l-H~~~~~~i~H~  163 (282)
                      +.......           ....++||||++++++.....    ....++...++.++.|++.+|.++ |+.   |++||
T Consensus        81 v~~p~~~~-----------~~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHr  142 (190)
T cd05147          81 IPCPEPIL-----------LKSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHA  142 (190)
T ss_pred             CCCCcEEE-----------ecCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            64322110           112379999998877654322    123578888999999999999999 677   89999


Q ss_pred             CCCCCcEEeecCCCceeecccCcc
Q psy16951        164 DLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ||||+||+++ ++.++++|||.+.
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~  165 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSV  165 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEccccc
Confidence            9999999998 5789999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.9e-20  Score=149.13  Aligned_cols=137  Identities=15%  Similarity=0.156  Sum_probs=105.1

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--------------------------HHHHHHHHHHhhhCCCCC
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--------------------------QAQAIREVEHHKTFVHPN   84 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--------------------------~~~~~~e~~~l~~l~H~n   84 (282)
                      ...||+|++|+||+|.+. +|..||||.+.......                          .....+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 89999999886542110                          112356888899998888


Q ss_pred             cccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCcccc
Q psy16951         85 ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAYAHR  163 (282)
Q Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~~i~H~  163 (282)
                      +........           ...++||||++++++......    ...++...+..++.|++.++.++|+ +   |++||
T Consensus        81 i~~p~~~~~-----------~~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHr  142 (190)
T cd05145          81 VPVPEPILL-----------KKNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHG  142 (190)
T ss_pred             CCCceEEEe-----------cCCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence            744332111           124799999988765443221    2346778889999999999999999 7   89999


Q ss_pred             CCCCCcEEeecCCCceeecccCcc
Q psy16951        164 DLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ||||+||+++ ++.++++|||.+.
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~  165 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAV  165 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEcccce
Confidence            9999999998 8999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.82  E-value=2.6e-20  Score=147.46  Aligned_cols=107  Identities=31%  Similarity=0.446  Sum_probs=88.6

Q ss_pred             CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCc
Q psy16951        117 GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS  196 (282)
Q Consensus       117 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~  196 (282)
                      |+|.+.+...   ...+++.+++.++.|++.||.|+|++   +      ||+||+++.++.+++  ||.+.....     
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~-----   61 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP-----   61 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc-----
Confidence            6788877632   34589999999999999999999997   4      999999999999998  886543210     


Q ss_pred             hhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       197 ~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                               ....+|+.|+|||++.+..+   +.++||||+|+++|||+||+.||...
T Consensus        62 ---------~~~~g~~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       62 ---------EQSRVDPYFMAPEVIQGQSY---TEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             ---------ccCCCcccccChHHhcCCCC---cchhhHHHHHHHHHHHHhCCCCcccc
Confidence                     11256889999999988776   78999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=5.8e-19  Score=140.81  Aligned_cols=194  Identities=15%  Similarity=0.121  Sum_probs=132.9

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh----HHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED----QAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      +.+...|++|+||+|+.+..  .+.+++.+.+.......    ...+.+|+++++++. |++++.++++           
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----------   70 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----------   70 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----------
Confidence            34678899999999997766  56677777665443311    224678999999995 5778888752           


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC-CCCcEEeecCCCceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL-KTANVLLANDNNPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl-k~~nil~~~~~~~~~~  181 (282)
                        ...+++|||+.+.+|...+.          . ....++.|++.++.++|++   |++|||| ||.||+++.++.++++
T Consensus        71 --~~~~lvmeyI~G~~L~~~~~----------~-~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LI  134 (218)
T PRK12274         71 --DGRHLDRSYLAGAAMYQRPP----------R-GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVI  134 (218)
T ss_pred             --cCEEEEEeeecCccHHhhhh----------h-hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEE
Confidence              24689999999988865321          0 1235678999999999999   8999999 7999999999999999


Q ss_pred             cccCccchhhhccC-----chhhhhhHhhhhccCCCCccCCcccccCcccCCC-CccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCG-----SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVD-QRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~-----~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~-~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.........     ..+..... .....+++.++.|+--.....  .+ ...+.++.|.-+|.++|+..|+-+
T Consensus       135 DFG~A~~~~~~~~~~r~L~~rDl~~ll-k~~~~y~~~~l~~~~~~~l~~--~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        135 DFQLAVRGNPRARWMRLLAREDLRHLL-KHKRMYCPAALTPVERRVLKR--TSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             ECCCceecCCcchHHHHHHHHHHHHHH-HHHHhcCCCCCCHHHHhhhcc--chhHHHHHHHhcchHHHHHhccCCccc
Confidence            99987633211100     00001111 122335666777765433211  12 234566999999999999977654

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4.6e-19  Score=143.39  Aligned_cols=137  Identities=18%  Similarity=0.241  Sum_probs=104.7

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-----CCCCcccccccccccCCCCCCCCCc
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-----VHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-----~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      .+.||+|+||.||.  +..+... +||++..........+.+|+.+++.+     +||||+++++++.+.+      +..
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~------g~g   77 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC------GTG   77 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC------CCe
Confidence            45799999999995  7667666 69988765555566789999999999     5799999999665431      112


Q ss_pred             e-EEEEecc--CCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCccccCCCCCcEEeecC----CC
Q psy16951        106 Q-VLMVLPY--YPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV-KVFHDAKPIAYAHRDLKTANVLLAND----NN  177 (282)
Q Consensus       106 ~-~~lv~e~--~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l-~~lH~~~~~~i~H~dlk~~nil~~~~----~~  177 (282)
                      . +.+|+||  +.+++|.+.+..     ..+++.  ..++.|++.++ .|||++   +|+||||||+||+++..    ..
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence            3 4478999  557999998853     124444  35577888787 999999   89999999999999743    37


Q ss_pred             ceeec-ccCc
Q psy16951        178 PLLMD-LGSV  186 (282)
Q Consensus       178 ~~~~d-f~~~  186 (282)
                      ++++| ||..
T Consensus       148 ~~LiDg~G~~  157 (210)
T PRK10345        148 PVVCDNIGES  157 (210)
T ss_pred             EEEEECCCCc
Confidence            89999 6643

>KOG0590|consensus

Probab=99.79  E-value=4.1e-20  Score=170.71  Aligned_cols=200  Identities=23%  Similarity=0.352  Sum_probs=148.8

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccC--Cchh----HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GRED----QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~----~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..+.+|.|++|.|+.+......+..+.|.....  ....    ......|..+-..+.|+|++..+......        
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--------  393 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--------  393 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--------
Confidence            566799999998887777666655666544311  1111    11245577777889999998776644331        


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                       ....-.||||+. .|..++...    ..+...++..++.|++.||+|+|+.   |+.|||+|++|+++..++.+|++||
T Consensus       394 -~~~~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  394 -DGILQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             -ccchhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence             222233999998 888877632    3477888899999999999999999   9999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |.+.-..     ..............|+-+|+|||++.+..|+  ....||||.|+++..|.+|+.||.-
T Consensus       465 g~~~vf~-----~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd--pr~vDiwS~~ii~~~m~~~~~~Wk~  527 (601)
T KOG0590|consen  465 GAASVFR-----YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD--PRAVDVWSCGIIYICMILGRFPWKV  527 (601)
T ss_pred             Ccceeec-----cCcchhhhhhcCcccCCcCcCcccccccccC--cchhhhhhccceEEEEecCCCcccc
Confidence            9653211     1111122334566788999999999999985  4689999999999999999999974

>KOG4158|consensus

Probab=99.78  E-value=2.6e-19  Score=151.66  Aligned_cols=187  Identities=23%  Similarity=0.243  Sum_probs=121.8

Q ss_pred             CCCCcccccccccccCCCC------------------CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHH
Q psy16951         81 VHPNILPLLDHALTGCADP------------------VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF  142 (282)
Q Consensus        81 ~H~ni~~~~~~~~~~~~~~------------------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~  142 (282)
                      +||||+.++..|.+.....                  -......+|+||..+ .-||..++     +....+......++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl-----~~~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYL-----WTRHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHH-----hcCCCchHHHHHHH
Confidence            4999999999887642110                  122346688999877 45676655     34456777778889


Q ss_pred             HHHHHHHHHhhcCCCCCccccCCCCCcEEee--cCC--CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCc
Q psy16951        143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLA--NDN--NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPE  218 (282)
Q Consensus       143 ~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~--~~~--~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE  218 (282)
                      .|+++|+.|||++   |++|||+|.+|||+.  .++  ...++|||.+...+...   ..-..........|....||||
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG---lqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG---LQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccc---cccccccccccCCCcceecchh
Confidence            9999999999999   899999999999984  333  34689999432111000   0001111122334566689999


Q ss_pred             ccccCcc--cCC-CCccchhhHHHHHHHHHhCCCCCCccccCccceeeeeeeccccCCCCCCCC
Q psy16951        219 LFHVDSY--CVV-DQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFP  279 (282)
Q Consensus       219 ~~~~~~~--~~~-~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~  279 (282)
                      +....+-  ..+ =.++|.|+.|.+.||++....||++-.+..-....--....|++|+..|+.
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~  485 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPV  485 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChH
Confidence            9865431  001 148999999999999999999998632222111111133357888888764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=2.6e-18  Score=143.87  Aligned_cols=211  Identities=23%  Similarity=0.314  Sum_probs=124.4

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCC---C--------Ccccccccc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVH---P--------NILPLLDHA   92 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H---~--------ni~~~~~~~   92 (282)
                      .+...+.||.|+++.||.+.+.+|+.++|+|........   ..+.+.+|....+.+.+   |        -++.+--.-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345667799999999999999999999999987544322   33455555555554433   1        111111111


Q ss_pred             cccCCCCC--CCCCce-----EEEEeccCCCCChHHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCccc
Q psy16951         93 LTGCADPV--LNSTSQ-----VLMVLPYYPKGTLANDLELRSVGKH---YMSSVDILKMFLKICEAVKVFHDAKPIAYAH  162 (282)
Q Consensus        93 ~~~~~~~~--~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H  162 (282)
                      +.+.....  ..+...     .+++|+.+ .++|.+.+..-.....   .+.....+.+..|+...+.++|..   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence            11110000  011112     35566665 6777776553211111   122334456678999999999999   9999


Q ss_pred             cCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-----cccCCCCccchhhH
Q psy16951        163 RDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-----SYCVVDQRTDVWSL  237 (282)
Q Consensus       163 ~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-----~~~~~~~~~Diws~  237 (282)
                      +||+|+|++++.+|.+.++||+...-.     ....       .....+..|.|||.....     ....++.+.|.|++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~-----g~~~-------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRA-----GTRY-------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEET-----TEEE-------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeec-----Ccee-------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence            999999999999999999999843211     0000       001234668899977442     11124778999999


Q ss_pred             HHHHHHHHhCCCCCCc
Q psy16951        238 GCLLYAMCYFKSPFDT  253 (282)
Q Consensus       238 G~il~el~tg~~pf~~  253 (282)
                      |+++|.|+++..||..
T Consensus       237 G~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  237 GITLYSLWCGRLPFGL  252 (288)
T ss_dssp             HHHHHHHHHSS-STCC
T ss_pred             HHHHHHHHHccCCCCC
Confidence            9999999999999974

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=2.7e-18  Score=142.00  Aligned_cols=140  Identities=15%  Similarity=0.132  Sum_probs=106.3

Q ss_pred             cEEEEEEeccCCceEEEEEE-ecCCCceEEEEEeccCCch------------------------hHHHHHHHHHHhhhCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIE-HSQTKKRYALKKIICHGRE------------------------DQAQAIREVEHHKTFV   81 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~i~~~~~~------------------------~~~~~~~e~~~l~~l~   81 (282)
                      .|++.+.||+|+||.||+|. +..+|..||+|.+......                        ....+.+|++.++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57888999999999999998 6678999999988643210                        0123457899999887


Q ss_pred             CCC--cccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         82 HPN--ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        82 H~n--i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +..  +.+.++             ....++|||++.+.++.....    .........+..++.|++.++.++|+.   |
T Consensus       109 ~~~i~~p~~~~-------------~~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g  168 (237)
T smart00090      109 EAGVPVPKPIA-------------WRRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---G  168 (237)
T ss_pred             hcCCCCCeeeE-------------ecCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---C
Confidence            532  222222             123579999999888765432    122345566788999999999999999   8


Q ss_pred             -ccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        160 -YAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       160 -i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                       ++|+||||+||+++ ++.++++|||.+.
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~  196 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSV  196 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence             99999999999998 8889999999654

>KOG1166|consensus

Probab=99.76  E-value=2.8e-18  Score=162.50  Aligned_cols=208  Identities=20%  Similarity=0.249  Sum_probs=154.2

Q ss_pred             hhcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC---CCCcccc
Q psy16951         12 MGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV---HPNILPL   88 (282)
Q Consensus        12 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~---H~ni~~~   88 (282)
                      +..+.....+.+..+.|.+...||+|+||.||+|.+.. |+.||+|.=+..+..+   |.--.+++.+|+   -+.|+++
T Consensus       684 ~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  684 VPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             ccccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHH
Confidence            34556677888999999999999999999999999976 9999999543332221   111122223333   1233333


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      ....+         -....++|+||.+.|||.+.+.    ..+.+++..+..+..|++..++.||..   +|||+||||+
T Consensus       760 ~~a~~---------~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPD  823 (974)
T KOG1166|consen  760 SSAHV---------FQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPD  823 (974)
T ss_pred             HHHHc---------cCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcc
Confidence            33211         1255789999999999999887    456789999999999999999999999   7889999999


Q ss_pred             cEEeec-------CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHH
Q psy16951        169 NVLLAN-------DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL  241 (282)
Q Consensus       169 nil~~~-------~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il  241 (282)
                      |.++-+       ...++|+|||.+..+  ++..     ..........|-.+-|+|+..|.++   +.+.|-|.++-++
T Consensus       824 Nfll~~~~~~~~~~~~l~lIDfG~siDm--~lfp-----~~~~F~~~~~td~f~C~EM~~grpW---tYq~DyfGlAa~~  893 (974)
T KOG1166|consen  824 NFLLRREICADSDSKGLYLIDFGRSIDM--KLFP-----DGTKFKAVWHTDLFDCIEMREGRPW---TYQIDYFGLAATV  893 (974)
T ss_pred             eeEeecccCCCCcccceEEEecccceee--eEcC-----CCcEEeeeeccccchhHHHhcCCCC---chhhhhHHHHHHH
Confidence            999843       235689999965422  2111     1123344566888999999999987   9999999999999


Q ss_pred             HHHHhCCC
Q psy16951        242 YAMCYFKS  249 (282)
Q Consensus       242 ~el~tg~~  249 (282)
                      +-|+.|+.
T Consensus       894 h~mLFG~y  901 (974)
T KOG1166|consen  894 HVMLFGKY  901 (974)
T ss_pred             HHHHHHHH
Confidence            99999973

>KOG0603|consensus

Probab=99.75  E-value=1.6e-19  Score=160.80  Aligned_cols=202  Identities=21%  Similarity=0.337  Sum_probs=152.5

Q ss_pred             EeccCCceEEEEEE---ecCCCceEEEEEeccCCchh--HHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCce
Q psy16951         33 KIGEGGFSTVSLIE---HSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        33 ~lg~G~~g~V~~~~---~~~~~~~vaiK~i~~~~~~~--~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      .+|+|+||.|++++   ....+.-+|.|.+.......  ......|..++...+ ||.+++++.         .+.....
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhy---------afqt~~k   71 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHY---------AFQTDGK   71 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeee---------eeccccc
Confidence            37999999998754   33456667887664332211  113344666777776 999999987         4555688


Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      .+++.++..+|.+...+.    ......+.....+...++.++.++|+.   ++++||+|++||+++.+|++++.|||++
T Consensus        72 l~l~ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgls  144 (612)
T KOG0603|consen   72 LYLILDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLS  144 (612)
T ss_pred             hhHhhhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhh
Confidence            999999999988887664    233456777888889999999999999   8999999999999999999999999986


Q ss_pred             cchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeeee
Q psy16951        187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVI  266 (282)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~~  266 (282)
                      +...             ......||..|||||++.+.     ...+|.||+|++++||+||..||.+      .+..++.
T Consensus       145 ke~v-------------~~~~~cgt~eymApEI~~gh-----~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il  200 (612)
T KOG0603|consen  145 KEAV-------------KEKIACGTYEYRAPEIINGH-----LSAADWWSFGVLAFELLTGTLPFGG------DTMKRIL  200 (612)
T ss_pred             hHhH-------------hhhhcccchhhhhhHhhhcc-----CCcccchhhhhhHHHHhhCCCCCch------HHHHHHh
Confidence            5321             11112778999999999843     6789999999999999999999975      3344555


Q ss_pred             eccccCCC
Q psy16951        267 SGNITFPE  274 (282)
Q Consensus       267 ~~~~~~p~  274 (282)
                      ...+..|.
T Consensus       201 ~~~~~~p~  208 (612)
T KOG0603|consen  201 KAELEMPR  208 (612)
T ss_pred             hhccCCch
Confidence            55555553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.3e-17  Score=133.58  Aligned_cols=133  Identities=18%  Similarity=0.204  Sum_probs=105.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.||+|++|.||+|++  ++..|++|........        ....+.+|++.+..+.|+++.....++.         .
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~---------~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV---------D   70 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE---------e
Confidence            5799999999999998  6667899976533221        1235678999999999988766544322         2


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....+++|||+++++|.+.+...       .. ....++.+++.+|.++|+.   +++|+|++|+||+++ ++.++++||
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence            34578999999999999877521       12 6788899999999999999   899999999999998 788999999


Q ss_pred             cCcc
Q psy16951        184 GSVA  187 (282)
Q Consensus       184 ~~~~  187 (282)
                      |.+.
T Consensus       139 ~~a~  142 (211)
T PRK14879        139 GLAE  142 (211)
T ss_pred             Cccc
Confidence            9764

>KOG0606|consensus

Probab=99.72  E-value=7.8e-18  Score=157.46  Aligned_cols=193  Identities=24%  Similarity=0.378  Sum_probs=135.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      -++|+.++.|-.|+||.||.++|+.+..++|+| ++.++     -      ++     .||..+-+              
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----l------il-----Rnilt~a~--------------  130 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----L------IL-----RNILTFAG--------------  130 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----h------hh-----hccccccC--------------
Confidence            468999999999999999999999999999984 53221     1      11     12333332              


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                       ..+.|-+      =...+.    ..+.++-        +++.+++|+|+-   ||+|||+||+|.++..-|++|++|||
T Consensus       131 -npfvvgD------c~tllk----~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfg  188 (1205)
T KOG0606|consen  131 -NPFVVGD------CATLLK----NIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFG  188 (1205)
T ss_pred             -Ccceech------hhhhcc----cCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchh
Confidence             1222211      111111    1111211        226789999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchh----hh--hhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        185 SVAPAVVKVCGSAE----AQ--NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       185 ~~~~~~~~~~~~~~----~~--~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      +++-..........    .+  -.......+||+.|.|||+++...|   +..+|.|++|+|+||.+.|..||.+  +.+
T Consensus       189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy---gkpvdwwamGiIlyeFLVgcvpffG--dtp  263 (1205)
T KOG0606|consen  189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY---GKPVDWWAMGIILYEFLVGCVPFFG--DTP  263 (1205)
T ss_pred             hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc---CCCccHHHHHHHHHHHheeeeeccC--CCH
Confidence            87654443332211    11  1223445678999999999999988   9999999999999999999999976  555


Q ss_pred             cceeeeeeeccccCCCC
Q psy16951        259 DSVALAVISGNITFPEN  275 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~  275 (282)
                      +.+.-.+++..+..|++
T Consensus       264 eelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  264 EELFGQVISDDIEWPEE  280 (1205)
T ss_pred             HHHHhhhhhhhcccccc
Confidence            55655666666666655

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=4.9e-17  Score=131.35  Aligned_cols=134  Identities=19%  Similarity=0.142  Sum_probs=102.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch----------------------hHHHHHHHHHHhhhCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE----------------------DQAQAIREVEHHKTFVHPN   84 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------------------~~~~~~~e~~~l~~l~H~n   84 (282)
                      .|.+.+.||+|+||.||++.+. ++..||||.+......                      ......+|...+..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4777899999999999999885 7999999987543211                      1123466888888887775


Q ss_pred             c--ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccc
Q psy16951         85 I--LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAH  162 (282)
Q Consensus        85 i--~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H  162 (282)
                      +  ....+             ....+++||++++++|.....          ......++.+++.++.++|+.   |++|
T Consensus        95 i~v~~~~~-------------~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H  148 (198)
T cd05144          95 FPVPKPID-------------WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIH  148 (198)
T ss_pred             CCCCceee-------------cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCc
Confidence            3  22221             134589999999988865321          133466788999999999998   8999


Q ss_pred             cCCCCCcEEeecCCCceeecccCcc
Q psy16951        163 RDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       163 ~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +||+|+||+++.++.++++|||.+.
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~  173 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMV  173 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccc
Confidence            9999999999999999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1240|consensus

Probab=99.71  E-value=5.1e-18  Score=159.09  Aligned_cols=204  Identities=21%  Similarity=0.298  Sum_probs=143.2

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHH---HHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQA---IREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~---~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .+...+.||.+.|=+|.+|+++ .|. |+||++....+ -....+   ++|++ ..-.+|||.+.+..         +..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk---------~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQK---------VLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHH---------HHH
Confidence            6888999999999999999995 454 78998865542 233333   33444 45568999999876         333


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ...-.|+|=+|. ..+|+|++.-+    ..+...+.+-++-|++.||.-+|..   ||+|+|||.+|||+..=+++.++|
T Consensus        92 t~kAAylvRqyv-khnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   92 TDKAAYLVRQYV-KHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             hhHHHHHHHHHH-hhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhc
Confidence            445566666766 67888877632    3456667777899999999999999   899999999999999989999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc-------ccC-CCCccchhhHHHHHHHHHh-CCCCCC
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS-------YCV-VDQRTDVWSLGCLLYAMCY-FKSPFD  252 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~-------~~~-~~~~~Diws~G~il~el~t-g~~pf~  252 (282)
                      |+..++...--........-. . ..+....|.|||.+-...       .++ ..++-||||+||++.||++ |.+||.
T Consensus       164 FAsFKPtYLPeDNPadf~fFF-D-TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFF-D-TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ccccCCccCCCCCcccceEEE-e-cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            996554321111111100000 0 111123499999985411       122 5678999999999999987 789984

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=1.7e-16  Score=128.20  Aligned_cols=128  Identities=17%  Similarity=0.230  Sum_probs=98.3

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ||+|+||.||+|.+  ++.+|++|........        ....+.+|+++++.++|+++.....++..         ..
T Consensus         2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---------~~   70 (199)
T TIGR03724         2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD---------PD   70 (199)
T ss_pred             CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE---------CC
Confidence            79999999999996  5678999975432211        12456789999999988775443322221         23


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..+++||++++++|.+.+....        .   .++.+++.++.++|+.   |++|+|++|+||+++ ++.++++|||.
T Consensus        71 ~~~lv~e~~~g~~l~~~~~~~~--------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~  135 (199)
T TIGR03724        71 NKTIVMEYIEGKPLKDVIEEGN--------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGL  135 (199)
T ss_pred             CCEEEEEEECCccHHHHHhhcH--------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCC
Confidence            4689999999999988664210        0   6788999999999999   899999999999999 89999999997


Q ss_pred             cc
Q psy16951        186 VA  187 (282)
Q Consensus       186 ~~  187 (282)
                      +.
T Consensus       136 a~  137 (199)
T TIGR03724       136 GK  137 (199)
T ss_pred             Cc
Confidence            64

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3.3e-16  Score=144.68  Aligned_cols=133  Identities=20%  Similarity=0.208  Sum_probs=101.7

Q ss_pred             EEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--c------hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--R------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...+.||+|+||+||++.+....  +++|+.....  .      .....+.+|+++++.++|++++....++..      
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~------  407 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD------  407 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe------
Confidence            45688999999999999885443  4444322111  1      123457789999999999998765443222      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++||||+++++|.+.+.            ....++.|++.++.++|+.   +++|||+||+||++ .++.+++
T Consensus       408 ---~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        408 ---PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             ---CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEE
Confidence               245689999999999988664            2366889999999999999   89999999999999 6788999


Q ss_pred             ecccCccc
Q psy16951        181 MDLGSVAP  188 (282)
Q Consensus       181 ~df~~~~~  188 (282)
                      +|||.+..
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.5e-15  Score=120.12  Aligned_cols=133  Identities=17%  Similarity=0.193  Sum_probs=90.2

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHH--HH----------------------HHHHHHhhhCCCCC--
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--QA----------------------IREVEHHKTFVHPN--   84 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~--~~----------------------~~e~~~l~~l~H~n--   84 (282)
                      .+.||+|+||+||+|.+. ++.+||||.+.........  ..                      ..|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 8899999987643221111  11                      12333333332221  


Q ss_pred             cccccccccccCCCCCCCCCceEEEEeccCCCCChHHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCccc
Q psy16951         85 ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND-LELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAYAH  162 (282)
Q Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~~i~H  162 (282)
                      +.+.+.             ....++++|+++++++... +...      ....++..++.+++.++.++|. .   +++|
T Consensus        81 ~~~~~~-------------~~~~~lv~e~~~g~~~~~~~l~~~------~~~~~~~~~~~~~~~~l~~lh~~~---~ivH  138 (187)
T cd05119          81 VPKPID-------------LNRHVLVMEFIGGDGIPAPRLKDV------RLLEDPEELYDQILELMRKLYREA---GLVH  138 (187)
T ss_pred             CCceEe-------------cCCCEEEEEEeCCCCccChhhhhh------hhcccHHHHHHHHHHHHHHHhhcc---CcCc
Confidence            111211             1246899999988544321 1110      0115678889999999999999 7   8999


Q ss_pred             cCCCCCcEEeecCCCceeecccCcc
Q psy16951        163 RDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       163 ~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +||+|+||+++ ++.++++|||.+.
T Consensus       139 ~Dl~p~Nili~-~~~~~liDfg~a~  162 (187)
T cd05119         139 GDLSEYNILVD-DGKVYIIDVPQAV  162 (187)
T ss_pred             CCCChhhEEEE-CCcEEEEECcccc
Confidence            99999999999 8999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.9e-14  Score=110.19  Aligned_cols=134  Identities=17%  Similarity=0.201  Sum_probs=104.4

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC--CCcccccccccccCCCCCCCCCceE
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH--PNILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H--~ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +++.||+|.++.||++...+  ..+++|.......  ...+.+|+..++.++|  ..+++++..         .......
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~---------~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS---------GESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEE---------cCCCCcc
Confidence            46789999999999999844  6789998754433  5567789999999876  477776652         2233679


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ++++|++.+.++...           +......++.+++.++..+|.....+++|+|++|+|++++..+.+++.||+.+.
T Consensus        69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            999999988776542           344556778899999999998643379999999999999988999999999654

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023|consensus

Probab=99.57  E-value=8.4e-15  Score=130.38  Aligned_cols=161  Identities=20%  Similarity=0.323  Sum_probs=121.4

Q ss_pred             hhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q psy16951         77 HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK  156 (282)
Q Consensus        77 l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  156 (282)
                      |+.+.|.|+.++.+.++.+         ...+.|.+||..|+|.+.+...   ...++.--...++++++.|+.|+|...
T Consensus         1 l~~l~h~n~~~f~g~~~~~---------~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~   68 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG---------PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP   68 (484)
T ss_pred             CcccchhhhhhheeeEecC---------CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc
Confidence            4678899999999977653         7799999999999999988752   334666777788999999999999985


Q ss_pred             CCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccC----CCCcc
Q psy16951        157 PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCV----VDQRT  232 (282)
Q Consensus       157 ~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~----~~~~~  232 (282)
                      + + .|..++.+|.+++..+.+|++|||+.....- .........      .....-|.|||.+.+.....    .+.++
T Consensus        69 i-~-~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~~------~~~~~lw~aPellr~~~~~~~~~~~~~~g  139 (484)
T KOG1023|consen   69 I-G-YHGALKSSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHHP------IRKALLWTAPELLRGALSQSLESALTQKG  139 (484)
T ss_pred             c-e-eeeeeccccceeeeeEEEEechhhhcccccc-cccccccch------hHHHHhccCHHHhcccccccccccccccC
Confidence            3 2 8999999999999999999999997543210 000000000      01123499999998753322    36789


Q ss_pred             chhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        233 DVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       233 Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      |+||||++++|+++.+.||.......
T Consensus       140 diYs~~ii~~ei~~r~~~~~~~~~~~  165 (484)
T KOG1023|consen  140 DIYSFGIIMYEILFRSGPFDLRNLVE  165 (484)
T ss_pred             CeehHHHHHHHHHhccCccccccccC
Confidence            99999999999999999998644433

>KOG1033|consensus

Probab=99.56  E-value=8.1e-16  Score=134.94  Aligned_cols=134  Identities=24%  Similarity=0.367  Sum_probs=104.5

Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++.|+.|...+|.+++..+. .....+....+.++.|++.|+.|   +   +.+|+|+||.||++..+..++|.|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            45889999999999999997432 12234566788999999999999   5   78899999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.....-..   .......+.....||..||+||.+.+..|   +.++||||||++++|+++ -..+|
T Consensus       402 l~ts~~~~~---~~~~~~a~~t~~~gt~~YmsPEQi~g~~y---~~kvdIyaLGlil~EL~~~f~T~~  463 (516)
T KOG1033|consen  402 LVTSQDKDE---TVAPAAASHTQQVGTLLYMSPEQIRGQQY---SEKVDIYALGLILAELLIQFSTQF  463 (516)
T ss_pred             heeecccCC---cccchhhhhhhcccccccCCHHHHhhhhh---hhhcchhhHHHHHHHHHHHhccHH
Confidence            754221111   11112334556678999999999999988   999999999999999998 34444

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=9.6e-14  Score=115.11  Aligned_cols=138  Identities=17%  Similarity=0.205  Sum_probs=97.9

Q ss_pred             EEec-cCCceEEEEEEecCCCceEEEEEeccCC-------------chhHHHHHHHHHHhhhCCCCCc--cccccccccc
Q psy16951         32 EKIG-EGGFSTVSLIEHSQTKKRYALKKIICHG-------------REDQAQAIREVEHHKTFVHPNI--LPLLDHALTG   95 (282)
Q Consensus        32 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~i~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--~~~~~~~~~~   95 (282)
                      ..|| .|+.|+||.+..  .+..+++|.+...+             ......+.+|++++..++|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3576 788888888877  36678998774321             1223456789999999998885  4444322111


Q ss_pred             CCCCCCCCCceEEEEeccCCC-CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         96 CADPVLNSTSQVLMVLPYYPK-GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                           .......++|+|++++ .+|.+.+..     ..++..    .+.|++.++.++|++   ||+|+||||+||+++.
T Consensus       115 -----~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~  177 (239)
T PRK01723        115 -----HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDP  177 (239)
T ss_pred             -----cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcC
Confidence                 0001234699999987 688776642     224443    256899999999999   8999999999999998


Q ss_pred             CCCceeecccCccc
Q psy16951        175 DNNPLLMDLGSVAP  188 (282)
Q Consensus       175 ~~~~~~~df~~~~~  188 (282)
                      ++.++++|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            88999999997653

>KOG0590|consensus

Probab=99.52  E-value=2.2e-15  Score=139.55  Aligned_cols=209  Identities=25%  Similarity=0.366  Sum_probs=155.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecC-CCceEEEEEeccCC--chhHHHHHHHHHHhhhCC-CCCcccccccccccCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICHG--REDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADP   99 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~   99 (282)
                      ....|++.+.||+|.|+.|-...... +...+|.|.+....  .........|...-..+. |.|++++.+         
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~---------   88 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIE---------   88 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCC---------
Confidence            57789999999999999998776633 34456676665443  222333344666666776 999999988         


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCccccCCCCCcEEeecCC-C
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH-DAKPIAYAHRDLKTANVLLANDN-N  177 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~~~~i~H~dlk~~nil~~~~~-~  177 (282)
                      ...+....++..++..++++...+..  ......+...+-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ .
T Consensus        89 ~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~  163 (601)
T KOG0590|consen   89 PSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSA  163 (601)
T ss_pred             ccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCc
Confidence            44456788999999989888876621  11113566777889999999999999 66   899999999999999999 9


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccC-CCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~-t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++.||+++......      ...........| ++.|++||...+..+  .....|+||+|+++.-+++|..|+...
T Consensus       164 l~~~df~~At~~~~~------~g~~~~~~~~~g~s~~y~a~E~~~~~~~--~~~~~d~~S~g~~l~~~~~g~~p~~~~  233 (601)
T KOG0590|consen  164 LKIADFGLATAYRNK------NGAERSLKDRCGSSPPYGAPEHLSGKAY--RGPSVDVWSLGIVLSAMLTGELPWDFP  233 (601)
T ss_pred             ccCCCchhhcccccc------CCcceeeecccCCCCCCCCcccccchhh--cCCCcccccccccccccccCCCCcccc
Confidence            999999976543221      111112223456 899999999988655  278899999999999999999998754

>KOG0601|consensus

Probab=99.37  E-value=4.1e-13  Score=119.92  Aligned_cols=213  Identities=17%  Similarity=0.181  Sum_probs=159.2

Q ss_pred             cccccEEEecccEEEEEEecc--CCceEEEEEEe--cCCCceEEEEE--eccCCchhHHHHHHHHHHhhhC-CCCCcccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGE--GGFSTVSLIEH--SQTKKRYALKK--IICHGREDQAQAIREVEHHKTF-VHPNILPL   88 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~--i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~   88 (282)
                      +..+-.......+-....+|.  |.+|.||.+..  ..++..+|+|+  +............+|+....++ .|+|.++.
T Consensus       104 ~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~  183 (524)
T KOG0601|consen  104 GASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRD  183 (524)
T ss_pred             CCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcccccccc
Confidence            334444455667778889999  99999999998  88999999997  4555566677778889888888 49999986


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCccccC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE----AVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~----~l~~lH~~~~~~i~H~d  164 (282)
                      ..         ..++....++-.|.| +.++......   ....++...+...+.+...    ||.++|++   +++|.|
T Consensus       184 ~~---------~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~  247 (524)
T KOG0601|consen  184 SP---------AWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDD  247 (524)
T ss_pred             Cc---------ccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccc
Confidence            55         455567788888888 5677665542   3344778888888888888    99999999   789999


Q ss_pred             CCCCcEEeecC-CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHH
Q psy16951        165 LKTANVLLAND-NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       165 lk~~nil~~~~-~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~e  243 (282)
                      +||+||++..+ ..+++.||++.......    .............+...|++||+..+..    +..+|++|+|.+..+
T Consensus       248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~----~~~~~~~~~~r~~~~~~Y~~ke~~~~l~----~~~~di~sl~ev~l~  319 (524)
T KOG0601|consen  248 LKPANIFTTSDWTSCKLTDFGLVSKISDG----NFSSVFKVSKRPEGDCIYAAKELLNGLA----TFASDIFSLGEVILE  319 (524)
T ss_pred             cchhheecccccceeecCCcceeEEccCC----ccccceeeeecCCCCceEeChhhhcccc----chHhhhcchhhhhHh
Confidence            99999999999 77889999965432111    1111111111223456699999998764    688999999999999


Q ss_pred             HHhCCCCCC
Q psy16951        244 MCYFKSPFD  252 (282)
Q Consensus       244 l~tg~~pf~  252 (282)
                      -.++..++.
T Consensus       320 ~~l~~~~~~  328 (524)
T KOG0601|consen  320 AILGSHLPS  328 (524)
T ss_pred             hHhhccccc
Confidence            999887664

>KOG1266|consensus

Probab=99.32  E-value=5.8e-13  Score=111.00  Aligned_cols=161  Identities=14%  Similarity=0.211  Sum_probs=118.7

Q ss_pred             HhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951         76 HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus        76 ~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      .+.++.|.|+++++.+|-+..    .++.....++.||+.-|++..+|.....+...+.......|+.||+.||.|||++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K----~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKK----YEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccc----cccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            345566999999999887642    3345678899999999999999998877888889999999999999999999999


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchh
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVW  235 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diw  235 (282)
                      .+ .++|.++..+.|++..++-+|+..-.   +..+......  ..........+-+.|.+||+=.-...   +.++|||
T Consensus       196 ~P-piihgnlTc~tifiq~ngLIkig~~a---p~s~h~s~~~--~~~~Ek~~~~~~~g~~a~~sg~~tn~---~~a~dIy  266 (458)
T KOG1266|consen  196 DP-PIIHGNLTCDTIFIQHNGLIKIGSVA---PDSTHPSVNS--TREAEKSVNTSLPGFSAPESGTTTNT---TGASDIY  266 (458)
T ss_pred             CC-ccccCCcchhheeecCCceEEecccC---ccccchhhhh--hhHhhhhccccCCccccCCcCccccc---ccchhhh
Confidence            99 59999999999999988877764322   1111110000  00011112234466888986543333   5689999


Q ss_pred             hHHHHHHHHHhCCC
Q psy16951        236 SLGCLLYAMCYFKS  249 (282)
Q Consensus       236 s~G~il~el~tg~~  249 (282)
                      +||....+|+.+..
T Consensus       267 ~fgmcAlemailEi  280 (458)
T KOG1266|consen  267 KFGMCALEMAILEI  280 (458)
T ss_pred             hhhHHHHHHHHhee
Confidence            99999999998874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.29  E-value=3.6e-12  Score=116.26  Aligned_cols=143  Identities=13%  Similarity=0.233  Sum_probs=88.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch----------------------------------hHHH---
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE----------------------------------DQAQ---   69 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------------------------------~~~~---   69 (282)
                      .|+. +.||+|++|+||+|+...+|..||||+....-..                                  ....   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 7899999999999999888999999988543110                                  0111   


Q ss_pred             ---HHHHHHHhhhCC----CCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--cCCCCCHHHHHH
Q psy16951         70 ---AIREVEHHKTFV----HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--GKHYMSSVDILK  140 (282)
Q Consensus        70 ---~~~e~~~l~~l~----H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~  140 (282)
                         +.+|+..+.++.    +.+.+.+...+        ..-.+..++||||+.|+.+.+.-.....  ....+....+..
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~--------~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVY--------WDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceee--------cccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence               223333333321    22222222111        0113457899999999999764221111  111233444444


Q ss_pred             HHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC----CceeecccCccc
Q psy16951        141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN----NPLLMDLGSVAP  188 (282)
Q Consensus       141 ~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~----~~~~~df~~~~~  188 (282)
                      ++.|+.       ..   |++|+|++|.||+++.++    .+++.|||....
T Consensus       272 ~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        272 FFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             HHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            555553       34   899999999999999888    899999997654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.28  E-value=2.8e-11  Score=108.89  Aligned_cols=139  Identities=13%  Similarity=0.142  Sum_probs=90.0

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhH----------------------------------------HHHH
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ----------------------------------------AQAI   71 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----------------------------------------~~~~   71 (282)
                      +.||.|++|+||+|+.. +|..||||+....-....                                        -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46999999999999984 789999998754321110                                        0123


Q ss_pred             HHHHHhhhCC----CCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Q psy16951         72 REVEHHKTFV----HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE  147 (282)
Q Consensus        72 ~e~~~l~~l~----H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~  147 (282)
                      +|+..+..+.    |.+-+.+...+.        .-.+..+++|||+++.+|.+.......   ...   ...++.+++.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--------~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~  267 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--------DRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLAR  267 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--------hhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHH
Confidence            3444444432    222222222111        112347899999999999886543211   112   2334444444


Q ss_pred             -HHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        148 -AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       148 -~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                       .+..+|..   |++|+|++|.||++..++.++++|||.+..
T Consensus       268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence             35778887   899999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243|consensus

Probab=99.28  E-value=2.8e-11  Score=109.63  Aligned_cols=181  Identities=19%  Similarity=0.196  Sum_probs=126.3

Q ss_pred             EEeccCCceEEE-EEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEE
Q psy16951         32 EKIGEGGFSTVS-LIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMV  110 (282)
Q Consensus        32 ~~lg~G~~g~V~-~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv  110 (282)
                      +..+-++.+ +| .|..+.++.+|.|.....++........+.++.++.++||||++|+.         ..+.....|+|
T Consensus        18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~---------t~e~~~~~ylv   87 (690)
T KOG1243|consen   18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLD---------TTEEEGTLYLV   87 (690)
T ss_pred             ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhh---------hhcccCceEEE
Confidence            444444544 34 46667788999998887666644455677888999999999999998         56667899999


Q ss_pred             eccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchh
Q psy16951        111 LPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV  190 (282)
Q Consensus       111 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~  190 (282)
                      +|.+.  .|...+..       +....+..-+.||+.||.|||+.+  +++|+++.-+.++++..|.-++.+|..+....
T Consensus        88 TErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen   88 TERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             eeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            99874  24333432       224445555789999999999766  89999999999999999999999988643210


Q ss_pred             hhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC
Q psy16951        191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg  247 (282)
                      -       . . .+......-..|..|+.+...     .-..|.|-||+++||++.|
T Consensus       157 ~-------~-~-~~~~~~~~~~s~~~P~~~~~s-----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  157 G-------F-N-APAKSLYLIESFDDPEEIDPS-----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c-------C-C-cccccchhhhcccChhhcCcc-----ccchhhhhHHHHHHHHhCc
Confidence            0       0 0 001111112236666644322     1246999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=3.1e-11  Score=94.68  Aligned_cols=130  Identities=19%  Similarity=0.198  Sum_probs=90.9

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcc-cccccccccCCCCCCCCCceEEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL-PLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~-~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      ++.|+.|.++.||++...  +..|++|...... .......+|+..++.+.+.+++ +++...           ....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----------~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFD-----------PETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEe-----------CCCCeE
Confidence            567899999999999873  7789999764332 1223456788888887654443 333211           123479


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--CCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKP--IAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~--~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      |||++++.++...        . ..   ......+++.++..||....  .+++|+|++|.||+++ ++.++++||+.+.
T Consensus        69 v~e~i~G~~l~~~--------~-~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          69 ITEFIEGSELLTE--------D-FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EEEecCCCccccc--------c-cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9999999887642        0 11   12345789999999999831  1259999999999998 6789999999654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.21  E-value=2.9e-11  Score=108.17  Aligned_cols=212  Identities=17%  Similarity=0.163  Sum_probs=148.3

Q ss_pred             hhhhhhhcccccccEEEecccEEEEEEeccCCceEEEEEEec-CCCceEEEEEeccCCchhHH--HHHHHHHHhhhC-CC
Q psy16951          7 NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-QTKKRYALKKIICHGREDQA--QAIREVEHHKTF-VH   82 (282)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~--~~~~e~~~l~~l-~H   82 (282)
                      |-+..+.....+++-.....+|.++..||.|.|+.|+....+ .++..|++|.+...-.....  .-..|+-+...+ .|
T Consensus       246 ~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~  325 (524)
T KOG0601|consen  246 DDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSH  325 (524)
T ss_pred             cccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcc
Confidence            444555566666666677889999999999999999987766 77888999977543333222  224566666655 47


Q ss_pred             CCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccc
Q psy16951         83 PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAH  162 (282)
Q Consensus        83 ~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H  162 (282)
                      .+++.+...|..         ....++-.|||.++++.....    ....+.+...+.+..|++.++.++|+.   .++|
T Consensus       326 ~~~~g~~~~W~~---------~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~  389 (524)
T KOG0601|consen  326 LPSVGKNSSWSQ---------LRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVH  389 (524)
T ss_pred             cccCCCCCCccc---------cccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhc
Confidence            787776654332         244568889999998876552    234478888899999999999999998   7889


Q ss_pred             cCCCCCcEEeecC-CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccC-Cccc-ccCcccCCCCccchhhHHH
Q psy16951        163 RDLKTANVLLAND-NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRA-PELF-HVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       163 ~dlk~~nil~~~~-~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~-PE~~-~~~~~~~~~~~~Diws~G~  239 (282)
                      +|++|+||++.++ +..++.||+......+...            .......+.+ .|.+ ....   ...+.|++|||+
T Consensus       390 ~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~------------~~~~~~r~~p~~~~~~e~~~---~~~~~~~~sl~~  454 (524)
T KOG0601|consen  390 LDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG------------VFHHIDRLYPIAEILLEDYP---HLSKADIFSLGL  454 (524)
T ss_pred             ccccccceeeccchhhhhccccccccccceecc------------cccccccccccchhhccccc---cccccccccccc
Confidence            9999999999886 6667888885432111000            0011222342 4444 3333   378999999999


Q ss_pred             HHHHHHhCCC
Q psy16951        240 LLYAMCYFKS  249 (282)
Q Consensus       240 il~el~tg~~  249 (282)
                      .+.+.+++..
T Consensus       455 ~~~e~~~~~~  464 (524)
T KOG0601|consen  455 SVDEAITGSP  464 (524)
T ss_pred             cccccccCcc
Confidence            9999999884

>KOG0606|consensus

Probab=99.18  E-value=1.4e-11  Score=116.33  Aligned_cols=232  Identities=19%  Similarity=0.243  Sum_probs=157.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...+.+.+...+-+|.++.++.+.-..++...++|.......-   +.+....+-.++-...+|.++.....        
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s--------  872 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS--------  872 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC--------
Confidence            4577888888899999999999988888766565543211111   11112222222223345666655432        


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                       +....-.+++++++.+++|...++...    ..+..-+.-+...+.++.++||..   .+.|+|++|++.+...+++.+
T Consensus       873 -~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~  944 (1205)
T KOG0606|consen  873 -FPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRP  944 (1205)
T ss_pred             -CCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcc
Confidence             223456889999999999988776432    234444455666788899999998   577999999999999999999


Q ss_pred             eecccCc-cchhhhccCc-------------------h--hhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhH
Q psy16951        180 LMDLGSV-APAVVKVCGS-------------------A--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSL  237 (282)
Q Consensus       180 ~~df~~~-~~~~~~~~~~-------------------~--~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~  237 (282)
                      +.+|+.. +.........                   .  ............+|+.|.+||.+++...   +..+|.|++
T Consensus       945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h---gs~ad~~~~ 1021 (1205)
T KOG0606|consen  945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH---GSAADWWSS 1021 (1205)
T ss_pred             cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC---CCcchhhhh
Confidence            9999822 2111100000                   0  0001122345568999999999999887   789999999


Q ss_pred             HHHHHHHHhCCCCCCccccCccceeeeeeeccccCCCC
Q psy16951        238 GCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPEN  275 (282)
Q Consensus       238 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~p~~  275 (282)
                      |++++|.++|.+||.+  +.+++....+..+.++-|.+
T Consensus      1022 g~~l~e~l~g~pp~na--~tpq~~f~ni~~~~~~~p~g 1057 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNA--ETPQQIFENILNRDIPWPEG 1057 (1205)
T ss_pred             hhhhhhhhcCCCCCCC--cchhhhhhccccCCCCCCCC
Confidence            9999999999999986  56666777777777766644

>KOG3741|consensus

Probab=98.92  E-value=1.8e-08  Score=89.31  Aligned_cols=173  Identities=19%  Similarity=0.218  Sum_probs=122.9

Q ss_pred             CceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCC-C
Q psy16951         38 GFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP-K  116 (282)
Q Consensus        38 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~  116 (282)
                      ...+.|++....+|.-|++|++.-...........-++.++++.|+|+|++.+.|...     -.+...+++|++|++ -
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-----tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-----TFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-----ccCcceEEEEEecCCCC
Confidence            3456799999999999999988211111111223357889999999999999988852     224567999999986 5


Q ss_pred             CChHHHHHHH-----------HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        117 GTLANDLELR-----------SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       117 ~sL~~~l~~~-----------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ++|.+.....           ...+...++..++-++.|+..||.++|+.   |++-+-|.+.+|++..+.+++++.-|.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i  439 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGI  439 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccc
Confidence            7887754321           12234567789999999999999999999   888899999999998887777765443


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCC-cccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAP-ELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~P-E~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      ....                        .--| +.+..      -++-|.=.||.+++.|+||.
T Consensus       440 ~Dvl------------------------~~d~~~~le~------~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  440 MDVL------------------------QEDPTEPLES------QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             eeee------------------------cCCCCcchhH------HhhhhHHHHHHHHHHHhhcc
Confidence            2110                        0001 11111      24678889999999999995

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.92  E-value=1.4e-08  Score=81.00  Aligned_cols=134  Identities=14%  Similarity=0.198  Sum_probs=90.2

Q ss_pred             EEeccCCceEEEEEEecC------CCceEEEEEeccCC------------c----------hhHH----HHHHHHHHhhh
Q psy16951         32 EKIGEGGFSTVSLIEHSQ------TKKRYALKKIICHG------------R----------EDQA----QAIREVEHHKT   79 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~i~~~~------------~----------~~~~----~~~~e~~~l~~   79 (282)
                      ..||.|-=+.||.|....      .+..+|||.....-            .          ....    ...+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468888889999997643      35789999654211            0          0011    12368888888


Q ss_pred             CCC--CCcccccccccccCCCCCCCCCceEEEEeccCCCCChHH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hcC
Q psy16951         80 FVH--PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAN-DLELRSVGKHYMSSVDILKMFLKICEAVKVF-HDA  155 (282)
Q Consensus        80 l~H--~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l-H~~  155 (282)
                      +..  -++.+.+.             ...-++||||+.+..+.. .+.     ...++..++..+..+++.++..+ |..
T Consensus        83 l~~~Gv~vP~pi~-------------~~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          83 MQKAGIPCPEVVV-------------LKKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHcCCCCCeEEE-------------ecCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            753  33444433             134789999997654422 121     11244556667788999999988 787


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                         |++|+||++.||++. ++.+.++||+-+.
T Consensus       145 ---glVHGDLs~~NIL~~-~~~v~iIDF~qav  172 (197)
T cd05146         145 ---NLVHADLSEYNMLWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             ---CeecCCCCHHHEEEE-CCcEEEEECCCce
Confidence               899999999999996 5789999999543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.90  E-value=1.4e-08  Score=82.89  Aligned_cols=145  Identities=13%  Similarity=0.153  Sum_probs=94.2

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCC--CcccccccccccCCCCCCCCCceE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHP--NILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~--ni~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      .+.|+.|..+.||++.... |..+++|....... .....+.+|.++++.+.+.  .+.+++...-..      ......
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~------~~~~~~   75 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP------SVLGTP   75 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC------CccCCc
Confidence            3678999999999998743 57899997643322 1344667899999888653  344454422110      001356


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK-------------------------------  156 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-------------------------------  156 (282)
                      ++++|++++.++.+.+.     ...++..+...++.+++.+|..+|+..                               
T Consensus        76 ~~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          76 FYVMERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             eEEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            89999998887765331     012444555555566666666665321                               


Q ss_pred             ----------------------CCCccccCCCCCcEEeec--CCCceeecccCcc
Q psy16951        157 ----------------------PIAYAHRDLKTANVLLAN--DNNPLLMDLGSVA  187 (282)
Q Consensus       157 ----------------------~~~i~H~dlk~~nil~~~--~~~~~~~df~~~~  187 (282)
                                            ...++|+|+.+.||+++.  ++.+.++||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                  125799999999999988  4556799998654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087|consensus

Probab=98.73  E-value=2.2e-07  Score=72.30  Aligned_cols=141  Identities=18%  Similarity=0.172  Sum_probs=94.0

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+..+-||+=+.|+++.+  .|...+||.=....-        .......+|+..+.++.--.|.--.-         .+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l---------~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL---------IF   79 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE---------EE
Confidence            467788999999999999  566667774221111        12334567888887765333221111         12


Q ss_pred             CCCceEEEEeccCCC-CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc--
Q psy16951        102 NSTSQVLMVLPYYPK-GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP--  178 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~--  178 (282)
                      .+...-.++|||.++ .++.+++.....+  .........++..|-..+.-||+.   +++|+||.++||++..++..  
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~  154 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT  154 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence            233556789999966 4677766544322  233333478888999999999999   78899999999999776543  


Q ss_pred             -eeecccCc
Q psy16951        179 -LLMDLGSV  186 (282)
Q Consensus       179 -~~~df~~~  186 (282)
                       .++|||++
T Consensus       155 ~~lIdfgls  163 (229)
T KOG3087|consen  155 PILIDFGLS  163 (229)
T ss_pred             eEEEeecch
Confidence             58999975

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.65  E-value=9.3e-07  Score=74.41  Aligned_cols=135  Identities=17%  Similarity=0.103  Sum_probs=88.5

Q ss_pred             EEEEEecCCCceEEEEEeccCCch-----------hHHHHHHHHHHhhhCCCCCcccc--cccccccCCCCCCCCCceEE
Q psy16951         42 VSLIEHSQTKKRYALKKIICHGRE-----------DQAQAIREVEHHKTFVHPNILPL--LDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        42 V~~~~~~~~~~~vaiK~i~~~~~~-----------~~~~~~~e~~~l~~l~H~ni~~~--~~~~~~~~~~~~~~~~~~~~  108 (282)
                      |.++..  .|..|.||......-.           ....+.+|...+..+...+|...  ..++...    ........+
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~----~~~~~~~s~  111 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG----SNPATRTSF  111 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec----CCCccceeE
Confidence            445555  4567888866433311           11136788888877754444333  2222111    111134578


Q ss_pred             EEeccCCCC-ChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-------CCCcee
Q psy16951        109 MVLPYYPKG-TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-------DNNPLL  180 (282)
Q Consensus       109 lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-------~~~~~~  180 (282)
                      +|+|++++. +|.+.+....  ....+......++.+++..+.-+|+.   |++|+|++++||+++.       +..+.+
T Consensus       112 LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEE
Confidence            999999875 7887764321  12345566778899999999999999   8999999999999985       356789


Q ss_pred             ecccCcc
Q psy16951        181 MDLGSVA  187 (282)
Q Consensus       181 ~df~~~~  187 (282)
                      +||+.+.
T Consensus       187 IDl~r~~  193 (268)
T PRK15123        187 IDLHRAQ  193 (268)
T ss_pred             EECCccc
Confidence            9999653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=2e-07  Score=74.13  Aligned_cols=122  Identities=19%  Similarity=0.230  Sum_probs=73.8

Q ss_pred             EEEEEecCCCceEEEEEeccCCc--h------------------------hHHHHHHHHHHhhhCCCC--Cccccccccc
Q psy16951         42 VSLIEHSQTKKRYALKKIICHGR--E------------------------DQAQAIREVEHHKTFVHP--NILPLLDHAL   93 (282)
Q Consensus        42 V~~~~~~~~~~~vaiK~i~~~~~--~------------------------~~~~~~~e~~~l~~l~H~--ni~~~~~~~~   93 (282)
                      ||.|.. ..+.++|+|.......  +                        ......+|.+.|+++...  ++.+.+.+  
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            788887 4677899996643210  0                        022446799999998755  34444431  


Q ss_pred             ccCCCCCCCCCceEEEEeccCC--CCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCccccCCCCCcE
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYP--KGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKV-FHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~-lH~~~~~~i~H~dlk~~ni  170 (282)
                                 ..-.+||||+.  +..+.. +....     ++......++.+++..+.. +|..   |++|+||.+.||
T Consensus        79 -----------~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NI  138 (188)
T PF01163_consen   79 -----------NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNI  138 (188)
T ss_dssp             -----------ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSE
T ss_pred             -----------eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhE
Confidence                       23569999997  544443 33211     1133456666777775555 5677   899999999999


Q ss_pred             EeecCCCceeecccCcc
Q psy16951        171 LLANDNNPLLMDLGSVA  187 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~  187 (282)
                      +++.+ .+.++||+.+.
T Consensus       139 lv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen  139 LVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             EEETT-CEEE--GTTEE
T ss_pred             Eeecc-eEEEEecCcce
Confidence            99876 99999999654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=6.3e-07  Score=69.87  Aligned_cols=127  Identities=20%  Similarity=0.240  Sum_probs=85.6

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCC
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLN  102 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~  102 (282)
                      .+++|+=+.++.+.+.  |.++++|.=..+.-.        ....-.+|+.++.++.--.  ...++.+           
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-----------   69 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-----------   69 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----------
Confidence            4789999999999773  444666632111111        1234467888888775333  2233321           


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...-.++|||.++..|.+.+...           ...++..+=.-+.-||..   ||+|+||.++||++...+ +.++|
T Consensus        70 D~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~ID  134 (204)
T COG3642          70 DPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFID  134 (204)
T ss_pred             cCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEE
Confidence            235577999999888887766522           134555666667789999   899999999999996544 88999


Q ss_pred             ccCcc
Q psy16951        183 LGSVA  187 (282)
Q Consensus       183 f~~~~  187 (282)
                      ||+..
T Consensus       135 fGLg~  139 (204)
T COG3642         135 FGLGE  139 (204)
T ss_pred             CCccc
Confidence            99764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.47  E-value=1.7e-06  Score=71.51  Aligned_cols=131  Identities=21%  Similarity=0.165  Sum_probs=89.2

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-----C-----------------chhHHHHHHHHHHhhhCCCC--
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-----G-----------------REDQAQAIREVEHHKTFVHP--   83 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-----~-----------------~~~~~~~~~e~~~l~~l~H~--   83 (282)
                      +.+..+||-|-=+.||.|... .|.++|||-=+..     .                 ...+....+|.++|+.|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346688999999999999984 7888999921110     0                 00123557899999998643  


Q ss_pred             CcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccc
Q psy16951         84 NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR  163 (282)
Q Consensus        84 ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~  163 (282)
                      .+.+-++             ...-.+|||+..+-.|...-         +....+..++..|+.-+.-+-..   |++|+
T Consensus       172 ~VP~P~~-------------~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHG  226 (304)
T COG0478         172 KVPKPIA-------------WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHG  226 (304)
T ss_pred             CCCCccc-------------cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence            4554443             35678999999887776422         11222233333444444333344   89999


Q ss_pred             CCCCCcEEeecCCCceeeccc
Q psy16951        164 DLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~  184 (282)
                      |+++=||+++.+|.+.++||-
T Consensus       227 DlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         227 DLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             CCchheEEEecCCCEEEEeCc
Confidence            999999999999999999987

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=4.9e-06  Score=67.48  Aligned_cols=109  Identities=17%  Similarity=0.248  Sum_probs=76.5

Q ss_pred             HHHHHHHHHHhhhCCCCCccc--ccccccccCCCCCCCCCceEEEEeccCCCC-ChHHHHHHHHhcCCCCCHHHHHHHHH
Q psy16951         67 QAQAIREVEHHKTFVHPNILP--LLDHALTGCADPVLNSTSQVLMVLPYYPKG-TLANDLELRSVGKHYMSSVDILKMFL  143 (282)
Q Consensus        67 ~~~~~~e~~~l~~l~H~ni~~--~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~  143 (282)
                      .....+|...+..+...+|..  ...+....     .......++|+|++++. +|.+.+....    ..+......++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r-----~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~  125 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERR-----KGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLR  125 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEc-----CCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHH
Confidence            345677888777775444432  22222111     00114568999999874 7877765321    155666788889


Q ss_pred             HHHHHHHHhhcCCCCCccccCCCCCcEEeecCC---CceeecccCcc
Q psy16951        144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDN---NPLLMDLGSVA  187 (282)
Q Consensus       144 qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~~~~df~~~~  187 (282)
                      +++..+.-||..   |+.|+|+++.|||++.++   .+.++||+.+.
T Consensus       126 ~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  126 ALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999   899999999999999887   77899998543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.29  E-value=1.7e-05  Score=63.79  Aligned_cols=142  Identities=15%  Similarity=0.157  Sum_probs=98.1

Q ss_pred             eccCCceEEEEEEecCCCceEEEEEeccCC------chhHHHHHHHHHHhhhCCCCCcc--cccccccccCCCCCCCCCc
Q psy16951         34 IGEGGFSTVSLIEHSQTKKRYALKKIICHG------REDQAQAIREVEHHKTFVHPNIL--PLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        34 lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~e~~~l~~l~H~ni~--~~~~~~~~~~~~~~~~~~~  105 (282)
                      -|+|+-+-|+.....+.  .+=+|+-...-      +-..+++.+|...++.+...+|.  +.. ++-..    -.....
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~----k~~~~~   98 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV----KIEGEW   98 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee----ccCCce
Confidence            46688888888776333  56778653111      23567899999999998754443  222 11111    111245


Q ss_pred             eEEEEeccCCC-CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC--ceeec
Q psy16951        106 QVLMVLPYYPK-GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN--PLLMD  182 (282)
Q Consensus       106 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--~~~~d  182 (282)
                      ..+||+|.+.+ .+|.+.+...  .....+......+..+++..+.-+|+.   |+.|+|+.++||+++..+.  +.++|
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEE
Confidence            68899997753 5777766432  122356666778889999999999999   8999999999999987777  78999


Q ss_pred             ccCcc
Q psy16951        183 LGSVA  187 (282)
Q Consensus       183 f~~~~  187 (282)
                      |..+.
T Consensus       174 lEk~r  178 (216)
T PRK09902        174 LEKSR  178 (216)
T ss_pred             hhccc
Confidence            98544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=2.8e-05  Score=62.91  Aligned_cols=141  Identities=21%  Similarity=0.266  Sum_probs=86.2

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHH---------HHHHHHhhhCCCCC---cccccccc
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---------IREVEHHKTFVHPN---ILPLLDHA   92 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~---------~~e~~~l~~l~H~n---i~~~~~~~   92 (282)
                      ..+|+..+.+....-..|.+.+-  .+..+++|.........+..+         .+.+..+..++...   ...++...
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            56788888888777666666555  667899997765544433322         12333333332211   11211100


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ...    ..+-....++++||++|..|.+...        +.+    .+...+.+++.-+|+.   |+.|+|..|.|+++
T Consensus       108 ekk----~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv  168 (229)
T PF06176_consen  108 EKK----IFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLV  168 (229)
T ss_pred             eee----eccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEE
Confidence            000    1111245678999999988865332        222    2334577788999999   89999999999988


Q ss_pred             ecCCCceeecccCcc
Q psy16951        173 ANDNNPLLMDLGSVA  187 (282)
Q Consensus       173 ~~~~~~~~~df~~~~  187 (282)
                      . ++.+++.||+-.+
T Consensus       169 ~-~~~i~iID~~~k~  182 (229)
T PF06176_consen  169 S-NNGIRIIDTQGKR  182 (229)
T ss_pred             E-CCcEEEEECcccc
Confidence            7 5569999998543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.13  E-value=5.2e-05  Score=66.40  Aligned_cols=203  Identities=15%  Similarity=0.166  Sum_probs=120.4

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCccc---ccccccccCCCCCCCCCc
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILP---LLDHALTGCADPVLNSTS  105 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~---~~~~~~~~~~~~~~~~~~  105 (282)
                      ..+.||+|+-+.+|-.....+  .|| |+.-.......++.   ++.|-.. .||-+..   +-...+.|     .....
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G-----~~~~~   83 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHG-----GRRGK   83 (637)
T ss_pred             CCccccCCccceeeecchhhc--hhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhC-----CCccc
Confidence            456799999999985443222  233 55433222222222   2333333 4665433   11111111     11122


Q ss_pred             eEEEEeccCCCC-ChHHHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        106 QVLMVLPYYPKG-TLANDLELR--SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       106 ~~~lv~e~~~~~-sL~~~l~~~--~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ..-+.|...++. .+.+++...  ...-....+..++...+.++.+..-+|..   |-.-+|++++|+++..++.+.+.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence            256777776543 222222211  11223456788899999999999999998   777899999999999999999887


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc--CCCCccchhhHHHHHHHHHhC-CCCCCcccc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC--VVDQRTDVWSLGCLLYAMCYF-KSPFDTVYE  256 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~--~~~~~~Diws~G~il~el~tg-~~pf~~~~~  256 (282)
                      -....     ++     .+.......+|...|.+||.-.-.+..  --...+|-|.+|+++++++.| .+||+++.-
T Consensus       161 sDsfq-----i~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~  227 (637)
T COG4248         161 SDSFQ-----IN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL  227 (637)
T ss_pred             cccee-----ec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence            54211     11     111122234566779999976521110  014579999999999999886 899987643

>KOG0576|consensus

Probab=98.07  E-value=1.5e-06  Score=79.32  Aligned_cols=185  Identities=14%  Similarity=0.122  Sum_probs=124.3

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC-cccccccccccCCCCCCCCCce
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN-ILPLLDHALTGCADPVLNSTSQ  106 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n-i~~~~~~~~~~~~~~~~~~~~~  106 (282)
                      +......++++++++++.+...++..+ .+.+...     ....-+++.|.+++||| .+.+++         ....+..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~---------d~~~E~~  308 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLE---------DYDGEDY  308 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccc---------cCCcccc
Confidence            445667899999999999986666554 4544222     23345789999999999 555554         3344678


Q ss_pred             EEEEeccCCCC-ChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        107 VLMVLPYYPKG-TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       107 ~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      .+++++++..+ +.........   -.+...+...+++.-+.++.++|+.   --+|+|    ||+.. ++..+..+|+.
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s-~~~~~~~~~~v  377 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSE---IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGS-EEEVKLLDFAV  377 (829)
T ss_pred             cchhhhhhcCCccccccCChhh---Hhhhhhhhhhhhhhhcccccccccc---cccCcc----ccccc-ccccccccccC
Confidence            99999999776 3222111111   1133445566677788899999987   345887    66654 46778888886


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCC
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF  251 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf  251 (282)
                      .....-..          ......+++.+++||+...+.+   ....|.|+.+.-..++.-|-+|-
T Consensus       378 ~~~L~~~~----------~~~t~~~~~~~~~pev~~~~~~---~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  378 PPQLTRTM----------KPRTAIGTPEPLAPEVIQENTI---DGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CcccCccc----------ccccCCCCCCCCCchhhccccc---ccCCCccCCCcchhhcCCCCCCC
Confidence            43221110          2234456888999999988776   67899999998777887777654

>KOG2137|consensus

Probab=98.01  E-value=7.3e-07  Score=81.81  Aligned_cols=106  Identities=15%  Similarity=0.173  Sum_probs=71.9

Q ss_pred             HHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc
Q psy16951        143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV  222 (282)
Q Consensus       143 ~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~  222 (282)
                      .+++.|+.|+|...  ++||+++.|++|.++.++..|++.|++........+.........-.........|.+||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            45568999999987  7999999999999999999999988854321110010000000000111122456999999988


Q ss_pred             CcccCCCCccchhhHHHHHHHHH-hCCCCCCc
Q psy16951        223 DSYCVVDQRTDVWSLGCLLYAMC-YFKSPFDT  253 (282)
Q Consensus       223 ~~~~~~~~~~Diws~G~il~el~-tg~~pf~~  253 (282)
                      ..-   +.++|++|+|+.+|.+. .|+..+..
T Consensus       184 ~~~---~~~sd~fSlG~li~~i~~~gk~i~~a  212 (700)
T KOG2137|consen  184 TTN---TPASDVFSLGVLIYTIYNGGKSIIAA  212 (700)
T ss_pred             ccc---cccccceeeeeEEEEEecCCcchhhc
Confidence            543   78999999999999887 56665543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.93  E-value=3e-05  Score=60.22  Aligned_cols=128  Identities=17%  Similarity=0.172  Sum_probs=82.3

Q ss_pred             EEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCccc-ccccccccCCCCCCCCCceE
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP-LLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~-~~~~~~~~~~~~~~~~~~~~  107 (282)
                      +....|++|.+|.||++.|  .|..+|+|.=  ..+..+..+..|++++..++-.++.+ ++.+             +.-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvr--r~ds~r~~l~kEakiLeil~g~~~~p~vy~y-------------g~~   87 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVR--RRDSPRRNLEKEAKILEILAGEGVTPEVYFY-------------GED   87 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEe--cCCcchhhHHHHHHHHHHhhhcCCCceEEEe-------------chh
Confidence            3456799999999999999  5558898843  23445566778999998887655532 2221             123


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCC-CCcEEeecCCCceeecccCc
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK-TANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk-~~nil~~~~~~~~~~df~~~  186 (282)
                      .+.|||..+..|.+.-..       ....+++.    +++. .|.-+..  ||-|..|. |...++..++.+.++||..+
T Consensus        88 ~i~me~i~G~~L~~~~~~-------~~rk~l~~----vlE~-a~~LD~~--GI~H~El~~~~k~vlv~~~~~~iIDFd~A  153 (201)
T COG2112          88 FIRMEYIDGRPLGKLEIG-------GDRKHLLR----VLEK-AYKLDRL--GIEHGELSRPWKNVLVNDRDVYIIDFDSA  153 (201)
T ss_pred             hhhhhhhcCcchhhhhhc-------ccHHHHHH----HHHH-HHHHHHh--ccchhhhcCCceeEEecCCcEEEEEccch
Confidence            345999988788764321       12233332    3333 2222322  88898886 55666666779999999965


Q ss_pred             c
Q psy16951        187 A  187 (282)
Q Consensus       187 ~  187 (282)
                      .
T Consensus       154 t  154 (201)
T COG2112         154 T  154 (201)
T ss_pred             h
Confidence            4

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.82  E-value=0.00034  Score=57.57  Aligned_cols=72  Identities=15%  Similarity=0.147  Sum_probs=44.9

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCc--ccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI--LPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni--~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      .+||+|..+.||+.    .+..+++|......  ......+|.+.++.+..-.+  .+.+..         .+......+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~---------~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDL---------VEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEE---------EecCCeeee
Confidence            67999999999973    23456778654322  33445788888887753333  333331         112344678


Q ss_pred             EeccCCCCC
Q psy16951        110 VLPYYPKGT  118 (282)
Q Consensus       110 v~e~~~~~s  118 (282)
                      +||++.|.+
T Consensus        72 v~e~i~G~~   80 (226)
T TIGR02172        72 IYELIVGKR   80 (226)
T ss_pred             eeeecCCcc
Confidence            999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.81  E-value=0.00018  Score=65.82  Aligned_cols=141  Identities=16%  Similarity=0.233  Sum_probs=84.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhH--------------------------H--------------HHH
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--------------------------A--------------QAI   71 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~--------------------------~--------------~~~   71 (282)
                      ..|+.++-|+||+|+.. +|+.||||+....-.+.-                          .              .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57899999999999995 599999997644321110                          0              112


Q ss_pred             HHHHHhhhCC----CCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Q psy16951         72 REVEHHKTFV----HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE  147 (282)
Q Consensus        72 ~e~~~l~~l~----H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~  147 (282)
                      +|+..+.++.    +..-+.+...        ..+-.+...++||++.|-.+.+.......+   .+...+.....++. 
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V--------~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k~ia~~~~~~f-  277 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKV--------YWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRKELAELLVRAF-  277 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEecee--------ehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHHHHHHHHHHHH-
Confidence            3444444332    1111122111        111235678999999998888865433221   33222222222211 


Q ss_pred             HHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       148 ~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                       +..+-..   |..|.|..|.||++..+++..+.|||.....
T Consensus       278 -~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         278 -LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             -HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence             1111122   7889999999999999999999999976543

>KOG1235|consensus

Probab=97.81  E-value=0.00034  Score=64.08  Aligned_cols=136  Identities=18%  Similarity=0.231  Sum_probs=86.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhH--------------------------------------HHHHHH
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--------------------------------------AQAIRE   73 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~--------------------------------------~~~~~e   73 (282)
                      +.||.-+.|+|++|+.+. |+.||||+ +..+-++.                                      -.|.+|
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKV-Q~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKV-QHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEe-cCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            569999999999999975 99999994 32222110                                      012234


Q ss_pred             HHHh----hhCCCCC------cccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHH
Q psy16951         74 VEHH----KTFVHPN------ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL  143 (282)
Q Consensus        74 ~~~l----~~l~H~n------i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~  143 (282)
                      ++-.    +.+.|-+      |.+++.           .-.....|+|||+.|..+.+.-...   ...++...+..-+.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~-----------~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~  310 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYW-----------DLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLV  310 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehh-----------hcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHH
Confidence            4332    2333444      333322           1235689999999998888754432   23366665555544


Q ss_pred             HHHHHHHHhhcCCCCCccccCCCCCcEEeec----CCCceeecccCccc
Q psy16951        144 KICEAVKVFHDAKPIAYAHRDLKTANVLLAN----DNNPLLMDLGSVAP  188 (282)
Q Consensus       144 qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~----~~~~~~~df~~~~~  188 (282)
                      +...  ..|-..   |.+|.|=.|.||++..    +..+.+.|||+...
T Consensus       311 ~~~~--~qIf~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  311 EAYL--EQIFKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             HHHH--HHHHhc---CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            4432  223333   7889999999999984    56778999997653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.53  E-value=0.00091  Score=54.69  Aligned_cols=81  Identities=15%  Similarity=0.193  Sum_probs=53.2

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCCceEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      ++.|+.|..+.||......  ..+++|.....  .......+|..+++.+....  +.+++.....      .......+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~------~~~~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS------DEFNGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE------TEETSEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc------ccccccce
Confidence            5789999999999999855  48889975332  44556677888888775332  3344432111      11123478


Q ss_pred             EEeccCCCCChHH
Q psy16951        109 MVLPYYPKGTLAN  121 (282)
Q Consensus       109 lv~e~~~~~sL~~  121 (282)
                      ++++++++.++..
T Consensus        72 ~~~~~i~g~~~~~   84 (239)
T PF01636_consen   72 LLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEEEESSEEHHH
T ss_pred             EEEEEeccccccc
Confidence            9999998887776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.51  E-value=0.0013  Score=54.04  Aligned_cols=136  Identities=18%  Similarity=0.209  Sum_probs=83.5

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHH------------------------HHHHHHHHhhhCCCCCcc
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA------------------------QAIREVEHHKTFVHPNIL   86 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~------------------------~~~~e~~~l~~l~H~ni~   86 (282)
                      ...|..|--+.||.|.. .++..+|+|+..........                        ....|+..|+++...+| 
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV-  130 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV-  130 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC-
Confidence            44678888889999987 56788999977543221111                        11235555555432221 


Q ss_pred             cccccccccCCCCCCCCCceEEEEeccCCCCChH-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         87 PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA-NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                      +..          ....-..-.|||||......- -.|.    . ..+...++..+..+++..+.-|-...  ++||.||
T Consensus       131 rvP----------~Pi~~~~nVLvMEfIg~~g~pAP~Lk----D-v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDL  193 (268)
T COG1718         131 RVP----------EPIAFRNNVLVMEFIGDDGLPAPRLK----D-VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDL  193 (268)
T ss_pred             CCC----------CceeecCCeEEEEeccCCCCCCCCcc----c-CCcCchhHHHHHHHHHHHHHHHHHhc--Ccccccc
Confidence            111          111123467999998543211 1111    1 11223356667778888887666622  8999999


Q ss_pred             CCCcEEeecCCCceeecccCc
Q psy16951        166 KTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~  186 (282)
                      +.=|||+. ++.+.++|++-+
T Consensus       194 SEyNiL~~-~~~p~iID~~Qa  213 (268)
T COG1718         194 SEYNILVH-DGEPYIIDVSQA  213 (268)
T ss_pred             hhhheEEE-CCeEEEEECccc
Confidence            99999998 999999999944

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.46  E-value=0.0013  Score=54.57  Aligned_cols=76  Identities=17%  Similarity=0.168  Sum_probs=45.1

Q ss_pred             EEeccCCc-eEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGF-STVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +.|-.|.+ +.||+....  +..+.+|......   .....+|+++++.+. +--+.+++...         ......++
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~---------~~~~~~~l   69 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYG---------SDDGRAWL   69 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEE---------ecCCccEE
Confidence            34555555 788998763  3567778654322   234556788777763 32233444321         12245788


Q ss_pred             EeccCCCCChHH
Q psy16951        110 VLPYYPKGTLAN  121 (282)
Q Consensus       110 v~e~~~~~sL~~  121 (282)
                      +||+.++.++..
T Consensus        70 v~e~i~G~~l~~   81 (244)
T cd05150          70 LTSAVPGVPAAA   81 (244)
T ss_pred             EEEeeCCccHhH
Confidence            999998877664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.31  E-value=0.0031  Score=50.68  Aligned_cols=130  Identities=18%  Similarity=0.263  Sum_probs=79.5

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCC----------------chhHHHHHHHHHHhhhCC------CCCccccc
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG----------------REDQAQAIREVEHHKTFV------HPNILPLL   89 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~----------------~~~~~~~~~e~~~l~~l~------H~ni~~~~   89 (282)
                      ..||+|+.-.||.--...   ...||++....                .....+..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            358999999888533322   24688776554                111234456666555554      67788888


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCC--CC----ChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccc
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYP--KG----TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR  163 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~--~~----sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~  163 (282)
                      |         +.++....-+|+|...  +|    ||.+++.     ...++. .....+.++   ..|+-+.   +|+.+
T Consensus        84 G---------~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~---~Iv~~  142 (199)
T PF10707_consen   84 G---------FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDH---HIVIR  142 (199)
T ss_pred             E---------EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHc---CCeec
Confidence            7         4555667788888743  33    4555442     122444 333333333   4666666   68899


Q ss_pred             CCCCCcEEeecCC----Cceeec-ccC
Q psy16951        164 DLKTANVLLANDN----NPLLMD-LGS  185 (282)
Q Consensus       164 dlk~~nil~~~~~----~~~~~d-f~~  185 (282)
                      |++|+||++....    .+.++| ||.
T Consensus       143 dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  143 DLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             CCCcccEEEEecCCCceEEEEEeCCCC
Confidence            9999999996543    456777 663

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.22  E-value=0.001  Score=53.08  Aligned_cols=101  Identities=17%  Similarity=0.097  Sum_probs=73.6

Q ss_pred             HHHHHhhhCCC-CCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q psy16951         72 REVEHHKTFVH-PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK  150 (282)
Q Consensus        72 ~e~~~l~~l~H-~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~  150 (282)
                      +|..+++.+++ +++++++|.+             ..+++.|+...+++.+.... ...-...++.....++.+++..+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C-------------G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC-------------GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC-------------CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHH
Confidence            47788888876 6888998854             34678899876655321000 000112578889999999999999


Q ss_pred             HhhcCCCCCccccCCCCCcEEeecCCCceeecccCc
Q psy16951        151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       151 ~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      +++....=.+.-.|++++|+.+..++++|+.|....
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence            999854313556999999999999999999998854

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.08  E-value=0.0059  Score=50.43  Aligned_cols=29  Identities=24%  Similarity=0.527  Sum_probs=23.8

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|+|+.+.|++++.++..-++||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            58999999999999865445699999654

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.08  E-value=0.0065  Score=48.69  Aligned_cols=134  Identities=19%  Similarity=0.188  Sum_probs=86.2

Q ss_pred             cccEEEEEEeccCCc-eEEEEEEecCCCceEEEEEe---ccCCch------------------hHHHHHHHHHHhhhCC-
Q psy16951         25 SDKYYIVEKIGEGGF-STVSLIEHSQTKKRYALKKI---ICHGRE------------------DQAQAIREVEHHKTFV-   81 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~i---~~~~~~------------------~~~~~~~e~~~l~~l~-   81 (282)
                      .++++.++-||.|.- |.||+++.  .|..+|+|..   ...+..                  ....|..|.....+|+ 
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            389999999999999 99999999  6679999972   211111                  0113556777666664 


Q ss_pred             --CCCc--ccccccccccCCC---------CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q psy16951         82 --HPNI--LPLLDHALTGCAD---------PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA  148 (282)
Q Consensus        82 --H~ni--~~~~~~~~~~~~~---------~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~  148 (282)
                        +.+.  ++.+|+..-....         ........+.||.|+.+...             .+...++    .+++.-
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~----~~~~~d  176 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDI----PQMLRD  176 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHH----HHHHHH
Confidence              3444  6666655322000         00122344667888765433             1222333    456677


Q ss_pred             HHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       149 l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      +..+|..   ||+-+|+++.|..     .-+++|||.
T Consensus       177 l~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~  205 (207)
T PF13095_consen  177 LKILHKL---GIVPRDVKPRNYR-----GGKLVDFSS  205 (207)
T ss_pred             HHHHHHC---CeeeccCcccccc-----CCEEEeccc
Confidence            7889998   8999999999975     347889884

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.78  E-value=0.021  Score=48.86  Aligned_cols=149  Identities=13%  Similarity=0.089  Sum_probs=78.7

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCCceEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      ++.+..|....+|+....  +..+++|....   ........|++++..+.+.+  +.+.+.. ..+  .......+..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~-~~g--~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIAD-RDG--EYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccC-CCC--cEeeeeCCceE
Confidence            567888888899988653  34688887643   23344556777777774332  3333221 011  11112234568


Q ss_pred             EEeccCCCCChHH--------------HHHHHHhcCC------CC-CHHHH----------HHHHHHHHHHHHHhhc---
Q psy16951        109 MVLPYYPKGTLAN--------------DLELRSVGKH------YM-SSVDI----------LKMFLKICEAVKVFHD---  154 (282)
Q Consensus       109 lv~e~~~~~sL~~--------------~l~~~~~~~~------~l-~~~~~----------~~~~~qi~~~l~~lH~---  154 (282)
                      .++++++|.++..              .++.......      .. .+...          ......+...+.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            8999998766421              0111110000      00 00000          0011112233333332   


Q ss_pred             -CCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        155 -AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       155 -~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                       ..+.+++|+|+.|.|++++.++.+.+.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence             112269999999999999887666799998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.75  E-value=0.0072  Score=50.59  Aligned_cols=30  Identities=20%  Similarity=0.252  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                      .++|+|+.|.||+++.++ +.++||+.+...
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            589999999999998766 789999876543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=96.74  E-value=0.025  Score=48.97  Aligned_cols=29  Identities=28%  Similarity=0.295  Sum_probs=24.3

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|+|+.|.||+++.+...-++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            79999999999999865445699999654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.67  E-value=0.045  Score=44.99  Aligned_cols=75  Identities=13%  Similarity=0.153  Sum_probs=44.1

Q ss_pred             EEEeccCCceEEEEEEecC-CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC-cccccccccccCCCCCCCCCceEE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN-ILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n-i~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      ++.|..|-.+.+|+..... .+..|++|..... ........+|+.+++.+...+ .++++..         ..    -.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~---------~~----~~   68 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYAT---------FQ----NG   68 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEE---------eC----Cc
Confidence            5678889999999987643 3567888855322 111122236777777774333 3333321         01    13


Q ss_pred             EEeccCCCCCh
Q psy16951        109 MVLPYYPKGTL  119 (282)
Q Consensus       109 lv~e~~~~~sL  119 (282)
                      +++||+++.++
T Consensus        69 ~l~e~i~G~~l   79 (235)
T cd05157          69 LIYEFIPGRTL   79 (235)
T ss_pred             EEEEeeCCCcC
Confidence            78999887665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.62  E-value=0.088  Score=47.02  Aligned_cols=77  Identities=16%  Similarity=0.149  Sum_probs=50.0

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccC----C---chhHHHHHHHHHHhhhCC---CCCcccccccccccCCCCC
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICH----G---REDQAQAIREVEHHKTFV---HPNILPLLDHALTGCADPV  100 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~----~---~~~~~~~~~e~~~l~~l~---H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+.||.|.++.||++.....+..|+||+-...    +   .........|.+.|+.+.   -..+++++.+         
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---------  101 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY---------  101 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE---------
Confidence            56799999999999998644468999974311    1   123445566788777753   2345555542         


Q ss_pred             CCCCceEEEEeccCCCCC
Q psy16951        101 LNSTSQVLMVLPYYPKGT  118 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~s  118 (282)
                        +....++|||++++..
T Consensus       102 --D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 --DEELAVTVMEDLSDHK  117 (401)
T ss_pred             --CCCCCEEEEecCCCcc
Confidence              2244679999887543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.58  E-value=0.065  Score=46.17  Aligned_cols=153  Identities=12%  Similarity=0.093  Sum_probs=78.3

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCCc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ..-+..++.|....+|+.... ++ .+++|......  .......|.+++..+....  +.+.+... .+.  ......+
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~-~g~--~~~~~~g   96 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR-DGR--QLSTLAG   96 (307)
T ss_pred             ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC-CCC--eehhcCC
Confidence            444667788888899988752 33 57788654321  1233345666666664222  33333211 111  0111235


Q ss_pred             eEEEEeccCCCCChH----H----------HHHHHHhcC--C-----CCCH-HHHH------------HHHHHHHHHHHH
Q psy16951        106 QVLMVLPYYPKGTLA----N----------DLELRSVGK--H-----YMSS-VDIL------------KMFLKICEAVKV  151 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~----~----------~l~~~~~~~--~-----~l~~-~~~~------------~~~~qi~~~l~~  151 (282)
                      ..++++++++|.++.    .          .++.....-  .     .... ....            .....+...+.+
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999998775432    0          011111100  0     0000 0000            001112233444


Q ss_pred             hhc----CCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        152 FHD----AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       152 lH~----~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +..    ..+.+++|+|+.+.|++++.++...++||+.+.
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            432    112379999999999999887766799999653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035|consensus

Probab=96.49  E-value=0.0043  Score=61.06  Aligned_cols=157  Identities=16%  Similarity=0.143  Sum_probs=95.8

Q ss_pred             HHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q psy16951         70 AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV  149 (282)
Q Consensus        70 ~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l  149 (282)
                      ...|.+.+.+..|+|+..++.+.+..-    . ......+..++|...++...+..    ...++...++.+..++..|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~----~-~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERL----F-RGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhh----c-chHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhH
Confidence            345777788999999999988765421    1 11123344578888888877763    34578889999999999999


Q ss_pred             HHhhcCCCCCccccCCCCC---cEEeecCCCceee--cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc
Q psy16951        150 KVFHDAKPIAYAHRDLKTA---NVLLANDNNPLLM--DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS  224 (282)
Q Consensus       150 ~~lH~~~~~~i~H~dlk~~---nil~~~~~~~~~~--df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~  224 (282)
                      .++|+..   +.|.-+.-+   +--.+..+.+..+  ||+........          ........+..+.++|......
T Consensus       300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~----------~~~~~~~~~~~~~~~e~~~~~~  366 (1351)
T KOG1035|consen  300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN----------EKSFSDLLAEIRNADEDLKENT  366 (1351)
T ss_pred             HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCc----------ccchhhcCcccccccccccccc
Confidence            9999973   334333333   2222333344433  55543321110          0111122244477788776554


Q ss_pred             ccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        225 YCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       225 ~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      . ..+...|+|.+|..+..+..+..
T Consensus       367 ~-~~~r~~dL~~lgll~~~~~~~~~  390 (1351)
T KOG1035|consen  367 A-KKSRLTDLWCLGLLLLQLSQGED  390 (1351)
T ss_pred             c-hhhhhhHHHHHHHHHhhhhhcCc
Confidence            3 12445799999999888877753

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.25  E-value=0.071  Score=45.70  Aligned_cols=31  Identities=29%  Similarity=0.562  Sum_probs=26.5

Q ss_pred             CCccccCCCCCcEEeecC----CCceeecccCccc
Q psy16951        158 IAYAHRDLKTANVLLAND----NNPLLMDLGSVAP  188 (282)
Q Consensus       158 ~~i~H~dlk~~nil~~~~----~~~~~~df~~~~~  188 (282)
                      ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            379999999999999874    7899999997643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826|consensus

Probab=96.14  E-value=0.0012  Score=66.66  Aligned_cols=164  Identities=13%  Similarity=-0.000  Sum_probs=108.0

Q ss_pred             HHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q psy16951         70 AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV  149 (282)
Q Consensus        70 ~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l  149 (282)
                      ...|..-.+...|+++......-.       .......+..++++..|.+.+.+........++...-+.....+.....
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~-------ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIP-------PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCC-------CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence            344555556677888876654211       1123557888999999999998876654444444443333333336666


Q ss_pred             HHhhcCCCC--CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccC
Q psy16951        150 KVFHDAKPI--AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCV  227 (282)
Q Consensus       150 ~~lH~~~~~--~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~  227 (282)
                      .-+|....+  -.+|++||+-|.++..+..+++.++|+.+.         ............+++.|+.|+......+  
T Consensus      1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI---------knp~~sf~Gl~l~sp~~v~qli~N~ik~-- 1417 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI---------KNPVLSFFGLELCSPIYVLQLIKNEIKF-- 1417 (2724)
T ss_pred             chhhhcccCCccchhhhhhhhccceecCCcccccccccccc---------cCchHhhhhhhhCCHHHHHHHHHHHHhh--
Confidence            666655422  267999999999999999999999997541         1111112233445666777777655554  


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        228 VDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       228 ~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                       +.++|+|..|+-+|+..-|..+|.
T Consensus      1418 -t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1418 -TKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             -hhHHHHHHHHHHHHHHhcccHHHH
Confidence             666999999999999988887763

>PLN02876 acyl-CoA dehydrogenase

Probab=95.99  E-value=0.068  Score=52.59  Aligned_cols=84  Identities=17%  Similarity=0.226  Sum_probs=53.7

Q ss_pred             EEEEeccCCceEEEEEEecCCC--ceEEEEEeccCCc-hhHHHHHHHHHHhhhCC-CCCc--ccccccccccCCCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTK--KRYALKKIICHGR-EDQAQAIREVEHHKTFV-HPNI--LPLLDHALTGCADPVLNS  103 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~-H~ni--~~~~~~~~~~~~~~~~~~  103 (282)
                      .++.++.|.++.+|.......+  ..+++|+...... .....+.+|.++++.+. |+++  .+++..+-..      ..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~------~v  115 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA------SV  115 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC------Cc
Confidence            3678999999999998775432  4677776543321 23346778999999985 6665  4444322110      01


Q ss_pred             CceEEEEeccCCCCCh
Q psy16951        104 TSQVLMVLPYYPKGTL  119 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL  119 (282)
                      ....++|||++++..+
T Consensus       116 ~G~~flVME~v~G~~~  131 (822)
T PLN02876        116 IGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCCceEEEEecCCccc
Confidence            1347899999987654

>PLN02236 choline kinase

Probab=95.48  E-value=0.16  Score=44.63  Aligned_cols=30  Identities=17%  Similarity=0.399  Sum_probs=25.4

Q ss_pred             CccccCCCCCcEEeec-CCCceeecccCccc
Q psy16951        159 AYAHRDLKTANVLLAN-DNNPLLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~-~~~~~~~df~~~~~  188 (282)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986 46789999997653

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.23  E-value=0.22  Score=42.73  Aligned_cols=27  Identities=26%  Similarity=0.544  Sum_probs=23.7

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSV  186 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~  186 (282)
                      +++|+|+.+.|++++. +.+.++||+.+
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            7899999999999987 67789999954

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2268|consensus

Probab=95.22  E-value=0.02  Score=49.28  Aligned_cols=131  Identities=12%  Similarity=0.170  Sum_probs=83.0

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEe-----ccCCch-----------------hHHHHHHHHHHhhhCC-CC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-----ICHGRE-----------------DQAQAIREVEHHKTFV-HP   83 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i-----~~~~~~-----------------~~~~~~~e~~~l~~l~-H~   83 (282)
                      -+.+.++||-|-=+-||.+.+ +.|.+.++|.=     ...+.+                 .+-...+|+..|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            455778999999999999988 45677777721     111111                 1123456888888774 22


Q ss_pred             -CcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccc
Q psy16951         84 -NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAH  162 (282)
Q Consensus        84 -ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H  162 (282)
                       -+.+-+             +-..-++|||+..+..|...-.       ....+.+..   .+..-+.-|...   |++|
T Consensus       172 fpVPkpi-------------D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~---~lm~~Iv~la~~---GlIH  225 (465)
T KOG2268|consen  172 FPVPKPI-------------DHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYD---DLMGLIVRLANH---GLIH  225 (465)
T ss_pred             CCCCCcc-------------cccceeeHHHhhcccceeeeee-------cCChHHHHH---HHHHHHHHHHHc---Ccee
Confidence             122222             2356789999998888765221       122233222   222223334444   8999


Q ss_pred             cCCCCCcEEeecCCCceeeccc
Q psy16951        163 RDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       163 ~dlk~~nil~~~~~~~~~~df~  184 (282)
                      +|.+-=||+++.+++++++||-
T Consensus       226 gDFNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             cccchheeEEecCCCEEEeech
Confidence            9999999999999999999996

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=94.79  E-value=0.52  Score=41.52  Aligned_cols=74  Identities=14%  Similarity=0.156  Sum_probs=45.2

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEec----cCC---chhHHHHHHHHHHhhhCC--CC-CcccccccccccCCCCCCC
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKII----CHG---REDQAQAIREVEHHKTFV--HP-NILPLLDHALTGCADPVLN  102 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~----~~~---~~~~~~~~~e~~~l~~l~--H~-ni~~~~~~~~~~~~~~~~~  102 (282)
                      .||-|....||++.....+..|+||+-.    ..+   +....+..-|.+.|+...  -| .+++++.+           
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-----------   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-----------   70 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-----------
Confidence            5799999999999985444679999642    111   222334445777776653  23 34444432           


Q ss_pred             CCceEEEEeccCCCC
Q psy16951        103 STSQVLMVLPYYPKG  117 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~  117 (282)
                      +.....++||+++..
T Consensus        71 D~e~~~~vMEdL~~~   85 (370)
T TIGR01767        71 DTEMAVTVMEDLSHH   85 (370)
T ss_pred             ccccceehHhhCccc
Confidence            335567888887543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK10593 hypothetical protein; Provisional

Probab=94.62  E-value=0.26  Score=42.26  Aligned_cols=110  Identities=13%  Similarity=0.025  Sum_probs=64.1

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC---CCcccccccccccCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH---PNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H---~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...-.+.||.|..+.||...... + ++.+|.. .. ......+..|.+.++.+.-   ..+.++++.+-.      ...
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~------~~~   84 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMA-RS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH------EQS   84 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC-C-CEEEEEe-cc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEecc------CCc
Confidence            44456789999999999987532 3 4556643 22 1233567788888887743   234455542211      112


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      .+..++|||++.+.++.+.         .........+..+++.++.-||+.
T Consensus        85 ~g~~~LVmE~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         85 PGPDVLLLERLRGVSVEAP---------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CCCeEEEEeccCCEecCCC---------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            3558999999988776530         012222334445555666666654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.52  E-value=0.21  Score=40.78  Aligned_cols=100  Identities=17%  Similarity=0.096  Sum_probs=61.6

Q ss_pred             EEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCC
Q psy16951         54 YALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY  132 (282)
Q Consensus        54 vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~  132 (282)
                      ..+|+++..... ...-+.++..++.++.  .|+++..           -....+-++.|.|-.....-           
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N-----------Dn~~~yGvIlE~Cy~~~i~~-----------  143 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN-----------DNNYKYGVILERCYKIKINF-----------  143 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec-----------CCCceeEEEEeeccCcccch-----------
Confidence            356666432222 3334456667766665  5666653           02345778889884322210           


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       133 l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                            ..++.-=+..|.-.|+... +.+|+|..|+||+-+..|.+|+.|=+
T Consensus       144 ------~N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  144 ------SNFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             ------hHHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChh
Confidence                  1111111356778886555 78999999999999999999998854

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.34  E-value=0.46  Score=41.43  Aligned_cols=30  Identities=23%  Similarity=0.449  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEeec-CCCceeecccCccc
Q psy16951        159 AYAHRDLKTANVLLAN-DNNPLLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~-~~~~~~~df~~~~~  188 (282)
                      -.+|.|+.+.||++.. ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999975 57899999997654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.19  E-value=0.75  Score=39.03  Aligned_cols=30  Identities=23%  Similarity=0.366  Sum_probs=24.3

Q ss_pred             CccccCCCCCcEEeecCCCc-eeecccCccc
Q psy16951        159 AYAHRDLKTANVLLANDNNP-LLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~-~~~df~~~~~  188 (282)
                      .++|+|+.|.|++++.++.+ -+.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            48999999999999875654 4999996543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.01  E-value=0.83  Score=39.36  Aligned_cols=29  Identities=10%  Similarity=0.275  Sum_probs=26.1

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|+|+.++|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999988888999998654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1033|consensus

Probab=92.98  E-value=0.015  Score=52.38  Aligned_cols=73  Identities=25%  Similarity=0.434  Sum_probs=59.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .++|+....+|.|+||+|+.+.....+..+|||+|...+.. ......+|+..+..+.|++++.++..|..+..
T Consensus        48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~~  121 (516)
T KOG1033|consen   48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERPP  121 (516)
T ss_pred             hccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCCC
Confidence            56788889999999999999998877888999999765544 34466788888999999999999887765433

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.79  E-value=4.1  Score=35.53  Aligned_cols=27  Identities=30%  Similarity=0.532  Sum_probs=23.7

Q ss_pred             ccccCCCCCcEEeecCCC-ceeecccCc
Q psy16951        160 YAHRDLKTANVLLANDNN-PLLMDLGSV  186 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~-~~~~df~~~  186 (282)
                      ++|.|+.|+|++++.+.. +.+.||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            899999999999988875 779999954

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=91.32  E-value=2.5  Score=34.96  Aligned_cols=78  Identities=19%  Similarity=0.287  Sum_probs=43.6

Q ss_pred             EEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC---cccccccccccCCCCCCCCCc
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN---ILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n---i~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +..+.+--|.-.+.|...+  ...++-+|.   +.......|..|+.-|.-+.-.|   +.+++.         +-.+..
T Consensus        19 ~er~~v~gG~inea~~v~d--g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~---------~G~~~~   84 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD--GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIA---------VGASRD   84 (286)
T ss_pred             hcccccCCccccceeEeec--CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEE---------ecCCCC
Confidence            3344454554444455444  234566663   23444556666776665554333   334433         233567


Q ss_pred             eEEEEeccCCCCChH
Q psy16951        106 QVLMVLPYYPKGTLA  120 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~  120 (282)
                      ..++|+||++-+.+.
T Consensus        85 ~sylVle~L~~~~~d   99 (286)
T COG3001          85 HSYLVLEYLPTGPLD   99 (286)
T ss_pred             eeEEEEeeccCCCCC
Confidence            899999999876665

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.29  E-value=0.49  Score=41.62  Aligned_cols=71  Identities=17%  Similarity=0.271  Sum_probs=47.2

Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      .+.|+++++. ++++.. +       ......+++.++.+.+..+.-+ +.+. ..=||++.-.||+++ +|++.++||.
T Consensus       299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~l-ekkf-~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDIL-EKKF-PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhh-hhcC-Ccccccccccceeee-cCceEEEEee
Confidence            4455666655 555432 1       1234566777777665444333 3333 577999999999999 9999999999


Q ss_pred             Ccc
Q psy16951        185 SVA  187 (282)
Q Consensus       185 ~~~  187 (282)
                      +++
T Consensus       367 lsR  369 (488)
T COG5072         367 LSR  369 (488)
T ss_pred             eee
Confidence            765

>KOG1236|consensus

Probab=91.15  E-value=1.2  Score=39.82  Aligned_cols=63  Identities=17%  Similarity=0.202  Sum_probs=35.8

Q ss_pred             EEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951        107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV-KVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus       107 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l-~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                      ..++-+|..+-++..++...     ..++.....++.=.+.|+ +.+--.   +.+|.|+.|.||++..+.+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlirf~~t  383 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIRFNKT  383 (565)
T ss_pred             ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEEecCC
Confidence            44556677787887766522     123323333322222232 233333   6899999999999865444

>KOG2270|consensus

Probab=90.68  E-value=2.8  Score=37.17  Aligned_cols=134  Identities=16%  Similarity=0.257  Sum_probs=78.8

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccC-----Cch-----------------hHH----HHHHHHHHhhhCCCCCc
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICH-----GRE-----------------DQA----QAIREVEHHKTFVHPNI   85 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-----~~~-----------------~~~----~~~~e~~~l~~l~H~ni   85 (282)
                      ..|..|-=+-||-|.. .+|..+|||+.+-+     ...                 .+.    ....|+.-+.+++...|
T Consensus       150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4566777788998776 57788999966321     100                 011    12346666666654443


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChH-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA-NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                      .-         +.|.  -...-.|||+|+....-. -.|     ....++...+..+-.|++.-+.-|-+..  ++||.|
T Consensus       229 P~---------PePI--lLk~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHAD  290 (520)
T KOG2270|consen  229 PC---------PEPI--LLKNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHAD  290 (520)
T ss_pred             CC---------CCce--eeecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccc
Confidence            21         1111  113467999998532211 111     1123555566666666666665544433  799999


Q ss_pred             CCCCcEEeecCCCceeecccC
Q psy16951        165 LKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       165 lk~~nil~~~~~~~~~~df~~  185 (282)
                      |.==|+|. .+|.+.++|.+-
T Consensus       291 LSEfN~Ly-hdG~lyiIDVSQ  310 (520)
T KOG2270|consen  291 LSEFNLLY-HDGKLYIIDVSQ  310 (520)
T ss_pred             hhhhhheE-ECCEEEEEEccc
Confidence            99999887 578888888773

>PRK11768 serine/threonine protein kinase; Provisional

Probab=90.48  E-value=5.7  Score=34.51  Aligned_cols=27  Identities=30%  Similarity=0.470  Sum_probs=22.7

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      +++|+|+.+.||++. + .+.++||+-+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            689999999999994 4 67899999543

>PTZ00384 choline kinase; Provisional

Probab=90.15  E-value=3  Score=37.25  Aligned_cols=28  Identities=21%  Similarity=0.345  Sum_probs=23.5

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      ..+|.|+-+.||+.. ++.+.++||..+.
T Consensus       228 VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEec-CCCEEEEEecccc
Confidence            689999999999864 5668999998664

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=89.89  E-value=3.4  Score=35.34  Aligned_cols=76  Identities=12%  Similarity=0.171  Sum_probs=40.5

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC---CCCcccccccccccCCCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV---HPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~---H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+-.+.++-|....+|+..  .++..+-+|.-.   ......+..|.+-|+.|.   --.+.+.+...-         ..
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~---------~~   84 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGE---------YD   84 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----------S
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe---------ec
Confidence            4456779999999999888  467788888654   333345666777666663   233445554221         12


Q ss_pred             ceEEEEeccCCCC
Q psy16951        105 SQVLMVLPYYPKG  117 (282)
Q Consensus       105 ~~~~lv~e~~~~~  117 (282)
                      ...+|++|+++.+
T Consensus        85 ~~~fLlle~l~~~   97 (288)
T PF03881_consen   85 DDAFLLLEFLEMG   97 (288)
T ss_dssp             SCCEEEEE-----
T ss_pred             CCceEEEEeecCC
Confidence            3358999998655

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=89.28  E-value=1.1  Score=39.19  Aligned_cols=38  Identities=24%  Similarity=0.381  Sum_probs=26.3

Q ss_pred             HHHHHHHHHHHHHHHHHhh-----cCCCCCccccCCCCCcEEeecCC
Q psy16951        135 SVDILKMFLKICEAVKVFH-----DAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus       135 ~~~~~~~~~qi~~~l~~lH-----~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                      ..-++.++.|++  |.|+-     .+.  +.+|-||||+|||+-...
T Consensus       274 ~~YvkfifLQia--LLyikIYelp~c~--nF~H~DLKPdNILiFds~  316 (434)
T PF05445_consen  274 VEYVKFIFLQIA--LLYIKIYELPCCT--NFLHVDLKPDNILIFDSK  316 (434)
T ss_pred             HHHHHHHHHHHH--HHHeeeecCCCcc--eeeecccCcCcEEEecCC
Confidence            345677778875  44422     233  689999999999986544

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PTZ00296 choline kinase; Provisional

Probab=88.76  E-value=5.5  Score=36.33  Aligned_cols=28  Identities=21%  Similarity=0.427  Sum_probs=23.4

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      .++|.|+-+.||+.. ++.++++||..+.
T Consensus       285 VfCHNDl~~~NiL~~-~~~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINT-NKCLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeec-CCCEEEEeecccc
Confidence            589999999999875 4459999999664

>PHA03111 Ser/Thr kinase; Provisional

Probab=88.20  E-value=2  Score=37.40  Aligned_cols=40  Identities=25%  Similarity=0.308  Sum_probs=27.7

Q ss_pred             HHHHHHHHHHHHHHHHHh---hcCCCCCccccCCCCCcEEeecCC
Q psy16951        135 SVDILKMFLKICEAVKVF---HDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus       135 ~~~~~~~~~qi~~~l~~l---H~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                      ..-++.++.|++.-...+   -.+.  +.+|-||||+|||+-...
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~--nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCD--NFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcc--eeeeccCCCCcEEEecCC
Confidence            345777888886544333   2233  689999999999986554

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=86.66  E-value=0.34  Score=35.45  Aligned_cols=28  Identities=14%  Similarity=0.111  Sum_probs=24.1

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEec
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKII   60 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~   60 (282)
                      +.||.|+.|+||+|+.. +|.+||||...
T Consensus        17 ~PlasASiaQVh~a~l~-~g~~VaVKV~r   44 (119)
T PF03109_consen   17 EPLASASIAQVHRARLK-DGEEVAVKVQR   44 (119)
T ss_pred             chhhheehhhheeeeec-ccchhhhhhcc
Confidence            57999999999999985 48999999753

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=85.78  E-value=0.92  Score=36.62  Aligned_cols=29  Identities=28%  Similarity=0.570  Sum_probs=20.8

Q ss_pred             CccccCCCCCcEEe-ecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLL-ANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~-~~~~~~~~~df~~~~  187 (282)
                      .++|+|+.+.||++ ..++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 888999999999754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	282
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-61
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-04

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score =  231 bits (590), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 117/269 (43%), Positives = 173/269 (64%), Gaps = 15/269 (5%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED 66
           NL FQ         V + +  Y  ++K+GEGGFS V L+E       YALK+I+CH ++D
Sbjct: 16  NLYFQ------GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69
Query: 67  QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR 126
           + +A RE + H+ F HPNIL L+ + L         +  +  ++LP++ +GTL N++E  
Sbjct: 70  REEAQREADMHRLFNHPNILRLVAYCLR-----ERGAKHEAWLLLPFFKRGTLWNEIERL 124
Query: 127 SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV 186
               ++++   IL + L IC  ++  H AK   YAHRDLK  N+LL ++  P+LMDLGS+
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIH-AK--GYAHRDLKPTNILLGDEGQPVLMDLGSM 181
Query: 187 APAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
             A + V GS +A  LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM +
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 247 FKSPFDTVYERGDSVALAVISGNITFPEN 275
            + P+D V+++GDSVALAV    ++ P++
Sbjct: 242 GEGPYDMVFQKGDSVALAV-QNQLSIPQS 269

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 120/246 (48%), Gaps = 18/246 (7%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHA 92
           + EGGF+ V   +   + + YALK+++ +  E     I+EV   K    HPNI+     A
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 93  LTGCADPVLNSTSQV-LMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFLKICEAVK 150
             G  +   + T Q   ++L    KG L   L+ + S G   +S   +LK+F + C AV+
Sbjct: 96  SIGKEE---SDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRAVQ 150
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV--VKVCGSAEAQNLQDVAAE 208
             H  KP    HRDLK  N+LL+N     L D GS            SA+ + L +    
Sbjct: 151 HMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 209 RCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS 267
           R + P YR PE+  + S   + ++ D+W+LGC+LY +C+ + PF+      D   L +++
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE------DGAKLRIVN 263
Query: 268 GNITFP 273
           G  + P
Sbjct: 264 GKYSIP 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 125/266 (46%), Gaps = 37/266 (13%)
Query: 13  GCLCSKEAVYVKS-DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQ 69
           G     E +Y +S +KY  ++KIGEG F    L++ ++  ++Y +K+I       +++ +
Sbjct: 10  GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           + REV       HPNI+   +                + +V+ Y   G L   +  +   
Sbjct: 70  SRREVAVLANMKHPNIVQYRES---------FEENGSLYIVMDYCEGGDLFKRINAQ--- 117
Query: 130 KHYMSSVD-ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
           K  +   D IL  F++IC A+K  HD K +   HRD+K+ N+ L  D    L D G    
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDRKIL---HRDIKSQNIFLTKDGTVQLGDFG---- 170
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
            + +V  S       ++A      PY  +PE+     Y   + ++D+W+LGC+LY +C  
Sbjct: 171 -IARVLNST-----VELARACIGTPYYLSPEICENKPY---NNKSDIWALGCVLYELCTL 221
Query: 248 KSPFDTVYERGDSVALAVISGNITFP 273
           K  F+    +  ++ L +ISG  +FP
Sbjct: 222 KHAFEAGSMK--NLVLKIISG--SFP 243

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 105/253 (41%), Gaps = 54/253 (21%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-- 70
           G + S E  ++ +  Y +++ IG+G F+ V L  H  T +  A+K I      D+ Q   
Sbjct: 1   GAMGSDEQPHIGN--YRLLKTIGKGNFAKVKLARHILTGREVAIKII------DKTQLNP 52
Query: 71  ------IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
                  REV   K   HPNI+ L +         V+ +   + +++ Y   G + + L 
Sbjct: 53  TSLQKLFREVRIMKILNHPNIVKLFE---------VIETEKTLYLIMEYASGGEVFDYL- 102
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
              V    M   +    F +I  AV+  H  + +   HRDLK  N+LL  D N  + D G
Sbjct: 103 ---VAHGRMKEKEARSKFRQIVSAVQYCHQKRIV---HRDLKAENLLLDADMNIKIADFG 156
Query: 185 -----SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
                +V   +   CGS                PY APELF    Y       DVWSLG 
Sbjct: 157 FSNEFTVGGKLDTFCGSP---------------PYAAPELFQGKKYD--GPEVDVWSLGV 199
Query: 240 LLYAMCYFKSPFD 252
           +LY +     PFD
Sbjct: 200 ILYTLVSGSLPFD 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           Y IV+ +GEG F  V L  H+ T ++ ALK   K +    + Q +  RE+ + +   HP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V+ S  +++MV+ Y       N+L    V +  MS  +  + F +
Sbjct: 75  IIKLYD---------VIKSKDEIIMVIEY-----AGNELFDYIVQRDKMSEQEARRFFQQ 120
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  AV+  H  K +   HRDLK  N+LL    N  + D            G +      +
Sbjct: 121 IISAVEYCHRHKIV---HRDLKPENLLLDEHLNVKIADF-----------GLSNIMTDGN 166
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                C  P Y APE+     Y       DVWS G +LY M   + PFD
Sbjct: 167 FLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           Y IV+ +GEG F  V L  H+ T ++ ALK   K +    + Q +  RE+ + +   HP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V+ S  +++MV+ Y       N+L    V +  MS  +  + F +
Sbjct: 70  IIKLYD---------VIKSKDEIIMVIEY-----AGNELFDYIVQRDKMSEQEARRFFQQ 115
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  AV+  H  K +   HRDLK  N+LL    N  + D            G +      +
Sbjct: 116 IISAVEYCHRHKIV---HRDLKPENLLLDEHLNVKIADF-----------GLSNIMTDGN 161
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                C  P Y APE+     Y       DVWS G +LY M   + PFD
Sbjct: 162 FLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           Y IV+ +GEG F  V L  H+ T ++ ALK   K +    + Q +  RE+ + +   HP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V+ S  +++MV+ Y       N+L    V +  MS  +  + F +
Sbjct: 76  IIKLYD---------VIKSKDEIIMVIEY-----AGNELFDYIVQRDKMSEQEARRFFQQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  AV+  H  K +   HRDLK  N+LL    N  + D            G +      +
Sbjct: 122 IISAVEYCHRHKIV---HRDLKPENLLLDEHLNVKIADF-----------GLSNIMTDGN 167
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                C  P Y APE+     Y       DVWS G +LY M   + PFD
Sbjct: 168 FLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           Y IV+ +GEG F  V L  H+ T ++ ALK   K +    + Q +  RE+ + +   HP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V+ S  +++MV+ Y       N+L    V +  MS  +  + F +
Sbjct: 66  IIKLYD---------VIKSKDEIIMVIEY-----AGNELFDYIVQRDKMSEQEARRFFQQ 111
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  AV+  H  K +   HRDLK  N+LL    N  + D            G +      +
Sbjct: 112 IISAVEYCHRHKIV---HRDLKPENLLLDEHLNVKIADF-----------GLSNIMTDGN 157
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                C  P Y APE+     Y       DVWS G +LY M   + PFD
Sbjct: 158 FLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 104/250 (41%), Gaps = 54/250 (21%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA----- 70
           C+ E  ++ +  Y +++ IG+G F+ V L  H  T +  A+K I      D+ Q      
Sbjct: 7   CADEQPHIGN--YRLLKTIGKGNFAKVKLARHILTGREVAIKII------DKTQLNPTSL 58
Query: 71  ---IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS 127
               REV   K   HPNI+ L +         V+ +   + +++ Y   G + + L    
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFE---------VIETEKTLYLIMEYASGGEVFDYL---- 105
Query: 128 VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG--- 184
           V    M   +    F +I  AV+  H  + +   HRDLK  N+LL  D N  + D G   
Sbjct: 106 VAHGRMKEKEARSKFRQIVSAVQYCHQKRIV---HRDLKAENLLLDADMNIKIADFGFSN 162
Query: 185 --SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             +V   +   CG+                PY APELF    Y       DVWSLG +LY
Sbjct: 163 EFTVGGKLDAFCGAP---------------PYAAPELFQGKKYD--GPEVDVWSLGVILY 205
Query: 243 AMCYFKSPFD 252
            +     PFD
Sbjct: 206 TLVSGSLPFD 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A+ KII   + + +   +  REV   K   HPN
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V   +M   +    F +
Sbjct: 68  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGWMKEKEARAKFRQ 114
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CGS   
Sbjct: 115 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP-- 169
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 170 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 96/238 (40%), Gaps = 52/238 (21%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--------IREVEHHKT 79
           Y + + IG+G F+ V L  H  T +  A+K I      D+ Q          REV   K 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKII------DKTQLNPTSLQKLFREVRIMKI 70
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HPNI+ L +         V+ +   + +V+ Y   G + + L    V    M   +  
Sbjct: 71  LNHPNIVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEAR 117
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVC 194
             F +I  AV+  H    +   HRDLK  N+LL  D N  + D G     +V   +   C
Sbjct: 118 AKFRQIVSAVQYCHQKYIV---HRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           GS                PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 175 GSP---------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A+ KII   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V    M   +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CGS   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A+ KII   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V    M   +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CGS   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 99/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A++ II   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVR-IIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V    M   +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    + + CGS   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A++ II   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVR-IIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V    M   +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CGS   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A+ KII   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V+ Y   G + + L    V    M   +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CG+   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTF 80
           +++ Y ++  IG G +     I      K    K++  +G   +A+    + EV   +  
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLREL 62
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            HPNI+   D         +++ T+  L +V+ Y   G LA+ +   +  + Y+    +L
Sbjct: 63  KHPNIVRYYDR--------IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 140 KMFLKICEAVKVFHDAKPIAYA--HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           ++  ++  A+K  H      +   HRDLK ANV L    N  L D G     + ++    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG-----LARILNHD 169
Query: 198 EAQNLQDVAAERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           E     D A E    PY  +PE  +  SY   ++++D+WSLGCLLY +C    PF
Sbjct: 170 E-----DFAKEFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPF 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVHPN 84
           Y I E +GEG F  V L  H +T+++ ALK I   +    +   +  RE+ + K   HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V+ + + ++MV+  Y  G L + +    V K  M+  +  + F +
Sbjct: 71  IIKLYD---------VITTPTDIVMVIE-YAGGELFDYI----VEKKRMTEDEGRRFFQQ 116
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A++  H  K +   HRDLK  N+LL ++ N  + D            G +      +
Sbjct: 117 IICAIEYCHRHKIV---HRDLKPENLLLDDNLNVKIADF-----------GLSNIMTDGN 162
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                C  P Y APE+ +   Y       DVWS G +LY M   + PFD
Sbjct: 163 FLKTSCGSPNYAAPEVINGKLYA--GPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 96/233 (41%), Gaps = 42/233 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVHPN 84
           Y +++ IG+G F+ V L  H  T K  A+ KII   + + +   +  REV   K   HPN
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAV-KIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         V+ +   + +V  Y   G + + L    V        +    F +
Sbjct: 75  IVKLFE---------VIETEKTLYLVXEYASGGEVFDYL----VAHGRXKEKEARAKFRQ 121
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVCGSAEA 199
           I  AV+  H    +   HRDLK  N+LL  D N  + D G     +    +   CG+   
Sbjct: 122 IVSAVQYCHQKFIV---HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP-- 176
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        PY APELF    Y       DVWSLG +LY +     PFD
Sbjct: 177 -------------PYAAPELFQGKKYD--GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 42/282 (14%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHG 63
           NL FQ   +  + +  + SD+Y     +G+G F  V L +   T +  A+K   K     
Sbjct: 13  NLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 72
Query: 64  REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL 123
           + D+   +REV+  K   HPNI+ L +                  +V   Y  G L +++
Sbjct: 73  KTDKESLLREVQLLKQLDHPNIMKLYE---------FFEDKGYFYLVGEVYTGGELFDEI 123
Query: 124 ELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLL 180
               + +   S VD  ++  ++   +   H  K +   HRDLK  N+LL   + D N  +
Sbjct: 124 ----ISRKRFSEVDAARIIRQVLSGITYMHKNKIV---HRDLKPENLLLESKSKDANIRI 176
Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           +D G           S   +  + +  +  +  Y APE+ H       D++ DVWS G +
Sbjct: 177 IDFGL----------STHFEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVI 222
Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGNITFPENTPFPQYQ 282
           LY +     PF+   E    +   V  G  TF      PQ++
Sbjct: 223 LYILLSGCPPFNGANEY--DILKKVEKGKYTF----ELPQWK 258

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 109/261 (41%), Gaps = 44/261 (16%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPN 84
           + I +KIG G FS V            ALKK+      D   +A  I+E++  K   HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    +  +   D  LN      +VL     G L+  ++     K  +    + K F++
Sbjct: 94  VI---KYYASFIEDNELN------IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVAPAVVKVCGSAE 198
           +C A++  H  + +   HRD+K ANV +       L DLG      S   A   + G+  
Sbjct: 145 LCSALEHMHSRRVM---HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                          Y +PE  H + Y   + ++D+WSLGCLLY M   +SPF      G
Sbjct: 202 ---------------YMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPF-----YG 238
Query: 259 DSVALAVISGNITFPENTPFP 279
           D + L  +   I   +  P P
Sbjct: 239 DKMNLYSLCKKIEQCDYPPLP 259

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTF 80
           +++ Y ++  IG G +     I      K    K++  +G   +A+    + EV   +  
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLREL 62
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            HPNI+   D         +++ T+  L +V+ Y   G LA+ +   +  + Y+    +L
Sbjct: 63  KHPNIVRYYDR--------IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 140 KMFLKICEAVKVFHDAKPIAYA--HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           ++  ++  A+K  H      +   HRDLK ANV L    N  L D G     + ++    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG-----LARILNHD 169
Query: 198 EAQNLQDVAAERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +      A      PY  +PE  +  SY   ++++D+WSLGCLLY +C    PF
Sbjct: 170 TS-----FAKTFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTF 80
           +++ Y ++  IG G +     I      K    K++  +G   +A+    + EV   +  
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLREL 62
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            HPNI+   D         +++ T+  L +V+ Y   G LA+ +   +  + Y+    +L
Sbjct: 63  KHPNIVRYYDR--------IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 140 KMFLKICEAVKVFHDAKPIAYA--HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           ++  ++  A+K  H      +   HRDLK ANV L    N  L D G     + ++    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG-----LARILNHD 169
Query: 198 EAQNLQDVAAERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +      A      PY  +PE  +  SY   ++++D+WSLGCLLY +C    PF
Sbjct: 170 TS-----FAKAFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPF 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 26/241 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 71  HPAIVAVYD---TGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 121
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+     S     
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAIADSGNS----- 172
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF    +  DSV
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF--TGDSPDSV 227
Query: 262 A 262
           A
Sbjct: 228 A 228

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 71  HPAIVAVYD---TGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 121
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+     S     
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAIADSGNS----- 172
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 37/263 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFV 81
           +++Y IV+K+G GG STV L E +    + A+K I    RE +    +  REV +     
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H NI+ ++D         V        +V+ Y    TL+  +E      H   SVD    
Sbjct: 70  HQNIVSMID---------VDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAIN 115
Query: 142 FL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           F  +I + +K  HD + +   HRD+K  N+L+ ++    + D G +A A+ +   +    
Sbjct: 116 FTNQILDGIKHAHDMRIV---HRDIKPQNILIDSNKTLKIFDFG-IAKALSETSLTQTNH 171
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
            L        ++ Y +PE    ++    D+ TD++S+G +LY M   + PF+   E   S
Sbjct: 172 VL-------GTVQYFSPEQAKGEA---TDECTDIYSIGIVLYEMLVGEPPFNG--ETAVS 219
Query: 261 VALAVISG---NITFPENTPFPQ 280
           +A+  I     N+T       PQ
Sbjct: 220 IAIKHIQDSVPNVTTDVRKDIPQ 242

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 88  HPAIVAVYD---TGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 138
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+          +
Sbjct: 139 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAIAD-----SGNS 189
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 71  HPAIVAVYD---TGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 121
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+     S     
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAIADSGNS----- 172
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 42/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G + SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GAMESKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV A
Sbjct: 111 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 164 PSSRRTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 205
Query: 246 YFKSPFD 252
             K PF+
Sbjct: 206 VGKPPFE 212

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 107/247 (43%), Gaps = 42/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G + SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GAMESKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P+G +  +L+  S  
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPRGEVYKELQKLSKF 110
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV A
Sbjct: 111 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 164 PSSRRTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 205
Query: 246 YFKSPFD 252
             K PF+
Sbjct: 206 VGKPPFE 212

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 71  HPAIVAVYD---TGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 121
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN+L++  N   ++D G +A A+     S     
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANILISATNAVKVVDFG-IARAIADSGNS----- 172
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 36/236 (15%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-I 71
           G L S  A+ +K  K  +++ IG+G F  V L ++   K   A+K   C   +  AQA +
Sbjct: 1   GPLGSGWALNMKELK--LLQTIGKGEFGDVMLGDYRGNK--VAVK---CIKNDATAQAFL 53
Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
            E        H N++ LL          ++     + +V  Y  KG+L +   LRS G+ 
Sbjct: 54  AEASVMTQLRHSNLVQLLG--------VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRS 103
Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV 191
            +    +LK  L +CEA++         + HRDL   NVL++ DN   + D G       
Sbjct: 104 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL------ 154
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
               + EA + QD    +  + + APE     ++     ++DVWS G LL+ +  F
Sbjct: 155 ----TKEASSTQDTG--KLPVKWTAPEALREAAFST---KSDVWSFGILLWEIYSF 201

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 42/264 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFV 81
           SD+Y     +G+G F  V L +   T +  A+K   K     + D+   +REV+  K   
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L +                  +V   Y  G L +++    + +   S VD  ++
Sbjct: 109 HPNIMKLYE---------FFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARI 155
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLMDLGSVAPAVVKVCGSAE 198
             ++   +   H  K +   HRDLK  N+LL   + D N  ++D G           S  
Sbjct: 156 IRQVLSGITYMHKNKIV---HRDLKPENLLLESKSKDANIRIIDFGL----------STH 202
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
            +  + +  +  +  Y APE+ H       D++ DVWS G +LY +     PF+   E  
Sbjct: 203 FEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY- 257
Query: 259 DSVALAVISGNITFPENTPFPQYQ 282
             +   V  G  TF      PQ++
Sbjct: 258 -DILKKVEKGKYTF----ELPQWK 276

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 42/264 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFV 81
           SD+Y     +G+G F  V L +   T +  A+K   K     + D+   +REV+  K   
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L +                  +V   Y  G L +++    + +   S VD  ++
Sbjct: 108 HPNIMKLYE---------FFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARI 154
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLMDLGSVAPAVVKVCGSAE 198
             ++   +   H  K +   HRDLK  N+LL   + D N  ++D G           S  
Sbjct: 155 IRQVLSGITYMHKNKIV---HRDLKPENLLLESKSKDANIRIIDFGL----------STH 201
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
            +  + +  +  +  Y APE+ H       D++ DVWS G +LY +     PF+   E  
Sbjct: 202 FEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY- 256
Query: 259 DSVALAVISGNITFPENTPFPQYQ 282
             +   V  G  TF      PQ++
Sbjct: 257 -DILKKVEKGKYTF----ELPQWK 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 108/264 (40%), Gaps = 42/264 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFV 81
           SD+Y     +G+G F  V L +   T +  A+K   K     + D+   +REV+  K   
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L +                  +V   Y  G L +++    + +   S VD  ++
Sbjct: 85  HPNIMKLYE---------FFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARI 131
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLMDLGSVAPAVVKVCGSAE 198
             ++   +   H  K +   HRDLK  N+LL   + D N  ++D G           S  
Sbjct: 132 IRQVLSGITYMHKNKIV---HRDLKPENLLLESKSKDANIRIIDFGL----------STH 178
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
            +  + +  +  +  Y APE+ H       D++ DVWS G +LY +     PF+   E  
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY- 233
Query: 259 DSVALAVISGNITFPENTPFPQYQ 282
             +   V  G  TF      PQ++
Sbjct: 234 -DILKKVEKGKYTF----ELPQWK 252

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 42/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G   SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GSHMSKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV A
Sbjct: 111 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 164 PSSRRTDLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 205
Query: 246 YFKSPFD 252
             K PF+
Sbjct: 206 VGKPPFE 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 39/264 (14%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVH 82
           +KY+ +EKIGEG +  V   +++  +  +ALKKI    +ED+   +  IRE+   K   H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLE-KEDEGIPSTTIREISILKELKH 59
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDILKM 141
            NI+ L D         V+++  ++++V  +     L  DL +L  V +  + SV     
Sbjct: 60  SNIVKLYD---------VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSF 105
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            L++   +   HD + +   HRDLK  N+L+  +    + D G            A    
Sbjct: 106 LLQLLNGIAYCHDRRVL---HRDLKPQNLLINREGELKIADFG---------LARAFGIP 153
Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
           ++    E  ++ YRAP+ L     Y       D+WS+GC+   M      F  V E    
Sbjct: 154 VRKYTHEVVTLWYRAPDVLMGSKKYSTT---IDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 261 VALAVISG---NITFPENTPFPQY 281
           + +  I G   +  +P  T  P+Y
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKY 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 39/264 (14%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVH 82
           +KY+ +EKIGEG +  V   +++  +  +ALKKI    +ED+   +  IRE+   K   H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLE-KEDEGIPSTTIREISILKELKH 59
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDILKM 141
            NI+ L D         V+++  ++++V  +     L  DL +L  V +  + SV     
Sbjct: 60  SNIVKLYD---------VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSF 105
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            L++   +   HD + +   HRDLK  N+L+  +    + D G            A    
Sbjct: 106 LLQLLNGIAYCHDRRVL---HRDLKPQNLLINREGELKIADFG---------LARAFGIP 153
Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
           ++    E  ++ YRAP+ L     Y       D+WS+GC+   M      F  V E    
Sbjct: 154 VRKYTHEVVTLWYRAPDVLMGSKKYSTT---IDIWSVGCIFAEMVNGAPLFPGVSEADQL 210
Query: 261 VALAVISG---NITFPENTPFPQY 281
           + +  I G   +  +P  T  P+Y
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKY 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 39/264 (14%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFVH 82
           +KY+ +EKIGEG +  V   +++  +  +ALKKI    +ED+   +  IRE+   K   H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLE-KEDEGIPSTTIREISILKELKH 59
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDILKM 141
            NI+ L D         V+++  ++++V  +     L  DL +L  V +  + SV     
Sbjct: 60  SNIVKLYD---------VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSF 105
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            L++   +   HD + +   HRDLK  N+L+  +    + D G            A    
Sbjct: 106 LLQLLNGIAYCHDRRVL---HRDLKPQNLLINREGELKIADFG---------LARAFGIP 153
Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
           ++    E  ++ YRAP+ L     Y       D+WS+GC+   M      F  V E    
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTT---IDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 261 VALAVISG---NITFPENTPFPQY 281
           + +  I G   +  +P  T  P+Y
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKY 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y +V+ IG G F    L+   Q+ +  A+ K I  G +  A   RE+ +H++  HPN
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAV-KYIERGEKIAANVKREIINHRSLRHPN 76
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +V+ Y   G L      R       S  +    F +
Sbjct: 77  IVRFKEVILT---------PTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQ 123
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   V   H    +   HRDLK  N LL           GS AP  +K+C  G +++  L
Sbjct: 124 LISGVSYCH---AMQVCHRDLKLENTLLD----------GSPAPR-LKICDFGYSKSSVL 169
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                     P Y APE+     Y    +  DVWS G  LY M     PF+
Sbjct: 170 HSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIRE 73
           SK    VK   Y + + +G G F  V + EH  T  + A+K   +      +   +  RE
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-Y 132
           +++ K F HP+I+ L           V+++ +   MV+ Y   G L +      + KH  
Sbjct: 62  IQNLKLFRHPHIIKLYQ---------VISTPTDFFMVMEYVSGGELFD-----YICKHGR 107
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +  ++  ++F +I  AV   H    +   HRDLK  NVLL    N  + D G        
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVV---HRDLKPENVLLDAHMNAKIADFGLSNMM--- 161
Query: 193 VCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               ++ + L+D     C  P Y APE+  +          D+WS G +LYA+     PF
Sbjct: 162 ----SDGEFLRD----SCGSPNYAAPEV--ISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 252 D 252
           D
Sbjct: 212 D 212

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           + E +G G F  V   +     K  A+K+I      ++   I E+       HPNI+ L 
Sbjct: 13  VEEVVGRGAFGVVC--KAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLY 68
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                 C +PV        +V+ Y   G+L N L       +Y ++   +   L+  + V
Sbjct: 69  G----ACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWCLQCSQGV 116
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD-VAAE 208
              H  +P A  HRDLK  N+LL                 V+K+C    A ++Q  +   
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGT------------VLKICDFGTACDIQTHMTNN 164
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG 268
           + S  + APE+F   +Y    ++ DV+S G +L+ +   + PFD +      +  AV +G
Sbjct: 165 KGSAAWMAPEVFEGSNY---SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 221
Query: 269 N 269
Sbjct: 222 T 222

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           + E +G G F  V   +     K  A+K+I      ++   I E+       HPNI+ L 
Sbjct: 12  VEEVVGRGAFGVVC--KAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                 C +PV        +V+ Y   G+L N L       +Y ++   +   L+  + V
Sbjct: 68  G----ACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWCLQCSQGV 115
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD-VAAE 208
              H  +P A  HRDLK  N+LL                 V+K+C    A ++Q  +   
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGT------------VLKICDFGTACDIQTHMTNN 163
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG 268
           + S  + APE+F   +Y    ++ DV+S G +L+ +   + PFD +      +  AV +G
Sbjct: 164 KGSAAWMAPEVFEGSNY---SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 269 N 269
Sbjct: 221 T 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 38/240 (15%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           D Y   + +G G FS V L E  +T+K  A+K I     E +  ++  E+       HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L         D +  S   + +++     G L +    R V K + +  D  ++  +
Sbjct: 78  IVAL---------DDIYESGGHLYLIMQLVSGGELFD----RIVEKGFYTERDASRLIFQ 124
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVL---LANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           + +AVK  HD   +   HRDLK  N+L   L  D+  ++ D            G ++ ++
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDF-----------GLSKMED 170
Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              V +  C  P Y APE+     Y    +  D WS+G + Y +     PF   Y+  D+
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYS---KAVDCWSIGVIAYILLCGYPPF---YDENDA 224

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPL 88
           +++ IG+G F  V L ++   K   A+K   C   +  AQA + E        H N++ L
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNK--VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           L          ++     + +V  Y  KG+L +   LRS G+  +    +LK  L +CEA
Sbjct: 80  LG--------VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           ++         + HRDL   NVL++ DN   + D G           + EA + QD    
Sbjct: 130 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTG-- 174
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           +  + + APE      +     ++DVWS G LL+ +  F
Sbjct: 175 KLPVKWTAPEALREKKFST---KSDVWSFGILLWEIYSF 210

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPL 88
           +++ IG+G F  V L ++   K   A+K   C   +  AQA + E        H N++ L
Sbjct: 10  LLQTIGKGEFGDVMLGDYRGNK--VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           L          ++     + +V  Y  KG+L +   LRS G+  +    +LK  L +CEA
Sbjct: 65  LG--------VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           ++         + HRDL   NVL++ DN   + D G           + EA + QD    
Sbjct: 115 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTG-- 159
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           +  + + APE      +     ++DVWS G LL+ +  F
Sbjct: 160 KLPVKWTAPEALREKKFST---KSDVWSFGILLWEIYSF 195

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 71  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 120
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 121 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGT-- 172
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 173 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 43/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G + SK    +  + + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GAMGSKRQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 58
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 59  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKF 109
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV A
Sbjct: 110 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 162
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 163 PSSRRTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 204
Query: 246 YFKSPFD 252
             K PF+
Sbjct: 205 VGKPPFE 211

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 42/242 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVH 82
           D Y   + +G G FS V L E  +T+K  A+K   K    G+E   +    V H     H
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH--KIKH 75
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L         D +  S   + +++     G L +    R V K + +  D  ++ 
Sbjct: 76  PNIVAL---------DDIYESGGHLYLIMQLVSGGELFD----RIVEKGFYTERDASRLI 122
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVL---LANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            ++ +AVK  HD   +   HRDLK  N+L   L  D+  ++ D            G ++ 
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDF-----------GLSKM 168
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
           ++   V +  C  P Y APE+     Y    +  D WS+G + Y +     PF   Y+  
Sbjct: 169 EDPGSVLSTACGTPGYVAPEVLAQKPYS---KAVDCWSIGVIAYILLCGYPPF---YDEN 222
Query: 259 DS 260
           D+
Sbjct: 223 DA 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +   +  RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ +     TG A+        ++M    Y  G    D+ + + G   M+    +++
Sbjct: 71  HPAIVAVY---ATGEAETPAGPLPYIVM---EYVDGVTLRDI-VHTEGP--MTPKRAIEV 121
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+     S     
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAIADSGNS----- 172
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 38/240 (15%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           D Y   + +G G FS V L E  +T+K  A+K I     E +  ++  E+       HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L         D +  S   + +++     G L +    R V K + +  D  ++  +
Sbjct: 78  IVAL---------DDIYESGGHLYLIMQLVSGGELFD----RIVEKGFYTERDASRLIFQ 124
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVL---LANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           + +AVK  HD   +   HRDLK  N+L   L  D+  ++ D            G ++ ++
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDF-----------GLSKMED 170
Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              V +  C  P Y APE+     Y    +  D WS+G + Y +     PF   Y+  D+
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYS---KAVDCWSIGVIAYILLCGYPPF---YDENDA 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 38/240 (15%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           D Y   + +G G FS V L E  +T+K  A+K I     E +  ++  E+       HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L         D +  S   + +++     G L +    R V K + +  D  ++  +
Sbjct: 78  IVAL---------DDIYESGGHLYLIMQLVSGGELFD----RIVEKGFYTERDASRLIFQ 124
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVL---LANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           + +AVK  HD   +   HRDLK  N+L   L  D+  ++ D            G ++ ++
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDF-----------GLSKMED 170
Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              V +  C  P Y APE+     Y    +  D WS+G + Y +     PF   Y+  D+
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYS---KAVDCWSIGVIAYILLCGYPPF---YDENDA 224

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 33/235 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y +V+ IG G F    L+   Q+ +  A+ K I  G +      RE+ +H++  HPN
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAV-KYIERGEKIDENVKREIINHRSLRHPN 76
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +V+ Y   G L      R       S  +    F +
Sbjct: 77  IVRFKEVILT---------PTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQ 123
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   V   H    +   HRDLK  N LL           GS AP  +K+C  G +++  L
Sbjct: 124 LISGVSYCH---AMQVCHRDLKLENTLLD----------GSPAPR-LKICAFGYSKSSVL 169
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
                +    P Y APE+     Y    +  DVWS G  LY M     PF+   E
Sbjct: 170 HSQPKDTVGTPAYIAPEVLLKKEYD--GKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPL 88
           +++ IG+G F  V L ++   K   A+K   C   +  AQA + E        H N++ L
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           L          ++     + +V  Y  KG+L +   LRS G+  +    +LK  L +CEA
Sbjct: 252 LG--------VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           ++         + HRDL   NVL++ DN   + D G           + EA + QD    
Sbjct: 302 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTG-- 346
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
           +  + + APE      +     ++DVWS G LL+ +  F
Sbjct: 347 KLPVKWTAPEALREKKFST---KSDVWSFGILLWEIYSF 382

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 3   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 62  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 113 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 166 RTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 207
Query: 250 PFD 252
           PF+
Sbjct: 208 PFE 210

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
           +++Y IV  +G+G F  V   +   T++ YA+K I       +D +  +REVE  K   H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L +         +L  +S   +V   Y  G L +++    + +   S  D  ++ 
Sbjct: 81  PNIMKLFE---------ILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARII 127
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPLLMDLGSVAPAVVKVCGSAEA 199
            ++   +   H    +   HRDLK  N+LL +   D +  ++D G      +  C     
Sbjct: 128 KQVFSGITYMHKHNIV---HRDLKPENILLESKEKDCDIKIIDFG------LSTCFQQNT 178
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +    +     +  Y APE+         D++ DVWS G +LY +     PF
Sbjct: 179 KMKDRIG----TAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAV--VKVCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+    ++CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 3   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 62  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 113 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 166 RTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 207
Query: 250 PFD 252
           PF+
Sbjct: 208 PFE 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
           +++Y IV  +G+G F  V   +   T++ YA+K I       +D +  +REVE  K   H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L +         +L  +S   +V   Y  G L +++    + +   S  D  ++ 
Sbjct: 81  PNIMKLFE---------ILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARII 127
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPLLMDLGSVAPAVVKVCGSAEA 199
            ++   +   H    +   HRDLK  N+LL +   D +  ++D G      +  C     
Sbjct: 128 KQVFSGITYMHKHNIV---HRDLKPENILLESKEKDCDIKIIDFG------LSTCFQQNT 178
Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +    +     +  Y APE+         D++ DVWS G +LY +     PF
Sbjct: 179 KMKDRIG----TAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 2   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 61  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 112 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 164
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 165 RXXLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 206
Query: 250 PFD 252
           PF+
Sbjct: 207 PFE 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 71  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 120
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 121 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGT-- 172
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 173 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 1   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 60  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 111 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 164 RDTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 205
Query: 250 PFD 252
           PF+
Sbjct: 206 PFE 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 1   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 60  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 111 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 164 RTDLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 205
Query: 250 PFD 252
           PF+
Sbjct: 206 PFE 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 3   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 62  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 113 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 165
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 166 RXXLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 207
Query: 250 PFD 252
           PF+
Sbjct: 208 PFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 67  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 116
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 117 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT-- 168
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 169 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 17  SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 76  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 126
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV AP+  
Sbjct: 127 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSR 179
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 180 RTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 221
Query: 250 PFD 252
           PF+
Sbjct: 222 PFE 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 34/243 (13%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G + SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GAMESKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P+G +  +L+  S  
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPRGEVYKELQKLSKF 110
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G    A
Sbjct: 111 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
                 S+    L        ++ Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 164 P-----SSRRXXLXG------TLDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 209
Query: 250 PFD 252
           PF+
Sbjct: 210 PFE 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 46/245 (18%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 26  SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 85  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 134 SSVDILKMF--LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APA 189
           ++  I ++   L  C + +V H         RD+K  N+LL +     + D G SV AP+
Sbjct: 136 TATYITELANALSYCHSKRVIH---------RDIKPENLLLGSAGELKIADFGWSVHAPS 186
Query: 190 VVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
             +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     
Sbjct: 187 SRRTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVG 228
Query: 248 KSPFD 252
           K PF+
Sbjct: 229 KPPFE 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 38/244 (15%)
Query: 16  CSKEAVYVK---SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQA 70
             +E +Y +   +++Y IV  +G+G F  V   +   T++ YA+K I       +D +  
Sbjct: 9   SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
           +REVE  K   HPNI+ L +         +L  +S   +V   Y  G L +++    + +
Sbjct: 69  LREVELLKKLDHPNIMKLFE---------ILEDSSSFYIVGELYTGGELFDEI----IKR 115
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPLLMDLGSVA 187
              S  D  ++  ++   +   H    +   HRDLK  N+LL +   D +  ++D G   
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIV---HRDLKPENILLESKEKDCDIKIIDFG--- 169
Query: 188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
              +  C     +    +     +  Y APE+         D++ DVWS G +LY +   
Sbjct: 170 ---LSTCFQQNTKMKDRIG----TAYYIAPEVLR----GTYDEKCDVWSAGVILYILLSG 218
Query: 248 KSPF 251
             PF
Sbjct: 219 TPPF 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G   SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GHXESKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 59
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL +     + D G SV A
Sbjct: 111 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE      +   D++ D+WSLG L Y   
Sbjct: 164 PSSRRTTLCGT---------------LDYLPPEXIEGRXH---DEKVDLWSLGVLCYEFL 205
Query: 246 YFKSPFD 252
             K PF+
Sbjct: 206 VGKPPFE 212

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 46/245 (18%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 26  SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 85  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 134 SSVDILKMF--LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APA 189
           ++  I ++   L  C + +V H         RD+K  N+LL +     + D G SV AP+
Sbjct: 136 TATYITELANALSYCHSKRVIH---------RDIKPENLLLGSAGELKIADFGWSVHAPS 186
Query: 190 VVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
             +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     
Sbjct: 187 SRRDDLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVG 228
Query: 248 KSPFD 252
           K PF+
Sbjct: 229 KPPFE 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +     E    + Q  REVE      H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 69  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 118
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV--APAVVKVCGSAEAQ 200
                A+   H  + I   HRD+K  N+LL +     + D G    AP+  +   S    
Sbjct: 119 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSG--- 169
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                     ++ Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 ----------TLDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFY-----A 140
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 141 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 196
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 197 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 242
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 243 -------IVSGKVRFP 251

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 44/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQA 70
           G L S E +    + +  VEKIGEG +  V    +  T +  ALKKI      +   + A
Sbjct: 1   GPLGSPEFM----ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA 56
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
           IRE+   K   HPNI+ LLD         V+++ +++ +V  +     L  DL      K
Sbjct: 57  IREISLLKELNHPNIVKLLD---------VIHTENKLYLVFEF-----LHQDL------K 96
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLG 184
            +M +  +  + L + ++  +F   + +A+       HRDLK  N+L+  +    L D G
Sbjct: 97  KFMDASALTGIPLPLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                       A    ++    E  ++ YRAPE+     Y       D+WSLGC+   M
Sbjct: 156 ---------LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY--STAVDIWSLGCIFAEM 204
Query: 245 CYFKSPF 251
              ++ F
Sbjct: 205 VTRRALF 211

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ IG G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ IG G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 95/235 (40%), Gaps = 33/235 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y +V+ IG G F    L+   Q+ +  A+ K I  G +      RE+ +H++  HPN
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAV-KYIERGEKIDENVKREIINHRSLRHPN 76
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +V+ Y   G L      R       S  +    F +
Sbjct: 77  IVRFKEVILT---------PTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQ 123
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   V   H    +   HRDLK  N LL           GS AP  +K+C  G +++  L
Sbjct: 124 LISGVSYCH---AMQVCHRDLKLENTLLD----------GSPAPR-LKICAFGYSKSSVL 169
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
                     P Y APE+     Y    +  DVWS G  LY M     PF+   E
Sbjct: 170 HSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 115
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 168
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 224
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 225 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 270
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 271 -------IVSGKVRFP 279

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q K   ALK +     E    + Q  REVE      H
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          +  ++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 65  PNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 114
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  + I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 115 ---ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT-- 166
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 167 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ IG G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 100/241 (41%), Gaps = 35/241 (14%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIRE 73
           SK    VK   Y + + +G G F  V + EH  T  + A+K   +      +   +  RE
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-Y 132
           +++ K F HP+I+ L           V+++ +   MV+ Y   G L +      + KH  
Sbjct: 62  IQNLKLFRHPHIIKLYQ---------VISTPTDFFMVMEYVSGGELFD-----YICKHGR 107
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +  ++  ++F +I  AV   H    +   HRDLK  NVLL    N  + D G        
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVV---HRDLKPENVLLDAHMNAKIADFGL------- 157
Query: 193 VCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               +   +  +     C  P Y APE+  +          D+WS G +LYA+     PF
Sbjct: 158 ----SNMMSDGEFLRTSCGSPNYAAPEV--ISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 252 D 252
           D
Sbjct: 212 D 212

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 33/231 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y +V+ IG G F    L+   Q+ +  A+ K I  G +      RE+ +H++  HPN
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAV-KYIERGEKIDENVKREIINHRSLRHPN 75
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +V+ Y   G L      R       S  +    F +
Sbjct: 76  IVRFKEVILT---------PTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQ 122
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   V   H    +   HRDLK  N LL           GS AP  +K+C  G +++  L
Sbjct: 123 LISGVSYCH---AMQVCHRDLKLENTLLD----------GSPAPR-LKICDFGYSKSSVL 168
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                     P Y APE+     Y    +  DVWS G  LY M     PF+
Sbjct: 169 HSQPKSTVGTPAYIAPEVLLKKEYD--GKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHA 92
           +GEG FS      H ++ + +A+K I    +  +A   +E+   K    HPNI+ L +  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHE-- 73
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
                  V +      +V+     G L      R   K + S  +   +  K+  AV   
Sbjct: 74  -------VFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSM 212
           HD   +   HRDLK  N+L  ++N+ L + +     A +K        + Q +     ++
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK------PPDNQPLKTPCFTL 173
Query: 213 PYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            Y APEL + + Y   D+  D+WSLG +LY M   + PF +
Sbjct: 174 HYAAPELLNQNGY---DESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F
Sbjct: 153 FGVPVRTYTHEVVTLWYRAPEILLGXKYY--STAVDIWSLGCIFAEMVTRRALF 204

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 92/230 (40%), Gaps = 31/230 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y +V+ IG G F    L+   Q  +  A+ K I  G +      RE+ +H++  HPN
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAV-KYIERGEKIDENVKREIINHRSLRHPN 76
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +V+ Y   G L      R       S  +    F +
Sbjct: 77  IVRFKEVILT---------PTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQ 123
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV-VKVCGSAEAQNLQ 203
           +   V   H    +  AHRDLK  N LL           GS AP + +   G ++A  L 
Sbjct: 124 LISGVSYAH---AMQVAHRDLKLENTLLD----------GSPAPRLKIADFGYSKASVLH 170
Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                    P Y APE+     Y    +  DVWS G  LY M     PF+
Sbjct: 171 SQPKSAVGTPAYIAPEVLLKKEYD--GKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 140
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 141 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 196
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 197 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 242
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 243 -------IVSGKVRFP 251

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L     +K   ALK +     E    + Q  REVE      H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L  +          + +++V ++L Y P GT+  +L+  S      ++  I ++ 
Sbjct: 68  PNILRLYGY---------FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL- 117
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
                A+   H  K I   HRD+K  N+LL +     + D G SV AP+  +  +CG+  
Sbjct: 118 ---ANALSYCHSKKVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGT-- 169
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                        + Y  PE+     +   D++ D+WSLG L Y     K PF+
Sbjct: 170 -------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 28/251 (11%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHA 92
           +G GGF  V   ++      YA+K+I    RE  + + +REV+      HP I+   +  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 93  LTGCADPVLNSTSQ---VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
           L       L  +S    + + +    K  L + +  R   +    SV  L +FL+I EAV
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV-CLHIFLQIAEAV 131
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA-------PAVVKVCGSAEAQNL 202
           +  H        HRDLK +N+    D+   + D G V           V     A A++ 
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
             V  +     Y +PE  H +SY     + D++SLG +L+ + Y   PF T  ER   V 
Sbjct: 189 GQVGTKL----YMSPEQIHGNSYS---HKVDIFSLGLILFELLY---PFSTQMER---VR 235
Query: 263 LAVISGNITFP 273
                 N+ FP
Sbjct: 236 TLTDVRNLKFP 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++E+EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKEIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 95/248 (38%), Gaps = 34/248 (13%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GR 64
           NL FQ    C++      +D Y + E++G+G FS V         + YA K I       
Sbjct: 17  NLYFQXMATCTR-----FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA 71
Query: 65  EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
            D  +  RE    +   HPNI+ L D          ++      +V      G L  D+ 
Sbjct: 72  RDHQKLEREARICRLLKHPNIVRLHDS---------ISEEGFHYLVFDLVTGGELFEDI- 121
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
              V + Y S  D      +I E+V   H    +   HRDLK  N+LLA+      + L 
Sbjct: 122 ---VAREYYSEADASHCIHQILESVNHIHQHDIV---HRDLKPENLLLASKCKGAAVKLA 175
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYA 243
               A+       E Q  Q         P Y +PE+   D Y    +  D+W+ G +LY 
Sbjct: 176 DFGLAI-------EVQGEQQAWFGFAGTPGYLSPEVLRKDPY---GKPVDIWACGVILYI 225
Query: 244 MCYFKSPF 251
           +     PF
Sbjct: 226 LLVGYPPF 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++E+EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKEIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 106/264 (40%), Gaps = 42/264 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFV 81
           SD+Y     +G+G F  V L +   T +  A+K   K     + D+   +REV+  K   
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI  L +                  +V   Y  G L +++    + +   S VD  ++
Sbjct: 85  HPNIXKLYE---------FFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARI 131
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLMDLGSVAPAVVKVCGSAE 198
             ++   +   H  K +   HRDLK  N+LL   + D N  ++D G           S  
Sbjct: 132 IRQVLSGITYXHKNKIV---HRDLKPENLLLESKSKDANIRIIDFGL----------STH 178
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
            +  +    +  +  Y APE+ H       D++ DVWS G +LY +     PF+   E  
Sbjct: 179 FEASKKXKDKIGTAYYIAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY- 233
Query: 259 DSVALAVISGNITFPENTPFPQYQ 282
             +   V  G  TF      PQ++
Sbjct: 234 -DILKKVEKGKYTF----ELPQWK 252

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 112/271 (41%), Gaps = 37/271 (13%)
Query: 17  SKEAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIR 72
            +E +Y +   +KY  +EK+GEG +  V   + SQ +   ALK+I     ++   + AIR
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIR 68
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   HPNI+ L+D         V++S   + +V  +  K  L   L+    G   
Sbjct: 69  EISLLKELHHPNIVSLID---------VIHSERCLTLVFEFMEK-DLKKVLDENKTG--- 115
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I     ++   V   H  + +   HRDLK  N+L+ +D    L D G        
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRIL---HRDLKPQNLLINSDGALKLADFG-------- 164
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               A    ++    E  ++ YRAP+ L     Y       D+WS+GC+   M   K  F
Sbjct: 165 -LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST---SVDIWSIGCIFAEMITGKPLF 220
Query: 252 DTVYERGDSVALAVISGNITFPENTPFPQYQ 282
             V    D   L  I   +  P    +PQ Q
Sbjct: 221 PGV---TDDDQLPKIFSILGTPNPREWPQVQ 248

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 43/236 (18%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVH 82
           D + IV  +G+G F  V L    Q K   ALK +     E +    Q  RE+E      H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL + ++          +   ++ ++L + P+G L  +L+     KH          F
Sbjct: 74  PNILRMYNY---------FHDRKRIYLMLEFAPRGELYKELQ-----KHGRFDEQRSATF 119
Query: 143 LK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSA 197
           ++ + +A+   H+ K I   HRD+K  N+L+       + D G SV AP++ +  +CG+ 
Sbjct: 120 MEELADALHYCHERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 176
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
           +               Y  PE+    ++   D++ D+W  G L Y       PFD+
Sbjct: 177 D---------------YLPPEMIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 37/262 (14%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           +K++ Y +V+ IG G F  V L+ H  T+K YA+K   K     R D A    E +    
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P ++ L                  + MV+ Y P G L N           MS+ D+ 
Sbjct: 131 ANSPWVVQLF---------YAFQDDRYLYMVMEYMPGGDLVN----------LMSNYDVP 171
Query: 140 KMFLKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           + + +    E V        + + HRD+K  N+LL    +  L D G+        C   
Sbjct: 172 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--------CMKM 223
Query: 198 EAQNLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
             + +        +  Y +PE+      D Y    +  D WS+G  LY M    +PF   
Sbjct: 224 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVGDTPFYAD 281
Query: 255 YERGDSVALAVISGNITFPENT 276
              G    +     ++TFP++ 
Sbjct: 282 SLVGTYSKIMNHKNSLTFPDDN 303

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 2   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 61  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + + G SV AP+  
Sbjct: 112 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWSVHAPSSR 164
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 165 RTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 206
Query: 250 PFD 252
           PF+
Sbjct: 207 PFE 209

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 37/262 (14%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           +K++ Y +V+ IG G F  V L+ H  T+K YA+K   K     R D A    E +    
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P ++ L                  + MV+ Y P G L N           MS+ D+ 
Sbjct: 131 ANSPWVVQLF---------YAFQDDRYLYMVMEYMPGGDLVN----------LMSNYDVP 171
Query: 140 KMFLKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           + + +    E V        + + HRD+K  N+LL    +  L D G+        C   
Sbjct: 172 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--------CMKM 223
Query: 198 EAQNLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
             + +        +  Y +PE+      D Y    +  D WS+G  LY M    +PF   
Sbjct: 224 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVGDTPFYAD 281
Query: 255 YERGDSVALAVISGNITFPENT 276
              G    +     ++TFP++ 
Sbjct: 282 SLVGTYSKIMNHKNSLTFPDDN 303

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 112/271 (41%), Gaps = 37/271 (13%)
Query: 17  SKEAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIR 72
            +E +Y +   +KY  +EK+GEG +  V   + SQ +   ALK+I     ++   + AIR
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIR 68
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   HPNI+ L+D         V++S   + +V  +  K  L   L+    G   
Sbjct: 69  EISLLKELHHPNIVSLID---------VIHSERCLTLVFEFMEK-DLKKVLDENKTG--- 115
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I     ++   V   H  + +   HRDLK  N+L+ +D    L D G        
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRIL---HRDLKPQNLLINSDGALKLADFG-------- 164
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               A    ++    E  ++ YRAP+ L     Y       D+WS+GC+   M   K  F
Sbjct: 165 -LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST---SVDIWSIGCIFAEMITGKPLF 220
Query: 252 DTVYERGDSVALAVISGNITFPENTPFPQYQ 282
             V    D   L  I   +  P    +PQ Q
Sbjct: 221 PGV---TDDDQLPKIFSILGTPNPREWPQVQ 248

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 43/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G L SK    +  + + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GPLGSKRQWTL--EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQ 58
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 59  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSRF 109
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL ++    + D G SV A
Sbjct: 110 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHA 162
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 163 PSSRRTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 204
Query: 246 YFKSPFD 252
               PF+
Sbjct: 205 VGMPPFE 211

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 80
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 134 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---- 189
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 190 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 235
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 236 -------IVSGKVRFP 244

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIRE 73
           SK+  +   D + I   +G+G F  V L    Q+K   ALK +     E    + Q  RE
Sbjct: 3   SKKRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
           VE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S      
Sbjct: 62  VEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVV 191
           ++  I ++      A+   H  + I   HRD+K  N+LL +     + + G SV AP+  
Sbjct: 113 TATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWSVHAPSSR 165
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           +  +CG+               + Y  PE+     +   D++ D+WSLG L Y     K 
Sbjct: 166 RTTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKP 207
Query: 250 PFD 252
           PF+
Sbjct: 208 PFE 210

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L+ DL      K +M +  +  + L
Sbjct: 64  NIVKLLD---------VIHTENKLYLVFEF-----LSMDL------KKFMDASALTGIPL 103
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 104 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG---------LARA 153
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 154 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 37/262 (14%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           +K++ Y +V+ IG G F  V L+ H  T+K YA+K   K     R D A    E +    
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P ++ L                  + MV+ Y P G L N           MS+ D+ 
Sbjct: 126 ANSPWVVQLF---------YAFQDDRYLYMVMEYMPGGDLVN----------LMSNYDVP 166
Query: 140 KMFLKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           + + +    E V        + + HRD+K  N+LL    +  L D G+        C   
Sbjct: 167 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--------CMKM 218
Query: 198 EAQNLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
             + +        +  Y +PE+      D Y    +  D WS+G  LY M    +PF   
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 255 YERGDSVALAVISGNITFPENT 276
              G    +     ++TFP++ 
Sbjct: 277 SLVGTYSKIMNHKNSLTFPDDN 298

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L+ DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEF-----LSMDL------KKFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 113/271 (41%), Gaps = 43/271 (15%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTF 80
           V  + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K  
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  
Sbjct: 64  NHPNIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTG 103
Query: 141 MFLKICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
           + L + ++  +F   + +A+       HRDLK  N+L+  +    L D G          
Sbjct: 104 IPLPLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------L 153
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
             A    ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F   
Sbjct: 154 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGD 211
Query: 255 YERGDSVALAVISGN---ITFPENTPFPQYQ 282
            E      +    G    + +P  T  P Y+
Sbjct: 212 SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 242

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 43/247 (17%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQ 69
           G L SK    +  + + I   +G+G F  V L    Q+K   ALK +     E    + Q
Sbjct: 1   GPLGSKRQWTL--EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQ 58
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
             REVE      HPNIL L  +          +  ++V ++L Y P GT+  +L+  S  
Sbjct: 59  LRREVEIQSHLRHPNILRLYGY---------FHDATRVYLILEYAPLGTVYRELQKLSRF 109
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-A 187
               ++  I ++      A+   H  + I   HRD+K  N+LL ++    + D G SV A
Sbjct: 110 DEQRTATYITEL----ANALSYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHA 162
Query: 188 PAVVK--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
           P+  +  +CG+               + Y  PE+     +   D++ D+WSLG L Y   
Sbjct: 163 PSSRRDTLCGT---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFL 204
Query: 246 YFKSPFD 252
               PF+
Sbjct: 205 VGMPPFE 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 64  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 103
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 104 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 153
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 154 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   +A+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V SD Y + E IG G +S      H  T   YA+ K+I   + D ++ I  +  +    H
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAV-KVIDKSKRDPSEEIEILLRYGQ--H 80
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D         V +    V +V      G L + + LR   + + S  +   + 
Sbjct: 81  PNIITLKD---------VYDDGKHVYLVTELMRGGELLDKI-LR---QKFFSEREASFVL 127
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
             I + V+  H        HRDLK +N+L  ++         S  P  +++C    A+ L
Sbjct: 128 HTIGKTVEYLHSQ---GVVHRDLKPSNILYVDE---------SGNPECLRICDFGFAKQL 175
Query: 203 Q---DVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +    +    C +  + APE+     Y   D+  D+WSLG LLY M    +PF
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGY---DEGCDIWSLGILLYTMLAGYTPF 225

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L+ DL      K +M +  +  + L
Sbjct: 65  NIVKLLD---------VIHTENKLYLVFEF-----LSMDL------KDFMDASALTGIPL 104
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 105 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 154
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 155 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   +A+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 65  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 104
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 105 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 154
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 155 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 70  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 109
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 110 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 159
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F
Sbjct: 160 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L+ DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEF-----LSMDL------KDFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 67  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 106
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 107 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 156
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 157 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 214
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 215 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 242

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 64  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 103
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 104 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 153
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 154 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   +A+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 64  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 103
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 104 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG---------LARA 153
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 154 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 64  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 103
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 104 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 153
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 154 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 65  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 104
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 105 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG---------LARA 154
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 155 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V SD Y + E IG G +S      H  T   YA+ K+I   + D ++ I  +  +    H
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAV-KVIDKSKRDPSEEIEILLRYGQ--H 80
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D         V +    V +V      G L + + LR   + + S  +   + 
Sbjct: 81  PNIITLKD---------VYDDGKHVYLVTELMRGGELLDKI-LR---QKFFSEREASFVL 127
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
             I + V+  H        HRDLK +N+L  ++         S  P  +++C    A+ L
Sbjct: 128 HTIGKTVEYLHSQ---GVVHRDLKPSNILYVDE---------SGNPECLRICDFGFAKQL 175
Query: 203 Q---DVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +    +    C +  + APE+     Y   D+  D+WSLG LLY M    +PF
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGY---DEGCDIWSLGILLYTMLAGYTPF 225

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 65  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 104
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 105 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 154
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 155 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KTFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y P G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 105/262 (40%), Gaps = 45/262 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEH-------- 76
           + Y   E +G G  S V    H  T K YA+K I +  G    A+ ++E+          
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 77  -HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K   HPNI+ L D            + +   +V     KG L + L      K  +S 
Sbjct: 64  LRKVSGHPNIIQLKD---------TYETNTFFFLVFDLMKKGELFDYL----TEKVTLSE 110
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            +  K+   + E +   H    +   HRDLK  N+LL +D N  L D G         C 
Sbjct: 111 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF-------SCQ 160
Query: 196 SAEAQNLQDVAAERCSMP-YRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               + L++V    C  P Y APE+      D++    +  D+WS G ++Y +     PF
Sbjct: 161 LDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216
Query: 252 DTVYERGDSVALAVI-SGNITF 272
              + R   + L +I SGN  F
Sbjct: 217 ---WHRKQMLMLRMIMSGNYQF 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 94/238 (39%), Gaps = 33/238 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD+Y  V+ IG G F    L+    TK+  A+ K I  G        RE+ +H++  HPN
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAV-KYIERGAAIDENVQREIINHRSLRHPN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+   +  LT          + + +++ Y   G L      R       S  +    F +
Sbjct: 78  IVRFKEVILT---------PTHLAIIMEYASGGELYE----RICNAGRFSEDEARFFFQQ 124
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   V   H  +     HRDLK  N LL           GS AP  +K+C  G +++  L
Sbjct: 125 LLSGVSYCHSMQ---ICHRDLKLENTLLD----------GSPAPR-LKICDFGYSKSSVL 170
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
                     P Y APE+     Y    +  DVWS G  LY M     PF+   E  D
Sbjct: 171 HSQPKSTVGTPAYIAPEVLLRQEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 47/270 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS-------V 136
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +       +
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            ++K +L ++ + +   H  + +   HRDLK  N+L+  +    L D G           
Sbjct: 103 PLIKSYLFQLLQGLSFCHSHRVL---HRDLKPQNLLINTEGAIKLADFG---------LA 150
Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
            A    ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 256 ERGDSVALAVISGN---ITFPENTPFPQYQ 282
           E      +    G    + +P  T  P Y+
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 105/262 (40%), Gaps = 45/262 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEH-------- 76
           + Y   E +G G  S V    H  T K YA+K I +  G    A+ ++E+          
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 77  -HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K   HPNI+ L D            + +   +V     KG L + L      K  +S 
Sbjct: 77  LRKVSGHPNIIQLKD---------TYETNTFFFLVFDLMKKGELFDYL----TEKVTLSE 123
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            +  K+   + E +   H    +   HRDLK  N+LL +D N  L D G         C 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF-------SCQ 173
Query: 196 SAEAQNLQDVAAERCSMP-YRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               + L++V    C  P Y APE+      D++    +  D+WS G ++Y +     PF
Sbjct: 174 LDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 252 DTVYERGDSVALAVI-SGNITF 272
              + R   + L +I SGN  F
Sbjct: 230 ---WHRKQMLMLRMIMSGNYQF 248

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KDFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  +  +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
              ++       +      S + MVL Y P G + +   LR +G+               
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 1   MNTMGLNLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII 60
           M T+G++ I Q      + ++   +D Y + E IG G +S      H  T   +A+K II
Sbjct: 1   MQTVGVHSIVQQ---LHRNSIQF-TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-II 55
Query: 61  CHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLA 120
              + D  + I  +  +    HPNI+ L D         V +    V +V      G L 
Sbjct: 56  DKSKRDPTEEIEILLRYGQ--HPNIITLKD---------VYDDGKYVYVVTELMKGGELL 104
Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           + + LR   + + S  +   +   I + V+  H        HRDLK +N+L  ++     
Sbjct: 105 DKI-LR---QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDE----- 152
Query: 181 MDLGSVAPAVVKVCGSAEAQNLQ---DVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWS 236
               S  P  +++C    A+ L+    +    C +  + APE+     Y   D   D+WS
Sbjct: 153 ----SGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY---DAACDIWS 205
Query: 237 LGCLLYAMCYFKSPF 251
           LG LLY M    +PF
Sbjct: 206 LGVLLYTMLTGYTPF 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 97/237 (40%), Gaps = 34/237 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD + +  ++G G  S V   +   T+K YALK  +     D+     E+       HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +         +  + +++ +VL     G L +    R V K Y S  D      +
Sbjct: 110 IIKLKE---------IFETPTEISLVLELVTGGELFD----RIVEKGYYSERDAADAVKQ 156
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I EAV   H+       HRDLK  N+L A             AP  +   G ++    Q 
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATP--------APDAPLKIADFGLSKIVEHQV 205
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYA-MCYFKSPFDTVYERGD 259
           +    C  P Y APE+      C      D+WS+G + Y  +C F+  +D   ERGD
Sbjct: 206 LMKTVCGTPGYCAPEILR---GCAYGPEVDMWSVGIITYILLCGFEPFYD---ERGD 256

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 104/262 (39%), Gaps = 45/262 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEH-------- 76
           + Y   E +G G  S V    H  T K YA+K I +  G    A+ ++E+          
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 77  -HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K   HPNI+ L D            + +   +V     KG L + L      K  +S 
Sbjct: 77  LRKVSGHPNIIQLKD---------TYETNTFFFLVFDLMKKGELFDYL----TEKVTLSE 123
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            +  K+   + E +   H    +   HRDLK  N+LL +D N  L D G         C 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF-------SCQ 173
Query: 196 SAEAQNLQDVAAERCSMP-YRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               + L+ V    C  P Y APE+      D++    +  D+WS G ++Y +     PF
Sbjct: 174 LDPGEKLRSV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 252 DTVYERGDSVALAVI-SGNITF 272
              + R   + L +I SGN  F
Sbjct: 230 ---WHRKQMLMLRMIMSGNYQF 248

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 81  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 126
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G         C     +  Q   
Sbjct: 127 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FCAQITPE--QSKR 173
Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +E    PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 174 SEMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 115
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 168
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V  A   +CG+ E    
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE---- 224
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 225 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 270
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 271 -------IVSGKVRFP 279

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVH 82
           D + I   +G+G F  V L    Q K   ALK +     E +    Q  RE+E      H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL + ++          +   ++ ++L + P+G L  +L+     KH          F
Sbjct: 75  PNILRMYNY---------FHDRKRIYLMLEFAPRGELYKELQ-----KHGRFDEQRSATF 120
Query: 143 LK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSA 197
           ++ + +A+   H+ K I   HRD+K  N+L+       + D G SV AP++ +  +CG+ 
Sbjct: 121 MEELADALHYCHERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 177
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
           +               Y  PE+    ++   D++ D+W  G L Y       PFD+
Sbjct: 178 D---------------YLPPEMIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  AL KI      +   + AIRE+   K   HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 63  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 102
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 103 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 152
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 153 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  AL KI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     L  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEF-----LHQDL------KKFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     +  DL      K +M +  +  + L
Sbjct: 66  NIVKLLD---------VIHTENKLYLVFEH-----VDQDL------KKFMDASALTGIPL 105
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 106 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 155
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 156 FGVPVRTYXHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 63/276 (22%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEH-HKTFVHPNILPLLD 90
           E +GEG ++ V      Q  K YA+K I       +++  REVE  ++   + NIL L++
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
                         ++  +V      G++   ++ +   KH+ +  +  ++   +  A+ 
Sbjct: 79  ---------FFEDDTRFYLVFEKLQGGSILAHIQKQ---KHF-NEREASRVVRDVAAALD 125
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDN--NPLLM---DLGS-----------VAPAVVKVC 194
             H       AHRDLK  N+L  +    +P+ +   DLGS             P +   C
Sbjct: 126 FLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF- 251
           GSAE               Y APE+  V  D     D+R D+WSLG +LY M     PF 
Sbjct: 183 GSAE---------------YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV 227
Query: 252 -----DTVYERGDSVAL-------AVISGNITFPEN 275
                D  ++RG+   +       ++  G   FP+ 
Sbjct: 228 GHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDK 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 38/255 (14%)
Query: 26  DKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           ++YY +E  IG G +  V +     T+ R A KKI  +  ED  +  +E+E  K+  HPN
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +              + + +V+     G L      R V K      D  ++   
Sbjct: 68  IIRLYE---------TFEDNTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKD 114
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLAND--NNPL-LMDLGSVAPAVVKVCGSAEAQN 201
           +  AV   H    +  AHRDLK  N L   D  ++PL L+D G  A              
Sbjct: 115 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-----------RFK 160
Query: 202 LQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              +   +   PY  +P++       +     D WS G ++Y +     PF    +    
Sbjct: 161 PGKMMRTKVGTPYYVSPQVLE----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTD--XE 214
Query: 261 VALAVISGNITFPEN 275
           V L +  G  TFPE 
Sbjct: 215 VMLKIREGTFTFPEK 229

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 38/255 (14%)
Query: 26  DKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           ++YY +E  IG G +  V +     T+ R A KKI  +  ED  +  +E+E  K+  HPN
Sbjct: 25  NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L +              + + +V+     G L      R V K      D  ++   
Sbjct: 85  IIRLYE---------TFEDNTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKD 131
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLAND--NNPL-LMDLGSVAPAVVKVCGSAEAQN 201
           +  AV   H    +  AHRDLK  N L   D  ++PL L+D G  A              
Sbjct: 132 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-----------RFK 177
Query: 202 LQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
              +   +   PY  +P++       +     D WS G ++Y +     PF    +    
Sbjct: 178 PGKMMRTKVGTPYYVSPQVLE----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTD--XE 231
Query: 261 VALAVISGNITFPEN 275
           V L +  G  TFPE 
Sbjct: 232 VMLKIREGTFTFPEK 246

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +   + AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD         V+++ +++ +V  +     +  DL      K +M +  +  + L
Sbjct: 62  NIVKLLD---------VIHTENKLYLVFEH-----VHQDL------KTFMDASALTGIPL 101
Query: 144 KICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            + ++  +F   + +A+       HRDLK  N+L+  +    L D G            A
Sbjct: 102 PLIKSY-LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG---------LARA 151
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               ++    E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F    E 
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYY--STAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 258 GDSVALAVISGN---ITFPENTPFPQYQ 282
                +    G    + +P  T  P Y+
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 46/280 (16%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQA--QAIRE 73
            K+ +     +Y  V +IGEG +  V      +   R+ ALK++     E+      IRE
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 74  V---EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSV 128
           V    H +TF HPN++ L D     C     +  +++ +V  +     +  DL   L  V
Sbjct: 62  VAVLRHLETFEHPNVVRLFD----VCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKV 112
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---- 184
            +  + +  I  M  ++   +   H  + +   HRDLK  N+L+ +     L D G    
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 185 -SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA 243
            S   A+  V                 ++ YRAPE+    SY       D+WS+GC+   
Sbjct: 170 YSFQMALTSVV---------------VTLWYRAPEVLLQSSYATP---VDLWSVGCIFAE 211
Query: 244 MCYFKSPF---DTVYERGDSVALAVISGNITFPENTPFPQ 280
           M   K  F     V + G  + +  + G   +P +   P+
Sbjct: 212 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 18  KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQA--QAIREV 74
           K+ +     +Y  V +IGEG +  V      +   R+ ALK++     E+      IREV
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 75  ---EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVG 129
               H +TF HPN++ L D     C     +  +++ +V  +     +  DL   L  V 
Sbjct: 63  AVLRHLETFEHPNVVRLFD----VCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVP 113
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
           +  + +  I  M  ++   +   H  + +   HRDLK  N+L+ +     L D G     
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFG----- 165
Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
           + ++     A     + +   ++ YRAPE+    SY       D+WS+GC+   M   K 
Sbjct: 166 LARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATP---VDLWSVGCIFAEMFRRKP 217
Query: 250 PF---DTVYERGDSVALAVISGNITFPENTPFPQ 280
            F     V + G  + +  + G   +P +   P+
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 36/275 (13%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQA--QAIRE 73
            K+ +     +Y  V +IGEG +  V      +   R+ ALK++     E+      IRE
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 74  V---EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSV 128
           V    H +TF HPN++ L D     C     +  +++ +V  +     +  DL   L  V
Sbjct: 62  VAVLRHLETFEHPNVVRLFD----VCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKV 112
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
            +  + +  I  M  ++   +   H  + +   HRDLK  N+L+ +     L D G    
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFG---- 165
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
            + ++     A     + +   ++ YRAPE+    SY       D+WS+GC+   M   K
Sbjct: 166 -LARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATP---VDLWSVGCIFAEMFRRK 216
Query: 249 SPF---DTVYERGDSVALAVISGNITFPENTPFPQ 280
             F     V + G  + +  + G   +P +   P+
Sbjct: 217 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H +T   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILP 87
           ++E +G+G +  V     S   +  A+K        D+    RE E + T +  H NIL 
Sbjct: 41  LLECVGKGRYGEV--WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILG 95
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
            +   +T       +S++Q+ ++  Y+  G+L + L+L +     + +V  L++ L I  
Sbjct: 96  FIASDMTS-----RHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIAS 145
Query: 148 AVKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            +   H        KP A AHRDLK+ N+L+  +    + DLG +A    +     +  N
Sbjct: 146 GLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLG-LAVMHSQSTNQLDVGN 203
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
              V  +R   P    E   VD +    +R D+W+ G +L+
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAFGLVLW 243

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           + I+  +G G F  V LI      + YA+K +    +++    +++VEH  T     +L 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEH--TNDERLMLS 61
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS-----VGKHYMSSVDILKMF 142
           ++ H              Q+ M++ Y   G L + L         V K Y + V      
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------ 115
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
              C A++  H +K I Y  RDLK  N+LL  + +  + D G              A+ +
Sbjct: 116 ---CLALEYLH-SKDIIY--RDLKPENILLDKNGHIKITDFGF-------------AKYV 156
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            DV    C  P Y APE+     Y   ++  D WS G L+Y M    +PF
Sbjct: 157 PDVTYXLCGTPDYIAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTPF 203

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILP 87
           ++E +G+G +  V     S   +  A+K        D+    RE E + T +  H NIL 
Sbjct: 12  LLECVGKGRYGEV--WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
            +   +T       +S++Q+ ++  Y+  G+L + L+L +     + +V  L++ L I  
Sbjct: 67  FIASDMTS-----RHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIAS 116
Query: 148 AVKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            +   H        KP A AHRDLK+ N+L+  +    + DLG +A    +     +  N
Sbjct: 117 GLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLG-LAVMHSQSTNQLDVGN 174
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
              V  +R   P    E   VD +    +R D+W+ G +L+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAFGLVLW 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 90/230 (39%), Gaps = 29/230 (12%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           +D+Y + E++G+G FS V       T + YA K I        D  +  RE    +   H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D          ++      +V      G L  D+    V + Y S  D     
Sbjct: 63  PNIVRLHDS---------ISEEGFHYLVFDLVTGGELFEDI----VAREYYSEADASHCI 109
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I E+V   H        HRDLK  N+LLA+ +    + L     A+       E Q  
Sbjct: 110 QQILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAI-------EVQGD 159
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           Q         P Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKDPY---GKPVDMWACGVILYILLVGYPPF 206

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILP 87
           ++E +G+G +  V     S   +  A+K        D+    RE E + T +  H NIL 
Sbjct: 12  LLECVGKGRYGEV--WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
            +   +T       +S++Q+ ++  Y+  G+L + L+L +     + +V  L++ L I  
Sbjct: 67  FIASDMTS-----RHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIAS 116
Query: 148 AVKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            +   H        KP A AHRDLK+ N+L+  +    + DLG +A    +     +  N
Sbjct: 117 GLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLG-LAVMHSQSTNQLDVGN 174
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
              V  +R   P    E   VD +    +R D+W+ G +L+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAFGLVLW 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 103/270 (38%), Gaps = 37/270 (13%)
Query: 20  AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEH 76
            + +K++ Y +V+ IG G F  V L+ H  ++K YA+K   K     R D A    E + 
Sbjct: 69  GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
                 P ++ L       CA         + MV+ Y P G L N           MS+ 
Sbjct: 129 MAFANSPWVVQLF------CA---FQDDKYLYMVMEYMPGGDLVN----------LMSNY 169
Query: 137 DILKMFLKI--CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
           D+ + + K    E V        +   HRD+K  N+LL    +  L D G+        C
Sbjct: 170 DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT--------C 221
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHV---DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              +   +        +  Y +PE+      D Y    +  D WS+G  L+ M    +PF
Sbjct: 222 MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLFEMLVGDTPF 279
Query: 252 DTVYERGDSVALAVISGNITFPENTPFPQY 281
                 G    +     ++ FPE+    ++
Sbjct: 280 YADSLVGTYSKIMDHKNSLCFPEDAEISKH 309

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--AQAIREVEHHKTFVHPN 84
           KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYP---KGTLANDLELRSVGKHYMSSVD-ILK 140
           ++ L++   T  A P     + + +V  +      G L+N L      K  +S +  +++
Sbjct: 79  VVNLIEICRTK-ASPYNRCKASIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQ 132
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           M L     +   H  K +   HRD+K ANVL+  D    L D G     + +    A+  
Sbjct: 133 MLL---NGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFG-----LARAFSLAKNS 181
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR-----TDVWSLGCLLYAMCYFKSPFDTVY 255
                     ++ YR PEL       ++ +R      D+W  GC++  M + +SP   + 
Sbjct: 182 QPNRYXNRVVTLWYRPPEL-------LLGERDYGPPIDLWGAGCIMAEM-WTRSPI--MQ 231
Query: 256 ERGDSVALAVIS---GNITFPENTP 277
              +   LA+IS   G+IT PE  P
Sbjct: 232 GNTEQHQLALISQLCGSIT-PEVWP 255

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 146
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A +    A       
Sbjct: 147 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQ------ 196
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 197 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 251
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 252 EKF-FPK 257

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 115
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY-----A 168
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 224
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 225 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 270
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 271 -------IVSGKVRFP 279

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 90/230 (39%), Gaps = 29/230 (12%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           +D+Y + E++G+G FS V       T + YA K I        D  +  RE    +   H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D          ++      +V      G L  D+    V + Y S  D     
Sbjct: 63  PNIVRLHDS---------ISEEGFHYLVFDLVTGGELFEDI----VAREYYSEADASHCI 109
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I E+V   H        HRDLK  N+LLA+ +    + L     A+       E Q  
Sbjct: 110 QQILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAI-------EVQGD 159
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           Q         P Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKDPY---GKPVDMWACGVILYILLVGYPPF 206

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-----QAQAIREVE 75
           V  ++ +Y  ++ +GEG F+TV       T +  A+KKI    R +        A+RE++
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             +   HPNI+ LLD              S + +V  +     +  DLE+       + +
Sbjct: 65  LLQELSHPNIIGLLD---------AFGHKSNISLVFDF-----METDLEVIIKDNSLVLT 110
Query: 136 VDILKMF-LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
              +K + L   + ++  H    +   HRDLK  N+LL  +    L D G     + K  
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHWIL---HRDLKPNNLLLDENGVLKLADFG-----LAKSF 162
Query: 195 GSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           GS        V        YRAPE LF    Y V     D+W++GC+L A    + PF
Sbjct: 163 GSPNRAYXHQVVTRW----YRAPELLFGARMYGV---GVDMWAVGCIL-AELLLRVPF 212

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 89
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY-----A 142
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 143 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 198
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 199 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 244
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 245 -------IVSGKVRFP 253

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 148
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 250
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 251 -------IVSGKVRFP 259

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 104/253 (41%), Gaps = 44/253 (17%)
Query: 13  GCLCSKEAVYVKS---DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGR 64
           G     E +Y +S   D Y + E++G G F+ V       T K YA K     ++    R
Sbjct: 10  GVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRR 69
Query: 65  EDQAQAI-REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL 123
               + I REV   +   HPNI+ L D         +  + + V+++L     G L + L
Sbjct: 70  GVSREEIEREVNILREIRHPNIITLHD---------IFENKTDVVLILELVSGGELFDFL 120
Query: 124 ELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----L 179
                 K  ++  +  +   +I + V   H  +    AH DLK  N++L + N P     
Sbjct: 121 ----AEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIK 173
Query: 180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLG 238
           L+D G       K+    E +N+          P + APE+    +Y  +    D+WS+G
Sbjct: 174 LIDFGIAH----KIEAGNEFKNI-------FGTPEFVAPEIV---NYEPLGLEADMWSIG 219
Query: 239 CLLYAMCYFKSPF 251
            + Y +    SPF
Sbjct: 220 VITYILLSGASPF 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--AQAIREVEHHKTFVHPN 84
           KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYP---KGTLANDLELRSVGKHYMSSVD-ILK 140
           ++ L++   T  A P       + +V  +      G L+N L      K  +S +  +++
Sbjct: 79  VVNLIEICRTK-ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQ 132
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           M L     +   H  K +   HRD+K ANVL+  D    L D G     + +    A+  
Sbjct: 133 MLL---NGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFG-----LARAFSLAKNS 181
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR-----TDVWSLGCLLYAMCYFKSPFDTVY 255
                     ++ YR PEL       ++ +R      D+W  GC++  M + +SP   + 
Sbjct: 182 QPNRYXNRVVTLWYRPPEL-------LLGERDYGPPIDLWGAGCIMAEM-WTRSPI--MQ 231
Query: 256 ERGDSVALAVIS---GNITFPENTP 277
              +   LA+IS   G+IT PE  P
Sbjct: 232 GNTEQHQLALISQLCGSIT-PEVWP 255

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 81  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 126
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G         C     +  Q   
Sbjct: 127 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FCAQITPE--QSKR 173
Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 174 STMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 35/231 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +D Y + E IG G +S      H  T   +A+K II   + D  + I  +  +    HPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVK-IIDKSKRDPTEEIEILLRYGQ--HPN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D         V +    V +V      G L + + LR   + + S  +   +   
Sbjct: 78  IITLKD---------VYDDGKYVYVVTELXKGGELLDKI-LR---QKFFSEREASAVLFT 124
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ- 203
           I + V+  H        HRDLK +N+L  ++         S  P  +++C    A+ L+ 
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDE---------SGNPESIRICDFGFAKQLRA 172
Query: 204 --DVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              +    C +  + APE+     Y   D   D+WSLG LLY      +PF
Sbjct: 173 ENGLLXTPCYTANFVAPEVLERQGY---DAACDIWSLGVLLYTXLTGYTPF 220

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 82  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 127
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G         C     +  Q   
Sbjct: 128 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FCAQITPE--QSKR 174
Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 175 SXMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 150
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A +    A       
Sbjct: 151 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQ------ 200
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 201 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 255
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 256 EKF-FPK 261

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPN 84
           KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYP---KGTLANDLELRSVGKHYMSSVD-ILK 140
           ++ L++   T  A P       + +V  +      G L+N L      K  +S +  +++
Sbjct: 78  VVNLIEICRTK-ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQ 131
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           M L     +   H  K +   HRD+K ANVL+  D    L D G     + +    A+  
Sbjct: 132 MLL---NGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFG-----LARAFSLAKNS 180
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR-----TDVWSLGCLLYAMCYFKSPFDTVY 255
                     ++ YR PEL       ++ +R      D+W  GC++  M + +SP   + 
Sbjct: 181 QPNRYXNRVVTLWYRPPEL-------LLGERDYGPPIDLWGAGCIMAEM-WTRSPI--MQ 230
Query: 256 ERGDSVALAVIS---GNITFPENTP 277
              +   LA+IS   G+IT PE  P
Sbjct: 231 GNTEQHQLALISQLCGSIT-PEVWP 254

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--AQAIREVEHHKTFVHPN 84
           KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYP---KGTLANDLELRSVGKHYMSSVD-ILK 140
           ++ L++   T  A P       + +V  +      G L+N L      K  +S +  +++
Sbjct: 79  VVNLIEICRTK-ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQ 132
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           M L     +   H  K +   HRD+K ANVL+  D    L D G     + +    A+  
Sbjct: 133 MLL---NGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFG-----LARAFSLAKNS 181
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR-----TDVWSLGCLLYAMCYFKSPFDTVY 255
                     ++ YR PEL       ++ +R      D+W  GC++  M + +SP   + 
Sbjct: 182 QPNRYXNRVVTLWYRPPEL-------LLGERDYGPPIDLWGAGCIMAEM-WTRSPI--MQ 231
Query: 256 ERGDSVALAVIS---GNITFPENTP 277
              +   LA+IS   G+IT PE  P
Sbjct: 232 GNTEQHQLALISQLCGSIT-PEVWP 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFAEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 81  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 126
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HRD+K+ N+LL  D +  L D G         C     +  Q   
Sbjct: 127 QALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FCAQITPE--QSKR 173
Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 174 SXMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNI 85
           Y  ++ +G G +  V      +T  + A+KK+    + +    +A RE+   K   H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-K 144
           + LLD       D  L+  +   +V+P+   GT     +L  + KH     D ++  + +
Sbjct: 87  IGLLD---VFTPDETLDDFTDFYLVMPFM--GT-----DLGKLMKHEKLGEDRIQFLVYQ 136
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + + ++  H A  I   HRDLK  N+ +  D    ++D G    A  ++ G         
Sbjct: 137 MLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXV------- 186
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 +  YRAPE+  + ++    Q  D+WS+GC++  M   K+ F
Sbjct: 187 -----VTRWYRAPEV--ILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 81
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 134
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 135 AQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 190
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 191 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 236
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 237 -------IVSGKVRFP 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 146
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 147 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 196
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 197 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 251
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 252 EKF-FPK 257

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 131
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 132 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 181
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 182 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 236
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 237 EKF-FPK 242

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 35/232 (15%)
Query: 26  DKYYIVEK---IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           + +Y V K   +G G F  V   E + T  + A K I   G +D+ +   E+       H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY-MSSVDILKM 141
            N++ L D            S + +++V+ Y   G L +    R + + Y ++ +D +  
Sbjct: 146 ANLIQLYD---------AFESKNDIVLVMEYVDGGELFD----RIIDESYNLTELDTILF 192
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +ICE ++  H    +   H DLK  N+L  N +              +K+     A+ 
Sbjct: 193 MKQICEGIRHMH---QMYILHLDLKPENILCVNRD-----------AKQIKIIDFGLARR 238
Query: 202 LQDVAAERCSMPYRAPELF--HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            +    E+  + +  PE     V +Y  V   TD+WS+G + Y +    SPF
Sbjct: 239 YK--PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 124
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 125 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 174
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 175 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 229
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 230 EKF-FPK 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 125
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 126 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 175
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 176 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 230
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 231 EKF-FPK 236

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 18/235 (7%)
Query: 18  KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QAIREVEH 76
           K  VY  S  + +   +GEG +  V    H  T +  A+KKI    +   A + +RE++ 
Sbjct: 3   KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K F H NI+ + +            + ++V ++     +  +  DL  R +    +S  
Sbjct: 63  LKHFKHENIITIFNIQRPDS----FENFNEVYII-----QELMQTDLH-RVISTQMLSDD 112
Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            I     +   AVKV H +  I   HRDLK +N+L+ ++ +  + D G           +
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 197 AEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
           +E    Q    E  +   YRAPE+    +     +  DVWS GC+L A  + + P
Sbjct: 170 SEPTGQQSGMTEXVATRWYRAPEVMLTSAK--YSRAMDVWSCGCIL-AELFLRRP 221

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 147
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 148 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 197
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 198 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 252
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 253 EKF-FPK 258

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 30/235 (12%)
Query: 13  GCLCSKEAVYVKS-DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-- 69
           G     E +Y +S +KY  +  +GEG +  V    +  T +  A+KK +    +   +  
Sbjct: 11  GVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI 70
Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           A+RE++  K   H N++ LL+         V     +  +V  +    T+ +DLEL   G
Sbjct: 71  AMREIKLLKQLRHENLVNLLE---------VCKKKKRWYLVFEFVDH-TILDDLELFPNG 120
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
             Y     + K   +I   +   H    I   HRD+K  N+L++      L D G     
Sbjct: 121 LDYQV---VQKYLFQIINGIGFCHSHNII---HRDIKPENILVSQSGVVKLCDFGFARTL 174
Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
                 +A  +   D  A R    YRAPEL   D      +  DVW++GCL+  M
Sbjct: 175 ------AAPGEVYDDEVATRW---YRAPELLVGD--VKYGKAVDVWAIGCLVTEM 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 108/261 (41%), Gaps = 45/261 (17%)
Query: 7   NLIFQ--MG-CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS----QTKKRYALKKI 59
           NL FQ  MG     ++    +      ++++G+G F +V +  +      T +  A+KK+
Sbjct: 19  NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78
Query: 60  ICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL 119
                E      RE+E  K+  H NI+       +            + +++ Y P G+L
Sbjct: 79  QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-------GRRNLKLIMEYLPYGSL 131
Query: 120 ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
            + L+     K  +  + +L+   +IC+ ++     +   Y HRDL T N+L+ N+N   
Sbjct: 132 RDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVK 185
Query: 180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP------YRAPELFHVDSYCVVDQRTD 233
           + D G     + KV         QD    +   P      + APE      + V    +D
Sbjct: 186 IGDFG-----LTKVLP-------QDKEXXKVKEPGESPIFWYAPESLTESKFSVA---SD 230
Query: 234 VWSLGCLLYAMCYF----KSP 250
           VWS G +LY +  +    KSP
Sbjct: 231 VWSFGVVLYELFTYIEKSKSP 251

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 126
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 127 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 176
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 177 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 231
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 232 EKF-FPK 237

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 147
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 148 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 197
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 198 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 252
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 253 EKF-FPK 258

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           V  D + I+  IG+G F  V +++ + TKK YA+K   K  C  R +     +E++  + 
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HP ++ L  ++     D        + MV+     G L   L+     K      + +
Sbjct: 72  LEHPFLVNLW-YSFQDEED--------MFMVVDLLLGGDLRYHLQQNVHFKE-----ETV 117
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD--LGSVAPAVVKVCGSA 197
           K+F  ICE V      +     HRD+K  N+LL    +  + D  + ++ P   ++   A
Sbjct: 118 KLF--ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA 175
Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +            PY APE+F            D WSLG   Y +   + P+
Sbjct: 176 GTK------------PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 127
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 128 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 177
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 178 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 232
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 233 EKF-FPK 238

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 150
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 151 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 200
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 201 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 255
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 256 EKF-FPK 261

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ EA   
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA--- 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                        APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 205 ------------LAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 23/218 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 152
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 153 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 202
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           Y +PEL    S C   + +D+W+LGC++Y +     PF
Sbjct: 203 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPF 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKT 79
           VK   Y + + +G G F  V + +H  T  + A+K   +      +   +  RE+++ K 
Sbjct: 13  VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HP+I+ L           V+++ S + MV+ Y   G L + +         +   +  
Sbjct: 73  FRHPHIIKLYQ---------VISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESR 119
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-----SVAPAVVKVC 194
           ++F +I   V   H    +   HRDLK  NVLL    N  + D G     S    +   C
Sbjct: 120 RLFQQILSGVDYCHRHMVV---HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC 176
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           GS                 Y APE+  +          D+WS G +LYA+     PFD
Sbjct: 177 GSPN---------------YAAPEV--ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 147
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 148 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANAFVGTAQ------ 197
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 198 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 252
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 253 EKF-FPK 258

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 18/235 (7%)
Query: 18  KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QAIREVEH 76
           K  VY  S  + +   +GEG +  V    H  T +  A+KKI    +   A + +RE++ 
Sbjct: 3   KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K F H NI+ + +            + ++V ++     +  +  DL  R +    +S  
Sbjct: 63  LKHFKHENIITIFNIQRPDS----FENFNEVYII-----QELMQTDLH-RVISTQMLSDD 112
Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            I     +   AVKV H +  I   HRDLK +N+L+ ++ +  + D G           +
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 197 AEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
           +E    Q    E  +   YRAPE+    +     +  DVWS GC+L A  + + P
Sbjct: 170 SEPTGQQSGMTEYVATRWYRAPEVMLTSAK--YSRAMDVWSCGCIL-AELFLRRP 221

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 32/264 (12%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-AQAIREVEHHKTFVHP 83
           S ++  +EK+G G ++TV    +  T    ALK++     E   + AIRE+   K   H 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS-SVDILKMF 142
           NI+ L D         V+++ +++ +V  +     L   ++ R+VG       ++++K F
Sbjct: 64  NIVRLYD---------VIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 143 -LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             ++ + +   H+ K +   HRDLK  N+L+       L D G      + V        
Sbjct: 114 QWQLLQGLAFCHENKIL---HRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-------- 162
Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
               ++E  ++ YRAP+ L    +Y       D+WS GC+L  M   K  F    +    
Sbjct: 163 -NTFSSEVVTLWYRAPDVLMGSRTYST---SIDIWSCGCILAEMITGKPLFPGTNDEEQL 218
Query: 261 VALAVISGNIT---FPENTPFPQY 281
             +  I G      +P  T  P+Y
Sbjct: 219 KLIFDIMGTPNESLWPSVTKLPKY 242

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 94/239 (39%), Gaps = 28/239 (11%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKT 79
            D Y + E IG+G FS V    + +T +++A+K     K             RE      
Sbjct: 23  EDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HP+I+ LL+           +S   + MV  +     L  ++  R+      S     
Sbjct: 83  LKHPHIVELLE---------TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I EA++  HD   I   HRD+K  NVLLA+  N   + LG    A+       + 
Sbjct: 134 HYMRQILEALRYCHDNNII---HRDVKPENVLLASKENSAPVKLGDFGVAI-------QL 183
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                VA  R   P + APE+   + Y    +  DVW  G +L+ +     PF    ER
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPY---GKPVDVWGCGVILFILLSGCLPFYGTKER 239

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+++       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIIISKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 154
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 155 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 204
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 205 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 259
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 260 EKF-FPK 265

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQA 68
           G    ++    +      ++++G+G F +V +  +      T +  A+KK+     E   
Sbjct: 4   GAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 63
Query: 69  QAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
              RE+E  K+  H NI+       +            + +++ Y P G+L + L+    
Sbjct: 64  DFEREIEILKSLQHDNIVKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH-- 114
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
            K  +  + +L+   +IC+ ++     +   Y HRDL T N+L+ N+N   + D G    
Sbjct: 115 -KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG---- 166
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
            + KV         QD    +   P      + APE      + V    +DVWS G +LY
Sbjct: 167 -LTKVLP-------QDKEXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLY 215
Query: 243 AMCYF----KSP 250
            +  +    KSP
Sbjct: 216 ELFTYIEKSKSP 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI----ICHGRE--DQAQAIREVEHHK 78
            D Y + E++G G F+ V       T K YA K I    +   R    + +  REV   +
Sbjct: 11  EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPNI+ L D         +  + + V+++L     G L + L      K  ++  + 
Sbjct: 71  EIRHPNIITLHD---------IFENKTDVVLILELVSGGELFDFL----AEKESLTEDEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I + V   H  +    AH DLK  N++L + N P     L+D G       K+ 
Sbjct: 118 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH----KIE 170
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 AGNEFKNI------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 28/240 (11%)
Query: 18  KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QAIREVEH 76
           K  VY  S  + +   +GEG +  V    H  T +  A+KKI    +   A + +RE++ 
Sbjct: 3   KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K F H NI+ + +            + ++V ++     +  +  DL  R +    +S  
Sbjct: 63  LKHFKHENIITIFNIQRPDS----FENFNEVYII-----QELMQTDLH-RVISTQMLSDD 112
Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            I     +   AVKV H +  I   HRDLK +N+L+ ++ +  + D G     + ++   
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFG-----LARIIDE 164
Query: 197 AEAQNLQDVAAER------CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
           + A N +    +        +  YRAPE+    +     +  DVWS GC+L A  + + P
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCGCIL-AELFLRRP 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQA 68
           G    ++    +      ++++G+G F +V +  +      T +  A+KK+     E   
Sbjct: 2   GAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 61
Query: 69  QAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
              RE+E  K+  H NI+       +            + +++ Y P G+L + L+    
Sbjct: 62  DFEREIEILKSLQHDNIVKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH-- 112
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
            K  +  + +L+   +IC+ ++     +   Y HRDL T N+L+ N+N   + D G    
Sbjct: 113 -KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG---- 164
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
            + KV         QD    +   P      + APE      + V    +DVWS G +LY
Sbjct: 165 -LTKVLP-------QDKEXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLY 213
Query: 243 AMCYF----KSP 250
            +  +    KSP
Sbjct: 214 ELFTYIEKSKSP 225

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 80  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 129
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 130 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 174
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 226

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI----ICHGRE--DQAQAIREVEHHK 78
            D Y + E++G G F+ V       T K YA K I    +   R    + +  REV   +
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPNI+ L D         +  + + V+++L     G L + L      K  ++  + 
Sbjct: 64  EIRHPNIITLHD---------IFENKTDVVLILELVSGGELFDFL----AEKESLTEDEA 110
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I + V   H  +    AH DLK  N++L + N P     L+D G       K+ 
Sbjct: 111 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH----KIE 163
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 164 AGNEFKNIF------GTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 92  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 141
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 142 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 186
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 238

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 72  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 121
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 122 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 166
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 77  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 126
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 127 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 171
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 38/238 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
            D+Y I+E IG G +  VS      T ++ A+KKI        +  + +RE++  K F H
Sbjct: 53  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS------SV 136
            NI+ + D         +L  T      +PY    ++   L+L     H +       ++
Sbjct: 113 DNIIAIKD---------ILRPT------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL 157
Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
           + ++ FL ++   +K  H A+ I   HRDLK +N LL N+N  L   +G    A      
Sbjct: 158 EHVRYFLYQLLRGLKYMHSAQVI---HRDLKPSN-LLVNENCEL--KIGDFGMARGLCTS 211
Query: 196 SAEAQN-LQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            AE Q  + +  A R    YRAPEL   +  Y    Q  D+WS+GC+   M   +  F
Sbjct: 212 PAEHQYFMTEYVATRW---YRAPELMLSLHEYT---QAIDLWSVGCIFGEMLARRQLF 263

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 74  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 123
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 124 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 168
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 74  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 123
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 124 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 168
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 78  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 127
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 128 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 172
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 224

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 92  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 141
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 142 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 186
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 238

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 73  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 122
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 123 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 167
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 219

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PNI+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             LD  L G          ++ +V+ Y   G+L +      V +  M    I  +  +  
Sbjct: 82  NYLDSYLVG---------DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECL 127
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           +A++  H  + I   HR++K+ N+LL  D +  L D G         C     +  Q   
Sbjct: 128 QALEFLHSNQVI---HRNIKSDNILLGMDGSVKLTDFG--------FCAQITPE--QSKR 174
Query: 207 AERCSMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     PY  APE+    +Y     + D+WSLG +   M   + P+
Sbjct: 175 STMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 38/238 (15%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
            D+Y I+E IG G +  VS      T ++ A+KKI        +  + +RE++  K F H
Sbjct: 54  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS------SV 136
            NI+ + D         +L  T      +PY    ++   L+L     H +       ++
Sbjct: 114 DNIIAIKD---------ILRPT------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL 158
Query: 137 DILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
           + ++ FL ++   +K  H A+ I   HRDLK +N LL N+N  L   +G    A      
Sbjct: 159 EHVRYFLYQLLRGLKYMHSAQVI---HRDLKPSN-LLVNENCEL--KIGDFGMARGLCTS 212
Query: 196 SAEAQN-LQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            AE Q  + +  A R    YRAPEL   +  Y    Q  D+WS+GC+   M   +  F
Sbjct: 213 PAEHQYFMTEYVATRW---YRAPELMLSLHEYT---QAIDLWSVGCIFGEMLARRQLF 264

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 97/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FST  L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 147
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 148 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 197
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S C   + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 198 YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 252
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 253 EKF-FPK 258

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      +CG+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y AP +     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPAIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 109/261 (41%), Gaps = 58/261 (22%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           S KY + + +G G F  V  +   ++ KR+ALKK++    +D     RE++  K   H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKNRELDIMKVLDHVN 61
Query: 85  ILPLLDHA-LTGCADP--------------------------VLN-STSQVLMVLPYYPK 116
           I+ L+D+   TG  +P                          ++N S ++ L V+  Y  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 117 GTLANDLE--LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN 174
            TL   L+  +RS     M+ + I     ++  AV   H    +   HRD+K  N+L+ +
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISI--YIYQLFRAVGFIHS---LGICHRDIKPQNLLVNS 176
Query: 175 DNNPLLMDLGSVAPAVVKVCGSAEAQNL---QDVAAERCSMPYRAPEL-FHVDSYCVVDQ 230
            +N L            K+C    A+ L   +   A  CS  YRAPEL      Y     
Sbjct: 177 KDNTL------------KLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYT---P 221
Query: 231 RTDVWSLGCLLYAMCYFKSPF 251
             D+WS+GC+   +   K  F
Sbjct: 222 SIDLWSIGCVFGELILGKPLF 242

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH----KTF 80
           SD Y + E++G+G FS V    H  T   +A K  I + ++  A+  +++E      +  
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 85
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+ L D          +   S   +V      G L  D+    V + + S  D   
Sbjct: 86  QHPNIVRLHDS---------IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASH 132
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I E++   H        HR+LK  N+LLA+      + L     A+       E  
Sbjct: 133 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-------EVN 182
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + +       +  Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLVGYPPF 230

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 74  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 123
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV    + +  +  
Sbjct: 124 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVL-PQDKEFFKVK 174
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
                 + + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 175 EPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH----KTF 80
           SD Y + E++G+G FS V    H  T   +A K  I + ++  A+  +++E      +  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+ L D          +   S   +V      G L  D+    V + + S  D   
Sbjct: 63  QHPNIVRLHDS---------IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASH 109
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I E++   H        HR+LK  N+LLA+      + L     A+       E  
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-------EVN 159
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + +       +  Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 160 DSEAWHGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLVGYPPF 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH----KTF 80
           SD Y + E++G+G FS V    H  T   +A K  I + ++  A+  +++E      +  
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 61
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+ L D          +   S   +V      G L  D+    V + + S  D   
Sbjct: 62  QHPNIVRLHDS---------IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASH 108
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I E++   H        HR+LK  N+LLA+      + L     A+       E  
Sbjct: 109 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-------EVN 158
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + +       +  Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 159 DSEAWHGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLVGYPPF 206

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/251 (21%), Positives = 103/251 (41%), Gaps = 33/251 (13%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           +KY I E +G G F  V     + +KK Y  K +   G  DQ    +E+       H NI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNI 63
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L L +            S  +++M+  +     +    E  +     ++  +I+    ++
Sbjct: 64  LHLHES---------FESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQV 111
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           CEA++  H        H D++  N++     +           + +K+    +A+ L+  
Sbjct: 112 CEALQFLHSHN---IGHFDIRPENIIYQTRRS-----------STIKIIEFGQARQLK-- 155
Query: 206 AAERCSMPYRAPELF--HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
             +   + + APE +   V  + VV   TD+WSLG L+Y +    +PF  + E    +  
Sbjct: 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF--LAETNQQIIE 213
Query: 264 AVISGNITFPE 274
            +++   TF E
Sbjct: 214 NIMNAEYTFDE 224

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+  +     +  + +L+   +I
Sbjct: 77  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQAHA---ERIDHIKLLQYTSQI 126
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 127 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 171
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 223

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 34/251 (13%)
Query: 7   NLIFQMGCLCSKEAVYVKSDK----YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH 62
           N +F +      + V +K D     Y I E++G G F  V  +    T   +A K ++  
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 63  GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND 122
              D+    +E++      HP ++ L D              ++++M+  +   G L   
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHD---------AFEDDNEMVMIYEFMSGGEL--- 241
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA--NDNNPLL 180
            E  +   + MS  + ++   ++C+ +   H+     Y H DLK  N++      N   L
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKL 298
Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           +D G  A    K          Q V     +  + APE   V     V   TD+WS+G L
Sbjct: 299 IDFGLTAHLDPK----------QSVKVTTGTAEFAAPE---VAEGKPVGYYTDMWSVGVL 345
Query: 241 LYAMCYFKSPF 251
            Y +    SPF
Sbjct: 346 SYILLSGLSPF 356

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH----KTF 80
           SD Y + E++G+G FS V    H  T   +A K  I + ++  A+  +++E      +  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKL 62
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+ L D          +   S   +V      G L  D+    V + + S  D   
Sbjct: 63  QHPNIVRLHDS---------IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASH 109
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I E++   H        HR+LK  N+LLA+      + L     A+       E  
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-------EVN 159
Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + +       +  Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 160 DSEAWHGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLVGYPPF 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 65  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 111
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 112 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 160
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 161 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 36/253 (14%)
Query: 7   NLIFQMGCLCSKEAVYVKSDK------YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI- 59
           NL FQ G L +   +++ S K      Y  V+K+G G +  V L     T    A+K I 
Sbjct: 13  NLYFQ-GDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 60  -ICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGT 118
                    ++ + EV   K   HPNI+ L D                  +V+  Y  G 
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD---------FFEDKRNYYLVMECYKGGE 122
Query: 119 LANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP 178
           L +++    + +   + VD   +  ++   V   H    +   HRDLK  N+LL +    
Sbjct: 123 LFDEI----IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV---HRDLKPENLLLESKEKD 175
Query: 179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG 238
            L+        +V    SA  +N + +     +  Y APE+         D++ DVWS+G
Sbjct: 176 ALI-------KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK----YDEKCDVWSIG 224
Query: 239 CLLYAMCYFKSPF 251
            +L+ +     PF
Sbjct: 225 VILFILLAGYPPF 237

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 92/242 (38%), Gaps = 30/242 (12%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQA 70
           G     E +Y +S  Y + E++G+G FS V         + YA K I        D  + 
Sbjct: 10  GVDLGTENLYFQS-MYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
            RE    +   HPNI+ L D          ++      ++      G L  D+    V +
Sbjct: 69  EREARICRLLKHPNIVRLHDS---------ISEEGHHYLIFDLVTGGELFEDI----VAR 115
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
            Y S  D      +I EAV   H    +   HRDLK  N+LLA+      + L     A+
Sbjct: 116 EYYSEADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAI 172
Query: 191 VKVCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
                  E +  Q         P Y +PE+   D Y    +  D+W+ G +LY +     
Sbjct: 173 -------EVEGEQQAWFGFAGTPGYLSPEVLRKDPY---GKPVDLWACGVILYILLVGYP 222
Query: 250 PF 251
           PF
Sbjct: 223 PF 224

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 34/251 (13%)
Query: 7   NLIFQMGCLCSKEAVYVKSDK----YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH 62
           N +F +      + V +K D     Y I E++G G F  V  +    T   +A K ++  
Sbjct: 28  NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 87
Query: 63  GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND 122
              D+    +E++      HP ++ L D              ++++M+  +   G L   
Sbjct: 88  HESDKETVRKEIQTMSVLRHPTLVNLHD---------AFEDDNEMVMIYEFMSGGEL--- 135
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA--NDNNPLL 180
            E  +   + MS  + ++   ++C+ +   H+     Y H DLK  N++      N   L
Sbjct: 136 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKL 192
Query: 181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
           +D G  A    K          Q V     +  + APE   V     V   TD+WS+G L
Sbjct: 193 IDFGLTAHLDPK----------QSVKVTTGTAEFAAPE---VAEGKPVGYYTDMWSVGVL 239
Query: 241 LYAMCYFKSPF 251
            Y +    SPF
Sbjct: 240 SYILLSGLSPF 250

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 88/230 (38%), Gaps = 29/230 (12%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           +D+Y + E IG+G FS V       T   YA K I        D  +  RE    +   H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+ L D          ++      +V      G L  D+    V + Y S  D     
Sbjct: 63  SNIVRLHDS---------ISEEGFHYLVFDLVTGGELFEDI----VAREYYSEADASHCI 109
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I EAV   H    +   HRDLK  N+LLA+      + L     A+       E Q  
Sbjct: 110 QQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAI-------EVQGD 159
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           Q         P Y +PE+   ++Y    +  D+W+ G +LY +     PF
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAY---GKPVDIWACGVILYILLVGYPPF 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 39/236 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHKT 79
           D Y I E++G G F+ V       T   YA K I         + +      REV   + 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            +HPNI+ L D         V  + + V+++L     G L + L      K  +S  +  
Sbjct: 72  VLHPNIITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEAT 118
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVCG 195
               +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++  
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIED 171
Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             E +N+           + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 172 GVEFKNIFGTPE------FVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      + G+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A +    A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S     + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKS---ASKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 45/249 (18%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++ +    G+G F TV L +   T    A+KK+I   R  + + ++ ++      HPNI
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNI 81
Query: 86  LPLLDHALT----GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD---- 137
           + L  +  T       D  LN      +V+ Y P      D   R    +Y   V     
Sbjct: 82  VQLQSYFYTLGERDRRDIYLN------VVMEYVP------DTLHRCCRNYYRRQVAPPPI 129
Query: 138 ILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
           ++K+FL ++  ++   H    +   HRD+K  NVL+            + A   +K+C  
Sbjct: 130 LIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLV------------NEADGTLKLCDF 176
Query: 197 AEAQNL---QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             A+ L   +   A  CS  YRAPEL   + +       D+WS+GC+   M   +  F  
Sbjct: 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTT--AVDIWSVGCIFAEMMLGEPIF-- 232
Query: 254 VYERGDSVA 262
              RGD+ A
Sbjct: 233 ---RGDNSA 238

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 97/247 (39%), Gaps = 26/247 (10%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +GEG FSTV L     T + YA+K +      ++   I+E +        +++  LDH  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL------EKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                       ++   L Y   G L     +R +G    +         +I  A++  H
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLK--YIRKIGSFDETCTRFYTA--EIVSALEYLH 149
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP 213
               I   HRDLK  N+LL  D +  + D G+ A  +      A A      A       
Sbjct: 150 GKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANXFVGTAQ------ 199
Query: 214 YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFP 273
           Y +PEL    S     + +D+W+LGC++Y +     PF    E    +   +I     FP
Sbjct: 200 YVSPELLTEKS---AXKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLEYDFP 254
Query: 274 ENTPFPQ 280
           E   FP+
Sbjct: 255 EKF-FPK 260

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 94/240 (39%), Gaps = 44/240 (18%)
Query: 22  YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK----KIICHGREDQAQAIREVEHH 77
           + K   ++ ++ IG+G F  V L  H   +  YA+K    K I   +E++          
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 78  KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-----LRSVGKHY 132
           K   HP ++ L  H     AD       ++  VL Y   G L   L+     L    + Y
Sbjct: 94  KNVKHPFLVGL--HFSFQTAD-------KLYFVLDYINGGELFYHLQRERCFLEPRARFY 144
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
            +         +I  A+   H    +   +RDLK  N+LL +  + +L D G        
Sbjct: 145 AA---------EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG-------- 184
Query: 193 VCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +C      N     +  C  P Y APE+ H   Y   D+  D W LG +LY M Y   PF
Sbjct: 185 LCKENIEHN--STTSTFCGTPEYLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 26/228 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G     V +        N   
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA--TVFRYNNRERLLNKM- 167
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                 ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 168 ----XGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G     +  V      + L +
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERLLN 164
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                 ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G G + +V     ++ +++ A+KK+      + H R    +  RE+   K   H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR----RTYRELRLLKHLKHENVIG 91
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
           LLD      +   +   S+V +V      G   N++    V    +S   +  +  ++  
Sbjct: 92  LLDVFTPATS---IEDFSEVYLVTTLM--GADLNNI----VKSQALSDEHVQFLVYQLLR 142
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +K  H A  I   HRDLK +NV +  D+   ++D G    A  ++ G           A
Sbjct: 143 GLKYIHSAGII---HRDLKPSNVAVNEDSELRILDFGLARQADEEMTG---------YVA 190
Query: 208 ERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            R    YRAPE+    ++   +Q  D+WS+GC++  +   K+ F
Sbjct: 191 TRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 43/259 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA---QAIREVEHHKTFVH 82
           D + I   +G+G F  V L    ++    ALK +     E +    Q  RE+E      H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L ++              ++ ++L Y P+G L  +L+ +S       +  I++  
Sbjct: 83  PNILRLYNY---------FYDRRRIYLILEYAPRGELYKELQ-KSCTFDEQRTATIME-- 130
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SV-APAVVK--VCGSAE 198
            ++ +A+   H  K I   HRD+K  N+LL       + D G SV AP++ +  +CG+  
Sbjct: 131 -ELADALMYCHGKKVI---HRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGT-- 184
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                        + Y  PE+     +   +++ D+W +G L Y +     PF++     
Sbjct: 185 -------------LDYLPPEMIEGRMH---NEKVDLWCIGVLCYELLVGNPPFESASH-- 226
Query: 259 DSVALAVISGNITFPENTP 277
           +     ++  ++ FP + P
Sbjct: 227 NETYRRIVKVDLKFPASVP 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T     I
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNEKRI 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L  ++       +      S + MV+ Y   G + +   LR +G+               
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFY-----A 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAVVKVCGSAEAQNL 202
            + V  F     +   +RDLK  N+L+       + D G    V      + G+ E    
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPE---- 203
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----VYER 257
                      Y APE+     Y   ++  D W+LG L+Y M     PF       +YE+
Sbjct: 204 -----------YLAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 258 GDSVALAVISGNITFP 273
                  ++SG + FP
Sbjct: 250 -------IVSGKVRFP 258

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 95  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 143
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + K     E  ++ + 
Sbjct: 144 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDK-----EFDSVHNK 195
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 196 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 253 QGRRLLQPEYCPDPLYE 269

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPN 84
           KY  +EKIGEG + TV   ++ +T +  ALK++     ++   + A+RE+   K   H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD--ILKMF 142
           I+ L D         VL+S  ++ +V  +        D +L+         +D  I+K F
Sbjct: 63  IVRLHD---------VLHSDKKLTLVFEFC-------DQDLKKYFDSCNGDLDPEIVKSF 106
Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV-CGSAEAQ 200
           L ++ + +   H    +   HRDLK  N+L+  +    L D G      + V C SAE  
Sbjct: 107 LFQLLKGLGFCHSRNVL---HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV 163
Query: 201 NLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            L           YR P+ LF    Y       D+WS GC+   +     P 
Sbjct: 164 TLW----------YRPPDVLFGAKLYST---SIDMWSAGCIFAELANAARPL 202

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            + ++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ + P G+L   L+     K  +  + +L+   +I
Sbjct: 77  VKYKGVCYSA-------GRRNLKLIMEFLPYGSLREYLQKH---KERIDHIKLLQYTSQI 126
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HRDL T N+L+ N+N   + D G     + KV         QD 
Sbjct: 127 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 171
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 32/240 (13%)
Query: 17  SKEAVYVK--SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYA---LKKIICHGREDQAQAI 71
            +E +Y +  SD+Y  V+K+G G +  V L +   T    A   +KK       +    +
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
            EV   K   HPNI+ L +                  +V+  Y  G L +++ LR     
Sbjct: 70  DEVAVLKQLDHPNIMKLYE---------FFEDKRNYYLVMEVYRGGELFDEIILR----Q 116
Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV 191
             S VD   +  ++       H    +   HRDLK  N+LL + +   L+ +     +  
Sbjct: 117 KFSEVDAAVIMKQVLSGTTYLHKHNIV---HRDLKPENLLLESKSRDALIKIVDFGLSAH 173
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              G    + L        +  Y APE+         D++ DVWS G +LY +     PF
Sbjct: 174 FEVGGKMKERL-------GTAYYIAPEVLRKK----YDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 69
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 70  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 122
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 123 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 171
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +   E C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 172 NSLTEPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            ++++G+G F +V +  +      T +  A+KK+     E      RE+E  K+  H NI
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +       +            + +++ Y P G+L + L+     K  +  + +L+   +I
Sbjct: 75  VKYKGVCYSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQI 124
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           C+ ++     +   Y HR+L T N+L+ N+N   + D G     + KV         QD 
Sbjct: 125 CKGMEYLGTKR---YIHRNLATRNILVENENRVKIGDFG-----LTKVLP-------QDK 169
Query: 206 AAERCSMP------YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF----KSP 250
              +   P      + APE      + V    +DVWS G +LY +  +    KSP
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGVVLYELFTYIEKSKSP 221

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 92
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 93  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 141
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 142 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEXXSVHNK 193
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 194 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 250
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 251 QGRRLLQPEYCPDPLYE 267

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  ++ IGEG +  VS       K R A+KKI     +   Q  +RE++    F H N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D         +L +++   M   Y  +  +  DL  + +    +S+  I     +I
Sbjct: 104 IGIRD---------ILRASTLEAMRDVYIVQDLMETDL-YKLLKSQQLSNDHICYFLYQI 153
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN--LQ 203
              +K  H A  +   HRDLK +N+L+    +  + D G     + ++          L 
Sbjct: 154 LRGLKYIHSANVL---HRDLKPSNLLINTTCDLKICDFG-----LARIADPEHDHTGFLT 205
Query: 204 DVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
           +  A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 206 EXVATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 152
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 153 LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 201
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 202 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 253
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 311 QGRRLLQPEYCPDPLYE 327

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 94
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 95  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 143
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 144 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 195
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 196 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 253 QGRRLLQPEYCPDPLYE 269

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 94  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 142
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 143 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 194
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 195 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 252 QGRRLLQPEYCPDPLYE 268

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 99/232 (42%), Gaps = 37/232 (15%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           + ++EK+GEG + +V    H +T +  A+K++      D  + I+E+   +    P+++ 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                            + + +V+ Y   G++++ + LR+     ++  +I  +     +
Sbjct: 89  YYGSYF---------KNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLK 136
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            ++  H  + I   HRD+K  N+LL  + +  L D G        V G      L D  A
Sbjct: 137 GLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFG--------VAG-----QLTDXMA 180
Query: 208 ER---CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
           +R      P + APE+     Y  V    D+WSLG     M   K P+  ++
Sbjct: 181 KRNXVIGTPFWMAPEVIQEIGYNCV---ADIWSLGITAIEMAEGKPPYADIH 229

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 98
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 99  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 147
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 148 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 199
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 200 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 256
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 257 QGRRLLQPEYCPDPLYE 273

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 56/268 (20%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           VK   +  +  +G+G F  V L +   T++ YA+K +       +   I++ +   T V 
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKIL------KKDVVIQDDDVECTMVE 69
Query: 83  PNILPLLDH-----ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK------- 130
             +L LLD       L  C      +  ++  V+ Y   G L     ++ VGK       
Sbjct: 70  KRVLALLDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLM--YHIQQVGKFKEPQAV 123
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
            Y + + I   FL            + I Y  RDLK  NV+L ++ +  + D G      
Sbjct: 124 FYAAEISIGLFFLH----------KRGIIY--RDLKLDNVMLDSEGHIKIADFG------ 165
Query: 191 VKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
             +C     +++ D    R  C  P Y APE+     Y    +  D W+ G LLY M   
Sbjct: 166 --MC----KEHMMDGVTTREFCGTPDYIAPEIIAYQPYG---KSVDWWAYGVLLYEMLAG 216
Query: 248 KSPFDTVYERGDSVALAVISGNITFPEN 275
           + PFD   E  D +  +++  N+++P++
Sbjct: 217 QPPFDG--EDEDELFQSIMEHNVSYPKS 242

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 94  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 142
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 143 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 194
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 195 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 252 QGRRLLQPEYCPDPLYE 268

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG    V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 161
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 91
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 92  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 140
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 141 AKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNK 192
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 193 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 249
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 250 QGRRLLQPEYCPDPLYE 266

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + I++ IG G F  V++++   T++ YA+K +      ++ + ++  E        ++
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL------NKWEMLKRAETACFREERDV 143
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L   D              + + +V+ YY  G L   L L S  +  +   D+ + +  I
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL---LTLLSKFEDKLPE-DMARFY--I 197
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            E V        + Y HRD+K  NVLL  + +  L D GS     +K+      Q+   V
Sbjct: 198 GEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSVAV 253
Query: 206 AAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                +  Y +PE+     D         D WSLG  +Y M Y ++PF
Sbjct: 254 G----TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHKTFVHPNILPL 88
           +G G + +V      ++ ++ A+KK+    R  Q++     A RE+   K   H N++ L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           LD   T  +   L +     +V+P+     +  DL+ + +G  + S   I  +  ++ + 
Sbjct: 107 LD-VFTPASS--LRNFYDFYLVMPF-----MQTDLQ-KIMGMEF-SEEKIQYLVYQMLKG 156
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +K  H A      HRDLK  N+ +  D    ++D G    A  ++ G             
Sbjct: 157 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 202
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +  YRAPE+  + S+   +Q  D+WS+GC++  M   K+ F
Sbjct: 203 -VTRWYRAPEV--ILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +    H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 67  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 113
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 162
Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 109/271 (40%), Gaps = 55/271 (20%)
Query: 25  SDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
            ++Y IV  +GEG F   V  ++H +   R ALK  I    E   +A R        +  
Sbjct: 32  QERYEIVSTLGEGTFGRVVQCVDHRRGGARVALK--IIKNVEKYKEAAR--------LEI 81
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK--- 140
           N+L  ++       DP  N    V M   +   G +    EL       +S+ D LK   
Sbjct: 82  NVLEKINEK-----DPD-NKNLCVQMFDWFDYHGHMCISFELLG-----LSTFDFLKDNN 130
Query: 141 -----------MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL------ 183
                      M  ++C+AVK  HD K     H DLK  N+L  N +  L  +L      
Sbjct: 131 YLPYPIHQVRHMAFQLCQAVKFLHDNK---LTHTDLKPENILFVNSDYELTYNLEKKRDE 187
Query: 184 GSVAPAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
            SV    V+V   GSA  + ++   + + R    YRAPE+     +    Q  DVWS+GC
Sbjct: 188 RSVKSTAVRVVDFGSATFDHEHHSTIVSTR---HYRAPEVILELGWS---QPCDVWSIGC 241
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGNI 270
           +++      + F T   R     +  I G I
Sbjct: 242 IIFEYYVGFTLFQTHDNREHLAMMERILGPI 272

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 40/230 (17%)
Query: 30  IVEKIGEGGFSTVSL-IEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNIL 86
           +VE +G+G +  V   + H ++    A+K  I   R++Q+   RE E + T +  H NIL
Sbjct: 12  LVECVGKGRYGEVWRGLWHGES---VAVK--IFSSRDEQSW-FRETEIYNTVLLRHDNIL 65
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             +   +T       NS++Q+ ++  Y+  G+L + L+ +++  H       L + L + 
Sbjct: 66  GFIASDMTS-----RNSSTQLWLITHYHEHGSLYDFLQRQTLEPH-------LALRLAVS 113
Query: 147 EA-------VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS--A 197
            A       V++F      A AHRD K+ NVL+ ++    + DLG    AV+   GS   
Sbjct: 114 AACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGL---AVMHSQGSDYL 170
Query: 198 EAQNLQDVAAERCSMPYRAPELF--HVDSYCVVDQR-TDVWSLGCLLYAM 244
           +  N   V  +R    Y APE+    + + C    + TD+W+ G +L+ +
Sbjct: 171 DIGNNPRVGTKR----YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +E IG GGF  V   +H    K Y +K++    + +  +A REV+      H NI+    
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV---- 67
Query: 91  HALTGCA-----DPVLNS-------TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
               GC      DP  +S       T  + + + +  KGTL   +E R   K  +  V  
Sbjct: 68  -HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           L++F +I + V   H  K I   +RDLK +N+ L +     + D G V            
Sbjct: 125 LELFEQITKGVDYIHSKKLI---NRDLKPSNIFLVDTKQVKIGDFGLVTS---------- 171
Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
            +N       + ++ Y +PE      Y    +  D+++LG +L  + +     DT +E
Sbjct: 172 LKNDGKRXRSKGTLRYMSPEQISSQDYG---KEVDLYALGLILAELLHV---CDTAFE 223

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 22/228 (9%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + I++ IG G F  V++++   T++ YA+K +      ++ + ++  E        ++
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL------NKWEMLKRAETACFREERDV 127
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L   D              + + +V+ YY  G L   L L S  +  +   D+ + +  I
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDL---LTLLSKFEDKLPE-DMARFY--I 181
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            E V        + Y HRD+K  NVLL  + +  L D GS     +K+      Q+   V
Sbjct: 182 GEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSVAV 237
Query: 206 AAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                +  Y +PE+     D         D WSLG  +Y M Y ++PF
Sbjct: 238 G----TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 93/238 (39%), Gaps = 28/238 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           D Y + E IG+G FS V    + +T +++A+K     K             RE       
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HP+I+ LL+           +S   + MV  +     L  ++  R+      S      
Sbjct: 86  KHPHIVELLE---------TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 136
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I EA++  HD   I   HRD+K   VLLA+  N   + LG    A+       +  
Sbjct: 137 YMRQILEALRYCHDNNII---HRDVKPHCVLLASKENSAPVKLGGFGVAI-------QLG 186
Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
               VA  R   P + APE+   + Y    +  DVW  G +L+ +     PF    ER
Sbjct: 187 ESGLVAGGRVGTPHFMAPEVVKREPY---GKPVDVWGCGVILFILLSGCLPFYGTKER 241

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G G + +V     ++ +++ A+KK+      + H R    +  RE+   K   H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR----RTYRELRLLKHLKHENVIG 91
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK-HYMSSVDILKMFLKIC 146
           LLD      +   +   S+V +V       T     +L ++ K   +S   +  +  ++ 
Sbjct: 92  LLDVFTPATS---IEDFSEVYLV-------TTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
             +K  H A  I   HRDLK +NV +  D+   ++D G    A  ++ G           
Sbjct: 142 RGLKYIHSAGII---HRDLKPSNVAVNEDSELRILDFGLARQADEEMTG---------YV 189
Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           A R    YRAPE+    ++   +Q  D+WS+GC++  +   K+ F
Sbjct: 190 ATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 92
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 93  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 141
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 142 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 193
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 194 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 250
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 251 QGRRLLQPEYCPDPLYE 267

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF 80
           + +K + + + + +G+G F  V L E  +T + +A+K +    ++D      +VE   T 
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVEC--TM 66
Query: 81  VHPNILPL-LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           V   +L L  +H           +   +  V+ Y   G L     ++S  K  +S     
Sbjct: 67  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFY 124
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I   ++  H +K I Y  RDLK  N+LL  D +  + D G     ++   G A+ 
Sbjct: 125 AA--EIILGLQFLH-SKGIVY--RDLKLDNILLDKDGHIKIADFGMCKENML---GDAKT 176
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                   E C  P Y APE+     Y   +   D WS G LLY M   +SPF
Sbjct: 177 N-------EFCGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 111
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 112 LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 160
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 161 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 212
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 213 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 269
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 270 QGRRLLQPEYCPDPLYE 286

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 90
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 91  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 139
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 140 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 191
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 192 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 249 QGRRLLQPEYCPDPLYE 265

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 93/239 (38%), Gaps = 28/239 (11%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKT 79
            D Y + E IG+G FS V    + +T +++A+K     K             RE      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HP+I+ LL+           +S   + MV  +     L  ++  R+      S     
Sbjct: 83  LKHPHIVELLE---------TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I EA++  HD   I   HRD+K   VLLA+  N   + LG    A+       + 
Sbjct: 134 HYMRQILEALRYCHDNNII---HRDVKPHCVLLASKENSAPVKLGGFGVAI-------QL 183
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                VA  R   P + APE+   + Y    +  DVW  G +L+ +     PF    ER
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPY---GKPVDVWGCGVILFILLSGCLPFYGTKER 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 91
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 92  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 140
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 141 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 192
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 193 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 249
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 250 QGRRLLQPEYCPDPLYE 266

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G     +  V      + L +
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERLLN 164
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                 ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G     +  V      + L  
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERL-- 162
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +     ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 163 LNKMXGTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR-EVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K +      D  + I+ E+  +K   H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G             + L Y   G L + +E   +G   M   D  + F +
Sbjct: 66  VVKFYGHRREGNIQ---------YLFLEYCSGGELFDRIE-PDIG---MPEPDAQRFFHQ 112
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H    I   HRD+K  N+LL   +N  + D G     +  V      + L +
Sbjct: 113 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFG-----LATVFRYNNRERLLN 164
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                 ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHA--EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 34/232 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFV 81
           SD+Y  V+K+G G +  V L +   T    A   +KK       +    + EV   K   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L +                  +V+  Y  G L +++ LR       S VD   +
Sbjct: 63  HPNIMKLYE---------FFEDKRNYYLVMEVYRGGELFDEIILR----QKFSEVDAAVI 109
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA-PAVVKVCGSAEAQ 200
             ++       H    +   HRDLK  N+LL + +   L+ +      A  +V G  +  
Sbjct: 110 MKQVLSGTTYLHKHNIV---HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK-- 164
Query: 201 NLQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                  ER    Y  APE+         D++ DVWS G +LY +     PF
Sbjct: 165 -------ERLGTAYYIAPEVLRKK----YDEKCDVWSCGVILYILLCGYPPF 205

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 86  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 135
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL   ++  + D G    A V          L + 
Sbjct: 136 LRGLKYIHSANVL---HRDLKPSNLLLNTTSDLKICDFGL---ARVADPDHDHTGFLTEY 189
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 190 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 223

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 36/257 (14%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-------REVEHHKTFVHPN 84
           ++IG+GGF  V      + K   A+K +I    E + + I       REV       HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L           ++++  +  MV+ + P G L + L  ++   H +     L++ L 
Sbjct: 85  IVKLYG---------LMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLD 130
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG-SAEAQNLQ 203
           I   ++   +  P    HRDL++ N+ L +        L   AP   KV   S   Q++ 
Sbjct: 131 IALGIEYMQNQNP-PIVHRDLRSPNIFLQS--------LDENAPVCAKVADFSLSQQSVH 181
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
            V+    +  + APE    +      ++ D +S   +LY +   + PFD  Y  G    +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE-YSYGKIKFI 239
Query: 264 AVISG---NITFPENTP 277
            +I       T PE+ P
Sbjct: 240 NMIREEGLRPTIPEDCP 256

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 85
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 86  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 134
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 135 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 186
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 187 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 243
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 244 QGRRLLQPEYCPDPLYE 260

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 88
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 89  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 138 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 189
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 190 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 247 QGRRLLQPEYCPDPLYE 263

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 84  IGIND----IIRAPTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 134 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKIXDFGL---ARVADPDHDHTGFLTEY 187
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 188 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 94  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 142
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 143 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 194
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 195 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 252 QGRRLLQPEYCPDPLYE 268

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 112
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 113 LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 161
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 162 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 213
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 214 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 270
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 271 QGRRLLQPEYCPDPLYE 287

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH 82
           +KY  + KIGEG +  V    +  T +  A+KK +    +D   +  A+RE+   K   H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQLKH 61
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAN-DLELRSVGKHYMSSVDILKM 141
           PN++ LL+         V     ++ +V  Y     L   D   R V +H + S+     
Sbjct: 62  PNLVNLLE---------VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT---- 108
Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +  +AV   H    I   HRD+K  N+L+                +V+K+C    A+ 
Sbjct: 109 -WQTLQAVNFCHKHNCI---HRDVKPENILITKH-------------SVIKLCDFGFARL 151
Query: 202 LQDVA----AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           L   +     E  +  YR+PEL   D+        DVW++GC+ 
Sbjct: 152 LTGPSDYYDDEVATRWYRSPELLVGDTQ--YGPPVDVWAIGCVF 193

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNI 85
           E IG G F  V   +L+++   K   A+K   +I   G  + +Q + E    K F HPN+
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL   L     P        L+VLPY   G L N +   +   H  +  D++   L++
Sbjct: 94  LSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 142
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +K     K   + HRDL   N +L       + D G     + +     E  ++ + 
Sbjct: 143 AKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEYYSVHNK 194
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              +  + + A E      +     ++DVWS G LL+ +    +P        D     +
Sbjct: 195 TGAKLPVKWMALESLQTQKFTT---KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 251
Query: 266 ISGNITFPENTPFPQYQ 282
               +  PE  P P Y+
Sbjct: 252 QGRRLLQPEYCPDPLYE 268

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHKTFVHPNILPL 88
           +G G + +V      ++ ++ A+KK+    R  Q++     A RE+   K   H N++ L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           LD   T  +   L +     +V+P+     +  DL+ + +G  + S   I  +  ++ + 
Sbjct: 89  LD-VFTPASS--LRNFYDFYLVMPF-----MQTDLQ-KIMGLKF-SEEKIQYLVYQMLKG 138
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +K  H A      HRDLK  N+ +  D    ++D G    A  ++ G             
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 184
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +  YRAPE+  + S+   +Q  D+WS+GC++  M   K+ F
Sbjct: 185 -VTRWYRAPEV--ILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF 80
           + +K + + + + +G+G F  V L E  +T + +A+K +    ++D      +VE   T 
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVEC--TM 65
Query: 81  VHPNILPL-LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           V   +L L  +H           +   +  V+ Y   G L     ++S  K  +S     
Sbjct: 66  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFY 123
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I   ++  H +K I Y  RDLK  N+LL  D +  + D G     ++   G A+ 
Sbjct: 124 AA--EIILGLQFLH-SKGIVY--RDLKLDNILLDKDGHIKIADFGMCKENML---GDAKT 175
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                     C  P Y APE+     Y   +   D WS G LLY M   +SPF
Sbjct: 176 NXF-------CGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 34/235 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           +  +E +G G FS V L++   T K +ALK I        +    E+   K   H NI+ 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
           L D         +  ST+   +V+     G L + +  R V     +  D   +  ++  
Sbjct: 71  LED---------IYESTTHYYLVMQLVSGGELFDRILERGV----YTEKDASLVIQQVLS 117
Query: 148 AVKVFHDAKPIAYAHRDLKTANVL-LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           AVK  H+       HRDLK  N+L L  + N  +M        +     S   QN   + 
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM--------ITDFGLSKMEQN--GIM 164
Query: 207 AERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
           +  C  P Y APE+     Y    +  D WS+G + Y +     PF   YE  +S
Sbjct: 165 STACGTPGYVAPEVLAQKPY---SKAVDCWSIGVITYILLCGYPPF---YEETES 213

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGIND----IIRAPTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKICDFGL---ARVADPDHDHTGFLTEY 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 39/245 (15%)
Query: 17  SKEAVYVKSD-----KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI 71
           S+E  +V+ D      + IV ++G+G F  V   ++ +T    A K I     E+    I
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGK 130
            E+E   T  HP I+ LL                ++ +++ + P G + A  LEL     
Sbjct: 65  VEIEILATCDHPYIVKLLG---------AYYHDGKLWIMIEFCPGGAVDAIMLEL----D 111
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
             ++   I  +  ++ EA+   H  + I   HRDLK  NVL+  + +  L D G      
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFG------ 162
Query: 191 VKVCGSAEAQNLQDVAAERC--SMPYR-APELFHVDSY--CVVDQRTDVWSLGCLLYAMC 245
                   A+NL+ +         PY  APE+   ++      D + D+WSLG  L  M 
Sbjct: 163 ------VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
Query: 246 YFKSP 250
             + P
Sbjct: 217 QIEPP 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKSQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D+   ++D G        
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDSELKILDFG-------- 170
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +C   + +    VA       YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 171 LCRHTDDEMTGYVATRW----YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGIND----IIRAPTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKICDFGL---ARVADPDHDHTGFLTEY 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPN 84
           KY  +EKIGEG + TV   ++ +T +  ALK++     ++   + A+RE+   K   H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD--ILKMF 142
           I+ L D         VL+S  ++ +V  +        D +L+         +D  I+K F
Sbjct: 63  IVRLHD---------VLHSDKKLTLVFEFC-------DQDLKKYFDSCNGDLDPEIVKSF 106
Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV-CGSAEAQ 200
           L ++ + +   H    +   HRDLK  N+L+  +    L + G      + V C SAE  
Sbjct: 107 LFQLLKGLGFCHSRNVL---HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 201 NLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            L           YR P+ LF    Y       D+WS GC+   +     P 
Sbjct: 164 TLW----------YRPPDVLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 84  IGIND----IIRAPTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 134 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKICDFGL---ARVADPDHDHTGFLTEY 187
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 188 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 221

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 32/229 (13%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-------REVEHHKTFVHPN 84
           ++IG+GGF  V      + K   A+K +I    E + + I       REV       HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L           ++++  +  MV+ + P G L + L  ++   H +     L++ L 
Sbjct: 85  IVKLYG---------LMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLD 130
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG-SAEAQNLQ 203
           I   ++   +  P    HRDL++ N+ L +        L   AP   KV       Q++ 
Sbjct: 131 IALGIEYMQNQNP-PIVHRDLRSPNIFLQS--------LDENAPVCAKVADFGTSQQSVH 181
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            V+    +  + APE    +      ++ D +S   +LY +   + PFD
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFD 229

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 85
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 86  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 138
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 139 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 187
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 188 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 233

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 84  IGIND----IIRAPTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 134 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKICDFGL---ARVADPDHDHTGFLTEY 187
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 188 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           + ++  IG G ++ V L+   +T + YA+K   K + +  ED      + E H  F   +
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV--QTEKH-VFEQAS 78
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDIL 139
             P L   L  C      + S++  V+ Y   G L   ++ +        + Y + + + 
Sbjct: 79  NHPFL-VGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 132
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
                   A+   H+   I   +RDLK  NVLL ++ +  L D G        +C   E 
Sbjct: 133 --------ALNYLHERGII---YRDLKLDNVLLDSEGHIKLTDYG--------MC--KEG 171
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
               D  +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 172 LRPGDTTSXFCGTPNYIAPEILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNI 85
           +  +GEG F  VSL      +  T +  A+K +    G + ++   +E++  +T  H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +        GC +    ++ Q  +V+ Y P G+L + L   S+G        +L    +I
Sbjct: 96  I-----KYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHSIG-----LAQLLLFAQQI 143
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           CE +   H      Y HRDL   NVLL ND    + D G +A AV       E      V
Sbjct: 144 CEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEXYRV 193
Query: 206 AAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
             +  S + + APE      +      +DVWS G  LY +
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYA---SDVWSFGVTLYEL 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH 91
           E +G+G F     + H +T +   +K++I    E Q   ++EV+  +   HPN+L  +  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG- 74
Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKV 151
                   VL    ++  +  Y   GTL   ++       +   V   K    I   +  
Sbjct: 75  --------VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK---DIASGMAY 123
Query: 152 FHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER-- 209
            H    I   HRDL + N L+  + N ++ D G     V +       ++L+    ++  
Sbjct: 124 LHSMNII---HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 210 --CSMPYR-APELFHVDSYCVVDQRTDVWSLGCLL 241
                PY  APE+ +  SY   D++ DV+S G +L
Sbjct: 181 TVVGNPYWMAPEMINGRSY---DEKVDVFSFGIVL 212

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 48/242 (19%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFV-- 81
           KY   + IG G  S V    H  T   +A+K +         +Q + +RE    +T +  
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 82  ----HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD 137
               HP+I+ L+D            S+S + +V     KG L + L      K  +S  +
Sbjct: 155 QVAGHPHIITLIDS---------YESSSFMFLVFDLMRKGELFDYL----TEKVALSEKE 201
Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
              +   + EAV   H    +   HRDLK  N+LL ++    L D G         C   
Sbjct: 202 TRSIMRSLLEAVSFLHANNIV---HRDLKPENILLDDNMQIRLSDFGF-------SCHLE 251
Query: 198 EAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQ-------RTDVWSLGCLLYAMCYFKS 249
             + L+++    C  P Y APE+      C +D+         D+W+ G +L+ +     
Sbjct: 252 PGEKLREL----CGTPGYLAPEILK----CSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
Query: 250 PF 251
           PF
Sbjct: 304 PF 305

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF 80
           V ++ D + I++ IG G FS V++++  QT + YA+K +      ++   ++  E     
Sbjct: 56  VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM------NKWDMLKRGEVSCFR 109
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
              ++L   D              + + +V+ YY  G L     L   G+      ++ +
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT--LLSKFGERI--PAEMAR 165
Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
            +L   E V        + Y HRD+K  N+LL    +  L D GS     +K+      +
Sbjct: 166 FYL--AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS----CLKLRADGTVR 219
Query: 201 NLQDVAAERCSMPYRAPELFHV----DSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +L  V     +  Y +PE+                 D W+LG   Y M Y ++PF
Sbjct: 220 SLVAVG----TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           + ++  IG G ++ V L+   +T + YA+K   K + +  ED      + E H  F   +
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV--QTEKH-VFEQAS 63
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDIL 139
             P L   L  C      + S++  V+ Y   G L   ++ +        + Y + + + 
Sbjct: 64  NHPFL-VGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 117
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
                   A+   H+   I   +RDLK  NVLL ++ +  L D G        +C   E 
Sbjct: 118 --------ALNYLHERGII---YRDLKLDNVLLDSEGHIKLTDYG--------MC--KEG 156
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
               D  +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 157 LRPGDTTSXFCGTPNYIAPEILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           + IV ++G+G F  V   ++ +T    A K I     E+    I E+E   T  HP I+ 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFLKIC 146
           LL                ++ +++ + P G + A  LEL       ++   I  +  ++ 
Sbjct: 73  LLG---------AYYHDGKLWIMIEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQML 119
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
           EA+   H  + I   HRDLK  NVL+  + +  L D G              A+NL+ + 
Sbjct: 120 EALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFG------------VSAKNLKTLQ 164
Query: 207 AERC--SMPY-RAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSP 250
                   PY  APE+   ++      D + D+WSLG  L  M   + P
Sbjct: 165 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYAL---KKIICHGREDQAQAIREVEHHKTFVHPN 84
           + ++  IG G ++ V L+   +T + YA+   KK + +  ED      + E H  F   +
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV--QTEKH-VFEQAS 110
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDIL 139
             P L   L  C      + S++  V+ Y   G L   ++ +        + Y + + + 
Sbjct: 111 NHPFL-VGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 164
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
                   A+   H+   I   +RDLK  NVLL ++ +  L D G        +C   E 
Sbjct: 165 --------ALNYLHERGII---YRDLKLDNVLLDSEGHIKLTDYG--------MC--KEG 203
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
               D  +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 32/245 (13%)
Query: 11  QMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA 70
           +M    +K    V  +++  ++ +G+G F  V L++   T + YA+K +    +++   A
Sbjct: 136 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVA 191
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
             EV H  T     +L    H           +  ++  V+ Y   G L   L    V  
Sbjct: 192 KDEVAH--TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-- 247
Query: 131 HYMSSVDILKMF-LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
               S D  + +  +I  A+   H  K + Y  RDLK  N++L  D +  + D G     
Sbjct: 248 ---FSEDRARFYGAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFG----- 297
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
              +C     + ++D A  +  C  P Y APE+   + Y    +  D W LG ++Y M  
Sbjct: 298 ---LC----KEGIKDGATMKTFCGTPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMC 347
Query: 247 FKSPF 251
            + PF
Sbjct: 348 GRLPF 352

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPN 84
           + ++  IG G ++ V L+   +T + YA+K   K + +  ED      + E H  F   +
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV--QTEKH-VFEQAS 67
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-----GKHYMSSVDIL 139
             P L   L  C      + S++  V+ Y   G L   ++ +        + Y + + + 
Sbjct: 68  NHPFL-VGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 121
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
                   A+   H+   I   +RDLK  NVLL ++ +  L D G        +C   E 
Sbjct: 122 --------ALNYLHERGII---YRDLKLDNVLLDSEGHIKLTDYG--------MC--KEG 160
Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
               D  +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD V
Sbjct: 161 LRPGDTTSXFCGTPNYIAPEILRGEDYGF---SVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 46/271 (16%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           D+Y  + K+GEG +  V     + T +  A+K+I     E+     AIREV   K   H 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L           V++   ++ ++  Y       NDL+ + + K+   S+ ++K FL
Sbjct: 94  NIIEL---------KSVIHHNHRLHLIFEY-----AENDLK-KYMDKNPDVSMRVIKSFL 138
Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQ 200
            ++   V   H  + +   HRDLK  N+LL+  +        S  P V+K+   G A A 
Sbjct: 139 YQLINGVNFCHSRRCL---HRDLKPQNLLLSVSD-------ASETP-VLKIGDFGLARAF 187
Query: 201 N--LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF------- 251
              ++    E  ++ YR PE+     +       D+WS+ C ++A    K+P        
Sbjct: 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTS--VDIWSIAC-IWAEMLMKTPLFPGDSEI 244
Query: 252 DTVYERGDSVALAVISGNITFPENTPFPQYQ 282
           D +++  + + L     + T+P  T  P ++
Sbjct: 245 DQLFKIFEVLGLP---DDTTWPGVTALPDWK 272

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 32/245 (13%)
Query: 11  QMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA 70
           +M    +K    V  +++  ++ +G+G F  V L++   T + YA+K +    +++   A
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVA 188
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
             EV H  T     +L    H           +  ++  V+ Y   G L   L    V  
Sbjct: 189 KDEVAH--TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-- 244
Query: 131 HYMSSVDILKMF-LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
               S D  + +  +I  A+   H  K + Y  RDLK  N++L  D +  + D G     
Sbjct: 245 ---FSEDRARFYGAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFG----- 294
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
              +C     + ++D A  +  C  P Y APE+   + Y    +  D W LG ++Y M  
Sbjct: 295 ---LC----KEGIKDGATMKTFCGTPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMC 344
Query: 247 FKSPF 251
            + PF
Sbjct: 345 GRLPF 349

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 77
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 78  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 130
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 131 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 179
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 180 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 88/230 (38%), Gaps = 29/230 (12%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           +++Y + E++G+G FS V         + YA   I        D  +  RE    +   H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D          ++      ++      G L  D+    V + Y S  D     
Sbjct: 70  PNIVRLHD---------SISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCI 116
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I EAV   H    +   HR+LK  N+LLA+      + L     A+       E +  
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI-------EVEGE 166
Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           Q         P Y +PE+   D Y    +  D+W+ G +LY +     PF
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPY---GKPVDLWACGVILYILLVGYPPF 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V  +++  ++ +G+G F  V L++   T + YA+K +    +++   A  EV H  T   
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAH--TLTE 59
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             +L    H           +  ++  V+ Y   G L   L    V      S D  + +
Sbjct: 60  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY 114
Query: 143 -LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  A+   H  K + Y  RDLK  N++L  D +  + D G        +C     + 
Sbjct: 115 GAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFG--------LC----KEG 160
Query: 202 LQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++D A  +  C  P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 161 IKDGATMKXFCGTPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 76
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 77  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 129
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 130 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 178
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 179 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 16  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 70
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 71  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 123
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 124 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 172
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 173 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 218

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V  +++  ++ +G+G F  V L++   T + YA+K +    +++   A  EV H  T   
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAH--TLTE 58
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             +L    H           +  ++  V+ Y   G L   L    V      S D  + +
Sbjct: 59  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY 113
Query: 143 -LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  A+   H  K + Y  RDLK  N++L  D +  + D G        +C     + 
Sbjct: 114 GAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFG--------LC----KEG 159
Query: 202 LQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++D A  +  C  P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 160 IKDGATMKXFCGTPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 69
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 70  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 122
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 123 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 171
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 172 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 86  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 135
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 136 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 189
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 190 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 223

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 75
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 76  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 128
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 129 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 177
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 178 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
            D Y I E++G G F+ V       T   YA K I         + +      REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
             +H N++ L D         V  + + V+++L     G L + L      K  +S  + 
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
                +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++ 
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIE 170
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 DGVEFKNI------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V  +++  ++ +G+G F  V L++   T + YA+K +    +++   A  EV H  T   
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAH--TLTE 60
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             +L    H           +  ++  V+ Y   G L   L    V      S D  + +
Sbjct: 61  NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY 115
Query: 143 -LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  A+   H  K + Y  RDLK  N++L  D +  + D G        +C     + 
Sbjct: 116 GAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFG--------LC----KEG 161
Query: 202 LQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++D A  +  C  P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 162 IKDGATMKXFCGTPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 39/275 (14%)
Query: 13  GCLCSKEAVYVKS----DKYYIV--EKIGEGGFSTVSLIEHSQTKKRYALK--KIICHGR 64
           G     E +Y +S    + +YI+  +++G G F+ V       T + YA K  K    G+
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 65  EDQAQAIREV---EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAN 121
           + +A+ + E+   E  K+   P ++ L +         V  +TS+++++L Y   G + +
Sbjct: 70  DCRAEILHEIAVLELAKSC--PRVINLHE---------VYENTSEIILILEYAAGGEIFS 118
Query: 122 DLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM 181
            L L  + +  +S  D++++  +I E V   H    +   H DLK  N+LL++     + 
Sbjct: 119 -LCLPELAE-MVSENDVIRLIKQILEGVYYLHQNNIV---HLDLKPQNILLSS-----IY 168
Query: 182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
            LG +   +V    S +  +  ++     +  Y APE+ + D    +   TD+W++G + 
Sbjct: 169 PLGDIK--IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP---ITTATDMWNIGIIA 223
Query: 242 YAMCYFKSPFDTVYERGDSVALAVISGNITFPENT 276
           Y +    SPF  V E      L +   N+ + E T
Sbjct: 224 YMLLTHTSPF--VGEDNQETYLNISQVNVDYSEET 256

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 40/226 (17%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     T K+ A+KK+    ++ +     EV   + + H N++ +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L +  A+   
Sbjct: 112 LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYL 157
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H+   I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 158 HNQGVI---HRDIKSDSILLTSDGRIKLSDFG--------FC----AQVSKEVPKRKXLV 202
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-----YFKSP 250
             PY  APE+     Y       D+WSLG ++  M      YF  P
Sbjct: 203 GTPYWMAPEVISRLPYGT---EVDIWSLGIMVIEMIDGEPPYFNEP 245

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 71
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 72  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 124
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 173
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D + I+ ++G+G F  V   ++ +T    A K I     E+    + E++   +  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFL 143
           I+ LLD              + + +++ +   G + A  LEL    +  ++   I  +  
Sbjct: 96  IVKLLD---------AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCK 142
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +  +A+   HD K I   HRDLK  N+L   D +  L D G              A+N +
Sbjct: 143 QTLDALNYLHDNKII---HRDLKAGNILFTLDGDIKLADFG------------VSAKNTR 187
Query: 204 DVAAERC--SMPYR-APELFHVDSYC--VVDQRTDVWSLGCLLYAMCYFKSP 250
            +         PY  APE+   ++      D + DVWSLG  L  M   + P
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 36/257 (14%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-------REVEHHKTFVHPN 84
           ++IG+GGF  V      + K   A+K +I    E + + I       REV       HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L           ++++  +  MV+ + P G L + L  ++   H +     L++ L 
Sbjct: 85  IVKLYG---------LMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLD 130
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG-SAEAQNLQ 203
           I   ++   +  P    HRDL++ N+ L +        L   AP   KV       Q++ 
Sbjct: 131 IALGIEYMQNQNP-PIVHRDLRSPNIFLQS--------LDENAPVCAKVADFGLSQQSVH 181
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
            V+    +  + APE    +      ++ D +S   +LY +   + PFD  Y  G    +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE-YSYGKIKFI 239
Query: 264 AVISG---NITFPENTP 277
            +I       T PE+ P
Sbjct: 240 NMIREEGLRPTIPEDCP 256

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 82  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 131
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 132 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 185
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 186 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 219

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLXEX 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 89  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 138
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 139 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLXEX 192
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 193 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 89  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 138
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 139 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 192
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 193 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 226

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 90  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 139
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 140 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 193
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 194 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 227

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 81  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 130
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 131 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 184
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 185 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 218

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 84  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 134 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 187
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 188 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 42/236 (17%)
Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI----- 85
           +E IG GGF  V   +H    K Y ++++    + +  +A REV+      H NI     
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIRRV----KYNNEKAEREVKALAKLDHVNIVHYNG 72
Query: 86  ---------------LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
                          L   D+      +   + T  + + + +  KGTL   +E R   K
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
             +  V  L++F +I + V   H  K I   HRDLK +N+ L +     + D G V    
Sbjct: 133 --LDKVLALELFEQITKGVDYIHSKKLI---HRDLKPSNIFLVDTKQVKIGDFGLVTS-- 185
Query: 191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
                    +N       + ++ Y +PE      Y    +  D+++LG +L  + +
Sbjct: 186 --------LKNDGKRTRSKGTLRYMSPEQISSQDYG---KEVDLYALGLILAELLH 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 82  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 131
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 132 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 185
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 186 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 219

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D + I+ ++G+G F  V   ++ +T    A K I     E+    + E++   +  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFL 143
           I+ LLD              + + +++ +   G + A  LEL    +  ++   I  +  
Sbjct: 96  IVKLLD---------AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCK 142
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +  +A+   HD K I   HRDLK  N+L   D +  L D G              A+N +
Sbjct: 143 QTLDALNYLHDNKII---HRDLKAGNILFTLDGDIKLADFG------------VSAKNTR 187
Query: 204 DVAAERC--SMPYR-APELFHVDSYC--VVDQRTDVWSLGCLLYAMCYFKSP 250
            +         PY  APE+   ++      D + DVWSLG  L  M   + P
Sbjct: 188 XIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G G + +V     ++ +++ A+KK+      + H R    +  RE+   K   H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR----RTYRELRLLKHLKHENVIG 83
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK-HYMSSVDILKMFLKIC 146
           LLD      +   +   S+V +V       T     +L ++ K   +S   +  +  ++ 
Sbjct: 84  LLDVFTPATS---IEDFSEVYLV-------TTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVA 206
             +K  H A  I   HRDLK +NV +  D    ++D G    A  ++ G           
Sbjct: 134 RGLKYIHSAGII---HRDLKPSNVAVNEDCELRILDFGLARQADEEMTG---------YV 181
Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           A R    YRAPE+    ++   +Q  D+WS+GC++  +   K+ F
Sbjct: 182 ATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 86  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 135
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 136 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 189
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 190 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 104 IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 153
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 154 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 207
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 208 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 241

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 92  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 141
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 142 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 195
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 196 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 229

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 84  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 133
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 134 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 187
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 188 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 71
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 72  HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 124
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 173
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D + I+ ++G+G F  V   ++ +T    A K I     E+    + E++   +  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-ANDLELRSVGKHYMSSVDILKMFL 143
           I+ LLD              + + +++ +   G + A  LEL    +  ++   I  +  
Sbjct: 96  IVKLLD---------AFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCK 142
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +  +A+   HD K I   HRDLK  N+L   D +  L D G              A+N +
Sbjct: 143 QTLDALNYLHDNKII---HRDLKAGNILFTLDGDIKLADFG------------VSAKNTR 187
Query: 204 DVAAER--CSMPYR-APELFHVDSYC--VVDQRTDVWSLGCLLYAMCYFKSP 250
            +         PY  APE+   ++      D + DVWSLG  L  M   + P
Sbjct: 188 XIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V        +  DL  + +   ++S+  I     +I
Sbjct: 104 IGIND----IIRAPTIEQMKDVYLV-----THLMGADL-YKLLKTQHLSNDHICYFLYQI 153
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 154 LRGLKYIHSANVL---HRDLKPSNLLLNTTXDLKICDFGL---ARVADPDHDHTGFLTEY 207
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 208 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 241

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
            D Y I E++G G F+ V       T   YA K I         + +      REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
             +H N++ L D         V  + + V+++L     G L + L      K  +S  + 
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
                +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++ 
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIE 170
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 DGVEFKNI------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
            D Y I E++G G F+ V       T   YA K I         + +      REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
             +H N++ L D         V  + + V+++L     G L + L      K  +S  + 
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
                +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++ 
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIE 170
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 DGVEFKNI------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 87  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 132
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 133 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 177
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 178 GTPYWMAPELISRLPYG---PEVDIWSLGIMVIEMVDGEPPY 216

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 115
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 116 HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 168
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 169 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 217
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 67  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 121
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 122 HIVRIVD-----VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 174
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 175 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 223
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 224 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
            D Y I E++G G F+ V       T   YA K I         + +      REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
             +H N++ L D         V  + + V+++L     G L + L      K  +S  + 
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
                +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++ 
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIE 170
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 DGVEFKNI------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
            D Y I E++G G F+ V       T   YA K I         + +      REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
             +H N++ L D         V  + + V+++L     G L + L      K  +S  + 
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
                +I + V   H  K    AH DLK  N++L + N P+    L+D G       ++ 
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIE 170
Query: 195 GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+          P + APE+    +Y  +    D+WS+G + Y +    SPF
Sbjct: 171 DGVEFKNI-------FGTPEFVAPEIV---NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 32/255 (12%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH-KTFV---HPNILP 87
           E IG GGF  V            A+K       ED +Q I  V    K F    HPNI+ 
Sbjct: 13  EIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII- 69
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
               AL G    V      + +V+ +   G L   L     GK     + ++   ++I  
Sbjct: 70  ----ALRG----VCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDI-LVNWAVQIAR 116
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQDV 205
            +   HD   +   HRDLK++N+L+        ++ G ++  ++K+   G A   +    
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQK-----VENGDLSNKILKITDFGLAREWHRTTK 171
Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
            +   +  + APE+     +    + +DVWS G LL+ +   + PF  +   G +VA  V
Sbjct: 172 MSAAGAYAWMAPEVIRASMFS---KGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGV 226
Query: 266 ISGNITFPENTPFPQ 280
               +  P  +  P+
Sbjct: 227 AMNKLALPIPSTCPE 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 91  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 136
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 137 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 181
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 182 GTPYWMAPELISRLPY---GPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKXQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDXELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPN 84
           +  +GEG F  VSL      +  T +  A+K  K  C G + ++   RE+E  +T  H +
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEH 71
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+        GC +        V +V+ Y P G+L + L      +H +    +L    +
Sbjct: 72  IV-----KYKGCCED--QGEKSVQLVMEYVPLGSLRDYLP-----RHCVGLAQLLLFAQQ 119
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           ICE +   H      Y HR L   NVLL ND    + D G +A AV       E      
Sbjct: 120 ICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEYYR 169
Query: 205 VAAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           V  +  S + + APE       C     +DVWS G  LY +
Sbjct: 170 VREDGDSPVFWYAPECL---KECKFYYASDVWSFGVTLYEL 207

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 54/256 (21%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE----HHKTFVHPNILPLL 89
           +G+G F  V L E   T + YA+K +    ++D      +VE      +    P   P L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-------YMSSVDILKMF 142
              L  C      +  ++  V+ Y   G L     ++ VG+        Y + + I   F
Sbjct: 84  TQ-LHSC----FQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           L+          +K I Y  RDLK  NV+L ++ +  + D G        +C     +N+
Sbjct: 137 LQ----------SKGIIY--RDLKLDNVMLDSEGHIKIADFG--------MC----KENI 172
Query: 203 QDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
            D    +  C  P Y APE+     Y    +  D W+ G LLY M   ++PF+   E  D
Sbjct: 173 WDGVTTKXFCGTPDYIAPEIIAYQPYG---KSVDWWAFGVLLYEMLAGQAPFEG--EDED 227
Query: 260 SVALAVISGNITFPEN 275
            +  +++  N+ +P++
Sbjct: 228 ELFQSIMEHNVAYPKS 243

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPN 84
           +  +GEG F  VSL      +  T +  A+K  K  C G + ++   RE+E  +T  H +
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGC-GPQLRSGWQREIEILRTLYHEH 72
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+        GC +        V +V+ Y P G+L + L      +H +    +L    +
Sbjct: 73  IV-----KYKGCCED--QGEKSVQLVMEYVPLGSLRDYLP-----RHCVGLAQLLLFAQQ 120
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           ICE +   H      Y HR L   NVLL ND    + D G +A AV       E      
Sbjct: 121 ICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEYYR 170
Query: 205 VAAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
           V  +  S + + APE       C     +DVWS G  LY +
Sbjct: 171 VREDGDSPVFWYAPECL---KECKFYYASDVWSFGVTLYEL 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 46/243 (18%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
           + Y  ++K+GEG ++TV   +   T    ALK+I + H       AIREV   K   H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS------SVDI 138
           I+ L D         ++++   + +V  Y     L  DL      K Y+       ++  
Sbjct: 62  IVTLHD---------IIHTEKSLTLVFEY-----LDKDL------KQYLDDCGNIINMHN 101
Query: 139 LKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           +K+FL ++   +   H  K +   HRDLK  N+L+       L D G            A
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVL---HRDLKPQNLLINERGELKLADFG---------LARA 149
Query: 198 EAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS--PFDTV 254
           ++   +    E  ++ YR P+ L     Y     + D+W +GC+ Y M   +   P  TV
Sbjct: 150 KSIPTKTYDNEVVTLWYRPPDILLGSTDYST---QIDMWGVGCIFYEMATGRPLFPGSTV 206
Query: 255 YER 257
            E+
Sbjct: 207 EEQ 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 99/248 (39%), Gaps = 60/248 (24%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRED-QAQAIREV---EHHKT 79
           + +Y  V +IG G + TV       +    ALK + + +G E      +REV      + 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------GKHY 132
           F HPN++ L+D     CA    +   +V +V  +        D +LR+        G   
Sbjct: 63  FEHPNVVRLMDV----CATSRTDREIKVTLVFEHV-------DQDLRTYLDKAPPPGLPA 111
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-------- 184
            +  D+++ FL+  +    F  A  I   HRDLK  N+L+ +     L D G        
Sbjct: 112 ETIKDLMRQFLRGLD----FLHANCIV--HRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 185 -SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA 243
            ++AP VV +                    YRAPE+    +Y       D+WS+GC+   
Sbjct: 166 MALAPVVVTLW-------------------YRAPEVLLQSTYATP---VDMWSVGCIFAE 203
Query: 244 MCYFKSPF 251
           M   K  F
Sbjct: 204 MFRRKPLF 211

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 98  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 143
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 144 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 188
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 189 GTPYWMAPELISRLPYG---PEVDIWSLGIMVIEMVDGEPPY 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A++KI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 96  LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 141
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 142 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 186
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 187 GTPYWMAPELISRLPYG---PEVDIWSLGIMVIEMVDGEPPY 225

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y +V K+G G +S V    +    ++  +K +    +    + I+ +E+ +    PN
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRG--GPN 93
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D       DPV  + + V             N+ + + + +  ++  DI     +
Sbjct: 94  IITLAD----IVKDPVSRTPALVF---------EHVNNTDFKQLYQ-TLTDYDIRFYMYE 139
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQ 203
           I +A+   H    +   HRD+K  NV++ +++  L L+D G     + +     +  N++
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LAEFYHPGQEYNVR 191
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 192 -VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNI 85
           +  +GEG F  VSL      +  T +  A+K +    G + ++   +E++  +T  H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +        GC +     + Q  +V+ Y P G+L + L   S+G        +L    +I
Sbjct: 79  I-----KYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHSIG-----LAQLLLFAQQI 126
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           CE +   H      Y HR+L   NVLL ND    + D G +A AV       E      V
Sbjct: 127 CEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEYYRV 176
Query: 206 AAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
             +  S + + APE      +      +DVWS G  LY +
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYA---SDVWSFGVTLYEL 213

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 108/250 (43%), Gaps = 34/250 (13%)
Query: 5   GLNLIFQMGCLCSKEAVYVKSDKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHG 63
           GL ++FQ      +   Y  +D Y + +++ G G    V    H +T ++ ALK +    
Sbjct: 11  GLEVLFQ----GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--- 63
Query: 64  REDQAQAIREVEHH-KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND 122
             D  +A +EV+HH +    P+I+ +LD       + + +    +L+++     G L + 
Sbjct: 64  --DSPKARQEVDHHWQASGGPHIVCILD-----VYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
           ++ R  G    +  +  ++   I  A++  H       AHRD+K  N+L  +     ++ 
Sbjct: 117 IQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLK 171
Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLL 241
           L     A          +  Q+     C  PY  APE+   + Y   D+  D+WSLG ++
Sbjct: 172 LTDFGFA---------KETTQNALQTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIM 219
Query: 242 YAMCYFKSPF 251
           Y +     PF
Sbjct: 220 YILLCGFPPF 229

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+    A      + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNIFGTPA------FVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 72
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 123
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D+   ++D G       +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDSELKILDFGLARHTDDE 180
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 181 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 141 LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 186
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 187 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 231
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 232 GTPYWMAPELISRLPYG---PEVDIWSLGIMVIEMVDGEPPY 270

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHPNI 85
           +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + + D        P +     V +V     +  +  DL  + +   ++S+  I     +I
Sbjct: 88  IGINDIIRA----PTIEQMKDVYIV-----QDLMETDL-YKLLKCQHLSNDHICYFLYQI 137
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
              +K  H A  +   HRDLK +N+LL    +  + D G    A V          L + 
Sbjct: 138 LRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFGL---ARVADPDHDHTGFLTEY 191
Query: 206 AAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAM 244
            A R    YRAPE + +   Y    +  D+WS+GC+L  M
Sbjct: 192 VATRW---YRAPEIMLNSKGYT---KSIDIWSVGCILAEM 225

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 55/279 (19%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-------- 68
           + E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q         
Sbjct: 3   ANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEI 61
Query: 69  QAIREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTLA 120
             + +++ H       I+ L D+ +T         C +  LNS         +  K    
Sbjct: 62  AYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKSI 108
Query: 121 NDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL 180
           +  E +S  K+ +             EAV   H        H DLK AN L+  D    L
Sbjct: 109 DPWERKSYWKNML-------------EAVHTIHQH---GIVHSDLKPANFLIV-DGMLKL 151
Query: 181 MDLG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSL 237
           +D G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWSL
Sbjct: 152 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWSL 209
Query: 238 GCLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           GC+LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 210 GCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 247

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  IG G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 75
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 126
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 184 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 76
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 127
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D+   ++D G       +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDSELKILDFGLARHTDDE 184
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 185 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 55/277 (19%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--------QA 70
           E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q           
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 59
Query: 71  IREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTLAND 122
           + +++ H       I+ L D+ +T         C +  LNS         +  K    + 
Sbjct: 60  LNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKSIDP 106
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
            E +S  K+ +             EAV   H        H DLK AN L+  D    L+D
Sbjct: 107 WERKSYWKNML-------------EAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 149
Query: 183 LG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
            G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWSLGC
Sbjct: 150 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWSLGC 207
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           +LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 208 ILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 243

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 54/256 (21%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE----HHKTFVHPNILPLL 89
           +G+G F  V L E   T + YA+K +    ++D      +VE      +    P   P L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH-------YMSSVDILKMF 142
              L  C      +  ++  V+ Y   G L     ++ VG+        Y + + I   F
Sbjct: 405 TQ-LHSC----FQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           L+          +K I Y  RDLK  NV+L ++ +  + D G        +C     +N+
Sbjct: 458 LQ----------SKGIIY--RDLKLDNVMLDSEGHIKIADFG--------MC----KENI 493
Query: 203 QDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
            D    +  C  P Y APE+     Y    +  D W+ G LLY M   ++PF+   E  D
Sbjct: 494 WDGVTTKXFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEG--EDED 548
Query: 260 SVALAVISGNITFPEN 275
            +  +++  N+ +P++
Sbjct: 549 ELFQSIMEHNVAYPKS 564

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 77
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 128
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G        
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFG-------- 177
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 A  +    A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 178 -LARHTADEMTGYVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 77
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 128
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G        
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFG-------- 177
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 A  +    A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 178 -LARHTADEMTGYVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNI 85
           +  +GEG F  VSL      +  T +  A+K +    G + ++   +E++  +T  H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +        GC +     + Q  +V+ Y P G+L + L   S+G        +L    +I
Sbjct: 79  I-----KYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRHSIG-----LAQLLLFAQQI 126
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           CE +   H      Y HR+L   NVLL ND    + D G +A AV       E      V
Sbjct: 127 CEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFG-LAKAV------PEGHEYYRV 176
Query: 206 AAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
             +  S + + APE      +      +DVWS G  LY +
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYA---SDVWSFGVTLYEL 213

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKXQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 77
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 128
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G        
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFG-------- 177
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 A  +    A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 178 -LARHTADEMTGYVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 110/250 (44%), Gaps = 24/250 (9%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V    ++   + YA+KKI  H  E  +  + EV    +  H  ++      L
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 94  --TGCADPV--LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                  P+  +   S + + + Y   GTL + +   ++ +      +  ++F +I EA+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---RDEYWRLFRQILEAL 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG--SAEAQNL----Q 203
              H    I   HRDLK  N+ +    N  + D G +A  V +       ++QNL     
Sbjct: 130 SYIHSQGII---HRDLKPMNIFIDESRNVKIGDFG-LAKNVHRSLDILKLDSQNLPGSSD 185
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
           ++ +   +  Y A E+  +D     +++ D++SLG + + M Y   PF T  ER + +  
Sbjct: 186 NLTSAIGTAMYVATEV--LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN-ILK 239
Query: 264 AVISGNITFP 273
            + S +I FP
Sbjct: 240 KLRSVSIEFP 249

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 64/283 (22%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEH-HKTFVHP 83
           D Y + E + GEG  + V    +  T + YA+K I       +++  REVE  ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           N+L L++         ++    +   +L +  K    N+LE   V +   S++D L    
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL---- 127
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--NPLLM---DLGS-----------VA 187
                    H+      AHRDLK  N+L  + N  +P+ +   DLGS             
Sbjct: 128 ---------HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMC 245
           P ++  CGSAE               Y APE+     +   + D+R D+WSLG +LY + 
Sbjct: 176 PELLTPCGSAE---------------YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 246 YFKSPF------DTVYERGDSVAL-------AVISGNITFPEN 275
               PF      D  ++RG++          ++  G   FP+ 
Sbjct: 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 69  GVCL---------EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 116
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+            
Sbjct: 117 AYLEEASVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 166
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 167 -PVKWASPEVFSFSRY---SSKSDVWSFGVLMW 195

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 81
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 132
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDXELKILDFGLARHTDDE 189
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 190 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 46/243 (18%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHGR-EDQAQAIR------- 72
            + Y+ V K+G G +  V L +    HS+   +   K     GR  D  + I        
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 73  -EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
            E+   K+  HPNI+ L D         V        +V  +Y  G L   +    + +H
Sbjct: 95  NEISLLKSLDHPNIIKLFD---------VFEDKKYFYLVTEFYEGGELFEQI----INRH 141
Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL---LMDLGSVAP 188
                D   +  +I   +   H    +   HRD+K  N+LL N N+ L   ++D G  + 
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIV---HRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
                   ++   L+D      +  Y APE+         +++ DVWS G ++Y +    
Sbjct: 199 F-------SKDYKLRDRLG---TAYYIAPEVLKKK----YNEKCDVWSCGVIMYILLCGY 244
Query: 249 SPF 251
            PF
Sbjct: 245 PPF 247

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 75
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 126
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 184 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 55/277 (19%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--------QA 70
           E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q           
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60
Query: 71  IREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTLAND 122
           + +++ H       I+ L D+ +T         C +  LNS         +  K    + 
Sbjct: 61  LNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKSIDP 107
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
            E +S  K+             + EAV   H        H DLK AN L+  D    L+D
Sbjct: 108 WERKSYWKN-------------MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150
Query: 183 LG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
            G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWSLGC
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWSLGC 208
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           +LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 209 ILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 244

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 42/249 (16%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI- 71
           G +  +E V    D Y   E++G G F+ V       T  +YA K I     +   + + 
Sbjct: 1   GTVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 57
Query: 72  -----REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR 126
                REV   K   HPN++ L +         V  + + V+++L     G L + L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL--- 105
Query: 127 SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMD 182
              K  ++  +  +   +I   V   H    +  AH DLK  N++L + N P     ++D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
            G       K+    E +N+        +  + APE+ +   Y  +    D+WS+G + Y
Sbjct: 162 FGLAH----KIDFGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITY 208
Query: 243 AMCYFKSPF 251
            +    SPF
Sbjct: 209 ILLSGASPF 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MAG---------FVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA 92
           KIGEG    V +     + K  A+KK+    ++ +     EV   + + H N++ + +  
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 93  LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF 152
           L G          ++ +V+ +   G L +      V    M+   I  + L + +A+ V 
Sbjct: 218 LVG---------DELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVL 263
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--C 210
           H    I   HRD+K+ ++LL +D    L D G         C    AQ  ++V   +   
Sbjct: 264 HAQGVI---HRDIKSDSILLTHDGRVKLSDFG--------FC----AQVSKEVPRRKXLV 308
Query: 211 SMPY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             PY  APEL     Y       D+WSLG ++  M   + P+
Sbjct: 309 GTPYWMAPELISRLPYG---PEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 55/277 (19%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--------QA 70
           +++ VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q           
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 71  IREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTLAND 122
           + +++ H       I+ L D+ +T         C +  LNS         +  K    + 
Sbjct: 80  LNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKSIDP 126
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
            E +S  K+             + EAV   H        H DLK AN L+  D    L+D
Sbjct: 127 WERKSYWKN-------------MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 169
Query: 183 LG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
            G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWSLGC
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWSLGC 227
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           +LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 263

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MAG---------FVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 42/249 (16%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI- 71
           G +  +E V    D Y   E++G G F+ V       T  +YA K I     +   + + 
Sbjct: 1   GTVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 57
Query: 72  -----REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR 126
                REV   K   HPN++ L +         V  + + V+++L     G L + L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL--- 105
Query: 127 SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMD 182
              K  ++  +  +   +I   V   H    +  AH DLK  N++L + N P     ++D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
            G       K+    E +N+        +  + APE+ +   Y  +    D+WS+G + Y
Sbjct: 162 FGLAH----KIDFGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITY 208
Query: 243 AMCYFKSPF 251
            +    SPF
Sbjct: 209 ILLSGASPF 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 49/221 (22%)
Query: 34  IGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           IG G F  V    L+E  +     A+KK++    +D+    RE++  +   HPN++ L  
Sbjct: 48  IGNGSFGVVFQAKLVESDEV----AIKKVL----QDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 91  HALTGCADPVLNSTSQVLM--VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL----- 143
              +       +   +V +  VL Y P+        +    +HY      + M L     
Sbjct: 100 FFYSNG-----DKKDEVFLNLVLEYVPE-------TVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQN 201
            ++  ++   H    I   HRD+K  N+LL   +  L L+D GS   A + + G      
Sbjct: 148 YQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGS---AKILIAGEPNVSX 201
Query: 202 LQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           +       CS  YRAPEL F   +Y       D+WS GC++
Sbjct: 202 I-------CSRYYRAPELIFGATNYTT---NIDIWSTGCVM 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 66
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 117
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 175 MAG---------FVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 55/280 (19%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA------- 68
            + E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q        
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 69  -QAIREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTL 119
              + +++ H       I+ L D+ +T         C +  LNS         +  K   
Sbjct: 105 IAYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKS 151
Query: 120 ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
            +  E +S  K+ +             EAV   H        H DLK AN L+  D    
Sbjct: 152 IDPWERKSYWKNML-------------EAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194
Query: 180 LMDLG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS 236
           L+D G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWS
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWS 252
Query: 237 LGCLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           LGC+LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 291

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 112/276 (40%), Gaps = 42/276 (15%)
Query: 13  GCLCSKEAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGR 64
           G L S  +VY K+  D+Y + + +G G    V L    +T K+ A+K I      I   R
Sbjct: 1   GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR 60
Query: 65  E-DQAQAIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND 122
           E D A  +  E+E  K   HP I+ + +                  +VL     G L + 
Sbjct: 61  EADPALNVETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD- 109
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
              + VG   +        F ++  AV+  H+   I   HRDLK  NVLL++     L  
Sbjct: 110 ---KVVGNKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL-- 161
Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGC 239
                   +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG 
Sbjct: 162 --------IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 213
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGNITF-PE 274
           +L+ +C    P  + +    S+   + SG   F PE
Sbjct: 214 ILF-ICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 248

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF+    I    TK+ +A K   K +      + +   E+  HK+  +P+++    
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-- 91
Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           H               V +VL    + +L   LEL    K  ++  +      +  + V+
Sbjct: 92  HGF-------FEDDDFVYVVLEICRRRSL---LELHKRRK-AVTEPEARYFMRQTIQGVQ 140
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H+ + I   HRDLK  N+ L +D +  + D G       K+    E +       + C
Sbjct: 141 YLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFG----LATKIEFDGERKK------DLC 187
Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             P Y APE+     +       D+WSLGC+LY +   K PF+T
Sbjct: 188 GTPNYIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFET 228

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 69  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 115
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 116 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 168
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 169 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 25/247 (10%)
Query: 30  IVEKIGEGGFSTVSLIE-HSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL 88
           I EKIG G F TV   E H        L +   H  E   + +REV   K   HPNI+ L
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIV-L 98
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
              A+T            + +V  Y  +G+L   L  +S  +  +     L M   + + 
Sbjct: 99  FMGAVT--------QPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKG 149
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +   H+  P    HRDLK+ N+L+       + D G           S  A    +    
Sbjct: 150 MNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPE---- 204
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG 268
                + APE+   +     ++++DV+S G +L+ +   + P+  +       A+     
Sbjct: 205 -----WMAPEVLRDEPS---NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
Query: 269 NITFPEN 275
            +  P N
Sbjct: 257 RLEIPRN 263

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 37/267 (13%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE 75
             K+A  +  +   +V+++G G F  V +  ++ + K     K +  G       + E  
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEAN 60
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             KT  H  ++ L  +A+    +P+        ++  Y  KG+L + L+    GK  +  
Sbjct: 61  LMKTLQHDKLVRL--YAVVTREEPIY-------IITEYMAKGSLLDFLKSDEGGKVLLPK 111
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             ++    +I E +          Y HRDL+ ANVL++      + D G     + +V  
Sbjct: 112 --LIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFG-----LARVIE 161
Query: 196 SAEAQNLQDVAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
             E       A E    P  + APE  +   + +   ++DVWS G LLY +  Y K P+ 
Sbjct: 162 DNEY-----TAREGAKFPIKWTAPEAINFGCFTI---KSDVWSFGILLYEIVTYGKIPYP 213
Query: 253 TVYERGDSVALAVISGNITFP--ENTP 277
               R ++  +  +S     P  EN P
Sbjct: 214 G---RTNADVMTALSQGYRMPRVENCP 237

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 89
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 140
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 198 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 90
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 141
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 199 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 44/240 (18%)
Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR---EVEHHKTF 80
           K + + +   +G+G F+ V   E   T    A+K I            R   EV+ H   
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR------SVGKHYMS 134
            HP+IL L ++            ++ V +VL     G +   L+ R      +  +H+M 
Sbjct: 69  KHPSILELYNY---------FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
            +    ++L                  HRDL  +N+LL  + N  + D G          
Sbjct: 120 QIITGMLYLH------------SHGILHRDLTLSNLLLTRNMNIKIADFGL--------- 158
Query: 195 GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            + + +   +     C  P Y +PE+    ++ +    +DVWSLGC+ Y +   + PFDT
Sbjct: 159 -ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL---ESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 90
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 141
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G               +  YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 199 MXGXV------------ATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 69  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 115
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 116 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 168
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 169 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 55/280 (19%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA------- 68
            + E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q        
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 69  -QAIREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTL 119
              + +++ H       I+ L D+ +T         C +  LNS         +  K   
Sbjct: 105 IAYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKS 151
Query: 120 ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
            +  E +S  K+             + EAV   H        H DLK AN L+  D    
Sbjct: 152 IDPWERKSYWKN-------------MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194
Query: 180 LMDLG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS 236
           L+D G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWS
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWS 252
Query: 237 LGCLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           LGC+LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 291

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 76
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 127
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+  + ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 185 MTG---------YVATRW---YRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 66
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 117
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 175 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G               +  YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTGXV------------ATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 24/238 (10%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTV--SLIEHSQTKKRYALKKIICHGREDQAQAIREV 74
           S   + V SD +     +G GGF  V    +          LK+    G E Q Q   EV
Sbjct: 21  SLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT--EV 78
Query: 75  EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS 134
           E     VH N+L L    +T          ++ L+V PY   G++A+ L  R   +  + 
Sbjct: 79  EMISMAVHRNLLRLRGFCMT---------PTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
                ++ L     +   HD       HRD+K AN+LL  +   ++ D G        + 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG--------LA 181
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
              + ++     A R  + + APE     S     ++TDV+  G +L  +   +  FD
Sbjct: 182 KLMDYKDXHVXXAVRGXIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF+    I    TK+ +A K   K +      + +   E+  HK+  +P+++    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-- 107
Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           H               V +VL    + +L   LEL    K  ++  +      +  + V+
Sbjct: 108 HGF-------FEDDDFVYVVLEICRRRSL---LELHKRRK-AVTEPEARYFMRQTIQGVQ 156
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H+ + I   HRDLK  N+ L +D +  + D G       K+    E +       + C
Sbjct: 157 YLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFG----LATKIEFDGERKK------DLC 203
Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             P Y APE+     +       D+WSLGC+LY +   K PF+T
Sbjct: 204 GTPNYIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFET 244

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRED-QAQAIREV---EHHKT 79
           + +Y  V +IG G + TV       +    ALK + + +G E      +REV      + 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------GKHY 132
           F HPN++ L+D     CA    +   +V +V  +        D +LR+        G   
Sbjct: 63  FEHPNVVRLMDV----CATSRTDREIKVTLVFEHV-------DQDLRTYLDKAPPPGLPA 111
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
            +  D+++ FL+  +    F  A  I   HRDLK  N+L+ +     L D G     + +
Sbjct: 112 ETIKDLMRQFLRGLD----FLHANCIV--HRDLKPENILVTSGGTVKLADFG-----LAR 160
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     A  L  V     ++ YRAPE+    +Y       D+WS+GC+   M   K  F
Sbjct: 161 IYSYQMA--LDPVV---VTLWYRAPEVLLQSTYATP---VDMWSVGCIFAEMFRRKPLF 211

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 22  YVKSDKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH-KT 79
           Y  +D Y + +++ G G    V    H +T ++ ALK +      D  +A +EV+HH + 
Sbjct: 5   YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQA 59
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P+I+ +LD       + + +    +L+++     G L + ++ R  G    +  +  
Sbjct: 60  SGGPHIVCILD-----VYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAA 112
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
           ++   I  A++  H       AHRD+K  N+L  +     ++ L     A          
Sbjct: 113 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------K 160
Query: 200 QNLQDVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  Q+     C  PY  APE+   + Y   D+  D+WSLG ++Y +     PF
Sbjct: 161 ETTQNALQTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 80
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 131
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 132 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 188
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 189 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 38/245 (15%)
Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYA---------LKKIICHGREDQ 67
           S   + V SD +     +G GGF  V        K R A         LK+    G E Q
Sbjct: 29  SLRELQVASDNFSNKNILGRGGFGKV-------YKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 68  AQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS 127
            Q   EVE     VH N+L L    +T          ++ L+V PY   G++A+ L  R 
Sbjct: 82  FQT--EVEMISMAVHRNLLRLRGFCMT---------PTERLLVYPYMANGSVASCLRERP 130
Query: 128 VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA 187
             +  +      ++ L     +   HD       HRD+K AN+LL  +   ++ D G   
Sbjct: 131 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG--- 187
Query: 188 PAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
                +    + ++     A R ++ + APE     S     ++TDV+  G +L  +   
Sbjct: 188 -----LAKLMDYKDXHVXXAVRGTIGHIAPEYL---STGKSSEKTDVFGYGVMLLELITG 239
Query: 248 KSPFD 252
           +  FD
Sbjct: 240 QRAFD 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 72
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 123
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 181 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 89
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 140
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 198 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 82
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 133
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 191 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 14  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 72  GVCL---------EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 119
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+            
Sbjct: 120 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 169
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 170 -PVKWASPEVFSFSRY---SSKSDVWSFGVLMW 198

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 72
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 123
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 181 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 77
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 128
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 185
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 186 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 82
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 133
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 191 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 75
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 126
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 184 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK----RTYR 82
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 133
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 191 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 69
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 120
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 177
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 178 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 98/248 (39%), Gaps = 60/248 (24%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRED-QAQAIREV---EHHKT 79
           + +Y  V +IG G + TV       +    ALK + + +G E      +REV      + 
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------GKHY 132
           F HPN++ L+D     CA    +   +V +V  +        D +LR+        G   
Sbjct: 63  FEHPNVVRLMDV----CATSRTDREIKVTLVFEHV-------DQDLRTYLDKAPPPGLPA 111
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-------- 184
            +  D+++ FL+  +    F  A  I   HRDLK  N+L+ +     L D G        
Sbjct: 112 ETIKDLMRQFLRGLD----FLHANCIV--HRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 185 -SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA 243
            ++ P VV +                    YRAPE+    +Y       D+WS+GC+   
Sbjct: 166 MALFPVVVTLW-------------------YRAPEVLLQSTYATP---VDMWSVGCIFAE 203
Query: 244 MCYFKSPF 251
           M   K  F
Sbjct: 204 MFRRKPLF 211

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 76
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 127
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 185 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 81
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 132
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 189
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 190 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 75
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 126
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 184 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 90
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 141
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 199 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 11  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 69  GVCL---------EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 116
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+            
Sbjct: 117 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 166
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 167 -PVKWASPEVFSFSRY---SSKSDVWSFGVLMW 195

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 55/277 (19%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--------QA 70
           +++ VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q           
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 71  IREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTLAND 122
           + +++ H       I+ L D+ +T         C +  LNS         +  K    + 
Sbjct: 80  LNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKSIDP 126
Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
            E +S  K+             + EAV   H        H DLK AN L+  D    L+D
Sbjct: 127 WERKSYWKN-------------MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 169
Query: 183 LG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
            G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWSLGC
Sbjct: 170 FGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWSLGC 227
Query: 240 LLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           +LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 263

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 67
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 118
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 176 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 93
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 144
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 201
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 202 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 104/260 (40%), Gaps = 45/260 (17%)
Query: 7   NLIFQMGCLCSKEAVYVKS---------DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK 57
           NL FQ      +   Y +          ++Y  +  +G G + +V     ++T  R A+K
Sbjct: 17  NLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 76
Query: 58  KI------ICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVL 111
           K+      I H +    +  RE+   K   H N++ LLD      +    N    V  ++
Sbjct: 77  KLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 132
Query: 112 PYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL 171
                G   N++    V    ++   +  +  +I   +K  H A  I   HRDLK +N+ 
Sbjct: 133 -----GADLNNI----VKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLA 180
Query: 172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQR 231
           +  D    ++D G       ++ G           A R    YRAPE+    ++   +Q 
Sbjct: 181 VNEDCELKILDFGLARHTDDEMXG---------YVATRW---YRAPEIML--NWMHYNQT 226
Query: 232 TDVWSLGCLLYAMCYFKSPF 251
            D+WS+GC++  +   ++ F
Sbjct: 227 VDIWSVGCIMAELLTGRTLF 246

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 72
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 123
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 181 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 68
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 119
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 176
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 177 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 107/236 (45%), Gaps = 23/236 (9%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           +Y  ++ +G GG   V     +   KR A+KKI+    +    A+RE++  +   H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 87  ---PLLDHALTGCADPVLNSTS-QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
               +L  + +   D V + T    + ++  Y +  LAN LE   + + +       ++F
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA------RLF 125
Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           + ++   +K  H A  +   HRDLK AN+ +  ++  L++ +G    A +     +   +
Sbjct: 126 MYQLLRGLKYIHSANVL---HRDLKPANLFINTED--LVLKIGDFGLARIMDPHYSHKGH 180
Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
           L +    +    YR+P  L   ++Y    +  D+W+ GC+   M   K+ F   +E
Sbjct: 181 LSEGLVTKW---YRSPRLLLSPNNYT---KAIDMWAAGCIFAEMLTGKTLFAGAHE 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 67
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 118
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 176 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 9   FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 67  GVCL---------EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 114
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+            
Sbjct: 115 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 164
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 165 -PVKWASPEVFSFSRY---SSKSDVWSFGVLMW 193

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 66
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 117
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 175 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 55/280 (19%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA------- 68
            + E + VK   Y I+++IG GG S V  +  ++ K+ YA+K +     ++Q        
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 69  -QAIREVEHHKTFVHPNILPLLDHALTG--------CADPVLNSTSQVLMVLPYYPKGTL 119
              + +++ H       I+ L D+ +T         C +  LNS         +  K   
Sbjct: 105 IAYLNKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNS---------WLKKKKS 151
Query: 120 ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
            +  E +S  K+             + EAV   H        H DLK AN L+  D    
Sbjct: 152 IDPWERKSYWKN-------------MLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLK 194
Query: 180 LMDLG---SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS 236
           L+D G    + P    V   ++   +  +  E       + E  +  S   +  ++DVWS
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE--NGKSKSKISPKSDVWS 252
Query: 237 LGCLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPE 274
           LGC+LY M Y K+PF  +  +   +  A+I  N  I FP+
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIEFPD 291

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  ++ G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL-----QDCPKARREVELHWRASQCP 115
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D       + +      +L+V      G L + ++ R  G    +  +  ++  
Sbjct: 116 HIVRIVD-----VYENLYAGRKCLLIVXECLDGGELFSRIQDR--GDQAFTEREASEIXK 168
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H    I  AHRD+K  N+L  +     ++ L           G A+     
Sbjct: 169 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------GFAKETTSH 217
Query: 204 DVAAERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     C  PY  APE+   + Y   D+  D WSLG + Y +     PF
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKY---DKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 95/247 (38%), Gaps = 25/247 (10%)
Query: 30  IVEKIGEGGFSTVSLIE-HSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL 88
           I EKIG G F TV   E H        L +   H  E   + +REV   K   HPNI+ L
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIV-L 98
Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
              A+T            + +V  Y  +G+L   L  +S  +  +     L M   + + 
Sbjct: 99  FMGAVT--------QPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKG 149
Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAE 208
           +   H+  P    HR+LK+ N+L+       + D G           S  A    +    
Sbjct: 150 MNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE---- 204
Query: 209 RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISG 268
                + APE+   +     ++++DV+S G +L+ +   + P+  +       A+     
Sbjct: 205 -----WMAPEVLRDEPS---NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
Query: 269 NITFPEN 275
            +  P N
Sbjct: 257 RLEIPRN 263

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 39/266 (14%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI----------ICHGREDQAQAIREVEHH 77
           Y I+  + +G F+ + L E  +  K YALKK                 D+     + +  
Sbjct: 33  YRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 78  KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGT-LANDLELRSVGKHY--MS 134
           K  +   I+  + +      + ++ +  +V ++  Y    + L  D     + K+Y    
Sbjct: 91  KNELQ--IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 135 SVDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
            + ++K  +K +  +    H+ K I   HRD+K +N+L+  +    L D G     V K 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDK- 205
Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
                      +   R +  +  PE F  +S      + D+WSLG  LY M Y   PF  
Sbjct: 206 ----------KIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 254 VYERGDSVALAVISGNITFPENTPFP 279
                  ++L  +  NI   +N  +P
Sbjct: 255 ------KISLVELFNNIR-TKNIEYP 273

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 76
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 127
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+  + ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 185 MTG---------YVATRW---YRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y +V K+G G +S V    +    ++ A+K +    ++   + I+ +E+ +    PN
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRG--GPN 93
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L D       DPV  + + V             N+ + + + +  ++  DI     +
Sbjct: 94  IITLAD----IVKDPVSRTPALVF---------EHVNNTDFKQLYQ-TLTDYDIRFYMYE 139
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQ 203
           I +A+   H    +   HRD+K  NVL+ +++  L L+D G     + +     +  N++
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWG-----LAEFYHPGQEYNVR 191
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 192 -VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF+    I    TK+ +A K   K +      + +   E+  HK+  +P+++    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-- 107
Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           H               V +VL    + +L   LEL    K  ++  +      +  + V+
Sbjct: 108 HGF-------FEDDDFVYVVLEICRRRSL---LELHKRRK-AVTEPEARYFMRQTIQGVQ 156
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H+ + I   HRDLK  N+ L +D +  + D G       K+    E +         C
Sbjct: 157 YLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFG----LATKIEFDGERKKXL------C 203
Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             P Y APE+     +       D+WSLGC+LY +   K PF+T
Sbjct: 204 GTPNYIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+GGF+    I    TK+ +A K   K +      + +   E+  HK+  +P+++    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF-- 107
Query: 91  HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           H               V +VL    + +L   LEL    K  ++  +      +  + V+
Sbjct: 108 HGF-------FEDDDFVYVVLEICRRRSL---LELHKRRK-AVTEPEARYFMRQTIQGVQ 156
Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
             H+ + I   HRDLK  N+ L +D +  + D G       K+    E +         C
Sbjct: 157 YLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFG----LATKIEFDGERKKTL------C 203
Query: 211 SMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             P Y APE+     +       D+WSLGC+LY +   K PF+T
Sbjct: 204 GTPNYIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPFET 244

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 31  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 89  GVCL---------EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 136
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+           +
Sbjct: 137 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--------TGTK 185
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 186 FPVKWASPEVFSFSRY---SSKSDVWSFGVLMW 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDYGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G +  V        + R A+K+I             E+  HK   H NI+  L    
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-- 73
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-ICEAVKVF 152
                   +    + + +   P G+L+    LRS       +   +  + K I E +K  
Sbjct: 74  -------FSENGFIKIFMEQVPGGSLS--ALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG-SVAPAVVKVCGSAEAQNLQDVAAERC 210
           HD + +   HRD+K  NVL+   +  L + D G S   A +  C       LQ       
Sbjct: 125 HDNQIV---HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ------- 174
Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
              Y APE+          +  D+WSLGC +  M   K PF   YE G+  A
Sbjct: 175 ---YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF---YELGEPQA 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 66
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCAK 117
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 175 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 44/257 (17%)
Query: 7   NLIFQMGCLCSKE------AVYVKSDKYYIVE---KIGEGGFSTVSLIEHSQTKKRYALK 57
           NL FQ G +  ++       V  + D   +++   KIGEG    V L     + ++ A+K
Sbjct: 17  NLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVK 76
Query: 58  KIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKG 117
            +    ++ +     EV   + + H N++ +    L G          + L VL  + +G
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG----------EELWVLMEFLQG 126
Query: 118 TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN 177
               D+    V +  ++   I  +   + +A+   H    I   HRD+K+ ++LL  D  
Sbjct: 127 GALTDI----VSQVRLNEEQIATVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGR 179
Query: 178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CSMPY-RAPELFHVDSYCVVDQRTDV 234
             L D G         C    AQ  +DV   +     PY  APE+     Y       D+
Sbjct: 180 VKLSDFG--------FC----AQISKDVPKRKXLVGTPYWMAPEVISRSLYAT---EVDI 224
Query: 235 WSLGCLLYAMCYFKSPF 251
           WSLG ++  M   + P+
Sbjct: 225 WSLGIMVIEMVDGEPPY 241

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 37/245 (15%)
Query: 16  CSKEAVYVKS---DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-- 70
             +E +Y +    D +    K+G G F  V L+E    ++   L+++I    +D++Q   
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVE----ERSSGLERVIKTINKDRSQVPM 64
Query: 71  ---IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS 127
                E+E  K+  HPNI+ + +         V      + +V+     G L   +    
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFE---------VFEDYHNMYIVMETCEGGELLERIVSAQ 115
Query: 128 VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA 187
                +S   + ++  ++  A+  FH    +   H+DLK  N+L   D +P        +
Sbjct: 116 ARGKALSEGYVAELMKQMMNALAYFHSQHVV---HKDLKPENILF-QDTSPH-------S 164
Query: 188 PAVVKVCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
           P  +   G AE     + +        Y APE+F  D    V  + D+WS G ++Y +  
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD----VTFKCDIWSAGVVMYFLLT 220
Query: 247 FKSPF 251
              PF
Sbjct: 221 GCLPF 225

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G +  V        + R A+K+I             E+  HK   H NI+  L    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-- 87
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-ICEAVKVF 152
                   +    + + +   P G+L+    LRS       +   +  + K I E +K  
Sbjct: 88  -------FSENGFIKIFMEQVPGGSLS--ALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 153 HDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG-SVAPAVVKVCGSAEAQNLQDVAAERC 210
           HD + +   HRD+K  NVL+   +  L + D G S   A +  C       LQ       
Sbjct: 139 HDNQIV---HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ------- 188
Query: 211 SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
              Y APE+          +  D+WSLGC +  M   K PF   YE G+  A
Sbjct: 189 ---YMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPF---YELGEPQA 233

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/240 (21%), Positives = 101/240 (42%), Gaps = 38/240 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D               +K
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNED-------------CELK 165
Query: 193 VCGSAEAQNLQD-VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G   A++  D +     +  YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 166 ILGFGLARHTDDEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDAGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
           +            + +VL Y P+        +  V +HY  +   L +        ++F 
Sbjct: 84  SSGEK---KDVVYLNLVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 154 DAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QDVAA 207
               I      HRD+K  N+LL  D             AV+K+C    A+ L   +   +
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEPNVS 181
Query: 208 ERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 182 XICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDRGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L  +   K + A+K I   G   +   I E E      HP ++ L 
Sbjct: 12  FVQEIGSGQFGLVHL-GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
              L           + + +V  +   G L++ L  +   +   ++  +L M L +CE +
Sbjct: 70  GVCL---------EQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM 117
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
               +A  I   HRDL   N L+  +    + D G     +     S+            
Sbjct: 118 AYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 167
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
             + + +PE+F    Y     ++DVWS G L++
Sbjct: 168 -PVKWASPEVFSFSRY---SSKSDVWSFGVLMW 196

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 79
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 80  F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 126
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E + +     
Sbjct: 127 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVL---- 175
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 176 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 88  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 135 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 182
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 183 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 31/238 (13%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKT 79
           +  D Y + E IG G  + V     +  K++ A+K+I    C    D+   ++E++    
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQ 64
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVD- 137
             HPNI+      +            ++ +V+     G++ + ++ + + G+H    +D 
Sbjct: 65  CHHPNIVSYYTSFVV---------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 115
Query: 138 --ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             I  +  ++ E ++  H    I   HRD+K  N+LL  D +  + D G    A +   G
Sbjct: 116 STIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG--VSAFLATGG 170
Query: 196 SAEAQNLQDV-AAERCSMPYRAPELF-HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 ++       C M   APE+   V  Y   D + D+WS G     +    +P+
Sbjct: 171 DITRNKVRKTFVGTPCWM---APEVMEQVRGY---DFKADIWSFGITAIELATGAAPY 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKII------CHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 105
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 106 F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 152
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E + +     
Sbjct: 153 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVL---- 201
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 202 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 39  KLGGGQYGEV----YVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +V  Y P G L +   LR   +  +++V +L M  +I  A+
Sbjct: 95  G---------VCTLEPPFYIVTEYMPYGNLLD--YLRECNREEVTAVVLLYMATQISSAM 143
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 144 EYLEKKN---FIHRDLAARNCLVGENHVVKVADFG--------LSRLMTGDTYTAHAGAK 192
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    +++ +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 193 FPIKWTAPESLAYNTFSI---KSDVWAFGVLLWEIATYGMSPY 232

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 103
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 104 F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 150
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E + +     
Sbjct: 151 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVL---- 199
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 200 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 90  LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 136
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 137 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 184
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 185 LVRGEPNVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 109/269 (40%), Gaps = 42/269 (15%)
Query: 20  AVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQA 70
           +VY K+  D+Y + + +G G    V L    +T K+ A+K I      I   RE D A  
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 71  IR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           +  E+E  K   HP I+ + +                  +VL     G L +    + VG
Sbjct: 62  VETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVVG 107
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
              +        F ++  AV+  H+   I   HRDLK  NVLL++     L         
Sbjct: 108 NKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL--------- 155
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C 
Sbjct: 156 -IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICL 213
Query: 247 FKSPFDTVYERGDSVALAVISGNITF-PE 274
              P  + +    S+   + SG   F PE
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 85  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 132 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 179
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 180 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 90  LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 136
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 137 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 184
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 185 LVRGEPNVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 225

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 30/170 (17%)
Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D       DPV  + + V             N+ + + + +  ++  DI    
Sbjct: 92  PNIITLAD----IVKDPVSRTPALVF---------EHVNNTDFKQL-RQTLTDYDIRFYM 137
Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQN 201
            +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + +     +  N
Sbjct: 138 YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LAEFYHPGQEYN 189
Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           ++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 190 VR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 92  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 139 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 186
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 187 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 109/269 (40%), Gaps = 42/269 (15%)
Query: 20  AVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQA 70
           +VY K+  D+Y + + +G G    V L    +T K+ A+K I      I   RE D A  
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 71  IR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           +  E+E  K   HP I+ + +                  +VL     G L +    + VG
Sbjct: 62  VETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVVG 107
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
              +        F ++  AV+  H+   I   HRDLK  NVLL++     L         
Sbjct: 108 NKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL--------- 155
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C 
Sbjct: 156 -IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICL 213
Query: 247 FKSPFDTVYERGDSVALAVISGNITF-PE 274
              P  + +    S+   + SG   F PE
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 103 SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 150 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 197
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 198 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 232

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 34/225 (15%)
Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILP 87
           + +IG G F  V      +  +  A+KK+   G+   E     I+EV   +   HPN + 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI- 117
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                  GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     +
Sbjct: 118 ----QYRGCY--LREHTAWLVM---EYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQ 165
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H    I   HRD+K  N+LL+    P L+ LG    A +              A 
Sbjct: 166 GLAYLHSHNMI---HRDVKAGNILLS---EPGLVKLGDFGSASIMAP-----------AN 208
Query: 208 ERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                PY  APE+         D + DVWSLG     +   K P 
Sbjct: 209 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 112 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 158
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 206
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 207 LVRGEPNVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 247

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDGGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 109/269 (40%), Gaps = 42/269 (15%)
Query: 20  AVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQA 70
           +VY K+  D+Y + + +G G    V L    +T K+ A+K I      I   RE D A  
Sbjct: 2   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 71  IR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           +  E+E  K   HP I+ + +                  +VL     G L +    + VG
Sbjct: 62  VETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVVG 107
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
              +        F ++  AV+  H+   I   HRDLK  NVLL++     L         
Sbjct: 108 NKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL--------- 155
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C 
Sbjct: 156 -IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICL 213
Query: 247 FKSPFDTVYERGDSVALAVISGNITF-PE 274
              P  + +    S+   + SG   F PE
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPE 242

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 38/270 (14%)
Query: 26  DKYYIVEKI-GEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEH-HKTFVHP 83
           D Y + E + GEG  + V    +  T + YA+K I       +++  REVE  ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           N+L L++         ++    +   +L +  K    N+LE   V +   S++D L    
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL---- 127
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--NPL-LMDLGSVAPAVVKVCGSAEAQ 200
                    H+      AHRDLK  N+L  + N  +P+ + D G    + +K+ G     
Sbjct: 128 ---------HNK---GIAHRDLKPENILCEHPNQVSPVKICDFG--LGSGIKLNGDCSPI 173
Query: 201 NLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPF------D 252
           +  ++     S  Y APE+     +   + D+R D+WSLG +LY +     PF      D
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
Query: 253 TVYERGDSVAL-------AVISGNITFPEN 275
             ++RG++          ++  G   FP+ 
Sbjct: 234 CGWDRGEACPACQNMLFESIQEGKYEFPDK 263

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 109/269 (40%), Gaps = 42/269 (15%)
Query: 20  AVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQA 70
           +VY K+  D+Y + + +G G    V L    +T K+ A+K I      I   RE D A  
Sbjct: 1   SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 60
Query: 71  IR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG 129
           +  E+E  K   HP I+ + +                  +VL     G L +    + VG
Sbjct: 61  VETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVVG 106
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
              +        F ++  AV+  H+   I   HRDLK  NVLL++     L         
Sbjct: 107 NKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL--------- 154
Query: 190 VVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C 
Sbjct: 155 -IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICL 212
Query: 247 FKSPFDTVYERGDSVALAVISGNITF-PE 274
              P  + +    S+   + SG   F PE
Sbjct: 213 SGYPPFSEHRTQVSLKDQITSGKYNFIPE 241

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 31/238 (13%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKT 79
           +  D Y + E IG G  + V     +  K++ A+K+I    C    D+   ++E++    
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQ 69
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVD- 137
             HPNI+      +            ++ +V+     G++ + ++ + + G+H    +D 
Sbjct: 70  CHHPNIVSYYTSFVV---------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 138 --ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             I  +  ++ E ++  H    I   HRD+K  N+LL  D +  + D G    A +   G
Sbjct: 121 STIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG--VSAFLATGG 175
Query: 196 SAEAQNLQDV-AAERCSMPYRAPELF-HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 ++       C M   APE+   V  Y   D + D+WS G     +    +P+
Sbjct: 176 DITRNKVRKTFVGTPCWM---APEVMEQVRGY---DFKADIWSFGITAIELATGAAPY 227

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 92/245 (37%), Gaps = 56/245 (22%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + I++ IG G F  V++++     K +A+K +                        N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL------------------------NK 109
Query: 86  LPLLDHALTGC----ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
             +L  A T C     D ++N  S+ +  L Y       +D  L  V  +Y+   D+L +
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHY----AFQDDNNLYLVMDYYVGG-DLLTL 164
Query: 142 FLK-------------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
             K             + E V        + Y HRD+K  N+L+  + +  L D GS   
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS--- 221
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCY 246
             +K+      Q+   V     +  Y +PE+               D WSLG  +Y M Y
Sbjct: 222 -CLKLMEDGTVQSSVAVG----TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 247 FKSPF 251
            ++PF
Sbjct: 277 GETPF 281

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 82
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 83  LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 129
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 130 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 177
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 178 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILP 87
           +V++IG+G +  V + +    K   A+K        ++A   RE E ++T +  H NIL 
Sbjct: 41  MVKQIGKGRYGEVWMGKWRGEK--VAVKVFFT---TEEASWFRETEIYQTVLMRHENILG 95
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-----ANDLELRSVGKHYMSSVDILKMF 142
            +   + G       S +Q+ ++  Y+  G+L     +  L+ +S+ K   SSV  L   
Sbjct: 96  FIAADIKGTG-----SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL--- 147
Query: 143 LKICEA-VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
              C    ++F      A AHRDLK+ N+L+  +    + DLG +A   +      +   
Sbjct: 148 ---CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG-LAVKFISDTNEVDIPP 203
Query: 202 LQDVAAERCSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLY 242
              V  +R    Y  PE+        H  SY +     D++S G +L+
Sbjct: 204 NTRVGTKR----YMPPEVLDESLNRNHFQSYIMA----DMYSFGLILW 243

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 27  KYYIVEKIGEGGFSTVSLIEH---SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           ++ +++ +G+G F  V L++    S  ++ YA+K +       +   ++  +  +T +  
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMER 78
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +IL  ++H           +  ++ ++L +   G L   L      K  M + + +K +L
Sbjct: 79  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 133
Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++  A+   H    +   +RDLK  N+LL  + +  L D G           S E+ + 
Sbjct: 134 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----------SKESIDH 180
Query: 203 QDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  A   C ++ Y APE+ +   +    Q  D WS G L++ M     PF
Sbjct: 181 EKKAYSFCGTVEYMAPEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPF 227

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 27  KYYIVEKIGEGGFSTVSLIEH---SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           ++ +++ +G+G F  V L++    S  ++ YA+K +       +   ++  +  +T +  
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMER 77
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +IL  ++H           +  ++ ++L +   G L   L      K  M + + +K +L
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 132
Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++  A+   H    +   +RDLK  N+LL  + +  L D G           S E+ + 
Sbjct: 133 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----------SKESIDH 179
Query: 203 QDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  A   C ++ Y APE+ +   +    Q  D WS G L++ M     PF
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPF 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 95/250 (38%), Gaps = 30/250 (12%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D +  +  +G+G F  V L    +T   YA+K +    ++D      +VE   T     I
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL----KKDVILQDDDVE--CTMTEKRI 76
Query: 86  LPLL-DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L L  +H           +  ++  V+ +   G    DL                    +
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG----DLMFHIQKSRRFDEARARFYAAE 132
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A+   HD K I Y  RDLK  NVLL ++ +  L D G        +C          
Sbjct: 133 IISALMFLHD-KGIIY--RDLKLDNVLLDHEGHCKLADFGMCKEG---ICNGV------- 179
Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
             A  C  P Y APE+     Y       D W++G LLY M    +PF+   E  D +  
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEA--ENEDDLFE 234
Query: 264 AVISGNITFP 273
           A+++  + +P
Sbjct: 235 AILNDEVVYP 244

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 34/225 (15%)
Query: 31  VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILP 87
           + +IG G F  V      +  +  A+KK+   G+   E     I+EV   +   HPN + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI- 78
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
                  GC   +   T+ ++M    Y  G+ ++ LE   V K  +  V+I  +     +
Sbjct: 79  ----QYRGCY--LREHTAWLVM---EYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQ 126
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H    I   HRD+K  N+LL+    P L+ LG    A +              A 
Sbjct: 127 GLAYLHSHNMI---HRDVKAGNILLS---EPGLVKLGDFGSASIMAP-----------AN 169
Query: 208 ERCSMPYR-APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                PY  APE+         D + DVWSLG     +   K P 
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 47/242 (19%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEH---SQTKKRYALK----KIICHGREDQAQAIREVE 75
           ++ + + ++  +G+GG+  V  +     + T K +A+K     +I    +D A    E  
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             +   HP I+ L+    TG          ++ ++L Y   G L   LE   +   +M  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTG---------GKLYLILEYLSGGELFMQLEREGI---FMED 121
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVV 191
                +  +I  A+   H  K I Y  RDLK  N++L +  +  L D G    S+    V
Sbjct: 122 TACFYL-AEISMALGHLHQ-KGIIY--RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 192 --KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
               CG+ E               Y APE+     +   ++  D WSLG L+Y M     
Sbjct: 178 THXFCGTIE---------------YMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAP 219
Query: 250 PF 251
           PF
Sbjct: 220 PF 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 122
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 123 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKTFCG 167
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 168 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 47/242 (19%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEH---SQTKKRYALK----KIICHGREDQAQAIREVE 75
           ++ + + ++  +G+GG+  V  +     + T K +A+K     +I    +D A    E  
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             +   HP I+ L+    TG          ++ ++L Y   G L   LE   +   +M  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTG---------GKLYLILEYLSGGELFMQLEREGI---FMED 121
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVV 191
                +  +I  A+   H  K I Y  RDLK  N++L +  +  L D G    S+    V
Sbjct: 122 TACFYL-AEISMALGHLHQ-KGIIY--RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 192 K--VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
               CG+ E               Y APE+     +   ++  D WSLG L+Y M     
Sbjct: 178 THTFCGTIE---------------YMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAP 219
Query: 250 PF 251
           PF
Sbjct: 220 PF 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 110/270 (40%), Gaps = 42/270 (15%)
Query: 19  EAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQ 69
           ++VY K+  D+Y + + +G G    V L    +T K+ A++ I      I   RE D A 
Sbjct: 140 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 199
Query: 70  AIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
            +  E+E  K   HP I+ + +                  +VL     G L +    + V
Sbjct: 200 NVETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVV 245
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
           G   +        F ++  AV+  H+   I   HRDLK  NVLL++     L        
Sbjct: 246 GNKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL-------- 294
Query: 189 AVVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
             +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C
Sbjct: 295 --IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-IC 351
Query: 246 YFKSPFDTVYERGDSVALAVISGNITF-PE 274
               P  + +    S+   + SG   F PE
Sbjct: 352 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 381

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 113
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 114 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 160
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 161 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 208
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 209 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 249

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 156
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 157 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 203
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 204 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 251
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 252 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 292

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ L    +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 97  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 144 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 191
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 192 NVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 105
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 106 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 152
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 153 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 200
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 201 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 241

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 81
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 82  F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 128
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E +       
Sbjct: 129 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKTL---- 177
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 178 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 112 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 158
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 206
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 207 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 247

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 110/270 (40%), Gaps = 42/270 (15%)
Query: 19  EAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGRE-DQAQ 69
           ++VY K+  D+Y + + +G G    V L    +T K+ A++ I      I   RE D A 
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 70  AIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
            +  E+E  K   HP I+ + +                  +VL     G L +    + V
Sbjct: 186 NVETEIEILKKLNHPCIIKIKN----------FFDAEDYYIVLELMEGGELFD----KVV 231
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
           G   +        F ++  AV+  H+   I   HRDLK  NVLL++     L        
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEEDCL-------- 280
Query: 189 AVVKVCGSAEAQNLQDVAAER--CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
             +K+     ++ L + +  R  C  P Y APE+         ++  D WSLG +L+ +C
Sbjct: 281 --IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-IC 337
Query: 246 YFKSPFDTVYERGDSVALAVISGNITF-PE 274
               P  + +    S+   + SG   F PE
Sbjct: 338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 133 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 184
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 185 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 81
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 82  F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 128
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E +       
Sbjct: 129 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKTL---- 177
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 178 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 24/250 (9%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V    ++   + YA+KKI  H  E  +  + EV    +  H  ++      L
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 94  --TGCADPV--LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                  P+  +   S + + + Y    TL + +   ++ +      +  ++F +I EA+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ---RDEYWRLFRQILEAL 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG--SAEAQNL----Q 203
              H    I   HRDLK  N+ +    N  + D G +A  V +       ++QNL     
Sbjct: 130 SYIHSQGII---HRDLKPMNIFIDESRNVKIGDFG-LAKNVHRSLDILKLDSQNLPGSSD 185
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
           ++ +   +  Y A E+  +D     +++ D++SLG + + M Y   PF T  ER + +  
Sbjct: 186 NLTSAIGTAMYVATEV--LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN-ILK 239
Query: 264 AVISGNITFP 273
            + S +I FP
Sbjct: 240 KLRSVSIEFP 249

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 27  KYYIVEKIGEGGFSTVSLIEH---SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           ++ +++ +G+G F  V L++    S  ++ YA+K +       +   ++  +  +T +  
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMER 77
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +IL  ++H           +  ++ ++L +   G L   L      K  M + + +K +L
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYL 132
Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++  A+   H    +   +RDLK  N+LL  + +  L D G           S E+ + 
Sbjct: 133 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----------SKESIDH 179
Query: 203 QDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +  A   C ++ Y APE+ +   +    Q  D WS G L++ M     PF
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHT---QSADWWSFGVLMFEMLTGTLPF 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 127 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 178
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 179 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           Y   + IG G F  V   +   + +  A+KK++    +D+    RE++  +   H NI+ 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 115
Query: 88  L--LDHALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           L    ++     D V LN      +VL Y P+        +  V +HY  +   L +   
Sbjct: 116 LRYFFYSSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYV 162
Query: 145 ICEAVKVFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                ++F     I      HRD+K  N+LL  D             AV+K+C    A+ 
Sbjct: 163 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQ 210
Query: 202 L---QDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
           L   +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 211 LVRGEPNVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 251

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    +    +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 39/227 (17%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKTFVHPNILP 87
           +G+GGF+    I  + TK+ +A K +        H RE  +    E+  H++  H +++ 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 85
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
              H               V +VL    + +L   LEL    K  ++  +      +I  
Sbjct: 86  F--HGF-------FEDNDFVFVVLELCRRRSL---LELHKRRK-ALTEPEARYYLRQIVL 132
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
             +  H  + I   HRDLK  N+ L  D    + D G       KV    E +       
Sbjct: 133 GCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKTL---- 181
Query: 208 ERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             C  P Y APE+     +       DVWS+GC++Y +   K PF+T
Sbjct: 182 --CGTPNYIAPEVLSKKGHSF---EVDVWSIGCIMYTLLVGKPPFET 223

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 126 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 177
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 178 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 127 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 178
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 179 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 23  VKSDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV 81
           V S +Y IV+ +GEG F   V  I+H    +  A+K  I    +   +A R         
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK--IVKNVDRYCEAAR--------- 59
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP-KGTLANDLELRSVGKHYMSSVD--- 137
             + + +L+H  T   DP  NST + + +L ++   G +    EL  +  +     +   
Sbjct: 60  --SEIQVLEHLNT--TDP--NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL 113
Query: 138 ------ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-----NP-LLMDLGS 185
                 I KM  +IC++V   H  K     H DLK  N+L    +     NP +  D  +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 186 VAPAVVKVC--GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           +    +KV   GSA   + +  +    +  YRAPE+     +    Q  DVWS+GC+L
Sbjct: 171 LINPDIKVVDFGSATYDD-EHHSTLVSTRHYRAPEVILALGWS---QPCDVWSIGCIL 224

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 122
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 123 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKXFCG 167
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 168 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 37/224 (16%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 122
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVAPAVVKVCGSAEAQNLQDVAA 207
            ++ + Y  RD+K  N++L  D +  + D G      S    +   CG+ E         
Sbjct: 123 -SRDVVY--RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE--------- 170
Query: 208 ERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 171 ------YLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 71
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 127
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 128 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKXFCG 172
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 173 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 122
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 123 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKTFCG 167
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 168 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 26  DKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI------REVEHHK 78
           D YY   E++G G F+ V       T  +YA K I     +   + +      REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++      G L + L      K  ++  + 
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILIGELVAGGELFDFL----AEKESLTEEEA 116
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP----LLMDLGSVAPAVVKVC 194
            +   +I   V   H    +  AH DLK  N++L + N P     ++D G       K+ 
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----KID 169
Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E +N+        +  + APE+ +   Y  +    D+WS+G + Y +    SPF
Sbjct: 170 FGNEFKNI------FGTPEFVAPEIVN---YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 16/120 (13%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           ++  DI     +I +A+   H    +   HRD+K  NV++ +++  L L+D G     + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG-----LA 179
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  N++ VA    S  ++ PEL  VD Y + D   D+WSLGC+L +M + K PF
Sbjct: 180 EFYHPGQEYNVR-VA----SRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 122
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 123 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKXFCG 167
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 168 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    + +A   RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHAL 93
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 69
Query: 94  TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH 153
                    +  ++  V+ Y   G L   L    V     +         +I  A++  H
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEYLH 125
Query: 154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER--CS 211
            ++ + Y  RD+K  N++L  D +  + D G        +C     + + D A  +  C 
Sbjct: 126 -SRDVVY--RDIKLENLMLDKDGHIKITDFG--------LC----KEGISDGATMKTFCG 170
Query: 212 MP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
            P Y APE+   + Y    +  D W LG ++Y M   + PF
Sbjct: 171 TPEYLAPEVLEDNDYG---RAVDWWGLGVVMYEMMCGRLPF 208

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 12  ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 66
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 67  ------AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASG 115
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 116 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 167
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 168 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 215

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    + +A   RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P+        +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPE-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSYICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 105/253 (41%), Gaps = 37/253 (14%)
Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +V+K+G G F  V +  ++ + K     K +  G       + E    KT  H  ++ L 
Sbjct: 16  LVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRL- 72
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            +A+    +P+        ++  +  KG+L + L+    GK  +    ++    +I E +
Sbjct: 73  -YAVVTKEEPIY-------IITEFMAKGSLLDFLKSDEGGKVLLPK--LIDFSAQIAEGM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
                     Y HRDL+ ANVL++      + D G     + +V    E       A E 
Sbjct: 123 AYIERKN---YIHRDLRAANVLVSESLMCKIADFG-----LARVIEDNEY-----TAREG 169
Query: 210 CSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVYERGDSVALAVI 266
              P  + APE  +   + +   +++VWS G LLY +  Y K P+     R ++  ++ +
Sbjct: 170 AKFPIKWTAPEAINFGCFTI---KSNVWSFGILLYEIVTYGKIPYPG---RTNADVMSAL 223
Query: 267 SGNITFP--ENTP 277
           S     P  EN P
Sbjct: 224 SQGYRMPRMENCP 236

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 15  ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 69
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 70  ------AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASG 118
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 119 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 170
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 171 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 218

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL--LDH 91
           IG G F  V   +   + +  A+KK++    + +A   RE++  +   H NI+ L    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 92  ALTGCADPV-LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVK 150
           +     D V LN      +VL Y P         +  V +HY  +   L +        +
Sbjct: 84  SSGEKKDEVYLN------LVLDYVPA-------TVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 151 VFHDAKPI---AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL---QD 204
           +F     I      HRD+K  N+LL  D             AV+K+C    A+ L   + 
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDT------------AVLKLCDFGSAKQLVRGEP 178
Query: 205 VAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
             +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 179 NVSXICSRYYRAPELIFGATDYT---SSIDVWSAGCVL 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 35  ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 89
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 90  ------AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASG 138
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 139 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 190
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 191 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 238

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 9   ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 63
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 64  ------AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASG 112
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 113 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 164
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 212

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y +V K+G G +S V    +    +R  +K +    ++   + ++ +E+ +     N
Sbjct: 37  QDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGT--N 94
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L+D       DPV  + + V   +         N+ + + + +  ++  DI     +
Sbjct: 95  IIKLID----TVKDPVSKTPALVFEYI---------NNTDFKQLYQ-ILTDFDIRFYMYE 140
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQ 203
           + +A+   H +K I   HRD+K  NV++ +    L L+D G     + +    A+  N++
Sbjct: 141 LLKALDYCH-SKGIM--HRDVKPHNVMIDHQQKKLRLIDWG-----LAEFYHPAQEYNVR 192
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                  S  ++ PEL  VD Y + D   D+WSLGC+L +M + + PF
Sbjct: 193 -----VASRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 10  ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 64
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 65  ------AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASG 113
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 114 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 165
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 166 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 213

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y +V K+G G +S V    +    +R  +K +    ++   + ++ +E+ +     N
Sbjct: 42  QDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGT--N 99
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L+D       DPV  + + V   +         N+ + + + +  ++  DI     +
Sbjct: 100 IIKLID----TVKDPVSKTPALVFEYI---------NNTDFKQLYQ-ILTDFDIRFYMYE 145
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQ 203
           + +A+   H +K I   HRD+K  NV++ +    L L+D G     + +    A+  N++
Sbjct: 146 LLKALDYCH-SKGIM--HRDVKPHNVMIDHQQKKLRLIDWG-----LAEFYHPAQEYNVR 197
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                  S  ++ PEL  VD Y + D   D+WSLGC+L +M + + PF
Sbjct: 198 -----VASRYFKGPELL-VD-YQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 43/97 (44%), Gaps = 26/97 (26%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVA-----PAVVKVCGSAEAQNLQDVAAERCSM--PY 214
           HRD+K  N+++A D    L+D GS A           CG+ E        A    M  PY
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE------YCAPEVLMGNPY 206
Query: 215 RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           R PEL             ++WSLG  LY + + ++PF
Sbjct: 207 RGPEL-------------EMWSLGVTLYTLVFEENPF 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 62/150 (41%), Gaps = 28/150 (18%)
Query: 105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD 164
           S++ +++ Y   G+    L+L   G        I  M  +I + +   H  K I   HRD
Sbjct: 94  SKLWIIMEYLGGGSA---LDLLRAGP--FDEFQIATMLKEILKGLDYLHSEKKI---HRD 145
Query: 165 LKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP----YRAPELF 220
           +K ANVLL+   +  L D G        V G      L D   +R +      + APE+ 
Sbjct: 146 IKAANVLLSEQGDVKLADFG--------VAG-----QLTDTQIKRNTFVGTPFWMAPEVI 192
Query: 221 HVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
              +Y   D + D+WSLG     +   + P
Sbjct: 193 QQSAY---DSKADIWSLGITAIELAKGEPP 219

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--HPNILPLL 89
           E IG+G F  V         +  A+K  I   RE+++   RE E ++T +  H NIL  +
Sbjct: 48  ESIGKGRFGEV--WRGKWRGEEVAVK--IFSSREERSW-FREAEIYQTVMLRHENILGFI 102
Query: 90  DHALTGCADPVLNST-SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                  AD   N T +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L     
Sbjct: 103 ------AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASG 151
Query: 149 VKVFH------DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +   H        KP A AHRDLK+ N+L+  +    + DLG              A + 
Sbjct: 152 LAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVR-------HDSATDT 203
Query: 203 QDVAAER--CSMPYRAPELF-------HVDSYCVVDQRTDVWSLGCLLYAMC 245
            D+A      +  Y APE+        H +S+    +R D++++G + + + 
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIA 251

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+      I H +    +  R
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK----RTYR 70
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 121
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D         +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFYLARHTDDE 178
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+    ++   +Q  D+WS+GC++  +   ++ F
Sbjct: 179 MTG---------YVATRW---YRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           HRD+K +N+LL    N  L D G     V  +  + +A          C  PY APE   
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG---------CR-PYMAPERID 198
Query: 222 VD-SYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              S    D R+DVWSLG  LY +   + P+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 61/142 (42%), Gaps = 23/142 (16%)
Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA-------PAVV 191
           L +F++I EAV+  H        HRDLK +N+    D+   + D G V           V
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                A A +   V  +     Y +PE  H ++Y     + D++SLG +L+ + Y    F
Sbjct: 224 LTPMPAYATHXGQVGTKL----YMSPEQIHGNNYS---HKVDIFSLGLILFELLY---SF 273
Query: 252 DTVYERGDSVALAVISGNITFP 273
            T  ER   V +     N+ FP
Sbjct: 274 STQMER---VRIITDVRNLKFP 292

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 23  VKSDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV 81
           V S +Y IV+ +GEG F   V  I+H    +  A+K  I    +   +A R         
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK--IVKNVDRYCEAAR--------- 59
Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP-KGTLANDLELRSVGKHYMSSVD--- 137
             + + +L+H  T   DP  NST + + +L ++   G +    EL  +  +     +   
Sbjct: 60  --SEIQVLEHLNT--TDP--NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL 113
Query: 138 ------ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-----NP-LLMDLGS 185
                 I KM  +IC++V   H  K     H DLK  N+L    +     NP +  D  +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 186 VAPAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           +    +KV   GSA  + ++   +   R    YRAPE+     +    Q  DVWS+GC+L
Sbjct: 171 LINPDIKVVDFGSATYDDEHHSTLVXXR---HYRAPEVILALGWS---QPCDVWSIGCIL 224

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +IC  ++  H  + +   +RDLK  N+LL +  +  + DLG      V V    E Q ++
Sbjct: 294 EICCGLEDLHRERIV---YRDLKPENILLDDHGHIRISDLG----LAVHV---PEGQTIK 343
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                  ++ Y APE+   + Y       D W+LGCLLY M   +SPF
Sbjct: 344 GRVG---TVGYMAPEVVKNERYTFS---PDWWALGCLLYEMIAGQSPF 385

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G F  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 18  KLGGGQFGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 74  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G ++  +     +A A         +
Sbjct: 123 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG-LSRLMTGDTXTAHA-------GAK 171
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 172 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           HRDLK+ N+ L  DN   + D G +A    +  GS + + L        S+ + APE+  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFG-LATEKSRWSGSHQFEQLS------GSILWMAPEVIR 195
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNIT 271
           +        ++DV++ G +LY +   + P+  +  R D +   V  G+++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLS 244

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +IC  ++  H  + +   +RDLK  N+LL +  +  + DLG      V V    E Q ++
Sbjct: 294 EICCGLEDLHRERIV---YRDLKPENILLDDHGHIRISDLG----LAVHV---PEGQTIK 343
Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                  ++ Y APE+   + Y       D W+LGCLLY M   +SPF
Sbjct: 344 GRVG---TVGYMAPEVVKNERYTFS---PDWWALGCLLYEMIAGQSPF 385

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           HRDLK+ N+ L  DN   + D G +A    +  GS + + L        S+ + APE+  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFG-LATVKSRWSGSHQFEQLS------GSILWMAPEVIR 183
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNIT 271
           +        ++DV++ G +LY +   + P+  +  R D +   V  G+++
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLS 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 94/223 (42%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 18  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +++ +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 74  G---------VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G ++  +     +A A         +
Sbjct: 123 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG-LSRLMTGDTXTAHA-------GAK 171
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 172 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 211

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 94/251 (37%), Gaps = 63/251 (25%)
Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-----QAIREV---EH 76
           + +Y  V +IG G + TV       +    ALK +                +REV     
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------G 129
            + F HPN++ L+D     CA    +   +V +V  +        D +LR+        G
Sbjct: 68  LEAFEHPNVVRLMDV----CATSRTDREIKVTLVFEHV-------DQDLRTYLDKAPPPG 116
Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----- 184
               +  D+++ FL+  +    F  A  I   HRDLK  N+L+ +     L D G     
Sbjct: 117 LPAETIKDLMRQFLRGLD----FLHANCIV--HRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 185 ----SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL 240
               ++ P VV +                    YRAPE+    +Y       D+WS+GC+
Sbjct: 171 SYQMALTPVVVTLW-------------------YRAPEVLLQSTYATP---VDMWSVGCI 208
Query: 241 LYAMCYFKSPF 251
              M   K  F
Sbjct: 209 FAEMFRRKPLF 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           HRDLK+ N+ L  DN   + D G +A    +  GS + + L        S+ + APE+  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFG-LATEKSRWSGSHQFEQLS------GSILWMAPEVIR 195
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNIT 271
           +        ++DV++ G +LY +   + P+  +  R D +   V  G+++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLS 244

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +++ +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 69  QAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
           + +RE+     F HPNIL L D       +P ++    V  ++    +  LA  +  + +
Sbjct: 75  RVLREIRLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM----RTDLAQVIHDQRI 129
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
               +S   I      I   + V H+A  +   HRDL   N+LLA++N+  + D      
Sbjct: 130 ---VISPQHIQYFMYHILLGLHVLHEAGVV---HRDLHPGNILLADNNDITICDFN---- 179
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
             +    +A+A     V        YRAPEL  V  +    +  D+WS GC++  M   K
Sbjct: 180 --LAREDTADANKTHYVTHRW----YRAPEL--VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 249 SPF 251
           + F
Sbjct: 232 ALF 234

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 69  QAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
           + +RE+     F HPNIL L D       +P ++    V  ++    +  LA  +  + +
Sbjct: 75  RVLREIRLLNHFHHPNILGLRD-IFVHFEEPAMHKLYLVTELM----RTDLAQVIHDQRI 129
Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
               +S   I      I   + V H+A  +   HRDL   N+LLA++N+  + D      
Sbjct: 130 ---VISPQHIQYFMYHILLGLHVLHEAGVV---HRDLHPGNILLADNNDITICDFN---- 179
Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
             +    +A+A     V        YRAPEL  V  +    +  D+WS GC++  M   K
Sbjct: 180 --LAREDTADANKTHYVTHRW----YRAPEL--VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 249 SPF 251
           + F
Sbjct: 232 ALF 234

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +++ +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 105/268 (39%), Gaps = 35/268 (13%)
Query: 20  AVYVKSDKYYIVEKIGEGGFSTVSL---IEHSQTKKRYALKKIICHGREDQAQAIREVEH 76
           A  V  + + +++ +G G +  V L   I    T K YA+K +    +    Q  +  EH
Sbjct: 48  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEH 104
Query: 77  HKT----FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
            +T      H    P L             + +++ ++L Y   G L   L  R   +  
Sbjct: 105 TRTERQVLEHIRQSPFL-----VTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFT 157
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
              V I      + E V        +   +RD+K  N+LL ++ + +L D G     + K
Sbjct: 158 EHEVQIY-----VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG-----LSK 207
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
              + E +   D      ++ Y AP++         D+  D WSLG L+Y +    SPF 
Sbjct: 208 EFVADETERAYDFCG---TIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFT 263
Query: 253 TVYERGDSVALAVISGNITFPENTPFPQ 280
                G+  + A IS  I   E  P+PQ
Sbjct: 264 V---DGEKNSQAEISRRILKSE-PPYPQ 287

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 18  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 74  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 123 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTFTAHAGAK 171
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 172 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 211

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     A
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLA 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 31/240 (12%)
Query: 15  LCSKEAVYVKSDKYYIVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA- 70
           L   E V   SD+      IG+G F  V     I+ +Q + + A+K +       Q +A 
Sbjct: 15  LIPHERVVTHSDRV-----IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF 69
Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
           +RE    +   HPN+L     AL G   P       VL  LPY   G L   L+     +
Sbjct: 70  LREGLLMRGLNHPNVL-----ALIGIMLPP-EGLPHVL--LPYMCHGDL---LQFIRSPQ 118
Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
              +  D++   L++   ++   + K   + HRDL   N +L       + D G     +
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFG-----L 170
Query: 191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
            +     E  ++Q     R  + + A E      +     ++DVWS G LL+ +    +P
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT---KSDVWSFGVLLWELLTRGAP 227

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 49/268 (18%)
Query: 25  SDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
            ++Y IV  +GEG F   V  ++H++ K + ALK I   G+  +A  +            
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----------I 67
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD------ 137
           N+L  +            N    VLM   +   G +    EL  +GK+    +       
Sbjct: 68  NVLKKIK------EKDKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFLKENNFQP 119
Query: 138 -----ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM------DLGSV 186
                +  M  ++C A++  H+ +     H DLK  N+L  N     L       +  SV
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 187 APAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
               ++V   GSA  + ++   + A R    YR PE+     +    Q  DVWS+GC+L+
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATR---HYRPPEVILELGWA---QPCDVWSIGCILF 230
Query: 243 AMCYFKSPFDTVYERGDSVALAVISGNI 270
                 + F T   R   V +  I G I
Sbjct: 231 EYYRGFTLFQTHENREHLVMMEKILGPI 258

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPN 84
           +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+   K   H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL+          L     V +V+          D  L  V +  +    +  +  +
Sbjct: 85  IISLLN---VFTPQKTLEEFQDVYLVMELM-------DANLXQVIQMELDHERMSYLLYQ 134
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G++       
Sbjct: 135 MLXGIKHLHSAGII---HRDLKPSNIVVKSDXTLKILDFG-----LARTAGTSFM----- 181
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  YRAPE+     Y    +  D+WS+GC++  M   K  F
Sbjct: 182 MTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILF 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/239 (20%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIR 72
           + ++   ++Y  +  +G G + +V      ++  + A+KK+      I H +    +  R
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK----RTYR 99
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   H N++ LLD      +    N    V  ++     G   N++    V    
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-----GADLNNI----VKCQK 150
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           ++   +  +  +I   +K  H A  I   HRDLK +N+ +  D    ++D G       +
Sbjct: 151 LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE 207
Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + G           A R    YRAPE+  + ++   +   D+WS+GC++  +   ++ F
Sbjct: 208 MTG---------YVATRW---YRAPEI--MLNWMHYNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 98/251 (39%), Gaps = 44/251 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------- 129
           K    H NI+ LL      C          + +++ Y  KG L   L+ R          
Sbjct: 88  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 130 -----KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                +  +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 195
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 196 -LARDIHHIDXXKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 245
Query: 245 CYF-KSPFDTV 254
                SP+  V
Sbjct: 246 FTLGGSPYPGV 256

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 25  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 81  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 130 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 178
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 179 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 49/268 (18%)
Query: 25  SDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
            ++Y IV  +GEG F   V  ++H++ K + ALK I   G+  +A  +            
Sbjct: 27  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----------I 76
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD------ 137
           N+L  +            N    VLM   +   G +    EL  +GK+    +       
Sbjct: 77  NVLKKIK------EKDKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFLKENNFQP 128
Query: 138 -----ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM------DLGSV 186
                +  M  ++C A++  H+ +     H DLK  N+L  N     L       +  SV
Sbjct: 129 YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 187 APAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
               ++V   GSA  + ++   + A R    YR PE+     +    Q  DVWS+GC+L+
Sbjct: 186 KNTSIRVADFGSATFDHEHHTTIVATR---HYRPPEVILELGWA---QPCDVWSIGCILF 239
Query: 243 AMCYFKSPFDTVYERGDSVALAVISGNI 270
                 + F T   R   V +  I G I
Sbjct: 240 EYYRGFTLFQTHENREHLVMMEKILGPI 267

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 21  VYVKSDKYYIVE-KIGEGGFSTVSLIEHSQTKKRYALK-KIICHGRE--DQAQAIREVEH 76
           +++K D   I + ++G G F +V    +   KK+  +  K++  G E  D  + +RE + 
Sbjct: 4   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
                +P I+ L+           +     +++V+     G L   L    VGK     V
Sbjct: 64  MHQLDNPYIVRLIG----------VCQAEALMLVMEMAGGGPLHKFL----VGKREEIPV 109
Query: 137 -DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            ++ ++  ++   +K   +     + HRDL   NVLL N +   + D G     + K  G
Sbjct: 110 SNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG-----LSKALG 161
Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTV 254
            A+       +A +  + + APE  +   +     R+DVWS G  ++ A+ Y + P+  +
Sbjct: 162 -ADDSYYTARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 96/242 (39%), Gaps = 29/242 (11%)
Query: 13  GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR 72
           G     E +Y +S    ++E    G F  V     +Q    Y   KI     +   Q   
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVW---KAQLLNEYVAVKIFPIQDKQSWQNEY 67
Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           EV       H NIL  +     G +  V      + ++  ++ KG+L++ L+   V  + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDV-----DLWLITAFHEKGSLSDFLKANVVSWNE 122
Query: 133 MSSV--DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPA 189
           +  +   + +    + E +    D    A +HRD+K+ NVLL N+    + D G ++   
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPEL------FHVDSYCVVDQRTDVWSLGCLLYA 243
             K  G    Q    V   R    Y APE+      F  D++     R D++++G +L+ 
Sbjct: 183 AGKSAGDTHGQ----VGTRR----YMAPEVLEGAINFQRDAFL----RIDMYAMGLVLWE 230
Query: 244 MC 245
           + 
Sbjct: 231 LA 232

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 49/268 (18%)
Query: 25  SDKYYIVEKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
            ++Y IV  +GEG F   V  ++H++ K + ALK I   G+  +A  +            
Sbjct: 50  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----------I 99
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD------ 137
           N+L  +            N    VLM   +   G +    EL  +GK+    +       
Sbjct: 100 NVLKKIK------EKDKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFLKENNFQP 151
Query: 138 -----ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM------DLGSV 186
                +  M  ++C A++  H+ +     H DLK  N+L  N     L       +  SV
Sbjct: 152 YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 187 APAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
               ++V   GSA  + ++   + A R    YR PE+     +    Q  DVWS+GC+L+
Sbjct: 209 KNTSIRVADFGSATFDHEHHTTIVATR---HYRPPEVILELGWA---QPCDVWSIGCILF 262
Query: 243 AMCYFKSPFDTVYERGDSVALAVISGNI 270
                 + F T   R   V +  I G I
Sbjct: 263 EYYRGFTLFQTHENREHLVMMEKILGPI 290

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 21  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +++ +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 77  G---------VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 125
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G ++  +     +A A         +
Sbjct: 126 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG-LSRLMTGDTXTAHA-------GAK 174
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 175 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 25/176 (14%)
Query: 86  LPLLDHA-----LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           +PL++H      + G      +   + L+V+ YYP G+L   L L     H    V   +
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCR 115
Query: 141 MFLKICEAVKVFHDAKPI------AYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKV 193
           +   +   +   H   P       A +HRDL + NVL+ ND   ++ D G S+     ++
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFH-----VDSYCVVDQRTDVWSLGCLLYAM 244
               E  N     +E  ++ Y APE+        D    + Q  D+++LG + + +
Sbjct: 176 VRPGEEDNA--AISEVGTIRYMAPEVLEGAVNLRDXESALKQ-VDMYALGLIYWEI 228

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 108/269 (40%), Gaps = 42/269 (15%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE 75
             K+A  +  +   + +K+G G F  V +  +++  K     K +  G       + E  
Sbjct: 5   WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEAN 62
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             KT  H  ++ L  HA+         +   + ++  +  KG+L + L+     K  +  
Sbjct: 63  VMKTLQHDKLVKL--HAVV--------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 112
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             ++    +I E +          Y HRDL+ AN+L++             A  V K+  
Sbjct: 113 --LIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS-------------ASLVCKIAD 154
Query: 196 SAEAQNLQD---VAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKS 249
              A+ ++D    A E    P  + APE  +  S+ +   ++DVWS G LL  +  Y + 
Sbjct: 155 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGILLMEIVTYGRI 211
Query: 250 PFDTVYERGDSVALAVISG-NITFPENTP 277
           P+  +      V  A+  G  +  PEN P
Sbjct: 212 PYPGM--SNPEVIRALERGYRMPRPENCP 238

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 14  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 71  GYS----------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 117
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D   L + +G    A VK   S   Q  Q      
Sbjct: 118 DYLH-AKSII--HRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSG--- 168
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 169 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 226
Query: 270 IT 271
           ++
Sbjct: 227 LS 228

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPN 84
           +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+   K   H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL+          L     V +V+          D  L  V +  +    +  +  +
Sbjct: 78  IISLLN---VFTPQKTLEEFQDVYLVMELM-------DANLXQVIQMELDHERMSYLLYQ 127
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G++       
Sbjct: 128 MLXGIKHLHSAGII---HRDLKPSNIVVKSDXTLKILDFG-----LARTAGTSFM----- 174
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  YRAPE+     Y    +  D+WS+GC++  M   K  F
Sbjct: 175 MTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILF 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 14/116 (12%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           +RDLK  NVLL +D N  + DLG    AV    G  + +             + APEL  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTKGYAGTPG------FMAPELLL 362
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA--VISGNITFPEN 275
            + Y   D   D ++LG  LY M   + PF    E+ ++  L   V+   +T+P+ 
Sbjct: 363 GEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/257 (21%), Positives = 99/257 (38%), Gaps = 54/257 (21%)
Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHG-------------- 63
           V+ ++Y + ++IG+G +  V L  +      YA+K     K+I                 
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 64  -------REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPK 116
                  R    Q  +E+   K   HPN++ L++       DP   +   + MV     +
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV----LDDP---NEDHLYMVFELVNQ 122
Query: 117 GTLANDLELRSVGKHYMSSVDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLAND 175
           G +     L+ +      S D  + + + + + ++  H  K I   HRD+K +N+L+  D
Sbjct: 123 GPVMEVPTLKPL------SEDQARFYFQDLIKGIEYLHYQKII---HRDIKPSNLLVGED 173
Query: 176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDV 234
            +  + D G           S E +    + +     P + APE           +  DV
Sbjct: 174 GHIKIADFGV----------SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDV 223
Query: 235 WSLGCLLYAMCYFKSPF 251
           W++G  LY   + + PF
Sbjct: 224 WAMGVTLYCFVFGQCPF 240

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 14/116 (12%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           +RDLK  NVLL +D N  + DLG    AV    G  + +             + APEL  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTKGYAGTPG------FMAPELLL 362
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA--VISGNITFPEN 275
            + Y   D   D ++LG  LY M   + PF    E+ ++  L   V+   +T+P+ 
Sbjct: 363 GEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 14/116 (12%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           +RDLK  NVLL +D N  + DLG    AV    G  + +             + APEL  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTKGYAGTPG------FMAPELLL 362
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA--VISGNITFPEN 275
            + Y   D   D ++LG  LY M   + PF    E+ ++  L   V+   +T+P+ 
Sbjct: 363 GEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 25  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        +++ +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 81  G---------VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 130 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 178
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 179 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 14/116 (12%)
Query: 162 HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH 221
           +RDLK  NVLL +D N  + DLG    AV    G  + +             + APEL  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGL---AVELKAGQTKTKGYAGTPG------FMAPELLL 362
Query: 222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA--VISGNITFPEN 275
            + Y   D   D ++LG  LY M   + PF    E+ ++  L   V+   +T+P+ 
Sbjct: 363 GEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 14  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 71  GYS----------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 117
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D   L + +G    A VK   S   Q  Q      
Sbjct: 118 DYLH-AKSII--HRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSG--- 168
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 169 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 226
Query: 270 IT 271
           ++
Sbjct: 227 LS 228

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 21/227 (9%)
Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
           + +VE +G G +  V    H +T +  A+K +   G E++ +  +E+   K + H   + 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 84
Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
               A      P ++   Q+ +V+ +   G++  DL +++   + +    I  +  +I  
Sbjct: 85  TYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVT-DL-IKNTKGNTLKEEWIAYICREILR 140
Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +   H  K I   HRD+K  NVLL  +    L+D G V+  + +  G            
Sbjct: 141 GLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTVGRRNT-------- 188
Query: 208 ERCSMPYR-APELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPF 251
                PY  APE+   D       D ++D+WSLG     M     P 
Sbjct: 189 -FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/242 (21%), Positives = 98/242 (40%), Gaps = 39/242 (16%)
Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE 75
             K+A  +  +   + +K+G G F  V +  +++  K     K +  G       + E  
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEAN 235
Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             KT  H  ++ L  HA+         +   + ++  +  KG+L + L+     K  +  
Sbjct: 236 VMKTLQHDKLVKL--HAVV--------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 285
Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             ++    +I E +          Y HRDL+ AN+L++             A  V K+  
Sbjct: 286 --LIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS-------------ASLVCKIAD 327
Query: 196 SAEAQNLQD---VAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKS 249
              A+ ++D    A E    P  + APE  +  S+ +   ++DVWS G LL  +  Y + 
Sbjct: 328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGILLMEIVTYGRI 384
Query: 250 PF 251
           P+
Sbjct: 385 PY 386

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 88  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 195
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 196 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 245
Query: 245 CYF-KSPFDTV 254
                SP+  V
Sbjct: 246 FTLGGSPYPGV 256

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPN 84
           +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+   K   H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL+          L     V +V+          D  L  V +  +    +  +  +
Sbjct: 85  IISLLN---VFTPQKTLEEFQDVYLVMELM-------DANLXQVIQMELDHERMSYLLYQ 134
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G++       
Sbjct: 135 MLXGIKHLHSAGII---HRDLKPSNIVVKSDXTLKILDFG-----LARTAGTSFM----- 181
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  YRAPE+     Y    +  D+WS+GC++  M   K  F
Sbjct: 182 MTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILF 225

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 129 KMIGKHKNIINLLG----ACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 236
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 237 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 286
Query: 245 CYF-KSPFDTV 254
                SP+  V
Sbjct: 287 FTLGGSPYPGV 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 29/267 (10%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRE 65
           N +  +G   S +   +   +  + ++IG G F TV      +     A+K + +     
Sbjct: 17  NRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTP 73
Query: 66  DQAQAIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
            Q QA + EV   +   H NIL  + ++          +  Q+ +V  +    +L + L 
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGYS----------TKPQLAIVTQWCEGSSLYHHLH 123
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
           +       +  +DI +   +  + +   H AK I   HRDLK+ N+ L  D   L + +G
Sbjct: 124 IIETKFEMIKLIDIAR---QTAQGMDYLH-AKSII--HRDLKSNNIFLHED---LTVKIG 174
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
               A VK   S   Q  Q       S+ + APE+  +        ++DV++ G +LY +
Sbjct: 175 DFGLATVKSRWSGSHQFEQLSG----SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230
Query: 245 CYFKSPFDTVYERGDSVALAVISGNIT 271
              + P+  +  R D +   V  G ++
Sbjct: 231 MTGQLPYSNINNR-DQIIFMVGRGYLS 256

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 88  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 195
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 196 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 245
Query: 245 CYF-KSPFDTV 254
                SP+  V
Sbjct: 246 FTLGGSPYPGV 256

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 19  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 76  GYS----------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D   L + +G    A VK   S   Q  Q      
Sbjct: 123 DYLH-AKSII--HRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSG--- 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 174 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 231
Query: 270 IT 271
           ++
Sbjct: 232 LS 233

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 91  FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 138
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 139 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 182
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 183 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 16  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 73  GYS----------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 119
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D   L + +G    A VK   S   Q  Q      
Sbjct: 120 DYLH-AKSII--HRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSG--- 170
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 171 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 228
Query: 270 IT 271
           ++
Sbjct: 229 LS 230

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 29/267 (10%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRE 65
           N +  +G   S +   +   +  + ++IG G F TV      +     A+K + +     
Sbjct: 16  NRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTP 72
Query: 66  DQAQAIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
            Q QA + EV   +   H NIL  + ++          +  Q+ +V  +    +L + L 
Sbjct: 73  QQLQAFKNEVGVLRKTRHVNILLFMGYS----------TKPQLAIVTQWCEGSSLYHHLH 122
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
           +       +  +DI +   +  + +   H AK I   HRDLK+ N+ L  D   L + +G
Sbjct: 123 IIETKFEMIKLIDIAR---QTAQGMDYLH-AKSII--HRDLKSNNIFLHED---LTVKIG 173
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
               A VK   S   Q  Q       S+ + APE+  +        ++DV++ G +LY +
Sbjct: 174 DFGLATVKSRWSGSHQFEQLSG----SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 229
Query: 245 CYFKSPFDTVYERGDSVALAVISGNIT 271
              + P+  +  R D +   V  G ++
Sbjct: 230 MTGQLPYSNINNR-DQIIFMVGRGYLS 255

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 74  FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 121
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 122 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 165
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 166 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 19  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 76  GYS----------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 122
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D   L + +G    A VK   S   Q  Q      
Sbjct: 123 DYLH-AKSII--HRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSG--- 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 174 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 231
Query: 270 IT 271
           ++
Sbjct: 232 LS 233

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV      
Sbjct: 151 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLG 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRE 65
           N +  +G   S +   +   +  + ++IG G F TV      +     A+K + +     
Sbjct: 17  NRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTP 73
Query: 66  DQAQAIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
            Q QA + EV   +   H NIL  + ++          +  Q+ +V  +    +L + L 
Sbjct: 74  QQLQAFKNEVGVLRKTRHVNILLFMGYS----------TKPQLAIVTQWCEGSSLYHHLH 123
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
           +       +  +DI +   +  + +   H AK I   HRDLK+ N+ L  D    + D G
Sbjct: 124 IIETKFEMIKLIDIAR---QTAQGMDYLH-AKSII--HRDLKSNNIFLHEDLTVKIGDFG 177
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A    +  GS + + L        S+ + APE+  +        ++DV++ G +LY +
Sbjct: 178 -LATEKSRWSGSHQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 230
Query: 245 CYFKSPFDTVYERGDSVALAVISGNIT 271
              + P+  +  R D +   V  G ++
Sbjct: 231 MTGQLPYSNINNR-DQIIFMVGRGYLS 256

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 32/229 (13%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D Y I+E++G G F  V       T + +  K I      D+     E+       HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L D               +++++L +   G L + +   +   + MS  +++    + 
Sbjct: 111 INLHD---------AFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQA 158
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL--- 202
           CE +K  H+    +  H D+K  N++             +   + VK+     A  L   
Sbjct: 159 CEGLKHMHEH---SIVHLDIKPENIMCE-----------TKKASSVKIIDFGLATKLNPD 204
Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           + V     +  + APE+   +    V   TD+W++G L Y +    SPF
Sbjct: 205 EIVKVTTATAEFAAPEIVDREP---VGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 88  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 195
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 196 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 101 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 148
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + Y HRDL   N+L+ N N             V KV     +
Sbjct: 149 GMLRGIASGMKYLSD---MGYVHRDLAARNILI-NSN------------LVCKVSDFGLS 192
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 193 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 81  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 188
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 189 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 238

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 20/137 (14%)
Query: 107 VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK 166
           + ++  Y   G+L + L+  S  K  ++   +L M  +I E +    +     Y HRDL+
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN---YIHRDLR 136
Query: 167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMP--YRAPELFHVDS 224
            AN+L+++  +  + D G     + ++   AE       A E    P  + APE  +  +
Sbjct: 137 AANILVSDTLSCKIADFG-----LARLIEDAEX-----TAREGAKFPIKWTAPEAINYGT 186
Query: 225 YCVVDQRTDVWSLGCLL 241
           + +   ++DVWS G LL
Sbjct: 187 FTI---KSDVWSFGILL 200

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 102/242 (42%), Gaps = 29/242 (11%)
Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIR-EVEHHKTFVHPNILPLL 89
           ++IG G F TV      +     A+K + +      Q QA + EV   +   H NIL  +
Sbjct: 14  QRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
            ++          +  Q+ +V  +    +L + L +       +  +DI +   +  + +
Sbjct: 71  GYS----------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGM 117
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H AK I   HRDLK+ N+ L  D    + D G +A    +  GS + + L       
Sbjct: 118 DYLH-AKSII--HRDLKSNNIFLHEDLTVKIGDFG-LATEKSRWSGSHQFEQLSG----- 168
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGN 269
            S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D +   V  G 
Sbjct: 169 -SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGY 226
Query: 270 IT 271
           ++
Sbjct: 227 LS 228

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 21  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 77  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 125
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 126 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAPAGAK 174
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 175 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 7   NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGRE 65
           N +  +G   S +   +   +  + ++IG G F TV      +     A+K + +     
Sbjct: 9   NRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTP 65
Query: 66  DQAQAIR-EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE 124
            Q QA + EV   +   H NIL  + ++          +  Q+ +V  +    +L + L 
Sbjct: 66  QQLQAFKNEVGVLRKTRHVNILLFMGYS----------TKPQLAIVTQWCEGSSLYHHLH 115
Query: 125 LRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
           +       +  +DI +   +  + +   H AK I   HRDLK+ N+ L  D    + D G
Sbjct: 116 IIETKFEMIKLIDIAR---QTAQGMDYLH-AKSII--HRDLKSNNIFLHEDLTVKIGDFG 169
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A    +  GS + + L        S+ + APE+  +        ++DV++ G +LY +
Sbjct: 170 -LATEKSRWSGSHQFEQLS------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 222
Query: 245 CYFKSPFDTVYERGDSVALAVISGNIT 271
              + P+  +  R D +   V  G ++
Sbjct: 223 MTGQLPYSNINNR-DQIIFMVGRGYLS 248

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 49/122 (40%), Gaps = 23/122 (18%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I  +  +I + +   H  K I   HRD+K ANVLL+      L D G        
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG-------- 149
Query: 193 VCGSAEAQNLQDVAAERCSMP----YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
           V G      L D   +R +      + APE+    +Y   D + D+WSLG     +   +
Sbjct: 150 VAG-----QLTDTQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGE 201
Query: 249 SP 250
            P
Sbjct: 202 PP 203

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 44/251 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 80  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 187
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 188 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 237
Query: 245 CYF-KSPFDTV 254
                SP+  V
Sbjct: 238 FTLGGSPYPGV 248

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 48/122 (39%), Gaps = 23/122 (18%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I  +  +I + +   H  K I   HRD+K ANVLL+      L D G        
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGV------- 170
Query: 193 VCGSAEAQNLQDVAAERCSMP----YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
                 A  L D   +R +      + APE+    +Y   D + D+WSLG     +   +
Sbjct: 171 ------AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGE 221
Query: 249 SP 250
            P
Sbjct: 222 PP 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 77  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 184
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 185 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 234

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 25  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 81  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G ++  +     +A A         +
Sbjct: 130 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG-LSRLMTGDTXTAHA-------GAK 178
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 179 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 22  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 78  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 126
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 127 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAPAGAK 175
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 176 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKIICHGRE-DQAQAIREVEHH 77
           D+  + + +GEG F  V L E     K       + A+K +     E D +  I E+E  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 78  KTF-VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHY--- 132
           K    H NI+ LL      C          + +++ Y  KG L   L+ R   G  Y   
Sbjct: 73  KMIGKHKNIINLL----GACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 133 --------MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG 184
                   +SS D++    ++   ++     K I   HRDL   NVL+  DN   + D G
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFG 180
Query: 185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +A  +  +    +  N       R  + + APE      Y     ++DVWS G LL+ +
Sbjct: 181 -LARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYT---HQSDVWSFGVLLWEI 230

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVHPN 84
           +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+   K   H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL+          L     V +V+          D  L  V +  +    +  +  +
Sbjct: 85  IISLLN---VFTPQKTLEEFQDVYLVMELM-------DANLXQVIQMELDHERMSYLLYQ 134
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   +K  H A  I   HRDLK +N+++ +D    ++D G     + +  G++       
Sbjct: 135 MLCGIKHLHSAGII---HRDLKPSNIVVKSDXTLKILDFG-----LARTAGTSFM----- 181
Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           +     +  YRAPE+     Y    +  D+WS+GC++  M   K  F
Sbjct: 182 MTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILF 225

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 107/281 (38%), Gaps = 56/281 (19%)
Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFV-HP 83
           KY +V+K+G+G +  V      +T +  A+KKI        D  +  RE+        H 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKG----TLANDLELRSVGKHYMSSVDIL 139
           NI+ LL+  L    D        V +V  Y          AN LE   V K Y       
Sbjct: 70  NIVNLLN-VLRADND------RDVYLVFDYMETDLHAVIRANILE--PVHKQY------- 113
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV--------V 191
            +  ++ + +K  H        HRD+K +N+LL  + +  + D G     V        +
Sbjct: 114 -VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 192 KVCGSAEAQN-------LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLLYA 243
            +  +   +N       L D  A R    YRAPE L     Y    +  D+WSLGC+L  
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRW---YRAPEILLGSTKYT---KGIDMWSLGCILGE 223
Query: 244 MCYFKSPFDTVYERGDSV--ALAVISGNITFPENTPFPQYQ 282
           +   K  F      G S    L  I G I FP N      Q
Sbjct: 224 ILCGKPIFP-----GSSTMNQLERIIGVIDFPSNEDVESIQ 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 49/122 (40%), Gaps = 23/122 (18%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I  +  +I + +   H  K I   HRD+K ANVLL+      L D G        
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG-------- 149
Query: 193 VCGSAEAQNLQDVAAER---CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
           V G      L D   +R      P + APE+    +Y   D + D+WSLG     +   +
Sbjct: 150 VAG-----QLTDTQIKRNXFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGE 201
Query: 249 SP 250
            P
Sbjct: 202 PP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 51/127 (40%), Gaps = 23/127 (18%)
Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +    I  +  +I + +   H  K I   HRD+K ANVLL+      L D G        
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG-------- 164
Query: 193 VCGSAEAQNLQDVAAER---CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
           V G      L D   +R      P + APE+    +Y   D + D+WSLG     +   +
Sbjct: 165 VAG-----QLTDTQIKRNXFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGE 216
Query: 249 SPFDTVY 255
            P   ++
Sbjct: 217 PPHSELH 223

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 25  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 81  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 130 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 178
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 179 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 24  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 80  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 128
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 129 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 177
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 178 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 20  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 76  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 124
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 173
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 174 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 33  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 89  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 137
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 138 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 186
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 187 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 25  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 81  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 129
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 130 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 178
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 179 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 22  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 78  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 126
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 127 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 175
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 176 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)
Query: 33  KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILPLL 89
           K+G G +  V    +    K+Y+L   +   +ED  +    ++E    K   HPN++ LL
Sbjct: 22  KLGGGQYGEV----YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                     V        ++  +   G L +   LR   +  +++V +L M  +I  A+
Sbjct: 78  G---------VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAM 126
Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
           +         + HRDL   N L+  ++   + D G        +            A  +
Sbjct: 127 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTYTAHAGAK 175
Query: 210 CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
             + + APE    + + +   ++DVW+ G LL+ +  Y  SP+
Sbjct: 176 FPIKWTAPESLAYNKFSI---KSDVWAFGVLLWEIATYGMSPY 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 35/169 (20%)
Query: 93  LTGCADPVLN-------STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L+ C  P +         ++++ +++ Y   G+  + L+   + + Y++++       +I
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATI-----LREI 125
Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
            + +   H  + I   HRD+K ANVLL+   +  L D G        V G      L D 
Sbjct: 126 LKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFG--------VAG-----QLTDT 169
Query: 206 AAER---CSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
             +R      P + APE+    +Y   D + D+WSLG     +   + P
Sbjct: 170 QIKRNXFVGTPFWMAPEVIKQSAY---DFKADIWSLGITAIELAKGEPP 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/255 (21%), Positives = 108/255 (42%), Gaps = 34/255 (13%)
Query: 21  VYVKSDKYYIVE-KIGEGGFSTVSLIEHSQTKKRYALK-KIICHGRE--DQAQAIREVEH 76
           +++K D   I + ++G G F +V    +   KK+  +  K++  G E  D  + +RE + 
Sbjct: 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 389
Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
                +P I+ L+           +     +++V+     G L   L    VGK     V
Sbjct: 390 MHQLDNPYIVRLIG----------VCQAEALMLVMEMAGGGPLHKFL----VGKREEIPV 435
Query: 137 -DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            ++ ++  ++   +K   +     + HR+L   NVLL N +   + D G     + K  G
Sbjct: 436 SNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFG-----LSKALG 487
Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTV 254
            A+       +A +  + + APE  +   +     R+DVWS G  ++ A+ Y + P+  +
Sbjct: 488 -ADDSYYTARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKKM 543
Query: 255 YERGDSVALAVISGN 269
             +G  V   +  G 
Sbjct: 544 --KGPEVMAFIEQGK 556

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 91/225 (40%), Gaps = 33/225 (14%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNI 85
           +  +GEG F  V L     E   T ++ A+K +    G    A   +E+E  +   H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +        G C +   +  + + +++ + P G+L    E     K+ ++    LK  ++
Sbjct: 86  V-----KYKGICTE---DGGNGIKLIMEFLPSGSLK---EYLPKNKNKINLKQQLKYAVQ 134
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+ +      +   Y HRDL   NVL+ +++   + D G        +  + E      
Sbjct: 135 ICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG--------LTKAIETDKEXX 183
Query: 205 VAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
              +    P  + APE      + +    +DVWS G  L+ +  +
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIA---SDVWSFGVTLHELLTY 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 31  VEKIGEGGFSTVSLIEHS----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNIL 86
           + ++G+G F +V L  +      T    A+K++   G + Q    RE++  K  +H + +
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-LHSDFI 70
Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL--- 143
                   G   P L       +V+ Y P G L + L+       + + +D  ++ L   
Sbjct: 71  VKYRGVSYGPGRPELR------LVMEYLPSGCLRDFLQ------RHRARLDASRLLLYSS 118
Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +IC+ ++     + +   HRDL   N+L+ ++ +  + D G     + K+          
Sbjct: 119 QICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFG-----LAKL---LPLDKDX 167
Query: 204 DVAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            V  E    P  + APE     S  +  +++DVWS G +LY +
Sbjct: 168 XVVREPGQSPIFWYAPESL---SDNIFSRQSDVWSFGVVLYEL 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 31  VEKIGEGGFSTVSLI----EHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNI 85
           +  +GEG F  V L     E   T ++ A+K +    G    A   +E+E  +   H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +        G C +   +  + + +++ + P G+L    E     K+ ++    LK  ++
Sbjct: 74  V-----KYKGICTE---DGGNGIKLIMEFLPSGSLK---EYLPKNKNKINLKQQLKYAVQ 122
Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+ +      +   Y HRDL   NVL+ +++   + D G        +    E   ++D
Sbjct: 123 ICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA----IETDKEXXTVKD 175
Query: 205 VAAERCS-MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
              +R S + + APE      + +    +DVWS G  L+ +  +
Sbjct: 176 ---DRDSPVFWYAPECLMQSKFYIA---SDVWSFGVTLHELLTY 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 39/180 (21%)
Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPNI+ L         + V+  +  V++V  Y   G+L  D  LR     + + + ++
Sbjct: 103 FDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL--DSFLRKHDAQF-TVIQLV 150
Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M   I   +K   D   + + HRDL   N+L+ N N             V KV     +
Sbjct: 151 GMLRGIASGMKYLSD---MGFVHRDLAARNILI-NSN------------LVCKVSDFGLS 194
Query: 200 QNLQD-------VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           + L+D           +  + + +PE     +Y      +DVWS G +L+  M Y + P+
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI---AYRKFTSASDVWSYGIVLWEVMSYGERPY 251

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	282
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-41
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-24
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-17
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-17
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-17
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-16
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-16
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-16
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-15
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-15
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-14
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-14
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-13
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-12
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-12
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-11
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-11
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-11
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-11
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-11
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-10
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-10
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-09
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-09
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-08
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-08
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-08
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-08
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-07
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-07
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-04
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-04

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  290 bits (745), Expect = 2e-98
 Identities = 110/260 (42%), Positives = 167/260 (64%), Gaps = 9/260 (3%)

Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF 80
           V + +  Y  ++K+GEGGFS V L+E       YALK+I+CH ++D+ +A RE + H+ F
Sbjct: 24  VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNIL L+ + L         +  +  ++LP++ +GTL N++E      ++++   IL 
Sbjct: 84  NHPNILRLVAYCLRER-----GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           + L IC  ++  H  K  A  HRDLK  N+LL ++  P+LMDLGS+  A + V GS +A 
Sbjct: 139 LLLGICRGLEAIHA-KGYA--HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
            LQD AA+RC++ YRAPELF V S+CV+D+RTDVWSLGC+LYAM + + P+D V+++GDS
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

Query: 261 VALAVISGNITFPENTPFPQ 280
           VALA +   ++ P++     
Sbjct: 256 VALA-VQNQLSIPQSPRHSS 274

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  255 bits (653), Expect = 2e-84
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 14/264 (5%)

Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF 80
           V +   +  +   + EGGF+ V   +   + + YALK+++ +  E     I+EV   K  
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL 82

Query: 81  V-HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HPNI+     A  G  +   ++     ++L    KG L   L+ +   +  +S   +L
Sbjct: 83  SGHPNIVQFCSAASIGKEE--SDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
           K+F + C AV+  H  KP    HRDLK  N+LL+N     L D GS          S  A
Sbjct: 140 KIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198

Query: 200 QN---LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
           Q    +++      +  YR PE+  + S   + ++ D+W+LGC+LY +C+ + PF+    
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---- 254

Query: 257 RGDSVALAVISGNITFPENTPFPQ 280
             D   L +++G  + P +     
Sbjct: 255 --DGAKLRIVNGKYSIPPHDTQYT 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  151 bits (384), Expect = 1e-44
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 27/235 (11%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFV 81
           +++ Y ++  IG G +     I      K    K++        ++   + EV   +   
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVL-MVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           HPNI+   D         +++ T+  L +V+ Y   G LA+ +   +  + Y+    +L+
Sbjct: 64  HPNIVRYYDR--------IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 141 MFLKICEAVKVFHDAKPIAYA--HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           +  ++  A+K  H      +   HRDLK ANV L    N  L D G           +  
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL----------ARI 165

Query: 199 AQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             +    A      P Y +PE  +  SY   ++++D+WSLGCLLY +C    PF 
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFT 217

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  145 bits (368), Expect = 1e-41
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 30/231 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHP 83
           +KY  ++KIGEG F    L++ ++  ++Y +K+I       +++ ++ REV       HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+   +                + +V+ Y   G L   +  +           IL  F+
Sbjct: 84  NIVQYRESFEEN---------GSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFV 132

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +IC A+K  HD K +   HRD+K+ N+ L  D    L D G           +    +  
Sbjct: 133 QICLALKHVHDRKIL---HRDIKSQNIFLTKDGTVQLGDFGI----------ARVLNSTV 179

Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
           ++A      P Y +PE+     Y   + ++D+W+LGC+LY +C  K  F+ 
Sbjct: 180 ELARACIGTPYYLSPEICENKPY---NNKSDIWALGCVLYELCTLKHAFEA 227

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (364), Expect = 2e-41
 Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 19/240 (7%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPN 84
             +  ++ +G GGF  V   ++      YA+K+I    RE  + + +REV+      HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 85  ILPLLDHALTGCADPVLNSTSQVLM---VLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           I+   +  L       L  +S  +     +    K  L + +  R            L +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHI 123

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
           FL+I EAV+  H    +   HRDLK +N+    D+   + D G +  A+ +         
Sbjct: 124 FLQIAEAVEFLHSKGLM---HRDLKPSNIFFTMDDVVKVGDFG-LVTAMDQDEEEQTVLT 179

Query: 202 LQDVAAERCSM---P-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                A          Y +PE  H +SY     + D++SLG +L+ + Y   PF T  ER
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY---SHKVDIFSLGLILFELLY---PFSTQMER 233

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 3e-41
 Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 29/249 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVH 82
             + I +KIG G FS V            ALKK+        + +A  I+E++  K   H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PN++      +           +++ +VL     G L+  ++     K  +    + K F
Sbjct: 92  PNVIKYYASFIED---------NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           +++C A++  H  + +   HRD+K ANV +       L DLG                + 
Sbjct: 143 VQLCSALEHMHSRRVM---HRDIKPANVFITATGVVKLGDLGL----------GRFFSSK 189

Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
              A      P Y +PE  H + Y   + ++D+WSLGCLLY M   +SPF        S+
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246

Query: 262 ALAVISGNI 270
              +   + 
Sbjct: 247 CKKIEQCDY 255

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (359), Expect = 6e-41
 Identities = 53/239 (22%), Positives = 92/239 (38%), Gaps = 36/239 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
             +  +E IG GGF  V   +H    K Y +K++    + +  +A REV+      H NI
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 86  LPLLDH-------ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
           +              T   +   + T  + + + +  KGTL   +E R      +  V  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GS 196
           L++F +I + V   H  K I   +RDLK +N+ L +                VK+   G 
Sbjct: 125 LELFEQITKGVDYIHSKKLI---NRDLKPSNIFLVDTKQ-------------VKIGDFGL 168

Query: 197 AEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT 253
             +               Y +PE      Y    +  D+++LG +L  + +   + F+T
Sbjct: 169 VTSLKNDGKRTRSKGTLRYMSPEQISSQDY---GKEVDLYALGLILAELLHVCDTAFET 224

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (347), Expect = 6e-39
 Identities = 56/260 (21%), Positives = 103/260 (39%), Gaps = 22/260 (8%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +  +  +  +G+G F  V    ++   + YA+ K I H  E  +  + EV    +  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAI-KKIRHTEEKLSTILSEVMLLASLNHQY 63

Query: 85  ILPL----LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           ++      L+          +   S + + + Y   GTL + +             +  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWR 120

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKVCGSAEA 199
           +F +I EA+   H    I   HRDLK  N+ +    N  + D G +            ++
Sbjct: 121 LFRQILEALSYIHSQGII---HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 200 QNLQDVAAERCSM----PYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
           QNL   +    S      Y A E+     +   +++ D++SLG + + M Y   PF T  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGH--YNEKIDMYSLGIIFFEMIY---PFSTGM 232

Query: 256 ERGDSVALAVISGNITFPEN 275
           ER  ++   + S +I FP +
Sbjct: 233 ER-VNILKKLRSVSIEFPPD 251

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  121 bits (304), Expect = 2e-32
 Identities = 52/285 (18%), Positives = 94/285 (32%), Gaps = 64/285 (22%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
             +  ++ +G GGF  V   ++      YA+K+I + +    + + +REV+      HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 85  I------------------------------------------------LPLLDHALTGC 96
           I                                                +       T  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 97  ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK 156
                +    + + +    K  L + +  R            L +F++I EAV+  H   
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 157 PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSM---- 212
            +   HRDLK +N+    D+   + D G +  A+ +              A         
Sbjct: 185 LM---HRDLKPSNIFFTMDDVVKVGDFG-LVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 213 PYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
            Y +PE  H ++Y     + D++SLG +L+ + Y    F T  ER
Sbjct: 241 LYMSPEQIHGNNY---SHKVDIFSLGLILFELLY---SFSTQMER 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (287), Expect = 4e-30
 Identities = 41/237 (17%), Positives = 83/237 (35%), Gaps = 29/237 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHP 83
           +  + + + +G+G  + V    H +T   +A+K              +RE E  K   H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L              +T   ++++ + P G+L   LE  S   + +   + L +  
Sbjct: 68  NIVKLFAI-------EEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLR 119

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQN 201
            +   +    +       HR++K  N++     +           +V K+   G+A    
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDG---------QSVYKLTDFGAARELE 167

Query: 202 LQDVAAERC-SMPYRAPELFHVDSYCVVDQRT-----DVWSLGCLLYAMCYFKSPFD 252
             +       +  Y  P+++         Q+      D+WS+G   Y       PF 
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  111 bits (281), Expect = 1e-29
 Identities = 68/263 (25%), Positives = 105/263 (39%), Gaps = 57/263 (21%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           + + I   +G+G F  V L    Q+K   ALK     ++   G E Q +  REVE     
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR--REVEIQSHL 66

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNIL L             +  ++V ++L Y P GT+    EL+ + K          
Sbjct: 67  RHPNILRLYG---------YFHDATRVYLILEYAPLGTVYR--ELQKLSK--FDEQRTAT 113

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVK---VCGS 196
              ++  A+   H  + I   HRD+K  N+LL +     + D G SV     +   +CG+
Sbjct: 114 YITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT 170

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT--- 253
                          + Y  PE+     +   D++ D+WSLG L Y     K PF+    
Sbjct: 171 ---------------LDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTY 212

Query: 254 --VYERGDSVALAVISGNITFPE 274
              Y+R       +     TFP+
Sbjct: 213 QETYKR-------ISRVEFTFPD 228

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (283), Expect = 2e-29
 Identities = 65/279 (23%), Positives = 107/279 (38%), Gaps = 53/279 (18%)

Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--IREVEH 76
           E + VK   Y I+++IG GG S V  + + + K+ YA+K +     ++Q       E+ +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60

Query: 77  HKTFVHPN--ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS 134
                  +  I+ L D+ +T            + MV+       L + L      K  + 
Sbjct: 61  LNKLQQHSDKIIRLYDYEIT---------DQYIYMVM-ECGNIDLNSWL----KKKKSID 106

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
             +    +  + EAV   H    +   H DLK AN L+ +                +K+ 
Sbjct: 107 PWERKSYWKNMLEAVHTIHQHGIV---HSDLKPANFLIVDGM--------------LKLI 149

Query: 195 --GSAEAQNLQDVAAERCSM----PYRAPELFHVDSYCV--------VDQRTDVWSLGCL 240
             G A        +  + S      Y  PE     S           +  ++DVWSLGC+
Sbjct: 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209

Query: 241 LYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPENTP 277
           LY M Y K+PF  +  +   +  A+I  N  I FP+   
Sbjct: 210 LYYMTYGKTPFQQIINQISKL-HAIIDPNHEIEFPDIPE 247

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 3e-29
 Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 53/281 (18%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--IREV 74
           + E + VK   Y I+++IG GG S V  + + + K+ YA+K +     ++Q       E+
Sbjct: 47  ANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEI 105

Query: 75  EHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
            +       +  I+ L D+ +T            + MV+       L + L      K  
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEIT---------DQYIYMVM-ECGNIDLNSWL----KKKKS 151

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +   +    +  + EAV   H    +   H DLK AN L+ +                +K
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHGIV---HSDLKPANFLIVDGM--------------LK 194

Query: 193 VC--GSAEAQNLQDVAAERCSM----PYRAPELFHVDSYCV--------VDQRTDVWSLG 238
           +   G A        +  + S      Y  PE     S           +  ++DVWSLG
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254

Query: 239 CLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPENTP 277
           C+LY M Y K+PF  +  +  S   A+I  N  I FP+   
Sbjct: 255 CILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPE 294

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 4e-29
 Identities = 34/276 (12%), Positives = 66/276 (23%), Gaps = 44/276 (15%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF 80
              K  +VE +  G  S V L+   +  + +ALK         R +  +           
Sbjct: 60  GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQ-------------------VLMVLPYYPKGTLAN 121
           +  +     D          +   SQ                   +LM         L +
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179

Query: 122 DLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM 181
            L+   V +     + +  +  ++            +   H      N+ +  D   +L 
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV---HGHFTPDNLFIMPDGRLMLG 236

Query: 182 DLGSVAPAVVK---VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG 238
           D+ ++     +                        Y   E  +  S        + W LG
Sbjct: 237 DVSALWKVGTRGPASSVPVT---------------YAPREFLN-ASTATFTHALNAWQLG 280

Query: 239 CLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPE 274
             +Y +     PF  V                    
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  111 bits (279), Expect = 5e-29
 Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 53/281 (18%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--IREV 74
             +++ VK   Y I+++IG GG S V  + + + K+ YA+K +     ++Q       E+
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEI 77

Query: 75  EHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
            +       +  I+ L D+ +T            + MV+       L + L      K  
Sbjct: 78  AYLNKLQQHSDKIIRLYDYEIT---------DQYIYMVMEC-GNIDLNSWL----KKKKS 123

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
           +   +    +  + EAV   H    +   H DLK AN L+ +                +K
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIV---HSDLKPANFLIVDGM--------------LK 166

Query: 193 VC--GSAEAQNLQDVAAERCSM----PYRAPELFHVDSYCV--------VDQRTDVWSLG 238
           +   G A        +  + S      Y  PE     S           +  ++DVWSLG
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 239 CLLYAMCYFKSPFDTVYERGDSVALAVISGN--ITFPENTP 277
           C+LY M Y K+PF  +  +   +  A+I  N  I FP+   
Sbjct: 227 CILYYMTYGKTPFQQIINQISKL-HAIIDPNHEIEFPDIPE 266

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (277), Expect = 6e-29
 Identities = 37/238 (15%), Positives = 83/238 (34%), Gaps = 25/238 (10%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFV- 81
           + +++ +EKIG G F +V           YA+K+      G  D+  A+REV  H     
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H +++                    +L+   Y   G+LA+ +        Y    ++  +
Sbjct: 70  HSHVVRYFSAWAED---------DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSV------APAVVKVCG 195
            L++   ++  H    +   H D+K +N+ ++  + P                 + K+  
Sbjct: 121 LLQVGRGLRYIHSMSLV---HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                 +     E     + A E+   + ++     + D+++L   +      +    
Sbjct: 178 LGHVTRISSPQVEEGDSRFLANEVLQENYTH---LPKADIFALALTVVCAAGAEPLPR 232

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (276), Expect = 8e-29
 Identities = 56/266 (21%), Positives = 96/266 (36%), Gaps = 58/266 (21%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           + + +   +G+G F+ V   E   T    A+K      +   G   + Q   EV+ H   
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHCQL 68

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HP+IL L +             ++ V +VL     G +   L+ R       S  +   
Sbjct: 69  KHPSILELYN---------YFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARH 116

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVK-----VC 194
              +I   +   H    +   HRDL  +N+LL  + N  + D G +    +       +C
Sbjct: 117 FMHQIITGMLYLHSHGIL---HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC 173

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT- 253
           G+                 Y +PE+    ++      +DVWSLGC+ Y +   + PFDT 
Sbjct: 174 GT---------------PNYISPEIATRSAH---GLESDVWSLGCMFYTLLIGRPPFDTD 215

Query: 254 ----VYERGDSVALAVISGNITFPEN 275
                  +       V+  +   P  
Sbjct: 216 TVKNTLNK-------VVLADYEMPSF 234

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  112 bits (281), Expect = 9e-29
 Identities = 41/237 (17%), Positives = 83/237 (35%), Gaps = 29/237 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHP 83
           +  + + + +G+G  + V    H +T   +A+K              +RE E  K   H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L              +T   ++++ + P G+L   LE  S   + +   + L +  
Sbjct: 68  NIVKLFAI-------EEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLR 119

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQN 201
            +   +    +       HR++K  N++     +           +V K+   G+A    
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDG---------QSVYKLTDFGAARELE 167

Query: 202 LQDVAAERC-SMPYRAPELFHVDSYCVVDQRT-----DVWSLGCLLYAMCYFKSPFD 252
             +       +  Y  P+++         Q+      D+WS+G   Y       PF 
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  110 bits (276), Expect = 2e-28
 Identities = 52/259 (20%), Positives = 90/259 (34%), Gaps = 49/259 (18%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQ---AQAIREVEHHK 78
           KY  +  +G G F  V      +  K   +K     K++     +     +   E+    
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSV 136
              H NI+ +LD         +  +     +V+  +  G     L+L         +   
Sbjct: 85  RVEHANIIKVLD---------IFENQGFFQLVMEKHGSG-----LDLFAFIDRHPRLDEP 130

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
               +F ++  AV            HRD+K  N+++A D    L+D GS           
Sbjct: 131 LASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS--------AAY 179

Query: 197 AEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
            E   L       C ++ Y APE+   + Y       ++WSLG  LY + + ++PF  + 
Sbjct: 180 LERGKLFYTF---CGTIEYCAPEVLMGNPY--RGPELEMWSLGVTLYTLVFEENPFCELE 234

Query: 256 ERGDSVALAVISGNITFPE 274
           E         +   I  P 
Sbjct: 235 E--------TVEAAIHPPY 245

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-28
 Identities = 44/232 (18%), Positives = 77/232 (33%), Gaps = 35/232 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFV-H 82
             +  + ++G G +  V  +   +  + YA+K+ +    G +D+A+ + EV  H+    H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P  + L      G           + +        +L    E        +    +    
Sbjct: 117 PCCVRLEQAWEEG---------GILYLQTE-LCGPSLQQHCEAW---GASLPEAQVWGYL 163

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
                A+   H    +   H D+K AN+ L       L D G     ++   G+A     
Sbjct: 164 RDTLLALAHLHSQGLV---HLDVKPANIFLGPRGRCKLGDFG-----LLVELGTA----- 210

Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
                 +   P Y APEL    SY       DV+SLG  +  +         
Sbjct: 211 -GAGEVQEGDPRYMAPELLQ-GSY---GTAADVFSLGLTILEVACNMELPHG 257

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (275), Expect = 3e-28
 Identities = 55/295 (18%), Positives = 92/295 (31%), Gaps = 67/295 (22%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKT 79
             KY++   IG+G +  V +   +QT+   A+K     KI     +D  +   EV   K 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL-------------------- 119
             HPNI  L +         V      + +V+     G L                    
Sbjct: 85  LHHPNIARLYE---------VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 120 ----------------ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR 163
                            +    R           I  +  +I  A+   H+       HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHR 192

Query: 164 DLKTANVLLANDNNPLLM--DLG-SVAPAVVKVCGSAEAQNLQDVAAERCSMP-YRAPEL 219
           D+K  N L + + +  +   D G S          + E   +          P + APE+
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSK---EFYKLNNGEYYGMTTK----AGTPYFVAPEV 245

Query: 220 FHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVISGNITFPE 274
            +  +      + D WS G LL+ +     PF  V +        V++  + F  
Sbjct: 246 LNTTNES-YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TISQVLNKKLCFEN 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (279), Expect = 6e-28
 Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 24/231 (10%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHPN 84
             + + E++G GGF  V    H  T ++ A+K+       +++ +   E++  K   HPN
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++   +          L      L+ + Y   G L   L         +    I  +   
Sbjct: 74  VVSAREVPDG---LQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSD 129

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           I  A++  H+ + I   HRDLK  N++L                 + K+   G A+  + 
Sbjct: 130 ISSALRYLHENRII---HRDLKPENIVLQPGPQ----------RLIHKIIDLGYAKELDQ 176

Query: 203 QDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            ++  E   ++ Y APEL     Y       D WS G L +       PF 
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKY---TVTVDYWSFGTLAFECITGFRPFL 224

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (272), Expect = 8e-28
 Identities = 49/261 (18%), Positives = 95/261 (36%), Gaps = 49/261 (18%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
            +Y     +G+GGF+    I  + TK+ +A K      ++   + ++     E+  H++ 
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSL 98

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            H +++                    V +VL    + +L          +  ++  +   
Sbjct: 99  AHQHVVGFHG---------FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY 145

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I    +  H  + I   HRDLK  N+ L  D    + D G           + + +
Sbjct: 146 YLRQIVLGCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGL----------ATKVE 192

Query: 201 NLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----V 254
              +     C +  Y APE+     +       DVWS+GC++Y +   K PF+T      
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249

Query: 255 YERGDSVALAVISGNITFPEN 275
           Y R       +     + P++
Sbjct: 250 YLR-------IKKNEYSIPKH 263

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  107 bits (270), Expect = 8e-28
 Identities = 49/261 (18%), Positives = 95/261 (36%), Gaps = 49/261 (18%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
            +Y     +G+GGF+    I  + TK+ +A K      ++   + ++     E+  H++ 
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSL 72

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            H +++                    V +VL    + +L          +  ++  +   
Sbjct: 73  AHQHVVGFHG---------FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY 119

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I    +  H  + I   HRDLK  N+ L  D    + D G           + + +
Sbjct: 120 YLRQIVLGCQYLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGL----------ATKVE 166

Query: 201 NLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT-----V 254
              +     C +  Y APE+     +       DVWS+GC++Y +   K PF+T      
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223

Query: 255 YERGDSVALAVISGNITFPEN 275
           Y R       +     + P++
Sbjct: 224 YLR-------IKKNEYSIPKH 237

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (269), Expect = 9e-28
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 57/263 (21%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTF 80
           D + I   +G+G F  V L    Q K   ALK     ++   G E Q +  RE+E     
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHL 71

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNIL + +           +   ++ ++L + P+G L    EL+  G+          
Sbjct: 72  RHPNILRMYN---------YFHDRKRIYLMLEFAPRGELYK--ELQKHGR--FDEQRSAT 118

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVK---VCGS 196
              ++ +A+   H+ K I   HRD+K  N+L+       + D G SV    ++   +CG+
Sbjct: 119 FMEELADALHYCHERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGT 175

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD---- 252
                          + Y  PE+    ++   D++ D+W  G L Y       PFD    
Sbjct: 176 ---------------LDYLPPEMIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

Query: 253 -TVYERGDSVALAVISGNITFPE 274
              + R       +++ ++ FP 
Sbjct: 218 TETHRR-------IVNVDLKFPP 233

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (272), Expect = 2e-27
 Identities = 58/265 (21%), Positives = 94/265 (35%), Gaps = 47/265 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--------ICHGREDQAQAIREVEH 76
            D+Y + + +G G    V L    +T K+ A++ I             +       E+E 
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMS 134
            K   HP I+ + +                  +VL     G      EL  + VG   + 
Sbjct: 194 LKKLNHPCIIKIKNFF----------DAEDYYIVLELMEGG------ELFDKVVGNKRLK 237

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
                  F ++  AV+  H+   I   HRDLK  NVLL++               ++K+ 
Sbjct: 238 EATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEE----------DCLIKIT 284

Query: 195 --GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSP 250
             G ++      +    C  P Y APE+         ++  D WSLG +L+     +  P
Sbjct: 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-PP 343

Query: 251 FDTVYERGD-SVALAVISGNITFPE 274
           F     R   S+   + SG   F  
Sbjct: 344 FSE--HRTQVSLKDQITSGKYNFIP 366

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  105 bits (263), Expect = 3e-26
 Identities = 54/270 (20%), Positives = 94/270 (34%), Gaps = 57/270 (21%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y I+E++G G F  V       T + +  K I      D+     E+       HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGK-HYMSSVDILKM 141
           ++ L D               +++++L +   G      EL  R   + + MS  +++  
Sbjct: 110 LINLHD---------AFEDKYEMVLILEFLSGG------ELFDRIAAEDYKMSEAEVINY 154

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM--DLG---SVAPAVV--KVC 194
             + CE +K  H+       H D+K  N++        +   D G    + P  +     
Sbjct: 155 MRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDT 253
            +AE               + APE+   +        TD+W++G L Y +     SPF  
Sbjct: 212 ATAE---------------FAAPEIVDREPV---GFYTDMWAIGVLGYVLLSGL-SPF-- 250

Query: 254 VYERGDS---VALAVISGNITFPENTPFPQ 280
               G+        V   +  F E+  F  
Sbjct: 251 ---AGEDDLETLQNVKRCDWEFDED-AFSS 276

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (266), Expect = 3e-26
 Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 55/269 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D Y I E++G G F  V  +    T   +A K ++     D+    +E++      HP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKH-YMSSVDILKM 141
           ++ L D              ++++M+  +   G      EL  +   +H  MS  + ++ 
Sbjct: 216 LVNLHD---------AFEDDNEMVMIYEFMSGG------ELFEKVADEHNKMSEDEAVEY 260

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM--DLGS---VAPAVV--KVC 194
             ++C+ +   H+     Y H DLK  N++     +  L   D G    + P        
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
           G+AE               + APE+            TD+WS+G L Y +    SPF   
Sbjct: 318 GTAE---------------FAAPEVAEGKPV---GYYTDMWSVGVLSYILLSGLSPF--- 356

Query: 255 YERGDS---VALAVISGNITFPENTPFPQ 280
              G++       V S +    ++  F  
Sbjct: 357 --GGENDDETLRNVKSCDWNMDDS-AFSG 382

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  103 bits (260), Expect = 4e-26
 Identities = 59/262 (22%), Positives = 109/262 (41%), Gaps = 46/262 (17%)

Query: 25  SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVH 82
           +D Y +  + +G G    V    H +T ++ ALK +      D  +A +EV+ H +    
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGG 81

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P+I+ +LD       + + +    +L+++     G L + ++ R  G    +  +  ++ 
Sbjct: 82  PHIVCILD-----VYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIM 134

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG---SVAPAVVK-VCG 195
             I  A++  H    I  AHRD+K  N+L  + + + +L   D G         ++  C 
Sbjct: 135 RDIGTAIQFLHS-HNI--AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF--D 252
           +                 Y APE+   + Y   D+  D+WSLG ++Y + C F  PF  +
Sbjct: 192 TPY---------------YVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGF-PPFYSN 232

Query: 253 TVYERGDSVALAVISGNITFPE 274
           T       +   +  G   FP 
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPN 254

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (260), Expect = 4e-26
 Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 47/265 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--------ICHGREDQAQAIREVEH 76
            D+Y + + +G G    V L    +T K+ A+K I             +       E+E 
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMS 134
            K   HP I+ + +                  +VL     G      EL  + VG   + 
Sbjct: 69  LKKLNHPCIIKIKNFF----------DAEDYYIVLELMEGG------ELFDKVVGNKRLK 112

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
                  F ++  AV+  H+   I   HRDLK  NVLL++               ++K+ 
Sbjct: 113 EATCKLYFYQMLLAVQYLHENGII---HRDLKPENVLLSSQEE----------DCLIKIT 159

Query: 195 --GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSP 250
             G ++      +    C  P Y APE+         ++  D WSLG +L+     +  P
Sbjct: 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-PP 218

Query: 251 FDTVYERGD-SVALAVISGNITFPE 274
           F     R   S+   + SG   F  
Sbjct: 219 FSE--HRTQVSLKDQITSGKYNFIP 241

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (262), Expect = 5e-26
 Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 47/263 (17%)

Query: 25  SDKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVH 82
            D Y +  + +G G    V  I + +T++++ALK +     +D  +A REVE H +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQC 114

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P+I+ ++D       +        +L+V+     G L + ++ R  G    +  +  ++ 
Sbjct: 115 PHIVRIVDV----YENLY-AGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIM 167

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG-----SVAPAVVKVC 194
             I EA++  H    I  AHRD+K  N+L  +   N +L   D G     +   ++   C
Sbjct: 168 KSIGEAIQYLHS-INI--AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF-- 251
            +                 Y APE+   + Y   D+  D+WSLG ++Y + C +  PF  
Sbjct: 225 YTPY---------------YVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGY-PPFYS 265

Query: 252 DTVYERGDSVALAVISGNITFPE 274
           +        +   +  G   FP 
Sbjct: 266 NHGLAISPGMKTRIRMGQYEFPN 288

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  102 bits (257), Expect = 6e-26
 Identities = 61/258 (23%), Positives = 103/258 (39%), Gaps = 35/258 (13%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +   +  + E +G G F  V   +        A+K+I      ++   I E+       H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNH 60

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L      G         + V +V+ Y   G+L N L       +Y ++   +   
Sbjct: 61  PNIVKLY-----GA------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYY-TAAHAMSWC 108

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQ 200
           L+  + V   H  +P A  HRDLK  N+LL                 V+K+C  G+A   
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT------------VLKICDFGTACDI 156

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
               +   + S  + APE+F   +Y    ++ DV+S G +L+ +   + PFD +      
Sbjct: 157 Q-THMTNNKGSAAWMAPEVFEGSNY---SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212

Query: 261 VALAVISGN-ITFPENTP 277
           +  AV +G      +N P
Sbjct: 213 IMWAVHNGTRPPLIKNLP 230

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (259), Expect = 6e-26
 Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 44/259 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           +D Y + E IG G +S      H  T   +A+ KII   + D      E+E   +   HP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAV-KIIDKSKRD---PTEEIEILLRYGQHP 76

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKM 141
           NI+ L D         V +    V +V      G      EL  + + + + S  +   +
Sbjct: 77  NIITLKD---------VYDDGKYVYVVTELMKGG------ELLDKILRQKFFSEREASAV 121

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--G-SAE 198
              I + V+  H    +   HRDLK +N+L  +++           P  +++C  G + +
Sbjct: 122 LFTITKTVEYLHAQG-V--VHRDLKPSNILYVDESGN---------PESIRICDFGFAKQ 169

Query: 199 AQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVYE 256
            +    +    C +  + APE+     Y   D   D+WSLG LLY M   + +PF    +
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVLERQGY---DAACDIWSLGVLLYTMLTGY-TPFANGPD 225

Query: 257 RGDSVAL-AVISGNITFPE 274
                 L  + SG  +   
Sbjct: 226 DTPEEILARIGSGKFSLSG 244

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 7e-26
 Identities = 63/260 (24%), Positives = 98/260 (37%), Gaps = 39/260 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKT 79
            D Y + E IG+G FS V    + +T +++A+K     K             RE      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HP+I+ LL+           +S   + MV  +     L  ++  R+      S     
Sbjct: 83  LKHPHIVELLE---------TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG---S 196
               +I EA++  HD   I   HRD+K   VLLA+  N           A VK+ G   +
Sbjct: 134 HYMRQILEALRYCHDNNII---HRDVKPHCVLLASKEN----------SAPVKLGGFGVA 180

Query: 197 AEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTV 254
            +      VA  R   P + APE+   + Y    +  DVW  G +L+ +      PF   
Sbjct: 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPY---GKPVDVWGCGVILFILLSGC-LPF--- 233

Query: 255 YERGDSVALAVISGNITFPE 274
           Y   + +   +I G      
Sbjct: 234 YGTKERLFEGIIKGKYKMNP 253

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  102 bits (257), Expect = 9e-26
 Identities = 62/271 (22%), Positives = 97/271 (35%), Gaps = 52/271 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHK 78
            D Y I E++G G F+ V       T   YA K I             + +  REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSV 136
             +H N++ L D         V  + + V+++L     G      EL      K  +S  
Sbjct: 71  QVLHHNVITLHD---------VYENRTDVVLILELVSGG------ELFDFLAQKESLSEE 115

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC-- 194
           +      +I + V   H  K    AH DLK  N++L + N P+           +K+   
Sbjct: 116 EATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPI---------PHIKLIDF 163

Query: 195 GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
           G A               P + APE+ + +         D+WS+G + Y +     SPF 
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGA-SPF- 218

Query: 253 TVYERGDS---VALAVISGNITFPENTPFPQ 280
                GD+       + S +  F E   F  
Sbjct: 219 ----LGDTKQETLANITSVSYDFDEE-FFSH 244

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (256), Expect = 2e-25
 Identities = 64/271 (23%), Positives = 99/271 (36%), Gaps = 52/271 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC------HGREDQAQAIREVEHHK 78
            D Y I E++G G F+ V       T   YA K I             + +  REV   +
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSV 136
             +HPNI+ L D         V  + + V+++L     G      EL      K  +S  
Sbjct: 71  QVLHPNIITLHD---------VYENRTDVVLILELVSGG------ELFDFLAQKESLSEE 115

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC-- 194
           +      +I + V   H  K    AH DLK  N++L + N P+           +K+   
Sbjct: 116 EATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPI---------PHIKLIDF 163

Query: 195 GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
           G A               P + APE+ + +         D+WS+G + Y +     SPF 
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGA-SPF- 218

Query: 253 TVYERGDS---VALAVISGNITFPENTPFPQ 280
                GD+       + + +  F E   F Q
Sbjct: 219 ----LGDTKQETLANITAVSYDFDEE-FFSQ 244

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  100 bits (252), Expect = 2e-25
 Identities = 60/271 (22%), Positives = 99/271 (36%), Gaps = 52/271 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHK 78
            D Y + E++G G F+ V       T K YA K I             + +  REV   +
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSV 136
              HPNI+ L D         +  + + V+++L     G      EL      K  ++  
Sbjct: 64  EIRHPNIITLHD---------IFENKTDVVLILELVSGG------ELFDFLAEKESLTED 108

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC-- 194
           +  +   +I + V   H  +    AH DLK  N++L + N P            +K+   
Sbjct: 109 EATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPN---------PRIKLIDF 156

Query: 195 GSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
           G A      +        P + APE+ + +         D+WS+G + Y +     SPF 
Sbjct: 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGA-SPF- 211

Query: 253 TVYERGDS---VALAVISGNITFPENTPFPQ 280
                G++       + + N  F E   F  
Sbjct: 212 ----LGETKQETLTNISAVNYDFDEE-YFSN 237

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (252), Expect = 6e-25
 Identities = 39/249 (15%), Positives = 86/249 (34%), Gaps = 29/249 (11%)

Query: 15  LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHGREDQAQ 69
           +  K    + S   Y+   +GEG F+ V          ++ K+++ LK        +   
Sbjct: 54  IKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI 113

Query: 70  AIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSV 128
             + +E  K  +    +      L           +  ++V   Y  GTL N +   ++ 
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLF---------QNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
            +  M    ++   +++   ++  HD + I   H D+K  N +L N       D      
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCEII---HGDIKPDNFILGNGFLEQ--DDEDDLS 219

Query: 189 AVVKVC--GSAEAQNLQD---VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLY 242
           A + +   G +    L     +   +C    ++  E+     +   + + D + +   +Y
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW---NYQIDYFGVAATVY 276

Query: 243 AMCYFKSPF 251
            M +     
Sbjct: 277 CMLFGTYMK 285

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  101 bits (252), Expect = 9e-25
 Identities = 30/274 (10%), Positives = 64/274 (23%), Gaps = 48/274 (17%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---------EDQAQAIREVEHHKT--- 79
             +G+            +T + + +       R         +++   +R +   K    
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 80  -FVHPNILPLLDHALTGCADPVLNSTSQ----------VLMVLPYYPKGTLANDLELRSV 128
             VH   +   D         ++                L         T    L   S 
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
               +     L++ L++   +   H        H  L+  +++L       L        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH--- 257

Query: 189 AVVKVCGSAEAQNLQDVAAERCSMPYRAPE-------LFHVDSYCVVDQRTDVWSLGCLL 241
                            A       +  PE        F      ++    D W+LG  +
Sbjct: 258 ----------LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 242 YAMCYFKSPFDTVYERGDSVALAVISGNITFPEN 275
           Y +     P     +     +  +       P+ 
Sbjct: 308 YWIWCADLPNTD--DAALGGSEWIFRSCKNIPQP 339

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 60/277 (21%), Positives = 98/277 (35%), Gaps = 64/277 (23%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHK 78
            D Y   E++G G F+ V       T  +YA K I             +    REV   K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSV 136
              HPN++ L +         V  + + V+++L     G      EL      K  ++  
Sbjct: 70  EIQHPNVITLHE---------VYENKTDVILILELVAGG------ELFDFLAEKESLTEE 114

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL----LMDLG---SVAPA 189
           +  +   +I   V   H  +    AH DLK  N++L + N P     ++D G    +   
Sbjct: 115 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 190 VV--KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CY 246
                + G+ E               + APE+ + +         D+WS+G + Y +   
Sbjct: 172 NEFKNIFGTPE---------------FVAPEIVNYEPL---GLEADMWSIGVITYILLSG 213

Query: 247 FKSPFDTVYERGDS---VALAVISGNITFPENTPFPQ 280
             SPF      GD+       V + N  F +   F  
Sbjct: 214 A-SPF-----LGDTKQETLANVSAVNYEFEDE-YFSN 243

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.2 bits (248), Expect = 1e-24
 Identities = 53/267 (19%), Positives = 97/267 (36%), Gaps = 52/267 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            +KY I E +G G F  V     + +KK Y  K +   G  DQ    +E+       H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRN 62

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           IL L +            S  +++M+  +     +   +          +  +I+    +
Sbjct: 63  ILHLHE---------SFESMEELVMIFEFISGLDIFERINTS--AFEL-NEREIVSYVHQ 110

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM--DLG---SVAPAVV--KVCGSA 197
           +CEA++  H        H D++  N++     +  +   + G    + P      +  + 
Sbjct: 111 VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVYE 256
           E               Y APE+   D        TD+WSLG L+Y +     +PF     
Sbjct: 168 E---------------YYAPEVHQHDVV---STATDMWSLGTLVYVLLSGI-NPF----- 203

Query: 257 RGDS---VALAVISGNITFPENTPFPQ 280
             ++   +   +++   TF E   F +
Sbjct: 204 LAETNQQIIENIMNAEYTFDEE-AFKE 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 44/245 (17%)

Query: 16  CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIR 72
           C+ E  ++    Y +++ IG+G F+ V L  H  T +  A+K II   +       +  R
Sbjct: 7   CADEQPHI--GNYRLLKTIGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFR 63

Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           EV   K   HPNI+ L +         V+ +   + +++ Y   G + + L    V    
Sbjct: 64  EVRIMKILNHPNIVKLFE---------VIETEKTLYLIMEYASGGEVFDYL----VAHGR 110

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVV 191
           M   +    F +I  AV+  H  +     HRDLK  N+LL  D N  + D G S    V 
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167

Query: 192 KV----CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
                 CG+                PY APELF    Y       DVWSLG +LY +   
Sbjct: 168 GKLDAFCGAP---------------PYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSG 210

Query: 248 KSPFD 252
             PFD
Sbjct: 211 SLPFD 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 54/268 (20%), Positives = 86/268 (32%), Gaps = 59/268 (22%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAI-REVEH 76
               +Y +   +G+GGF TV        + + A+K     +++       +     EV  
Sbjct: 28  AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87

Query: 77  HK----TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
                    HP ++ LLD            +    ++VL          DL      K  
Sbjct: 88  LWKVGAGGGHPGVIRLLD---------WFETQEGFMLVLERPLPA---QDLFDYITEKGP 135

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVV 191
           +        F ++  A++  H        HRD+K  N+L+        L+D GS   A++
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS--GALL 190

Query: 192 K------VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
                    G               +  Y  PE      Y        VWSLG LLY M 
Sbjct: 191 HDEPYTDFDG---------------TRVYSPPEWISRHQY--HALPATVWSLGILLYDMV 233

Query: 246 YFKSPFDTVYERGDSVALAVISGNITFP 273
               PF+   E        ++   + FP
Sbjct: 234 CGDIPFERDQE--------ILEAELHFP 253

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 2e-24
 Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 48/261 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII---CHGREDQAQAIREVEHHKTFV 81
           SD+Y     +G+G F  V L +   T +  A+K I       + D+   +REV+  K   
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L +                  +V   Y  G L    +   + +   S VD  ++
Sbjct: 85  HPNIMKLYE---------FFEDKGYFYLVGEVYTGGEL---FD-EIISRKRFSEVDAARI 131

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG-----SVAPAVVKV 193
             ++   +   H  K +   HRDLK  N+LL +   +  + ++D G       +  +   
Sbjct: 132 IRQVLSGITYMHKNKIV---HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            G+A                Y APE+ H  +Y   D++ DVWS G +LY +     PF+ 
Sbjct: 189 IGTAY---------------YIAPEVLH-GTY---DEKCDVWSTGVILYILLSGCPPFNG 229

Query: 254 VYERGDSVALAVISGNITFPE 274
             E    +   V  G  TF  
Sbjct: 230 ANEYD--ILKKVEKGKYTFEL 248

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.7 bits (249), Expect = 2e-24
 Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 39/264 (14%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
            SD+Y  V+ IG G F    L+    TK+  A+ K I  G        RE+ +H++  HP
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAV-KYIERGAAIDENVQREIINHRSLRHP 76

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKM 141
           NI+   +         V+ + + + +++ Y   G      EL  R       S  +    
Sbjct: 77  NIVRFKE---------VILTPTHLAIIMEYASGG------ELYERICNAGRFSEDEARFF 121

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEA 199
           F ++   V   H  +     HRDLK  N LL  D +P            +K+C  G +++
Sbjct: 122 FQQLLSGVSYCHSMQ---ICHRDLKLENTLL--DGSPAPR---------LKICDFGYSKS 167

Query: 200 QNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD--TVYE 256
             L         +  Y APE+     Y    +  DVWS G  LY M     PF+      
Sbjct: 168 SVLHSQPKSTVGTPAYIAPEVLLRQEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

Query: 257 RGDSVALAVISGNITFPENTPFPQ 280
                   ++S   + P++     
Sbjct: 226 DYRKTIQRILSVKYSIPDDIRISP 249

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 99.0 bits (247), Expect = 3e-24
 Identities = 52/287 (18%), Positives = 94/287 (32%), Gaps = 65/287 (22%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-------------------KIICHGRED 66
           + Y I+  + +G F+ + L E     K YALK                   KI    + D
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 67  QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTL----AND 122
             +   E++      +   L             ++ +  +V ++  Y    ++       
Sbjct: 89  DFK--NELQIITDIKNEYCLTCEG---------IITNYDEVYIIYEYMENDSILKFDEYF 137

Query: 123 LELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD 182
             L      ++    I  +   +  +    H+ K I   HRD+K +N+L+  +    L D
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSD 195

Query: 183 LGSVAPAVVKVCGSAEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
            G           S    +          +  +  PE F  +S      + D+WSLG  L
Sbjct: 196 FGE----------SEYMVD--KKIKGSRGTYEFMPPEFFSNESSYN-GAKVDIWSLGICL 242

Query: 242 YAMCYFKSPFD------TVYERGDSVALAVISGNITFPENTPFPQYQ 282
           Y M Y   PF        ++         + + NI +P +     Y 
Sbjct: 243 YVMFYNVVPFSLKISLVELFNN-------IRTKNIEYPLDRNHFLYP 282

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.0 bits (245), Expect = 3e-24
 Identities = 62/260 (23%), Positives = 96/260 (36%), Gaps = 49/260 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
              +  +E +G G FS V L++   T K +ALK I        +    E+   K   H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKMF 142
           I+ L D         +  ST+   +V+     G      EL  R + +   +  D   + 
Sbjct: 68  IVTLED---------IYESTTHYYLVMQLVSGG------ELFDRILERGVYTEKDASLVI 112

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG---SVAPAVVK-VCG 195
            ++  AVK  H+   I   HRDLK  N+L    + N  +M  D G        ++   CG
Sbjct: 113 QQVLSAVKYLHENG-I--VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTV 254
           +                 Y APE+     Y    +  D WS+G + Y + C +  PF   
Sbjct: 170 TPG---------------YVAPEVLAQKPY---SKAVDCWSIGVITYILLCGY-PPFYE- 209

Query: 255 YERGDSVALAVISGNITFPE 274
            E    +   +  G   F  
Sbjct: 210 -ETESKLFEKIKEGYYEFES 228

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 97.0 bits (242), Expect = 6e-24
 Identities = 57/261 (21%), Positives = 98/261 (37%), Gaps = 40/261 (15%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-------IREVEHHKTFVH 82
             ++IG+GGF  V      + K   A+K +I    E + +         REV       H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L      G         +   MV+ + P G L + L  +    H +     L++ 
Sbjct: 83  PNIVKLY-----GL------MHNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLM 128

Query: 143 LKICEAVKVFHDAKP--IAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAE 198
           L I   ++   +  P  +   HRDL++ N+ L + +          AP   KV   G ++
Sbjct: 129 LDIALGIEYMQNQNPPIV---HRDLRSPNIFLQSLDEN--------APVCAKVADFGLSQ 177

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                 V+    +  + APE    +      ++ D +S   +LY +   + PFD      
Sbjct: 178 QSV-HSVSGLLGNFQWMAPETIGAEEES-YTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

Query: 259 DSVALAVISGNI--TFPENTP 277
                 +    +  T PE+ P
Sbjct: 236 IKFINMIREEGLRPTIPEDCP 256

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.9 bits (242), Expect = 6e-24
 Identities = 63/262 (24%), Positives = 97/262 (37%), Gaps = 50/262 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII---CHGREDQAQAIREVEHHKTFV 81
           SD Y + E++G+G FS V    H  T   +A K I       R+ Q    RE    +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L D          +   S   +V      G L  D+    V + + S  D    
Sbjct: 64  HPNIVRLHD---------SIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHC 110

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG---SVAPAVV--KV 193
             +I E++   H    I   HR+LK  N+LLA+      +   D G    V  +      
Sbjct: 111 IQQILESIAYCHSNG-I--VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
            G+                 Y +PE+   D Y    +  D+W+ G +LY +   +  PF 
Sbjct: 168 AGTPG---------------YLSPEVLKKDPY---SKPVDIWACGVILYILLVGY-PPFW 208

Query: 253 TVYERGDSVALAVISGNITFPE 274
              E    +   + +G   +P 
Sbjct: 209 D--EDQHRLYAQIKAGAYDYPS 228

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 8e-24
 Identities = 60/272 (22%), Positives = 101/272 (37%), Gaps = 59/272 (21%)

Query: 25  SDKYYI--VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +  Y +   E +G G F  V   E + T  + A K I   G +D+ +   E+       H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGK-HYMSSVDIL 139
            N++ L D            S + +++V+ Y   G      EL  R + + + ++ +D +
Sbjct: 146 ANLIQLYD---------AFESKNDIVLVMEYVDGG------ELFDRIIDESYNLTELDTI 190

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM--DLG---SVAPAVV--K 192
               +ICE ++  H        H DLK  N+L  N +   +   D G      P      
Sbjct: 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF 251
             G+ E               + APE   V +Y  V   TD+WS+G + Y +     SPF
Sbjct: 248 NFGTPE---------------FLAPE---VVNYDFVSFPTDMWSVGVIAYMLLSGL-SPF 288

Query: 252 DTVYERGDS---VALAVISGNITFPENTPFPQ 280
                 GD+       +++      +   F  
Sbjct: 289 -----LGDNDAETLNNILACRWDLEDE-EFQD 314

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 60/271 (22%), Positives = 98/271 (36%), Gaps = 61/271 (22%)

Query: 25  SDKYYI---VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTF 80
              Y +    + +GEG FS      H ++ + +A+K I    +  +A   +E+       
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCE 63

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDI 138
            HPNI+ L +         V +      +V+     G      EL  R   K + S  + 
Sbjct: 64  GHPNIVKLHE---------VFHDQLHTFLVMELLNGG------ELFERIKKKKHFSETEA 108

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG------SVAPA 189
             +  K+  AV   HD   +   HRDLK  N+L  + ++N  +   D G           
Sbjct: 109 SYIMRKLVSAVSHMHD-VGV--VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165

Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFK 248
           +   C +                 Y APEL + + Y   D+  D+WSLG +LY M     
Sbjct: 166 LKTPCFTLH---------------YAAPELLNQNGY---DESCDLWSLGVILYTMLSGQ- 206

Query: 249 SPF-----DTVYERGDSVALAVISGNITFPE 274
            PF              +   +  G+ +F  
Sbjct: 207 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 43/242 (17%), Positives = 82/242 (33%), Gaps = 33/242 (13%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFV 81
           V    +   + +G G   T+ +       +  A+K+I+    E  + A REV+   ++  
Sbjct: 21  VGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDE 76

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN++                      + +      TL   +E +         ++ + +
Sbjct: 77  HPNVIRYFC---------TEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLGLEPITL 123

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN-----PLLMDLGSVAPAVVKVCGS 196
             +    +   H    +   HRDLK  N+L++  N       ++ D G          G 
Sbjct: 124 LQQTTSGLAHLHSLNIV---HRDLKPHNILISMPNAHGKIKAMISDFG---LCKKLAVGR 177

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVY 255
                   V     +  + APE+   D         D++S GC+ Y +      PF    
Sbjct: 178 HSFSRRSGVPG---TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 256 ER 257
           +R
Sbjct: 235 QR 236

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.8 bits (239), Expect = 2e-23
 Identities = 65/271 (23%), Positives = 98/271 (36%), Gaps = 57/271 (21%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---------ICHGREDQAQAIREVE 75
            + Y   E +G G  S V    H  T K YA+K I             +E +   ++EV+
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 76  -HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHY 132
              K   HPNI+ L D            + +   +V     KG      EL      K  
Sbjct: 76  ILRKVSGHPNIIQLKD---------TYETNTFFFLVFDLMKKG------ELFDYLTEKVT 120

Query: 133 MSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPA 189
           +S  +  K+   + E +   H    +   HRDLK  N+LL +D N  L D G    + P 
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIV---HRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 190 VV--KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVV---DQRTDVWSLGCLLYAM 244
               +VCG+                 Y APE+             +  D+WS G ++Y +
Sbjct: 178 EKLREVCGTPS---------------YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222

Query: 245 -CYFKSPFDTVYERGDSVALAVISGNITFPE 274
                 PF     +   +   ++SGN  F  
Sbjct: 223 LAGS-PPFWH--RKQMLMLRMIMSGNYQFGS 250

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 47/260 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           S+ Y  V+K+G G +  V L     T    A+K I          ++ + EV   K   H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L D                  +V+  Y  G L    +   + +   + VD   + 
Sbjct: 96  PNIMKLYD---------FFEDKRNYYLVMECYKGGEL---FD-EIIHRMKFNEVDAAVII 142

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG-----SVAPAVVKVC 194
            ++   V   H    +   HRDLK  N+LL +   +  + ++D G          + +  
Sbjct: 143 KQVLSGVTYLHKHNIV---HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
           G+A                Y APE+     Y   D++ DVWS+G +L+ +     PF   
Sbjct: 200 GTAY---------------YIAPEVLR-KKY---DEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 255 YERGDSVALAVISGNITFPE 274
            ++   +   V  G  TF  
Sbjct: 241 TDQE--ILRKVEKGKYTFDS 258

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.5 bits (238), Expect = 6e-23
 Identities = 65/257 (25%), Positives = 99/257 (38%), Gaps = 40/257 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII---CHGREDQAQAIREVEHHKTFV 81
           SD Y + E++G+G FS V    H  T   +A K I       R+ Q    RE    +   
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 86

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+ L D          +   S   +V      G L  D+    V + + S  D    
Sbjct: 87  HPNIVRLHD---------SIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHC 133

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEA 199
             +I E++   H    +   HR+LK  N+LLA+              A VK+   G A  
Sbjct: 134 IQQILESIAYCHSNGIV---HRNLKPENLLLASKAK----------GAAVKLADFGLAIE 180

Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVYER 257
            N  +        P Y +PE+   D Y    +  D+W+ G +LY +   +  PF    E 
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPY---SKPVDIWACGVILYILLVGY-PPFWD--ED 234

Query: 258 GDSVALAVISGNITFPE 274
              +   + +G   +P 
Sbjct: 235 QHRLYAQIKAGAYDYPS 251

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.4 bits (233), Expect = 1e-22
 Identities = 66/246 (26%), Positives = 99/246 (40%), Gaps = 45/246 (18%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAI 71
           SK    VK   Y + + +G G F  V + EH  T  + A+K     KI       + +  
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-- 59

Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
           RE+++ K F HP+I+ L           V+++ +   MV+ Y   G L + +        
Sbjct: 60  REIQNLKLFRHPHIIKLYQ---------VISTPTDFFMVMEYVSGGELFDYI----CKHG 106

Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAV 190
            +  ++  ++F +I  AV   H        HRDLK  NVLL    N  + D G S   + 
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

Query: 191 VKV----CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY 246
            +     CGS                 Y APE+     Y       D+WS G +LYA+  
Sbjct: 164 GEFLRTSCGSP---------------NYAAPEVISGRLY--AGPEVDIWSCGVILYALLC 206

Query: 247 FKSPFD 252
              PFD
Sbjct: 207 GTLPFD 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 47/266 (17%), Positives = 95/266 (35%), Gaps = 38/266 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHPN 84
           +     + +G G   TV   + S   +  A+K+++    +    A+ E++   ++  HPN
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPN 70

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---GKHYMSSVDILKM 141
           ++                +   + + L       L + +E ++V           + + +
Sbjct: 71  VIRYYC---------SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--G---- 195
             +I   V   H  K     HRDLK  N+L++  +              + +   G    
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 196 -SAEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRT----DVWSLGCLLYAM-CYFK 248
             +   + +        +  +RAPEL    +     +R     D++S+GC+ Y +    K
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 249 SPFDTVYERGDSVALAVISGNITFPE 274
            PF   Y R       +I G  +  E
Sbjct: 238 HPFGDKYSRES----NIIRGIFSLDE 259

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 61/259 (23%), Positives = 96/259 (37%), Gaps = 43/259 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVH 82
           +++Y + E++G+G FS V         + YA   I        D  +  RE    +   H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILK 140
           PNI+ L D          ++      ++      G      EL    V + Y S  D   
Sbjct: 70  PNIVRLHD---------SISEEGHHYLIFDLVTGG------ELFEDIVAREYYSEADASH 114

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLGSVAPAVVKVCGSA 197
              +I EAV   H    +   HR+LK  N+LLA+      + L D G           + 
Sbjct: 115 CIQQILEAVLHCHQMGVV---HRNLKPENLLLASKLKGAAVKLADFGL----------AI 161

Query: 198 EAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVY 255
           E +  Q         P Y +PE+   D Y    +  D+W+ G +LY +   +  PF    
Sbjct: 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPY---GKPVDLWACGVILYILLVGY-PPFWD-- 215

Query: 256 ERGDSVALAVISGNITFPE 274
           E    +   + +G   FP 
Sbjct: 216 EDQHRLYQQIKAGAYDFPS 234

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 29/267 (10%), Positives = 66/267 (24%), Gaps = 61/267 (22%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK------------------KIICHGRE 65
           +         +G+            +T + + +                   +++     
Sbjct: 71  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130

Query: 66  DQAQAIREVEHHKTFV----------HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYP 115
              +  ++ + H  F+             ++ +                   L       
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF-----FLYPRMQSN 185

Query: 116 KGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND 175
             T    L   S     +     L++ L++   +   H        H  L+  +++L   
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 242

Query: 176 NNPLLMDLGSVAP--AVVKVCGSAEAQNLQDVAAERCSMPYRAPEL--------FHVDSY 225
               L     +    A V    S                 +  PEL        +H D  
Sbjct: 243 GGVFLTGFEHLVRDGARVVSSVSRG---------------FEPPELEARRATISYHRDRR 287

Query: 226 CVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            ++    D W+LG ++Y +     P  
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPIT 314

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.1 bits (232), Expect = 3e-22
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 48/275 (17%)

Query: 25  SDKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVE-HHKT 79
            D Y + E  +GEG  + V    +  T + YA+K I     H R       REVE  ++ 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEMLYQC 67

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H N+L L++               +  +V      G++ + +  R   +H+ + ++  
Sbjct: 68  QGHRNVLELIE---------FFEEEDRFYLVFEKMRGGSILSHIHKR---RHF-NELEAS 114

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG-SVAPAVVKVCG 195
            +   +  A+   H+ K I  AHRDLK  N+L  +    +P+ + D        +   C 
Sbjct: 115 VVVQDVASALDFLHN-KGI--AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 196 SAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVV--DQRTDVWSLGCLLYAM-C-----Y 246
                 L       C    Y APE+    S      D+R D+WSLG +LY +        
Sbjct: 172 PISTPELLTP----CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

Query: 247 FKSPFDTVYERGDSVAL-------AVISGNITFPE 274
            +   D  ++RG++          ++  G   FP+
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.2 bits (232), Expect = 4e-22
 Identities = 71/262 (27%), Positives = 105/262 (40%), Gaps = 53/262 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           SD + +  ++G G  S V   +   T+K YALK +      D+     E+       HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPN 109

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKMF 142
           I+ L +         +  + +++ +VL     G      EL  R V K Y S  D     
Sbjct: 110 IIKLKE---------IFETPTEISLVLELVTGG------ELFDRIVEKGYYSERDAADAV 154

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG-SV----APAVVKVC 194
            +I EAV   H+   I   HRDLK  N+L A    + PL + D G S        +  VC
Sbjct: 155 KQILEAVAYLHENG-I--VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDT 253
           G+                 Y APE+    +Y       D+WS+G + Y + C F  PF  
Sbjct: 212 GTPG---------------YCAPEILRGCAY---GPEVDMWSVGIITYILLCGF-EPFYD 252

Query: 254 VYERGDS-VALAVISGNITFPE 274
             ERGD  +   +++    F  
Sbjct: 253 --ERGDQFMFRRILNCEYYFIS 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 91.9 bits (229), Expect = 5e-22
 Identities = 63/264 (23%), Positives = 104/264 (39%), Gaps = 53/264 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGREDQAQAIREVEHHKTFVH 82
           +++Y IV  +G+G F  V   +   T++ YA+K I       +D +  +REVE  K   H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILK 140
           PNI+ L +         +L  +S   +V   Y  G      EL    + +   S  D  +
Sbjct: 81  PNIMKLFE---------ILEDSSSFYIVGELYTGG------ELFDEIIKRKRFSEHDAAR 125

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG---SVAPAVV--K 192
           +  ++   +   H    +   HRDLK  N+LL +   +  + ++D G             
Sbjct: 126 IIKQVFSGITYMHKHNIV---HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 193 VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF 251
             G+A                Y APE+    +Y   D++ DVWS G +LY +      PF
Sbjct: 183 RIGTAY---------------YIAPEVLR-GTY---DEKCDVWSAGVILYILLSGT-PPF 222

Query: 252 DTVYERGDSVALAVISGNITFPEN 275
               +    +   V +G   F   
Sbjct: 223 YG--KNEYDILKRVETGKYAFDLP 244

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.0 bits (234), Expect = 6e-22
 Identities = 57/271 (21%), Positives = 93/271 (34%), Gaps = 58/271 (21%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-------------ICHGREDQAQAI 71
            + Y+ V K+G G +  V L +        A+K I               +  +   +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 72  REVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKH 131
            E+   K+  HPNI+ L D         V        +V  +Y  G L    E + + +H
Sbjct: 95  NEISLLKSLDHPNIIKLFD---------VFEDKKYFYLVTEFYEGGEL---FE-QIINRH 141

Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG---- 184
                D   +  +I   +   H        HRD+K  N+LL N      + ++D G    
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 185 -SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA 243
            S    +    G+A                Y APE+     Y   +++ DVWS G ++Y 
Sbjct: 199 FSKDYKLRDRLGTAY---------------YIAPEVLK-KKY---NEKCDVWSCGVIMYI 239

Query: 244 MCYFKSPFDTVYERGDSVALAVISGNITFPE 274
           +     PF    +    +   V  G   F  
Sbjct: 240 LLCGYPPFGG--QNDQDIIKKVEKGKYYFDF 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 64/262 (24%), Positives = 96/262 (36%), Gaps = 51/262 (19%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +  Y +   IG G +  V +     T+ R A KKI  +  ED  +  +E+E  K+  HPN
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKMF 142
           I+ L +              + + +V+     G      EL  R V K      D  ++ 
Sbjct: 68  IIRLYE---------TFEDNTDIYLVMELCTGG------ELFERVVHKRVFRESDAARIM 112

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG---SVAPAVV--KVC 194
             +  AV   H        HRDLK  N L      ++PL L+D G      P  +     
Sbjct: 113 KDVLSAVAYCHKLNVA---HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDT 253
           G+                 Y +P++     Y       D WS G ++Y + C +  PF  
Sbjct: 170 GTPY---------------YVSPQVLE-GLY---GPECDEWSAGVMMYVLLCGY-PPFSA 209

Query: 254 VYERGDSVALAVISGNITFPEN 275
                  V L +  G  TFPE 
Sbjct: 210 --PTDSEVMLKIREGTFTFPEK 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.0 bits (229), Expect = 7e-22
 Identities = 58/263 (22%), Positives = 88/263 (33%), Gaps = 57/263 (21%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAI-REVEHHKT 79
            +Y +   +G GGF +V            A+K     +I   G       +  EV   K 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 80  FVH--PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD 137
                  ++ LLD                 +++L   P+     DL      +  +    
Sbjct: 103 VSSGFSGVIRLLD---------WFERPDSFVLILE-RPEP--VQDLFDFITERGALQEEL 150

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL-ANDNNPLLMDLGSVAPAVVK---- 192
               F ++ EAV+  H+       HRD+K  N+L+  N     L+D GS   A++K    
Sbjct: 151 ARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS--GALLKDTVY 205

Query: 193 --VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
               G               +  Y  PE      Y    +   VWSLG LLY M     P
Sbjct: 206 TDFDG---------------TRVYSPPEWIRYHRY--HGRSAAVWSLGILLYDMVCGDIP 248

Query: 251 FDTVYERGDSVALAVISGNITFP 273
           F+   E        +I G + F 
Sbjct: 249 FEHDEE--------IIRGQVFFR 263

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.1 bits (227), Expect = 1e-21
 Identities = 49/259 (18%), Positives = 86/259 (33%), Gaps = 42/259 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHP 83
            D +    K+G G F  V L+E   +     +K I     +    Q   E+E  K+  HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ + +         V      + +V+     G L   +         +S   + ++  
Sbjct: 81  NIIKIFE---------VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLGS---VAPAVV--KVCG 195
           ++  A+  FH    +   H+DLK  N+L  +   +  +   D G               G
Sbjct: 132 QMMNALAYFHSQHVV---HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
           +A                Y APE+F          + D+WS G ++Y +     PF    
Sbjct: 189 TAL---------------YMAPEVFK-RDV---TFKCDIWSAGVVMYFLLTGCLPFTG-- 227

Query: 256 ERGDSVALAVISGNITFPE 274
              + V          +  
Sbjct: 228 TSLEEVQQKATYKEPNYAV 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.7 bits (226), Expect = 1e-21
 Identities = 55/260 (21%), Positives = 94/260 (36%), Gaps = 35/260 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHP 83
           + + +V+ +GEG +  V L  +  T++  A+ KI+   R  +      +E+  +K   H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAV-KIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           N++                  +   + L Y   G L +    R      M   D  + F 
Sbjct: 66  NVVKFYG---------HRREGNIQYLFLEYCSGGELFD----RIEPDIGMPEPDAQRFFH 112

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++   V   H        HRD+K  N+LL   +N  + D G        +       N +
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRE 161

Query: 204 DVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
            +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D   +  DS  
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQ 216

Query: 263 L--AVISGNITFPENTPFPQ 280
                               
Sbjct: 217 EYSDWKEKKTYLNPWKKIDS 236

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 56/275 (20%), Positives = 108/275 (39%), Gaps = 61/275 (22%)

Query: 25  SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIIC--HGREDQAQAIREVE-----H 76
           ++ Y +  +++G G F+ V       T + YA K +     G++ +A+ + E+       
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
                 P ++ L +         V  +TS+++++L Y   G + +           +S  
Sbjct: 87  S----CPRVINLHE---------VYENTSEIILILEYAAGGEIFSLCLPELAE--MVSEN 131

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLG---SVAPAV 190
           D++++  +I E V   H        H DLK  N+LL++      +   D G    +  A 
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 191 V--KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYF 247
              ++ G+ E               Y APE+ + D        TD+W++G + Y +  + 
Sbjct: 189 ELREIMGTPE---------------YLAPEILNYDPI---TTATDMWNIGIIAYMLLTHT 230

Query: 248 KSPF--DTVYERGDSVALAVISGNITFPENTPFPQ 280
            SPF  +   E      L +   N+ + E   F  
Sbjct: 231 -SPFVGEDNQE----TYLNISQVNVDYSEE-TFSS 259

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 47/260 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVH 82
           +++Y IV  +G+G F  V   +   T++ YA+K I       +D +  +REVE  K   H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNI+ L +         +L  +S   +V   Y  G L +++  R   K + S  D  ++ 
Sbjct: 81  PNIMKLFE---------ILEDSSSFYIVGELYTGGELFDEIIKR---KRF-SEHDAARII 127

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPL-LMDLG-SVA----PAVVKVC 194
            ++   +   H        HRDLK  N+LL +   +  + ++D G S        +    
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV 254
           G+A                Y APE+    +Y   D++ DVWS G +LY +     PF   
Sbjct: 185 GTAY---------------YIAPEVLR-GTY---DEKCDVWSAGVILYILLSGTPPFYGK 225

Query: 255 YERGDSVALAVISGNITFPE 274
            E    +   V +G   F  
Sbjct: 226 NEYD--ILKRVETGKYAFDL 243

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 90.5 bits (225), Expect = 4e-21
 Identities = 60/270 (22%), Positives = 93/270 (34%), Gaps = 56/270 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--------ICHGREDQAQAIREVE- 75
             KY   + IG G  S V    H  T   +A+K +             E +    RE   
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYM 133
             +   HP+I+ L+D            S+S + +V     KG      EL      K  +
Sbjct: 153 LRQVAGHPHIITLID---------SYESSSFMFLVFDLMRKG------ELFDYLTEKVAL 197

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG---SVAPAV 190
           S  +   +   + EAV   H    I   HRDLK  N+LL ++    L D G    + P  
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANN-I--VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 191 V--KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVV---DQRTDVWSLGCLLYAM- 244
              ++CG+                 Y APE+             +  D+W+ G +L+ + 
Sbjct: 255 KLRELCGTPG---------------YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

Query: 245 CYFKSPFDTVYERGDSVALAVISGNITFPE 274
                PF     R   +   ++ G   F  
Sbjct: 300 AGS-PPFWH--RRQILMLRMIMEGQYQFSS 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 89.3 bits (222), Expect = 4e-21
 Identities = 56/262 (21%), Positives = 97/262 (37%), Gaps = 46/262 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-----ALKKIICHGREDQAQAI----REVEHHKTF 80
           + E IG GGF  V        +  +     A+K       ED +Q I    +E +     
Sbjct: 11  LEEIIGIGGFGKVY-------RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 81  VHPNILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            HPNI+ L      G C          + +V+ +   G L   L         +    ++
Sbjct: 64  KHPNIIALR-----GVCLKE-----PNLCLVMEFARGGPLNRVLS-----GKRIPPDILV 108

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
              ++I   +   HD   +   HRDLK++N+L+        +        ++K+   G A
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK-----ILKITDFGLA 163

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
              +     +   +  + APE+     +    + +DVWS G LL+ +   + PF  +   
Sbjct: 164 REWHRTTKMSAAGAYAWMAPEVIRASMF---SKGSDVWSYGVLLWELLTGEVPFRGI--D 218

Query: 258 GDSVALAVISGNI--TFPENTP 277
           G +VA  V    +    P   P
Sbjct: 219 GLAVAYGVAMNKLALPIPSTCP 240

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.1 bits (224), Expect = 4e-21
 Identities = 53/239 (22%), Positives = 88/239 (36%), Gaps = 48/239 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHP 83
           + + +V+ +GEG +  V L  +  T++  A+ KI+   R  +      +E+  +K   H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAV-KIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLEL--RSVGKHYMSSVDILKM 141
           N++                  +   + L Y   G      EL  R      M   D  + 
Sbjct: 66  NVVKFYG---------HRREGNIQYLFLEYCSGG------ELFDRIEPDIGMPEPDAQRF 110

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN--------PLLMDLGSVAPAVVKV 193
           F ++   V   H        HRD+K  N+LL   +N          +    +    + K+
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           CG+                PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 168 CGTL---------------PYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWD 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.4 bits (227), Expect = 4e-21
 Identities = 66/267 (24%), Positives = 105/267 (39%), Gaps = 57/267 (21%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHH 77
           VK   Y + + +G G F  V + +H  T  + A+K     KI       + +  RE+++ 
Sbjct: 13  VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNL 70

Query: 78  KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD 137
           K F HP+I+ L           V+++ S + MV+ Y   G L + +         +   +
Sbjct: 71  KLFRHPHIIKLYQ---------VISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKE 117

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKV--- 193
             ++F +I   V   H        HRDLK  NVLL    N  + D G S   +  +    
Sbjct: 118 SRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

Query: 194 -CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            CGS                 Y APE+     Y       D+WS G +LYA+     PFD
Sbjct: 175 SCGSP---------------NYAAPEVISGRLYA--GPEVDIWSSGVILYALLCGTLPFD 217

Query: 253 -----TVYERGDSVALAVISGNITFPE 274
                T++++       +  G    P+
Sbjct: 218 DDHVPTLFKK-------ICDGIFYTPQ 237

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 89.3 bits (222), Expect = 6e-21
 Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 58/257 (22%)

Query: 26  DKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  + +G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 71

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D      A         +L+V+     G L + ++ R  G    +  +  ++  
Sbjct: 72  HIVRIVDVYENLYAGR-----KCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMK 124

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNPLLM--DLGSVAPAVVKVCGSAEAQ 200
            I EA++  H       AHRD+K  N+L  +   N +L   D G  A             
Sbjct: 125 SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG-FAKETTG-------- 172

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPF--DTVYER 257
                                 + Y   D+  D+WSLG ++Y + C +  PF  +     
Sbjct: 173 ----------------------EKY---DKSCDMWSLGVIMYILLCGY-PPFYSNHGLAI 206

Query: 258 GDSVALAVISGNITFPE 274
              +   +  G   FP 
Sbjct: 207 SPGMKTRIRMGQYEFPN 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 49/240 (20%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFV 81
           +  KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI--- 138
           H N++ L++      A P       + +V  +       +DL         +S+V +   
Sbjct: 75  HENVVNLIE-ICRTKASPYNRCKGSIYLVFDF-----CEHDL------AGLLSNVLVKFT 122

Query: 139 ---LKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
              +K  ++ +   +   H  K +   HRD+K ANVL+  D              V+K+ 
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKIL---HRDMKAANVLITRDG-------------VLKLA 166

Query: 195 --GSAEAQNLQDVAAERCSMP------YRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMC 245
             G A A +L   +             YR PE L     Y       D+W  GC++  M 
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP---PIDLWGAGCIMAEMW 223

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 66/244 (27%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREVEHHK 78
           ++ +Y  ++ +GEG F+TV       T +  A+KKI    R +        A+RE++  +
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSV 136
              HPNI+ LLD              S + +V  +     +  DLE  ++        + 
Sbjct: 68  ELSHPNIIGLLD---------AFGHKSNISLVFDF-----METDLEVIIKDNSLVL--TP 111

Query: 137 DILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             +K ++    + ++  H    +   HRDLK  N+LL  +    L D G           
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWIL---HRDLKPNNLLLDENGVLKLADFG----------- 157

Query: 196 SAEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLGCLL 241
                 L    A+    P            YRAPE LF    Y   V    D+W++GC+L
Sbjct: 158 ------L----AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV----DMWAVGCIL 203

Query: 242 YAMC 245
             + 
Sbjct: 204 AELL 207

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 87.6 bits (218), Expect = 2e-20
 Identities = 54/244 (22%), Positives = 84/244 (34%), Gaps = 59/244 (24%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----AIREV---E 75
            + +Y  V +IG G + TV       +    ALK +                +REV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYM 133
             + F HPN++ L+D     CA    +   +V +V  +     +  DL   L       +
Sbjct: 67  RLEAFEHPNVVRLMD----VCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGL 117

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
            +  I  +  +    +   H    +   HRDLK  N+L+ +     L D G         
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFG--------- 165

Query: 194 CGSAEAQNLQDVAAERCSMP-----------YRAPELFHVDSY-CVVDQRTDVWSLGCLL 241
                   L    A   S             YRAPE+    +Y   V    D+WS+GC+ 
Sbjct: 166 --------L----ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIF 209

Query: 242 YAMC 245
             M 
Sbjct: 210 AEMF 213

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 5e-20
 Identities = 50/242 (20%), Positives = 93/242 (38%), Gaps = 49/242 (20%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI----ICHGREDQAQAIREVEHHKTFVH 82
           KY + + +GEG +  V  +  S+T  R A+K +    +      +A   +E++  +   H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 83  PNILPLLDHALTGCADPVLN--STSQVLMVLPYYPKGTLANDLEL-RSVGKHYMSSVDIL 139
            N++ L+D         VL      ++ MV+ Y   G      E+  SV +         
Sbjct: 66  KNVIQLVD---------VLYNEEKQKMYMVMEYCVCGM----QEMLDSVPEKRFPVCQAH 112

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVK------ 192
             F ++ + ++  H        H+D+K  N+LL       +  LG + A           
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 193 -VCGSAEAQNLQDVAAERCSMPYRAPELFH-VDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
              GS                 ++ PE+ + +D++     + D+WS G  LY +     P
Sbjct: 170 TSQGSP---------------AFQPPEIANGLDTF--SGFKVDIWSAGVTLYNITTGLYP 212

Query: 251 FD 252
           F+
Sbjct: 213 FE 214

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 5e-20
 Identities = 67/236 (28%), Positives = 101/236 (42%), Gaps = 46/236 (19%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTFV 81
            Y I E +GEG F  V L  H +T+++ ALK      +       + +  RE+ + K   
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLR 67

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP+I+ L D         V+ + + ++MV+ Y   G L + +    V K  M+  +  + 
Sbjct: 68  HPHIIKLYD---------VITTPTDIVMVIEY-AGGELFDYI----VEKKRMTEDEGRRF 113

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKV----CGS 196
           F +I  A++  H  K     HRDLK  N+LL ++ N  + D G S            CGS
Sbjct: 114 FQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                            Y APE+ +   Y       DVWS G +LY M   + PFD
Sbjct: 171 P---------------NYAAPEVINGKLYA--GPEVDVWSCGIVLYVMLVGRLPFD 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 8e-20
 Identities = 61/249 (24%), Positives = 96/249 (38%), Gaps = 71/249 (28%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
            KY  +EKIGEG + TV   ++ +T +  ALK++     ++   + A+RE+   K   H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV------D 137
           NI+ L D         VL+S  ++ +V  +        DL      K Y  S       +
Sbjct: 62  NIVRLHD---------VLHSDKKLTLVFEF-----CDQDL------KKYFDSCNGDLDPE 101

Query: 138 ILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
           I+K FL  + + +   H    +   HRDLK  N+L+  +    L + G            
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVL---HRDLKPQNLLINRNGELKLANFG------------ 146

Query: 197 AEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLGCLLY 242
                L    A    +P            YR P+ LF    Y   +    D+WS GC+  
Sbjct: 147 -----L----ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI----DMWSAGCIFA 193

Query: 243 AMCYFKSPF 251
            +     P 
Sbjct: 194 ELANAGRPL 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 54/251 (21%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
             S KY + + +G G F  V  +   ++ KR+ALKK+     +D     RE++  K   H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDH 59

Query: 83  PNILPLLDH-----------ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE------- 124
            NI+ L+D+                    L   +  +           + +         
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 125 ----LRSVGKHYMSSVDIL-----KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLAN 174
               L  V K ++ S   +      +++ ++  AV   H        HRD+K  N+L+  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC---HRDIKPQNLLV-- 174

Query: 175 DNNPLLMDLGSVAPAVVKVC--GSA-EAQNLQDVAAERCSMPYRAPEL-FHVDSYCVVDQ 230
             N     L        K+C  GSA +    +   A  CS  YRAPEL      Y     
Sbjct: 175 --NSKDNTL--------KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY---TP 221

Query: 231 RTDVWSLGCLL 241
             D+WS+GC+ 
Sbjct: 222 SIDLWSIGCVF 232

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 82/295 (27%)

Query: 27  KYYIVEKIGEGGFSTVSLIEHSQTKKRYALK-----KIICHG------------------ 63
           +Y + ++IG+G +  V L  +      YA+K     K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 64  ---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN--STSQVLMVLPYYPKGT 118
              R    Q  +E+   K   HPN++ L++         VL+  +   + MV     +G 
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVE---------VLDDPNEDHLYMVFELVNQGP 124

Query: 119 LANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAY------AHRDLKTANVL 171
           +   +E+ ++              L   +A   F D  K I Y       HRD+K +N+L
Sbjct: 125 V---MEVPTLKP------------LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169

Query: 172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQ 230
           +  D +  + D G           S E +    + +    +  + APE           +
Sbjct: 170 VGEDGHIKIADFGV----------SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219

Query: 231 RTDVWSLGCLLYAMCYFKSPFD-----TVYERGDSVALAVISGNITFPENTPFPQ 280
             DVW++G  LY   + + PF       ++ +       + S  + FP+     +
Sbjct: 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK-------IKSQALEFPDQPDIAE 267

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 57/264 (21%), Positives = 100/264 (37%), Gaps = 55/264 (20%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-----ALKKIICHGREDQAQA--IREVEHHKTFVH 82
           I EKIG G F TV        +  +     A+K ++      +     +REV   K   H
Sbjct: 41  IKEKIGAGSFGTVH-------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 83  PNILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           PNI+  +     G    P       + +V  Y  +G+L   L  +S  +  +     L M
Sbjct: 94  PNIVLFM-----GAVTQP-----PNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSM 142

Query: 142 FLKICEAVKVFHDAKP--IAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
              + + +   H+  P  +   HR+LK+ N+L+                  VKVC  G +
Sbjct: 143 AYDVAKGMNYLHNRNPPIV---HRNLKSPNLLVDKKY-------------TVKVCDFGLS 186

Query: 198 --EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
             +A       +   +  + APE+   +     ++++DV+S G +L+ +   + P+  + 
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDVYSFGVILWELATLQQPWGNL- 242

Query: 256 ERGDSVALAVISGNI--TFPENTP 277
                V  AV         P N  
Sbjct: 243 -NPAQVVAAVGFKCKRLEIPRNLN 265

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 61/242 (25%), Positives = 90/242 (37%), Gaps = 70/242 (28%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-AQAIREVEHHKTFVHPN 84
           + Y  ++K+GEG ++TV   +   T    ALK+I     E     AIREV   K   H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL----- 139
           I+ L D         ++++   + +V  Y     L  DL      K Y+     +     
Sbjct: 62  IVTLHD---------IIHTEKSLTLVFEY-----LDKDL------KQYLDDCGNIINMHN 101

Query: 140 -KMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
            K+FL  +   +   H  K +   HRDLK  N+L+       L D G             
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVL---HRDLKPQNLLINERGELKLADFG------------- 145

Query: 198 EAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLGCLLYA 243
               L    A   S+P            YR P+ L     Y   +    D+W +GC+ Y 
Sbjct: 146 ----L----ARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI----DMWGVGCIFYE 193

Query: 244 MC 245
           M 
Sbjct: 194 MA 195

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 4e-19
 Identities = 61/248 (24%), Positives = 91/248 (36%), Gaps = 77/248 (31%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ------AIREVEHHKT 79
           D+Y  + K+GEG +  V     + T +  A+K+I    R +  +      AIREV   K 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKE 89

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H NI+ L           V++   ++ ++  Y       NDL      K YM     +
Sbjct: 90  LQHRNIIELKS---------VIHHNHRLHLIFEY-----AENDL------KKYMDKNPDV 129

Query: 140 -----KMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
                K FL  +   V   H  + +   HRDLK  N+LL   +     +       V+K+
Sbjct: 130 SMRVIKSFLYQLINGVNFCHSRRCL---HRDLKPQNLLL---SVSDASETP-----VLKI 178

Query: 194 C--GSAEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSL 237
              G A A            +P            YR PE L     Y   V    D+WS+
Sbjct: 179 GDFGLARA----------FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV----DIWSI 224

Query: 238 GCLLYAMC 245
            C+   M 
Sbjct: 225 ACIWAEML 232

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.8 bits (210), Expect = 6e-19
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 38/226 (16%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           +   Y   + IG G F  V   +   + +  A+KK+     +D+    RE++  +   H 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 107

Query: 84  NILPLLD---HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           NI+ L      +     +  LN      +VL Y P+ T+       S  K  +  + + K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLN------LVLDYVPE-TVYRVARHYSRAKQTLPVIYV-K 159

Query: 141 MFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
           +++ ++  ++   H        HRD+K  N+LL + +            AV+K+C  GSA
Sbjct: 160 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL-DPDT-----------AVLKLCDFGSA 204

Query: 198 -EAQNLQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
            +    +   +  CS  YRAPEL F    Y       DVWS GC+L
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDY---TSSIDVWSAGCVL 247

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.5 bits (207), Expect = 9e-19
 Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 52/242 (21%)

Query: 21  VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREV---EHH 77
            +   D Y +V K+G G +S V    +    ++  +K +       + +  RE+   E+ 
Sbjct: 31  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENL 87

Query: 78  KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS--S 135
           +    PNI+ L D         V +  S+   ++  +   T   D       K      +
Sbjct: 88  RG--GPNIITLAD--------IVKDPVSRTPALVFEHVNNT---DF------KQLYQTLT 128

Query: 136 VDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
              ++ ++  I +A+   H    +   HRD+K  NV++ +++  L            ++ 
Sbjct: 129 DYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKL------------RLI 173

Query: 195 --GSAEAQNLQDVAAER-CSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKS 249
             G AE  +       R  S  ++ PEL  VD   Y   D   D+WSLGC+L +M + K 
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMY---DYSLDMWSLGCMLASMIFRKE 229

Query: 250 PF 251
           PF
Sbjct: 230 PF 231

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 83.4 bits (206), Expect = 1e-18
 Identities = 52/249 (20%), Positives = 95/249 (38%), Gaps = 44/249 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-----ALKKIICHGREDQAQAIREVEHHKTFV--H 82
           ++E IG G +  V        K        A+K        ++   I E   ++  +  H
Sbjct: 17  LLELIGRGRYGAVY-------KGSLDERPVAVKVFS---FANRQNFINEKNIYRVPLMEH 66

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI   +     G      +   + L+V+ YYP G+L   L       H    V   ++ 
Sbjct: 67  DNIARFI----VGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117

Query: 143 LKICEAVKVFHDAKPI------AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
             +   +   H   P       A +HRDL + NVL+ ND   ++ D G    ++      
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL---SMRLTGNR 174

Query: 197 AEAQNLQDVA--AERCSMPYRAPEL----FHVDSYCVVDQRTDVWSLGCLLYAM---CYF 247
                 +D A  +E  ++ Y APE+     ++       ++ D+++LG + + +   C  
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 248 KSPFDTVYE 256
             P ++V E
Sbjct: 235 LFPGESVPE 243

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 83.1 bits (206), Expect = 2e-18
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 39/230 (16%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           +   Y   + IG G F  V   +  ++ +  A+KK+     +D+    RE++  +   HP
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRFKNRELQIMRIVKHP 92

Query: 84  NILPLLD---HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           N++ L            +  LN      +VL Y P+ T+       +  K  M  + I K
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLN------LVLEYVPE-TVYRASRHYAKLKQTMPMLLI-K 144

Query: 141 MFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
           +++ ++  ++   H        HRD+K  N LL +  +            V+K+   GSA
Sbjct: 145 LYMYQLLRSLAYIHSIG---ICHRDIKPQN-LLLDPPS-----------GVLKLIDFGSA 189

Query: 198 EAQN-LQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLLYAMC 245
           +     +   +  CS  YRAPEL F   +Y       D+WS GC++  + 
Sbjct: 190 KILIAGEPNVSYICSRYYRAPELIFGATNY---TTNIDIWSTGCVMAELM 236

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 36/235 (15%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE- 75
           + E    + D++ +    G+G F TV L +   T    A+KK+     +D     RE++ 
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQI 69

Query: 76  --HHKTFVHPNILPLLDHALTGCADPVLNSTSQV--LMVLPYYPKGTLANDLELRSVGKH 131
                   HPNI+ L  +  T            +   +V+ Y P  TL          + 
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYT----LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124

Query: 132 YMSSVDILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
               + I K+FL ++  ++   H    +   HRD+K  NVL+    N     L       
Sbjct: 125 APPPILI-KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLV----NEADGTL------- 171

Query: 191 VKVC--GSA-EAQNLQDVAAERCSMPYRAPEL-FHVDSYCVVDQRTDVWSLGCLL 241
            K+C  GSA +    +   A  CS  YRAPEL F    Y       D+WS+GC+ 
Sbjct: 172 -KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY---TTAVDIWSVGCIF 222

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 59/240 (24%), Positives = 92/240 (38%), Gaps = 57/240 (23%)

Query: 26  DKYYIVEKIGEGGFSTVSL-IEHSQTKKRYALKKIICHGRED--QAQAIREV---EHHKT 79
            +Y  V +IGEG +  V    +     +  ALK++     E+      IREV    H +T
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMSSVD 137
           F HPN++ L D     C     +  +++ +V  +     +  DL   L  V +  + +  
Sbjct: 71  FEHPNVVRLFDV----CTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTET 121

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           I  M  ++   +   H  + +   HRDLK  N+L+ +     L D G             
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVV---HRDLKPQNILVTSSGQIKLADFG------------- 165

Query: 198 EAQNLQDVAAERCSMP-----------YRAPELFHVDSY-CVVDQRTDVWSLGCLLYAMC 245
               L    A   S             YRAPE+    SY   V    D+WS+GC+   M 
Sbjct: 166 ----L----ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMF 213

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 3e-18
 Identities = 59/242 (24%), Positives = 90/242 (37%), Gaps = 69/242 (28%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ------AIREVEHHKT 79
           +KY  +  +GEG +  V    +  T +  A+KK      E          A+RE++  K 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQ 80

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             H N++ LL+         V     +  +V  +    T+ +DLEL   G   +    + 
Sbjct: 81  LRHENLVNLLE---------VCKKKKRWYLVFEFVDH-TILDDLELFPNG---LDYQVVQ 127

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
           K   +I   +   H    I   HRD+K  N+L++                VVK+C  G A
Sbjct: 128 KYLFQIINGIGFCHSHNII---HRDIKPENILVSQSG-------------VVKLCDFGFA 171

Query: 198 EAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLGCLLYA 243
                        + P            YRAPE L     Y   V    DVW++GCL+  
Sbjct: 172 RT----------LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAV----DVWAIGCLVTE 217

Query: 244 MC 245
           M 
Sbjct: 218 MF 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 7e-18
 Identities = 55/249 (22%), Positives = 88/249 (35%), Gaps = 83/249 (33%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ------AIREVEHHKT 79
           +KY  + KIGEG +  V    +  T +  A+KK      E +        A+RE+   K 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQ 58

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV--- 136
             HPN++ LL+         V     ++ +V  Y       + +       H +      
Sbjct: 59  LKHPNLVNLLE---------VFRRKRRLHLVFEY-----CDHTV------LHELDRYQRG 98

Query: 137 ---DILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
               ++K       +AV   H    I   HRD+K  N+L+   +             V+K
Sbjct: 99  VPEHLVKSITWQTLQAVNFCHKHNCI---HRDVKPENILITKHS-------------VIK 142

Query: 193 VC--GSAEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWS 236
           +C  G A             + P            YR+PE L     Y   V    DVW+
Sbjct: 143 LCDFGFARL----------LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV----DVWA 188

Query: 237 LGCLLYAMC 245
           +GC+   + 
Sbjct: 189 IGCVFAELL 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 71/247 (28%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-----AQAIREVEHHK 78
            S ++  +EK+G G ++TV    +  T    ALK++    + D      + AIRE+   K
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMK 58

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKHYMS-- 134
              H NI+ L D         V+++ +++ +V  +     + NDL+  + S         
Sbjct: 59  ELKHENIVRLYD---------VIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRG 104

Query: 135 -SVDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK 192
             ++++K F   + + +   H+ K +   HRDLK  N+L+       L D G        
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKIL---HRDLKPQNLLINKRGQLKLGDFG-------- 153

Query: 193 VCGSAEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLG 238
                    L    A    +P            YRAP+ L    +Y   +    D+WS G
Sbjct: 154 ---------L----ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI----DIWSCG 196

Query: 239 CLLYAMC 245
           C+L  M 
Sbjct: 197 CILAEMI 203

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 80.1 bits (198), Expect = 1e-17
 Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 26/260 (10%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
             E +G+G F     + H +T +   +K++I    E Q   ++EV+  +   HPN+L  +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                G    VL    ++  +  Y   GTL   + ++S+          +     I   +
Sbjct: 74  -----G----VLYKDKRLNFITEYIKGGTLR-GI-IKSMDSQ-YPWSQRVSFAKDIASGM 121

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
              H        HRDL + N L+  + N ++ D G +A  +V      E          +
Sbjct: 122 AYLHSMN---IIHRDLNSHNCLVRENKNVVVADFG-LARLMVDEKTQPEGLRSLKKPDRK 177

Query: 210 CSMPYR------APELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
                       APE+ +  SY   D++ DV+S G +L  +    +       R     L
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSY---DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234

Query: 264 AVISG-NITFPENTPFPQYQ 282
            V    +   P N P   + 
Sbjct: 235 NVRGFLDRYCPPNCPPSFFP 254

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 37/218 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
             KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+  LD  L G          ++ +V+ Y   G+L  D+    V +  M    I  +  +
Sbjct: 79  IVNYLDSYLVG---------DELWVVMEYLAGGSLT-DV----VTETCMDEGQIAAVCRE 124

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             +A++  H  + I   HRD+K+ N+LL  D +  L D G         C    AQ +  
Sbjct: 125 CLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG--------FC----AQ-ITP 168

Query: 205 VAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
             ++R +M   PY  APE+    +Y     + D+WSLG
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLG 203

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 37/218 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
                   KIGEG    V L     + ++ A+K +    ++ +     EV   + + H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++ +    L G          ++ +++ +   G L  D+    V +  ++   I  +   
Sbjct: 104 VVEMYKSYLVG---------EELWVLMEFLQGGALT-DI----VSQVRLNEEQIATVCEA 149

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + +A+   H    I   HRD+K+ ++LL  D    L D G         C    AQ +  
Sbjct: 150 VLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFG--------FC----AQ-ISK 193

Query: 205 VAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
              +R S+   PY  APE+     Y       D+WSLG
Sbjct: 194 DVPKRKSLVGTPYWMAPEVISRSLY---ATEVDIWSLG 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 3e-17
 Identities = 47/231 (20%), Positives = 94/231 (40%), Gaps = 39/231 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
             +Y  ++ +G GG   V     +   KR A+KKI+    +    A+RE++  +   H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 85  ILPLLD-----HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           I+ + +      +        L   + V +V  Y        + +L +V +      +  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-------ETDLANVLEQGPLLEEHA 122

Query: 140 KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           ++F+ ++   +K  H A  +   HRDLK AN+ + N  + +L           K+     
Sbjct: 123 RLFMYQLLRGLKYIHSANVL---HRDLKPANLFI-NTEDLVL-----------KIGDFGL 167

Query: 199 AQNLQDVAAERCSMP-------YRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
           A+ +    + +  +        YR+P  L   ++Y    +  D+W+ GC+ 
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY---TKAIDMWAAGCIF 215

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 4e-17
 Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 72/243 (29%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHP 83
           +KY+ +EKIGEG +  V   +++   + +ALKKI     ++   +  IRE+   K   H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV------D 137
           NI+ L D         V+++  ++++V  +     L  DL      K  +          
Sbjct: 61  NIVKLYD---------VIHTKKRLVLVFEH-----LDQDL------KKLLDVCEGGLESV 100

Query: 138 ILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
             K FL  +   +   HD + +   HRDLK  N+L+  +    + D G            
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVL---HRDLKPQNLLINREGELKIADFG------------ 145

Query: 197 AEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQRTDVWSLGCLLY 242
                L    A    +P            YRAP+ L     Y   +    D+WS+GC+  
Sbjct: 146 -----L----ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI----DIWSVGCIFA 192

Query: 243 AMC 245
            M 
Sbjct: 193 EMV 195

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 78.0 bits (193), Expect = 4e-17
 Identities = 42/262 (16%), Positives = 81/262 (30%), Gaps = 52/262 (19%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-----ALKKIICHGREDQAQAI----REVEHHKTF 80
            + K+ E     +        K R+      +K +    R+   +       E    + F
Sbjct: 14  FLTKLNENHSGELW-------KGRWQGNDIVVKVL--KVRDWSTRKSRDFNEECPRLRIF 64

Query: 81  VHPNILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
            HPN+LP+L     G C  P         ++  + P G+L N L         +     +
Sbjct: 65  SHPNVLPVL-----GACQSPPAP---HPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAV 114

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
           K  L +   +   H  +P+      L + +V++  D                ++      
Sbjct: 115 KFALDMARGMAFLHTLEPLIP-RHALNSRSVMIDEDM-------------TARISMADVK 160

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
            +           +  + APE           +  D+WS   LL+ +   + PF  +   
Sbjct: 161 FSFQSP---GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--S 215

Query: 258 GDSVALAVISGNI--TFPENTP 277
              + + V    +  T P    
Sbjct: 216 NMEIGMKVALEGLRPTIPPGIS 237

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 4e-17
 Identities = 63/254 (24%), Positives = 100/254 (39%), Gaps = 74/254 (29%)

Query: 17  SKEAVYVKS--DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIR 72
            +E +Y +   +KY  +EK+GEG +  V   + S   +  ALK+I     ++   + AIR
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR 68

Query: 73  EVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHY 132
           E+   K   HPNI+ L+D         V++S   + +V  +     +  DL      K  
Sbjct: 69  EISLLKELHHPNIVSLID---------VIHSERCLTLVFEF-----MEKDL------KKV 108

Query: 133 MSSVDI------LKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS 185
           +           +K++L  +   V   H  + +   HRDLK  N+L+ +D    L D G 
Sbjct: 109 LDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL---HRDLKPQNLLINSDGALKLADFG- 164

Query: 186 VAPAVVKVCGSAEAQNLQDVAAERCSMP------------YRAPE-LFHVDSY-CVVDQR 231
                           L    A    +P            YRAP+ L     Y   V   
Sbjct: 165 ----------------L----ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV--- 201

Query: 232 TDVWSLGCLLYAMC 245
            D+WS+GC+   M 
Sbjct: 202 -DIWSIGCIFAEMI 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 78.1 bits (193), Expect = 6e-17
 Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 35/240 (14%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA-QA--IREVEHHKTFVHPN 84
           Y +   +G GG   V   E +  ++  ALK +      D   +    RE         P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++P+ D    G  D  L       + +       LA    LR  G   ++    + +  +
Sbjct: 96  VVPIHD---FGEIDGQL------YVDMRLINGVDLAA--MLRRQGP--LAPPRAVAIVRQ 142

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A+   H A      HRD+K  N+L++ D+   L+D G +A A          + L  
Sbjct: 143 IGSALDAAHAAGAT---HRDVKPENILVSADDFAYLVDFG-IASAT-------TDEKLTQ 191

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALA 264
           +     ++ Y APE F          R D+++L C+LY       P+      GD +++ 
Sbjct: 192 LGNTVGTLYYMAPERFSESH---ATYRADIYALTCVLYECLTGSPPYQ-----GDQLSVM 243

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 78.3 bits (193), Expect = 7e-17
 Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQAQAIREVEHHKTFV--HPNIL 86
           + E IG+G F  V      + +    A+K        ++    RE E ++T +  H NIL
Sbjct: 46  LQESIGKGRFGEVW---RGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL 99

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             +        +    + +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L   
Sbjct: 100 GFI-----AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTA 149

Query: 147 EAV------KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
             +       V    KP A AHRDLK+ N+L+  +    + DLG    AV     +    
Sbjct: 150 SGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGL---AVRHDSATDTID 205

Query: 201 NLQDVAAERCSMPYRAPELFH---VDSYCVVDQRTDVWSLGCLLYAMC 245
              +      +  Y APE+        +    +R D++++G + + + 
Sbjct: 206 IAPN--HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 49/227 (21%), Positives = 94/227 (41%), Gaps = 32/227 (14%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQAQAIREVEHHKTFV--HPNIL 86
           ++E +G+G +  V        +    A+K        D+    RE E + T +  H NIL
Sbjct: 12  LLECVGKGRYGEVW---RGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENIL 65

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             +            +S++Q+ ++  Y+  G+L + L+        + +V  L++ L I 
Sbjct: 66  GFI-----ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIA 115

Query: 147 EAV-----KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +     ++F      A AHRDLK+ N+L+  +    + DLG    AV+    + +   
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDV 172

Query: 202 LQDVAAERCSMPYRAPELFH---VDSYCVVDQRTDVWSLGCLLYAMC 245
             +      +  Y APE+             +R D+W+ G +L+ + 
Sbjct: 173 GNN--PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 46/237 (19%), Positives = 90/237 (37%), Gaps = 31/237 (13%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           ++E    G F  V   +        A+K      ++   Q   EV       H NIL  +
Sbjct: 28  LLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFI 84

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC--- 146
                G      +    + ++  ++ KG+L++ L+      + +S  ++  +   +    
Sbjct: 85  -----GAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGL 134

Query: 147 -----EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                +   +    KP A +HRD+K+ NVLL N+    + D G    A+    G +    
Sbjct: 135 AYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGL---ALKFEAGKSAGDT 190

Query: 202 LQDVAAERCSMPYRAPELF--HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
              V   R    Y APE+    ++       R D++++G +L+ +    +  D   +
Sbjct: 191 HGQVGTRR----YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 75.0 bits (185), Expect = 6e-16
 Identities = 55/262 (20%), Positives = 93/262 (35%), Gaps = 48/262 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQA-IREVEHHKTFVHPNILP 87
           + ++IG G F TV      +     A+K +        Q QA   EV   +   H NIL 
Sbjct: 28  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 88  LLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
            +     G    P L       +V  +    +L + L      +       ++ +  +  
Sbjct: 85  FM-----GYSTAPQL------AIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTA 130

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--G----SAEAQ 200
             +   H AK I   HRDLK+ N+ L  DN              VK+   G     +   
Sbjct: 131 RGMDYLH-AKSII--HRDLKSNNIFLHEDN-------------TVKIGDFGLATEKSRWS 174

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
                     S+ + APE+  +        ++DV++ G +LY +   + P+  +  R D 
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQ 233

Query: 261 VALAVISGNI-----TFPENTP 277
           +   V  G++         N P
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCP 255

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 75.5 bits (186), Expect = 7e-16
 Identities = 47/227 (20%), Positives = 91/227 (40%), Gaps = 32/227 (14%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGREDQAQAIREVEHHKTFV--HPNIL 86
           +V++IG+G +  V      + +    A+K        ++A   RE E ++T +  H NIL
Sbjct: 41  MVKQIGKGRYGEVW---MGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENIL 94

Query: 87  PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
             +             S +Q+ ++  Y+  G+L + L+        + +  +LK+     
Sbjct: 95  GFI-----AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSV 144

Query: 147 EAVKVFHDAKPI-----AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +   H          A AHRDLK+ N+L+  +    + DLG    AV  +  + E   
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL---AVKFISDTNEVDI 201

Query: 202 LQDVAAERCSMPYRAPELF---HVDSYCVVDQRTDVWSLGCLLYAMC 245
             +      +  Y  PE+       ++       D++S G +L+ + 
Sbjct: 202 PPN--TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 7e-16
 Identities = 54/245 (22%), Positives = 88/245 (35%), Gaps = 50/245 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
            D+Y I   IG G +  V        K+  A+KKI  +     D  + +RE+       H
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL--- 139
            +++ +LD  +       +    ++ +VL         +D       K    +   L   
Sbjct: 112 DHVVKVLDIVIP----KDVEKFDELYVVLEI-----ADSDF------KKLFRTPVYLTEL 156

Query: 140 --KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG---SVAPAVVK 192
             K  L  +   VK  H A  +   HRDLK AN L+ N +  + + D G   +V      
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGIL---HRDLKPANCLV-NQDCSVKVCDFGLARTVDYPENG 212

Query: 193 VCGSAEAQNLQDVAAERCSMP---------------YRAPE-LFHVDSYCVVDQRTDVWS 236
                 +    D+                       YRAPE +   ++Y    +  DVWS
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY---TEAIDVWS 269

Query: 237 LGCLL 241
           +GC+ 
Sbjct: 270 IGCIF 274

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.0 bits (187), Expect = 8e-16
 Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 40/225 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
             +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+   K   H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+ LL+          L     V +V+          D  L  V +  +    +  + 
Sbjct: 121 KNIISLLN---VFTPQKTLEEFQDVYLVMELM-------DANLCQVIQMELDHERMSYLL 170

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC------GS 196
            ++   +K  H A  I   HRDLK +N+++   +  L            K+        +
Sbjct: 171 YQMLCGIKHLHSAGII---HRDLKPSNIVV-KSDCTL------------KILDFGLARTA 214

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
             +  +      R    YRAPE+     Y    +  D+WS+GC++
Sbjct: 215 GTSFMMTPYVVTR---YYRAPEVILGMGY---KENVDIWSVGCIM 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 47/219 (21%), Positives = 93/219 (42%), Gaps = 39/219 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-REVEHHKTFVHP 83
            + + ++EK+GEG + +V    H +T +  A+K++     E   Q I +E+   +    P
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSP 84

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +++                  + + +V+ Y   G++    ++  +    ++  +I  +  
Sbjct: 85  HVVKYYGSYFKN---------TDLWIVMEYCGAGSV---SDIIRLRNKTLTEDEIATILQ 132

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
              + ++  H  + I   HRD+K  N+LL  + +  L D G        V G      L 
Sbjct: 133 STLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFG--------VAGQ-----LT 176

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
           D  A+R ++   P+  APE+     Y   +   D+WSLG
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGY---NCVADIWSLG 212

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.9 bits (182), Expect = 2e-15
 Identities = 50/240 (20%), Positives = 93/240 (38%), Gaps = 39/240 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHP 83
            D Y + E IG G  + V     +  K++ A+K+I +   +    + ++E++      HP
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVD----- 137
           NI+      +            ++ +V+     G++ + +  + + G+H    +D     
Sbjct: 74  NIVSYYTSFVVK---------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124

Query: 138 -ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            IL+  L+    ++  H    I   HRD+K  N+LL  D +  + D G        V   
Sbjct: 125 TILREVLE---GLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG--------VSAF 170

Query: 197 AEAQNLQDVAAERCSM---PYR-APELFH-VDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                       R +    P   APE+   V  Y   D + D+WS G     +    +P+
Sbjct: 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY---DFKADIWSFGITAIELATGAAPY 227

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 45/238 (18%), Positives = 88/238 (36%), Gaps = 37/238 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRY-ALKKIICHGRED-QAQAIREVEHHKTFVH 82
           + +Y +   I  GG   + L        R   LK ++  G  + QA A+ E +     VH
Sbjct: 79  AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P+I+ + +           +      +V+ Y    +L      +      +   + +   
Sbjct: 139 PSIVQIFNFV----EHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYL 188

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP--AVVKVCGSAEAQ 200
           L+I  A+   H    +   + DLK  N++L  +    L+DLG+V+   +   + G+    
Sbjct: 189 LEILPALSYLHSIGLV---YNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLYGTPG-- 242

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                        ++APE+            TD++++G  L A+       +  Y  G
Sbjct: 243 -------------FQAPEIVRTG----PTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 74.0 bits (182), Expect = 2e-15
 Identities = 44/218 (20%), Positives = 78/218 (35%), Gaps = 37/218 (16%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH 91
            ++G G F  V  ++  QT  + A+KK+       +   + E+        P I+PL   
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPLYGA 118

Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKV 151
              G           V + +     G+L   L ++ +G   +     L    +  E ++ 
Sbjct: 119 VREG---------PWVNIFMELLEGGSLG-QL-IKQMGC--LPEDRALYYLGQALEGLEY 165

Query: 152 FHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQDVAAERC 210
            H  + +   H D+K  NVLL++D +   L D G             +   L        
Sbjct: 166 LHTRRIL---HGDVKADNVLLSSDGSRAALCDFG--------HALCLQPDGLGKSLLTGD 214

Query: 211 SM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAM 244
            +       APE+         D + D+WS  C++  M
Sbjct: 215 YIPGTETHMAPEVVMGKPC---DAKVDIWSSCCMMLHM 249

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 38/232 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAI-REVEHHKTFVHP 83
            + +  +EKIG+G F  V     ++T+K  A+K I     ED+ + I +E+        P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
            +       L           +++ +++ Y   G+  + LE   + +  +++  IL+  L
Sbjct: 81  YVTKYYGSYLKD---------TKLWIIMEYLGGGSALDLLEPGPLDETQIAT--ILREIL 129

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           K    +   H  K I   HRD+K ANVLL+      L D G        V G      L 
Sbjct: 130 K---GLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFG--------VAGQ-----LT 170

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           D   +R +    P+  APE+    +Y   D + D+WSLG     +   + P 
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGEPPH 219

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 64/242 (26%), Positives = 96/242 (39%), Gaps = 47/242 (19%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVE 75
            K  VY  S  + +   +GEG +  V    H  T +  A+KKI    +   A   +RE++
Sbjct: 2   PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK 61

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K F H NI+ + +            + ++V ++             +L  V    M S
Sbjct: 62  ILKHFKHENIITIFNIQR----PDSFENFNEVYIIQELM-------QTDLHRVISTQMLS 110

Query: 136 VDILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
            D ++ F+ +   AVKV H +  I   HRDLK +N LL N N  L            KVC
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVI---HRDLKPSN-LLINSNCDL------------KVC 154

Query: 195 -------GSAEAQNLQDVAAERCSMP-------YRAPE-LFHVDSYCVVDQRTDVWSLGC 239
                      A +  +   ++  M        YRAPE +     Y    +  DVWS GC
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY---SRAMDVWSCGC 211

Query: 240 LL 241
           +L
Sbjct: 212 IL 213

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 45/240 (18%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-------- 75
           K  +Y +V K+G G FSTV L +        A+K I+   +     A  E++        
Sbjct: 17  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDA 75

Query: 76  ---HHKTFVHPNILPLLDH-ALTGCADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGK 130
                 +    +IL LLDH    G       +   V+MV        L  +L  L    +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKG------PNGVHVVMVFE-----VLGENLLALIKKYE 124

Query: 131 HYMSSVDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
           H    +  +K   K +   +   H    I   H D+K  NVL+   ++P           
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSP-------ENLI 175

Query: 190 VVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
            +K+   G+A    ++  +    R    YR+PE+     +       D+WS  CL++ + 
Sbjct: 176 QIKIADLGNACWYDEHYTNSIQTR---EYRSPEVLLGAPW---GCGADIWSTACLIFELI 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 36/223 (16%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
             +Y  ++ IG G    V     +  ++  A+KK+      +    +A RE+   K   H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            NI+ LL+          L     V +V+          D  L  V +  +   + +   
Sbjct: 84  KNIIGLLN---VFTPQKSLEEFQDVYIVMELM-------DANLCQVIQMELDH-ERMSYL 132

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEA 199
           L ++   +K  H A  I   HRDLK +N+++ +D               +K+   G A  
Sbjct: 133 LYQMLCGIKHLHSAGII---HRDLKPSNIVVKSD-------------CTLKILDFGLART 176

Query: 200 QNLQDVAAE-RCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
                +      +  YRAPE+     Y    +  D+WS+GC++
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIM 216

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 5e-15
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 40/225 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
              Y  ++ +G G +  V      +T  + A+KK+           +A RE+   K   H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            N++ LLD   T   D  L+  +   +V+P+          +L  + KH     D ++  
Sbjct: 84  ENVIGLLD-VFT--PDETLDDFTDFYLVMPFM-------GTDLGKLMKHEKLGEDRIQFL 133

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA-- 197
           + ++ + ++  H A  I   HRDLK  N L  N++  L            K+   G A  
Sbjct: 134 VYQMLKGLRYIHAAGII---HRDLKPGN-LAVNEDCEL------------KILDFGLARQ 177

Query: 198 EAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
               +      R    YRAPE + +   Y    Q  D+WS+GC++
Sbjct: 178 ADSEMTGYVVTR---WYRAPEVILNWMRY---TQTVDIWSVGCIM 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 51/258 (19%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH-- 91
           +G GGF  V   +   T K YA KK+     + + +  +  +     V   IL  +    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKL----NKKRLKKRKGYQG--AMVEKKILAKVHSRF 246

Query: 92  --ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK----- 144
             +L         + + + +V+     G      ++R    H  +  +    F +     
Sbjct: 247 IVSLAYA----FETKTDLCLVMTIMNGG------DIRY---HIYNVDEDNPGFQEPRAIF 293

Query: 145 ----ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
               I   ++  H  + I Y  RDLK  NVLL +D N  + DLG           + E +
Sbjct: 294 YTAQIVSGLEHLHQ-RNIIY--RDLKPENVLLDDDGNVRISDLGL----------AVELK 340

Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
             Q         P + APEL   + Y   D   D ++LG  LY M   + PF    E+ +
Sbjct: 341 AGQTKTKGYAGTPGFMAPELLLGEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

Query: 260 SVAL--AVISGNITFPEN 275
           +  L   V+   +T+P+ 
Sbjct: 398 NKELKQRVLEQAVTYPDK 415

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 72.3 bits (178), Expect = 7e-15
 Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 52/252 (20%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFV 81
           +++Y IV+K+G GG STV L E +    + A+K I    RE +       REV +     
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           H NI+ ++D       D          +V+ Y    TL ++  + S G   +S    +  
Sbjct: 70  HQNIVSMID---VDEEDDC------YYLVMEYIEGPTL-SEY-IESHGP--LSVDTAINF 116

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV--------KV 193
             +I + +K  HD + +   HRD+K  N+L+ ++    + D G +A A+          V
Sbjct: 117 TNQILDGIKHAHDMRIV---HRDIKPQNILIDSNKTLKIFDFG-IAKALSETSLTQTNHV 172

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
            G+ +               Y +PE    ++    D+ TD++S+G +LY M   + PF+ 
Sbjct: 173 LGTVQ---------------YFSPEQAKGEA---TDECTDIYSIGIVLYEMLVGEPPFN- 213

Query: 254 VYERGDS-VALA 264
               G++ V++A
Sbjct: 214 ----GETAVSIA 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.3 bits (178), Expect = 9e-15
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 28/221 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-AIREVEHHKTFVHP 83
             +Y  +  IGEG +  V     +  K R A+KKI     +   Q  +RE++    F H 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ + D  +     P +     V +V           + +L  + K    S D +  FL
Sbjct: 86  NIIGIND-IIR---APTIEQMKDVYIVQDLM-------ETDLYKLLKTQHLSNDHICYFL 134

Query: 144 -KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQN 201
            +I   +K  H A  +   HRDLK +N LL N    L + D G    A V          
Sbjct: 135 YQILRGLKYIHSANVL---HRDLKPSN-LLLNTTCDLKICDFGL---ARVADPDHDHTGF 187

Query: 202 LQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
           L +  A R    YRAPE + +   Y    +  D+WS+GC+L
Sbjct: 188 LTEYVATR---WYRAPEIMLNSKGY---TKSIDIWSVGCIL 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 9e-15
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 41/225 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
              Y     +G G + +V      ++ ++ A+KK+           +A RE+   K   H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            N++ LLD          L +     +V+P+          +L+ +     S  + ++  
Sbjct: 83  ENVIGLLDVFT---PASSLRNFYDFYLVMPFM-------QTDLQKIMGLKFSE-EKIQYL 131

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA-- 197
           + ++ + +K  H A  +   HRDLK  N L  N++  L            K+   G A  
Sbjct: 132 VYQMLKGLKYIHSAGVV---HRDLKPGN-LAVNEDCEL------------KILDFGLARH 175

Query: 198 EAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
               +      R    YRAPE +     Y   +Q  D+WS+GC++
Sbjct: 176 ADAEMTGYVVTR---WYRAPEVILSWMHY---NQTVDIWSVGCIM 214

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 71.6 bits (176), Expect = 1e-14
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           ++ + IV ++G+G F  V   ++ +T    A K I     E+    I E+E   T  HP 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL                ++ +++ + P G +   +         ++   I  +  +
Sbjct: 78  IVKLLGAYYHD---------GKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQ 125

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           + EA+   H  + I   HRDLK  NVL+  + +  L D G        V     A+    
Sbjct: 126 MLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFG--------VS----AK-NLK 169

Query: 205 VAAERCSM---PY-RAPELFHVDSYCVV--DQRTDVWSLG 238
              +R S    PY  APE+   ++      D + D+WSLG
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 32/225 (14%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLL 89
            +IG G F TV     ++T    A  ++      + ++ +   E E  K   HPNI+   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-ICEA 148
           D   +            +++V      GTL   L+     +  +  + +L+ + + I + 
Sbjct: 92  DSWESTVKGK-----KCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKG 141

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQDVA 206
           ++  H   P    HRDLK  N+ +                  VK+   G A  +      
Sbjct: 142 LQFLHTRTP-PIIHRDLKCDNIFITGPTG------------SVKIGDLGLATLKRASFAK 188

Query: 207 AERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
           A   +  + APE++  + Y   D+  DV++ G  +  M   + P+
Sbjct: 189 AVIGTPEFMAPEMYE-EKY---DESVDVYAFGMCMLEMATSEYPY 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 54/236 (22%), Positives = 90/236 (38%), Gaps = 41/236 (17%)

Query: 26  DKY-YIVEKIGEGGFSTV--SLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           D + Y   K+G G +  V  +  +  +  K YALK+I   G    A   RE+   +   H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKH 77

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYP---KGTLANDLELRSVGKHYMSSVDIL 139
           PN++ L        AD  +       ++  Y        +      ++  K       ++
Sbjct: 78  PNVISLQK-VFLSHADRKVW------LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 140 KMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GS 196
           K  L  I + +   H    +   HRDLK AN+L+  +      + G      VK+   G 
Sbjct: 131 KSLLYQILDGIHYLHANWVL---HRDLKPANILVMGEGP----ERG-----RVKIADMGF 178

Query: 197 AEA-----QNLQDVAAERCSMPYRAPE-LFHVDSY-CVVDQRTDVWSLGCLLYAMC 245
           A       + L D+     +  YRAPE L     Y   +D    +W++GC+   + 
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID----IWAIGCIFAELL 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 40/225 (17%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
            ++Y  +  +G G + +V     ++T  R A+KK+           +  RE+   K   H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            N++ LLD   T      L   + V +V             +L ++ K    + D ++  
Sbjct: 88  ENVIGLLD-VFT--PARSLEEFNDVYLVTHLM-------GADLNNIVKCQKLTDDHVQFL 137

Query: 143 L-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA-- 197
           + +I   +K  H A  I   HRDLK +N+ + N++  L            K+   G A  
Sbjct: 138 IYQILRGLKYIHSADII---HRDLKPSNLAV-NEDCEL------------KILDFGLARH 181

Query: 198 EAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
            A  +    A R    YRAPE + +   Y   +Q  D+WS+GC++
Sbjct: 182 TADEMTGYVATR---WYRAPEIMLNWMHY---NQTVDIWSVGCIM 220

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 70.6 bits (173), Expect = 3e-14
 Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 37/244 (15%)

Query: 13  GCLCSKEAVY-VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQA 70
             L  K+ V  +K D +  + ++G G    V  + H  +    A K I +      + Q 
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78

Query: 71  IREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGK 130
           IRE++       P I         G      +   ++ + + +   G+L  D  L+  G+
Sbjct: 79  IRELQVLHECNSPYI--------VGFYGAFYSD-GEISICMEHMDGGSL--DQVLKKAGR 127

Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
             +    + K+ + + + +    +   I   HRD+K +N+L+ +     L D G      
Sbjct: 128 --IPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG------ 177

Query: 191 VKVCGSAEAQNLQDVAAER---CSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF 247
             V G      L D  A         Y +PE      Y     ++D+WS+G  L  M   
Sbjct: 178 --VSG-----QLIDSMANSFVGTR-SYMSPERLQGTHY---SVQSDIWSMGLSLVEMAVG 226

Query: 248 KSPF 251
           + P 
Sbjct: 227 RYPI 230

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 6e-14
 Identities = 32/250 (12%), Positives = 68/250 (27%), Gaps = 61/250 (24%)

Query: 28  YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVHPN 84
           Y ++   G            +   ++ AL  +   G        + +           P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +  +LD         V+++ +  L+V  +   G+L    +         S V  ++    
Sbjct: 93  VARVLD---------VVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQS 137

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +  A    H A            + V ++ D + +L    ++  A               
Sbjct: 138 LAAAADAAHRAGVA---LSIDHPSRVRVSIDGDVVLAYPATMPDA--------------- 179

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD-TVYERGDSVAL 263
                                   + + D+  +G  LYA+   + P        G + A 
Sbjct: 180 ------------------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215

Query: 264 AVISGNITFP 273
              +G    P
Sbjct: 216 RDTAGQPIEP 225

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 37/236 (15%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTFVH 82
            D Y I   IG G +  V L     T+K  A+KK+  +     D  + +RE+        
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMS-SVDILKM 141
             I+ L D          L    ++ +VL          D +L+ + K  +  + + +K 
Sbjct: 85  DYIIRLYDL----IIPDDLLKFDELYIVLEIA-------DSDLKKLFKTPIFLTEEHIKT 133

Query: 142 FL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG---SVAPAVVKVCGS 196
            L  +       H++  I   HRDLK AN LL N +  + + D G   ++         +
Sbjct: 134 ILYNLLLGENFIHESGII---HRDLKPANCLL-NQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 197 AEAQNLQDVAAERCSMP----------YRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
              +N +     +              YRAPE +   ++Y    +  D+WS GC+ 
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY---TKSIDIWSTGCIF 242

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 69.3 bits (170), Expect = 9e-14
 Identities = 51/258 (19%), Positives = 93/258 (36%), Gaps = 53/258 (20%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQA-IREVEHHKTFVHPNILP 87
           I E IG+G F  V    H +     A++ I      EDQ +A  REV  ++   H N++ 
Sbjct: 37  IGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 88  LLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
            +     G C  P       + ++       TL + +      K  +      ++  +I 
Sbjct: 94  FM-----GACMSP-----PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIV 140

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC---------GSA 197
           + +   H AK I   H+DLK+ NV   N                V +             
Sbjct: 141 KGMGYLH-AKGIL--HKDLKSKNVFYDNGK--------------VVITDFGLFSISGVLQ 183

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVV------DQRTDVWSLGCLLYAMCYFKSPF 251
             +    +  +   + + APE+    S           + +DV++LG + Y +   + PF
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

Query: 252 DTVYERGDSVALAVISGN 269
            T     +++   + +G 
Sbjct: 244 KTQ--PAEAIIWQMGTGM 259

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.8 bits (171), Expect = 9e-14
 Identities = 62/260 (23%), Positives = 96/260 (36%), Gaps = 62/260 (23%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           +G+G F  V L++   T + YA+K +    +++   A  EV H  T     +L    H  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAH--TLTENRVLQNSRHPF 209

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDILKM 141
           LT      L  + Q    +  V+ Y   G L   L       E R+  + Y +       
Sbjct: 210 LTA-----LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA--RFYGAE------ 256

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
              I  A+   H  K + Y  RDLK  N++L  D +  + D G             E   
Sbjct: 257 ---IVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFGL----------CKEGIK 301

Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----DTVY 255
                   C  P Y APE+   + Y    +  D W LG ++Y M   + PF     + ++
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

Query: 256 ERGDSVALAVISGNITFPEN 275
           E        ++   I FP  
Sbjct: 359 EL-------ILMEEIRFPRT 371

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 61/270 (22%), Positives = 100/270 (37%), Gaps = 81/270 (30%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALK-----KIICHGREDQAQAIREVEHHKTFVHPNILPL 88
           +GEG FSTV L     T + YA+K      II   +E++      V +       +++  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHII---KENK------VPY--VTRERDVMSR 86

Query: 89  LDH----ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-----LRSVGKHYMSSVDIL 139
           LDH     L            ++   L Y   G L   +        +  + Y +     
Sbjct: 87  LDHPFFVKLYFT----FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----- 137

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV------ 193
               +I  A++  H    I   HRDLK  N+LL  D +  + D G+ A  +         
Sbjct: 138 ----EIVSALEYLHGKGII---HRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARA 189

Query: 194 ---CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
               G+A+               Y +PEL    S C   + +D+W+LGC++Y +     P
Sbjct: 190 NSFVGTAQ---------------YVSPELLTEKSAC---KSSDLWALGCIIYQLVAGLPP 231

Query: 251 F-----DTVYERGDSVALAVISGNITFPEN 275
           F       ++++       +I     FPE 
Sbjct: 232 FRAGNEYLIFQK-------IIKLEYDFPEK 254

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 57/253 (22%), Positives = 93/253 (36%), Gaps = 44/253 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH-- 91
           +G+GGF  V   +   T K YA KK+     + + +  +            IL  ++   
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAM--ALNEKQILEKVNSRF 245

Query: 92  --ALTGCADPVLNSTSQVLMVLPYYPKGTLANDL--ELRSVGKHYMSSVDILKMFLKICE 147
             +L    +    +   + +VL     G    DL   +  +G+        +    +IC 
Sbjct: 246 VVSLAYAYE----TKDALCLVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICC 297

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ--DV 205
            ++  H  + I Y  RDLK  N+LL +  +  + DLG              A ++     
Sbjct: 298 GLEDLHR-ERIVY--RDLKPENILLDDHGHIRISDLGL-------------AVHVPEGQT 341

Query: 206 AAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT--VYERGDSVA 262
              R     Y APE+   + Y       D W+LGCLLY M   +SPF       + + V 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERY---TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

Query: 263 LAVISGNITFPEN 275
             V      + E 
Sbjct: 399 RLVKEVPEEYSER 411

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 54/258 (20%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           IG+G F  V +++ + TKK YA+K +     + +     EV +   F    I+  L+H  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYM----NKQKCVERNEVRN--VFKELQIMQGLEHPF 76

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRS-VGKHYMSSVDILKMFLKICE 147
           L       L  + Q    + MV+     G      +LR  + ++     + +K+F  ICE
Sbjct: 77  LVN-----LWYSFQDEEDMFMVVDLLLGG------DLRYHLQQNVHFKEETVKLF--ICE 123

Query: 148 ---AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK------VCGSAE 198
              A+    + + I   HRD+K  N+LL    +  + D   +A  + +      + G+  
Sbjct: 124 LVMALDYLQNQRII---HRDMKPDNILLDEHGHVHITDFN-IAAMLPRETQITTMAGT-- 177

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY-ER 257
                         PY APE+F            D WSLG   Y +   + P+       
Sbjct: 178 -------------KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

Query: 258 GDSVALAVISGNITFPEN 275
              +     +  +T+P  
Sbjct: 225 SKEIVHTFETTVVTYPSA 242

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 67.4 bits (165), Expect = 4e-13
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 29/221 (13%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HP 83
           +  + +VE +G G +  V    H +T +  A+K +   G +++ +  +E+   K +  H 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI       +            Q+ +V+ +   G++  DL +++   + +    I  +  
Sbjct: 82  NIATYYGAFIKKNPP---GMDDQLWLVMEFCGAGSVT-DL-IKNTKGNTLKEEWIAYICR 136

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +I   +   H  K I   HRD+K  NVLL  +    L+D G        V        L 
Sbjct: 137 EILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFG--------VSAQ-----LD 180

Query: 204 DVAAERCSM---PY-RAPELFHVDSYCVV--DQRTDVWSLG 238
                R +    PY  APE+   D       D ++D+WSLG
Sbjct: 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 67.6 bits (165), Expect = 4e-13
 Identities = 43/239 (17%), Positives = 92/239 (38%), Gaps = 37/239 (15%)

Query: 25  SDKYYIVEKIGEG--GFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAI-REVEHHKTF 80
              Y ++  IG+G     TV+L  +  T +   +++I +     +    +  E+   K F
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HPNI+P     +           +++ +V  +   G+   DL + +     M+ + I  
Sbjct: 84  NHPNIVPYRATFIAD---------NELWVVTSFMAYGSAK-DL-ICTHFMDGMNELAIAY 132

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS---- 196
           +   + +A+   H    +   HR +K +++L++ D    L  L            S    
Sbjct: 133 ILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLR--------SNLSMISH 181

Query: 197 -AEAQNLQDVAAERCSMPY-RAPELF--HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
               + + D       +    +PE+   ++  Y   D ++D++S+G     +     PF
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY---DAKSDIYSVGITACELANGHVPF 237

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 66.9 bits (164), Expect = 5e-13
 Identities = 52/233 (22%), Positives = 85/233 (36%), Gaps = 48/233 (20%)

Query: 32  EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDH 91
             +G+G +  V        + R A+K+I             E+  HK   H NI+  L  
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 92  ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK-ICEAVK 150
                          + + +   P G+L+  L LRS       +   +  + K I E +K
Sbjct: 88  FSEN---------GFIKIFMEQVPGGSLS-AL-LRSKWGPLKDNEQTIGFYTKQILEGLK 136

Query: 151 VFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNLQDVAAER 209
             HD + +   HRD+K  NVL+   +  L + D G+             ++ L  +    
Sbjct: 137 YLHDNQIV---HRDIKGDNVLINTYSGVLKISDFGT-------------SKRLAGINPCT 180

Query: 210 CSM---PY-RAPELFHVDSYCVVDQRT-------DVWSLGCLLYAMCYFKSPF 251
            +        APE        ++D+         D+WSLGC +  M   K PF
Sbjct: 181 ETFTGTLQYMAPE--------IIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 66.9 bits (164), Expect = 5e-13
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 30/244 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +      D +      RE ++     
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D   TG A+          +V+ Y    TL  D+ + + G   M+    +++
Sbjct: 71  HPAIVAVYD---TGEAETPAGPL--PYIVMEYVDGVTL-RDI-VHTEGP--MTPKRAIEV 121

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G +A A+     +    +
Sbjct: 122 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFG-IARAI-----ADSGNS 172

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS- 260
           +   AA   +  Y +PE    DS   VD R+DV+SLGC+LY +   + PF      GDS 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS---VDARSDVYSLGCVLYEVLTGEPPFT-----GDSP 224

Query: 261 VALA 264
           V++A
Sbjct: 225 VSVA 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.9 bits (164), Expect = 6e-13
 Identities = 48/238 (20%), Positives = 81/238 (34%), Gaps = 55/238 (23%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQ-----------AIRE 73
              Y +   I  G +  V     S      A+K++     + +              +RE
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE--LRSVGKH 131
           +     F HPNIL L D  +         +  ++ +V        +  DL   +    + 
Sbjct: 80  IRLLNHFHHPNILGLRDIFV----HFEEPAMHKLYLVTEL-----MRTDLAQVIHD--QR 128

Query: 132 YMSSVDILKMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
            + S   ++ F+  I   + V H+A  +   HRDL   N +L  DNN +           
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVV---HRDLHPGN-ILLADNNDI----------- 173

Query: 191 VKVC------GSAEAQNLQDVAAERCSMPYRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
             +C            N       R    YRAPE +     +    +  D+WS GC++
Sbjct: 174 -TICDFNLAREDTADANKTHYVTHR---WYRAPELVMQFKGF---TKLVDMWSAGCVM 224

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 43/237 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTF-V 81
             KY +V+K+G+G +  V      +T +  A+KKI        D  +  RE+        
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 82  HPNILPLLDHALTGCADPVLNSTS--QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           H NI+ LL+         VL + +   V +V  Y        + +L +V +  +      
Sbjct: 68  HENIVNLLN---------VLRADNDRDVYLVFDYM-------ETDLHAVIRANILEPVHK 111

Query: 140 KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLG-----SVAPAVVK 192
           +  + ++ + +K  H    +   HRD+K +N+LL N    + + D G          V  
Sbjct: 112 QYVVYQLIKVIKYLHSGGLL---HRDMKPSNILL-NAECHVKVADFGLSRSFVNIRRVTN 167

Query: 193 VCGSAEAQNLQDVAAERCSMP-------YRAPE-LFHVDSYCVVDQRTDVWSLGCLL 241
               +  +N ++   ++  +        YRAPE L     Y    +  D+WSLGC+L
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY---TKGIDMWSLGCIL 221

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 67.1 bits (164), Expect = 8e-13
 Identities = 49/229 (21%), Positives = 88/229 (38%), Gaps = 39/229 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +  K+G G +  V      +     A+K +      +  + ++E    K   HPN++ LL
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFLKICEA 148
                G    V        ++  +   G L   L+ LR   +  +S+V +L M  +I  A
Sbjct: 283 -----G----VCTREPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSA 330

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---V 205
           ++         + HR+L   N L+  ++             +VKV     ++ +      
Sbjct: 331 MEYLEKKN---FIHRNLAARNCLVGENH-------------LVKVADFGLSRLMTGDTYT 374

Query: 206 AAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLYAMC-YFKSPF 251
           A      P +  APE      Y     ++DVW+ G LL+ +  Y  SP+
Sbjct: 375 AHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 56/253 (22%), Positives = 93/253 (36%), Gaps = 44/253 (17%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKK-----IICHGREDQAQAIREV-EHHKTFVHPNILP 87
           IG GGF  V     + T K YA+K      I     E  A   R +     T   P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-KIC 146
           +        A    ++  ++  +L     G L   L      +H + S   ++ +  +I 
Sbjct: 257 M------SYA---FHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEII 302

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG-SVAPAVVKVCGSAEAQNLQDV 205
             ++  H+   + Y  RDLK AN+LL    +  + DLG +                 +  
Sbjct: 303 LGLEHMHNRF-VVY--RDLKPANILLDEHGHVRISDLGLAC-------------DFSKKK 346

Query: 206 AAERCSMP-YRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER-GDSVA 262
                    Y APE L    +Y   D   D +SLGC+L+ +    SPF     +    + 
Sbjct: 347 PHASVGTHGYMAPEVLQKGVAY---DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

Query: 263 LAVISGNITFPEN 275
              ++  +  P++
Sbjct: 404 RMTLTMAVELPDS 416

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.8 bits (161), Expect = 1e-12
 Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 60/268 (22%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
            + D++  ++ +G G F  V L++H ++   YA+K +     + +   ++++EH  T   
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL----DKQKVVKLKQIEH--TLNE 91

Query: 83  PNILPLLDH----ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR-----SVGKHYM 133
             IL  ++      L           S + MV+ Y   G + + L           + Y 
Sbjct: 92  KRILQAVNFPFLVKLEFS----FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
           +          I    +  H    + Y  RDLK  N+L+       + D G         
Sbjct: 148 AQ---------IVLTFEYLHS-LDLIY--RDLKPENLLIDQQGYIQVTDFGF-------- 187

Query: 194 CGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF- 251
                A+ ++      C  P   APE+     Y   ++  D W+LG L+Y M     PF 
Sbjct: 188 -----AKRVKGRTWTLCGTPEALAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFF 239

Query: 252 ----DTVYERGDSVALAVISGNITFPEN 275
                 +YE+       ++SG + FP +
Sbjct: 240 ADQPIQIYEK-------IVSGKVRFPSH 260

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 49/221 (22%), Positives = 76/221 (34%), Gaps = 40/221 (18%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFV 81
              +  + +IG G F  V      +  +  A+KK+        E     I+EV   +   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN +      L                ++  Y  G+ ++ LE+    K  +  V+I  +
Sbjct: 113 HPNTIQYRGCYLRE----------HTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAV 159

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                + +   H    I   HRD+K  N+LL+      L D G              +  
Sbjct: 160 THGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG--------SA----SI- 203

Query: 202 LQDVAAERCSM---PY-RAPELFHVDSYCVVDQRTDVWSLG 238
                A   S    PY  APE+         D + DVWSLG
Sbjct: 204 ----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 54/235 (22%), Positives = 87/235 (37%), Gaps = 50/235 (21%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           IG G FS V++++  QT + YA+K +     +       EV         ++L   D   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSC--FREERDVLVNGDRRW 122

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-KICE 147
           +T      L+   Q    + +V+ YY  G L     L   G+      ++ + +L +I  
Sbjct: 123 ITQ-----LHFAFQDENYLYLVMEYYVGGDLLT--LLSKFGERI--PAEMARFYLAEIVM 173

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVK-------VCGSAEAQ 200
           A+   H    + Y HRD+K  N+LL    +  L D GS                G+ +  
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD-- 228

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQR----TDVWSLGCLLYAMCYFKSPF 251
                        Y +PE+                 D W+LG   Y M Y ++PF
Sbjct: 229 -------------YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 64.4 bits (157), Expect = 6e-12
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 39/228 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +  K+G+G F  V +        R A+K +   G       ++E +  K   H  ++ L 
Sbjct: 188 LEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                        S   + +V  Y  KG+L +   L+     Y+    ++ M  +I   +
Sbjct: 246 -----AVV-----SEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGM 293

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA-EAQNLQDVA 206
                     Y HRDL+ AN+L+  +              V KV   G A   ++ +  A
Sbjct: 294 AYVERMN---YVHRDLRAANILVGENL-------------VCKVADFGLARLIEDNEYTA 337

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
            +    P +  APE      Y     ++DVWS G LL       + P+
Sbjct: 338 RQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPY 382

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 63.9 bits (156), Expect = 6e-12
 Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 38/237 (16%)

Query: 11  QMGCLCSKEAVY-VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQA 68
           Q G L      Y  + +    + ++G G    V  +   +T    A+K++     +E+  
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68

Query: 69  QAIREVE-HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS 127
           + + +++   K+   P I+        G       + + V + +     GT A  L+ R 
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCF-----GT----FITNTDVFIAMELM--GTCAEKLKKRM 117

Query: 128 VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA 187
            G   +    + KM + I +A+    +   +   HRD+K +N+LL       L D G   
Sbjct: 118 QGP--IPERILGKMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFG--- 170

Query: 188 PAVVKVCGSAEAQNLQDVAAER----CSMPYRAPELFHVDSYCVV--DQRTDVWSLG 238
                + G      L D  A+     C+  Y APE            D R DVWSLG
Sbjct: 171 -----ISG-----RLVDDKAKDRSAGCA-AYMAPERIDPPDPTKPDYDIRADVWSLG 216

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 64.1 bits (156), Expect = 7e-12
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 39/228 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +  K+G+G F  V +        R A+K +   G       ++E +  K   H  ++ L 
Sbjct: 271 LEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                        S   + +V  Y  KG+L +   L+     Y+    ++ M  +I   +
Sbjct: 329 -----AVV-----SEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGM 376

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA-EAQNLQDVA 206
                     Y HRDL+ AN+L+  +              V KV   G A   ++ +  A
Sbjct: 377 AYVERMN---YVHRDLRAANILVGENL-------------VCKVADFGLARLIEDNEYTA 420

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
            +    P +  APE      Y     ++DVWS G LL       + P+
Sbjct: 421 RQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPY 465

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 40/227 (17%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVE-HHKTF 80
             ++    + +IG G + +V+ + H  + +  A+K+I     E  Q Q + +++   ++ 
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
             P I+        G     L       + +      +     +        +   +IL 
Sbjct: 79  DCPYIVQFY-----GA----LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILG 128

Query: 141 MFLKICEAV----KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
              KI  A         +   I   HRD+K +N+LL    N  L D G        + G 
Sbjct: 129 ---KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFG--------ISG- 174

Query: 197 AEAQNLQDVAAER----CSMPYRAPELFHVDSYCVV-DQRTDVWSLG 238
                L D  A+     C  PY APE     +     D R+DVWSLG
Sbjct: 175 ----QLVDSIAKTRDAGCR-PYMAPERIDPSASRQGYDVRSDVWSLG 216

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 38/227 (16%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPN 84
           + + +GEG F +V   +L +   T  + A+K  K+    + +  + + E    K F HPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 85  ILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELR--SVGKHYMSSVDILKM 141
           ++ LL     G C +       + +++LP+   G L   L       G  ++    +LK 
Sbjct: 98  VIRLL-----GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEA 199
            + I   ++   +     + HRDL   N +L +D               V V   G ++ 
Sbjct: 153 MVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM-------------TVCVADFGLSKK 196

Query: 200 QNLQDV--AAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
               D         MP +  A E        V   ++DVW+ G  ++
Sbjct: 197 IYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVTMW 240

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 53/283 (18%), Positives = 94/283 (33%), Gaps = 79/283 (27%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFV-- 81
            +Y+++ K+G G FSTV L    Q KK  A+K  K   H  E    A+ E+   K+    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---TALDEIRLLKSVRNS 93

Query: 82  ---HPN---ILPLLDH-ALTG------CADPVLNSTSQVLMVLPYYPKGTLANDLELRSV 128
               PN   ++ LLD   ++G      C            MV      G   + L+    
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHIC------------MVFE--VLGH--HLLKWIIK 137

Query: 129 GKHYMSSVDILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-------- 179
             +    +  +K  ++ + + +   H    I   H D+K  N+LL+ +   +        
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEAT 195

Query: 180 ----------------------------LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCS 211
                                        ++  +     VK+     A  +     E   
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ 255

Query: 212 -MPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
              YR+ E+     Y   +   D+WS  C+ + +      F+ 
Sbjct: 256 TRQYRSLEVLIGSGY---NTPADIWSTACMAFELATGDYLFEP 295

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 46/240 (19%), Positives = 84/240 (35%), Gaps = 67/240 (27%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVE-HHKTF 80
           VK+D    + ++G G +  V  + H  + +  A+K+I      ++Q + + +++   +T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM--SSVDI 138
             P  +        G                  + +G +   +E        M  S    
Sbjct: 64  DCPFTVTFY-----GA----------------LFREGDVWICME-------LMDTSLDKF 95

Query: 139 LKMFLKICEAVKVFHDAKPIAYA---------------HRDLKTANVLLANDNNPLLMDL 183
            K  +   + +      K IA +               HRD+K +NVL+       + D 
Sbjct: 96  YKQVIDKGQTIPEDILGK-IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154

Query: 184 GSVAPAVVKVCGSAEAQNLQDVAAER----CSMPYRAPELFHVDSYCVV-DQRTDVWSLG 238
           G        + G      L D  A+     C  PY APE  + +        ++D+WSLG
Sbjct: 155 G--------ISG-----YLVDDVAKDIDAGCK-PYMAPERINPELNQKGYSVKSDIWSLG 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 42/225 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQA-IREVEHHKTFVHPNI 85
            ++++G+G F +V +  +   +         K + H  E+  +   RE+E  K+  H NI
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 86  LPLLDHALTGCADPVLNSTSQ-VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +        G      ++  + + +++ Y P G+L + L+     K  +  + +L+   +
Sbjct: 74  VKYK-----GV---CYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQ 122

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+ ++     +   Y HRDL T N+L+ N+N              VK+      + L  
Sbjct: 123 ICKGMEYLGTKR---YIHRDLATRNILVENEN-------------RVKIGDFGLTKVLPQ 166

Query: 205 -----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
                   E    P    APE             +DVWS G +LY
Sbjct: 167 DKEFFKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 38/220 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNILPL 88
           + E+IG G F  V            A+K        D     ++E    K + HPNI+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 89  LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
           +         P+        +V+     G     L  R+ G   +    +L+M       
Sbjct: 178 IGVCTQK--QPIY-------IVMELVQGGDFLTFL--RTEGAR-LRVKTLLQMVGDAAAG 225

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA--EAQNLQD 204
           ++           HRDL   N L+   N             V+K+   G +  EA  +  
Sbjct: 226 MEYLESKC---CIHRDLAARNCLVTEKN-------------VLKISDFGMSREEADGVYA 269

Query: 205 VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            +     +P +  APE  +   Y      +DVWS G LL+
Sbjct: 270 ASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGILLW 306

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 61.6 bits (150), Expect = 4e-11
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 42/225 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQA-IREVEHHKTFVHPNI 85
            ++++G+G F +V +  +   +         K + H  E+  +   RE+E  K+  H NI
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 86  LPLLDHALTGCADPVLNSTSQ-VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +        G      ++  + + +++ Y P G+L + L+     K  +  + +L+   +
Sbjct: 105 VKYK-----GV---CYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQ 153

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+ ++     +   Y HRDL T N+L+ N+N              VK+      + L  
Sbjct: 154 ICKGMEYLGTKR---YIHRDLATRNILVENEN-------------RVKIGDFGLTKVLPQ 197

Query: 205 -----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
                   E    P    APE             +DVWS G +LY
Sbjct: 198 DKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVLY 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 41/229 (17%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFVHPN 84
           +   +G+G F +V    L +   +  + A+K  K       D  + +RE    K F HP+
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 85  ILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG--KHYMSSVDIL 139
           +  L+     G    +          +++LP+   G L   L    +G     +    ++
Sbjct: 87  VAKLV-----GVSLRSRAK-GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA 197
           +  + I   ++         + HRDL   N +LA D               V V   G +
Sbjct: 141 RFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM-------------TVCVADFGLS 184

Query: 198 EAQNLQDV--AAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
                 D         +P +  A E        +    +DVW+ G  ++
Sbjct: 185 RKIYSGDYYRQGCASKLPVKWLALESLA---DNLYTVHSDVWAFGVTMW 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.3 bits (149), Expect = 7e-11
 Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 49/243 (20%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +K++ Y +V+ IG G F  V L+ H  T+K YA+K +     + +     +      +  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAF--FWEE 119

Query: 83  PNILPLLDH----ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR----SVGKHYMS 134
            +I+   +      L             + MV+ Y P G L N +          + Y +
Sbjct: 120 RDIMAFANSPWVVQLFYA----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
                    ++  A+   H    + + HRD+K  N+LL    +  L D G+         
Sbjct: 176 ---------EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT--------- 214

Query: 195 GSAEAQNLQDVAAERCSMP-----YRAPE-LFHVDSYCVVDQRTDVWSLGCLLYAMCYFK 248
                  +      RC        Y +PE L          +  D WS+G  LY M    
Sbjct: 215 ----CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 249 SPF 251
           +PF
Sbjct: 271 TPF 273

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 60.3 bits (147), Expect = 8e-11
 Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 36/218 (16%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +  K+G G +  V      +     A+K +      +  + ++E    K   HPN++ LL
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                G    V        ++  +   G L +   LR   +  +S+V +L M  +I  A+
Sbjct: 76  -----G----VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAM 124

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
           +         + HRDL   N L+  ++             +VKV     ++ +      A
Sbjct: 125 EYLEKKN---FIHRDLAARNCLVGENH-------------LVKVADFGLSRLMTGDTYTA 168

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
                 P +  APE      Y     ++DVW+ G LL+
Sbjct: 169 HAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLLW 203

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.9 bits (148), Expect = 9e-11
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 47/232 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            +Y +++ IG+G F  V      +  +  ALK ++ + +    QA  E+          I
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEI---------RI 146

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPY-YPKG-------TLANDL-ELRSVGKHYMSSV 136
           L  L        D   ++T  V+ +L     +         L+ +L EL    K    S+
Sbjct: 147 LEHLRKQ-----DK--DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199

Query: 137 DILKMFLK-ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC- 194
            +++ F   I + +   H  + I   H DLK  N+LL                  +KV  
Sbjct: 200 PLVRKFAHSILQCLDALHKNRII---HCDLKPENILLKQQGRS-----------GIKVID 245

Query: 195 -GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
            GS+  ++ Q V     S  YRAPE+     Y       D+WSLGC+L  + 
Sbjct: 246 FGSSCYEH-QRVYTYIQSRFYRAPEVILGARY---GMPIDMWSLGCILAELL 293

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 60.4 bits (147), Expect = 9e-11
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 45/226 (19%)

Query: 30  IVEKIGEGGFSTVSL----IEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
            +  +GEG F  VSL      +  T +  A+K +    G + ++   +E++  +T  H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 85  ILPLLDHALTGCADPVLNSTSQ-VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           I+        GC     ++ +  + +V+ Y P G+L + L      +H +    +L    
Sbjct: 95  IIKYK-----GC---CEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQ 141

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           +ICE +   H      Y HRDL   NVLL ND              +VK+     A+ + 
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDR-------------LVKIGDFGLAKAVP 185

Query: 204 D-----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +        E    P    APE             +DVWS G  LY
Sbjct: 186 EGHEYYRVREDGDSPVFWYAPECL---KEYKFYYASDVWSFGVTLY 228

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 44/226 (19%)

Query: 30  IVEKIGEGGFSTVSL----IEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
            + ++G+G F +V L         T    A+K++   G + Q    RE++  K      I
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 86  LPLLDHALTGCADPVLNSTSQ-VLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFL 143
           +        G          Q + +V+ Y P G L    + L+   +  + +  +L    
Sbjct: 87  VKYR-----GV---SYGPGRQSLRLVMEYLPSGCL---RDFLQR-HRARLDASRLLLYSS 134

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQN 201
           +IC+ ++     +     HRDL   N+L+ ++               VK+   G A+   
Sbjct: 135 QICKGMEYLGSRR---CVHRDLAARNILVESEA-------------HVKIADFGLAKLLP 178

Query: 202 LQD---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           L     V  E    P    APE        +  +++DVWS G +LY
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVVLY 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 42/225 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
             E IG G F  V   +L+++   K   A+K +       + +Q + E    K F HPN+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL     G     L S    L+VLPY   G L N +       H  +  D++   L++
Sbjct: 89  LSLL-----GI---CLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQV 137

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQ 203
            + +K     K   + HRDL   N +L                  VKV   G A     +
Sbjct: 138 AKGMKYLASKK---FVHRDLAARNCMLDEKF-------------TVKVADFGLARDMYDK 181

Query: 204 DVAAERCS----MPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +  +        +P +  A E            ++DVWS G LL+
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLW 223

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 46/220 (20%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVHPNILP 87
           +++ IG+G F  V  +       + A+K I    + D      + E        H N++ 
Sbjct: 197 LLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQ 250

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFLKIC 146
           LL     G    ++     + +V  Y  KG+L   ++ LRS G+  +    +LK  L +C
Sbjct: 251 LL-----GV---IVEEKGGLYIVTEYMAKGSL---VDYLRSRGRSVLGGDCLLKFSLDVC 299

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD 204
           EA++         + HRDL   NVL++ DN             V KV   G  +  +   
Sbjct: 300 EAMEYLEGNN---FVHRDLAARNVLVSEDN-------------VAKVSDFGLTKEASSTQ 343

Query: 205 VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
              +   +P +  APE            ++DVWS G LL+
Sbjct: 344 DTGK---LPVKWTAPEALR---EKKFSTKSDVWSFGILLW 377

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 56/247 (22%), Positives = 97/247 (39%), Gaps = 59/247 (23%)

Query: 26  DKYYIVEKIGEGGFSTVSL-IEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           ++Y IV  +GEG F  V   ++H++ K + ALK II +  + +  A  E+         N
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALK-IIRNVGKYREAARLEI---------N 68

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPY-YPKGTL--------AN--DLELRSVGKHYM 133
           +L  +        D    +    +++  +    G +         N  +  L+       
Sbjct: 69  VLKKIKEK-----DK--ENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEF-LKENNFQPY 120

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND------NNPLLMDLGSVA 187
               +  M  ++C A++  H+ +     H DLK  N+L  N       N     +  SV 
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 188 PAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVV-----DQRTDVWSLG 238
              ++V   GSA  + ++   + A R    YR PE        V+      Q  DVWS+G
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRH---YRPPE--------VILELGWAQPCDVWSIG 226

Query: 239 CLLYAMC 245
           C+L+   
Sbjct: 227 CILFEYY 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 42/225 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
             E IG G F  V   +L+++   K   A+K +       + +Q + E    K F HPN+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L LL     G     L S    L+VLPY   G L N +       H  +  D++   L++
Sbjct: 153 LSLL-----GI---CLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQV 201

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQ 203
            + +K     K   + HRDL   N +L                  VKV   G A     +
Sbjct: 202 AKGMKFLASKK---FVHRDLAARNCMLDEKF-------------TVKVADFGLARDMYDK 245

Query: 204 DVAAERCS----MPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +  +        +P +  A E            ++DVWS G LL+
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLW 287

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 47/237 (19%), Positives = 87/237 (36%), Gaps = 44/237 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQA--IREVEHHKTFVHPN 84
            ++ +G G F TV         ++  +    K +      +A    + E     +  +P+
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +  LL     G        TS V ++    P G L + +      K  + S  +L   ++
Sbjct: 79  VCRLL-----GIC-----LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           I + +    D +     HRDL   NVL+                  VK+   G A+    
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQ-------------HVKITDFGLAKLLGA 169

Query: 203 QD--VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTV 254
           ++    AE   +P +  A E      + +   ++DVWS G  ++  M +   P+D +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 45/227 (19%)

Query: 30  IVEKIGEGGFSTVSL----IEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
            +  +GEG F  V L     E   T ++ A+K +    G    A   +E+E  +   H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 85  ILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMF 142
           I+        G C +   N    + +++ + P G+L    E L    K+ ++    LK  
Sbjct: 85  IVKYK-----GICTEDGGNG---IKLIMEFLPSGSL---KEYLPK-NKNKINLKQQLKYA 132

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           ++IC+ +      +   Y HRDL   NVL+ +++              VK+      + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEH-------------QVKIGDFGLTKAI 176

Query: 203 QD-----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +         +    P    APE             +DVWS G  L+
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECL---MQSKFYIASDVWSFGVTLH 220

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 38/218 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           + +K+G G F  V +  +++  K  A+K +   G       + E    KT  H  ++ L 
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                        +   + ++  +  KG+L +   L+S          ++    +I E +
Sbjct: 250 -----AVV-----TKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGM 297

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
                     Y HRDL+ AN+L++                V K+     A+ ++D    A
Sbjct: 298 AFIEQRN---YIHRDLRAANILVSASL-------------VCKIADFGLARVIEDNEYTA 341

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            E    P +  APE  +   +     ++DVWS G LL 
Sbjct: 342 REGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLM 376

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 54/234 (23%), Positives = 88/234 (37%), Gaps = 49/234 (20%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D+Y I   IG+G F  V        ++  A+K II + +    QA  EV          +
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEV---------RL 103

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPY-YPKG-------TLANDLE--LRSVGKHYMSS 135
           L L++       D        ++ +  +   +         L+ +L   LR+     +S 
Sbjct: 104 LELMNKH-----DT--EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL 156

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC- 194
               K   ++C A+      + ++  H DLK  N+LL N                +K+  
Sbjct: 157 NLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRS-----------AIKIVD 204

Query: 195 -GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC 245
            GS+    Q +      R    YR+PE+     Y   D   D+WSLGC+L  M 
Sbjct: 205 FGSSCQLGQRIYQYIQSRF---YRSPEVLLGMPY---DLAIDMWSLGCILVEMH 252

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 48/233 (20%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           IG G F  V++++     K +A+K +     + +     E          ++L   D   
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETAC--FREERDVLVNGDSKW 135

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLE------LRSVGKHYMSSVDILKMF 142
           +T      L+   Q    + +V+ YY  G L   L          + + Y++        
Sbjct: 136 ITT-----LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-------- 182

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++  A+   H    + Y HRD+K  N+L+  + +  L D GS            +    
Sbjct: 183 -EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS----------CLKLMED 228

Query: 203 QDVAAER-CSMP-YRAPELFHVDSYCVV--DQRTDVWSLGCLLYAMCYFKSPF 251
             V +      P Y +PE+               D WSLG  +Y M Y ++PF
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 58.3 bits (142), Expect = 5e-10
 Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 68/261 (26%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           +G G F  V LI      + YA+K +    +++    +++VEH  T     +L ++ H  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEH--TNDERLMLSIVTHPF 67

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL--ELR---SVGKHYMSSVDILKMFL 143
           +       +  T Q    + M++ Y   G L + L    R    V K Y +         
Sbjct: 68  IIR-----MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------- 114

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV----CGSAEA 199
            +C A++  H  K I Y  RDLK  N+LL  + +  + D G  A  V  V    CG+ + 
Sbjct: 115 -VCLALEYLHS-KDIIY--RDLKPENILLDKNGHIKITDFG-FAKYVPDVTYTLCGTPD- 168

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----DTV 254
                         Y APE+     Y   ++  D WS G L+Y M    +PF        
Sbjct: 169 --------------YIAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 255 YERGDSVALAVISGNITFPEN 275
           YE+       +++  + FP  
Sbjct: 212 YEK-------ILNAELRFPPF 225

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.4 bits (142), Expect = 5e-10
 Identities = 61/260 (23%), Positives = 97/260 (37%), Gaps = 63/260 (24%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           +G+G F  V L+    T + YA+K +    R++   A  EV H  T     +L    H  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAH--TVTESRVLQNTRHPF 66

Query: 93  LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDILKM 141
           LT      L    Q    +  V+ Y   G L   L       E R+  + Y +       
Sbjct: 67  LTA-----LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA--RFYGA------- 112

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I  A++  H  + + Y  RD+K  N++L  D +  + D G             E  +
Sbjct: 113 --EIVSALEYLHS-RDVVY--RDIKLENLMLDKDGHIKITDFGL----------CKEGIS 157

Query: 202 LQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----DTVY 255
                   C  P Y APE+   + Y    +  D W LG ++Y M   + PF     + ++
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

Query: 256 ERGDSVALAVISGNITFPEN 275
           E        ++   I FP  
Sbjct: 215 EL-------ILMEEIRFPRT 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 58.1 bits (141), Expect = 5e-10
 Identities = 47/237 (19%), Positives = 86/237 (36%), Gaps = 44/237 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRY-ALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
            ++ +G G F TV     I   ++ K    +K I    GR+        +    +  H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LL     G         S + +V  Y P G+L + +      +  +    +L   ++
Sbjct: 77  IVRLL-----GLC-----PGSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQ 123

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           I + +    +       HR+L   NVLL + +              V+V   G A+    
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPS-------------QVQVADFGVADLLPP 167

Query: 203 QD--VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTV 254
            D  +       P +  A E  H   +     ++DVWS G  ++  M +   P+  +
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 57.6 bits (140), Expect = 6e-10
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 44/219 (20%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQA--IREVEHHKTFVHPNILP 87
           +++ IG+G F  V  +       + A+K I    + D      + E        H N++ 
Sbjct: 25  LLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQ 78

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
           LL     G    ++     + +V  Y  KG+L +   LRS G+  +    +LK  L +CE
Sbjct: 79  LL-----GV---IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCE 128

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQDV 205
           A++         + HRDL   NVL++ DN             V KV   G  +  +    
Sbjct: 129 AMEYLEGNN---FVHRDLAARNVLVSEDN-------------VAKVSDFGLTKEASSTQD 172

Query: 206 AAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
             +   +P +  APE            ++DVWS G LL+
Sbjct: 173 TGK---LPVKWTAPEALR---EKKFSTKSDVWSFGILLW 205

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 57.7 bits (140), Expect = 7e-10
 Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 44/226 (19%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
               IG+G F  V     I+ +Q + + A+K +      +     +RE    +   HPN+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFLK 144
           L L+     G    +L       ++LPY   G L   L+ +RS  ++  +  D++   L+
Sbjct: 85  LALI-----GI---MLPPEGLPHVLLPYMCHGDL---LQFIRSPQRN-PTVKDLISFGLQ 132

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           +   ++   + K   + HRDL   N +L                  VKV   G A     
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESF-------------TVKVADFGLARDILD 176

Query: 203 QDVAAERCS----MPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           ++  + +      +P +  A E            ++DVWS G LL+
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQ---TYRFTTKSDVWSFGVLLW 219

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 57.2 bits (139), Expect = 8e-10
 Identities = 49/265 (18%), Positives = 102/265 (38%), Gaps = 47/265 (17%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
           +   IGEG F  V     +         A+K    C     + + ++E    + F HP+I
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           + L+     G        + + V +++     G L +   L+   K+ +    ++    +
Sbjct: 79  VKLI-----GVI------TENPVWIIMELCTLGELRS--FLQV-RKYSLDLASLILYAYQ 124

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +  A+      +   + HRD+   NVL+++++              VK+     ++ ++D
Sbjct: 125 LSTALAYLESKR---FVHRDIAARNVLVSSND-------------CVKLGDFGLSRYMED 168

Query: 205 ---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTVYERG 258
                A +  +P +  APE  +   +      +DVW  G  ++  + +   PF  V  + 
Sbjct: 169 STYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KN 223

Query: 259 DSVALAVISGN-ITFPENTPFPQYQ 282
           + V   + +G  +  P N P   Y 
Sbjct: 224 NDVIGRIENGERLPMPPNCPPTLYS 248

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 49/250 (19%), Positives = 89/250 (35%), Gaps = 61/250 (24%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           + + ++ K+G+G F  V L +H   KK YA+K ++ + ++    A  E          +I
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSAKIEA---------DI 84

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKG-------TLANDLE--LRSVGKHYMSSV 136
           L  + +      D   N+ + V     +            L   L   +     +     
Sbjct: 85  LKKIQND-----DI--NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIE 137

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND------------NNPLLMDLG 184
           DI    ++I +A+            H DLK  N+LL +              +   + + 
Sbjct: 138 DIKLYCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194

Query: 185 SVAPAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVV-----DQRTDVW 235
                 +K+   G A  ++     +   R    YRAPE        V+     D  +D+W
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ---YRAPE--------VILNLGWDVSSDMW 243

Query: 236 SLGCLLYAMC 245
           S GC+L  + 
Sbjct: 244 SFGCVLAELY 253

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 62/258 (24%), Positives = 97/258 (37%), Gaps = 58/258 (22%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           +G+G F  V L E   T + YA+K +    ++D      +VE   T V   +L L     
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVEC--TMVEKRVLALPGKPP 402

Query: 93  -LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK--- 144
            LT      L+S  Q    +  V+ Y   G L             M  +  +  F +   
Sbjct: 403 FLTQ-----LHSCFQTMDRLYFVMEYVNGGDL-------------MYHIQQVGRFKEPHA 444

Query: 145 ------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
                 I   +      K I Y  RDLK  NV+L ++ +  + D G             E
Sbjct: 445 VFYAAEIAIGLFFLQS-KGIIY--RDLKLDNVMLDSEGHIKIADFGM----------CKE 491

Query: 199 AQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                      C  P Y APE+     Y    +  D W+ G LLY M   ++PF+   E 
Sbjct: 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEG--ED 546

Query: 258 GDSVALAVISGNITFPEN 275
            D +  +++  N+ +P++
Sbjct: 547 EDELFQSIMEHNVAYPKS 564

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 47/237 (19%), Positives = 87/237 (36%), Gaps = 44/237 (18%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQAQA--IREVEHHKTFVHPN 84
            ++ +G G F TV         ++  +    K +      +A    + E     +  +P+
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           +  LL     G        TS V ++    P G L + +      K  + S  +L   ++
Sbjct: 79  VCRLL-----GIC-----LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQ 125

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNL 202
           I + +    D +     HRDL   NVL+                  VK+   G A+    
Sbjct: 126 IAKGMNYLEDRR---LVHRDLAARNVLVKTPQ-------------HVKITDFGLAKLLGA 169

Query: 203 QD--VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTV 254
           ++    AE   +P +  A E      + +   ++DVWS G  ++  M +   P+D +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 54/240 (22%), Positives = 87/240 (36%), Gaps = 52/240 (21%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA----IREVEHHKTFVH 82
           ++EK+G+G F  V        S      A+K  +      Q +A    IREV    +  H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 83  PNILPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILK 140
            N++ L      G         T  + MV    P G+L   L+ LR   + +     + +
Sbjct: 81  RNLIRLY-----GVV------LTPPMKMVTELAPLGSL---LDRLRK-HQGHFLLGTLSR 125

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAE 198
             +++ E +      +   + HRDL   N+LLA  +             +VK+   G   
Sbjct: 126 YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD-------------LVKIGDFGLMR 169

Query: 199 AQNLQD---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFD 252
           A    D   V  E   +P+   APE             +D W  G  L+    Y + P+ 
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWI 226

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.4 bits (134), Expect = 4e-09
 Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 59/247 (23%)

Query: 26  DKYYIVEKIGEGGFSTV-SLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            +Y IV+ +GEG F  V   I+H    +  A+K I+ +       A  E+          
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARSEI---------Q 63

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPY-YPKGTL--------AN--DLELRSVGKHYM 133
           +L  L+       DP  NST + + +L +    G +         +  D  ++  G    
Sbjct: 64  VLEHLNTT-----DP--NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDF-IKENGFLPF 115

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG------SVA 187
               I KM  +IC++V   H  K     H DLK  N+L    +     +        ++ 
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 188 PAVVKVC--GSA--EAQNLQDVAAERCSMPYRAPELFHVDSYCVV-----DQRTDVWSLG 238
              +KV   GSA  + ++   + + R    YRAPE        V+      Q  DVWS+G
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVSTRH---YRAPE--------VILALGWSQPCDVWSIG 221

Query: 239 CLLYAMC 245
           C+L    
Sbjct: 222 CILIEYY 228

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 54.9 bits (133), Expect = 5e-09
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 38/218 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +VE++G G F  V +  +     + A+K +   G       + E    K   H  ++ L 
Sbjct: 17  LVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                        +   + ++  Y   G+L +   L++     ++   +L M  +I E +
Sbjct: 75  -----AVV-----TQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGM 122

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
               +     Y HRDL+ AN+L+++                 K+     A+ ++D    A
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTL-------------SCKIADFGLARLIEDNEYTA 166

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            E    P +  APE  +   Y     ++DVWS G LL 
Sbjct: 167 REGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLT 201

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 54.5 bits (132), Expect = 7e-09
 Identities = 46/233 (19%), Positives = 85/233 (36%), Gaps = 44/233 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNI 85
           +   +GEG F  V       H   K   A+K        D  +  + E    K   HP+I
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           + L+     G              +++  YP G L +   L    K+ +  + ++   L+
Sbjct: 76  VKLI-----GII------EEEPTWIIMELYPYGELGH--YLER-NKNSLKVLTLVLYSLQ 121

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           IC+A+            HRD+   N+L+A+                VK+     ++ ++D
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPE-------------CVKLGDFGLSRYIED 165

Query: 205 ---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
                A    +P +  +PE  +   +      +DVW     ++  + + K PF
Sbjct: 166 EDYYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVCMWEILSFGKQPF 215

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 54.6 bits (132), Expect = 7e-09
 Identities = 53/234 (22%), Positives = 84/234 (35%), Gaps = 43/234 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNI 85
           I + IG G    V    L    Q     A+K +     E Q +  + E      F HPNI
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L      G    V+      ++V  Y   G+L     LR+      + + ++ M   +
Sbjct: 113 IRLE-----G----VVTRGRLAMIVTEYMENGSLDT--FLRT-HDGQFTIMQLVGMLRGV 160

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA---EAQ 200
              ++   D     Y HRDL   NVL+ ++              V KV   G +   E  
Sbjct: 161 GAGMRYLSDLG---YVHRDLAARNVLVDSNL-------------VCKVSDFGLSRVLEDD 204

Query: 201 NLQDVAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
                      +P R  APE      +      +DVWS G +++  + Y + P+
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIA---FRTFSSASDVWSFGVVMWEVLAYGERPY 255

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 54.6 bits (132), Expect = 8e-09
 Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 63/266 (23%)

Query: 34  IGEGGFSTVSLIEHSQ---TKKRYALK-----KIICHGREDQAQAIREVEHHKTFVHPNI 85
           +G G +  V L+       T K YA+K      I+   +          EH  T     +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT--------TEH--TRTERQV 111

Query: 86  LPLLDHA--LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           L  +  +  L       L+   Q    + ++L Y   G L   L      +    +   +
Sbjct: 112 LEHIRQSPFLVT-----LHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEV 161

Query: 140 KMFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK-- 192
           ++++ +I  A++  H    I Y  RD+K  N+LL ++ + +L D G     VA    +  
Sbjct: 162 QIYVGEIVLALEHLHK-LGIIY--RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 193 -VCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             CG+ E               Y AP++         D+  D WSLG L+Y +    SPF
Sbjct: 219 DFCGTIE---------------YMAPDIVRGGDS-GHDKAVDWWSLGVLMYELLTGASPF 262

Query: 252 DTVYERGDSVAL--AVISGNITFPEN 275
               E+     +   ++     +P+ 
Sbjct: 263 TVDGEKNSQAEISRRILKSEPPYPQE 288

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 54.1 bits (131), Expect = 8e-09
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 39/228 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            V++IG G F  V L      K + A+K  I  G   +   I E E      HP ++ L 
Sbjct: 12  FVQEIGSGQFGLVHLGYW-LNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                G    V    + + +V  +   G L++   LR+  +   ++  +L M L +CE +
Sbjct: 70  -----G----VCLEQAPICLVTEFMEHGCLSD--YLRT-QRGLFAAETLLGMCLDVCEGM 117

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
               +A      HRDL   N L+  +              V+KV      + + D    +
Sbjct: 118 AYLEEAC---VIHRDLAARNCLVGENQ-------------VIKVSDFGMTRFVLDDQYTS 161

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           +     P +  +PE+F    +     ++DVWS G L++      K P+
Sbjct: 162 STGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 47/231 (20%), Positives = 90/231 (38%), Gaps = 45/231 (19%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRY--ALKKI-ICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           ++G G F +V    +   KK+   A+K +     + D  + +RE +      +P I+ L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 90  DHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEA 148
                G C          +++V+     G L     L    +  +   ++ ++  ++   
Sbjct: 403 -----GVC------QAEALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMG 448

Query: 149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD-- 204
           +K   +     + HR+L   NVLL N +               K+   G ++A    D  
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRH-------------YAKISDFGLSKALGADDSY 492

Query: 205 -VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
             A      P +  APE  +   +     R+DVWS G  ++ A+ Y + P+
Sbjct: 493 YTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 50/265 (18%), Positives = 102/265 (38%), Gaps = 47/265 (17%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNI 85
           +   IGEG F  V     +         A+K    C     + + ++E    + F HP+I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 86  LPLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           + L+     G        + + V +++     G L + L++R   K  +    ++    +
Sbjct: 454 VKLI-----GVI------TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQ 499

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +  A+      +   + HRD+   NVL+++++              VK+     ++ ++D
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSND-------------CVKLGDFGLSRYMED 543

Query: 205 ---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPFDTVYERG 258
                A +  +P +  APE  +   +      +DVW  G  ++  + +   PF  V  + 
Sbjct: 544 STYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KN 598

Query: 259 DSVALAVISGNI-TFPENTPFPQYQ 282
           + V   + +G     P N P   Y 
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYS 623

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 63/261 (24%), Positives = 96/261 (36%), Gaps = 64/261 (24%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL-LDHA 92
           +G+G F  V L E  +T + +A+K +    ++D      +VE   T V   +L L  +H 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVEC--TMVEKRVLSLAWEHP 78

Query: 93  -LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDILK 140
            LT      +  T Q    +  V+ Y   G L   +         R+    Y +      
Sbjct: 79  FLTH-----MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAA------ 125

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I   ++  H  K I Y  RDLK  N+LL  D +  + D G             E  
Sbjct: 126 ---EIILGLQFLHS-KGIVY--RDLKLDNILLDKDGHIKIADFGM----------CKENM 169

Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----DTV 254
                    C  P Y APE+     Y   +   D WS G LLY M   +SPF     + +
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

Query: 255 YERGDSVALAVISGNITFPEN 275
           +        ++   N  +P  
Sbjct: 227 FH-------SIRMDNPFYPRW 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 43/234 (18%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPNI 85
           I + +G G F  V    L   S+ +   A+K +     E Q +  + E      F HPNI
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L           V+  +  V++V  Y   G+L  D  LR       + + ++ M   I
Sbjct: 109 IRLE---------GVVTKSKPVMIVTEYMENGSL--DSFLRK-HDAQFTVIQLVGMLRGI 156

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD- 204
              +K   D     Y HRDL   N+L+ ++              V KV      + L+D 
Sbjct: 157 ASGMKYLSDMG---YVHRDLAARNILINSNL-------------VCKVSDFGLGRVLEDD 200

Query: 205 ----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
                      +P R  +PE      Y      +DVWS G +L+  M Y + P+
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIA---YRKFTSASDVWSYGIVLWEVMSYGERPY 251

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 44/230 (19%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--------FVHPNI 85
           IG G ++ V L+   +T + YA++ +    +++      +++  +T          HP +
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVV----KKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-K 144
           + L  H+   C      + S++  V+ Y   G L   ++     +      +  + +  +
Sbjct: 116 VGL--HS---C----FQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAE 161

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I  A+   H+ + I Y  RDLK  NVLL ++ +  L D G             E     D
Sbjct: 162 ISLALNYLHE-RGIIY--RDLKLDNVLLDSEGHIKLTDYGM----------CKEGLRPGD 208

Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
             +  C  P Y APE+   + Y       D W+LG L++ M   +SPFD 
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDI 255

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 53.3 bits (129), Expect = 1e-08
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 39/228 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           +++++G G F  V L +  + +   A+K I   G   + +  +E +      HP ++   
Sbjct: 12  LLKELGSGQFGVVKLGKW-KGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFY 69

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                G    V +    + +V  Y   G L N   LRS GK  +    +L+M   +CE +
Sbjct: 70  -----G----VCSKEYPIYIVTEYISNGCLLN--YLRSHGKG-LEPSQLLEMCYDVCEGM 117

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
                 +   + HRDL   N L+  D               VKV      + + D   V+
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDL-------------CVKVSDFGMTRYVLDDQYVS 161

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           +     P +  APE+FH   Y     ++DVW+ G L++      K P+
Sbjct: 162 SVGTKFPVKWSAPEVFH---YFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 54/235 (22%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--------FVHPNI 85
           IG G ++ V L+   +T + YA+K +    +++      +++  +T          HP +
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVV----KKELVNDDEDIDWVQTEKHVFEQASNHPFL 72

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL-K 144
           + L  H+   C      + S++  V+ Y   G L   ++     +      +  + +  +
Sbjct: 73  VGL--HS---C----FQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAE 118

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK--VCGSAE 198
           I  A+   H+ + I Y  RDLK  NVLL ++ +  L D G     + P       CG+  
Sbjct: 119 ISLALNYLHE-RGIIY--RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
                          Y APE+   + Y       D W+LG L++ M   +SPFD 
Sbjct: 176 ---------------YIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDI 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 65/266 (24%), Positives = 99/266 (37%), Gaps = 74/266 (27%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPL-LDHA 92
           IG+G F  V L  H   +  YA+K +    ++      +E +H       N+L   + H 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVL----QKKAILKKKEEKH--IMSERNVLLKNVKHP 99

Query: 93  -LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDILK 140
            L G     L+ + Q    +  VL Y   G L   L       E R+  + Y +      
Sbjct: 100 FLVG-----LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA--RFYAA------ 146

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK--VC 194
              +I  A+   H    I Y  RDLK  N+LL +  + +L D G    ++         C
Sbjct: 147 ---EIASALGYLHSLN-IVY--RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200

Query: 195 GSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF--- 251
           G+ E               Y APE+ H   Y   D+  D W LG +LY M Y   PF   
Sbjct: 201 GTPE---------------YLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPFYSR 242

Query: 252 --DTVYERGDSVALAVISGNITFPEN 275
               +Y+        +++  +    N
Sbjct: 243 NTAEMYDN-------ILNKPLQLKPN 261

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 53.4 bits (129), Expect = 2e-08
 Identities = 47/228 (20%), Positives = 85/228 (37%), Gaps = 39/228 (17%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
            ++++G G F  V         +     K+I  G   + + I E +      H  ++ L 
Sbjct: 28  FLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
                G    V      + ++  Y   G L N   LR   +H   +  +L+M   +CEA+
Sbjct: 86  -----G----VCTKQRPIFIITEYMANGCLLN--YLRE-MRHRFQTQQLLEMCKDVCEAM 133

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD---VA 206
           +     +   + HRDL   N L+ +               VVKV     ++ + D    +
Sbjct: 134 EYLESKQ---FLHRDLAARNCLVNDQG-------------VVKVSDFGLSRYVLDDEYTS 177

Query: 207 AERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
           +     P R   PE+     Y     ++D+W+ G L++      K P+
Sbjct: 178 SVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.0 bits (128), Expect = 3e-08
 Identities = 58/240 (24%), Positives = 89/240 (37%), Gaps = 66/240 (27%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA- 92
           +G+G F  V L E   T + YA+K +    ++D      +VE   T V   +L L     
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVEC--TMVEKRVLALPGKPP 81

Query: 93  -LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK--- 144
            LT      L+S  Q    +  V+ Y   G L             M  +  +  F +   
Sbjct: 82  FLTQ-----LHSCFQTMDRLYFVMEYVNGGDL-------------MYHIQQVGRFKEPHA 123

Query: 145 ------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVKV- 193
                 I   +      K I Y  RDLK  NV+L ++ +  + D G    ++   V    
Sbjct: 124 VFYAAEIAIGLFFLQS-KGIIY--RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180

Query: 194 -CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            CG+ +               Y APE+     Y    +  D W+ G LLY M   ++PF+
Sbjct: 181 FCGTPD---------------YIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFE 222

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.0 bits (126), Expect = 3e-08
 Identities = 37/219 (16%), Positives = 67/219 (30%), Gaps = 42/219 (19%)

Query: 15  LCSKEAVY-----VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---- 65
            CS++        + ++K    EKIGEG F  V       T    A+K I   G +    
Sbjct: 4   ECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNG 61

Query: 66  ----DQAQAIREVEHHKTF---------VHPNILPLLDHAL-TGCADPVL--------NS 103
                  + + E+   K                + L       G   P+L        ++
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 104 TSQVLMVLPYYPKGTL-------ANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK 156
                    ++    L          ++L  +     S      +  ++  ++ V     
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--A 179

Query: 157 PIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            + + HRDL   NVLL   +   L    +   + +  CG
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 61/265 (23%), Positives = 96/265 (36%), Gaps = 72/265 (27%)

Query: 34  IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--------FVHPNI 85
           +G+G F  V L    +T   YA+K +    ++D      +VE   T          HP +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVL----KKDVILQDDDVECTMTEKRILSLARNHPFL 86

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK- 144
             L       C      +  ++  V+ +   G L             M  +   + F + 
Sbjct: 87  TQLF------CC---FQTPDRLFFVMEFVNGGDL-------------MFHIQKSRRFDEA 124

Query: 145 --------ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK 192
                   I  A+   HD K I Y  RDLK  NVLL ++ +  L D G     +   V  
Sbjct: 125 RARFYAAEIISALMFLHD-KGIIY--RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181

Query: 193 V--CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
              CG+ +               Y APE+     Y       D W++G LLY M    +P
Sbjct: 182 ATFCGTPD---------------YIAPEILQEMLY---GPAVDWWAMGVLLYEMLCGHAP 223

Query: 251 FDTVYERGDSVALAVISGNITFPEN 275
           F+   E  D +  A+++  + +P  
Sbjct: 224 FEA--ENEDDLFEAILNDEVVYPTW 246

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 33/238 (13%), Positives = 81/238 (34%), Gaps = 46/238 (19%)

Query: 30  IVEKIGEGGFSTV---SLIEHSQTKKRYALK---KIICHGREDQAQA-IREVEHHKTFVH 82
             E +G+G F+ +      E     + +  +   K++     + +++            H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKM 141
            +++      +  C D  +       +V  +   G+L      L+   K+ ++ +  L++
Sbjct: 72  KHLVLNY--GVCVCGDENI-------LVQEFVKFGSL---DTYLKK-NKNCINILWKLEV 118

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             ++  A+    +       H ++   N+LL  + +    +     P  +K+     +  
Sbjct: 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGN-----PPFIKLSDPGISIT 170

Query: 202 LQDVAAERCSMPYR--APELFHVDSYCVVDQR-----TDVWSLGCLLYAMCYF-KSPF 251
           +     +          PE       C+ + +     TD WS G  L+ +C     P 
Sbjct: 171 VLP--KDILQERIPWVPPE-------CIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 47/232 (20%)

Query: 33  KIGEGGFSTVSLIEHSQTKKRY--ALKKI-ICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           ++G G F +V    +   KK+   A+K +     + D  + +RE +      +P I+ L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 90  DHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLE-LRSVGKHYMSSVDILKMFLKICE 147
                G C          +++V+     G L    + L    +  +   ++ ++  ++  
Sbjct: 77  -----GVC------QAEALMLVMEMAGGGPL---HKFLVGKREE-IPVSNVAELLHQVSM 121

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD- 204
            +K   +     + HRDL   NVLL N +               K+   G ++A    D 
Sbjct: 122 GMKYLEEKN---FVHRDLAARNVLLVNRH-------------YAKISDFGLSKALGADDS 165

Query: 205 --VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
              A      P +  APE  +   +     R+DVWS G  ++ A+ Y + P+
Sbjct: 166 YYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPY 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 51.8 bits (125), Expect = 7e-08
 Identities = 58/239 (24%), Positives = 89/239 (37%), Gaps = 61/239 (25%)

Query: 34  IGEGGFSTVSLIEHSQ---TKKRYALK-----KIICHGREDQAQAIREVEHHKTFVHPNI 85
           +G+GG+  V  +       T K +A+K      I+ + ++          H  T    NI
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD--------TAH--TKAERNI 74

Query: 86  LPLLDHA-LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
           L  + H  +       L    Q    + ++L Y   G L   LE     +  +   D   
Sbjct: 75  LEEVKHPFIVD-----LIYAFQTGGKLYLILEYLSGGELFMQLE-----REGIFMEDTAC 124

Query: 141 MFL-KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG----SVAPAVVK--V 193
            +L +I  A+   H    I Y  RDLK  N++L +  +  L D G    S+    V    
Sbjct: 125 FYLAEISMALGHLHQKG-IIY--RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181

Query: 194 CGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           CG+ E               Y APE+     +   ++  D WSLG L+Y M     PF 
Sbjct: 182 CGTIE---------------YMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAPPFT 222

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 50.6 bits (122), Expect = 2e-07
 Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 41/167 (24%)

Query: 33  KIGEGGFSTV--SLIEHSQTKKRYALKKIICHGREDQAQAIR----EVEHHKTFVHPNIL 86
           K+GEGGF  V    + +       A+KK+         +  +    E++      H N++
Sbjct: 38  KMGEGGFGVVYKGYVNN----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93

Query: 87  PLLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL--KMFL 143
            LL     G  +D        + +V  Y P G+L + L         +     L   M  
Sbjct: 94  ELL-----GFSSDG-----DDLCLVYVYMPNGSLLDRL-------SCLDGTPPLSWHMRC 136

Query: 144 KICEAVKVFHDAKPIAYAH------RDLKTANVLLANDNNPLLMDLG 184
           KI +       A  I + H      RD+K+AN+LL       + D G
Sbjct: 137 KIAQGA-----ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 49/241 (20%), Positives = 78/241 (32%), Gaps = 57/241 (23%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV-H 82
             + +G G F  V       +  S      A+K +       ++   + E++       H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 83  PNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDI 138
            NI+ LL     G      P L       ++  Y   G L N L   R       +S  I
Sbjct: 87  MNIVNLL-----GACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 139 LKMFLKICEAVKVFHDAKPIA----------YAHRDLKTANVLLANDNNPLLMDLGSVAP 188
           ++      +   +   +  +A            HRDL   N+LL +              
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR------------ 182

Query: 189 AVVKVC--GSAEAQNLQDV--AAERCSMPYR--APE-LFHVDSYCVVDQRTDVWSLGCLL 241
            + K+C  G A                +P +  APE +F     CV    +DVWS G  L
Sbjct: 183 -ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGIFL 237

Query: 242 Y 242
           +
Sbjct: 238 W 238

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 46/167 (27%), Positives = 68/167 (40%), Gaps = 39/167 (23%)

Query: 33  KIGEGGFSTV---SLIEHSQT--KKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILP 87
            +G GGF  V    L + +    K+   LK+    G E Q Q   EVE     VH N+L 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVKR---LKEERTQGGELQFQT--EVEMISMAVHRNLLR 91

Query: 88  LLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
           L      G C  P     ++ L+V PY   G++A+ L  R   +  +          +I 
Sbjct: 92  LR-----GFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLD----WPKRQRIA 137

Query: 147 EAVKVFHDAKPIAY---------AHRDLKTANVLLANDNNPLLMDLG 184
                   A+ +AY          HRD+K AN+LL  +   ++ D G
Sbjct: 138 LGS-----ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 52/235 (22%), Positives = 82/235 (34%), Gaps = 44/235 (18%)

Query: 30  IVEKIGEGGFSTVSL----IEHSQTKKRYALKKIICHGREDQAQA-IREVEHHKTFVHPN 84
             + IG G F  V          + +   A+K +     E Q    + E      F H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ L      G    V++    ++++  Y   G L     LR       S + ++ M   
Sbjct: 108 IIRLE-----G----VISKYKPMMIITEYMENGALDK--FLRE-KDGEFSVLQLVGMLRG 155

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSA---EA 199
           I   +K   +     Y HRDL   N+L+ ++              V KV   G +   E 
Sbjct: 156 IAAGMKYLANMN---YVHRDLAARNILVNSNL-------------VCKVSDFGLSRVLED 199

Query: 200 QNLQDVAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
                       +P R  APE      Y      +DVWS G +++  M Y + P+
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPY 251

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 42/234 (17%), Positives = 85/234 (36%), Gaps = 52/234 (22%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHP 83
           +  ++G+G F  V       +   + + R A+K +       ++ + + E    K F   
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 84  NILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL------ELRSVGKHYMS 134
           +++ LL     G      P L       +++    +G L + L         +      S
Sbjct: 89  HVVRLL-----GVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC 194
              +++M  +I + +   +  K   + HRDL   N ++A D               VK+ 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF-------------TVKIG 180

Query: 195 GSAEAQNLQD----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
                +++ +        +  +P R  +PE        V    +DVWS G +L+
Sbjct: 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLW 231

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 48/241 (19%), Positives = 84/241 (34%), Gaps = 58/241 (24%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV-H 82
           + + +G G F  V       I+ + T +  A+K +       +    + E++       H
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL--------ELRSVGKHYMS 134
            N++ LL     G           +++++ +   G L+  L          +   +    
Sbjct: 91  LNVVNLL-----GA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 135 SVDILKMFLKICEAVKVFHDAKPIAY------AHRDLKTANVLLANDNNPLLMDLGSVAP 188
               L+  +     V     AK + +       HRDL   N+LL+  N            
Sbjct: 143 DFLTLEHLICYSFQV-----AKGMEFLASRKCIHRDLAARNILLSEKN------------ 185

Query: 189 AVVKVC--GSAEAQNLQDV--AAERCSMPYR--APE-LFHVDSYCVVDQRTDVWSLGCLL 241
            VVK+C  G A                +P +  APE +F      V   ++DVWS G LL
Sbjct: 186 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLL 240

Query: 242 Y 242
           +
Sbjct: 241 W 241

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 48.8 bits (117), Expect = 6e-07
 Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 33  KIGEGGFSTVS--LIEHSQTKKRYALKKIICHGREDQAQA---IREVEHHKTFVHPNILP 87
           ++G G F TV     +  +  K  A+K I+ +   D A     + E    +   +P I+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 88  LLDHALTG-CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKIC 146
           ++     G C           ++V+     G L   L+       ++   +I+++  ++ 
Sbjct: 83  MI-----GIC------EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVS 127

Query: 147 EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQD 204
             +K   ++    + HRDL   NVLL   +               K+   G ++A    +
Sbjct: 128 MGMKYLEESN---FVHRDLAARNVLLVTQH-------------YAKISDFGLSKALRADE 171

Query: 205 ---VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY-AMCYFKSPF 251
               A      P +  APE  +   Y     ++DVWS G L++ A  Y + P+
Sbjct: 172 NYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 48.8 bits (117), Expect = 6e-07
 Identities = 50/246 (20%), Positives = 84/246 (34%), Gaps = 62/246 (25%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHP 83
           + + +GEG F  V       ++        A+K +       +    + E    K   HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 84  NILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDIL 139
           +++ L      G      P+L       +++ Y   G+L   L E R VG  Y+ S    
Sbjct: 87  HVIKLY-----GACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 140 KMFLKICEAVKVFHDAKPIAYA----------------HRDLKTANVLLANDNNPLLMDL 183
                     +       I++A                HRDL   N+L+A          
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR------- 187

Query: 184 GSVAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRTDVWS 236
                  +K+   G +     +D  V   +  +P +  A E LF      +   ++DVWS
Sbjct: 188 ------KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF----DHIYTTQSDVWS 237

Query: 237 LGCLLY 242
            G LL+
Sbjct: 238 FGVLLW 243

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 48.4 bits (116), Expect = 7e-07
 Identities = 45/239 (18%), Positives = 76/239 (31%), Gaps = 57/239 (23%)

Query: 30  IVEKIGEGGFSTVSL-----IEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +  ++GEG F  V L     +  ++ K   A+K +       +    RE E      H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 85  ILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTL------------ANDLELRSVG 129
           I+        G     DP++       MV  Y   G L                      
Sbjct: 79  IVKFY-----GVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126

Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
           K  +    +L +  +I   +          + HRDL T N L+  +              
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL------------- 170

Query: 190 VVKVCGSAEAQNLQD----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           +VK+     ++++             +P R   PE      Y      +DVWS G +L+
Sbjct: 171 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVILW 226

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 52/238 (21%), Positives = 78/238 (32%), Gaps = 56/238 (23%)

Query: 30  IVEKIGEGGFSTVSL-----IEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +  ++GEG F  V L     +   Q K   A+K +       +    RE E      H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 85  ILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDILK 140
           I+        G      P+L       MV  Y   G L   L       K      D+  
Sbjct: 105 IVRFF-----GVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 141 MFLKICEAVKVFHDAKPIA----------YAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
             L + + + V   A  +A          + HRDL T N L+                 V
Sbjct: 153 GPLGLGQLLAV---ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-------------V 196

Query: 191 VKVCGSAEAQNLQD----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
           VK+     ++++          R  +P R   PE      Y      +DVWS G +L+
Sbjct: 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDVWSFGVVLW 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 51/246 (20%), Positives = 82/246 (33%), Gaps = 62/246 (25%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV-H 82
             + +G G F  V       I  +    + A+K +       ++   + E++       H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 83  PNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVDI 138
            NI+ LL     G    + P+        ++  Y   G L N L   R          + 
Sbjct: 109 ENIVNLL-----GACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 139 LKMFLKICEAVKVFHD-----AKPIA----------YAHRDLKTANVLLANDNNPLLMDL 183
            K   +  +   +  +     A  +A            HRDL   NVL+ +         
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK------- 209

Query: 184 GSVAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRTDVWS 236
                 VVK+C  G A         V      +P +  APE LF      +   ++DVWS
Sbjct: 210 ------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF----EGIYTIKSDVWS 259

Query: 237 LGCLLY 242
            G LL+
Sbjct: 260 YGILLW 265

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 54/241 (22%), Positives = 84/241 (34%), Gaps = 61/241 (25%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALK--KIICHGREDQAQAIREVEHHKTFV- 81
             + +G G F  V       +       + A+K  K   H  E +A  + E++       
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQ 108

Query: 82  HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL----------ELRSV 128
           H NI+ LL     G      PVL       ++  Y   G L N L             ++
Sbjct: 109 HENIVNLL-----GACTHGGPVL-------VITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 129 GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP 188
                S+ D+L    ++ + +            HRD+   NVLL N +            
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH------------ 201

Query: 189 AVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRTDVWSLGCLL 241
            V K+   G A         +      +P +  APE +F     CV   ++DVWS G LL
Sbjct: 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILL 256

Query: 242 Y 242
           +
Sbjct: 257 W 257

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 54/263 (20%), Positives = 95/263 (36%), Gaps = 67/263 (25%)

Query: 34  IGEGGFSTVSLIEHSQ---TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLD 90
           +G+G F  V L++       ++ YA+K +    ++   +    V    T +  +IL  ++
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVL----KKATLKVRDRVR---TKMERDILVEVN 84

Query: 91  HA-LTGCADPVLNSTSQ----VLMVLPYYPKGTLANDL-------ELRSVGKHYMSSVDI 138
           H  +       L+   Q    + ++L +   G L   L       E     K Y++    
Sbjct: 85  HPFIVK-----LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV--KFYLA---- 133

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
                ++  A+   H    I Y  RDLK  N+LL  + +  L D G           S E
Sbjct: 134 -----ELALALDHLHS-LGIIY--RDLKPENILLDEEGHIKLTDFGL----------SKE 175

Query: 199 AQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF-----D 252
           + + +  A   C    Y APE+ +   +    Q  D WS G L++ M     PF      
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGH---TQSADWWSFGVLMFEMLTGTLPFQGKDRK 232

Query: 253 TVYERGDSVALAVISGNITFPEN 275
                       ++   +  P+ 
Sbjct: 233 ETMTM-------ILKAKLGMPQF 248

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 46.4 bits (111), Expect = 4e-06
 Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 39/165 (23%)

Query: 33  KIGEGGFSTV---SLIEHSQTKKRYALKKIICHGREDQAQAIR----EVEHHKTFVHPNI 85
            IG G F  V    L +      + ALK+       + +Q I     E+E      HP++
Sbjct: 46  LIGHGVFGKVYKGVLRD----GAKVALKR----RTPESSQGIEEFETEIETLSFCRHPHL 97

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L+     G  D      ++++++  Y   G L   L    +    MS     +  L+I
Sbjct: 98  VSLI-----GFCD----ERNEMILIYKYMENGNLKRHLYGSDLPTMSMS----WEQRLEI 144

Query: 146 CEAVKVFHDAKPIAYAH------RDLKTANVLLANDNNPLLMDLG 184
           C        A+ + Y H      RD+K+ N+LL  +  P + D G
Sbjct: 145 CIGA-----ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 53/250 (21%), Positives = 88/250 (35%), Gaps = 75/250 (30%)

Query: 30  IVEKIGEGGFSTV-------SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV 81
           + + +GEG F  V          +  +     A+K +      +D +  + E+E  K   
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 82  -HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTL------------ANDLEL 125
            H NI+ LL     G      P+        +++ Y  KG L                ++
Sbjct: 99  KHKNIINLL-----GACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 126 RSVGKHYMSSVDILKMFLKIC------EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
             V +  M+  D++    ++        + K           HRDL   NVL+  +N   
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---------CIHRDLAARNVLVTENN--- 194

Query: 180 LMDLGSVAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRT 232
                     V+K+   G A   N  D         +P +  APE LF      V   ++
Sbjct: 195 ----------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF----DRVYTHQS 240

Query: 233 DVWSLGCLLY 242
           DVWS G L++
Sbjct: 241 DVWSFGVLMW 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 54/248 (21%), Positives = 80/248 (32%), Gaps = 66/248 (26%)

Query: 30  IVEKIGEGGFSTVSL-----IEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFV 81
            V  IGEG F  V       +   +     A   LK+      + QA   RE      F 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALMAEFD 108

Query: 82  HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDL-ELRSVGKHYMSSVD 137
           +PNI+ LL     G      P+        ++  Y   G L   L  +       +S  D
Sbjct: 109 NPNIVKLL-----GVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 138 ILKMFLKICEAVKVF------HDAKPIA----------YAHRDLKTANVLLANDNNPLLM 181
           +                      A+ +A          + HRDL T N L+  +      
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM----- 211

Query: 182 DLGSVAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRTDV 234
                   VVK+   G +      D   A    ++P R   PE +F    Y      +DV
Sbjct: 212 --------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF----YNRYTTESDV 259

Query: 235 WSLGCLLY 242
           W+ G +L+
Sbjct: 260 WAYGVVLW 267

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 53/250 (21%), Positives = 88/250 (35%), Gaps = 75/250 (30%)

Query: 30  IVEKIGEGGFSTV-------SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV 81
           + + +GEG F  V          +  +     A+K +      +D +  + E+E  K   
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 82  -HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTL------------ANDLEL 125
            H NI+ LL     G      P+        +++ Y  KG L                ++
Sbjct: 145 KHKNIINLL-----GACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 126 RSVGKHYMSSVDILKMFLKIC------EAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
             V +  M+  D++    ++        + K           HRDL   NVL+  +N   
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---------CIHRDLAARNVLVTENN--- 240

Query: 180 LMDLGSVAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRT 232
                     V+K+   G A   N  D         +P +  APE LF      V   ++
Sbjct: 241 ----------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF----DRVYTHQS 286

Query: 233 DVWSLGCLLY 242
           DVWS G L++
Sbjct: 287 DVWSFGVLMW 296

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 41/231 (17%), Positives = 79/231 (34%), Gaps = 46/231 (19%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHP 83
           ++  +G G F  V     S + +  +  + A+K +      +D+   + E      F H 
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 84  NILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLAN---DLELRSVGKHYMSSVD 137
           NI+  +     G    + P         +++     G L +   +   R      ++ +D
Sbjct: 94  NIVRCI-----GVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           +L +   I    +   +     + HRD+   N LL                 V K+    
Sbjct: 142 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR----------VAKIGDFG 188

Query: 198 EAQNLQD----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            A+++             +P +   PE F      +   +TD WS G LL+
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVLLW 236

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.7 bits (101), Expect = 7e-05
 Identities = 54/244 (22%), Positives = 87/244 (35%), Gaps = 63/244 (25%)

Query: 30  IVEKIGEGGFSTV-------SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV 81
           + + +GEG F  V          +      + A+K +      +D +  I E+E  K   
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 82  -HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTL------------ANDLEL 125
            H NI+ LL     G      P+        +++ Y  KG L                  
Sbjct: 133 KHKNIINLL-----GACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNP 180

Query: 126 RSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS 185
               +  +SS D++    ++   ++     K     HRDL   NVL+  DN         
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN--------- 228

Query: 186 VAPAVVKVC--GSAEAQNLQD--VAAERCSMPYR--APE-LFHVDSYCVVDQRTDVWSLG 238
               V+K+   G A   +  D         +P +  APE LF      +   ++DVWS G
Sbjct: 229 ----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFG 280

Query: 239 CLLY 242
            LL+
Sbjct: 281 VLLW 284

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 46/231 (19%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYALKKII-CHGREDQAQAIREVEHHKTFVHP 83
           ++  +G G F  V     S + +  +  + A+K +      +D+   + E      F H 
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 84  NILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLAN---DLELRSVGKHYMSSVD 137
           NI+  +     G    + P         ++L     G L +   +   R      ++ +D
Sbjct: 135 NIVRCI-----GVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV--CG 195
           +L +   I    +   +     + HRD+   N LL                 V K+   G
Sbjct: 183 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR----------VAKIGDFG 229

Query: 196 SAEAQNLQD--VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLLY 242
            A                +P +   PE F      +   +TD WS G LL+
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVLLW 277

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 46/241 (19%), Positives = 69/241 (28%), Gaps = 60/241 (24%)

Query: 30  IVEKIGEGGFSTV-----SLIEHSQTKKRYA---LKKIICHGREDQAQAIREVEHHKTFV 81
            +E++GE  F  V           +  +  A   LK         + +   E        
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD--KAEGPLREEFRHEAMLRARLQ 70

Query: 82  HPNILPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
           HPN++ LL     G      P+        M+  Y   G L     L     H       
Sbjct: 71  HPNVVCLL-----GVVTKDQPLS-------MIFSYCSHGDLHE--FLVMRSPHSDVGSTD 116

Query: 139 LKMFLKICEAVKVFHD-AKPIA----------YAHRDLKTANVLLANDNNPLLMDLGSVA 187
               +K       F      IA            H+DL T NVL+ +             
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL----------- 165

Query: 188 PAVVKVCGSAEAQNLQD----VAAERCSMPYR--APELFHVDSYCVVDQRTDVWSLGCLL 241
              VK+      + +             +P R  APE      Y      +D+WS G +L
Sbjct: 166 --NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVVL 220

Query: 242 Y 242
           +
Sbjct: 221 W 221

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 57/237 (24%)

Query: 30  IVEKIGEGGFSTV--SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFV-HPNI 85
             + IGEG F  V  + I+    +   A+K++     ++D      E+E       HPNI
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 86  LPLLDHALTGC---ADPVLNSTSQVLMVLPYYPKGTL------------ANDLELRSVGK 130
           + LL     G       +        + + Y P G L                 + +   
Sbjct: 89  INLL-----GACEHRGYLY-------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
             +SS  +L     +   +      +   + HRDL   N+L+  +              V
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY-------------V 180

Query: 191 VKVC--GSAEAQNLQDVAAERCSMPYR--APE-LFHVDSYCVVDQRTDVWSLGCLLY 242
            K+   G +  Q +  V      +P R  A E L     Y V    +DVWS G LL+
Sbjct: 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLW 232

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	282
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.14
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.13
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.98
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.81
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.72
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.68
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.51
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.31
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.03
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.94
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.88
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.7
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.15
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.46
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.79
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	82.68

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-52  Score=362.93  Aligned_cols=231  Identities=26%  Similarity=0.507  Sum_probs=182.4

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ..+.++...++|+++++||+|+||+||+|++..+|+.||||++....  ....+.+.+|+.++++++||||+++++.+. 
T Consensus        15 ten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-   93 (350)
T 4b9d_A           15 TENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-   93 (350)
T ss_dssp             CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             CcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-
Confidence            33445556789999999999999999999999999999999986543  345667899999999999999999999544 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              +...+|+|||||++|+|.+.+...  ....+++.+++.++.||+.||.|||++   ||+||||||+|||++.
T Consensus        94 --------~~~~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~  160 (350)
T 4b9d_A           94 --------ENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTK  160 (350)
T ss_dssp             --------ETTEEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECT
T ss_pred             --------ECCEEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECC
Confidence                    457899999999999999988643  334578999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.+||+|||+++..         ...........||+.|||||++.+..|   +.++||||+||++|||+||+.||.+.
T Consensus       161 ~g~vKl~DFGla~~~---------~~~~~~~~~~~GT~~YmAPE~l~~~~y---~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          161 DGTVQLGDFGIARVL---------NSTVELARACIGTPYYLSPEICENKPY---NNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             TCCEEECSTTEESCC---------CHHHHHHHHHHSCCTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCEEEcccccceee---------cCCcccccccCCCccccCHHHHCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999987532         111122334579999999999998877   88999999999999999999999863


Q ss_pred             ccCccceeeeeeeccc-cCCCC
Q psy16951        255 YERGDSVALAVISGNI-TFPEN  275 (282)
Q Consensus       255 ~~~~~~~~~~~~~~~~-~~p~~  275 (282)
                      +  ...+...+..+.+ +.|..
T Consensus       229 ~--~~~~~~~i~~~~~~~~~~~  248 (350)
T 4b9d_A          229 S--MKNLVLKIISGSFPPVSLH  248 (350)
T ss_dssp             S--HHHHHHHHHHTCCCCCCTT
T ss_pred             C--HHHHHHHHHcCCCCCCCcc
Confidence            2  2333334444443 34433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7e-53  Score=359.31  Aligned_cols=226  Identities=23%  Similarity=0.348  Sum_probs=189.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++++.||+|+||+||+|++..+++.||||.+....   ....+.+.+|+++++.++||||+++++.         
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~---------  100 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT---------  100 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE---------
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE---------
Confidence            3578999999999999999999999999999999986432   2334578899999999999999999984         


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      +++...+|+|||||++|+|.+.+...    ..+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl  173 (311)
T 4aw0_A          101 FQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI  173 (311)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEE
Confidence            44568899999999999999988643    4599999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||+++....       ...........||+.|||||++.+..|   +.++||||+||++|||+||+.||.+.  ....
T Consensus       174 ~DFGla~~~~~-------~~~~~~~~~~~GTp~YmAPEvl~~~~y---~~~~DiWSlGvilyeml~G~~PF~~~--~~~~  241 (311)
T 4aw0_A          174 TDFGTAKVLSP-------ESKQARANSFVGTAQYVSPELLTEKSA---CKSSDLWALGCIIYQLVAGLPPFRAG--NEGL  241 (311)
T ss_dssp             CCCTTCEECCT-------TTTCCCBCCCCSCGGGCCHHHHHHSCB---CHHHHHHHHHHHHHHHHHSSCSSCCS--SHHH
T ss_pred             EEcCCceecCC-------CCCcccccCcccCcccCCHHHHcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC--CHHH
Confidence            99998763211       001112234579999999999999887   88999999999999999999999763  3344


Q ss_pred             eeeeeeeccccCCCCCC
Q psy16951        261 VALAVISGNITFPENTP  277 (282)
Q Consensus       261 ~~~~~~~~~~~~p~~~~  277 (282)
                      +...+..+.+.+|+..+
T Consensus       242 ~~~~i~~~~~~~p~~~s  258 (311)
T 4aw0_A          242 IFAKIIKLEYDFPEKFF  258 (311)
T ss_dssp             HHHHHHHTCCCCCTTCC
T ss_pred             HHHHHHcCCCCCCcccC
Confidence            55566777888886654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-51  Score=351.33  Aligned_cols=234  Identities=21%  Similarity=0.322  Sum_probs=186.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      ..|+.++|.+.++||+|+||+||+|++.     .++..||||++...+....+++.+|++++++++||||+++++++.  
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe--
Confidence            3578899999999999999999999975     357889999998777777788999999999999999999999654  


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHH---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRS---------VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK  166 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk  166 (282)
                             +...+++|||||++|+|.+++....         .....+++.+++.++.||+.||.|||++   +|+|||||
T Consensus        86 -------~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlK  155 (299)
T 4asz_A           86 -------EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLA  155 (299)
T ss_dssp             -------SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             -------eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccC
Confidence                   3467999999999999999986431         2234689999999999999999999998   89999999


Q ss_pred             CCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       167 ~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      |+|||++.++.+||+|||+++....       ...........||+.|||||++.+..|   +.++|||||||++|||+|
T Consensus       156 p~NILl~~~~~~Ki~DFGla~~~~~-------~~~~~~~~~~~gt~~ymAPE~~~~~~~---~~k~DVwS~Gvvl~Ellt  225 (299)
T 4asz_A          156 TRNCLVGENLLVKIGDFGMSRDVYS-------TDYYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEIFT  225 (299)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTG-------GGCEEETTTEEECGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHT
T ss_pred             HhhEEECCCCcEEECCcccceecCC-------CCceeecCceecChhhcCHHHHcCCCC---CchhhHHHHHHHHHHHHc
Confidence            9999999999999999998753210       000111223457899999999998876   899999999999999999


Q ss_pred             -CCCCCCccccCccceeeeeeec-cccCCCCCCC
Q psy16951        247 -FKSPFDTVYERGDSVALAVISG-NITFPENTPF  278 (282)
Q Consensus       247 -g~~pf~~~~~~~~~~~~~~~~~-~~~~p~~~~~  278 (282)
                       |+.||.+...  ..+...+..+ .++.|+.+|.
T Consensus       226 ~G~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~  257 (299)
T 4asz_A          226 YGKQPWYQLSN--NEVIECITQGRVLQRPRTCPQ  257 (299)
T ss_dssp             TTCCTTTTSCH--HHHHHHHHHTCCCCCCTTCCH
T ss_pred             CCCCCCCCCCH--HHHHHHHHcCCCCCCCccchH
Confidence             8999986432  2233333333 4677777664

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-51  Score=349.24  Aligned_cols=222  Identities=20%  Similarity=0.259  Sum_probs=173.5

Q ss_pred             hhhhhhhcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCC
Q psy16951          7 NLIFQMGCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPN   84 (282)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~n   84 (282)
                      |.....+...+...|.|+.+++++.++||+|+||+||+|++.+   .||||.++...  ....+.+.+|++++++++|||
T Consensus        17 ~~~~p~~~~~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpN   93 (307)
T 3omv_A           17 NKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN   93 (307)
T ss_dssp             ------------CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTT
T ss_pred             cccCCcccCCCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCC
Confidence            4455556667778899999999999999999999999999854   48999886433  344567899999999999999


Q ss_pred             cccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         85 ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                      |+++++++..          ..+++|||||++|+|.+.+..   ....+++.+++.++.||+.||.|||++   +|+|||
T Consensus        94 IV~l~g~~~~----------~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRD  157 (307)
T 3omv_A           94 ILLFMGYMTK----------DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRD  157 (307)
T ss_dssp             BCCEEEEECS----------SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred             EeeEEEEEEC----------CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCc
Confidence            9999985422          357999999999999998863   234689999999999999999999998   899999


Q ss_pred             CCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        165 LKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       165 lk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |||+|||++.++.+||+|||+++...       ............||+.|||||++.+....+++.++|||||||++|||
T Consensus       158 lKp~NILl~~~~~~Ki~DFGla~~~~-------~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~El  230 (307)
T 3omv_A          158 MKSNNIFLHEGLTVKIGDFGLATVKS-------RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL  230 (307)
T ss_dssp             CCSSSEEEETTEEEEECCCSSCBC-------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEECCCCcEEEeeccCceecc-------cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHH
Confidence            99999999999999999999875321       01111223345789999999999765444458899999999999999


Q ss_pred             HhCCCCCCcc
Q psy16951        245 CYFKSPFDTV  254 (282)
Q Consensus       245 ~tg~~pf~~~  254 (282)
                      +||+.||.+.
T Consensus       231 ltg~~Pf~~~  240 (307)
T 3omv_A          231 MTGELPYSHI  240 (307)
T ss_dssp             HHSSCTTTTC
T ss_pred             HHCCCCCCCC
Confidence            9999999764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-51  Score=355.60  Aligned_cols=201  Identities=23%  Similarity=0.353  Sum_probs=176.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.|+++++||+|+||+||+|+++.+|+.||||++........+.+.+|+++++.++||||+++++++.         +.
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~---------~~  143 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL---------VG  143 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE---------ET
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE---------EC
Confidence            467999999999999999999999999999999997665556667889999999999999999999554         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+|+|||||++|+|.+.+..     ..+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||
T Consensus       144 ~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          144 DELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             TEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence            789999999999999998753     3489999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++...         ..........||+.|||||++.+..|   +.++||||+||++|||++|++||.+.
T Consensus       216 la~~~~---------~~~~~~~~~~GTp~YmAPEvl~~~~y---~~~~DiWSlGvilyeml~G~~PF~~~  273 (346)
T 4fih_A          216 FCAQVS---------KEVPRRKSLVGTPYWMAPELISRLPY---GPEVDIWSLGIMVIEMVDGEPPYFNE  273 (346)
T ss_dssp             TCEECC---------SSSCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CceecC---------CCCCcccccccCcCcCCHHHHCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            875321         01111234579999999999998887   89999999999999999999999763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.6e-51  Score=341.72  Aligned_cols=222  Identities=30%  Similarity=0.422  Sum_probs=173.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++++.||+|+||+||+|++..++..||||.+....   ......+.+|+++++.++||||+++++.+         
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~---------   82 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI---------   82 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE---------
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE---------
Confidence            478999999999999999999999999999999986442   23355788999999999999999999944         


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .+...+++||||+ +|+|.+.+..    ...+++.++..++.||+.||.|+|++   ||+||||||+||+++.++.+|++
T Consensus        83 ~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           83 KSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             ECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEEC
T ss_pred             EECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEe
Confidence            4567899999999 7899888763    35699999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||+++...          .........||+.|||||++.+..|  .+.++||||+||++|||+||+.||.+.  ....+
T Consensus       155 DFGla~~~~----------~~~~~~~~~GT~~Y~APE~~~~~~y--~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~  220 (275)
T 3hyh_A          155 DFGLSNIMT----------DGNFLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVL  220 (275)
T ss_dssp             CSSCC-------------------------CTTSCHHHHSSSSC--CCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHH
T ss_pred             ecCCCeecC----------CCCccCCeeECcccCChhhhcCCCC--CCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHH
Confidence            999875211          1112234578999999999998876  267999999999999999999999753  23334


Q ss_pred             eeeeeeccccCCCCCC
Q psy16951        262 ALAVISGNITFPENTP  277 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~~  277 (282)
                      ...+..+.+++|+..+
T Consensus       221 ~~~i~~~~~~~p~~~s  236 (275)
T 3hyh_A          221 FKNISNGVYTLPKFLS  236 (275)
T ss_dssp             HHHHHHTCCCCCTTSC
T ss_pred             HHHHHcCCCCCCCCCC
Confidence            4456667777776554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=350.21  Aligned_cols=236  Identities=20%  Similarity=0.278  Sum_probs=184.2

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ...|..++|.+.++||+|+||+||+|+++     .++..||||++...+....+.|.+|++++++++||||+++++++. 
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-  113 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-  113 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence            34577889999999999999999999975     368899999998777777788999999999999999999999654 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHH-----------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcccc
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRS-----------VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHR  163 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~  163 (282)
                              +...+++|||||++|+|.+++....           .....+++.+++.++.|++.||.|||++   +|+||
T Consensus       114 --------~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHR  182 (329)
T 4aoj_A          114 --------EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHR  182 (329)
T ss_dssp             --------SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             --------ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceecc
Confidence                    3467999999999999999886321           1234589999999999999999999998   89999


Q ss_pred             CCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHH
Q psy16951        164 DLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       164 dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~e  243 (282)
                      ||||+|||++.++.+||+|||+++....       ...........||+.|||||++.+..|   +.++|||||||++||
T Consensus       183 DLKp~NILl~~~~~~Ki~DFGla~~~~~-------~~~~~~~~~~~gt~~ymAPE~~~~~~~---~~~sDvwS~Gvvl~E  252 (329)
T 4aoj_A          183 DLATRNCLVGQGLVVKIGDFGMSRDIYS-------TDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWE  252 (329)
T ss_dssp             CCCGGGEEEETTTEEEECCCC-----------------------CCCCGGGCCHHHHTTCCC---CHHHHHHHHHHHHHH
T ss_pred             cccHhhEEECCCCcEEEcccccceeccC-------CCcceecCcccccccccChhhhcCCCC---CccccccchHHHHHH
Confidence            9999999999999999999998753210       111111234568999999999998876   899999999999999


Q ss_pred             HHh-CCCCCCccccCccceeeeee-eccccCCCCCCCC
Q psy16951        244 MCY-FKSPFDTVYERGDSVALAVI-SGNITFPENTPFP  279 (282)
Q Consensus       244 l~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~p~~~~~~  279 (282)
                      |+| |+.||.+...  ..+...+. +.+++.|+.+|+.
T Consensus       253 llt~G~~Pf~~~~~--~~~~~~i~~g~~~~~p~~~~~~  288 (329)
T 4aoj_A          253 IFTYGKQPWYQLSN--TEAIDCITQGRELERPRACPPE  288 (329)
T ss_dssp             HHTTSCCTTCSSCH--HHHHHHHHHTCCCCCCTTCCHH
T ss_pred             HHcCCCCCCCCCCH--HHHHHHHHcCCCCCCcccccHH
Confidence            999 8999986432  22222233 3357778777643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.3e-52  Score=352.15  Aligned_cols=225  Identities=20%  Similarity=0.331  Sum_probs=179.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ..++|++++.||+|+||+||+|++.   .+++.||||.+....  ......+.+|++++++++||||+++++.+.     
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----   96 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----   96 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----
Confidence            4578999999999999999999974   467899999986432  223346778999999999999999999544     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          +...+|+|||||++|+|.+.+...    ..+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+
T Consensus        97 ----~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v  165 (304)
T 3ubd_A           97 ----TEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI  165 (304)
T ss_dssp             ----ETTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCE
T ss_pred             ----ECCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCE
Confidence                457899999999999999988743    4589999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      |++|||+++...         ..........||+.|||||++.+..|   +.++||||+||++|||+||+.||.+.+  .
T Consensus       166 Kl~DFGla~~~~---------~~~~~~~~~~GT~~YmAPE~~~~~~y---~~~~DiwSlGvilyemltG~~PF~~~~--~  231 (304)
T 3ubd_A          166 KLTDFGLSKESI---------DHEKKAYSFCGTVEYMAPEVVNRRGH---TQSADWWSFGVLMFEMLTGTLPFQGKD--R  231 (304)
T ss_dssp             EEESSEEEEC--------------CCCCSCCCCGGGCCHHHHHTSCC---CTHHHHHHHHHHHHHHHHSSCSSCCSS--H
T ss_pred             Eecccccceecc---------CCCccccccccCcccCCHHHhccCCC---CCCCcccchHHHHHHHHhCCCCCCCcC--H
Confidence            999999875321         11112234578999999999998877   889999999999999999999998632  3


Q ss_pred             cceeeeeeeccccCCCCCCC
Q psy16951        259 DSVALAVISGNITFPENTPF  278 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ..+...+..+.+.+|+..++
T Consensus       232 ~~~~~~i~~~~~~~p~~~s~  251 (304)
T 3ubd_A          232 KETMTMILKAKLGMPQFLSP  251 (304)
T ss_dssp             HHHHHHHHHCCCCCCTTSCH
T ss_pred             HHHHHHHHcCCCCCCCcCCH
Confidence            33444566777777766543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=356.92  Aligned_cols=201  Identities=23%  Similarity=0.354  Sum_probs=177.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.|+++++||+|+||+||+|+++.+|..||||++........+.+.+|+.+|+.++||||+++++.+..         .
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---------~  220 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV---------G  220 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE---------T
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE---------C
Confidence            4679999999999999999999999999999999987766667778899999999999999999996544         5


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+|+|||||++|+|.+.+..     ..+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||
T Consensus       221 ~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          221 DELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             TEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCc
Confidence            789999999999999998753     3489999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++...         ..........||+.|||||++.+..|   +.++||||+||++|||++|+.||.+.
T Consensus       293 la~~~~---------~~~~~~~~~~GTp~YmAPEvl~~~~y---~~~~DiWSlGvilyeml~G~~PF~~~  350 (423)
T 4fie_A          293 FCAQVS---------KEVPRRKSLVGTPYWMAPELISRLPY---GPEVDIWSLGIMVIEMVDGEPPYFNE  350 (423)
T ss_dssp             TCEECC---------SSCCCBCCCEECTTTCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cceECC---------CCCccccccccCcCcCCHHHHCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            875321         01112234578999999999998887   89999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-49  Score=334.41  Aligned_cols=206  Identities=22%  Similarity=0.321  Sum_probs=171.2

Q ss_pred             EecccE-EEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKY-YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...++| ++.++||+|+||+||+|.+..++..||+|++...  .....+.+.+|++++++++||||+++++++..     
T Consensus        22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----   96 (290)
T 3fpq_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES-----   96 (290)
T ss_dssp             CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee-----
Confidence            344565 7888999999999999999999999999998643  33445678999999999999999999997654     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCc
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNP  178 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~  178 (282)
                      .......+++|||||++|+|.+.+...    ..+++..+..++.||+.||.|||++.+ +|+||||||+|||++. ++.+
T Consensus        97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~v  171 (290)
T 3fpq_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSV  171 (290)
T ss_dssp             EETTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCE
T ss_pred             ccCCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCE
Confidence            122346789999999999999988643    458999999999999999999999832 2999999999999974 7899


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||+|||+++...           ........||+.|||||++.+ .|   +.++|||||||++|||+||+.||.+
T Consensus       172 Kl~DFGla~~~~-----------~~~~~~~~GTp~YmAPE~~~~-~y---~~~~DiwSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          172 KIGDLGLATLKR-----------ASFAKAVIGTPEFMAPEMYEE-KY---DESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             EECCTTGGGGCC-----------TTSBEESCSSCCCCCGGGGGT-CC---CTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEEeCcCCEeCC-----------CCccCCcccCccccCHHHcCC-CC---CcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999999875210           111234579999999999865 35   8999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.3e-50  Score=344.90  Aligned_cols=204  Identities=21%  Similarity=0.264  Sum_probs=169.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ...+.|++.++||+|+||+||+|+++.+|..||||++.....     ..+|+.+++.++||||+++++++.         
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~---------  120 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR---------  120 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE---------
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE---------
Confidence            345679999999999999999999999999999999964432     246999999999999999999544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~  181 (282)
                      +...+|+|||||++|+|.+++...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++ .+||+
T Consensus       121 ~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~  193 (336)
T 4g3f_A          121 EGPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC  193 (336)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence            457899999999999999988643    4589999999999999999999999   899999999999999987 69999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||+++.....    .............||+.|||||++.+..|   +.++||||+||++|||+||++||.+.
T Consensus       194 DFGla~~~~~~----~~~~~~~~~~~~~GT~~YmAPE~~~~~~y---~~~~DiwSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          194 DFGHALCLQPD----GLGKSLLTGDYIPGTETHMAPEVVMGKPC---DAKVDIWSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             CCTTCEEC----------------CCCCCCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             eCCCCeEccCC----CcccceecCCccccCccccCHHHHCCCCC---CcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            99987632110    00011111223468999999999998877   88999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-50  Score=343.20  Aligned_cols=235  Identities=20%  Similarity=0.283  Sum_probs=184.7

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ..++.+++++.++||+|+||+||+|++.     .++..||||++.... ....+.|.+|+.++++++||||+++++++. 
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-   99 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-   99 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-
Confidence            3478899999999999999999999974     356889999986443 334678999999999999999999999654 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccc
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAH  162 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H  162 (282)
                              +...+++|||||++|+|.+++.....            ....+++.+++.++.||+.||.|||++   +|+|
T Consensus       100 --------~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiH  168 (308)
T 4gt4_A          100 --------KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVH  168 (308)
T ss_dssp             --------SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             --------ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCC
Confidence                    34678999999999999999864311            123588999999999999999999999   7899


Q ss_pred             cCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHH
Q psy16951        163 RDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       163 ~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~  242 (282)
                      |||||+|||++.++.+||+|||+++.....       ..........||+.|||||++.+..|   +.++|||||||++|
T Consensus       169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~-------~~~~~~~~~~gt~~ymAPE~l~~~~~---s~ksDVwSfGvvl~  238 (308)
T 4gt4_A          169 KDLATRNVLVYDKLNVKISDLGLFREVYAA-------DYYKLLGNSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLW  238 (308)
T ss_dssp             SCCSGGGEEECGGGCEEECCSCCBCGGGGG-------GCBCSSSSSCBCGGGCCHHHHHHCCC---CHHHHHHHHHHHHH
T ss_pred             CCccccceEECCCCCEEECCcccceeccCC-------CceeEecccccCCcccCHHHHhCCCC---CccchhhhHHHHHH
Confidence            999999999999999999999987632111       11111223467899999999998876   89999999999999


Q ss_pred             HHHh-CCCCCCccccCccceeeeee-eccccCCCCCCCC
Q psy16951        243 AMCY-FKSPFDTVYERGDSVALAVI-SGNITFPENTPFP  279 (282)
Q Consensus       243 el~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~p~~~~~~  279 (282)
                      ||+| |..||.+...  ..+...+. +..++.|+++|..
T Consensus       239 El~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~  275 (308)
T 4gt4_A          239 EVFSYGLQPYCGYSN--QDVVEMIRNRQVLPCPDDCPAW  275 (308)
T ss_dssp             HHHTTTCCTTTTCCH--HHHHHHHHTTCCCCCCTTCCHH
T ss_pred             HHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCcccchHH
Confidence            9998 8999986433  22222233 3346777777653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-49  Score=345.90  Aligned_cols=240  Identities=18%  Similarity=0.279  Sum_probs=188.4

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCC-----ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCC-CCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-----KRYALKKIICHGR-EDQAQAIREVEHHKTFVH-PNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H-~ni~~~~~~   91 (282)
                      +.|.|+.++|++.++||+|+||+||+|.+.+++     +.||||.+..... .....+.+|++++++++| |||++++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            458899999999999999999999999986543     6799999865543 345678999999999965 999999996


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +..        ....+++|||||++|+|.+++.....            ....+++.+++.++.||+.||.|||++   +
T Consensus       137 ~~~--------~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~  205 (353)
T 4ase_A          137 CTK--------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---K  205 (353)
T ss_dssp             ECC--------TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             EEe--------cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---C
Confidence            543        23568999999999999999875322            124578899999999999999999999   7


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      |+||||||+|||++.++.+||+|||+++.....       ..........||+.|||||++.+..|   +.++|||||||
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~-------~~~~~~~~~~gt~~ymAPE~l~~~~y---~~ksDVwS~Gv  275 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-------PDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGV  275 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTC-------TTSEEETTEEECGGGCCHHHHHHCCC---CHHHHHHHHHH
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccC-------CCceeeccccccccccCHHHHhcCCC---CCcccEeehHH
Confidence            899999999999999999999999987632110       01111234467899999999998877   89999999999


Q ss_pred             HHHHHHh-CCCCCCccccCccceeeeeeeccccCCCCCCCC
Q psy16951        240 LLYAMCY-FKSPFDTVYERGDSVALAVISGNITFPENTPFP  279 (282)
Q Consensus       240 il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~  279 (282)
                      ++|||+| |..||.+.............+.+++.|+.+|+.
T Consensus       276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~  316 (353)
T 4ase_A          276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE  316 (353)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHH
Confidence            9999998 899998643322222222233457778776643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.5e-47  Score=324.57  Aligned_cols=218  Identities=24%  Similarity=0.383  Sum_probs=162.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC---CC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP---VL  101 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~---~~  101 (282)
                      ++|++++.||+|+||+||+|+++.++..||||++..... ...+.+.+|+.++++++||||+++++.+.......   ..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            479999999999999999999999999999999975543 34567889999999999999999999876532100   01


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....+|+|||||++|+|.+++.... .........++.++.||+.||.|||++   ||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence            12346899999999999999886431 112345567889999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCch---hhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSA---EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~---~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||+++..........   ............||+.|||||++.+..|   +.++||||+||++|||++   ||.+
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y---~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY---SHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCC---CTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC---CCHHHHHHHHHHHHHHcc---CCCC
Confidence            9998764321111000   0001112234579999999999998877   899999999999999996   8865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=334.89  Aligned_cols=213  Identities=25%  Similarity=0.341  Sum_probs=174.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++++.||+|+||+||+|+++.||..||||++....  ......+.+|+++|+.++||||+++++++....   .+.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---~~~  129 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV---PYG  129 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS---CTT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc---ccc
Confidence            368999999999999999999999999999999996443  234567789999999999999999998665321   234


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+|+|||||. |+|.+.+.    ....+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+|++|
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEee
Confidence            5578999999995 67887774    345799999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      ||+++.....     ............||+.|+|||++.+..+  ++.++||||+||++|||++|++||.+.+
T Consensus       202 FGla~~~~~~-----~~~~~~~~~~~~GT~~Y~APEv~~~~~~--~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          202 FGMARGLCTS-----PAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             CTTCBCC------------CCCCCSSCCCCTTCCHHHHTTCSC--CCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cceeeecccC-----ccccccccccceeChHhcCHHHhcCCCC--CCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            9987632110     0111112234578999999999987654  4889999999999999999999997643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.5e-46  Score=344.54  Aligned_cols=226  Identities=23%  Similarity=0.315  Sum_probs=180.9

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHH---HHHHHHhhhCCCCCccccccccccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQA---IREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~---~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .+..++|++++.||+|+||+||+|+++.||..||||++....   .......   .+++.+++.++||||+++++.    
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~----  260 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA----  260 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE----
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE----
Confidence            556789999999999999999999999999999999985321   1111222   334667788899999999984    


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                           +.+...+|+||||+++|+|.+++...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.+
T Consensus       261 -----f~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~  328 (689)
T 3v5w_A          261 -----FHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH  328 (689)
T ss_dssp             -----EECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT
T ss_pred             -----EEECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCC
Confidence                 44568899999999999999988643    4589999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++||+|||+++...           ........||+.|||||++.+ ..|   +.++|+||+||++|||++|.+||.+.
T Consensus       329 G~vKL~DFGlA~~~~-----------~~~~~t~~GTp~YmAPEvl~~~~~y---~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          329 GHVRISDLGLACDFS-----------KKKPHASVGTHGYMAPEVLQKGVAY---DSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             SCEEECCCTTCEECS-----------SCCCCSCCSCGGGCCHHHHSTTCCC---CTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CCEEecccceeeecC-----------CCCCCCccCCcCccCHHHHhCCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999875321           011234579999999999974 455   88999999999999999999999864


Q ss_pred             ccCcc-ceeeeeeeccccCCCCCC
Q psy16951        255 YERGD-SVALAVISGNITFPENTP  277 (282)
Q Consensus       255 ~~~~~-~~~~~~~~~~~~~p~~~~  277 (282)
                      ..... .+...+....+.+|+..+
T Consensus       395 ~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          395 KTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             GCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ChHHHHHHHHhhcCCCCCCCccCC
Confidence            33221 223334555666776544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-45  Score=315.62  Aligned_cols=209  Identities=20%  Similarity=0.213  Sum_probs=158.6

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ++|.+.++||+|+||+||+|++  +|..||||++..... ....+..|+..+..++||||+++++++...     .....
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-----~~~~~   74 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-----NGTWT   74 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-----CSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEec-----CCCce
Confidence            5789999999999999999998  688999999854322 122233466667789999999999977652     11224


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCccccCCCCCcEEeecCCCcee
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK-----PIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .+++||||+++|+|.+.+..     ..+++..+..++.|++.||.|||++.     ..+|+||||||+|||++.++.+||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            68999999999999998863     34788999999999999999999751     117999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc---cCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY---CVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~---~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +|||+++.....     ............||+.|||||++.+...   ..++.++|||||||++|||+||.+||.
T Consensus       150 ~DFGla~~~~~~-----~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          150 ADLGLAVRHDSA-----TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CCCTTCEEEETT-----TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EeCCCCccccCC-----CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            999987532111     0000111223468999999999976421   012678999999999999999987664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-45  Score=340.52  Aligned_cols=220  Identities=24%  Similarity=0.407  Sum_probs=183.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++++.||+|+||+||+|+++.+|..||+|.+......+...+.+|+.+|+.++||||+++++.+         .+.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~---------~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF---------EDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE---------ECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE---------EEC
Confidence            36899999999999999999999999999999999877777777889999999999999999999844         456


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC--CCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND--NNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~~~~~~d  182 (282)
                      ..+++|||||++|+|.+.+..   ....+++.++..++.||+.||.|||++   ||+||||||+|||++.+  +.+|++|
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEee
Confidence            889999999999999987742   234589999999999999999999999   89999999999999854  8899999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||+++....          ........||+.|||||++.+..|   +.++||||+||++|||++|.+||.+...  ..+.
T Consensus       301 FG~a~~~~~----------~~~~~~~~GT~~y~APEv~~~~~y---~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~  365 (573)
T 3uto_A          301 FGLTAHLDP----------KQSVKVTTGTAEFAAPEVAEGKPV---GYYTDMWSVGVLSYILLSGLSPFGGEND--DETL  365 (573)
T ss_dssp             CSSCEECCT----------TSEEEEECSSGGGCCHHHHTTCCB---CHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH
T ss_pred             ccceeEccC----------CCceeeeEECccccCHHHhCCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH
Confidence            998764211          111234568999999999999887   8899999999999999999999986332  3333


Q ss_pred             eeeeeccccCCC
Q psy16951        263 LAVISGNITFPE  274 (282)
Q Consensus       263 ~~~~~~~~~~p~  274 (282)
                      ..+....+.+|+
T Consensus       366 ~~i~~~~~~~~~  377 (573)
T 3uto_A          366 RNVKSCDWNMDD  377 (573)
T ss_dssp             HHHHTTCCCCCS
T ss_pred             HHHHhCCCCCCc
Confidence            344555555443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.5e-44  Score=313.75  Aligned_cols=206  Identities=23%  Similarity=0.342  Sum_probs=164.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .++|++.++||+|+||+||+|+++   .+++.||||.+....  ....+.+|+++++.+ +||||+++++.+        
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~--------   89 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF--------   89 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE--------
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE--------
Confidence            478999999999999999999875   467899999886443  344567899999988 699999999844        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCce
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNPL  179 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~~  179 (282)
                       .+...+++||||+++++|.+.+.       .+++.++..++.|++.||.|||++   ||+||||||+|||++.+ +.+|
T Consensus        90 -~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           90 -RKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             -EETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             -EECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence             44578999999999999998762       389999999999999999999999   89999999999999877 7899


Q ss_pred             eecccCccchhhhccCch-------------------hhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHH
Q psy16951        180 LMDLGSVAPAVVKVCGSA-------------------EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL  240 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~i  240 (282)
                      ++|||+++..........                   ............||+.|+|||++.+..+  ++.++||||+||+
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--y~~~~DiWSlG~i  236 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPN--QTTAIDMWSAGVI  236 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSC--CCTHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC--CCCccchhhhHHH
Confidence            999998763211000000                   0001112234579999999999987642  3889999999999


Q ss_pred             HHHHHhCCCCCCc
Q psy16951        241 LYAMCYFKSPFDT  253 (282)
Q Consensus       241 l~el~tg~~pf~~  253 (282)
                      +|||++|+.||..
T Consensus       237 l~ell~G~~Pf~~  249 (361)
T 4f9c_A          237 FLSLLSGRYPFYK  249 (361)
T ss_dssp             HHHHHHTCSSSSC
T ss_pred             HHHHHHCCCCCCC
Confidence            9999999999964

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-42  Score=299.10  Aligned_cols=227  Identities=29%  Similarity=0.408  Sum_probs=184.0

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .-....++|++.+.||+|+||.||+|++..++..||||++...  .......+.+|+++++.++||||+++++.+     
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----   83 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----   83 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            3344578999999999999999999999999999999998643  334456778999999999999999999854     


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                          ......++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.
T Consensus        84 ----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~  152 (328)
T 3fe3_A           84 ----ETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMN  152 (328)
T ss_dssp             ----ECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ----EECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCC
Confidence                3457899999999999999988643    4589999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +|++|||++....          .........||+.|+|||++.+..+  .+.++||||+|+++|+|++|+.||.+..  
T Consensus       153 ~kl~DFG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~--  218 (328)
T 3fe3_A          153 IKIADFGFSNEFT----------VGGKLDAFCGAPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSLPFDGQN--  218 (328)
T ss_dssp             EEECSTTCCGGGS----------SSCGGGTTSSSGGGCCHHHHHTCCC--CSHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             EEEeeccCceecC----------CCCccccccCCcceeCcccccCCCc--CCchhhhhhhHHHHHHHHhCCCCCCCCC--
Confidence            9999999764321          1112234568999999999988765  2478999999999999999999997632  


Q ss_pred             ccceeeeeeeccccCCCCC
Q psy16951        258 GDSVALAVISGNITFPENT  276 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~~  276 (282)
                      ...+...+..+.+.+|...
T Consensus       219 ~~~~~~~i~~~~~~~p~~~  237 (328)
T 3fe3_A          219 LKELRERVLRGKYRIPFYM  237 (328)
T ss_dssp             HHHHHHHHHHCCCCCCTTS
T ss_pred             HHHHHHHHHhCCCCCCCCC
Confidence            2333334555556666443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-42  Score=299.09  Aligned_cols=225  Identities=21%  Similarity=0.339  Sum_probs=181.9

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +..++|++++.||+|+||+||+|++..++..||+|.+...   .......+.+|+.+++.++||||+++++.+.      
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~------   75 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ------   75 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE------
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE------
Confidence            3568999999999999999999999999999999998543   1223456788999999999999999998544      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         ....+++||||+++++|...+...    ..+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+|
T Consensus        76 ---~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk  145 (337)
T 1o6l_A           76 ---THDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             ---eCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEE
Confidence               457899999999999999887642    4589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      ++|||++.....         .........||+.|+|||++.+..+   +.++|+||+|+++|||++|..||.+..  ..
T Consensus       146 L~DFG~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~--~~  211 (337)
T 1o6l_A          146 ITDFGLCKEGIS---------DGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQD--HE  211 (337)
T ss_dssp             ECCCTTCBCSCC---------TTCCBCCCEECGGGCCGGGGSSSCB---CTTHHHHHHHHHHHHHHHSSCSSCCSS--HH
T ss_pred             Eeeccchhhccc---------CCCcccccccChhhCChhhhcCCCC---CchhhcccchhHHHHHhcCCCCCCCCC--HH
Confidence            999998653110         0111224467899999999988776   889999999999999999999997532  22


Q ss_pred             ceeeeeeeccccCCCCCC
Q psy16951        260 SVALAVISGNITFPENTP  277 (282)
Q Consensus       260 ~~~~~~~~~~~~~p~~~~  277 (282)
                      .+...+....+.+|...+
T Consensus       212 ~~~~~i~~~~~~~p~~~s  229 (337)
T 1o6l_A          212 RLFELILMEEIRFPRTLS  229 (337)
T ss_dssp             HHHHHHHHCCCCCCTTSC
T ss_pred             HHHHHHHcCCCCCCCCCC
Confidence            333334445556665443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=301.53  Aligned_cols=226  Identities=23%  Similarity=0.340  Sum_probs=178.5

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGC   96 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~   96 (282)
                      ..+..++|++++.||+|+||+||+|++..++..||||.+...   .........+|..+++.+ +||||+++++.+.   
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~---   94 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ---   94 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE---
Confidence            346788999999999999999999999999999999998533   122345567899999988 7999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            ....+++||||+++++|...+...    ..+++..+..++.||+.||.|||++   ||+||||||+||+++.++
T Consensus        95 ------~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g  161 (353)
T 3txo_A           95 ------TPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG  161 (353)
T ss_dssp             ------CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             ------eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCC
Confidence                  457899999999999999888643    4589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+|++|||+++...         ..........||+.|+|||++.+..+   +.++||||+|+++|||++|..||.+.  
T Consensus       162 ~ikL~DFG~a~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~G~~Pf~~~--  227 (353)
T 3txo_A          162 HCKLADFGMCKEGI---------CNGVTTATFCGTPDYIAPEILQEMLY---GPAVDWWAMGVLLYEMLCGHAPFEAE--  227 (353)
T ss_dssp             CEEECCCTTCBCSC---------C---------CCGGGCCHHHHHHHHC---TTHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred             CEEEccccceeecc---------cCCccccccCCCcCeEChhhcCCCCc---CCccCCCcchHHHHHHHhCCCCCCCC--
Confidence            99999999865211         11112234568999999999988776   88999999999999999999999763  


Q ss_pred             CccceeeeeeeccccCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENT  276 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~  276 (282)
                      ....+...+..+.+.+|...
T Consensus       228 ~~~~~~~~i~~~~~~~p~~~  247 (353)
T 3txo_A          228 NEDDLFEAILNDEVVYPTWL  247 (353)
T ss_dssp             SHHHHHHHHHHCCCCCCTTS
T ss_pred             CHHHHHHHHHcCCCCCCCCC
Confidence            23344445566666666543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=287.86  Aligned_cols=230  Identities=44%  Similarity=0.824  Sum_probs=187.4

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +...+.+..++|++.+.||+|+||.||++++..++..||||.+..........+.+|+++++.++||||+++++++... 
T Consensus        20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   98 (317)
T 2buj_A           20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-   98 (317)
T ss_dssp             EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-
T ss_pred             cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-
Confidence            3456778889999999999999999999999999999999998777667777889999999999999999999876531 


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                          .......++|+||+.+++|.+.+.........+++..++.++.|++.||.|||++   |++|+||||+||+++.++
T Consensus        99 ----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~  171 (317)
T 2buj_A           99 ----RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEG  171 (317)
T ss_dssp             ----ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred             ----cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence                1234678999999999999998886544556789999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++++|||.+.......................||+.|+|||++.+.....++.++||||||+++|+|++|..||...
T Consensus       172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  249 (317)
T 2buj_A          172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV  249 (317)
T ss_dssp             CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred             CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence            999999997654322211122222222334456799999999997665333478999999999999999999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-41  Score=301.37  Aligned_cols=231  Identities=23%  Similarity=0.339  Sum_probs=181.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~   94 (282)
                      ....+..++|++++.||+|+||+||+|++..++..||+|++....   ......+.+|..+++++ +||||+++++.+. 
T Consensus        45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-  123 (396)
T 4dc2_A           45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-  123 (396)
T ss_dssp             ----CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             cccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-
Confidence            345677899999999999999999999999999999999986432   22233567788888876 8999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              +...+++||||+++|+|...+...    ..+++..+..++.||+.||.|||++   ||+||||||+||+++.
T Consensus       124 --------~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~  188 (396)
T 4dc2_A          124 --------TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS  188 (396)
T ss_dssp             --------CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT
T ss_pred             --------ECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECC
Confidence                    457899999999999999888643    4589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.+|++|||+++...         ..........||+.|+|||++.+..+   +.++|+||+||++|||++|+.||...
T Consensus       189 ~g~ikL~DFGla~~~~---------~~~~~~~~~~gt~~Y~aPE~l~~~~~---~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          189 EGHIKLTDYGMCKEGL---------RPGDTTSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             TSCEEECCCTTCBCCC---------CTTCCBCCCCBCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             CCCEEEeecceeeecc---------cCCCccccccCCcccCCchhhcCCCC---ChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            9999999999865210         01112234568999999999998877   89999999999999999999999643


Q ss_pred             ccCc-------cceeeeeeeccccCCCCCC
Q psy16951        255 YERG-------DSVALAVISGNITFPENTP  277 (282)
Q Consensus       255 ~~~~-------~~~~~~~~~~~~~~p~~~~  277 (282)
                      ....       +.+...+....+.+|...+
T Consensus       257 ~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  286 (396)
T 4dc2_A          257 GSSDNPDQNTEDYLFQVILEKQIRIPRSLS  286 (396)
T ss_dssp             TC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccchhhHHHHHHHHhccccCCCCcCC
Confidence            2211       1122334555666665543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-41  Score=296.42  Aligned_cols=228  Identities=22%  Similarity=0.327  Sum_probs=179.5

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~   94 (282)
                      ....+..++|++.+.||+|+||+||+|++..++..||||.+....   .........|..+++.+ +||||+++++.+. 
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-   88 (345)
T 1xjd_A           10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-   88 (345)
T ss_dssp             ------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             ccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-
Confidence            345678899999999999999999999999999999999985432   22344567788888876 8999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              +...+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.
T Consensus        89 --------~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~  153 (345)
T 1xjd_A           89 --------TKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDK  153 (345)
T ss_dssp             --------CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT
T ss_pred             --------eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECC
Confidence                    457899999999999999988642    4589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.++++|||++.....         .........||+.|+|||++.+..+   +.++|+||+|+++|||++|..||.+.
T Consensus       154 ~g~vkL~DFG~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          154 DGHIKIADFGMCKENML---------GDAKTNTFCGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             TSCEEECCCTTCBCCCC---------TTCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCEEEeEChhhhhccc---------CCCcccCCCCCcccCChhhhcCCCC---CChhhhHHHHHHHHHHhcCCCCCCCC
Confidence            99999999998653210         0111234568999999999988776   88999999999999999999999753


Q ss_pred             ccCccceeeeeeeccccCCCCC
Q psy16951        255 YERGDSVALAVISGNITFPENT  276 (282)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~p~~~  276 (282)
                      ..  ..+...+..+.+.+|...
T Consensus       222 ~~--~~~~~~i~~~~~~~p~~~  241 (345)
T 1xjd_A          222 DE--EELFHSIRMDNPFYPRWL  241 (345)
T ss_dssp             SH--HHHHHHHHHCCCCCCTTS
T ss_pred             CH--HHHHHHHHhCCCCCCccc
Confidence            22  233333444555555443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-41  Score=291.03  Aligned_cols=221  Identities=22%  Similarity=0.325  Sum_probs=181.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +..++|++++.||+|+||+||+|++..++..||+|.+....   ....+.+.+|..+++.++||||+++++.+.      
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~------   76 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ------   76 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE------
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE------
Confidence            35689999999999999999999999999999999885332   123456678999999999999999998543      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         +...+++||||+++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|
T Consensus        77 ---~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k  146 (318)
T 1fot_A           77 ---DAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK  146 (318)
T ss_dssp             ---CSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred             ---eCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence               45789999999999999998863    34589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      ++|||++....            .......||+.|+|||++.+..+   +.++|+||+|+++|||++|..||.+...  .
T Consensus       147 L~Dfg~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~~~--~  209 (318)
T 1fot_A          147 ITDFGFAKYVP------------DVTYTLCGTPDYIAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTPFYDSNT--M  209 (318)
T ss_dssp             ECCCSSCEECS------------SCBCCCCSCTTTCCHHHHTTCCB---CTTHHHHHHHHHHHHHHHSSCTTCCSSH--H
T ss_pred             EeecCcceecC------------CccccccCCccccCHhHhcCCCC---CcccchhhhHHHHHHHHhCCCCCCCCCH--H
Confidence            99999865321            01123468999999999988776   8899999999999999999999975322  2


Q ss_pred             ceeeeeeeccccCCCCC
Q psy16951        260 SVALAVISGNITFPENT  276 (282)
Q Consensus       260 ~~~~~~~~~~~~~p~~~  276 (282)
                      .....+..+.+.+|+..
T Consensus       210 ~~~~~i~~~~~~~p~~~  226 (318)
T 1fot_A          210 KTYEKILNAELRFPPFF  226 (318)
T ss_dssp             HHHHHHHHCCCCCCTTS
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            23334445555666543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=284.42  Aligned_cols=219  Identities=20%  Similarity=0.282  Sum_probs=180.6

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...+..++|++.+.||+|+||+||+|.+..++..||+|.+..........+.+|+++++.++||||+++++++..     
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   78 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----   78 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----
Confidence            456788999999999999999999999999999999999877777778889999999999999999999996543     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                          ....++|+||+++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus        79 ----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~k  148 (310)
T 3s95_A           79 ----DKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVV  148 (310)
T ss_dssp             ----TTEEEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEE
T ss_pred             ----CCeeEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEE
Confidence                47799999999999999988642   34588999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchh-----hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAE-----AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~-----~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+............     ...........||+.|+|||++.+..+   +.++||||+|+++|||++|..||...
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY---DEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC---CcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            9999987543211110000     000111124568999999999988766   88999999999999999999999764


Q ss_pred             cc
Q psy16951        255 YE  256 (282)
Q Consensus       255 ~~  256 (282)
                      ..
T Consensus       226 ~~  227 (310)
T 3s95_A          226 LP  227 (310)
T ss_dssp             SC
T ss_pred             hh
Confidence            33

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.9e-41  Score=292.91  Aligned_cols=203  Identities=24%  Similarity=0.365  Sum_probs=172.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      +..++|++++.||+|+||+||+|++..++..||+|.+...   .......+.+|..+++.+ +||||+++++.+.     
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----
Confidence            4678999999999999999999999999999999998643   223445677899999887 8999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          ....+++||||+++++|.+.+...    ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.+
T Consensus        81 ----~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  149 (345)
T 3a8x_A           81 ----TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI  149 (345)
T ss_dssp             ----CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             ----eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence                457899999999999999888643    4589999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |++|||++....         ..........||+.|+|||++.+..+   +.++|+||+||++|||++|..||..
T Consensus       150 kL~DFG~a~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          150 KLTDYGMCKEGL---------RPGDTTSTFCGTPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             EECCGGGCBCSC---------CTTCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEEecccccccc---------CCCCcccccCCCccccCccccCCCCC---ChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            999999765211         00111234468999999999998776   8899999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-41  Score=296.07  Aligned_cols=226  Identities=20%  Similarity=0.309  Sum_probs=181.9

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++++.||+|+||+||+|++..++..||+|.+....   ......+.+|..++..+ +||+|+++++.+     
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----   90 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----   90 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----
Confidence            467889999999999999999999999999999999985431   22345667899999887 799999999844     


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                          .....+++||||+++|+|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.
T Consensus        91 ----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           91 ----QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             ----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             ----EcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence                3457899999999999999988643    3589999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      ++++|||++.....         .........||+.|+|||++.+..+   +.++|+||+|+++|||++|+.||.+..  
T Consensus       160 vkL~DFG~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~G~~Pf~~~~--  225 (353)
T 2i0e_A          160 IKIADFGMCKENIW---------DGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEGED--  225 (353)
T ss_dssp             EEECCCTTCBCCCC---------TTCCBCCCCSCGGGCCHHHHTTCCB---STHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             EEEEeCCccccccc---------CCcccccccCCccccChhhhcCCCc---CCcccccchHHHHHHHHcCCCCCCCCC--
Confidence            99999998653110         0111234468999999999988776   889999999999999999999997632  


Q ss_pred             ccceeeeeeeccccCCCCCC
Q psy16951        258 GDSVALAVISGNITFPENTP  277 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ...+...+....+.+|+..+
T Consensus       226 ~~~~~~~i~~~~~~~p~~~s  245 (353)
T 2i0e_A          226 EDELFQSIMEHNVAYPKSMS  245 (353)
T ss_dssp             HHHHHHHHHHCCCCCCTTSC
T ss_pred             HHHHHHHHHhCCCCCCCCCC
Confidence            23344445556666665543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-41  Score=304.71  Aligned_cols=208  Identities=22%  Similarity=0.327  Sum_probs=171.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ..+..++|+++++||+|+||+||+|++..+++.||+|++......   ....+.+|..++..++||||+++++.+.    
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~----  144 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ----  144 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE----
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe----
Confidence            446678999999999999999999999999999999998532111   1223678999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           +...+++||||+++|+|.+++..   ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.
T Consensus       145 -----~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          145 -----DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             -----CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             -----eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence                 45789999999999999998863   234689999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc-----cCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH-----VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~-----~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +|++|||++....        ...........||+.|+|||++.     ...+   +.++||||+||++|||++|+.||.
T Consensus       214 vkL~DFGla~~~~--------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~---~~~~DvwSlGvil~elltG~~Pf~  282 (437)
T 4aw2_A          214 IRLADFGSCLKLM--------EDGTVQSSVAVGTPDYISPEILQAMEGGKGRY---GPECDWWSLGVCMYEMLYGETPFY  282 (437)
T ss_dssp             EEECCCTTCEECC--------TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEE---CTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEcchhhhhhcc--------cCCCcccccccCCcCeeChHHHhhcccCCCCC---CCcCeeHHHHHHHHHHHhCCCCCC
Confidence            9999999865321        00011122346899999999997     3344   889999999999999999999997


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       283 ~~  284 (437)
T 4aw2_A          283 AE  284 (437)
T ss_dssp             CS
T ss_pred             CC
Confidence            63

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-40  Score=286.38  Aligned_cols=236  Identities=21%  Similarity=0.349  Sum_probs=175.7

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ....+.+.+..++|++.+.||+|+||+||+|++  ++..||+|.+.....  .....+.+|++++++++||||+++++.+
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            455667788899999999999999999999988  678899999865543  3345788999999999999999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ccccCCCCCcE
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA--YAHRDLKTANV  170 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~--i~H~dlk~~ni  170 (282)
                      .         .....++||||+++++|.+.+..... ...+++..++.++.|++.||.|||++   |  ++||||||+||
T Consensus       104 ~---------~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NI  170 (309)
T 3p86_A          104 T---------QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNL  170 (309)
T ss_dssp             C---------STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGE
T ss_pred             E---------ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhE
Confidence            3         44678999999999999998863211 12388999999999999999999999   7  99999999999


Q ss_pred             EeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        171 LLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      +++.++.++++|||.+...         ...........||+.|+|||++.+..+   +.++||||+|+++|+|++|..|
T Consensus       171 ll~~~~~~kL~Dfg~a~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~P  238 (309)
T 3p86_A          171 LVDKKYTVKVCDFGLSRLK---------ASTFLSSKSAAGTPEWMAPEVLRDEPS---NEKSDVYSFGVILWELATLQQP  238 (309)
T ss_dssp             EECTTCCEEECCCC--------------------------CCTTSCHHHHTTCCC---CTTHHHHHHHHHHHHHHHCCCT
T ss_pred             EEeCCCcEEECCCCCCccc---------cccccccccCCCCccccChhhhcCCCC---CchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999976421         111112234567999999999988766   8899999999999999999999


Q ss_pred             CCccccCccceeeeeeeccccCCCCCC
Q psy16951        251 FDTVYERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       251 f~~~~~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      |.+................+.+|...+
T Consensus       239 f~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T 3p86_A          239 WGNLNPAQVVAAVGFKCKRLEIPRNLN  265 (309)
T ss_dssp             TTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred             CCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            986433222112212333445555444

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.6e-42  Score=303.67  Aligned_cols=210  Identities=24%  Similarity=0.351  Sum_probs=172.5

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ...+..++|++++.||+|+||+||+|++..++..||+|.+.....   .....+.+|+.+++.++||||+++++.+.   
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~---  139 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ---  139 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE---
Confidence            455678999999999999999999999999999999998853211   11234678999999999999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            +...+++||||+++|+|.+.+..     ..+++..+..++.|++.||.|||++   ||+||||||+||+++.++
T Consensus       140 ------~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g  205 (410)
T 3v8s_A          140 ------DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  205 (410)
T ss_dssp             ------CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             ------ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCC
Confidence                  45789999999999999997753     3489999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc-CCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC-VVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~-~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+|++|||++....        ...........||+.|+|||++.+.... .++.++||||+|+++|||++|+.||.+.
T Consensus       206 ~ikL~DFG~a~~~~--------~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          206 HLKLADFGTCMKMN--------KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             CEEECCCTTCEECC--------TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CEEEeccceeEeec--------cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            99999999865321        0001112245689999999999865410 0278999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-40  Score=281.70  Aligned_cols=205  Identities=27%  Similarity=0.422  Sum_probs=169.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +..++|++++.||+|+||.||+|++..++..||+|.+....   ......+.+|+..++.++||||+++++.+       
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-------   80 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-------   80 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-------
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-------
Confidence            34679999999999999999999999999999999885433   23345778999999999999999999854       


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        ......++||||+++++|.+++...    ..+++..++.++.|++.||.|+|++   |++||||||+||+++.++.++
T Consensus        81 --~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~k  151 (294)
T 4eqm_A           81 --EEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLK  151 (294)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             --eeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence              3457899999999999999988643    3589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+....        ...........||+.|+|||++.+..+   +.++||||+|+++|+|++|+.||.+.
T Consensus       152 l~Dfg~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~~l~~ll~g~~pf~~~  215 (294)
T 4eqm_A          152 IFDFGIAKALS--------ETSLTQTNHVLGTVQYFSPEQAKGEAT---DECTDIYSIGIVLYEMLVGEPPFNGE  215 (294)
T ss_dssp             ECCCSSSTTC---------------------CCSSCCHHHHHTCCC---CTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             EEeCCCccccc--------cccccccCccccCccccCHhHhcCCCC---CchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999765321        111112233457999999999988766   88999999999999999999999763

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-41  Score=287.29  Aligned_cols=202  Identities=25%  Similarity=0.365  Sum_probs=175.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||+||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++.+..         
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------   88 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV---------   88 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE---------
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE---------
Confidence            46789999999999999999999999999999999976666667788899999999999999999986554         


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++||||+.+++|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           89 GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeC
Confidence            4679999999999999998863     2488999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++.....         .........||+.|+|||++.+..+   +.++||||+|+++|||++|..||.+.
T Consensus       161 g~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          161 GFCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             TTCEECCS---------TTCCBCCCCSCGGGCCHHHHHCSCB---CTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCceecCC---------cccccCCccCCcCccChhhhcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            97643210         1111223467899999999988876   88999999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.8e-41  Score=292.91  Aligned_cols=223  Identities=21%  Similarity=0.307  Sum_probs=183.9

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ....++|++++.||+|+||.||+|++..++..||+|.+....   ......+.+|+.+++.++||||+++++.+.     
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----
Confidence            456789999999999999999999999999999999985332   123456788999999999999999988543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          +...+++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+
T Consensus       112 ----~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  180 (350)
T 1rdq_E          112 ----DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             ----CSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             ----cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCE
Confidence                457899999999999999988643    3589999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      +++|||++.....            ......||+.|+|||++.+..+   +.++|+||+|+++|||++|..||.+.  ..
T Consensus       181 kL~DFg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~--~~  243 (350)
T 1rdq_E          181 QVTDFGFAKRVKG------------RTWTLCGTPEALAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFAD--QP  243 (350)
T ss_dssp             EECCCTTCEECSS------------CBCCCEECGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCS--SH
T ss_pred             EEcccccceeccC------------CcccccCCccccCHHHhcCCCC---CCcCCEecccHhHhHHhhCCCCCCCC--CH
Confidence            9999998653210            1123467899999999988776   88999999999999999999999753  22


Q ss_pred             cceeeeeeeccccCCCCCC
Q psy16951        259 DSVALAVISGNITFPENTP  277 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~~~  277 (282)
                      ..+...+..+.+.+|+..+
T Consensus       244 ~~~~~~i~~~~~~~p~~~~  262 (350)
T 1rdq_E          244 IQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             HHHHHHHHHCCCCCCTTCC
T ss_pred             HHHHHHHHcCCCCCCCCCC
Confidence            3333445556666665543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.7e-41  Score=294.75  Aligned_cols=226  Identities=23%  Similarity=0.359  Sum_probs=174.8

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHH-hhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEH-HKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~-l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++++.||+|+||+||+|++..++..||+|.+.....   .....+.+|..+ ++.++||||+++++.+.    
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~----  109 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ----  109 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE----
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE----
Confidence            3567899999999999999999999999999999999864432   233445667766 57789999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           +...+++||||+++++|.+.+...    ..+++..+..++.||+.||.|||++   ||+||||||+||+++.+++
T Consensus       110 -----~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          110 -----TADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             -----CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             -----eCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence                 457899999999999999888642    4588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +|++|||+++...         ..........||+.|+|||++.+..+   +.++|+||+|+++|||++|..||.+..  
T Consensus       178 ikL~DFG~a~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~G~~Pf~~~~--  243 (373)
T 2r5t_A          178 IVLTDFGLCKENI---------EHNSTTSTFCGTPEYLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPFYSRN--  243 (373)
T ss_dssp             EEECCCCBCGGGB---------CCCCCCCSBSCCCCCCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCTTCCSB--
T ss_pred             EEEeeCccccccc---------cCCCccccccCCccccCHHHhCCCCC---CchhhhHHHHHHHHHHHcCCCCCCCCC--
Confidence            9999999865211         00111234568999999999988776   889999999999999999999997532  


Q ss_pred             ccceeeeeeeccccCCCCCC
Q psy16951        258 GDSVALAVISGNITFPENTP  277 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ...+...+....+.+|+..+
T Consensus       244 ~~~~~~~i~~~~~~~~~~~~  263 (373)
T 2r5t_A          244 TAEMYDNILNKPLQLKPNIT  263 (373)
T ss_dssp             HHHHHHHHHHSCCCCCSSSC
T ss_pred             HHHHHHHHHhcccCCCCCCC
Confidence            23333344555555665443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-40  Score=288.27  Aligned_cols=228  Identities=21%  Similarity=0.326  Sum_probs=174.0

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC----chhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG----REDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~----~~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      ....+..++|++.+.||+|+||.||+|++.   .++..||+|.+....    ......+.+|+.+++.++||||+++++.
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            344567899999999999999999999985   688999999986442    2334556789999999999999999985


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                      +.         .....++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+
T Consensus        90 ~~---------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nil  153 (327)
T 3a62_A           90 FQ---------TGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIM  153 (327)
T ss_dssp             EE---------CSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEE
T ss_pred             EE---------cCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeE
Confidence            44         357899999999999999888643    4588999999999999999999999   8999999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF  251 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf  251 (282)
                      ++.++.+|++|||++....         ..........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||
T Consensus       154 l~~~~~~kl~Dfg~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          154 LNHQGHVKLTDFGLCKESI---------HDGTVTHTFCGTIEYMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             ECTTSCEEECCCSCC-------------------CTTSSCCTTSCHHHHTTSCC---CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ECCCCcEEEEeCCcccccc---------cCCccccccCCCcCccCHhhCcCCCC---CCcccchhHHHHHHHHHHCCCCC
Confidence            9999999999999764211         01111233468999999999987766   88999999999999999999999


Q ss_pred             CccccCccceeeeeeeccccCCCCC
Q psy16951        252 DTVYERGDSVALAVISGNITFPENT  276 (282)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~p~~~  276 (282)
                      .+...  ......+....+.+|+..
T Consensus       222 ~~~~~--~~~~~~i~~~~~~~p~~~  244 (327)
T 3a62_A          222 TGENR--KKTIDKILKCKLNLPPYL  244 (327)
T ss_dssp             CCSSH--HHHHHHHHHTCCCCCTTS
T ss_pred             CCCCH--HHHHHHHHhCCCCCCCCC
Confidence            75322  222333444555555543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=293.93  Aligned_cols=209  Identities=22%  Similarity=0.364  Sum_probs=174.4

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ...+..++|++++.||+|+||.||+|++..++..||+|.+....   ......+.+|+.+++.++||||+++++.+.   
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~---   85 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ---   85 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE---
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence            34567899999999999999999999999999999999885322   223456788999999999999999998544   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            +....++|+||+.+++|...+.    ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++
T Consensus        86 ------~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g  152 (384)
T 4fr4_A           86 ------DEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHG  152 (384)
T ss_dssp             ------CSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             ------eCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCC
Confidence                  4578999999999999998876    334689999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++++|||++....          .........||+.|+|||++.+.....++.++||||+||++|||++|..||...
T Consensus       153 ~vkL~DFG~a~~~~----------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          153 HVHITDFNIAAMLP----------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             CEEECCCTTCEECC----------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CEEEeccceeeecc----------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            99999999865321          011123456899999999997532222388999999999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-40  Score=287.05  Aligned_cols=223  Identities=29%  Similarity=0.405  Sum_probs=179.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++.+.||+|+||+||+|.+..++..||+|.+....   ......+.+|+.+++.++||||+++++.+.       
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-------   79 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-------   79 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-------
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-------
Confidence            3578999999999999999999999999999999885321   112346788999999999999999998543       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++||||+ +|+|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|+
T Consensus        80 --~~~~~~lv~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  149 (336)
T 3h4j_B           80 --TPTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKI  149 (336)
T ss_dssp             --CSSEEEEEECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEE
T ss_pred             --eCCEEEEEEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEE
Confidence              457899999999 78888877643    4589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||++....          .........||+.|+|||++.+..+.  +.++||||+|+++|+|++|..||.+..  ...
T Consensus       150 ~DFG~s~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~  215 (336)
T 3h4j_B          150 ADFGLSNIMT----------DGNFLKTSCGSPNYAAPEVINGKLYA--GPEVDVWSCGIVLYVMLVGRLPFDDEF--IPN  215 (336)
T ss_dssp             CCSSCTBTTT----------TSBTTCCCTTSTTTSCGGGSCCSGGG--CHHHHHHHHHHHHHHHHHSSCSSBCSS--STT
T ss_pred             EEeccceecc----------CCcccccccCCcCcCCHHHHcCCCCC--CCccchhHHHHHHHHHHhCCCCCCCcc--HHH
Confidence            9999765321          11112234678999999999887652  678999999999999999999997632  233


Q ss_pred             eeeeeeeccccCCCCCC
Q psy16951        261 VALAVISGNITFPENTP  277 (282)
Q Consensus       261 ~~~~~~~~~~~~p~~~~  277 (282)
                      ....+..+.+.+|+..+
T Consensus       216 ~~~~i~~~~~~~p~~~s  232 (336)
T 3h4j_B          216 LFKKVNSCVYVMPDFLS  232 (336)
T ss_dssp             CBCCCCSSCCCCCTTSC
T ss_pred             HHHHHHcCCCCCcccCC
Confidence            33444555556665443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-40  Score=291.13  Aligned_cols=201  Identities=27%  Similarity=0.373  Sum_probs=171.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------hHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------DQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+......      ..+.+.+|+.+++.++||||+++++.+      
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~------   84 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY------   84 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE------
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE------
Confidence            57899999999999999999999999999999998654332      356788999999999999999999854      


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--  176 (282)
                         .+...+++||||+++++|.+++.    ....+++..+..++.||+.||.|||++   |++||||||+||+++.++  
T Consensus        85 ---~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~  154 (361)
T 2yab_A           85 ---ENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (361)
T ss_dssp             ---ECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             ---EeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCC
Confidence               34578999999999999999875    345689999999999999999999999   899999999999998776  


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        .++++|||++.....          ........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       155 ~~~vkl~DFG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          155 IPHIKLIDFGLAHEIED----------GVEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             SCCEEECCCSSCEECCT----------TCCCCCCCSCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ccCEEEEecCCceEcCC----------CCccccCCCCccEECchHHcCCCC---CccccHHHHHHHHHHHHhCCCCCCCC
Confidence              799999998653211          111223468999999999987766   88999999999999999999999763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.6e-41  Score=301.73  Aligned_cols=228  Identities=22%  Similarity=0.326  Sum_probs=173.7

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ...+..++|++++.||+|+||.||+|++..++..||||.+...   .......+.+|+.+++.++||||+++++.+..  
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--  219 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--  219 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--
Confidence            3445678999999999999999999999999999999988532   23334567789999999999999999985543  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCccccCCCCCcEEeecC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~~i~H~dlk~~nil~~~~  175 (282)
                             ...+++||||+++++|.+.+...    ..+++..+..++.|++.||.|||+ +   ||+||||||+||+++.+
T Consensus       220 -------~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~  285 (446)
T 4ejn_A          220 -------HDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD  285 (446)
T ss_dssp             -------TTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSS
T ss_pred             -------CCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCC
Confidence                   46799999999999999888643    458999999999999999999998 7   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +.+||+|||++...         ...........||+.|+|||++.+..+   +.++||||+|+++|||++|..||.+..
T Consensus       286 ~~~kl~DFG~a~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~  353 (446)
T 4ejn_A          286 GHIKITDFGLCKEG---------IKDGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQD  353 (446)
T ss_dssp             SCEEECCCCCCCTT---------CC-----CCSSSCGGGCCHHHHHTSCC---CTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCEEEccCCCceec---------cCCCcccccccCCccccCHhhcCCCCC---CCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            99999999986521         111112234568999999999988776   899999999999999999999997532


Q ss_pred             cCccceeeeeeeccccCCCCCC
Q psy16951        256 ERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       256 ~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                        ...+...+....+.+|...+
T Consensus       354 --~~~~~~~i~~~~~~~p~~~~  373 (446)
T 4ejn_A          354 --HEKLFELILMEEIRFPRTLG  373 (446)
T ss_dssp             --HHHHHHHHHHCCCCCCTTSC
T ss_pred             --HHHHHHHHHhCCCCCCccCC
Confidence              22333334445555665443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-40  Score=288.57  Aligned_cols=207  Identities=25%  Similarity=0.328  Sum_probs=173.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-----CchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-----GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-----~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++.+.||+|+||+||+|.+..++..||||.+...     .....+.+.+|+.+++.++||||+++++.+.    
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----   96 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----   96 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            3457899999999999999999999999999999988532     1224567889999999999999999998544    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++||||+++++|.+.+.........+++..+..++.|++.||.|||++   |++||||||+||+++.++.
T Consensus        97 -----~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A           97 -----SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             -----ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred             -----eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence                 35789999999999999988876554455689999999999999999999999   8999999999999987654


Q ss_pred             ---ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        178 ---PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       178 ---~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                         +|++|||++.....         .........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       169 ~~~vkl~Dfg~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          169 SAPVKLGGFGVAIQLGE---------SGLVAGGRVGTPHFMAPEVVKREPY---GKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             TCCEEECCCTTCEECCT---------TSCBCCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCcEEEecCcceeEecC---------CCeeecCCcCCcCccCHHHHcCCCC---CchHhhHHHHHHHHHHHHCCCCCCC
Confidence               89999998653210         0011123468999999999988776   8899999999999999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=295.72  Aligned_cols=219  Identities=26%  Similarity=0.389  Sum_probs=176.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+.....  .....+.+|+.+++.++||||+++++.+         .
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---------~   80 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI---------S   80 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE---------E
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE---------E
Confidence            5789999999999999999999999999999999865443  3455678999999999999999999844         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee---cCCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA---NDNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~~  179 (282)
                      +....++||||+.+++|.+.+..    ...+++..+..++.|++.||.|||++   ||+||||||+||+++   .++.+|
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            45789999999999999988863    35689999999999999999999999   899999999999998   457899


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      ++|||++.....         .........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+..  ..
T Consensus       154 L~DFG~a~~~~~---------~~~~~~~~~gt~~Y~APE~l~~~~~---~~~~DIwSlGvilyell~G~~Pf~~~~--~~  219 (444)
T 3soa_A          154 LADFGLAIEVEG---------EQQAWFGFAGTPGYLSPEVLRKDPY---GKPVDLWACGVILYILLVGYPPFWDED--QH  219 (444)
T ss_dssp             ECCCSSCBCCCT---------TCCBCCCSCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSCCCSS--HH
T ss_pred             EccCceeEEecC---------CCceeecccCCcccCCHHHhcCCCC---CCccccHHHHHHHHHHHhCCCCCCCcc--HH
Confidence            999998643210         1111223468999999999988776   889999999999999999999997532  22


Q ss_pred             ceeeeeeeccccCC
Q psy16951        260 SVALAVISGNITFP  273 (282)
Q Consensus       260 ~~~~~~~~~~~~~p  273 (282)
                      .+...+..+.+.+|
T Consensus       220 ~~~~~i~~~~~~~~  233 (444)
T 3soa_A          220 RLYQQIKAGAYDFP  233 (444)
T ss_dssp             HHHHHHHHTCCCCC
T ss_pred             HHHHHHHhCCCCCC
Confidence            33333444444444

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.7e-40  Score=287.03  Aligned_cols=213  Identities=17%  Similarity=0.238  Sum_probs=172.3

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEE-----EecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC---CCCcccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLI-----EHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV---HPNILPL   88 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~---H~ni~~~   88 (282)
                      ....+.+..++|++.+.||+|+||+||+|     .+..++..||+|.+....   ...+.+|++.++.++   |+||+.+
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            44677888999999999999999999999     466789999999986543   335566677776665   9999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      ++.+..         ....++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++   ||+||||||
T Consensus       133 ~~~~~~---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp  200 (365)
T 3e7e_A          133 YSAHLF---------QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKP  200 (365)
T ss_dssp             EEEEEC---------SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSG
T ss_pred             heeeec---------CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCH
Confidence            985543         4678999999999999999876433 245689999999999999999999998   899999999


Q ss_pred             CcEEeec-----------CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhh
Q psy16951        168 ANVLLAN-----------DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS  236 (282)
Q Consensus       168 ~nil~~~-----------~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws  236 (282)
                      +||+++.           ++.+|++|||++......       ..........||..|+|||++.+..+   +.++||||
T Consensus       201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Diws  270 (365)
T 3e7e_A          201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF-------PKGTIFTAKCETSGFQCVEMLSNKPW---NYQIDYFG  270 (365)
T ss_dssp             GGEEECGGGTCC------CTTEEECCCTTCEEGGGS-------CTTEEECCSSCTTSCCCHHHHTTCCB---STHHHHHH
T ss_pred             HHEEecccccCccccccccCCEEEeeCchhhhhhcc-------CCCceeeeecCCCCCCChHHhcCCCC---CccccHHH
Confidence            9999998           899999999987532110       11112234468999999999998876   89999999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q psy16951        237 LGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~  254 (282)
                      ||+++|||+||+.||...
T Consensus       271 lG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          271 VAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             HHHHHHHHHHSSCCCEEE
T ss_pred             HHHHHHHHHhCCCccccC
Confidence            999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-40  Score=303.93  Aligned_cols=232  Identities=22%  Similarity=0.273  Sum_probs=185.1

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .+..++|++.+.||+|+||+||+|++..++..||+|++.....   .....+.+|+.+++.++||||+++++.+.     
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----  255 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----  255 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----
Confidence            3567899999999999999999999999999999999853321   22456788999999999999999988543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          ....+++||||+++++|...+.........+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+
T Consensus       256 ----~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~v  328 (543)
T 3c4z_A          256 ----TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV  328 (543)
T ss_dssp             ----CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             ----eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCE
Confidence                45789999999999999988764332344689999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      |++|||++.....         .........||+.|+|||++.+..+   +.++|+||+||++|||++|..||.+.....
T Consensus       329 kL~DFGla~~~~~---------~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~DiwSlGvilyelltG~~PF~~~~~~~  396 (543)
T 3c4z_A          329 RISDLGLAVELKA---------GQTKTKGYAGTPGFMAPELLLGEEY---DFSVDYFALGVTLYEMIAARGPFRARGEKV  396 (543)
T ss_dssp             EECCCTTCEECCT---------TCCCBCCCCSCTTTSCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCTTCCC
T ss_pred             EEeecceeeeccC---------CCcccccccCCccccChhhhcCCCC---ChHHhcCcchHHHHHHHhCCCCCCCCccch
Confidence            9999998753210         0011123468999999999998776   899999999999999999999998643221


Q ss_pred             --cceeeeeeeccccCCCCCC
Q psy16951        259 --DSVALAVISGNITFPENTP  277 (282)
Q Consensus       259 --~~~~~~~~~~~~~~p~~~~  277 (282)
                        ..+...+....+.+|+..+
T Consensus       397 ~~~~~~~~i~~~~~~~p~~~s  417 (543)
T 3c4z_A          397 ENKELKQRVLEQAVTYPDKFS  417 (543)
T ss_dssp             CHHHHHHHHHHCCCCCCTTSC
T ss_pred             hHHHHHHHHhhcccCCCcccC
Confidence              2223334445556665443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.8e-40  Score=288.48  Aligned_cols=200  Identities=28%  Similarity=0.418  Sum_probs=169.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++.+.         
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~---------   98 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ---------   98 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---------
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE---------
Confidence            468999999999999999999999999999999986543  334567889999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC---Cce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN---NPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~~  179 (282)
                      +....++||||+.+++|.+.+.    ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++   .+|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k  171 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK  171 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred             eCCEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            4578999999999999988775    345689999999999999999999999   899999999999997654   589


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||++....          .........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       172 l~DfG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          172 LADFGLAIEVN----------DSEAWHGFAGTPGYLSPEVLKKDPY---SKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             ECCCTTCBCCT----------TCCSCCCSCSCTTTCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeecCcceEec----------CCcccccCCCCccccCHHHHccCCC---CchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99999865321          0011123468999999999988766   8899999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=296.61  Aligned_cols=209  Identities=25%  Similarity=0.331  Sum_probs=172.8

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ...+..++|++++.||+|+||+||+|++..++..||+|++.....   .....+.+|..++..++||||+++++.+.   
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~---  131 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ---  131 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE---
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe---
Confidence            345678999999999999999999999999999999999853221   12234678999999999999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            +...+++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++   ||+||||||+||+++.++
T Consensus       132 ------~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          132 ------DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             ------CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             ------eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence                  457899999999999999988643   23589999999999999999999998   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-------CcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-------DSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-------~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      ++|++|||++.....        ..........||+.|+|||++..       ..+   +.++|+||+||++|||++|+.
T Consensus       200 ~vkL~DFGla~~~~~--------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~---~~~~DiwSlGvilyelltG~~  268 (412)
T 2vd5_A          200 HIRLADFGSCLKLRA--------DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY---GPECDWWALGVFAYEMFYGQT  268 (412)
T ss_dssp             CEEECCCTTCEECCT--------TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE---CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEEeechhheeccC--------CCccccceeccccCcCCHHHHhhcccCcCCCCC---ChHHhhhHHhHHHHHHHhCCC
Confidence            999999998653211        00011123468999999999973       334   889999999999999999999


Q ss_pred             CCCcc
Q psy16951        250 PFDTV  254 (282)
Q Consensus       250 pf~~~  254 (282)
                      ||.+.
T Consensus       269 Pf~~~  273 (412)
T 2vd5_A          269 PFYAD  273 (412)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-40  Score=283.71  Aligned_cols=200  Identities=23%  Similarity=0.386  Sum_probs=171.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++.+.         +.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---------~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE---------SM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE---------ET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe---------cC
Confidence            47899999999999999999999999999999988644 345566789999999999999999998544         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec--CCCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~~~~d  182 (282)
                      ...++||||+++++|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.  ++.++++|
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEE
Confidence            789999999999999987742   234589999999999999999999999   8999999999999987  78999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ||.+.....          ........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       148 fg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          148 FGQARQLKP----------GDNFRLLFTAPEYYAPEVHQHDVV---STATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             CTTCEECCT----------TCEEEEEESCGGGSCHHHHTTCEE---CHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCCCeECCC----------CCccccccCChhhcCcHHhcCCCC---CchhhHHHHHHHHHHHHhCCCCCcC
Confidence            998653210          111223467889999999988766   7899999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-39  Score=280.54  Aligned_cols=211  Identities=26%  Similarity=0.380  Sum_probs=168.7

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...++|++.+.||+|+||.||+|++..++..||||.+.....   .....+.+|+..++.++||||+++++.+...    
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   84 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE----   84 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE----
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc----
Confidence            346899999999999999999999999999999999865432   2345678999999999999999999866542    


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                       .......++||||+++++|.+.+...    ..+++..++.++.|++.||.|||++   |++||||||+||+++.++.++
T Consensus        85 -~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           85 -TPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             -ETTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEE
T ss_pred             -CCCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEE
Confidence             11223569999999999999988643    3589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+.....      ............||+.|+|||++.+..+   +.++||||+|+++|+|++|+.||.+.
T Consensus       157 l~Dfg~a~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~~l~~ll~g~~pf~~~  222 (311)
T 3ork_A          157 VMDFGIARAIAD------SGNSVTQTAAVIGTAQYLSPEQARGDSV---DARSDVYSLGCVLYEVLTGEPPFTGD  222 (311)
T ss_dssp             ECCCSCC------------------------CCTTCCHHHHHTCCC---CHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EeeccCcccccc------cccccccccccCcCcccCCHHHhcCCCC---CchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999997653211      0011112233457999999999988765   88999999999999999999999753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-40  Score=292.86  Aligned_cols=237  Identities=20%  Similarity=0.303  Sum_probs=184.6

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ...+.|.++.++|++.+.||+|+||+||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++.+. 
T Consensus       104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-  182 (377)
T 3cbl_A          104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-  182 (377)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence            4456788999999999999999999999999999999999998864432 33456788999999999999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              .....++||||+++++|.+++...   ...++...++.++.|++.||.|||++   |++||||||+||+++.
T Consensus       183 --------~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~  248 (377)
T 3cbl_A          183 --------QKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTE  248 (377)
T ss_dssp             --------SSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             --------cCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcC
Confidence                    346789999999999999988643   23488999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++.+|++|||++......       ..........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+
T Consensus       249 ~~~~kl~DfG~s~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          249 KNVLKISDFGMSREEADG-------VYAASGGLRQVPVKWTAPEALNYGRY---SSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             TCCEEECCGGGCEECTTS-------EEECCSSCCEEEGGGSCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCcEEECcCCCceecCCC-------ceeecCCCCCCCcCcCCHhHhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999976532100       00000011223567999999987766   789999999999999998 9999976


Q ss_pred             cccCccceeeeeeeccccCCCCCCC
Q psy16951        254 VYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ..... .........+++.|+.+|.
T Consensus       319 ~~~~~-~~~~~~~~~~~~~~~~~~~  342 (377)
T 3cbl_A          319 LSNQQ-TREFVEKGGRLPCPELCPD  342 (377)
T ss_dssp             SCHHH-HHHHHHTTCCCCCCTTCCH
T ss_pred             CCHHH-HHHHHHcCCCCCCCCCCCH
Confidence            43211 1111112334566665553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.5e-40  Score=307.66  Aligned_cols=227  Identities=20%  Similarity=0.317  Sum_probs=183.7

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhC-CCCCcccccccccccC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGC   96 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~   96 (282)
                      ..+..++|++++.||+|+||+||+|++..++..||||++...   .....+....|..++..+ +||+|+.++..     
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----  410 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----  410 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----
Confidence            345678999999999999999999999999999999998532   122344567888888887 79999999884     


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                          +.+...+++||||+++|+|..++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++
T Consensus       411 ----~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g  479 (674)
T 3pfq_A          411 ----FQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG  479 (674)
T ss_dssp             ----CBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSS
T ss_pred             ----EEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCC
Confidence                44567899999999999999988743    4589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+||+|||+++....         .........||+.|+|||++.+..+   +.++||||||+++|||++|..||.+.  
T Consensus       480 ~ikL~DFGla~~~~~---------~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~DvwSlGvilyelltG~~Pf~~~--  545 (674)
T 3pfq_A          480 HIKIADFGMCKENIW---------DGVTTKTFCGTPDYIAPEIIAYQPY---GKSVDWWAFGVLLYEMLAGQAPFEGE--  545 (674)
T ss_dssp             CEEECCCTTCEECCC---------TTCCBCCCCSCSSSCCHHHHTCCCB---STHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred             cEEEeecceeecccc---------CCcccccccCCCcccCHhhhcCCCC---CccceEechHHHHHHHHcCCCCCCCC--
Confidence            999999998753110         0111234568999999999988877   89999999999999999999999863  


Q ss_pred             CccceeeeeeeccccCCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ....+...+....+.+|+..+
T Consensus       546 ~~~~~~~~i~~~~~~~p~~~s  566 (674)
T 3pfq_A          546 DEDELFQSIMEHNVAYPKSMS  566 (674)
T ss_dssp             SHHHHHHHHHSSCCCCCTTSC
T ss_pred             CHHHHHHHHHhCCCCCCccCC
Confidence            334445556667777776543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=289.33  Aligned_cols=214  Identities=19%  Similarity=0.287  Sum_probs=171.7

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      +...+..++|++.+.||+|+||+||+|.+     ..++..||||.+... .......+.+|+.+++.++||||+++++.+
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            44567789999999999999999999994     456788999998644 344556788999999999999999999855


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV---GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      .         .....++||||+++++|.+++.....   ....++..+++.++.|++.||.|||++   ||+||||||+|
T Consensus       144 ~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  211 (367)
T 3l9p_A          144 L---------QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARN  211 (367)
T ss_dssp             C---------SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             e---------cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhh
Confidence            4         34667999999999999998876431   123588899999999999999999999   89999999999


Q ss_pred             EEeecCC---CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        170 VLLANDN---NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       170 il~~~~~---~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      |+++.++   .+|++|||++.....       ...........+|+.|+|||++.+..+   +.++|||||||++|||++
T Consensus       212 Ill~~~~~~~~~kL~DFG~a~~~~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DvwslG~il~ellt  281 (367)
T 3l9p_A          212 CLLTCPGPGRVAKIGDFGMARDIYR-------AGYYRKGGCAMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLLWEIFS  281 (367)
T ss_dssp             EEESCSSTTCCEEECCCHHHHHHHH-------HSSCTTCCGGGSCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHT
T ss_pred             EEEecCCCCceEEECCCcccccccc-------ccccccCCCcCCcccEECHHHhcCCCC---CcHHHHHHHHHHHHHHHh
Confidence            9998555   489999997642210       001111223456888999999987766   889999999999999998


Q ss_pred             -CCCCCCcc
Q psy16951        247 -FKSPFDTV  254 (282)
Q Consensus       247 -g~~pf~~~  254 (282)
                       |..||.+.
T Consensus       282 ~g~~pf~~~  290 (367)
T 3l9p_A          282 LGYMPYPSK  290 (367)
T ss_dssp             TSCCSSTTC
T ss_pred             CCCCCCCCC
Confidence             99999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-39  Score=277.71  Aligned_cols=213  Identities=22%  Similarity=0.411  Sum_probs=172.8

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEE----ecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      +...+..++|++++.||+|+||+||+|+    +..++..||||++..........+.+|+++++.++||||+++++.+..
T Consensus         3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3456778999999999999999999999    567899999999987776677788999999999999999999986543


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                      .       +...+++||||+++++|.+.+...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.
T Consensus        83 ~-------~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~  149 (295)
T 3ugc_A           83 A-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN  149 (295)
T ss_dssp             H-------HHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE
T ss_pred             C-------CCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcC
Confidence            1       234589999999999999988643   23488999999999999999999998   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|||++|..||..
T Consensus       150 ~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          150 ENRVKIGDFGLTKVLPQD------KEFFKVKEPGESPIFWYAPESLTESKF---SVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             TTEEEECCCCSCC-------------------CTTCGGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEEccCcccccccCC------cceeeeccCCCCccceeCcHHhcCCCC---ChHHHHHHHHHHHHHHHhcccccCC
Confidence            999999999986532110      000111222345667999999988766   8899999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-39  Score=287.15  Aligned_cols=220  Identities=20%  Similarity=0.321  Sum_probs=177.1

Q ss_pred             cccccEEEecccEEEEEEeccC--CceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEG--GFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      .....+....++|++++.||+|  +||.||+|++..++..||||++....  ......+.+|+.+++.++||||++++++
T Consensus        15 ~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             C--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            3445566789999999999999  99999999999999999999986443  3344567889999999999999999996


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                      +..         ....++||||+++++|.+.+...  ....+++..+..++.|++.||.|||++   ||+||||||+||+
T Consensus        95 ~~~---------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIl  160 (389)
T 3gni_B           95 FIA---------DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHIL  160 (389)
T ss_dssp             EEE---------TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             EEE---------CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            554         47899999999999999988643  234589999999999999999999999   8999999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc--CcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~--~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      ++.++.++++|||.+......  ...............||..|+|||++.+  ..+   +.++||||+||++|||++|+.
T Consensus       161 l~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~~~DiwslG~il~el~~g~~  235 (389)
T 3gni_B          161 ISVDGKVYLSGLRSNLSMISH--GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY---DAKSDIYSVGITACELANGHV  235 (389)
T ss_dssp             ECTTCCEEECCGGGCEECEET--TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB---CTHHHHHHHHHHHHHHHHSSC
T ss_pred             EcCCCCEEEcccccceeeccc--cccccccccccccccccccccCHHHHhccCCCC---CcHhHHHHHHHHHHHHHHCCC
Confidence            999999999999965421100  0000000111123357888999999987  344   889999999999999999999


Q ss_pred             CCCcc
Q psy16951        250 PFDTV  254 (282)
Q Consensus       250 pf~~~  254 (282)
                      ||.+.
T Consensus       236 pf~~~  240 (389)
T 3gni_B          236 PFKDM  240 (389)
T ss_dssp             TTTTC
T ss_pred             CCCCC
Confidence            99764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=279.60  Aligned_cols=209  Identities=21%  Similarity=0.324  Sum_probs=166.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--------------------------hHHHHHHHH
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------------------------DQAQAIREV   74 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------------------------~~~~~~~e~   74 (282)
                      -.+..++|++.+.||+|+||.||+|++..++..||||.+......                          ..+.+.+|+
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A            8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            345678999999999999999999999999999999988644321                          124578899


Q ss_pred             HHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q psy16951         75 EHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHD  154 (282)
Q Consensus        75 ~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~  154 (282)
                      ++++.++||||+++++.+...       .....++||||+++++|.+.+     ....+++..+..++.|++.||.|||+
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~-------~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~  155 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDP-------NEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHY  155 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECS-------SSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCeEEEEEEcC-------CCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999865431       246799999999999998743     33568999999999999999999999


Q ss_pred             CCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccch
Q psy16951        155 AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDV  234 (282)
Q Consensus       155 ~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Di  234 (282)
                      +   |++||||||+||+++.++.++++|||++......         ........||+.|+|||++.+......+.++||
T Consensus       156 ~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di  223 (298)
T 2zv2_A          156 Q---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS---------DALLSNTVGTPAFMAPESLSETRKIFSGKALDV  223 (298)
T ss_dssp             T---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSS---------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred             C---CeeccCCCHHHEEECCCCCEEEecCCCccccccc---------cccccCCcCCccccChhhhccCCCCCCCchhhh
Confidence            9   8999999999999999999999999976532100         001123467899999999976542112568999


Q ss_pred             hhHHHHHHHHHhCCCCCCc
Q psy16951        235 WSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       235 ws~G~il~el~tg~~pf~~  253 (282)
                      ||+|+++|+|++|..||.+
T Consensus       224 ~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          224 WAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             HHHHHHHHHHHHSSCSSCC
T ss_pred             HhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.5e-39  Score=283.81  Aligned_cols=205  Identities=26%  Similarity=0.385  Sum_probs=163.8

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ....++|++++.||+|+||+||++++..++..||||.+.... .....+.+|+..++.++||||+++++++.        
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~--------   86 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL--------   86 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE--------
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe--------
Confidence            345789999999999999999999999999999999886443 23356778999999999999999998554        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC--ce
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN--PL  179 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--~~  179 (282)
                       ....+++||||+.+++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.  +|
T Consensus        87 -~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           87 -TPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred             -eCCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence             357899999999999999888642    3589999999999999999999998   8999999999999987765  89


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      ++|||++...          ..........||+.|+|||++.+..+.  +.++||||+|+++|+|++|+.||.+..
T Consensus       159 l~Dfg~a~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          159 ICDFGYSKSS----------VLHSQPKSTVGTPAYIAPEVLLRQEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ECCCCCC-------------------------CTTSCHHHHHCSSCC--HHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             EeecCccccc----------cccCCCCCCcCCCCcCChhhhcCCCCC--CCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence            9999976421          111122344689999999999877651  344899999999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-39  Score=286.19  Aligned_cols=213  Identities=23%  Similarity=0.372  Sum_probs=172.7

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEec-------CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCcccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHS-------QTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLD   90 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~   90 (282)
                      .+.+..++|++.+.||+|+||.||+|++.       .++..||||.+..... .....+.+|+++++.+ +||||+++++
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            34567899999999999999999999975       3456799999865533 3456788999999999 8999999998


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~  158 (282)
                      .+.         ....+++||||+++++|.+++.....            ....++...++.++.|++.||.|||++   
T Consensus       155 ~~~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---  222 (370)
T 2psq_A          155 ACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---  222 (370)
T ss_dssp             EEC---------SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             EEc---------cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            543         34679999999999999998875321            123578899999999999999999999   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHH
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLG  238 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G  238 (282)
                      |++||||||+||+++.++.+|++|||++......       ..........+|+.|+|||++.+..+   +.++||||||
T Consensus       223 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-------~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DvwslG  292 (370)
T 2psq_A          223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DYYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFG  292 (370)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCSSCEETTCC-------CTTCTTTTTTSCGGGCCHHHHHTCCC---CHHHHHHHHH
T ss_pred             CeeccccchhhEEECCCCCEEEccccCCcccCcc-------cceecccCCCcccceECHhHhcCCCC---CcHHHHHHHH
Confidence            8999999999999999999999999987532110       00011122345778999999988766   8899999999


Q ss_pred             HHHHHHHh-CCCCCCcc
Q psy16951        239 CLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       239 ~il~el~t-g~~pf~~~  254 (282)
                      +++|||++ |..||.+.
T Consensus       293 ~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          293 VLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             HHHHHHHTTSCCSSTTC
T ss_pred             HHHHHHHcCCCCCCCCC
Confidence            99999999 99999763

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=288.18  Aligned_cols=202  Identities=22%  Similarity=0.374  Sum_probs=172.2

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+......+...+.+|+.+++.++||||+++++.+.         +.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~---------~~  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE---------DK  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE---------CS
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE---------eC
Confidence            468999999999999999999999999999999987766666778899999999999999999998543         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec--CCCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~~~~d  182 (282)
                      ...++||||+.+++|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.  .+.++++|
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEe
Confidence            789999999999999887742   223589999999999999999999999   8999999999999974  46799999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++.....          ........+|+.|+|||++.+..+   +.++||||+|+++|||++|..||.+.
T Consensus       195 FG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~Pf~~~  253 (387)
T 1kob_A          195 FGLATKLNP----------DEIVKVTTATAEFAAPEIVDREPV---GFYTDMWAIGVLGYVLLSGLSPFAGE  253 (387)
T ss_dssp             CTTCEECCT----------TSCEEEECSSGGGCCHHHHTTCCB---CHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             cccceecCC----------CcceeeeccCCCccCchhccCCCC---CCcccEeeHhHHHHHHHhCCCCCCCC
Confidence            998653210          011123457899999999988766   88999999999999999999999763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=281.72  Aligned_cols=210  Identities=19%  Similarity=0.308  Sum_probs=170.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ..+..++|++.+.||+|+||+||+|++..++.   .||||.+... .......+.+|+.+++.++||||+++++++.   
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---  120 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT---  120 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence            35678899999999999999999999976554   5999998654 3344567899999999999999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            .....++||||+++++|.+++..   ....+++..++.++.|++.||.|||++   |++||||||+||+++.++
T Consensus       121 ------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  188 (325)
T 3kul_A          121 ------RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNL  188 (325)
T ss_dssp             ------GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             ------eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCC
Confidence                  34678999999999999998853   234589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      .++++|||++......      ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       189 ~~kl~Dfg~a~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~~g~~p~~~~  258 (325)
T 3kul_A          189 VCKVSDFGLSRVLEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTF---SSASDVWSFGVVMWEVLAYGERPYWNM  258 (325)
T ss_dssp             CEEECCCSSCEECC----------CCEECC---CCGGGSCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             CEEECCCCcccccccC------ccceeeccCCCCcccccCHhHhcCCCC---CcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999987532111      000001112234667999999987776   889999999999999999 99999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=279.09  Aligned_cols=200  Identities=25%  Similarity=0.373  Sum_probs=170.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------hHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------DQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+......      ..+.+.+|+.+++.++||||+++++.+.     
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            46799999999999999999999999999999988654322      3567889999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--  176 (282)
                          .....++||||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.++  
T Consensus        85 ----~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~  153 (326)
T 2y0a_A           85 ----NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP  153 (326)
T ss_dssp             ----CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSS
T ss_pred             ----eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCC
Confidence                4578999999999999999875    345689999999999999999999999   899999999999998877  


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                        .++++|||++......          .......||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       154 ~~~~kl~Dfg~a~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          154 KPRIKIIDFGLAHKIDFG----------NEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             SCCEEECCCTTCEECCTT----------SCCCCCCSCTTTCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCEEEEECCCCeECCCC----------CccccccCCcCcCCceeecCCCC---CcHHHHHHHHHHHHHHHHCcCCCCC
Confidence              7999999986532110          11123457999999999987765   8899999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-39  Score=270.92  Aligned_cols=209  Identities=23%  Similarity=0.427  Sum_probs=172.5

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..|.+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|++++++++||||+++++++.    
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   75 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL----   75 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence            3567889999999999999999999999986 57789999886543 33456889999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++||||+++++|.+.+..   ....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        76 -----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~  144 (269)
T 4hcu_A           76 -----EQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQV  144 (269)
T ss_dssp             -----SSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGC
T ss_pred             -----cCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCC
Confidence                 44679999999999999998853   234588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+...        ............+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||.+.
T Consensus       145 ~kl~Dfg~~~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          145 IKVSDFGMTRFV--------LDDQYTSSTGTKFPVKWASPEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             EEECCTTGGGGB--------CCHHHHSTTSTTCCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEeccccccccc--------cccccccccCcccccccCCHHHhcCCCC---CchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            999999976421        1111122233445778999999987765   889999999999999999 99999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-39  Score=299.76  Aligned_cols=205  Identities=26%  Similarity=0.372  Sum_probs=174.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +..++|++.+.||+|+||.||+|++..++..||+|++....   ......+.+|+.+++.++||||+++++.+.      
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~------  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE------  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE------
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe------
Confidence            67889999999999999999999999999999999985332   223456788999999999999999988543      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         +...+++||||+++|+|.+++...  ....+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+|
T Consensus       255 ---~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          255 ---TKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             ---CSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             ---eCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence               457899999999999999877632  223489999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||++.....          ........||+.|+|||++.+..+   +.++||||+||++|||++|..||.+.
T Consensus       327 L~DFGla~~~~~----------~~~~~~~~GT~~Y~APEvl~~~~~---~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          327 ISDLGLAVHVPE----------GQTIKGRVGTVGYMAPEVVKNERY---TFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             ECCCTTCEECCT----------TCCEECCCSCGGGCCHHHHTTCEE---SSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             EEecccceeccc----------CccccccCCCccccCHHHHcCCCC---CccchHHHHHHHHHHHHhCCCCCccc
Confidence            999998753210          011123468999999999988776   88999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.4e-40  Score=286.46  Aligned_cols=216  Identities=19%  Similarity=0.333  Sum_probs=174.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEE-----ecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIE-----HSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~   91 (282)
                      ..|.+..++|++.+.||+|+||.||+|+     +..++..||||.+..... .....+.+|+++++.+ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            4567889999999999999999999999     556678999999875433 3446788999999999 79999999986


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------------------------------------------
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------------------------------------------  129 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------------------------------  129 (282)
                      +..        .....++||||+++++|.+++......                                          
T Consensus        95 ~~~--------~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           95 CTK--------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             ECS--------TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eec--------CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            543        234589999999999999988643210                                          


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccch
Q psy16951        130 --------------------KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA  189 (282)
Q Consensus       130 --------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~  189 (282)
                                          ...+++..++.++.|++.||.|||++   |++||||||+||+++.++.++++|||.+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                11278889999999999999999999   8999999999999999999999999976532


Q ss_pred             hhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q psy16951        190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVY  255 (282)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~  255 (282)
                      ..       ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+..
T Consensus       244 ~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          244 YK-------DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             TS-------CTTCEEC--CEECGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cc-------cccchhccccCCCceeEChhhhcCCCC---CchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            10       001111223456788999999987765   889999999999999998 999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-39  Score=294.01  Aligned_cols=225  Identities=26%  Similarity=0.370  Sum_probs=181.3

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .+..++|++.+.||+|+||.||+|++..+|..||||.+.....   .....+.+|+.+++.++||||+++++.+.     
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            4567899999999999999999999999999999999853321   22456789999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++|+||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.+
T Consensus        87 ----~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           87 ----TPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             ----CSSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCE
T ss_pred             ----ECCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCe
Confidence                4578999999999999998775    345689999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      |++|||++.....          ........||+.|+|||++.+..+  .+.++||||+|+++|+|++|..||.+..  .
T Consensus       156 kL~DFG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~--~  221 (476)
T 2y94_A          156 KIADFGLSNMMSD----------GEFLRTSCGSPNYAAPEVISGRLY--AGPEVDIWSSGVILYALLCGTLPFDDDH--V  221 (476)
T ss_dssp             EECCCSSCEECCT----------TCCBCCCCSCSTTCCHHHHTTCCB--CSHHHHHHHHHHHHHHHHHSSCSSCCSS--S
T ss_pred             EEEeccchhhccc----------cccccccCCCcCeEChhhccCCCC--CCCcceehhhHHHHHHHhhCCCCCCCCC--H
Confidence            9999998653210          011223468999999999988765  2678999999999999999999997532  2


Q ss_pred             cceeeeeeeccccCCCCC
Q psy16951        259 DSVALAVISGNITFPENT  276 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~~  276 (282)
                      ..+...+..+.+..|...
T Consensus       222 ~~~~~~i~~~~~~~p~~~  239 (476)
T 2y94_A          222 PTLFKKICDGIFYTPQYL  239 (476)
T ss_dssp             HHHHHHHHTTCCCCCTTC
T ss_pred             HHHHHHHhcCCcCCCccC
Confidence            223334445555555443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-38  Score=287.81  Aligned_cols=206  Identities=23%  Similarity=0.343  Sum_probs=167.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...++|++++.||+|+||+||+|.+..++..||||++...  .......+.+|+.+++.++||||+++++++....   .
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---~  135 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK---T  135 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC---S
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC---c
Confidence            4468899999999999999999999999999999998643  3344567789999999999999999999775421   1


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .+....+++||||+.+ ++.+.+.      ..+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+||
T Consensus       136 ~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl  205 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI  205 (464)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             cccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEE
Confidence            2344678999999965 4555442      3488999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++.....          ........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+.
T Consensus       206 ~DFG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          206 LDFGLARTAGT----------SFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             CCCCCC---------------CCCC----CCCTTCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEeeeecCC----------CcccCCCcccccccCHHHHcCCCC---CHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99998653210          111233567999999999998776   88999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-39  Score=276.99  Aligned_cols=206  Identities=25%  Similarity=0.377  Sum_probs=156.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++++.||+|+||+||+|.+..++..||+|.+..... .....+.+|+++++.++||||+++++.+         ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---------~~   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI---------HT   74 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE---------CC
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE---------EE
Confidence            4689999999999999999999999999999999865432 2345678899999999999999999854         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVG--KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ....++||||+. ++|.+.+......  ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|++
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence            578999999997 6999888755322  23478999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+......         ........+|+.|+|||++.+...  ++.++||||+|+++|||++|+.||.+.
T Consensus       151 Dfg~~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          151 DFGLARAFGIP---------VNTFSSEVVTLWYRAPDVLMGSRT--YSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             CCSSCEETTSC---------CCCCCCCCSCCTTCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCccceecCCC---------cccCCCCcccccccCchHhhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99986532110         011123457889999999976432  388999999999999999999999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.8e-39  Score=277.71  Aligned_cols=219  Identities=21%  Similarity=0.279  Sum_probs=173.9

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      -+...++.+..++|++.+.||+|+||+||+|++.  +..||||++.... .......+|+..++.++||||+++++.+..
T Consensus        13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            4566788999999999999999999999999984  7899999885442 334455668999999999999999997765


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCCccccCCC
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA--------KPIAYAHRDLK  166 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------~~~~i~H~dlk  166 (282)
                      ..     .....+++||||+++++|.+++..     ..+++..++.++.|++.||.|||+.        .. |++|||||
T Consensus        90 ~~-----~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~-~ivH~Dlk  158 (322)
T 3soc_A           90 GT-----SVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP-AISHRDIK  158 (322)
T ss_dssp             EC-----SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC-EEECSCCS
T ss_pred             CC-----CCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC-CEEeCCCC
Confidence            31     113568999999999999998853     3488999999999999999999986        11 58999999


Q ss_pred             CCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHH
Q psy16951        167 TANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       167 ~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el  244 (282)
                      |+||+++.++.+|++|||.+......       ..........||+.|+|||++.+...  ..++.++||||||+++|||
T Consensus       159 p~Nill~~~~~~kL~DFg~a~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el  231 (322)
T 3soc_A          159 SKNVLLKNNLTACIADFGLALKFEAG-------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL  231 (322)
T ss_dssp             GGGEEECTTCCEEECCCTTCEEECTT-------SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHhEEECCCCeEEEccCCcccccccc-------cCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence            99999999999999999987532111       01111223467899999999986321  0125678999999999999


Q ss_pred             HhCCCCCCcc
Q psy16951        245 CYFKSPFDTV  254 (282)
Q Consensus       245 ~tg~~pf~~~  254 (282)
                      +||+.||.+.
T Consensus       232 ~tg~~pf~~~  241 (322)
T 3soc_A          232 ASRCTAADGP  241 (322)
T ss_dssp             HTTBTTSSSC
T ss_pred             HhCCCCCCCC
Confidence            9999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8e-39  Score=276.28  Aligned_cols=199  Identities=21%  Similarity=0.323  Sum_probs=171.8

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ..|+..+.||+|+||.||+|++..+|..||||.+........+.+.+|+.+++.++||||+++++.+..         ..
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------~~  115 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV---------GE  115 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE---------TT
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE---------CC
Confidence            358888999999999999999999999999999987766677788999999999999999999986554         46


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++||||+++++|.+.+.     ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||+
T Consensus       116 ~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  187 (321)
T 2c30_A          116 ELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGF  187 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeee
Confidence            7999999999999998764     34589999999999999999999998   899999999999999999999999997


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +.....         .........||+.|+|||++.+..+   +.++||||+|+++|||++|..||.+
T Consensus       188 ~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          188 CAQISK---------DVPKRKSLVGTPYWMAPEVISRSLY---ATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             CEECCS---------SSCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eeeccc---------CccccccccCCccccCHhhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            653211         0011123467899999999987766   8899999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-39  Score=280.63  Aligned_cols=205  Identities=24%  Similarity=0.375  Sum_probs=168.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.         .
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---------~   76 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR---------E   76 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE---------C
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe---------c
Confidence            47899999999999999999999999999999988644332 3456788999999999999999998543         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++||||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Df  149 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  149 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEe
Confidence            578999999999999998774    334589999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......       ..........||+.|+|||++.+..+  .+.++||||+|+++|+|++|..||.+.
T Consensus       150 g~a~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          150 GLATVFRYN-------NRERLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             TTCEECEET-------TEECCBCSCCSCGGGSCHHHHHCSSB--CHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             eccceeccC-------CcccccCCCccCcCccCcHHhccCCC--CCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            986532110       00111223467899999999987654  256899999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.1e-39  Score=290.66  Aligned_cols=209  Identities=20%  Similarity=0.343  Sum_probs=173.5

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.+..++|++.+.||+|+||+||+|.+. ++..||||.+.... ...+.+.+|+.+++.++||||+++++.+.    
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----  253 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT----  253 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe----
Confidence            4668899999999999999999999999985 46789999986543 45678899999999999999999988542    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                            ....++||||+++|+|.+++....  ...++...++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       254 ------~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~  322 (454)
T 1qcf_A          254 ------KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLV  322 (454)
T ss_dssp             ------SSSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCC
T ss_pred             ------CCccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCc
Confidence                  245899999999999999886432  22478889999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|++|||++....        ...........+|..|+|||++....+   +.++||||||+++|||+| |..||.+.
T Consensus       323 ~kl~DFG~a~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          323 CKIADFGLARVIE--------DNEYTAREGAKFPIKWTAPEAINFGSF---TIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             EEECSTTGGGGBC--------CHHHHTTCSSSSCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEEeeCCCceEcC--------CCceeccCCCcccccccCHHHhccCCC---CcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999765321        011111223345678999999987665   889999999999999999 99999763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-38  Score=270.80  Aligned_cols=201  Identities=26%  Similarity=0.415  Sum_probs=163.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++++.||+|+||+||+|++ .++..||+|++......  ....+.+|+++++.++||||+++++.+.         .
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH---------T   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE---------C
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc---------c
Confidence            6899999999999999999999 67899999998654332  2356789999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+|++.+ +|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|++||
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             CCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeEC
Confidence            4679999999964 88877653   234588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+....         ..........+|+.|+|||++.+...  ++.++||||+|+++|||++|..||.+.
T Consensus       145 g~~~~~~---------~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          145 GLARAFG---------IPVRKYTHEIVTLWYRAPDVLMGSKK--YSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             THHHHHC---------C---------CCCTTCCHHHHTTCCS--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccC---------ccccccccccccccccCchheeCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9754210         01112233467899999999976432  388999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=275.82  Aligned_cols=209  Identities=19%  Similarity=0.319  Sum_probs=171.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ....++|++.+.||+|+||+||+|++..++..||||.+.... ......+.+|+++++.++||||+++++++...     
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   79 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET-----   79 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT-----
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC-----
Confidence            456789999999999999999999999999999999986433 23356678999999999999999999865432     


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----ecCC
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----ANDN  176 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~  176 (282)
                        .....++||||+++++|.+.+.... ....+++..++.++.|++.||.|||++   |++||||||+||++    +.++
T Consensus        80 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           80 --TTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             --TTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCE
T ss_pred             --CCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCc
Confidence              2347899999999999999887432 223389999999999999999999999   89999999999998    6667


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc--------cCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH--------VDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~--------~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      .+|++|||.+.....          ........+|..|+|||++.        +..+   +.++||||+|+++|||++|+
T Consensus       154 ~~kL~Dfg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~---~~~~DiwslG~il~el~~g~  220 (319)
T 4euu_A          154 VYKLTDFGAARELED----------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY---GATVDLWSIGVTFYHAATGS  220 (319)
T ss_dssp             EEEECCCTTCEECCT----------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB---CTTHHHHHHHHHHHHHHHSS
T ss_pred             eEEEccCCCceecCC----------CCceeecccCCCccCHHHhhhccccccccCCC---CcHHHHHHHHHHHHHHHhCC
Confidence            799999998653210          01112345788999999986        2334   88999999999999999999


Q ss_pred             CCCCcc
Q psy16951        249 SPFDTV  254 (282)
Q Consensus       249 ~pf~~~  254 (282)
                      .||...
T Consensus       221 ~pf~~~  226 (319)
T 4euu_A          221 LPFRPF  226 (319)
T ss_dssp             CSEECT
T ss_pred             CCCCCC
Confidence            999753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.3e-39  Score=272.04  Aligned_cols=211  Identities=19%  Similarity=0.315  Sum_probs=164.5

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      +.+.+.+..++|++.+.||+|+||.||+|.+..+   +..||+|.+.... ....+.+.+|+..++.++||||+++++++
T Consensus         6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A            6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            3456889999999999999999999999998654   4569999876543 33456788999999999999999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      .          ....++|||++++++|.+++...   ...+++..++.++.|++.||.|||++   |++||||||+||++
T Consensus        86 ~----------~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  149 (281)
T 1mp8_A           86 T----------ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLV  149 (281)
T ss_dssp             C----------SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             c----------cCccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEE
Confidence            2          24578999999999999988642   33588999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.++.++++|||.+....        ...........+|+.|+|||++.+..+   +.++||||+|+++|||++ |..||
T Consensus       150 ~~~~~~kl~Dfg~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          150 SSNDCVKLGDFGLSRYME--------DSTYYKASKGKLPIKWMAPESINFRRF---TSASDVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             EETTEEEECC---------------------------CCGGGCCHHHHHHCCC---SHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCCCEEECccccccccC--------cccccccccCCCcccccChhhcccCCC---CCccCchHHHHHHHHHHhcCCCCC
Confidence            999999999999765321        111111223345678999999987765   789999999999999997 99999


Q ss_pred             Ccc
Q psy16951        252 DTV  254 (282)
Q Consensus       252 ~~~  254 (282)
                      .+.
T Consensus       219 ~~~  221 (281)
T 1mp8_A          219 QGV  221 (281)
T ss_dssp             TTC
T ss_pred             CcC
Confidence            864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-38  Score=272.50  Aligned_cols=214  Identities=27%  Similarity=0.375  Sum_probs=168.6

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ..+-..-+-..++|++++.||+|+||+||+|++. ++..||+|++.....  .....+.+|+++++.++||||+++++.+
T Consensus        10 ~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   88 (311)
T 3niz_A           10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI   88 (311)
T ss_dssp             -----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            3344455566899999999999999999999995 588999999864432  2345778999999999999999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                               .+....++||||+. ++|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||++
T Consensus        89 ---------~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~  152 (311)
T 3niz_A           89 ---------HSERCLTLVFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLI  152 (311)
T ss_dssp             ---------CCSSCEEEEEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             ---------ccCCEEEEEEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEE
Confidence                     34578999999997 477776642   334589999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +.++.+|++|||.+.....         .........+|+.|+|||++.+...  ++.++||||+|+++|+|++|+.||.
T Consensus       153 ~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~  221 (311)
T 3niz_A          153 NSDGALKLADFGLARAFGI---------PVRSYTHEVVTLWYRAPDVLMGSKK--YSTSVDIWSIGCIFAEMITGKPLFP  221 (311)
T ss_dssp             CTTCCEEECCCTTCEETTS---------CCC---CCCCCCTTCCHHHHTTCCS--CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCCCEEEccCcCceecCC---------CcccccCCcccCCcCCHHHhcCCCC--CCchHHhHHHHHHHHHHHhCCCCCC
Confidence            9999999999998653210         1111233467899999999976432  3889999999999999999999997


Q ss_pred             cccc
Q psy16951        253 TVYE  256 (282)
Q Consensus       253 ~~~~  256 (282)
                      +...
T Consensus       222 ~~~~  225 (311)
T 3niz_A          222 GVTD  225 (311)
T ss_dssp             CSST
T ss_pred             CCCh
Confidence            6433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.7e-39  Score=276.61  Aligned_cols=224  Identities=20%  Similarity=0.362  Sum_probs=163.2

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLL   89 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~   89 (282)
                      ......+.+..++|++.+.||+|+||+||+|.+..++.   .||||.+...  .....+.+.+|+++++.++||||++++
T Consensus        12 ~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           12 KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             ----CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             HHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence            33455677889999999999999999999999877764   8999988654  344567788999999999999999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG--KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      +++.....   .......++++||+.+++|.+.+......  ...+++..++.++.|++.||.|||++   |++||||||
T Consensus        92 ~~~~~~~~---~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp  165 (323)
T 3qup_A           92 GVSLRSRA---KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAA  165 (323)
T ss_dssp             EEEECC----------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ceeecccc---ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCc
Confidence            97654210   11112359999999999999988754322  22588999999999999999999999   899999999


Q ss_pred             CcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-
Q psy16951        168 ANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-  246 (282)
Q Consensus       168 ~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-  246 (282)
                      +||+++.++.++++|||.+.....       ...........+|+.|+|||++.+..+   +.++||||+|+++|||++ 
T Consensus       166 ~NIli~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~~  235 (323)
T 3qup_A          166 RNCMLAEDMTVCVADFGLSRKIYS-------GDYYRQGCASKLPVKWLALESLADNLY---TVHSDVWAFGVTMWEIMTR  235 (323)
T ss_dssp             GGEEECTTSCEEECCCCC------------------------CCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEEcCCCCEEEeeccccccccc-------cccccccccccCcccccCchhhcCCCC---CCccchhhHHHHHHHHHhC
Confidence            999999999999999997653211       111111223345778999999988766   889999999999999999 


Q ss_pred             CCCCCCcc
Q psy16951        247 FKSPFDTV  254 (282)
Q Consensus       247 g~~pf~~~  254 (282)
                      |..||.+.
T Consensus       236 g~~p~~~~  243 (323)
T 3qup_A          236 GQTPYAGI  243 (323)
T ss_dssp             SCCTTTTC
T ss_pred             CCCCcccc
Confidence            89999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.2e-39  Score=295.28  Aligned_cols=211  Identities=19%  Similarity=0.325  Sum_probs=177.5

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.+..++|++.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.++++++||||+++++++.    
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~----  286 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT----  286 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe----
Confidence            4568889999999999999999999999999999999999886543 34667899999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           ....+++||||+++++|.+++...  ....++...++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       287 -----~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~  356 (495)
T 1opk_A          287 -----REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHL  356 (495)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             -----cCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCc
Confidence                 346789999999999999988642  234588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +||+|||++.....        ..........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       357 ~kl~DFG~a~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDvwSlG~~l~el~t~g~~p~~~~  423 (495)
T 1opk_A          357 VKVADFGLSRLMTG--------DTYTAHAGAKFPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGI  423 (495)
T ss_dssp             EEECCTTCEECCTT--------CCEECCTTCCCCGGGCCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEEeecccceeccC--------CceeecCCCcCCcceeCHhHHhcCCC---CcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999998753210        00111123345678999999987766   889999999999999999 99999764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.1e-39  Score=270.68  Aligned_cols=207  Identities=15%  Similarity=0.248  Sum_probs=171.1

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      +.+..++|++.+.||+|+||.||+|++  ++..||+|.+....  ......+.+|+.+++.++||||+++++++...   
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   79 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---   79 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---
Confidence            457789999999999999999999999  47889999986553  34456788999999999999999999865432   


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ccccCCCCCcEEeecCC
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA--YAHRDLKTANVLLANDN  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~--i~H~dlk~~nil~~~~~  176 (282)
                          .....++++||+++++|.+.+...  ....+++..++.++.|++.||.|||++   +  ++|+||||+||+++.++
T Consensus        80 ----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  150 (271)
T 3kmu_A           80 ----PAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDM  150 (271)
T ss_dssp             ----TSSSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTS
T ss_pred             ----CCCCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCc
Confidence                236789999999999999988632  223589999999999999999999998   6  99999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .+++.||++...              .......+|+.|+|||++.+..+...+.++||||+|+++|||++|+.||.+..
T Consensus       151 ~~~l~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          151 TARISMADVKFS--------------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             CEEEEGGGSCCT--------------TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             ceeEEeccceee--------------ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            999998885431              01123456889999999988766333447999999999999999999997643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-38  Score=286.67  Aligned_cols=227  Identities=24%  Similarity=0.425  Sum_probs=181.2

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ...|.+..++|++.+.||+|+||.||+|.+.  +..||||.+....  ..+.+.+|+.++++++||||+++++.+..   
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  257 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE---  257 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc---
Confidence            4567899999999999999999999999984  6799999986443  45678899999999999999999986543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++||||+++++|.+++...  ....++...++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       258 -----~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~  327 (450)
T 1k9a_A          258 -----EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNV  327 (450)
T ss_dssp             -----TTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSC
T ss_pred             -----CCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCC
Confidence                 234689999999999999988754  233478899999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      +|++|||++.....            ......+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+...
T Consensus       328 ~kl~DfG~a~~~~~------------~~~~~~~~~~y~aPE~~~~~~~---~~~sDvwslG~~l~el~t~g~~P~~~~~~  392 (450)
T 1k9a_A          328 AKVSDFGLTKEASS------------TQDTGKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRIPL  392 (450)
T ss_dssp             EEECCCTTCEECC------------------CCCTTTSCHHHHHSSCC---CHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred             EEEeeCCCcccccc------------cccCCCCCcceeCHHHhcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999998652210            0112245788999999987765   889999999999999998 9999976432


Q ss_pred             Cccceeeee-eeccccCCCCCCC
Q psy16951        257 RGDSVALAV-ISGNITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~-~~~~~~~p~~~~~  278 (282)
                      .  .+...+ .+.++..|+.+|+
T Consensus       393 ~--~~~~~i~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          393 K--DVVPRVEKGYKMDAPDGCPP  413 (450)
T ss_dssp             T--THHHHHHTTCCCCCCTTCCH
T ss_pred             H--HHHHHHHcCCCCCCCCcCCH
Confidence            2  121222 2234566666654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-38  Score=287.54  Aligned_cols=207  Identities=25%  Similarity=0.404  Sum_probs=154.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++++.||+|+||+||+|++..++..||||++...  .......+.+|+++++.++||||+++++++...    ..+
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~  127 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK----DVE  127 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS----CTT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC----Ccc
Confidence            47899999999999999999999999999999998543  334556788999999999999999999977653    234


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+++|+|++ +++|.+.+.    ....+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECC
T ss_pred             cCceEEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecc
Confidence            456799999987 678887764    345689999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCch------------------hhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHH
Q psy16951        183 LGSVAPAVVKVCGSA------------------EAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       183 f~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~e  243 (282)
                      ||++...........                  ............||+.|+|||++.. ..+   +.++||||+||++||
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~~~~DiwSlG~il~e  276 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY---TEAIDVWSIGCIFAE  276 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCC---CTHHHHHHHHHHHHH
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCC---CcHhHHHHHHHHHHH
Confidence            998764321110000                  0000112344567999999998753 344   889999999999999


Q ss_pred             HHh
Q psy16951        244 MCY  246 (282)
Q Consensus       244 l~t  246 (282)
                      |++
T Consensus       277 llt  279 (458)
T 3rp9_A          277 LLN  279 (458)
T ss_dssp             HHT
T ss_pred             HHH
Confidence            999

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.6e-39  Score=270.40  Aligned_cols=223  Identities=26%  Similarity=0.363  Sum_probs=177.1

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ....++|++.+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   79 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----   79 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----
Confidence            3467899999999999999999999999999999998853321   12456788999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          +....+++|||+++++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+||+++.++.+
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           80 ----DATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             ----CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred             ----cCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence                457899999999999999888643    4589999999999999999999998   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG  258 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~  258 (282)
                      +++|||.+...           .........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||.....  
T Consensus       149 ~l~Dfg~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~~~--  212 (279)
T 3fdn_A          149 KIADFGWSVHA-----------PSSRRTDLCGTLDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTY--  212 (279)
T ss_dssp             EECSCCEESCC-------------------CCCCTTCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCTTCCSSH--
T ss_pred             EEEeccccccC-----------CcccccccCCCCCccCHhHhccCCC---CccchhHhHHHHHHHHHHCCCCCCCCcH--
Confidence            99999965321           1111234467899999999987765   7899999999999999999999975322  


Q ss_pred             cceeeeeeeccccCCCCC
Q psy16951        259 DSVALAVISGNITFPENT  276 (282)
Q Consensus       259 ~~~~~~~~~~~~~~p~~~  276 (282)
                      ......+....+.+|+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~  230 (279)
T 3fdn_A          213 QETYKRISRVEFTFPDFV  230 (279)
T ss_dssp             HHHHHHHHHTCCCCCTTS
T ss_pred             HHHHHHHHhCCCCCCCcC
Confidence            222223334444555443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.6e-39  Score=270.34  Aligned_cols=200  Identities=26%  Similarity=0.370  Sum_probs=171.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+++++.++||||+++++.+.         ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------~~   78 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE---------DN   78 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE---------CS
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe---------cC
Confidence            468999999999999999999999999999999987665566778899999999999999999998543         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCceee
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLM  181 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~~~  181 (282)
                      ...++|+||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||++   +.++.++++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEE
Confidence            7899999999999999877643    4589999999999999999999999   89999999999999   778899999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+.....          ........+|+.|+|||++.+. +   +.++||||+|+++|+|++|..||.+.
T Consensus       152 Dfg~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~-~---~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          152 DFGLAARFKP----------GKMMRTKVGTPYYVSPQVLEGL-Y---GPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             CCTTCEECCT----------TSCBCCCCSCTTTCCHHHHTTC-B---CTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecccceeccC----------ccchhccCCCCCccChHHhccc-C---CchhhehhHHHHHHHHHHCCCCCCCC
Confidence            9997643210          1112234578899999998764 4   88999999999999999999999763

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-39  Score=272.37  Aligned_cols=200  Identities=24%  Similarity=0.378  Sum_probs=165.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++++.||+|+||+||+|++..++..||+|++.....  .....+.+|+.+++.++||||+++++.+.         +
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH---------S   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE---------E
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE---------e
Confidence            689999999999999999999999999999999865433  33467789999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|||++.+ ++.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Df  145 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence            5789999999965 55554442   345689999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      |.+.....         .........+|..|+|||++.+...  ++.++||||+|+++|+|++|..||.
T Consensus       146 g~~~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          146 GLARAFGI---------PVRCYSAEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             TTCEECCS---------CCSCCCSCCSCGGGCCHHHHTTCSC--CCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             ccceecCC---------ccccccCCccccCCcChHHHcCCCC--cCchHHHHHHHHHHHHHHHcCCCCc
Confidence            98653210         0111223456888999999987652  3889999999999999999887753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=277.70  Aligned_cols=199  Identities=28%  Similarity=0.365  Sum_probs=157.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||+|++..++..||||.+....  ..+.+.+|+++++.++||||+++++++.         ..
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~---------~~  120 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE---------TP  120 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE---------CS
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe---------cC
Confidence            467999999999999999999999999999999886432  3456778999999999999999998544         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCceee
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPLLM  181 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~~~  181 (282)
                      ...++|+||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.   ++.++++
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             CeEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEc
Confidence            78999999999999998775    345689999999999999999999999   8999999999999975   8899999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....          .........||+.|+|||++.+..+   +.++||||||+++|||++|..||.+.
T Consensus       194 Dfg~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          194 DFGLSKIVE----------HQVLMKTVCGTPGYCAPEILRGCAY---GPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             CCC--------------------------CGGGSCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             cCccccccC----------cccccccccCCCCccCHHHhcCCCC---CcccchHHHHHHHHHHHhCCCCCCCC
Confidence            999764221          1111223457899999999988765   88999999999999999999999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=266.68  Aligned_cols=202  Identities=25%  Similarity=0.355  Sum_probs=152.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------   81 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE--------   81 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE--------
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc--------
Confidence            4789999999999999999999999999999998853321   12356788999999999999999998543        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +....++++|++++++|.+.+..   ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++
T Consensus        82 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           82 -DSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             -CSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEEC
T ss_pred             -cCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEE
Confidence             45789999999999999988763   234589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.....         .........+|+.|+|||++.+..+   +.++||||+|+++|+|++|+.||..
T Consensus       155 dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          155 DFGLATQLKM---------PHEKHYTLCGTPNYISPEIATRSAH---GLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             CCTTCEECC----------------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecceeeccC---------CCCcceeccCCCCcCCcchhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9997653210         0111223457889999999987765   7899999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-38  Score=268.16  Aligned_cols=210  Identities=18%  Similarity=0.376  Sum_probs=171.8

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +...|.+..++|++++.||+|+||.||++.+. ++..||+|.+.... .....+.+|+++++.++||||+++++++    
T Consensus        15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   88 (283)
T 3gen_A           15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC----   88 (283)
T ss_dssp             -CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred             CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEE----
Confidence            45678899999999999999999999999885 67789999886443 2346688999999999999999999854    


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                           ......++|||++++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++.++
T Consensus        89 -----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~  157 (283)
T 3gen_A           89 -----TKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQG  157 (283)
T ss_dssp             -----CSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTS
T ss_pred             -----ecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCC
Confidence                 3456799999999999999988632   34589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      .++++|||.+...        ............+|+.|+|||++.+..+   +.++||||+|+++|+|++ |..||...
T Consensus       158 ~~kl~Dfg~~~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          158 VVKVSDFGLSRYV--------LDDEYTSSVGSKFPVRWSPPEVLMYSKF---SSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             CEEECSTTGGGGB--------CCHHHHSTTSTTSCGGGCCHHHHHHCCC---SHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CEEEccccccccc--------cccccccccCCccCcccCCHHHhccCCC---CchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            9999999976421        1111122233445778999999987765   889999999999999998 99999764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7e-39  Score=277.49  Aligned_cols=210  Identities=17%  Similarity=0.177  Sum_probs=171.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+..++|++.+.||+|+||+||+|.+..++..||||.+.....  ...+.+|+++++.+ +||||+++++++..      
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~------   76 (330)
T 2izr_A            5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC------   76 (330)
T ss_dssp             CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE------
T ss_pred             EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec------
Confidence            3456899999999999999999999999999999998864432  23567899999999 89999999985443      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---  177 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---  177 (282)
                         ....++|||++ +++|.+++...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.++.   
T Consensus        77 ---~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~  146 (330)
T 2izr_A           77 ---GKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQ  146 (330)
T ss_dssp             ---TTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCT
T ss_pred             ---CCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCC
Confidence               46799999999 99999988643   34689999999999999999999999   8999999999999998887   


Q ss_pred             --ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 --PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 --~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        ++++|||++.........  ............||+.|+|||++.+..+   +.++||||||+++|||++|..||.+.
T Consensus       147 ~~~kl~DFg~a~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~g~~Pf~~~  220 (330)
T 2izr_A          147 QVIHIIDFALAKEYIDPETK--KHIPYREHKSLTGTARYMSINTHLGKEQ---SRRDDLEALGHMFMYFLRGSLPWQGL  220 (330)
T ss_dssp             TSEEECCCTTCEESBCTTTC--CBCCCCCCCCCCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ceEEEEEcccceeeecCCCC--ccccccccCCcCCCccccChHHHcCCCC---CchhHHHHHHHHHHHHhcCCCCcccc
Confidence              999999987532110000  0000011234568999999999988766   88999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-38  Score=270.75  Aligned_cols=202  Identities=16%  Similarity=0.268  Sum_probs=168.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCC-------ceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-------KRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      .+..++|++.+.||+|+||+||+|.+..++       ..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            357889999999999999999999998777       4799999877666677889999999999999999999985543


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                               ....++||||+.+++|.+++...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.
T Consensus        84 ---------~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  148 (289)
T 4fvq_A           84 ---------GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIR  148 (289)
T ss_dssp             ---------TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEE
T ss_pred             ---------CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEec
Confidence                     46678999999999999988643   23488999999999999999999999   8999999999999998


Q ss_pred             CCC--------ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        175 DNN--------PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       175 ~~~--------~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      ++.        ++++|||.+...        .     ......+|..|+|||++.+...  ++.++||||+|+++|||++
T Consensus       149 ~~~~~~~~~~~~kl~Dfg~~~~~--------~-----~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~  213 (289)
T 4fvq_A          149 EEDRKTGNPPFIKLSDPGISITV--------L-----PKDILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICS  213 (289)
T ss_dssp             CCBGGGTBCCEEEECCCCSCTTT--------S-----CHHHHHHTTTTSCHHHHHCGGG--CCHHHHHHHHHHHHHHHHT
T ss_pred             CCcccccccceeeeccCcccccc--------c-----CccccCCcCcccCHHHhCCCCC--CCchhHHHHHHHHHHHHHc
Confidence            887        899999975421        0     0112235778999999987322  3889999999999999999


Q ss_pred             CC-CCCCc
Q psy16951        247 FK-SPFDT  253 (282)
Q Consensus       247 g~-~pf~~  253 (282)
                      |. +||..
T Consensus       214 g~~~~~~~  221 (289)
T 4fvq_A          214 GGDKPLSA  221 (289)
T ss_dssp             TTCCTTTT
T ss_pred             CCCCCccc
Confidence            55 55643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-38  Score=281.06  Aligned_cols=212  Identities=24%  Similarity=0.341  Sum_probs=160.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++++.||+|+||.||+|.+..++..||||++...  .........+|+.+++.+. ||||+++++.+...      
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------   81 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD------   81 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT------
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC------
Confidence            47899999999999999999999999999999998533  3445567789999999997 99999999865432      


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +...+++||||+. ++|...+..     ..+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++
T Consensus        82 -~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           82 -NDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             -TSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             -CCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence             3357999999996 688777652     3588999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCc------------hhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        182 DLGSVAPAVVKVCGS------------AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       182 df~~~~~~~~~~~~~------------~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      |||++..........            .............||+.|+|||++.+...  ++.++||||+||++|||++|++
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK--YTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC--CCChhhHHHHHHHHHHHHhCCC
Confidence            999876421100000            00011112334568999999999986322  3889999999999999999999


Q ss_pred             CCCcc
Q psy16951        250 PFDTV  254 (282)
Q Consensus       250 pf~~~  254 (282)
                      ||.+.
T Consensus       230 pf~~~  234 (388)
T 3oz6_A          230 IFPGS  234 (388)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2e-38  Score=271.49  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=167.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++.+.||+|+||.||+|++..++..||+|.+..........+.+|+.+++.++||||+++++.+.         ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~~   78 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE---------ST   78 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE---------CS
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc---------cC
Confidence            578999999999999999999999999999999997665555667889999999999999999998543         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCceee
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLLM  181 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~~~  181 (282)
                      ...++++|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||++   +.++.++++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             CEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEc
Confidence            7899999999999999887643    3588999999999999999999999   89999999999999   678899999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....     .      .......+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       152 Dfg~~~~~~-----~------~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          152 DFGLSKMEQ-----N------GIMSTACGTPGYVAPEVLAQKPY---SKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             SCSTTCCCC-----C------BTTHHHHSCCCBCCTTTBSSCSC---CHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCCcceecC-----C------CccccccCCCCccChHHhccCCC---CchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999764211     0      01123357899999999987765   88999999999999999999999753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.1e-38  Score=266.33  Aligned_cols=207  Identities=22%  Similarity=0.410  Sum_probs=171.9

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .+.+..++|++.+.||+|+||.||+|++. ++..||+|.+..... ....+.+|+++++.++||||+++++.+       
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-------   72 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-------   72 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-------
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-------
Confidence            34678899999999999999999999885 567799998865433 345688999999999999999999854       


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        ......++|||++++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus        73 --~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~  144 (268)
T 3sxs_A           73 --SKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVK  144 (268)
T ss_dssp             --CSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEE
T ss_pred             --ccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEE
Confidence              3456799999999999999988653   23489999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++|||.+.....        ..........+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||...
T Consensus       145 l~Dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          145 VSDFGMTRYVLD--------DQYVSSVGTKFPVKWSAPEVFHYFKY---SSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             ECCTTCEEECCT--------TCEEECCSCCCCGGGCCHHHHHHSEE---ETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             EccCccceecch--------hhhhcccCCCcCcccCCHHHHhccCC---chhhhhHHHHHHHHHHHcCCCCCcccc
Confidence            999997653210        01111223345677999999988776   789999999999999999 99999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.9e-39  Score=276.31  Aligned_cols=208  Identities=21%  Similarity=0.321  Sum_probs=164.2

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCce----EEEEEeccC-CchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR----YALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      -.+..++|++.+.||+|+||+||+|++..++..    ||+|.+... .......+.+|+.+++.++||||+++++++.. 
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   88 (327)
T 3poz_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-   88 (327)
T ss_dssp             EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-
T ss_pred             hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-
Confidence            456789999999999999999999998777654    588877433 23445678899999999999999999986654 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ...++++|++.+++|.+.+..   ....+++..++.++.|++.||.|||++   |++||||||+||+++.+
T Consensus        89 ---------~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~  153 (327)
T 3poz_A           89 ---------STVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP  153 (327)
T ss_dssp             ---------SSEEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET
T ss_pred             ---------CCeEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCC
Confidence                     247899999999999998864   234589999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.+|++|||++.....       ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       154 ~~~kl~Dfg~a~~~~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~ellt~g~~p~~~~  223 (327)
T 3poz_A          154 QHVKITDFGLAKLLGA-------EEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             TEEEECCTTHHHHHTT-------TCC-------CCCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCEEEccCcceeEccC-------CcccccccCCCccccccChHHhccCCC---CchhhhhhhHHHHHHHHhcCCCCccCC
Confidence            9999999997643211       001111223345778999999988766   889999999999999999 99999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-38  Score=266.12  Aligned_cols=209  Identities=26%  Similarity=0.472  Sum_probs=174.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.+++.++||||+++++.+...      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   77 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR------   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG------
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC------
Confidence            4679999999999999999999999999999999986543  34456788999999999999999999865431      


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----ccccCCCCCcEEeecCC
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA-----YAHRDLKTANVLLANDN  176 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~-----i~H~dlk~~nil~~~~~  176 (282)
                       .....++|+||+++++|.+.+.........+++..++.++.|++.||.|||++   +     ++|+||||+||+++.++
T Consensus        78 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~  153 (279)
T 2w5a_A           78 -TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQ  153 (279)
T ss_dssp             -GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSS
T ss_pred             -CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCC
Confidence             34679999999999999999887655556689999999999999999999998   6     99999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++++|||.+....         ..........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||...
T Consensus       154 ~~kl~dfg~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          154 NVKLGDFGLARILN---------HDTSFAKTFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             CEEECCCCHHHHC------------CHHHHHHHSCCTTCCHHHHHCC-C---CHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CEEEecCchheeec---------cccccccccCCCccccChHHhccCCC---CchhhHHHHHHHHHHHHHCCCCCccc
Confidence            99999999654210         01111223457899999999987765   78999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=281.81  Aligned_cols=201  Identities=24%  Similarity=0.381  Sum_probs=164.3

Q ss_pred             ccEEE--EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYI--VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      +.|++  .+.||+|+||.||+|.+..++..||+|.+........+.+.+|+++++.++||||+++++++.         .
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---------~  157 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE---------S  157 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE---------C
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE---------E
Confidence            34555  678999999999999999999999999998777677788999999999999999999998544         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe--ecCCCceee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL--ANDNNPLLM  181 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~--~~~~~~~~~  181 (282)
                      ....++||||+++++|.+.+...   ...+++..+..++.|++.||.|||++   ||+||||||+||++  +.++.++++
T Consensus       158 ~~~~~lv~E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~  231 (373)
T 2x4f_A          158 KNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKII  231 (373)
T ss_dssp             SSEEEEEEECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEE
Confidence            57899999999999999877642   23588999999999999999999999   89999999999999  456789999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++.....          ........||+.|+|||++.+..+   +.++||||||+++|||++|..||.+.
T Consensus       232 DFG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          232 DFGLARRYKP----------REKLKVNFGTPEFLAPEVVNYDFV---SFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             CCSSCEECCT----------TCBCCCCCSSCTTCCHHHHTTCBC---CHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eCCCceecCC----------ccccccccCCCcEeChhhccCCCC---CcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9998653211          011123457899999999987665   78999999999999999999999763

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-38  Score=267.12  Aligned_cols=204  Identities=23%  Similarity=0.360  Sum_probs=169.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||.||+|++..++..||+|.+.... ......+.+|+++++.++||||+++++.+.         .
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---------~   91 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE---------D   91 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE---------C
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee---------c
Confidence            478999999999999999999999999999999886443 334567889999999999999999998543         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCcee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~~  180 (282)
                      ....++|+||+++++|.+.+.........+++..++.++.|++.||.|||++   |++||||||+||++   +.++.+++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl  168 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKI  168 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEE
Confidence            5789999999999999998876544556789999999999999999999999   89999999999999   45578999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+....          .........+|..|+|||++.+. +   +.++||||+|+++|+|++|..||.+.
T Consensus       169 ~Dfg~a~~~~----------~~~~~~~~~~t~~y~aPE~~~~~-~---~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          169 IDFGLAELFK----------SDEHSTNAAGTALYMAPEVFKRD-V---TFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             CCCCCCCC--------------------CTTGGGCCHHHHTTC-C---CHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeeecceecC----------CcccCcCcccccCcCChHHhccC-C---CcccCeehHHHHHHHHHhCCCCCCCC
Confidence            9999764221          01112334578899999998643 3   78999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-39  Score=281.86  Aligned_cols=219  Identities=26%  Similarity=0.413  Sum_probs=172.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      -.++|++.+.||+|+||+||+|.+..++..||+|.+......    ..+|++++.++ +||||+++++.+         .
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~---------~   86 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY---------D   86 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE---------E
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE---------E
Confidence            467899999999999999999999999999999998644322    34577888777 799999999854         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-C---Cc
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-N---NP  178 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~---~~  178 (282)
                      +....++||||+.+++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||++..+ +   .+
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~  159 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESI  159 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGE
T ss_pred             cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeE
Confidence            4578999999999999998875    335689999999999999999999999   89999999999998543 2   48


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc-cC
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY-ER  257 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~-~~  257 (282)
                      |++|||++.....         .........+|+.|+|||++.+..+   +.++||||+|+++|||++|..||.+.. ..
T Consensus       160 kl~Dfg~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~~~~  227 (342)
T 2qr7_A          160 RICDFGFAKQLRA---------ENGLLMTPCYTANFVAPEVLERQGY---DAACDIWSLGVLLYTMLTGYTPFANGPDDT  227 (342)
T ss_dssp             EECCCTTCEECBC---------TTCCBCCSSCCSSCCCHHHHHHHHH---HHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred             EEEECCCcccCcC---------CCCceeccCCCccccCHHHhcCCCC---CCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence            9999998653211         0111223457899999999987766   789999999999999999999997532 12


Q ss_pred             ccceeeeeeeccccCCC
Q psy16951        258 GDSVALAVISGNITFPE  274 (282)
Q Consensus       258 ~~~~~~~~~~~~~~~p~  274 (282)
                      ...+...+..+.+.++.
T Consensus       228 ~~~~~~~i~~~~~~~~~  244 (342)
T 2qr7_A          228 PEEILARIGSGKFSLSG  244 (342)
T ss_dssp             HHHHHHHHHHCCCCCCS
T ss_pred             HHHHHHHHccCCcccCc
Confidence            22333344555555543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.9e-39  Score=274.63  Aligned_cols=209  Identities=24%  Similarity=0.369  Sum_probs=167.1

Q ss_pred             cccEEEE-EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++. +.||+|+||.||+|.+..++..||||.+..........+.+|+++++++ +||||+++++++.         
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~---------   81 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE---------   81 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE---------
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe---------
Confidence            5788885 6799999999999999999999999999766666677888999999885 7999999998554         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---ce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---PL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~~  179 (282)
                      .....++|||++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.   ++
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           82 EEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceE
Confidence            347899999999999999988643    4589999999999999999999999   8999999999999988776   89


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-----CcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-----DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-----~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||++........  .............||..|+|||++.+     ..+   +.++||||+|+++|||++|..||.+.
T Consensus       155 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~---~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGD--CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY---DKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             ECCTTCCC---------------------CCSGGGCCHHHHHHTSHHHHHH---TTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             EEEccCccccccCCc--cccccccccccccCCcCccChHHhhcccccccCC---CcccccHhHHHHHHHHHHCCCCCccc
Confidence            999997653211100  00001111223458899999999975     334   78999999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8e-39  Score=278.12  Aligned_cols=213  Identities=22%  Similarity=0.317  Sum_probs=172.7

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      .+.+..++|++.+.||+|+||.||+|++..     ++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            346678999999999999999999999873     458899999865433 34567889999999999999999998543


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--------------------GKHYMSSVDILKMFLKICEAVKVFH  153 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~~l~~lH  153 (282)
                               .....++||||+++++|.+++.....                    ....+++.+++.++.|++.||.|||
T Consensus       121 ---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  191 (343)
T 1luf_A          121 ---------VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  191 (343)
T ss_dssp             ---------SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ---------cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                     34678999999999999998875211                    1246889999999999999999999


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ++   |++||||||+||+++.++.++++|||.+.....       ...........+|..|+|||++.+..+   +.++|
T Consensus       192 ~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~D  258 (343)
T 1luf_A          192 ER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS-------ADYYKADGNDAIPIRWMPPESIFYNRY---TTESD  258 (343)
T ss_dssp             HT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG-------GGCBC----CCBCGGGCCHHHHHHCCC---CHHHH
T ss_pred             hC---CeecCCCCcceEEECCCCeEEEeecCCCccccc-------CccccccCCCcccceecChhhhccCCc---Ccccc
Confidence            99   899999999999999999999999997643210       000111223456788999999987765   88999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCcc
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~~  254 (282)
                      |||||+++|||++ |..||.+.
T Consensus       259 i~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          259 VWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             HHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999 99999763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-39  Score=279.62  Aligned_cols=216  Identities=19%  Similarity=0.300  Sum_probs=172.0

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPLL   89 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~~   89 (282)
                      ....|.+..++|++.+.||+|+||.||+|.+.     .++..||+|.+.... ......+.+|+.+++.+ +||||++++
T Consensus        36 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           36 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34467888999999999999999999999973     466789999986442 23445788999999999 899999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHH
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG-------------------KHYMSSVDILKMFLKICEAVK  150 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~l~~~~~~~~~~qi~~~l~  150 (282)
                      +.+.         .....++||||+++++|.+++......                   ...+++..++.++.|++.||.
T Consensus       116 ~~~~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~  186 (344)
T 1rjb_A          116 GACT---------LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME  186 (344)
T ss_dssp             EEEC---------SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred             EEEe---------eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence            8544         346789999999999999988643210                   123788999999999999999


Q ss_pred             HhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCC
Q psy16951        151 VFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQ  230 (282)
Q Consensus       151 ~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~  230 (282)
                      |||++   |++||||||+||+++.++.++++|||.+......       ..........+|+.|+|||++.+..+   +.
T Consensus       187 ~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~t~~y~aPE~~~~~~~---~~  253 (344)
T 1rjb_A          187 FLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-------SNYVVRGNARLPVKWMAPESLFEGIY---TI  253 (344)
T ss_dssp             HHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC-------TTSEEETTEEECGGGCCHHHHHHCCC---CH
T ss_pred             HHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccC-------ccceeccCccCccCccCHHHhccCCC---Ch
Confidence            99999   8999999999999999999999999976532110       00011223445778999999987765   88


Q ss_pred             ccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        231 RTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       231 ~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++||||||+++|+|+| |..||.+.
T Consensus       254 ~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          254 KSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999998 99999764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.9e-39  Score=287.96  Aligned_cols=209  Identities=21%  Similarity=0.345  Sum_probs=170.4

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.+..++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||+++++.+..   
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  250 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---  250 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---
Confidence            56788999999999999999999999999964 4679999886543 345678999999999999999999985432   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++||||+++++|.+++....  ...++...++.++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       251 -------~~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~  318 (452)
T 1fmk_A          251 -------EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV  318 (452)
T ss_dssp             -------SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             -------CceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCC
Confidence                   45789999999999999886432  24588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|++|||++....        ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       319 ~kl~DfG~a~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          319 CKVADFGLARLIE--------DNEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             EEECCCCTTC----------------------CCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EEECCCccceecC--------CCceecccCCcccccccCHhHHhcCCC---CccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999865321        111111223345778999999987765   889999999999999999 99999763

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.9e-38  Score=275.19  Aligned_cols=203  Identities=23%  Similarity=0.328  Sum_probs=170.6

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-----CCCccccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-----HPNILPLLDHALTG   95 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-----H~ni~~~~~~~~~~   95 (282)
                      ..+..++|+++++||+|+||+||+|++..++..||||.+.. .......+..|+++++.++     ||||+++++.+.. 
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-  107 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-  107 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-
Confidence            34557899999999999999999999999999999998853 2344556677899998886     9999999986544 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-  174 (282)
                              ....++|||++ +++|.+.+...  ....++...+..++.|++.||.|||++   ||+||||||+||+++. 
T Consensus       108 --------~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          108 --------YDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             --------TTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             --------CCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence                    46899999999 99999988743  223488999999999999999999999   8999999999999975 


Q ss_pred             ------------------------CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCC
Q psy16951        175 ------------------------DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQ  230 (282)
Q Consensus       175 ------------------------~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~  230 (282)
                                              ++.++++|||.+....            .......||+.|+|||++.+..+   +.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~  238 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------DYHGSIINTRQYRAPEVILNLGW---DV  238 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT------------SCCCSCCSCGGGCCHHHHTTCCC---CT
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecC------------CCCcCccCcccccCcHHHcCCCC---CC
Confidence                                    7889999999865311            01123467889999999988776   89


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        231 RTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       231 ~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++||||+||++|+|++|+.||.+.
T Consensus       239 ~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          239 SSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             THHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccchHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999999753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.2e-39  Score=271.52  Aligned_cols=211  Identities=20%  Similarity=0.331  Sum_probs=177.3

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      -+.|.+..++|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+++++.++||||+++++++.    
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   79 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----   79 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc----
Confidence            457788999999999999999999999999999999999988643 445667889999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++|+|++.+++|.+.+...  ....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        80 -----~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~  149 (288)
T 3kfa_A           80 -----REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHL  149 (288)
T ss_dssp             -----SSSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGC
T ss_pred             -----cCCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCC
Confidence                 456799999999999999988642  334588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+.....        ..........+|+.|+|||++.+..+   +.++||||+|+++|+|++ |..||.+.
T Consensus       150 ~~l~Dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          150 VKVADFGLSRLMTG--------DTYTAHAGAKFPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             EEECCCCGGGTSCS--------SSSEEETTEEECGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEEccCccceeccC--------CccccccCCccccCcCChhhhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999997643210        01111223345778999999987765   889999999999999999 99999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.1e-38  Score=272.82  Aligned_cols=221  Identities=22%  Similarity=0.325  Sum_probs=168.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC----
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP----   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~----   99 (282)
                      .++|++.+.||+|+||+||+|++..++..||||++.... ....+.+.+|+.+++.++||||+++++.+.......    
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            368999999999999999999999999999999986544 335667889999999999999999998775431100    


Q ss_pred             --------------------------------------------CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCH
Q psy16951        100 --------------------------------------------VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS  135 (282)
Q Consensus       100 --------------------------------------------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~  135 (282)
                                                                  ........+++|||+++++|.+++.... .......
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                        0112235899999999999999887432 2223456


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhh---hhhHhhhhccCCC
Q psy16951        136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA---QNLQDVAAERCSM  212 (282)
Q Consensus       136 ~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~---~~~~~~~~~~~t~  212 (282)
                      ..++.++.|++.||.|||++   |++||||||+||+++.++.++++|||.+.............   ..........||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            67899999999999999999   89999999999999999999999999875432111000000   0001122346789


Q ss_pred             CccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        213 PYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       213 ~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .|+|||++.+..+   +.++||||+|+++|||++|..|+.
T Consensus       241 ~y~aPE~~~~~~~---~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          241 LYMSPEQIHGNNY---SHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             GGSCHHHHHCCCC---CTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             CccChHHhcCCCC---cchhhHHHHHHHHHHHHHcCCChh
Confidence            9999999988766   889999999999999999988774

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.5e-38  Score=280.03  Aligned_cols=215  Identities=22%  Similarity=0.318  Sum_probs=166.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++.+.||+|+||+||+|.+..++..||||++...  .......+.+|+.+++.++||||+++++.+...    ..
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~~   99 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD----DL   99 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS----CT
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC----CC
Confidence            367999999999999999999999999999999998643  334456788999999999999999999876543    12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....+++|+|++. ++|.+.+.    ....+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+|++
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CcCCeEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEc
Confidence            23367999999985 68888775    345689999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchh-------------hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        182 DLGSVAPAVVKVCGSAE-------------AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      |||++............             ...........||..|+|||++.....  ++.++||||+||++|||++|.
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~--~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN--YTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC--CCTHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC--CCcccccchHHHHHHHHHhcc
Confidence            99987643211100000             000012345678999999999744331  388999999999999999866


Q ss_pred             CCCC
Q psy16951        249 SPFD  252 (282)
Q Consensus       249 ~pf~  252 (282)
                      .||.
T Consensus       250 ~p~~  253 (432)
T 3n9x_A          250 QSHI  253 (432)
T ss_dssp             TTTC
T ss_pred             cccc
Confidence            5554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-38  Score=273.77  Aligned_cols=218  Identities=18%  Similarity=0.307  Sum_probs=175.6

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      ......+.+..++|++.+.||+|+||.||+|.+.     .++..||+|.+.... ......+.+|+++++.++||||+++
T Consensus        12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   91 (314)
T 2ivs_A           12 ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL   91 (314)
T ss_dssp             --CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence            3455677888999999999999999999999873     455889999886543 3345678899999999999999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHH
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--------------------GKHYMSSVDILKMFLKICEA  148 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~~  148 (282)
                      ++.+.         .....++|+||+++++|.+++.....                    ....+++..++.++.|++.|
T Consensus        92 ~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  162 (314)
T 2ivs_A           92 YGACS---------QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG  162 (314)
T ss_dssp             EEEEC---------SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHH
T ss_pred             EEEEe---------cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence            98543         34678999999999999998875321                    11237888999999999999


Q ss_pred             HHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCC
Q psy16951        149 VKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVV  228 (282)
Q Consensus       149 l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~  228 (282)
                      |.|||++   |++|+||||+||+++.++.++++|||.+......       ..........+|+.|+|||++.+..+   
T Consensus       163 l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---  229 (314)
T 2ivs_A          163 MQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-------DSYVKRSQGRIPVKWMAIESLFDHIY---  229 (314)
T ss_dssp             HHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTT-------SCEECSSCCCSCGGGCCHHHHHHCEE---
T ss_pred             HHHHHHC---CCcccccchheEEEcCCCCEEEcccccccccccc-------ccceeccCCCCcccccChhhhcCCCc---
Confidence            9999999   8999999999999999999999999976532110       00011123345678999999988766   


Q ss_pred             CCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        229 DQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       229 ~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.++||||+|+++|||++ |..||.+.
T Consensus       230 ~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          230 TTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            889999999999999999 99999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.7e-38  Score=268.43  Aligned_cols=203  Identities=22%  Similarity=0.341  Sum_probs=171.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.++||||+++++++.       
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------   85 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-------   85 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-------
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-------
Confidence            357899999999999999999999999999999988543   2334567788999999999999999998543       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++++|++.+++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+||+++.++.+++
T Consensus        86 --~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  156 (294)
T 2rku_A           86 --DNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKI  156 (294)
T ss_dssp             --CSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             --cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEE
Confidence              457899999999999999877642    4589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+.....         .........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       157 ~dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          157 GDFGLATKVEY---------DGERKKVLCGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             CCCTTCEECCS---------TTCCBCCCCSCCSSCCHHHHTTSCB---CTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             EeccCceeccc---------CccccccccCCCCcCCcchhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99997653210         0111223457889999999987766   88999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-38  Score=280.95  Aligned_cols=202  Identities=26%  Similarity=0.417  Sum_probs=160.6

Q ss_pred             cccEEEE-EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHh-hhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH-KTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l-~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++. +.||+|+||+||+|.+..++..||||.+..     .....+|++++ +..+||||+++++.+..     ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~-----~~~  129 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN-----LYA  129 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE-----EET
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEee-----ccc
Confidence            4678887 689999999999999999999999998852     23456788876 45589999999986543     223


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~  179 (282)
                      +...+++||||+.+++|.+++...  ....+++..+..++.|++.||.|||++   ||+||||||+||+++.   ++.+|
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEE
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEE
Confidence            356799999999999999988632  223589999999999999999999998   8999999999999987   78899


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||++....          .........||+.|+|||++.+..+   +.++|||||||++|||++|..||.+.
T Consensus       205 l~DFG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          205 LTDFGFAKETT----------SHNSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             ECCCTTCEECC---------------------CTTCCGGGSCCCCS---SSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             EEecccccccC----------CCCccccCCCCCCccCHhhcCCCCC---CCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            99999865321          0111234467899999999987766   88999999999999999999999764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-38  Score=274.03  Aligned_cols=201  Identities=22%  Similarity=0.346  Sum_probs=171.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||.||++.+..++..||+|.+...   .....+.+.+|+.+++.++||||+++++++.        
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------  111 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--------  111 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--------
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--------
Confidence            57899999999999999999999999999999988543   2344567788999999999999999998544        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +....++++||+.+++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++++
T Consensus       112 -~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          112 -DNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             -CSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             -cCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEe
Confidence             457899999999999999877643    4589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.....         .........+|..|+|||++.+..+   +.++||||||+++|+|++|+.||..
T Consensus       184 Dfg~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          184 DFGLATKVEY---------DGERKKVLCGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             CCTTCEECCS---------TTCCBCCCCSCCSSCCHHHHHTSCB---CTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eccCceeccc---------CcccccccCCCccccCHHHhccCCC---CchhhHHHHHHHHHHHHHCcCCCCC
Confidence            9997653210         0111223457889999999988766   8899999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-38  Score=274.03  Aligned_cols=211  Identities=24%  Similarity=0.341  Sum_probs=160.9

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--HHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--QAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      .+........++|++++.||+|+||+||+|.+..++..||||++.......  ...+.+|+.+++.++||||+++++.+.
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             --------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             eccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            344445567889999999999999999999999999999999986544332  445678999999999999999998544


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                               .....++||||+. ++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++
T Consensus       104 ---------~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~  166 (329)
T 3gbz_A          104 ---------HNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLS  166 (329)
T ss_dssp             ---------ETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             ---------cCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEe
Confidence                     3578999999996 588887753    34589999999999999999999999   899999999999995


Q ss_pred             cC-----CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        174 ND-----NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       174 ~~-----~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      .+     +.++++|||.+...         ...........+|..|+|||++.+...  ++.++||||+|+++|||++|.
T Consensus       167 ~~~~~~~~~~kl~Dfg~a~~~---------~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~  235 (329)
T 3gbz_A          167 VSDASETPVLKIGDFGLARAF---------GIPIRQFTHEIITLWYRPPEILLGSRH--YSTSVDIWSIACIWAEMLMKT  235 (329)
T ss_dssp             C-----CCEEEECCTTHHHHH---------C-----------CCTTCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCccceEEECcCCCcccc---------CCcccccCCCcCCccccCHHHhcCCCC--CCcHHHHHHHHHHHHHHHHCC
Confidence            44     45899999975421         111112233456889999999987542  388999999999999999999


Q ss_pred             CCCCcc
Q psy16951        249 SPFDTV  254 (282)
Q Consensus       249 ~pf~~~  254 (282)
                      .||.+.
T Consensus       236 ~pf~~~  241 (329)
T 3gbz_A          236 PLFPGD  241 (329)
T ss_dssp             CSSCCS
T ss_pred             CCcCCC
Confidence            999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=279.16  Aligned_cols=207  Identities=23%  Similarity=0.344  Sum_probs=168.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC----chhHHHHHHHHHHhhhC-CCCCcccccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG----REDQAQAIREVEHHKTF-VHPNILPLLDHALT   94 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~----~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~   94 (282)
                      +..++|++.+.||+|+||.||+|++.   .++..||||.+....    ......+.+|+++++.+ +||||+++++.+. 
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-  129 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-  129 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-
Confidence            34589999999999999999999984   588999999885432    12334566789999999 6999999988544 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              .....++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++.
T Consensus       130 --------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          130 --------TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS  194 (355)
T ss_dssp             --------ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             --------eCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence                    346899999999999999988643    3589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.++++|||++....        ...........||+.|+|||++.+... .++.++||||||+++|||++|..||...
T Consensus       195 ~~~~kl~DfG~a~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFV--------ADETERAYDFCGTIEYMAPDIVRGGDS-GHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             TSCEEESCSSEEEECC--------GGGGGGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCcEEEeeCCCCeecc--------cCCCCcccCcccCcCccChhhhcCCCC-CCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            9999999999765321        111122234568999999999986432 2378999999999999999999999753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5e-39  Score=277.32  Aligned_cols=208  Identities=20%  Similarity=0.312  Sum_probs=172.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||.||+|.+. ++..||||++........+.+.+|+++++.++||||+++++++         ..
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---------~~  106 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC---------DE  106 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---------CC
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---------cC
Confidence            4588999999999999999999974 6889999998777667778889999999999999999999854         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+||+++++|.+.+.........+++..++.++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            5678999999999999987753322233588999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......       ..........||+.|+|||++.+..+   +.++||||||+++|||++|+.||.+.
T Consensus       184 g~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          184 GISKKGTEL-------DQTHLSTVVKGTLGYIDPEYFIKGRL---TEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             TTCEECSSS-------SCCCCBCCCEEETTTCCHHHHHHCBC---CTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             ccccccccc-------cccccccccCCCccccCHHHhcCCCC---CcccchHhHHHHHHHHHhCCCccccc
Confidence            976531100       00011122346888999999987765   88999999999999999999999754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.7e-38  Score=266.31  Aligned_cols=200  Identities=29%  Similarity=0.423  Sum_probs=169.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------   75 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ---------   75 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---------
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE---------
Confidence            57899999999999999999999999999999988543  2334567789999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---ce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---PL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~~  179 (282)
                      .....++++|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||+++.++.   ++
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~k  148 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK  148 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEE
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEE
Confidence            457789999999999998877643    4589999999999999999999999   8999999999999976655   89


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++|||.+....          .........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       149 l~Dfg~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          149 LADFGLAIEVN----------DSEAWHGFAGTPGYLSPEVLKKDPY---SKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             ECCCTTCEECC----------SSCBCCCSCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EeeceeeEEcc----------cCccccCCCCCcCCcCchhhcCCCC---CcccchHHHHHHHHHHHHCCCCCCC
Confidence            99999764221          0111123457889999999988766   8899999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-38  Score=273.60  Aligned_cols=218  Identities=21%  Similarity=0.285  Sum_probs=176.9

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILP   87 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~   87 (282)
                      +.....|.+..++|++.+.||+|+||.||+|.+     ..++..||+|.+..... ...+.+.+|+.+++.+ +||||++
T Consensus        12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~   91 (313)
T 1t46_A           12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN   91 (313)
T ss_dssp             SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeee
Confidence            445667889999999999999999999999985     45778999999875543 3456788999999999 8999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV--------------GKHYMSSVDILKMFLKICEAVKVFH  153 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~~l~~lH  153 (282)
                      +++.+.         .....++|+|++++++|.+.+.....              ....+++..++.++.|++.||.|||
T Consensus        92 ~~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  162 (313)
T 1t46_A           92 LLGACT---------IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA  162 (313)
T ss_dssp             EEEEEC---------SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEe---------cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            998543         34678999999999999998875321              1124889999999999999999999


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ++   |++|+||||+||+++.++.++++|||.+......       ..........+|+.|+|||++.+..+   +.++|
T Consensus       163 ~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~D  229 (313)
T 1t46_A          163 SK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND-------SNYVVKGNARLPVKWMAPESIFNCVY---TFESD  229 (313)
T ss_dssp             HT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC-------TTSEECSSSEECGGGCCHHHHHHCCC---CHHHH
T ss_pred             HC---CeecCCCccceEEEcCCCCEEEcccccccccccc-------ccceeccCCCCcceeeChHHhcCCCC---ChHHH
Confidence            99   8999999999999999999999999976532110       00011122345678999999987765   88999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCcc
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~~  254 (282)
                      |||+|+++|+|++ |..||.+.
T Consensus       230 i~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          230 VWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999 99999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=269.56  Aligned_cols=203  Identities=24%  Similarity=0.326  Sum_probs=164.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++++.||+|+||+||+|.+..++..||+|++......  ....+.+|++++++++||||+++++.+.         
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------   72 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR---------   72 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---------
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee---------
Confidence            47899999999999999999999999999999988654433  3456788999999999999999998554         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++|+|++.+++|...+.    ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++|
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  145 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCD  145 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             cCCeEEEEEEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEee
Confidence            3478999999999988887664    345589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+....         ..........+|..|+|||++.+...  ++.++||||+|+++|+|++|..||.+.
T Consensus       146 fg~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          146 FGFARLLT---------GPSDYYDDEVATRWYRSPELLVGDTQ--YGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             CTTCEECC---------------------GGGCCHHHHHTCSC--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCchhcc---------CcccccCCCcCCccccChHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            99765321         01111223456888999999976432  388999999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-38  Score=271.77  Aligned_cols=200  Identities=26%  Similarity=0.364  Sum_probs=170.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------hHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------DQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+......      ..+.+.+|+.+++.++||||+++++.+.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            57899999999999999999999999999999988654322      3567889999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--  176 (282)
                          .....++|+|++++++|.+.+.    ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++  
T Consensus        86 ----~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           86 ----NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             ----CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred             ----cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCC
Confidence                4578999999999999999885    234588999999999999999999999   899999999999999887  


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                        .++++|||.+.....          ........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       155 ~~~~kl~Dfg~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIED----------GVEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             SCCEEECCCTTCEECCT----------TCCCCCCCSCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cCCEEEccCccceecCc----------cccccccCCCCCccCcccccCCCC---CCccccHHHHHHHHHHHHCCCCCCC
Confidence              799999997653210          011123457889999999987765   8899999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-38  Score=273.63  Aligned_cols=198  Identities=28%  Similarity=0.473  Sum_probs=149.1

Q ss_pred             ccEEEE---EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCC
Q psy16951         26 DKYYIV---EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        26 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ++|++.   +.||+|+||+||+|.+..++..||||.+..   .......+|+..++.+. ||||+++++++.        
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~--------   76 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH--------   76 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE--------
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE--------
Confidence            456665   679999999999999999999999999853   34456678999999997 999999998543        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC---Cc
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN---NP  178 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~  178 (282)
                       +....++|||++++++|.+.+..    ...+++..+..++.|++.||.|||++   |++||||||+||+++.++   .+
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  148 (325)
T 3kn6_A           77 -DQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEI  148 (325)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEE
T ss_pred             -cCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccE
Confidence             45789999999999999998863    35689999999999999999999999   899999999999998766   78


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+....         ..........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       149 kl~Dfg~a~~~~---------~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          149 KIIDFGFARLKP---------PDNQPLKTPCFTLHYAAPELLNQNGY---DESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             EECCCTTCEECC---------C----------------------CCC---CHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             EEeccccceecC---------CCCCcccccCCCcCccCHHHhcCCCC---CCccchHHHHHHHHHHHhCCCCCCCC
Confidence            999999765221         01112233456889999999988766   88999999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=270.18  Aligned_cols=209  Identities=23%  Similarity=0.354  Sum_probs=165.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-----hhHHHHHHHHHHhhhC---CCCCcccccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-----EDQAQAIREVEHHKTF---VHPNILPLLDHALT   94 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~   94 (282)
                      +..++|++.+.||+|+||+||+|++..++..||||.+.....     .......+|+..++.+   +||||+++++.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            456899999999999999999999999999999998864321     1123455677766655   49999999997765


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                      .    ........++++|++. ++|.+.+...  ....+++..+..++.|++.||.|||++   |++||||||+||+++.
T Consensus        86 ~----~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           86 S----RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTS  155 (308)
T ss_dssp             C----CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECT
T ss_pred             c----CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcC
Confidence            3    1122346899999996 6998877632  223489999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.++++|||.+.....          ........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       156 ~~~~kl~Dfg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          156 GGTVKLADFGLARIYSY----------QMALTPVVVTLWYRAPEVLLQSTY---ATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             TSCEEECSCSCTTTSTT----------CCCSGGGGCCCSSCCHHHHHTSCC---CSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             CCCEEEeeCccccccCC----------CcccCCccccccccCchHHcCCCC---CchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999997653210          111233467999999999988776   88999999999999999999999763

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-38  Score=268.49  Aligned_cols=202  Identities=24%  Similarity=0.396  Sum_probs=171.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|.+....   ......+.+|+++++.++||||+++++++.     
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----
Confidence            356789999999999999999999999999999999885332   122456788999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++++|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||+++.++.+
T Consensus        85 ----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           85 ----DRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             ----CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCE
T ss_pred             ----cCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCE
Confidence                357899999999999999988643    3588999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +++|||.+.....           .......++..|+|||++.+..+   +.++||||+|+++|+|++|..||..
T Consensus       154 kl~Dfg~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          154 KIADFGWSVHAPS-----------LRRRTMCGTLDYLPPEMIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             EECCCTTCEECSS-----------SCBCCCCSCGGGCCHHHHTTCCB---CTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEecccccccCcc-----------cccccccCCCCcCCHHHhccCCC---CcccchhhHHHHHHHHHHCCCCCCC
Confidence            9999997542210           01123457888999999988766   8899999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-38  Score=266.69  Aligned_cols=208  Identities=24%  Similarity=0.352  Sum_probs=168.9

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh--H-----HHHHHHHHHhhhCCCCCccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED--Q-----AQAIREVEHHKTFVHPNILPLL   89 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~-----~~~~~e~~~l~~l~H~ni~~~~   89 (282)
                      ......+..++|++.+.||+|+||+||+|++..++..||+|.+.......  .     ..+.+|+++++.++||||++++
T Consensus        10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             --CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             chhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            33444577899999999999999999999999999999999886443321  1     5678999999999999999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ccccCCCC
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA--YAHRDLKT  167 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~--i~H~dlk~  167 (282)
                      +.+..         .  .++|+||+++++|.+.+..   ....+++..++.++.|++.||.|||++   |  ++|+||||
T Consensus        90 ~~~~~---------~--~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp  152 (287)
T 4f0f_A           90 GLMHN---------P--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRS  152 (287)
T ss_dssp             EEETT---------T--TEEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSG
T ss_pred             eeecC---------C--CeEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCc
Confidence            86533         2  2699999999999887753   334689999999999999999999999   7  99999999


Q ss_pred             CcEEeecCCC-----ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHH
Q psy16951        168 ANVLLANDNN-----PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       168 ~nil~~~~~~-----~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~  242 (282)
                      +||+++.++.     ++++|||.+....            .......+|+.|+|||++.+... .++.++||||+|+++|
T Consensus       153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~------------~~~~~~~g~~~y~aPE~~~~~~~-~~~~~~Di~slG~~l~  219 (287)
T 4f0f_A          153 PNIFLQSLDENAPVCAKVADFGLSQQSV------------HSVSGLLGNFQWMAPETIGAEEE-SYTEKADTYSFAMILY  219 (287)
T ss_dssp             GGEEESCCCTTCSCCEEECCCTTCBCCS------------SCEECCCCCCTTSCGGGSSCSSC-EECHHHHHHHHHHHHH
T ss_pred             ceEEEeccCCCCceeEEeCCCCcccccc------------ccccccCCCccccCchhhccCCC-CcCchhhHHHHHHHHH
Confidence            9999988776     8999999764211            11223467899999999843321 1378999999999999


Q ss_pred             HHHhCCCCCCcc
Q psy16951        243 AMCYFKSPFDTV  254 (282)
Q Consensus       243 el~tg~~pf~~~  254 (282)
                      +|++|..||...
T Consensus       220 ~l~~g~~pf~~~  231 (287)
T 4f0f_A          220 TILTGEGPFDEY  231 (287)
T ss_dssp             HHHHSSCTTTTC
T ss_pred             HHHcCCCCCccc
Confidence            999999999754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-38  Score=267.68  Aligned_cols=211  Identities=20%  Similarity=0.319  Sum_probs=170.5

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecC---CCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ---TKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      +...+.+..++|++.+.||+|+||+||+|.+..   ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             -CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            356677889999999999999999999998653   34569999886543 34566788999999999999999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ..          ...++++|++++++|.+.+...   ...++...+..++.|++.||.|||++   |++|+||||+||++
T Consensus        83 ~~----------~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~  146 (281)
T 3cc6_A           83 EE----------EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILV  146 (281)
T ss_dssp             CS----------SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEE
T ss_pred             cC----------CCCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEE
Confidence            32          3468999999999999988643   34588999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.++.++++|||.+....        ...........+|..|+|||++.+..+   +.++||||||+++|+|++ |+.||
T Consensus       147 ~~~~~~kl~Dfg~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          147 ASPECVKLGDFGLSRYIE--------DEDYYKASVTRLPIKWMSPESINFRRF---TTASDVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             EETTEEEECCCCGGGCC-----------------CCCCCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcEEeCccCCCcccc--------cccccccccCCCCcceeCchhhccCCC---CchhccHHHHHHHHHHHhCCCCCc
Confidence            999999999999764221        111111223445778999999987665   789999999999999998 99999


Q ss_pred             Ccc
Q psy16951        252 DTV  254 (282)
Q Consensus       252 ~~~  254 (282)
                      ...
T Consensus       216 ~~~  218 (281)
T 3cc6_A          216 FWL  218 (281)
T ss_dssp             TTS
T ss_pred             ccC
Confidence            753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.9e-38  Score=267.76  Aligned_cols=206  Identities=28%  Similarity=0.445  Sum_probs=166.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+...   .......+.+|+.+++.++||||+++++.+..      
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------  103 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE------  103 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE------
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc------
Confidence            457899999999999999999999999999999998643   33455678899999999999999999986544      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++++|++.+++|.+.+.........+++..++.++.|++.||.|||++   |++|+||||+||+++.++.+++
T Consensus       104 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          104 ---DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             ---TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             ---CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEE
Confidence               4689999999999999998876554556789999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||.+....         ..........++..|+|||++.+..+   +.++||||||+++|+|++|..||.+
T Consensus       178 ~Dfg~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          178 GDLGLGRFFS---------SKTTAAHSLVGTPYYMSPERIHENGY---NFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             CCC---------------------------CCSSCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             Eeccceeeec---------CCCccccccCCCeeEeChHHhCCCCC---CchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9999754221         01111223457889999999987765   7899999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=279.53  Aligned_cols=216  Identities=25%  Similarity=0.395  Sum_probs=175.1

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCC-------CceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT-------KKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILP   87 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~   87 (282)
                      ....+.+..++|++.+.||+|+||+||+|++..+       +..||+|++..... .....+.+|+++++.+ +||||++
T Consensus        60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            3456788899999999999999999999997543       35799999865433 3456788999999999 8999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDA  155 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~  155 (282)
                      +++.+.         .....++||||+++++|.+++.....            ....+++..++.++.|++.||.|||++
T Consensus       140 ~~~~~~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  210 (382)
T 3tt0_A          140 LLGACT---------QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK  210 (382)
T ss_dssp             EEEEEC---------SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             heeeec---------cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            998544         34678999999999999998875421            123589999999999999999999999


Q ss_pred             CCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchh
Q psy16951        156 KPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVW  235 (282)
Q Consensus       156 ~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diw  235 (282)
                         |++||||||+||+++.++.+|++|||++......       ..........+|+.|+|||++.+..+   +.++|||
T Consensus       211 ---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Diw  277 (382)
T 3tt0_A          211 ---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-------DYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW  277 (382)
T ss_dssp             ---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCC-------CTTCCCTTCCCGGGGSCHHHHHSCCC---CHHHHHH
T ss_pred             ---CEecCCCCcceEEEcCCCcEEEcccCcccccccc-------cccccccCCCCCcceeCHHHhcCCCC---CchhHHH
Confidence               8999999999999999999999999986532100       00011122345678999999988765   8899999


Q ss_pred             hHHHHHHHHHh-CCCCCCcc
Q psy16951        236 SLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       236 s~G~il~el~t-g~~pf~~~  254 (282)
                      |||+++|+|++ |..||.+.
T Consensus       278 slG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          278 SFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             HHHHHHHHHHTTSCCSSTTC
T ss_pred             HHHHHHHHHHhCCCCCCCCC
Confidence            99999999999 99999753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-38  Score=266.42  Aligned_cols=208  Identities=28%  Similarity=0.415  Sum_probs=164.6

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      .....+..++|++.+.||+|+||.||+|.+..++..||||.+....   ......+.+|+..++.++||||+++++.+. 
T Consensus         3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   81 (276)
T 2h6d_A            3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-   81 (276)
T ss_dssp             ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             cccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-
Confidence            3445567789999999999999999999999999999999885432   122456788999999999999999998543 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              .....++++|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||+++.
T Consensus        82 --------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~  146 (276)
T 2h6d_A           82 --------TPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDA  146 (276)
T ss_dssp             --------CSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECT
T ss_pred             --------cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECC
Confidence                    357899999999999999988643    3588999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++.++++|||.+....          .........+|+.|+|||++.+..+  .+.++||||+|+++|+|++|..||.+
T Consensus       147 ~~~~~l~dfg~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          147 HMNAKIADFGLSNMMS----------DGEFLRTSCGSPNYAAPEVISGRLY--AGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             TSCEEECCCCGGGCCC----------C-------------CCTGGGTTSCC--CHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCEEEeecccccccC----------CCcceecccCCccccCHHHHcCCCC--CCccchHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999754221          0111123456888999999987654  25689999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-38  Score=288.41  Aligned_cols=201  Identities=29%  Similarity=0.468  Sum_probs=170.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||||.+....   ......+.+|+.+++.++||||+++++++        
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--------   95 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF--------   95 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE--------
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE--------
Confidence            4578999999999999999999999999999999986442   34567788999999999999999999854        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCC
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNN  177 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~  177 (282)
                       ......++|+|++.+++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||++   ..++.
T Consensus        96 -~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  167 (484)
T 3nyv_A           96 -EDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDAN  167 (484)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred             -EeCCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCc
Confidence             34578999999999999998775    345689999999999999999999999   89999999999999   46788


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++++|||++....          .........||+.|+|||++.+. +   +.++||||+|+++|+|++|.+||.+.
T Consensus       168 ~kl~Dfg~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          168 IRIIDFGLSTHFE----------ASKKMKDKIGTAYYIAPEVLHGT-Y---DEKCDVWSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             EEECCTTHHHHBC----------CCCSHHHHTTGGGTCCHHHHHTC-C---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEeeeeeEEcc----------cccccccCCCCccccCceeecCC-C---CCcceeHHHHHHHHHHHHCCCCCCCC
Confidence            9999999754211          01112334578899999999763 4   88999999999999999999999763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-38  Score=275.72  Aligned_cols=216  Identities=23%  Similarity=0.319  Sum_probs=175.8

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCc-----eEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK-----RYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLL   89 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~   89 (282)
                      ..+.+.+..++|++.+.||+|+||.||+|.+..++.     .||+|.+..... .....+.+|+.+++.+ +||||++++
T Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            345678889999999999999999999999877664     799998865443 3456788999999999 899999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG----------KHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +++.         .....++|||++++++|.+.+......          ...++...++.++.|++.||.|||++   |
T Consensus       117 ~~~~---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~  184 (333)
T 2i1m_A          117 GACT---------HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---N  184 (333)
T ss_dssp             EEEC---------SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             EEEe---------cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---C
Confidence            8543         346789999999999999988754321          23578999999999999999999999   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      ++|+||||+||+++.++.++++|||++......       ..........+|..|+|||++.+..+   +.++||||||+
T Consensus       185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~  254 (333)
T 2i1m_A          185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-------SNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGI  254 (333)
T ss_dssp             EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGC-------TTSEECSSCEECGGGSCHHHHHHCCC---CHHHHHHHHHH
T ss_pred             cccCCcccceEEECCCCeEEECccccccccccc-------cceeecCCCCCCccccCHHHhccCCC---ChHHHHHHHHH
Confidence            999999999999999999999999976532110       00011122345678999999987765   88999999999


Q ss_pred             HHHHHHh-CCCCCCcc
Q psy16951        240 LLYAMCY-FKSPFDTV  254 (282)
Q Consensus       240 il~el~t-g~~pf~~~  254 (282)
                      ++|||+| |..||.+.
T Consensus       255 il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          255 LLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             HHHHHTTTSCCSSTTC
T ss_pred             HHHHHHcCCCCCCccc
Confidence            9999999 99999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-37  Score=267.45  Aligned_cols=205  Identities=22%  Similarity=0.333  Sum_probs=163.9

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...++|++.+.||+|+||.||+|.+..++..||+|.+.....   .....+.+|+.+++.++||||+++++++..     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----  105 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence            346899999999999999999999999999999998864422   234678899999999999999999985543     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                          ....++++|++++++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus       106 ----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          106 ----DGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             ----TTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ----CCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEE
Confidence                46899999999999999988643    3589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+....        ...........+|..|+|||++.+..+   +.++||||||+++|+|++|+.||.+.
T Consensus       175 l~Dfg~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          175 LVDFGIASATT--------DEKLTQLGNTVGTLYYMAPERFSESHA---TYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             ECSCCC------------------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             EecCccCcccc--------ccccccccccCCCcCccCHHHHcCCCC---CchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            99999764221        111112234457889999999987765   88999999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-38  Score=265.52  Aligned_cols=203  Identities=22%  Similarity=0.347  Sum_probs=160.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch----hHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE----DQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||.||+|.+  ++..||+|.+......    ..+.+.+|+++++.++||||+++++++.    
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL----   76 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe----
Confidence            35678999999999999999999998  4788999988644322    2456788999999999999999998544    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---  174 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---  174 (282)
                           .....++|+||+++++|.+.+.     ...+++..++.++.|++.||.|||++...+++|+||||+||+++.   
T Consensus        77 -----~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~  146 (271)
T 3dtc_A           77 -----KEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE  146 (271)
T ss_dssp             -----CC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred             -----cCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence                 3467899999999999988763     346899999999999999999999993222889999999999986   


Q ss_pred             -----CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        175 -----DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       175 -----~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                           ++.++++|||.+....           ........+|+.|+|||++.+..+   +.++||||+|+++|+|++|+.
T Consensus       147 ~~~~~~~~~kl~Dfg~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~  212 (271)
T 3dtc_A          147 NGDLSNKILKITDFGLAREWH-----------RTTKMSAAGAYAWMAPEVIRASMF---SKGSDVWSYGVLLWELLTGEV  212 (271)
T ss_dssp             SSCCSSCCEEECCCCC------------------------CCGGGSCHHHHHHCCC---SHHHHHHHHHHHHHHHHHCCC
T ss_pred             cccccCcceEEccCCcccccc-----------cccccCCCCccceeCHHHhccCCC---CchhhHHHHHHHHHHHHhCCC
Confidence                 6789999999764211           111123467889999999987765   889999999999999999999


Q ss_pred             CCCcc
Q psy16951        250 PFDTV  254 (282)
Q Consensus       250 pf~~~  254 (282)
                      ||.+.
T Consensus       213 p~~~~  217 (271)
T 3dtc_A          213 PFRGI  217 (271)
T ss_dssp             TTTTS
T ss_pred             CCCCC
Confidence            99764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=267.02  Aligned_cols=231  Identities=27%  Similarity=0.463  Sum_probs=166.4

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCccccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTG   95 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~   95 (282)
                      ....+.+...+|++.+.||+|+||.||+|++..++..||+|++..........+.+|+..++++. ||||+++++.+..+
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           19 VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             TTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             hcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            34577888999999999999999999999999999999999987776677778899999999996 99999999877543


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ccccCCCCCcEEee
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA--YAHRDLKTANVLLA  173 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~--i~H~dlk~~nil~~  173 (282)
                      ... .......+++++|++. |+|.+.+.... ....+++..++.++.|++.||.|||++   +  ++|+||||+||+++
T Consensus        99 ~~~-~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           99 KEE-SDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             TTT-STTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEEC
T ss_pred             ccc-cccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEEC
Confidence            211 2244567899999994 78988876532 234589999999999999999999998   6  99999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchh---hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAE---AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~---~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      .++.++++|||.+............   ...........+|+.|+|||++.......++.++||||||+++|+|++|+.|
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            9999999999987542211110000   0001112234578899999998422211237899999999999999999999


Q ss_pred             CCc
Q psy16951        251 FDT  253 (282)
Q Consensus       251 f~~  253 (282)
                      |.+
T Consensus       253 ~~~  255 (337)
T 3ll6_A          253 FED  255 (337)
T ss_dssp             C--
T ss_pred             Ccc
Confidence            975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-38  Score=279.33  Aligned_cols=209  Identities=20%  Similarity=0.325  Sum_probs=162.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEec---CCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHS---QTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||.||+|++.   .++..||||.+.... ......+.+|+.++++++||||+++++++.    
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            456779999999999999999999986   467789999986543 344567899999999999999999998543    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++||||+++++|.+++..   ....+++.+++.++.|++.||.|||++   |++||||||+||+++.++.
T Consensus       117 -----~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  185 (373)
T 2qol_A          117 -----KSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV  185 (373)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             -----eCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCC
Confidence                 34678999999999999998863   234588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|++|||++......      ...........+|..|+|||++.+..+   +.++||||||+++||+++ |+.||.+.
T Consensus       186 ~kl~Dfg~a~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~SlG~il~ellt~g~~P~~~~  254 (373)
T 2qol_A          186 CKVSDFGLGRVLEDD------PEAAYTTRGGKIPIRWTSPEAIAYRKF---TSASDVWSYGIVLWEVMSYGERPYWEM  254 (373)
T ss_dssp             EEECCC----------------------------CTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred             EEECcCccccccccC------CccceeccCCCcCCCccChhhhccCCc---CchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999976532110      000011112234678999999987765   889999999999999998 99999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.5e-38  Score=274.50  Aligned_cols=206  Identities=19%  Similarity=0.252  Sum_probs=174.0

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ...+..++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+..    
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  102 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----  102 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----
Confidence            34577899999999999999999999999999999999886553 3345678899999999999999999985543    


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                           ....++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++.  |++|+||||+||+++.++.+
T Consensus       103 -----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~  171 (360)
T 3eqc_A          103 -----DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI  171 (360)
T ss_dssp             -----TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCE
T ss_pred             -----CCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCE
Confidence                 46799999999999999988643    35889999999999999999999853  68999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+...           .........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||...
T Consensus       172 kl~Dfg~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          172 KLCDFGVSGQL-----------IDSMANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             EECCCCCCHHH-----------HHHC----CCCCTTCCHHHHTTCCC---SHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             EEEECCCCccc-----------ccccccCCCCCCCeECHHHHcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999975421           1111234467899999999988765   88999999999999999999999753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-38  Score=274.79  Aligned_cols=207  Identities=19%  Similarity=0.294  Sum_probs=166.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCce----EEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR----YALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .+..++|++++.||+|+||+||+|.+..++..    ||+|.+.... ......+.+|+..++.++||||+++++++.   
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---   85 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---   85 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---
Confidence            45678999999999999999999999888765    7788764332 222345678999999999999999998542   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                             ....++|+||+.+++|.+.+...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.++
T Consensus        86 -------~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~  152 (325)
T 3kex_A           86 -------GSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPS  152 (325)
T ss_dssp             -------BSSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSS
T ss_pred             -------CCccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCC
Confidence                   24688999999999999987532   24588889999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      .++++|||++......       ..........+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||.+.
T Consensus       153 ~~kl~Dfg~a~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~el~~~g~~p~~~~  221 (325)
T 3kex_A          153 QVQVADFGVADLLPPD-------DKQLLYSEAKTPIKWMALESIHFGKY---THQSDVWSYGVTVWELMTFGAEPYAGL  221 (325)
T ss_dssp             CEEECSCSGGGGSCCC-------TTCCC-----CCTTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             eEEECCCCcccccCcc-------cccccccCCCCcccccChHHhccCCC---ChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence            9999999976532110       00111223456778999999987766   889999999999999999 99999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-38  Score=275.76  Aligned_cols=201  Identities=24%  Similarity=0.352  Sum_probs=167.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+.|++++.||+|+||+||+|++..++..||||++......   ....+.+|+++++.++||||+++++++..       
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------  125 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------  125 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-------
Confidence            35699999999999999999999999999999998754332   33567899999999999999999986544       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ....++||||+. |++.+.+...   ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|++
T Consensus       126 --~~~~~lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          126 --EHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             --TTEEEEEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             --CCeEEEEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEe
Confidence              468999999996 6787766532   34589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....             ......||+.|+|||++.+.....++.++||||||+++|||++|..||.+.
T Consensus       197 DfG~a~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          197 DFGSASIMA-------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             CCTTCBSSS-------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             eccCceecC-------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999764321             112346789999999986422222388999999999999999999999753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-38  Score=288.10  Aligned_cols=200  Identities=29%  Similarity=0.469  Sum_probs=167.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++++.||+|+||+||+|.+..++..||||.+...  .......+.+|+++++.++||||+++++++         .
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~---------~   91 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL---------E   91 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE---------E
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE---------E
Confidence            47899999999999999999999999999999998532  223456788999999999999999999854         3


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee---cCCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA---NDNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~~  179 (282)
                      .....++|+|++.+++|.+.+...    ..+++..+..++.|++.||.|||++   ||+||||||+||+++   .++.+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           92 DSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            457899999999999999887643    4589999999999999999999999   899999999999995   456799


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||++....          .........||+.|+|||++.+. +   +.++||||+|+++|+|++|..||.+.
T Consensus       165 l~Dfg~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          165 IIDFGLSTCFQ----------QNTKMKDRIGTAYYIAPEVLRGT-Y---DEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             ECSCSCTTTBC----------CC----CCTTGGGGCCGGGGGSC-C---CHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEECCcCeECC----------CCCccCCCcCCCCCCCHHHhCCC-C---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999764211          11122344678999999999764 4   78999999999999999999999763

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-38  Score=276.53  Aligned_cols=213  Identities=28%  Similarity=0.388  Sum_probs=167.8

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC--
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP--   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~--   99 (282)
                      ....++|++.+.||+|+||+||+|.+..++..||||++.....    ...+|+++++.++||||+++++++.......  
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3557899999999999999999999999999999998854322    2236899999999999999998775421100  


Q ss_pred             ---------------------------CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh
Q psy16951        100 ---------------------------VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVF  152 (282)
Q Consensus       100 ---------------------------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~l  152 (282)
                                                 ...+...+++||||++ ++|.+.+.........+++..+..++.|++.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                       0033456899999997 688887776555567799999999999999999999


Q ss_pred             hcCCCCCccccCCCCCcEEee-cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCc
Q psy16951        153 HDAKPIAYAHRDLKTANVLLA-NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQR  231 (282)
Q Consensus       153 H~~~~~~i~H~dlk~~nil~~-~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~  231 (282)
                      |++   |++||||||+||+++ .++.++++|||.+.....          ........+|..|+|||++.+...  ++.+
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~--~~~~  222 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP----------SEPSVAYICSRFYRAPELMLGATE--YTPS  222 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT----------TSCCCCCCCCSSCCCHHHHTTCSS--CCTH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC----------CCCCcCcccCCCccCHHHhcCCCC--CCcc
Confidence            998   899999999999998 578899999998653210          111224467888999999987542  3889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCcc
Q psy16951        232 TDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       232 ~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +||||+||++|||++|+.||.+.
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~  245 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=271.14  Aligned_cols=208  Identities=21%  Similarity=0.324  Sum_probs=166.9

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceE----EEEEeccC-CchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRY----ALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      -.+..++|++++.||+|+||+||+|++..++..|    |+|.+... .......+.+|+.+++.++||||+++++++.. 
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   88 (327)
T 3lzb_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-   88 (327)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-
T ss_pred             cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-
Confidence            3466899999999999999999999998777654    77766433 34456778899999999999999999986654 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ...++++|++.+++|.+.+...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.+
T Consensus        89 ---------~~~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~  153 (327)
T 3lzb_A           89 ---------STVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP  153 (327)
T ss_dssp             ---------SSEEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET
T ss_pred             ---------CCceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCC
Confidence                     2488999999999999988642   34588999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.++++|||.+.....       ...........+|..|+|||++.+..+   +.++||||+|+++|||++ |..||.+.
T Consensus       154 ~~~kL~DfG~a~~~~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~~g~~p~~~~  223 (327)
T 3lzb_A          154 QHVKITDFGLAKLLGA-------EEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             TEEEECCTTC-----------------------CCCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCEEEccCcceeEccC-------ccccccccCCCccccccCHHHHcCCCC---ChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999998653210       111111223345778999999988776   889999999999999999 99999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-38  Score=262.49  Aligned_cols=206  Identities=23%  Similarity=0.444  Sum_probs=171.5

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .|.++.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+++++.++||||+++++.+.      
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~------   73 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL------   73 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc------
Confidence            46788999999999999999999999996 677899998865433 3467889999999999999999998544      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++++|++++++|.+++...   ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++
T Consensus        74 ---~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~k  144 (267)
T 3t9t_A           74 ---EQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIK  144 (267)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEE
T ss_pred             ---cCCCeEEEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEE
Confidence               346789999999999999988642   34588999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++|||.+....        ...........+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||.+
T Consensus       145 l~dfg~~~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          145 VSDFGMTRFVL--------DDQYTSSTGTKFPVKWASPEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             ECCTTGGGGBC--------CHHHHSTTSTTCCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             Ecccccccccc--------cccccccccccccccccChhhhcCCCc---cchhchhhhHHHHHHHhccCCCCCCC
Confidence            99999754210        111112223445778999999987665   789999999999999999 8999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5e-38  Score=280.74  Aligned_cols=203  Identities=24%  Similarity=0.329  Sum_probs=158.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .++|++.+.||+|+||+||+|.+..++..||||.+.....        .....+.+|+.++++++||||+++++++-   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            5789999999999999999999999999999998854321        11224678999999999999999998542   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                             ....++||||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.++
T Consensus       211 -------~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          211 -------AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             -------SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             -------cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence                   245789999999999988664    345689999999999999999999999   899999999999997544


Q ss_pred             ---CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 ---NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 ---~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                         .+|++|||++....          .........||+.|+|||++.+.....++.++||||+|+++|+|++|..||.+
T Consensus       277 ~~~~~kl~DFG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILG----------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             SSCCEEECCSSTTTSCC---------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcceEEEeecccceecC----------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence               59999999865321          01112234678999999998653222347799999999999999999999975


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       347 ~  347 (419)
T 3i6u_A          347 H  347 (419)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.6e-37  Score=271.04  Aligned_cols=205  Identities=23%  Similarity=0.329  Sum_probs=164.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++++.||+|+||.||+|.+..++..||||++...  .......+.+|+.+++.++||||+++++++....   ..
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~   99 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK---SL   99 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC---ST
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc---cc
Confidence            458999999999999999999999999999999998643  2334567789999999999999999998765421   12


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......++|||++. ++|.+.+.      ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|++
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEE
Confidence            33457999999996 57777663      2488999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....          .........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       170 Dfg~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          170 DFGLARTAG----------TSFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             CCCC--------------------------CTTCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Eeecccccc----------cccccCCceecCCccCHHHhcCCCC---CchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            999764221          1111223467889999999988766   88999999999999999999999764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.3e-38  Score=271.30  Aligned_cols=220  Identities=18%  Similarity=0.289  Sum_probs=177.7

Q ss_pred             hcccccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcc
Q psy16951         13 GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNIL   86 (282)
Q Consensus        13 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~   86 (282)
                      ......+.|.+..++|++.+.||+|+||.||+|.+.     .++..||+|.+..... .....+.+|+.+++.++||||+
T Consensus        12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   91 (322)
T 1p4o_A           12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV   91 (322)
T ss_dssp             CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred             ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            344455677888999999999999999999999886     3578899998864433 3455788999999999999999


Q ss_pred             cccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q psy16951         87 PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------KHYMSSVDILKMFLKICEAVKVFHDAKPIAY  160 (282)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i  160 (282)
                      ++++++.         .....++|||++++++|.+.+......      ...++...++.++.|++.||.|||++   |+
T Consensus        92 ~~~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i  159 (322)
T 1p4o_A           92 RLLGVVS---------QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KF  159 (322)
T ss_dssp             CEEEEEC---------SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eeEEEEc---------cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            9998543         346789999999999999988754211      13468899999999999999999999   89


Q ss_pred             cccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHH
Q psy16951        161 AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL  240 (282)
Q Consensus       161 ~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~i  240 (282)
                      +||||||+||+++.++.++++|||.+.....       ...........+|+.|+|||++.+..+   +.++||||+|++
T Consensus       160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~i  229 (322)
T 1p4o_A          160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGKGLLPVRWMSPESLKDGVF---TTYSDVWSFGVV  229 (322)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGG-------GGCEEGGGSSEECGGGCCHHHHHHCCC---CHHHHHHHHHHH
T ss_pred             ccCCCccceEEEcCCCeEEECcCcccccccc-------ccccccccCCCCCCCccChhhhccCCC---CchhhHHHHHHH
Confidence            9999999999999999999999997653211       011111223345778999999987765   889999999999


Q ss_pred             HHHHHh-CCCCCCcc
Q psy16951        241 LYAMCY-FKSPFDTV  254 (282)
Q Consensus       241 l~el~t-g~~pf~~~  254 (282)
                      +|+|++ |..||.+.
T Consensus       230 l~el~~~g~~p~~~~  244 (322)
T 1p4o_A          230 LWEIATLAEQPYQGL  244 (322)
T ss_dssp             HHHHHHTSCCTTTTS
T ss_pred             HHHHHhcCCCccccC
Confidence            999999 88999763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.5e-38  Score=267.50  Aligned_cols=209  Identities=25%  Similarity=0.372  Sum_probs=164.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhh--CCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--FVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~--l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +..++|++.+.||+|+||+||+|++  ++..||||++..   .....+.+|.+++..  ++||||+++++.+...     
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-----   74 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTS-----   74 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-----
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccc-----
Confidence            3467999999999999999999998  788999998853   334455566666655  7899999999876542     


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCccccCCCCCcEEe
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH--------DAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------~~~~~~i~H~dlk~~nil~  172 (282)
                      .......++|+||+++++|.+++.     ...+++..++.++.|++.||.|||        ++   +++||||||+||++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILV  146 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEE
T ss_pred             cCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEE
Confidence            334567999999999999999884     345899999999999999999999        76   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc---CCCCccchhhHHHHHHHHHhC--
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC---VVDQRTDVWSLGCLLYAMCYF--  247 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~---~~~~~~Diws~G~il~el~tg--  247 (282)
                      +.++.+|++|||++......     ............||+.|+|||++.+....   .++.++||||||+++|||++|  
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~  221 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQS-----TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV  221 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETT-----TTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             cCCCCEEEeeCCCeeecccc-----cccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence            99999999999986532110     00000011233678999999999876320   114689999999999999999  


Q ss_pred             --------CCCCCcc
Q psy16951        248 --------KSPFDTV  254 (282)
Q Consensus       248 --------~~pf~~~  254 (282)
                              ..||...
T Consensus       222 ~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          222 SNGIVEDYKPPFYDV  236 (301)
T ss_dssp             BTTBCCCCCCTTTTT
T ss_pred             Ccccccccccccccc
Confidence                    8888754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-38  Score=277.25  Aligned_cols=215  Identities=17%  Similarity=0.228  Sum_probs=167.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCC-----CceEEEEEeccCCchhH-----------HHHHHHHHHhhhCCCCCcc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQT-----KKRYALKKIICHGREDQ-----------AQAIREVEHHKTFVHPNIL   86 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~-----------~~~~~e~~~l~~l~H~ni~   86 (282)
                      +..++|++.+.||+|+||.||+|.+..+     +..||||.+........           ...+.|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456999999999999999999998764     58899998865543211           1234566677888999999


Q ss_pred             cccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCC
Q psy16951         87 PLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLK  166 (282)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk  166 (282)
                      ++++.+...     .......++||||+ +++|.+++..   ....+++..++.++.|++.||.|||++   |++|||||
T Consensus       112 ~~~~~~~~~-----~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlk  179 (364)
T 3op5_A          112 KYWGSGLHD-----KNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIK  179 (364)
T ss_dssp             CEEEEEEEE-----ETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             eEEeeeeec-----cCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCC
Confidence            999976652     22346689999999 9999998864   235689999999999999999999999   89999999


Q ss_pred             CCcEEee--cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHH
Q psy16951        167 TANVLLA--NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM  244 (282)
Q Consensus       167 ~~nil~~--~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el  244 (282)
                      |+||+++  .++.+|++|||++............  .........||+.|+|||++.+..+   +.++||||||+++|||
T Consensus       180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~~l~el  254 (364)
T 3op5_A          180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY--AADPKRCHDGTIEFTSIDAHNGVAP---SRRGDLEILGYCMIQW  254 (364)
T ss_dssp             GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCS--SCCSSCCCCCCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHH
T ss_pred             HHHEEEecCCCCeEEEEECCcceecccCCccccc--ccCcccccCCCCCccCHHHhCCCCC---CchhhHHHHHHHHHHH
Confidence            9999999  8899999999987543211100000  0011123348999999999988766   8899999999999999


Q ss_pred             HhCCCCCCcc
Q psy16951        245 CYFKSPFDTV  254 (282)
Q Consensus       245 ~tg~~pf~~~  254 (282)
                      +||+.||.+.
T Consensus       255 ~~g~~Pf~~~  264 (364)
T 3op5_A          255 LTGHLPWEDN  264 (364)
T ss_dssp             HHSCCTTGGG
T ss_pred             HhCCCCcccc
Confidence            9999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=273.02  Aligned_cols=206  Identities=24%  Similarity=0.377  Sum_probs=165.0

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +-..++|++++.||+|+||.||+|.+..+|..||||++...  .......+.+|+++++.++||||+++++.+....   
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---   97 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE---   97 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS---
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC---
Confidence            33468899999999999999999999999999999998543  3334567789999999999999999998765421   


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                      .......+++|+|++ +++|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEE
Confidence            112235679999999 8899887753     3588999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||++.....            ......+|..|+|||++.+ ..+   +.++||||+||++|||++|+.||.+.
T Consensus       169 l~Dfg~a~~~~~------------~~~~~~~t~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          169 ILDFGLARQADS------------EMTGYVVTRWYRAPEVILNWMRY---TQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             ECCCTTCEECCS------------SCCSSCSCGGGCCTHHHHTTTCC---CTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeeeccccccc------------ccCcCcCCCCcCCHHHHhCCCCC---ChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998653210            1223467889999999987 344   88999999999999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.7e-38  Score=271.37  Aligned_cols=210  Identities=20%  Similarity=0.347  Sum_probs=176.1

Q ss_pred             EEecccEEEEEEeccCCceEEEEEE----ecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||.||+|+    +..++..||||++........+.+.+|+++++.++||||+++++.+..   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   95 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---   95 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence            4678999999999999999999999    567889999999987777777788999999999999999999886543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                          .+....++|+||+++++|.+++....   ..+++..++.++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        96 ----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A           96 ----PGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             ----SSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             ----CCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCC
Confidence                24567999999999999999887532   3489999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||..
T Consensus       166 ~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          166 VKIADFGLAKLLPLD------KDYYVVREPGQSPIFWYAPESLSDNIF---SRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             EEECCGGGCEECCTT------CSEEECSSCCCSCGGGSCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             EEEcccccceecccC------CccceeeccCCccccccCHHHhccCCC---ChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            999999976532110      000011122346777999999988776   7899999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-38  Score=267.02  Aligned_cols=212  Identities=19%  Similarity=0.278  Sum_probs=161.4

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHH-HHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQA-QAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~-~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      +.+..++|++.+.||+|+||+||+|++..++..||+|.+...... ... .+.++...++.++||||+++++.+.     
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   76 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----   76 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----
Confidence            456789999999999999999999999999999999998654332 222 3344555678889999999998554     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++|+|++. ++|.+.+.........+++..++.++.|++.||.|||++.  |++|+||||+||+++.++.+
T Consensus        77 ----~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           77 ----REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             ----CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCE
T ss_pred             ----ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCE
Confidence                3467999999996 5888877665455667999999999999999999999863  68899999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-cccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+....          .........+|+.|+|||++... ....++.++||||+|+++|+|++|..||...
T Consensus       150 kl~Dfg~~~~~~----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          150 KMCDFGISGYLV----------DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             EBCCC-------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             EEeecCCccccc----------ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            999999764221          11112233578999999997321 0112378999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-37  Score=271.92  Aligned_cols=209  Identities=25%  Similarity=0.330  Sum_probs=170.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++++.||+|+||.||+|.+..++..||||++..... .....+.+|+++++.++||||+++++++...    ....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~  101 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP----TIEQ  101 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS----STTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC----Cccc
Confidence            5789999999999999999999999999999999864433 3446788999999999999999999876543    2233


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++. ++|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++||
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeC
Confidence            467999999996 588887752     3489999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......      ...........||+.|+|||++.+...  ++.++||||+|+++|+|++|+.||.+.
T Consensus       173 g~a~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          173 GLARVADPD------HDHTGFLTEYVATRWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             TTCEECCGG------GCBCCTTCCCCSCGGGCCHHHHHTBCS--CSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceEecCCC------CCccccccccccccCCCCCHHhcCCCC--CCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            986532111      000111223467899999999765432  388999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.9e-37  Score=261.03  Aligned_cols=207  Identities=21%  Similarity=0.285  Sum_probs=171.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .......|++.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++.+..    
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   96 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES----   96 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc----
Confidence            334466689999999999999999999999999999988643  34455678899999999999999999987654    


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ccccCCCCCcEEee-cC
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIA--YAHRDLKTANVLLA-ND  175 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~--i~H~dlk~~nil~~-~~  175 (282)
                       ........++|+||+++++|.+++...    ..++...++.++.|++.||.|||++   +  ++|+||||+||+++ .+
T Consensus        97 -~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  168 (290)
T 1t4h_A           97 -TVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             -ESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTT
T ss_pred             -ccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCC
Confidence             233457799999999999999988643    4588999999999999999999999   6  99999999999997 78


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.++++|||.+....           ........+|+.|+|||++.+. +   +.++||||+|+++|+|++|..||.+.
T Consensus       169 ~~~kl~Dfg~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~-~---~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          169 GSVKIGDLGLATLKR-----------ASFAKAVIGTPEFMAPEMYEEK-Y---DESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             SCEEECCTTGGGGCC-----------TTSBEESCSSCCCCCGGGGGTC-C---CTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCEEEeeCCCccccc-----------ccccccccCCcCcCCHHHHhcc-C---CCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            899999999753210           1112234578999999988753 3   88999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-38  Score=269.34  Aligned_cols=224  Identities=19%  Similarity=0.291  Sum_probs=153.6

Q ss_pred             hcccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         13 GCLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        13 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      +...+...+.+..++|++.+.||+|+||.||+|.+..++..||||.+.... ......+.+|+..++.++||||+++++.
T Consensus         2 ~~~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   81 (303)
T 2vwi_A            2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS   81 (303)
T ss_dssp             -----------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEE
T ss_pred             CCcccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence            344556678899999999999999999999999999999999999885443 2334567889999999999999999985


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV----GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      +..         ....++|+|++++++|.+.+.....    ....+++..+..++.|++.||.|||++   |++|+||||
T Consensus        82 ~~~---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p  149 (303)
T 2vwi_A           82 FVV---------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKA  149 (303)
T ss_dssp             EES---------SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSG
T ss_pred             Eee---------cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCCh
Confidence            543         4679999999999999998865322    134588999999999999999999999   899999999


Q ss_pred             CcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC
Q psy16951        168 ANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       168 ~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg  247 (282)
                      +||+++.++.++++|||.+......    .............+|+.|+|||++.+..  .++.++||||+|+++|+|++|
T Consensus       150 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          150 GNILLGEDGSVQIADFGVSAFLATG----GDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             GGEEECTTCCEEECCCHHHHHCC-------------------CCCTTCCHHHHHHHH--CCCTHHHHHHHHHHHHHHHHS
T ss_pred             hhEEEcCCCCEEEEeccchheeccC----CCccchhhhcccCCCccccCHHHhcccc--CCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999965422110    0000111122346789999999987522  137899999999999999999


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||...
T Consensus       224 ~~pf~~~  230 (303)
T 2vwi_A          224 AAPYHKY  230 (303)
T ss_dssp             SCTTTTS
T ss_pred             CCCCccC
Confidence            9999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-37  Score=267.96  Aligned_cols=222  Identities=21%  Similarity=0.358  Sum_probs=169.5

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecC---CCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ---TKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLD   90 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~   90 (282)
                      .....+.+..++|++.+.||+|+||.||+|.+..   ++..||+|.+....  ......+.+|+.+++.++||||+++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            3456677889999999999999999999998765   56689999886543  334567889999999999999999999


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS--VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      ++....    .......++++|++++++|.+.+....  .....+++..++.++.|++.||.|||++   |++|+||||+
T Consensus       104 ~~~~~~----~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~  176 (313)
T 3brb_A          104 VCIEMS----SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAAR  176 (313)
T ss_dssp             EEEC-----------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGG
T ss_pred             EEeecc----ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcc
Confidence            765421    111235799999999999999885432  2335689999999999999999999999   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-C
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-F  247 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g  247 (282)
                      ||+++.++.++++|||.+.....       ...........+++.|+|||++.+..+   +.++||||||+++|+|++ |
T Consensus       177 NIli~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~~g  246 (313)
T 3brb_A          177 NCMLRDDMTVCVADFGLSKKIYS-------GDYYRQGRIAKMPVKWIAIESLADRVY---TSKSDVWAFGVTMWEIATRG  246 (313)
T ss_dssp             GEEECTTSCEEECSCSCC-----------------------CCGGGSCHHHHHSSCC---CHHHHHHHHHHHHHHHHTTS
T ss_pred             eEEEcCCCcEEEeecCcceeccc-------ccccCcccccCCCccccCchhhcCCCc---cchhhhHHHHHHHHHHHhcC
Confidence            99999999999999997653211       001111223345778999999987765   889999999999999999 8


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||.+.
T Consensus       247 ~~p~~~~  253 (313)
T 3brb_A          247 MTPYPGV  253 (313)
T ss_dssp             CCSSTTC
T ss_pred             CCCCccC
Confidence            8999753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.9e-38  Score=287.15  Aligned_cols=199  Identities=28%  Similarity=0.431  Sum_probs=163.5

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|++++.||+|+||+||+|++..++..||+|.+....  ......+.+|+.+++.++||||+++++++.         .
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---------~  107 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE---------D  107 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE---------C
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE---------e
Confidence            47999999999999999999999999999999986443  233567789999999999999999998543         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---CCcee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---NNPLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~~~  180 (282)
                      ....++||||+.+++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+++..   +.+|+
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  180 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKI  180 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEE
Confidence            57899999999999999877643    4589999999999999999999999   89999999999999764   45899


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++....          .........||+.|+|||++.+ .+   +.++||||+||++|+|++|..||.+.
T Consensus       181 ~DfG~a~~~~----------~~~~~~~~~gt~~y~aPE~l~~-~~---~~~~DiwslG~il~~ll~g~~pf~~~  240 (494)
T 3lij_A          181 VDFGLSAVFE----------NQKKMKERLGTAYYIAPEVLRK-KY---DEKCDVWSIGVILFILLAGYPPFGGQ  240 (494)
T ss_dssp             CCCTTCEECB----------TTBCBCCCCSCTTTCCHHHHTT-CB---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EECCCCeECC----------CCccccccCCCcCeeCHHHHcc-cC---CCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999765321          0111233468999999999864 34   88999999999999999999999763

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-37  Score=270.35  Aligned_cols=213  Identities=23%  Similarity=0.328  Sum_probs=170.9

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ....+-++...++|++++.||+|+||.||+|++..++..||+|++......  ....+.+|+.+++.++||||+++++++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   93 (331)
T 4aaa_A           14 LGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC   93 (331)
T ss_dssp             -----CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence            344456677889999999999999999999999999999999988654332  345677899999999999999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      .         .....++|||++.+++|.....    ....+++..+..++.|++.||.|||++   |++|+||||+||++
T Consensus        94 ~---------~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~  157 (331)
T 4aaa_A           94 K---------KKKRWYLVFEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILV  157 (331)
T ss_dssp             E---------ETTEEEEEEECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             e---------cCCEEEEEEecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEE
Confidence            4         3578999999999888877554    334589999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +.++.++++|||.+....         ..........+|..|+|||++.+...  ++.++||||+|+++|+|++|..||.
T Consensus       158 ~~~~~~kl~Dfg~~~~~~---------~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~  226 (331)
T 4aaa_A          158 SQSGVVKLCDFGFARTLA---------APGEVYDDEVATRWYRAPELLVGDVK--YGKAVDVWAIGCLVTEMFMGEPLFP  226 (331)
T ss_dssp             CTTSCEEECCCTTC---------------------CCCCCTTCCHHHHTTCTT--CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCCcEEEEeCCCceeec---------CCccccCCCcCCccccCcccccCCCC--cchHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999764211         11112234467889999999987532  3889999999999999999999997


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       227 ~~  228 (331)
T 4aaa_A          227 GD  228 (331)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=271.11  Aligned_cols=210  Identities=27%  Similarity=0.406  Sum_probs=166.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCC--CCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVH--PNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H--~ni~~~~~~~~~   94 (282)
                      +.+.+..++|++++.||+|+||.||++.+ .++..||||.+....  ......+.+|+.+++.++|  |||+++++++. 
T Consensus         2 e~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-   79 (343)
T 3dbq_A            2 ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-   79 (343)
T ss_dssp             CCEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             ceeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-
Confidence            35677889999999999999999999998 468899999886543  3344678899999999976  99999998554 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                              .....++||| +.+++|.+++..    ...+++..+..++.|++.||.|||++   ||+||||||+||+++ 
T Consensus        80 --------~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-  142 (343)
T 3dbq_A           80 --------TDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-  142 (343)
T ss_dssp             --------CSSEEEEEEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-
T ss_pred             --------eCCEEEEEEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-
Confidence                    3468999999 568899998863    34689999999999999999999999   899999999999996 


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--------ccCCCCccchhhHHHHHHHHHh
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--------YCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--------~~~~~~~~Diws~G~il~el~t  246 (282)
                      ++.+|++|||++.....       ...........||+.|+|||++.+..        ...++.++||||||+++|||++
T Consensus       143 ~~~~kl~DFG~a~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  215 (343)
T 3dbq_A          143 DGMLKLIDFGIANQMQP-------DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  215 (343)
T ss_dssp             TTEEEECCCSSSCCC-------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred             CCcEEEeecccccccCc-------ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence            68899999998653211       11111123446899999999996511        0123779999999999999999


Q ss_pred             CCCCCCcc
Q psy16951        247 FKSPFDTV  254 (282)
Q Consensus       247 g~~pf~~~  254 (282)
                      |..||.+.
T Consensus       216 g~~pf~~~  223 (343)
T 3dbq_A          216 GKTPFQQI  223 (343)
T ss_dssp             SSCTTTTC
T ss_pred             CCCcchhh
Confidence            99999753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-37  Score=265.71  Aligned_cols=205  Identities=25%  Similarity=0.367  Sum_probs=168.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ...++|++++.||+|+||.||+|.+..++..||+|.+..........+.+|+++++.++||||+++++.+..        
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------   87 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH--------   87 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--------
Confidence            457899999999999999999999999999999999877666667788999999999999999999985543        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++|+|++++++|.+.+...   ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++|
T Consensus        88 -~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           88 -DGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             -C-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECC
T ss_pred             -CCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEE
Confidence             46799999999999999877642   34589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc-----cCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH-----VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~-----~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+...         ...........+|..|+|||++.     +..   ++.++||||+|+++|+|++|..||...
T Consensus       161 fg~~~~~---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          161 FGVSAKN---------LKTLQKRDSFIGTPYWMAPEVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             CHHHHHH---------HHHHHC-----CCGGGCCHHHHHHHHTTSTT---TTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCCccc---------cccccccccccCChhhcCCeeeccccCCCCC---CchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            9964311         11111223346788999999984     333   378999999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=273.00  Aligned_cols=202  Identities=25%  Similarity=0.394  Sum_probs=160.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhH-HHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ-AQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ++|++++.||+|+||+||+|++..++..||+|.+........ ..+.+|+++++.++||||+++++++.         ..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---------~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH---------TE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE---------CS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe---------eC
Confidence            689999999999999999999999999999998864432221 23457999999999999999998543         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ...++||||+. ++|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|||
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             CEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCc
Confidence            67999999996 588877754   234588999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+....         ..........+|..|+|||++.+...  ++.++||||+|+++|+|++|..||.+.
T Consensus       146 ~a~~~~---------~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          146 LARAKS---------IPTKTYDNEVVTLWYRPPDILLGSTD--YSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             EEECC---------------------CGGGCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccc---------CCccccccccCcccccChhhhcCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            764221         01111223456888999999976432  388999999999999999999999763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-38  Score=275.74  Aligned_cols=212  Identities=23%  Similarity=0.316  Sum_probs=164.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-----CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-----GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-----~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+...     .......+.+|+.+++.++||||+++++++.      
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------   98 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE------   98 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE------
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc------
Confidence            57899999999999999999999999999999988533     2345567889999999999999999998543      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHh------------------------------------cCCCCCHHHHHHHHH
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSV------------------------------------GKHYMSSVDILKMFL  143 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------~~~~l~~~~~~~~~~  143 (282)
                         +....++||||+++++|.+.+.....                                    ....+++..+..++.
T Consensus        99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence               45789999999999999987631000                                    011235667888999


Q ss_pred             HHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc
Q psy16951        144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH  221 (282)
Q Consensus       144 qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~  221 (282)
                      |++.||.|||++   |++||||||+||+++.++  .++++|||.+......     ............||+.|+|||++.
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKL-----NNGEYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGT-----TCC--------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeecccccccccc-----CccccccccccCCCccccCchhhc
Confidence            999999999999   899999999999998776  8999999987532110     001111223456889999999997


Q ss_pred             cCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        222 VDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       222 ~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +... .++.++||||||+++|||++|..||.+.
T Consensus       248 ~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  279 (345)
T 3hko_A          248 TTNE-SYGPKCDAWSAGVLLHLLLMGAVPFPGV  279 (345)
T ss_dssp             CSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            5311 2388999999999999999999999764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=275.13  Aligned_cols=202  Identities=23%  Similarity=0.306  Sum_probs=168.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .++|++.+.||+|+||+||+|++..++..||||.+......        ....+.+|+.+++.++||||+++++++.   
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~---   99 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE---   99 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            46899999999999999999999999999999988654321        2335567999999999999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCC-ChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKG-TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                            .....++|+|++..| +|.+++.    ....+++..+..++.|++.||.|||++   |++||||||+||+++.+
T Consensus       100 ------~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          100 ------NQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             ------CSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             ------eCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence                  457899999998766 8888775    344689999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.++++|||.+.....          ........||+.|+|||++.+..+  .+.++||||+|+++|+|++|..||...
T Consensus       167 ~~~kL~Dfg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          167 FTIKLIDFGSAAYLER----------GKLFYTFCGTIEYCAPEVLMGNPY--RGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             SCEEECCCTTCEECCT----------TCCBCEECSCGGGCCHHHHTTCCB--CSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             CcEEEeecccceECCC----------CCceeccCCCccccChhhhcCCCC--CCCcccchhHHHHHHHHHhCCCchhhH
Confidence            9999999997653210          011123457899999999987765  267899999999999999999999753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.5e-38  Score=285.25  Aligned_cols=200  Identities=26%  Similarity=0.431  Sum_probs=166.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-------------hhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-------------EDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      .++|+++++||+|+||+||+|.+..++..||+|.+.....             .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            5789999999999999999999999999999999864431             234567899999999999999999985


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                      +         .+...+++||||+++++|.+.+...    ..+++..+..++.|++.||.|||++   |++||||||+||+
T Consensus       115 ~---------~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          115 F---------EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENIL  178 (504)
T ss_dssp             E---------ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             E---------EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEE
Confidence            4         3457899999999999999888643    4589999999999999999999999   8999999999999


Q ss_pred             eecCC---CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        172 LANDN---NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       172 ~~~~~---~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      ++.++   .++++|||++.....          ........||+.|+|||++.+ .+   +.++||||+|+++|+|++|.
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~-~~---~~~~DiwslG~il~~ll~g~  244 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSK----------DYKLRDRLGTAYYIAPEVLKK-KY---NEKCDVWSCGVIMYILLCGY  244 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCT----------TSCBCCCCSCTTTCCHHHHTT-CB---CTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCCCccEEEEECCCCEEcCC----------CCccccccCCcCCCCHHHhcc-CC---CchHHHHHHHHHHHHHHhCC
Confidence            98776   589999998653210          111234468999999999874 34   88999999999999999999


Q ss_pred             CCCCcc
Q psy16951        249 SPFDTV  254 (282)
Q Consensus       249 ~pf~~~  254 (282)
                      .||.+.
T Consensus       245 ~pf~~~  250 (504)
T 3q5i_A          245 PPFGGQ  250 (504)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-38  Score=289.57  Aligned_cols=209  Identities=21%  Similarity=0.345  Sum_probs=173.5

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.+..++|++.++||+|+||+||+|.+.. +..||||.+.... ...+.+.+|+++++.++||||+++++++..   
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---  333 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---  333 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---
Confidence            56788999999999999999999999999964 4679999986543 345678999999999999999999985432   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++||||+.+++|.+++....  ...++..+++.++.||+.||.|||++   +++||||||+||+++.++.
T Consensus       334 -------~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~  401 (535)
T 2h8h_A          334 -------EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV  401 (535)
T ss_dssp             -------SSCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             -------ccceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCc
Confidence                   45899999999999999886432  23588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +||+|||++....        ...........++..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       402 ~kl~DFG~a~~~~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          402 CKVADFGLARLIE--------DNEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             EEECCTTSTTTCC--------CHHHHTTCSTTSCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             EEEcccccceecC--------CCceecccCCcCcccccCHHHhccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999865321        111111223345778999999987765   889999999999999999 89999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-37  Score=261.72  Aligned_cols=201  Identities=26%  Similarity=0.380  Sum_probs=168.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.....      ...+.+.+|+.+++.++||||+++++.+.     
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----
Confidence            4689999999999999999999999999999998864432      13567889999999999999999998544     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--  176 (282)
                          .....++++|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||||+||+++.++  
T Consensus        79 ----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           79 ----NKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             ----CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSS
T ss_pred             ----CCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCC
Confidence                357899999999999999988642    4589999999999999999999999   899999999999998877  


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        .++++|||.+.....          ........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       148 ~~~~kl~dfg~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIEA----------GNEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             SCCEEECCCTTCEECC------------------CCCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCceEEEecccceeccC----------CCcccccCCCcCccCcceecCCCC---CcchhhhhHHHHHHHHHHCCCCCCCc
Confidence              799999997643210          111223457889999999987765   88999999999999999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-37  Score=273.93  Aligned_cols=211  Identities=27%  Similarity=0.404  Sum_probs=167.1

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCC--CCCccccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFV--HPNILPLLDHAL   93 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~--H~ni~~~~~~~~   93 (282)
                      .+...+..++|++.+.||+|+||+||+|.+.. +..||||.+....  ......+.+|+.+++.++  ||||+++++++.
T Consensus        48 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           48 NECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             -CCEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            44567778889999999999999999999864 8899999886543  344567889999999996  599999998554


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .         ...+++||| +.+++|.+++..    ...+++..+..++.||+.||.|||++   ||+||||||+||+++
T Consensus       127 ~---------~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~  189 (390)
T 2zmd_A          127 T---------DQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV  189 (390)
T ss_dssp             C---------SSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES
T ss_pred             c---------CCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE
Confidence            3         467999999 668899988863    34588889999999999999999999   899999999999995


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--------cCCCCccchhhHHHHHHHHH
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--------CVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--------~~~~~~~Diws~G~il~el~  245 (282)
                       ++.+|++|||++.....       ...........||+.|+|||++.+...        ..++.++|||||||++|||+
T Consensus       190 -~~~~kl~DFG~a~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell  261 (390)
T 2zmd_A          190 -DGMLKLIDFGIANQMQP-------DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  261 (390)
T ss_dssp             -SSCEEECCCSSSCCC----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred             -CCeEEEEecCccccccC-------CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence             68999999998753210       001111234468999999999975211        12478999999999999999


Q ss_pred             hCCCCCCcc
Q psy16951        246 YFKSPFDTV  254 (282)
Q Consensus       246 tg~~pf~~~  254 (282)
                      +|+.||.+.
T Consensus       262 ~G~~Pf~~~  270 (390)
T 2zmd_A          262 YGKTPFQQI  270 (390)
T ss_dssp             HSSCTTTTC
T ss_pred             HCCCcchhh
Confidence            999999753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.3e-38  Score=266.58  Aligned_cols=216  Identities=19%  Similarity=0.270  Sum_probs=162.5

Q ss_pred             cccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        14 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      ....++.+.+..++|++.+.||+|+||+||+|.+..   .||+|.+....  ......+.+|+++++.++||||++++++
T Consensus        12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             ------CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            445678889999999999999999999999998754   49999886543  3345678899999999999999999874


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEE
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVL  171 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil  171 (282)
                      ..          ....++|+|++.+++|.+.+..   ....+++..++.++.|++.||.|||++   |++|+||||+||+
T Consensus        89 ~~----------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil  152 (289)
T 3og7_A           89 ST----------APQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIF  152 (289)
T ss_dssp             EC----------SSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             cc----------CCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence            32          2458899999999999987742   234588999999999999999999999   8999999999999


Q ss_pred             eecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCC
Q psy16951        172 LANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF  251 (282)
Q Consensus       172 ~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf  251 (282)
                      ++.++.++++|||.+.....       ...........||+.|+|||++.......++.++||||+|+++|+|++|+.||
T Consensus       153 ~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  225 (289)
T 3og7_A          153 LHEDNTVKIGDFGLATEKSR-------WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY  225 (289)
T ss_dssp             EETTTEEEECCCC-------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ECCCCCEEEccceecccccc-------ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence            99999999999997642210       01111223346789999999997332223477999999999999999999999


Q ss_pred             Cccc
Q psy16951        252 DTVY  255 (282)
Q Consensus       252 ~~~~  255 (282)
                      .+..
T Consensus       226 ~~~~  229 (289)
T 3og7_A          226 SNIN  229 (289)
T ss_dssp             SSCC
T ss_pred             cccc
Confidence            7643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=265.88  Aligned_cols=197  Identities=20%  Similarity=0.269  Sum_probs=160.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++|++.++||+|+||+||+|++..++..||||++....  .........|+..+..+ +||||+++++++.         
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~---------  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE---------  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---------
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE---------
Confidence            78999999999999999999999999999999875433  33344555666666555 8999999998554         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++|+|++ +++|.+.+...   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+|++|
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECC
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcc
Confidence            357899999999 77888877643   34589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ||++....          .........||+.|+|||++.+ .+   +.++||||||+++|||++|..||.
T Consensus       201 FG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~-~~---~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          201 FGLLVELG----------TAGAGEVQEGDPRYMAPELLQG-SY---GTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             CTTCEECC----------------CCCCCGGGCCGGGGGT-CC---STHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             ceeeeecc----------cCCCCcccCCCccccCHhHhcC-CC---CchhhHHHHHHHHHHHHhCCCCCC
Confidence            99764221          1111223457899999999876 34   889999999999999999976554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=266.19  Aligned_cols=202  Identities=27%  Similarity=0.452  Sum_probs=162.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+..++|++.+.||+|+||+||+|.+  ++..||+|.+..  ....+.+.+|++.+++++||||+++++.+..       
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------   72 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------   72 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence            46778999999999999999999998  477899998753  3455678899999999999999999985432       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC-cee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN-PLL  180 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~-~~~  180 (282)
                          ..++||||+++++|.+.+.... ....++...++.++.|++.||.|||+.+..|++||||||+||+++.++. +|+
T Consensus        73 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl  147 (307)
T 2eva_A           73 ----PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI  147 (307)
T ss_dssp             ----TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred             ----CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence                3689999999999999886321 1224678899999999999999999932118999999999999998887 699


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+....            .......||..|+|||++.+..+   +.++||||||+++|||++|+.||...
T Consensus       148 ~Dfg~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          148 CDFGTACDIQ------------THMTNNKGSAAWMAPEVFEGSNY---SEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             CCCCC------------------------CCTTSSCHHHHTCCCC---CTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             cccccccccc------------cccccCCCCCceEChhhhCCCCC---CcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            9999764211            11123357899999999987765   88999999999999999999999754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=279.41  Aligned_cols=209  Identities=19%  Similarity=0.326  Sum_probs=170.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ....++|++.+.||+|+||+||+|++..++..||||.+.... ......+.+|+++++.++||||+++++++...     
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----   79 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET-----   79 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT-----
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC-----
Confidence            355789999999999999999999999999999999986433 23355678899999999999999999865432     


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----ecCC
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----ANDN  176 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~  176 (282)
                        .....++||||+++++|.+.+.... ....+++..++.++.|++.||.|||++   |++||||||+||++    +.++
T Consensus        80 --~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           80 --TTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             --TTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCE
T ss_pred             --CCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCce
Confidence              2347899999999999999876432 122389999999999999999999999   89999999999998    6667


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc--------CcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--------DSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~--------~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      .+|++|||.+....          .........||..|+|||++.+        ..+   +.++||||||+++|||++|+
T Consensus       154 ~~kL~DFG~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~---~~~~DiwSlG~il~el~tg~  220 (396)
T 4eut_A          154 VYKLTDFGAARELE----------DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY---GATVDLWSIGVTFYHAATGS  220 (396)
T ss_dssp             EEEECCGGGCEECC----------CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH---HHHHHHHHHHHHHHHHHHSS
T ss_pred             eEEEecCCCceEcc----------CCCccccccCCccccCHHHhhccccccccccCC---CcHHHHHHHHHHHHHHHHCC
Confidence            79999999765321          0111223468999999999865        233   67899999999999999999


Q ss_pred             CCCCcc
Q psy16951        249 SPFDTV  254 (282)
Q Consensus       249 ~pf~~~  254 (282)
                      .||...
T Consensus       221 ~Pf~~~  226 (396)
T 4eut_A          221 LPFRPF  226 (396)
T ss_dssp             CSEECT
T ss_pred             CCCCCC
Confidence            999753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-38  Score=265.76  Aligned_cols=211  Identities=20%  Similarity=0.369  Sum_probs=171.8

Q ss_pred             ccEEEecccEEEEE-EeccCCceEEEEEEec--CCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVE-KIGEGGFSTVSLIEHS--QTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      +.+.+..++|.+.+ .||+|+||.||+|.+.  .++..||+|.+.... ....+.+.+|+++++.++||||+++++++. 
T Consensus         2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            45678889999998 9999999999999864  467889999987643 345667889999999999999999998652 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                               ....++|+|++++++|.+.+..   ....+++..+..++.|++.||.|||++   |++|+||||+||+++.
T Consensus        81 ---------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~  145 (287)
T 1u59_A           81 ---------AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVN  145 (287)
T ss_dssp             ---------SSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEE
T ss_pred             ---------CCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcC
Confidence                     2458999999999999987752   234589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++.++++|||.+......      ...........+|+.|+|||++.+..+   +.++||||+|+++|||++ |..||.+
T Consensus       146 ~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          146 RHYAKISDFGLSKALGAD------DSYYTARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             TTEEEECCCTTCEECTTC------SCEECCCCSSCCCGGGCCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCEEECcccceeeeccC------cceeeccccccccccccCHHHhccCCC---CchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999976532110      000011122335778999999987766   789999999999999998 9999976


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       217 ~  217 (287)
T 1u59_A          217 M  217 (287)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-37  Score=262.53  Aligned_cols=202  Identities=19%  Similarity=0.290  Sum_probs=168.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||+||+|.+..++..||+|.+...  .......+.+|+..+..+ +||||+++++.+..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-------   82 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-------   82 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-------
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-------
Confidence            47899999999999999999999999999999988653  344566778899999999 89999999985543       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC------
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND------  175 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~------  175 (282)
                        ....++|+|++++++|.+.+.........+++..++.++.|++.||.|||++   |++||||||+||+++.+      
T Consensus        83 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           83 --DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             --TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------
T ss_pred             --CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccc
Confidence              4689999999999999999886554446689999999999999999999999   89999999999999844      


Q ss_pred             -------------CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHH
Q psy16951        176 -------------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       176 -------------~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~  242 (282)
                                   ..++++|||.+....             ......+|..|+|||++.+...  .+.++||||+|+++|
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~--~~~~~Di~slG~il~  222 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRIS-------------SPQVEEGDSRFLANEVLQENYT--HLPKADIFALALTVV  222 (289)
T ss_dssp             ------------CCCEEECCCTTCEETT-------------CSCCCCCCGGGCCHHHHTTCCT--THHHHHHHHHHHHHH
T ss_pred             ccccccccccCCceEEEEcccccccccC-------------CccccCCCccccChhHhcCCCC--CCchhhHHHHHHHHH
Confidence                         478999999765321             0112347889999999986532  257999999999999


Q ss_pred             HHHhCCCCCCc
Q psy16951        243 AMCYFKSPFDT  253 (282)
Q Consensus       243 el~tg~~pf~~  253 (282)
                      +|++|.+|+..
T Consensus       223 ~l~~~~~~~~~  233 (289)
T 1x8b_A          223 CAAGAEPLPRN  233 (289)
T ss_dssp             HHTTCCCCCSS
T ss_pred             HHhcCCCCCcc
Confidence            99999987753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.5e-38  Score=279.34  Aligned_cols=207  Identities=25%  Similarity=0.316  Sum_probs=164.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ..+|++.+.||+|+||+||+|++..++..||||++....    ....+|+++++.++||||+++++++....   ...+.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~---~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSG---EKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEE---TTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccC---CCCcc
Confidence            347999999999999999999999999999999885432    12346899999999999999988765421   11233


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-CCceeecc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-NNPLLMDL  183 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~~~~df  183 (282)
                      ..+++|+||+++ ++.+.+.........+++..+..++.||+.||.|||++   ||+||||||+||+++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            557899999964 67666654444556789999999999999999999998   89999999999999966 45799999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++.....          ........+|..|+|||++.+...  ++.++||||+||++|||++|+.||.+.
T Consensus       202 G~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          202 GSAKQLVR----------GEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             TTCEECCT----------TCCCCSCCSCTTSCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhccc----------CCCceeeeeCCCcCCHHHHcCCCC--CCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            98753210          011223467899999999976521  388999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-37  Score=264.06  Aligned_cols=210  Identities=18%  Similarity=0.172  Sum_probs=170.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+|+..++.+ +|+|++.+++++.       
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-------   76 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-------   76 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-------
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-------
Confidence            456889999999999999999999999999999999885432  233567889999999 7999999987543       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---  177 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---  177 (282)
                        .....++++|++ +++|.+.+...   ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.   
T Consensus        77 --~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~  147 (298)
T 1csn_A           77 --EGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA  147 (298)
T ss_dssp             --ETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred             --CCceeEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCC
Confidence              347899999999 99999988642   34589999999999999999999999   8999999999999987776   


Q ss_pred             --ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 --PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 --~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        ++++|||.+.........  ............||+.|+|||++.+..+   +.++||||||+++|||++|+.||.+.
T Consensus       148 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          148 NMIYVVDFGMVKFYRDPVTK--QHIPYREKKNLSGTARYMSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             TCEEECCCTTCEESBCTTTC--CBCCCCCCCCCCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CeEEEEECcccccccccccc--ccccccCccCCCCCcccCCchhhcCCCC---ChHHHHHHHHHHHHHHHcCCCCcchh
Confidence              999999987532111000  0000011234468899999999988765   88999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=289.92  Aligned_cols=232  Identities=19%  Similarity=0.343  Sum_probs=177.1

Q ss_pred             cEEEecccEEEEE-EeccCCceEEEEEEec--CCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         20 AVYVKSDKYYIVE-KIGEGGFSTVSLIEHS--QTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        20 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .+.+..+++.+.+ +||+|+||.||+|.+.  .++..||||.+.... ....+.+.+|+++++.++||||+++++++.. 
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence            4567778888887 8999999999999875  356679999986543 3456788999999999999999999986532 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ..+++||||+.+++|.+++..   ....+++..++.++.|++.||.|||++   +|+||||||+||+++.+
T Consensus       408 ---------~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~  472 (613)
T 2ozo_A          408 ---------EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR  472 (613)
T ss_dssp             ---------SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred             ---------CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCC
Confidence                     358999999999999988752   234589999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.+||+|||++......      ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       473 ~~vkL~DFGla~~~~~~------~~~~~~~~~~~~~~~y~APE~~~~~~~---~~~sDvwSlGv~l~ellt~G~~Pf~~~  543 (613)
T 2ozo_A          473 HYAKISDFGLSKALGAD------DSYYTARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKKM  543 (613)
T ss_dssp             TEEEECCCSTTTTCC--------------------CCTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcEEEeeccCcccccCC------CceeeeccCCCCccceeCHhhhcCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999987532110      000111122334678999999987766   889999999999999998 99999864


Q ss_pred             ccCccceeeeee-eccccCCCCCCC
Q psy16951        255 YERGDSVALAVI-SGNITFPENTPF  278 (282)
Q Consensus       255 ~~~~~~~~~~~~-~~~~~~p~~~~~  278 (282)
                      ..  ..+...+. +.++..|+++|.
T Consensus       544 ~~--~~~~~~i~~~~~~~~p~~~~~  566 (613)
T 2ozo_A          544 KG--PEVMAFIEQGKRMECPPECPP  566 (613)
T ss_dssp             CS--HHHHHHHHTTCCCCCCTTCCH
T ss_pred             CH--HHHHHHHHcCCCCCCCCcCCH
Confidence            32  22222222 334566666554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-37  Score=270.15  Aligned_cols=218  Identities=23%  Similarity=0.369  Sum_probs=174.4

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEec-------CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-------QTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNI   85 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni   85 (282)
                      +.+...|.+..++|++.+.||+|+||.||+|++.       .++..||+|.+..... .....+.+|+++++.+ +||||
T Consensus        24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i  103 (334)
T 2pvf_A           24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI  103 (334)
T ss_dssp             CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE
Confidence            4456778899999999999999999999999975       3567899998865433 3456788999999999 89999


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhh
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFH  153 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH  153 (282)
                      +++++++.         .....++|+||+++++|.+++.....            ....++...++.++.|++.||.|||
T Consensus       104 v~~~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  174 (334)
T 2pvf_A          104 INLLGACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA  174 (334)
T ss_dssp             CCEEEEEC---------SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEc---------cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            99998543         34678999999999999998864321            1124788999999999999999999


Q ss_pred             cCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccc
Q psy16951        154 DAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTD  233 (282)
Q Consensus       154 ~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~D  233 (282)
                      ++   |++|+||||+||+++.++.++++|||.+......       ..........+|+.|+|||++.+..+   +.++|
T Consensus       175 ~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~D  241 (334)
T 2pvf_A          175 SQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DYYKKTTNGRLPVKWMAPEALFDRVY---THQSD  241 (334)
T ss_dssp             HT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTT-------SSEECCSCCCCCGGGCCHHHHHHCEE---CHHHH
T ss_pred             hC---CeeCCCCccceEEEcCCCCEEEcccccccccccc-------ccccccCCCCcccceeChHHhcCCCc---ChHHH
Confidence            99   8999999999999999999999999976532110       00011122345678999999987766   88999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCcc
Q psy16951        234 VWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       234 iws~G~il~el~t-g~~pf~~~  254 (282)
                      |||+|+++|+|++ |..||.+.
T Consensus       242 i~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          242 VWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTC
T ss_pred             HHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999 99999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.2e-37  Score=270.21  Aligned_cols=206  Identities=23%  Similarity=0.352  Sum_probs=156.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...++|++++.||+|+||.||+|.+..++..||||++...  .......+.+|+.+++.++||||+++++.+....   .
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~  102 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR---S  102 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS---S
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC---c
Confidence            3458999999999999999999999999999999998543  3344567789999999999999999998765421   1


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .......++++|++ +++|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.+|+
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEE
Confidence            22335689999998 7888887642     4589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||++....            .......+|..|+|||++.+...  ++.++||||+||++|||++|+.||.+.
T Consensus       174 ~DFG~a~~~~------------~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          174 LDFGLARHTA------------DEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             CC---------------------------CCCTTCCHHHHTTCCS--CCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecccccccc------------ccCCCcCcCcCccChHHHcCCcC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999764211            11234567899999999986322  388999999999999999999999764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-38  Score=269.66  Aligned_cols=215  Identities=20%  Similarity=0.336  Sum_probs=172.9

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEe-----cCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~   91 (282)
                      ..|.+..++|++.+.||+|+||+||+|++     ..++..||||.+..... .....+.+|+.+++.+ +||||+++++.
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            35677889999999999999999999985     35678999999865443 3445788999999999 79999999986


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG------------KHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +..        .....++++||+++++|.+.+......            ...+++..++.++.|++.||.|||++   |
T Consensus       100 ~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~  168 (316)
T 2xir_A          100 CTK--------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---K  168 (316)
T ss_dssp             ECC--------TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             Eec--------CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            543        234589999999999999988643211            12278889999999999999999999   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      ++|+||||+||+++.++.++++|||.+.....       ...........+|+.|+|||++.+..+   +.++||||+|+
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~  238 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYK-------DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGV  238 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTT-------CTTSEEETTEEECGGGCCHHHHHHCCC---CHHHHHHHHHH
T ss_pred             cccccCccceEEECCCCCEEECCCcccccccc-------CccceeccCCCcceeecCchhhccccc---cchhHHHHHHH
Confidence            99999999999999999999999997653211       001111223456788999999987765   88999999999


Q ss_pred             HHHHHHh-CCCCCCcc
Q psy16951        240 LLYAMCY-FKSPFDTV  254 (282)
Q Consensus       240 il~el~t-g~~pf~~~  254 (282)
                      ++|+|++ |..||.+.
T Consensus       239 il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          239 LLWEIFSLGASPYPGV  254 (316)
T ss_dssp             HHHHHHTTSCCSSTTC
T ss_pred             HHHHHHhCCCCCCccc
Confidence            9999998 99999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=263.20  Aligned_cols=216  Identities=23%  Similarity=0.317  Sum_probs=166.5

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC----
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA----   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~----   97 (282)
                      ....++|++.+.||+|+||.||+|.+..++..||+|++...+......+.+|+++++.++||||+++++++.....    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            3446899999999999999999999999999999999987776677788999999999999999999986643210    


Q ss_pred             -CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-C
Q psy16951         98 -DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-D  175 (282)
Q Consensus        98 -~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~  175 (282)
                       ..........++|+|++. ++|.+.+.     ...+++..+..++.|++.||.|||++   |++|+||||+||+++. +
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence             002234578999999996 68888763     34588999999999999999999999   8999999999999974 5


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.++++|||.+......      ...........+|..|+|||++.+...  ++.++||||||+++|||++|+.||.+.
T Consensus       158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPH------YSHKGHLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             TEEEECCCTTCBCC--------------CCCGGGSCCTTCCHHHHHCTTC--CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CeEEEccCccccccCCC------cccccccccccccccccCcHHhcCccc--CCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            68999999976532110      001111223356888999999875322  378999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-38  Score=275.62  Aligned_cols=214  Identities=25%  Similarity=0.330  Sum_probs=172.7

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .....+..++|++.+.||+|+||.||+|++. ++..||||++...... ....+.+|+++++.++||||+++++++.   
T Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---   97 (326)
T 3uim_A           22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM---   97 (326)
T ss_dssp             THHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC---
T ss_pred             HHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe---
Confidence            3445566889999999999999999999864 6889999988644322 2236789999999999999999998554   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            .....++|+||+.+++|.+.+.........+++..+..++.|++.||.|||++...|++||||||+||+++.++
T Consensus        98 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           98 ------TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             ------CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             ------cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence                  34678899999999999998875443444589999999999999999999997333689999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .++++|||.+......        .........||+.|+|||++.+..+   +.++||||+|+++|+|++|..||.
T Consensus       172 ~~kl~Dfg~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKS---SEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CEEECCCSSCEECCSS--------SSCEECCCCSCGGGCCHHHHHHSEE---CHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CEEeccCccccccCcc--------cccccccccCCcCccCHHHhccCCC---CccccchhHHHHHHHHHhCCCccc
Confidence            9999999986532110        1111123347899999999987776   889999999999999999999996

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.3e-38  Score=276.92  Aligned_cols=209  Identities=12%  Similarity=0.141  Sum_probs=160.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEecc---CCchhHHHHHHHH---HHhhhCCCCCcccccccccccCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC---HGREDQAQAIREV---EHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~e~---~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ..++|++.+.||+|+||+||+|.+..++..||||++..   ......+.+.+|+   ..++.++||||+++++.+.....
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            35889999999999999999999999999999999863   3344567788999   45566689999999865442100


Q ss_pred             CCCCCCC------------c-----eEEEEeccCCCCChHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q psy16951         98 DPVLNST------------S-----QVLMVLPYYPKGTLANDLELRSVG---KHYMSSVDILKMFLKICEAVKVFHDAKP  157 (282)
Q Consensus        98 ~~~~~~~------------~-----~~~lv~e~~~~~sL~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~~  157 (282)
                        +++..            .     ..+++|||+ +|+|.+++.....-   ...+++..++.++.|++.||.|||++  
T Consensus       151 --~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  225 (377)
T 3byv_A          151 --LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--  225 (377)
T ss_dssp             --EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             --hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--
Confidence              11111            1     378999999 68999988754221   01223477888999999999999999  


Q ss_pred             CCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-----------ccc
Q psy16951        158 IAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-----------SYC  226 (282)
Q Consensus       158 ~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-----------~~~  226 (282)
                       ||+||||||+||+++.++.+|++|||++....            .......| ..|+|||++.+.           .+ 
T Consensus       226 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-  290 (377)
T 3byv_A          226 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-  290 (377)
T ss_dssp             -TEECSCCCGGGEEECTTCCEEECCGGGCEETT------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEEechhheecC------------CcccCCCC-cCccChhhhcccccccccccccccC-
Confidence             89999999999999999999999999765210            01123345 789999999876           44 


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        227 VVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       227 ~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        +.++||||||+++|||++|+.||.+.
T Consensus       291 --~~~~DvwSlG~il~elltg~~Pf~~~  316 (377)
T 3byv_A          291 --TFSFDAWALGLVIYWIWCADLPITKD  316 (377)
T ss_dssp             --CHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             --ChhhhHHHHHHHHHHHHHCCCCCccc
Confidence              88999999999999999999999753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=275.68  Aligned_cols=213  Identities=18%  Similarity=0.228  Sum_probs=165.0

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC---CCceEEEEEeccCCchh-----------HHHHHHHHHHhhhCCCCCcccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ---TKKRYALKKIICHGRED-----------QAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~-----------~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      +..++|++.+.||+|+||+||+|.+..   ++..||||.+.......           ...+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            446899999999999999999999987   78899999886554321           1235678888999999999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      ++.+..     ...+....++|||++ +++|.+.+...    ..+++..++.++.|++.||.|||++   |++||||||+
T Consensus       114 ~~~~~~-----~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  180 (345)
T 2v62_A          114 YGSGLT-----EFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA  180 (345)
T ss_dssp             EEEEEE-----ESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             eccccc-----ccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence            997665     233467899999999 99999877532    3689999999999999999999999   8999999999


Q ss_pred             cEEeecCC--CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        169 NVLLANDN--NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       169 nil~~~~~--~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      ||+++.++  .++++|||++..........  ...........||..|+|||++.+..+   +.++||||||+++|||++
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~ell~  255 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHK--QYQENPRKGHNGTIEFTSLDAHKGVAL---SRRSDVEILGYCMLRWLC  255 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCC--CCCCCGGGCSCSCTTTCCHHHHHTCCC---CHHHHHHHHHHHHHHHHH
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccc--cchhccccccCCCccccCHHHhcCCCC---CchhhHHHHHHHHHHHHh
Confidence            99999887  99999999875432111000  001111234568999999999988765   889999999999999999


Q ss_pred             CCCCCCc
Q psy16951        247 FKSPFDT  253 (282)
Q Consensus       247 g~~pf~~  253 (282)
                      |+.||.+
T Consensus       256 g~~pf~~  262 (345)
T 2v62_A          256 GKLPWEQ  262 (345)
T ss_dssp             SSCTTGG
T ss_pred             CCCCccc
Confidence            9999965

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.8e-37  Score=265.69  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=163.2

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .++|++.+.||+|+||.||+|.+..++..||||.+.....        .....+.+|+++++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            4689999999999999999999999999999998864321        122356789999999999999999885432  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                              ...++|+||+++++|.+.+.    ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++
T Consensus        87 --------~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  151 (322)
T 2ycf_A           87 --------EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  151 (322)
T ss_dssp             --------SSEEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred             --------CceEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence                    23899999999999988774    345689999999999999999999999   899999999999998765


Q ss_pred             C---ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 N---PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 ~---~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .   ++++|||.+....          .........+|..|+|||++.+.....++.++||||||+++|+|++|..||..
T Consensus       152 ~~~~~kl~Dfg~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (322)
T 2ycf_A          152 EDCLIKITDFGHSKILG----------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  221 (322)
T ss_dssp             SSCCEEECCCTTCEECC----------CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCCeEEEccCccceecc----------cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            4   9999999765321          01112234578999999998532222347899999999999999999999975


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       222 ~  222 (322)
T 2ycf_A          222 H  222 (322)
T ss_dssp             T
T ss_pred             c
Confidence            4

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-37  Score=265.71  Aligned_cols=212  Identities=20%  Similarity=0.333  Sum_probs=169.9

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEE----ecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      +...+..++|++++.||+|+||.||+|+    +..++..||+|.+.... ......+.+|+++++.++||||+++++.+.
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            3344557789999999999999999999    56789999999986443 234567889999999999999999998655


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      ..       .....+++|||+++++|.+++...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++
T Consensus        94 ~~-------~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~  160 (302)
T 4e5w_A           94 ED-------GGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE  160 (302)
T ss_dssp             C----------CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             cC-------CCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEc
Confidence            32       235689999999999999988543   34589999999999999999999999   899999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .++.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|+|++|..|+.
T Consensus       161 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          161 SEHQVKIGDFGLTKAIETD------KEYYTVKDDRDSPVFWYAPECLMQSKF---YIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             ETTEEEECCCTTCEECCTT------CCEEECCCCTTCCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             CCCCEEECcccccccccCC------CcceeccCCCCCCccccCCeeecCCCC---CcchhHHHHHHHHHHHHHccCCCc
Confidence            9999999999976532111      000011223346777999999988776   789999999999999999998864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-37  Score=265.41  Aligned_cols=210  Identities=19%  Similarity=0.288  Sum_probs=166.3

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCC----ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK----KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      ..+..++|++.+.||+|+||+||+|.+..++    ..||+|.+..... .....+.+|+.+++.++||||+++++.+   
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---  115 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI---  115 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE---
Confidence            3567899999999999999999999986553    4599999865433 3455788999999999999999999854   


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                            ......++|||++++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++.+
T Consensus       116 ------~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~  183 (333)
T 1mqb_A          116 ------SKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN  183 (333)
T ss_dssp             ------CSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             ------ecCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCC
Confidence                  3456799999999999999988642   34588999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+.
T Consensus       184 ~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          184 LVCKVSDFGLSRVLEDD------PEATYTTSGGKIPIRWTAPEAISYRKF---TSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             CCEEECCCCC-----------------------CCCGGGSCHHHHHSCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcEEECCCCcchhhccc------cccccccCCCCccccccCchhcccCCC---CchhhhHHHHHHHHHHHcCCCCCcccC
Confidence            99999999976532110      000111122345678999999987765   789999999999999999 99999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-37  Score=265.14  Aligned_cols=211  Identities=18%  Similarity=0.346  Sum_probs=168.5

Q ss_pred             cccEEEecccEEEEE-EeccCCceEEEEEE--ecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         18 KEAVYVKSDKYYIVE-KIGEGGFSTVSLIE--HSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ...+.+..++|++.+ .||+|+||.||+|.  ...++..||||.+....  ......+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345677889999999 99999999999995  45677899999886443  23356788999999999999999999865


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      .          ....++|+|++++++|.+++..    ...+++..++.++.|++.||.|||++   |++|+||||+||++
T Consensus        88 ~----------~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~  150 (291)
T 1xbb_A           88 E----------AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLL  150 (291)
T ss_dssp             E----------SSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             C----------CCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEE
Confidence            2          2568899999999999998863    34589999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.++.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~  221 (291)
T 1xbb_A          151 VTQHYAKISDFGLSKALRAD------ENYYKAQTHGKWPVKWYAPECINYYKF---SSKSDVWSFGVLMWEAFSYGQKPY  221 (291)
T ss_dssp             EETTEEEECCCTTCEECCTT------CSEEEC----CCCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             eCCCcEEEccCCcceeeccC------CCcccccccCCCCceeeChHHhccCCC---ChhhhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999976532110      000011122335678999999987766   789999999999999999 99999


Q ss_pred             Ccc
Q psy16951        252 DTV  254 (282)
Q Consensus       252 ~~~  254 (282)
                      .+.
T Consensus       222 ~~~  224 (291)
T 1xbb_A          222 RGM  224 (291)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-37  Score=261.62  Aligned_cols=209  Identities=21%  Similarity=0.354  Sum_probs=171.6

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+.|.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+|+++++.++||||+++++.+..   
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   79 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---   79 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---
Confidence            3567889999999999999999999999985 56789999886443 345678899999999999999999985432   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++++++|.+.+....  ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        80 -------~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~  147 (279)
T 1qpc_A           80 -------EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLS  147 (279)
T ss_dssp             -------SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred             -------CCcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCC
Confidence                   35789999999999999875321  12488999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+.....        ..........++..|+|||++.+..+   +.++||||+|+++|||++ |..||.+.
T Consensus       148 ~kl~Dfg~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          148 CKIADFGLARLIED--------NEYTAREGAKFPIKWTAPEAINYGTF---TIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             EEECCCTTCEECSS--------SCEECCTTCCCCTTTSCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             EEECCCcccccccC--------cccccccCCCCccCccChhhhccCCC---CchhhhHHHHHHHHHHHhCCCCCCccc
Confidence            99999997653210        00011123345778999999987766   789999999999999999 89999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-37  Score=262.06  Aligned_cols=204  Identities=22%  Similarity=0.326  Sum_probs=172.9

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .-..+.|++++.||+|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++||||+++++.+..      
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   91 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK------   91 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            345678999999999999999999999999999999986543 3445678899999999999999999985543      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                         ....++|+|++++++|.+.+.     ...+++..+..++.|++.||.|||++   |++|+||||+||+++.++.+++
T Consensus        92 ---~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  160 (303)
T 3a7i_A           92 ---DTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL  160 (303)
T ss_dssp             ---TTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ---CCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEE
Confidence               467999999999999998774     34589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||.+.....         .........+|..|+|||++.+..+   +.++||||||+++|+|++|..||...
T Consensus       161 ~Dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          161 ADFGVAGQLTD---------TQIKRNTFVGTPFWMAPEVIKQSAY---DSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             CCCTTCEECBT---------TBCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             eecccceecCc---------cccccCccCCCcCccCHHHHhcCCC---CchhhhHHHHHHHHHHccCCCCCCCc
Confidence            99997643211         0011223457888999999987766   78999999999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.7e-37  Score=260.51  Aligned_cols=205  Identities=24%  Similarity=0.380  Sum_probs=169.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+.         .
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------~   76 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR---------E   76 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE---------E
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE---------c
Confidence            468999999999999999999999999999999986443 334567889999999999999999998544         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++|+|++++++|.+.+.    ....+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.++++||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  149 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  149 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeC
Confidence            477899999999999988764    234588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......       ..........+|..|+|||++.+..+  .+.++||||+|+++|+|++|..||.+.
T Consensus       150 g~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          150 GLATVFRYN-------NRERLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             TTCEECEET-------TEECCBCCCCSCGGGCCGGGGTCSSB--CHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             CCccccCCC-------cchhcccCCccccCccChHHHhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence            976532110       00011123457888999999987654  256899999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.9e-37  Score=260.09  Aligned_cols=205  Identities=24%  Similarity=0.444  Sum_probs=164.9

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ...|.+..++|++.+.||+|+||.||++.+  ++..||+|.+...  ...+.+.+|+.+++.++||||+++++.+..   
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   85 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE---   85 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC---
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc---
Confidence            345678899999999999999999999998  5789999988643  345678899999999999999999985433   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           .....++++|++++++|.+.+....  ...+++..++.++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        86 -----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  155 (278)
T 1byg_A           86 -----EKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNV  155 (278)
T ss_dssp             -----C--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             -----CCCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCc
Confidence                 2356899999999999999887542  22378889999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      ++++|||.+....            .......++..|+|||++.+..+   +.++||||+|+++|+|++ |..||...
T Consensus       156 ~~l~Dfg~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          156 AKVSDFGLTKEAS------------STQDTGKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             EEECCCCC------------------------CCTTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             EEEeecccccccc------------ccccCCCccccccCHHHhCCCCC---CchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999754211            01112345778999999987665   789999999999999998 99999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.8e-37  Score=268.09  Aligned_cols=216  Identities=23%  Similarity=0.341  Sum_probs=169.2

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|++++.||+|+||+||+|++..++..||+|++......  ....+.+|+.+++.++||||+++++.+...... ..
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP-YN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc-cc
Confidence            458999999999999999999999999999999988544332  245677899999999999999999876642110 11


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......++||||+. +++.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++
T Consensus        94 ~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           94 RCKGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ---CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             cCCceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            22457899999996 477666542   234589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+......     ............+|+.|+|||++.+...  ++.++||||+|+++|+|++|..||.+.
T Consensus       167 Dfg~a~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          167 DFGLARAFSLA-----KNSQPNRYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             CCTTCEECCCC-----SSSSCCCCCSSCSCGGGCCHHHHTTCCS--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cchhccccccc-----ccccccccCCcccccCccCchhhcCCCC--CCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99986532110     0001111223457889999999976432  388999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=266.42  Aligned_cols=215  Identities=22%  Similarity=0.409  Sum_probs=172.7

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEE----ecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIE----HSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ..+...+..++|++++.||+|+||.||+|+    +..++..||+|.+..........+.+|+++++.++||||+++++.+
T Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           32 DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             -----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            334556678899999999999999999999    4668999999999877777777899999999999999999998865


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ...       .....++|+|++++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||++
T Consensus       112 ~~~-------~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli  178 (326)
T 2w1i_A          112 YSA-------GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV  178 (326)
T ss_dssp             CC-----------CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             Eec-------CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEE
Confidence            432       234689999999999999988642   34588999999999999999999998   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +.++.++++|||.+.......      ..........++..|+|||++.+..+   +.++||||+|+++|||++|..||.
T Consensus       179 ~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          179 ENENRVKIGDFGLTKVLPQDK------EYYKVKEPGESPIFWYAPESLTESKF---SVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             EETTEEEECCCTTCEECCSSC------SEEECSSCCSCCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             cCCCcEEEecCcchhhccccc------cccccccCCCCceeEECchhhcCCCC---CchhhHHHHHHHHHHHHhcCCCCC
Confidence            999999999999765321100      00000112345667999999987766   789999999999999999999886


Q ss_pred             c
Q psy16951        253 T  253 (282)
Q Consensus       253 ~  253 (282)
                      .
T Consensus       250 ~  250 (326)
T 2w1i_A          250 S  250 (326)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-36  Score=264.34  Aligned_cols=216  Identities=23%  Similarity=0.350  Sum_probs=170.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++...    .+.
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   84 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD----SFE   84 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS----CST
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc----ccC
Confidence            45899999999999999999999999999999999864433 3455678999999999999999999866543    334


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++|++. ++|.+.+..     ..+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  155 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCD  155 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEe
Confidence            4577999999996 688877653     3589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchh-hhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAE-AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+............ ...........||..|+|||++.+...  ++.++||||+|+++|+|++|..||.+.
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK--YSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHSCCC--CCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeeccCCC--ccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9987543211100000 000011223467889999999865322  378999999999999999999999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-36  Score=262.63  Aligned_cols=216  Identities=21%  Similarity=0.318  Sum_probs=156.4

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHH-HhhhCCCCCccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVE-HHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~-~l~~l~H~ni~~~~~~~~   93 (282)
                      .....|.+..++|++.+.||+|+||.||+|.+..++..||||.+..... .....+.+|+. +++.++||||+++++.+.
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            3456677889999999999999999999999999999999999875533 33445556666 677889999999998554


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS-VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      .         ....++|+|++. ++|.+.+.... .....+++..+..++.|++.||.|||++.  |++|+||||+||++
T Consensus        92 ~---------~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll  159 (327)
T 3aln_A           92 R---------EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILL  159 (327)
T ss_dssp             C---------SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEE
T ss_pred             e---------CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEE
Confidence            3         468999999996 48877765422 22456889999999999999999999963  58899999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc----cCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH----VDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~----~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      +.++.+|++|||.+.....          ........||..|+|||++.    +..+   +.++||||||+++|+|++|.
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~---~~~~Di~slG~il~~l~~g~  226 (327)
T 3aln_A          160 DRSGNIKLCDFGISGQLVD----------SIAKTRDAGCRPYMAPERIDPSASRQGY---DVRSDVWSLGITLYELATGR  226 (327)
T ss_dssp             ETTTEEEECCCSSSCC----------------------------------------C---CSHHHHHHHHHHHHHHHHSC
T ss_pred             cCCCCEEEccCCCceeccc----------ccccccCCCCccccCceeeccccCcCCC---CchhhHHHHHHHHHHHHHCC
Confidence            9999999999997653210          01112235788899999984    3333   78999999999999999999


Q ss_pred             CCCCcccc
Q psy16951        249 SPFDTVYE  256 (282)
Q Consensus       249 ~pf~~~~~  256 (282)
                      .||.+...
T Consensus       227 ~pf~~~~~  234 (327)
T 3aln_A          227 FPYPKWNS  234 (327)
T ss_dssp             CCSSCC--
T ss_pred             CCCCCcch
Confidence            99976433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-37  Score=268.66  Aligned_cols=219  Identities=18%  Similarity=0.280  Sum_probs=169.1

Q ss_pred             cccccccEEEecccEEEEEEeccCCceEEEEEE-----ecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCccc
Q psy16951         14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIE-----HSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILP   87 (282)
Q Consensus        14 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~   87 (282)
                      .+...+...+..++|++.+.||+|+||.||+|.     ...++..||||.+... .......+.+|+.+++.++||||++
T Consensus        18 sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   97 (327)
T 2yfx_A           18 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR   97 (327)
T ss_dssp             EECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCe
Confidence            334445556889999999999999999999999     4567889999998644 3345567889999999999999999


Q ss_pred             ccccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccC
Q psy16951         88 LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVG---KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRD  164 (282)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~d  164 (282)
                      +++.+.         .....++|||++++++|.+++......   ...++...++.++.|++.||.|||++   |++|+|
T Consensus        98 ~~~~~~---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~d  165 (327)
T 2yfx_A           98 CIGVSL---------QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD  165 (327)
T ss_dssp             EEEEEC---------SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEc---------CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCc
Confidence            998544         345679999999999999988754211   13478899999999999999999999   899999


Q ss_pred             CCCCcEEeec---CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHH
Q psy16951        165 LKTANVLLAN---DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL  241 (282)
Q Consensus       165 lk~~nil~~~---~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il  241 (282)
                      |||+||+++.   +..++++|||.+.....       ...........+|+.|+|||++.+..+   +.++||||||+++
T Consensus       166 lkp~NIli~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il  235 (327)
T 2yfx_A          166 IAARNCLLTCPGPGRVAKIGDFGMARDIYR-------ASYYRKGGCAMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLL  235 (327)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHC-------------CCGGGSCGGGCCHHHHHHCCC---CHHHHHHHHHHHH
T ss_pred             CCHhHEEEecCCCcceEEECcccccccccc-------ccccccCCCcCCCcceeCHhHhcCCCC---CchhhHHHHHHHH
Confidence            9999999984   44689999997542110       001111223456788999999987765   8899999999999


Q ss_pred             HHHHh-CCCCCCcc
Q psy16951        242 YAMCY-FKSPFDTV  254 (282)
Q Consensus       242 ~el~t-g~~pf~~~  254 (282)
                      |+|++ |..||.+.
T Consensus       236 ~ellt~g~~p~~~~  249 (327)
T 2yfx_A          236 WEIFSLGYMPYPSK  249 (327)
T ss_dssp             HHHHTTSCCSSTTC
T ss_pred             HHHHcCCCCCCCCc
Confidence            99998 99999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=262.78  Aligned_cols=207  Identities=21%  Similarity=0.380  Sum_probs=165.6

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .......++|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+|+.+++.++||||+++++.+..    
T Consensus        22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   95 (314)
T 3com_A           22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK----   95 (314)
T ss_dssp             --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred             hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe----
Confidence            334556789999999999999999999999999999999886543  34567889999999999999999985543    


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                           ....++++|++.+++|.+.+...   ...+++..+..++.|++.||.|||++   |++|+||+|+||+++.++.+
T Consensus        96 -----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  164 (314)
T 3com_A           96 -----NTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA  164 (314)
T ss_dssp             -----TTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred             -----CCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCE
Confidence                 46799999999999999987632   34589999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+.....         .........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       165 kl~dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          165 KLADFGVAGQLTD---------TMAKRNTVIGTPFWMAPEVIQEIGY---NCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             EECCCTTCEECBT---------TBSCBCCCCSCGGGCCHHHHSSSCB---CTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EEeecccchhhhh---------hccccCccCCCCCccChhhcCCCCC---CccccHHHHHHHHHHHHhCCCCCCCC
Confidence            9999997643210         0011223457888999999988766   88999999999999999999999753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-36  Score=258.63  Aligned_cols=210  Identities=26%  Similarity=0.365  Sum_probs=165.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ....+|++.+.||+|+||+||+|.+..+   +..||+|.+..... .....+.+|+.++++++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----   97 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----   97 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----
Confidence            3456799999999999999999996543   34689998865433 345678899999999999999999986443    


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++++|++.+++|.+++..   ....++...++.++.|++.||.|||++   |++||||||+||+++.++.+
T Consensus        98 ----~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A           98 ----SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             ----SSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             ----CCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence                34578899999999999998853   234578899999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +++|||.+.....     .............+|+.|+|||++.+..+   +.++||||+|+++|+|++ +.+||.+.
T Consensus       168 kl~Dfg~a~~~~~-----~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          168 KVADFGLARDMYD-----KEYYSVHNKTGAKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             EECSCGGGCCCSC-----GGGCBC-----CCBCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             EECcccccccccc-----cchhccccccCCCCCccccChHHhcCCCC---ChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            9999997653211     11111122334456788999999987765   789999999999999999 55777653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-37  Score=268.44  Aligned_cols=202  Identities=26%  Similarity=0.341  Sum_probs=167.7

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhC-CCCCcccccccccccC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTF-VHPNILPLLDHALTGC   96 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~   96 (282)
                      ++|++.+.||+|+||.||+|.+..+|..||||.+.....        .....+.+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            679999999999999999999998999999998865432        1134567899999999 7999999998543   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            .....++||||+.+++|.+.+...    ..+++..+..++.|++.||.|||+.   |++|+||||+||+++.++
T Consensus       171 ------~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          171 ------SSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             ------BSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             ------eCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence                  357899999999999999988642    4589999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc---ccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS---YCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~---~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      .++++|||++.....          ........||+.|+|||++.+..   ...++.++||||||+++|+|++|..||.+
T Consensus       238 ~ikl~DfG~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEP----------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             CEEECCCTTCEECCT----------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CEEEEecCcccccCC----------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            999999997653211          01122346789999999986431   11237899999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-37  Score=270.50  Aligned_cols=209  Identities=14%  Similarity=0.171  Sum_probs=149.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhC--CCCCccccccccc------
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTF--VHPNILPLLDHAL------   93 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l--~H~ni~~~~~~~~------   93 (282)
                      ..+|++.+.||+|+||+||+|.+..++..||||++.....   .....+.+|+.+++.+  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3459999999999999999999999999999999876543   2344566775444444  6999888654332      


Q ss_pred             -c-cCCCC-------CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHhhcCCCC
Q psy16951         94 -T-GCADP-------VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI------LKMFLKICEAVKVFHDAKPI  158 (282)
Q Consensus        94 -~-~~~~~-------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~------~~~~~qi~~~l~~lH~~~~~  158 (282)
                       . ++...       .......+++||||+. ++|.+++.....   .+.....      +.++.|++.||.|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence             0 00000       0001145899999998 899999876422   2344444      56679999999999999   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc--CcccCCCCccchhh
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWS  236 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~--~~~~~~~~~~Diws  236 (282)
                      ||+||||||+||+++.++.+|++|||++....            .......+|+.|+|||++.+  ..+   +.++||||
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~---~~~~DiwS  278 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------------TRGPASSVPVTYAPREFLNASTATF---THALNAWQ  278 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETT------------CEEEGGGSCGGGCCHHHHTCSEEEC---CHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecC------------CCccCccCCcCCcChhhccCCCCCc---CccccHHH
Confidence            89999999999999999999999999865321            01113345688999999976  444   88999999


Q ss_pred             HHHHHHHHHhCCCCCCccc
Q psy16951        237 LGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~~  255 (282)
                      ||+++|||++|+.||.+..
T Consensus       279 lG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBCC
T ss_pred             HHHHHHHHHhCCCCCCCcC
Confidence            9999999999999998653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-37  Score=289.45  Aligned_cols=209  Identities=19%  Similarity=0.347  Sum_probs=165.8

Q ss_pred             cEEEecccEEEEE-EeccCCceEEEEEEe--cCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         20 AVYVKSDKYYIVE-KIGEGGFSTVSLIEH--SQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        20 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      .+.+..+.+.+.. +||+|+||+||+|.+  ..++..||||++....  ......+.+|+++++.++||||+++++++-.
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4556667777655 799999999999954  4567889999886432  3346788999999999999999999985432


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                                ...++||||+++++|.+++..    ...+++..++.++.||+.||.|||++   ||+||||||+||+++.
T Consensus       442 ----------~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~  504 (635)
T 4fl3_A          442 ----------ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT  504 (635)
T ss_dssp             ----------SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE
T ss_pred             ----------CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeC
Confidence                      358899999999999998863    34589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++.+||+|||++......      ...........+|..|+|||++.+..+   +.++||||||+++|||++ |..||.+
T Consensus       505 ~~~~kL~DFGla~~~~~~------~~~~~~~~~~~~t~~y~APE~~~~~~~---~~~sDvwSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          505 QHYAKISDFGLSKALRAD------ENYYKAQTHGKWPVKWYAPECINYYKF---SSKSDVWSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             TTEEEECCTTHHHHTTC-------------------CGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCEEEEEcCCccccccC------ccccccccCCCCceeeeChhhhcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999976432110      000111222345778999999987766   889999999999999998 9999976


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       576 ~  576 (635)
T 4fl3_A          576 M  576 (635)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.9e-37  Score=260.51  Aligned_cols=205  Identities=27%  Similarity=0.356  Sum_probs=168.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---------hhHHHHHHHHHHhhhCC-CCCcccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---------EDQAQAIREVEHHKTFV-HPNILPLLDHA   92 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~~e~~~l~~l~-H~ni~~~~~~~   92 (282)
                      -..++|++.+.||+|+||.||+|.+..++..||||.+.....         .....+.+|+++++++. ||||+++++.+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            446899999999999999999999999999999999865431         12346778999999995 99999999854


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      .         .....++|+|++++++|.+.+...    ..+++..+..++.|++.||.|||++   |++|+||+|+||++
T Consensus        94 ~---------~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~  157 (298)
T 1phk_A           94 E---------TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILL  157 (298)
T ss_dssp             E---------CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             c---------cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEE
Confidence            3         457899999999999999988643    4589999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC---cccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD---SYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~---~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                      +.++.++++|||.+.....          ........++..|+|||++.+.   ....++.++||||+|+++|+|++|..
T Consensus       158 ~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  227 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDP----------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP  227 (298)
T ss_dssp             CTTCCEEECCCTTCEECCT----------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCcEEEecccchhhcCC----------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence            9999999999997653211          0111234578889999998521   01123789999999999999999999


Q ss_pred             CCCc
Q psy16951        250 PFDT  253 (282)
Q Consensus       250 pf~~  253 (282)
                      ||.+
T Consensus       228 p~~~  231 (298)
T 1phk_A          228 PFWH  231 (298)
T ss_dssp             SSCC
T ss_pred             CCcC
Confidence            9975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-37  Score=267.45  Aligned_cols=208  Identities=23%  Similarity=0.363  Sum_probs=168.3

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCceE--EEEEeccC-CchhHHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRY--ALKKIICH-GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~i~~~-~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||.||+|++..++..+  |+|.+... .......+.+|+++++++ +||||+++++.+.    
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----   96 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----   96 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE----
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee----
Confidence            466799999999999999999999998888765  99988643 233445678899999999 8999999998554    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHH------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRS------------VGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                           .....++|||++++++|.+++....            .....+++..++.++.|++.||.|||++   |++||||
T Consensus        97 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dl  168 (327)
T 1fvr_A           97 -----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  168 (327)
T ss_dssp             -----ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             -----eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCC
Confidence                 3478999999999999999886431            1224689999999999999999999999   8999999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+||+++.++.++++|||++.....          ........++..|+|||++.+..+   +.++||||+|+++|||+
T Consensus       169 kp~NIl~~~~~~~kL~Dfg~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~ell  235 (327)
T 1fvr_A          169 AARNILVGENYVAKIADFGLSRGQEV----------YVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV  235 (327)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCE----------ECCC----CCTTTCCHHHHHHCEE---CHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEcCCCeEEEcccCcCccccc----------cccccCCCCCccccChhhhccccC---CchhcchHHHHHHHHHH
Confidence            99999999999999999997642110          011122345778999999987766   78999999999999999


Q ss_pred             h-CCCCCCcc
Q psy16951        246 Y-FKSPFDTV  254 (282)
Q Consensus       246 t-g~~pf~~~  254 (282)
                      + |..||.+.
T Consensus       236 t~g~~pf~~~  245 (327)
T 1fvr_A          236 SLGGTPYCGM  245 (327)
T ss_dssp             TTSCCTTTTC
T ss_pred             cCCCCCCCCC
Confidence            8 99999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1e-36  Score=273.04  Aligned_cols=200  Identities=23%  Similarity=0.292  Sum_probs=165.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC------CCCCcccccccccccCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF------VHPNILPLLDHALTGCA   97 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l------~H~ni~~~~~~~~~~~~   97 (282)
                      ...+|++++.||+|+||+||+|.+..++..||||.+... ......+.+|+.+++.+      +|+||+++++.+..   
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence            456899999999999999999999999999999988543 33345566777777665      57799999985443   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                            ....++++|++. ++|.+.+...  ....+++..+..++.||+.||.|||++   ||+||||||+||+++.++.
T Consensus       171 ------~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~  238 (429)
T 3kvw_A          171 ------RNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGR  238 (429)
T ss_dssp             ------TTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTS
T ss_pred             ------CCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCC
Confidence                  478999999995 6898877643  223488999999999999999999999   8999999999999999887


Q ss_pred             --ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 --PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 --~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        +|++|||++....            .......+|+.|+|||++.+..+   +.++|||||||++|||++|.+||.+.
T Consensus       239 ~~vkL~DFG~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          239 SGIKVIDFGSSCYEH------------QRVYTYIQSRFYRAPEVILGARY---GMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CCEEECCCTTCEETT------------CCCCSSCSCGGGCCHHHHHTBCC---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cceEEeecccceecC------------CcccccCCCCCccChHHHhCCCC---CchHHHHhHHHHHHHHHhCCCCCCCC
Confidence              8999999864221            11223467889999999998776   89999999999999999999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.8e-37  Score=272.28  Aligned_cols=209  Identities=23%  Similarity=0.374  Sum_probs=154.0

Q ss_pred             cccEEE-EEEeccCCceEEEEEEec--CCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYI-VEKIGEGGFSTVSLIEHS--QTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+.|++ .++||+|+||+||+|++.  .++..||||.+.....  ...+.+|+++++.++||||+++++++..       
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-------   89 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS-------   89 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEE-------
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEec-------
Confidence            355666 457999999999999976  5688999998864432  3457789999999999999999986643       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVG-----KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----  172 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----  172 (282)
                      ......++|+||+. ++|.+.+......     ...+++..++.++.||+.||.|||++   ||+||||||+||++    
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~  165 (405)
T 3rgf_A           90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  165 (405)
T ss_dssp             TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSS
T ss_pred             CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCC
Confidence            23467999999995 5787776543221     12488999999999999999999999   89999999999999    


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +.++.+||+|||++.....      ............||+.|+|||++.+...  ++.++||||+||++|||++|..||.
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          166 PERGRVKIADMGFARLFNS------PLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             TTTTCEEECCTTCCC----------------------CCCTTCCHHHHTTCCS--CCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCcEEEEECCCceecCC------CCcccccCCCceecCcccCchhhcCCCc--ccchhhhHHHHHHHHHHHhCCCCCC
Confidence            6778999999998753211      0111122334567999999999987442  3889999999999999999999997


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       238 ~~  239 (405)
T 3rgf_A          238 CR  239 (405)
T ss_dssp             CC
T ss_pred             Cc
Confidence            53

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=267.95  Aligned_cols=208  Identities=26%  Similarity=0.381  Sum_probs=159.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ...|++.+.||+|+||+||+|.+..+   +..||+|.+... .....+.+.+|+.++++++||||+++++++..      
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~------  161 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR------  161 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC------
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc------
Confidence            34578899999999999999997543   346899988543 33456788999999999999999999986443      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        .....++|+||+++++|.+++..   ....++...++.++.|++.||.|||++   |++||||||+||+++.++.+|+
T Consensus       162 --~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          162 --SEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             --CSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             --CCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEE
Confidence              34568899999999999998853   234578889999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +|||++......     ............+|+.|+|||++.+..+   +.++||||||+++|||+| |.+||.+.
T Consensus       234 ~DFG~a~~~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          234 ADFGLARDMYDK-----EFDSVHNKTGAKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             CCC--------------------------CCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             eecccccccccc-----ccccccccCCCCCcccccChHHhcCCCC---CcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            999986532110     0001111233456778999999987766   889999999999999999 67888754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-36  Score=265.26  Aligned_cols=202  Identities=25%  Similarity=0.377  Sum_probs=164.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+..++..||||++....  ......+.+|+.+++.++||||+++++++....   ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~  117 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS---SLR  117 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS---SST
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC---Ccc
Confidence            479999999999999999999999999999999986543  233567789999999999999999998765421   111


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++|+|++. ++|.+.+      ...+++..+..++.|++.||.|||++   |++||||||+||+++.++.++++|
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred             cceeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence            2234599999996 6776644      23489999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc-CcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV-DSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~-~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+....            .......+|+.|+|||++.+ ..+   +.++||||+|+++|+|++|..||.+.
T Consensus       188 fg~a~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          188 FGLARHAD------------AEMTGYVVTRWYRAPEVILSWMHY---NQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             TTCC--------------------CTTCCCTTSCHHHHSCCSCC---CTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCcccccc------------cCcCCcccCccccCHHHhcCCCCC---CcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99764221            11234467899999999977 344   88999999999999999999999763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-37  Score=269.26  Aligned_cols=204  Identities=25%  Similarity=0.364  Sum_probs=160.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-----HHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-----QAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      ..++|++.+.||+|+||.||+|.+..++..||||.+.......     ...+.+|+++++.++||||+++++.+.     
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence            4578999999999999999999999999999999886433221     235678999999999999999998543     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                          .....++|+|++.+ +|.+.+..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.+
T Consensus        83 ----~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           83 ----HKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             ----CTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             ----eCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence                45679999999975 77766642   234578889999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+....         ..........+|+.|+|||++.+...  ++.++||||+|+++|||++|.+||.+.
T Consensus       152 kl~Dfg~a~~~~---------~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          152 KLADFGLAKSFG---------SPNRAYTHQVVTRWYRAPELLFGARM--YGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             EECCCGGGSTTT---------SCCCCCCCSCCCCTTCCHHHHTTCSC--CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEecccceecc---------CCcccCCcccccccccCchHhhCCCC--CCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999999765321         00111223457889999999976432  378999999999999999999999763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-36  Score=268.67  Aligned_cols=206  Identities=21%  Similarity=0.295  Sum_probs=167.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC--------CCCcccccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV--------HPNILPLLDHALT   94 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~--------H~ni~~~~~~~~~   94 (282)
                      +..++|++.+.||+|+||+||+|++..++..||||.+... ......+.+|+.+++.++        |+||+++++.+..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            3468999999999999999999999999999999988533 344567788999998885        7889999986653


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                      .     .......++|||++ ++++.+.+...  ....+++..++.++.||+.||.|||++.  ||+||||||+||+++.
T Consensus       113 ~-----~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~  182 (397)
T 1wak_A          113 S-----GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV  182 (397)
T ss_dssp             E-----ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred             c-----CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence            1     11346799999999 66777666532  2245899999999999999999999964  6899999999999987


Q ss_pred             CC-------------------------------------------------CceeecccCccchhhhccCchhhhhhHhh
Q psy16951        175 DN-------------------------------------------------NPLLMDLGSVAPAVVKVCGSAEAQNLQDV  205 (282)
Q Consensus       175 ~~-------------------------------------------------~~~~~df~~~~~~~~~~~~~~~~~~~~~~  205 (282)
                      ++                                                 .++++|||.+....            ...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~------------~~~  250 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH------------KHF  250 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT------------BCS
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc------------ccC
Confidence            75                                                 79999999765321            012


Q ss_pred             hhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       206 ~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ....+|..|+|||++.+..+   +.++|||||||++|||++|..||.+.
T Consensus       251 ~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          251 TEDIQTRQYRSLEVLIGSGY---NTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             CSCCSCGGGCCHHHHHTSCC---CTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccCCCCCcccCChhhcCCCC---CcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            23467889999999998776   88999999999999999999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-36  Score=257.66  Aligned_cols=210  Identities=17%  Similarity=0.190  Sum_probs=168.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||.||+|++..++..||+|.+......  ..+.+|+.+++.++|++++..+..+..        .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~--------~   76 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA--------E   76 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEE--------E
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccC--------C
Confidence            468999999999999999999999999999999988654332  357789999999999887776654322        3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCcee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~~  180 (282)
                      ....++++|++ +++|.+.+...   ...+++..++.++.|++.||.|||++   |++||||||+||++   +.++.+++
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             CCceEEEEEec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEE
Confidence            46789999999 99999988632   34589999999999999999999999   89999999999999   48899999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +|||.+.........  ............+|..|+|||++.+..+   +.++||||||+++|||++|+.||.+..
T Consensus       150 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          150 IDFGLAKKYRDARTH--QHIPYRENKNLTGTARYASINTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CCCTTCEECBCTTTC--CBCCCCCSCCCCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             eeCCCcccccccccc--cccccccccccccccccCChhhhcCCCC---CcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            999976532111000  0000011234467899999999988765   889999999999999999999998643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-36  Score=264.90  Aligned_cols=207  Identities=24%  Similarity=0.296  Sum_probs=162.7

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-----------hhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-----------EDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----------~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++.....           .....+.+|+++++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            46789999999999999999999854 89999998854322           1236788999999999999999999977


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ...    ........++|||++. ++|.+.+..   ....+++..+..++.|++.||.|||++   |++|+||||+||++
T Consensus        99 ~~~----~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           99 VHF----EEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL  167 (362)
T ss_dssp             EEC----CTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             Eec----cCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence            542    1133467999999996 678776652   334689999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +.++.++++|||.+...          ..........+|..|+|||++.+...  ++.++||||+|+++|+|++|+.||.
T Consensus       168 ~~~~~~kl~Dfg~~~~~----------~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          168 ADNNDITICDFNLARED----------TADANKTHYVTHRWYRAPELVMQFKG--FTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             CTTCCEEECCTTC-------------------------CGGGCCHHHHTTCTT--CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCCCEEEEecCccccc----------ccccccceecccceecCcHHhcCCCC--CCcHhHHHhHHHHHHHHHhCCCCCC
Confidence            99999999999976421          11112233457888999999976322  3889999999999999999999997


Q ss_pred             cc
Q psy16951        253 TV  254 (282)
Q Consensus       253 ~~  254 (282)
                      +.
T Consensus       236 ~~  237 (362)
T 3pg1_A          236 GS  237 (362)
T ss_dssp             CS
T ss_pred             CC
Confidence            63

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-36  Score=262.59  Aligned_cols=206  Identities=24%  Similarity=0.338  Sum_probs=169.3

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALT   94 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~   94 (282)
                      .+...-....++|++.+.||+|+||+||+|.+..++..||+|.+...   ....+.+|+++++.++ ||||+++++.+..
T Consensus        26 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             hhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            33444456689999999999999999999999999999999998633   3456789999999997 9999999986543


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                      .       .....++++|++.+++|.+.+.       .+++..+..++.|++.||.|||++   |++||||||+||+++.
T Consensus       103 ~-------~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~  165 (330)
T 3nsz_A          103 P-------VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDH  165 (330)
T ss_dssp             T-------TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred             C-------CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcC
Confidence            1       2467899999999999987652       388999999999999999999999   8999999999999997


Q ss_pred             CC-CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        175 DN-NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       175 ~~-~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++ .++++|||.+.....          ........+|..|+|||++.+...  ++.++||||+|+++|+|++|..||..
T Consensus       166 ~~~~~kl~Dfg~a~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          166 EHRKLRLIDWGLAEFYHP----------GQEYNVRVASRYFKGPELLVDYQM--YDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTTEEEECCCTTCEECCT----------TCCCCSCCSCGGGCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCEEEEEeCCCceEcCC----------CCccccccccccccChhhhcCCCc--CCchhhHHHHHHHHHHHHhCCCCccc
Confidence            77 799999998653211          011223457888999999976322  38899999999999999999999953

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.5e-37  Score=261.77  Aligned_cols=211  Identities=21%  Similarity=0.334  Sum_probs=162.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecC-CC--ceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-TK--KRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      ....+..++|++.+.||+|+||+||+|.+.. ++  ..||+|.+...   .......+.+|+++++.++||||+++++++
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            4467788999999999999999999998643 33  36899987543   234456788999999999999999999865


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ..          ...++++|++++++|.+.+...   ...+++..+..++.|++.||.|||++   |++|+||||+||++
T Consensus        91 ~~----------~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili  154 (291)
T 1u46_A           91 LT----------PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLL  154 (291)
T ss_dssp             CS----------SSCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             cc----------CCceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEE
Confidence            43          2378999999999999988753   23488999999999999999999999   89999999999999


Q ss_pred             ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCC
Q psy16951        173 ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPF  251 (282)
Q Consensus       173 ~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf  251 (282)
                      +.++.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|+|++ |..||
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~g~~p~  225 (291)
T 1u46_A          155 ATRDLVKIGDFGLMRALPQN------DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPW  225 (291)
T ss_dssp             EETTEEEECCCTTCEECCC-------CCEEEC-----CCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCCCCEEEcccccccccccc------ccchhhhccCCCCceeeCchhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999999999976532111      000011122345778999999987766   789999999999999999 99999


Q ss_pred             Ccc
Q psy16951        252 DTV  254 (282)
Q Consensus       252 ~~~  254 (282)
                      .+.
T Consensus       226 ~~~  228 (291)
T 1u46_A          226 IGL  228 (291)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-36  Score=258.82  Aligned_cols=211  Identities=17%  Similarity=0.191  Sum_probs=165.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ..++|++.+.||+|+||+||+|++..++..||||.+.....  ...+.+|+++++.++|++++..+..+..        .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~--------~   76 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA--------E   76 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE--------E
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC--------C
Confidence            35789999999999999999999999999999997644322  2346789999999999888777654332        3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCcee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~~  180 (282)
                      ....+++||++ +++|.+.+...   ...+++..++.++.|++.||.|||++   |++||||||+||++   +.++.+++
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEE
T ss_pred             CCceEEEEEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEE
Confidence            56789999999 99999987632   34589999999999999999999999   89999999999999   78899999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      +|||.+.........  ............+|..|+|||++.+..+   +.++||||+|+++|+|++|+.||.+...
T Consensus       150 ~Dfg~a~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 4hgt_A          150 IDFGLAKKYRDARTH--QHIPYRENKNLTGTARYASINTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             CCCTTCEECBCTTTC--CBCCCCCSCCCCSCGGGCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ecCccceeccCcccC--ccCCCCcccccCCCccccchHHhcCCCC---CchhHHHHHHHHHHHHhcCCCCCcccch
Confidence            999987532111000  0000011224467899999999988765   8899999999999999999999986433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-36  Score=257.61  Aligned_cols=205  Identities=21%  Similarity=0.335  Sum_probs=162.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .|++.+.||+|+||+||+|.+..++.   .||+|.+..... ...+.+.+|+.+++.++||||+++++++..        
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------   93 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP--------   93 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC--------
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec--------
Confidence            55667999999999999999765544   799998865433 345678899999999999999999986543        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....++++|++.+++|.+.+..   ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++|
T Consensus        94 ~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~D  167 (298)
T 3pls_A           94 PEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVAD  167 (298)
T ss_dssp             SSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECC
T ss_pred             CCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCc
Confidence            23445899999999999998853   235578899999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC-CCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK-SPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~-~pf~~  253 (282)
                      ||.+......     ............+|..|+|||.+.+..+   +.++||||+|+++|+|++|. +||..
T Consensus       168 fg~~~~~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~~~~~~  231 (298)
T 3pls_A          168 FGLARDILDR-----EYYSVQQHRHARLPVKWTALESLQTYRF---TTKSDVWSFGVLLWELLTRGAPPYRH  231 (298)
T ss_dssp             TTSSCTTTTG-----GGGCSCCSSCTTCGGGGSCHHHHTTCCC---CHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             CCCcccccCC-----cccccccCcCCCCCccccChhhhccCCC---ChhhchhhHHHHHHHHhhCCCCCCcc
Confidence            9986532110     0001111223345778999999987765   78999999999999999965 55543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=260.76  Aligned_cols=217  Identities=21%  Similarity=0.298  Sum_probs=169.7

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~   98 (282)
                      ......++|++.+.||+|+||.||+|++..++..||||.+.... .....+.+|+..++.+ +||||+++++.+..... 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-   95 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP-   95 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC-
Confidence            34446789999999999999999999999999999999886543 3445678899999998 79999999997765210 


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                        .......++|+|++.+++|.+++...  ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.+
T Consensus        96 --~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           96 --PGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ---CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             --ccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence              11246799999999999999988753  234588999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+....         ..........+|..|+|||++.+..  ...++.++||||||+++|+|++|..||.+.
T Consensus       169 kl~Dfg~~~~~~---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          169 KLVDFGVSAQLD---------RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             EECCCTTTC----------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EEeeCcCceecC---------cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            999999764221         1111122345788999999997321  112378999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.3e-37  Score=266.03  Aligned_cols=203  Identities=23%  Similarity=0.386  Sum_probs=166.2

Q ss_pred             cccEEEE-EEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCC
Q psy16951         25 SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~  100 (282)
                      .++|.+. +.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.+. ||||+++++.+        
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--------   98 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY--------   98 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE--------
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE--------
Confidence            4567777 8899999999999999999999999988643  2334667889999999994 69999999854        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCC
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNN  177 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~  177 (282)
                       ......++|+||+.+++|.+.+...  ....+++..++.++.|++.||.|||++   |++||||||+||+++.   ++.
T Consensus        99 -~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           99 -ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             -ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred             -EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence             3457899999999999998876421  235689999999999999999999999   8999999999999987   789


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++++|||.+....          .........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       173 ~kL~Dfg~a~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          173 IKIVDFGMSRKIG----------HACELREIMGTPEYLAPEILNYDPI---TTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             EEECCGGGCEEC-------------------CCCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeeCccccccC----------CccccccccCCcCccCCeeecCCCC---CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999765321          1111223467899999999987765   88999999999999999999999753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=264.16  Aligned_cols=219  Identities=21%  Similarity=0.298  Sum_probs=160.8

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHH--HHHHhhhCCCCCcccccccccccC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIR--EVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~--e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ....+..++|++.+.||+|+||.||+|++  ++..||||.+....   ...+..  |+..+..++||||+++++.+... 
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERV-   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccc-
Confidence            34567889999999999999999999987  78899999986432   233333  44445568999999998754432 


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCCccccCCCCCc
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA-------KPIAYAHRDLKTAN  169 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-------~~~~i~H~dlk~~n  169 (282)
                         .......+++||||+++++|.+++..     ...++..++.++.|++.||.|||++       +. |++||||||+|
T Consensus        80 ---~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~-~ivH~Dikp~N  150 (336)
T 3g2f_A           80 ---TADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP-AISHRDLNSRN  150 (336)
T ss_dssp             ---CTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBC-CEECSSCSGGG
T ss_pred             ---ccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhcccccccc-ceeecccccce
Confidence               23345678999999999999998853     2357888999999999999999987       22 58899999999


Q ss_pred             EEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc----cCCCCccchhhHHHHHHHHH
Q psy16951        170 VLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY----CVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       170 il~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~----~~~~~~~Diws~G~il~el~  245 (282)
                      |+++.++.+|++|||++........... ...........||+.|+|||++.+...    ..++.++||||||+++|||+
T Consensus       151 ill~~~~~~kL~DFG~a~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          151 VLVKNDGTCVISDFGLSMRLTGNRLVRP-GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCC----------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCcEEEeeccceeecccccccCc-cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            9999999999999998753211100000 011112234468999999999976311    11256899999999999999


Q ss_pred             hCCCCCCc
Q psy16951        246 YFKSPFDT  253 (282)
Q Consensus       246 tg~~pf~~  253 (282)
                      +|..||..
T Consensus       230 ~g~~p~~~  237 (336)
T 3g2f_A          230 MRCTDLFP  237 (336)
T ss_dssp             TTBGGGST
T ss_pred             hcCCcCCC
Confidence            99866643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.7e-37  Score=258.27  Aligned_cols=207  Identities=24%  Similarity=0.343  Sum_probs=168.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC-----
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP-----   99 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~-----   99 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....    ..+.+|+++++.++||||+++++.+......+     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            468999999999999999999999999999999986543    24567999999999999999988654310000     


Q ss_pred             --CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951        100 --VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus       100 --~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                        ........+++|||+++++|.+++...  ....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence              112345689999999999999988754  234588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      ++++|||.+......          .......+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||..
T Consensus       161 ~kl~Dfg~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          161 VKIGDFGLVTSLKND----------GKRTRSKGTLRYMSPEQISSQDY---GKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             EEECCCTTCEESSCC----------SCCCCCCSCCTTSCHHHHHCSCC---CTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             EEECcchhheecccc----------ccccccCCcccccChhhhccCCC---cchhhhHHHHHHHHHHHhcCCcchh
Confidence            999999976532110          11123457889999999987765   8899999999999999999988853

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.5e-37  Score=260.16  Aligned_cols=212  Identities=23%  Similarity=0.279  Sum_probs=169.2

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      .+....++|.....||+|+||.||+|.+..++..||||.+..........+.+|+.+++.++||||+++++.+..     
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   90 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----   90 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----
Confidence            344445555555589999999999999999999999999987766667788999999999999999999985543     


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-CCCc
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-DNNP  178 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~  178 (282)
                          ....++++|++++++|.+.+.... ....+++..+..++.|++.||.|||++   |++|+||||+||+++. ++.+
T Consensus        91 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~  162 (295)
T 2clq_A           91 ----NGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVL  162 (295)
T ss_dssp             ----TTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCE
T ss_pred             ----CCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCE
Confidence                468999999999999999886431 223456888899999999999999999   8999999999999988 8999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +++|||.+.....         .........+|..|+|||++.+... .++.++||||||+++|+|++|+.||...
T Consensus       163 kl~Dfg~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (295)
T 2clq_A          163 KISDFGTSKRLAG---------INPCTETFTGTLQYMAPEIIDKGPR-GYGKAADIWSLGCTIIEMATGKPPFYEL  228 (295)
T ss_dssp             EECCTTTCEESCC--------------CCCCCCGGGCCHHHHHHGGG-GCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred             EEeecccccccCC---------CCCcccccCCCccccChhhhcCCCC-CCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence            9999997653210         0111223457889999999976531 1378999999999999999999999753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.7e-37  Score=263.40  Aligned_cols=216  Identities=23%  Similarity=0.346  Sum_probs=169.4

Q ss_pred             cccccccEEEecccEEEEEEeccCCceEEEEEEe----cCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccc
Q psy16951         14 CLCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEH----SQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        14 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      .....+.-.+..+.|++++.||+|+||+||++.+    ..++..||||.+..... .....+.+|+++++.++||||+++
T Consensus        19 ~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           19 FQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             -----CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            3444444556666679999999999999988754    45789999999875543 445678899999999999999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      ++++...       +...+++|||++++++|.+.+.     ...+++..++.++.|++.||.|||++   |++|+||||+
T Consensus        99 ~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~  163 (318)
T 3lxp_A           99 KGCCEDA-------GAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAAR  163 (318)
T ss_dssp             EEEEEET-------TTTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             EEEEecC-------CCceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchh
Confidence            9866542       2467899999999999998774     23489999999999999999999999   8999999999


Q ss_pred             cEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        169 NVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      ||+++.++.++++|||.+......      ...........+|..|+|||++.+..+   +.++||||+|+++|+|++|.
T Consensus       164 Nil~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~ll~g~  234 (318)
T 3lxp_A          164 NVLLDNDRLVKIGDFGLAKAVPEG------HEYYRVREDGDSPVFWYAPECLKEYKF---YYASDVWSFGVTLYELLTHC  234 (318)
T ss_dssp             GEEECTTCCEEECCGGGCEECCTT------CSEEEC---CCCCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEEcCCCCEEECCcccccccccc------ccccccccCCCCCceeeChHHhcCCCC---CcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999976532110      000011223346778999999988766   78999999999999999999


Q ss_pred             CCCCc
Q psy16951        249 SPFDT  253 (282)
Q Consensus       249 ~pf~~  253 (282)
                      .||..
T Consensus       235 ~p~~~  239 (318)
T 3lxp_A          235 DSSQS  239 (318)
T ss_dssp             CGGGS
T ss_pred             Ccccc
Confidence            99975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-36  Score=269.35  Aligned_cols=207  Identities=24%  Similarity=0.341  Sum_probs=162.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ...+|++.+.||+|+||+||+|++..++. ||+|++.....    ...+|+++++.++||||+++++++....   ....
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~---~~~~  109 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNG---DKKD  109 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEES---SSSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecC---CCCC
Confidence            45689999999999999999999977665 88888753322    2236899999999999999998776531   1123


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee-cCCCceeec
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA-NDNNPLLMD  182 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~~~~~~~d  182 (282)
                      ...+++||||+++ ++...+.........+++..+..++.|++.||.|||++   ||+||||||+||+++ .++.+|++|
T Consensus       110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEee
Confidence            4568899999965 44444443333456789999999999999999999999   899999999999999 789999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++.....          ........+|+.|+|||++.+...  ++.++||||+||++|||++|+.||.+.
T Consensus       186 FG~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          186 FGSAKILIA----------GEPNVSYICSRYYRAPELIFGATN--YTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             CTTCEECCT----------TCCCCSSCSCGGGCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcccccC----------CCCCcccccCcCccCHHHHcCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998653210          111224467888999999976542  388999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-36  Score=265.30  Aligned_cols=218  Identities=25%  Similarity=0.329  Sum_probs=160.3

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ........++|++.+.||+|+||+||+|.+..++..||||++.... .......++++.++.++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3334456789999999999999999999999999999999885432 223345677888888999999999997764211


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCccccCCCCCcEEeec-
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH--DAKPIAYAHRDLKTANVLLAN-  174 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~~~~i~H~dlk~~nil~~~-  174 (282)
                        ........++||||+.+ ++...+.........+++..+..++.|++.||.|+|  ++   |++||||||+||+++. 
T Consensus        94 --~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           94 --RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             --SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             --ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence              11223458899999965 665555544445566889999999999999999999  77   8999999999999997 


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.++++|||.+.....          ........+|..|+|||++.+...  ++.++||||+|+++|+|++|+.||.+.
T Consensus       168 ~~~~kl~Dfg~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSP----------SEPNVAYICSRYYRAPELIFGNQH--YTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             TTEEEECCCTTCBCCCT----------TSCCCSTTSCGGGCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcEEEeeCCCceecCC----------CCCcccccCCcceeCHHHHcCCCC--CCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            89999999998653211          011123457888999999976542  388999999999999999999999763

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-37  Score=263.43  Aligned_cols=230  Identities=20%  Similarity=0.309  Sum_probs=173.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC----chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG----REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....    ......+.+|+.+++.++||||+++++.+..      
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   77 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN------   77 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC------
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc------
Confidence            478999999999999999999999999999999885432    2345678899999999999999999986532      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       ......++|+|++.++ +.+.+...  ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++.+++
T Consensus        78 -~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           78 -EEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             -C---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             -CCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEe
Confidence             2346789999999766 66666532  345689999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||.+......       ..........+|..|+|||++.+... ..+.++||||+|+++|+|++|..||.+...  ..
T Consensus       151 ~dfg~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~  220 (305)
T 2wtk_C          151 SALGVAEALHPF-------AADDTCRTSQGSPAFQPPEIANGLDT-FSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YK  220 (305)
T ss_dssp             CCCTTCEECCTT-------CSSCEECCCCSCGGGCCHHHHTCCSC-EESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred             eccccccccCcc-------ccccccccCCCCCCCcChhhccCccc-CCcchhhHHHHHHHHHHHHhCCCCCCCchH--HH
Confidence            999976532110       00011123457889999999976432 125689999999999999999999975321  22


Q ss_pred             eeeeeeeccccCCCCCC
Q psy16951        261 VALAVISGNITFPENTP  277 (282)
Q Consensus       261 ~~~~~~~~~~~~p~~~~  277 (282)
                      ....+..+.+.+|.+.+
T Consensus       221 ~~~~i~~~~~~~~~~~~  237 (305)
T 2wtk_C          221 LFENIGKGSYAIPGDCG  237 (305)
T ss_dssp             HHHHHHHCCCCCCSSSC
T ss_pred             HHHHHhcCCCCCCCccC
Confidence            22233344455554443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-36  Score=284.76  Aligned_cols=209  Identities=19%  Similarity=0.319  Sum_probs=168.9

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      ..+.+..++|++.+.||+|+||.||+|.+..+   +..||||.+.... ....+.+.+|+.+++.++||||+++++++. 
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            45667788999999999999999999998643   4679999876443 334567889999999999999999998542 


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                               ....++||||+++++|.+++...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.
T Consensus       462 ---------~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~  526 (656)
T 2j0j_A          462 ---------ENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS  526 (656)
T ss_dssp             ---------SSSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE
T ss_pred             ---------cCceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeC
Confidence                     24578999999999999988642   33588999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++.+|++|||++....        ...........+|+.|+|||++.+..+   +.++||||||+++|||++ |..||.+
T Consensus       527 ~~~vkL~DFG~a~~~~--------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          527 NDCVKLGDFGLSRYME--------DSTYYKASKGKLPIKWMAPESINFRRF---TSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             TTEEEECCCCCCCSCC--------C----------CCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCEEEEecCCCeecC--------CCcceeccCCCCCcceeCHHHhcCCCC---CchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999865321        001111122345678999999987765   889999999999999997 9999976


Q ss_pred             c
Q psy16951        254 V  254 (282)
Q Consensus       254 ~  254 (282)
                      .
T Consensus       596 ~  596 (656)
T 2j0j_A          596 V  596 (656)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-37  Score=266.85  Aligned_cols=215  Identities=15%  Similarity=0.210  Sum_probs=166.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCC--------CceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCccccccccccc-
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQT--------KKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTG-   95 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~-   95 (282)
                      .++|++.+.||+|+||.||+|++..+        +..||+|.+...     ..+.+|+++++.++||||+++++..... 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            58999999999999999999999874        789999988543     3577899999999999999865432210 


Q ss_pred             ------CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         96 ------CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        96 ------~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                            ............++||||+ +++|.+++...  ....+++..++.++.|++.||.|||++   |++||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  0000112357899999999 99999988743  134589999999999999999999999   89999999999


Q ss_pred             EEeecCC--CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC
Q psy16951        170 VLLANDN--NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       170 il~~~~~--~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg  247 (282)
                      |+++.++  .++++|||++...........  ..........||+.|+|||++.+..+   +.++||||||+++|||++|
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVA--YVEGSRSPHEGDLEFISMDLHKGCGP---SRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCC--CCTTSSCTTCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHS
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCcccc--ccccccccccCCccccCHHHHccCCC---CchhhHHHHHHHHHHHHhC
Confidence            9999988  899999998753321110000  00011123468899999999988765   8899999999999999999


Q ss_pred             CCCCCccc
Q psy16951        248 KSPFDTVY  255 (282)
Q Consensus       248 ~~pf~~~~  255 (282)
                      +.||....
T Consensus       265 ~~pf~~~~  272 (352)
T 2jii_A          265 FLPWTNCL  272 (352)
T ss_dssp             CCTTGGGT
T ss_pred             CCCcccCC
Confidence            99998643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.8e-36  Score=259.48  Aligned_cols=209  Identities=24%  Similarity=0.374  Sum_probs=166.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEec-CCCceEEEEEeccCCch--hHHHHHHHHHHhhhC---CCCCcccccccccccC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHS-QTKKRYALKKIICHGRE--DQAQAIREVEHHKTF---VHPNILPLLDHALTGC   96 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~   96 (282)
                      ...++|++.+.||+|+||.||+|++. .++..||+|.+......  ....+.+|+.+++.+   +||||+++++++... 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~-   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS-   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE-
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec-
Confidence            45689999999999999999999995 67889999988643221  122445666666555   899999999866521 


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                         ........++|+|++. ++|.+.+...  ....+++..+..++.|++.||.|||++   |++|+||||+||+++.++
T Consensus        87 ---~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~  157 (326)
T 1blx_A           87 ---RTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG  157 (326)
T ss_dssp             ---ECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             ---ccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCC
Confidence               1224577999999997 6998887643  233488999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .++++|||.+....          .........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       158 ~~kl~Dfg~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          158 QIKLADFGLARIYS----------FQMALTSVVVTLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             CEEECSCCSCCCCC----------GGGGGCCCCCCCTTCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CEEEecCccccccc----------CCCCccccccccceeCHHHHhcCCC---CcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999765321          0112234567889999999987765   88999999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-35  Score=253.71  Aligned_cols=216  Identities=20%  Similarity=0.331  Sum_probs=162.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCC----CCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA----DPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~----~~~  100 (282)
                      .++|++.+.||+|+||.||+|++..++..||||.+... ......+.+|+.+++.++||||+++++.+.....    ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46899999999999999999999999999999988532 3445677899999999999999999987654211    002


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .......++|+|++++++|.+.+...   ...+++..++.++.|++.||.|||++   |++|+||||+||+++.++.+++
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence            23457899999999999999988642   33467888999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCch-----hhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        181 MDLGSVAPAVVKVCGSA-----EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~-----~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      +|||.+...........     ............+|..|+|||++.+...  ++.++||||+|+++|+|++   ||.
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~---p~~  229 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH--YNEKIDMYSLGIIFFEMIY---PFS  229 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSC--CCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCC--CcchhhHHHHHHHHHHHHh---ccC
Confidence            99997653211100000     0000112234457889999999976532  3889999999999999998   664

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-36  Score=264.95  Aligned_cols=202  Identities=23%  Similarity=0.370  Sum_probs=167.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-----------------HHHHHHHHHHhhhCCCCCc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-----------------QAQAIREVEHHKTFVHPNI   85 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------------~~~~~~e~~~l~~l~H~ni   85 (282)
                      +..++|++.+.||+|+||.||+|.+  ++..||+|.+.......                 ...+.+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            3467999999999999999999999  89999999885332111                 1678899999999999999


Q ss_pred             ccccccccccCCCCCCCCCceEEEEeccCCCCChHHH------HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCC
Q psy16951         86 LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLAND------LELRSVGKHYMSSVDILKMFLKICEAVKVFHD-AKPI  158 (282)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~~~  158 (282)
                      +++++.+.         .....++||||+++++|.++      +..  .....+++..++.++.|++.||.|||+ +   
T Consensus       106 ~~~~~~~~---------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---  171 (348)
T 2pml_X          106 LTCEGIIT---------NYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---  171 (348)
T ss_dssp             CCCSEEEE---------SSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---
T ss_pred             ceEEEEEe---------eCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---
Confidence            99998544         34789999999999999886      321  114568999999999999999999998 7   


Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-cccCCCC-ccchhh
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQ-RTDVWS  236 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-~~~~~~~-~~Diws  236 (282)
                      |++|+||+|+||+++.++.++++|||.+.....           .......+|..|+|||++.+. .+   +. ++||||
T Consensus       172 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~---~~~~~Di~s  237 (348)
T 2pml_X          172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-----------KKIKGSRGTYEFMPPEFFSNESSY---NGAKVDIWS  237 (348)
T ss_dssp             CEECCCCCGGGEEECTTSCEEECCCTTCEECBT-----------TEECSSCSCGGGCCGGGGSSCCCE---EHHHHHHHH
T ss_pred             CEeecCCChHhEEEcCCCcEEEecccccccccc-----------ccccCCCCCcCccCchhhcCCCCC---CcchhhHHH
Confidence            899999999999999999999999997653210           012334578899999999876 44   44 899999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q psy16951        237 LGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~  254 (282)
                      +|+++|||++|..||...
T Consensus       238 lG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          238 LGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             HHHHHHHHHHSSCSSCCS
T ss_pred             HHHHHHHHHhCCCCCCCC
Confidence            999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=258.98  Aligned_cols=204  Identities=24%  Similarity=0.347  Sum_probs=164.4

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|.+.+.||+|+||.||+|.+..+|..||||.+....  ......+.+|+.+++.++||||+++++.+....   ..
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~   98 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS---SL   98 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS---SG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc---cc
Confidence            3578999999999999999999999999999999986432  233567789999999999999999998765421   01


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ......+++||++. ++|.+.+.      ..+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++++
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEEC
T ss_pred             ccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEe
Confidence            11234699999996 67776542      3489999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....            .......+|..|+|||++.+...  ++.++||||+|+++|+|++|..||.+.
T Consensus       169 Dfg~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          169 DFGLARHAD------------AEMTGYVVTRWYRAPEVILSWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             STTCTTC--------------------CCSBCCSCHHHHSCCSC--CCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             ecccccCCC------------CCccccccCcCcCCHHHHhCcCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999764221            11223467889999999976322  388999999999999999999999763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-35  Score=257.56  Aligned_cols=201  Identities=24%  Similarity=0.344  Sum_probs=165.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEe-cCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC------ccccccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEH-SQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN------ILPLLDHALTG   95 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n------i~~~~~~~~~~   95 (282)
                      +..++|++.+.||+|+||.||+|.+ ..++..||+|.+... ......+.+|+++++.++|++      ++++++.+.  
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~--   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE--
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc--
Confidence            4467999999999999999999998 568899999988533 344566788999988887665      777777443  


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-  174 (282)
                             .....++|||++ +++|.+.+...  ....+++..+..++.|++.||.|||++   |++||||||+||+++. 
T Consensus        88 -------~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           88 -------HHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS  154 (339)
T ss_dssp             -------ETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred             -------cCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence                   346899999999 89999888643  223578999999999999999999999   8999999999999987 


Q ss_pred             ------------------CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhh
Q psy16951        175 ------------------DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS  236 (282)
Q Consensus       175 ------------------~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws  236 (282)
                                        ++.++++|||.+....            .......+|..|+|||++.+..+   +.++||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~s  219 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD------------EHHSTLVSTRHYRAPEVILALGW---SQPCDVWS  219 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETT------------SCCCSSCSCGGGCCHHHHTTSCC---CTHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCc------------cccccccCCccccChHHhhCCCC---CcchhhHH
Confidence                              6679999999765311            11123467889999999988766   88999999


Q ss_pred             HHHHHHHHHhCCCCCCcc
Q psy16951        237 LGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       237 ~G~il~el~tg~~pf~~~  254 (282)
                      +|+++|||++|..||...
T Consensus       220 lG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          220 IGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             HHHHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHHhCCCCCCCC
Confidence            999999999999999754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=254.51  Aligned_cols=213  Identities=20%  Similarity=0.241  Sum_probs=155.4

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-HHH-HHHHHHHhhhCCCCCccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQ-AIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~-~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      .+...+.+..++|++++.||+|+||.||+|.+..++..||||.+....... ... +.++..+++.++||||+++++++.
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             ESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            455678888999999999999999999999999999999999986554332 223 344445678889999999998554


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .         ....++|||++ ++.+..... .  ....+++..+..++.|++.||.|||++.  |++|+||||+||+++
T Consensus        95 ~---------~~~~~lv~e~~-~~~~~~l~~-~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~  159 (318)
T 2dyl_A           95 T---------NTDVFIAMELM-GTCAEKLKK-R--MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLD  159 (318)
T ss_dssp             C---------SSEEEEEECCC-SEEHHHHHH-H--HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEEC
T ss_pred             c---------CCcEEEEEecc-CCcHHHHHH-H--hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEEC
Confidence            3         46899999999 444444333 2  2345899999999999999999999842  789999999999999


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--ccCCCCccchhhHHHHHHHHHhCCCCC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--YCVVDQRTDVWSLGCLLYAMCYFKSPF  251 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--~~~~~~~~Diws~G~il~el~tg~~pf  251 (282)
                      .++.++++|||.+....          .........+|+.|+|||++....  ...++.++||||+|+++|+|++|..||
T Consensus       160 ~~~~~kl~dfg~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          160 ERGQIKLCDFGISGRLV----------DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             TTSCEEECCCTTC------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCCEEEEECCCchhcc----------CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence            99999999999764221          011122345788999999995321  112378999999999999999999999


Q ss_pred             Cc
Q psy16951        252 DT  253 (282)
Q Consensus       252 ~~  253 (282)
                      ..
T Consensus       230 ~~  231 (318)
T 2dyl_A          230 KN  231 (318)
T ss_dssp             TT
T ss_pred             CC
Confidence            75

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-36  Score=253.12  Aligned_cols=200  Identities=29%  Similarity=0.461  Sum_probs=165.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+++++.++||||+++++.+.         
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------   91 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE---------   91 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE---------
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe---------
Confidence            468999999999999999999999999999999885432  345667889999999999999999998543         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---CCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---NNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~~  179 (282)
                      .....++++|++++++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+||+++.+   +.++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            357899999999999999877643    3589999999999999999999999   89999999999999764   4689


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+......          .......+|..|+|||++.+. +   +.++||||+|+++|+|++|..||.+.
T Consensus       165 L~Dfg~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~-~---~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          165 IIDFGLSTCFQQN----------TKMKDRIGTAYYIAPEVLRGT-Y---DEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             ECSTTGGGTBCCC----------SSCSCHHHHHTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCcceeecCC----------CccccccCcccccChHHhcCC-C---CCchhhHhHHHHHHHHHhCCCCCCCC
Confidence            9999975422100          001122346779999998764 3   78999999999999999999999763

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=254.98  Aligned_cols=206  Identities=23%  Similarity=0.385  Sum_probs=158.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhh--CCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--FVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~--l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|++  ++..||||.+...   ......+|.+++..  ++||||+++++.+...     ..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-----~~  105 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG-----TG  105 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-----CG
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC-----CC
Confidence            46899999999999999999998  4889999988532   23344455555544  4899999999876652     12


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCccccCCCCCcEEeecCC
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA------KPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~------~~~~i~H~dlk~~nil~~~~~  176 (282)
                      .....++||||+++++|.+++..     ..+++..++.++.|++.||.|||++      +. |++||||||+||+++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP-AIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-CEECSCCCGGGEEECTTS
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC-CEEecccchHHEEECCCC
Confidence            23679999999999999998853     2488999999999999999999986      22 689999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCc------cchhhHHHHHHHHHhC---
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQR------TDVWSLGCLLYAMCYF---  247 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~------~Diws~G~il~el~tg---  247 (282)
                      .+|++|||.+......     ............||+.|+|||++.+..+   ...      +||||||+++|||++|   
T Consensus       180 ~~kl~Dfg~a~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~DiwslG~il~el~tg~~~  251 (337)
T 3mdy_A          180 TCCIADLGLAVKFISD-----TNEVDIPPNTRVGTKRYMPPEVLDESLN---RNHFQSYIMADMYSFGLILWEVARRCVS  251 (337)
T ss_dssp             CEEECCCTTCEECC--------------CCSSCSCGGGCCHHHHTTCCC---TTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             CEEEEeCCCceeeccc-----cccccCCCCCCccCcceeChhhcccccC---CccccCccccchHHHHHHHHHHHhccCc
Confidence            9999999976432110     0001111224468899999999987654   333      8999999999999999   


Q ss_pred             -------CCCCCcc
Q psy16951        248 -------KSPFDTV  254 (282)
Q Consensus       248 -------~~pf~~~  254 (282)
                             +.||...
T Consensus       252 ~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          252 GGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTBCCCCCCTTTTT
T ss_pred             ccccccccccHhhh
Confidence                   6777643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-35  Score=258.41  Aligned_cols=207  Identities=23%  Similarity=0.348  Sum_probs=147.3

Q ss_pred             cEEEecccEEEEE-EeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         20 AVYVKSDKYYIVE-KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        20 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .-+.-.++|++.+ .||+|+||+||+|.+..++..||||.+...    .....+....++.+.||||+++++.+...   
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~---   94 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENM---   94 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE---
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhc---
Confidence            3344578899966 599999999999999999999999988532    11122223345677899999999866541   


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC---
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND---  175 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---  175 (282)
                        .......++||||+.+++|.+.+...  ....+++..++.++.|++.||.|||++   |++||||||+||+++.+   
T Consensus        95 --~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~  167 (336)
T 3fhr_A           95 --HHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKD  167 (336)
T ss_dssp             --ETTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTT
T ss_pred             --cCCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCC
Confidence              22346689999999999999988643  224589999999999999999999999   89999999999999764   


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.++++|||.+....           ........+|+.|+|||++.+..+   +.++||||+|+++|+|++|..||.+.
T Consensus       168 ~~~kl~Dfg~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          168 AVLKLTDFGFAKETT-----------QNALQTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CCEEECCCTTCEEC---------------------------------CHH---HHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceEEEeccccceecc-----------ccccccCCCCcCccChhhhCCCCC---CchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            458999999765221           111223456888999999977766   78999999999999999999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.7e-36  Score=261.84  Aligned_cols=208  Identities=22%  Similarity=0.261  Sum_probs=167.7

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-----------CCCccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-----------HPNILPLL   89 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-----------H~ni~~~~   89 (282)
                      -.+..++|++.+.||+|+||+||+|.+..++..||||.+.. .......+.+|+.+++.++           ||||++++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            34577899999999999999999999999999999998853 3344566778999888876           88999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      +.+...     .......++++|++ +++|.+.+...  ....+++..+..++.|++.||.|||++.  |++||||||+|
T Consensus        93 ~~~~~~-----~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~N  162 (373)
T 1q8y_A           93 DHFNHK-----GPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPEN  162 (373)
T ss_dssp             EEEEEE-----ETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGG
T ss_pred             HHhhcc-----CCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHH
Confidence            876542     11234789999999 99999988643  2344889999999999999999999963  68999999999


Q ss_pred             EEeecC------CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHH
Q psy16951        170 VLLAND------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       170 il~~~~------~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~e  243 (282)
                      |+++.+      +.++++|||.+.....            ......+|+.|+|||++.+..+   +.++||||||+++||
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~~t~~y~aPE~~~~~~~---~~~~Di~slG~il~e  227 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDE------------HYTNSIQTREYRSPEVLLGAPW---GCGADIWSTACLIFE  227 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTB------------CCCSCCSCGGGCCHHHHHTCCC---CTHHHHHHHHHHHHH
T ss_pred             eEEeccCCCcCcceEEEcccccccccCC------------CCCCCCCCccccCcHHHhCCCC---CchHhHHHHHHHHHH
Confidence            999543      3789999998653210            1123457889999999988766   889999999999999


Q ss_pred             HHhCCCCCCcc
Q psy16951        244 MCYFKSPFDTV  254 (282)
Q Consensus       244 l~tg~~pf~~~  254 (282)
                      |++|..||.+.
T Consensus       228 l~~g~~pf~~~  238 (373)
T 1q8y_A          228 LITGDFLFEPD  238 (373)
T ss_dssp             HHHSSCCC---
T ss_pred             HHhCCCCCCCC
Confidence            99999999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-35  Score=260.90  Aligned_cols=201  Identities=26%  Similarity=0.308  Sum_probs=162.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCC-----cccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPN-----ILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~n-----i~~~~~~~~~~~~~   98 (282)
                      .++|++.+.||+|+||+||+|.+..++..||||++... ......+.+|+.+++.++ |++     |+++.+.+.     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~-----  126 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM-----  126 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-----
Confidence            58999999999999999999999999999999988633 333456677888888774 554     777766443     


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee--cCC
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA--NDN  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~--~~~  176 (282)
                          .....++|||++. ++|.+.+...  ....+++..+..++.|++.||.|||.... ||+||||||+||++.  .++
T Consensus       127 ----~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          127 ----FRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             ----ETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTT-CEECCCCSGGGEEESSTTSC
T ss_pred             ----cCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCC-CEEcCCCCcccEEEecCCCC
Confidence                3478999999995 5999888643  22458899999999999999999995322 899999999999995  467


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+|++|||++....            .......+|+.|+|||++.+..+   +.++|||||||++|||++|+.||.+.
T Consensus       199 ~~kL~DFG~a~~~~------------~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          199 AIKIVDFGSSCQLG------------QRIYQYIQSRFYRSPEVLLGMPY---DLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEEECCCTTCEETT------------CCCCSSCSCGGGCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cEEEEeccCceecc------------cccccccCCccccChHHHcCCCC---CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            89999999865321            11223467888999999988766   89999999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-35  Score=269.14  Aligned_cols=211  Identities=18%  Similarity=0.206  Sum_probs=167.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ...++|++.+.||+|+||.||+|.+..++..||||.+......  ..+.+|+++++.++|.+.+..+..+..        
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~--------   73 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGV--------   73 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEE--------
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEe--------
Confidence            3468999999999999999999999999999999987544332  346789999999987655544433222        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe---ecCCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL---ANDNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~~  179 (282)
                      .....++||||+ +++|.+++...   ...+++..++.++.||+.||.|||++   ||+||||||+|||+   +.++.+|
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEE
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEE
Confidence            346789999999 99999988642   34689999999999999999999999   89999999999999   6889999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |+|||++.........  ............||..|+|||++.+..+   +.++||||||+++|||++|+.||.+..
T Consensus       147 L~DFGla~~~~~~~~~--~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          147 IIDFGLAKKYRDTSTH--QHIPYRENKNLTGTARYASVNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             ECCCTTCEECBCTTTC--CBCCCCCCCCCCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             EEeCCcceeccCCccc--cccccccccccCCCccccCHHHhcCCCC---ChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            9999987532111000  0000111224568999999999988776   889999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.2e-35  Score=256.24  Aligned_cols=200  Identities=23%  Similarity=0.331  Sum_probs=163.0

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCC-ceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC------cccccccccccC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTK-KRYALKKIICHGREDQAQAIREVEHHKTFVHPN------ILPLLDHALTGC   96 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n------i~~~~~~~~~~~   96 (282)
                      ..++|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+|+.+++.++|++      ++.+.+.     
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~-----   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW-----   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE-----
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee-----
Confidence            4689999999999999999999998777 68999988533 344566778999999888766      6666653     


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe----
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL----  172 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~----  172 (282)
                          +......++|||++ ++++.+.+...  ....+++..++.++.|++.||.|||++   |++||||||+||++    
T Consensus        91 ----~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           91 ----FNFHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSE  160 (355)
T ss_dssp             ----EEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCC
T ss_pred             ----eeeCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccc
Confidence                33356899999999 67777766542  224589999999999999999999999   89999999999999    


Q ss_pred             ---------------ecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhH
Q psy16951        173 ---------------ANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSL  237 (282)
Q Consensus       173 ---------------~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~  237 (282)
                                     +.++.++++|||.+....            .......||..|+|||++.+..+   +.++||||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~sl  225 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDH------------EHHTTIVATRHYRPPEVILELGW---AQPCDVWSI  225 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETT------------SCCCSSCSCGGGCCHHHHTTCCC---CTHHHHHHH
T ss_pred             ccccccccccccccccCCCcEEEeecCcccccc------------ccccCCcCCCcccCCeeeecCCC---CCccchHHH
Confidence                           667899999999765311            11123467889999999987766   889999999


Q ss_pred             HHHHHHHHhCCCCCCcc
Q psy16951        238 GCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       238 G~il~el~tg~~pf~~~  254 (282)
                      |+++|||++|..||.+.
T Consensus       226 G~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          226 GCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             HHHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHhCCCCCCCC
Confidence            99999999999999764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.5e-35  Score=251.61  Aligned_cols=214  Identities=27%  Similarity=0.376  Sum_probs=166.4

Q ss_pred             ccccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCC--CCCcccccc
Q psy16951         15 LCSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFV--HPNILPLLD   90 (282)
Q Consensus        15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~--H~ni~~~~~   90 (282)
                      ........+..++|++.+.||+|+||.||++.+. ++..||+|.+....  ......+.+|+++++.++  |+||+++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            3455667888999999999999999999999985 58899999986443  334567889999999997  599999998


Q ss_pred             cccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcE
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANV  170 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~ni  170 (282)
                      ++..         ....+++|| +.+++|.+.+..    ...+++..+..++.|++.||.|||++   |++|+||||+||
T Consensus        96 ~~~~---------~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  158 (313)
T 3cek_A           96 YEIT---------DQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANF  158 (313)
T ss_dssp             EEEC---------SSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             Eeec---------CCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccE
Confidence            5543         467999999 668899998863    34588999999999999999999999   899999999999


Q ss_pred             EeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc--------ccCCCCccchhhHHHHHH
Q psy16951        171 LLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS--------YCVVDQRTDVWSLGCLLY  242 (282)
Q Consensus       171 l~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~--------~~~~~~~~Diws~G~il~  242 (282)
                      +++ ++.++++|||.+.....       ...........+|+.|+|||++.+..        ...++.++||||||+++|
T Consensus       159 l~~-~~~~kL~Dfg~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          159 LIV-DGMLKLIDFGIANQMQP-------DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             EEE-TTEEEECCCSSSCC---------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             EEE-CCeEEEeeccccccccC-------ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence            996 58899999997653211       00011122345789999999997521        012377999999999999


Q ss_pred             HHHhCCCCCCcc
Q psy16951        243 AMCYFKSPFDTV  254 (282)
Q Consensus       243 el~tg~~pf~~~  254 (282)
                      +|++|..||...
T Consensus       231 el~~g~~pf~~~  242 (313)
T 3cek_A          231 YMTYGKTPFQQI  242 (313)
T ss_dssp             HHHHSSCTTTTC
T ss_pred             HHHhCCCchhhH
Confidence            999999999753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-35  Score=251.72  Aligned_cols=201  Identities=23%  Similarity=0.288  Sum_probs=162.8

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccC----CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH----GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      |...+.||+|+||.||+|.+  ++..||+|.+...    .......+.+|+.+++.++||||+++++++.         .
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------~  101 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS---------D  101 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC---------S
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe---------c
Confidence            33447899999999999997  6788999988543    2334567889999999999999999998543         3


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++++++|.+.+.... ....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.++++||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  177 (307)
T 2nru_A          102 GDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF  177 (307)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            467899999999999999886432 234588999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+......       ..........||+.|+|||++.+. +   +.++||||||+++|+|++|..||...
T Consensus       178 g~~~~~~~~-------~~~~~~~~~~g~~~y~aPE~~~~~-~---~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          178 GLARASEKF-------AQTVMTSRIVGTTAYMAPEALRGE-I---TPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             TTCEECCSC-------SSCEECSSCCSCGGGCCHHHHTTE-E---CTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             ccccccccc-------cccccccccCCCcCcCChHHhcCC-C---CccchhHHHHHHHHHHHHCCCCcccC
Confidence            976532100       000011234578899999998764 3   78999999999999999999999764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.1e-35  Score=249.82  Aligned_cols=177  Identities=15%  Similarity=0.155  Sum_probs=150.6

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      +..++|++.+.||+|+||.||+|++..++..||||.+.....   .....+.+|+..++.++||||+++++++.      
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~------  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH------  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE------
Confidence            445789999999999999999999999999999999865433   23467889999999999999999998554      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++||||+++++|.+++..     . ....++..++.|++.||.|||++   |++||||||+||+++.++.++
T Consensus       102 ---~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k  169 (286)
T 3uqc_A          102 ---TRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV  169 (286)
T ss_dssp             ---ETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred             ---ECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence               34679999999999999998741     1 45667889999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      +++++                             |++|       +   +.++||||||+++|||+||+.||.+...
T Consensus       170 l~~~~-----------------------------~~~~-------~---~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          170 LAYPA-----------------------------TMPD-------A---NPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             ECSCC-----------------------------CCTT-------C---CHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             EEecc-----------------------------ccCC-------C---CchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence            87543                             4443       2   7799999999999999999999986433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.6e-35  Score=254.27  Aligned_cols=207  Identities=22%  Similarity=0.296  Sum_probs=163.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhh--CCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT--FVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~--l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++.+.||+|+||.||+|.+  ++..||||.+..   .....+.+|.++++.  ++||||+++++.+...     ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~-----~~  110 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD-----NG  110 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC-----CS
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc-----CC
Confidence            47899999999999999999998  588999998853   344566788888876  7899999999866542     11


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCccccCCCCCcEEeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH--------DAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--------~~~~~~i~H~dlk~~nil~~~  174 (282)
                      .....++|+||+++++|.+++..     ..+++..++.++.|++.||.|||        ++   +++||||||+||+++.
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK  182 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence            12379999999999999998853     34889999999999999999999        66   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc---CCCCccchhhHHHHHHHHHhC----
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC---VVDQRTDVWSLGCLLYAMCYF----  247 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~---~~~~~~Diws~G~il~el~tg----  247 (282)
                      ++.++++|||.+.......     ...........+|+.|+|||++.+....   ..+.++||||||+++|||++|    
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSAT-----DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             TSCEEECCCTTCEEEETTT-----TEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             CCCEEEEECCCceeccccc-----cccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            9999999999765321100     0000012234678899999999765320   013589999999999999999    


Q ss_pred             ------CCCCCcc
Q psy16951        248 ------KSPFDTV  254 (282)
Q Consensus       248 ------~~pf~~~  254 (282)
                            ..||...
T Consensus       258 ~~~~~~~~p~~~~  270 (342)
T 1b6c_B          258 GIHEDYQLPYYDL  270 (342)
T ss_dssp             TBCCCCCCTTTTT
T ss_pred             CcccccccCcccc
Confidence                  7888754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.9e-36  Score=257.70  Aligned_cols=208  Identities=24%  Similarity=0.300  Sum_probs=166.5

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------hHHHHHHHHHHhhhCC--CCCcccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------DQAQAIREVEHHKTFV--HPNILPL   88 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~e~~~l~~l~--H~ni~~~   88 (282)
                      .........++|++.+.||+|+||.||+|.+..++..||||.+......      ....+.+|+.+++.++  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            3445556688999999999999999999999999999999998643221      2234567899999986  5999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCC-CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPK-GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKT  167 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~  167 (282)
                      ++++.         .....++++|++.+ ++|.+++...    ..+++..++.++.|++.||.|||++   |++||||||
T Consensus       114 ~~~~~---------~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp  177 (320)
T 3a99_A          114 LDWFE---------RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKD  177 (320)
T ss_dssp             EEEEE---------CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEe---------cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCH
Confidence            98544         45789999999975 8999888643    4588999999999999999999999   899999999


Q ss_pred             CcEEee-cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        168 ANVLLA-NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       168 ~nil~~-~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      +||+++ .++.+|++|||.+.....           .......+|..|+|||++.+..+  .+.++||||||+++|||++
T Consensus       178 ~NIll~~~~~~~kL~Dfg~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          178 ENILIDLNRGELKLIDFGSGALLKD-----------TVYTDFDGTRVYSPPEWIRYHRY--HGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             GGEEEETTTTEEEECCCTTCEECCS-----------SCBCCCCSCGGGSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHH
T ss_pred             HHEEEeCCCCCEEEeeCcccccccc-----------ccccCCCCCccCCChHHhccCCC--CCccchHHhHHHHHHHHHH
Confidence            999999 678999999997653210           01123457889999999977654  2568899999999999999


Q ss_pred             CCCCCCc
Q psy16951        247 FKSPFDT  253 (282)
Q Consensus       247 g~~pf~~  253 (282)
                      |+.||..
T Consensus       245 g~~pf~~  251 (320)
T 3a99_A          245 GDIPFEH  251 (320)
T ss_dssp             SSCSCCS
T ss_pred             CCCCCCC
Confidence            9999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-36  Score=256.02  Aligned_cols=204  Identities=25%  Similarity=0.318  Sum_probs=159.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------hHHHHHHHHHHhhhC----CCCCcccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------DQAQAIREVEHHKTF----VHPNILPLLD   90 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~e~~~l~~l----~H~ni~~~~~   90 (282)
                      .....++|++.+.||+|+||.||+|.+..++..||||.+......      ....+.+|+..++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344568899999999999999999999999999999998654332      222345688888888    8999999998


Q ss_pred             cccccCCCCCCCCCceEEEEecc-CCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         91 HALTGCADPVLNSTSQVLMVLPY-YPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      ++.         .....++++|+ +.+++|.+.+...    ..+++..++.++.|++.||.|||++   |++|+||||+|
T Consensus       106 ~~~---------~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  169 (312)
T 2iwi_A          106 WFE---------TQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDEN  169 (312)
T ss_dssp             EC--------------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGG
T ss_pred             EEe---------cCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhh
Confidence            543         34678899999 7899999988643    3589999999999999999999999   89999999999


Q ss_pred             EEee-cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCC
Q psy16951        170 VLLA-NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFK  248 (282)
Q Consensus       170 il~~-~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~  248 (282)
                      |+++ .++.++++|||.+.....           .......+|..|+|||++.+..+  .+.++||||+|+++|+|++|+
T Consensus       170 il~~~~~~~~kl~dfg~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~  236 (312)
T 2iwi_A          170 ILIDLRRGCAKLIDFGSGALLHD-----------EPYTDFDGTRVYSPPEWISRHQY--HALPATVWSLGILLYDMVCGD  236 (312)
T ss_dssp             EEEETTTTEEEECCCSSCEECCS-----------SCBCCCCSCTTTSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEeCCCCeEEEEEcchhhhccc-----------CcccccCCcccccCceeeecCCC--CCccchHHHHHHHHHHHHHCC
Confidence            9999 788999999997653211           11123457889999999987654  145899999999999999999


Q ss_pred             CCCCc
Q psy16951        249 SPFDT  253 (282)
Q Consensus       249 ~pf~~  253 (282)
                      .||..
T Consensus       237 ~pf~~  241 (312)
T 2iwi_A          237 IPFER  241 (312)
T ss_dssp             CSCCS
T ss_pred             CCCCC
Confidence            99975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-35  Score=261.21  Aligned_cols=211  Identities=19%  Similarity=0.287  Sum_probs=155.5

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCccccccccccc
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTG   95 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~   95 (282)
                      ....+.+...+|++.+.||+|+||+|+. ....++..||||++......   .+.+|+++++.+ +||||+++++.+.  
T Consensus        15 ~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~--   88 (432)
T 3p23_A           15 ETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEK--   88 (432)
T ss_dssp             ---CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEE--
T ss_pred             cCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEe--
Confidence            3455778888999999999999999754 33357889999998643322   345789999999 7999999998543  


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-  174 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-  174 (282)
                             +....++|||++. ++|.+.+...   .....+..+..++.|++.||.|||++   ||+||||||+||+++. 
T Consensus        89 -------~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~  154 (432)
T 3p23_A           89 -------DRQFQYIAIELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMP  154 (432)
T ss_dssp             -------ETTEEEEEEECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCC
T ss_pred             -------cCCEEEEEEECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecC
Confidence                   4578999999995 6998877632   22344556788999999999999999   8999999999999953 


Q ss_pred             --CC--CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCC
Q psy16951        175 --DN--NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKS  249 (282)
Q Consensus       175 --~~--~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~  249 (282)
                        ++  .++++|||++......      ...........||+.|+|||++.+......+.++||||+||++|||++ |..
T Consensus       155 ~~~~~~~~kL~DFG~a~~~~~~------~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~  228 (432)
T 3p23_A          155 NAHGKIKAMISDFGLCKKLAVG------RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH  228 (432)
T ss_dssp             BTTTBCCEEECCTTEEECC------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred             CCCCceeEEEecccceeeccCC------CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence              23  4679999986532111      011112234568999999999975433234779999999999999999 899


Q ss_pred             CCCc
Q psy16951        250 PFDT  253 (282)
Q Consensus       250 pf~~  253 (282)
                      ||..
T Consensus       229 pf~~  232 (432)
T 3p23_A          229 PFGK  232 (432)
T ss_dssp             TTBS
T ss_pred             Ccch
Confidence            9964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-35  Score=273.43  Aligned_cols=209  Identities=23%  Similarity=0.316  Sum_probs=168.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++.+.||+|+||.||+|.+..++..||||.+... .......+.+|+++++.++||||+++++++....   ....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~---~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ---KLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC---CCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc---cccC
Confidence            47899999999999999999999999999999987643 3344567889999999999999999988653310   1223


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC---cee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN---PLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~~~  180 (282)
                      ....++||||+++++|.+++.... ....+++..++.++.|++.||.|||++   |++|+||||+||+++.++.   +++
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence            567899999999999999886421 122578889999999999999999998   8999999999999997765   789


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||.+.....          ........+|..|+|||++.+..+   +.++||||+|+++|+|++|..||.+
T Consensus       166 ~DFG~a~~~~~----------~~~~~~~~gt~~Y~APE~l~~~~~---s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          166 IDLGYAKELDQ----------GELCTEFVGTLQYLAPELLEQKKY---TVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CSCCCCCBTTS----------CCCCCCCCSCCTTCSSCSSCCSCC---STTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccccc----------ccccccccCCcccCChHHhccCCC---CchhHHHHHHHHHHHHHHCCCCCCc
Confidence            99997653211          011123467899999999987766   8899999999999999999999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-34  Score=272.54  Aligned_cols=200  Identities=21%  Similarity=0.324  Sum_probs=163.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecC-CCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQ-TKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      +..++|++.+.||+|+||+||+|.+.. ++..||||.+..... .....+.+|+++++.++||||+++++++....    
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----  152 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD----  152 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC----
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC----
Confidence            446899999999999999999999976 789999998864433 44557789999999999999999999766531    


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      .......++||||+++++|.+.+.      ..+++.+++.++.||+.||.|+|++   ||+||||||+||+++.+ .+|+
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence            112233799999999999987653      2589999999999999999999999   89999999999999875 8999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||++....             ......||+.|+|||++.+..    +.++||||||+++|+|++|..||.+
T Consensus       223 ~DFG~a~~~~-------------~~~~~~gt~~y~aPE~~~~~~----~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          223 IDLGAVSRIN-------------SFGYLYGTPGFQAPEIVRTGP----TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CCCTTCEETT-------------CCSCCCCCTTTSCTTHHHHCS----CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             Eecccchhcc-------------cCCccCCCccccCHHHHcCCC----CCceehhhhHHHHHHHHhCCCCCcc
Confidence            9999765321             013446899999999987643    6799999999999999999998875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.8e-36  Score=261.75  Aligned_cols=203  Identities=20%  Similarity=0.204  Sum_probs=157.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------hhHHHHHHHHHHhhhCC---------CCCc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------EDQAQAIREVEHHKTFV---------HPNI   85 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------~~~~~~~~e~~~l~~l~---------H~ni   85 (282)
                      +..++|++.+.||+|+||+||+|++  ++..||||++.....        .....+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4568899999999999999999998  789999999975432        23366788888888775         5555


Q ss_pred             cc-----------------ccccccccC----CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHH
Q psy16951         86 LP-----------------LLDHALTGC----ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK  144 (282)
Q Consensus        86 ~~-----------------~~~~~~~~~----~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~q  144 (282)
                      ++                 +++.+....    ..+.......+++||||+++|++.+.+.     ...+++..++.++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQ  169 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHH
Confidence            54                 444333200    0001123578999999999997766552     245799999999999


Q ss_pred             HHHHHHHhh-cCCCCCccccCCCCCcEEeecCC--------------------CceeecccCccchhhhccCchhhhhhH
Q psy16951        145 ICEAVKVFH-DAKPIAYAHRDLKTANVLLANDN--------------------NPLLMDLGSVAPAVVKVCGSAEAQNLQ  203 (282)
Q Consensus       145 i~~~l~~lH-~~~~~~i~H~dlk~~nil~~~~~--------------------~~~~~df~~~~~~~~~~~~~~~~~~~~  203 (282)
                      |+.||.||| ++   ||+||||||+|||++.++                    .+|++|||++....             
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------  233 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------  233 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE-------------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC-------------
Confidence            999999999 88   899999999999999887                    89999999875321             


Q ss_pred             hhhhccCCCCccCCcccccCcccCCCCccchhhHHHH-HHHHHhCCCCCCc
Q psy16951        204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCL-LYAMCYFKSPFDT  253 (282)
Q Consensus       204 ~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~i-l~el~tg~~pf~~  253 (282)
                       .....||+.|+|||++.+..    +.++||||++++ .+++++|..||.+
T Consensus       234 -~~~~~gt~~y~aPE~~~g~~----~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          234 -DGIVVFCDVSMDEDLFTGDG----DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             -TTEEECCCCTTCSGGGCCCS----SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             -CCcEEEeecccChhhhcCCC----ccceehhhhhCCCCcccccccCCCcc
Confidence             11347899999999998654    679999998877 6778889999964

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=257.36  Aligned_cols=216  Identities=19%  Similarity=0.226  Sum_probs=165.9

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      .....+.+..++|++.+.||+|+||.||+|.+..   .||+|.+.....  .....+.+|+.+++.++||||+++++.+.
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            4446778889999999999999999999999854   489998864322  22345678999999999999999998554


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA  173 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~  173 (282)
                      .         ....++++|++.+++|.+.+..   ....+++..++.++.|++.||.|||++   |++|+||||+||+++
T Consensus       100 ~---------~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~  164 (319)
T 2y4i_B          100 S---------PPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD  164 (319)
T ss_dssp             C---------SSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC
T ss_pred             c---------CCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe
Confidence            3         4679999999999999987752   233588999999999999999999999   899999999999998


Q ss_pred             cCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc------cCCCCccchhhHHHHHHHHHhC
Q psy16951        174 NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY------CVVDQRTDVWSLGCLLYAMCYF  247 (282)
Q Consensus       174 ~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~------~~~~~~~Diws~G~il~el~tg  247 (282)
                       ++.++++|||.+.......    ............||..|+|||++.+...      ..++.++||||||+++|||++|
T Consensus       165 -~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g  239 (319)
T 2y4i_B          165 -NGKVVITDFGLFSISGVLQ----AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR  239 (319)
T ss_dssp             ---CCEECCCSCCC--------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             -CCCEEEeecCCcccccccc----ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence             7899999999764321100    0000111122346788999999975321      1237789999999999999999


Q ss_pred             CCCCCcc
Q psy16951        248 KSPFDTV  254 (282)
Q Consensus       248 ~~pf~~~  254 (282)
                      ..||.+.
T Consensus       240 ~~p~~~~  246 (319)
T 2y4i_B          240 EWPFKTQ  246 (319)
T ss_dssp             SCSSSSC
T ss_pred             CCCCCCC
Confidence            9999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-34  Score=256.94  Aligned_cols=208  Identities=20%  Similarity=0.295  Sum_probs=148.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .+.|...+.||+|+||+||.+. ..+|..||||++...   ....+.+|+.+++.+ +||||+++++.+         ..
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~---------~~   80 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE---------TT   80 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE---------EC
T ss_pred             hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE---------ec
Confidence            3455667889999999998654 457899999988532   334567899999876 899999998844         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC-----
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKH---YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND-----  175 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-----  175 (282)
                      ....++|+|++. ++|.+.+........   ...+..++.++.|++.||.|||++   ||+||||||+||+++.+     
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~  156 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTA  156 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHS
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccc
Confidence            578999999995 699998864321111   112334577999999999999999   89999999999999754     


Q ss_pred             --------CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCc----ccCCCCccchhhHHHHHHH
Q psy16951        176 --------NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDS----YCVVDQRTDVWSLGCLLYA  243 (282)
Q Consensus       176 --------~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~----~~~~~~~~Diws~G~il~e  243 (282)
                              +.++++|||++......     ............||+.|+|||++.+..    ...++.++||||+||++||
T Consensus       157 ~~~~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e  231 (434)
T 2rio_A          157 DQQTGAENLRILISDFGLCKKLDSG-----QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY  231 (434)
T ss_dssp             CCTTCCCSCEEEECCCTTCEECCC-------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred             ccccCCCceEEEEcccccceecCCC-----CccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence                    47899999987532111     000011122346899999999997621    1124889999999999999


Q ss_pred             HHh-CCCCCCcc
Q psy16951        244 MCY-FKSPFDTV  254 (282)
Q Consensus       244 l~t-g~~pf~~~  254 (282)
                      |++ |..||.+.
T Consensus       232 llt~g~~Pf~~~  243 (434)
T 2rio_A          232 ILSKGKHPFGDK  243 (434)
T ss_dssp             HHTTSCCTTCST
T ss_pred             HHhCCCCCCCCc
Confidence            999 99999753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-33  Score=251.62  Aligned_cols=210  Identities=13%  Similarity=0.099  Sum_probs=152.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh---HHHHHHHHHHhhhCCC-CCccccccc---------
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED---QAQAIREVEHHKTFVH-PNILPLLDH---------   91 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~e~~~l~~l~H-~ni~~~~~~---------   91 (282)
                      ..+|.+.+.||+|+||+||+|.+..++..||||++.......   .+.+.+|+.+++.++| +|.......         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            446889999999999999999999999999999886443332   4578899999999987 333222111         


Q ss_pred             -ccccCCCC--CCC-----CCceEEEEeccCCCCChHHHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q psy16951         92 -ALTGCADP--VLN-----STSQVLMVLPYYPKGTLANDLELR---SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAY  160 (282)
Q Consensus        92 -~~~~~~~~--~~~-----~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i  160 (282)
                       ...+....  ...     ....++++++.+ +++|.+++...   ......+++..++.++.|++.||.|||++   ||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence             00000000  000     023466777765 78898877532   11233466778888999999999999999   89


Q ss_pred             cccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccc----------cCcccCCCC
Q psy16951        161 AHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFH----------VDSYCVVDQ  230 (282)
Q Consensus       161 ~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~----------~~~~~~~~~  230 (282)
                      +||||||+||+++.++.+|++|||++.....            ......| +.|+|||++.          +..+   +.
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~---~~  296 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM---TF  296 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE---CH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC------------ccccCCC-CceeCchhhhccccccccccCcCC---Cc
Confidence            9999999999999999999999997653210            1223345 8899999993          3333   77


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        231 RTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       231 ~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||||||++|||++|+.||.+.
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~  320 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999999764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.5e-33  Score=236.05  Aligned_cols=181  Identities=27%  Similarity=0.429  Sum_probs=149.8

Q ss_pred             cccEEEE-EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHh-hhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIV-EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHH-KTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l-~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|.+. +.||+|+||.||+|.+..++..||+|.+..     .....+|++.+ +..+||||+++++.+..     ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~-----~~~   85 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN-----LYA   85 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE-----EET
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhh-----hcC
Confidence            5678887 779999999999999999999999998853     23456788877 66689999999986654     123


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~  179 (282)
                      .....++||||+++++|.+.+...  ....+++..++.++.|++.||.|||++   |++||||||+||+++.   ++.++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEE
T ss_pred             CCceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEE
Confidence            357799999999999999988753  234589999999999999999999999   8999999999999998   78899


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||.+...                               .+..+   +.++||||+|+++|||++|..||.+.
T Consensus       161 l~Dfg~a~~~-------------------------------~~~~~---~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          161 LTDFGFAKET-------------------------------TGEKY---DKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             ECCCTTCEEC-------------------------------TTCGG---GGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             Eecccccccc-------------------------------ccccC---CchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            9999975321                               01123   67899999999999999999999754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.3e-31  Score=244.59  Aligned_cols=186  Identities=13%  Similarity=0.059  Sum_probs=126.1

Q ss_pred             EeccCCceEEEEEEecCCCceEEEEEeccCC----------chhHHHHHHHHHHhhhC-CCCCcccccccccccCCCCCC
Q psy16951         33 KIGEGGFSTVSLIEHSQTKKRYALKKIICHG----------REDQAQAIREVEHHKTF-VHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        33 ~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~----------~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ....|++|.+..++....|..||+|.+....          ....+++.+|+++|+++ .|+||+++++         .+
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~---------~~  311 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLA---------HG  311 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEE---------EE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEE---------EE
Confidence            4678888888888887889999999886442          12345688999999999 7999999998         45


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      ++...+||||||++|++|.+.+..    ...++..   .++.||+.||.|+|++   ||+||||||+|||++.++.+||+
T Consensus       312 ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~  381 (569)
T 4azs_A          312 ENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLI  381 (569)
T ss_dssp             ECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEEC
T ss_pred             EECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEe
Confidence            567899999999999999998863    3345554   4788999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCC
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP  250 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~p  250 (282)
                      |||+++....         .........||+.|+|||++.+..    ..++|+||+|++++++.++..+
T Consensus       382 DFGlAr~~~~---------~~~~~~t~vGTp~YmAPE~l~g~~----~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          382 DFGSIVTTPQ---------DCSWPTNLVQSFFVFVNELFAENK----SWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCTTEESCC------------CCSHHHHHHHHHHHHHHC---------------------CCCCTTHHH
T ss_pred             ecccCeeCCC---------CCccccCceechhhccHHHhCCCC----CCcccccccccchhhhccccch
Confidence            9998753211         111122345788999999998753    5689999999988776655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1e-26  Score=213.37  Aligned_cols=189  Identities=15%  Similarity=0.153  Sum_probs=136.7

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCch--------hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--------DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .+.||+|+||+||+|..  .+..+++|+.......        ..+.+.+|++++++++||||+++..++..        
T Consensus       341 ~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------  410 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--------  410 (540)
T ss_dssp             -------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--------
T ss_pred             CCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--------
Confidence            56899999999999955  5678899976443211        13457899999999999999955443332        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++||||+++++|.+.+..            +..++.|++.||.|||++   +|+||||||+||+++.  .+|++|
T Consensus       411 -~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          411 -LDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             -TTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             -CCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence             2346999999999999987642            568899999999999999   8999999999999988  999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCccccc--CcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHV--DSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~--~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      ||+++......  ..............||+.|+|||++..  ..|   +..+|+||..+-..+-..++.+|.
T Consensus       473 FGla~~~~~~~--~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y---~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          473 FGLGKISNLDE--DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGY---KSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CTTCEECCCHH--HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHH---HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccCEECCCcc--ccccchhhhhhhhcCCCCcCCHHHHHHHHHHH---HHHHhHHHHHHHHHHHHHhccccC
Confidence            99876431100  000000011234567999999999986  444   667899999998888888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.2e-24  Score=181.45  Aligned_cols=132  Identities=17%  Similarity=0.085  Sum_probs=105.3

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------------------hhHHHHHHHHHHhhhCCCCCcccc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------------------EDQAQAIREVEHHKTFVHPNILPL   88 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------------------~~~~~~~~e~~~l~~l~H~ni~~~   88 (282)
                      .|++.+.||+|+||.||+|.+ .++..||+|.+.....                  .....+.+|+++++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            344559999999999999999 8899999998854321                  13456789999999998  4 555


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCC
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTA  168 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~  168 (282)
                      .+.+-          ....++||||+++++|.+ +.          ......++.|++.||.|+|++   |++||||||+
T Consensus       167 ~~~~~----------~~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~  222 (282)
T 1zar_A          167 PKVYA----------WEGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQY  222 (282)
T ss_dssp             CCEEE----------EETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             CeEEe----------ccceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence            54221          145699999999999987 31          123457899999999999998   8999999999


Q ss_pred             cEEeecCCCceeecccCcc
Q psy16951        169 NVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       169 nil~~~~~~~~~~df~~~~  187 (282)
                      ||+++ ++.++++|||.+.
T Consensus       223 NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCE
T ss_pred             HEEEE-CCcEEEEECCCCe
Confidence            99999 9999999999764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2.2e-20  Score=155.85  Aligned_cols=139  Identities=16%  Similarity=0.160  Sum_probs=103.7

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCce--EEEEEeccCCch------------------------hHHHHHHHHHHhhhC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKR--YALKKIICHGRE------------------------DQAQAIREVEHHKTF   80 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~------------------------~~~~~~~e~~~l~~l   80 (282)
                      -|++.+.||+|+||.||+|.+..+|..  ||||.+......                        ....+.+|+..++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999999778888  999986433111                        123567899999999


Q ss_pred             CCCCcccccccccccCCCCCCCCCceEEEEeccCCC-C----ChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-c
Q psy16951         81 VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPK-G----TLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFH-D  154 (282)
Q Consensus        81 ~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~  154 (282)
                      .|+++.....+.           ....++||||+.+ |    +|.+...    .   .++..+..++.|++.||.|+| +
T Consensus       128 ~~~~i~~p~~~~-----------~~~~~lVmE~~g~~g~~~~~L~~~~~----~---~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          128 KEAGVSVPQPYT-----------YMKNVLLMEFIGEDELPAPTLVELGR----E---LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHTTCCCCCEEE-----------EETTEEEEECCEETTEECCBHHHHGG----G---GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCCeEEE-----------cCCCEEEEEecCCCCCccccHHHHhh----c---cChHHHHHHHHHHHHHHHHHHHH
Confidence            888652211110           1246899999942 4    5544321    1   234567889999999999999 8


Q ss_pred             CCCCCccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        155 AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       155 ~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      +   |++||||||+||+++.  .++++|||.+..
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            8   8999999999999987  899999998753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=4.1e-17  Score=142.24  Aligned_cols=143  Identities=13%  Similarity=0.205  Sum_probs=93.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--------------hhHHHHHHHHHHhhhCCCCCcccccccc
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--------------EDQAQAIREVEHHKTFVHPNILPLLDHA   92 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------------~~~~~~~~e~~~l~~l~H~ni~~~~~~~   92 (282)
                      -|++..+||+|++|.||+|.+ .+|.+||||.++....              ........++.+.....|+|+.+++...
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            388999999999999999998 4799999997643210              0111222222222222344444443322


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      +.. ..+.  .....++||||+.+++|....          ....+..++.|++.++.++|++   ||+||||||.|||+
T Consensus       175 v~v-p~p~--~~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl  238 (397)
T 4gyi_A          175 FPV-PEPI--AQSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILI  238 (397)
T ss_dssp             CSC-CCEE--EEETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             CCC-Ceee--eccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence            211 0000  012236999999888875421          1223456789999999999998   89999999999999


Q ss_pred             ecCCC----------ceeecccCc
Q psy16951        173 ANDNN----------PLLMDLGSV  186 (282)
Q Consensus       173 ~~~~~----------~~~~df~~~  186 (282)
                      ..++.          +.++||+-+
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTC
T ss_pred             eCCCCcccccccccceEEEEeCCc
Confidence            88773          789999843

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=2.6e-11  Score=100.79  Aligned_cols=142  Identities=14%  Similarity=0.158  Sum_probs=101.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      +.|++...++.|+.+.||++...  +..+++|............+.+|++.++.+. +..+.++++.+.         ..
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~---------~~   82 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER---------HD   82 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE---------ET
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe---------cC
Confidence            46888999999999999999863  5789999875422122335778888888884 566667766332         34


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK----------------------------  156 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----------------------------  156 (282)
                      ...+++||+++|.++.+.+         .+......++.+++.++..||+..                            
T Consensus        83 ~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             CceEEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            6789999999999887531         112233466778888899999710                            


Q ss_pred             ----------------------------CCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        157 ----------------------------PIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       157 ----------------------------~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                                                  ...++|+|++|.||+++.+..+.++||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                        0258999999999999765445699999654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.89  E-value=3e-09  Score=87.80  Aligned_cols=136  Identities=13%  Similarity=0.144  Sum_probs=86.8

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~  104 (282)
                      .+.+....+.|..+.||++.. .+|..+++|.....   ....+.+|++.++.+.+.+  +.+++....         ..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~---------~~   87 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT---------EA   87 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE---------CS
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc---------CC
Confidence            455444334666699999975 45678999976433   2234567888888885434  344555322         23


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK----------------------------  156 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----------------------------  156 (282)
                      ...+++||++++.++.  ..     .  ...   ..++.+++..+..+|+..                            
T Consensus        88 ~~~~~v~e~i~G~~l~--~~-----~--~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS-----H--LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ  155 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS-----C--CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred             CCCEEEEEecCCcccC--cC-----c--CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence            5689999999988874  10     0  111   234455555666666532                            


Q ss_pred             ---------------------------CCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        157 ---------------------------PIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       157 ---------------------------~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                                                 ..+++|+|++|.||+++.++.+.++||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                       1138999999999999766555699999754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.82  E-value=1.4e-08  Score=88.23  Aligned_cols=145  Identities=10%  Similarity=0.122  Sum_probs=97.5

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEec--cCCc-hhHHHHHHHHHHhhhCCC--CCcccccccccccCCCCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKII--CHGR-EDQAQAIREVEHHKTFVH--PNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~-~~~~~~~~e~~~l~~l~H--~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++.|+.|.++.||+....  +..+++|+..  .... .....+.+|..+++.+..  ..+.+++..+-..      ...
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~------~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE------SVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT------TTT
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC------Ccc
Confidence            4778999999999999874  3578888654  2211 223456789999988864  3455665533221      111


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK----------------------------  156 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~----------------------------  156 (282)
                      ...++|||++++.++.+.      ....++..+...++.+++..|..||+..                            
T Consensus       114 g~~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             SSCEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence            457899999998877431      1123567777888889999999999620                            


Q ss_pred             ---------------------------CCCccccCCCCCcEEeecCCC--ceeecccCccc
Q psy16951        157 ---------------------------PIAYAHRDLKTANVLLANDNN--PLLMDLGSVAP  188 (282)
Q Consensus       157 ---------------------------~~~i~H~dlk~~nil~~~~~~--~~~~df~~~~~  188 (282)
                                                 ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                       126999999999999987754  46999997643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.67  E-value=1.4e-08  Score=86.11  Aligned_cols=195  Identities=12%  Similarity=0.117  Sum_probs=112.0

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCc--ccccccccccCCCCCCCCCceE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNI--LPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni--~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      ++.++.|..+.||++.     ..+++|...  .......+.+|.+.++.+. +..+  .+.+.....      .......
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~------~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP------SETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC------CSSCSCS
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC------CCCCCcc
Confidence            3458999999999764     358888643  2234556788999998874 3332  222221100      0011235


Q ss_pred             EEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q psy16951        108 LMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA--------------------------------  155 (282)
Q Consensus       108 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--------------------------------  155 (282)
                      |+||+++++.++.....      ..++..+...++.+++..+..||+.                                
T Consensus        92 ~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             CEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             eEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence            78899999988865322      1245555566666666666666641                                


Q ss_pred             -----------------------CCCCccccCCCCCcEEeecC--CCceeecccCccchhhhc----cCch----hhhhh
Q psy16951        156 -----------------------KPIAYAHRDLKTANVLLAND--NNPLLMDLGSVAPAVVKV----CGSA----EAQNL  202 (282)
Q Consensus       156 -----------------------~~~~i~H~dlk~~nil~~~~--~~~~~~df~~~~~~~~~~----~~~~----~~~~~  202 (282)
                                             ....++|+|++|.||+++.+  ..+.++||+.+...+...    ....    .....
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV  245 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence                                   11258999999999999884  456799998654322110    0000    00000


Q ss_pred             HhhhhccCCCCccC-CcccccCcccCCCCccchhhHHHHHHHHHhCCCCCC
Q psy16951        203 QDVAAERCSMPYRA-PELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD  252 (282)
Q Consensus       203 ~~~~~~~~t~~y~~-PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~  252 (282)
                      .......   .... |+.....     ....+.|+++.++|.+.+|..+|.
T Consensus       246 ~~~l~~Y---~~~~~~~~~~r~-----~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          246 SKILNHY---KHKDIPTVLEKY-----RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHH---TCSCHHHHHHHH-----HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHc---CCCCcHHHHHHH-----HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0000000   1122 3322211     123689999999999999998874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.13  E-value=2.3e-05  Score=66.27  Aligned_cols=76  Identities=14%  Similarity=0.124  Sum_probs=50.3

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC---cccccccccccCCCCCCCCCceE
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN---ILPLLDHALTGCADPVLNSTSQV  107 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n---i~~~~~~~~~~~~~~~~~~~~~~  107 (282)
                      ++.++.|....||+.     +..+++|..  ........+.+|.++++.+.+..   +.+.+....        ......
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--------~~~g~~   88 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--------RSDGNP   88 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--------CTTSCE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--------cCCCce
Confidence            456789999999987     456788863  22334556788999999986432   233332211        123457


Q ss_pred             EEEeccCCCCChHH
Q psy16951        108 LMVLPYYPKGTLAN  121 (282)
Q Consensus       108 ~lv~e~~~~~sL~~  121 (282)
                      +++||++++.++..
T Consensus        89 ~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           89 FVGYRKVQGQILGE  102 (306)
T ss_dssp             EEEEECCCSEECHH
T ss_pred             EEEEeccCCeECch
Confidence            89999999888765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.98  E-value=7e-05  Score=61.83  Aligned_cols=136  Identities=12%  Similarity=0.071  Sum_probs=82.1

Q ss_pred             EEeccCCce-EEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGFS-TVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      +.+..|..| .||+......+..+.+|.-.   ......+.+|...++.+. +--+.+++.++         .+....++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~---~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~---------~~~~~~~l   97 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGK---GSVANDVTDEMVRLNWLTAFMPLPTIKHFI---------RTPDDAWL   97 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEE---THHHHHHHHHHHHHHHHTTTSCCCCEEEEE---------EETTEEEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECC---CCCHhHHHHHHHHHHHhccCCCcCeEEEEE---------EECCeEEE
Confidence            344455554 68988887777788898653   223445677888888774 21233444322         23467899


Q ss_pred             EeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q psy16951        110 VLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDA----------------------------------  155 (282)
Q Consensus       110 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----------------------------------  155 (282)
                      |||++++.++.+.....        ......+..++...|.-||..                                  
T Consensus        98 vme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (272)
T 4gkh_A           98 LTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD  169 (272)
T ss_dssp             EEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred             EEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence            99999988776543210        111122233333333333321                                  


Q ss_pred             ---------------------CCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        156 ---------------------KPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       156 ---------------------~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                                           ....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                 11137899999999999876555699998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.72  E-value=0.0002  Score=61.02  Aligned_cols=29  Identities=31%  Similarity=0.542  Sum_probs=26.0

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      .++|+|+.+.||+++.++.+.++||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            79999999999999878889999999654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.68  E-value=4.3e-05  Score=66.98  Aligned_cols=77  Identities=14%  Similarity=0.149  Sum_probs=45.9

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-------hhHHHHHHHHHHhhhCCC--CC-cccccccccccCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-------EDQAQAIREVEHHKTFVH--PN-ILPLLDHALTGCADP   99 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~~e~~~l~~l~H--~n-i~~~~~~~~~~~~~~   99 (282)
                      -++.||.|..+.||++....++..+++|.......       ........|.+.++.+..  +. +.+++..        
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--------  105 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--------  105 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--------
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--------
Confidence            36689999999999998765677899997643211       112345668888877632  22 3333321        


Q ss_pred             CCCCCceEEEEeccCCCC
Q psy16951        100 VLNSTSQVLMVLPYYPKG  117 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~  117 (282)
                         +....++|||++++.
T Consensus       106 ---d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 ---DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             ---ETTTTEEEECCCTTS
T ss_pred             ---cCCccEEEEEeCCCc
Confidence               112357899998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.44  E-value=0.00031  Score=60.46  Aligned_cols=86  Identities=8%  Similarity=-0.007  Sum_probs=48.8

Q ss_pred             EEEEEEe-ccCCceEEEEEEec--C----CCceEEEEEeccCC---chhHHHHHHHHHHhhhCC-C--CCcccccccccc
Q psy16951         28 YYIVEKI-GEGGFSTVSLIEHS--Q----TKKRYALKKIICHG---REDQAQAIREVEHHKTFV-H--PNILPLLDHALT   94 (282)
Q Consensus        28 y~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~-H--~ni~~~~~~~~~   94 (282)
                      ....+.| +.|..+.+|+....  .    ++..+++|......   ......+.+|+..++.+. +  ..+.+++...-.
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445778 89999999988753  1    15678888653221   001134556777777663 2  234445443221


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCCh
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTL  119 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL  119 (282)
                      +      .-....+++||++++.++
T Consensus       102 ~------~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 G------DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             S------TTTSSCEEEEECCCCBCC
T ss_pred             C------CccCCceEEEEecCCCCh
Confidence            1      001346789999987654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.0031  Score=52.45  Aligned_cols=56  Identities=9%  Similarity=-0.104  Sum_probs=42.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV   81 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~   81 (282)
                      .....-++.+|.|..+.||+.+. .+|.+|.+|.-..........+..|+..|+.+.
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence            34566688999999999999987 467889999765444444456778888888774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.51  E-value=0.015  Score=49.00  Aligned_cols=77  Identities=14%  Similarity=0.072  Sum_probs=53.0

Q ss_pred             EEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC---CCcccccccccccCCCCCCCCCc
Q psy16951         29 YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH---PNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H---~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      .-++.|+.|....+|+...  ++..+++|....   .....+..|.+.++.+..   ..+++.+....         ...
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~---------~~g  104 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGN---------SQG  104 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE---------CSS
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEee---------cCC
Confidence            3467899999999999886  456788886542   235567788888877742   33455544221         235


Q ss_pred             eEEEEeccCCCCCh
Q psy16951        106 QVLMVLPYYPKGTL  119 (282)
Q Consensus       106 ~~~lv~e~~~~~sL  119 (282)
                      ..+++||++++.++
T Consensus       105 ~~~lvme~l~G~~~  118 (312)
T 3jr1_A          105 HSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEEECCCCCCC
T ss_pred             ceEEEEEeccCCCC
Confidence            78999999987764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.31  E-value=0.047  Score=45.81  Aligned_cols=154  Identities=14%  Similarity=0.083  Sum_probs=74.6

Q ss_pred             cEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCC
Q psy16951         27 KYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~  104 (282)
                      ...-++.|+.|....+|+.... ++ .+++|.....  .....+..|..+++.+...+  +.+++... .+  .......
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g--~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DG--ELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TC--CSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CC--CEEEEEC
Confidence            3445677888999999998763 23 6888876542  11223445666666653212  22332210 01  0011112


Q ss_pred             ceEEEEeccCCCCChHH--------------HHHHHHhc--CC---CCCHHHHHH---------------HHHHHHHHHH
Q psy16951        105 SQVLMVLPYYPKGTLAN--------------DLELRSVG--KH---YMSSVDILK---------------MFLKICEAVK  150 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~--------------~l~~~~~~--~~---~l~~~~~~~---------------~~~qi~~~l~  150 (282)
                      ...+++++++++.++..              .++.....  ..   .........               +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            45788999998755321              11111100  00   000000000               0001223333


Q ss_pred             Hhhc----CCCCCccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        151 VFHD----AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       151 ~lH~----~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      .+..    ..+.+++|+|+.+.||+++.+..+.++||+.+.
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3331    112279999999999999876545799998654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.03  E-value=0.011  Score=49.32  Aligned_cols=29  Identities=21%  Similarity=0.156  Sum_probs=24.5

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      .++|+|+.+.|++ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 6677889999986543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.94  E-value=0.05  Score=47.99  Aligned_cols=74  Identities=12%  Similarity=0.110  Sum_probs=44.9

Q ss_pred             EEEEeccCCceEEEEEEecC-------CCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCc-ccccccccccCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQ-------TKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI-LPLLDHALTGCADPVL  101 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni-~~~~~~~~~~~~~~~~  101 (282)
                      -++.|+.|....+|++....       ++..+++|+.....  ....+.+|..+++.+...++ .++++.+         
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~---------  145 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIF---------  145 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE---------
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEe---------
Confidence            35678999999999998642       25678888652211  12455578888887743333 4444321         


Q ss_pred             CCCceEEEEeccCCCCC
Q psy16951        102 NSTSQVLMVLPYYPKGT  118 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~s  118 (282)
                      .  .  .+++||+++.+
T Consensus       146 ~--~--g~v~e~l~G~~  158 (429)
T 1nw1_A          146 S--G--GRLEEYIPSRP  158 (429)
T ss_dssp             T--T--EEEECCCCEEE
T ss_pred             C--C--CEEEEEeCCcc
Confidence            1  1  27788886533

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.88  E-value=0.034  Score=48.79  Aligned_cols=29  Identities=28%  Similarity=0.345  Sum_probs=25.1

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      .++|+|++|.||+++.++ +.++||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            799999999999998766 89999986653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.49  E-value=0.11  Score=43.71  Aligned_cols=81  Identities=15%  Similarity=0.183  Sum_probs=45.4

Q ss_pred             EEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCCceEEE
Q psy16951         32 EKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVLM  109 (282)
Q Consensus        32 ~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~~~~~l  109 (282)
                      ..++ |....||+.... +|..+++|..... ......+..|..+++.+....  +++.+..  .+.  ......+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~--~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQ--TLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTB--SCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeec--CCc--EEEEECCEEEE
Confidence            3466 778889987653 4567889977422 123345556777777664222  3333332  110  01112346788


Q ss_pred             EeccCCCCCh
Q psy16951        110 VLPYYPKGTL  119 (282)
Q Consensus       110 v~e~~~~~sL  119 (282)
                      +++++++.++
T Consensus       105 l~~~i~G~~~  114 (328)
T 1zyl_A          105 VFPSVGGRQF  114 (328)
T ss_dssp             EEECCCCEEC
T ss_pred             EEEecCCCCC
Confidence            9999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.24  E-value=0.05  Score=47.18  Aligned_cols=152  Identities=12%  Similarity=0.101  Sum_probs=80.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecC-------CCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCccccccccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQ-------TKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHAL   93 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~   93 (282)
                      .+..+..+ ++.|..|....+|++....       ++..+.+|+.-. .........+|..+++.+. +.-..+++..+ 
T Consensus        47 ~~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-  123 (379)
T 3feg_A           47 RVQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVF-  123 (379)
T ss_dssp             GCCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred             CCCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-
Confidence            34445565 4568888899999988742       346788886421 1123345567888887774 22234444321 


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCChHH--------------HHHHHHhc----CCCC--CHHHHHHHHHHHHH------
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTLAN--------------DLELRSVG----KHYM--SSVDILKMFLKICE------  147 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~~~~----~~~l--~~~~~~~~~~qi~~------  147 (282)
                              .+    .+|+|++++.++..              .+.....-    ....  ...++..+..++..      
T Consensus       124 --------~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~  191 (379)
T 3feg_A          124 --------PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGL  191 (379)
T ss_dssp             --------TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSC
T ss_pred             --------CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCccc
Confidence                    11    28889987654431              11111110    0111  12444545443321      


Q ss_pred             -------------HHHH----hhc-CCCCCccccCCCCCcEEeecC----CCceeecccCccc
Q psy16951        148 -------------AVKV----FHD-AKPIAYAHRDLKTANVLLAND----NNPLLMDLGSVAP  188 (282)
Q Consensus       148 -------------~l~~----lH~-~~~~~i~H~dlk~~nil~~~~----~~~~~~df~~~~~  188 (282)
                                   .+..    |.. .....++|+|+.+.||++..+    +.+.++||..+..
T Consensus       192 ~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          192 PEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             chhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                         1122    211 122369999999999999876    6788999997653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.75  E-value=0.22  Score=44.27  Aligned_cols=76  Identities=11%  Similarity=0.056  Sum_probs=43.2

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCc-ccccccccccCCCCCCCCCceEE
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI-LPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni-~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      -++.|+.|-...+|++....++..+++|...... .......+|..+++.+...++ .++++.+         .  .  .
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~---------~--~--G  177 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF---------T--N--G  177 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE---------T--T--E
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe---------C--C--e
Confidence            3567899999999999875445778888653211 111111367888887754443 3444422         1  1  1


Q ss_pred             EEeccCCCCCh
Q psy16951        109 MVLPYYPKGTL  119 (282)
Q Consensus       109 lv~e~~~~~sL  119 (282)
                      +++||+++.++
T Consensus       178 ~v~e~I~G~~l  188 (458)
T 2qg7_A          178 RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEeeCCccC
Confidence            48888876443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.70  E-value=0.21  Score=42.41  Aligned_cols=29  Identities=24%  Similarity=0.483  Sum_probs=25.7

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      .++|+|+.+.|++++.++.+.++||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            69999999999999887888999998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.15  E-value=0.23  Score=39.40  Aligned_cols=103  Identities=16%  Similarity=0.124  Sum_probs=63.6

Q ss_pred             CCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccC
Q psy16951        116 KGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG  195 (282)
Q Consensus       116 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~  195 (282)
                      .-||.+.|..+   ..++++.+++.++.|.+.+|.-+-.++  .-..+=..|..|++..+|.+.+.+-. +         
T Consensus        32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~~~-s---------   96 (229)
T 2yle_A           32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAPAA-D---------   96 (229)
T ss_dssp             EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECCC------------
T ss_pred             cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccccc-c---------
Confidence            44788888765   456999999999999999987762211  11123345689999999988765311 0         


Q ss_pred             chhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCC
Q psy16951        196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS  249 (282)
Q Consensus       196 ~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~  249 (282)
                         .         .....+.|||.....    .+.+.-|+|+|+++|.-+--..
T Consensus        97 ---~---------~~~~~~~~pe~~~~~----~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           97 ---D---------AGEPPPVAGKLGYSQ----CMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ----------------------CCSSSS----SCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---c---------ccccCCCChhhcccc----chHHHHHHHHHHHHHHHhhcCC
Confidence               0         002236788876311    2467789999999998766443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.46  E-value=1  Score=39.45  Aligned_cols=29  Identities=34%  Similarity=0.500  Sum_probs=25.2

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCccc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVAP  188 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~~  188 (282)
                      .++|+|+.+.|++ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            6899999999999 7778889999997653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.79  E-value=0.028  Score=50.18  Aligned_cols=55  Identities=7%  Similarity=0.053  Sum_probs=13.6

Q ss_pred             ceEEEEEEecCCCceEEE------EEeccCC--chhHHHHHHHHHHhhhCCCCCccccccccc
Q psy16951         39 FSTVSLIEHSQTKKRYAL------KKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHAL   93 (282)
Q Consensus        39 ~g~V~~~~~~~~~~~vai------K~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~   93 (282)
                      ||+||+|.+..+..+||+      |......  ......+.+|..+++.++|||+++.+.+-.
T Consensus       152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            999999999776678888      6553221  122345678888889999999998876543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=82.68  E-value=1.3  Score=37.06  Aligned_cols=29  Identities=21%  Similarity=0.429  Sum_probs=24.6

Q ss_pred             CccccCCCCCcEEeecC----CCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLAND----NNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~----~~~~~~df~~~~  187 (282)
                      .++|+|+.+.||+++.+    +.+.++||+.+.
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            69999999999999764    567899998654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	282
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-38
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-37
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-36
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-32
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-31
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-30
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-30
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-29
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-28
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-28
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-27
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-27
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-26
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-26
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-25
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-25
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-23
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-22
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-06

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (353), Expect = 6e-40
 Identities = 52/254 (20%), Positives = 95/254 (37%), Gaps = 32/254 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D Y I E++G G F  V  +    T   +A K ++     D+    +E++      HP +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L D              ++++M+  +   G L   +       + MS  + ++   ++
Sbjct: 86  VNLHD---------AFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQV 133

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL--LMDLGSVAPAVVKVCGSAEAQNLQ 203
           C+ +   H+   +   H DLK  N++     +    L+D G           +A     Q
Sbjct: 134 CKGLCHMHENNYV---HLDLKPENIMFTTKRSNELKLIDFGL----------TAHLDPKQ 180

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
            V     +  + APE+            TD+WS+G L Y +    SPF    E  D    
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPV---GYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLR 235

Query: 264 AVISGNITFPENTP 277
            V S +    ++  
Sbjct: 236 NVKSCDWNMDDSAF 249

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-39
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 23/233 (9%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFV 81
           +++ Y ++  IG G +     I      K    K++        ++   + EV   +   
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPNI+   D       D    + + + +V+ Y   G LA+ +   +  + Y+    +L++
Sbjct: 62  HPNIVRYYDR----IIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 114

Query: 142 FLKICEAVKVFHDAKPIA--YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
             ++  A+K  H          HRDLK ANV L    N  L D G     + ++      
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG-----LARILNH--- 166

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
            +     A   +  Y +PE  +  SY   ++++D+WSLGCLLY +C    PF 
Sbjct: 167 -DTSFAKAFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFT 215

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-39
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 28/231 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
            D + I+ ++G+G F  V   ++ +T    A K I     E+    + E++   +  HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LLD              + + +++ +   G +     +    +  ++   I  +  +
Sbjct: 71  IVKLLDAFYYE---------NNLWILIEFCAGGAV---DAVMLELERPLTESQIQVVCKQ 118

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             +A+   HD K I   HRDLK  N+L   D +  L D G           SA+      
Sbjct: 119 TLDALNYLHDNKII---HRDLKAGNILFTLDGDIKLADFGV----------SAKNTRTIQ 165

Query: 205 VAAERCSMP-YRAPELFHVDSYC--VVDQRTDVWSLGCLLYAMCYFKSPFD 252
                   P + APE+   ++      D + DVWSLG  L  M   + P  
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  135 bits (342), Expect = 2e-38
 Identities = 51/255 (20%), Positives = 92/255 (36%), Gaps = 34/255 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           D Y I+E++G G F  V       T + +  K I      D+     E+       HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           + L D               +++++L +   G L + +       + MS  +++    + 
Sbjct: 89  INLHD---------AFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQA 136

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQNLQ 203
           CE +K  H+   +   H D+K  N++                   VK+   G A   N  
Sbjct: 137 CEGLKHMHEHSIV---HLDIKPENIMCETKKAS-----------SVKIIDFGLATKLNPD 182

Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
           ++     +   + APE+   +        TD+W++G L Y +    SPF    E      
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPV---GFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETL 237

Query: 263 LAVISGNITFPENTP 277
             V   +  F E+  
Sbjct: 238 QNVKRCDWEFDEDAF 252

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-37
 Identities = 42/231 (18%), Positives = 83/231 (35%), Gaps = 30/231 (12%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE-DQAQAIREVEHHKTFV 81
           +K D +  + ++G G    V  + H  +    A K I    +   + Q IRE++      
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
            P I+                S  ++ + + +   G+L   L+        +    + K+
Sbjct: 63  SPYIVGFYG---------AFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKV 109

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
            + + + +    +   I   HRD+K +N+L+ +     L D G     +  +  S     
Sbjct: 110 SIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                    +  Y +PE      Y     ++D+WS+G  L  M   + P  
Sbjct: 163 ------FVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIP 204

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-37
 Identities = 52/252 (20%), Positives = 94/252 (37%), Gaps = 29/252 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           +KY I E +G G F  V     + +KK Y  K +   G  DQ    +E+       H NI
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNI 63

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           L L +            S  +++M+  +     +   +         ++  +I+    ++
Sbjct: 64  LHLHE---------SFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQV 111

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDV 205
           CEA++  H        H D++  N++     +             +K+    +A+ L+  
Sbjct: 112 CEALQFLHSHNIG---HFDIRPENIIYQTRRSS-----------TIKIIEFGQARQLKPG 157

Query: 206 AAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV 265
              R            V  + VV   TD+WSLG L+Y +    +PF    E    +   +
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENI 215

Query: 266 ISGNITFPENTP 277
           ++   TF E   
Sbjct: 216 MNAEYTFDEEAF 227

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-37
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
             KY   EKIG+G   TV       T +  A++++    +  +   I E+   +   +PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+  LD  L G          ++ +V+ Y   G+L + +      +  M    I  +  +
Sbjct: 79  IVNYLDSYLVG---------DELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             +A++  H  + I   HRD+K+ N+LL  D +  L D G            A+    Q 
Sbjct: 125 CLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGF----------CAQITPEQS 171

Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             +     P + APE+    +Y     + D+WSLG +   M   + P+ 
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPYL 217

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (327), Expect = 1e-36
 Identities = 50/259 (19%), Positives = 86/259 (33%), Gaps = 34/259 (13%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ---AQAIREVEHHKTFV 81
              +  + +IG G F  V      +  +  A+KK+   G++        I+EV   +   
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN +      L               +V+ Y          +L  V K  +  V+I  +
Sbjct: 74  HPNTIQYRGCYLRE---------HTAWLVMEYCLGS----ASDLLEVHKKPLQEVEIAAV 120

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
                + +   H    I   HRD+K  N+LL+      L D GS             A  
Sbjct: 121 THGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGS-------------ASI 164

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
           +    +   +  + APE+         D + DVWSLG     +   K P   +     S 
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SA 222

Query: 262 ALAVISGNITFPENTPFPQ 280
              +        ++  + +
Sbjct: 223 LYHIAQNESPALQSGHWSE 241

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-36
 Identities = 45/260 (17%), Positives = 97/260 (37%), Gaps = 30/260 (11%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEHHKTF 80
           +   +  + ++IG G F TV   +        A+K +       +       EV   +  
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            H NIL  + ++              + +V  +    +L + L +    +     + ++ 
Sbjct: 62  RHVNILLFMGYSTAPQ----------LAIVTQWCEGSSLYHHLHII---ETKFEMIKLID 108

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           +  +  + +   H    I   HRDLK+ N+ L  D    + D G +A    +  GS + +
Sbjct: 109 IARQTAQGMDYLHAKSII---HRDLKSNNIFLHEDLTVKIGDFG-LATVKSRWSGSHQFE 164

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
            L        S+ + APE+  +        ++DV++ G +LY +   + P+  +  R   
Sbjct: 165 QL------SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--D 216

Query: 261 VALAVISGNITFPENTPFPQ 280
             + ++      P+ +    
Sbjct: 217 QIIFMVGRGYLSPDLSKVRS 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-36
 Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 29/253 (11%)

Query: 26  DKYYIVEK-IGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVE-HHKTFVHP 83
           D Y +  + +G G    V  I + +T++++ALK +     +D  +A REVE H +    P
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           +I+ ++D      A         +L+V+     G L +   ++  G    +  +  ++  
Sbjct: 66  HIVRIVDVYENLYAGR-----KCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMK 118

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            I EA++  H       AHRD+K  N+L  +     ++ L     A        E  +  
Sbjct: 119 SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA-------KETTSHN 168

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF--DTVYERGDSV 261
            +     +  Y APE+   + Y   D+  D+WSLG ++Y +     PF  +        +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225

Query: 262 ALAVISGNITFPE 274
              +  G   FP 
Sbjct: 226 KTRIRMGQYEFPN 238

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-35
 Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 35/255 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVH 82
           + + I   +G+G F  V L    Q+K   ALK +          + Q  REVE      H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PNIL L             +  ++V ++L Y P GT+  +L+                  
Sbjct: 66  PNILRLYG---------YFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI 112

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++  A+   H  + I   HRD+K  N+LL +     + D G            A +   
Sbjct: 113 TELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRR 161

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
             +     ++ Y  PE+     +   D++ D+WSLG L Y     K PF+          
Sbjct: 162 TTLC---GTLDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETY 213

Query: 263 LAVISGNITFPENTP 277
             +     TFP+   
Sbjct: 214 KRISRVEFTFPDFVT 228

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-35
 Identities = 55/258 (21%), Positives = 86/258 (33%), Gaps = 33/258 (12%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTF 80
           + + +   + +GEG FSTV L     T + YA+K +               RE +     
Sbjct: 6   RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            HP  + L                 ++   L Y   G L   +                 
Sbjct: 66  DHPFFVKLYF---------TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRF 112

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
              +I  A++  H    I   HRDLK  N+LL  D +  + D G               +
Sbjct: 113 YTAEIVSALEYLHGKGII---HRDLKPENILLNEDMHIQITDFG--------TAKVLSPE 161

Query: 201 NLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
           + Q  A        Y +PEL    S     + +D+W+LGC++Y +     PF        
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSA---CKSSDLWALGCIIYQLVAGLPPFRA--GNEY 216

Query: 260 SVALAVISGNITFPENTP 277
            +   +I     FPE   
Sbjct: 217 LIFQKIIKLEYDFPEKFF 234

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  121 bits (305), Expect = 1e-33
 Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 26/256 (10%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFV 81
           SD+Y + E +G GG S V L    +  +  A+K +   +        +  RE ++     
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP I+ + D            +     +V+ Y    TL + +      +  M+    +++
Sbjct: 66  HPAIVAVYDTGEAET-----PAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEV 116

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
               C+A+   H    I   HRD+K AN++++  N   +MD G           +    +
Sbjct: 117 IADACQALNFSHQNGII---HRDVKPANIMISATNAVKVMDFGIAR------AIADSGNS 167

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
           +   AA   +  Y +PE    DS    D R+DV+SLGC+LY +   + PF    +   SV
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSV---DARSDVYSLGCVLYEVLTGEPPFTG--DSPVSV 222

Query: 262 ALAVISGNITFPENTP 277
           A   +  +   P    
Sbjct: 223 AYQHVREDPIPPSARH 238

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-33
 Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 28/229 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
           + + +V+ +GEG +  V L  +  T++  A+K + +    +      +E+  +K   H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           ++    H   G         +   + L Y   G L + +E        M   D  + F +
Sbjct: 65  VVKFYGHRREG---------NIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQ 111

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           +   V   H        HRD+K  N+LL   +N  + D G        +       N + 
Sbjct: 112 LMAGVVYLHGIGIT---HRDIKPENLLLDERDNLKISDFG--------LATVFRYNNRER 160

Query: 205 VAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           +  + C ++PY APEL     +    +  DVWS G +L AM   + P+D
Sbjct: 161 LLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWD 207

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-32
 Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 31/231 (13%)

Query: 27  KYY-IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHP 83
           ++     +IG G F TV     ++T    A  ++      + ++ +   E E  K   HP
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+   D   +            +++V      GTL   L+        M    +     
Sbjct: 69  NIVRFYDSWESTVKGK-----KCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCR 119

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GSAEAQN 201
           +I + ++  H   P    HRDLK  N+ +                  VK+   G A  + 
Sbjct: 120 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTG------------SVKIGDLGLATLKR 166

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                A   +  + APE++  + Y   D+  DV++ G  +  M   + P+ 
Sbjct: 167 ASFAKAVIGTPEFMAPEMYE-EKY---DESVDVYAFGMCMLEMATSEYPYS 213

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  117 bits (294), Expect = 4e-32
 Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 41/261 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---------REDQAQAIREVE- 75
           + Y   E +G G  S V    H  T K YA+K I   G         +E +   ++EV+ 
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K   HPNI+ L D   T              +V     KG L + L      K  +S 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNT---------FFFLVFDLMKKGELFDYLT----EKVTLSE 109

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            +  K+   + E +   H        HRDLK  N+LL +D N  L D G           
Sbjct: 110 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF---------- 156

Query: 196 SAEAQNLQDVAAERCSMPYRAPELF---HVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
           S +    + +     +  Y APE+      D++    +  D+WS G ++Y +     PF 
Sbjct: 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216

Query: 253 TVYERGDSVALAVISGNITFP 273
             + +   +   ++SGN  F 
Sbjct: 217 --HRKQMLMLRMIMSGNYQFG 235

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-32
 Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 32/255 (12%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +   +  +++ IG+G F  V L ++   K   A+K I           + E        H
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRH 59

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
            N++ LL          ++     + +V  Y  KG+L +   LRS G+  +    +LK  
Sbjct: 60  SNLVQLLGV--------IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFS 109

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           L +CEA++       +   HRDL   NVL++ DN   + D G           + EA + 
Sbjct: 110 LDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGL----------TKEASST 156

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
           QD    +  + + APE      +     ++DVWS G LL+ +  F           D V 
Sbjct: 157 QDTG--KLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211

Query: 263 LAVISGNITFPENTP 277
                  +  P+  P
Sbjct: 212 RVEKGYKMDAPDGCP 226

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (292), Expect = 2e-31
 Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 31/255 (12%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-QAQAIREVEHHKTFVHP 83
            D Y   + +G G FS V L E  +T+K  A+K I     E  +     E+       HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L D         +  S   + +++     G L + +      K + +  D  ++  
Sbjct: 68  NIVALDD---------IYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIF 114

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++ +AVK  HD   +   HRDLK  N+L  + +    + +           G ++ ++  
Sbjct: 115 QVLDAVKYLHDLGIV---HRDLKPENLLYYSLDEDSKIMISD--------FGLSKMEDPG 163

Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
            V +  C  P Y APE+     Y    +  D WS+G + Y +     PF    E    + 
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPY---SKAVDCWSIGVIAYILLCGYPPFYD--ENDAKLF 218

Query: 263 LAVISGNITFPENTP 277
             ++     F     
Sbjct: 219 EQILKAEYEFDSPYW 233

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-31
 Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 24/228 (10%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPN 84
            +Y  +  IGEG +  V     +  K R A+KKI     +    + +RE++    F H N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ + D        P +     V +V  +     L   L+       ++S+  I     +
Sbjct: 68  IIGINDI----IRAPTIEQMKDVYLVT-HLMGADLYKLLK-----TQHLSNDHICYFLYQ 117

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
           I   +K  H A  +   HRDLK +N+LL    +  + D G     + +V           
Sbjct: 118 ILRGLKYIHSANVL---HRDLKPSNLLLNTTCDLKICDFG-----LARVADPDHDH--TG 167

Query: 205 VAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              E  +   YRAPE+          +  D+WS+GC+L  M   +  F
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGY--TKSIDIWSVGCILAEMLSNRPIF 213

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 6e-31
 Identities = 54/262 (20%), Positives = 93/262 (35%), Gaps = 39/262 (14%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHK 78
            D Y   E++G G F+ V       T  +YA K I             +    REV   K
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
              HPN++ L +         V  + + V+++L     G L +        K  ++  + 
Sbjct: 69  EIQHPNVITLHE---------VYENKTDVILILELVAGGELFD----FLAEKESLTEEEA 115

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVC--GS 196
            +   +I   V   H  +     H DLK  N++L + N P            +K+   G 
Sbjct: 116 TEFLKQILNGVYYLHSLQIA---HFDLKPENIMLLDRNVP---------KPRIKIIDFGL 163

Query: 197 AEAQNLQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY 255
           A   +  +       +  + APE+ + +         D+WS+G + Y +    SPF    
Sbjct: 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLG-- 218

Query: 256 ERGDSVALAVISGNITFPENTP 277
           +        V + N  F +   
Sbjct: 219 DTKQETLANVSAVNYEFEDEYF 240

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (287), Expect = 9e-31
 Identities = 52/256 (20%), Positives = 87/256 (33%), Gaps = 38/256 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKTFVH 82
             + I+  +G G F  V LI      + YA+K +   I    +       E        H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P I+ +                 Q+ M++ Y        +L           +       
Sbjct: 64  PFIIRMWGTFQDA---------QQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            ++C A++  H    I   +RDLK  N+LL  + +             +K+     A+ +
Sbjct: 111 AEVCLALEYLHSKDII---YRDLKPENILLDKNGH-------------IKITDFGFAKYV 154

Query: 203 QDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV 261
            DV    C  P Y APE+     Y   ++  D WS G L+Y M    +PF          
Sbjct: 155 PDVTYTLCGTPDYIAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTPFYD--SNTMKT 209

Query: 262 ALAVISGNITFPENTP 277
              +++  + FP    
Sbjct: 210 YEKILNAELRFPPFFN 225

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-30
 Identities = 47/255 (18%), Positives = 92/255 (36%), Gaps = 28/255 (10%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           V  +   +VE++G G F  V +  +     + A+K +   G       + E    K   H
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQH 67

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             ++ L              +   + ++  Y   G+L +   L++     ++   +L M 
Sbjct: 68  QRLVRLYAVV----------TQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMA 115

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I E +    +   I   HRDL+ AN+L+++  +  + D G        +    E    
Sbjct: 116 AQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFG--------LARLIEDNEY 164

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
                 +  + + APE     +Y     ++DVWS G LL  +              + + 
Sbjct: 165 TAREGAKFPIKWTAPEAI---NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

Query: 263 LAVISGNITFPENTP 277
                  +  P+N P
Sbjct: 222 NLERGYRMVRPDNCP 236

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 4e-30
 Identities = 46/255 (18%), Positives = 88/255 (34%), Gaps = 26/255 (10%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           ++     +  K+G G +  V      +     A+K +      +  + ++E    K   H
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKH 72

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           PN++ LL                   ++  +   G L     LR   +  +S+V +L M 
Sbjct: 73  PNLVQLLGVCTRE---------PPFYIITEFMTYGNL--LDYLRECNRQEVSAVVLLYMA 121

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
            +I  A++       I   HRDL   N L+  ++   + D G        +         
Sbjct: 122 TQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFG--------LSRLMTGDTY 170

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
              A  +  + + APE    + +     ++DVW+ G LL+ +  +        +      
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

Query: 263 LAVISGNITFPENTP 277
           L      +  PE  P
Sbjct: 228 LLEKDYRMERPEGCP 242

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-30
 Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 17/259 (6%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--QAIREVEHHKTFVHP 83
            KY  + KIG+G F  V    H +T ++ ALKK++    ++     A+RE++  +   H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           N++ L++   T  A P       + +V  +         L    + K  +S  +I ++  
Sbjct: 70  NVVNLIEICRTK-ASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLS--EIKRVMQ 124

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
            +   +   H  K +   HRD+K ANVL+  D    L D G     + +    A+     
Sbjct: 125 MLLNGLYYIHRNKIL---HRDMKAANVLITRDGVLKLADFG-----LARAFSLAKNSQPN 176

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
                  ++ YR PEL   +         D+W  GC++  M           E+     +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

Query: 264 AVISGNITFPENTPFPQYQ 282
           + + G+IT         Y+
Sbjct: 235 SQLCGSITPEVWPNVDNYE 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-30
 Identities = 51/259 (19%), Positives = 95/259 (36%), Gaps = 35/259 (13%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVEHHKT 79
           V  + +  ++ +G+G F  V L+    T + YA+K +   +   +++ A  + E    + 
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
             HP +  L     T           ++  V+ Y   G L   L      +   +     
Sbjct: 62  TRHPFLTALKYAFQTH---------DRLCFVMEYANGGELFFHLS----RERVFTEERAR 108

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I  A++  H    +   +RD+K  N++L  D +  + D G             E 
Sbjct: 109 FYGAEIVSALEYLHSRDVV---YRDIKLENLMLDKDGHIKITDFGL----------CKEG 155

Query: 200 QNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
            +        C  P Y APE+   + Y    +  D W LG ++Y M   + PF    +  
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYN--QDH 210

Query: 259 DSVALAVISGNITFPENTP 277
           + +   ++   I FP    
Sbjct: 211 ERLFELILMEEIRFPRTLS 229

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 1e-29
 Identities = 49/255 (19%), Positives = 86/255 (33%), Gaps = 28/255 (10%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +   +   V++IG G F  V L      K + A+K  I  G   +   I E E      H
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSH 59

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
           P ++ L    L           + + +V  +   G L    +     +   ++  +L M 
Sbjct: 60  PKLVQLYGVCLEQ---------APICLVFEFMEHGCL---SDYLRTQRGLFAAETLLGMC 107

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
           L +CE +    +A  I   HRDL   N L+  +    + D G        +         
Sbjct: 108 LDVCEGMAYLEEACVI---HRDLAARNCLVGENQVIKVSDFG--------MTRFVLDDQY 156

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA 262
                 +  + + +PE+F    Y     ++DVWS G L++ +              + V 
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213

Query: 263 LAVISGNITFPENTP 277
                  +  P    
Sbjct: 214 DISTGFRLYKPRLAS 228

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-29
 Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 36/257 (14%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIREVE-HHKTFV 81
           + + + + +G+G F  V L E  +T + +A+K +   +    +D    + E       + 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HP +  +              +   +  V+ Y   G L   ++      H          
Sbjct: 62  HPFLTHMFC---------TFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFY 108

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
             +I   ++  H    +   +RDLK  N+LL  D +  + D G             E   
Sbjct: 109 AAEIILGLQFLHSKGIV---YRDLKLDNILLDKDGHIKIADFGM----------CKENML 155

Query: 202 LQDVAAERC-SMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
                   C +  Y APE+     Y   +   D WS G LLY M   +SPF    +  + 
Sbjct: 156 GDAKTNTFCGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPFHG--QDEEE 210

Query: 261 VALAVISGNITFPENTP 277
           +  ++   N  +P    
Sbjct: 211 LFHSIRMDNPFYPRWLE 227

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 2e-29
 Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 31/259 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQA--QAIREVEHHKTFVHP 83
           + +  VEKIGEG +  V    +  T +  ALKKI      +     AIRE+   K   HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ LLD             T   L ++  +    L   ++  ++    +    I     
Sbjct: 62  NIVKLLDV----------IHTENKLYLVFEFLHQDLKKFMDASALTGIPLP--LIKSYLF 109

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++ + +   H  + +   HRDLK  N+L+  +    L D G            A    ++
Sbjct: 110 QLLQGLAFCHSHRVL---HRDLKPQNLLINTEGAIKLADFG---------LARAFGVPVR 157

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL 263
               E  ++ YRAPE+     Y       D+WSLGC+   M   ++ F       +   L
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYY--STAVDIWSLGCIFAEMVTRRALFP---GDSEIDQL 212

Query: 264 AVISGNITFPENTPFPQYQ 282
             I   +  P+   +P   
Sbjct: 213 FRIFRTLGTPDEVVWPGVT 231

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 6e-29
 Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 24/231 (10%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHP 83
           +   Y   + IG G F  V   +   + +  A+KK+     +D+    RE++  +   H 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L     +            + +VL Y P+          S  K  +  + +     
Sbjct: 74  NIVRLRYFFYSSGEK---KDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMY 129

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEAQNL 202
           ++  ++   H        HRD+K  N+LL  D   L L D GS          + +    
Sbjct: 130 QLFRSLAYIHSFGIC---HRDIKPQNLLLDPDTAVLKLCDFGS----------AKQLVRG 176

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT 253
           +   +  CS  YRAPEL             DVWS GC+L  +   +  F  
Sbjct: 177 EPNVSYICSRYYRAPELIF--GATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-28
 Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 26/250 (10%)

Query: 32  EKIGEGGFSTV---SLIEHSQTKKRYALKKI-ICHGREDQAQAIREVEHHKTFVHPNILP 87
           E IG G F  V   +L+++   K   A+K +       + +Q + E    K F HPN+L 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 88  LLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICE 147
           LL           L S    L+VLPY   G L           H  +  D++   L++ +
Sbjct: 93  LLGI--------CLRSEGSPLVVLPYMKHGDL---RNFIRNETHNPTVKDLIGFGLQVAK 141

Query: 148 AVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAA 207
            +K     K +   HRDL   N +L       + D G     + +     E  ++ +   
Sbjct: 142 GMKFLASKKFV---HRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHNKTG 193

Query: 208 ERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAVIS 267
            +  + + A E            ++DVWS G LL+ +    +P        D     +  
Sbjct: 194 AKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

Query: 268 GNITFPENTP 277
             +  PE  P
Sbjct: 251 RRLLQPEYCP 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  109 bits (273), Expect = 3e-28
 Identities = 48/233 (20%), Positives = 81/233 (34%), Gaps = 35/233 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI------ICHGREDQAQAIREVEHHKT 79
           + + +   IG GGF  V     + T K YA+K +      +  G          +    T
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
              P I+ +             ++  ++  +L     G L   L          S  D+ 
Sbjct: 64  GDCPFIVCMSY---------AFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMR 110

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +I   ++  H+   +   +RDLK AN+LL    +  + DLG     +       + 
Sbjct: 111 FYAAEIILGLEHMHNRFVV---YRDLKPANILLDEHGHVRISDLG-----LACDFSKKKP 162

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                      +  Y APE+         D   D +SLGC+L+ +    SPF 
Sbjct: 163 HASV------GTHGYMAPEVLQKGVA--YDSSADWFSLGCMLFKLLRGHSPFR 207

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (269), Expect = 3e-28
 Identities = 33/233 (14%), Positives = 73/233 (31%), Gaps = 21/233 (9%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
           ++Y +  KIG G F  + L       +  A+K      +    Q   E + +K       
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVG 64

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +P +                   +++      +L    +L +      S   +L +  ++
Sbjct: 65  IPTIRWCGA---------EGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQM 112

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLA-NDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
              ++  H      + HRD+K  N L+       L+  +        +   + +    ++
Sbjct: 113 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
                 +  Y +             +R D+ SLG +L        P+  +   
Sbjct: 170 NKNLTGTARYASINTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (271), Expect = 4e-28
 Identities = 50/265 (18%), Positives = 93/265 (35%), Gaps = 38/265 (14%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI---ICHGREDQAQAIRE 73
           +      + D++  ++ +G G F  V L++H ++   YA+K +        +     + E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 74  VEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
               +    P ++ L                  + MV+ Y   G + + L          
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNS---------NLYMVMEYVAGGEMFSHLR----RIGRF 138

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
           S         +I    +  H    I   +RDLK  N+L+       + D G         
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLI---YRDLKPENLLIDQQGYIQVTDFG--------- 186

Query: 194 CGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                A+ ++      C  P   APE+     Y   ++  D W+LG L+Y M     PF 
Sbjct: 187 ----FAKRVKGRTWTLCGTPEALAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFF 239

Query: 253 TVYERGDSVALAVISGNITFPENTP 277
              ++   +   ++SG + FP +  
Sbjct: 240 A--DQPIQIYEKIVSGKVRFPSHFS 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 5e-28
 Identities = 38/231 (16%), Positives = 83/231 (35%), Gaps = 29/231 (12%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH 82
           +       ++++G G F  V   +  + +   A+K +I  G   + + I E +      H
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSH 58

Query: 83  PNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMF 142
             ++ L                  + ++  Y   G L   L      +H   +  +L+M 
Sbjct: 59  EKLVQLYGVCTKQ---------RPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMC 106

Query: 143 LKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNL 202
             +CEA++     + +   HRDL   N L+ +     + D G        +         
Sbjct: 107 KDVCEAMEYLESKQFL---HRDLAARNCLVNDQGVVKVSDFG--------LSRYVLDDEY 155

Query: 203 QDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFD 252
                 +  + +  PE+     +     ++D+W+ G L++ +    K P++
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKF---SSKSDIWAFGVLMWEIYSLGKMPYE 203

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 1e-27
 Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 28/261 (10%)

Query: 17  SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEH 76
           +K+A  +  +   +  K+G+G F  V +   + T  R A+K +   G       ++E + 
Sbjct: 8   AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQEAQV 65

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K   H  ++ L              S   + +V  Y  KG+L     L+     Y+   
Sbjct: 66  MKKLRHEKLVQLYAV----------VSEEPIYIVTEYMSKGSL--LDFLKGETGKYLRLP 113

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            ++ M  +I   +        +   HRDL+ AN+L+  +    + D G     + ++   
Sbjct: 114 QLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFG-----LARLIED 165

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
            E    Q     +  + + APE      +     ++DVWS G LL  +            
Sbjct: 166 NEYTARQGA---KFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPGMV 219

Query: 257 RGDSVALAVISGNITFPENTP 277
             + +        +  P   P
Sbjct: 220 NREVLDQVERGYRMPCPPECP 240

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-27
 Identities = 44/240 (18%), Positives = 84/240 (35%), Gaps = 26/240 (10%)

Query: 25  SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN 84
           +    + E IG+G F  V   +     +  A+K I     E       E+       H N
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHEN 58

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           IL  +             + +Q+ +V  Y+  G+L + L      ++ ++   ++K+ L 
Sbjct: 59  ILGFIAADNKDN-----GTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALS 108

Query: 145 ICEAVKVFHDAKPIAYA-----HRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
               +   H             HRDLK+ N+L+  +    + DLG     +     SA  
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG-----LAVRHDSATD 163

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCV---VDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
                      +  Y APE+             +R D++++G + + +    S      +
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-27
 Identities = 49/228 (21%), Positives = 84/228 (36%), Gaps = 32/228 (14%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-----QAQAIREVEHHKTFVHPN 84
            ++ +GEG F+TV       T +  A+KKI    R +        A+RE++  +   HPN
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 85  ILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLK 144
           I+ LLD              S + +V  +       +   +       ++   I    L 
Sbjct: 62  IIGLLDAFGHK---------SNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLM 108

Query: 145 ICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQD 204
             + ++  H    +   HRDLK  N+LL  +    L D G            +     + 
Sbjct: 109 TLQGLEYLHQHWIL---HRDLKPNNLLLDENGVLKLADFG---------LAKSFGSPNRA 156

Query: 205 VAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
              +  +  YRAPEL       +     D+W++GC+L  +        
Sbjct: 157 YTHQVVTRWYRAPELLF--GARMYGVGVDMWAVGCILAELLLRVPFLP 202

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 4e-27
 Identities = 52/261 (19%), Positives = 80/261 (30%), Gaps = 45/261 (17%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED------QAQAIREVEHHKT 79
            +Y +   +G GGF +V            A+K +      D        +   EV   K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 80  F--VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD 137
                  ++ LLD                 +++L          D       +  +    
Sbjct: 64  VSSGFSGVIRLLDWFERP---------DSFVLILERPEPVQDLFDFITE---RGALQEEL 111

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL-ANDNNPLLMDLGSVAPAVVKVCGS 196
               F ++ EAV+  H+       HRD+K  N+L+  N     L+D            GS
Sbjct: 112 ARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF-----------GS 157

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE 256
                         +  Y  PE      Y    +   VWSLG LLY M     PF+   E
Sbjct: 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYH--GRSAAVWSLGILLYDMVCGDIPFEHDEE 215

Query: 257 RGDSVALAVISGNITFPENTP 277
                   +I G + F +   
Sbjct: 216 --------IIRGQVFFRQRVS 228

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-27
 Identities = 52/263 (19%), Positives = 105/263 (39%), Gaps = 33/263 (12%)

Query: 21  VYVKSDKYYIVE-KIGEGGFSTVSLIEHSQTKKR--YALKKI-ICHGREDQAQAIREVEH 76
           +++K D   I + ++G G F +V    +   KK+   A+K +     + D  + +RE + 
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
                +P I+ L+                 +++V+     G L   L  +   +  +   
Sbjct: 63  MHQLDNPYIVRLIGVC----------QAEALMLVMEMAGGGPLHKFLVGK---REEIPVS 109

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
           ++ ++  ++   +K   +   +   HRDL   NVLL N +   + D G     + K  G+
Sbjct: 110 NVAELLHQVSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFG-----LSKALGA 161

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTVY 255
            ++      A  +  + + APE  +   +     R+DVWS G  ++    Y + P+    
Sbjct: 162 DDSYYTARSAG-KWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKK-- 215

Query: 256 ERGDSVALAVISGN-ITFPENTP 277
            +G  V   +  G  +  P   P
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECP 238

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-26
 Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 30/237 (12%)

Query: 18  KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVE 75
            +  +     Y  ++ +G G +  V      +T  + A+KK+           +A RE+ 
Sbjct: 10  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             K   H N++ LLD       D  L+  +   +V+P+            + +    +  
Sbjct: 70  LLKHMRHENVIGLLDV---FTPDETLDDFTDFYLVMPFMG------TDLGKLMKHEKLGE 120

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             I  +  ++ + ++  H A      HRDLK  N+ +  D                K+  
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL-------------KILD 164

Query: 196 SAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              A+              YRAPE+          Q  D+WS+GC++  M   K+ F
Sbjct: 165 FGLARQADSEMTGYVVTRWYRAPEVILNWMRY--TQTVDIWSVGCIMAEMITGKTLF 219

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 62/261 (23%), Positives = 100/261 (38%), Gaps = 32/261 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKR-YALKKIICHGREDQA--QAIREVE---HHKT 79
            +Y  V +IGEG +  V      +   R  ALK++     E+      IREV    H +T
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDIL 139
           F HPN++ L D     C     +  +++ +V  +  +        L  V +  + +  I 
Sbjct: 67  FEHPNVVRLFDV----CTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIK 119

Query: 140 KMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEA 199
            M  ++   +   H  +     HRDLK  N+L+ +     L D G           +   
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG----------LARIY 166

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD 259
                + +   ++ YRAPE+    SY       D+WS+GC+   M   K  F       D
Sbjct: 167 SFQMALTSVVVTLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFRRKPLF---RGSSD 220

Query: 260 SVALAVISGNITFPENTPFPQ 280
              L  I   I  P    +P+
Sbjct: 221 VDQLGKILDVIGLPGEEDWPR 241

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-26
 Identities = 54/268 (20%), Positives = 94/268 (35%), Gaps = 38/268 (14%)

Query: 22  YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR---YALKKI---ICHGREDQAQAIREVE 75
            +      ++EK+G+G F  V   E      +    A+K +   +    E     IREV 
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
              +  H N++ L    LT            + MV    P G+L   L+     + +   
Sbjct: 64  AMHSLDHRNLIRLYGVVLTP----------PMKMVTELAPLGSL---LDRLRKHQGHFLL 110

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
             + +  +++ E +      + I   HRDL   N+LLA  +   + D G        +  
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFG--------LMR 159

Query: 196 SAEAQNLQDVAAERCSMP--YRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFD 252
           +    +   V  E   +P  + APE     ++      +D W  G  L+ M  Y + P+ 
Sbjct: 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 253 TVYERGDSVALAVISGNITFPENTPFPQ 280
                G  +   +       P     PQ
Sbjct: 217 G--LNGSQILHKIDKEGERLPRPEDCPQ 242

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-26
 Identities = 47/260 (18%), Positives = 95/260 (36%), Gaps = 31/260 (11%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALK---KIICHGREDQA--QAIREVEHH 77
           +K  ++  ++ +G G F TV         ++  +    K +      +A  + + E    
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 78  KTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVD 137
            +  +P++  LL   LT            V ++    P G L   L+     K  + S  
Sbjct: 66  ASVDNPHVCRLLGICLTS----------TVQLITQLMPFGCL---LDYVREHKDNIGSQY 112

Query: 138 ILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSA 197
           +L   ++I + +    D + +   HRDL   NVL+    +  + D G     + K+ G+ 
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFG-----LAKLLGAE 164

Query: 198 EAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER 257
           E +   +    +  + + A E      Y     ++DVWS G  ++ +  F S        
Sbjct: 165 EKEYHAEGG--KVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPA 219

Query: 258 GDSVALAVISGNITFPENTP 277
            +  ++      +  P    
Sbjct: 220 SEISSILEKGERLPQPPICT 239

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 5e-26
 Identities = 47/236 (19%), Positives = 93/236 (39%), Gaps = 28/236 (11%)

Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEH 76
           + ++   ++Y  +  +G G + +V     ++T  R A+KK+           +  RE+  
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K   H N++ LLD      +    N      + L  +  G   N++         ++  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFND-----VYLVTHLMGADLNNIV----KCQKLTDD 121

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            +  +  +I   +K  H A      HRDLK +N+ +  D    ++D G       ++ G 
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG- 177

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                         +  YRAPE+     +   +Q  D+WS+GC++  +   ++ F 
Sbjct: 178 -----------YVATRWYRAPEIMLNWMHY--NQTVDIWSVGCIMAELLTGRTLFP 220

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  100 bits (250), Expect = 1e-25
 Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 32/230 (13%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHP 83
           +KY+ +EKIGEG +  V   ++    + +ALKKI          +  IRE+   K   H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L D   T           ++++V  +  +    +  +L  V +  + SV      L
Sbjct: 61  NIVKLYDVIHTKK---------RLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLL 107

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++   +   HD + +   HRDLK  N+L+  +    + D G           +       
Sbjct: 108 QLLNGIAYCHDRRVL---HRDLKPQNLLINREGELKIADFGL----------ARAFGIPV 154

Query: 204 DVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                      YRAP++             D+WS+GC+   M      F 
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGTPLFP 202

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  100 bits (250), Expect = 1e-25
 Identities = 34/232 (14%), Positives = 74/232 (31%), Gaps = 27/232 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNI 85
             Y +  +IGEG F  +    +    ++ A+K      R D  Q   E   +K       
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 86  LPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKI 145
           +P + +                ++V+         +  +L  +     S   +     ++
Sbjct: 63  IPNVYY--------FGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQM 110

Query: 146 CEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-----LMDLGSVAPAVVKVCGSAEAQ 200
              V+  H+       +RD+K  N L+   N+       ++D G V     +   + +  
Sbjct: 111 LARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHI 165

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
             ++      +  Y +             +R D+ +LG +         P+ 
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQ 214

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 34/232 (14%)

Query: 22  YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTF- 80
           +   D Y +V K+G G +S V    +    ++  +K +       + +  RE++  +   
Sbjct: 31  WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLR 87

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
             PNI+ L D       DPV   +    +V  +                   ++  DI  
Sbjct: 88  GGPNIITLADI----VKDPV---SRTPALVFEHVNNTDFKQLY-------QTLTDYDIRF 133

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL-LMDLGSVAPAVVKVCGSAEA 199
              +I +A+   H        HRD+K  NV++ +++  L L+D G           +   
Sbjct: 134 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL----------AEFY 180

Query: 200 QNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
              Q+      S  ++ PEL     Y + D   D+WSLGC+L +M + K PF
Sbjct: 181 HPGQEYNVRVASRYFKGPELLV--DYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.8 bits (248), Expect = 2e-25
 Identities = 40/232 (17%), Positives = 80/232 (34%), Gaps = 27/232 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIIC----HGREDQAQAIREVEHHKTFV 81
               I + IG G F  V         KR     I      +  + +   + E      F 
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKM 141
           HPN++ L           V+  ++ V+++  +   G+L +            + + ++ M
Sbjct: 86  HPNVIHLE---------GVVTKSTPVMIITEFMENGSLDS---FLRQNDGQFTVIQLVGM 133

Query: 142 FLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQN 201
              I   +K   D   +   HRDL   N+L+ ++    + D G        +        
Sbjct: 134 LRGIAAGMKYLADMNYV---HRDLAARNILVNSNLVCKVSDFGL----SRFLEDDTSDPT 186

Query: 202 LQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFD 252
                  +  + + APE      +      +DVWS G +++ +  + + P+ 
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFT---SASDVWSYGIVMWEVMSYGERPYW 235

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =   99 bits (248), Expect = 3e-25
 Identities = 59/280 (21%), Positives = 90/280 (32%), Gaps = 52/280 (18%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGRED-QAQAIREVEHHKT 79
           +    V  IGEG F  V           +     A+K +      D QA   RE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 80  FVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR------------- 126
           F +PNI+ LL     G           + ++  Y   G L   L                
Sbjct: 73  FDNPNIVKLLGVCAVG---------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 127 -------SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL 179
                  S G   +S  + L +  ++   +    + K +   HRDL T N L+  +    
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVK 180

Query: 180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC 239
           + D G              A   +    +   + +  PE      Y      +DVW+ G 
Sbjct: 181 IADFGLSRNI-------YSADYYKADGNDAIPIRWMPPESI---FYNRYTTESDVWAYGV 230

Query: 240 LLYAM-CYFKSPFDTVYERGDSVALAVISGNI-TFPENTP 277
           +L+ +  Y   P+       + V   V  GNI   PEN P
Sbjct: 231 VLWEIFSYGLQPYYG--MAHEEVIYYVRDGNILACPENCP 268

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-25
 Identities = 46/228 (20%), Positives = 88/228 (38%), Gaps = 29/228 (12%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQ--AQAIREVEHHKTFVHP 83
            KY  +EKIGEG + TV   ++ +T +  ALK++     ++   + A+RE+   K   H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 84  NILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFL 143
           NI+ L D   +           ++ +V  +  +    +  +        +    +     
Sbjct: 62  NIVRLHDVLHSDK---------KLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLF 108

Query: 144 KICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQ 203
           ++ + +   H        HRDLK  N+L+  +    L + G            A    ++
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG---------LARAFGIPVR 156

Query: 204 DVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             +AE  ++ YR P++             D+WS GC+   +     P 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPL 202

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 9e-25
 Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 33/264 (12%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEH---SQTKKRYALKKI----ICHGREDQAQAIREVE 75
           V  + + +++ +G G +  V L+       T K YA+K +    I    +       E +
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             +       L  L +A          + +++ ++L Y   G L   L      +   + 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQ--------TETKLHLILDYINGGELFTHLS----QRERFTE 128

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            ++     +I  A++  H    I   +RD+K  N+LL ++ + +L D G        +  
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGII---YRDIKLENILLDSNGHVVLTDFG--------LSK 177

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF--DT 253
              A   +       ++ Y AP++         D+  D WSLG L+Y +    SPF  D 
Sbjct: 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDG 236

Query: 254 VYERGDSVALAVISGNITFPENTP 277
                  ++  ++     +P+   
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMS 260

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 2e-24
 Identities = 42/259 (16%), Positives = 90/259 (34%), Gaps = 31/259 (11%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR---YALKKI-ICHGREDQAQAIREVEHHK 78
           ++ ++  +   IGEG F  V    +   +      A+K    C     + + ++E    +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 79  TFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDI 138
            F HP+I+ L+                 V +++     G L        V K+ +    +
Sbjct: 64  QFDHPHIVKLIGVITENP----------VWIIMELCTLGEL---RSFLQVRKYSLDLASL 110

Query: 139 LKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAE 198
           +    ++  A+      + +   HRD+   NVL+++++   L D G        +    E
Sbjct: 111 ILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFG--------LSRYME 159

Query: 199 AQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERG 258
                  +  +  + + APE  +   +      +DVW  G  ++ +           +  
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFT---SASDVWMFGVCMWEILMHGVKPFQGVKNN 216

Query: 259 DSVALAVISGNITFPENTP 277
           D +        +  P N P
Sbjct: 217 DVIGRIENGERLPMPPNCP 235

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 2e-24
 Identities = 47/264 (17%), Positives = 98/264 (37%), Gaps = 35/264 (13%)

Query: 21  VYVKSDKYYIVEK-IGEGGFSTVSLIEH--SQTKKRYALKKIICHGREDQA--QAIREVE 75
           VY+      + +K +G G F TV    +   +  K  A+K +     +     + + E  
Sbjct: 1   VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60

Query: 76  HHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSS 135
             +   +P I+ ++                  ++V+     G L   L+       ++  
Sbjct: 61  VMQQLDNPYIVRMIGI----------CEAESWMLVMEMAELGPLNKYLQ----QNRHVKD 106

Query: 136 VDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCG 195
            +I+++  ++   +K   ++  +   HRDL   NVLL   +   + D G      +    
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFG------LSKAL 157

Query: 196 SAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAM-CYFKSPFDTV 254
            A+    +     +  + + APE  +   +     ++DVWS G L++    Y + P+   
Sbjct: 158 RADENYYKAQTHGKWPVKWYAPECINYYKF---SSKSDVWSFGVLMWEAFSYGQKPYRG- 213

Query: 255 YERGDSVALAVISGN-ITFPENTP 277
             +G  V   +  G  +  P   P
Sbjct: 214 -MKGSEVTAMLEKGERMGCPAGCP 236

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 3e-24
 Identities = 46/285 (16%), Positives = 89/285 (31%), Gaps = 51/285 (17%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKR-----YALKKIICHGREDQAQAI-REVEH 76
              +     + +G G F  V         K       A+K +       + +A+  E++ 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 77  HKTFV-HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR--------- 126
                 H NI+ LL              +  + ++  Y   G L N L  +         
Sbjct: 94  MTQLGSHENIVNLLG---------ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144

Query: 127 ----------SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN 176
                         + ++  D+L    ++ + ++       +   HRDL   NVL+ +  
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGK 201

Query: 177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWS 236
              + D G     +          N       R  + + APE      Y     ++DVWS
Sbjct: 202 VVKICDFGLARDIM-------SDSNYVVRGNARLPVKWMAPESLFEGIY---TIKSDVWS 251

Query: 237 LGCLLYAMCYF-KSPFDTVYERGDSVALAVISGNITFPENTPFPQ 280
            G LL+ +     +P+  +    D+    +I       +     +
Sbjct: 252 YGILLWEIFSLGVNPYPGIPV--DANFYKLIQNGFKMDQPFYATE 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.1 bits (243), Expect = 3e-24
 Identities = 48/235 (20%), Positives = 88/235 (37%), Gaps = 28/235 (11%)

Query: 19  EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI--ICHGREDQAQAIREVEH 76
           ++ +    +Y  ++ IG G    V     +   +  A+KK+      +    +A RE+  
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSV 136
            K   H NI+ LL+          L     V +V+                V +  +   
Sbjct: 70  MKCVNHKNIISLLNV---FTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHE 119

Query: 137 DILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGS 196
            +  +  ++   +K  H A  I   HRDLK +N+++ +D    ++D G           +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFG----------LA 166

Query: 197 AEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
             A     +     +  YRAPE+          +  D+WS+GC++  M   K  F
Sbjct: 167 RTAGTSFMMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILF 218

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 4e-24
 Identities = 39/257 (15%), Positives = 84/257 (32%), Gaps = 29/257 (11%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKR----YALKKI-ICHGREDQAQAIREVEHHKTF 80
                 + IG G F  V       +  +     A+K +   +  + +   + E      F
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 81  VHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILK 140
            H NI+ L           V++    ++++  Y   G      +         S + ++ 
Sbjct: 67  SHHNIIRLEG---------VISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVG 114

Query: 141 MFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQ 200
           M   I   +K   +     Y HRDL   N+L+ ++    + D G      +      + +
Sbjct: 115 MLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG------LSRVLEDDPE 165

Query: 201 NLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS 260
                +  +  + + APE      +      +DVWS G +++ +  +           + 
Sbjct: 166 ATYTTSGGKIPIRWTAPEAISYRKFT---SASDVWSFGIVMWEVMTYGERPYWELSNHEV 222

Query: 261 VALAVISGNITFPENTP 277
           +        +  P + P
Sbjct: 223 MKAINDGFRLPTPMDCP 239

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 8e-24
 Identities = 50/277 (18%), Positives = 84/277 (30%), Gaps = 44/277 (15%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSL-----IEHSQTKKRYALKKIICHGREDQAQAI-REVEH 76
              ++    + +G G F  V       +  S      A+K +       + +A+  E++ 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 77  HKTFV-HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL------------ 123
                 H NI+ LL     G            L++  Y   G L N L            
Sbjct: 80  LSYLGNHMNIVNLLGACTIG---------GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130

Query: 124 --ELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM 181
              +    +  +   D+L    ++ + +        I   HRDL   N+LL +     + 
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKIC 187

Query: 182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           D G                N       R  + + AP        CV    +DVWS G  L
Sbjct: 188 DFG-------LARDIKNDSNYVVKGNARLPVKWMAP---ESIFNCVYTFESDVWSYGIFL 237

Query: 242 YAMCYFKSPFDTVYERGDSVALAVISG-NITFPENTP 277
           + +    S               +  G  +  PE+ P
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP 274

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.1 bits (235), Expect = 4e-23
 Identities = 45/240 (18%), Positives = 84/240 (35%), Gaps = 31/240 (12%)

Query: 24  KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKI-----ICHGREDQAQAIREVEH-- 76
           K  +Y +V K+G G FSTV L +        A+K +          ED+ + ++ V    
Sbjct: 11  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 70

Query: 77  ---HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYM 133
                +    +IL LLDH          N    V++               ++      +
Sbjct: 71  NTKEDSMGANHILKLLDH----FNHKGPNGVHVVMVFEVLGEN----LLALIKKYEHRGI 122

Query: 134 SSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKV 193
             + + ++  ++   +   H    I   H D+K  NVL+   ++P            +K+
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSP-------ENLIQIKI 173

Query: 194 CGSAEAQNLQDVAAERCSMP-YRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFD 252
                A    +          YR+PE+     +       D+WS  CL++ +      F+
Sbjct: 174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW---GCGADIWSTACLIFELITGDFLFE 230

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 2e-22
 Identities = 51/268 (19%), Positives = 84/268 (31%), Gaps = 41/268 (15%)

Query: 26  DKYYIVEKIGEGGFSTVSLIEHSQTKKRY--ALKKIICHG-REDQAQAIREVEHHKTFV- 81
           +     + IGEG F  V      +   R   A+K++  +  ++D      E+E       
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 82  HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------G 129
           HPNI+ LL                 + + + Y P G L + L    V             
Sbjct: 70  HPNIINLLGACEHR---------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 130 KHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPA 189
              +SS  +L     +   +      + I   HRDL   N+L+  +    + D G     
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGL---- 173

Query: 190 VVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKS 249
                 S   +        R  + + A E     +Y V    +DVWS G LL+ +     
Sbjct: 174 ------SRGQEVYVKKTMGRLPVRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 250 PFDTVYERGDSVALAVISGNITFPENTP 277
                    +          +  P N  
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCD 252

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 3e-22
 Identities = 56/252 (22%), Positives = 91/252 (36%), Gaps = 44/252 (17%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK-------RYALKKI-ICHGREDQAQAIREV 74
           +  D+  + + +GEG F  V L E     K       + A+K +      +D +  I E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 75  EHHKTFV-HPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELR------- 126
           E  K    H NI+ LL                 + +++ Y  KG L   L+ R       
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDG---------PLYVIVEYASKGNLREYLQARRPPGLEY 120

Query: 127 -----SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM 181
                   +  +SS D++    ++   ++     K I   HRDL   NVL+  DN   + 
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIA 177

Query: 182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLL 241
           D                    +     R  + + APE      Y     ++DVWS G LL
Sbjct: 178 DF-------GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLL 227

Query: 242 YAM-CYFKSPFD 252
           + +     SP+ 
Sbjct: 228 WEIFTLGGSPYP 239

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 3e-21
 Identities = 45/267 (16%), Positives = 91/267 (34%), Gaps = 34/267 (12%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSLIEH-----SQTKKRYALKKI-ICHGREDQAQAIREVEH 76
           V  +K  +  ++G+G F  V           + + R A+K +       ++ + + E   
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDL------ELRSVGK 130
            K F   +++ LL     G            L+++    +G L + L         +   
Sbjct: 77  MKEFNCHHVVRLLGVVSQG---------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127

Query: 131 HYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAV 190
              S   +++M  +I + +   +  K +   HRDL   N ++A D    + D G      
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFG------ 178

Query: 191 VKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSP 250
                  E    +        + + +PE      +      +DVWS G +L+ +      
Sbjct: 179 -MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF---TTYSDVWSFGVVLWEIATLAEQ 234

Query: 251 FDTVYERGDSVALAVISGNITFPENTP 277
                     +   +  G +  P+N P
Sbjct: 235 PYQGLSNEQVLRFVMEGGLLDKPDNCP 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 9e-19
 Identities = 44/267 (16%), Positives = 90/267 (33%), Gaps = 25/267 (9%)

Query: 23  VKSDKYYIVEKIGEGGFSTVSL-----IEHSQTKKRYALKKI-ICHGREDQAQAIREVEH 76
              D+  + + +G G F  V       I+ + T +  A+K +       +    + E++ 
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 77  HKTFVHPNILPLLDHALTGCADPVLNSTSQV-----LMVLPYYPKGTLANDLELRSVGKH 131
                H   +  L  A T    P++              L       +   +    + K 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 132 YMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVV 191
           +++   ++    ++ + ++     K I   HRDL   N+LL+  N   + D G       
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGL------ 180

Query: 192 KVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPF 251
                 +  +       R  + + APE      Y     ++DVWS G LL+ +    +  
Sbjct: 181 -ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASP 236

Query: 252 DTVYERGDSVALAVISGN-ITFPENTP 277
               +  +     +  G  +  P+ T 
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTT 263

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.2 bits (106), Expect = 2e-06
 Identities = 23/156 (14%), Positives = 47/156 (30%), Gaps = 11/156 (7%)

Query: 30  IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLL 89
           I + +GEG  S V      +      +K         +    +       F    I    
Sbjct: 4   IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 90  DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAV 149
           +          L     + +   Y  +G       + +   + +   +  ++   I E V
Sbjct: 63  NEF------RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS 185
             F+    +   H DL   NVL+ ++    ++D   
Sbjct: 117 AKFYHRGIV---HGDLSQYNVLV-SEEGIWIIDFPQ 148

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	282
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.09
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.28
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.76

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=336.28  Aligned_cols=211  Identities=26%  Similarity=0.464  Sum_probs=167.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|++++.||+|+||+||+|+++.+|..||||.+....  ....+.+.+|++++++++||||+++++.+...       
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-------   75 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR-------   75 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--------
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC-------
Confidence            478999999999999999999999999999999986553  33456788999999999999999999866532       


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--CCccccCCCCCcEEeecCCCcee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKP--IAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~--~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      ....+++|||||++|+|.+.+.........+++..++.++.|++.||.|||++..  -+|+||||||+||+++.++.+|+
T Consensus        76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence            2356899999999999999987665556679999999999999999999998620  03999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +|||+++..         ...........||+.|+|||++.+..+   +.++|||||||++|||+||+.||.+.
T Consensus       156 ~DFG~a~~~---------~~~~~~~~~~~gt~~Y~APE~l~~~~~---~~~~DIwSlGvilyel~tg~~Pf~~~  217 (269)
T d2java1         156 GDFGLARIL---------NHDTSFAKAFVGTPYYMSPEQMNRMSY---NEKSDIWSLGCLLYELCALMPPFTAF  217 (269)
T ss_dssp             CCHHHHHHC--------------------CCCSCCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eeccceeec---------ccCCCccccCCCCcccCCHHHHcCCCC---ChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence            999976432         111112234568999999999988776   88999999999999999999999763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=336.37  Aligned_cols=221  Identities=26%  Similarity=0.377  Sum_probs=184.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||+||+|+++.++..||+|.+....   ......+.+|+.+++.++||||+++++++.        
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--------   76 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--------   76 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--------
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE--------
Confidence            478999999999999999999999999999999885322   233557789999999999999999999544        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +...+++||||+++|+|.+.+...    ..+++..+..++.||+.||.|||++   ||+||||||+||+++.++.+|++
T Consensus        77 -~~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~  148 (263)
T d2j4za1          77 -DATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  148 (263)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             -ECCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeec
Confidence             457899999999999999988643    4589999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||++....           ........||+.|+|||++.+..+   +.++||||+||++|||++|+.||.+.  ....+
T Consensus       149 DFG~a~~~~-----------~~~~~~~~Gt~~Y~APE~~~~~~~---~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~  212 (263)
T d2j4za1         149 DFGWSVHAP-----------SSRRTTLCGTLDYLPPEMIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEAN--TYQET  212 (263)
T ss_dssp             CCCSCSCCC-----------CCCCEETTEEGGGCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHH
T ss_pred             ccceeeecC-----------CCcccccCCCCcccCHHHHcCCCC---CchhhhhhHhHHHHHHhcCCCCCCCC--CHHHH
Confidence            999875321           011223468999999999998876   88999999999999999999999763  23334


Q ss_pred             eeeeeeccccCCCCCC
Q psy16951        262 ALAVISGNITFPENTP  277 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~~  277 (282)
                      ...+....+.+|+..|
T Consensus       213 ~~~i~~~~~~~p~~~s  228 (263)
T d2j4za1         213 YKRISRVEFTFPDFVT  228 (263)
T ss_dssp             HHHHHTTCCCCCTTSC
T ss_pred             HHHHHcCCCCCCccCC
Confidence            4455667777776654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-50  Score=337.63  Aligned_cols=226  Identities=23%  Similarity=0.337  Sum_probs=184.1

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      ..++|++++.||+|+||+||+|++..++..||||.+....   ......+.+|++++++++||||+++++++        
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--------   77 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--------   77 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE--------
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE--------
Confidence            3478999999999999999999999999999999985332   22345688999999999999999999854        


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                       .+...+++||||+++|+|.+.+...    ..+++..+..++.|++.||.|+|++   ||+||||||+||+++.++.+|+
T Consensus        78 -~~~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl  149 (288)
T d1uu3a_          78 -QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQI  149 (288)
T ss_dssp             -ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             -EECCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEe
Confidence             4457899999999999999877643    4589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||+++....       ...........||+.|+|||++.+..+   +.++||||+||++|||+||+.||.+.  ....
T Consensus       150 ~DFG~a~~~~~-------~~~~~~~~~~~GT~~Y~APE~~~~~~~---~~~~DiwSlGvilyell~g~~Pf~~~--~~~~  217 (288)
T d1uu3a_         150 TDFGTAKVLSP-------ESKQARANSFVGTAQYVSPELLTEKSA---CKSSDLWALGCIIYQLVAGLPPFRAG--NEYL  217 (288)
T ss_dssp             CCCTTCEECC-----------------CCCCGGGCCHHHHHTCCC---CHHHHHHHHHHHHHHHHHSSCSSCCS--SHHH
T ss_pred             cccccceeccc-------CCcccccccccCCccccCceeeccCCC---CcccceehhhHHHHHHhhCCCCCCCc--CHHH
Confidence            99998753210       111122334568999999999998877   88999999999999999999999863  2333


Q ss_pred             eeeeeeeccccCCCCCC
Q psy16951        261 VALAVISGNITFPENTP  277 (282)
Q Consensus       261 ~~~~~~~~~~~~p~~~~  277 (282)
                      +...+..+++.+|+..+
T Consensus       218 ~~~~i~~~~~~~p~~~s  234 (288)
T d1uu3a_         218 IFQKIIKLEYDFPEKFF  234 (288)
T ss_dssp             HHHHHHTTCCCCCTTCC
T ss_pred             HHHHHHcCCCCCCccCC
Confidence            44456677777776554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=335.27  Aligned_cols=207  Identities=24%  Similarity=0.366  Sum_probs=176.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .|.|+++++||+|+||+||+|++..++..||||++........+.+.+|++++++++||||+++++++.         +.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~---------~~   81 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY---------YE   81 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE---------ET
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---------eC
Confidence            467999999999999999999999999999999998777777778899999999999999999999554         35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++||||+++|+|.+.+...   ...+++.++..++.||+.||.|||++   ||+||||||+||+++.++.+|++|||
T Consensus        82 ~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          82 NNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence            7899999999999999877643   34589999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc--cCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY--CVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~--~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      ++...         ...........||+.|+|||++.+...  .+++.++||||+||++|||+||+.||.+..
T Consensus       156 ~a~~~---------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         156 VSAKN---------TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             TCEEC---------HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             hhhcc---------CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence            86421         111223345678999999999853321  124789999999999999999999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=341.26  Aligned_cols=226  Identities=21%  Similarity=0.338  Sum_probs=188.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      |..++|++++.||+|+||+||+|++..++..||||++...   .......+.+|+.+++.++||||+++++.+       
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-------   74 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-------   74 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-------
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-------
Confidence            3567999999999999999999999999999999998533   222356678999999999999999999844       


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                        .+...+++||||+++|+|.+.+..    ...+++..++.++.|++.||.|+|++   ||+||||||+|||++.++.+|
T Consensus        75 --~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk  145 (337)
T d1o6la_          75 --QTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             --ccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence              456889999999999999988764    34589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      ++|||+++...         ..........||+.|+|||++.+..|   +.++||||+||++|||++|++||.+.+  ..
T Consensus       146 l~DFG~a~~~~---------~~~~~~~~~~GT~~Y~aPE~~~~~~y---~~~~DiwSlGvilyeml~G~~pf~~~~--~~  211 (337)
T d1o6la_         146 ITDFGLCKEGI---------SDGATMKTFCGTPEYLAPEVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQD--HE  211 (337)
T ss_dssp             ECCCTTCBCSC---------CTTCCBCCCEECGGGCCGGGGSSSCB---CTTHHHHHHHHHHHHHHHSSCSSCCSS--HH
T ss_pred             Eeecccccccc---------cCCcccccceeCHHHhhhhhccCCCC---ChhhcccchhhHHHHHHHCCCCCCCcC--HH
Confidence            99999875321         01112234568999999999999887   889999999999999999999998633  33


Q ss_pred             ceeeeeeeccccCCCCCCC
Q psy16951        260 SVALAVISGNITFPENTPF  278 (282)
Q Consensus       260 ~~~~~~~~~~~~~p~~~~~  278 (282)
                      .+...+..+.+.+|+..++
T Consensus       212 ~~~~~i~~~~~~~p~~~s~  230 (337)
T d1o6la_         212 RLFELILMEEIRFPRTLSP  230 (337)
T ss_dssp             HHHHHHHHCCCCCCTTSCH
T ss_pred             HHHHHHhcCCCCCCccCCH
Confidence            3444566677788776543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-50  Score=334.90  Aligned_cols=206  Identities=24%  Similarity=0.377  Sum_probs=171.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++++.||+|+||+||+|+++.++..||||++..... ...+.+.+|++++++++||||+++++++.         +
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~---------~   74 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR---------E   74 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE---------E
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec---------c
Confidence            4789999999999999999999999999999999865433 23456789999999999999999999554         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...+++||||+++|+|.+.+.    ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++||
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             CceeEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccc
Confidence            578999999999999998774    335689999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |++......       ..........||+.|+|||++.+..+  .+.++||||+||++|||+||+.||....
T Consensus       148 G~a~~~~~~-------~~~~~~~~~~GT~~Y~APE~~~~~~~--~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         148 GLATVFRYN-------NRERLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             TTCEECEET-------TEECCBCCCCSCGGGSCTHHHHCSSB--CHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             hhheeeccC-------CccccccceeeCcCccCHhHhcCCCC--CCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence            987632110       01111234568999999999988765  2568999999999999999999997543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=335.65  Aligned_cols=201  Identities=25%  Similarity=0.368  Sum_probs=175.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|+++++||+|+||+||+|++..+|..||||++........+.+.+|++++++++||||+++++.+..         .
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---------~   89 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV---------G   89 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE---------T
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE---------C
Confidence            4689999999999999999999999999999999976666667788999999999999999999996544         4


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++|||||++|+|.+.+..     ..+++.++..++.||+.||.|||++   ||+||||||+||+++.++.+|++|||
T Consensus        90 ~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          90 DELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccch
Confidence            789999999999999986642     3589999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.....         .........||+.|+|||++.+..+   +.++||||+||++|+|+||..||.+.
T Consensus       162 ~a~~~~~---------~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~~DiwSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         162 FCAQITP---------EQSKRSTMVGTPYWMAPEVVTRKAY---GPKVDIWSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             TCEECCS---------TTCCBCCCCSCGGGCCHHHHSSSCB---CTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hheeecc---------ccccccccccCCCccChhhhcCCCC---CchhceehHhHHHHHHhhCCCCCCCC
Confidence            8753210         1112234568999999999998877   88999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=335.99  Aligned_cols=203  Identities=20%  Similarity=0.276  Sum_probs=174.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      +..++|+++++||+|+||+||+|++..+|..||+|++.... ......+.+|+.++++++||||+++++.+.        
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--------   74 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--------   74 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--------
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--------
Confidence            56789999999999999999999999999999999986543 344567889999999999999999999554        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +...+++||||+++|+|.+.+...    ..+++..+..++.|++.||.|||++.  ||+||||||+|||++.++.+|++
T Consensus        75 -~~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          75 -SDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             -CSSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEEC
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEe
Confidence             457899999999999999988643    45899999999999999999999742  69999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....           ........||+.|+|||++.+..|   +.++||||+||++|||++|+.||.+.
T Consensus       148 DFGla~~~~-----------~~~~~~~~GT~~Y~APEvl~~~~y---~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         148 DFGVSGQLI-----------DSMANSFVGTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCCCCHHHH-----------HHTC---CCSSCCCCHHHHHCSCC---CTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             eCCCccccC-----------CCccccccCCccccCchHHcCCCC---CcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            999865321           112234578999999999998877   89999999999999999999999764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-49  Score=335.91  Aligned_cols=236  Identities=19%  Similarity=0.292  Sum_probs=186.6

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      +-+.|.|+.++|++.++||+|+||+||+|.+..++..||||++... ....+++.+|+.++++++||||+++++.+.   
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~---   83 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT---   83 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe---
Confidence            3456889999999999999999999999999999999999988644 344567899999999999999999999554   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                            +....+++|||+++|+|.+.+...  ....+++..++.++.|++.||.|||++   ||+||||||+|||++.++
T Consensus        84 ------~~~~~~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~  152 (287)
T d1opja_          84 ------REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENH  152 (287)
T ss_dssp             ------SSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             ------eCCeeEEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCC
Confidence                  346789999999999999988643  345689999999999999999999999   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+||+|||+++...        ...........||+.|+|||++.+..+   +.++|||||||++|||++|..||....+
T Consensus       153 ~~Kl~DFG~a~~~~--------~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~k~DiwS~Gv~l~ell~~~~p~~~~~~  221 (287)
T d1opja_         153 LVKVADFGLSRLMT--------GDTYTAHAGAKFPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGID  221 (287)
T ss_dssp             CEEECCCCCTTTCC--------SSSSEEETTEEECGGGCCHHHHHHCCC---SHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cEEEccccceeecC--------CCCceeeccccccccccChHHHcCCCC---CchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence            99999999875321        011111223457888999999988776   8899999999999999997766543222


Q ss_pred             CccceeeeeeeccccCCCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ..........+.++..|+..|.
T Consensus       222 ~~~~~~~i~~~~~~~~~~~~~~  243 (287)
T d1opja_         222 LSQVYELLEKDYRMERPEGCPE  243 (287)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHHHHhcCCCCCCCccchH
Confidence            2211111112234566665553

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=332.29  Aligned_cols=211  Identities=18%  Similarity=0.280  Sum_probs=172.1

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      ++|.|+.++|++.+.||+|+||+||+|++.+   .||||++...  .....+.+.+|++++++++||||+++++++.   
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---   74 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---   74 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---
Confidence            4678999999999999999999999998743   5999998644  3445678899999999999999999998532   


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                             ...+++||||+++|+|.+.+..   ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        75 -------~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~  141 (276)
T d1uwha_          75 -------APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDL  141 (276)
T ss_dssp             -------SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTS
T ss_pred             -------ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCC
Confidence                   2457999999999999998853   234589999999999999999999998   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .+||+|||++....       ............||+.|+|||++.+....+++.++|||||||++|||+||+.||.+..
T Consensus       142 ~~Kl~DFGla~~~~-------~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         142 TVKIGDFGLATVKS-------RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             SEEECCCCCSCC-------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CEEEccccceeecc-------ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence            99999999875321       0111112234568999999999976544445889999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-48  Score=331.85  Aligned_cols=218  Identities=25%  Similarity=0.392  Sum_probs=166.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .+.|++.+.||+|+||+||+|++..++..||||.+..... .....+.+|+.+++.++||||+++++++         .+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~---------~~   78 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY---------ES   78 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE---------EC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE---------EE
Confidence            4679999999999999999999999999999999865433 2345677899999999999999999854         34


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee---cCCCcee
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA---NDNNPLL  180 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~~~  180 (282)
                      ...+++|||||++|+|.+.+.    ....+++..+..++.||+.||.|||++   ||+||||||+||++.   .++.+|+
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl  151 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMI  151 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             CCEEEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEE
Confidence            578999999999999999886    345699999999999999999999999   899999999999995   4788999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||++....          .........||+.|+|||++.+..|   +.++||||+||++|||++|+.||.+..  ...
T Consensus       152 ~DFG~a~~~~----------~~~~~~~~~GT~~y~APE~~~~~~~---~~~~DiwSlGvilyell~g~~Pf~~~~--~~~  216 (307)
T d1a06a_         152 SDFGLSKMED----------PGSVLSTACGTPGYVAPEVLAQKPY---SKAVDCWSIGVIAYILLCGYPPFYDEN--DAK  216 (307)
T ss_dssp             CCC----------------------------CTTSCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred             eccceeEEcc----------CCCeeeeeeeCccccCcHHHcCCCC---CcHHHhhhhhHHHHHHHhCCCCCCCCC--HHH
Confidence            9999865221          1112234568999999999998876   889999999999999999999997632  233


Q ss_pred             eeeeeeeccccCC
Q psy16951        261 VALAVISGNITFP  273 (282)
Q Consensus       261 ~~~~~~~~~~~~p  273 (282)
                      +...+..+.+.+|
T Consensus       217 ~~~~i~~~~~~~~  229 (307)
T d1a06a_         217 LFEQILKAEYEFD  229 (307)
T ss_dssp             HHHHHHTTCCCCC
T ss_pred             HHHHHhccCCCCC
Confidence            3344555554444

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-48  Score=332.16  Aligned_cols=220  Identities=22%  Similarity=0.333  Sum_probs=183.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++++.||+|+||+||+|+++.+|..||||++...   .....+.+.+|+.+++.++||||+++++++.        
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--------   74 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--------   74 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--------
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe--------
Confidence            47899999999999999999999999999999998532   2233567889999999999999999999544        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                       +...+++||||+.++++...+..    ...+++..+..++.||+.||.|+|++   ||+||||||+|||++.++.+|++
T Consensus        75 -~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          75 -DAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             -eCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEe
Confidence             45789999999999999887763    34578899999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccce
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSV  261 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~  261 (282)
                      |||+++...            .......||+.|+|||++.+..|   +.++||||+||++|||+||+.||.+.  ....+
T Consensus       147 DFG~a~~~~------------~~~~~~~Gt~~Y~APE~l~~~~y---~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~  209 (316)
T d1fota_         147 DFGFAKYVP------------DVTYTLCGTPDYIAPEVVSTKPY---NKSIDWWSFGILIYEMLAGYTPFYDS--NTMKT  209 (316)
T ss_dssp             CCSSCEECS------------SCBCCCCSCTTTCCHHHHTTCCB---CTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHH
T ss_pred             cCccceEec------------cccccccCcccccCHHHHcCCCC---CchhhccccchhHHHHHhCCCCCCCc--CHHHH
Confidence            999875321            11224578999999999998877   88999999999999999999999763  22334


Q ss_pred             eeeeeeccccCCCCCC
Q psy16951        262 ALAVISGNITFPENTP  277 (282)
Q Consensus       262 ~~~~~~~~~~~p~~~~  277 (282)
                      ...+..+.+.+|+..+
T Consensus       210 ~~~i~~~~~~~p~~~s  225 (316)
T d1fota_         210 YEKILNAELRFPPFFN  225 (316)
T ss_dssp             HHHHHHCCCCCCTTSC
T ss_pred             HHHHHcCCCCCCCCCC
Confidence            4455666677776554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-49  Score=328.49  Aligned_cols=234  Identities=19%  Similarity=0.295  Sum_probs=181.8

Q ss_pred             ccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccC
Q psy16951         17 SKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGC   96 (282)
Q Consensus        17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~   96 (282)
                      .++.|.|+.++|++.++||+|+||+||+|++. ++.+||||++.... .....+.+|++++++++||||+++++++..  
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--   79 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--   79 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--
Confidence            46788999999999999999999999999985 67789999986443 345678999999999999999999985432  


Q ss_pred             CCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN  176 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~  176 (282)
                              ...++||||+++|+|.+.+....  ...+++..++.++.||+.||.|||++   +|+||||||+||+++.++
T Consensus        80 --------~~~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~  146 (272)
T d1qpca_          80 --------EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTL  146 (272)
T ss_dssp             --------SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred             --------CCeEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeeccc
Confidence                    34689999999999998665332  23489999999999999999999998   899999999999999999


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      .+||+|||+++...        ...........+|+.|+|||++.+..+   +.++|||||||++|||+||..|+.....
T Consensus       147 ~~Kl~DFGla~~~~--------~~~~~~~~~~~gt~~y~APE~~~~~~~---~~~sDvwS~Gvvl~ellt~~~~~~~~~~  215 (272)
T d1qpca_         147 SCKIADFGLARLIE--------DNEYTAREGAKFPIKWTAPEAINYGTF---TIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (272)
T ss_dssp             CEEECCCTTCEECS--------SSCEECCTTCCCCTTTSCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ceeeccccceEEcc--------CCccccccccCCcccccChHHHhCCCC---CchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence            99999999876321        011111234467889999999988776   8899999999999999996554433222


Q ss_pred             CccceeeeeeeccccCCCCCCC
Q psy16951        257 RGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ..+.........++..|+..|.
T Consensus       216 ~~~~~~~i~~~~~~~~p~~~~~  237 (272)
T d1qpca_         216 NPEVIQNLERGYRMVRPDNCPE  237 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCH
T ss_pred             HHHHHHHHHhcCCCCCcccChH
Confidence            2221111122234566665553

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=318.12  Aligned_cols=204  Identities=22%  Similarity=0.322  Sum_probs=169.5

Q ss_pred             ccE-EEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         26 DKY-YIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        26 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++| ++.++||+|+||+||+|.+..++..||+|.+...  .....+.+.+|++++++++||||+++++.+..     ...
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~   82 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES-----TVK   82 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----ESS
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-----ccc
Confidence            345 7788999999999999999999999999998644  33445678899999999999999999997654     233


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee-cCCCceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA-NDNNPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~~~~~~~  181 (282)
                      ....+++||||+++|+|.+.+...    ..+++..+..++.||+.||.|||++.. +|+||||||+|||++ .++.+|++
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEe
Confidence            456789999999999999988643    458999999999999999999999832 299999999999996 47899999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....           ........||+.|+|||++.+. +   +.++||||+||++|||++|+.||.+.
T Consensus       158 DFGla~~~~-----------~~~~~~~~GT~~Y~aPE~~~~~-~---~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         158 DLGLATLKR-----------ASFAKAVIGTPEFMAPEMYEEK-Y---DESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             CTTGGGGCC-----------TTSBEESCSSCCCCCGGGGGTC-C---CTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ecCcceecc-----------CCccCCcccCccccCHHHhCCC-C---CCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            999864210           1112345689999999998753 4   89999999999999999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.5e-48  Score=335.21  Aligned_cols=220  Identities=22%  Similarity=0.361  Sum_probs=182.4

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      ++|++++.||+|+||+||+|++..+|..||||.+......+...+.+|++++++++||||+++++++         .+..
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~---------~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---------EDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE---------ECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE---------EECC
Confidence            6799999999999999999999999999999999877666777888999999999999999999954         4457


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEee--cCCCceeecc
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLA--NDNNPLLMDL  183 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~--~~~~~~~~df  183 (282)
                      .+++|||||++|+|.+.+..   ....+++.+++.++.||+.||.|||++   ||+||||||+|||++  .++.+|++||
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence            89999999999999876542   234589999999999999999999998   899999999999997  5688999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceee
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVAL  263 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~  263 (282)
                      |++....          .........||+.|+|||++.+..+   +.++||||+||++|||+||..||.+...  ..+..
T Consensus       174 Gla~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~  238 (352)
T d1koba_         174 GLATKLN----------PDEIVKVTTATAEFAAPEIVDREPV---GFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQ  238 (352)
T ss_dssp             TTCEECC----------TTSCEEEECSSGGGCCHHHHTTCCB---CHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHH
T ss_pred             ccceecC----------CCCceeeccCcccccCHHHHcCCCC---CCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence            9875321          1111234567899999999998877   8899999999999999999999976322  23333


Q ss_pred             eeeeccccCCCC
Q psy16951        264 AVISGNITFPEN  275 (282)
Q Consensus       264 ~~~~~~~~~p~~  275 (282)
                      .+..+.+.+|+.
T Consensus       239 ~i~~~~~~~~~~  250 (352)
T d1koba_         239 NVKRCDWEFDED  250 (352)
T ss_dssp             HHHHCCCCCCSS
T ss_pred             HHHhCCCCCCcc
Confidence            455555555543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-48  Score=328.24  Aligned_cols=201  Identities=22%  Similarity=0.300  Sum_probs=170.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .+.|+++++||+|+||+||+|++..++..||||++......   ..+.+.+|+.++++++||||+++++++..       
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------   86 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------   86 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-------
Confidence            35699999999999999999999999999999998755432   34568899999999999999999996544       


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                        ...+++|||||.+|++...+.    ....+++.+++.++.||+.||.|||++   ||+||||||+|||++.++.+|++
T Consensus        87 --~~~~~iv~E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          87 --EHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             --TTEEEEEEECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             --CCEEEEEEEecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEe
Confidence              478999999999998865543    235689999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||++....             ......||+.|+|||++.+.....++.++|||||||++|||++|..||.+.
T Consensus       158 DFG~a~~~~-------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~  217 (309)
T d1u5ra_         158 DFGSASIMA-------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (309)
T ss_dssp             CCTTCBSSS-------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ecccccccC-------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence            999865321             112346899999999997644333488999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=319.73  Aligned_cols=203  Identities=24%  Similarity=0.450  Sum_probs=163.1

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      |+.++|++.++||+|+||+||+|++. ++..||||++... ....+++.+|++++++++||||+++++++..        
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--------   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--------   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc--------
Confidence            56789999999999999999999985 5678999998654 3445678999999999999999999996543        


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                       ....++||||+++|+|.+.+..   ....+++..++.++.|++.||.|+|++   +|+||||||+||+++.++.+||+|
T Consensus        72 -~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~D  144 (263)
T d1sm2a_          72 -QAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD  144 (263)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECS
T ss_pred             -CCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecc
Confidence             4678999999999999997753   335578899999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhC-CCCCCc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYF-KSPFDT  253 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg-~~pf~~  253 (282)
                      ||+++..        ............||+.|+|||++.+..+   +.++||||||+++|||+|+ .+||..
T Consensus       145 FGla~~~--------~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         145 FGMTRFV--------LDDQYTSSTGTKFPVKWASPEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             CC--------------------------CTTSCCHHHHTTCCC---CHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             cchheec--------cCCCceeecceecCcccCChHHhcCCCC---CchhhhcchHHHHHHHHHCCCCCCCC
Confidence            9986532        1111112233467899999999998776   8899999999999999995 566653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.1e-48  Score=333.34  Aligned_cols=219  Identities=24%  Similarity=0.396  Sum_probs=181.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|++++.||+|+||+||+|++..+|..||||++......+.+.+.+|+.++++++||||+++++++.         +.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~---------~~   95 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE---------DD   95 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE---------ET
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE---------EC
Confidence            468999999999999999999999999999999998777777788899999999999999999999544         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec--CCCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN--DNNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~~~~d  182 (282)
                      ..+++||||+++|+|.+.+..   ....+++..+..++.||+.||.|||++   |++||||||+||++..  ++.+|++|
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             CEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEee
Confidence            789999999999999987742   234589999999999999999999999   8999999999999954  57899999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++....          .........||+.|+|||++.+..+   +.++||||+||++|||++|..||.+..  ...+.
T Consensus       170 FG~a~~~~----------~~~~~~~~~gT~~Y~aPEv~~~~~~---~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~  234 (350)
T d1koaa2         170 FGLTAHLD----------PKQSVKVTTGTAEFAAPEVAEGKPV---GYYTDMWSVGVLSYILLSGLSPFGGEN--DDETL  234 (350)
T ss_dssp             CTTCEECC----------TTSCEEEECSCTTTCCHHHHHTCCB---CHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH
T ss_pred             cchheecc----------cccccceecCcccccCHHHHcCCCC---ChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHH
Confidence            99865321          1111234568999999999998877   889999999999999999999997532  22333


Q ss_pred             eeeeeccccCC
Q psy16951        263 LAVISGNITFP  273 (282)
Q Consensus       263 ~~~~~~~~~~p  273 (282)
                      ..+..+.+..|
T Consensus       235 ~~i~~~~~~~~  245 (350)
T d1koaa2         235 RNVKSCDWNMD  245 (350)
T ss_dssp             HHHHHTCCCSC
T ss_pred             HHHHhCCCCCC
Confidence            34444444443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=332.51  Aligned_cols=222  Identities=21%  Similarity=0.314  Sum_probs=185.2

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhhhCCCCCcccccccccccCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADP   99 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~   99 (282)
                      ...++|+++++||+|+||+||+|+++.+|..||||++....   ....+.+.+|+.+++.++||||+++++.+.      
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------  111 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK------  111 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE------
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc------
Confidence            34589999999999999999999999999999999985321   223456789999999999999999998544      


Q ss_pred             CCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCce
Q psy16951        100 VLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPL  179 (282)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~  179 (282)
                         .....++|+|++.+|+|...+...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+|
T Consensus       112 ---~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ik  181 (350)
T d1rdqe_         112 ---DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ---cccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEE
Confidence               457899999999999999888643    4589999999999999999999999   899999999999999999999


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGD  259 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~  259 (282)
                      |+|||+++...            .......||+.|+|||++.+..+   +.++||||+||++|||+||+.||.+.  ...
T Consensus       182 L~DFG~a~~~~------------~~~~~~~Gt~~Y~APE~~~~~~~---~~~~DiwSlGvilyemltG~~Pf~~~--~~~  244 (350)
T d1rdqe_         182 VTDFGFAKRVK------------GRTWTLCGTPEALAPEIILSKGY---NKAVDWWALGVLIYEMAAGYPPFFAD--QPI  244 (350)
T ss_dssp             ECCCTTCEECS------------SCBCCCEECGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCS--SHH
T ss_pred             eeeceeeeecc------------cccccccCccccCCHHHHcCCCC---CccccccchhHHHHHHHhCCCCCCCc--CHH
Confidence            99999876321            11123568999999999998877   88999999999999999999999763  233


Q ss_pred             ceeeeeeeccccCCCCCC
Q psy16951        260 SVALAVISGNITFPENTP  277 (282)
Q Consensus       260 ~~~~~~~~~~~~~p~~~~  277 (282)
                      .+...+..+.+.+|+..+
T Consensus       245 ~~~~~i~~~~~~~p~~~s  262 (350)
T d1rdqe_         245 QIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             HHHHHHHHCCCCCCTTCC
T ss_pred             HHHHHHhcCCCCCCccCC
Confidence            444455666667766554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-48  Score=330.57  Aligned_cols=241  Identities=19%  Similarity=0.254  Sum_probs=182.2

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCc-----eEEEEEeccCC-chhHHHHHHHHHHhhhC-CCCCcccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK-----RYALKKIICHG-REDQAQAIREVEHHKTF-VHPNILPL   88 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~-~~~~~~~~~e~~~l~~l-~H~ni~~~   88 (282)
                      ..+..|.++.++|++.++||+|+||+||+|++..++.     .||+|.+.... ......+.+|+.+++++ +||||+++
T Consensus        27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3345677899999999999999999999999876553     69999885433 33455788999999998 89999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHH
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV-------------------GKHYMSSVDILKMFLKICEAV  149 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~l~~~~~~~~~~qi~~~l  149 (282)
                      ++++.         +...+++|||||++|+|.+++.....                   ....+++..++.++.|++.||
T Consensus       107 ~~~~~---------~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl  177 (325)
T d1rjba_         107 LGACT---------LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM  177 (325)
T ss_dssp             EEEEC---------SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred             EEEEe---------eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence            99544         45679999999999999998864211                   123478899999999999999


Q ss_pred             HHhhcCCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCC
Q psy16951        150 KVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVD  229 (282)
Q Consensus       150 ~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~  229 (282)
                      .|||++   +|+||||||+||+++.++.+||+|||+++....       ...........||+.|+|||++.+..+   +
T Consensus       178 ~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~-------~~~~~~~~~~~gt~~y~aPE~l~~~~~---~  244 (325)
T d1rjba_         178 EFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS-------DSNYVVRGNARLPVKWMAPESLFEGIY---T  244 (325)
T ss_dssp             HHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGG-------CTTSEEETTEEECGGGCCHHHHHHCCC---C
T ss_pred             HHHHhC---CeeeccCchhccccccCCeEEEeeccccccccC-------CCceeeeccccCCCccCChHHHcCCCC---C
Confidence            999999   899999999999999999999999998753211       001111223456889999999988776   8


Q ss_pred             CccchhhHHHHHHHHHh-CCCCCCccccCccceeeeeeeccccCCCCCCC
Q psy16951        230 QRTDVWSLGCLLYAMCY-FKSPFDTVYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       230 ~~~Diws~G~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      .++|||||||++|||+| |..||.+.........+...+.++..|+.+|.
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~  294 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE  294 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCH
Confidence            89999999999999998 89999864332221111112224556665553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=322.78  Aligned_cols=232  Identities=19%  Similarity=0.343  Sum_probs=182.3

Q ss_pred             cEEEecccEEEEE-EeccCCceEEEEEEecC--CCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         20 AVYVKSDKYYIVE-KIGEGGFSTVSLIEHSQ--TKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        20 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .+.++.++|.+.+ +||+|+||+||+|.++.  ++..||||.+.... ....+.+.+|++++++++||||+++++++.. 
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            4567889999998 49999999999998764  45579999986543 3446788999999999999999999985432 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ..+++||||+++|+|.+++..   ....+++..++.++.|++.||.|||++   +++||||||+||+++.+
T Consensus        81 ---------~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~  145 (285)
T d1u59a_          81 ---------EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNR  145 (285)
T ss_dssp             ---------SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEET
T ss_pred             ---------CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccC
Confidence                     358999999999999987642   234689999999999999999999998   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.+|++|||+++.....      ...........||+.|+|||++.+..+   +.++|||||||++|||+| |+.||.+.
T Consensus       146 ~~~Kl~DFGla~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDVwS~Gv~l~E~lt~G~~Pf~~~  216 (285)
T d1u59a_         146 HYAKISDFGLSKALGAD------DSYYTARSAGKWPLKWYAPECINFRKF---SSRSDVWSYGVTMWEALSYGQKPYKKM  216 (285)
T ss_dssp             TEEEECCCTTCEECTTC------SCEECCCCSSCCCGGGCCHHHHHHCEE---CHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             Cceeeccchhhhccccc------ccccccccccccCccccChHHHhCCCC---CccchhhcchHHHHHHHhCCCCCCCCC
Confidence            99999999987643111      001111223457889999999988776   889999999999999998 89999864


Q ss_pred             ccCccceeeeee-eccccCCCCCCC
Q psy16951        255 YERGDSVALAVI-SGNITFPENTPF  278 (282)
Q Consensus       255 ~~~~~~~~~~~~-~~~~~~p~~~~~  278 (282)
                      ..  ..+...+. +.++..|+++|+
T Consensus       217 ~~--~~~~~~i~~~~~~~~p~~~~~  239 (285)
T d1u59a_         217 KG--PEVMAFIEQGKRMECPPECPP  239 (285)
T ss_dssp             CT--HHHHHHHHTTCCCCCCTTCCH
T ss_pred             CH--HHHHHHHHcCCCCCCCCcCCH
Confidence            32  22222233 335677777764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=326.43  Aligned_cols=224  Identities=21%  Similarity=0.331  Sum_probs=182.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC---chhHHHHHHHHHHhh-hCCCCCcccccccccccCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG---REDQAQAIREVEHHK-TFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~e~~~l~-~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      .|+|+++++||+|+||+||+|.+..+++.||||++....   ....+.+..|..++. .++||||+++++.+.       
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-------   73 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-------   73 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-------
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-------
Confidence            478999999999999999999999999999999985321   223345566777654 689999999999544       


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        +...+++||||+++|+|.+++...    ..+++.++..++.||+.||.|||++   +++||||||+|||++.++.+|+
T Consensus        74 --~~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl  144 (320)
T d1xjda_          74 --TKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  144 (320)
T ss_dssp             --CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             --cCCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceec
Confidence              457899999999999999988643    4589999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDS  260 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~  260 (282)
                      +|||.++....         .........||+.|+|||++.+..+   +.++||||+||++|||+||+.||.+.  ....
T Consensus       145 ~DFG~a~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlGvilyemltG~~PF~~~--~~~~  210 (320)
T d1xjda_         145 ADFGMCKENML---------GDAKTNTFCGTPDYIAPEILLGQKY---NHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEE  210 (320)
T ss_dssp             CCCTTCBCCCC---------TTCCBCCCCSCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCS--SHHH
T ss_pred             cccchhhhccc---------ccccccccCCCCCcCCHHHHcCCCC---CchhhhhhhhHHHHHHHhCCCCCCCC--CHHH
Confidence            99998753211         1111233568999999999998887   88999999999999999999999863  3344


Q ss_pred             eeeeeeeccccCCCCCCC
Q psy16951        261 VALAVISGNITFPENTPF  278 (282)
Q Consensus       261 ~~~~~~~~~~~~p~~~~~  278 (282)
                      +...+..+.+.+|+..|+
T Consensus       211 ~~~~i~~~~~~~p~~~s~  228 (320)
T d1xjda_         211 LFHSIRMDNPFYPRWLEK  228 (320)
T ss_dssp             HHHHHHHCCCCCCTTSCH
T ss_pred             HHHHHHcCCCCCCccCCH
Confidence            444566677777766543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=321.21  Aligned_cols=201  Identities=24%  Similarity=0.358  Sum_probs=171.9

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------hhHHHHHHHHHHhhhCCCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------EDQAQAIREVEHHKTFVHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|+++++||+|+||+||+|+++.+|..||||++.....      ...+.+.+|+.++++++||||+++++++      
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~------   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY------   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE------
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE------
Confidence            4679999999999999999999999999999999864322      2356788999999999999999999954      


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC--
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN--  176 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--  176 (282)
                         .+...+++|||||++|+|.+.+...    ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++  
T Consensus        83 ---~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          83 ---ENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             ---ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSS
T ss_pred             ---EECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCc
Confidence               4568899999999999999988643    4589999999999999999999999   899999999999998776  


Q ss_pred             --CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        177 --NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       177 --~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                        .+|++|||++.....          ........+|+.|+|||++.+..+   +.++||||+||++|||++|+.||.+.
T Consensus       153 ~~~vkl~DfG~a~~~~~----------~~~~~~~~~t~~y~APE~~~~~~~---~~~~DiwSlGvilyell~g~~Pf~~~  219 (293)
T d1jksa_         153 KPRIKIIDFGLAHKIDF----------GNEFKNIFGTPEFVAPEIVNYEPL---GLEADMWSIGVITYILLSGASPFLGD  219 (293)
T ss_dssp             SCCEEECCCTTCEECTT----------SCBCSCCCCCGGGCCHHHHTTCCB---CTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceEecchhhhhhcCC----------CccccccCCCCcccCHHHHcCCCC---CCcccchhhhHHHHHHHcCCCCCCCC
Confidence              489999998653211          111234467889999999998776   89999999999999999999999863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.3e-47  Score=318.07  Aligned_cols=209  Identities=26%  Similarity=0.392  Sum_probs=168.4

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      .++|++.+.||+|+||+||+|++..+++.||||.+.....   .....+.+|+++++.++||||+++++.+...     .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-----~   80 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-----T   80 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-----C
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-----c
Confidence            5789999999999999999999999999999999865432   3345788999999999999999999876652     2


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....+++||||+++++|.+.+...    ..+++.+++.++.||+.||.|||++   |++||||||+||+++.++..+++
T Consensus        81 ~~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          81 PAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             SSSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred             CCCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceee
Confidence            2335689999999999999877643    4589999999999999999999998   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....      .............||+.|+|||++.+..+   +.++||||+||++|||+||++||.+.
T Consensus       154 d~~~~~~~~------~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---~~~~DiwSlGvilyelltG~~Pf~~~  217 (277)
T d1o6ya_         154 DFGIARAIA------DSGNSVTQTAAVIGTAQYLSPEQARGDSV---DARSDVYSLGCVLYEVLTGEPPFTGD  217 (277)
T ss_dssp             CCTTCEECC----------------------TTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhhhhhc------cccccccccccccCcccccCHHHHcCCCC---CcceecccchHHHHHHHhCCCCCCCc
Confidence            999754321      11111223345578999999999988776   88999999999999999999999763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-47  Score=321.39  Aligned_cols=232  Identities=19%  Similarity=0.306  Sum_probs=171.4

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCc---eEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK---RYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      .+..++|++.+.||+|+||+||+|+++.++.   .||||.+.... ....+.+.+|++++++++||||+++++++..   
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---   98 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK---   98 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee---
Confidence            4667899999999999999999999977664   58899876543 3445678999999999999999999996543   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                            ...+++||||+++|+|.+++..   ....+++.+++.++.||+.||.|||++   +++||||||+|||++.++.
T Consensus        99 ------~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~  166 (299)
T d1jpaa_          99 ------STPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLV  166 (299)
T ss_dssp             ------SSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             ------CCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCc
Confidence                  4678999999999999987753   234589999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      +||+|||+++.....    .............+|+.|+|||++.+..+   +.++|||||||++|||+| |..||.+...
T Consensus       167 ~Kl~DFGla~~~~~~----~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         167 CKVSDFGLSRFLEDD----TSDPTYTSALGGKIPIRWTAPEAIQYRKF---TSASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             EEECCC---------------------------CGGGSCHHHHHSCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEECCcccceEccCC----CCcceeeecccccCCccccCHHHHhcCCC---CcccccccchHHHHHHHhCCCCCCCCCCH
Confidence            999999987532110    01111112223456889999999988776   889999999999999998 8999976433


Q ss_pred             Cccceeeeee-eccccCCCCCC
Q psy16951        257 RGDSVALAVI-SGNITFPENTP  277 (282)
Q Consensus       257 ~~~~~~~~~~-~~~~~~p~~~~  277 (282)
                        ..+...+. +.+++.|.++|
T Consensus       240 --~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         240 --QDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             --HHHHHHHHTTCCCCCCTTCC
T ss_pred             --HHHHHHHHcCCCCCCCccch
Confidence              22222222 23455555554

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-47  Score=318.59  Aligned_cols=234  Identities=20%  Similarity=0.285  Sum_probs=179.7

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      .+++.|.|..++|++.+.||+|+||+||+|++..+ .+||||++... ....+.+.+|+.++++++||||+++++++.. 
T Consensus         7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3           7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            46788889999999999999999999999999655 57999998644 3445779999999999999999999996532 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ...++||||+++|+|.+.+...  ....+++.+++.++.||+.||.|||++   |++||||||+||+++.+
T Consensus        84 ---------~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~  149 (285)
T d1fmka3          84 ---------EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN  149 (285)
T ss_dssp             ---------SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             ---------CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCC
Confidence                     3478999999999999877643  234589999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      +.+||+|||++....        ...........+|+.|+|||++....+   +.++||||||+++|||+||..||....
T Consensus       150 ~~~kl~DfGla~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDI~S~Giil~el~t~~~p~~~~~  218 (285)
T d1fmka3         150 LVCKVADFGLARLIE--------DNEYTARQGAKFPIKWTAPEAALYGRF---TIKSDVWSFGILLTELTTKGRVPYPGM  218 (285)
T ss_dssp             GCEEECCCCTTC----------------------CCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CcEEEcccchhhhcc--------CCCceeeccccccccccChHHHhCCCC---CcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence            999999999865321        111112233467889999999988776   889999999999999999765554322


Q ss_pred             cCccceeeeeeeccccCCCCCC
Q psy16951        256 ERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       256 ~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ...+.........+++.|+.+|
T Consensus       219 ~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         219 VNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTSC
T ss_pred             CHHHHHHHHHhcCCCCCCcccC
Confidence            2222222222233456666655

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-46  Score=325.14  Aligned_cols=224  Identities=23%  Similarity=0.310  Sum_probs=175.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc---hhHHHH---HHHHHHhhhCCCCCcccccccccccCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR---EDQAQA---IREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~---~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ..++|++++.||+|+||+||+|++..+|..||||.+.....   .....+   .+++.+++.++||||+++++.+     
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----   76 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----   76 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----
Confidence            46899999999999999999999999999999999853211   112223   3456778888999999999854     


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                          .....+++||||+++|+|.+.+...    ..+++..+..++.||+.||.|||++   |++||||||+|||++.++.
T Consensus        77 ----~~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~  145 (364)
T d1omwa3          77 ----HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGH  145 (364)
T ss_dssp             ----ECSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSC
T ss_pred             ----EECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCc
Confidence                3457899999999999999988643    4588999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccC-cccCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVD-SYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~-~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~  256 (282)
                      +|++|||+++....           .......||+.|+|||++... .|   +.++||||+||++|||+||+.||.+...
T Consensus       146 iKl~DFGla~~~~~-----------~~~~~~~GT~~y~APE~~~~~~~~---~~~~DiwSlGvilyemltG~~Pf~~~~~  211 (364)
T d1omwa3         146 VRISDLGLACDFSK-----------KKPHASVGTHGYMAPEVLQKGVAY---DSSADWFSLGCMLFKLLRGHSPFRQHKT  211 (364)
T ss_dssp             EEECCCTTCEECSS-----------SCCCSCCSCGGGCCHHHHSTTCCC---CTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred             EEEeeeceeeecCC-----------CcccccccccccchhHHhhcCCCC---CcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence            99999998753210           112345689999999999754 44   8899999999999999999999986433


Q ss_pred             Ccc-ceeeeeeeccccCCCCCC
Q psy16951        257 RGD-SVALAVISGNITFPENTP  277 (282)
Q Consensus       257 ~~~-~~~~~~~~~~~~~p~~~~  277 (282)
                      ... .+........+.+|+..+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~s  233 (364)
T d1omwa3         212 KDKHEIDRMTLTMAVELPDSFS  233 (364)
T ss_dssp             SCHHHHHHHSSSCCCCCCSSSC
T ss_pred             HHHHHHHHhcccCCCCCCCCCC
Confidence            221 112223344455555443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=316.11  Aligned_cols=228  Identities=18%  Similarity=0.316  Sum_probs=174.3

Q ss_pred             EecccEEEE-EEeccCCceEEEEEEecC--CCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIV-EKIGEGGFSTVSLIEHSQ--TKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~--~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      ++.+.+.+. ++||+|+||+||+|.++.  +++.||||++...  +....+.+.+|++++++++||||+++++++..   
T Consensus         3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---   79 (277)
T d1xbba_           3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---   79 (277)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred             echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---
Confidence            444555554 469999999999998653  4578999998643  33345678999999999999999999986532   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++||||+++|+|.+++..    ...+++..++.++.||+.||.|||++   +|+||||||+||+++.++.
T Consensus        80 -------~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~  145 (277)
T d1xbba_          80 -------ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHY  145 (277)
T ss_dssp             -------SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             -------CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCc
Confidence                   347899999999999998763    35589999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      +|++|||+++....      ............||+.|+|||++.+..+   +.++||||||+++|||+| |+.||.+...
T Consensus       146 ~kl~DFGla~~~~~------~~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~  216 (277)
T d1xbba_         146 AKISDFGLSKALRA------DENYYKAQTHGKWPVKWYAPECINYYKF---SSKSDVWSFGVLMWEAFSYGQKPYRGMKG  216 (277)
T ss_dssp             EEECCCTTCEECCT------TCSEEEC----CCCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             ccccchhhhhhccc------cccccccccccCCCceecCchhhcCCCC---CchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence            99999998763211      1111111223467889999999988776   789999999999999998 8999986432


Q ss_pred             Cccceeeeee-eccccCCCCCCC
Q psy16951        257 RGDSVALAVI-SGNITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~~-~~~~~~p~~~~~  278 (282)
                        ..+...+. +.+++.|+.+|.
T Consensus       217 --~~~~~~i~~~~~~~~p~~~~~  237 (277)
T d1xbba_         217 --SEVTAMLEKGERMGCPAGCPR  237 (277)
T ss_dssp             --HHHHHHHHTTCCCCCCTTCCH
T ss_pred             --HHHHHHHHcCCCCCCCcccCH
Confidence              22222233 335677776654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=314.05  Aligned_cols=230  Identities=19%  Similarity=0.315  Sum_probs=175.1

Q ss_pred             cEEEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         20 AVYVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      +|.|+.++|++.+.||+|+||+||+|.+..+   +..||||.+.... ......+.+|++++++++||||+++++++.. 
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4778999999999999999999999998654   3568999886443 3345678999999999999999999985432 


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                               ..+++||||+++|++.+.+..   ....+++..++.++.||+.||.|+|++   +++||||||+||+++.+
T Consensus        80 ---------~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~  144 (273)
T d1mp8a_          80 ---------NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN  144 (273)
T ss_dssp             ---------SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred             ---------CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCC
Confidence                     468999999999999987653   234589999999999999999999999   88999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~  254 (282)
                      +.+|++|||+++...        ...........+|+.|+|||++.+..+   +.++|||||||++|||+| |.+||.+.
T Consensus       145 ~~~Kl~DfG~a~~~~--------~~~~~~~~~~~gt~~y~apE~l~~~~~---~~~~DiwSlGvil~e~lt~g~~P~~~~  213 (273)
T d1mp8a_         145 DCVKLGDFGLSRYME--------DSTYYKASKGKLPIKWMAPESINFRRF---TSASDVWMFGVCMWEILMHGVKPFQGV  213 (273)
T ss_dssp             TEEEECC---------------------------CCGGGCCHHHHHHCCC---SHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcEEEccchhheecc--------CCcceeccceecCcccchhhHhccCCC---CCccccccchHHHHHHHhcCCCCCCCC
Confidence            999999999865321        111112233457889999999988776   889999999999999998 89999864


Q ss_pred             ccCccceeeeeeec-cccCCCCCCC
Q psy16951        255 YERGDSVALAVISG-NITFPENTPF  278 (282)
Q Consensus       255 ~~~~~~~~~~~~~~-~~~~p~~~~~  278 (282)
                      ..  ..+...+..+ .+++|+++|.
T Consensus       214 ~~--~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         214 KN--NDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             CG--GGHHHHHHTTCCCCCCTTCCH
T ss_pred             CH--HHHHHHHHcCCCCCCCCCCCH
Confidence            33  2222233333 4667776654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=314.00  Aligned_cols=230  Identities=18%  Similarity=0.262  Sum_probs=172.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCC----ceEEEEEeccCCc-hhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTK----KRYALKKIICHGR-EDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      |..++|++.+.||+|+||+||+|.++.++    ..||||++..... .....+.+|+.++++++||||+++++++.    
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~----   79 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS----   79 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe----
Confidence            56688999999999999999999987665    4799999865433 34557889999999999999999999554    


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                           +....++++||+.++++.+.+..   ....+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus        80 -----~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~  148 (283)
T d1mqba_          80 -----KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV  148 (283)
T ss_dssp             -----SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             -----cCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCe
Confidence                 34678999999999999886653   334689999999999999999999999   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccC
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYER  257 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~  257 (282)
                      +||+|||+++....      ............||+.|+|||++.+..+   +.++||||||+++|||+++..||......
T Consensus       149 ~Kl~DFGla~~~~~------~~~~~~~~~~~~gt~~Y~APE~l~~~~~---~~~sDI~S~Gvil~el~t~~~~~~~~~~~  219 (283)
T d1mqba_         149 CKVSDFGLSRVLED------DPEATYTTSGGKIPIRWTAPEAISYRKF---TSASDVWSFGIVMWEVMTYGERPYWELSN  219 (283)
T ss_dssp             EEECCCCC-----------------------CCCGGGSCHHHHHSCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEEcccchhhcccC------CCccceEeccCCCCccccCHHHHccCCC---CCcccccccHHHHHHHHhCCCCccccCCH
Confidence            99999998753211      1111112234457889999999988776   88999999999999999976555432222


Q ss_pred             ccceeeee-eeccccCCCCCC
Q psy16951        258 GDSVALAV-ISGNITFPENTP  277 (282)
Q Consensus       258 ~~~~~~~~-~~~~~~~p~~~~  277 (282)
                       ..+...+ .+.+++.|.+.|
T Consensus       220 -~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         220 -HEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             -HHHHHHHHTTCCCCCCTTCB
T ss_pred             -HHHHHHHhccCCCCCchhhH
Confidence             2222222 223456666554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=312.03  Aligned_cols=225  Identities=18%  Similarity=0.363  Sum_probs=180.4

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ++.++|++.++||+|+||+||+|+++ ++.+||||.++... ....++.+|+.++++++||||+++++++.         
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~---------   69 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT---------   69 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC---------
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe---------
Confidence            35689999999999999999999984 78899999987543 34567899999999999999999999544         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+++|++...+..   ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++|
T Consensus        70 ~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~D  143 (258)
T d1k2pa_          70 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD  143 (258)
T ss_dssp             CSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECC
T ss_pred             eCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECc
Confidence            34679999999999999887653   334588899999999999999999998   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccccCccce
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYERGDSV  261 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~~~~~~  261 (282)
                      ||++....        ...........+|+.|+|||++.+..+   +.++||||||+++|||+| |+.||.+...  ..+
T Consensus       144 fG~a~~~~--------~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~  210 (258)
T d1k2pa_         144 FGLSRYVL--------DDEYTSSVGSKFPVRWSPPEVLMYSKF---SSKSDIWAFGVLMWEIYSLGKMPYERFTN--SET  210 (258)
T ss_dssp             CSSCCBCS--------SSSCCCCCCSCCCGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHH
T ss_pred             chhheecc--------CCCceeecccCCCCCcCCcHHhcCCCC---CcceeecccchhhHhHHhcCCCCCCCCCH--HHH
Confidence            99875321        111111223467888999999998776   889999999999999998 7999986433  223


Q ss_pred             eeeeee-ccccCCCCCC
Q psy16951        262 ALAVIS-GNITFPENTP  277 (282)
Q Consensus       262 ~~~~~~-~~~~~p~~~~  277 (282)
                      ...+.. .++..|+.+|
T Consensus       211 ~~~i~~~~~~~~p~~~~  227 (258)
T d1k2pa_         211 AEHIAQGLRLYRPHLAS  227 (258)
T ss_dssp             HHHHHTTCCCCCCTTCC
T ss_pred             HHHHHhCCCCCCccccc
Confidence            223333 3456666554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=318.55  Aligned_cols=218  Identities=22%  Similarity=0.391  Sum_probs=178.7

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      -++|++.++||+|+||+||+|.+..++..||||.+.... .+...+.+|+++++.++||||+++++.+         .+.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~---------~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF---------ESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE---------EET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEE---------EEC
Confidence            478999999999999999999999999999999986553 4455678999999999999999999954         445


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC--CCceeec
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND--NNPLLMD  182 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~~~~~~d  182 (282)
                      ..+|+|||||++++|.+.+..   ....+++.++..++.||+.||.|||++   ||+||||||+||+++.+  ..++++|
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcc
Confidence            789999999999999987752   233589999999999999999999998   89999999999999854  4788999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCcccee
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVA  262 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~  262 (282)
                      ||++....          .........+|+.|+|||.+.+..+   +.++||||+||++|+|++|..||.+..  ...+.
T Consensus       148 FG~~~~~~----------~~~~~~~~~~t~~y~ape~~~~~~~---~~~~DiWSlGvily~ll~G~~Pf~~~~--~~~~~  212 (321)
T d1tkia_         148 FGQARQLK----------PGDNFRLLFTAPEYYAPEVHQHDVV---STATDMWSLGTLVYVLLSGINPFLAET--NQQII  212 (321)
T ss_dssp             CTTCEECC----------TTCEEEEEESCGGGSCHHHHTTCEE---CHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHH
T ss_pred             cchhhccc----------cCCcccccccccccccchhccCCCC---CchhhcccHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence            99765321          1111234467889999999998877   889999999999999999999997632  23334


Q ss_pred             eeeeeccccCC
Q psy16951        263 LAVISGNITFP  273 (282)
Q Consensus       263 ~~~~~~~~~~p  273 (282)
                      ..+..+.+.+|
T Consensus       213 ~~i~~~~~~~~  223 (321)
T d1tkia_         213 ENIMNAEYTFD  223 (321)
T ss_dssp             HHHHHTCCCCC
T ss_pred             HHHHhCCCCCC
Confidence            44555555554

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=314.50  Aligned_cols=228  Identities=19%  Similarity=0.296  Sum_probs=174.5

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCc----eEEEEEeccC-CchhHHHHHHHHHHhhhCCCCCcccccccccccCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKK----RYALKKIICH-GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCA   97 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~i~~~-~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~   97 (282)
                      +..++|++++.||+|+||+||+|.+..+|.    +||+|++... .....+.+.+|++++++++||||+++++++..   
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---   82 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---   82 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            456789999999999999999999987775    5889988543 33456788999999999999999999997654   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNN  177 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~  177 (282)
                             ...++++|++.+++|.+.+..   ....+++..++.++.||+.||.|||++   +|+||||||+||+++.++.
T Consensus        83 -------~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~  149 (317)
T d1xkka_          83 -------STVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH  149 (317)
T ss_dssp             -------SSEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred             -------CCeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCC
Confidence                   357788999999999887653   345689999999999999999999998   8999999999999999999


Q ss_pred             ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q psy16951        178 PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYE  256 (282)
Q Consensus       178 ~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~  256 (282)
                      +|++|||++.....       ...........||+.|+|||++.+..+   +.++|||||||++|||+| |.+||.+...
T Consensus       150 ~kl~DFGla~~~~~-------~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~sDvwS~Gvil~el~t~g~~p~~~~~~  219 (317)
T d1xkka_         150 VKITDFGLAKLLGA-------EEKEYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPA  219 (317)
T ss_dssp             EEECCCSHHHHTTT-------TCC--------CCTTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred             eEeeccccceeccc-------ccccccccccccCccccChHHHhcCCC---ChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence            99999997653210       001111223457899999999988776   889999999999999999 7899976432


Q ss_pred             Cccceeeeee-eccccCCCCCCC
Q psy16951        257 RGDSVALAVI-SGNITFPENTPF  278 (282)
Q Consensus       257 ~~~~~~~~~~-~~~~~~p~~~~~  278 (282)
                        ..+...+. +.+++.|+..|+
T Consensus       220 --~~~~~~i~~~~~~~~p~~~~~  240 (317)
T d1xkka_         220 --SEISSILEKGERLPQPPICTI  240 (317)
T ss_dssp             --GGHHHHHHHTCCCCCCTTBCH
T ss_pred             --HHHHHHHHcCCCCCCCcccCH
Confidence              22222232 334666766553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-45  Score=308.10  Aligned_cols=219  Identities=26%  Similarity=0.352  Sum_probs=177.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch---------hHHHHHHHHHHhhhCC-CCCcccccccccc
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE---------DQAQAIREVEHHKTFV-HPNILPLLDHALT   94 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---------~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~   94 (282)
                      .++|++.+.||+|+||+||+|++..++..||||++......         ..+.+.+|+.++++++ ||||+++++.+  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            47999999999999999999999999999999998654321         1235778999999997 99999999954  


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                             .+...+|+||||+++|+|.+.+...    ..+++.+++.++.||+.||.|||++   ||+||||||+||+++.
T Consensus        80 -------~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~  145 (277)
T d1phka_          80 -------ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  145 (277)
T ss_dssp             -------ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             -------ccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcC
Confidence                   4568899999999999999988643    4589999999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcc---cCCCCccchhhHHHHHHHHHhCCCCC
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSY---CVVDQRTDVWSLGCLLYAMCYFKSPF  251 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~---~~~~~~~Diws~G~il~el~tg~~pf  251 (282)
                      ++.+||+|||++.....          ........||..|+|||.+.+...   ..++.++||||+||++|||++|+.||
T Consensus       146 ~~~~kl~DFG~a~~~~~----------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf  215 (277)
T d1phka_         146 DMNIKLTDFGFSCQLDP----------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF  215 (277)
T ss_dssp             TCCEEECCCTTCEECCT----------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCeEEccchheeEccC----------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence            99999999998753211          111234568999999999975321   12377899999999999999999999


Q ss_pred             CccccCccceeeeeeecccc
Q psy16951        252 DTVYERGDSVALAVISGNIT  271 (282)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~  271 (282)
                      .+...  ......+..+++.
T Consensus       216 ~~~~~--~~~~~~i~~~~~~  233 (277)
T d1phka_         216 WHRKQ--MLMLRMIMSGNYQ  233 (277)
T ss_dssp             CCSSH--HHHHHHHHHTCCC
T ss_pred             CCCCH--HHHHHHHHhCCCC
Confidence            86432  2233334444443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=310.21  Aligned_cols=232  Identities=21%  Similarity=0.316  Sum_probs=171.0

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCC---CceEEEEEeccC---CchhHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQT---KKRYALKKIICH---GREDQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~~---~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      -.|+.++|++++.||+|+||+||+|++..+   ..+||||++...   .....+.+.+|+.++++++||||+++++.+..
T Consensus         3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            467889999999999999999999986533   246899988543   33445678999999999999999999986533


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                                ...++|+||++++++.+.+...   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.
T Consensus        83 ----------~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~  146 (273)
T d1u46a_          83 ----------PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLAT  146 (273)
T ss_dssp             ----------SSCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE
T ss_pred             ----------cchheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccc
Confidence                      3568999999999999877643   23489999999999999999999998   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDT  253 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~  253 (282)
                      ++.+|++|||++......      ...........+|..|+|||++.+..+   +.++||||||+++|||+| |..||.+
T Consensus       147 ~~~vkl~DfGl~~~~~~~------~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~S~Gvil~emlt~G~~Pf~~  217 (273)
T d1u46a_         147 RDLVKIGDFGLMRALPQN------DDHYVMQEHRKVPFAWCAPESLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIG  217 (273)
T ss_dssp             TTEEEECCCTTCEECCC-------CCEEEC-----CCGGGCCHHHHHHCEE---EHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccceeeccchhhhhcccC------CCcceecCccccCcccCCHHHHhCCCC---CcchhhhhhHHHHHHHHhCCCCCCCC
Confidence            999999999987532111      011111223356788999999998877   889999999999999998 8999986


Q ss_pred             cccCccceeeeeeeccccCCCCCC
Q psy16951        254 VYERGDSVALAVISGNITFPENTP  277 (282)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~p~~~~  277 (282)
                      ....+....+.....+++.|++.|
T Consensus       218 ~~~~~~~~~i~~~~~~~~~~~~~~  241 (273)
T d1u46a_         218 LNGSQILHKIDKEGERLPRPEDCP  241 (273)
T ss_dssp             CCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cCHHHHHHHHHhCCCCCCCccccc
Confidence            433221111112223455555554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=313.07  Aligned_cols=239  Identities=18%  Similarity=0.290  Sum_probs=174.3

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLLDH   91 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~~~   91 (282)
                      +.|.++.++|++.++||+|+||+||+|.+..     +++.||||++..... .....+.+|...+.++ +|+||+.+++.
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            4567899999999999999999999999754     346899999864433 3455677888877776 68999999875


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------------GKHYMSSVDILKMFLKICEAVKVFHDAKPIA  159 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~  159 (282)
                      +..        ....++++||||++|+|.+++.....            ....+++.+++.++.||+.||.|||++   +
T Consensus        86 ~~~--------~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~  154 (299)
T d1ywna1          86 CTK--------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---K  154 (299)
T ss_dssp             ECS--------TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecc--------CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            433        34568999999999999999875422            123578899999999999999999999   8


Q ss_pred             ccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHH
Q psy16951        160 YAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGC  239 (282)
Q Consensus       160 i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~  239 (282)
                      |+||||||+||+++.++.+||+|||+++....       ...........||+.|+|||++.+..+   +.++|||||||
T Consensus       155 ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~-------~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~sDiwS~Gv  224 (299)
T d1ywna1         155 CIHRDLAARNILLSEKNVVKICDFGLARDIYK-------DPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGV  224 (299)
T ss_dssp             CCCSCCCGGGEEECGGGCEEECC------CCS-------CTTSCCTTSCCCGGGGCCHHHHHHCCC---CHHHHHHHHHH
T ss_pred             CcCCcCCccceeECCCCcEEEccCcchhhccc-------cccccccCceeeCccccchhHhhcCCC---CcccceeehHH
Confidence            99999999999999999999999998753210       001111234468899999999988776   88999999999


Q ss_pred             HHHHHHhCC-CCCCccccCccceeeeeeeccccCCCCCCC
Q psy16951        240 LLYAMCYFK-SPFDTVYERGDSVALAVISGNITFPENTPF  278 (282)
Q Consensus       240 il~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~p~~~~~  278 (282)
                      ++|||+||. +||.+.............+.++..|+..|+
T Consensus       225 il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (299)
T d1ywna1         225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP  264 (299)
T ss_dssp             HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            999999974 688754332221121122335666665553

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=315.71  Aligned_cols=202  Identities=26%  Similarity=0.400  Sum_probs=166.9

Q ss_pred             cccEEEEE-EeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhh-CCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVE-KIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKT-FVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~-l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|+++. .||+|+||+||+|++..++..||||++..     .....+|++++.+ .+||||+++++++..     ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~-----~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN-----LYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE-----EET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEee-----ccc
Confidence            47899886 59999999999999999999999999853     2356678988654 589999999986543     223


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCce
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPL  179 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~  179 (282)
                      ....+|+|||||++|+|.+++...  ....+++.++..++.||+.||.|||++   ||+||||||+||+++.   .+.+|
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccc
Confidence            356799999999999999988632  234689999999999999999999999   8999999999999975   45789


Q ss_pred             eecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        180 LMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       180 ~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++|||+++....          ........||+.|+|||++.+..|   +.++||||+||++|+|+||+.||.+.
T Consensus       155 l~DFG~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~y---~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         155 LTDFGFAKETTS----------HNSLTTPCYTPYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             ECCCTTCEECCC----------CCCCCCCSCCCSSCCCCCCCGGGG---SHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             ccccceeeeccC----------CCccccccCCcccCCcHHHcCCCC---CHHHHHHhhchhHHHHhhCCCCCCCC
Confidence            999998753211          111234568999999999998877   88999999999999999999999764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-45  Score=310.19  Aligned_cols=234  Identities=23%  Similarity=0.348  Sum_probs=181.5

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCCch-hHHHHHHHHHHhhhCCCCCcccccccccc
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHGRE-DQAQAIREVEHHKTFVHPNILPLLDHALT   94 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~-~~~~~~~e~~~l~~l~H~ni~~~~~~~~~   94 (282)
                      +.+++++|+++++||+|+||+||+|++.+     ++..||||++...... ....+.+|++++++++||||+++++.+..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            55688999999999999999999999753     5678999998755444 35678999999999999999999995543


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHH--------------------hcCCCCCHHHHHHHHHHHHHHHHHhhc
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRS--------------------VGKHYMSSVDILKMFLKICEAVKVFHD  154 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~  154 (282)
                               ....++++|++++|+|.+.+....                    .....++...++.++.|++.||.|+|+
T Consensus        88 ---------~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~  158 (301)
T d1lufa_          88 ---------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  158 (301)
T ss_dssp             ---------SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ---------CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence                     467999999999999999885321                    122347888999999999999999999


Q ss_pred             CCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccch
Q psy16951        155 AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDV  234 (282)
Q Consensus       155 ~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Di  234 (282)
                      +   +++||||||+||+++.++.+||+|||+++....       ...........+|+.|+|||.+.+..+   +.++||
T Consensus       159 ~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~-------~~~~~~~~~~~~~~~y~aPE~~~~~~~---t~ksDV  225 (301)
T d1lufa_         159 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS-------ADYYKADGNDAIPIRWMPPESIFYNRY---TTESDV  225 (301)
T ss_dssp             T---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG-------GGCBC----CCBCGGGCCHHHHHHCCC---CHHHHH
T ss_pred             C---CeEeeEEcccceEECCCCcEEEccchhheeccC-------CccccccCCCCcCcCcCCHHHHccCCC---Chhhhh
Confidence            9   899999999999999999999999998652210       111111223457788999999998776   889999


Q ss_pred             hhHHHHHHHHHhCC-CCCCccccCccceeeeeeec-cccCCCCCCC
Q psy16951        235 WSLGCLLYAMCYFK-SPFDTVYERGDSVALAVISG-NITFPENTPF  278 (282)
Q Consensus       235 ws~G~il~el~tg~-~pf~~~~~~~~~~~~~~~~~-~~~~p~~~~~  278 (282)
                      |||||++|||++|. +||.+...  ..+...+..+ .++.|++.|+
T Consensus       226 wS~Gvvl~ell~~~~~p~~~~~~--~e~~~~v~~~~~~~~p~~~~~  269 (301)
T d1lufa_         226 WAYGVVLWEIFSYGLQPYYGMAH--EEVIYYVRDGNILACPENCPL  269 (301)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccchhhHHHHHccCCCCCCCCCH--HHHHHHHHcCCCCCCCccchH
Confidence            99999999999986 67876433  2222233333 4566766654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=300.69  Aligned_cols=224  Identities=24%  Similarity=0.414  Sum_probs=175.8

Q ss_pred             EEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCC
Q psy16951         21 VYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPV  100 (282)
Q Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~  100 (282)
                      |.|..++|++.+.||+|+||.||+|++  +|.+||||++...  ...+.+.+|++++++++||||+++++++..      
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------   71 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE------   71 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC------
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe------
Confidence            678889999999999999999999999  4678999998543  345678999999999999999999996543      


Q ss_pred             CCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCcee
Q psy16951        101 LNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                        ....+++||||+++|+|.+++....  ...+++..++.++.||+.||.|||++   +++||||||+||+++.++.+++
T Consensus        72 --~~~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl  144 (262)
T d1byga_          72 --EKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  144 (262)
T ss_dssp             --C--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             --cCCcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEee
Confidence              2355899999999999999886542  23478999999999999999999999   8999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh-CCCCCCccccCcc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY-FKSPFDTVYERGD  259 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t-g~~pf~~~~~~~~  259 (282)
                      +|||.++...            .......+|..|+|||++.+..+   +.++||||||+++|||+| |.+||.....  .
T Consensus       145 ~dfg~s~~~~------------~~~~~~~~~~~y~aPE~l~~~~~---t~~sDIwSfG~il~el~t~~~~p~~~~~~--~  207 (262)
T d1byga_         145 SDFGLTKEAS------------STQDTGKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRIPL--K  207 (262)
T ss_dssp             CCCCC------------------------CCTTTSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSCTTSCG--G
T ss_pred             cccccceecC------------CCCccccccccCCChHHHhCCCC---ChHHHHHhHHHHHHHHHHCCCCCCCCCCH--H
Confidence            9999765210            11123356888999999988766   889999999999999998 6888875322  2


Q ss_pred             ceeeee-eeccccCCCCCCC
Q psy16951        260 SVALAV-ISGNITFPENTPF  278 (282)
Q Consensus       260 ~~~~~~-~~~~~~~p~~~~~  278 (282)
                      .+...+ .+.++++|+..|+
T Consensus       208 ~~~~~i~~~~~~~~~~~~~~  227 (262)
T d1byga_         208 DVVPRVEKGYKMDAPDGCPP  227 (262)
T ss_dssp             GHHHHHTTTCCCCCCTTCCH
T ss_pred             HHHHHHHcCCCCCCCccCCH
Confidence            222223 3346777776654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=306.21  Aligned_cols=204  Identities=27%  Similarity=0.407  Sum_probs=167.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .|+|+++++||+|+||+||+|.+..++..||||++......  ....+.+|++++++++||||+++++++.         
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~---------   71 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH---------   71 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE---------
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc---------
Confidence            37999999999999999999999999999999998644322  2457889999999999999999999554         


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      +...+++||||+.+ ++...+...  ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++|
T Consensus        72 ~~~~~~iv~e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          72 TENKLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             cccceeEEEeecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceecc
Confidence            45789999999965 444444322  345589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.++..         ...........||+.|+|||++....+  .+.++||||+||++|+|++|+.||.+.
T Consensus       146 FG~a~~~---------~~~~~~~~~~~gt~~y~apE~~~~~~~--~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         146 FGLARAF---------GVPVRTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             TTHHHHH---------CCCSBCTTCCBCCCTTCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCcceec---------cCCcccceeecccceeeehhhhccccC--CCccccccccchhhhHHhhCCCCCCCC
Confidence            9976421         111122334568999999999887765  378999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=307.60  Aligned_cols=198  Identities=25%  Similarity=0.332  Sum_probs=159.6

Q ss_pred             EEEEeccCCceEEEEEEecCCCceEEEEEeccCCchh-----HHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRED-----QAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++.||+|+||+||+|++..+|..||||++.......     ...+.+|+.++++++||||+++++++.         ..
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~---------~~   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---------HK   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC---------CT
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec---------cC
Confidence            4788999999999999999999999999986443222     235789999999999999999999544         45


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeeccc
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLG  184 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~  184 (282)
                      ..+++||||+.++++....    .....+++..+..++.||+.||.|||++   |++||||||+||+++.++.+|++|||
T Consensus        73 ~~~~ivmE~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CceeehhhhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence            7799999999877665433    2345688999999999999999999999   89999999999999999999999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      .+....         ..........||+.|+|||++.....  ++.++||||+||++|||+||.+||.+.
T Consensus       146 ~a~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         146 LAKSFG---------SPNRAYTHQVVTRWYRAPELLFGARM--YGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             GGSTTT---------SCCCCCCCSCCCCTTCCHHHHTTCSC--CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccC---------CCcccccceecChhhccHHHHccCCC--CChhhhhhhcchHHHHHHhCcCCCCCC
Confidence            764221         11111223467999999999875532  388999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=307.38  Aligned_cols=230  Identities=21%  Similarity=0.317  Sum_probs=178.2

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecCCCc--eEEEEEeccC-CchhHHHHHHHHHHhhhC-CCCCcccccccccccCC
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQTKK--RYALKKIICH-GREDQAQAIREVEHHKTF-VHPNILPLLDHALTGCA   97 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~i~~~-~~~~~~~~~~e~~~l~~l-~H~ni~~~~~~~~~~~~   97 (282)
                      .|+.++|++.++||+|+||+||+|.+..++.  .||||++... .....+.+.+|+++++++ +||||+++++++..   
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~---   82 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---   82 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE---
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec---
Confidence            4678999999999999999999999988876  4778887543 334556789999999998 79999999996654   


Q ss_pred             CCCCCCCceEEEEeccCCCCChHHHHHHH------------HhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         98 DPVLNSTSQVLMVLPYYPKGTLANDLELR------------SVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                            ...+++||||+++|+|.+++...            ......+++.++..++.||+.||.|+|++   +++||||
T Consensus        83 ------~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDl  153 (309)
T d1fvra_          83 ------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  153 (309)
T ss_dssp             ------TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             ------CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Ccccccc
Confidence                  47899999999999999988532            12345689999999999999999999999   8999999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+|||++.++.+|++|||++.....          ........+|..|+|||.+.+..+   +.++||||||+++|||+
T Consensus       154 kp~NIL~~~~~~~kl~DfG~a~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDvwSfGvil~ell  220 (309)
T d1fvra_         154 AARNILVGENYVAKIADFGLSRGQEV----------YVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV  220 (309)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCE----------ECCC----CCTTTCCHHHHHHCEE---CHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEcCCCceEEccccccccccc----------cccccceecCCcccchHHhccCCC---CccceeehhHHHHHHHH
Confidence            99999999999999999998653210          011123457889999999988877   88999999999999999


Q ss_pred             hCC-CCCCccccCccceeeeee-eccccCCCCCCC
Q psy16951        246 YFK-SPFDTVYERGDSVALAVI-SGNITFPENTPF  278 (282)
Q Consensus       246 tg~-~pf~~~~~~~~~~~~~~~-~~~~~~p~~~~~  278 (282)
                      +|. +||.+..  ...+...+. +.+++.|.+.|+
T Consensus       221 ~~~~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~  253 (309)
T d1fvra_         221 SLGGTPYCGMT--CAELYEKLPQGYRLEKPLNCDD  253 (309)
T ss_dssp             TTSCCTTTTCC--HHHHHHHGGGTCCCCCCTTBCH
T ss_pred             hcCCCCCCCCC--HHHHHHHHHhcCCCCCCccCCH
Confidence            976 5776532  222222233 335666666543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=301.55  Aligned_cols=207  Identities=24%  Similarity=0.373  Sum_probs=166.0

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCC-CceEEEEEeccCCch--hHHHHHHHHHHhhhC---CCCCcccccccccccCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQT-KKRYALKKIICHGRE--DQAQAIREVEHHKTF---VHPNILPLLDHALTGCAD   98 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l---~H~ni~~~~~~~~~~~~~   98 (282)
                      .++|+++++||+|+||+||+|++..+ ++.||||++......  ....+.+|+.+++.+   +||||+++++.+...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~---   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS---   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE---
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc---
Confidence            47999999999999999999999765 567999998543222  223455677666554   799999999877543   


Q ss_pred             CCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCc
Q psy16951         99 PVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNP  178 (282)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~  178 (282)
                       ........++++|++.++.+.....   .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+
T Consensus        83 -~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          83 -RTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             -ECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             -ccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCe
Confidence             2334578999999998776654332   2445688999999999999999999999   89999999999999999999


Q ss_pred             eeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        179 LLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       179 ~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++|||.+...          ..........||+.|+|||++.+..|   +.++||||+||++|||++|++||.+.
T Consensus       156 kl~dfg~~~~~----------~~~~~~~~~~gT~~Y~APE~~~~~~y---~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         156 KLADFGLARIY----------SFQMALTSVVVTLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             EECSCCSCCCC----------CGGGGGCCCCCCCTTCCHHHHTTCCC---CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecchhhhhhh----------cccccCCCcccChhhcCcchhcCCCC---ChhehhhchHHHHHHHHHCCCCCCCC
Confidence            99999975421          11122345678999999999998876   89999999999999999999999754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-44  Score=303.09  Aligned_cols=235  Identities=24%  Similarity=0.371  Sum_probs=178.5

Q ss_pred             ccEEEecccEEEEEEeccCCceEEEEEEecCCC-------ceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCccccc
Q psy16951         19 EAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTK-------KRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPLL   89 (282)
Q Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~~   89 (282)
                      ..|.|+.++|++.+.||+|+||.||+|+...++       ..||||++..... .....+.+|+..+.++ +||||++++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            448899999999999999999999999976654       4799998865544 3456788899988888 799999999


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS------------VGKHYMSSVDILKMFLKICEAVKVFHDAKP  157 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~  157 (282)
                      +.+.         +....++||||+.+|+|.+.+....            .....+++.+++.++.|++.||.|||++  
T Consensus        86 ~~~~---------~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--  154 (299)
T d1fgka_          86 GACT---------QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--  154 (299)
T ss_dssp             EEEC---------SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             cccc---------cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--
Confidence            9554         4567999999999999999886432            1234589999999999999999999999  


Q ss_pred             CCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhH
Q psy16951        158 IAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSL  237 (282)
Q Consensus       158 ~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~  237 (282)
                       +++||||||+|||++.++.+|++|||.+.....       ...........+|+.|+|||.+.+..|   +.++|||||
T Consensus       155 -~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~~~~~~~y~aPE~l~~~~y---~~k~DiwS~  223 (299)
T d1fgka_         155 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH-------IDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSF  223 (299)
T ss_dssp             -TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGG-------CCTTCCCTTSCCGGGGSCHHHHHHCCC---CHHHHHHHH
T ss_pred             -CEEeeeecccceeecCCCCeEeccchhhccccc-------cccccccccCCCChhhhhhhHhcCCCC---CchhhhHHh
Confidence             899999999999999999999999998753211       111111234457888999999988776   899999999


Q ss_pred             HHHHHHHHh-CCCCCCccccCccceeeee-eeccccCCCCCC
Q psy16951        238 GCLLYAMCY-FKSPFDTVYERGDSVALAV-ISGNITFPENTP  277 (282)
Q Consensus       238 G~il~el~t-g~~pf~~~~~~~~~~~~~~-~~~~~~~p~~~~  277 (282)
                      |+++|||++ |.+||.+...  +.+...+ .+..+..|...|
T Consensus       224 Gvvl~ell~~g~~p~~~~~~--~~~~~~i~~~~~~~~p~~~~  263 (299)
T d1fgka_         224 GVLLWEIFTLGGSPYPGVPV--EELFKLLKEGHRMDKPSNCT  263 (299)
T ss_dssp             HHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCCCCCCSSCC
T ss_pred             HHHHHHhccCCCCCCCCCCH--HHHHHHHHcCCCCCCCccch
Confidence            999999998 6889975332  2222222 233556666554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-43  Score=297.46  Aligned_cols=201  Identities=25%  Similarity=0.380  Sum_probs=163.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch--hHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE--DQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|+++++||+|+||+||+|++. +++.||||++......  ....+.+|+.++++++||||+++++.+.         .
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~---------~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH---------T   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE---------C
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc---------c
Confidence            79999999999999999999995 7899999999654332  2467889999999999999999998554         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....++++|++.++.+.....    ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|++||
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             CCceeEEEEeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccc
Confidence            577999999997665544332    446699999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |.+...         ...........+++.|+|||.+.+..+  ++.++||||+||++|||++|+.||.+.
T Consensus       145 G~a~~~---------~~~~~~~~~~~~~~~y~~pE~~~~~~~--~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         145 GLARAF---------GIPVRKYTHEIVTLWYRAPDVLMGSKK--YSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             THHHHH---------CC---------CCCTTCCHHHHTTCCS--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccceec---------ccCccccceecccchhhhHHHHhCCCC--CCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            975421         111122334467889999999987654  488999999999999999999999753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=303.37  Aligned_cols=217  Identities=20%  Similarity=0.273  Sum_probs=175.3

Q ss_pred             cccccEEEecccEEEEEEeccCCceEEEEEEec-----CCCceEEEEEeccCCc-hhHHHHHHHHHHhhhC-CCCCcccc
Q psy16951         16 CSKEAVYVKSDKYYIVEKIGEGGFSTVSLIEHS-----QTKKRYALKKIICHGR-EDQAQAIREVEHHKTF-VHPNILPL   88 (282)
Q Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~~e~~~l~~l-~H~ni~~~   88 (282)
                      ..+..|.++.++|++.++||+|+||.||+|.+.     .++..||||++..... .....+.+|+.+++++ +||||+++
T Consensus        13 ~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            345678899999999999999999999999863     4667899999975443 4555788999999999 69999999


Q ss_pred             cccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHH--------------hcCCCCCHHHHHHHHHHHHHHHHHhhc
Q psy16951         89 LDHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRS--------------VGKHYMSSVDILKMFLKICEAVKVFHD  154 (282)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~l~~~~~~~~~~qi~~~l~~lH~  154 (282)
                      ++.+.         +....+++||||++|+|.+++....              .....+++..++.++.||+.||.|||+
T Consensus        93 ~g~~~---------~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~  163 (311)
T d1t46a_          93 LGACT---------IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS  163 (311)
T ss_dssp             EEEEC---------SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEe---------eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            99544         3467999999999999999886432              122358889999999999999999999


Q ss_pred             CCCCCccccCCCCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccch
Q psy16951        155 AKPIAYAHRDLKTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDV  234 (282)
Q Consensus       155 ~~~~~i~H~dlk~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Di  234 (282)
                      +   +++||||||+||+++.++.++++|||.++....       ...........+|+.|+|||++.+..+   +.++||
T Consensus       164 ~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DI  230 (311)
T d1t46a_         164 K---NCIHRDLAARNILLTHGRITKICDFGLARDIKN-------DSNYVVKGNARLPVKWMAPESIFNCVY---TFESDV  230 (311)
T ss_dssp             T---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTS-------CTTSEECSSSEECGGGCCHHHHHHCCC---CHHHHH
T ss_pred             C---CeeecccccccccccccCcccccccchheeccC-------CCcceEeeecccChHHcCHHHhcCCCC---CCcccc
Confidence            9   889999999999999999999999997653210       001111223467899999999987766   889999


Q ss_pred             hhHHHHHHHHHh-CCCCCCcc
Q psy16951        235 WSLGCLLYAMCY-FKSPFDTV  254 (282)
Q Consensus       235 ws~G~il~el~t-g~~pf~~~  254 (282)
                      ||||+++|||+| |.+||.+.
T Consensus       231 wS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         231 WSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTC
T ss_pred             cchHHHHHHHHhCCCCCCCCC
Confidence            999999999999 56666553

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=301.24  Aligned_cols=237  Identities=19%  Similarity=0.307  Sum_probs=184.0

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecC-----CCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQ-----TKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDH   91 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~   91 (282)
                      .+.|.|+.++|++.++||+|+||+||+|.+..     ++..||||++.... ......+.+|++++++++||||+++++.
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            35678999999999999999999999999853     35689999986443 3444578899999999999999999995


Q ss_pred             ccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCC
Q psy16951         92 ALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSV------GKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDL  165 (282)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dl  165 (282)
                      +..         ....++||||+++|+|.+++.....      ....++...+..++.|++.||.|||++   +|+||||
T Consensus        92 ~~~---------~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDl  159 (308)
T d1p4oa_          92 VSQ---------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDL  159 (308)
T ss_dssp             ECS---------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCC
T ss_pred             Eec---------CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceE
Confidence            543         4679999999999999998764321      113467888999999999999999999   7899999


Q ss_pred             CCCcEEeecCCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHH
Q psy16951        166 KTANVLLANDNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMC  245 (282)
Q Consensus       166 k~~nil~~~~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~  245 (282)
                      ||+|||++.++++||+|||++....       ............+|+.|+|||.+.+..+   +.++||||||+++|||+
T Consensus       160 k~~NiLld~~~~~Kl~DFGla~~~~-------~~~~~~~~~~~~~t~~y~aPe~l~~~~~---~~~~Dv~S~G~il~El~  229 (308)
T d1p4oa_         160 AARNCMVAEDFTVKIGDFGMTRDIY-------ETDYYRKGGKGLLPVRWMSPESLKDGVF---TTYSDVWSFGVVLWEIA  229 (308)
T ss_dssp             SGGGEEECTTCCEEECCTTCCCGGG-------GGGCEEGGGSSEECGGGCCHHHHHHCCC---CHHHHHHHHHHHHHHHH
T ss_pred             cCCceeecCCceEEEeecccceecc-------CCcceeeccceecccccCCHHHHccCCC---CcccccccHHHHHHHHH
Confidence            9999999999999999999875321       1111112233457899999999988776   78999999999999999


Q ss_pred             hCC-CCCCccccCccceeeeeee-ccccCCCCCCC
Q psy16951        246 YFK-SPFDTVYERGDSVALAVIS-GNITFPENTPF  278 (282)
Q Consensus       246 tg~-~pf~~~~~~~~~~~~~~~~-~~~~~p~~~~~  278 (282)
                      ||. +||.+...  ......+.. ..+..|+.+|+
T Consensus       230 t~~~~p~~~~~~--~~~~~~i~~~~~~~~p~~~~~  262 (308)
T d1p4oa_         230 TLAEQPYQGLSN--EQVLRFVMEGGLLDKPDNCPD  262 (308)
T ss_dssp             HTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred             hCCCCCCCCCCH--HHHHHHHHhCCCCCCcccchH
Confidence            985 78865322  222222223 34566666553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=302.26  Aligned_cols=208  Identities=23%  Similarity=0.350  Sum_probs=170.3

Q ss_pred             EecccEEEEEEeccCCceEEEEEEe---cCCCceEEEEEeccC----CchhHHHHHHHHHHhhhCCC-CCcccccccccc
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEH---SQTKKRYALKKIICH----GREDQAQAIREVEHHKTFVH-PNILPLLDHALT   94 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~i~~~----~~~~~~~~~~e~~~l~~l~H-~ni~~~~~~~~~   94 (282)
                      +..++|+++++||+|+||+||+|++   ..+|..||||.+...    .....+.+.+|++++++++| |||+++++.   
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~---   97 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA---   97 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE---
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee---
Confidence            4568999999999999999999987   457899999988533    22334567789999999976 899999884   


Q ss_pred             cCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec
Q psy16951         95 GCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN  174 (282)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~  174 (282)
                            +.+....++++||+.+++|.+.+...    ..+++..+..++.|++.||.|+|++   +++||||||+||+++.
T Consensus        98 ------~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~  164 (322)
T d1vzoa_          98 ------FQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS  164 (322)
T ss_dssp             ------EEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             ------eccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence                  44457899999999999999988643    4578899999999999999999999   8999999999999999


Q ss_pred             CCCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        175 DNNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       175 ~~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.++++|||++....        ...........|++.|++||.+.+..+ .++.++||||+||++|||++|+.||.+.
T Consensus       165 ~~~vkL~DFG~a~~~~--------~~~~~~~~~~~g~~~~~~pe~~~~~~~-~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         165 NGHVVLTDFGLSKEFV--------ADETERAYDFCGTIEYMAPDIVRGGDS-GHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             TSCEEESCSSEEEECC--------GGGGGGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCCEEEeeccchhhhc--------ccccccccccccccccchhHHhhcCCc-CCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999765321        112222344568899999999976543 2377999999999999999999999764


Q ss_pred             c
Q psy16951        255 Y  255 (282)
Q Consensus       255 ~  255 (282)
                      .
T Consensus       236 ~  236 (322)
T d1vzoa_         236 G  236 (322)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=295.56  Aligned_cols=227  Identities=25%  Similarity=0.343  Sum_probs=172.0

Q ss_pred             EEEEeccCCceEEEEEEecCC---CceEEEEEecc-CCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         30 IVEKIGEGGFSTVSLIEHSQT---KKRYALKKIIC-HGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        30 ~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~i~~-~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      +.++||+|+||+||+|.+..+   ...||||++.. .+....+.+.+|++++++++||||+++++++..        .+.
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--------~~~  102 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR--------SEG  102 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE--------TTT
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe--------cCC
Confidence            367899999999999998654   34689999864 445566789999999999999999999997554        245


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecccC
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDLGS  185 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df~~  185 (282)
                      ..++|||||++++|.+++..   ....++...++.++.|++.||.|+|++   +|+||||||+|||++.++.+|++|||+
T Consensus       103 ~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         103 SPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             EEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             ceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccc
Confidence            79999999999999987753   234467788899999999999999999   899999999999999999999999998


Q ss_pred             ccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccccCccceeeee
Q psy16951        186 VAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVYERGDSVALAV  265 (282)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~~~~~~~~~~~  265 (282)
                      +.......     ...........||..|+|||++....+   +.++||||||+++|||+||..||.......+......
T Consensus       177 ~~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~  248 (311)
T d1r0pa_         177 ARDMYDKE-----FDSVHNKTGAKLPVKWMALESLQTQKF---TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL  248 (311)
T ss_dssp             GCCTTTTT-----CCCTTCTTCSSCCGGGSCHHHHHHCCC---CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH
T ss_pred             hhhccccc-----cccceecccccccccccChHHHhcCCC---CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            75432111     111112233467889999999987766   8899999999999999998877765333222222222


Q ss_pred             eeccccCCCCCCC
Q psy16951        266 ISGNITFPENTPF  278 (282)
Q Consensus       266 ~~~~~~~p~~~~~  278 (282)
                      .+.++..|+.+|.
T Consensus       249 ~g~~~~~p~~~~~  261 (311)
T d1r0pa_         249 QGRRLLQPEYCPD  261 (311)
T ss_dssp             TTCCCCCCTTCCH
T ss_pred             cCCCCCCcccCcH
Confidence            3335566665543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=298.32  Aligned_cols=209  Identities=25%  Similarity=0.331  Sum_probs=165.5

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC-chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG-REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      .++|++++.||+|+||+||+|.+..+|..||||++.... ......+.+|++++++++||||+++++.+...    ....
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~----~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP----TIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS----STTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec----cccc
Confidence            367999999999999999999999999999999996543 33456788999999999999999999876543    2222


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ...++++ +++.+++|.+.+..     ..+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|++||
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cceEEEE-EeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEccc
Confidence            3345555 45669999998853     3589999999999999999999999   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |++......      ...........||+.|+|||++.....  ++.++||||+||++|||++|+.||.+.
T Consensus       154 G~a~~~~~~------~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         154 GLARVADPD------HDHTGFLTEYVATRWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             TTCEECCGG------GCBCCTTCCCCSCGGGCCGGGTTTBCS--CSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CceeeccCC------CccceeeccccccceechHHHhhcCCC--CCchhhhhccCceehHHhhCCCCCCCC
Confidence            987532111      111111234567889999999865432  378999999999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=299.01  Aligned_cols=200  Identities=24%  Similarity=0.319  Sum_probs=163.6

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc------hhHHHHHHHHHHhhhCC--CCCcccccccccccC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR------EDQAQAIREVEHHKTFV--HPNILPLLDHALTGC   96 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~e~~~l~~l~--H~ni~~~~~~~~~~~   96 (282)
                      .++|++.+.||+|+||+||+|++..++..||||++.....      .....+.+|+.++++++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            4689999999999999999999999999999999853321      11233567999999886  89999999854    


Q ss_pred             CCCCCCCCceEEEEeccCCC-CChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         97 ADPVLNSTSQVLMVLPYYPK-GTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                           .+....++|||++.+ +++.+.+..    ...+++..+..++.|++.||.|||++   ||+||||||+||+++.+
T Consensus        79 -----~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~  146 (273)
T d1xwsa_          79 -----ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  146 (273)
T ss_dssp             -----ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             -----eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecC
Confidence                 445789999999975 566665543    24589999999999999999999999   89999999999999865


Q ss_pred             -CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        176 -NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       176 -~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                       +.+|++|||++.....           .......||+.|+|||++.+..+  .+.++||||+||++|||+||+.||.+
T Consensus       147 ~~~vkl~DFG~a~~~~~-----------~~~~~~~GT~~y~aPE~~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         147 RGELKLIDFGSGALLKD-----------TVYTDFDGTRVYSPPEWIRYHRY--HGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TTEEEECCCTTCEECCS-----------SCBCCCCSCGGGSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             CCeEEECccccceeccc-----------ccccccccCCCcCCHHHHcCCCC--CCcccccccceeeehhHhhCCCCCCC
Confidence             7899999998753210           11223568999999999987765  25679999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-43  Score=298.34  Aligned_cols=215  Identities=22%  Similarity=0.331  Sum_probs=166.3

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCc--hhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGR--EDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|+++++||+|+||+||+|++..+|..||||++.....  ....++.+|++++++++||||+++++.+..... ....
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~-~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS-PYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc-cccc
Confidence            5899999999999999999999999999999998854432  334577899999999999999999987754311 1233


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      .....+++||++.++.+....    .....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++|
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             cCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence            456799999999776654322    2345688999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||++.....     .............||+.|+|||++.+...  ++.++||||+||++|||++|+.||.+.
T Consensus       161 fg~~~~~~~-----~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~--~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         161 FGLARAFSL-----AKNSQPNRYTNRVVTLWYRPPELLLGERD--YGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             CTTCEECCC----------CCCCCSCCSCGGGCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceeeeccc-----ccccccccccceecCHHHhhHHHHcCCCC--CCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            998753211     11111112234568999999999986632  388999999999999999999999753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=298.15  Aligned_cols=205  Identities=23%  Similarity=0.359  Sum_probs=165.3

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccC--CchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICH--GREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVL  101 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~  101 (282)
                      ..++|+++++||+|+||+||+|.+..+|..||||++...  +......+.+|+++++.++||||+++++++....   ..
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~---~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE---TL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS---ST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc---cc
Confidence            378999999999999999999999999999999998643  2334567889999999999999999999776431   23


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceee
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLM  181 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~  181 (282)
                      .....+++||||+ +.+|.....     ...+++..++.++.||+.||.|||++   ||+||||||+|||++.++.++++
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             cccceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccc
Confidence            3445789999999 566665543     24599999999999999999999999   89999999999999999999999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      |||.+....            .......+|+.|+|||++.+..+  .+.++||||+||++|+|++|+.||.+.
T Consensus       164 Dfg~a~~~~------------~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         164 DFGLARQAD------------SEMTGYVVTRWYRAPEVILNWMR--YTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             CCTTCEECC------------SSCCSSCSCGGGCCTHHHHTTTC--CCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccceeccC------------CccccccccccccCHHHHcCCCC--CCccchhhcchHHHHHHHHCcCCCCCC
Confidence            999875321            11234567899999999987544  378999999999999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=300.44  Aligned_cols=206  Identities=25%  Similarity=0.321  Sum_probs=165.3

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      -+|+.+++||+|+||+||+|++..+++.||||++.....    ...+|++++++++||||+++++++....   ...+..
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~---~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG---EKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC-----CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecC---ccCCce
Confidence            379999999999999999999999999999999864332    2346999999999999999999776421   123456


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceeeccc
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLMDLG  184 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~df~  184 (282)
                      .+++||||++++ +.+.+.........+++.++..++.||+.||+|||++   ||+||||||+|||++.++ .+|++|||
T Consensus        93 ~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          93 YLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence            789999999755 4444444434556789999999999999999999998   899999999999999775 78999999


Q ss_pred             CccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        185 SVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ++.....          ........||..|+|||.+.+...  ++.++||||+||++|||++|+.||...
T Consensus       169 ~a~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         169 SAKQLVR----------GEPNVSYICSRYYRAPELIFGATD--YTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             TCEECCT----------TSCCCSCCSCTTSCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             chhhccC----------CcccccccccccccChHHhhcccC--CCcceeecccceEEEehhhCCCCCCCC
Confidence            7653210          111234568899999999876532  389999999999999999999999753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=293.59  Aligned_cols=204  Identities=23%  Similarity=0.332  Sum_probs=162.1

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      .++|+++++||+|+||+||+|++..+|..||||++....  ......+.+|+.+++.++||||+++++.+....   ..+
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~---~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK---TLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC---STT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc---ccc
Confidence            367999999999999999999999999999999986443  334456789999999999999999999776421   234


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeec
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMD  182 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~d  182 (282)
                      ....+|+||||+.++.+ +.+      ...+++..+..++.||+.||.|||++   ||+||||||+||+++.++.++++|
T Consensus        93 ~~~~~~iv~Ey~~~~l~-~~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLC-QVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             TCCEEEEEEECCSEEHH-HHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             cCceeEEEEeccchHHH-Hhh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeec
Confidence            56889999999965544 333      24589999999999999999999999   899999999999999999999999


Q ss_pred             ccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        183 LGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       183 f~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      ||.+...          ..........+|+.|+|||++.+..+   +.++||||+||++|+|++|+.||.+.
T Consensus       163 f~~~~~~----------~~~~~~~~~~~t~~y~aPE~l~~~~~---~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         163 FGLARTA----------GTSFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             CCC-------------------------CCTTCCHHHHTTCCC---CTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhhhcc----------ccccccccccccccccChhhhcCCCC---CCCcccccccchHHHHhhCCCCCCCC
Confidence            9975422          11222334467899999999988766   88999999999999999999999753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-42  Score=289.97  Aligned_cols=210  Identities=20%  Similarity=0.211  Sum_probs=160.1

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCc
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTS  105 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~  105 (282)
                      .+|.+.++||+|+||+||+|++  +|..||||++..... .......|+..+..++||||+++++++...     .....
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-----~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-----NGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-----CSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC-----CCcce
Confidence            5788999999999999999997  688999998864322 122223455566788999999999987753     22335


Q ss_pred             eEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCccccCCCCCcEEeecCCCcee
Q psy16951        106 QVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAK-----PIAYAHRDLKTANVLLANDNNPLL  180 (282)
Q Consensus       106 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-----~~~i~H~dlk~~nil~~~~~~~~~  180 (282)
                      ..++||||+++|+|.+.+..     ..+++.+++.++.|++.||.|+|+..     ..||+||||||+||+++.++.+||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            78999999999999998863     24788999999999999999999731     018999999999999999999999


Q ss_pred             ecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCccc---CCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        181 MDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYC---VVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       181 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~---~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      +|||++......     ............||+.|+|||++.+....   .++.++|||||||++|||+||..||..
T Consensus       150 ~DFGl~~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         150 ADLGLAVRHDSA-----TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CCCTTCEEEETT-----TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             EecCccccccCC-----CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            999987532111     01111122345689999999998764310   125689999999999999999988753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=287.98  Aligned_cols=201  Identities=23%  Similarity=0.348  Sum_probs=168.2

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNS  103 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~  103 (282)
                      ++|+++++||+|+||+||+|++..++..||||+++...  ......+.+|+.+++.++||||+++.+.+.         .
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---------~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH---------S   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE---------C
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc---------c
Confidence            68999999999999999999999999999999986443  334677889999999999999999998554         4


Q ss_pred             CceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCCCceeecc
Q psy16951        104 TSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDNNPLLMDL  183 (282)
Q Consensus       104 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~~~~df  183 (282)
                      ....+++++++.++++...+.    ....+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+|++||
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DF  145 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ccceeEEeeeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeec
Confidence            578999999998888876554    445688999999999999999999998   8999999999999999999999999


Q ss_pred             cCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        184 GSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |.+.....         .........++..|+|||.+.+..+  .+.++||||+||++|||++|..||..
T Consensus       146 G~a~~~~~---------~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         146 GLARAFGI---------PVRCYSAEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             TTCEECCS---------CCSCCCSCCSCGGGCCHHHHTTCSC--CCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             chhhcccC---------CCccceeeccccchhhhhHhccCCC--CCchhhccccchHHHHHhhCCCCCCC
Confidence            97653211         1111223345677999999887654  37899999999999999999988743

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-41  Score=286.88  Aligned_cols=210  Identities=18%  Similarity=0.172  Sum_probs=167.8

Q ss_pred             EecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC-CCcccccccccccCCCCCC
Q psy16951         23 VKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH-PNILPLLDHALTGCADPVL  101 (282)
Q Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H-~ni~~~~~~~~~~~~~~~~  101 (282)
                      +-.++|++.++||+|+||+||+|++..+|+.||||.+....  +...+.+|++.++.++| +|++.+++++.        
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--------   71 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--------   71 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--------
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--------
Confidence            34689999999999999999999999999999999875433  22345678888888865 88888887543        


Q ss_pred             CCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec-----CC
Q psy16951        102 NSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN-----DN  176 (282)
Q Consensus       102 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~-----~~  176 (282)
                       .....++|||++ +++|.+.+..   ....++...+..++.|++.||.|+|++   ||+||||||+||+++.     ++
T Consensus        72 -~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          72 -EGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             -ETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             -cCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence             347899999998 7899887753   234589999999999999999999999   8999999999999964     56


Q ss_pred             CceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        177 NPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       177 ~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      .++++|||+++........  ............||+.|+|||++.+..+   +.++||||+|+++|||+||+.||.+..
T Consensus       144 ~vkl~DFG~a~~~~~~~~~--~~~~~~~~~~~~GT~~y~aPE~~~~~~~---~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTK--QHIPYREKKNLSGTARYMSINTHLGREQ---SRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             CEEECCCTTCEESBCTTTC--CBCCCCCCCCCCSCTTTCCHHHHTTCCC---CHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ceEEcccceeEEcccCccc--cceeecccCceEEchhhcCHHHhcCCCC---ChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            7899999987643211100  0011112234568999999999998776   889999999999999999999997543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.9e-41  Score=289.56  Aligned_cols=198  Identities=24%  Similarity=0.356  Sum_probs=165.6

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCC
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLN  102 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~  102 (282)
                      ..++|+++++||+|+||+||+|++..++..||||++...   ....+.+|+++++.++ ||||+++++.+...       
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-------  102 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP-------  102 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-------
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec-------
Confidence            467899999999999999999999999999999998643   3456788999999995 99999999865432       


Q ss_pred             CCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecCC-Cceee
Q psy16951        103 STSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLANDN-NPLLM  181 (282)
Q Consensus       103 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~~~~  181 (282)
                      ....+++||||+.+++|....       ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++ .++++
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeec
Confidence            345699999999999987632       4589999999999999999999999   899999999999999766 48999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDT  253 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~  253 (282)
                      |||.+.....          ........+|+.|+|||.+.+...  ++.++||||+||++||+++|..||..
T Consensus       173 DFG~a~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         173 DWGLAEFYHP----------GQEYNVRVASRYFKGPELLVDYQM--YDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             CGGGCEECCT----------TCCCCSCCSCGGGCCHHHHTTCCC--CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccceeccC----------CCcccccccCccccCcccccCCCC--CCcccchhhhhhhhHHhccCCCCCCC
Confidence            9998653211          112234467889999999887542  38899999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=292.30  Aligned_cols=210  Identities=22%  Similarity=0.319  Sum_probs=167.6

Q ss_pred             cccEEEecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCC--chhHHHHHHHHHHhhhCCCCCccccccccccc
Q psy16951         18 KEAVYVKSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHG--REDQAQAIREVEHHKTFVHPNILPLLDHALTG   95 (282)
Q Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~   95 (282)
                      ...|.+ .++|+++++||+|+||+||+|++..+|..||||++....  ......+.+|+++++.++||||+++++.+...
T Consensus        11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            444555 478999999999999999999999999999999986443  33455778999999999999999999876542


Q ss_pred             CCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeecC
Q psy16951         96 CADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAND  175 (282)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~~  175 (282)
                      .   ..++ ...+++++++.+++|.+.+.     ...+++..+..++.||+.||.|||++   ||+||||||+||+++.+
T Consensus        90 ~---~~~~-~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~  157 (348)
T d2gfsa1          90 R---SLEE-FNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  157 (348)
T ss_dssp             S---STTT-CCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             c---cccc-CceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccc
Confidence            1   1222 33455566777999998773     34699999999999999999999999   89999999999999999


Q ss_pred             CCceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCcc
Q psy16951        176 NNPLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTV  254 (282)
Q Consensus       176 ~~~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~  254 (282)
                      +.++++|||.+....            .......||+.|+|||++.+..+  .+.++||||+||++|+|++|+.||.+.
T Consensus       158 ~~~kl~dfg~a~~~~------------~~~~~~~g~~~y~apE~~~~~~~--~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         158 CELKILDFGLARHTD------------DEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             CCEEECCC----CCT------------GGGSSSCHHHHTSCHHHHTTCSC--CCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccchhcccC------------cccccccccccccCchhhcCCcc--CCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            999999999754221            12233456778999999877654  378999999999999999999999753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-41  Score=286.21  Aligned_cols=209  Identities=17%  Similarity=0.191  Sum_probs=163.8

Q ss_pred             cccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCC
Q psy16951         25 SDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      .++|+++++||+|+||+||+|++..++..||||.+.....  ..++.+|+++++.++|+|++..+..+..        ..
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~--------~~   75 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA--------EG   75 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE--------ET
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe--------cC
Confidence            3579999999999999999999999999999998765432  2346789999999988877666543332        35


Q ss_pred             ceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEeec---CCCceee
Q psy16951        105 SQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLLAN---DNNPLLM  181 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~~~~  181 (282)
                      ...++|||++ ++++...+..   ....+++..+..++.|++.||+|||++   ||+||||||+||++..   +..++++
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             CEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeee
Confidence            6789999998 6666665543   345689999999999999999999999   8999999999998753   4578999


Q ss_pred             cccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHhCCCCCCccc
Q psy16951        182 DLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCYFKSPFDTVY  255 (282)
Q Consensus       182 df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~tg~~pf~~~~  255 (282)
                      |||+++........  ............||+.|+|||++.+..+   +.++|||||||++|||+||+.||....
T Consensus       149 DFG~a~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         149 DFGLAKKYRDARTH--QHIPYRENKNLTGTARYASINTHLGIEQ---SRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             CCSSCEECBCTTTC--CBCCCCBCCSCCCCSSSCCHHHHTTBCC---CHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccCcceeccccccc--cceeccccCCcCCCccccCHHHHhCCCC---CChhhEEecCHHHHHHHhCCCcccccc
Confidence            99987643211000  0001112234568999999999998776   889999999999999999999997643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-35  Score=256.94  Aligned_cols=204  Identities=22%  Similarity=0.291  Sum_probs=155.8

Q ss_pred             ecccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCC-----------CCcccccccc
Q psy16951         24 KSDKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVH-----------PNILPLLDHA   92 (282)
Q Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H-----------~ni~~~~~~~   92 (282)
                      ..++|+++++||+|+||+||+|++..+|..||||++.... .....+.+|+.+++.++|           +||+++++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            3467999999999999999999999999999999986432 334566788888877754           6677777654


Q ss_pred             cccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCcEEe
Q psy16951         93 LTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTANVLL  172 (282)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~nil~  172 (282)
                      ..       ......+++++++..+........ ......+++..+..++.|++.||.|||+..  ||+||||||+||++
T Consensus        90 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll  159 (362)
T d1q8ya_          90 NH-------KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLM  159 (362)
T ss_dssp             EE-------EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEE
T ss_pred             ee-------ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeee
Confidence            32       123456666666654443333222 234456889999999999999999999843  89999999999999


Q ss_pred             ecCCC------ceeecccCccchhhhccCchhhhhhHhhhhccCCCCccCCcccccCcccCCCCccchhhHHHHHHHHHh
Q psy16951        173 ANDNN------PLLMDLGSVAPAVVKVCGSAEAQNLQDVAAERCSMPYRAPELFHVDSYCVVDQRTDVWSLGCLLYAMCY  246 (282)
Q Consensus       173 ~~~~~------~~~~df~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~~PE~~~~~~~~~~~~~~Diws~G~il~el~t  246 (282)
                      +.++.      ++++|||.+....            .......||+.|+|||++.+..+   +.++|+||+||++++|++
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~------------~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~~  224 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYD------------EHYTNSIQTREYRSPEVLLGAPW---GCGADIWSTACLIFELIT  224 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETT------------BCCCSCCSCGGGCCHHHHHTCCC---CTHHHHHHHHHHHHHHHH
T ss_pred             eccCcccccceeeEeecccccccc------------cccccccccccccChhhccccCC---CccccccchHHHHHHHHH
Confidence            87654      7899999764221            11234567889999999998776   889999999999999999


Q ss_pred             CCCCCCc
Q psy16951        247 FKSPFDT  253 (282)
Q Consensus       247 g~~pf~~  253 (282)
                      |+.||..
T Consensus       225 g~~pF~~  231 (362)
T d1q8ya_         225 GDFLFEP  231 (362)
T ss_dssp             SSCCC--
T ss_pred             CCCCCCC
Confidence            9999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.1e-23  Score=166.14  Aligned_cols=131  Identities=16%  Similarity=0.094  Sum_probs=101.2

Q ss_pred             EEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCch------------------hHHHHHHHHHHhhhCCCCCccccc
Q psy16951         28 YYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGRE------------------DQAQAIREVEHHKTFVHPNILPLL   89 (282)
Q Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------------------~~~~~~~e~~~l~~l~H~ni~~~~   89 (282)
                      +.+.++||+|+||+||+|.+ .+|.+||||.+......                  ......+|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            35789999999999999998 47899999976432110                  112345688889999999988776


Q ss_pred             ccccccCCCCCCCCCceEEEEeccCCCCChHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCccccCCCCCc
Q psy16951         90 DHALTGCADPVLNSTSQVLMVLPYYPKGTLANDLELRSVGKHYMSSVDILKMFLKICEAVKVFHDAKPIAYAHRDLKTAN  169 (282)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~~~~i~H~dlk~~n  169 (282)
                      +.             ...+++||++.+..+.+           ++...+..++.|++.++.|||++   |++||||||+|
T Consensus        81 ~~-------------~~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~N  133 (191)
T d1zara2          81 AW-------------EGNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  133 (191)
T ss_dssp             EE-------------ETTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             Ee-------------cCCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhh
Confidence            42             12368999998765532           45555678899999999999999   89999999999


Q ss_pred             EEeecCCCceeecccCcc
Q psy16951        170 VLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       170 il~~~~~~~~~~df~~~~  187 (282)
                      |+++. +.++++|||.+.
T Consensus       134 ILv~~-~~~~liDFG~a~  150 (191)
T d1zara2         134 VLVSE-EGIWIIDFPQSV  150 (191)
T ss_dssp             EEEET-TEEEECCCTTCE
T ss_pred             eeeeC-CCEEEEECCCcc
Confidence            99985 458899999765

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.99  E-value=1e-05  Score=64.63  Aligned_cols=85  Identities=11%  Similarity=-0.013  Sum_probs=51.9

Q ss_pred             ccEEEEEEeccCCceEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCcccccccccccCCCCCCCCC
Q psy16951         26 DKYYIVEKIGEGGFSTVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHALTGCADPVLNST  104 (282)
Q Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~~~~~~~~~~~~  104 (282)
                      ..|+.++..+-++.+.||+...  .+..+.+|..............+|...++.+. +--+.+++..         ....
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~---------~~~~   82 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF---------ERHD   82 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE---------EEET
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE---------EecC
Confidence            4667666655555678998864  55567788775443333444566777766653 2223344431         2234


Q ss_pred             ceEEEEeccCCCCChHH
Q psy16951        105 SQVLMVLPYYPKGTLAN  121 (282)
Q Consensus       105 ~~~~lv~e~~~~~sL~~  121 (282)
                      ...++||++.++.++..
T Consensus        83 ~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             TEEEEEEECCSSEEHHH
T ss_pred             CceEEEEEecccccccc
Confidence            67889999998877643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.09  E-value=0.0015  Score=55.01  Aligned_cols=78  Identities=15%  Similarity=0.148  Sum_probs=44.6

Q ss_pred             EEEeccCCceEEEEEEecCCCceEEEEEecc----CCc---hhHHHHHHHHHHhhhCC-C--CCcccccccccccCCCCC
Q psy16951         31 VEKIGEGGFSTVSLIEHSQTKKRYALKKIIC----HGR---EDQAQAIREVEHHKTFV-H--PNILPLLDHALTGCADPV  100 (282)
Q Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~i~~----~~~---~~~~~~~~e~~~l~~l~-H--~ni~~~~~~~~~~~~~~~  100 (282)
                      .+.||.|....||++....++..|++|.-..    .+.   ........|.+.++.+. +  ..+++++.+         
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~---------  101 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---------  101 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE---------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE---------
Confidence            5579999999999999877788899996532    111   11223345777776552 2  223333321         


Q ss_pred             CCCCceEEEEeccCCCCCh
Q psy16951        101 LNSTSQVLMVLPYYPKGTL  119 (282)
Q Consensus       101 ~~~~~~~~lv~e~~~~~sL  119 (282)
                        +....+++||++.+.++
T Consensus       102 --d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         102 --DTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             --ETTTTEEEECCCTTSEE
T ss_pred             --cCCCCEEEEeccCCccc
Confidence              12345689999876544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.28  E-value=0.014  Score=45.28  Aligned_cols=75  Identities=12%  Similarity=0.084  Sum_probs=43.6

Q ss_pred             EEeccCCc-eEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCC--cccccccccccCCCCCCCCCceEE
Q psy16951         32 EKIGEGGF-STVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPN--ILPLLDHALTGCADPVLNSTSQVL  108 (282)
Q Consensus        32 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~n--i~~~~~~~~~~~~~~~~~~~~~~~  108 (282)
                      +.+..|.. +.||+.... ++..+.+|.-....   ...+..|...++.+....  +.+++..         ..+....+
T Consensus        16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~---------~~~~~~~~   82 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDV---------VTEAGRDW   82 (255)
T ss_dssp             EECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEE---------EECSSCEE
T ss_pred             EEcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeee---------cccccceE
Confidence            34555554 678988763 45567788654332   223456777776664322  3344432         22345688


Q ss_pred             EEeccCCCCCh
Q psy16951        109 MVLPYYPKGTL  119 (282)
Q Consensus       109 lv~e~~~~~sL  119 (282)
                      ++|+++++.++
T Consensus        83 ~v~~~i~G~~~   93 (255)
T d1nd4a_          83 LLLGEVPGQDL   93 (255)
T ss_dssp             EEEECCSSEET
T ss_pred             EEEEeeecccc
Confidence            99999976554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.02  E-value=0.012  Score=47.88  Aligned_cols=74  Identities=16%  Similarity=0.198  Sum_probs=42.8

Q ss_pred             eEEEEEEecCCCceEEEEEeccCCchhHHHHHHHHHHhhhCCCCCcccccccccccCCCCCCCCCceEEEEeccCCCC
Q psy16951         40 STVSLIEHSQTKKRYALKKIICHGREDQAQAIREVEHHKTFVHPNILPLLDHALTGCADPVLNSTSQVLMVLPYYPKG  117 (282)
Q Consensus        40 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~H~ni~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  117 (282)
                      ..||++.. .+|.+|++|... .+....+++..|...+..|....+.........  ...........+.++++..|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~r-p~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~--g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYR-PERWTADQILEEHQFALQLVNDEVPVAAPVAFN--GQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEEC-TTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBT--TBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeC-CCCCCHHHHHHHHHHHHHHHhcCCCCCCceecC--CCeeeeeeeEEEEEEeecCCc
Confidence            67999987 467889999653 333445667778888777753333211111111  111233456677888887653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.96  E-value=0.02  Score=47.84  Aligned_cols=82  Identities=16%  Similarity=0.096  Sum_probs=48.3

Q ss_pred             EEecccEEEEEEeccCCceEEEEEEecC-------CCceEEEEEeccCCchhHHHHHHHHHHhhhCC-CCCccccccccc
Q psy16951         22 YVKSDKYYIVEKIGEGGFSTVSLIEHSQ-------TKKRYALKKIICHGREDQAQAIREVEHHKTFV-HPNILPLLDHAL   93 (282)
Q Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~e~~~l~~l~-H~ni~~~~~~~~   93 (282)
                      .++.+.+++ ++|+-|-...+|++....       ....|.++..- . ........+|..+++.+. +.-..++++.+-
T Consensus        39 ~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          39 TVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             HCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             CCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            455566764 679999999999998643       23456665443 2 222334457888887774 333345555321


Q ss_pred             ccCCCCCCCCCceEEEEeccCCCCCh
Q psy16951         94 TGCADPVLNSTSQVLMVLPYYPKGTL  119 (282)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~sL  119 (282)
                      .             .+|+||.++.++
T Consensus       116 ~-------------g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G-------------GRLEEYIPSRPL  128 (395)
T ss_dssp             T-------------EEEECCCCEEEC
T ss_pred             C-------------ceEEEEeccccC
Confidence            1             467788765433

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.76  E-value=0.59  Score=36.86  Aligned_cols=29  Identities=28%  Similarity=0.290  Sum_probs=25.5

Q ss_pred             CccccCCCCCcEEeecCCCceeecccCcc
Q psy16951        159 AYAHRDLKTANVLLANDNNPLLMDLGSVA  187 (282)
Q Consensus       159 ~i~H~dlk~~nil~~~~~~~~~~df~~~~  187 (282)
                      |++|+|+.++|++++.+...-+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            89999999999999987766799999654